-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 Hj1EGxS56yZ/1VsBC+oTkAv6/Ae6VWRuH2x7897oNY/ERl9x0/LYTGXw3XYGtCeV
 5OA5ILMW72Tgnd1f6tsf3Q==

<SEC-DOCUMENT>0001167379-10-000075.txt : 20100427
<SEC-HEADER>0001167379-10-000075.hdr.sgml : 20100427
<ACCEPTANCE-DATETIME>20100427143252
ACCESSION NUMBER:		0001167379-10-000075
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		7
CONFORMED PERIOD OF REPORT:	20100427
FILED AS OF DATE:		20100427
DATE AS OF CHANGE:		20100427

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ALCON INC
		CENTRAL INDEX KEY:			0001167379
		STANDARD INDUSTRIAL CLASSIFICATION:	OPHTHALMIC GOODS [3851]
		IRS NUMBER:				980205094
		STATE OF INCORPORATION:			V8
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-31269
		FILM NUMBER:		10772986

	BUSINESS ADDRESS:	
		STREET 1:		6201 SOUTH FREEWAY
		CITY:			FORT WORTH
		STATE:			TX
		ZIP:			76134
		BUSINESS PHONE:		8175686248

	MAIL ADDRESS:	
		STREET 1:		BOSCH 69 6331 HUNENBERG
		CITY:			SWITZERLAND
		STATE:			V8
		ZIP:			0000
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>acl6kq12010results.htm
<DESCRIPTION>Q1 RESULTS
<TEXT>
<html>
<head>
    <title>acl6kq12010results.htm</title>
<!-- Licensed to: Alcon-->
<!-- Document Created using EDGARizer 5.1.6.0 -->
<!-- Copyright 1995 - 2009 Thomson Reuters. All rights reserved. -->
</head>
<body bgcolor="#ffffff" style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">
<div><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">UNITED STATES</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">SECURITIES AND EXCHANGE COMMISSION</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Washington, D.C. 20549</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Form 6-K</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">For the month of <font style="DISPLAY: inline; FONT-WEIGHT: bold">April 2010</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Commission File Number 001-31269</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ALCON, INC.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(Translation of registrant's name into English)</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">B&#246;sch 69</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">P.O. Box 62</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">6331 H&#252;nenberg, Switzerland</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;41-41-785-8888</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(Address of principal executive office)</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Form 20-F</font></div>
</td>
<td valign="top" width="2%" style="BORDER-RIGHT: black 0.5pt solid; BORDER-TOP: black 0.5pt solid; BORDER-LEFT: black 0.5pt solid; BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: center">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">x</font></div>
</td>
<td align="left" valign="top" width="9%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Form 40-F</font></div>
</td>
<td valign="top" width="2%" style="BORDER-RIGHT: black 0.5pt solid; BORDER-TOP: black 0.5pt solid; BORDER-LEFT: black 0.5pt solid; BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b) (1): ____</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b) (7): ____</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.</font></div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="right" valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Yes</font></div>
</td>
<td valign="top" width="2%" style="BORDER-RIGHT: black 0.5pt solid; BORDER-TOP: black 0.5pt solid; BORDER-LEFT: black 0.5pt solid; BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="top" width="9%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">No</font></div>
</td>
<td valign="top" width="2%" style="BORDER-RIGHT: black 0.5pt solid; BORDER-TOP: black 0.5pt solid; BORDER-LEFT: black 0.5pt solid; BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: center">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">x</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- ______</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Incorporation by Reference</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">This Report of Foreign Private Issuer on Form 6-K shall be incorporated by reference into the Registration Statement on Form S-8 filed with the Securities and Exchange Commission on April 24, 2002, the Registration Statement on Form S-8 filed with the Securities and Exchange Commission on October 25, 2002 and amended on December 12, 2003 the Registration Statement on Form S-8 filed with the Securities and Exchange Commission on December 12, 2003, and the two Registration Statements on Form S-8 filed with the Securities and Exchange Commission on October 29, 2009.</font></div>

<div><br>
</div>

<div>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ALCON, INC.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">FINANCIAL INFORMATION FOR THE</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">THREE-MONTH PERIODS ENDED MARCH 31, 2010 AND 2009</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ITEM 1.</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED):</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 122px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>
</td>
<td width="860">
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 122px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>
</td>
<td width="860">
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS (UNAUDITED)</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 122px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>
</td>
<td width="860">
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 122px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>
</td>
<td width="860">
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ITEM 2.</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ITEM 3.</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK </font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ITEM 4.</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASERS </font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div><br>
</div>

<div>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ITEM 1.&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ALCON, INC. AND SUBSIDIARIES</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Condensed Consolidated Balance Sheets (Unaudited)</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(in millions, except share data)</font></div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">March 31,</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">December 31,</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Assets</font></div>
</td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Current assets:</font></div>
</td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Cash and cash equivalents</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,129</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,007</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Short term investments</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">542</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">479</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Trade receivables, net</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,456</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,346</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Inventories</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">612</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">626</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Deferred income tax assets</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">163</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">162</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%" style="PADDING-BOTTOM: 0.5pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Other current assets</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">226</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">213</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total current assets</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6,128</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5,833</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Long term investments</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">64</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">73</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Property, plant and equipment, net</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,291</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,304</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Intangible assets, net</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">524</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">255</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Goodwill</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">700</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">688</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Long term deferred income tax assets</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">363</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">391</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%" style="PADDING-BOTTOM: 0.5pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Other assets</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">143</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">142</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total assets</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">9,213</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8,686</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Liabilities and Shareholders' Equity</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Current liabilities:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Accounts payable</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">309</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">321</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Short term borrowings</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">667</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">607</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Current maturities of long term debt</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">54</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 0.5pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Other current liabilities</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">921</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,047</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 0.5pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total current liabilities</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,951</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,975</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Long term debt, net of current maturities</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">56</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Long term deferred income tax liabilities</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">73</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">59</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Other long term liabilities</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">723</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">691</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Contingencies</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Shareholders' equity:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Common shares, par value CHF 0.20 per share, 320,254,200</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">shares authorized; 304,184,709 shares issued and</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">300,232,045 shares outstanding at March 31, 2010;</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">304,016,290 shares issued and 299,550,733 shares</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">outstanding at December 31, 2009</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">42</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">42</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Additional paid-in capital</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,563</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,535</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Accumulated other comprehensive income</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">123</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">203</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Retained earnings</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5,104</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,533</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Treasury shares, at cost; 3,952,664 shares at March 31, 2010</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 0.5pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">and 4,465,557 shares at December 31, 2009</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(366 </font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(408 </font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 0.5pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total shareholders' equity</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6,466</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5,905</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total liabilities and shareholders' equity</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">9,213</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8,686</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" colspan="8" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">See accompanying notes to condensed consolidated financial statements.</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div><br>
</div>

<div>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ALCON, INC. AND SUBSIDIARIES</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Condensed Consolidated Statements of Earnings (Unaudited)</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(in millions, except share data)</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Three months ended March 31,</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Sales</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,721</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,493</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 0.5pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Cost of goods sold</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">392</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">354</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Gross profit</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,329</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,139</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Selling, general and administrative</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">492</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">472</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Research and development</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">169</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">146</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Amortization of intangibles</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">11</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 0.5pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Other operating expenses</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Operating income</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">653</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">514</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Other income (expense):</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font id="TAB1" style="MARGIN-LEFT: 18pt"></font>Loss from foreign currency, net</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(2 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(10 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font id="TAB1" style="MARGIN-LEFT: 18pt"></font>Interest income</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">11</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font id="TAB1" style="MARGIN-LEFT: 18pt"></font>Interest expense</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(3 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(5 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 0.5pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font id="TAB1" style="MARGIN-LEFT: 18pt"></font>Other, net</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">20</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Earnings before income taxes</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">676</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">514</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 0.5pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Income taxes</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">103</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">62</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Net earnings</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">573</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">452</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Basic earnings per common share</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.91</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.51</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Diluted earnings per common share</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.89</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1.51</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Basic weighted average common shares</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">299,980,871</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">298,581,689</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Diluted weighted average common shares</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">303,569,998</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">300,015,135</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" colspan="4" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">See accompanying notes to condensed consolidated financial statements.</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div><br>
</div>

<div>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">ALCON, INC. AND SUBSIDIARIES</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Condensed Consolidated Statements of Cash Flows (Unaudited)</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(in millions)</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Three months ended March 31,</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Cash provided by (used in) operating activities:</font></div>
</td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net earnings</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">573</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">452</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Adjustments to reconcile net earnings to cash provided from</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">operating activities:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Depreciation</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">51</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">44</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Amortization of intangibles</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">11</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Share-based payments</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">18</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">23</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Tax benefits (reversals) from share-based compensation</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(2 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Deferred income taxes</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">21</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">76</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Loss (gain) on sale of assets</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(15 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">36</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Unrealized appreciation on trading securities</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(4 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(40 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Other, net</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 36pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Changes in operating assets and liabilities, net of effects from business acquisition:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 54pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Trade receivables</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(139 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(117 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 54pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Inventories</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(9 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(43 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 54pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Other assets</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(15 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(36 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 54pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Accounts payable</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(7 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">19</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 54pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Other current liabilities</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(116 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(22 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 0.5pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 54pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Other long term liabilities</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">15</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">9</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 0.5pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 63pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net cash from operating activities</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">388</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">409</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Cash provided by (used in) investing activities:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Purchases of property, plant and equipment</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(69 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(52 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Acquisition of business, net of cash acquired</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(157 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Purchases of intangible assets</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(113 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Purchases of investments</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(569 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(246 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Proceeds from sales and maturities of investments</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">520</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">420</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 0.5pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Other, net</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 0.5pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 63pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net cash from investing activities</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(387 </font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">121</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Cash provided by (used in) financing activities:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net proceeds from short term debt</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">78</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">113</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Repayment of long term debt</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Acquisition of treasury shares</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(9 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(4 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Proceeds from exercise of stock options</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">45</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 0.5pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Tax benefits from share-based payment arrangements</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">13</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 0.5pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 63pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net cash from financing activities</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">127</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">114</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 0.5pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Effect of exchange rates on cash and cash equivalents</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(6 </font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(3 </font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net increase in cash and cash equivalents</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">122</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">641</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 0.5pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Cash and cash equivalents, beginning of period</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,007</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,449</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Cash and cash equivalents, end of period</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,129</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,090</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">See accompanying notes to condensed consolidated financial statements.</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div><br>
</div>

<div>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div>&#160;</div>

<div style="TEXT-ALIGN: center"><font style="FONT-WEIGHT: bold">ALCON, INC. AND SUBSIDIARIES</font></div>

<div style="TEXT-ALIGN: center"><font style="FONT-WEIGHT: bold">Notes to Condensed Consolidated Financial Statements (Unaudited)</font></div>

<div style="TEXT-ALIGN: center"><font style="FONT-WEIGHT: bold">(in millions, except share and per share data)</font></div>

<div><br>
&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(1)&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">Condensed Consolidated Financial Statemen</font>t<font style="DISPLAY: inline; FONT-WEIGHT: bold">s</font></font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Alcon, Inc. ("Alcon"), a Swiss corporation, is a majority owned subsidiary of Nestl&#233; S.A.&#160;&#160;During July 2008, Nestl&#233; sold approximately 74 million of its Alcon common shares to Novartis AG.&#160;&#160;At December 31, 2009, Nestl&#233; owned 156,076,263 common shares of Alcon.&#160;&#160;In January 2010, Novartis exercised its call option for Nestl&#233;'s remaining Alcon common shares and proposed a merger of Alcon with and into Novartis, as discussed in note 13.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The interim condensed consolidated financial statements of Alcon and its subsidiaries (collectively, the "Company") are unaudited.&#160;&#160;Amounts presented at December 31, 2009 are based on the audited consolidated financial statements appearing in Alcon's annual report on Form 20-F filed with the U.S. Securities and Exchange Commission.&#160;&#160;The interim condensed consolidated financial statements and notes thereto do not include all disclosures required by accounting principles generally accepted in the United States of America ("U.S. GAAP") and should be read in conjunction with the audited consolidated financial statements and the notes thereto included in Alcon's annual report on Form 20-F.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Management of the Company has made a number of estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities to prepare these financial statements in conformity with U.S. GAAP.&#160;&#160;Actual results could differ from those estimates.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In management's opinion, the interim condensed consolidated financial statements reflect all adjustments (consisting only of normal recurring accruals) necessary to present fairly the results for the interim periods presented.&#160;&#160;Results for interim periods are not necessarily indicative of results that ultimately will be achieved for a full year.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(2)&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Earnings Per Share</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Basic earnings per common share were computed by dividing net earnings by the weighted average number of common shares outstanding for the relevant period.&#160;&#160;The unvested portion of restricted common shares was excluded in the calculation of basic weighted average common shares outstanding.&#160;&#160;Diluted weighted average common shares reflect the potential dilution, using the treasury stock method, that could occur if employee stock options for the purchase of common shares and share-settled stock appreciation rights were exercised and if share-settled restricted share units, performance share units and contingent restricted common shares granted to employees were vested.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The following table reconciles the weighted average shares of the basic and diluted share computations:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td colspan="4" valign="bottom" width="20%" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Three months ended March 31,</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="10%" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div>
</td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="7%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Basic weighted average common shares outstanding</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">299,980,871</font></div>
</td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">298,581,689</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Effect of dilutive securities:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="7%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font id="TAB1" style="MARGIN-LEFT: 17.5pt"></font>Employee stock options</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,087,235</font></div>
</td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,261,409</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font id="TAB1" style="MARGIN-LEFT: 17.5pt"></font>Share-settled stock appreciation rights</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,126,119</font></div>
</td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font id="TAB1" style="MARGIN-LEFT: 17.5pt"></font>Share-settled restricted share units and performance share units</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">334,272</font></div>
</td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">45,349</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font id="TAB1" style="MARGIN-LEFT: 17.5pt"></font>Contingent restricted common shares</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="10%" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">41,501</font></div>
</td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">126,688</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="7%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Diluted weighted average common shares outstanding</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="10%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">303,569,998</font></div>
</td>
<td valign="bottom" width="2%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="7%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">300,015,135</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="7%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Certain executives of the Company had deferred the receipt of 119,188 and 141,954 Alcon common shares at March 31, 2010 and 2009, respectively, into the Alcon Executive Deferred Compensation Plan.&#160;&#160;Alcon common shares held in the plan were reflected as outstanding in the condensed consolidated balance sheets and were included in the applicable basic and diluted earnings per share calculations.</font></div>

<div><br>
</div>

<div>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The computations of diluted weighted average common shares outstanding for the periods ended March 31, 2010 and 2009 did not include the following instruments, as their exercise prices and unrecognized costs were greater than the average market price of the common shares:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="10%" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="1%" style="BORDER-BOTTOM: black 0.5pt solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="9%" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="top" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Stock options</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="top" width="9%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">728,392</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Share-settled stock appreciation rights</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="top" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,350</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="top" width="9%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5,514,471</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="top" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The effect of their inclusion would have been anti-dilutive.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(3)&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Cash Flows &#8211; Supplemental Disclosure</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Three months ended March 31,</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Supplemental Disclosure of Cash Flow Information</font></div>
</td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Cash paid during the period for the following:</font></div>
</td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Interest expense, net of amount capitalized</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Income taxes</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">23</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">62</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(4)&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Supplemental Balance Sheet Information</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">March 31,</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">December 31,</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Inventories, at Lower of Cost or Market</font></div>
</td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Finished products</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">376</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">375</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Work in process</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">51</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">50</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 0.5pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Raw materials</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">185</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">201</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font id="TAB1" style="MARGIN-LEFT: 38.15pt"></font>Total</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">612</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">626</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div><br>
</div>

<div>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">March 31,</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">December 31,</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Property, Plant and Equipment, Net</font></div>
</td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Property, plant and equipment, at cost</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,647</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,650</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Accumulated depreciation</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1,356 </font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1,346 </font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font id="TAB1" style="MARGIN-LEFT: 38.15pt"></font>Total</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,291</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,304</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">March 31,</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">December 31,</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Accumulated Other Comprehensive Income (Loss)</font></div>
</td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Foreign currency translation adjustment</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">197</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">265</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Unrealized gains (losses) on investments, net of income taxes</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">16</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">30</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Unrecognized postretirement benefits losses and prior service costs,</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 0.5pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">net of tax benefits</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(90 </font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(92 </font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font id="TAB1" style="MARGIN-LEFT: 38.15pt"></font>Total</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">123</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">203</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(5)&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Investments</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 14.4pt"></font>At March 31, 2010 and December 31, 2009, investments were:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="PADDING-BOTTOM: 0.5pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">March 31</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="PADDING-BOTTOM: 0.5pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">December 31,</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="PADDING-BOTTOM: 1px; BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;<font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></font></td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;<font style="FONT-WEIGHT: bold">2009</font></font></td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Short term investments:</font></div>
</td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Trading securities</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">22</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 0.5pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Available-for-sale investments</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">534</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">457</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total short term investments</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">542</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">479</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Long term investments&#8212;available-for-sale investments</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">64</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">73</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 14.4pt"></font>At March 31, 2010 and December 31, 2009, trading securities were:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">March 31, 2010</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">December 31, 2009</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Estimated</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Estimated</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Unrealized</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Fair</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Unrealized</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Fair</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Gains (Losses)</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Value</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Gains (Losses)</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Value</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total trading securities</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(5</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(9</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">22</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div><br>
</div>

<div>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">At March 31, 2010, available-for-sale investments were:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Gross</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Gross</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Estimated</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Amortized</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Unrealized</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Unrealized</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Fair</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="52%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Cost</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Gains</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Losses</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Value</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Short term investments:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">U.S. government and agency securities</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">128</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">128</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Mortgage-backed securities</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">12</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">12</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Senior secured bank loans fund</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">80</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">17</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">97</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Corporate debt securities</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">266</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">265</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Equity securities</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">30</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">31</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Other investments</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 0.5pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total short term investments</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">517</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">18</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1 </font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">534</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Long term investments:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">U.S. government and agency securities</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">58</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">57</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Mortgage-backed securities</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Equity securities</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 0.5pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total long term investments</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">65</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1 </font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">64</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total available-for-sale investments</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">582</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">18</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(2</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">598</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The senior secured bank loans fund is a professionally managed fund investing in loans made by banks to large corporate borrowers whose assets are pledged as collateral.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div><br>
</div>

<div>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">9</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">At December 31, 2009, available-for-sale investments were as follows:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Gross</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Gross</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Estimated</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Amortized</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Unrealized</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Unrealized</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Fair</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Cost</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Gains</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Losses</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Value</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Short term investments:</font></div>
</td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">U.S. government and agency securities</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">129</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">128</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Mortgage-backed securities fund</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">75</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">82</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Mortgage-backed securities</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Senior secured bank loans fund</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">131</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">23</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">154</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Corporate debt securities</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">43</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">43</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Equity securities</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">29</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">29</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 0.5pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Other investments</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">15</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">15</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 0.5pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total short term investments</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">428</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">30</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1 </font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">457</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Long term investments:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">U.S. government and agency securities</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">52</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">51</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Mortgage-backed securities</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Equity securities</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 0.5pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Other investments</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 0.5pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total long term investments</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">72</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1 </font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">73</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total available-for-sale investments</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">500</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">32</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(2</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">530</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The senior secured bank loans fund is a professionally managed fund investing in loans made by banks to large corporate borrowers whose assets are pledged as collateral.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The contractual maturities of available-for-sale investments at March 31, 2010 were:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Estimated</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Amortized</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Fair</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Cost</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Value</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Securities not due at a single maturity date*</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">81</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">98</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Other debt securities, maturing:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Within one year</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">128</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">128</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">After 1 year through 10 years</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">322</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">321</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">After 10 years through 15 years</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 0.5pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Beyond 15 years</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">19</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">18</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total debt securities recorded at market</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">550</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">565</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 0.5pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Equity and other investments</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">32</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">33</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total available-for-sale investments</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">582</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">598</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" colspan="8" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">*Mortgage-backed securities and a senior secured bank loans fund.</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div><br>
</div>

<div>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 18pt"></font>Activities related to available-for-sale investments were as shown below.&#160;&#160;The cost of securities was based on the specific identification method.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="6" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Three months ended</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">March 31,</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Proceeds from sales and principal repayments</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">506</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Gross realized gains on sales</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">19</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Gross realized losses on sales</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The net unrealized holding gains (losses) for available-for-sale investments included in accumulated other comprehensive income (loss) in shareholders' equity at March 31, 2010 and December 31, 2009 were $16 and $30, respectively.&#160;&#160;Net unrealized holding gains on trading securities included in earnings for the three months ended March 31, 2010 and 2009 were $4 and $40, respectively.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The changes in net unrealized gains (losses) on investments, net of taxes, included in accumulated other comprehensive income (loss) were:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Three months ended</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">March 31,</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Changes in unrealized holding gains arising during the period</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 0.5pt">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Reclassification adjustment for gains included in net income</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(19 </font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1 </font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Changes in net unrealized gains (losses) on investments, net of taxes</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(14</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 18pt"></font>As of March 31, 2010, gross unrealized losses and fair value of individual securities with unrealized losses greater than $1 that were not deemed to be other-than-temporarily impaired, summarized by investment category and length of time the individual securities had been in a continuous unrealized loss position, were:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="25%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td colspan="5" valign="bottom" width="17%" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Less than 12 months</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td colspan="5" valign="bottom" width="17%" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">12 months or greater</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td colspan="5" valign="bottom" width="18%" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="bottom" width="25%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="5%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Fair</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Unrealized</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="5%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Fair</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Unrealized</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="6%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Fair</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Unrealized</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="bottom" width="25%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Value</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="8%" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Losses</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="5%" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Value</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="8%" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Losses</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="6%" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Value</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="8%" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Losses</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="bottom" width="25%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="6%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="25%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Long term investments:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="5%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="6%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="25%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 7.35pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">U.S. government and agencies</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 7.35pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font id="TAB1" style="MARGIN-LEFT: 18.4pt"></font>securities</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td align="right" valign="bottom" width="5%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td align="right" valign="bottom" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td align="right" valign="bottom" width="5%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="1%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td align="right" valign="bottom" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="1%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td align="right" valign="bottom" width="6%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="1%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td align="right" valign="bottom" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 18pt"></font>As of December 31, 2009, there were no gross unrealized losses on available-for-sale investments greater than $1.</font></div>

<div><br>
</div>

<div>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">11</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Investment Income</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 18pt"></font>In the condensed consolidated statements of earnings, other, net, included gains (losses) on investments as follows:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Three months ended</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">March 31,</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Realized gains (losses) on sale of investments</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">15</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(36</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net unrealized gains on investments</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 0.5pt">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">classified as trading securities</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">40</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net gains on investments</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">19</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(6)&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Financial Instruments</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Foreign Currency Risk Management</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">A significant portion of the Company's cash flows is denominated in foreign currencies.&#160;&#160;Alcon relies on ongoing cash flows generated from foreign sources to support its long term commitments to U.S. dollar-based research and development.&#160;&#160;To the extent the dollar value of cash flows is diminished as a result of weakening local currencies relative to the dollar, the Company's ability to fund research and other dollar-based strategic initiatives at a consistent level may be impaired.&#160;&#160;The Company has established a foreign currency risk management program to protect against volatility of non-functional currency monetary assets and liabilities and changes in fair value caused by fluctuations in foreign exchange rates.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Company primarily utilizes forward exchange contracts in countries where they are available and economically beneficial to offset the impact of fluctuations in foreign exchange rates on monetary assets and their related cash flows.&#160;&#160;All outstanding foreign exchange forward contracts are entered into to protect the value of assets or liabilities denominated in currencies other than the entity's functional currency.&#160;&#160;To the extent hedged, the changes in fair value of the forward contracts offset the changes in the value of the assets or liabilities.&#160;&#160;The changes in value of the foreign exchange forward contracts and the assets/liabilities that are being protected are recorded in foreign exchange gains and losses within other income (expense).</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The fair values of forward exchange and option contracts are reported in other current assets and other current liabilities.&#160;&#160;At March 31, 2010, the fair value hedge derivative instruments have settlement dates in the second and third quarters of 2010 and cover a gross notional amount of $606.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Company believes that, at the balance sheet date, counterparty credit risk was not significant due to the credit quality of the counterparties to the derivatives, which were all large financial institutions primarily in Switzerland, and the short-term maturities of most derivatives.&#160;&#160;The credit exposure related to these financial instruments is represented by the fair value of contracts with a positive fair value at the reporting date.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div><br>
</div>

<div>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">12</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">For the three months ended March 31, 2010, the effects of foreign exchange derivative instruments were:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="19%" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Derivatives in Fair Value Hedging Relationships</font></div>
</td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="18%" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Location of Gain (Loss) Recognized in Earnings on Derivatives</font></div>
</td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="17%" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Amount of Gain (Loss) Recognized in Earnings on Derivatives</font></div>
</td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="17%" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Amount of Gain (Loss) on the Hedged Items</font></div>
</td>
</tr><tr>
<td valign="top" width="19%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="18%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="17%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="17%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="19%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Foreign exchange forward contracts</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="18%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Gain (loss) from foreign currency, net</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="17%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;17</font></div>
</td>
<td valign="top" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="17%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(19)</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Interest Rate Risk Management</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Company may use interest rate swaps on certain investing and borrowing transactions to manage its net exposure to interest rate changes and to reduce its overall cost of borrowing.&#160;&#160;The Company does not use leveraged swaps and does not leverage any of its investment activities that would put capital at risk.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">At March 31, 2010, in connection with a long term bank loan, the Company had an interest rate swap fair value hedge outstanding in the notional principal amount of $54 at the respective quarter-end exchange rate.&#160;&#160;The fair value of the interest rate swap agreement is reported in other current assets.&#160;&#160;This interest rate swap did not have a significant effect on results of operations in 2010 and 2009.&#160;&#160;The long term bank loan matures in January 2011.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Fair Value of Financial Instruments</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">At March 31, 2010 and December 31, 2009, the Company's financial instruments included cash and cash equivalents, investments, trade receivables, accounts payable, short term borrowings, long term debt and the estimated fair value of certain contingent payments.&#160;&#160;The estimated fair value of all of these financial instruments is as noted below.&#160;&#160;Due to the short term maturities of cash and cash equivalents, trade receivables, accounts payable and short term borrowings, the carrying amounts approximate fair values at the respective balance sheet dates.&#160;&#160;The fair values of long term debt were based on interest rates then currently available to the Company for issuance of debt with similar terms and remaining maturities.&#160;&#160;The fair values of investments and acquisition-related contingent payments were de
termined as discussed below.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="14" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">March 31, 2010</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">December 31, 2009</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Carrying</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Fair</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Carrying</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Fair</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Amounts</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Value</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Amounts</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Value</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Assets:</font></div>
</td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Short term trading and available-for-sale investments</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">542</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">542</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">479</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">479</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Long term available-for-sale investments</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">64</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">64</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">73</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">73</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Forward exchange contracts</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Interest rate swaps</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Liabilities:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Long term debt, excluding capital lease obligations</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">54</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">54</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">56</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">56</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Liability for acquisition-related contingent payments</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">88</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">88</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">71</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">71</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Forward exchange and option contracts</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div><br>
</div>

<div>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">13</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Financial instruments, such as equity and fixed income securities, other investments, financial liabilities and derivatives, were presented at fair value.&#160;&#160;Fair value is defined as the price at which an asset could be exchanged or a </font>liability could be transferred in an orderly transaction between knowledgeable and willing market participants within the principal or most advantageous market at the measurement date.&#160;&#160;Where available, fair value is based on or derived from observable market prices or parameters.&#160;&#160;Where observable prices or inputs are not available, pricing for similar financial assets or liabilities, dealer quotes or valuation models are applied.&#160;&#160;These valuation techniques involve some level of manage
ment estimation and judgment, the degree of which is dependent on the price transparency for the instruments or market and the instruments' complexity.</font></div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 18pt"></font>Financial assets and liabilities recorded at fair value in the condensed consolidated balance sheets were categorized based upon the level of judgment associated with the inputs used to measure their fair values.&#160;&#160;The categories, from lowest to highest based on the amount of subjectivity associated with the inputs to fair valuation of these assets and liabilities, are as follows:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Level 1 &#8211; Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The types of Company assets carried at Level 1 fair value are equities listed in active markets.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Level 2 &#8211; Inputs (other than quoted prices included in Level 1) are either directly or indirectly observable for the assets or liabilities through correlation with market data at the measurement date and for the duration of each instrument's anticipated life.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Company's assets generally included in this fair value category are various government agency securities, certain investment funds, mortgage backed securities, collateralized mortgage obligations, foreign exchange derivatives and interest rate derivatives.&#160;&#160;Foreign exchange derivatives and interest rate derivatives are valued using corroborated, observable market data.&#160;&#160;The Company's liabilities generally included in this fair value category consist of certain foreign exchange derivatives.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Level 3 &#8211; Inputs are unobservable inputs for the assets or liabilities.&#160;&#160;These inputs reflect management's best estimate of what market participants would use in pricing the assets or liabilities at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Generally, the Company's assets carried at fair value included in this category are various hedge fund investments.&#160;&#160;The Company's liabilities carried at fair value in this category are acquisition-related contingent payments.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Company's Level 3 financial investments are held in funds professionally managed by investment managers.&#160;&#160;The net asset values are furnished in statements received from fund custodians whose statements reflect valuations conducted according to their respective fund pricing policies and asset types.&#160;&#160;The complete details of the fund holdings of several of the Company's professionally managed funds may be unavailable at times, limiting the Company's ability to look through to the underlying assets at the date the financial statements are prepared.&#160;&#160;Because of these constraints, the Company classified these fund investments as Level 3.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As of March 31, 2010, the Company has recorded $88, as the fair value of its obligations to make contingent payments related to acquisitions. The fair value measurements were based on significant inputs not observable in the market and thus represent a level 3 measurement.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In connection with an acquisition in 2009, the Company is obligated to make acquisition-related contingent payments of up to $439 based upon the achievement of future research and development milestones that would be expected to create value for Alcon.&#160;&#160;At March 31, 2010, the fair value of these payments was estimated to be $71.&#160;&#160;Each milestone was assigned a probability based on its current status.&#160;&#160;The resultant probability-weighted cash</font></div>

<div><br>
</div>

<div>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">14</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">flows were then discounted using a discount rate of 6%, which the Company believes is appropriate and representative of a market participant assumption.&#160;&#160;The probabilities assigned to payment streams ranged from 5% to 39%.&#160;&#160;An increase or decrease of 10 percentage points in the probability assumptions would result in an adjustment to the estimated value of approximately $30.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In connection with an acquisition in 2010, the Company is obligated to make acquisition-related contingent payments of up to $145 upon achieving certain sales objectives through 2014.&#160;&#160;The fair value of these payments at the acquisition date was estimated to total $17 and was included as a cost of the acquisition.&#160;&#160;&#160;&#160;The fair value estimate was based on the Company&#8217;s estimates of the probability and timing of these sales projection streams.&#160;&#160;Each revenue projection assumption was assigned a probability and the resultant probability-weighted cash flows were then discounted using a discount rate of 6%, which the Company believes is appropriate and representative of a market participant assumption.&#160;&#160;Achieving the Company's most optimistic sales assumption would not increase the estimat
ed fair value more than $5.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The fair values of these contingent payments are reviewed each reporting period.&#160;&#160;Any changes in the estimated value not associated with the original purchase price valuation are recorded in the Company&#8217;s results of operations.&#160;&#160;No such changes were recognized in the current period.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Fair Value by Category</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 18pt"></font>Financial assets and financial liabilities measured at fair value on a recurring basis were categorized in the tables below based upon the lowest level of input that is significant to the fair value measurement.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="14" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Fair Value as of March 31, 2010</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: center">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Level 1</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: center">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Level 2</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: center">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Level 3</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: center">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Financial Assets</font></div>
</td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Trading securities - Hedge funds</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Available-for-sale securities:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font id="TAB1" style="MARGIN-LEFT: 17.25pt"></font>U.S. government and agency securities</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">185</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">185</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font id="TAB1" style="MARGIN-LEFT: 17.75pt"></font>Mortgage-backed securities</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">17</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">17</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font id="TAB1" style="MARGIN-LEFT: 17.75pt"></font>Senior secured bank loans fund</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">97</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">97</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font id="TAB1" style="MARGIN-LEFT: 17.75pt"></font>Corporate debt securities</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">265</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">265</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font id="TAB1" style="MARGIN-LEFT: 17.75pt"></font>Equity securities</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">33</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">33</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font id="TAB1" style="MARGIN-LEFT: 17.75pt"></font>Other investments</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Forward exchange contracts</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 0.5pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Interest rate swaps</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">33</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">571</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">612</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Financial Liabilities</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Liability for acquisition-related contingent payments</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">88</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">88</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 0.5pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Foreign exchange and option contracts</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">88</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">90</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Cash and cash equivalents of $3,129 were excluded from the table above.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div><br>
</div>

<div>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">15</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="14" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Fair Value as of December 31, 2009</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: center">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Level 1</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: center">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Level 2</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: center">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Level 3</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: center">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Financial Assets</font></div>
</td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Trading securities - Hedge funds</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">22</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">22</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Available-for-sale securities:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font id="TAB1" style="MARGIN-LEFT: 17.25pt"></font>U.S. government and agency securities</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">179</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">179</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font id="TAB1" style="MARGIN-LEFT: 17.75pt"></font>Mortgage-backed securities fund</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">82</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">82</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font id="TAB1" style="MARGIN-LEFT: 17.75pt"></font>Mortgage-backed securities</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">16</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">16</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font id="TAB1" style="MARGIN-LEFT: 17.75pt"></font>Senior secured bank loans fund</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">154</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">154</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font id="TAB1" style="MARGIN-LEFT: 17.75pt"></font>Corporate debt securities</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">43</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">43</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font id="TAB1" style="MARGIN-LEFT: 17.75pt"></font>Equity securities</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">31</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">31</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font id="TAB1" style="MARGIN-LEFT: 17.75pt"></font>Other investments</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">25</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">25</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Forward exchange contracts</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 0.5pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Interest rate swaps</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">31</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">506</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">22</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">559</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Financial Liabilities</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Liability for acquisition-related contingent payments</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">71</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">71</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 0.5pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Foreign exchange and option contracts</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">71</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">73</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Cash and cash equivalents of $3,007 were excluded from the table above.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Level 3 Gains and Losses</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">At March 31, 2010, trading securities were the only type of financial assets included in Level 3.&#160;&#160;The trading securities were professionally managed investment funds, which consisted of hedge funds of $8.&#160;&#160;The fair value of the investment funds classified as Level 3 could not be determined by independent market observation or through the use of other observable valuation techniques. The valuation was based on the net asset values as furnished by the funds' custodians.&#160;&#160;If more than an insignificant proportion of a particular fund's assets were Level 3, the entire fund was classified as Level 3, although many of such fund's individual holdings may meet the definition of Level 1 or Level 2.&#160;&#160;The only liabilities included in Level 3 were the acquisition-related contingency payments, discussed earlier
 in this note.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Total gains or losses (realized and unrealized) for financial assets and liabilities classified as Level 3 that were included in earnings were a component of other, net, in the condensed consolidated statements of earnings.&#160;&#160;For the three months ended March 31, 2010, net gains (realized and unrealized) from trading securities were not significant, and the Company received proceeds from sales of Level 3 trading securities of $14.&#160;&#160;Realized and unrealized net gains during the period were approximately 1% of the beginning balance for Level 3 trading securities and did not negatively affect or materially impact operations, liquidity or capital resources.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The table presented below summarizes the change in carrying values associated with Level 3 financial instruments during the three months ended March 31, 2010.</font></div>

<div><br>
</div>

<div>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">16</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Assets</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Liabilities</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td rowspan="2" valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" rowspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Trading Securities - Hedge</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;Funds</font></div>
</td>
<td nowrap rowspan="2" valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td rowspan="2" valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" rowspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Acquisition Related Contingent Payments</font></div>
</td>
<td nowrap rowspan="2" valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Beginning balance</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">22</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">71</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total gains or losses (realized/unrealized)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Included in earnings before income taxes</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Included in other comprehensive income</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Acquisition-related activities</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">17</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Proceeds on sales and maturities</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(14 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Ending balance</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">88</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Gains and losses (realized and unrealized) on Level 3 financial instruments included in earnings for the three months ended March 31, 2010 were not significant.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">At March 31, 2009, trading securities were the only type of financial assets included in Level 3.&#160;&#160;Total gains or losses (realized and unrealized) for financial assets and liabilities classified as Level 3 that were included in earnings were a component of other, net, in the condensed consolidated statements of earnings.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The table presented below summarizes the change in carrying values associated with Level 3 financial instruments during the three months ended March 31, 2009.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Assets</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Trading</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Securities</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="88%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Beginning balance</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">261</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="88%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total gains or losses (realized/unrealized)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="88%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Included in earnings</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="88%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Included in other comprehensive income</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="88%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="88%" style="PADDING-BOTTOM: 0.5pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Proceeds on sales and maturities</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(155 </font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr>
<td valign="bottom" width="88%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="88%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Ending balance</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">108</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="88%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Gains and losses (realized and unrealized) on Level 3 financial instruments included in earnings for the three months ended March 31, 2009 were reported in other, net, as follows:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td align="left" valign="bottom" width="88%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total gains or losses included in earnings for the period</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="88%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="88%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Change in unrealized gains (losses) related to assets still held at reporting date</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="88%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div><br>
</div>

<div>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">17</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Valuation Techniques</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 18pt"></font>Valuation techniques used for financial assets and liabilities accounted for at fair value are generally categorized into three types:&#160;&#160;market approach, income approach and cost approach.&#160;&#160;The Company valued its Level 3 financial assets and liabilities at March 31, 2010 and 2009 primarily using the market approach and, to a lesser extent, the income approach.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 18pt"></font><font style="DISPLAY: inline; FONT-STYLE: italic">Market Approach</font>.&#160;&#160;The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities.&#160;&#160;Valuation techniques consistent with the market approach include comparables.&#160;&#160;A majority of the Company's balances measured at fair value on a recurring basis were valued using the market approach.&#160;&#160;Most measurements were market quotes or obtained from other reliable market sources.&#160;&#160;The Company did not use market indices for valuing material balances measured at fair value.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 18pt"></font><font style="DISPLAY: inline; FONT-STYLE: italic">Income Approach</font>.&#160;&#160;Income approach valuation techniques convert future amounts, such as cash flows or earnings, to a single present or discounted amount.&#160;&#160;The measurement is based on the value indicated by current market expectations about those future amounts.&#160;&#160;Examples of income approach valuation techniques include present value techniques, option-pricing models, and binomial or lattice models that incorporate present value techniques and option-pricing models.&#160;&#160;The Company valued certain derivatives, in part or whole, and acquisition-related contingent payments using the income approach.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 18pt"></font><font style="DISPLAY: inline; FONT-STYLE: italic">Cost Approach</font>.&#160;&#160;The cost approach is based on the amount that currently would be required to replace the service capacity of an asset.&#160;&#160;The Company did not employ the cost approach for determining fair value of financial assets and liabilities.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 18pt"></font>The valuation approaches are consistent with generally accepted valuation methodologies.&#160;&#160;While all three approaches are not applicable to all assets or liabilities accounted for at fair value, where appropriate and possible, one or more valuation techniques may be used.&#160;&#160;Professionally managed investment funds may use a combination of market, income and cost approaches.&#160;&#160;The process of selecting which valuation method(s) to apply considers the definition of an exit price and the nature of the asset or liability being valued and significant expertise and judgment is required.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Other-Than-Temporary Impairment of Available-for-Sale Investments</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Company reviews quarterly its available-for-sale investments to identify impaired equity and debt securities. An individual security is impaired if the fair value of the investment is less than its amortized cost basis.&#160;&#160;Impairment may be either temporary or other-than-temporary.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Company normally reviews securities held in its portfolio that have been in a continuous loss position for twelve months or longer and securities whose fair value is significantly lower than its amortized cost basis.&#160;&#160;Impairment is evaluated using a combination of quantitative and qualitative factors such as considering the length of time and extent to which the fair value has been below cost, the financial condition and near-term prospects of the issuer, as well as the Company's ability and intent to hold the investments for an adequate period of time until an anticipated market price recovery or maturity.&#160;&#160;If impairment is determined to be other-than-temporary, the investment is written down to fair value, and a loss is recognized immediately through earnings.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div><br>
</div>

<div>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">18</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(7)&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Intangible Assets and Goodwill</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: center">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">March 31, 2010</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="6" valign="bottom" style="PADDING-BOTTOM: 1px; BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">December 31, 2009</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Gross</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Gross</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Carrying</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Accumulated</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Carrying</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Accumulated</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Amount</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Amortization</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Amount</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Amortization</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Intangible Assets</font></div>
</td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Subject to amortization:</font></div>
</td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Licensed technology</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">444</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(297</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">332</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(296</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Patents</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">278</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(29 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">111</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(24 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 0.5pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Other</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">120</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(96 </font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">121</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(93 </font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr>
<td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total subject to amortization</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">842</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(422 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">564</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(413 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr>
<td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Not subject to amortization:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 0.5pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Purchased in process research and </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">development assets</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">104</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">104</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total intangible assets</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">946</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(422</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">668</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(413</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">During the three months ended March 31, 2010, the Company added patents and licensed technology through a business acquisition and an asset purchase.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Minor changes in the carrying amount of goodwill for the three months ended March 31, 2010 were as follows:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">United States</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">International</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="64%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Segment</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Segment</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="64%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Goodwill</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="64%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Balance, December 31, 2009</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">423</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">265</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">688</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="64%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Acquisition of business</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">16</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">21</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Impact of changes in foreign exchange rates</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(5 </font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(4 </font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(9 </font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr>
<td valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Balance, March 31, 2010</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">434</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">266</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">700</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div align="left">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(8)&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Short Term Borrowings and Long Term Debt</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">March 31,</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">December 31,</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Short Term Borrowings</font></div>
</td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Lines of credit</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">263</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">273</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Commercial paper</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">361</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">286</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">From affiliates</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 0.5pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Bank overdrafts</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">37</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">41</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total short term borrowings</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">667</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">607</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div><br>
</div>

<div>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">19</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">At March 31, 2010, the Company had unsecured credit and commercial paper facilities totaling $2,748, including bank overdraft agreements, with third parties that were denominated in various currencies.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As of March 31, 2010, total borrowings from Nestl&#233; and its subsidiaries were $6 under unsecured revolving credit facilities of $75.&#160;&#160;In the event of a change of control, these agreements would no longer be available for additional borrowings, and any outstanding balances would become payable in accordance with the related terms.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">March 31,</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="left" colspan="2" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">December 31,</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Long Term Debt</font></div>
</td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Bank loan</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">54</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">56</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 0.5pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Less current maturities of long term debt</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">54</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Long term debt, net of current maturities</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">56</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 18pt"></font>The bank loan, guaranteed by Nestl&#233;, contains provisions that may accelerate the obligation in the event that Nestl&#233;'s ownership of Alcon falls below 51%.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(9)&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Income Taxes</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 18pt"></font>The Company or one of its subsidiaries files income tax returns in Switzerland, the U.S. federal jurisdiction, and various state and other foreign jurisdictions.&#160;&#160;With few exceptions, the Company is no longer subject to Swiss, U.S. federal, state and local, or non-U.S. income tax examinations by tax authorities for years before 2003.&#160;&#160;In June 2009, the Internal Revenue Service ("IRS") commenced an examination of the Company's U.S. income tax returns for 2006 and 2007 that is anticipated to be completed substantially by the end of 2010.&#160;&#160;In May 2009, the IRS and the Company entered the Compliance Assurance Process (&#8243;CAP&#8243;) program for 2009.&#160;&#160;In January 2010, the IRS and the Company extended the CAP program to 2010.&#160;&#160;The Company als
o currently is subject to income tax examinations by various state, local and other foreign tax authorities.&#160;&#160;In addition, in June 2009, the Company and the IRS signed an advance pricing agreement ("APA") contract memorializing the mutual agreement letter between Switzerland and the United States for years through 2014 that covers all material intercompany transactions involving the Company and its subsidiaries in these two jurisdictions.&#160;&#160;Finally, during the fourth quarter of 2007, the Company submitted a similar request for a bilateral APA between Japanese and Swiss tax authorities that would cover the tax years 2008 through 2012.&#160;&#160;The Company expects that the Japanese-Swiss APA will be concluded in 2010.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 18pt"></font>The Company believes that it takes reasonable positions on its tax returns filed throughout the world; however, tax laws are complex and susceptible to differing interpretations.&#160;&#160;Tax authorities throughout the world, from time to time, routinely challenge positions taken by the Company, particularly in the case of transfer pricing issues.&#160;&#160;The Company has identified its uncertain tax positions and prepared its reserve for contingent tax liabilities to reflect the associated unrecognized tax benefits (the "Tax Reserves") in accordance with Financial Accounting Standards Board ("FASB") guidance which, among other things, requires that the Company assume that it will be subject to examination in every jurisdiction in which it is subject to tax.&#160;&#160;Management believ
es that the Tax Reserves are fairly stated but believes it is reasonably possible that the total amount of unrecognized tax benefits related to transfer pricing, currency translations and other tax positions reflected in the Tax Reserves will significantly increase or decrease within 12 months of the reporting of this financial statement as the result of, among other things, (i) developments with respect to currently active audits or advance pricing agreements and/or (ii) the further </font></div>

<div><br>
</div>

<div>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">20</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">development of tax laws through judicial or administrative actions.&#160;&#160;Although tax laws are complex and significant uncertainty exists with respect to the actual date that any of the currently active audits or APA negotiations could reach final resolution or a new audit could commence, management believes it is reasonably possible that unrecognized tax benefits could increase in the next 12 months by at least 10% or decrease by over 70% as a result of actual payment of amounts included in the Tax Reserves and/or developments in various negotiations with tax authorities.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 18pt"></font>The total amount of gross unrecognized tax benefits included in the Tax Reserves and the amount that would impact the effective tax rate, if recognized, did not change materially during the first three months of 2010.&#160;&#160;The </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Company's policy is to classify interest and penalties in income tax expense.&#160;&#160;The gross amount of interest and penalties accrued as part of Tax Reserves did not change materially during the first three months of 2010.&#160;&#160;At March 31, 2010, the condensed consolidated balance sheet included $23 in other current liabilities and $58 in other long term liabilities for the Tax Reserves, net of deposits with statutory authorities.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 18pt"></font>During the three months ended March 31, 2010, the Company recognized a $25 tax charge for the write-off of deferred tax assets as a result of provisions of U.S. healthcare reform laws enacted during the period.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(10)&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Business Segments</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 18pt"></font>The Company conducts its global business through two business segments:&#160;&#160;Alcon United States and Alcon International.&#160;&#160;Alcon United States includes sales to unaffiliated customers located in the United States of America, excluding Puerto Rico.&#160;&#160;Alcon United States operating income is derived from operating profits within the United States.&#160;&#160;Alcon International includes sales to all other unaffiliated customers.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 18pt"></font>Each business segment markets and sells products principally in three product categories of the ophthalmic market: (1) pharmaceutical (prescription drugs), (2) surgical equipment and devices (cataract, vitreoretinal and refractive) and (3) consumer eye care (contact lens disinfectants and cleaning solutions, artificial tears and ocular vitamins).&#160;&#160;Business segment operations generally do not include research and development, certain manufacturing and other corporate functions.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 18pt"></font>Certain manufacturing costs and manufacturing variances are not assigned to business segments because most manufacturing operations produce products for more than one business segment.&#160;&#160;Research and development costs, excluding regulatory costs which are included in the business segments, are treated as general corporate costs and are not assigned to business segments.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 18pt"></font>Identifiable assets are not assigned by business segment and are not considered in evaluating the performance of the business segments.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="6" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: -0.15pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Depreciation and</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Sales</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Operating Income</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: -0.15pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Amortization</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 0.5pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Three months ended March 31,</font></div>
</td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="28%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">United States</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">726</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">658</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">431</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">353</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">12</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">12</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="28%" style="PADDING-BOTTOM: 0.5pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">International</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">995</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">835</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">463</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">379</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">28</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">20</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="28%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="28%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font id="TAB1" style="MARGIN-LEFT: 15.75pt"></font>Segments total</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,721</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,493</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">894</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">732</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">40</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">32</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="28%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Manufacturing operations</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(17 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(17 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">14</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">12</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="28%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Research and development</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(150 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(119 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="28%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">General corporate</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(56 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(59 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="28%" style="PADDING-BOTTOM: 0.5pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Share-based compensation</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(18 </font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(23 </font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="28%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="28%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font id="TAB1" style="MARGIN-LEFT: 15.75pt"></font>Total</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,721</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,493</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">653</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">514</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">62</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">51</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div><br>
</div>

<div>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">21</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 18pt"></font>During the three months ended March 31, 2010, advancements in its sales reporting system permitted the Company to better estimate allowable deductions from sales in the calculation of accrued royalties.&#160;&#160;This change in estimate resulted in a $24 addition to U.S. operating income during the period.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 18pt"></font>The Company incurred pretax expenses totaling $4 in the three months ended March 31, 2010 for costs related to the anticipated change of control discussed in note 13 and other costs to support Alcon's board of directors in its evaluation of Novartis's merger proposal.&#160;&#160;These expenses were included above in general corporate expenses.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On February 11, 2009, the Company announced that it initiated programs to align its operations with the evolving economic conditions and market environment.&#160;&#160;These programs included a staffing reduction of approximately 260 employee positions that resulted in a pretax charge of $18 for the three months ended March 31, 2009, which was included in general corporate expenses.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(11)&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Share-Based Compensation</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On February 10, 2010, pursuant to the Amended 2002 Alcon Incentive Plan, the Company's board of directors approved the grant, effective February 17, 2010, to certain employees of approximately 543,000 share-settled restricted share units ("RSUs").&#160;&#160;The RSUs vest at the end of a three-year period, with forfeitures if the recipient is not fully vested at termination of employment or at retirement before age 62.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Restricted share units are recognized over the required service period at the closing market price for Alcon common shares on the date of grant.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 18pt"></font>Forfeitures were estimated based on historical experience.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 18pt"></font>If factors change and the Company employs different assumptions to account for share-based payments in future periods, the compensation expense that the Company records may differ significantly from what the Company has recorded in the current period.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 18pt"></font>The effects of share-based equity awards on operating income and net earnings were as follows:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Three months ended March 31,</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total share-based equity award costs applicable for period</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">18</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">23</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 0.5pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Costs capitalized in inventory</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Costs recognized in operating income</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">18</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">23</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 0.5pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Less tax benefit recognized in net earnings</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Reduction to net earnings</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">12</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">16</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 18pt"></font>Compensation expense for equity awards was calculated on a straight-line basis over the three-year vesting period of the applicable share-based awards, with acceleration of the expense for individuals meeting the requirements for retirement, as described above.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 18pt"></font>The effects of share-based liability awards on operating income for the three months ended March 31, 2010 and 2009 were not significant.</font></div>

<div><br>
</div>

<div>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">22</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 18pt"></font>The Company intends to satisfy all equity awards granted prior to December 31, 2003 and after December 31, 2007 with the issuance of new shares from conditional capital authorized for the Amended 2002 Alcon Incentive Plan.&#160;&#160;At March 31, 2010, the Company had reserved approximately 21.7 million Alcon common shares for issuance pursuant to the Amended 2002 Alcon Incentive Plan.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 18pt"></font>The Company's board of directors has authorized the acquisition on the open market of Alcon common shares to, among other things, satisfy the share-based awards requirements granted under the Amended 2002 Alcon Incentive Plan.&#160;&#160;At March 31, 2010, outstanding authorizations by the Company's board of directors would have permitted the purchase of approximately 1.7 million Alcon common shares.&#160;&#160;The Company has purchased treasury shares on the open market to satisfy the majority of the outstanding equity awards granted subsequent to December 31, 2003 and prior to January 1, 2008.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Change of Control Provisions</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Upon a change of control in the ownership of Alcon, such as Novartis's intended purchase of Nestl&#233;'s common shares of Alcon (discussed in note 13), the Company's share-based compensation awards granted to employees prior to January 1, 2009 will vest immediately.&#160;&#160;However, the vesting of similar awards granted after January 1, 2009 will accelerate only if the respective participant's employment with the Company or its successor is terminated without cause, or by the participant under certain circumstances, within six months preceding or during the two years following a change of control.&#160;&#160;If Alcon is not the surviving corporation under a change in control, the equivalent value of the successor's securities may be substituted for Alcon shares under the awards.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(12)&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Pension and Postretirement Benefits</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Components of net periodic benefit costs:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Pension Benefits</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="6" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Postretirement Benefits</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 0.5pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Three months ended March 31,</font></div>
</td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Service cost</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Interest cost</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Expected return on assets</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(3 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(2 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Prior service cost</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 0.5pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net losses (gains)</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="52%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 27pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Net periodic benefit cost</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">15</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">12</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="52%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Certain U.S. defined benefit plans contain change of control provisions such that, upon a change in control in the ownership of Alcon, such as Novartis's intended purchase of Nestl&#233;'s common shares of Alcon (discussed in note 13), the Company immediately would recognize special termination benefits and curtailment charges, and payments of related pension benefits would be accelerated.&#160;&#160;Management estimates that such charges would impact significantly the Company's results of operations in the period in which a change of control occurs.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Company maintains an irrevocable Rabbi trust to be held and invested in an unfunded arrangement for the payment of benefits to participants under certain defined benefit pension plans of the Company.&#160;&#160;At March 31, 2010, the accompanying condensed consolidated balance sheet included net assets of the trust (cash and cash equivalents of $43 and short term investments of $248) that were restricted to the payment of pension benefits except under certain conditions, such as the Company's insolvency or termination of the trust.&#160;&#160;The Alcon Executive Retirement Plans Trust Agreement provides for the Company to fund the current actuarially determined present value of the aggregate accrued pension benefits of all participants in the event the Company undergoes a change of </font><br>
</div>

<div>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">23</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">control, such as Novartis's intended purchase of Nestl&#233;'s common shares of Alcon (discussed in note 13).&#160;&#160;Management estimates that a significant contribution to the trust would be required.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In certain countries, the Company's employees participate in defined benefit plans of Nestl&#233;.&#160;&#160;No separate valuation for the Company's employees has historically been prepared for the plans, as they are not individually material to the Company or to Nestl&#233;.&#160;&#160;Accordingly, these plans are treated as multi-employer plans.&#160;&#160;Annual contributions to these plans are determined by Nestl&#233; and charged to the Company.&#160;&#160;Under a change of control, the participants may or may not be migrated to another plan, and additional contributions by the Company may or may not be required in any new single-employer plans.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(13)&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Proposed Change of Control</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On April 6, 2008, Nestl&#233; and Novartis executed the Purchase and Option Agreement pursuant to which Nestl&#233; agreed to sell approximately 74 million of its shares of Alcon common stock to Novartis in a cash transaction at a price of $143.18 per share.&#160;&#160;This sale was consummated on July 7, 2008, and Novartis now owns a minority stake in Alcon of slightly less than 25% of Alcon's outstanding shares, while Nestl&#233; remains Alcon's majority shareholder with approximately 156 million Alcon shares comprising approximately 52% of the Company's outstanding shares.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 18pt"></font>The Purchase and Option Agreement between Nestl&#233; and Novartis also contains put and call option rights on the balance of approximately 156 million Alcon shares owned by Nestl&#233;.&#160;&#160;The option rights commenced on January 1, 2010 and expire on July 31, 2011.&#160;&#160;As outlined by the two parties, these rights grant (i) Novartis a call option to buy all but 4.1 million (or 2.5%) of Nestl&#233;'s remaining Alcon shares at a fixed price of $181 per share and the 4.1 million shares at the first stage price of $143.18 per share, and (ii) Nestl&#233; a put option to sell to Novartis all but 4.1 million of its remaining Alcon shares to Novartis at the lower of Novartis's call price of $181 per share or a premium of approximately 20.5% above the then-market price of Alcon shares,
 which will be calculated as the average market price of Alcon shares during the five trading days immediately preceding the exercise date of the put option, with the 4.1 million share balance to be sold at the first stage closing price of $143.18 per share.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On January 4, 2010, Novartis announced that it had exercised its option to purchase the remaining approximately 156 million Alcon shares owned by Nestl&#233; at a weighted average price of $180 per share in cash, pursuant to the Purchase and Option Agreement.&#160;&#160;Upon consummation of the purchase, Novartis would own an approximate 77% interest in Alcon.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The consummation of a purchase and sale transaction under the option right is subject to regulatory approvals.&#160;&#160;The consummation would trigger certain change of control provisions in the Company's share-based awards plan (including the vesting of certain outstanding share-based awards), certain retirement plans for Company employees and other agreements.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Upon consummation, the Company will no longer benefit from certain synergies as a result of Nestl&#233;'s ownership.&#160;&#160;Alcon has taken advantage of the synergies in several functional areas.&#160;&#160;Management does not anticipate a significant financial impact to Alcon due to the loss of these synergies because the Company is currently negotiating with certain vendors/suppliers and financial services providers to mitigate any potential impact from a change of control.&#160;&#160;However, no assurances can be made at this time.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As a result of Novartis's planned acquisition of Nestl&#233;'s remaining Alcon shares, Alcon's relationships with third parties in the pharmaceutical and other industries may be impacted, which in some cases may affect Alcon's business development and licensing opportunities.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Novartis also announced that it submitted to the Alcon board of directors a proposal for a merger of Alcon with and into Novartis to be effected under Swiss merger law.&#160;&#160;Under the terms of the merger proposal, holders of the approximate 23% of Alcon shares that are publicly traded would receive 2.8 Novartis shares for each Alcon share.&#160;&#160;The proposed merger would be contingent upon, among other things, approval by the Alcon board of directors, the</font></div>

<div><br>
</div>

<div>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">24</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">closing of the purchase and sale transaction related to the Novartis option exercise as well as receipt of required regulatory approvals.&#160;&#160;Upon Novartis becoming a majority shareholder of Alcon, management believes that the Organizational Regulations provide that the Alcon board of directors may only approve the proposed merger if a majority of the Independent Director Committee so recommends; however, management cannot predict the outcome of any judicial proceeding that might be initiated to interpret or challenge this position.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 18pt"></font>The Independent Director Committee was formed in 2008 in connection with Novartis's initial purchase of slightly less than 25% of the Alcon shares from Nestl&#233; to evaluate transactions such as the merger proposed by Novartis.&#160;&#160;The Independent Director Committee engaged independent financial and legal advisors in connection with its evaluation of the proposed merger.&#160;&#160;On January 20, 2010, the Independent Director Committee issued its formal response rejecting the Novartis merger proposal.&#160;&#160;The committee rejected the merger proposal based on its assessment that the price offered and other terms were not acceptable and that Novartis's merger proposal was not in the best interests of Alcon and its minority shareholders.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(14)&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Commitments and Contingencies</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Minority Shareholder Class Action Lawsuits</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 18pt"></font>On January 4, 2010, Novartis announced that it submitted to the Alcon board of directors a proposal for a merger of Alcon with and into Novartis to be effected under Swiss merger law (note 13).&#160;&#160;Under the terms of the merger proposal, holders of the approximate 23% of Alcon shares that are publicly traded would receive 2.8 Novartis shares for each Alcon share.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 18pt"></font>The Independent Director Committee was formed in 2008 in connection with Novartis's initial purchase of slightly less than 25% of the Alcon shares from Nestl&#233; to evaluate transactions such as the merger proposed by Novartis.&#160;&#160;The Independent Director Committee engaged independent financial and legal advisors in connection with its evaluation of the proposed merger.&#160;&#160;On January 20, 2010, the Independent Director Committee issued its formal response rejecting the Novartis merger proposal.&#160;&#160;The committee rejected the merger proposal based on its assessment that the price offered and other terms were not acceptable and that Novartis's merger proposal was not in the best interests of Alcon and its minority shareholders.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 18pt"></font>Certain Alcon minority shareholders have filed several class action lawsuits related to Novartis's merger proposal concerning the acquisition of the remaining 23% publicly held minority interest.&#160;&#160;The claims vary among the cases, but include allegations of: (i) breach of contract against Alcon; (ii) tortious interference with contract against Novartis and Nestl&#233;; (iii) breach of fiduciary duties against the Alcon board of directors, Nestl&#233; and Novartis; (iv) aiding and abetting breaches of fiduciary duties against the Alcon board of directors, Nestl&#233; and Novartis; (v) breach of Section 13(d) of the Exchange Act against Novartis and Nestl&#233; for an alleged failure to disclose that they were acting as a "group;" and (vi) breach of Section 14(d) of the Exchange Act 
against Novartis and Nestl&#233; for an alleged failure to file with the U.S. Securities and Exchange Commission the materials required in connection with a "tender offer."&#160;&#160;Seven cases filed in the Southern District of New York have been consolidated into one class action case.&#160;&#160;One case is pending in the U.S. District Court for the Northern District of Texas, Fort Worth Division, but the plaintiffs there have agreed to join the plaintiffs in the Southern District of New York action rather than pursue their claims separately.&#160;&#160;One case, which did not name Alcon, Inc. and its board of directors as parties, had been filed in the Eastern District of New York but was voluntarily dismissed by the plaintiffs on March 18, 2010.&#160;&#160;Two cases filed in District Court, Tarrant County and two cases filed in the County Court at Law, Dallas County, Texas have been consolidated for pre-trial purposes by the Texas Multidistrict Litigation Panel in the District Court, Dallas County.</fo
nt></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On April 14, 2010, plaintiffs in the Southern District of New York action agreed to dismiss their claims against Nestl&#233; and the five Alcon directors nominated by Nestl&#233; in exchange for Nestl&#233;&#8217;s and its directors&#8217; agreement that, without impairing the directors&#8217; ability to exercise their fiduciary obligations to Alcon, among other things, during the pendency of the action, they will take no action to (1) amend the Alcon Organizational Regulations, (2) remove</font></div>
</div>

<div>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">25</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">or replace the Alcon independent directors or (3) facilitate Novartis&#8217;s proposal to take Alcon private other than pursuant to a recommendation of the Independent Director Committee.&#160;&#160;On April 21, 2010, plaintiffs in the Southern District of New York action voluntarily dismissed their breach of fiduciary duty and aiding and abetting claims against Novartis, Nestl&#233; and the Alcon board of directors.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 18pt"></font>We are currently unable to express an opinion on the outcome of these class action cases due to their infancy.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Other Contingencies</font><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;&#160;&#160;&#160;&#160;&#160;&#160; Alcon, either alone or jointly with its commercial partners, has filed fourteen North American patent infringement actions against six different generic drug companies.&#160;&#160;With the exception of international generic challenges, all of these generic drug companies are seeking U.S. Food and Drug Administration ("FDA") approval to market generic versions of Alcon products, under what are known as Abbreviated New Drug Applications ("ANDAs").</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The first infringement action was filed after Alcon received notice that Teva Pharmaceuticals USA, Inc. had filed an ANDA seeking approval to sell a generic version of Alcon's <font style="DISPLAY: inline; FONT-STYLE: italic">Vigamox</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> antibiotic ophthalmic solution.&#160;&#160;Moxifloxacin, the primary ingredient in <font style="DISPLAY: inline; FONT-STYLE: italic">Vigamox</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font>, is licensed to Alcon by Bayer Schering Pharma AG.&#160;&#160;As part of its ANDA, Teva challenged three patents covering Alcon's innovator product <font style="DISPLAY: inline; FONT-STYLE: italic">Vigamox</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;
</font>. Two of the patents are owned by Alcon's licensor, Bayer Schering Pharma AG, and the third, which expires in 2020, is owned by Alcon.&#160;&#160;The two Bayer Schering Pharma AG patents were also the subject of another Teva ANDA seeking approval to sell a generic version of Bayer Schering Pharma AG's systemic moxifloxacin product, Avelox<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font>.&#160;&#160;Suit was filed by Alcon and Bayer Schering Pharma AG as co-plaintiffs against Teva relative to the ANDA challenging <font style="DISPLAY: inline; FONT-STYLE: italic">Vigamox</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> on April 5, 2006 in the U.S. District Court in Delaware.&#160;&#160;Bayer Schering Pharma AG subsequently filed suit in the same court relative to the Avelox<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> ANDA, and the two suits were merged.&#160;&#160;Trial was scheduled t
o begin February 26, 2008, but the dispute between Bayer Schering Pharma AG and Teva relative to the two Bayer Schering Pharma AG patents was resolved by settlement on the eve of trial.&#160;&#160;Under the terms of the settlement, Teva acknowledged the validity and enforceability of both Bayer Schering Pharma AG patents, and further acknowledged that its proposed generic ophthalmic product would infringe both patents.&#160;&#160;Teva has therefore relinquished any claim that it is entitled to market the generic ophthalmic product prior to September 4, 2014.&#160;&#160;Alcon remains the exclusive ophthalmic licensee under the Bayer Schering Pharma patents.&#160;&#160;The trial relative to the Alcon patent began on February 28, 2008 and concluded on March 6, 2008.&#160;&#160;Since then, Alcon has received a notice of allowance on a related patent application with claims that will cover the <font style="DISPLAY: inline; FONT-STYLE: italic">Vigamox</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-AL
IGN: text-top; FONT-STYLE: italic">&#174;</font> product and Teva's proposed generic product.&#160;&#160;The issue fee has been paid on that application, and the patent should issue by the first quarter of 2010.&#160;&#160;On October 19, 2009, the court ruled in Alcon's favor on all counts, finding the Alcon patent to be valid and infringed by the proposed generic product.&#160;&#160;On November 19, 2009, Teva filed a Notice of Appeal, but that appeal was subsequently set aside by the Federal Circuit Court of Appeals as being premature.&#160;&#160;It is expected that the appeal will be reinstated after the lower court amends its form of judgment.&#160;&#160;However, even if Teva were to succeed in having the district court decision reversed on appeal, it would still have to address Alcon's recently allowed second patent before competing with Alcon's <font style="DISPLAY: inline; FONT-STYLE: italic">Vigamox</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> product in 
September 2014 when the underlying Bayer patent expires.&#160;&#160;If Teva were to win on appeal and overcome Alcon's second patent, the resulting generic competition would be expected to impact significantly the Company's sales and profits.&#160;&#160;On a related note, Alcon's European counterpart patent to the patent-in-suit was determined to be invalid in a European Patent Office Opposition Proceeding.&#160;&#160;That invalidity decision was upheld by an Enlarged Board of Appeal on October 22, 2009.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The second patent infringement action was filed after Alcon received notice that Apotex, a Canadian-based generic drug company, had filed an ANDA challenging one of the patents covering Alcon's <font style="DISPLAY: inline; FONT-STYLE: italic">Patanol</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> anti-allergy eye product.&#160;&#160;Alcon's raw material supplier, Kyowa Hakko Kirin Co., Ltd., holds another U.S. patent, which has not been challenged in this case and which expires on December 18, 2010.&#160;&#160;In addition, Alcon has secured a six-month pediatric extension to the patent coverage, which means this generic challenge poses no threat to the <font style="DISPLAY: inline; FONT-STYLE: italic">Patanol</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;
 <font size="2">product market prior to June 2011.&#160;&#160;The patent that Apotex has challenged, which is co-owned by Alcon and Kyowa, will expire in 2015.&#160;&#160;Alcon and Kyowa, as co-plaintiffs, filed suit against Apotex Inc. and Apotex Corp. on </font></font></font></div>
</div>

<div><br>
</div>

<div>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">26</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">November 15, 2006 in the U.S. District Court in Indianapolis, Indiana.&#160;&#160;As a result of the lawsuit filing, the FDA was required to delay any approval of the Apotex ANDA for 30 months until April 2009, unless the litigation were earlier resolved or the court were to modify the 30-month stay on FDA approval.&#160;&#160;Because of the protection until June 2011, provided by the unchallenged Kyowa patent, the expiration of the 30-month period was inconsequential. </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Trial had been scheduled for July 27, 2009, but was postponed and has now been rescheduled for April 26, 2010 (consolidated with the Sandoz case described below).&#160;&#160;Should Apotex succeed in overcoming the challenged patent and secure FDA approval, it would not be entitled to begin s
elling a generic olopatadine product that would compete with Alcon's <font style="DISPLAY: inline; FONT-STYLE: italic">Patanol</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> product in the United States until June 18, 2011.&#160;&#160;Such competition would be expected to impact significantly the Company's sales and profits.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The third patent infringement action was filed after Alcon received notice on October 1, 2007 that Barr Laboratories, Inc. had filed an ANDA challenging the patents underlying Alcon's <font style="DISPLAY: inline; FONT-STYLE: italic">Patanol</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> product.&#160;&#160;Unlike the Apotex ANDA described above, which is challenging only the patent jointly owned by Kyowa and Alcon, the Barr ANDA was also challenging Kyowa's composition patent on olopatadine, the active agent in <font style="DISPLAY: inline; FONT-STYLE: italic">Patanol</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font>.&#160;&#160;Alcon and Kyowa filed suit in the Federal District Court in Indianapolis (where the Apotex case is pending) on October 23, 2
007.&#160;&#160;As a result of the lawsuit filing, the FDA was required to delay any approval of the Barr ANDA for 30 months unless the litigation were earlier resolved or the court modified the 30-month stay on FDA approval.&#160;&#160;The 30-month period after which the FDA could approve Barr's generic product would expire at the end of March 2010, nine months before the Kyowa composition patent expires.&#160;&#160;Trial was scheduled for late April 2010.&#160;&#160;However, in September 2009, Barr withdrew its ANDA and subsequently has been dismissed from the suit.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The fourth patent infringement action was filed after Alcon received notice in late November 2008 that Barr Laboratories, Inc. had filed an ANDA challenging the patents underlying Alcon's <font style="DISPLAY: inline; FONT-STYLE: italic">Pataday</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#8482;</font> once daily olopatadine product.&#160;&#160;The Barr ANDA is challenging the patent jointly owned by Kyowa and Alcon (described above), as well as two later issued patents owned by Alcon that cover the <font style="DISPLAY: inline; FONT-STYLE: italic">Pataday</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#8482;</font> formulation.&#160;&#160;Of the two Alcon patents, the latest expiry date is November 2023.&#160;&#160;Barr is not challenging the Kyowa patent on olopatadine 
that expires in December 2010 (effectively extended until June 2011 by a pediatric extension).&#160;&#160;Alcon and Kyowa filed suit in the Federal District Court in Indianapolis on January 8, 2009.&#160;&#160;As a result of the lawsuit filing, the FDA must delay any approval of the Barr ANDA for 30 months unless the litigation is earlier resolved or the court modifies the 30-month stay on FDA approval.&#160;&#160;The 30-month period after which the FDA could approve Barr's generic product will expire in May 2011.&#160;&#160;This case has been consolidated with the Apotex case (<font style="DISPLAY: inline; FONT-STYLE: italic">Pataday</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#8482;</font>) described below.&#160;&#160;Trial has not yet been scheduled in this case.&#160;&#160;If Barr succeeds in overcoming all of the challenged patents and secures FDA approval, it would be entitled to begin selling a generic olopatadine product that would compete with Alcon's <font style="
DISPLAY: inline; FONT-STYLE: italic">Pataday</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#8482;</font> product in the United States on June 18, 2011.&#160;&#160;Such competition would be expected to impact significantly the Company's sales and profits.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The fifth and sixth ANDA patent suits were filed February 2, 2009 in the U.S. District Court in Indianapolis against Apotex and Sandoz, respectively.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Alcon received notice January 12, 2009, that Apotex has followed Barr in filing an ANDA challenging the patents underlying Alcon's <font style="DISPLAY: inline; FONT-STYLE: italic">Pataday</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#8482;</font> once daily olopatadine product.&#160;&#160;Like Barr's ANDA, the Apotex ANDA is challenging the patent jointly owned by Kyowa and Alcon (described above), as well as two later issued patents owned by Alcon that cover the <font style="DISPLAY: inline; FONT-STYLE: italic">Pataday</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#8482;</font> formulation.&#160;&#160;Apotex is not challenging the Kyowa patent on olopatadine that expires in December 2010 (June 2011 with the pediatric extension).&#160;&#160;Because the suit was filed wit
hin the statutory 45-day period, the FDA must delay any approval of the Apotex ANDA for 30 months (until June 2011), unless the litigation is earlier resolved or the court modifies the 30-month stay on FDA approval.&#160;&#160;In addition, because Apotex is the second filer, it is also subject to the first filer's 180-day exclusivity period, which could further delay its FDA approval.&#160;&#160;Trial has not yet been scheduled in this case.&#160;&#160;If Apotex succeeds in overcoming both of the challenged patents and secures FDA approval, then after the expiration of Barr's potential 180-day "first filer" exclusivity period, it would be entitled to begin selling a generic olopatadine product that would compete with Alcon's <font style="DISPLAY: inline; FONT-STYLE: italic">Pataday</font><font size="2"><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#8482;</font> product in the United States in June 2011.&#160;&#160;Such competition would be expected to impact significantly the Compa
ny's sales and profits.</font></font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>
</div>

<div>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">27</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div><br>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Alcon received notice on January 15, 2009 that Sandoz Inc. (an affiliate of Novartis) has filed an ANDA challenging one of the patents underlying Alcon's <font style="DISPLAY: inline; FONT-STYLE: italic">Patanol</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> product.&#160;&#160;Similar to the Apotex ANDA on <font style="DISPLAY: inline; FONT-STYLE: italic">Patanol</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font>, the Sandoz ANDA is challenging only the patent jointly owned by Kyowa and Alcon, but not the Kyowa-owned patent on olopatadine, which expires December 2010 (June 2011 with the pediatric extension).&#160;&#160;Because the suit was filed within the statutory 45-day period, the FDA must delay any approval of the Sandoz ANDA for 30 months (until 
June 2011) unless the litigation is earlier resolved or the court modifies the 30-month stay on FDA approval.&#160;&#160;However, as a third ANDA filer (behind both Apotex and Barr), Sandoz would not be entitled to receive FDA approval until the expiration or forfeiture of a 180-day exclusivity period that would be granted to Apotex (the first filer) if it were successful in its patent challenge.&#160;&#160;Trial has been scheduled for April 26, 2010, and consolidation with the above-described Apotex suit (<font style="DISPLAY: inline; FONT-STYLE: italic">Patanol</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic">&#174;</font>) has been ordered by the court.&#160;&#160;Apotex has advised the court of recent public statements of intent by Novartis to acquire all outstanding shares of Alcon stock, and filed a motion to sever Sandoz from the trial.&#160;&#160;On February 22, 2010, the court granted the motion, ordering the suit against Sandoz to proceed separately 
and confirming the April 26, 2010 trial date with Apotex.&#160;&#160;A new trial date for the Sandoz case has not yet been set.&#160;&#160;Subject to the possibility of the 180-day exclusivity period that could accrue to Apotex, if Sandoz succeeds in overcoming the challenged patent and secures FDA approval, it would be entitled to begin selling a generic olopatadine product that would compete with Alcon's <font style="DISPLAY: inline; FONT-STYLE: italic">Patanol</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> product in the United States in June 2011.&#160;&#160;Such competition would be expected to impact significantly the Company's sales and profits.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The seventh ANDA patent suit was filed after Alcon received notice by letter dated March 17, 2009, that Barr Laboratories, Inc. had filed a Paragraph IV certification with its ANDA for a generic version of Alcon's <font style="DISPLAY: inline; FONT-STYLE: italic">TRAVATAN</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> product containing 0.004% travoprost.&#160;&#160;Barr is challenging the following patents listed in the Orange Book for <font style="DISPLAY: inline; FONT-STYLE: italic">TRAVATAN</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font>: U.S. Patent Nos. 5,510,383; 5,631,287; 5,849,792; 5,889,052; and 6,011,062.&#160;&#160;With the exception of the '383 patent, which expires in 2013, all of the patents will expire in December 2014.&#160;&#160;Al
con filed suit against Barr in the U.S. District Court in Delaware on April 30, 2009 and thereby secured the statutory 30-month stay on FDA approval of the generic product.&#160;&#160;The FDA must delay any approval of the Barr ANDA until September 2011, unless the litigation is earlier resolved or the court modifies the 30-month stay on FDA approval.&#160;&#160;This case has been consolidated with the Par and Apotex cases on <font style="DISPLAY: inline; FONT-STYLE: italic">TRAVATAN</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174; </font>described below.&#160;&#160;Trial has been scheduled to commence March 7, 2011.&#160;&#160;Should Barr succeed in overcoming all of the challenged patents and secure FDA approval, it would be entitled to begin selling a generic travoprost product that would compete with Alcon's <font style="DISPLAY: inline; FONT-STYLE: italic">TRAVATAN</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> product in t
he United States.&#160;&#160;Such competition would be expected to impact significantly the Company's sales and profits.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The eighth patent suit was filed after Sandoz Canada Inc. (an affiliate of Novartis) notified Alcon Canada by letter dated April 9, 2009, that Sandoz had filed an Abbreviated New Drug Submission (ANDS) seeking approval from the Canadian Minister of Health to market a generic version of Alcon's <font style="DISPLAY: inline; FONT-STYLE: italic">Patanol</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> product.&#160;&#160;The Sandoz ANDS is challenging only one of the two patents listed in the Canadian Patent Register for the <font style="DISPLAY: inline; FONT-STYLE: italic">Patanol</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> product.&#160;&#160;The challenged patent (Canadian Patent No. 2,195,094) is jointly owned by Kyowa and Alcon and expires in May
 2016.&#160;&#160;Alcon and Kyowa filed suit on May 25, 2009 in the Federal Court in Toronto, thereby securing a 24-month delay (until May 25, 2011) in the regulatory approval from the Minister of Health, which can only be shortened if the litigation is earlier resolved or the court modifies the 24-month stay on such approval.&#160;&#160;Trial has not yet been scheduled in this case.&#160;&#160;Should Sandoz succeed in overcoming the challenged patent and secure Minister of Health approval, it would be entitled to begin selling a generic olopatadine product that would compete with Alcon's <font style="DISPLAY: inline; FONT-STYLE: italic">Patanol</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> product in Canada well before the patent expiration in 2016, but not before expiration of the unchallenged patent in November 2012.&#160;&#160;Such competition would be expected to impact the Company's sales and profits.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The ninth ANDA patent suit was filed after Alcon received notice by letter dated June 1, 2009, that Par Pharmaceutical, Inc. had filed a Paragraph IV certification with its two ANDAs for generic versions of Alcon's <font style="DISPLAY: inline; FONT-STYLE: italic">TRAVATAN</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic">&#174;</font> and <font style="DISPLAY: inline; FONT-STYLE: italic">TRAVATAN Z</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic">&#174;</font><font style="DISPLAY: inline; FONT-STYLE: italic">&#160;</font>products.&#160;&#160;Par is challenging the following patents listed in the Orange Book for <font style="DISPLAY: inline; FONT-STYLE: italic">TRAVATAN</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-
top; FONT-STYLE: italic">&#174;</font> and <font style="DISPLAY: inline; FONT-STYLE: italic">TRAVATAN Z</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic">&#174;</font>:&#160;&#160;U.S. Patent Nos. 5,510,383; 5,631,287; 5,849,792; 5,889,052; 6,011,062; 6,503,497; and 6,849,253.&#160;&#160;All of these patents will expire by the end of 2014.&#160;&#160;On July 1, 2009, Alcon filed suit in </font>the U.S. District Court in Delaware, thereby securing a statutory stay under which the FDA must delay any approval of the Par ANDAs until December 2011, unless the litigation is earlier resolved or the court modifies the 30-month stay on FDA approval.&#160;&#160;All of the cases about <font style="DISPLAY: inline; FONT-STYLE: italic">TRAVATAN</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174; </font>and<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#160;</font><font style="DISPLAY: inline; FONT-STYLE: italic">TRA
VATAN Z</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> (Barr, Par and Apotex) have now </div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">28</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">been consolidated.&#160;&#160;Trial has been scheduled for March 7, 2011.&#160;&#160;Subject to the possibility of the 180-day exclusivity period that could accrue to Barr (as first filer) relative to the <font style="DISPLAY: inline; FONT-STYLE: italic">TRAVATAN</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic">&#174;</font><font style="DISPLAY: inline; FONT-STYLE: italic">&#160;</font>product, if Par succeeds in overcoming all of the challenged patents and secures FDA approval, it would be entitled to begin selling generic travoprost products that would compete with Alcon's<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic">&#160;</font><font style="DISPLAY: inline; FONT-STYLE: italic">TRAVATAN</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERT
ICAL-ALIGN: text-top; FONT-STYLE: italic"> &#174;</font><font style="DISPLAY: inline; FONT-STYLE: italic">&#160;</font>and <font style="DISPLAY: inline; FONT-STYLE: italic">TRAVATAN Z</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic">&#174; </font>products in the United States in December 2011.&#160;&#160;Such competition would be expected to impact significantly the Company's sales and profits.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The tenth ANDA patent suit was filed after Alcon received notice by letter dated June 24, 2009, that Barr Laboratories, Inc. had filed a Paragraph IV certification with its ANDA for a generic version of Alcon's <font style="DISPLAY: inline; FONT-STYLE: italic">TRAVATAN Z</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic">&#174;</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#160;</font>product.&#160;&#160;Barr is challenging the following patents listed in the Orange Book for <font style="DISPLAY: inline; FONT-STYLE: italic">TRAVATAN Z</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic">&#174;</font>:&#160;&#160;U.S. Patent Nos. 5,510,383; 5,889,052; 6,503,497; and 6,849,253.&#160;&#160;All of the patents will expi
re by the end of 2014.&#160;&#160;On July 13, 2009, Alcon filed suit in the U.S. District Court in Delaware, thereby securing a statutory stay under which the FDA must delay any approval of the Barr ANDA until December 2011, unless the litigation is earlier resolved or the court modifies the 30-month stay on FDA approval.&#160;&#160;Trial has been scheduled for March 7, 2011 in this case, which has been consolidated with the above-described Barr suit (<font style="DISPLAY: inline; FONT-STYLE: italic">TRAVATAN</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic">&#174;</font>) and Par suit (<font style="DISPLAY: inline; FONT-STYLE: italic">TRAVATAN</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic">&#174;</font> and <font style="DISPLAY: inline; FONT-STYLE: italic">TRAVATAN Z</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic">&#174;</font>) and consolidated further to incl
ude the Apotex suit (<font style="DISPLAY: inline; FONT-STYLE: italic">TRAVATAN</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font>) described below.&#160;&#160;Subject to the possibility of the 180-day exclusivity period that could accrue to Par (as first filer) relative to the <font style="DISPLAY: inline; FONT-STYLE: italic">TRAVATAN Z</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic">&#174;</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#160;</font>product, if Barr succeeds in overcoming all of the challenged patents and secures FDA approval, it would be entitled to begin selling a generic travoprost product that would compete with Alcon's <font style="DISPLAY: inline; FONT-STYLE: italic">TRAVATAN Z</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic">&#174;</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#160;<
/font>product in the United States in December 2011.&#160;&#160;Such competition would be expected to impact significantly the Company's sales and profits.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The eleventh ANDA patent suit was filed after Alcon received notice by letter dated September 11, 2009, that Apotex Corp. and Apotex Inc. had filed an ANDA for a generic version of Alcon's <font style="DISPLAY: inline; FONT-STYLE: italic">TRAVATAN</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic">&#174;</font> product.&#160;&#160;Apotex is challenging all five of the Orange Book listed patents for <font style="DISPLAY: inline; FONT-STYLE: italic">TRAVATAN</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic">&#174;</font>: 5,510,383; 5,631,287; 5,849,792; 5,889,052; and 6,011,062.&#160;&#160;Alcon filed suit in the U.S. District Court in Delaware, thereby securing a statutory stay under which the FDA must delay any approval of the Barr ANDA until 
March 2012, unless the litigation is earlier resolved or the court modifies the 30-month stay on FDA approval.&#160;&#160;This case has been consolidated with the Barr and Par cases (<font style="DISPLAY: inline; FONT-STYLE: italic">TRAVATAN</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174; </font>and <font style="DISPLAY: inline; FONT-STYLE: italic">TRAVATAN Z</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font>)<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#160;</font>described above.&#160;&#160;Trial has been scheduled for March 7, 2011.&#160;&#160;Subject to the possibility of the 180-day exclusivity period that could accrue to Barr (as first filer) relative to the <font style="DISPLAY: inline; FONT-STYLE: italic">TRAVATAN</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic">&#174;</font><font style="DISPLAY: inline; FONT-STYLE: italic">&#160;</font>product, if
 Apotex succeeds in overcoming all of the challenged patents and secures FDA approval, it would be entitled to begin selling a generic travoprost product that would compete with Alcon's<font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic">&#160;</font><font style="DISPLAY: inline; FONT-STYLE: italic">TRAVATAN</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic"> &#174;</font><font style="DISPLAY: inline; FONT-STYLE: italic">&#160;</font>product in the United States in March 2012.&#160;&#160;Such competition would be expected to impact significantly the Company's sales and profits.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Alcon received notice dated October 19, 2009, that Apotex Corp. and Apotex Inc. have filed an ANDA challenging U.S. Patent No. 5,116,863, which covers Alcon's <font style="DISPLAY: inline; FONT-STYLE: italic">Patanase</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> olopatadine hydrochloride nasal spray solution. The patent, which is owned by Alcon's raw material supplier, Kyowa Hakko Kirin Co., Ltd., and licensed to Alcon, has a term extended by regulatory exclusivity that expires October 15, 2011.&#160;&#160;Alcon had until December 3, 2009, to file suit and avail itself of the statutory stay on FDA approval of the ANDA.&#160;&#160;Had suit been filed by that date, the FDA could not have approved the Apotex ANDA for 30 months unless the litigation were earlier resolved or the court modified th
e 30-month stay on FDA approval.&#160;&#160;In this case, however, the 30-month period would be shortened to coincide with the expiration date of the challenged patent in December 2010 and therefore would be inconsequential.&#160;&#160;Moreover, Alcon has regulatory exclusivity for the <font style="DISPLAY: inline; FONT-STYLE: italic">Patanase</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic">&#174; </font>product<font style="DISPLAY: inline; FONT-STYLE: italic">&#160;</font>extending until October 2011.&#160;&#160;Under these circumstances, Alcon and Kyowa elected not to file suit.&#160;&#160;Alcon also has additional pending patent applications that are potentially relevant to the <font style="DISPLAY: inline; FONT-STYLE: italic">Patanase</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic">&#174;</font> product, which are not currently listed in the FDA Orange Book, and which have not been challenged by Apotex.&#1
60;&#160;These pending applications may or may not issue and may not cover the <font style="DISPLAY: inline; FONT-STYLE: italic">Patanase</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic">&#174;</font> product.&#160;&#160;Should Apotex succeed in securing FDA approval and overcoming the challenged patent and any other applicable patents that may issue, it would be entitled to immediately begin selling a generic olopatadine product that would compete with Alcon's <font style="DISPLAY: inline; FONT-STYLE: italic">Patanase</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> product in the United States.&#160;&#160;Such competition would be expected to impact significantly the Company's sales and profits.</font></div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;&#160;&#160;&#160;&#160;&#160;&#160; The twelfth ANDA patent suit was filed after Alcon received notice on December 15, 2009 that Sandoz Inc. (an affiliate of Novartis), had filed an ANDA with a Paragraph IV certification directed to the Alcon and Kyowa patents</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">29</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">on <font style="DISPLAY: inline; FONT-STYLE: italic">Pataday</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#8482;</font>.&#160;&#160;The Sandoz ANDA is challenging the patent jointly owned by Kyowa and Alcon (described above), as well as two later issued patents owned by Alcon that cover the <font style="DISPLAY: inline; FONT-STYLE: italic">Pataday</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#8482;</font> formulation.&#160;&#160;Of the two Alcon patents, the latest expiry date is November 2023.&#160;&#160;Sandoz is not challenging the Kyowa patent on olopatadine that expires in December 2010 (effectively extended until June 2011 by a pediatric extension).&#160;&#160;On January 27, 2010, Alcon and Kyowa filed suit in the Federal District Court in Indianapolis.&#160;&#160;Because the suit was filed within the statutory 45-day period, the FDA must delay any approval of
 the Sandoz ANDA for 30 months (until June 2012) unless the litigation is earlier resolved or the court modifies the 30-month stay on FDA approval.&#160;&#160;However, because Sandoz is the third filer (behind both Barr and Apotex) and subject to a potential 180-day exclusivity period of the first filer, the 30-month stay is of no practical consequence.&#160;&#160;Subject to the possibility of the 180-day exclusivity period that potentially could accrue to Barr (as first filer) relative to the <font style="DISPLAY: inline; FONT-STYLE: italic">Pataday</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#8482;</font> product, if Sandoz were to succeed in overcoming all the challenged patents and to secure FDA approval, it would be entitled to begin selling a generic product that would compete with Alcon's <font style="DISPLAY: inline; FONT-STYLE: italic">Pataday</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#8482;</font> product in the United States.&
#160;&#160;Such competition would be expected to impact significantly the Company's sales and profits.</font></div>

<div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The thirteenth ANDA patent suit was filed after Alcon received notice that Wockhardt Limited (headquartered in India) had filed an ANDA with a Paragraph IV certification for a generic version of Alcon's <font style="DISPLAY: inline; FONT-STYLE: italic">Patanol</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> product.&#160;&#160;Wockhardt is challenging U.S. Patent No. 5,641,805, which is jointly owned by Alcon and its raw material supplier, Kyowa Hakko Kirin Co., Ltd.&#160;&#160;The challenged patent will expire in 2015.&#160;&#160;Wockhardt is not challenging, however, another Kyowa-owned U.S. patent covering <font style="DISPLAY: inline; FONT-STYLE: italic">Patanol</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font>, which expires on December 18, 2010 (e
ffectively extended until June 2011 by a pediatric extension).&#160;&#160;Consequently, Wockhardt's generic challenge poses no threat to the <font style="DISPLAY: inline; FONT-STYLE: italic">Patanol</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> product market prior to June 2011.&#160;&#160;Alcon and Kyowa filed suit against Wockhardt in the Federal District Court in Indianapolis on February 12, 2010, to avail themselves of the statutory 30-month stay on FDA approval of the proposed generic product.&#160;&#160;That 30-month period will expire August 2, 2012, unless the litigation is earlier resolved or the court modifies the 30-month stay on FDA approval.&#160;&#160;However, as a third ANDA filer (behind both Apotex and Sandoz), Wockhardt would not be entitled to receive FDA approval until the expiration or forfeiture of a 180-day exclusivity period that would be granted to Apotex (the first filer) if it were successful in its patent challenge.&#160;&#160;Subject 
to the possibility of such a 180-day exclusivity period that could potentially accrue to Apotex (as first filer) relative to the <font style="DISPLAY: inline; FONT-STYLE: italic">Patanol</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> product, if Wockhardt were to succeed in overcoming the challenged patent and to secure FDA approval, it would be entitled to begin selling a generic product that would compete with Alcon's <font style="DISPLAY: inline; FONT-STYLE: italic">Patanol</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> product in the United States.&#160;&#160;Such competition would be expected to impact significantly the Company's sales and profits.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The fourteenth patent suit was filed after Apotex, Inc. notified Alcon Canada that Apotex had filed an ANDS seeking approval from the Canadian Minister of Health to market a generic version of Alcon's Patanol&#174; product.&#160;&#160;The Apotex ANDS is challenging only one of the two patents listed in the Canadian Patent Register for the Patanol&#174; product.&#160;&#160;The challenged patent (Canadian Patent No. 2,195,094) is jointly owned by Kyowa and Alcon and expires in May 2016.&#160;&#160;Alcon and Kyowa, by timely initiating this action, are entitled to a 24-month delay (until April 2012) in the regulatory approval from the Minister of Health, which can only be shortened if the litigation is earlier resolved or the court modifies the 24-month stay on such approval.&#160;&#160;Should Apotex succeed in overcoming the challenged pat
ent and secure Minister of Health approval, it would be entitled to begin selling a generic olopatadine product that would compete with Alcon's Patanol&#174; product in Canada well before the patent expiration in 2016, but not before expiration of the unchallenged patent in November 2012.&#160;&#160;Such competition would be expected to impact the Company's sales and profits.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Alcon is also enforcing patents against generic challengers in China (Patanol&#174;) and Chile (Vigamox&#174;).</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On April 16, 2008, Synergetics USA, Inc., a microsurgical device company, filed a civil antitrust lawsuit in the U.S. District Court for the Southern District of New York against the Company and its subsidiary, Alcon Laboratories, Inc.&#160;&#160;Synergetics asserted that it had suffered losses resulting from alleged unlawful/unfair practices and sought a recovery that it claimed could exceed $100.&#160;&#160;Synergetics also asserted that Alcon engaged in allegedly anti-competitive behavior.&#160;&#160;On June 23, 2008, the Company filed its answer and counterclaim in the district court.&#160;&#160;In 2008 and 2009, subsidiaries of the Company filed suits against Synergetics for patent infringement in the U.S. District Court for the Northern District of Texas in Fort Worth.&#160;&#160;Synergetics answered the complaints.&#160;&#160;A se
ries of </font></div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">30</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>

<font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">counterclaims and motions followed.&#160;&#160;On April 23, 2010, the parties entered a Confidential Settlement and License Agreement together with a Supply Agreement.&#160;&#160;Under the agreements, Alcon will pay $32 in exchange for worldwide rights to sell Synergetics patented vitreoretinal products.&#160;&#160;The products will be manufactured by Synergetics and supplied to Alcon.&#160;&#160;The agreements also settle all pending litigation between Alcon and Synergetics, including both the antitrust and the patent litigation, and provide a process for future dispute resolution.</font></div>

<div>
<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On December 18, 2008, James M. Nielsen, M.D. filed a patent infringement suit against Alcon, Inc. and Alcon Laboratories, Inc. in the U.S. District Court for the Northern District of Texas in Dallas.&#160;&#160;Dr. Nielsen is asserting that his U.S. Patent No. 5,158,572 entitled "Multifocal Intraocular Lens" is being infringed by the Company's <font style="DISPLAY: inline; FONT-STYLE: italic">AcrySof</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic">&#174;</font><font style="DISPLAY: inline; FONT-STYLE: italic"> ReSTOR</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font><font style="DISPLAY: inline; FONT-STYLE: italic">&#160;</font>intraocular lens.&#160;&#160;The patent, which expired at the end of October 2009, was previously licensed to Advanced Med
ical Optics, Inc.&#160;&#160;Alcon filed its Answer January 12, 2009.&#160;&#160;The Answer included a counterclaim for a declaratory judgment that the patent-in-suit is invalid and not infringed.&#160;&#160;The case has been set for trial in August, 2010.&#160;&#160;An adverse ruling by the court, while possible, would not be expected to impact significantly the Company's sales and profits.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On January 22, 2009, Elan Pharma International Ltd. sued two of the Company's subsidiaries, Alcon Laboratories, Inc. and Alcon Research, Ltd., in the U.S. District Court for the Eastern District of Texas in Sherman, alleging infringement of two Elan patents on nanoparticle technology (U.S. Patent Nos. 5,298,262 and 5,429,842).&#160;&#160;The complaint claims that the Company's <font style="DISPLAY: inline; FONT-STYLE: italic">Azopt</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic">&#174;</font> product and, potentially, other products infringe the two patents.&#160;&#160;The Company answered and counterclaimed on May 12, 2009.&#160;&#160;Elan then moved to dismiss certain of the Company's affirmative defenses and counterclaims.&#160;&#160;The Company has filed an amended answer and counterc
laims providing greater detail with respect to the Company's inequitable conduct counterclaims.&#160;&#160;The case has been set for trial March 21, 2011.&#160;&#160;The Company believes that it has strong defenses and intends to defend itself vigorously.&#160;&#160;An adverse ruling by the court, however, could impact significantly the Company's sales and profits.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Company and its subsidiaries are parties to a variety of other legal proceedings arising out of the ordinary course of business, including proceedings relating to product liability and patent infringement.&#160;&#160;The Company believes that it has valid defenses and is vigorously defending the litigation pending against it.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">While the results of the aforementioned contingencies cannot be predicted with certainty, management believes that the ultimate liability, if any, will not have a material adverse effect on the Company's consolidated financial position or results of operations.&#160;&#160;Litigation contingencies are subject to change based on settlements and court decisions.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Company may be subject to future litigation and infringement claims, which could cause the Company to incur significant expenses or prevent the Company from selling its products.&#160;&#160;The Company operates in an industry susceptible to significant product liability claims.&#160;&#160;Product liability claims may be asserted against the Company in the future arising out of events not known to the Company at the present time.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Company self-insures through captive insurance subsidiaries almost all of its property and casualty, business interruption and liability risks.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In the normal course of business, the Company has entered into research and development arrangements with third parties that require milestone and royalty payments to the third parties contingent upon certain future events linked to the success of the research and development efforts.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="LETTER-SPACING: 9pt">D</font>uring 2008, Lehman Brothers International (Europe) London filed for administration in England.&#160;&#160;At that time, the Company's cash and cash equivalents included $707 of short term securities held in a segregated custodial account of Lehman Brothers International (Europe) London pursuant to a Custody Agreement.&#160;&#160;Nestl&#233; invoiced the Company in December 2008 and, in 2009, the Company reimbursed Nestl&#233;, for a total of $5 in fees paid by Nestl&#233; to the Joint Administrators of Lehman Brothers International (Europe) London (in administration) related to the release of the short-term securities held in the custodial account.&#160;&#160;This amount of fees is subject to adjustment depending on the final costs incurred to settle the administration of Lehman Brothers Internat
ional (Europe) </font></div>
</div>

<div>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">31</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">London. In order to receive an expedited return of assets held by Lehman Brothers International (Europe) (in administration), Alcon has agreed to return any assets which the Joint Administrators determine should not have been disbursed in settlement.&#160;&#160;The amount of any funds to be returned, if any, would result from the determination by the Joint Administrators that the rights of another claimant in the proceeding have precedence over the Company's claim.</font></div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div><br>
</div>

<div>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">32</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div>&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">ITEM 2.</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</font></font></div>
</td>
</tr></table>
</div>

<div>&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Results of Operations</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Three months ended March 31, 2010 compared to three months ended March 31, 2009.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The following discussion compares operations for the three months ended March 31, 2010 to operations for the three months ended March 31, 2009.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Sales</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Company's global sales increased 15.3% to $1,721 million for the three months ended March 31, 2010 from the same period in 2009.&#160;&#160;The effect of favorable exchange rates increased global sales 5.5%.&#160;&#160;Excluding the effect of foreign exchange fluctuations, global sales would have grown 9.8%, including 0.2% for additional surgical sales subsequent to the January 2010 acquisition of Optonol Ltd.&#160;&#160;This improvement primarily reflected volume growth and, to a lesser extent, price increases during the three months ended March 31, 2010.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="41%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td colspan="5" valign="bottom" width="19%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Three Months Ended</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Foreign</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Change in</font></div>
</td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="bottom" width="41%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td colspan="5" valign="bottom" width="19%" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">March 31,</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Currency</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Constant</font></div>
</td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="bottom" width="41%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="2%" style="BORDER-BOTTOM: black 0.5pt solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="8%" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Change</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="10%" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Change</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="10%" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Currency</font></div>
</td>
<td align="left" valign="bottom" width="2%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(a)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="bottom" width="41%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td colspan="5" valign="bottom" width="19%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(in millions)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="bottom" width="41%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Geographic Sales</font></div>
</td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="7%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="bottom" width="41%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="7%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="bottom" width="41%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Alcon United States:</font></div>
</td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="7%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="bottom" width="41%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Pharmaceutical</font></div>
</td>
<td align="right" valign="bottom" width="2%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td align="right" valign="bottom" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">337</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="1%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td align="right" valign="bottom" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">307</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">9.8</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;% </font></td>
<td align="left" valign="bottom" width="1%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></div>
</td>
<td align="right" valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;% </font></td>
<td valign="bottom" width="3%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></div>
</td>
<td align="right" valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">9.8</font></div>
</td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;% </font></td>
<td valign="bottom" width="1%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></div>
</td>
</tr><tr>
<td valign="bottom" width="41%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Surgical</font></div>
</td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">287</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">258</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">11.2</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">11.2</font></div>
</td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="bottom" width="41%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Consumer Eye Care</font></div>
</td>
<td valign="bottom" width="2%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">102</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="8%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">93</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">9.7</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="10%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="3%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="10%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">9.7</font></div>
</td>
<td valign="bottom" width="2%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="bottom" width="41%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="7%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="bottom" width="41%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total United States Sales</font></div>
</td>
<td valign="bottom" width="2%" style="BORDER-BOTTOM: black 0.5pt solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">726</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="8%" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">658</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10.3</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10.3</font></div>
</td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="bottom" width="41%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="7%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="bottom" width="41%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Alcon International:</font></div>
</td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="7%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="bottom" width="41%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Pharmaceutical</font></div>
</td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">391</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">319</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">22.6</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">9.1</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">13.5</font></div>
</td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="bottom" width="41%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Surgical</font></div>
</td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">485</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">415</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">16.9</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">9.7</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7.2</font></div>
</td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="bottom" width="41%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Consumer Eye Care</font></div>
</td>
<td valign="bottom" width="2%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">119</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="8%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">101</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="9%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">17.8</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="10%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">11.9</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="3%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="10%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5.9</font></div>
</td>
<td valign="bottom" width="2%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="bottom" width="41%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="7%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="bottom" width="41%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total International Sales</font></div>
</td>
<td valign="bottom" width="2%" style="BORDER-BOTTOM: black 0.75pt solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">995</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="8%" style="BORDER-BOTTOM: black 0.75pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">835</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">19.2</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">9.7</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">9.5</font></div>
</td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="bottom" width="41%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="7%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="bottom" width="41%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total Global Sales</font></div>
</td>
<td align="right" valign="bottom" width="2%" style="BORDER-BOTTOM: black 2.25pt double">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td align="right" valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.25pt double">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,721</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td align="right" valign="bottom" width="8%" style="BORDER-BOTTOM: black 2.25pt double">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,493</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">15.3</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5.5</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">9.8</font></div>
</td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 18pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Change in constant currency (as referenced throughout this discussion) is determined by comparing adjusted 2010 reported amounts, calculated using 2009 monthly average exchange rates, to the actual 2009 reported amounts.&#160;&#160;Sales change in constant currency is not a U.S. GAAP defined measure of revenue growth.&#160;&#160;Change in constant currency calculates sales growth without the impact of foreign exchange fluctuations.&#160;&#160;Management believes constant currency sales growth is an important measure of the Company's operations because it provides investors with a clearer picture of the core rate of sales growth attributable to changes in unit volumes and local currency prices.&#160;&#160;Sales change in constant currency, as defined and presented by the Company, may not be comparable to similar measures reported by other companies.</f
ont></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Alcon United States sales increased 10.3% to $726 million for the three months ended March 31, 2010, from $658 million for the comparable period in 2009.&#160;&#160;The increase was mostly due to volume growth in several pharmaceutical product categories and in intraocular lenses, especially our advanced technology intraocular lenses, <font style="DISPLAY: inline; FONT-STYLE: italic">AcrySof</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> <font style="DISPLAY: inline; FONT-STYLE: italic">ReSTOR</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> and<font style="DISPLAY: inline; FONT-STYLE: italic"> AcrySof</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic">&#174;</font><font style="DISPLAY: inline; FONT-STYLE:
 italic"> Toric</font> intraocular lenses.&#160;&#160;Sales of surgical glaucoma products subsequent to the January 2010 acquisition of Optonol Ltd. added 0.3% to the growth.&#160;&#160;The overall improvement occurred against the backdrop of U.S. healthcare reform legislation, which reduced U.S. pharmaceutical sales by $5 million.&#160;&#160;This </font></div>

<div><br>
</div>

<div>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">33</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">reduction included the impact of healthcare reform legislation rebate increases on sales made during the fourth quarter of 2009 that were still in the wholesale and retail distribution channels at the beginning of 2010, as well as sales made during the three months ended March 31, 2010.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Alcon International sales increased 19.2% to $995 million in the three months ended March 31, 2010, from $835 million in the same period of 2009.&#160;&#160;The effect of favorable exchange rates increased Alcon International sales 9.7%.&#160;&#160;Excluding the effect of foreign exchange fluctuations, Alcon International sales would have grown 9.5%, primarily reflecting volume growth during the period.&#160;&#160;International sales grew on a constant currency basis across all product lines.&#160;&#160;Pharmaceutical sales growth in Japan and certain European nations, surgical sales growth in Europe and the sales growth in emerging markets were the main contributors to this performance.&#160;&#160;Sales of surgical glaucoma products subsequent to the January 2010 acquisition of Optonol Ltd. were 0.1% of the growth.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="41%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td colspan="5" valign="bottom" width="18%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Three Months Ended</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Foreign</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Change in</font></div>
</td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="bottom" width="41%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td colspan="5" valign="bottom" width="18%" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">March 31,</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Currency</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Constant</font></div>
</td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="bottom" width="41%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="8%" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Change</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="10%" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Change</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="10%" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Currency</font></div>
</td>
<td valign="bottom" width="2%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(a)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="bottom" width="41%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td colspan="5" valign="bottom" width="18%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(in millions)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="41%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Global Product Sales</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="7%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="bottom" width="41%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="7%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="41%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Infection/inflammation</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td align="right" valign="bottom" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">230</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="bottom" width="1%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td align="right" valign="bottom" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">202</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">13.9</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;% </font></td>
<td align="left" valign="bottom" width="1%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></div>
</td>
<td align="right" valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.0</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;% </font></td>
<td align="left" valign="bottom" width="3%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></div>
</td>
<td align="right" valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">9.9</font></div>
</td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;% </font></td>
<td align="left" valign="bottom" width="1%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></div>
</td>
</tr><tr>
<td align="left" valign="bottom" width="41%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Glaucoma</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">303</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">233</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">30.0</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6.0</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">24.0</font></div>
</td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="41%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Allergy</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">138</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">143</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(3.5</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.1</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(5.6</font></div>
</td>
<td align="left" valign="bottom" width="2%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="41%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Otic/nasal</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">84</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">76</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10.5</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2.6</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7.9</font></div>
</td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="41%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Other pharmaceuticals/rebates</font></div>
</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(27</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></div>
</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="8%" style="BORDER-BOTTOM: black 0.75pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(28</font></div>
</td>
<td align="left" valign="bottom" width="1%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N/M</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N/M</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N/M</font></div>
</td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="bottom" width="41%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="7%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="41%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total Pharmaceutical</font></div>
</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">728</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="8%" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">626</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">16.3</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.6</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">11.7</font></div>
</td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="bottom" width="41%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="7%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="41%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Intraocular lenses</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">291</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">248</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">17.3</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6.4</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10.9</font></div>
</td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="41%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Cataract/vitreoretinal/other</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">453</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">400</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">13.3</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5.8</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7.5</font></div>
</td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="41%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Refractive</font></div>
</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">28</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="8%" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">25</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">12.0</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.0</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8.0</font></div>
</td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="bottom" width="41%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="7%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="41%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total Surgical</font></div>
</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">772</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="8%" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">673</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">14.7</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5.9</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8.8</font></div>
</td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="bottom" width="41%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="7%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="41%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Contact lens disinfectants</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">115</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">106</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8.5</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.7</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3.8</font></div>
</td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="41%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Artificial tears</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="7%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">81</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="8%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">65</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">24.6</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">9.2</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">15.4</font></div>
</td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="41%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Other</font></div>
</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">25</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="8%" style="BORDER-BOTTOM: black 0.75pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">23</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8.7</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.4</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4.3</font></div>
</td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="bottom" width="41%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="7%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="41%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total Consumer Eye Care</font></div>
</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="7%" style="BORDER-BOTTOM: black 0.75pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">221</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.75pt solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="8%" style="BORDER-BOTTOM: black 0.75pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">194</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">13.9</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">6.2</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7.7</font></div>
</td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="bottom" width="41%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="7%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="8%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="9%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="10%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="41%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total Global Sales</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td align="right" valign="bottom" width="7%" style="BORDER-BOTTOM: black 2.25pt double">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,721</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="bottom" width="1%" style="BORDER-BOTTOM: black 2.25pt double">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td align="right" valign="bottom" width="8%" style="BORDER-BOTTOM: black 2.25pt double">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,493</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="9%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">15.3</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">5.5</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="3%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="bottom" width="10%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">9.8</font></div>
</td>
<td valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">N/M - Not Meaningful</font></div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 54pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">See (a) on previous table.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Pharmaceutical</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 18pt"></font>Global sales of our pharmaceutical products grew 16.3% during the three months ended March 31, 2010.&#160;&#160;The effect of favorable exchange rates increased global sales of our pharmaceutical products 4.6%.&#160;&#160;Excluding the effect of foreign exchange fluctuations, our sales of pharmaceutical products would have grown 11.7%.&#160;&#160;Sales of key products in most major therapeutic categories reflected volume gains and share growth.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our prostaglandin family of glaucoma products includes <font style="DISPLAY: inline; FONT-STYLE: italic">TRAVATAN</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> ophthalmic solution, <font style="DISPLAY: inline; FONT-STYLE: italic">TRAVATAN Z</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174; </font>ophthalmic solution and <font style="DISPLAY: inline; FONT-STYLE: italic">DuoTrav</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> ophthalmic solution.&#160;&#160;Combined sales of our family of <font style="DISPLAY: inline; FONT-STYLE: italic">TRAVATAN</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> products grew 26.7% for the three months ended March 31, 2010, reflecting market
 share gains in both the United States and </font></div>

<div><br>
</div>

<div>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">34</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">the International business segments, price increases in the United States and the effects of foreign currency changes.&#160;&#160;During the three months ended March 31, 2010, <font style="DISPLAY: inline; FONT-STYLE: italic">Azopt</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> ophthalmic suspension, the Company's topical carbonic anhydrase inhibitor, and <font style="DISPLAY: inline; FONT-STYLE: italic">AZARGA</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> ophthalmic suspension, a combination formulation of brinzolamide and timolol, posted a 30.3% combined sales increase as a result of the increasing acceptance of <font style="DISPLAY: inline; FONT-STYLE: italic">AZARGA</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#
174; </font>and market share gains for <font style="DISPLAY: inline; FONT-STYLE: italic">Azopt</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font>.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Sales of <font style="DISPLAY: inline; FONT-STYLE: italic">Vigamox</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> ophthalmic solution, our leading anti-infective fluoroquinolone drug, increased 19.4% compared to 2009, reflecting volume growth and price increases.&#160;&#160;Moxifloxacin<font style="DISPLAY: inline; FONT-STYLE: italic">, </font>the primary ingredient in <font style="DISPLAY: inline; FONT-STYLE: italic">Vigamox</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font>, is licensed to Alcon by Bayer Schering Pharma AG.&#160;&#160;<font style="DISPLAY: inline; FONT-STYLE: italic">NEVANAC</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> ophthalmic suspension is our non-steroidal anti-inflammatory drug ("NS
AID") for the treatment of pain and inflammation associated with cataract surgery.&#160;&#160;Sales of <font style="DISPLAY: inline; FONT-STYLE: italic">NEVANAC</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> grew 65.5% in the three months ended March 31, 2010 over the same period of the prior year, due to market share gains, wholesale and retail purchasing patterns that were reduced in 2009, price increases and launches in additional countries.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Pursuant to a prior legal settlement, a competitor of Alcon's launched a generic version of Alcon's branded <font style="DISPLAY: inline; FONT-STYLE: italic">TobraDex</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> ophthalmic suspension in the United States on January 1, 2009.&#160;&#160;Falcon Pharmaceuticals, our generic pharmaceutical subsidiary, also launched a generic version of <font style="DISPLAY: inline; FONT-STYLE: italic">TobraDex</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> ophthalmic suspension on January 2, 2009.&#160;&#160;During the three months ended March 31, 2010, combined sales of <font style="DISPLAY: inline; FONT-STYLE: italic">TobraDex</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font>
 ophthalmic suspension and Falcon's generic version of <font style="DISPLAY: inline; FONT-STYLE: italic">TobraDex</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> decreased 17.1% globally, primarily within the United States, over the same period of 2009.&#160;&#160;This decrease reflected the launch and distribution pipeline fill of Falcon's generic version in the three months ended March 31, 2009.&#160;&#160;Furthermore, the comparable period in 2009 did not reflect the full effect of the conversion to the lower priced generic products, which continued into the second quarter of 2009.&#160;&#160;With the expiration in September 2009 of a U.S. patent related to <font style="DISPLAY: inline; FONT-STYLE: italic">TobraDex</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font>, the introduction of additional generic products by competitors may further reduce our sales and profits for <font style="DISPLAY: inline; FONT-STYLE: italic">
TobraDex</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174; </font>in 2010.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Global sales of our leading allergy products, <font style="DISPLAY: inline; FONT-STYLE: italic">Patanol</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> and <font style="DISPLAY: inline; FONT-STYLE: italic">Pataday</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#8482;</font> ophthalmic solutions, declined 3.1% in the three months ended March 31, 2010.&#160;&#160;This was mainly due to contraction in the U.S. prescription allergy market and a delayed allergy season in the northern hemisphere.&#160;&#160;The decrease in U.S. sales was partially offset by growth outside the United States.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Sales of otic/nasal products increased 10.5% in the three months ended March 31, 2010 over the same period of 2009, despite contraction in the market for otic products.&#160;&#160;Price increases positively influenced sales of <font style="DISPLAY: inline; FONT-STYLE: italic">CIPRODEX</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> otic suspension.&#160;&#160;(<font style="DISPLAY: inline; FONT-STYLE: italic">CIPRODEX</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic">&#174;</font><font style="DISPLAY: inline; FONT-STYLE: italic">&#160;</font>is a registered trademark of Bayer AG, licensed to Alcon by Bayer Schering Pharma AG.)<font style="DISPLAY: inline; FONT-STYLE: italic">&#160;&#160;Patanase</font><font style="DISPLAY: inline; FONT-SIZE: 70%; 
VERTICAL-ALIGN: text-top">&#174;</font> nasal spray continued to gain market share in 2010.&#160;&#160;<font style="DISPLAY: inline; FONT-STYLE: italic">Patanase</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> gained an indication in December 2009 for patients 6 years of age or older for the relief of seasonal allergic rhinitis, which likely added to sales growth.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The change in the other pharmaceuticals/rebates line for the period ended March 31, 2010, compared to 2009, reflects growth attributable to increased statutory rebate levels pursuant to the U.S. healthcare reform legislation, increasing utilization of U.S. government programs and higher commercial rebates.&#160;&#160;As a result of healthcare reform legislation in the United States, we recognized provisions totaling $5 million for additional rebates primarily related to Medicaid.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Surgical</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Global sales of our surgical products grew 14.7% to $772 million in the three months ended March 31, 2010, compared to 2009.&#160;&#160;The effect of favorable exchange rates increased global sales of our surgical products 5.9%.&#160;&#160;Excluding the effect of foreign exchange fluctuations, our sales of surgical products would have increased 8.8%.&#160;&#160;Higher sales of intraocular lenses, as well as cataract and vitreoretinal products (which include surgical equipment, devices and disposable products), accounted for the constant currency growth.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Sales of intraocular lenses increased 17.3% in the three months ended March 31, 2010 over the same period in 2009.&#160;&#160;Excluding the 6.4% favorable effect of foreign exchange fluctuations, intraocular lens sales would have increased 10.9%.&#160;&#160;Global sales of our advanced technology lenses increased 49.8% in the three months ended March 31, 2010 and would have grown 43.0% without the 6.8% favorable effect of foreign exchange fluctuations.&#160;&#160;Sales of our advanced technology lenses rose with volume gains for the <font style="DISPLAY: inline; FONT-STYLE: italic">AcrySof</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> <font style="DISPLAY: inline; FONT-STYLE: italic">ReSTOR</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> multifocal 
intraocular</font></div>

<div><br>
</div>

<div>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">35</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;lens that corrects presbyopia and increased adoption by surgeons of the <font style="DISPLAY: inline; FONT-STYLE: italic">AcrySof</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> <font style="DISPLAY: inline; FONT-STYLE: italic">Toric </font>intraocular lens that corrects astigmatism.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Solid constant currency sales growth came from most other major product categories within the cataract and vitreoretinal segments.&#160;&#160;Sales of these surgical products grew slightly faster on a constant currency basis in the International business segment due to growth of phaco surgery in emerging markets, increased acceptance of advanced technology products and market share growth.&#160;&#160;Sales of surgical glaucoma products totaling $3 million subsequent to the January 2010 acquisition of Optonol Ltd. were included in this category.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The increase in refractive sales for the three months ended March 31, 2010 reflected U.S. sales growth of 27.3% from procedure growth and, outside the United States, favorable foreign exchange fluctuations.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Consumer Eye Care</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Our global consumer eye care sales, consisting of contact lens care solutions, artificial tears and other general eye care products, increased 13.9% to $221 million in the three months ended March 31, 2010, compared to $194 million in the three months ended March 31, 2009.&#160;&#160;The effect of favorable exchange rates increased global sales of our consumer eye care products 6.2%.&#160;&#160;Excluding the effect of foreign exchange fluctuations, our sales of consumer eye care products would have increased 7.7% over a weaker comparable period in 2009.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Sales of our contact lens disinfectants rose 8.5% in the three months ended March 31, 2010 compared to the same period in 2009.&#160;&#160;The increase resulted from favorable foreign exchange fluctuations and volume growth, the majority of which occurred in the United States.&#160;&#160;A portion of the U.S. volume growth reflected the return of retailers' inventories to more normal levels compared to the low levels in the same period of 2009.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Sales of our artificial tears products increased 24.6% over the same period in 2009.&#160;&#160;Excluding the 9.2% effect of foreign exchange fluctuations, sales of our artificial tears products would have improved 15.4% primarily from volume growth in both the United States and International business segments.&#160;&#160;A portion of the improvement is due to market share growth of <font style="DISPLAY: inline; FONT-STYLE: italic">Systane</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> <font style="DISPLAY: inline; FONT-STYLE: italic">Ultra</font> lubricant eye drops.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Sales of our other consumer eye care products increased 8.7% to $25 million in the three months ended March 31, 2010 from 2009.&#160;&#160;Excluding the 4.4% effect of foreign exchange fluctuations, sales of our other consumer eye care products would have increased 4.3%.&#160;&#160;The constant currency increase reflected growth in sales of ocular vitamins and redness relief products.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Gross Profit</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Gross profit increased 16.7% to $1,329 million in the three months ended March 31, 2010 from $1,139 million in 2009.&#160;&#160;Gross profit increased as a percent of sales to 77.2% in the three months ended March 31, 2010 from 76.2% in 2009.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">During the three months ended March 31, 2010, advancements in our sales reporting system permitted us to better estimate allowable deductions from sales in the calculation of accrued royalties.&#160;&#160;This change in estimate resulted in a $24 million addition to gross profit during the period.&#160;&#160;The remaining gross profit margin reflected the effects of price increases in the United States, manufacturing efficiencies, lapping the severance charges for the first quarter of 2009 and improvements in product sales mix, which primarily were offset by the loss of gross margin on sales of tobramycin/dexamethasone combination products from generic competition to <font style="DISPLAY: inline; FONT-STYLE: italic">TobraDex</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font>,<font style="DISPLAY: 
inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#160;</font>differences in foreign currency exchange rates, and increased rebates from the enactment of U.S. healthcare reform legislation.</font><br>
</div>

<div>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">36</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Operating Expenses</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><br>
</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Selling, general and administrative expenses increased 4.2% to $492 million in the three months ended March 31, 2010 from $472 million in 2009, primarily due to foreign exchange impacts, partially offset by lapping the 2009 charges for a reduction in force.&#160;&#160;In 2009, we experienced the in-period costs of $9 million for a reduction in </font></font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">workforce.&#160;&#160;Selling, general and administrative expenses decreased as a percentage of sales to 28.6% from 31.6% in 2009.&#160;&#160;Although these expenses rose in 2010, disciplined cost management controlled their increase to levels below sales growth.</font></div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Research and development expenses increased 15.8% to $169 million (or 9.8% of sales) in the three months ended March 31, 2010 from $146 million (or 9.8% of sales) in 2009.&#160;&#160;The increase in research and development expenses represented a continued investment across pharmaceutical, surgical and consumer eye care product lines.&#160;&#160;The 2009 expense included $6 million of in-period costs for reductions in workforce.&#160;&#160;The increase in research and development expenses also included operations of our ESBATech biotech laboratories, acquired in September 2009.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Amortization of intangibles increased to $11 million in the three months ended March 31, 2010, from $7 million in 2009.&#160;&#160;The increase arose from amortization of licenses and technology related to ESBATech, acquired in September 2009, and Optonol, acquired in January 2010.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Other operating expenses for the three months ended March 31, 2010 represented legal and other costs related to the anticipated change of control discussed in note 13 to the condensed consolidated financial statements and other costs to support Alcon's board of directors in its evaluation of Novartis's merger proposal.&#160;&#160;A change of control would accelerate the recognition of certain compensation expenses, including share-based payments and pensions.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Operating Income</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Operating income increased 27.0% to $653 million in the three months ended March 31, 2010 from $514 million in 2009.&#160;&#160;This improvement in 2010 reflected the sales growth, the change in estimating royalties, lapping the 2009 charges for a reduction in force, disciplined cost management discussed above and foreign currency exchange fluctuations.&#160;&#160;Share-based compensation costs reduced operating income by $18 million and $23 million in the three months ended March 31, 2010 and 2009, respectively.&#160;&#160;Share-based compensation costs in the three months ended March 31, 2010 represent approximately 25% of the normal share-based compensation expense to be recognized in the full year 2010, as a result of changes in the vesting of the 2010 awards.&#160;&#160;Because more awards were expensed on their grant date in Februa
ry 2009, share-based compensation costs in the three months ended March 31, 2009 represented approximately 30% of the share-based compensation expense recognized in the full year 2009.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Alcon United States business segment operating income increased 22.1% to $431 million, or 59.4% of sales, in the three months ended March 31, 2010 from $353 million, or 53.6% of sales, in 2009.&#160;&#160;Operating income as a percent of sales improved in 2010 as a result of sales volume growth, price increases, the change in estimating royalties and holding operating expenses essentially flat.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Alcon International business segment operating income increased 22.2% to $463 million, or 46.5% of sales, in the three months ended March 31, 2010 from $379 million, or 45.4% of sales in 2009.&#160;&#160;In 2010, the operating income margin improved as result of sales growth, foreign exchange fluctuations, and improved operating expense ratio leverage.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Operating income for the Alcon United States and Alcon International business segments does not include: (1) certain manufacturing costs (e.g., manufacturing operation period costs and manufacturing variances); (2) all research and development costs other than regulatory costs; (3) certain other general corporate expenses; and (4) share-based compensation.</font><br>
</div>

<div><br>
</div>

<div>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">37</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Interest and Other Income (Expenses)</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Interest income decreased 27.3% to $8 million in the three months ended March 31, 2010 from $11 million in 2009, primarily as a result of lower short term interest rates, partially offset by higher balances of cash and cash equivalents in 2010.&#160;&#160;Interest expense decreased 40.0% to $3 million in the three months ended March 31, 2010 from $5 million in 2009, resulting from decreased borrowings and lower interest rates.</font><br>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Other, net, included gains (losses) on investments for the three months ended March 31, 2010 and 2009 as follows:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom" width="76%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="6" valign="bottom" width="11%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Three months ended March 31,</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" width="10%" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td colspan="7" valign="bottom" width="23%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(in millions)</font></div>
</td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Realized gains (losses) on sale of investments</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">15</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(36</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Unrealized gains (losses) on investments classified as trading securities</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">40</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 0.5pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Other</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">--</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">20</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Alcon and its subsidiaries invest cash flow generated from operations to fund ongoing operating expenses, research and development and long term corporate liabilities.&#160;&#160;The majority of the funds needed to accommodate expenses and liabilities are invested in cash and cash equivalents, the income from which is recorded in interest income.&#160;&#160;Despite the significant weighting to cash, the Company does have material exposure to the following investment markets:&#160;&#160;fixed income securities, a senior secured bank loans fund and, to a lesser extent, equities.&#160;&#160;The realized and unrealized gains and losses on investments in the three months ended March 31, 2010 reflect the volatility in the public markets in line with market indices.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Company had material exposure during the first quarter of 2009 to the following investment markets: fixed income securities, hedge funds, senior secured bank loans funds, equities and real estate investment trusts.&#160;&#160;The Company sold its investments in real estate investment trusts, a portion of its fixed income securities and a portion of the senior secured bank loans funds portfolio in the first quarter of 2009.&#160;&#160;The realized losses on sale of investments in the three months ended March 31, 2009 reflect the sale of these instruments, for which the majority of the losses were recognized as unrealized losses on trading securities during fiscal year 2008.&#160;&#160;The Company also requested redemption of its investments in hedge funds in 2009 and the balance in hedge funds has declined to $8 million at March 31, 2
010.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Income Tax Expense</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Income tax expense increased to $103 million in the three months ended March 31, 2010 from $62 million in the same period of 2009.&#160;&#160;The effective tax rate was 15.2% in the three months ended March 31, 2010, compared to 12.0% in the three months ended March 31, 2009.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The higher effective tax rate for the three months ended March 31, 2010 reflected differences in product and geographic earnings mix, a $25 million tax charge from the newly enacted provisions of U.S. healthcare reform laws (discussed below), and the expiration of the U.S. research and experimentation tax credit at the end of 2009.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Net Earnings</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Net earnings increased 26.8% to $573 million in the three months ended March 31, 2010 from $452 million in 2009.&#160;&#160;This increase resulted from 2010 sales growth, the change in estimating royalties, disciplined cost management, the costs recognized in 2009 for the reduction in workforce and improved financial investment returns.</font><br>
</div>

<div>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">38</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Liquidity and Capital Resources</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Cash, Debt and Liquidity</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">At March 31, 2010, the Company reported cash and cash equivalents of $3,129 million, short term borrowings and total debt of $721 million and consolidated shareholders' equity of $6,466 million.&#160;&#160;As part of our cash management strategy, the Company maintains large balances of cash and cash equivalents in Switzerland and Bermuda, while the Company's debt is borrowed in subsidiary operating companies located elsewhere.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">A portion of the Company's assets was held and invested through an irrevocable Rabbi trust in an unfunded arrangement for the payment of benefits to participants under certain defined benefit pension plans of the Company.&#160;&#160;At March 31, 2010, the accompanying condensed consolidated balance sheet included net assets of the trust (cash and cash equivalents of $43 million and short term investments of $248 million) that were restricted to the payment of pension benefits except under certain conditions, such as the Company's insolvency or termination of the trust.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In order to receive an expedited return in 2009 of assets held by Lehman Brothers International (Europe) London (in administration) as discussed in note 14 to the condensed consolidated financial statements, Alcon has agreed to return any assets which the Joint Administrators determine should not have been disbursed in settlement.&#160;&#160;The amount of funds to be returned, if any, would result from the determination by the Joint Administrators that the rights of another claimant in the proceeding have precedence over the Company's claim.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">U.S. Healthcare Reform</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In March 2010, the United States government enacted legislation that is expected to have far reaching implications for the healthcare industry.&#160;&#160;The U.S. Department of Health and Human Services has broad discretion to interpret certain sections of these new laws, and numerous regulations are anticipated to follow.&#160;&#160;The more significant changes and their estimated effects on the Company for 2010 and future years are discussed below.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 54pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Beginning January 1, 2010, the legislation increases the Medicaid drug rebate minimum percentage for single source and innovator multiple source drugs from 15.1% to 23.1% of average manufacturer price and for non-innovator multiple source drugs from 11% to 13%.&#160;&#160;The legislation further extends this drug rebate to utilization made through risk-based, Medicaid managed care plans.&#160;&#160;This portion of the legislation appears to be effective as of the date of enactment (March 23, 2010).&#160;&#160;The impact of this legislation will be to increase rebates paid by Alcon and potentially could put pressure on overall rebates paid to managed care organizations.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 54pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Beginning January 1, 2011, pharmaceutical manufacturers must enter into agreements with the U.S. government to provide a 50% discount on covered brand name Medicare Part D drugs for eligible Part D enrollees in the coverage gap.&#160;&#160;The legislation requires that the U.S. government must establish a model agreement within 180 days of enactment and pharmaceutical manufacturers should sign respective agreements within 30 days thereafter.&#160;&#160;The discounts are excluded from "Best Price" for Medicaid rebate purposes.&#160;&#160;The impact will cause Alcon to increase its rebates beginning in 2011.&#160;&#160;To the extent patients were foregoing purchasing their medicines once they entered the Medicare Part D coverage gap, this provision could result in a modest increase in prescriptions, although at a lower price.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 54pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The legislation also expands the section 340B drug discount program eligibility to the outpatient settings of qualified children's hospitals, free-standing cancer centers, critical access hospitals, rural referral facilities, and sole community hospitals with disproportionate share adjustment percentages equal to or greater than 8%.&#160;&#160;This will effectively increase volume to those facilities where we offer larger discounts.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 54pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The legislation imposes a non-deductible pharmaceutical industry fee, requiring brand manufacturers to pay an annual fee in the aggregate of $2.5 billion in 2011, escalating to $4.1 billion in 2018.&#160;&#160;The</font></div>
</td>
</tr></table>
</div>

<div><br>
</div>

<div>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">39</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div>&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 54pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">fee is determined based on each manufacturer's proportion of total specified government program sales as a </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">percentage of the entire brand manufacturing industry total of specified government program sales.&#160;&#160;We believe there will be no fees recognized in 2010.&#160;&#160;Based on 2009 sales and our assumptions about which sales will be subject to the fee, we estimate its effect on the Company would have been less than $10 million.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 54pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The legislation imposes a 2.3% excise tax on the sale of medical devices (as defined in section 201(h) of the Federal Food, Drug and Cosmetic Act) intended for humans.&#160;&#160;This provision becomes effective for sales after December 31, 2012 and will likely be imposed on a majority of the Company's surgical revenue but will exclude sales of our over-the-counter products such as contact lens disinfectants, artificial tears, and ocular vitamins.&#160;&#160;Based on 2009 sales and our assumptions about which products will be subject to the tax, we estimate its effect on the Company would have been less than $30 million.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 54pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The legislation should serve to increase the population that will have access to drugs by expanding Medicaid eligibility to 133% of the Federal Poverty Level.&#160;&#160;It also will create separate health benefit exchanges through which individuals and small businesses can purchase coverage.&#160;&#160;Quantifying this impact is not possible at this time.&#160;&#160;This portion of the legislation does not go into effect until January 1, 2014.</font></div>
</td>
</tr></table>
</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 54pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</td>
<td>&#160;</td>
</tr></table>
</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 54pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt;" face="Symbol, serif">&#183;&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Finally, the legislation changes the taxation of subsidies received by employers as a result of funding prescription drug benefits for retirees under the Medicare Prescription Drug Improvement and Modernization Act of 2003.&#160;&#160;The elimination of this benefit resulted in an initial $25 million charge to income taxes in the first quarter of 2010 and is expected to add an annual income tax cost of approximately $4 million at today's tax rates.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We anticipate that the provisions in the first and third bulleted paragraphs above will decrease sales by $20 million for 2010, including $5 million recognized in the first quarter.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Contingencies</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Change of Control</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As discussed in note 13 to the condensed consolidated financial statements, Novartis has exercised its call option to purchase all of Nestl&#233;'s controlling ownership of Alcon.&#160;&#160;The consummation of the transaction under the option right is subject to regulatory approvals.&#160;&#160;The consummation would trigger certain change of control provisions in the Company's share-based awards plan (including the vesting of certain outstanding share-based awards), certain retirement plans for Company employees and other agreements.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Upon a change of control in the ownership of Alcon, the Company's share-based compensation awards granted to employees prior to January 1, 2009 will vest immediately.&#160;&#160;However, the vesting of similar awards granted after January 1, 2009 will accelerate only if the respective participant's employment with the Company or its successor is terminated without cause, or by the participant under certain circumstances, within six months preceding or during the two years following a change of control.&#160;&#160;If Alcon is not the surviving corporation under a change in control, the equivalent value of the successor's securities may be substituted for Alcon shares under the awards.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Alcon Executive Retirement Plans Trust Agreement provides for the Company to fund the current actuarially determined present value of the aggregate accrued pension benefits of all participants in the event the Company undergoes a change of control.&#160;&#160;Management estimates that a significant contribution to the trust would be required.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Certain U.S. defined benefit plans contain change of control provisions such that, upon a change in control in the ownership of Alcon, such as Novartis's intended purchase of Nestl&#233;'s common shares of Alcon, the Company immediately would recognize special termination benefits and curtailment charges, and payments of related pension benefits would be accelerated.&#160;&#160;Management estimates that such charges would impact significantly the Company's results of operations in the period in which a change of control occurs.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">40</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In certain countries, the Company's employees participate in defined benefit plans of Nestl&#233;.&#160;&#160;No separate valuation for the Company's employees has historically been prepared for the plans, as they are not individually </font><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">material to the Company or to Nestl&#233;.&#160;&#160;Accordingly, these plans are treated as multi-employer plans.&#160;&#160;Annual contributions to these plans are determined by Nestl&#233; and charged to the Company.&#160;&#160;Under a change of control, the participants may or may not be migrated to another plan, and additional contributions by the Company may or may not be required in any new single-employer plans.</font></div>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Upon consummation of a change of control, we will no longer benefit from certain synergies as a result of our ownership by Nestl&#233;.&#160;&#160;Alcon has taken advantage of the synergies in several functional areas.&#160;&#160;We do not anticipate a significant financial impact to Alcon due to the loss of these synergies because we are currently negotiating with certain vendors/suppliers and financial services providers to mitigate any potential impact from a change of control.&#160;&#160;However, no assurances can be made at this time.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Other Contingencies</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We are aware of and are monitoring issues regarding climate change regulations but have not identified impacts on our operations of a material nature.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 18pt"></font>As further discussed in note 14 to the condensed consolidated financial statements, the Company and its subsidiaries are parties to a variety of other legal proceedings arising out of the ordinary course of business, including proceedings relating to product liability and patent infringement.&#160;&#160;The Company believes that it has valid defenses and is vigorously defending the litigation pending against it.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">While the results of the aforementioned contingencies cannot be predicted with certainty, management believes that the ultimate liability, if any, will not have a material adverse effect on the Company's consolidated financial position or results of operations.&#160;&#160;Litigation contingencies are subject to change based on settlements and court decisions.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Cash Flows</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">During the three months ended March 31, 2010, the Company generated operating cash flow of $388 million, compared to $409 million in 2009.&#160;&#160;The decrease in operating cash flow primarily reflected increased working capital requirements.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Investing Activities</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Net cash used in investing activities in the three months ended March 31, 2010 was $387 million, compared to $121 million provided by investing activities in 2009.&#160;&#160;The Company increased its investing activities in 2010 through an acquisition, the purchase of intangible assets and adjustments to the investment portfolio.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Capital expenditures in 2010 grew slightly from 2009.&#160;&#160;Our capital expenditures were made principally to expand and upgrade our manufacturing and research and development facilities and other infrastructure.&#160;&#160;In 2009, we broke ground to build a facility in Singapore that will manufacture pharmaceuticals to be distributed throughout most of Asia.&#160;&#160;Construction continued in 2010, and we plan for the 331,000 square foot facility to be fully functional in 2012.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In January 2010, we acquired Optonol, Ltd., a medical device company that develops, manufactures and markets novel miniature surgical implants used to lower intraocular pressure in patients with glaucoma.&#160;&#160;With this acquisition, Alcon acquired Optonol's <font style="DISPLAY: inline; FONT-STYLE: italic">Ex-PRESS</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> ophthalmic glaucoma device.&#160;&#160;This medical device will complement Alcon's pharmaceutical products that lower intraocular pressure in patients with glaucoma and ocular hypertension, and will be additive to the Company's growth opportunities.</font></div>

<div><br>
</div>

<div>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">41</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div>&#160;</div>

<div>
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The device is currently reimbursed in the U.S by Medicare and other payors, and it is also approved and currently marketed in Europe, Canada, Australia and several other countries.&#160;&#160;Because the product is already approved in the United States and other major markets, it began contributing commercially in the first quarter of 2010.</font><br>
</div>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">&#160;</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In the first quarter of 2010, we also purchased certain intangible assets.&#160;&#160;The intangible assets included the technology and licenses to manufacture, market and sell <font style="DISPLAY: inline; FONT-STYLE: italic">Durezol</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#8482;</font> ophthalmic steroid for post-surgical ocular pain and inflammation.&#160;&#160;We were unable to complete a purchase of the technology and rights to <font style="DISPLAY: inline; FONT-STYLE: italic">ZIRGAN</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#8482;</font> topical ophthalmic gel for herpetic keratitis during the first quarter of 2010.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Financing Activities</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">During the three months ended March 31, 2010, we increased our short term borrowings by $60 million.&#160;&#160;Our short term borrowings are discussed more fully under "Credit and Commercial Paper Facilities" below.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In February 2010, approximately 1.3 million employee share-settled stock appreciation rights and approximately 168,000 employee stock options became exercisable.&#160;&#160;The exercise price applicable to these instruments was $130.56 per share.&#160;&#160;During 2010, approximately 654,000 stock options were exercised, providing proceeds of $45 million to the Company, and approximately 297,000 share-settled stock appreciation rights were exercised.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We intend to issue new common shares from conditional capital for the exercise of stock options held by employees that were granted in 2002 and 2003, as well as for share-based awards granted after December 31, 2007.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Since 2002, the Company's board of directors has authorized the purchase on the open market of up to 27 million Alcon common shares to, among other things, satisfy the exercise of equity awards granted to employees that are scheduled to become exercisable in 2007 through 2012.&#160;&#160;To the extent such share purchases are not required for employee awards, the board may present the shares for approval of cancellation at future shareholders' meetings.&#160;&#160;Through March 31, 2010, we cumulatively have purchased approximately 25.4 million Alcon common shares (including approximately 56,000 shares in 2010) for $2,716 million (including $9 million in 2010).</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In December 2008, as a result of the Purchase and Option Agreement between Nestl&#233; and Novartis discussed in note 13 to the condensed consolidated financial statements, the Company discontinued the purchase of Alcon common shares in the open market under all share repurchase programs.&#160;&#160;However, the Company continues to acquire shares withheld from employees' exercises of share-based awards to cover their taxes.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 18pt"></font>The payment of dividends is subject to the availability of retained earnings or dividendable reserves under Swiss law, the proposal by our board of directors, and ultimately the approval of our shareholders.&#160;&#160;Future dividend payments will depend on various factors, including our net earnings, financial condition, cash requirements, future prospects and other factors deemed relevant by our board of directors in their proposal for approval to the shareholders.&#160;&#160;On February 10, 2010, Alcon's board of directors voted to propose to shareholders the payment of a dividend of CHF 3.95 per common share, or approximately $3.70 per common share at the exchange rate in effect on March 31, 2010, totaling an estimated $1,112 million depending on exchange rates.&#160;&#160;If the propo
sed dividend is approved by the shareholders at their annual general meeting on May 20, 2010, we expect that it will be paid on or about June 9, 2010.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Capital Resources</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 18pt"></font>We expect to meet our current working capital and liquidity needs, including the approximately $1,112 million anticipated dividend payment subject to shareholder approval, primarily through cash and cash equivalents, the liquidation of short term investments, and, to the extent necessary, short term borrowings.&#160;&#160;We expect to meet future liquidity requirements through operating cash flows and through issuances of commercial paper under the facility described below or other debt, the combination of which we believe would be sufficient, even if our sales were adversely affected as compared to expectations.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div><br>
</div>

<div>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">42</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Credit and Commercial Paper Facilities</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 18pt"></font>As of March 31, 2010, the Company had credit and commercial paper facilities totaling approximately $2.9 billion available worldwide, including a $2.0 billion commercial paper facility.&#160;&#160;As of March 31, 2010, $361 million of the commercial paper was outstanding at an average interest rate of 0.1% before fees.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 18pt"></font>Nestl&#233; guarantees the commercial paper facility and assists in its management, for which we pay Nestl&#233; an annual fee based on the average outstanding commercial paper balances.&#160;&#160;In addition, we pay Nestl&#233; a fee for serving as a guarantor on a bank loan for Japanese yen 5.0 billion ($54 million) maturing in January 2011 arranged by ABN AMRO for our subsidiary in Japan.&#160;&#160;Nestl&#233;'s guarantees permit us to obtain more favorable interest rates, based upon Nestl&#233;'s credit rating, than might otherwise be obtained.&#160;&#160;We believe that any fees paid by us to Nestl&#233; for its guaranty of any indebtedness or for the management of the commercial paper program are comparable to the fees that would be paid in an arm's-length transaction.&#160;&#160;Th
e loan contains a provision that may accelerate the obligations in the event that Nestl&#233;'s ownership of Alcon falls below 51%.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 18pt"></font>The Company also had available commitments of $75 million under unsecured revolving credit facilities with Nestl&#233; and its affiliates; at March 31, 2010, $6 million was outstanding under these credit facilities.&#160;&#160;Alcon's subsidiaries had third-party lines of credit, including bank overdraft facilities, totaling approximately $748 million under which there was an aggregate outstanding balance of $300 million at March 31, 2010.&#160;&#160;Most of the credit facilities with Nestl&#233; and third parties have terms for less than one year and accrue interest at a rate consistent with local borrowing rates.&#160;&#160;In aggregate, these facilities had a weighted average interest rate of 2.8% at March 31, 2010.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Valuation of Financial Instruments</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Fair Value Measurements and Disclosures Topic of the FASB's Accounting Standards Codification ("ASC") defines fair value, establishes a framework for measuring fair value, establishes a fair value hierarchy based on the inputs used to measure fair value and enhances disclosure requirements for fair value measurements.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Company has hired investment managers to invest funds primarily in liquid, short term high-quality fixed income investments or equity securities.&#160;&#160;The investments are held at a global custodian and priced using the custodian's pricing matrix, which primarily includes broker/dealer quotes in active markets.&#160;&#160;The pricing on these securities has not been adjusted by the Company.&#160;&#160;We have reviewed our global custodian's pricing source hierarchy, which details the preferred pricing source and method for each asset class.&#160;&#160;Due to the nature of the pricing sources, the Company has classified these investments as either Level 1 or Level 2.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As indicated in note 6 to the condensed consolidated financial statements, financial assets presented at fair value and categorized as Level 3 were corporate investments held in funds professionally managed by investment managers.&#160;&#160;These Level 3 financial assets were marked to net asset values furnished in statements received from fund custodians, whose statements reflect valuations conducted according to their respective fund pricing policies and asset types.&#160;&#160;The Company evaluated these pricing policies utilized by the investment advisors and validated certain fair value measurements.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">As discussed in note 6 to the condensed consolidated financial statements, in connection with certain acquisitions, the Company agreed to potential contingent payments, with an estimated fair value of $88 million, upon the achieve-ment of certain future research and development milestones and/or certain revenue objectives.&#160;&#160;These contingent liability payments were classified as Level 3 under the fair value hierarchy and were valued using discounted probability weighted cash flow models.&#160;&#160;The sensitivities of the estimates to the assumed probabilities are discussed in that same note.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div><br>
</div>

<div>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">43</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The Company's financial assets and liabilities presented at fair value and categorized as Level 3 as of March 31, 2010 and December 31, 2009 were summarized in the table presented below:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">March 31,</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">December 31,</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2010</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2009</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="6" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(in millions)</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Level 3 assets</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">22</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total assets</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">9,213</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8,686</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total financial assets measured at fair value</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">612</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">559</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Level 3 assets as a percent of total assets</font></div>
</td>
<td align="right" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Less than 1 %</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Less than 1 %</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Level 3 assets as a percent of total financial assets measured at</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">fair value</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Level 3 liabilities</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">88</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">71</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total liabilities</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,747</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">2,781</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total financial liabilities measured at fair value (including short <font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">term borrowings)</font></font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">811</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">736</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Level 3 liabilities as a percent of total liabilities</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Level 3 liabilities as a percent of total financial liabilities measured</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="76%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">at fair value</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">11 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10 </font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">%</font></td>
</tr><tr>
<td valign="bottom" width="76%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">For a further discussion regarding the measurement of financial instruments, see note 6 to the condensed consolidated financial statements.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Market Risks</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Interest Rate Risks</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Because we have previously financed, and expect to continue to finance, our operations in part through short term loans, we are exposed to interest rate risks.&#160;&#160;At March 31, 2010, the majority of our borrowings were short term, floating rate loans that will become more expensive when interest rates rise and less expensive when they fall.&#160;&#160;We have partly mitigated this risk by investing the majority of our cash and cash equivalents and certain short term investments in floating rate investments.&#160;&#160;We evaluate the use of interest rate swaps and periodically use such agreements to manage our interest rate risk on selected debt instruments.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Credit Risks</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In the normal course of our business, we incur credit risk because we extend trade credit to our customers.&#160;&#160;We believe that these credit risks are well diversified, and our internal staff actively manages these risks.&#160;&#160;Our principal concentrations of trade credit are generally with large and financially sound corporations, such as large retailers and grocery chains, drug wholesalers and governmental agencies.&#160;&#160;It is not unusual for our five largest customers in the United States to represent in the aggregate approximately 17% of the outstanding balance of our gross accounts receivable.&#160;&#160;No single customer accounted for more than 10% of the Company's consolidated sales in the three months ended March 31, 2010.</font></div>

<div><br>
</div>

<div>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">44</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div>&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In connection with our sales of surgical equipment, we frequently finance the purchase of our equipment and enter into leases and other financial transactions with our customers.&#160;&#160;In general, these loans and other transactions range in duration from one to five years and in principal amount range from $15,000 to $500,000.&#160;&#160;We conduct credit analyses of the customers to whom we extend credit and secure the loans and leases with the purchased surgical equipment.&#160;&#160;Over the last 23 years, we have offered financing programs for surgical equipment and losses have not been material to our operations.&#160;&#160;In countries that may be subject to high inflation, the credit risks to which we are exposed can be larger and less predictable.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We conduct some of our business through export operations and are exposed to country credit risk.&#160;&#160;This risk is mitigated by the use, where applicable, of letters of credit confirmed by large commercial banks in Switzerland and the United States.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; TEXT-DECORATION: underline">Currency Risks</font></font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We are exposed to market risk from changes in currency exchange rates that could impact our results of operations and financial position.&#160;&#160;We manage our exposure to these currency risks through our regular operating and financing activities and, when appropriate, through the use of derivative financial instruments.&#160;&#160;We use foreign currency derivative financial instruments as risk management tools.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We use foreign currency forward contracts and options to manage the volatility of non-functional currency cash flows resulting from changes in exchange rates.&#160;&#160;Foreign currency forward contracts are primarily used to hedge intercompany purchases and sales.&#160;&#160;The use of these derivative financial instruments allows us to reduce our overall exposure to exchange rate fluctuations, since the gains and losses on these derivative contracts substantially offset losses and gains on the assets and liabilities being hedged.&#160;&#160;A number of these contracts are executed through Nestl&#233; to take advantage of its expertise and economies of scale.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">New Accounting Standards</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In September 2009, the FASB issued Accounting Standards Update No. 2009-13, "Multiple-Deliverable Revenue Arrangements-a consensus of the FASB Emerging Issues Task Force."&#160;&#160;This update provides amendments to ASC Topic 605, "Revenue Recognition" for the measurement of revenue under multiple-deliverable revenue arrangements.&#160;&#160;The update is effective prospectively for revenue arrangements entered into or materially modified in fiscal years beginning on or after June 15, 2010.&#160;&#160;The Company continues to review this update and has not yet determined the impact, if any, of its adoption on the Company's consolidated financial statements.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div><br>
</div>

<div>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">45</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div>&#160;</div>

<div>&#160;</div>

<div>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">ITEM 3.</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</font></font></div>
</td>
</tr></table>

<br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Currency Risk</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Because a significant portion of our revenues and earnings are denominated in foreign currencies, we are exposed to market risk from changes in currency exchange rates that could impact our results of operations and financial position.&#160;&#160;We manage our exposure to these currency risks through our regular operating and financing activities and, when appropriate, through the use of derivative financial instruments.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">We use foreign currency forward contracts and options to manage the volatility of non-functional currency monetary assets and liabilities resulting from changes in exchange rates.&#160;&#160;Foreign currency forward contracts are used primarily to hedge intercompany receivables and payables.&#160;&#160;The use of these derivative financial instruments allows us to reduce our overall exposure to exchange rate fluctuations, since the gains and losses on the derivative contracts substantially offset losses and gains on the underlying assets and liabilities being hedged.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">The fair value of foreign currency forward contracts is subject to changes in currency exchange rates.&#160;&#160;Because we target hedging less than 100% of currency risk, we believe that any gains or losses to foreign currency forward contracts resulting from exchange rate fluctuations would primarily offset gains or losses on the underlying foreign currency assets or liabilities.&#160;&#160;Regarding foreign currency forward contracts, an instantaneous 10% appreciation in the value of foreign currencies against the U.S. dollar at March 31, 2010 would have decreased our earnings before income taxes by approximately $61 million.&#160;&#160;We believe that such losses would be offset primarily by gains on the underlying foreign currency assets or liabilities.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">At March 31, 2010, our financial instruments were as follows:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">$582 million equivalent notional amount of foreign currency forward contracts intended to offset potential earnings effects from intercompany receivables and loans (denominated in various currencies) held by a Swiss subsidiary.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">$2 million equivalent notional amount of foreign currency forward contracts intended to offset potential earnings effects from intercompany payables (denominated in U.S. dollars) held by our Korean subsidiary.</font></div>

<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">$22 million equivalent notional amount of foreign currency forward contracts intended to offset potential earnings effects from intercompany loans (denominated in euros) held by Alcon.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Interest Rate Risks</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Because we have previously, and expect to continue, to finance our operations, in part, through loans, we are exposed to interest rate risks that could impact our results of operations and financial position.&#160;&#160;At March 31, 2010, the majority of our borrowings were short term, floating rate loans that will become more expensive when interest rates rise and less expensive when they fall.&#160;&#160;We have partly mitigated this risk by investing our cash, cash equivalents and short term investments in floating rate investments.&#160;&#160;We evaluate the use of interest rate swaps and periodically use such agreements to manage interest rate risk on selected debt instruments.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In January 2001, we entered into a 10-year interest rate swap with a notional amount of 5 billion Japanese yen, effectively converting our 5 billion Japanese yen fixed interest rate (1.6%) obligation to a floating rate LIBOR (0.3% at March 31, 2010) instrument.&#160;&#160;At March 31, 2010, the fair value of the interest rate swap was $1 million, based on market data including the relevant interest rate.&#160;&#160;The equivalent notional principal amount at March 31, 2010 was $54 million.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div><br>
</div>

<div>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">46</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">At March 31, 2010, our interest rate sensitivity was largely dependent on the following balance sheet components:</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td colspan="12" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Interest Rate Sensitivity</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td colspan="3" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="7" valign="bottom" style="BORDER-BOTTOM: black 2px solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline">Annual Pretax Earnings Effect</font></font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td colspan="3" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Fair Value/</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="3" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">100 Basis</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="3" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">100 Basis</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td colspan="3" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Notional Amount</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="3" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Points Decrease</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="3" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Points Increase</font></div>
</td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td colspan="3" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Segment</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="3" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">in Rates</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="3" valign="bottom" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">in Rates</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman; TEXT-DECORATION: underline"><font style="DISPLAY: inline">Variable Rate Instruments</font></font></div>
</td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(in millions)</font></div>
</td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Assets:</font></div>
</td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td colspan="2" valign="bottom"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="64%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Cash and Cash Equivalents - Variable Rate</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">3,129</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(31</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">31</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="64%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Liabilities:</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="64%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Short Term Debt - Variable Rate</font></div>
</td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">667</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(7</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr>
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 0.5pt">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Interest Rate Swaps &#8211; Variable Rate</font></div>
</td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">54</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(1</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
</tr><tr>
<td valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td align="left" valign="bottom" width="64%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font id="TAB1" style="MARGIN-LEFT: 36pt"></font>Net</font></div>
</td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(23</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">)</font></td>
<td align="right" valign="bottom" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></td>
<td valign="bottom" width="9%" style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">23</font></td>
<td nowrap valign="bottom" width="1%" style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr><tr>
<td valign="bottom" width="64%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td valign="bottom" width="9%" style="TEXT-ALIGN: right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
<td nowrap valign="bottom" width="1%" style="TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;</font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 18pt"></font>Additionally, the Company holds fixed income portfolios with various strategies, all of which are actively managed within specific risk parameters.&#160;&#160;The market value of the Company's fixed income portfolios classified as available-for-sale investments was approximately $565 million at March 31, 2010; of which $185 million were U.S. government and agency securities, $97 million were a senior secured bank loans fund, $17 million were mortgage-backed securities, $265 million were corporate debt securities and $1 million were certain other investments.&#160;&#160;The senior secured bank loans fund is a professionally managed fund investing in loans made by banks to large corporate borrowers whose assets are pledged as collateral.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman">Equity and Other Market Risk</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 18pt"></font>Management reevaluated the Company's overall investment portfolio strategy and mix of investments in light of market conditions late in 2008.&#160;&#160;In December 2008, the board of directors authorized the Company to liquidate holdings in hedge funds and real estate investment trusts in an effort to reduce investment portfolio volatility.&#160;&#160;In January 2009, the Company sold its investment in real estate investment trusts.&#160;&#160;The Company filed redemption requests with the managers of the hedge funds and received the majority of the proceeds of these redemptions during 2009.&#160;&#160;Proceeds from these liquidations in 2009 were reinvested primarily in cash, cash equivalents and investment-grade fixed income investments.&#160;&#160;The Company expects to receive addition
al proceeds from the remaining hedge funds redemptions during 2010.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 18pt"></font>We purchase equity securities and other investments as part of our overall investment strategy for corporate liquidities.&#160;&#160;The Company's hedge fund investments are professionally managed by firms with long term performance records.&#160;&#160;Asset allocation and manager performance are monitored regularly.&#160;&#160;At March 31, 2010, the fair value of the Company's equity securities and hedge funds were $33 million and $8 million, respectively.&#160;&#160;The equity securities were classified as available-for-sale, while the hedge funds were classified as trading securities.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 18pt"></font>The values of these investments are subject to market price volatility.&#160;&#160;The following table shows the potential impact to the fair value of this portion of the investment portfolio assuming a hypothetical change in value of each security of a decline and an increase of 10%.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div><br>
</div>

<div>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">47</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="24%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="23%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Value of Securities</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="23%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="23%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Value of Securities</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="top" width="24%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="23%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Given Hypothetical</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="23%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="23%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Given Hypothetical</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="top" width="24%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="23%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10% Decline in Price</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="23%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Fair Value as of</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="23%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10% Increase in Price</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="top" width="24%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="1%" style="BORDER-BOTTOM: black 0.5pt solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="23%" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">of All Securities</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="1%" style="BORDER-BOTTOM: black 0.5pt solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="23%" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">March 31, 2010</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="1%" style="BORDER-BOTTOM: black 0.5pt solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="23%" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">of All Securities</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="top" width="24%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="23%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="23%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(in millions)</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="23%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="24%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Equities</font></div>
</td>
<td align="right" valign="top" width="1%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td align="right" valign="top" width="23%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">30</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="top" width="1%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td align="right" valign="top" width="23%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">33</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="top" width="1%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td align="right" valign="top" width="23%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">36</font></div>
</td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="24%" style="PADDING-BOTTOM: 2px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Hedge funds</font></div>
</td>
<td valign="top" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="23%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">7</font></div>
</td>
<td valign="top" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="23%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">8</font></div>
</td>
<td valign="top" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="1%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="23%" style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">9</font></div>
</td>
<td valign="top" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="1%" style="PADDING-BOTTOM: 2px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="top" width="24%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="23%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="23%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="23%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="left" valign="top" width="24%" style="PADDING-BOTTOM: 4px">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total</font></div>
</td>
<td align="right" valign="top" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td align="right" valign="top" width="23%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">37</font></div>
</td>
<td valign="top" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="top" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td align="right" valign="top" width="23%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">41</font></div>
</td>
<td valign="top" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="right" valign="top" width="1%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td align="right" valign="top" width="23%" style="BORDER-BOTTOM: black 4px double">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">45</font></div>
</td>
<td valign="top" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="1%" style="PADDING-BOTTOM: 4px"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="top" width="24%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="23%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="23%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="23%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 18pt"></font>While actual market prices for individual securities of this type can be volatile, this sensitivity assumes that all securities in the portfolio exhibit the same volatility concurrently.&#160;&#160;Security market prices change in a more complex fashion than presented.</font></div>

<div><br>
</div>

<div>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">48</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">ITEM 4.</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASERS</font></font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">&#160;</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 18pt"></font>The following table provides information with respect to purchases made during the three-month period ended March 31, 2010 by or on behalf of Alcon or any "affiliated purchaser" of Alcon common shares that are registered pursuant to Section 12 of the Exchange Act.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div align="left">
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td colspan="6" valign="bottom" width="74%" style="BORDER-RIGHT: medium none; BORDER-TOP: black 0.5pt; BORDER-LEFT: medium none; BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: center">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">PURCHASES OF EQUITY SECURITIES</font></div>
</td>
<td valign="bottom" width="1%" style="BORDER-TOP: black 0.5pt; BORDER-LEFT: medium none; TEXT-ALIGN: left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="BORDER-TOP: black 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td colspan="2" valign="bottom" width="1%" style="BORDER-TOP: black 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="1%" style="BORDER-TOP: black 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="1%" style="BORDER-RIGHT: black 0.5pt; BORDER-TOP: black 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="bottom" width="19%" style="BORDER-RIGHT: black 0.5pt solid; BORDER-LEFT: black 0.5pt solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%" style="BORDER-RIGHT: black 0.5pt solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="15%" style="BORDER-RIGHT: black 0.5pt solid; BORDER-LEFT: black 0.5pt solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="16%" style="BORDER-RIGHT: black 0.5pt solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td colspan="3" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td colspan="2" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="BORDER-RIGHT: black 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="bottom" width="19%" style="BORDER-RIGHT: black 0.5pt solid; BORDER-LEFT: black 0.5pt solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%" style="BORDER-RIGHT: black 0.5pt solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="15%" style="BORDER-RIGHT: black 0.5pt solid; BORDER-LEFT: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total Number of</font></div>
</td>
<td valign="bottom" width="16%" style="BORDER-RIGHT: black 0.5pt solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td colspan="3" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td colspan="2" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="BORDER-RIGHT: black 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="bottom" width="19%" style="BORDER-RIGHT: black 0.5pt solid; BORDER-LEFT: black 0.5pt solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%" style="BORDER-RIGHT: black 0.5pt solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="15%" style="BORDER-RIGHT: black 0.5pt solid; BORDER-LEFT: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Shares Purchased</font></div>
</td>
<td valign="bottom" width="16%" style="BORDER-RIGHT: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Maximum Number</font></div>
</td>
<td colspan="3" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td colspan="2" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="BORDER-RIGHT: black 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="bottom" width="19%" style="BORDER-RIGHT: black 0.5pt solid; BORDER-LEFT: black 0.5pt solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%" style="BORDER-RIGHT: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total Number</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="15%" style="BORDER-RIGHT: black 0.5pt solid; BORDER-LEFT: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">as Part of Publicly</font></div>
</td>
<td valign="bottom" width="16%" style="BORDER-RIGHT: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">of Shares That May</font></div>
</td>
<td colspan="3" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td colspan="2" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="BORDER-RIGHT: black 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="bottom" width="19%" style="BORDER-RIGHT: black 0.5pt solid; BORDER-LEFT: black 0.5pt solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%" style="BORDER-RIGHT: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">of Shares</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Average</font></div>
</td>
<td valign="bottom" width="15%" style="BORDER-RIGHT: black 0.5pt solid; BORDER-LEFT: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Announced Plans</font></div>
</td>
<td valign="bottom" width="16%" style="BORDER-RIGHT: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Yet Be Purchased</font></div>
</td>
<td colspan="3" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td colspan="2" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="BORDER-RIGHT: black 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="bottom" width="19%" style="BORDER-RIGHT: black 0.5pt solid; BORDER-LEFT: black 0.5pt solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%" style="BORDER-RIGHT: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Purchased</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Price Paid</font></div>
</td>
<td valign="bottom" width="15%" style="BORDER-RIGHT: black 0.5pt solid; BORDER-LEFT: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">or Programs</font></div>
</td>
<td valign="bottom" width="16%" style="BORDER-RIGHT: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">under the Plans</font></div>
</td>
<td colspan="3" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td colspan="2" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="BORDER-RIGHT: black 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="bottom" width="19%" style="BORDER-RIGHT: black 0.5pt solid; BORDER-LEFT: black 0.5pt solid; BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Period</font></div>
</td>
<td valign="bottom" width="12%" style="BORDER-RIGHT: black 0.5pt solid; BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(a)(b)(c)</font></div>
</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="11%" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">per Share</font></div>
</td>
<td valign="bottom" width="15%" style="BORDER-RIGHT: black 0.5pt solid; BORDER-LEFT: black 0.5pt solid; BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(a)(b)(c)</font></div>
</td>
<td valign="bottom" width="16%" style="BORDER-RIGHT: black 0.5pt solid; BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">or Programs (d) (e)</font></div>
</td>
<td colspan="3" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td colspan="2" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="BORDER-RIGHT: black 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="bottom" width="19%" style="BORDER-RIGHT: black 0.5pt solid; BORDER-LEFT: black 0.5pt solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%" style="BORDER-RIGHT: black 0.5pt solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="15%" style="BORDER-RIGHT: black 0.5pt solid; BORDER-LEFT: black 0.5pt solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="16%" style="BORDER-RIGHT: black 0.5pt solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td colspan="3" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td colspan="2" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="BORDER-RIGHT: black 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="19%" style="BORDER-RIGHT: black 0.5pt solid; BORDER-LEFT: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">January 1 to 31, 2010</font></div>
</td>
<td valign="bottom" width="12%" style="BORDER-RIGHT: black 0.5pt solid; TEXT-ALIGN: center">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,369</font></div>
</td>
<td align="right" valign="bottom" width="1%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">$</font></div>
</td>
<td valign="bottom" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">155.67</font></div>
</td>
<td valign="bottom" width="15%" style="BORDER-RIGHT: black 0.5pt solid; BORDER-LEFT: black 0.5pt solid; TEXT-ALIGN: center">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">4,369</font></div>
</td>
<td valign="bottom" width="16%" style="BORDER-RIGHT: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,759,660</font></div>
</td>
<td colspan="3" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td colspan="2" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="BORDER-RIGHT: black 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="19%" style="BORDER-RIGHT: black 0.5pt solid; BORDER-LEFT: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">February 1 to 28, 2010</font></div>
</td>
<td valign="bottom" width="12%" style="BORDER-RIGHT: black 0.5pt solid; TEXT-ALIGN: center">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">41,175</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">157.58</font></div>
</td>
<td valign="bottom" width="15%" style="BORDER-RIGHT: black 0.5pt solid; BORDER-LEFT: black 0.5pt solid; TEXT-ALIGN: center">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">41,175</font></div>
</td>
<td valign="bottom" width="16%" style="BORDER-RIGHT: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,718,485</font></div>
</td>
<td colspan="3" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td colspan="2" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="BORDER-RIGHT: black 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="19%" style="BORDER-RIGHT: black 0.5pt solid; BORDER-LEFT: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">March 1 to 31, 2010</font></div>
</td>
<td valign="bottom" width="12%" style="BORDER-RIGHT: black 0.5pt solid; BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: center">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10,204</font></div>
</td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">162.33</font></div>
</td>
<td valign="bottom" width="15%" style="BORDER-RIGHT: black 0.5pt solid; BORDER-LEFT: black 0.5pt solid; BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: center">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">10,204</font></div>
</td>
<td valign="bottom" width="16%" style="BORDER-RIGHT: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">1,708,281</font></div>
</td>
<td colspan="3" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td colspan="2" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="BORDER-RIGHT: black 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="bottom" width="19%" style="BORDER-RIGHT: black 0.5pt solid; BORDER-LEFT: black 0.5pt solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="12%" style="BORDER-RIGHT: black 0.5pt solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="15%" style="BORDER-RIGHT: black 0.5pt solid; BORDER-LEFT: black 0.5pt solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="16%" style="BORDER-RIGHT: black 0.5pt solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td colspan="3" valign="bottom" width="2%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td colspan="2" valign="bottom" width="1%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="BORDER-RIGHT: black 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="left" valign="bottom" width="19%" style="BORDER-RIGHT: black 0.5pt solid; BORDER-LEFT: black 0.5pt solid; BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Total</font></div>
</td>
<td valign="bottom" width="12%" style="BORDER-RIGHT: black 0.5pt solid; BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: center">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">55,748</font></div>
</td>
<td valign="bottom" width="1%" style="BORDER-BOTTOM: black 0.5pt solid"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="11%" style="BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">158.30</font></div>
</td>
<td valign="bottom" width="15%" style="BORDER-RIGHT: black 0.5pt solid; BORDER-LEFT: black 0.5pt solid; BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: center">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">55,748</font></div>
</td>
<td valign="bottom" width="16%" style="BORDER-RIGHT: black 0.5pt solid; BORDER-BOTTOM: black 0.5pt solid">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">N/A</font></div>
</td>
<td colspan="3" valign="bottom" width="2%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td colspan="2" valign="bottom" width="1%" style="PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="bottom" width="1%" style="BORDER-RIGHT: black 0.5pt; PADDING-BOTTOM: 0.5pt"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
</table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(a)&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Based on settlements occurring within the month.</font></font></div>
</div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(b)&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">Shares purchased were shares withheld to cover employee taxes under provisions of employee share-based compensation plans.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(c)&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In addition to the purchases disclosed in this table, during 2010 the Company also acquired 239 treasury shares from forfeitures of restricted shares by employees who terminated employment with the Company before vesting in such shares.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(d)&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">On September 7, 2007, Alcon's board of directors authorized the purchase in the market of up to an additional 2,000,000 Alcon common shares.&#160;&#160;The Company plans to use the acquired shares to cover expected future exercises of employee share-based awards.&#160;&#160;From time to time, the Company may purchase shares in the open market.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" id="list" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td align="right" style="WIDTH: 36pt">
<div><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">(e)&#160;&#160;</font></div>
</td>
<td>
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">In 2008, as a result of the agreement between Nestl&#233; and Novartis discussed in note 13 to the condensed consolidated financial statements, the Company halted the purchase of Alcon common shares in the open market under all share repurchase programs.&#160;&#160;However, the Company has continued to acquire shares withheld from employees' exercises of share-based awards to cover their taxes.</font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div><br>
</div>

<div>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">49</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">CAUTION CONCERNING FORWARD-LOOKING STATEMENTS</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 18pt"></font>This report contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.&#160;&#160;These forward-looking statements principally relate to statements regarding the expectations of our management with respect to the future performance of various aspects of our business.&#160;&#160;These statements involve known and unknown risks, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performances or achievements expressed or implied by our forward-looking statements.&#160;&#160;Words such as "may," "will," "should," "could," "would," "expect," "plan," "anticipate," "believe," "intend," "estimate," "project," "predict," "potential" and similar express
ions are intended to identify forward-looking statements.&#160;&#160;These statements reflect the views of our management as of the date of this report with respect to future events and are based on assumptions and subject to risks and uncertainties and are not intended to give any assurance as to future results.&#160;&#160;Given these uncertainties, you should not place undue reliance on these forward-looking statements.&#160;&#160;Factors that might cause future results to differ include, but are not limited to, the following: the development of commercially viable products may take longer and cost more than expected; changes in reimbursement procedures by third-party payors; competition may lead to worse than expected financial condition and results of operations; foreign exchange rate fluctuations may negatively affect our financial condition and results of operations; pending or future litigation may negatively impact our financial condition and results of operations; litigation settlements may negative
ly impact our financial condition and results of operations; resources devoted to research and development may not yield new products that achieve commercial success; changes caused by regulatory or market forces in the prices we receive for our products; the impact of any future events with material unforeseen impacts, including, but not limited to, war, natural disasters, or acts of terrorism; inability to attract qualified personnel, which could negatively impact our ability to grow our business; difficulty protecting our intellectual property rights; the occurrence of environmental liabilities arising from our operations; a weakening economy could affect demand for our products; product recalls or withdrawals may negatively impact our financial condition or results of operations; government regulation or legislation may negatively impact our financial condition or results of operations; changes in tax law or regulations in jurisdictions in which we and our subsidiaries are subject to taxation may adverse
ly impact our financial performance; supply and manufacturing disruptions could negatively impact our financial condition or results of operations; and the occurrence of any losses from property and casualty, general liability, business interruption and environmental liability risks could negatively affect our financial condition because we self-insure against those risks through our captive insurance subsidiaries.&#160;&#160;You should read this report with the understanding that our actual future results may be materially different from what we currently expect.&#160;&#160;We qualify all of our forward-looking statements by these cautionary statements.&#160;&#160;Except to the extent required under the federal securities laws and the rules and regulations promulgated by the Securities and Exchange Commission, we undertake no obligation to publicly update or revise any of these forward-looking statements, whether to reflect new information or future events or circumstances or otherwise.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">TRADEMARKS</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 18pt"></font>Trademarks used by Alcon appear in this report and are the property of or are licensed by one of Alcon's subsidiaries.&#160;&#160;<font style="DISPLAY: inline; FONT-STYLE: italic">Cipro</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> and <font style="DISPLAY: inline; FONT-STYLE: italic">CIPRODEX</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font> are registered trademarks of Bayer AG, licensed to Alcon by Bayer Schering Pharma AG.&#160;&#160;Moxifloxacin, the primary ingredient in <font style="DISPLAY: inline; FONT-STYLE: italic">Vigamox</font><font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top">&#174;</font>, is licensed to Alcon by Bayer Schering Pharma AG.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">&#160;</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 72pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">ITEM 5.</font></div>
</td>
<td>
<div align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold">EXHIBITS</font></font></div>
</td>
</tr></table>

<br>
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="95%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 96px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">101.INS</font></div>
</td>
<td width="837">
<div align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="FONT-WEIGHT: normal">XBRL Instance Document</font></font></font></div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt">
<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="95%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 96px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">101.SCH</font></div>
</td>
<td width="837">
<div align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="FONT-WEIGHT: normal">XBRL Taxonomy Extension Schema Document</font></font></font></div>
</td>
</tr></table>

<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="95%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 96px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">101.CAL</font></font></div>
</div>
</td>
<td width="837">
<div align="left">
<div align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="FONT-WEIGHT: normal"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="FONT-WEIGHT: normal">XBRL Taxonomy Extension&#160;Calculation Linkbase&#160;Document</font></font></font></font></font></font></div>
</div>
</td>
</tr></table>

<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="95%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 96px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">101.LAB</font></font></div>
</div>
</td>
<td width="837">
<div align="left">
<div align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="FONT-WEIGHT: normal"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="FONT-WEIGHT: normal">XBRL Taxonomy Extension&#160;Label Linkbase&#160;Document</font></font></font></font></font></font></div>
</div>
</td>
</tr></table>

<table align="center" border="0" cellpadding="0" cellspacing="0" id="hangingindent" width="95%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr valign="top">
<td style="WIDTH: 96px">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-WEIGHT: normal; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">101.PRE</font></font></div>
</div>
</td>
<td width="837">
<div align="left">
<div align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="FONT-WEIGHT: normal"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"><font style="DISPLAY: inline; FONT-WEIGHT: bold"><font style="FONT-WEIGHT: normal">XBRL Taxonomy Extension&#160;Presentation Linkbase&#160;Document</font></font></font></font></font></font></div>
</div>
</td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div><br>
</div>

<div>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">50</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>

<div><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman">SIGNATURES</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"><font id="TAB1" style="MARGIN-LEFT: 18pt"></font>Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</font></div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div>
<table cellpadding="0" cellspacing="0" width="100%" style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">
<tr>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="16%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" colspan="2" valign="top" width="38%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Alcon, Inc.</font></div>
</td>
</tr><tr>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="16%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" valign="top" width="15%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">(Registrant)</font></div>
</td>
<td valign="top" width="23%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="16%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="15%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="23%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="16%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="15%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="23%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Date&#160; </font></div>
</td>
<td align="left" valign="top" width="16%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">April 27, 2010</font></div>
</td>
<td align="right" valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">By&#160; </font></div>
</td>
<td colspan="2" valign="top" width="38%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;/s/ Joanne Beck&#160;</font></td>
</tr><tr>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="16%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" colspan="2" valign="top" width="38%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Name: Joanne Beck</font></div>
</td>
</tr><tr>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="16%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" colspan="2" valign="top" width="38%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Title: General Manager</font></div>
</td>
</tr><tr>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="16%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="15%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="23%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="16%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="15%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="23%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="16%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="15%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="23%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr><tr>
<td align="right" valign="top" width="12%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Date&#160; </font></div>
</td>
<td align="left" valign="top" width="16%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">April 27, 2010</font></div>
</td>
<td align="right" valign="top" width="11%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">By&#160; </font></div>
</td>
<td colspan="2" valign="top" width="38%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160;/s/ Stefan Basler&#160;</font></td>
</tr><tr>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="16%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" colspan="2" valign="top" width="38%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Name: Stefan Basler</font></div>
</td>
</tr><tr>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="16%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td align="left" colspan="2" valign="top" width="38%">
<div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">Title: Attorney-in-Fact</font></div>
</td>
</tr><tr>
<td valign="top" width="12%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="16%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="11%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="15%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
<td valign="top" width="23%"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">&#160; </font></td>
</tr></table>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div style="DISPLAY: block; TEXT-INDENT: 0pt"><br>
</div>

<div><br>
</div>

<div>
<div id="PGBRK" style="MARGIN-LEFT: 0pt; WIDTH: 100%; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt">
<div id="FTR">
<div id="GLFTR" style="WIDTH: 100%" align="left"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="PN" style="PAGE-BREAK-AFTER: always; WIDTH: 100%">
<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman">51</font></div>

<div style="WIDTH: 100%; TEXT-ALIGN: center"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>

<div id="HDR">
<div id="GLHDR" style="WIDTH: 100%" align="right"><font style="DISPLAY: inline; FONT-SIZE: 8pt; FONT-FAMILY: Times New Roman">&#160; </font></div>
</div>
</div>
</div>
</body>
</html>



</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>2
<FILENAME>acl6kq12010results.pdf
<DESCRIPTION>PDF
<TEXT>
<PDF>
begin 644 acl6kq12010results.pdf
M)5!$1BTQ+C,-)>+CS],-"C$W.2`P(&]B:@T\/"`-+TQI;F5A<FEZ960@,2`-
M+T\@,3@Q(`TO2"!;(#@R."`X-#D@72`-+TP@,S8V.38X(`TO12`Y,#(R,B`-
M+TX@-3$@#2]4(#,V,S(V.2`-/CX@#65N9&]B:@T@("`@("`@("`@("`@("`@
M("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("`@("!X<F5F#3$W
M.2`Q.2`-,#`P,#`P,#`Q-B`P,#`P,"!N#0HP,#`P,#`P-S,Q(#`P,#`P(&X-
M"C`P,#`P,#$V-S<@,#`P,#`@;@T*,#`P,#`P,3@S-2`P,#`P,"!N#0HP,#`P
M,#`R,#`P(#`P,#`P(&X-"C`P,#`P,#(R,S`@,#`P,#`@;@T*,#`P,#`P,C@P
M.2`P,#`P,"!N#0HP,#`P,#`S,#0U(#`P,#`P(&X-"C`P,#`P,#,X-3(@,#`P
M,#`@;@T*,#`P,#`P,S@Y,R`P,#`P,"!N#0HP,#`P,#`V,S`Q(#`P,#`P(&X-
M"C`P,#`P,#8T.#,@,#`P,#`@;@T*,#`P,#`P-C8Y,"`P,#`P,"!N#0HP,#`P
M,#`V-S8Y(#`P,#`P(&X-"C`P,#`P,S@U,C$@,#`P,#`@;@T*,#`P,#`X,#(R
M,B`P,#`P,"!N#0HP,#`P,#@W,SDR(#`P,#`P(&X-"C`P,#`P,#`X,C@@,#`P
M,#`@;@T*,#`P,#`P,38U-2`P,#`P,"!N#0IT<F%I;&5R#3P\#2]3:7IE(#$Y
M.`TO26YF;R`Q-S<@,"!2(`TO4F]O="`Q.#`@,"!2(`TO4')E=B`S-C,R-3@@
M#2])1%L\,&%A83%C.3-F.65D93AA-#@W,#@W8S(S9F,R-3(Y,S0^/&(Q9&$S
M-F$Y,#=E-68U-&$T.#0X-3<U,61B9F,T,3<W/ET-/CX-<W1A<G1X<F5F#3`-
M)25%3T8-("`@(`TQ.#`@,"!O8FH-/#P@#2]4>7!E("]#871A;&]G(`TO4&%G
M97,@,3<Q(#`@4B`-+TUE=&%D871A(#$W."`P(%(@#2]086=E3&%B96QS(#$V
M.2`P(%(@#3X^(`UE;F1O8FH-,3DV(#`@;V)J#3P\("]3(#DX,R`O3"`Q,#<U
M("]&:6QT97(@+T9L871E1&5C;V1E("],96YG=&@@,3DW(#`@4B`^/B`-<W1R
M96%M#0I(B6)@8&`&(AL&%@8&%D4&008$$&1@!4(6!HX##+C`JBD,#(P)#_P5
M7!Y8E/`LXGS*=(BI[:"PPBJ'G`*+`LE;/%=9VIM5'),6?%2H\M!ND3W!5\#F
MSG*\R2W106!A@N\>%1V&LVR+F$N8DA;L>!#YP"!")HUO-=O<Y@+'HPS;%[A/
MT&41SV-ZS?*+^4.#,$-2T)2-G5Y!WU1[O"7%#'NJ;QPS[)PRZ<BFH&2A(TL[
MDX6@;F*<<$A[VC*1%,%I3PT6*_1LUVR59$G=Z2-P(EKR=?+40IY6XS=/-[W2
M.*&L>RK1S5$R+YC+B.-TT8S`"6[14PYV+&OC3-^MG7I%<<*R*V''M5.A>H.=
M^:*-%O*TFA@\W:P%UIO&XCB-K>CFU`@7R;ATW>D!/4%\YZ??V&\9NO2(D<CY
MS=-.KW!6]/EMF;.K!97;%BC1OZ5DZ<[9^UHB9C0?$7FZV1IJ_!J.9AT>H/$'
M.HP.G$-P89:#O>7B>I''9+%`TIR]3Y<*=M@X67F)/-VX\PZ7CF1?6$&@P\7+
M,^>N4A7K.:Y=U=&5.#$G[$[&BR42D_K.SXZ:<TU1Z7E:L$OSI;E;-R[2W"KC
M>";L<U,76]^<,V\#-;:D648#+7+WBS9;U'%8Z<9R2/@Y*_K*6N;<Z@*'$#!(
MG&*VF3I)<F4DGDX+`0<8,&DP:71T,#!*=#0P,``9#!PP!I#5`95%"")D01)`
MMF`'3`2BDL4#KHRA`T$J&7=T(!0ADT";06PEB'$@\^""$!<@DV!QB%L97-(Z
M0%H$75Q".^".8(V`6P]Q&8.QL06$P0QA**6AN1OL8J`^*)?9`FZ""UA-*%0E
M7?,*$$QG8&DL`M+\0*P`SAF:#`(,I0PU#'N9I!@.,_UC8."T9^AE6,:@5GU_
MT1[IFUR^#).89!@W,U0P>##LD>]G6"N_D>%,U%.&BR%;&.09?C)L8V2#YK$5
M#*RU_T&1",1^``$&`"'^8I0-96YD<W1R96%M#65N9&]B:@TQ.3<@,"!O8FH-
M-S,R(`UE;F1O8FH-,3@Q(#`@;V)J#3P\(`TO5'EP92`O4&%G92`-+U!A<F5N
M="`Q-S`@,"!2(`TO4F5S;W5R8V5S(#$X,B`P(%(@#2]#;VYT96YT<R`Q.#@@
M,"!2(`TO365D:6%";W@@6R`P(#`@-C$R(#<Y,B!=(`TO0W)O<$)O>"!;(#`@
M,"`V,3(@-SDR(%T@#2]2;W1A=&4@,"`-/CX@#65N9&]B:@TQ.#(@,"!O8FH-
M/#P@#2]0<F]C4V5T(%L@+U!$1B`O5&5X="!=(`TO1F]N="`\/"`O5%0R(#$X
M-"`P(%(@+U14-"`Q.#8@,"!2("]45#8@,3@Y(#`@4B`^/B`-+T5X=$=3=&%T
M92`\/"`O1U,Q(#$Y,2`P(%(@/CX@#2]#;VQO<E-P86-E(#P\("]#<S8@,3@W
M(#`@4B`^/B`-/CX@#65N9&]B:@TQ.#,@,"!O8FH-/#P@#2]4>7!E("]&;VYT
M1&5S8W)I<'1O<B`-+T%S8V5N="`X.3$@#2]#87!(96EG:'0@-C4V(`TO1&5S
M8V5N="`M,C$V(`TO1FQA9W,@,S0@#2]&;VYT0D)O>"!;("TU-C@@+3,P-R`R
M,#`P(#$P,#<@72`-+T9O;G1.86UE("]'4$A!1T(K5&EM97-.97=2;VUA;B`-
M+TET86QI8T%N9VQE(#`@#2]3=&5M5B`Y-"`-+UA(96EG:'0@,"`-+T9O;G1&
M:6QE,B`Q.3,@,"!2(`T^/B`-96YD;V)J#3$X-"`P(&]B:@T\/"`-+U1Y<&4@
M+T9O;G0@#2]3=6)T>7!E("]4<G5E5'EP92`-+T9I<G-T0VAA<B`S,B`-+TQA
M<W1#:&%R(#$U,"`-+U=I9'1H<R!;(#(U,"`P(#`@,"`U,#`@,3`P,"`P(#(W
M."`S,S,@,S,S(#`@,"`R-3`@,S,S(#(U,"`R-S@@-3`P(#4P,"`U,#`@#34P
M,"`U,#`@-3`P(#4P,"`U,#`@-3`P(#4P,"`S,S,@,"`P(#`@,"`P(#`@-S(R
M(#8V-R`W,C(@-S(R(#8V-R`--C$Q(#<W."`W-S@@,S@Y(#`@-S<X(#8V-R`Y
M-#0@-S(R(#<W."`V,3$@-S<X(#<R,B`U-38@-C8W(#<R,B`W,C(@#3$P,#`@
M-S(R(#<R,B`P(#`@,"`P(#`@,"`P(#4P,"`U-38@-#0T(#4U-B`T-#0@,S,S
M(#4P,"`U-38@,C<X(#`@#34U-B`R-S@@.#,S(#4U-B`U,#`@-34V(#4U-B`T
M-#0@,S@Y(#,S,R`U-38@-3`P(#<R,B`U,#`@-3`P(#0T-"`-,"`P(#`@,"`P
M(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@
M-3`P(%T@#2]%;F-O9&EN9R`O5VEN06YS:45N8V]D:6YG(`TO0F%S949O;G0@
M+T=02$%&4"M4:6UE<TYE=U)O;6%N+$)O;&0@#2]&;VYT1&5S8W)I<'1O<B`Q
M.#4@,"!2(`T^/B`-96YD;V)J#3$X-2`P(&]B:@T\/"`-+U1Y<&4@+T9O;G1$
M97-C<FEP=&]R(`TO07-C96YT(#@Y,2`-+T-A<$AE:6=H="`V-38@#2]$97-C
M96YT("TR,38@#2]&;&%G<R`S-"`-+T9O;G1"0F]X(%L@+34U."`M,S`W(#(P
M,#`@,3`R-B!=(`TO1F]N=$YA;64@+T=02$%&4"M4:6UE<TYE=U)O;6%N+$)O
M;&0@#2])=&%L:6-!;F=L92`P(`TO4W1E;58@,38P(`TO6$AE:6=H="`P(`TO
M1F]N=$9I;&4R(#$Y,B`P(%(@#3X^(`UE;F1O8FH-,3@V(#`@;V)J#3P\(`TO
M5'EP92`O1F]N="`-+U-U8G1Y<&4@+U1R=654>7!E(`TO1FER<W1#:&%R(#,R
M(`TO3&%S=$-H87(@,C4R(`TO5VED=&AS(%L@,C4P(#`@-#`X(#`@-3`P(#@S
M,R`P(#$X,"`S,S,@,S,S(#4P,"`P(#(U,"`S,S,@,C4P(#(W."`U,#`@-3`P
M(#4P,"`--3`P(#4P,"`U,#`@-3`P(#4P,"`U,#`@-3`P(#(W."`R-S@@,"`P
M(#`@,"`P(#<R,B`V-C<@-C8W(#<R,B`V,3$@#34U-B`W,C(@-S(R(#,S,R`S
M.#D@-S(R(#8Q,2`X.#D@-S(R(#<R,B`U-38@-S(R(#8V-R`U-38@-C$Q(#<R
M,B`--S(R(#DT-"`W,C(@-S(R(#`@,"`P(#`@,"`U,#`@,"`T-#0@-3`P(#0T
M-"`U,#`@-#0T(#,S,R`U,#`@-3`P(`TR-S@@,C<X(#4P,"`R-S@@-S<X(#4P
M,"`U,#`@-3`P(#4P,"`S,S,@,S@Y(#(W."`U,#`@-3`P(#<R,B`U,#`@#34P
M,"`T-#0@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P
M(#`@,"`P(#,S,R`P(#`@,"`--3`P(#$P,#`@,"`Y.#`@,"`P(#`@,"`P(#`@
M,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#<V,"`P(#`@,"`-,"`P(#`@
M,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P
M(#`@,"`P(#`@,"`P(`TP(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P
M(#`@,"`P(#`@,"`P(#`@-#0T(#`@,"`P(#`@,"`P(#`@#3`@,"`P(#`@,"`U
M,#`@,"`P(#`@,"`P(#4P,"!=(`TO16YC;V1I;F<@+U=I;D%N<VE%;F-O9&EN
M9R`-+T)A<V5&;VYT("]'4$A!1T(K5&EM97-.97=2;VUA;B`-+T9O;G1$97-C
M<FEP=&]R(#$X,R`P(%(@#3X^(`UE;F1O8FH-,3@W(#`@;V)J#5L@#2])0T-"
M87-E9"`Q.34@,"!2(`U=#65N9&]B:@TQ.#@@,"!O8FH-/#P@+TQE;F=T:"`R
M,S,R("]&:6QT97(@+T9L871E1&5C;V1E(#X^(`US=')E86T-"DB)[%=+<]LX
M$K[[5Z#F,M26B1`@`))S<V0Y\69&<DGT/BK>FE(HRN*.0KI(*L[L#]_3'J:!
M!BF2HFSO:2_KI$00C^[&UU\_^#Z^>!?'G#`2;R^81SU.//B'HP#^^Y(J$G^]
M>#>M%$DJL^J1*LDOWGU8,?)877@D3O3/\X5#)O$_+WQ%_2#0<N+K"T[#R`_T
M#H>859<%U&.<N(RRP%=Z#^CR/&:DP(@)(^I^?AO/KLDJOHIG*SRI:.AQ84\&
M[<F@.>F%^N1G9S6;WB]OXULX=S6_)K._35SFT\"9?KR:?YB1Z>*77VY7J]O%
MG$S^$?_Y0E(9JG`HEAN#7"-7H=R_KJM=-A%4.OF$4>$\UD5^2:[IE!+N21&A
M.%`5A0BB&?EP7(6"!J&&<0B6RRGC0J)V9K2[1SS,D)G=-T7YE2CWDSD%+A.M
MRQIM7JM-2JI1/-5VWM4AN#DD2OC40SNU#;+UB1&QG-TMEC%9W)";Q7)V^V%.
M[I:W?P'_$(#S?K8D=UH']RAG4J'[S6&_=1!'URY7]U?SF,0+LKS_>08XK5VF
MR&))F-SHT?W\&J3%'V<(44`%B_A_Y?>ASZ^FQFX6^0*=9._.B1^%U!-$^8SZ
M_`QF+V'-0AKI8[AY)(*4![P5#:8CM`+/DMK0:C>!A<A)R=<)&"^=(K?SI-@B
MN8X.Q"@R(']VKIY*).;>_`(=F=?L;XQO;\S"@`:B:]?@QB.7D%%#*=SB&6^H
MX*5PF8(MPBGP3O9&]H'&5A4^BYS<=,U/)Y`U'#(_V-U?+"PE`3*Y/N.J";6!
M0[2A@8?^>('ZJKV>&7&IM.NE!%TM]8,!9Z]^GB[FE^1V#L%^PHH>6AQL5D0*
M#_.FB8#P"(Z/X#PX<;G.*WUA[JSAPM*IS3@SOP`)N+Q,'_&UPC4X@8,?)R'U
MG0JR4."0?&UPX@8W<#X>R2$`X('["WPAL_QQW]&"`G8/DY&8\$7G#J<$.0D$
MR2&.E,X4#4=`91A$F%AE*-MT($PU>/_O*MD1[4F]%11YC)UL#0:X.7=T0<G[
MXCM1'`^"SUAT>I`/W*=\GY&/_\G3_$M:/EZ2U7-6_RLM]^M\8^1PT*_44`SG
M1_TA7E\P%_X'H71#^!L-%PY(@,>%DM1O^:1:@R(CZ,&YVFS*M*JTGR%Z\R1[
M6N])^CU-#G7V+87I;9:DX)HQO$-(;:JC85A4(#F$F#"%#LSK\X$MP,?A,>.'
MK9D!\O0VWV3)ND[)E]])LDN3WW1NXH:S#,A6_D:>=VF]@]B$'R2LX9*BC!F;
MFVS=%@&&'JEJS6:RS?8I8%"2YVR_-V]DG><'@*),GXK26`UE5(:L4U!.PZFN
MR"'?@!5)\0U^=;'$F(!4Z-YH^9TI`5-T-(%(Z'9ZF+R>&05X.VBS^]$PV29W
MHU982R`00Z;SXG<8RD@GNLX68;:,6<8]Z""TMH"&HS$YBP$H*+U`"S^$L/6H
M@-`SOV5ZL>TO8F?2717(J/&C4?#&Q1.YG+$WF:1SCUG5'NJO<DF%%BS/V#MV
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MOR4#>.!U"@0="AR/#;QM)3'S_84U>`*953O-/'4UQD:_4Y(CTT;RIB2;C:8N
MXTAW@-*Q)5K/5+A@>DH]:&5N#V5NMYC/W!V^Y(]#478>7[>FBADS<!NN0B.;
M%%;#VAY(-_VC?;E=U;9J:ZFD-[_>XULQL*E,FUMT77+:UI@[5KM,7PKZEBQO
MS$=GYZ0NS,*TP#B%BAUU.Q#9>NRS8PVT#VMFI84\'<KJH+L<D+8\`$\8?_1=
MCES0_0H*#RCG\-5[[)5$&\*&0`XV5RMH#<NLSJ!?FGU/=NO\,25726V^#4TK
M#,T\?!N=I*3@R"X6^8*.MO!0]B"E>%&GH1S//,S3:8?#?L:QVS]VZB!)!A&B
M\G<P$UH<WPLC"*QY0:#%@0\"W??H2Q_;%=\+C(;QYL"NGFM8SAW&*OZFU7,]
MRVMV*2J;,@^.9_UE'@D:GFU;SA[&97OXK-EG#N/R&<WMI<8/V^4SFE]M7G@H
M@'.6#H-D]F(CPP,.7YH='C4I;TM^``;]T(_Z09Y+-Y=-(CE-D"EFB`(3P_,P
M=VWQ`&Y*L53E!ZL`OA&A=E2XY5'GJ[HK[.TIM9_F(!'F:3+(CL\XZHDD2W@+
M=0W2;ST;.QGD)]01<K>7[,R'EO.K^3,!?.PQH&OD@G#E424ZSCK;8G`1TDCT
M>HQCL+?=!O8825'"]QK@#TR`V^E?N)W)QH&^D#`W$,X6<G2>I&^M??&NQP`$
M!K$`=19FR(!0*-+&7^2NQ.$W!+`EQ6U5'<"U8%>GKBCW$ZEVMJ#L;2D<%+?V
M<D;.IBV59=I<I[?]1;9TKS#DS8`;O1HFVZ*`D*]J:.%,0P,F08UI;Z4GH$$)
M@>-[L/4YJW?#^K'.-RB<,W!U%'4J&VM+I4`];:V9%@8RZ=B'-E/:2@?_KY[*
M;&\_7GW*H*'M5+2HE:J,J[FXA$]:CU\:RZ#KRG3G:"HOUC+@C_"#82WS@E9.
MV$<!4ED?!3TQ1*$Q3BD1=(P;(CL"5A\$AN6>&5]Q+/<H6U(9A9V+\V.D2!2.
M8"V2NM!9ADO$P2A9@TP?6)Y"9[`AC?]='D%J]N7K6%RG20.%ELVXD>V?0JQ!
M0WL5Y6$@.EB<=$JI;8L&X/)1BC4`RU"=>!]\]1*F4`<<^]#$\H_$:E$`2_D0
MA5.^MBC('@J71J<VLGXN6C@:%)3?8\2`KD")!K;4V@AP5%T\_"X>#0RAS_VS
M/'/.!6:+"T8"E&$5L).NKL,LZZFIR4F0=3S(+X9*JGGH?*P,2_6SI2"^&1Y&
M!J6(&M.A9'-;LJ$AB51#D$&JAA[NCP$`N!^!CPIE;F1S=')E86T-96YD;V)J
M#3$X.2`P(&]B:@T\/"`-+U1Y<&4@+T9O;G0@#2]3=6)T>7!E("]4<G5E5'EP
M92`-+T9I<G-T0VAA<B`S,B`-+TQA<W1#:&%R(#,R(`TO5VED=&AS(%L@,C<X
M(%T@#2]%;F-O9&EN9R`O5VEN06YS:45N8V]D:6YG(`TO0F%S949O;G0@+T=0
M2$%)0RM!<FEA;"`-+T9O;G1$97-C<FEP=&]R(#$Y,"`P(%(@#3X^(`UE;F1O
M8FH-,3DP(#`@;V)J#3P\(`TO5'EP92`O1F]N=$1E<V-R:7!T;W(@#2]!<V-E
M;G0@.3`U(`TO0V%P2&5I9VAT(#`@#2]$97-C96YT("TR,3$@#2]&;&%G<R`S
M,B`-+T9O;G1"0F]X(%L@+38V-2`M,S(U(#(P,#`@,3`P-B!=(`TO1F]N=$YA
M;64@+T=02$%)0RM!<FEA;"`-+TET86QI8T%N9VQE(#`@#2]3=&5M5B`P(`TO
M1F]N=$9I;&4R(#$Y-"`P(%(@#3X^(`UE;F1O8FH-,3DQ(#`@;V)J#3P\(`TO
M5'EP92`O17AT1U-T871E(`TO4T$@9F%L<V4@#2]332`P+C`R(`TO5%(R("]$
M969A=6QT(`T^/B`-96YD;V)J#3$Y,B`P(&]B:@T\/"`O1FEL=&5R("]&;&%T
M941E8V]D92`O3&5N9W1H(#,Q-C8P("],96YG=&@Q(#4R-C0X(#X^(`US=')E
M86T-"DB)7%4)=(UG&G[>[_O_>R.(D)*([<:5")*&2(BM2>3>B#UFM&([$DF(
M)1KD$,M8@K:V:3HTI72&"F.:GLE5.[444VV%4&4<'(+41`EF3NF,ROWG2?1,
MV_G?\Y_S+>_W?L^[/1\$0&,L@4;J\-]&14\<G+8?..O@ZK#,W(R\,T%'DH`O
MOP%D>>:<?$=Z8745]ZX#/CZ3\B;G?I*2&\TQU\PKDZ?/FS2YWY),H/<!(/]A
M3G9&5L7,V.&TE\<S/7*X$&`T>PKX?<IYAYS<_(*Q__1MQGDE$!P^_?7,#'4[
MH!`HV\EY1&Y&09[?$5G'\U2'8T9&;O:*"3D<GBD@GC?S7I^=3]QU\[2Z_;Q9
MV7G3BD94`)U\@*8>\_=H9PZI_UOK]6@%6+?X$ZM5[1UD/3>GP>F=:E7J`%KK
M\.+_Z0O%<G1`-8IQ#.-Q1FFXY66DP9`@M(227A@L_@B$*;X(AQ.#D8KF&(1O
MI3'*T`W?23*62BB&8S/:8QA:(!'O8(L,L.YA*2[*%)3R]$Y)0$<,D13K)D8@
MU=K/.X`^>`_OBQ_:<<=7G-8-6IB--W$(EV%A##:86V@E%;_!#&L_QN&"C)&Q
M5FL,Q`PLP@9LQ1%4R5MRW#"M=,1B(F:)70(D7!=:.Q%G7FFPUSIEG8<_];?2
MZ@/5Q4BV'B(!U898.8QH`+I39N!#[,-U"9)8G00_Q/"N\5B(,AU.C"E82=\.
MR0(ITWY6";WIB4PL1J44R'$58EXQ'UOST8S^Q1#I*I3@,YS$?5I+EI$ZUQMO
M#8/`!UW@YDW+\0;^RLB=H)R2)A(B`VGY,[DAM_0,?9>6_XP:/,6_)5RFR"(5
MKPK-Z-JEUEZ$T<,$VAB(49B.CR5,$F0LSVY6<]4BM5COT]>-<..1%6>=A`U1
MU"W$1_3K'"[B[\Q7L@R5RVJ1WFV^82T@WBCDT(OEV(Z#>"*F-)!&\I(XI+OT
MI&<+Y+C<4FV44Z7IB;K,7&/-L]8BA+4R'MD\.17+L`+[48';N(\:">;)*)Z,
MEU19*V_+*56A1^EQNMA(,(J-4N.$\=QL:I[P7O!6,NIU=KIB*&4\)F$^8WV`
M<A)714LK:4M+_600+4V02;)0BN1=V28[9)^<EO-R3Q[)?U206J/6J\/J;ZI"
MG==M=&?MTG_2Y4:(<=7XT9Y1V\9[S/O(:FAUL;I;1=9FZYI54Y^%UJSX>"2Q
MNJ:1"Y:C"._B`\9\#UOO$NON9KU4X3%S\*/86$TMB:B].*6C1-"[49(F<V65
MK),2^5QN294\5U"-5'M*9]5##5+C5*%ZH)YK7^W4B;I`OZ>_UL^,>68TI=3<
M:SZV5=E#?<J?;ZJ]X85WBK?8N\F*92W:6'D![+D8]&?-#6*6LS"3,@MS,)<Q
MFL^(;V;EE.$3',87*&?L*W"-#%6'MT[N,1/?HQ9>4<RG*3Z4%]B[,C-)K)9T
MR69N7\@"*925LH&R2?XH6QG?"_*U7)2;<D>>T">H2)6H!M"C5#56C:=,4)EJ
MJ5JM]E#.J<OJFKJMGFE_W52WTQVU6T_6;^E5VJ/WZ&_T)2/,2#12C&G&:>,"
M/4\Q!YH3S$QSM;G5W&:>,+\RJTS+ML[VH>V`K=KN:^]A3[6/M*^T_\5^V'[=
M;OET9#T-)?I.^/E;)V.-*%4DECI`OX^J?'U&K9?27VC`7$4$69B@#N@CZH.%
M1?JV_EB19PU7_78_LE@Y/D6Y>=%H;E;CM`K&0_+A>IVACJJ-*DAZZ#[&"J.<
MK#./.+>IF\JNRJAQG]F8@%>E)?YEO(9'C'^%N8HQ358WI%1]K@:QDJ^@1!W&
M1FQ!MO0DNBSLQ3.\(P>U0_:Q[A;C/!Z@\F>T1E1M?Q5O"U)S;+V9H8,RPCJM
M.EGWV?6W9`6NZ6>L_==DF$1A!^XPZY<D1MH97J,5+I#YVF(3J_8?V,T>_,KH
MP`YZ@H,Z!F.,2N8\JO9+K\O,U\ODJ4ID.@/KF7MX'1N3@S>0J^IXU`]EK`2R
M2'U'W\=9:<\H7K1=Q?MX&X=T<X3J[6J)LO07A@-_0*4>PEM_1WYJ+3&TE(LI
M],-AW?66T,)4Q"%.)LH8N+B3@K96+I'O(!<E6..LC>9HLPO.R1!ICF-DKR!&
ML=ALX*VAYA[VX36DR&KL]F;A.-^5(`F5:%93C3G'+#(_,O>81\VSMFXH8-=N
M8A9OXWN^&@[)9"R^PP^L]?[LG@CV3R)1I/`-FZY&ZR-(DF#DD0/#R=O]&8,Q
MS.1L6BG$&O;3=KXAY_!8_&4<CN(*.R>0?9[)^WUH9S!>9=9G8P?9<9GLYDH6
MVJ(SX_1,_"1.Y?.^.IXM)L\>)Z;KN$OFL.IQ14@?<3%[F?BAKI=Y0P^DRBZ^
MR?O0BR^E2Y?C6W3@Z]J?/5K"<^FL#3^T02_SCBA$>(=9<6J*/B(M^!KZL:I&
M\F7O)S.)H@G]J$5S&8Y8[P!:*R67I9K;$Q)')L2_TJ]OG]Z]XGK&QG2/[M8U
MZN7(B"Z=.X5W#`OMX&P?XFC7MDWK5L$M@P);-'\IH%E3_R9^C1LU]&W@8[>9
MAE:""+<S.=WA"4OW&&'.E)3(NKDS@PL9OUA(]SBXE/QK'8\CO5[-\6O-!&I.
M^C_-A!>:"?_3%']'7_2-C'"XG0[/69?3<4#&C$CC>*W+.=KAJ:D?#ZT?%]6/
M&W,<$L(##G=0CLOAD72'VY,\)V>5.]U%<[L:^B8YD[)](R.PR[<AAPTY\@0Z
M\W9)X"M2/U"![MZ[%'P:$Y0GV.ER>UHZ774(/#K4G9'E21V1YG:U"@D9'1GA
MD:1,YW]9K];8**XK?.;.[.R:+GAM8AZV";LLMK'7!L(C?H6R^`6V>?D!V75I
MNWY``8L&:D%+::B3@C"#:1JB)B1!!$5-'Z8-8R=*#*+($5+2_D#]41FE28.C
M)JD@`9)4256EBJ??N3NSK(U;:%7$YW/O.?=Q[KG?/6>VS:1@A9D:DD.H4FYC
MZI6F6V[CW\:GH2/^_L(AHW?01VVQD+<CV-&Z*6*JK5'>(RV$?:O,Z=]_?\:M
M+A9/KXP<2K9FJ4;UC&U^[AK&(;]YJB&2;`WPWV@4:V"NR*F)&378NA=!K&_R
M8S=Q,!HQE8/8TL\GX5/%S[<Y6,V:V':_F1*L"&XUML=P-9F&28U[`P.9F>&S
MUKN46>TWFB/!@+D\*QAMK<KNOX>,QKTOS0S[9XZU%!7V^]+B@>V?DFHWO).3
M&YL3-MF2P[E5WYB(K,(>!6M!"-/?[H<GD2#.5,)_-I>0T5Z"8?@753#+[,"-
M;#-3*F.&KXSU/-]TY?B"?N-S`@."-ZZ/U;3:&CW']SEQDWF2H!KL3ML,A<R"
M`J:(NQ)W"A^_*OM+BPKW#(KG@CM]?@B$C]8CMJW1L@4(?R#`%WQD,$QMZ)C=
M#9%XWT]M60,47A"*FB+&EB''DK&!+=V.)3$]%@237R;^@9)A>G(3_U-]TZ96
M;RTSE6G_P;PY;J]O"M8WM$3\U4;,CFU]\YA>W%Z2L-DM<VIE1,T2=DMDJ=(*
M4FY*#.9.Q&MJ.?BO2U)W#+H]8*74*/X:TQ=;%?\;G10(W.6D0>L3GB7%K6FV
MFV99:&R_?$Q_C'M>0X7#6JZH;VXQC$EC;#7(0(91$_37&#&C==#J;@OZ?4'C
M+#Y7\HR=U3'G1@>M<T>RS)K>*`ZQ52D#6P55]`>5GH;^L-+3U!(YZ\//KI[F
MR(!01&6L(MH_%[;(6?QZ#$NM2&BYY^<>?CB!Z0/"(TU99\-$W=*J287LMP\J
M)'4>1Z=0^Z"(ZWQ2AW]%?/?NP&@U/>BC?QX>S84S"HWYIQMZJ9+-+>&@C\YH
MN\C4B.8!Z_!#\<=Z'S6*4NH5+/MH)O3?T1ZC>1A?@?XBR!;8!?1UP"%@$1``
M%@/5P&I;K@*6\Q[`<:R1S^M(2?2P>Q=M<KU!/M=&"D$V`%EHYVOOT7R]E)J`
MD#I+CIV&]GS8<MU'*1_C9J&_'N.6L$0_5^NB[;#7H;V0U\0YTB&G`.G0![#_
M9?89LE+[.3VAD74#[5RLO0ES0^I16@NY#G(=]!70KT&_!G,*1)_U!MI5:(<0
MF]6LEV?OHCQ@+>;4P\\&N5X7+8=M*O9-@UP`I,&>H>;1"\I%>@[R:UH^>>6Y
M,4:>>^.M,T&NE#Y-`/:1_4L&^R1*K4^!=X#W;-]J;P/[E0RB=G4QE4-V`T%>
M7US"F1M)@;W,]065,SQD?8ESO0],TSHH%?UK\+/!]3(MY3XP18*_4T_`I\]H
M+6PA_4F:#_T2<1\XMH7FBY]1B9Y#*3A?"\96`5V2>\R%#FK&?5B0D[4/*!.V
MN4`N[O",'2<?QP9]OE^<S_H8?ES'F`:@B;DE^=5!/NS/,>>[3U,VCH*;UC78
MO@Y\$^<J!^Z'_=O@<%3.P7RL6V[S,#\A`>9>$N:Q#P[XGAS$.4(9P#TV\H"+
MP`'@<6`GL(7'8-T"C&>>=&+-:O3G,#^8&UB+[Z'.YDX:^)TO.19_,\\@CG7`
M#"!5Q]NR,1EC,_B],&?E>\%;8#XRMY@SCF1^2]Z?5E[E<_*=)\DLUQ5J8A_D
MV<&M))G+/&.I#E&!E`4TCSG+?'.D?)-Q_W/Y33@RX0_>)[\1EEJ(<OBM,A<3
M$N^48Y&0TRD?:Z[1GX?OWZ4'M3RJ4SMIA=9"M:J)_#/*^UDWM&%Z4?R.0NXA
MR1F<D9X>)_F>C[N'E>VN(7H%L<S1+M'3D$%M6,S1AA67Z[1US75:[(_#:2?+
M\5"&XC:6C&3;?ZO_7R`NNT[3%K0_=`WC[0S3,9R5W!\I"P&_(Z$?`+J!`D](
M.>[I5`;=&_">B#X#'M+">.MA*M:&D!,R*(PXY4"_0?\I.-=)>5C[2Q&FU]%^
M$[FO6"6\3^PE+B-?`+P^Y)HD'HWAW`1<DM+AZP0R9'-)2N8S\MI;MGS;EC<A
M"\')/*X-G)^Y/G".!E8E^.KP,H\*(>L=?H[GJ<W/M38_;^?E+;D8LM*N+9R[
MT_F=8B^W_68W<7[D',<YDO,<YSAG_'B9F-]'3^$,;\H\?`ESX^]Z-A`""F'?
M:^<1Y&'K@,R''=9N=XVU6RNR=NNE5H_^$>16:X_89^U(U%2-[K-S6<"II;*.
MGJ<4IXZZ.JG+SFE<=Y>XRE&;XG54UD]]&?S8*NM;(?K3^!W*-WB$TL4^Q#6/
M)FG%M$6]0*JZ%G43>JT(.9EMNVBN>I.RM</(=4]8U]7':9FLFZMHLQJC4IZK
M#E"JZQ$*N/Z$6K;/^D2NQ_4*DG7LO[Z%5G`N<.V0M7>[G8\+^>X].GD]&N7)
M,9>0FT8HG<\B8U!'<V0<>.XC1+R6^QK-UDIE'/P,.>?OY.5X<(S&Q")>F^OD
MFB,RGTV1:X]@S]_31H8^F^K<;R-G\EX[*)8B."]:5^V:78MZ6JL^C^\@+Y'D
M_R7RJL64A5I98V.E]C!BWH6Q)^SO"I;(^[+>WT2N`D=<AZE1?D^P[4?X[GF-
M5C*T/IJK+T=^+$?NWTW9^BS$J)F"DM>KXWM#7RN_3[A.\7<"OY=EY-5CF(]W
M(7W@>L-KY\O8UH*C*SR34%O:*%7T*0JXERV__?IP[WT*?T<]EH2?V+KLN%0"
MXJJLKVR[*2Z(,^*"U2GK?3$5JK]&??P8.?Y5\&$F+1/M5"(,*M%2\&WV`-H_
MH!+U5\`QQ&"?-:)-1PZO@OY9X!#F_1'Q3(7M4XSY)7AP`'/O1?L=JE1?H1+7
MH^CG@*NO0XX`_\"\KU"O^B+UZCXZ*-JM8W)]QK[1OS%X/9X'+'`D^^I@0I]_
M0=X)_:VZY6?"QPG\XS5X73F/QQ1;(T36GX&<N!QM$$?I-'!*O(6Y0[1?>=(Z
MI^">E`^`$S9^0ZND[`<:<(?[E1Y@/:!I^^DD9!'DA\`P<`(X#]S4EB(61^DU
MR)=T_%1@B`L480G["\!O@2N.+1F\UT3Z9&A_M<XE]UV+J)0A"JUSC-O&GZ0E
MVO>0:Q=:YQCJ'N0'0)^"=^M!WO\+]!LQ;US?-8^>TAZB>^_DSYV@_($6RAC&
M$;Z;,]XM^!N-Z_/_:[V[!>[WA\"W9/Q/T7S)H:OX)G=;%Y7S]`WE7>L+]03I
MC'B?,F4\3Z(NV?<$?8_4C[L_<.5^M9'4\7JT'V`X_?'W>J<^UMV6#(<'#MR+
M*,S0KF`\,+[OZ:8P0V>.%=[>3^S[[_`O[JLUMLWJ#)^+X\1Q/MM)VK2DE\_8
M;DG=IC9?0M-E6O*Y%]:QN4VK2*,#-?G!(@%;DW72)KJ"7:9IFU112Z"QI!,-
M!&C'V)J>CZUN0U;_V`I;A1*J24F!-5TO@S)(LH[`>DOVG&,[!+=95C;^3-;S
M/N][SGLN/N=\YWU/(ZG&.MUI:\1<SEQOXPX)2;`VV#]%_5^1AP"3=B/B1V/Z
M?$I@;?T26.LC$NP,WJ,`WX2Z3<J_3F+*NMXMUY6G9%O57NU/]ISG[@_:$MOO
M$%_.$1_T\ER>/-^9^^(39WYC^KQ/VO(N.9_C\_$W\?&W@6]ENC[_GX!OYX_`
M*\"QSW0<G'-*<%8!#Z!RU*W(5;?@NWB-U!-R+4;(E:.$7$U!OPKN!W<B1I2#
M?PV$4/83\&KP7.!UU'V$.(*4?;S%5DZ>S.25J!O?`+_'@&2ZG_$RZ)7H_V]`
M%_!CE)\'6@`O(/WNRF`;ZM]*MQW_+OA'L"^#OP,<1]DF^#P,_47@7NC#P#^!
MIX!0NK\K\+MR2.8C-WB'_F]YFO?'?\KI]P8)9CGW#7%3O'5FSGUS9/=_)LZ^
M)6[`:ATR[Z9WIKQ]IGOC?()Q?AQ3@5S:CYS2)_-HF<O*_%GFCUE6[S;<!YGQ
M2Z>P2^:O,G>6^2M8O>_R+I`&K//*R7EEX\B4NY4M(U\'RC+`O4=6P^<$SMHH
MW4_<=/_$6#H')0D9VU0<`S#?XV`W[MRC].6),?!KL!<@ECFR,2U[MUYWQUX?
MTSY3^V9CY*>(J1LRN#\'V?*6#'+K0QGX)')C\<UBIMC]J6/Y-#%Z:IS^;^UL
MG,]BIKPT-P^8R9ZIOYNU<_..*?9!B7]3K^S<O"1KY^*Z^NO/7CJ?*<?WED7.
M=W>SP'>ZRM8Z<3+[O6;GD/,=%TY^;QG;'B-K@+59QOU1@7MD";`K\^[R0T<\
MF]@.WEQPE1@%OR0&;,38B=_(.P>\6=:!=]&7D$LCRL+^`>Q\W,72]^X,-L]T
MGG//K<S/57Z(-5-S3V`O/B`AX/-`"7`0^.;D7N/MB;%?YPW(`?'.Y><FQM#7
MV'2YX'2,=]XV^=Z#[8;M/D(:)U(V;JU=:YA)\-+EBD7%$N.PK!#E\XU>&V?M
MY#:BHX"*LGFJAHA5JS+*BI5IQ0I6&D.10ESO(P"S$1O%HJM65L5R8_0H;,K'
M<5%36<JO6IY9&(U?L]REAAGQ\$N($9<((]W\($D!C+3R,1(#&-P/B,K;Y4#\
M@%7H,CSP'R%>(`YPT@E)E6T"TG_$*BV3W;\MW,6JW9`(5Z<5RS/7:(C,XF]A
M/G_@)XB?Z/P,>"'X%?`"\#'^*M'4/)^UW!XCCO&ZX-[%'R)+4/T<WXX3H//]
M_!$R3[F=%*[T."=%1="(%/)]?(=R^3;_%JD&?X,_*`S=V\.?Q4Q-_I[E<,KY
MO2<\LXU>?H$_2&;!ZQR\YNCN7KZ5A`#Y3Y*60S,2D2*>Q-],8EETS)&2O4J:
M_(1`1QCOYSQ.RE#7QW>2V>`7^*-BMI[JX1\IMP]E+QCO&5%0)<G27$8JXD"4
MIUCQBUCQBVJT#ZS%*PT26<QWD3#`L*AGH9V%YN'#T(:Q3</8FF%LS3!F,8S,
MEO#W4?,^?$+\%&GC;Y($L!>Z#5T^)+""AY42J#`.\X?Y#JR$IP=K1U'ZB.5P
MR9GM$"6ERFV'5>0RZGOY`!*S`?1I\D%KSERCM8<_IOY*PIH[3S;XDW`48>F^
ME]X+--PN]Z"7Q_FC:B5VJA7H_BU,2MS\^ZKQA%54;,2P^XTP6R%W`_W`"&"#
M6R/^0R-I`CC<&RR7VW#W\*^IQE\2KBJ]EZ_#7U^G5FN=F.U3<_ZB!65C#_\R
M#LD&OE[<IV."&P4:R]KUULI:(]S#UZL_O%[H_G2Q*+U%*7<*1_KPK+8*B^5P
M:Y3C4E'@4L5+,]\=#UJSYA@Z#F.M^DM5D(378(]JL/XU^!BJU(H;EJ<$1_P^
M;JAI&Z09Z`2Z`1LVTH"[@8TTR&E5XN8K\)]6X!FQ`G^[#7(48"B_G=0#NX&C
MP&D@3Y4V`PSE88S0#)D`&'H,P?9`FD`S$`<Z@10P"N23/EZ)<2KA'8:,`]W`
M$&##ABS#/):AKH1[R;4"0G028^UF+8V1&(VQ&(_98GDQ3ZRXP+QCT3+#?$"*
MY5)40-0T.]H<<0</.TQ'@X-['%X'2TZD1'YM%<@LL==6O1%]-WHYRDMJ$O9$
M/NN+%-%B,@2,`)ST40\L#RR/^4/>5S=4-U+'^Z)#T9$H[SLU=&KD%.^K'*H<
MJ>1F=%ZM4=-$6VF,[J8VG89H/=U`;4V\E<?X;F[3>8C7XRS8FIUMSKB3AYVF
ML\')/4ZODR6<G<YN9\K9[\SKMJ?L_?;3]E%[7H.]V=YFC]L3]DZ[7<\/Y=?G
MFW;;:&0U>Q.+V@G9#3`2ATPHS:-J4I#]RDXHNQFR3=DF9(/2_)!AJ0%^]/4&
M_.*0"4#Z2=L/&98V@/#(3J*L#3(!,';2G.\+!\P`\P2\`48"=#1`^P.G`ZP[
MD`JP5*26#:I9#F*6@VJ6@V@YJ,8>1+_0`#]F.Z#\!N`WH/P&X">U&Y4U0[8I
MS81L4)H?,BPU-B#\->[('+8'/39![@6&`(YT;@^I!UJ5I4L/M@?29!W6;<N,
M>))UB,6X"$&^-"U,TWQ%UBWE1E/$S3K090>Z[$`GTM*!>FE-I%B[6"-]V\47
MTE1;-12I0:B44VDG!P"&C+L=/4@M!%FOM`/*QSUI=T.>5EH;9.=DNR:EZ9#9
MMIQUX-<.S<VVHW2[Z62DK`QI24EQ04F2'1'WE^A)]I*H\("L-`E)D5+&L?8:
M'5;R5TKN5?());^JI-MT^K5+?NWW?FV?7XL4LKM(`,6C2EY0\@'3%=#>"6C'
M`EI70'LFH/70L\2'BEO-<I]VWJ?]V:<=\FDO^+3'?=J]/FVC3_N*3W950;Q$
M8PNDI%N4G&_.\6I7O=I?O-IQK_:J5WO:JVWV:K5>N-.+")H:_9F23RIYQZ%J
M3:_6%E1K1QAN)GJ/<!-'#V/T'J+Q0A&LTY/<H8C=*J*+0/-%-`*:)Z*;0.4B
MN@U4*J*/ZQ$'<].#R$ATYJ('"R07B>!.5#O35"""6T!Y(O@Y/4G'1=`/NB):
M%H`NBY:%H`]%2S5H3-++]!]X5:$;^G?1\A2ZI^^2"MDM?9LL9K\`)T6T'MZ'
MTJ,CH:RCBU`LD#1*MQ=%$).C^T6P`K1/!`.@Y]/4)8(ZZ&G1\B_BJSZVJ>N*
MW_N>[??BK]B)OV+'/!N/%_,>=D)B)T$XYN'8*=1U^"S874*35#'A8QG!2;0B
MC95.C"(*$^LZ&-HH59F$VG78+X&9\K&H00.Z(KF3*O[81/,'FZIMV50U95.;
M+#OW.6N*Q#1I_^S:]Y[SSN]WS[F?]GE!$&?E["L@?BIG'X`X(_OW$G\_1G[%
MSVG$*S(GIUP`#\DIXF&?G*H'\4TY%0:Q1X[>!;%+CCX@77?B`H:3C;-(4$;:
M*V<%@)]=F$@W\BMP%PHKGI^04V1).HB3M0:<6)A('+>3Q`['<$'Q(LE"`]"B
MLL"#:"NO7$3.BB!:93^L,6Z1_6=AY9H7`BPG^W,-?PV&01SY9.$M('%R=CF(
M)7(V`<)%>L*@JA>B5L%[""&;98&P3++@X6Y@'<HJ'K6(QV<N<W/@]XMH$6^3
MN<^E(HME[N]^$)>YOZ3ZN#^GBI#6<G^"*_S69>XCH-Z/@BKIN-\+#[C?99=R
M[PG`D%S<'2'(3?+/<T7_56XLM80KP,#RV3[N8E;Q\`L>NLG<!7^1PM#[7/8I
M[K0@<J?X(AG##X!\A,0`1X>%Y[D7^4/<"!R%X=11+B>XN7W^'=QN/PEDYW8)
MF[D!F,A.Z-.?W<GU"J]P/6%EQ#N$N]R6L#*'9%:9T?JH`JS+;N8Z8`0`K"$`
MC&`UG,M&Z!H,7R5KA`*X?>PN]W3+-0K^A?$+4/=+0>8Z<Y#I8[8R,?B_J6.6
M,5YF"6-AJU@3:V3UK)9E60VK8BD6L8BR%.>G)!'!KY=%8R)"HR*M2M%-%&FA
M(3D)A5D*/8GRU7222FZ)Y5O$9)&9WYQO%9-Y9N/7TP6,3V1P,C_Q'$KV>?(/
MM_B*6+OIF;S:%\/YJB1*;HTY@)RG7BIBM#5=Q/.DQV%7OJH]?05AO.+P<1>1
M'8>/9S+(-KK&L:8J:E[5$7],T[/0)N+B8G&(XB-/[OR/DEO2^3?=F7PC4>;=
MF61^^19/5_H*M9?:G8A?H?80D4E?P0/4WL1F8L<#\0S05BLT%*7V``VEB``:
MU86BA`;VKJ_0<`',\4(T6B9MP`5"@DNS02$]4R:U?Y5$'\/M"JF=/J:0SI8#
M"C`.""@1`33U7B0H`07U7H7F(+0"SX.G+$\HA48>"`6^48$W+<+^,OQV&7Z;
MP$6,%_$P7QZM'_%*!)[R`T?\/Y;^V/_0"8^UC0ZF$_V^1(\OT0^U)W]L=,"1
M?Z'/XRD,CA+`DZ?YGK[G!HCL[<^/^OKC^4%?W%-H2S\&3A.XS1<OH'1B:[J0
MEOKC<IO4EO#UQC-CG8=:AQZ)=?3+6*V''N/L$''62F)U#CT&'B)P)XDU1&(-
MD5B=4J<2*[DYAI,;TP46Q3+M764Y1NFT<%MZ7-Y,S&;:%U6NSFJOXZ#K'17"
M%Y!.S.3UOEC>`)5`@;6!M02"*TT@(Y@K%R#'P=5>USOXP@)D`K/9%T/#CL2N
M.'QS4(:'1Z#`&N=RY;5VE(%A,:'@0!@&;5@IP`2=U)QB7<"'T<AB$<4R%^7$
M]G0AE4HX=L5=D,2/D;Q;S.20*)8#BB*"F#!K)=&W*8F^3F-K^C#UA]1G*7I"
MR?!+4*>4#'\"LOL2U"G(\)?0$]%2="I*3Z1*J2G@WB_=G[I/3P1*@:D`W;(P
M`A(J@V&$BY\1,3="S")69JO,&QZ'Q9Q(IOSO-8`GD5C)JD`IVY5^(G@1O^PK
M+BJY,CBB="E;<XL'&'Y7:Q%2UZKAK0_>I&+C%)[4,$6:E:J16C5)(RVCFL2H
MAM6H)RGZ&EZ+*O`RO`TY1-/#R%RDTS032<U%T!K03;/0K&SPFKWF9=#@6A6:
M]=`3LY(:?8$\J@D28</\*/TK]1#B41"%\=/24@/6!=S8%;AC5H>M(;86U;(!
M''15!+"EPF4-X4``4C"ISAJR6*VA`+:&5$YMR-IHQP&5R'%NC]>K=1L,U=I*
MH]')5A2IV[*VUG4#.Y$3U4/JPJ!J?'J<^4!KX*_"HQO5X=-C;J?*6\2ORAX/
M=Q68\*Z*7QTW&@T?V(O4S"51,EM"XG7J4^1"*FH&-<()`4MCD?I4<K,LP]37
MA\,(\;S;75NAU5976RS!8%V=TUE;Q%V2R>5Q-;AZ7/M<*E=+\V>?.$1SU:KN
M^NF(Z3]_'HK34.=F(J9I$VE@-:=-TVL>0`-K"M^J5?41<%-/*GG`H*PB%9FK
M[*N.&(.B\=NFFY505C:@;FRSVZP6#6/UA7F^SMRTA+*;>3X<:FX)-UEM=K,/
MK'Q=G8;16"TV>W5S<SC$UU'-?XNE2U>V[SZ_6[!L^V[O)Z_=OKW]S9_7N3=)
M*S=N7[^B8^V![=LV/O$LW7XJ-7#\S(>FD4&*6X[;!U]*L/BOIRY]Z\5;-?7U
M^NY_?M1W,."UT9JEX61PQZ;9<4OO^C6#'7#$T(GY6\Q^]1[RW@/[WXC6XXV7
M)M$D38G%^7^,.=TA=D'6@Y2,H!A99VUHI:/*0DP?CX$$ZL>2$93EQ&HD#;L`
MZ0E4`8J&6)/DTE:"`G_I%RG:0E$TA8NT^7*@+K*O"3<5J9!4&8VL"`8,B%9I
M(]]Q81>QF4P1=:5*G;3;G25A2J"$(G7WE_%[I=:I5JH5]'%IH@$W0+)ZV8,N
M3M"8AD[C#+XH48JMQ$PQ%$/Z>.^5K%-6R@JZ5#%A*!DH0\V3R6OX'O*B`]@!
M%TCLG.E.S>U_.+??.>=TP!'H=LPYY[J=#L76F>B/_Q%.`EROA]W3ID@$5$6;
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MV(:UC3<8[QAC7`Z#0\IAPJ;&!0IM),M<*;F4-$5<H2`4TIJTA2KB2`OELF$Y
M4E(BI4I+0J)4:J6Z!ZW55)56J(JABHJ'?F_65=D_WIL=?>^;[_W>]_N^W^-O
MP!-$F091>X!T*3!"(!P5'-M1FNU.A$S3YL"*CI[>,+IYN:>]<]7:UAE/,[_+
MK8WT,/KUD3ZS9K?GBDIG\S^@;SA/TQ-.`6X13KZE^!591MNF@"K&4<9R>*1'
M3*>I@;;2/_0F^VRND,,*R/B+W\\6;.+E((BL$AU>S8=X!JN(5R/T\*:9\ZN:
M5BUNSOW+N@!+A6\US.]<<^"<]8'U>RN_84'+K"?A"[SKF%#`V*(86[\=VW)3
M;^5W"WO4O,J_24><)^D[3AZC\V-T6*DU,3$=E7<9BRJ`>2[+2I-_^5Z,;G*Z
ML&"0CT7G;VEE!^S5*)YP2XA%%]TTLZNZ&!PLLRY8&QNZ.]>\?AZ>@!KHL8.S
M%.N&]4O+SY";9XW`NY`F83+;]'Y)0;0CNNU;*+OXQ4$D@.F&=%P%M3-R]@`+
M(S<YQ8YG$@\HPPZ(A6`G6`5F73'_[--R;-RV611%AUQFS%FUOF?E\V>MD?I9
MQY[R.B71N[9CWOI=VP[^B44P"X;H3MJ!-21FRO0/A,0$B/+L8TNU">WOI+$7
M]PK)EB3=.765]L#0';9JS://X10T$S?11\E"AYO+@]]T)YQ-3NJ,RD-[V>J'
MN5X6*JY^C!Q`%JP;[.Y>MPZ:[:F[>]"^DCRZ2[-V)6LURQ#X;+'`$`Z`NKES
M+*ASM)Z_T<TP*"S5'C#72.#_$Q=Y2K-6URMP$YFR0]B']QNRZ-$$-R9L(B%B
MP"(SZBQQQ!TI9VU8C)0$$\%4I-8I2O"<5(;WFHL^H1JG2P[%%\YS+C-%S,JJ
M9F(:#3BD6W&8,[?9)'WD.$-JAD_5XSK5F:7GH`**Z0\V*]%ZUITP.&-+;R'7
MM=H,ZV9E=;/.G.C,B<Z<#.DPS&I+/QK:#[T%=E\*8U-$XS"33VAOS[B$S6.X
M:B`\O6HZ^[IVFH-0ETC&D]2A>C0/=516I"JHPRV[9*<LR;PC&`J$J",:B45*
M(IR#`@<\<(XZH]:@CG*O/DBJ1!Q*_>%!J!%P2'K*!J%"KAXDD1`^&8!/=@UD
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MW_'0:(B&2BG&Y')+J(L&+OL:P^?#-)P'_2+X))8N;@5;-U<YZA%`1D).FB5$
MT`0JC/L^4TOA9BF4QLI5@)L`$"V[!JOA$+%9GAO&NC;<.SF5FR#9;('I=-,O
MF2$E*YEA#PY1%0<E8^<?@M"U=CI?T<+.4S2RYQ+-GB^6>K.V[837%E6LE^2\
M&5\&_VH?LJ)%<LED"_&A3&)8V0G$.HP#6VUKZ^PTU_?PKS#TH^\\<W1%JG7\
MT#=^.K!H@W4&4L]VUNF5(1B#AD.;]Q]5WLL/G%JX:^]5:\QG=#,<DX_^QNU#
M'`URQXR+:EC=9.PT=@5WA=[R'PF]XSL9NN9WSRC-EM*`A+T/VP\AV$X(2;H[
MG3!`))*DMTD5_1BEKH3;4;S--JX^E-%Y^O%ETR/$%!+(4_]H`D!P78,CQ`VQ
MR^5%F+$87/%^1FJU6EK+"H-7#4,X-D,MAW)6'LJC]8]A;B#FPU@E)K'I34YY
M,XW16*&=1++96,$PM*D);0)5::Y@-V&$"UHZZ.-H,37*("-)O;I8\VW&,>$)
MC5M6FSO7O#Z8^LK=?0>NK'AZ^PO61Y9U9EEFGI$LT]Y?L>B;[]'3%<G,]O:G
MGGM#.77ZS-;%^ULRIU[^K?6[3$VVH=,C'=N^9N_G"$P:\_(LXNE"<3!B1K(*
MI`$XU/"BTR5(BDQX25'<;ENE$PC@$;@)B));`9Y<AX>H4%U4,V4)!$E6B*1)
M5+K..=&Q"`-FI)'/\E3EXSSE8RIA$)&HIUA!)Y@<R/5.MMN,RV+W?=".R<,2
MR9?9W6#P17%>Q,8/:6\Z6(&7I.3LI#=-O_O\BR]:!2NX#O;!(V[SP^_?L3Z!
MICLTC!G2C1WADK"$Z-!G-G@<X'1%736DAN,#KF!)L)1K<RQT7!$XMP"Q$E<I
M7Z;A6,9#C.>XXBYUW*6.U1^(KMD-P#GJ(SSP>;AWV9?@;G(4#?5+0/A8'HZ:
M+M4?]U/_N*Q0O$E=@D\E<ITZB$[*X+X9,Z4^Z;C$2;%*[=.#.N@,`SU:4<1@
M$KO(!"9)`=OP)!*SD"O@G9"1SPQP)E*,,Y%O'&,HQ[AJ,\X:MLG)8]:B!3]-
M2GZ:I/:,IFR^&)#M)49_(<<6F>4Z<ZHSISISJC.GNHEFNNES%VV-_NF&:U^3
M@`THA(9SL"4W#$DN*?+V18FO^%]6AHHJ&/.R,JF+T$9?V##USS3T7QOYGF4=
M/=G?T6E4]ZV;6Q^O7K[5.FY-EK0*2RQKMW+LM?=?NO=J1WV;,2\QOTZ3O_W5
M\^.H$L@2/+];=NVO1HX[`QQL#.T(41>[WP3Q;E+'509_%>2RDJ!'(G'!615\
ME_X:]<010H@3CHY556E$B&.C']44?5S.P]U+)%8;R=,/Q]18/$9CC+CN_U)=
MK;%-G6?X^\ZQS\6QC\\YMH\OQX[M<W/P/4X@I#/$)=`FG4*94@JA&$9HQR4J
M)&5-!HR14IH`DT@I50FWKI-(RYBTEB%"H#^@&5I+64?1:+6MK*,:*T-;I$G+
M:'>)V?<=F\!D^?TN.O+E?=_G?9['C0OA]M?<*P3"J:DY3&6,QG\&^<B;9B^6
M93(BX[2LVUR:$91#,D&).F?H-J435@N!3A!QHIU:971"V17N!%$'"N`>L2;B
MB1=>`$7$)4CJ<@2-U&09WE@O(<B+&D1>0BPGD<?\2HZ?_FR[F@P]/&_X\H8/
M-VV[UO<9W%^ZQ,Q,1U/IEN9$:XUU;3"][\K!:M;]A_,#-[;LALSAFW#W[:D-
M>PI[2J5ZO>L8=*^;7T'#%80&&WBM4`58OY6@&`1MVQA\O>`L`]H&`<G2D*$Q
MG]C%"'&>(`#!$P1R9\HHRS(68*?&B,L%&QNPOTQ#^D[5/\_"?9@WORSBG&%*
MR2/2*#<N@7N,P#U&X!XCIAOWIEANIT&SO>Z)6RM$74/1JBL*81?L*=T::7_(
M,#K)FE)CT+(R4=T.1_X]C(84:$'_9,RZ&O6%AA1M2Z&&M%M<@MWM6F!?:VPV
M:!TV>)_,]5E>)';Z#SD.:R<<)[0Q9M1M/TD1S4\@I<:2'F>\5I'MN@_8Z^OP
M8@FGPV5EF$;+2<IA2J_IQI<+F01H`O5VLMV^2%]MWV1_$5AUN\.1\VD:L#M]
M>JT"/++N0V.2$G-0T[#<\#AR;O0(U$@EYZAU.C28LU`/?,W/*8=<X7)YC`2%
MD"=;>[U`+B+?($DR4%^6G=>=V7B!==3'\1/<$`M9W+"LOPXW+):?$PG,*VAV
M3$XES%]=_M$F&S<.<NG$(+=M&L/FI=A(<WQ^D.,O7L3&IJ/BOJ3[RKW!N&\N
MZ'N>`_6F1%*FWZWP#W%N:.-7URY=W_[JCY^Z=6G\:L\O=&UV_+'F%>M288<[
MDNW(M#Y-E-:=?O[8GWXY].RQ^5N/K-EUY4S_M_<SN>\_MF/!S%4MK4=+'P2]
MZD#KBNVSNXKC"/5-J+IG3!U?`RX49!L9(.,D.<P>9\?8#^R6^8S5JUH9;S@&
MWS61SL!#IV(Q@--:L#NMP.&]"OR\G_!C=(NN0%R]7G45XIQ!_XQID)=]144$
ME4'^_QC/!0Q6C.H.0]#E0#`0"I"4;D0XM1-4\_Y.:+!HI]C#G3`@HJ#98@_@
M/([>&.BPZ$54WD!5DHKS*7K<A`6:"2WK9P^/X=[TYJU!>>Z2[*&/-OYZ8]^U
M'WQ46@]GV.*^C+\F%XS-2[3&@D'CU=_OC?@_?V_@CUMWE4HCGY:^-T'LZEX\
M>G3)#"GQC3=+?T4P1_E[&[FU_Y+CR*UY0>XL\-^]4/"+KGJJ%=#V5K'*2;:R
MR?,>Z/'[?GO%3`:BWJE\Q6D@)_"`?W,]Z.6>-`W<JE7S*YZ.'%]5]G2KIIZ[
M[^X()+*`]1U4ORC08+:P7^&KQ*;O\+U\GSK(#Z@G'&=X^C7'*0<!-94`BJI&
M;5Q5R.:-^D+>*M3<!!-B)<$3DE!.@2)M4IU\1`51/DI$52*:$GBW(/`JH4:)
M&L[IYC@GT<M!SK9%@%&!=UHD-2IP*,->U:EH-6BF07B3+_!.$DDFFXUEG!*4
MSL$=0(7I@AJQ^;-&M]%OO&%\;-PP*)TW(D;!6(1N7C;>,>BA9U&">OCBI#_0
M-C511(HMSZ-74SZ`W<$44BG3`Z*(5*\)-@9--+3Z\*9X,8%%<6.C#_`3D+]0
MCL4'#S2?S]/Y?`6!"1A%'>%&/(HL!A+'2())Y0,V6&;3Q-!H>*(4;0RFY?6E
M.:TK%L`_N^#M1U+*W*EN^?&(1!'!]1]^#'?LG)=HE'E&UZM6'[8\])_CK\\(
M6W5=XJM%%SOO'_`WI12:I`E4*PYQ@HPF:2U<7-@W[(7B,W(OT9M]R_?3Y+GJ
M<\E?T==3_\K8:N!LV`);Y<5$A_P,,4#LS!Z'[R>O);^L_HMRI_IKY>NLT,(8
M>E#38EPDQ"J*,Q)R*VI6KR8UD(YD:^-`K]:"B)C=P;2NLVXM[4%0B*<9AF5`
MA(\0D<_]1T5+H$ZK=<;",2*6<G+^7-T8M)R*SEGJ2R063N8Q7C%LFY>.@C2?
M)M)MMXORR73;1`>:@,BL\1/X+6`X^W$T$5WQ)*A&Z$-HGLOC;&.`)U)15?)9
M::^N&%Z=,I*Z*D4R4,$A0:<S,.K3<%#1G9JRQC,(X'S^'I6;$"^#').=N"5[
M.T48R42V4>E(#B0_I2ESM*(@>4V[@TS0M&><&34]$&7%-^B"%@3:+=553N30
M>PN[MQXHW9AZ?$6S+,\O$GMNCW?OG?IB[V#+HSM?@0VS%@VV+#U$7$D5GMIW
M\.G-NCI[`]F]H5'1VT>*G0?%PG>7+=N4AU-'2FVY60V/#K:O/)#'CNE;=[^P
M+K%V(5R&S@+I;O\IUE8?'"NO5&5UH+70@3;V`"O/<K4%!J0?!H;DW4&F2^@2
M-PN;Q=W"6]1QQXCW?>]EV49)P&B6'@[V2R]Y!^2=P3.6=ZMM&6-MN(_J=?3*
M`ZYS3KJ!$T0M!)81(8B,F+N`MM&?"")G71\BN?4>%J[,"%`(=!O0$/4-9V'.
M-$W-2PNLTQ:V$;8VOW\2%_I4>3?1L9`OWBEBK8$9NK'Q;Y,(2!.3$P#;S6^V
M;SZ98U!Y-2E(.>RHL`Q+LP0E&P[)I@,JB$*5C],!&[#JL%S,."XE+/8`I&MQ
M7:&@&ICN,!1%7)4&#Q[AFJG0L/G"5]8EL>3?A[=?JVU:?O%(_R>]SWTU\KO2
MVV<NPX[QH1\M]T<RM+6K%!^[^$KO@;.CI4\.=N]^OJ_K9_"1L7&X_,)<+5.'
M9Z6,\-=CXB\!JPK+`_TH\2H./`X)'-:XUOK6Z(=FC-58UPCKT.&`,"P=<U&K
M.3H2`HK"1$*<H@;33HY09LHR8,14T!D*AXC07"9+PT5(I6U+SCE=GO0]&$+Y
M-IQ<'AB\01AMP,V[LV[2/0NE%"5YU&C+NJ%YFNBH0`J9U')B5^#$_H_OJHUM
MXKSC]SQGWYW/+W=V_'*).?M\YSN_7.R\."\DMA,OP6R\+610M4+)`I/*6VE)
M&`):8&4M*P6M(P(D&*)KUB)*A320&"-HK%`5NFYLJ[1^Z#9M*_NP[,NH-(U1
M:=1F_^?LE"RCLWS//<_Y?++_O^?W\E^JF6*3K\';@)ED(I5()VCFX0HSP4`H
M(`4:`S8FKINBH:,T&;0F&!(-"\A@PC53#ZCZ'#JER:O&)K+,=9(2U\E"V!(B
MQ@F)F=%HK]_J,KJ[O"+QT'`FWR\X@H,]&3SVSV.7?CIRY-JAXHMKQ(9P[LTG
M=GWM2^N_HNM*8!.]9V-'0A\8KDY_</@?KXXUN6P/[O]YM<$+VTZB1<A^ZKGF
M*#`D15&V?P,>;>BKI3M!6Z,#*[G6W'AN,G<V])'_H]!,Z-.0XUE^>V!/]B!]
MQ&\_R)^@3_!'`V?ILSRC^,N!4FYE[EG:SM,\CW.DG3IF.^4X;?N1XXS?[D(4
M.^QRW>)D5E%D257-X;:VOS3+)C.,T"V[S,04.:5JB*%<K)L*B`$<")K^0)`.
ML:'@15]6:DNF4-;EDE)8XAA68(=8W`_#8?8\^P'[,<L([%86L^VY\^8U$[>8
M_>:0.69N-9\W#YNOF9SYHA@<#TX&Z6!3*8=RE.".NK&[+Z8TMM>WA[4YZN0:
MG0#-')W8U@+)H-X$B7?N%&93Y&@M29I`O+]38J5^FEW2HKUN:>;$*+RH">0E
M@.:\6A9K7I(>K25=\S4+:"L/`=2$>S##V?"WMXN&X5JQ?EU#1^_PVW]MUXOW
MMV3R\2:/T\Z'C8&,;:LA;UJ[\*2M6OG=ZS^H]&X_EJN^,-ZN7/AQ=5@/>%1I
M/;UG)*#!IJMN/;HOX@-\LX#O&<"W&<5**UB;@V^F5>=2IYVQ,SR0@39L!F\X
M#=<0O9@?<J[G=_`O\9[G4I/92[9+_'NV]_@9VPQ_SWZ/YSV6O<F*'%!58[BY
M>1HG2YL3LB%PB",@.V2.`NH-8WR+D=F((L=5C6-9`[N&W'@(&==TI#==R*(L
MA=R")^K!GCY9H**@"7V1B-R8\0>:DW&<1$GH,>)^C]Q#+NA44H_C`)?)7D48
M`E81L:"5)FFZ"#Z%NP7B>H4[U@)9B(K0&@"JA1JNL)X19ZR;ZEC]:W3>F7"=
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M7&)'IR_9V-%Y%:T"K)Y!MRDKQ9#T(CBB#NRPTHO#,C3S7F$%B3!WK&:D`#T:
M@H,29[W-)+H(!Y"*"'&9"'&[DF8$)Y1?3\1!A%G=I3ETRA,3!Y`2%40F#2L^
MX=8I07$/4%S*\CN06Q)A+=>S]';"$EP"MV;$P?3PK.?-(@S>!T;H96S0!P#4
MG2)%Y+CF@=_1!ZMW7SOQR]4COWZE;4-7L-RFX:/+\J+CA>K?CK_SX-WNQ0@L
M[\GAYIN^!:U^,$3UQJ_.57_SPW>K?S@4\*.FE2V&KMNC\8:EU9G>_*9S3QTZ
MA]K1&9%;ENHAB07R*>,'O@ZB_I)O4(4^`)*BS*FJ5/(Y^R529T_W@GY*$J4I
MB2:J.HU_?UEM5^2TJO:2CQO@OMX2W"/T1GO/]](#BMP+]_Q$9<D3V,^?P(KL
M%$LC16;)$S2O0F!/S3XA93TA%4V=3]$:J#3<4_JZEE/D'E538\E!BE"W'P(U
MFTZE)"F$>WMZ.([E-&I`',`#?>U"#L%[#'1W+U5>6\:E\LKR5/E"V596!!1%
M&/5Y*1'!>Z6(Q+V+BCOJ?KVM;MBC$_=F%]1L$T)&7P\H=*5@[0VS/LZ96D(L
M$BU&7T3@`&E""<"Q_[DR_QNX=3ZS\4TR%YSHX^"BGF9\H[F@P8K,*X7:''^W
M.C*?ZK5Y=1_:]W#UV?Z'<W2:JGDQ_@2PCU*'2ID8`8!79*RJ38KL4]6P(D,J
M=RJR5]5\7HP1UR2$HV$<[G/R!#5IL=9_FT>M?(D?YZ_SMC$8,-^HQ,B'X;#<
M<3N&QF/78[@U5HJ-Q?;%+L""L>H.A3:MVINS]>XG?"&Z"+'EBPM(RH4_>51Y
MH&SZ(RI@_>>:*S$KX9_FT;HK5/'!]8MJLJ-(?N<IT=O!(=[M;''FEZ`E[F?<
M.Z@#U$ETTCU5G$8_<TV[+^<O%#^C?%/@!-E0-H_ZW*M:5N<WHPU9CO+D\X(@
MY+/9EHP`5N3F+!\*JFI&D8T1M3N_4.YF$.0.H%1@1(LJLJYJ0A?J:NF4NW[>
M@EJR-_,HFQ3R?G@*HBA*!'?*>-Q^C\=-Y:%1N'X1BIPG/W0AF;1`!G4CBBN*
MGT^#W5V&CH,!EN&8IE(1%3."&!6QV!>=BJ!(8Z%X%:^V?*RQIHT3LQ%D!JI>
M*)"C%CA"/:;)'5B1-4<]>\4;M@-9J38;E2@1%/(Z;';K7%O5%Z,B5^`*5LMG
MA1$B=8BT8V13DU8K@5@+M4>`6L<4D;N,1$T%Z<?0GYY<TIFO]`TF1JJ_:)<6
M+:NLGH/V&V4`VX4^W60&'\?>+P\?H<N5<]_**+K.1(+I[>A`NOJ]S1WS=H+?
M$VO<4%V#CC^6,X).&N0PM0/VA`&=@1OVA$X=+G5]`^U$N[7QA&U2FXR?B=,/
MB;!<K5$`E)L.:W&*TD5]7-^G3^EV?1I=*8E*+(F!'XC#G/Y;ZE4TC<^7@@^I
MTFBT)DJ)J01=?(+L_'H&O'NW`ID"%*92N#M:`"_RDOJ;5A%'$?W_*!"RHAU8
M@SMW?_F<VGR8MY@@:8UK)[9,;FI!?ZS&'\&(J8T]'L?RTU,U_K,;H0)=:*BT
M+2(Z??W."')$=D?P?^@N]]BFKCN.GW/]B!_W^EY?/ZY]'[;OO;FVL8F=TMC$
M+"7>($7EL:35H*3%*S`*;*",L)4P&!O;**%EF@)H.%';O019M?W#(`73=16J
M$&5=M69T4]A#C'5(3%,M,0E%="0W^YUKIZ/2%N?^SCD^1U%TS^_S_7U_[9T]
MQ;[.GZ*KR&'(13R$AN0AY3`:EH>5,>55Y9_*OQ5Z5^?-3BK.QP/Q(-?*&0Z6
M9P-L$+4BPUUT/B@DN25*4FN^Q?@2@D`^H10T\!A'RLN0(B<@\].R%)1E"16+
M"+4IL:"BQ!`N*K(MCD54+%"82AJ*S/M=""WNE#@1BTL][WG_ZJ6\8J?E!>18
MA_4/=1*'X@Z%.SIC\70^1_;\9"]W,T==RDWFJ%QT<6<-?^Z<"DI4PPN?)U!4
M+"$"*K*[L\3"P05%B86+6(PT*"&>'"!Q#>>R#L#"10`ADVPDFVUJ5Z6RF[2X
M:!`8^/\:CW6H%$*3B7#QP5NV3>)=5'IA5VOTOQ)/YK/W(K-W',R3%;/=U_;9
MM)>"S2R5P;^U?0-N58T\._/M!RI`_7[6_NY,SQ9A4;=AX'A'WONT[:EM#Z<,
MHOG*W-\<5;AS%0^>Y7G0ZGMGF1(9RD-TB9-EEI,5A666$`L@D1*M44N4%HV4
MZ_!J<`><2JG@R55.%C"K*$L1#L*?520-^5D?QHJ@0E5N0900=K%N3*5]+(.?
M83!SH$_'.N=/RTC"?1)&TI<!CP-:LPP/5DCE)55XNC$CAGN^_EKMD-4,#?MR
MV6'[@<L(OHS,JU(V.\QU';@\S%W&Y!:6K;^(T-R9<C900"S'+D:[$[O4@XF#
MZC$TPHXD1M0)-*$R]H1=S=A37BV0$9U<;>[ILX$"#./@10IV<`E!S'$C^$?R
M&>Z,[$)$U4#:^I=M6/\:YPI*W7#T9MG-1[J1RQ?H1K6Y.\T5&^QF:W.WS\$9
M&/]TUB=T8RL]4#;;CS%IPEJ`9A\5\I,T:&0&"*4_!<ZO@$WJ%;U]$%]:]RE5
MF]FQHR=AQG>M5[*?6>I8/7.!6K$ONX0R#*_>N_%^U?[%F9\\]P1<\%,[;;]J
M+6J4`;6C#V[WCF,'8E`,_[S\\'9N>V#4,\5/1:^+U^4IY3;O;HFTQ`0J0@NB
M(*>X5"`53(N>V$&P]`()H:;19YLCTQQ=!*LMI!,@IS`)?!6?I,:<8ZZ3=)49
MI\;IMQUONZ\H4WB*82A[B\OI=GH$+%`"+3!AQ;TUNE7>ZQBB]T3W*%7V?.2\
M,B7=<7G7^7P%9`L76MR\-QH?6&^E`QCX<A1)'*3(FK(-V\1\HCM!)5@^SE,\
M>'K2:0T2;U]F/W&`7U-O;-7[+:/_4#NQ\H\3*]^%8YRA)(-)M^%(1L6(2#E9
MAC?@/4D&#KE@)CAAYJ=]!F9D"B(.>,(&$NT0LMDN^%@7F;%N\UL8**]`.DRX
MG'S)49N[6_;R)2K"EVAXJ-K</\[Z2]`\?0B#@ZR8DAM6OV!**-O\Z<?S,T@M
MW`J]30NE)E))/X<<H!Q^#G0>%(,O<%32)N#E^/O5J^8)\_C5'^"7<.?KFWKW
MK1W;UK-^\Y:7',_0YH!YS30OFS/W+F,&Y_")U6^^;/[%/#W^U45E'/T`OO,.
M@-E#'0C93P/](LCT>Q=1`NBG2PE"_P9OJ3>)JY%I83KQD6;/N&2$:?#JF@:.
MW:GI#)%R7<KQ*"?+S@!/@>'@5*S>V!@^&/YAV!9^,9_$2:EAM=L81',TU4=O
MI"GZ@)%\`U.6!VEI>)#*QYY[NF+U9(`ZJ&V=J\\;:L#X:^587`^*$2$J4$X]
MJ.9Q7(2@A5KS."'$\@B13BN;L5JL"EG,&XU%Q::B%M1$.!0$$;;Y23-5Z$CJ
MU`*I9\-L[^>72=+R"M6+6\U3(YMNJ_Y]APY]A]IJ'ADH:8:A=P[8=I'9Y,N'
MWM`BU.CL>>K8:/6[Y`WVF=]S_`L("Z,D_G6YQ^[='MTN;S/LO)?U!!YC'PL,
M,T?9%[@7^*.!X9!G.5[FV:YM,\:8*E?EQT+CD9\E3B7?8=\),&'"4(($NLE8
MK#ERS3%"F.N&2=+"C02$W&Z/A_8Z:"?GX3WA3W,K^</LD0`]1`]Q>\-#VA[C
MJ*<:N8*O>-R/^][T8)"FZ^4(Z^_PIB&,H[^C#[TVY-4EH>"WD=[LG+&PHZ6&
MBQ.VAYP%1PT_6_9[X]>0R_DD[XNFTCM5@B3<&4&203JG4_J:H'@IC=.DM'H9
MOB/=L#H6EMG*-,'RP@-G7B-')`(FV:SWWP(RNZ;K=^O9[CH1]A*(:Z4!ZFH"
M:I%.J@!JU#"2B;!NX!@M&=!]0DCRL-1"<0->OLS`0'M%5C!P:P`")`#717X_
MQ@H8'9R?H\H@P%KF&,Y?"L'#`J4!>%"#Q(HC3&`+.76M-94$%)&:(!$_`**?
M2R5M[^?>.IYNJPZ];OYYY;3Y/A[%2W`)GS3?,@<F-C^Q?UUU=.W^-1OIYP^[
M'DF>/].!]V$G;L<GS)WF[\Q[YCZ'XY>OF#?,4Z\^]Y73>!5^]'@-,HKXT#\"
MDSIJPWO+W6O%W>)HR.;2(_HJ<86\0MLD?T%KX9$#.3D'Y[2WY[=)0]*0=D1_
M5_J-/IEWC85_+WX4N1^]+SKR+KI&_6'"HM::$'!A4BX1>,%>69+:IFM!7=>^
MJ1^%RT09694.:K>TNYJ-T_JT2<TVJ6%-R,B:GC1R4@U_4!9T:)]:VW(!P#YQ
M354U#:RZ"QH]["B[:93A,E3FAE"S4>4PW6J`S6BJ`$WWD<J?>^2BU7UP8*TX
MX)Y4=6ZV7N%(F6^LZI83!@WHJL]V05*0Q!C<72GY2=6OD+)O]2(1RV=!DB12
M"X-BR(@FT\;"8":/4R*$;+@MCQ=$DGDD2I`(S4QHZ`/1ZHLH#4+GI4M9%UV2
M(X'04MPHRQ4X\3_$8U$8U`,\'.EGA)"*;7[BNRT528!ZS*YLJLB>Z5LC.WN^
MCA\M2PN*YEIS57_IZ(N]QWY,?<D\]$D]67YA_\G-2^-FH3_\'\++/K:)\X[C
MSW.V[^R<<W=VXMQ+<K[S7?QR-GZ+C1,G`5]X#P(27EI**BML4TN`\I+0IAV(
M!K70B*HM,&UL$]($U3865%$**SC96T71AJI-3-J0^`>I$VQ:I\(F-8Q-X&2_
M.P=&-VF+=7>/'UN6\OP^O^_O^U4<86(;\=WJV=RA[2>^:3FS;;.?.D.@+$6<
M-(M"9J/Q<LA!,MC#4@DR([!\(LDF.,.7UM1$Z[Q"O)#88APV#L<G\I7X5+ZA
M**,!0L:X@GO-`!I@"TJ!*$QDP4</J+*B*EBI`%W+@@-(XB1"F@@8"=8=86F6
M;:%;6.<H.VJ<8']`?TA?8<F$P=).W34_Z]#G!SQ]>!#OPF/X"';AC2C"18A(
M!7,FXY>ZH/_S7:Q;@>@#6S]6LBFQLX*+'\Q-\=MW+$F`IB_?+MOS&$).>=AN
M^B+B/B]/WREC#I2@MK:7'Y#$X@W/F*J#=K!$V(@DMM%;V;WTU]DWC$.);['O
MT3^A/Z$_8>NAH3=986D8TE*##N72R`"8ZMHKT.C4M4C4VJ1T7ZYI3OPCT10Q
M/U_(M?'V3KOC,FW(MPX^_W)`-M-G[JY?-W/_U^;(TQE%ZO2'P_,>'-M]*#=T
M</+=C7<_7+0P/=XL!>M=VV>ZSUS;L3RIIU.A#2\-#;UQYI[4VA@S"'3CUMZU
MF8&U/<\>^-[@N[<Y;X^ZP*KJ2NAN+W2WBMZ;1!KHK2#E-4LZNSA_7M5,:+F/
M-&<&%@2^25$/H8:"*G.:YE%E%O+234EZ&)052HHAE>!8-]J-K2+'30W\M>(A
M/`M%3L"JT"\<%1R"RBE85?J5,>6HXE2F<!P)Q-D+MH9S?Y\N#W=S<%GQL]QM
M3]UJ-YSZYXBK0K?4%A!CABV[ZX-#A1/4_RN^V+%&][F\K>J:)9'!Y_C%G<EJ
M9]+.GE\]O'`C'W&MFCDVMBOD?_"7?X<29U/GVN-XEW4BF=E/7=^'$TEAAWE*
M8$6-$.JB6ES?I[_-O*._K_]&G]4]\#T".3C,$9QC-X2BL:8Q?I*Y&KL1^W.,
M<>D!AM/44$3/A@8TZG+HGD[\D+G($#DWI<I8TQ15%C0MKJ9DI+7ZK!2C"SR/
MX3>]VUH]D$+4,04/*K,*H>S/9,Q,?V9WYF3&E7&SE$(1U$+#Z(_C^/[T7#JQ
MK,HCOS)<2R=W:L*5>"1(6BCF8>LBD3`3IL/N-(K&ZG4.W$K($_6F$:O!S3IB
M>T+-B=+P"`RHD08K*))S,7%.?**6^EC;=GPD82I!.K!5B<H0/]7[NL3V5S?O
M/+$Z(B?7X>LMQ56^^M+T[\YM?OT%R7S:M2H<ZGRQ.G1Q=,W7SMX@C&?7P(P,
MIU+J^FKUK[\_GS:O3A#?>:FH8:L6'.2%\W8:E">1#E1V2JWYW^HXY_QV@.!T
MW,'C(K^5G^`KO+.)YP."*/+(A64D@K`'&+G>ZZ9E;TB$0&A69M\R"SQ%JFY$
M@9>EJ"0/+<D'7"09XT58B0$W13J]+A$L7<#M<E&A>B\"'^G1H1\N)7OS.L]+
M:`JG$(]?,_VJUX2]S5[L%37]A="1'4(%SSMD^\>$)*ZN5H4U2Y];\J>$#7)W
MMY\O8A`6D)CQU:F$-2U<XRG!6I2O)"0!V7'QR7NY]ACGF&[KJBG/)4%U^_*0
M6R#S60(#11H!&X$#I#4(=&RE-*LT4)G&)B#*G@=6O5SG5W;&U\\D0S/I#<4^
MXLVF9U2>2^$0]F::5"6Q',KB7=PV^6#:6?AXB2<<;F)E?W9[M4QLVK%2"J:\
MOK!5#__L'ZB[4(\L09H7CGC^81"]PE9Q0J@(5\7/Q,\,JBA@:AZ/PJB`^MH&
MV_ISVR%SMG$Y,]>?VYT[D#N:.YD[E_-<QM?:;J$OT&R;:X]GC_AB[)#G=?$D
M.ATXASY&'D$T`-!TKHAZU679$32"/8AKYDH'$/:((@464Q0%27+3J!FZ\(].
MJ#>X(1_AX_VR3XV%9!5!9WI9F5,DT*9L/"-G3:?A1'1E]N`%@:Z#1+'/W&I`
M-TK(S<%T<">-6*-AQ+R(YFB"II,"WR@(O*?.XZZ+"2*L19*B8D8<OA3GO72=
MDXM)H@=X$<BGH!6-N`'O!=X+F9+.J@IX,X*N<U.>G(5,3QW^&0BL070C$P2O
M!&MN]J.+G"_/B6VY"K'EPI/TV/!(0E42YPA"%C[6]0BB$8LB_W^`Y/X244^P
ME4"V82G^#\:>?'.O/,ZYN]W[KXQSW;B<F,,NKGKJ\VIL#COP*^7A830"P3!`
MSI'W&#[2FG2X`8:9I1+PJ?6^H:%&XGSJ;B3?2!9G-D9GSLV\$YY9M*1@$JN6
MI[.X[GI'JJVG1!Q;&@P(R?LW=:ZC#ZATM(:]1QZ<<FQ[>-RY_O0R,APFHG)D
M7W4G01P=[0/W@NNH4(`?K;Y*+!U8U&*D"9M4!N;:))!:PL?,7_E[ZU=PO<&5
MRCC^YP+2:#<Z5N(M^/G47G5OZ)7T\7D3ZB5B4OU%:"HUE9DJ_:W'U\@U!L6,
M@\6>*)M6<+-329.9-,X&%97)!EF5*7$HC4L<R5`R*08E63P:Q=%T3(X62YUR
MT86=L@L)6.!X68BH$!<ZLNUR1T9AD=-EWR-BB>-BP6QC,)C%Z;<8G%ZH,HTJ
M_'`VK08Y!KM=CU<1L0<H<@T6?TXDX%][#47@J1`)DQ5%L]@1C1"B0+K<9D\%
M7Y\C*0XD/<8&6UYG>KHZ/5W#R6=3!/@PP$\9L`'_*B3@^?B3_T=*[8Z_M,?"
M7XT,9)E9LU'A1+;$V+<8TU#"JE\HX5J>P4V689UO(1&-1!TUL;+M+8SP=HQ!
ML>9TS&*';VBW[9&-DT6;XRMXM-Q7J&[O2U%,QR^OE3/I0$_U_J;<XE=P_<SI
MI[S-^11Q2NM,44M_=&2GTKD`?]&UPI"&',W5ZV]V`4%DJ^1G@NMPN+K'D-MH
MV*G74]_`*_"#_4RHA0J'PRU-W-`L>G^\T/POLJL^MHGS#M]['_:=$]OGSSM_
MW<4?=_XXFTM\=A+C8!_?!$(P4MM!F4>F%4IA7>RH304="Y2/MFQ#8ANDC$HP
M-"@J3&0-"P940;6"AH2V=/\TF[0MFM"&V#Q`#6C:FF3OG1-$M3]\O]?GUV?Y
M_3W/[WF>!5X(,9_`[M;G'T35"$15"FRZ@D1F[XTZ@T6H#@_5<^8<+R29))N(
M2`+A9)T>/K)=Q`^)9XC3D3&BQHY%:N*(_/<(E?.L"*ORR]Q+X3?"@Y&=45+`
M(T1$%)-BJAUI!VF<=$4DMB)CNHZY6P*6GI`4`($(%PA`]V#N"=-^X&=]`3^=
M`BDQ&4A%!*L`A!3#.AE!9%A1$&(&PFD0(@8"_E4&2:4"`3]JMI"M(H#6N'U4
M)0!10\TJ98B\QK/K6!0B1E1=C,'(S!D,Q*VZ*^X1-^Z^BMY#9"B\9JL],RF#
M!;*N=))4EIZ4ZWI6FBK7M5=9USG-=``/'#CRVV1C`GVJ+QKQZ"M0*DO/%MW7
MZ>"1YM7L_ZP=>!85<*+HZ,D2(TLCZ6_/_-&]N+UGVKBR*PR-WLPGFWL7HX<"
M>;GT>&J3-[0)#A**2UR;<<W47E'F31]T;\LO+`*"$')$CLP4P?%C;3Z[AX#S
M`T6^/OL%]F?LUT@;TH6N5ET&FL[A+70NK78MRWP_^V/CB2Q6T&SR-]=DQW+@
M>\:SJ0M=EU.W4A/!SU,3V;^EJ*QQN7&U8S73G=W`;"6/(B>R9\`8&".;%2/8
M4SB._S3U?AN.%$J%;[G["@/,,==%<&;A=3!9,)'N4N&U/+:*1%UV%YK7?N53
M)O<@#](*"25'2L:DI"`EXUW*>>6:@N'*(F6MLEOYH7)2^87RL?);Y4]*76FJ
M*$#).\D@N85\G<11,D_VD+O(=\F3Y%GR-^0?2*J)])$5$G/:28PUB[P$GQC?
M*N=7H>EAI"S+**O&I8R5Y=G-;#][DKW(7F>-?V'_R7X)?3RK6N@,BT*L-%F3
M?%).%I-X<EE\J57@!52XCR`R5:2&J.L4W@(+BE`T3`(U<$VEU<*>`JH6^@IH
MX9P+N'S:OXN58L59'_!)2`?=@7:D"34L9/J)AP3:2JA$B>@C<,*SJ/-Y"-.V
M`[KAK4IKZ]6IJO1)&0:&J7)YH`L:X"=:BBO:<Y(,/]>`6:?K]/347;J1ZP;L
MVL66R^D!C[Y-TEV6KBZ(-S#0$+E+S6R`19'R1MTQISL7^L,F&L.M<'P'A28Q
M)UHX&X<TMU`<"(478AT<0OO-'#"%X*43SW,(M-`2F'/0NHG>NQ=`C=1ULBHA
M57A/@&99A"%/T`>:;M.T/#AW%V8_+1XVO'8'HSEK,6HS-'8I:;3[_#NE[360
M9=38XH37+W;GB\\/W/G.@1.,Q>0T>WU<>L>RTHNFG?EHT)-*'QI^9=V.\X>_
ML;TC'K"S+EZ*M2WO45;M6U%=DAB>.:H&:8%=O73-49!;N;Z]8T'8I^%>FKV+
M^^"$8Y`H6*]:[2M(A*$9%+`>6X1G:N!?JB\L[L>,G-C49!FP6NDF!D'H$`BI
M1J\]#KOYT9JL5M3._*),*3X>1UOC:KP4K\1/Q4?B-^+&N,6"6#V\!_4D;':5
M!JVT2I?H&_0X3=">6&]52X+E*E20*YI)&O4$BW1-BZ4M>OV(X8N:A&@A,2?3
MY0%)TK?&&UOC<UOCSVQ],C^:[L)45)<P"PTEL=SHL5?`S800$7U>OQ<U4%"J
M!3P4!8%F#X>8+;P)KL,&,0J\9HY#@B07_4J/$UJ/EVY0P[N)"E5I&8H<(S\@
MSI*7<?(M\@"%#N%#IB%^2#A&#$<,4"RKY8W`IK58:[C>6IA3,[K4P5G'S.4K
M>",<`A<'?]#W8=^N._MZ!G,G0D:3I(#]!E-/7NEN:X\N@2%J>GI7=?R=X__9
MU]J^!3^SWN'WH<+TSV?ZAL+Y[H47)C\O+=3TJG?V+K893K$P\DA]];$!1"BP
MD3K+W41OAB?`??!7U&@B01)-.+_&;Z5>Y@>I0=,`-^RXX+C@K*%7G6/<U?!-
M[G>"#0$N!X)9_./(),3(.)@$*`Z<``5!!\Q<[$,;L/V#%9N,P55XD]4"+!+0
M&I'V%+6J^BA;Q@K`*3`"O^&]*#R`,\+JY_VH/VV<VZ?5L9B4&3<";:E2S9:,
MT1/I/*P'7*@VD/#E7CW@PN7=`2WAUNM5N@ORV09YG:L"S;S0MS4+`D\:\D[0
M^8-F,QW:F3<X%M6R4&C>;Z3;,95?<K/_VN36-R>.G%_>F5]+&1B&;PUEGNON
M6-.VX1'[W9W`>^OZD8L_>C&WK/>EHL>CK#VY_U%>6J!Q91WDRG+(%0[Z@5UJ
M^#WS.?,5\V4W;K=WD`A'<RC#IRB2/<US-\,-887\N01.&WBXV'29E/8WPWS*
MU\!FU</L#(I.(WP4TD@D"82EH3`G]`.TP!.R@G4`'0$`>.4&R[0R"DFF5=4)
MSZLDC\MH13XEHS(/E5[5^**ZM*_.LVR<QFG/@LZ][-,AJITIY)#TI/$.*KK&
ME?I4'?*E3C^N?PD>EQN4>4J:6"AA=D2$L(`:[&(L&H^B!@M44#&*),SP(MB"
MT`I;)9TJ0&=)0F>)7#%7')50)3$BWY`-%<N0?9`9"E?B;Z8.,H=2[YF'W2>2
M9]WGDU>3ECW6=VVHUL7R1IW=<H/=\AR[Y3EV:T_?B)0;Y&%<1%9K>/3I(-6Y
M%<XZ]([/M[P#^[V!3'7.O+ZR?\7HMN>V_6K;TFUYJKEUR=NK=PBL(&=23&Q#
M+]'SWSNO.H,M>'#M3UXHG'KKX^$'NS*+@7>'.^!/3!\\[.3?_]DO/Q0=AQHH
MP,J08RZD!635#0;[&F?9V>_<YMK"[G0:!=,'Z"WTMNTS]#-LPCSA^@+[M]DT
MY(+STN'*O(!MQ?I#;V!#H7W80<M]\ST7E2!GW8"D*$F#00N)D66BQ8V`%>X:
MB%WRB0XC40/<:',3Y=:ZVP2[ZU8]H?]Q7;VQ;9QE_-X[^QP[9]_YOQW;=[[S
MV<[YG#LG.2=-XMAODZ:$TF29JFXTG<MH0\76LBXI(T/3H-W6M6-`BRJV#P6M
M8Q\&2*A5,Z:T_&DJU@]#DV9`5%N+U$I$$T-D*U+6#S"G/._98X-(?I[WGOA>
MWSWO\_L]O\>*/$01!)'#!MB3/'7Z+.)QS%^FNDREIGQ)^5!Q*&F-1Q+`L$]H
M(\_V8J#E<R7+KAH.RJDA("$NMQ%8)WPWU:RO$@SJ.BD67:_8*%QOME3@*A+>
MG+<K!-ID*AN+QJ,TFPQ((M45BHA(]"=$%`V#:=5%03\*XR4YY'DDM]#8ZGCD
M``-P?B[K$["&F7KSKGMVXLN5O9N4[<O?;!RXK_GS[__A@TPVG+'D$?31I8,[
MQN^/G#EZ]NCEOZ/P^S]Y^7$IT+_K3`92,491S)CS`"!4QP]@$[%!2:5YEG))
MK.!R%'0*(<TO>#DN`(2O"SRG2JZK"E(E%C";D!*U!',.I$E?[JDPZO$]782O
M0#_VF#CJJ\%H:-XT&1.F,Q0C:2O%$U9,U!0,7CFEF==O@D2_1E%:.^D%KL$C
M_EH#&/*:UQO0.))SV(AX;&I]5IIK<#1(#*[$'>%.<6<YEN($[D%[V>!N<RXN
MGC9+)FV8OY<OH3G$4B#%YZ<!RPN$%J''S:_.@Q2R5^\)=_3U*W!Z9.JKZW83
MK%2FFH#O-4*C`L@?`+:+^+8E$`=`M2`U"-*[2I?]F7)_.6]]2J*$45MMB@U'
MP_UA=#.4OJ_Y;JT<.G$"_>FU)Q:WC5JCK(,3HJD\_1UFHKFX)Y9E5!4E2MOI
MY_9.F*=6'MC4,S8@NY-^/NSA2^5SBWOAF*BIC:W,#4!2B1JEMJ.W\+U9H9.O
M%;/'W2=Z3FN_=%QT7]!>-VZK'VWQ>/K=97:('4E/.SL`MII;DS9)D])W.XX5
MSKA?[7EUO!-/JF.R5XL)%#/L4D-5S6MRMF+O@F*OXL!0%>?R5A6+$IAPS"I5
M$?GW4B!F59<9!PZ'0@2BH=3@BQR7,FD&F[T6L\PD,0<5W/NBZ9K(I?A)&VJ!
M&O'8`T^;GD23D['AY;L-FWJ]PVBX+[;@HM&"Y$(FZ6X,B[7B&(:;P/`U<PSQ
M8](8/38I"R0HV$$!\8(DT,(RX\2AG%6"K6@+\99DT1:6<WJ1_)X$T2+NUJPB
M$<Q\\5#Q9)&9*3:*='%Q"N2RK:0`MZL5<M["6AU0W+;-^OS'4"-K=EC76T"N
M-/4*&=W6B(9N:^(0EF1+W[6FVPR@MZ(7J2J\=A;21Y@X)5G`PT14PP>U/?GX
MA^QJ`@6L(QC;(M&V\,F3`2[2/]AG!URDI@AI#[8,L?U]KM9W^NQ*8UHMNWV5
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M6?;YO)X.R8W<A5`0RYMK03SQ.2N(1\M!/`Z?H6&X*/6"R7>#T7O`*"H8J.X@
M%OS6VT'$!U$Z^':0%H(H2$:QP(J!)..\09O&HR03U3)YD278RO:PF^UA0]O#
M3K8O&K;'/@"'0;5D7*$[;X?@P6[GD9E?R3?R#`DM#0Y;M@?LV!X>ROZJ.R5;
M^7C/=$N*D,J""@5NJE>$]O0$E`:#'>&U__X1T0\L!MT&**Q&I)\=9@AUH;JM
M%&2"X,Z:;/]&B*OY0!FUKH(1+UP!V?IPG`>3$&H^4KURJ/;)_KL(_:'Z`M2L
M#B7K'VB)=1C'HD"%`\!Z?GMJ8UV$'C\3`P'_NZDC$U]\4NL>W<CUQ0,!/=&]
MO<@'1S9R(W%_O@IZ_:_WCL\=/[MQ^D#9I:HNN>LKZ.6OC\B#$QN=<W&E0U79
M=.0`\_K#5D<6-$4!Y&7&>9#JI)+4#1P1C_BC-=Y/!:BDY!<"0I*-JE*`B$G%
MJTI^LLC$5"GY*_0!2'T6WM9O#5CG6,1B"G%)-N#WN$D.DA"EW(*;=F-&XSC>
M*WEI;R$6Q;!]E"1CN$S<4CICV3X8M3TV>TK6^2@Z&47V,!A]`HLS(BV)#XIG
MQ?.BPQ1KXDE8K(BW1#8UO0+$`P=WIVZ33^O8A/6U=@>JK=E,8J=:1Y_VE('@
M_^89<IK;/+L;X]G9MXSQ#5=5#!ECSH-V`./=&R/-Q+Y!AZK22G0?K<`R"^C<
M`NA\%M!IH'_@<3H='KI(_\;W#OT^_2^O,^7NZLPE%47)#"9W>N>\A[V+_B/>
M[R5^X'V!?T'X6=<%[VO\.\+?A!#-,X*[JRO0'7"VZ`[+2"QH(:UD(C'%.[(=
M/9)!=0(<V5!4R4IJ1/60LFQ>O7JUUKQ:6R.3B,V#9K.2P(<IE3($53!*&2?/
M"ZE44A1]"-%@)8^O4_)$DE$IHJF2"DQ`PZYA(22%)57*9#(%53(R&<9YA0;U
ML`)W;15](;A1X/D]J60(]N*]8BHI\#X:=90DRJ`\;M:WP(-&O)#:+8)FQ#%5
MS43"GINE#TOTMTNH!&(EO,6#KKN7T:-+F@=YEM&Y"[X%X1+R43P2<20YPZ>D
M%)U:%$6)IR12C86"1LI``-":VHK6T&YI#BUNEGZ-&$JFIM$JD2&@0@#!T%E`
M5=RIKS97U]?KS?>$]6DB/Z`'$/$1GQ+6UV/-55((]L#6<=S0?4\*;SB.&S&]
M3E9URC\4(WT*"2N4;3^[%CHJ'97CMH7A`$H(-JX#5`<'H#5`S<AAEG6Y@I$6
M/.U^P;C"_U]85]X=EXL8O5*9?7K_7XZ!?-Y(I5.%BY7NZD:JC=>/G_GSYN%$
M0NW(9IG^(W,;OWTC]A_"RS^VC;.,X_>>?6?'9_O.EW/LL^,[VW>^2WRYV$[M
M_%#2Y=*6Q/V1'T#IFI6H7:=V##KD=@.M#<4I=,`0(E!0H8)I99I@FP0-R]8%
M"=1(U7Z4?QJ!:$'\026*:#4B(315B*DIS_O>I>U6)*SHGKOW7E_D>[[?Y_D\
M>5!;,IIX"/&#+Q,7WV=9T)X%GM5!>P(%1A.Q8_>):$%$/$.QE*`R`BL(+`=@
M27P+A,D0WP)P"G#BM&GP398)4>NHR&%7<JXK<5BTJU7.<R>.C@;V7.#0/(<H
M3N!H;E85SXH+HJ\D#HOSXK)X361$O+]2K>)XWNZNQH@Y<7']D#N),==-">OH
M`2LNWK/@C@^^>-=XOG?W8^/!K]]!4>P7@-U&Z0E'':.1**I.2.D+\JW4$#6J
MMD+1'F51;Y^LJ](2??7UO*VK'7#B2/D171W2\KRNMFJ:8Z*\KII+]!_?U)Q!
MU*>K@W#N%+5-NCJJ:8&\W9L+(+\RU'/0KQP,A?P!:I0=&NPPI=90W0$>(B#V
M*25?I>IGZPOUY;J_#HJ/\KS*TWPQ)4/+E'%_?$&^(%^6?8X\+]/RS5R^V&W#
M+9O<LB_8EVV?8\_;M'V3XOO4/KJON&F$P&,F7]TW<FV$/CNR,+(\XBO!867$
M-R*/U9?H3R[F<$.S7!XGW8P`V-#M]3@SY+H!$]<0_N`7/RZL"G=K!DX"_KO7
MU\A(I9<JZ0P78=BRT6Y4F&X%L8$,EU)0.%)B>Q24#BON8"4,60).Y0GX4%MW
M'G5$-1MLR085DU%;<B:5S04#"'=0Z'`G3FS>[>C[ZM?J-!O6P]6P4[_",9/,
M9'"B99);KC/]]"0[&?X/Z\<SP>$CTZ3%UD%2;1GRHA>%^#"[=.??B]!D2836
M"[/,/^_&6,1=ATBN><Z]YKW[@O<]B/CZE]P`=:_=PY`X#?\X3MIPXO\W8SRK
MD*4`7ON(@"^-?W7BD6.YJ>]-/?J4;8+/!]*B9&6LW78L,;+6;MJ\5$IWY$HU
MN*>0&N#[V>S.S3MW/3(U_=SIM1.'JM"C&3/]*#IU?$MN>'@M="!5P"[0*I]`
MIYJ.'E>WKX4>&V9)63A$"Z0LN+S8![ZP:#_FQ1MO<`,M++*QEOJWUZ9LQ``K
M%EC?G^@KOC^D?'&V!A3INX+^DJ9%/@K5U5*C0DZPSO$7^"!*MTNZRKOL:``O
M:OD0L"1AQRQFQ[@&1&EI6BZ;Y?EH2#[(^/R!]!+:N[B"$%JZ\X:S*UE#1RG*
M8D.$)N-Q">.D!-KG)925+DNTA-%2`JR4,%9*3JT7#D"#$O:&A`%3PFPI8;:4
M,%L*$I(P4/*JO6#3);L!M@&:M#V:)!$>8GM4:7L4:7MT:7MT2=X)#U1IMWMM
MQS2-NUAIH)*Q;*P8/L/#2L/#2L/%2;UJR%WW<)+0I'`?3L+*^S/WM$7L*'@\
M^;YU&'!R:-5%RP>8,NLR97:=*7G,E-EUIN0Q4_*8*7G,E/Q'F1)&H",P`P%6
M6A145D_-_T/(#VKV8OWDCCW/2`)(TJPE!-%*[=IFUM9,3YY')\8.;!]X<>W[
MAPA2%N3'T-FGAG*S:]P3_8$/R1!>YK8[UWUO@@XC5`[M=)+OI)`91N+#P:@1
M050@801:@ES&\9/W#674[QA6E?<C?TK#/VA[C80Q-PR3L#BPL8JCHW=8U65M
M1:,IS='V:?B4<;07-%KC156D16>%0Z1QP7-)A$?C>#X<K7)R'IXQ][I9ZS^,
M*Z>;O/'5F0EAG?UO0:K&5RDW04.KI!QN03FA0!=4):O0K-0:;Z59UDBWI]KE
M=A_+1T03?F5&06TMHD(E`QD3Q<)1$RF^J():0PF%:F<2)N75&,LJ6L4B5$PH
MAI4.-("VHJW"T3#38)OAIM"0Y]CY\+PP)[]+OZV&FH%&I,$WD_.!N<@</Y\,
M(N"/P].`(0A7)PD/LW2M*B;R+$RLB3:86?L@H3B?!EH[]KLG#QR[^OOK-R]O
MV)J(<O5N6S$CDE%(^2Y^^<8WW_G:BZCCXB5DC8W_];>?FQG;)N<W[D6Y5YN9
M.,Z@N;;-#QMAH"RAIQU9+`5YE@I0,945`D*,;2UIP/JZ&L`PP6&^8-_2O.G`
M26OVR40@)L(DP!8,E6,#4:$3=3KIE%AQ\XO#XN#&*HY.&5PX55FIT.6*4YFJ
M-"K^BNAA241TPJ@<=L)3X>7P2I@)R^4)R!P0WV%BEC`\1L[A:KZ\F,R2^%I"
MQ7:8)NU/F,%9)5LK[M:*M[5RW]9;H``,):ONQ(`-&15PO_3:8=;H2BIRP3(R
MAEGH2G::R%#@4$S9)NIH+Y@4Y:76<IO<H.X,CU4U?&@FFTK3:';YGY::<B/S
M):UA-JUGI6]IIZ4?),\H9_(_TG\JO9)_53\O_5H7M\01!;F=@>=-%\"@;1ON
M=V@N#J>D+4DL)-XT3))O@$[L9W0N41Z]_1ZA)O2-RH:MNQY_9?>>GW]V?'-/
MWZ[]O5IUP'`.C.Q=>ZE>318*="ZQS_=G/,?,UK.EK_SMY+??F\VG7CHVL/,?
M_YH>/(45,`$*V`8*R,!\\X0CB>)HD$]0234A)/T*E1%U-8&3;6B9M]7D6WG=
M"`>Z3OJY9"+*'Q&$6(#G8ZI*902`^V),7+<Z+TZ*-'"JF"J[4BA[4L`12EVT
M.E5>*=.-\MDR758[8*0(XALA_-4@6@DB<MD"^X)RJ=^KP%!?71/C;-\BU1BR
M#WQ3P@7W.DGMJI=5+Z<]68N)&H60D<OFLS1;--A"@>LP*2VB*BC*6PR<FRVZ
MB;)174&=@2Z294BS6[*+7JJ+#:;!-0H-:Z&\7&;!Q*&FT2C.=C_7_4-TAOEQ
M]\O,N>XEYD+WI>XHIAJ7:<JN%,N>%,N>%+&$I@ML@.061E12NOLVK`-'#PP=
M,6)MS!QX=4-/+_VKC;71'0L'/SY[]9FIX_;S>2$U>?OZ0_UQK90L["AN&C`?
MTO?L=U+Z\\=_\=T[7^_M>_*#CWTZ44"%0GOW&/H-.O&3SQBMFQ]?NW'UX<$>
M3-;;*<KW><AZ)S*=$&=P`YP4%MQ""FT8XM\7TVK5\D@?XMQK:HU<9A1WF1=(
M=$RIK2I8Z#3W'8OFY$BLRF<HA>I4,X(B=++_9;M:8^.XJO"]\]K'K&?NS.S.
M[,LSXWUZ=]:[KC.)[>*PDZ9)5!ZV4]10"S9)E0>A`1$G:M4DA(K&8%6%ICP2
ME4:(4J1&Y0<I=DFVY0>.5`)(2(E$$84?K86L"J5U:16W)$3KY=S9=2@JN]I[
M[IT]<^?>N>=\Y_MP3#<,E'G.,GV!8ERV>GV!DLU9)1I6O=GPD.R98U#GTL-U
M^4N46J"28/:&Y08*OX)W(0[ONOA4X&I@,<`""KWBB:@D&Y;!&.5LIA-:&9\#
MN*YO4[9O(9!U=R&##V4PRI`,D_E;>?P^'U$Z"@5@`Y3D\C)9\F4*K0&.0R$A
MX$,"C1[DX*Z:`6+MK!592,ILIGLX`2$6,R@>^Q66IF^QX-/"QG<VC6S>5%T_
M'@CW]"9+,1L'(K61U<!&)Q@N#++G7OO>KBWUS9^ZFQ/T3/V!A_XR,DI2"1:H
MX.@QAI_4TTF>LKSM[27F-3BC(6;6^Z(X&"-UCO24HJ2WQ`E1/7HY?[GP5W*-
MW"2!$LF71\B&\JQX.GLZ]X+XLVQ3?"DK\A&^)UB*1;:)GXX(GNA%&'7(0F<9
M"V/*-K`GJO6?4`J'MW@:.JO6X();N^[$K<39E)5,TG(*+D\E<;*)#WK9Q%G]
MNJKR!2>@F@55[**WI\9<_`45]9$^IH^^>E&4W<XH(]%Q%9+:DK"4E%U<<R?<
M7>[7W$?=\Z[@JG+0"C)!#V[H]#+)4C]]*H4!`(4U#.A/K*.5G&(`0,#2<L.A
M=>%701NXD0\4!MP0]*)]]>!8+`N-GH<A++U+EVC=__`P!8_.C7TV;!_6NNB%
M8(:^G7`W7?D\3.!;F,.W,`VU<[=G<J:6_!F\!/;ZX_`&TPHT)`6-9$#3HW<<
MIU!]F3[(-$VY;C;;?Y^/1#L6/*B=`W??T?=[&?'`HE7PY4UPY$WPXJ-K+N2=
M%5@X)LLKRXB\0\N<)]>\L%*O>2$9&M@+=:-.'2_ZY/P`+`WR^.I\Q\)6@4WF
M!X!7PNA/7@@Z^0&@FOEF^_UY@"6P2Q=I<4T#9OU7,$VA:4@%6JV@7&$MZZLC
M2D*XV_4)4B'+KJ.L!(H4I(:/:NN&?.`:9GXH9S:>W%2Z,VKC0F/\R1V;#YEB
MG]Y',@,_WCJX<>S`CP;N.OW=SVQ+*:H>9R^M7GKRP'`NE2C][HD=XV<FR^(0
MGIR9^41Y<.NV!T?NW?.5\WE9!DJ""NWKS!FNA1+H:4\Z)9Z*,'XC1E"BB2_`
M\7#1*!L[R6#!%@=%3V3%PZ%]DLBP32QYO;QX(9),88Y#,F_Q#%_6]-C1:%3S
MX.5K-)Y(;\:M:0O:58W5$DF*'!![\'J!_J_X#!\H_3@!0@%#5&\M->IC+7H-
MAIC\X8Y!/(VFL;(NEO6K^]"PT0&-]4H6<&(8-]]X0RZ037>:VR],'5?"Q[[Q
MR[NXUNK/][1^L[W6NT=?V+,Q<P;?S$Z]>I1B=;V]Q-W!GD,9_/V740Y6]SQH
MO-S5'!.*I"+ER#T1;C3R3/J%=#/-_3/P;I#)>&*/VT<;F4>:Q1.->S.`VP$,
M](W/9N6<I66S9L[*9+.\P(<3^T)B6$29#+P``0GE+B<S!2K9!-!P`L@V@<HV
M@2HV@8HU@8HU@6HW@2HV@2JV*P*6!6P+5P0&"41@!"K?PCFJ!'.@W')=Y9;K
M*K9<5[%1.U?N_`TSY[K"C5HO`91Q(8>MW(LYII8[E&-R42N&8V69XLH\3"QU
M=9O4U6U29S(?=C20;^])N"8M2%<E5DIDNT*N"^H^=[BM!^AGI?'1$2T1R[Z2
M@Z^O$WQ*T)BFM0%JN)\3AQW<%5@T%0J%+H/KGOJ&87_(_K%_X^K)S=_^W,3Q
M<O&3^(162N5Z^T>HVFKE#H+,.C%YSP.//8>/4%G5^N;>.TTM.8%7?)&%D08:
MZUTX_32>\9(J@QBL(A5S@^:4,16?-"]&%LWWS(!)*W3/>I-NO)"VW+H^H>\0
MV(`4M`*<@8T4$+K.J6#>$G02L_1F^W'O01FE[50ZO54F45DF&*&=L@0]*2UA
MQ`G$!H`@%"P'B4<8DC+D%)$ES*>AZ`4"@I!&8NI?Y.B@[,F3,BLWI&O8@UO\
M\F+C9S%#@^D*9O$D7=G\V(3KKS"5+;JFUR.[Q-QM/FLNFAPQ\8NP#Z87>`([
MWW<),L[IG,;*-.1=*['26(DO^[6:GH=JC&+@?:/P%W1GJXYT@KPZRU?C?L>)
M([*,R4*G;?RO\0^OT:`H&C/I8DVZ6(8HZ3JF#<3.XEQTU#<Q:F[,B7(=K\$A
MCRG"`4F'^@\PJ&D^YL%8$"#!WE[][:AM#.#W:TJ\\LSQ]0.C>*@R,K+Z^S3S
MYY/99"B?5W0SOW_UI[CVV`:KR.3SPH:95H9FN=)>XN?@G"O,YU]2D8(K\&3O
MG!IU$8LX41<-@@A+N$`M6M-K1CU:U^O&1'1"GS#NY^]7=YA?Y?>']XH'U(/Z
M06.ON=]ZF!Q33^A?-XZ81^U'BJ>J3SNO"_]`;TG7*C?0!^$/Q`^E6Y6"$!9$
M0>((KW"F5YVL[JZ&,&945=$T%":B%09!9,6Y(BXZ_581A4B("7%!*V1H-JQ,
MTRVC8.>M@M=L/SROL(S=;!_QOFRABNU4*ELM.VI9MH9"2+`8M-,R86AR;(C%
M[$Z%1!6%`,X@9JNB0E\E',MPH8JIJ1@)BFCCM^U;-F,[1<NQ+;BJ$`Z'*\5"
MW`B'A`K+(+%*8[ZRONICP(CK6[O/MUX\D72KGBBY"/;$G*_BJF$DBP_95A,/
M7/!V*X<41ODU'D`V"H%WC/*-T*.A=H@=#'FAR1`;2@Q4F\P./Q*;N/(MQQFG
MP)%,`&HDXZUDHA4?W[+O[K<:'<"`P!RC(`&?VZ$Y#3T%@O.S52<(0<G/0G1.
M2Q_O^1'K)#\:L\[_#=U..TN"8\$Q6F(:#0`AGSV8[<5YX"BD>=O>`'XPJ@>C
MHP;\\%KHLEEV+7H[P>OS51J['PME=JF-;KDW1XJ)=?CUP9S]^$S8'*CA-T?,
MWIE'DH5A'*MN<%;_G69^T;J7>?YLS99`:ZC*?:L_^`_[51_;U'7%S[W/WW[7
M[\5^3OP1^R78CA,<Y\7!"<28VH3$"3&A`0(E@%E9"0$6/I(VHIJ*5FG=:"E_
M(%91BL9HMTI%530)6EB@5*JT:H*MFJ9N4K5I*FA%W8H6RA`KE2#)SK5=1J52
MM*K:7^]9OWO/O<_OOOON_9US?X?L\.0;+)&(X*VJS&.SO\<7#1N0Z:U/37LY
MTS7,/2XATU/TW6P^&GA)I;YJ.46=KP5)BCW9?#8E.!V*6J?NH8<=1Q,7R:6T
M13;+%IEGI)XJBSF+TD4U]YNO8T9@-GF3K741.4S"X:)<E3+AMI")4^!IES=S
MM.U<&VV*$RT05)D6<*@L)4&<I"0SP\#H#?A4;S@>4<-MJ?EJVSD3*49'#^87
MGI`Z1PVU:DFUM2GHP%!8+$/>X]J$1C=H![3SFJ`%7I0F4N=3PH;4@=0M27A$
MVB<=3PF!G)3"$)J*<SXBL;"^D/TQBN2/XF15_.GX1/R/<4.<.%D]NI"1N$F$
MC)%GB/$Y]FOUEBH,J#]4?Z*>4`V_8']EGS'A>?(2>8L(?T:=OI&I"F-J*NL,
M920B,4F34@:5J$S5U)0AI<75@,2(Q737\K:UAD,FK\=LLKV<?B=-TSBE7TD5
MR30Z`U^C,Z@X\=@VG2,.("1X2CL8>)L$(4[WP$)(T]P;M3=X(+XY]=DTJI\B
MX6.%NUPO,KVJ?70TML^!)"_P:S16)"1!(N(N$4[(JGBI5NI+M10LUJ=0:Y5X
MB?Q'*N,@Z`PX1+$)%7QTQ)="^;TE*=SOCH17(7;21)<,K,TJ`8_-D91XX>!%
MD!=%>3N(/H2.&MNK%3SI](=IM)_2"C$/FBAV1Z%X1/A:8UTQNAVVV8>#VYM>
M(Q/J1,U9]7?L$V;#['`0)U$@KLJJ+S+`9#1:3`OY^8\]J'_G"R47,Q>/B\JJ
MJOGW>!G=^?.!A%^;OK4H4+.B2S-97+6-,X<Z1T?Z7GEX>3,U^9,6H^!=6M<?
MBI/\HNT==-',>Z_$JBAFBI6NZO21H2[F0K)*X7#^^!B9>Z@#W8PXS;(DF[5G
MVW8VN@/&2(1V;RF>+S,Y80J]3B./G9:8RJC(DX)?NMP/&8A">J&7]?@&?>O\
M:YNV^[;[MS8]YY_T7_`[ZEWUR@)8X,M!C@V;ALW#XA'M!)SP?>!E."K3F*@Y
M3*)9-;F]E:I;-A(C,:B8N[A49:X[6A^..30MY_,J/I]79,R#B0W;"$0!QAE7
MJ_F\#B:"V1W5(,Q-8C3ZPE=C!X-2^&K0K6"&833YP/YHXG+B>D)(<+]F2GTR
M@026W)J;NE$N9*N,#0TUT62T,RI$+];&P/@'U/3>YL1_I00&[[Z;TX4K*-U+
M+!Z[*R7ZY*G,U!2G&Q*`\-K9OL_2%"M)"D<Y0$/I9OM7*8M2:;;(I;C,PW(!
M9<+](BLU<ZE83)$X<4I"D=R8>;]S<1/Y5Z*^Y>4="Q,/D?:F5.?,OX<275M7
M#7<G6Q818K%('G]]6QT]?:P'HRV=XZG;/7.(^%]<&&E$)6%<='(Z/W,G/?"=
M):EEV25U=GM@[F&^\VZ,MR.X\TXZ-VMW@E`I?"+<%@QL<O8?66LHDA1J?($D
M;[T1K.'U]6S>ZT^F:"_=*OQ`&!?WTP/"879;^)S9\D).[&3KA37B6\)O!3.5
M\?%Q\0:EFD6SUE34.->('XA_%V^)%CLUB'ZJB(:R']:+5''9J(_NI?OI:6JD
MC!A%MS@N_D@\)QI%P2;D;":6(S;(X'[@2A<XBB>I_RPX<=_;*VP9B[7"68&?
M(#+G9O8$>X:]P%YE;[+?L"L8*JUL(Q442@5*!`964;%3!Q%R=NND4)=E=ALX
M92=J&V(S.7E//<L!/0/$IF0Q2H-"%*X7%&26W7+&:K6M)\*XO<$9@V)"J+1#
M%N-U!F:![L)%G:214VR<\'LVKAXP/'M=RB3)WV7<:*QONIALW+S)TT1Y:KE<
MI-XH5PN8.4Y=RSC;M8*<OB9/E=G%O];)Y>Q8,8HRC);<87C4Q&B)]3E^O!?;
MLKM42\7^RZ<<KDQ9H>[;^RX?2[XH7P0>Y(!'93)6S'I(H3BP@`]:I8S(]]J*
MFI=ZL,!AKIVL:D<Q$R.QP=K:5A*:@WP-5=2ZR3R,9/.$)7?>I_3PIH%D=4AP
MS=#L.Z_'JBN%@5#?8T3VWWESYR%DV^RGY)A!II6H6OU91C,P`SXC\1IZNWCR
M=47^&#)]4^@EM:VU!OGV)4,M.89);OD:N3_H5@##D3*N`Q@/`.:J]V`"\3<`
M<POB60#K1@!;,X#]20#Q`@`["B"M`Y!/`%2,`;CZ`92#`&[Y_J@\#^!Y'<"7
M!O"_!Q#`=ZCX7.T&@-!:@'!'"75K`*+8;E@&$,.YQ'L!FG!^S1\"M'P,D,1Q
M6G\/,!_?O^`JP,(7`!9AG?G3UZ,#W]F)\^[Z'*![!F#I3P'R/0!]_P3H7PFP
M8G\)`R:`U0:`M=4`ZUX%V(`!?R.NUZ.X!M^E`$-!@"TV@*T6@&VX=B-_`=B-
MWS&&\WQB4L>WBFLZ=.C0H4.'#ATZ=.C0H4.'#ATZ=.C0H4.'CF\"H$"`7PH(
MW"(^A`D>>`D(LP5L=A%`DBN<+L5=6>7Q^OS5@=(?PI&Z:'W#W%@C-&G-B99Y
MR=:V^0O:4PO3Y0$ZNW+=/4M[\\M@^</]*U:N&EB]YI&U@^O6;RA\S5M//GAB
MW]9E@-U85H*,GVJ"&HA``Z1@*0S"-O@^'*YQS<[B_1H(0Q0:83'D81-\K]0_
M^]&7?^"__+/R*G_5)3QP+A;84GY>`"^6I#Q#+_Y*M@FM%KZ#!BOVM.!L2C8%
M!^PMVP+V/U^V#6B_7;9-:'_:W=^S.-<?&]BV8^CQY4-[5N[:L6EG8\>ND<W_
M^PWHAG[HP27)81V#`5RP'3`$C\-R+/?`2MB%[4VP$Y>M`^T1V(Q]0S`,XVAO
M@K%O\/S_XPF^TJ;]<`/2V&'"E95!@]7H!?N0"0*V<5')03""Q8`6;WU1PY;_
MC$D(J!T.T*/7'@@8'(!I:1H'R)@S'*;,Q=!8!J:-Q5F-=^+Y;;YR2'*`52]Z
M;.H&HG=>W>KYN_-OCP`#ARF0"XIWL,D`6BLU@PIE;F1S=')E86T-96YD;V)J
M#3$Y,R`P(&]B:@T\/"`O1FEL=&5R("]&;&%T941E8V]D92`O3&5N9W1H(#0Q
M-C`Y("],96YG=&@Q(#8U-S@X(#X^(`US=')E86T-"DB)7%4)4)1'%OY>=_\S
M",$+.>+%P'`I@QQ!131*A$$4#U!1,(<,*I<@HQ*CKHD:XE'@D5C$(Z4DKDLP
MDC6#B4:-NT$WNNL5--ZN$=UH/#8:UQC++6%Z'^Q1R?Y?S=3K[M?]OG[]^FL0
M`&\L@43&N`G1<7GIV8]!*.?>L=-*'<Z%'5,V`ZT!`)V8-J_<\I/M\E(>NP*8
MC^0["TK_]&$O7L'C=X`IMJ!D07YFUJGW@(0$8,=GA3,<TYM>[%7!ZWW%<P84
M<D?7'[L^!CI>Y'9(86GY_(;A?L>XW0)TCR@IF^90L;L;@;_]P&U;J6.^TUO0
M>SQ_(OM;9CE*9X2O32T&M&(^&<ZRN>7,FS_WC;9QYYP9SAL)U<RE3PC0R<=8
M`QBC$<B_GK(:/7C>=?ZQK[[M'J5;C)FPNHOU->G#LW__GQ\0BO5X'R%X0+$X
MA$:,PH=X`1FHQ@@TX1-TQ`(Z#@4K4K`=H10(@53XDX%-N(27,`<W<0T12,=5
MZLKKV.&$'P;I._R?CI5Z'WMY(AD[L9]*:`*BV4X3-HKDR&MU(_P1H4_JB]S:
M@IL4HAN0QM;WZ()P+,8[Z(IB'-,M;1E$'NIH$=U!$')1I>)5I9Z)P=B-<Y3.
MUA@L,"YVV(T2GK6-_*E1-^M;^*,BS."5WL1*9KP+C:*?3#8^@`5A>!YCX>#1
MW^`2^5"L3-+A>KC>Q+UU>"@BQ1%I9AZ1&(FI6(VMG(WSN(&?R8OZTQ:J9YRF
M^T;;Z:;C52SDNMK"V:O#Q]A'L10K_(4_9\L??9#%8VM1R_$_Q2E*IQQJI(.R
MUHAQ#]/=M*^^I37Z(IL9OH^#'.,1Q;`/1Y#!LESU5N5&7.M2WN%T;,8IG&8>
M5SGO/^,)]65<%V^(Q7JRWJYO,A</!"(!F9B",LS#:_@MG^HAKLE_T%/1@3V;
MU&%CH?%`K^/<AF$X<Q_'WA-X[2H^I5W8RSC/N^Q"%MY%`HVE\51`:VD][:5+
M=$F81)"8+>Y*ESPNKZ@!AJ$3>24_].:X5DQ&(9_`&YSM=;S?[3B,H^1+813%
M.SK/\Q^+P2*%L4TTB:MRF5RK6HSE[FONO[N?ZDJ8N<I&<!Y>Q0[.PH_DQQSZ
M4#'-I>^8^=OB,]E1=I96V5^^("?*'+E25LN_R*_5'%6O+ALC#8=1;W:X9[E/
MZW3]%N>"8&)>X;`A'@.Y?O*YFF8R/R=C#A9A*2JQANME'3Y`/>_[2QS%.7R+
M'_@$0$',N8BCEW+5+:,UC$WT,1VDPW24KM/C-HA@1H08((:)9)$J"L0R1K4X
M)<Z+V[*GG"87RR6,&KE'7E)02FDCCI%F5!EUIN/F"'.:.<_C1,N]UKZM.:U7
MW7!W=[_H7N\^Z+ZE)^D%S#\44>C'3%<PRTU<@[6,'5R)>W`$)W"AG>M#$F1P
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M$E]2L`PT$F4^5D%3O;@N'HE;RI<FBCL4H=ZAST693!:FMB#&&>6K*HS;@+B`
M1/$Z-8K#LD)6Z#\@T:BA9J-&G(9%71,^:.9;O4)LX$E?BR)1A6P5;SQ%$>?]
M(V,^YWNH6$E]Y5E5@YO2*GZB![2>5>,DC5(AXA4QB.I9<5NI-^[1;#CI7231
M%_0M[071=EE'H\4S?%HNX4T#^1$Z*8/HK/1$3AM'"A.^E"$>B"QYP'1*]B=B
ME?@&"TE2#-?.?S\W9O$-J!;AK&EV5I,S%(<`;&"]?^0^T*;8QD6CBNMLJ[1A
M/&+PLCB.1+X;-QG96(XX[.<:7(D8L1&+]!*:SKH_AO538"\5(YJ\6"W]F=MB
M?B_\1#!KX52.^H3U_QBK?CK=QVMDX9O5B`C5-K)*V5F9<EE_JQC3\3*W-F.=
M:;=Q!N/('U`6=PU7^16\PF_.=QR_.X8PORG8JFS,VL+*/)MG;':G(8FQ',=)
MX'7F/)3O>89*8^5=KXMYAT7\1HWF-_$HBO0&)//9C=<5N@I3]5;]$@HP06]G
M_9VG=V$`5A@Y8I(1J>)98X_25_P>_96J6+?3<)GU*)0"<)>QD_D/-;Y`I;K`
MVCE,K]+GX,OY".8,Y?$K>@.EN,]Y2Y.->,X]5C3H5.GD%ZH9F;I.!Y(G"G4)
M*^\!U)H-UIXEZ&W4<NTB:7C6Q*1A0Y\?,CAQ4,+``?WCGXN+C8GN%V6+[-LG
M(CPL-,0:'&0)[-VK9X_NSP;X^W7SZ=JE<Z>.WL]X>7;P,)L,)07!9K>FYEI<
M8;DN%69-2XMJ:UL=W.'X14>NR\)=J;_V<5ERV]TLO_9,8L_\__-,^K=GTO\\
MJ;-E"(9$V2QVJ\5U,L5JV4M3,K/97IUBS;&X[K7;8]KMM]MM;[:#@GB"Q1Y0
MF&)Q4:[%[DJ=5UAISTWAY1J\/).MR3,\HVQH\/1BTXLME[_5V4#^0ZG=$/[V
MQ`8!#V\FY>IN3;&[GK6FM#%PR5"[8[HK(S/;GM(C*"@GRN:BY&G6/!>LPUV=
M(MM=D-P>QO4OUJL&-JKC",_;]^XGQ,;G'_Y\AMSQ."/[;,Q/^3E3G"OV70RF
M28R-N7.=Y@PF`MPF5/Q$M%$PBOC)`]J2MA%!!"'41@BWX=DDK4TE9%1%**UH
M6E4&):%M2D);V@0B!*T@DE^_V7?O.%]HH54M?S>[,SN[L[,S._O<]:9'+A-8
MQ[NA/8&^JB%C[X"/5J7">5UZ5V='PE0[D[Q&81CK-I@3OOG1Q#M=3%Y4G]B5
M+?6K1FSBN@!W#6-7P#S2G,B6!ODWF<0<I@C%4T8<"^^%"YM:`EA+[$@F3&4'
M%@SP/GA/]N[6Z#'FI-8'S`?TQ?I:8WT*!U-JF+1\:["_M#0Z:'U`I;&`T9K0
M@^;#?CW9V5#65T+&\JTG)T4#DT9+JJOZ?(6V6_O&%J0;>?G9C349F6S)X=QJ
M6I[QJ\(6Z4L0#F9@=0"6)'3L:0'_K%E`QNH%&(:_I`(MLPOGL<Y\H#YE^&K!
M][&^Z0KY](!QDW#^^B<?C^9TICGND.\F<9.C)!-HD#MM,QPV*RLY0#SU.%'8
M6"?[<ZNKM@P(4]_@"X#`??0X?-N9K*V!\X-!/MX]`U%:A8[9TYRP^P%:Y>^G
M:$TX:8H42X8<R;@5+.EQ)!GUE(XX?H/X^V*<Z2W/_!?XQA?'UM::ROC_(%YC
MRYM:]*;F]D0@9J32OFUJ'=6SY0LRLG1+L05PN*F%X*DE.D)O>7N"&?AWA>)Z
M;%VJ$:D&&\WB^H3J%TF[)?RJG`KQVY&9F3N)/)Y+"[EE_'<->+P(8,E1`G'3
MEVJT?Y-C@L'[5!JP/F4M2>ZHI?=DUH9']Q>.ZH\R+\]08;!6+II:VPUCS"A9
M')>58<3U0-Q(&9T#5L\J/>#3C4$UH2:,#;&4<_P#UJD]?C.^-XE-K%5J$=J"
M%O?IRN[FOJBRNZ4],>C#)];NUD2_4$1]:G&R;QIDB<$`[F?)%<QE)G<"W$%]
M0U;T"Z\<[Q^,$O5(J289LK]Z0"')\SH\A58/")OG<W@"/,WF126/__BFJ&]-
M9,>`3*QDM7P`X`LU.!*CE3[Z;--(N4]RLO_<ACNBE'%+.,`+6VV@'?BX#`%?
M<Q^G1G<$N_@&-4/6"LP`?[_V`H4P_FGT6T#WBPBIX"\%/@6J@!8@`*P"$L`R
MX#F@&6--X-L\AP-U'W5XODJ=KK/D<[715&`IVKKV(55J&RF(=B/WL=X<=3)5
MHCT5L@K/9(P]:UUF.<9-E>/:H+>1>B"O0_]!H,BSC_R@!4`Q^*68YQC;#-JD
MGN&]6M?0W@([EJ#]&6@<MC:`+@/_,;07`?G0^:*(6*O1+D1[$7Q3B'8>$(/>
M+=;!^'S8V`5Y"?J"QV+=?%`_C\6<%>H%Q:\<Q)OJ`O5IK50"^5@)[)OW[.R)
M[6>;_@WB;%\V;/LDV%9QQ[;/0>1@C3I'GM7V]%X/B7.T03UB74=;=Y=0C.&Y
M0%.POX^!B-9%DSR3K;_"QB6N-V@N^EY@H@3/>8AVJC<H"EG8_3+BIHOJQ"P(
MYEJWQ;=HLCM$CV"_\#=-A^U)CCW$PC2,:Y'Z731%NTRE:$<97J(_9_P$W^#L
MFT#KX?>K7K(^P1SU#,PS")R!_@2L7\,^X'-7VD9Z,?8*9,\"&Q$CDX`)D.^1
M,0P=UL<Z7^(U[',@GXQ!@&,/F.T@?3X.'G0@_7]<8CPP`9@/\+HO`S\''@6^
MSV,P[WB,GP([GN>8X=CD^.#8D/&/>)(QR^>X$;[A&+-SYD?B*=H-E`!5^"C9
MF48EQLI\X7-DFSD7>&Z.+8X9AT)>;L>]<HWWR3&51757E5Q;YB#'5A:MX-AG
MJD;E'BK$$,WCF+5][5!I0XSSD7/"H8X]G)\R1T#5;BIFW_&Y.]3Q188>H1!D
MRUSOTB/:+%JIOH7X[T#[<=#Y\,]AF8/7M!_01V('"<\05>$L.7=?R:$'&)YA
M93WF&X(OR[5S](JDPV*J-JRX7+W6%5>O>-Z&T\ZFN5"&;!E31K;LO^7_+Q#G
M7;WT%-I_<PU;EC9,+V&OY/F[,A,(.!3\?J`'J/2&E0/>;F7`LX)\B)L;P#-:
M%-^O49JO#='#VCB9=R'P5V#N&JV;%D)/Q9?:B^H*.NKNI2^HPSA'K"7.TPL,
MGA]T0R:.<F/N\[$DJ1.O=Z&<`_D.E3D5L?X@\RIB_5'F9,0:L2E%N#;P_2SK
M`\F[N=")UTQ<ODKEZLVL^,R)TZSX7`@]7VY<9M&Q3-.U)=_)4^B,YUK#^Y?W
M8YO,)WG/0=;OC,^E&?WC-"".6^_+>_@<M3MY#<P"0I#_(GV/X![&>7/-W&=U
MN)^U.M2E5@?V^5/W+M#KUDDQW>K+U-00S4[?9:5.+64_N<Y16::.ANBQ]'T6
MXGJJ'4,-M^MHL:R??Z&)KNOR;ILM[>4\Y!RLP;TW'77\']9MK8B>5E\D4I&7
MS$>,-+-,\](X]4^X<Y?2)O6P]3MUO[R#8NH()=4P<ABZ\-E$EZ`R5P,U08?D
M?#P&E'ELOUM#?/)=T(@^SLJYE_GLW;<I'YCNNHK[J`UCCLN]AN0]?H"FL1^D
M[F;4%<SE"5.1)BB<'A.2.E_'>T'Z`W=@EB_2M;F.YW0OES%;('7F6+>]111A
MN%ZC>5@_)-=JI%IOA,I=;=95^:XHHD?5LS13;:2'T"Z5<;\+-:H"];(1]1%0
M/P1&$)L^NR]KM:36+5GOM\EZGN>JH97R/<$R-TUQ5]`,AJ9#EJ)J]37,\PSB
MZC;:KUN6?!_\G@IY;?#CZ?<)OQ.$S)??0N]MJN8<8QMDO6%[#B+>WJ&'N"9Z
MCL*'8S@'%07^+DO7P2+T!>AWLO#=-*_,IDI0O$MM4M9*'XC3XH0X;77S.U!]
MCYY4?XCS.T%!M1WU^RW4QH6HX4OAJ]]00OTUVE/!/PQLP=MO$Q5H!=2E7L*X
MV9!M@-XYS'$4<L9.Z%P$?9T6J;^D=>H0W@>7^(U`06TSZ!-``]4K/Z9N<8NZ
MW?-0DQ=:K\KY&9NLKT@<1=V\E-9-0]KJX&XV;\7;[B[V2ENS[60;[V(?S\'S
M2CV,T30J(+(N`B&;CC2+?=0+'!'O8>R7::MRS#JE'**X<ADXE,9/J%'2/J`9
M.397>0Z8H<VEGP';T:X"/0V<L/MT$'@?V(&YSX">=.-3@2$6(YY!P3L,'`!^
MY<BRP6O=C9\-E]\Z-:K_)FH-H-S`'FZ,ELDUM],\K#=/6V2=8JA74$,`]S8J
M\6RA$G4Z^%.@E]-W^7'/O4G3[F7/O:"\0S.E#VU$[V>/]PO.7:[/_Z_Y[A<X
MWVW`$]*&J[B/90S16.6\=1&T33F/NKT9=RF`?C7ZQ8X_G7,"_WN2GW-^B!52
MR?IG+C^WGWNN]^J+D_1D-IPXR,3#2U3'T![&>""W[WV;ZAC_XKY:8Z,ZKO#,
MG>N[NRS7NRR&"!LS-NO%-EYBLY28P+:^2TR('XJ=A@)QI2SE$20>LBFT454[
MAK:TD":U&V@@D&"'X":J[7JYB\GR:+%4D2A1`JY4M56E@FFI^J.JZCR@HK5Q
MOYF]UYAUD.,T_5.MOO/-.6=>.W=FSAGM(GP7Q^OJZQ.@#CG*$3$G[,'\\;I6
M0_(%E#S,-5.TP9D#1O7+N%<!45>VUQ$O`7EV`>448C$PZE^,.Q\8LZX/B'5E
M1Y)^^_O8WR7U^V!^AGH)J$,^>XF4@!\'1VP>W=_6?7'7GG\LN=]'=7&7_"6E
MSITS<>=LX*S<J\__)^#LO`N\#;SUOQZ+$NQ5P`O(''496:$M1NZYFN"Y.OP>
M(4,9X.F("SAY0P,H_P;E]4`1RF_"=AB\#XRK9N@V[".((PQ\3,U$_D[(/@!]
MW&Y(MAV^"3R=[&/X'"'__KV%7<GV0\\!#\.'S&SH%/`&\'.@'&WL?GX,?0?X
M5]!7)OL:0GGX&O`#H`HXE.2A9P'A=V&,WXE\Y!/>H9\KW^O]\6G9>F>$;1[W
MAI@,+_M4?->;P_[^$[']EO@$ENM@S5\;,Y][O7'N8NP?UU@@E_:+G%+DT2*7
M34/^+/+'41;OMD<D3[?ZL=DC8J#(G47^FK8(.7/RG5<TYCVXPHX;8^]6^C$Y
M!GB!+(NWHLXMO'4N(39Y<*?>P/\[(2!CFXAK`.9[6?I_.W)!U`&_#ST;?,..
M:?;=.NZ.G2"F?=[Z9&/D9XBI(0O1%-S+;F.)A0J!U%@\64P4NS]S++]'C!X;
MI_];W8[S-B;*2\?E`1/H$_4W63TU[YBTGI*7V'HJQOE3]YZ=SV22S%&DG+O)
M0KPMU-X[N;\]A]1S/'K>[#=",V+J&.`>*$#,*@2.X[XH`;(!'_`";,\XATC(
MV4U"T'N!T[#]';Q1^,!M]'E<;C='AJ%_![I7?5_676MAXT3[.77?BOQ<YH=8
M,WD/MHKYDV)@&>`#3@+;[6\MWIX8^Z_*>4+$.U>M&[FA7@)2<L`)>3'9`71#
M]T#WG"6K1OK8M?B*%2$C`2ZZ7[)94!@Z(QQFYNS0+]@UI8OD$P[#57-FEO1<
M,9<OMPH/+$D6XO,7A*Y&IK`KY!^`PJZPJUATV2I><']H,*+#0-DSN*DIX:2=
M_9'$`(48[`_QO'FAM@OL/?C?9>^0C;+9.Z8^+80.WV9O$A_A[#3KM3R]\?1I
M(1+9B9!"21]D/S``#`(JJ6>ODV:@!>@!5.*!Y$`Q4",LK)-U8IX=:.^!+`;J
M@19`):O8SV#?*B1[@VTA<]'V.7:0S`#_D!V0?`*<"3X.^QSPJ]`%MUGZ4;#P
M'['L+T&?"3YL\2'8L\`O0A?\$TO_)K:U:+?+XG:VTYS#O9$Y\.<`)0!#Z2!*
M![%T!Z$12,J^R[;)D4Z"0^#M2<9R-9FY?OF-FN+WS0JU8TF;L/1-6+DFK%P3
M4>%JM.LT)NLL8(VHTX@ZC:C3B%4I83LQWDZ1+$!Z@1R`8=UW8MV%/0;9!_1+
M^_<@6X%VH;&GL8Z%F-5^ML4LX-ADF^,/&J&R<^PI++7!GHK/R@ZUW-%<4\1&
M!*=;[!%U-TGOIKAKJK!NBF=F)QFUMD;2V0;R;4#!U;B!Y`%?`,H!E6TP\XKY
M6?8HV>XD1CIO5II9L]J<II:44]\%%B*UR*0Y\;$%)(P*A3P:IJ7K7`VNW2[F
M=>6X2ER&J]:55L^:60MCG!6S,E;#HBPM,=)G.I8N`ADKM:6+6MWM[IB[S]WO
M3HMI?5J_-J`-:FDY6HEF:+7:.JU!VZVU:NV:JU5K=2CKW`WNW6[F=>>X2]R&
MN]:=QAVT/;*7K<??))!>H`%H!52L<13V'/8D$,77B&(IGH2=0!)H7J`?Y0%P
M&C0/ZGE0SP.K!U8/K`12>&J!=4"#Y=5&/78;47]0>``\"U@ZK.E8VP'(05$"
M*J'IT'1H.FKU*T.8H1<R!Z@%F+0-`-@UD+:OQ/*O`S3I'Y1U;)\AVBI#QM?R
M^PIIK)"V%]+60FJ$RR(A8RZ$S^>+^J.!:$&T0ZWWUP?J"^H[U!I_3:"FH*9#
M+?.7!<H*RCK48G]QH+B@N$/E?A[@!;Q#;:GNJ;Y0?;E:C5;75S=7LU)\NKA9
M5!*2/#<@N-><E1DJ]426*3WX.U'(-N`JP`B'+`;*@'I`57H@N=(-:S>LW:0&
MB`)I:-$MKA=(;OF$O4WZ1$GXE;O\#'^\RURZJ"92B2LW"K0!#'UWP=\E:R=+
M/=(>@QR0]AJK?KNT<TB[#<,%5R>ON3H<OSI2!D2!!B"-7&9KR%4`/4-RH`'H
M`516A]\:MD;IQJ]+Z6)!0U\X@Y.9,PDAOFE.;\2K3,4>T!%<A3PLY7XIRZ3,
M,](K]9N5^B\K]>]7ZODH*`4D`L=!*7,-=T0_%=%K(GIA1$=O]Y%<HBLSI-2$
MI'^3\E$I@T9&KGXK5_\H5_\@5W\E5]^1JW\Q5[2;C;.K*QE2NH6D+TI9*>4\
MP\WUM[B^ANNE7(_H]!C%Z&2YE'.DS!*2?GC*4^XAKG/T0U*.GJ@9+N0)A4BB
M(V8X`KIMAE>"ALWP,="_S/`!?I[>HC*DT9MFWG4>F4$_IA6JT#^R^`-:03K!
M@^#-X)^2,`V`3YCA/:+^:VA_!/IQ,M<IZK]*:F6[-EHA[:]8[5XV@^LQZE$S
M^"V,>H0$Y:B'S.!U6`^8P?V@%\S@-E"+&1`3W&*&Y_/(-+J9Y"FB[@824,1,
MJJT1'T'/V\`KDXU7F$'1JEP,D*`/F?Z%H'PQR_/43VKE<-STRS^93?RRB]G$
M+R>=10*2TZE'3EXG<R4[3?\>]**="ESG_PR?$W^<W*`>\QC_\WG\O]50_T0K
MS$[^ZS-BN4Q^.9B@@=/\DO\<OYB7H*M-WA=,..&X$$PHM)>?Q"+'4%>AIWE/
M<#/O]DMOAQ]>?.JV\`)^U%_'7PI`-_F>X'DQ#;(=_W@UW$\$O\2KPYW\X4""
MPFV$,9@QA2_U?YT_"/.2!*V(=_*%>0DQE1+TT7F:S\>(\_QR*E\I/:LL)@[Z
M#2/HV.58[UCM>,RQS+'(L<"1X\AVS'9D.'U.KS/=.=4YQ>ET:D[5J3B),R,Q
M,F`4$9S"#,TK2%.%5&79JP@)(6Y]A3H5G)W8=%:E5#V^G,9\5:1JU?)8:5%5
MPC'RY=B2HJJ8L_:K:T]2^J,GH,64?0E*5JW%!A6FO5DQWT-KSQ!*B_<^G_4?
M5JL]IJWKC)]SKZ\!O[`Q?H+!ON;:A(N)WP;BX0O8I-0!DD!7C$+"(R1E218H
M&"V/%JHNZQA+D[1+UDI=,RT3>2QI;)PE)HF2K)FF:/]4W31ICVCJNFJJ*J%5
M6D2WC,>^<\WRD/+/I!WY^[YSSO>[Y[L^W^-^1!X^<C21P/'4G4$4'["F%COA
M?\BV]*08>Y,1Z2<BQDA1@Z:N)?H,UK?&^<?#R#\YC);4J7AG=^J")9'RDLFJ
M)1%/;>RT;NN>IT:I_;'H/#5"1*)['A^D1F-;R3X^&$T\@B&6&@$8"A-!8!G$
M$AAB<4:$;1)A$*9L+)IFV1SH0]Q*0!`^'XJ@W;FS*L`$G+69"(!19:A"/*N"
M*B,PB(?<885/'J9`N%`\K%"!Q,-*"2C-<0"IY@@D'>(`D.9"HOIGC]5V+O<Z
M"<2)=CB<$.U@_!A3F<-`%*QAJ'S`\/_/,=3T/X!QIO_^SL'8D#W69X\-`?6E
M9B9>,J:F!JS6],[[1&%-T8Z^@<&7B.P?2MVW#T53.^U1:[I_\!GJ0:+NMT?3
M:##6U9T>%(:B<_U"?\S>'TUD9B>;XT_9FGYDJWGR&8=-DL.:B:W9^#/4<:*>
M);;BQ%:<V)H59D5;\:U-.+ZY.YV/FA+-VW(R0\EED`]]);9$DUX]TB`FQP:;
M\=62ZQ($GRTYGT@I[$TI)1!1N1I=C40%V4E4*M@N7%,97]U@*[F.SZVIU+"M
ML3<A'AECP]%'O[&QL7%"R20/?#QI%/?&(6EMG?%4RY:>[E0X%8ZEA+YH`A-W
M)-=&<[>@OAW^*$SM#T^&CX5/AR^'F60R`=M%M]F/6&H'NY^=9(^QI]G+K)0H
MMG5?%<*GV;^S=!*B"8_#B$5%FTF0\"/+\>08&0@,C`'ES/%)OKF[D46#T.UB
MZ,Q=2`MD!_(!=0(QZ"[PWP+]%>@?0!+T.O"W@<X`9<@.[:)=,>-PE%A,\*3H
M&&EOQAWPUF9!]N_*R<Z>G(RUYV2XT6L$.1?QR1H+H?'&Z#KP7P/]$>@+H(=`
M#.VEO>+AR5S4)L;0&(_A]1$LQ@D;X\<Q#Q-,KGM\C.<1(1+@X`&`\OCIN$=X
M+(G@*L`A(``D[HZ1QY)$/@9"#2Y%B"DEW3+*0VUI"M^@;D&;FD?=GD.,)$O=
MND(C61Z9_!PC4[Z4N0UZ"M%X'2K`>_!V9.35B^'E<+OZ0;AM.8PB,%<O`?.X
M;1J;A@.&2R5HR4K?61(8]&]DE=R!YX_0=NHFLP?Z$3-Z[UK6=,_TE8)69%?_
MF;%S?E&ZW'Z<7?T\4Q7PH^SJ/<$"$Y,1F+D6V%<*G*<P*"A9Z1'5[J`297%7
M)H\VJT#.%=,H2P>N*)4RB0HF@MYL-FAD^R1W#?N0!FN.E)3^P/:-@U#>%WN7
M%Q<T177K<PQ%EL,1\N(\'NU=JR`O8]KI"/B#/J]>5YQ'V^@G%I00U%.U-7R=
MMFYE(*0/N*KKS4':CBL.F$R1^GK/"X,K?\*5!ZN%^@T>YYLK?R!WO'=U)_TN
M<PMQJ!H%\+%T:2B+3PH)[7#0:5X?^J[A^^NGW4R]/^[?X=]5?<`P84I63[@/
M!*:94Y9+TDMYEXLOZW[A^U7@7\S#@%9FPD*^T\%()+:`RV246/4Z+^>2!!PF
M1H*U>IU1X53=QB>0CC*A0J3"IY$3#UXI+%0P^":^B"30(=GPNU=8MER);^"C
M\%'6X:.9R\6X.(N/"WKOIS\NQ:5F%,+6D!#J"WT2DH14UBSM%`J4R-9G&['1
MMBQ5-%?U:4$6?R$HU,B*=J#]D#^FX'5\$AHH(P]1T=OV8.%!KQ@AO:.+O6VP
M6%##78?5GRTL`%^&U6=P_T5U=1H#X9@L#&21EE+-79!LIM4O,P5%?D=V]4M!
M"1-&#2Q`&!(3QN-N/B!4U7@JUUG*9'*W9[V'DM:4>0=PI;QJ`'DLK@%45E[C
M6B=SPI93KD#JL#K,BPPRI^HU&&BT%_?R6I]>;]`X1(^'`CZ=W@!+N\/AU.C!
MX](\G3T`"ZR12G7%>FTP%`P&_`[GWFKYJ9-_B0>N71"VUEK..)4S,TO'/KXN
M;/_)`![8V=]]*5Y9V]CQ(]P^_9:*>FYFSZ9]A[+:;=L855[#RN].OZU:D:3.
M'O[>;]134Q)[)6W&'RMVM[=.+AU7&NVC0M/$7DA0]-SJ/>D@Y`N--(A%'M2(
M8X(=:@!-G9?.*LZKSW.SU>?=\]*KBGGU/'>U>MZM>"N?IBCBKF)HQ<`;F"K7
M(;HA6-(B*VJ197'BJH26(&\+-$D)P5S?4E5%0=],8[FSMN%AL'9S#5;7"#54
M39;ZLZ!LRJLM?ZBK59F:NGI$M[9!ZJ@7>T=!H$B$W*5Z`5P9!@$.)3ZL(_1&
M#?^*^I<>MQ$\-,(T^CFW@^,$1ZVCF@MS:H?-8=`;]28]+55P%L[G"5I08T6#
M!=?Q,-NP#F9:C<Z"6*;<@LURF)46P"RPWFO!$0>PD*O>@KY6":RXL,B"K5)@
M>F6)!97E`T./&H''):_JT>PU!"['V(YM))VE=M9!W!XTL.!<\+O>YPV!>YT.
M[-4_K<\3`?]5,R-+%0GZ_M(+;YP\-]'Q[8[-,RV^#KVF0E?N9KT>*WU^X]&V
M"^.MTQT=TQO==E<-ZZZI<+MMS)Z'O<R93TY\<.O%B\/#Z1=KOW5GIC545N1O
MNW*KS;?\S9Z+N],W>L[N&?[@ZX%@R]W,1E^H=>YFW`=?D2U08\P0"PJT12B1
MJ:;*=@?EI#`J2&',RN_)?R__7"Y1D)IX34JK#`9S`2F(@DRA*-A'3RF[?DIJ
M]@)4O'9U;"CZ-Q1I(U4/OPR7HGVRP+T?-/A=K@UB4:L\Q$,=<W,G2!V#+GSE
M>>HP\R;2HGK!?DIS5D-]1S&MH63O%&C0.U@+W;VLX)R*W2S%TJGBKNW$8._"
M,D0'?"$6(@L>MWCY.D@U*J!&(9U42L&EEE'4X1\.'7\/>Q</O=]N,S__RLI^
M;M.N$_\AN]J#HKK.^#GGOO;NZ^Y[[]UEWP]@EUT6V%U81#@\RTNAV#%12T%J
M@VE2%+5IC6;`CL;HQ&`R46FE0MK$-FK'!U57_,/4:AO-'SA3;2?3ATQ+9FP,
MK=,AM=:P]-QEC7]TF#U[N/?.W>]\W_=[?'#_;9B$BP.AAL\RAZ___O3^G_V(
MQ!`E,:S.QI#"_D(ZI&AF*/+C>A*$D4P#O)($X&9C+&8I=MC\[+O_'P3L-B9(
MI0UF'>`2R:2!U),T_.BW1L8RTP]WC*_P2&T[F0VAMN?>RGSO3N9F!@X$&N_#
M%Z[?.;/_N!S!FZB3VDPBZ`*?X@/FK^T1UB4O::_8)ILN=DW;?MWT%]OM)D4Y
MLTQ;(53:E@43Y<FFLBZ%R:'SZJI,M:8Z4WV1O:AQN7UYXTK[RL8>>T_C=G%K
MWM;Z[<VOB:_F[:G?USPJ'LX[5#_:?$(\GO=>_<F6F\&;Y>ZOMM2GZ-+V>%.2
MMH7S_0ZKCG8I-2`_64HKP[2K)KK32R:]B]AGB'?LY``8U=PQQUUW\D>3=VIJ
MW.VQ]NGV6^UT^YY5L@B2E!`.7EB87R`XGI]?J)HEV+6FEO";_7ZRS=:,"",,
M/E5$EI-),+=E.9++'%3R@_GDG^P^^W2R7+XOWY&I5?Z3'\F]QP+_08O>$K\K
MFF#+BQKJO)Y(W>X59?&V[6T1I[.ENG`Y,OMC]H#3'%4SRXI:`K8\;ZRPT-Y;
MO2S9ML,1B3@]K0.TJ;&A+T!^J33R3H.OM",8<04J'7J+76NIRW<6A5I*PJGZ
ME\(%Y0YS-+:WK#0_UF711?.D<H/:I)'L@LWL*;9'0D-R=P]D3L)1\"&P@E4X
M?PU:8[UFH7AKKW1+HG@(.)H6%`9PP8#5*KI2,+O,PV;*G(8AK'()/0(2)''L
MW9SV+723M,[-&E)P*86DZ0>-B626.7S>)PE92N!`_R#/<:J`P512V9:LZQ_)
MG"SRCG0:-;R)KRPK:=K:TW]6CFX5'$;/(BO1@AKL1LRP8T-RB"$$C\`9B@)(
M!SMA+SP()^`MR,(TC)\'P[3,VKI_+W3+O5\\1U8YE+#18_:L0LS"8V0](K_Y
MS<59N`E<!2H0QGD`LRH*\[@RP>.:1`\/Q_G3/.+WJ)?:9I#0A7RVDEC@"7^2
MDT!0C&NCT=K:J]DU6HSE]U*+LZB:X(0"79@'S$>N_B0!J*Q-&D29$")A$R>J
M(HSEPB8W%:-ZJ<W4!#5#L=1E^`OT$9V&F\[>S;+6O)S0JIJJO4Q.6<(RA:/J
MC+D3WF?>^.]JY@1Y%VA=O$==9#8"'?"#J7/K%>XT9,\QC%G^TFAL:2A@`V\#
M01Q$.-@;G`C.!.F@7KZLE3W,$!@!$T1VI<`4=#YU,G-9#[-B+D<?1-/:H=_G
M]_H1BR`%$<L%\NP.N]-.L<:@$%`%1<DJ(=9#Z_N`B[7U09.6["QJLO-#=Q^T
M*\ABT)G[@*0DRY=2%<I^0J%=QKBAG'2'U:(WH2R4RG6R\A#\Z.,R?N060JVO
M;UO;.[;SZ&N_Z[NZZSO7&E.#R6W.:,R?*JQL2#3'T;%[L*.K=OQZYO1GF0N'
M/OG5P\R]LX?6;SD%4_>.;HUYEJ_*C)$:/2#VE"49LX`CV(3%7G%"G!%I(&(1
MO01>!4A;:X3/PUKB^B>(`Z&R>P79^TB!_P,$^#RPD"L`_@MKH2`@'D&&5Z@1
M!:;@0_)X"S9HM0+6)V+"D'!0F!!H0;).(3^<S24W7+6"&$&9FDEU]3)@4N#S
MN2_@Y^%PCGF,@3*]B1@TLR=1C1)R`N3S/X"M'F/5US.HM\*BY`*V0!W]VW<>
M[]U2X42!`'*4O(S^]';([73)?5A$SGB2G-$)-^(?<*(J917SEL=%3!9)7@2G
MQ5+(57$MW/L<B]WKZ+6*==:UX@N*;?IMAC'5C[4_U)]2G=+>8&Y8/Q0_MGXL
MSK@?T8^L9C-TT!)C-TL6R>H0.=ZJ$E6.N/05:9]UQ,V)$D)6FZ266`TE(885
M96+DC+0F3<+@>6Q2UPSSD$]39<1$,[81"8Y+IR4D35%E)'$')B%2.]/P`-8`
M]J\=QA[C)N.0D3:F(8>-F!S*!MS8/>RF>MT3;N26+L-'!&<:B+&I!VU"0V@$
M74'3Z"[Z)U(@R34%WWC:S[-5<SE7_L24SRUT#Y(A:'#)>E\<X>$5?II'H'MP
M37@V)PA9<X=T2X_\\A7I@$3NK]%6[=4QKUS3$DC"P2W=I&+R@!F&E"<!`+')
M/B_+^7):0:0`<9Y2H@K4R9XO9N!ZZ#XVL&$\&)"FC[[WYUCK\4?5L._%9YIL
MD,D\#L`Z./K^KN/?';STF]L'^_M_<C[SH$)7$I&9D*!\-:EG*6R_!)2+,^?4
M*3Z]^`&N4J=J^49EDZK-2T_SL+"PHA#'>^/3\9GX0R4'XK"6'_*]'#WAO^2?
MBMZ(WO7=#?PQ^JGW[P%UBZ(P#5^?+"C0@32:G;P5@[$T%3]/,3H+M*3A^'D'
M#A?''6E8/ZG3%!9<AAN!"?#H;UC526J`#F9K0"HY>48-U?(8I>J,#$?0P<A$
M!$7(]?,]W!`Y>QI]@I4X#B?B'\01F6]A]45LO&)$1JE,)IQ[7Q8H6YVY[L%Y
M>9G5S<O.)3RWI6:N>TX>6;,<E(P6.X-*@6:]'I_'[PEX:)8):(-!)2&78CK2
M!YT"V7E49/I1\E$VU@==&H?,-DOS3_C)""1C;`L8)"8PF>4<4B=+MEB>G$@1
M=<^R3R++/4&?3\:A7%EN8^79W3]]IF[JE>'-;V7N[_MFL4>RZ;]O#82>.^*S
MN<*'5[H[QIMW]1[=2+?N._3MCK5O'RNYL./,KI\WY#N*%$P-JSKV8D=;A:.@
MUJG\QNZ._J'C,H>["5HOD>HJ@0;\`1=8-%``C1HL4%B`(34T<X1P(<4S+*35
M*@V@U1J:56L(JO*P@5.8.$ZAH&B.52L`&7`UE^'8_Z@N_Z"HKBN.W_M^[7OL
MOGUO=X']_78?R^ZZ"[+HLEB($Q\DH['@CXQ5I)6*V`""J8(1!*5N"`8%#31M
M;%*FNC9:HTXF(!:!6#-VU%IC.OTQK=I..X1A$FE+_J+3:`5[WMM-5&;NNW?O
MV]FYG/.]G_,]B$%Z?%SA:<QP+,.P-&4P4!_BE7!?6%RKZ#E.(/%Q\@.2($?Q
M?Q4;7J9=+P%7`Z\F!%)@%!W6V8U/W*&FI5J&EL(%@N5GXAPD:%E1)-D/B7/-
M2TU%)NW"0"-$0;U2EX(@`-&:P0`W->,,G\EGDF,X"A,FQT9.S?V:V/W]4_/9
M>/:-^9_BVCC9^?`P<6)NL\JO&M![&UV.9"PISYVDL+E2VB;MI_<S^]V'J2-N
M78R(R>O)]=X*N='50K>YNHD>1X_K7?(]+N&;\`G(AP719+9`7\NF0^4EU5"9
MO#*47,HK.YPN4F>C:-@]/NSURI9Q((F-M"@04SR)B$E91A30_%GDQ"M^&=<E
M5!WC_X".?5CQ5?L('UR0^R,BD9"QK/Z(PGD5,2$2HCUK'+^%I[6(354!YL4J
M-3J:M*<`.K"&>JH)&JBO4J:;S<NA(5Q(_9`$C<(WXV:BV=N).XE.+P/$44$#
MG'ENTT9%WTCM,']/VDGO=--5E6"R=+*.TOPG\X3'2HE7=9Z8;%L]7U^)N8$#
M%5TO[FIKWY'G<P0C9:MV#QWK??D2INCRLR/!8P='&T?BP27K%KMR1+E@:/_>
M/Q<OU!&"JLZ-D(LA4*<-+4`/E?!NKB6MU=C)W?5/^QF&Q!UD.]6>><!*+647
M,#3ILR^P,Z1W,XM98,>(-X`#`0',V9%A&Z)5<S(L\!B"JZ@Y4LQZ!PHK84()
M5X<3X8DP%;8GXPZOD$6T>"WY%L72;TE8=!9[Z+%%>0B&<RKE4314`-`AJE4S
MS1!&_#B6%_2,DR&T$`(_<EU^SNQV22Z",?GY@)_S`2%$9PV2C;#*3@O48)?9
M6X.R#/!`7WD4%1H:,G"&D=1]Q775HY@*S-F%4<QDI'\=<8`_>;3K]+N-V?T_
M[+U5M^]6[Y;+;V+AR\:Y6^85RZ,K*PX=[`A4T/5^?LW/?W-HZ\3@V<-G-PUC
M]PA^87[CW//=ZZH_+8V<?/O<`R_<@O)'4^0IN`5Z=&4,48\FABW.9^G11Q-*
M#BSL+*;),%>*%+Z:3_`W\6^)._@.,<%#2+$>(U[A28*FP%'^2'&01#I)$A3)
MT\J*&#V)&9B820PR'\7OC"3T6&\WT./$/402GRL&1(F40JVE$A1-72(^0X94
MW-6N<DK#]:Q:07/$F9RD/^TV=EQ-B9=[A7Z%Z:*[&"HE7*B0S1!'<.!@7V6P
M<;K@[XC;\TMWXK?F>YOROQ5UT^6!!Y>I:\Z\:CV`$.T#O?6`WNPH@**X71FO
MA!8WZHF&@SNB[5EQ?=P0=\2=G?YXH"=ZQG;*<=H_;+C@N!CX,'@M[9K^-I^I
M0VF8X0D'%\SDK0X_[S>6X</X-?Z`\0PR/H.*<1DJPRL7;,;?"6Z*-J`&O(VH
M"S0$ZZ-[\;Y@2^Z^:!_51\=U<;;3U&GN2^_+?)LZRO[8=-0\D/F+P/O!]Z.C
MU`@[K?^G8=HX'9Q>'-+Q7+`8%>%O+*:?9Y'!$:2TAVC5O#A#+U0G"^\NX8#K
M'"A?'?FP%H'%(HHI,4*)5<<2L8D8%?-=@A<DW($PW(&T?*MB[;>25GO!./XB
M!1;5GL]J4)F9FDTZ=%7P6.VZ0.2+<R)2EBF38C/\,NT#.ZYSU^#<]'`-RC-#
M1<RBH$1*JAW/R5Q8@R*FA4FII[2NUD<5-DUJU@*/6S;=4TVNOS"E=57Y%D:=
M4M42'SI1=>O,R1O;SPT6E?]UZ,KV#6UXT1ZEI;8V'EM4N&[MD9>W=P96$.>Z
M$ANZ/CK?7'ZL\>#JVJ:^C]NV[/KVT%^V=ZS9UMJRIJ`^,O_Y\E/5KPZT5[Q0
MU``,>A%NPGN@"2L*8H,2W1N\2]_.NANDZJDVNH-MYUH->_@V2ZNWEWW-DL:Q
M?2'B&98.VN2@C28E/X5T]#C>BFQ8N1!<"Y4-R*1P$?\./SAG)*GI,=+`J,,7
MK%;$VU0".;!P$9E%L]=,FD?Q2T"CD!**AT@E5!U*A"9"5`BK#)/A:TK:1VE$
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MB=/I]'YS^J+BLL+2NCYR2$F>77GP(#>K;ZV%Y]*YXNBBY;LVUPW!?R,B1`_2
MC<B%/(1MB-!H:L8>B9#<"&H6<GLP5*[TR^0DLL+0P4@C)Q4K2[@D4F!=F6[D
MV8GCF,"8%0@619:IHOOD]Y]$(JKBQ)F9+_Z-(\D_L:/[ZE41QJ)\I^)DC8+`
MBVD2YUDK,QF"1728'$ZGR^9F9&@RSOMCZC2<O[%`FW/RM/E\*+GM#22W'5)R
MVZIMG\_0)N4GHJ6`%_3PXT7"-X7EXDIIC5PI5(CKTS=*#4*=6"^UB'&JV]@C
M=(O=YD/20<^`,""^8QJ0QH0Q\5>.,>ECX:9XPWU3^IMP1_R7<$^\)]T7OA3O
MN^]+N9Q0YB0\4)L@2,@M22[N_V27#6P3YQG'[WW/OCL[L7WG^//.OO/Y[NP+
MY]@F%R?@>>2@@%HZFG0E&4180`-E&FA-',I'.Y9L:@D@54%%0\!4UHJAT<E2
MN]%0`QM;JZD2G;0)P1BP#Y@V4AAD8EO62C"[>]\+M)T:.<^;>RQ;T?M[GN?_
M?[QNP16*A840`VF!"7(!(;A=]+$)5HS%DAP;X(8XP+$^K[<&SUD<%`,0BE+\
M&$',7EP-3%K-#.LC@Z$0P[B86`W<LUP^]!EXS&MQ-9@_T2,"L0;O6-Z$Y>WU
MWO62WA\E-NVUJSO*H^J)\-CPX0T36V,49Y`%K)?&O;,^;[SLS4:,<;0_&A&"
MG0;L+[\8Q]F=ORK1)?2RC9_Q\`=4D..3:7OH!N5"9U=G%S!!:/8!%V,3)-^H
M_WMU\DM/-_KZHN8"\"<%7)Y??JI^Z\GY^C>G[H#W+_6DI1RM:;Y(?K]C]?V#
MNY]T:IHC*V?6``]4ZW_$^ILD",<4<ATB81#SX$XK/T`,B'N(W>(>\Q#_:KK*
M5].W^+^G/\PUSR.>3^\P#[<?,H^I/S8O\Y?3EW6WHUB#'Y[P;>PLXJJ()3OP
M:?TU&.XP+3F#0E3L:+<4'04AWK%87:SMX:^`2^I5\X9&.U2@>=I9,D@)?$`,
MJ2$]F,^V+U&7=7P-K(P.I`]`CB788A\84-<6AXICQ=>*#)_GVWL)DJ5Y5=2C
M.0<%23$L]IB[U</J%9-.%*UB;W$0#I)KG6NIM?3:_%9JA!\1AL0MZDCZ>?U%
M:I>P2YPPQXH?Y*[F;JOWU.@JQB<)+CG)2D)(5DR5(!T9HF!(*IELG9<QR6Q2
M+Q1<H58]'`[!K(XK91_RN;CLBP7[6(2/L1/="SOPXXE'EMJG%4#YKZR)`;>8
MC\%8G\.0YF7FXC?8)06_A?P6)%"X[B`=..GV<!V$`R0<`)FX\Y:6H5I:8%^F
MV>?#T>-!,8EJV<?"/E\"/_J.S"_^#)PG9&(=B*"):SPQ8QBEY=.H=NKE8:,\
M_,C*4\1<LNV68!_3JPRV5,(56IFV"ZPR*U;HE\,K"AH:>'!PLX;:,&RY6ICK
M4/2("&A>B`J0HE(J$E$SI4=2)LC1<TV@B"F3[`!S33(MM)H@[\R:A!9/FH38
M3A9,Y"/9DE'ZG)!A>XW$K#P,*I4*41G^U(P02-[`K.V@%+E@MG=U%C@\<96"
MC'0.Y[40UK99+T)S#RPX5CV:_.G+2]>-7;M1'S/[M'`\O=R$RWXX>.#(M^HO
M:&OFO[+_B?=.K^_=,CQYMO^]B04K!?BVN&CU2QM.]6F=2H7<_&TYHT74=[8]
M\[J/IKN_NWS;\=#]9X6CVWM>6>%PXOUTV2=_<?K0K%8!M!:YQ!S(P1R9DP[X
M#HE'?4?])WWO^)L8$?WW:#UZ(;@]]#*Y-_0J>8"ODF=(5S/I=<#XH^0JTIEC
M6$X5D`EW3D(!@--$C7S\9.*P4X^1H`:O37+&6RQ@:^3"R0G/#SS04R-S5B[@
M@E4"`-#.5M_D@,1U<Y#C+52`KE(B`GP1*0(C=GE$'M/6#]JZ9I0KRZ?1OO11
M91B9QV&L;\,SY9FI[ND[,VCD8#]YSL:;"`I4,ZWQJ:942*,$5QO1'$2!B3K;
M@#OL:<,>!'S>@5307M2BV)<.@P$_9M`5IAQ*`AM%OXH="2;7Y3@O20NF7A^_
MNG/K],$7/]@A/=.X>Z;QYJF])T'WS_=/S/$+`;[)N:EA_O;DGL;%:[7&O_8-
M'P],'K]W^K^_!BO./!IJ$?)8\Q6DDCO0=`HA[T5:JYJ$IO@N]GOL[UCG5G9K
M8)P]V'(H>$XX%[_(,A'.'XB+)!T$X_QN$>H,)0D$VD`DP2,K83DJZ5ZO!T;U
M4(A@8J4>/Y@U?'F_Y7?Z:Y_\^22^0_]C"N[%!=T%2P$)!0PIKRG7%5*1PW8W
MANUN#-O7'496H)E%W4C928K'2>I(<MT#!K@7ZW9$WK!B?&1#^:SEYC]LL1@O
M^H*L%DB)OE@_X(,HQ#FI'P@MT?Z'UX]74M0QY6'S_QLCX?`'69J2T^C6"30K
M45\H9K\:BN$.T$$>?/G=ZKN-Y_XPVG\3M#=^<W=@1.N21\C-HXF,MK=Q]D+C
MQMF+3\?`4A`&4;`XCFM]#M*#M]&-FZ#3ZK8*&V/;8M_/OQ&IYL_DKQ>8_N@0
M-42/,J.N,6J,GF`F7"Y5$N)R4I,$0U88"U\((WN]DDM@:'R5,L[0,H02)=`Q
M5H!`0?XC;A+'C"S1QK;!MAJ\@*0B8Z"".A87;L9B<<9591BJVDV/TI"@6;J'
M)M%W35F]]G=MS58SAM260Q_=S%<3R-%<$TCAJ=["$%JJR`+!VJA8FPIKHV*3
MFFJC4NVD:J-2CW1</P7&;:N*,=FL4,^4IV?*?ZLC7.7I$FL#NX,4'1T-6]K1
MJ"S52]@HLM-W"/8_!GAP8IQHA)4!)^,.,#DEE4:-(G,!-+9PGZ`<.3O8/@.(
M>PG]!:I@SI9T!Z5I7J__JWV-2ZP^;VKDZ_D%"_7G[M_.YXU$F%=7Y!U!7SIH
MMNL;G+!^4\EN:>B#,45O+!Q(AQ.Y!3L;52W,6H/D\'=$76O\?E-OT(>)RHBH
MA(BV@3D_T7,U(%I=VOI.E\/E?BM''C1.&^\;5\@+QBW'+?=]QWVW:\@Y1(TB
MQF/.,6H",69HMVL.I.7FYAI(61Y&H..2$):3%(**,ZU.@?+:VBE*0DI6C(SN
M9IH=3HA0H^L/MQ%*BM!9'>J8M)9.IV`HS*0-O4JT`J(UCU:M(;1A[:,HB08]
M-/B%O;)-6EG":Y/TVM"\-DEO4HS;).-V,FZ3C!_)?J'I9E#/E9!+&[9W,D3O
M'^5/X=E+F;V3&0_HU1^>""&:<$@]`8>1(8A9J"@<VJK08#.#G].EA_S0^^#H
MQWT]'DT#Z26+/_:X$YG\W/KI_(I4Q..64%&0__0H_)(-WT#0;C_^;*/0LTQK
M]&^4H_Z(IOV/\*J!;>.JX^^]\\?YX^SS1WQWN33G.\<?B1/[XES<)G&:2]/4
M'84UL*Q=V$(;+92.I6H2^I55L$@P2DN!2JR=,K%0P39IT$'6KWEEM`8&4K56
M!`DVAHH:I`JZ=A555[8Q:H?WGM.EG9B0?7?O[IXCY??__W\?S>''F)'*NOS&
MAH$$J==JK#8_P6ICP$&SWVE9E4)2O#J!>)&74#AK9C=F=[&CXJBTJ^&`>$":
M$6<D5U-ZAVN/BQ&SJ>J^[&AVO^5%RUS6XF:^Z2IFF=4LKHOXKN8G58L85'^.
M4?V!Q[`#7&/V-#_=*(BB9DLT,IZ$YH!)I=9-D*^E(-?:",BUFL_7YS_@1U[_
M6C\BW/FX?]YO\5M(-?R80"\=IP1:0!^8+F>N+P:],26&L!&Z;O+DS\1X\CYV
M3^OPOH5:84+$<Y9.TE+1JEVB<9%4B;^M5`LL:823=IZ-)N+U\88X8W-C(^)5
M?1TPK/`^>]+9!+@(/O%A3P=PQ&U-T!7U-(&*M2#.G!B/BH0EZ8P2ZT&$#%<Q
M3"QV1<E\Q$ZTJE4DY57YL`^ALH8'EZ0]@6ZQO(W+WC]QNES:,W;HW<DU^[N5
M[L\A3KIW2?`K<WO+.\]-K=MT].#KGYK8NBP0D!DL<?V'/[O]_(O__'6Y>#`6
MA=_:U*7&8D9T2WEH>?NM7[Y_[-G?/+)>K*^*M.#*$[5[!D]J+]Q9280OYTT"
M&H@6YM\[02H2-0KSMTP_61JT]PU:(B.`-Y@!\C@`-5H[C<Z+5IB_;-*!T>A&
MK;J;QTER"3X:\9'&1PJX\=F!CRY\Y'#&='6"NKI4)TK5.!'H2M-D>1X'RG?>
MH2>8)I)4/)\DU[\FB\UZ4C;'1O.'\[/YN;PED)^N,;-]>(EPQ[E435/D&E4S
M%#FE:KV*O%S5D"([U4A`D64U@H6C28VT*G*G&L$(1.KJY.6=G2Z7$Z6:FFIJ
M9-8?T)"IP8L:#&NZ-JH=UF:U.<VF%5#8K.;S&_/%/!/.PWQO5&OM,S8:R)A>
M-71!3'Z&OSF.R2#'CXU3,BCE%E,:_E2HX+8KQ=%K,`E)X%J<;=H&N`\^/OSJ
M)]/!PD_@<V@'YH&DKJ.5E+PQ$33J>NE5_;Z85-I'7S67?K%`$?@-ZL4@8B/W
M)OS&Y@HQ"'SW\*V#BRP!GRD_?`=G/'K'-L(9+=@L[<*=HX!?F5M5JL(J;1W5
M3+1*ZI!O.,LJ,E(U49']JB8I,E0C#D7VJ1&_#Q,U*TJ(=(W$DBZ1+.2GDN88
M92?9.9:99Z'.]K$;668#6V1G68:UD&TL[4"V,/_!<?);O"B;2Z@!&`J/JI/J
MG,KH:I^Z466*ZJR*2%'NQ96@-(V'?FQ\@:LI05>J0,[13\#U=B70KH]!AT&E
MD$;OXE.ROO4D75-?,_\WQH<1BH"WS8Y>/]P0V!!$P\*H\(3[I]YBU.H7H1XU
MHZB:K0"UA$(4$FOXD(0@TH-F$/4%8;#`.$]("<ZQI*8P_R']O_'BYG&"!UF8
M*L&D1G,X=-9DO\?^D/TY:SW#7F3G,6IH`:8K9I#"%*+X54<O8M<_5Q<MH.9C
MZMR/2)*[-$A-R>`8=H\+&%V[-CC6E:/Q["/OR%?+3G>UNZ8#NIRR2^H`6,=R
ME.?&<9P:"RPBA\E,HUQVF\ENHWN.`BCV/+OM"R.2VAANB0MU<IKB:8U3$$N/
M3)W^SF"N65(:'LRNZ&>F/\)4PWSU9XQI#YHQ"[L]ISUH!,#'P7:TV[-#GVA]
M+'O&>8ICMP#HM_2F<`MFT?WHBV@2[34/H"GS&'?<<ZKE5,^?N#<SG-\%&0^R
M(6OFVV!/9AH<@8<]?\BP+IQ\`+*Z%4<MUP"B,.WH<JQU[`>_,]X"-PROPR6Y
M=-B*6LP59E_O\_#'Z#GS)#KIG%EQ'EP`L_"/Z`WF*K@*K\-_.:^[;W!BJ"5D
M&!G=Z(=3X$GN4.:@X7C)1IC65-->K397V[NR"E3IR*,#)BZ&)%FTB6Q]3(YW
MQ!&AC])OZ<GG%]K&:"'2I9QLMMDXNVPC*JMJ:45.J%JNNU/.62T6V>JEJJLH
M<ER-=!CM<@<$0/-P01Q&N@$HH+-FOVX$==T`D#.ZK;TZZ#8L[1Q$;I?38;=[
M1CUG/,@3LUOL]E!(.B+F.CH2B7AG>WM]?>Q(7!0$F\T:1U8V]WV+1]?3EDDK
M'+5":P$M,]TFU\>A20[.<)`KH'^;C6DO=51>J@5>JA!>#8L]Z<8%L:<S73N]
MLO=5F,/6<0A*@#3D'=8*FZKQ$NY,PJ(\5NPNOK(LY?C%3^4&(S28QECA+\3'
M'D\J^57^-7P1R54$/-;X(E9H<KGK9@`3,HX[8&R\YP'3D6YIZDZO:.JQ#`X,
M)GL>>L!T9L40U^4,!]LRA?FYDWR;R7O:(-:ZHYXV@)\<I7?%HSRY*[Z$+Q6:
MQVY@@,18[/%@*"1@HL&#8,3B\/]2NB^[%"PE>^DS#[+;[&@8WMS]L_6EW>TM
M@=9R(QV95.GT'=2T(I5N5,3@=EB_7&[(*/!&X^K-GPZ=0-?+WMT#V.S'13%F
MP-^7U]SE!C6QPNSF<'DH,`+Y!Q.U0@2[RU#7JN`K>.KJL9]_&4]=&,R8,@]X
M&`9A:&KKT9?03K0O/!5^(?Q*V`VU`ORNV>(9SMZ/'JI%F.L950LME7V=FE.1
M>3425L)`!R9@P#]J?#RJB2"&Q6,W@@KH-3,=^E^!U^%PTE9QTJ=.VBK.:75H
M<-%\5]CJYDT2G$C0O31(R(KHZSC65R@PZMT)MBJV(+$T(V4MA]1M__E[R[IH
M%8VPFT;6AWEWYNL/_^!KF^%.>_E`=%EX&_,HB:]1V&!.W#IRGU(53&VO<)'M
M!D9%AV?-RUX1>@`K>"0NX:WW-EATN[\3=J8'Q*UPL[@E/2$^!9].OR[^1;P,
MKXH<)T*G8--7Z4Q6S.IYD0GI<3&F,S;1J@L"DP3U^*X#M`MM8JO4JG=EUF8V
M@\?`#G%"VJ;O`WO%)_0I\)3^`GA>/YR9R9P3SHK%S`7A+7$V<TVX(EZ1YC+O
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MCDOG)3J+WY,JI*-Z`S0`II>P<8Z(PTFTX&B],:1)+:ES6LX5/BO0`YDZV1(I
MZ!S<90-%D';FA]A,RDR19@G2]"#\ST^1"=]#""Y08,4LYZYNA_+"Y07!F1<X
M/H]8(>^;G)T:]^5]FCM/\$RA\G,-D`$F&5S>2R4UZ`!W.8*[/@;F@=LWQ=@*
MK:1JCRE>MWWIHS`(?X4/8#"[2O$&8RNRMZ]HJZ+>V_\T;9WIWQFNC<6:(KU,
M_UHUE(C=NFXR7LZ,W/E@Y-:S9,[-WIC]B"2R92@!;^A+1WC@#P)@O3-W$`,?
MPI#`:=<"US;7"_B/>!9;7++,<]3ARA)UN#)#ZQIUT[I&>=X)&,N\[.9YF1!Z
M0G<DSD*EU0I8#+"\E3'J4<T_ZG1&.(W3.88C<O:JDQ2'F[<9]#!!T>..)HFZ
MZ5Q[3D]")`G'D^\E<=+EII?P2)(FPQ69I`'#_1L13*9AK-+(!7YU_8EY:LLN
M@Y:[IS=EV`YR_A/UR^WE6A>+0^4R(SX/>:/$%JZM7D,%*L^JE??S26A'>;X3
M/<RO0VOY+O1-?H#_,9R&UV"<?Q/^`_PG&&CR6H-Z4M!#6N(BPK.GQFKX=DQ^
MPQA1<Q(A/YP@3:4'\_0X.K>)QC;ASQ./2H_3NH//\UX^CSD/>?KS)/I,CU;E
MR66FRMN_Q]UYK#OG-9^*OO%'NPH5&-)43?>XRN@7NRQ.I5^$;F8A[1B8IKVD
MS.P6XYVDL6@CM2YL#;6:E\U8&/M\J]P:-GUUYO4[C7-N29W+BC!Z:/9]\S;S
MMU`U$M$K>OT1_I3E=.5ISO0T;+<,P7Z+:3%K4Q'C42NL0EN8R3(8,1P3831&
M9\Q,1XC6-]">BX3T$`XYVSAKQ(H=UK`56SN"W]A@%+#0N[RXG.M)?48/Q":V
M%PUKV`"B(U85#\1=<7NU,XU$$-+@MI"3UTQ.7*4M#7Y,%I[UI)'/1):[;U9J
M%P&83!8GAR2ZWM?L(S?+R5'OR#NY1!P7@84]I8'2QZ4/2WO^</E?$YN'#SPU
M=OGSX<TD]':5?E=ZL[0)#D`;+/[-*QU#ITJ72J^.[8=:6`1?/[.?2!)5;%/*
MR"QUL.TBRI"?^H.67#:S5>@3^X+?4;LSAX.6[<(%Y6?J=?%Z\%VEPI_@,FH\
M'\LG6E4MLS;Q9*([,YBINH8@$$P&EP9_[[\NFD^I\&OE'=^[RCN):?5CI2*H
M1T,J:Z=2*D-8M$A1(K0>*8I"D;K:D-H>[8SB:-3BJ56]7@]F+2R/`EQ`"^B!
M[H`YT)&A);B_/8<RH&?.9_"QS)7,5(;)U($Q(,$8A6`,2)`==H,VN_&FW9B/
M]J/IS"0\/2:MW_`%'S7'6V'Y8@)#G$G_132VXAHC#W%%8IZRA2+QF'QY@I*B
M!I6D+RC$U'C2%V\$)4B6A+^V$6)BM!'-%6_7+M2QDD2#&B(_T5:37!-I)24,
M(Z"B32#891B@7NBE.*:^1&$I&@WD7KAI9$AXC;#01'17ML!+P?CRIMNOD?GL
M%LE\AK]/_/;0]5_5]R[*/1+:=.2AO2L;5^`=I:V#83*?%X3[F&_3T]+1@9-3
M]@<K*W\RN/K(4A>EHM1EWDZH\*`XNJTGE\!JRV%@*NRPBIPV0C_L@T/H>?:7
MCAO(:G+HZ"O`/,8R1TR3>$K/LEZ58U#-69:E_J4;#2(3>H1E;4Q*;@N[LBZ,
M7)PKXM)<NLOLZE#G"5)U%:N!-LX6L6&'+6S#MH[$EQ'T`;GKQ0+AJ*V]R-TL
MLZ1;XY%8,%Y575F-*X28$HU%<478(Z<A9`T0>!QDB3O)2\E=DR:_2JPFFY7U
MV[UIB/)D(:ZVC?X;!:HEC[DJ%,S4A<85A;I-G"NSYD9P![7[FHV9Q^S;6#PR
M4KI6^O/&0RL'AF`$B&6!9PA[`Q-=SQW8/'YIR]##^=<=YT]61\Q/C#W1LF@]
MB&^`!M\O/55ZZ_/2?M-'NU\LG2]=&!T>/@%M_S@YN)T2&"7Y;1,A4$5-&.NC
MBD#;-F8T[Y`,_#/QJ]&K::9#^6D:"V%?9J/"6,$:B\<>1*NA"W<I.V`'WA+>
M$NF7M\5&8"CR0OH,G(E=B%]*SRJ>BLA>>$[9F_B1\C*\A$\JY]*7T]/:)^G9
MM(U'7@A@7B64U;=D6K2-RI/9REH6!X/@"8L.248Q541L6+1+46]8#$I1'=?%
M%$7&X,88E+,X@BVUR9<MM+@^^G4MG&6%Y7$+<\ARW((M2#P;;)J$[^F.!C44
M"F*'W4YB),M+-!.LSM%-7]*90](Y"7<24X2E<:X9].;NYJEFIKF)-<AFC?O`
M&F2SLM=CD.TQWO089'N.YM9?-.+1O/DUL.8*O3<+/:D4I3I;ICH[1_6<>2H6
M.8)UH3>;HBG)'^"*\XD(^'Q`F(M`J2'.O/,7]9I`N4_7UT3#L70TVPCU-63)
MR'6-**IHD89&0/.=M6L7])*NZC4LUT44(SFHFN:@3T?=>97F)+<Q,,GQTW$N
MKW$.,B*A/!F)W4JE)`D,Y/^?)%AH;H*&.5$@FF#>5'J^E&N,V&JX8'Q9SA`'
MP[S#WZ;?.OCB&1`>'^F:6>@*6G]^]=B>E@UX``.4^N^5B/;36W=.QDL[]JVN
MQC^$4[N_>\Q%?!<:G'W?9"8ZL0"OTOW\X3IP@`-7,<AA4E'2G.J$3FQUMDS"
M`_I4\X+F`".:U@GK_.L"Z\0*L\UL1[576DQ]57VV/GN_H[NF.]R=[=:&V7U5
M_R6[^F.;N.[XO?/]]/G'^<X^_SC[?L2Q?8Z3W#FV0R[0Y*062DE*@V9!G,84
MJ4##P@:)&`(A!EI;A7:5QJ]MD/TQJOT@9*R008-A:-!5;*J$5+K]@_;'H%/'
MF%94JF72$`W9>Q=HI\W6W7OWWMW)?N_S_?R8\$\$7@M.%*:(J1(O^$O^LK^2
M*J7*J0JTT'@;H2F:FL^WE7I`#]Y+6'%+L51+?ZK\5&6E?V5+E5OK7\>OS:\M
MI%2@XG))K<B=U5@U7DW4.H9+P^7ARG#GT)*`A^/R(B?GTYS6O31O=8\+X^(;
MS<?H8^9Q:\J\:KS7\KO"U>[[W>'53)>,;</E,^!#@(-]`(!+6,/3Y_@KD\6D
MG-JFRHIR*85&RO'),"2/9;Y`V.<+%'PM`2++N@V5!O,P`1E%3]H(L_AIX"A-
M90#4+,@V0-KAS="5$'XK!+30F="MD"?4P"<NJ*>5`@\K&MV@_K@=7&G_K'T!
M2IOS;,5I_Q!>>+!VK=V"@D>T7P8K,!NL`+%%N-?KA3%(EN-S]^:AB,V/VV9A
MT7NXNH6B`3Q!5!<"*!-@_*=S$-+W8"I$O3K@Q^X]IM;.9HL6C2S7RI:P?!")
MF@A/M`4OO6V^$L;Y6@LY'DI<,)!OR0A0YAB30I@ON'+FGA8]"T0_Q'X=&E+V
M96ZS_Q7^Y0)1K]4!U%AL#'-3B(^+!6W""MHE*^C:PQH(I=OQ=!,5@9"/*KBK
M>2AC-%%T.E12\$68Y[+-V6REW%GJ0)S<N<3SBXQ0/ST\<J#0\_???+?OL\M+
MR^K[B7B*SF02@^]NW7MH27?NT4^/]-_^Y=;=7=&$[H6.J#!Q8OV^-3VEOKV;
MOW%TS>0MENQ53/#1X4,;7AOJV-RJO+_CK>KA/U;BJHF0WP.]T5G7&WWN=`^!
M(7PH-:2,@E%\-#6J,*;>J[^@'R-_*$^1/Y=I'*042).\WL0B]DS3L32FXGR0
MT1OX54=D00%SHH%>(0A?-X"=@7K9P`TGP;`NS[$NI;$NS[%-44DM*(@?`^@)
M3.&5EY03"J%<P@U,6OC4X1`+2B[_2?#MY[2-]5B!AZ%AKHX(3X$$RU70"W[%
M!<MP@0N?\,M<6IQS=P9SN`H\GDS=<:W._#)H7?@/^`]0:H2N1$QGT1ZD_X>'
MD%N'VR(2;P>SG*B^4KT"';DY_QZRYS]YR2BOHK,\V?_HM]7F[B4/YYY8<<(7
M$+<.@QZTJMS";7(&KFH[>/4B9L'8T6*6+10_M&:W=:I2LFQ0W50_M3M(9-*9
M7$>Z([<\O3SWLQR=S]DY?,#:P>T)3N:NY/Z=I98%H$3A>I.JRG&]J465@9X6
M53FFI^.Q&-0I/&/XV1:8T3X_CU8-=NZX`<[MH!7,HZ3&LRSC^&S&@2:%L1B<
M@?'."87#2'M<':+0PVATUA6DA/M+G^FM\!;8;IVPSEJW+<)2-7<S-7<S-7<S
MM29!V">";2(07>T2`VA.5-"<&#?GOLI_*.^YF[0:6E(W`1;JKD%U!U%=N])5
M<&UHWYK=,TL86+I9W?"&FO2TCE/!3"[3'-#:,#Z4]>7;`.?5^4P;9G`9E"K`
MHOF!S@?5**Q%;`R5+/@R@84I5W>R4&O^.YB%W?I[K$">C\#MTD`ALN;>]3_?
ML;3ESY?P5>5J<SS5_[V1U__P/%0<,I?)/*V.S?_I^L=O3WZG]B]<V+LZDZDT
MC\_/O'!]?-6.=V_BF7U:*\2!`%/9.ZBZ<.&\-TBI^`R./UT=/"\!A?<W/'^Y
M$%!QB0Y`(V'V"G8O/W_CQE5@%BW9\0F\#B2&LT])P'43,==-G"M5RF[;:KJM
M\ZJ6+O]3>*C>USV7HA=COTZ<U1_0Y*GXZ<1E<I:Z2)/3Y$GJ%#T=.2F1/Z(/
M!@\*D])!G=P2V1C=0>SV[M?)(6E==$#?1&VAR1?I&O.B=WV@%B$=?0"K>M:1
M7Z-(32\379$5V',!,D/E:8,Q(H9$0@>I6_H&_89.SE#H3SE)+*!K7BDAM4@>
MB?:COR@'H([3C!K`4?W5^?EKUZ[!M%&'K&W;LA/&2"!CP0@O!P,,O%F-*K+:
M6)AP0A)-:0Q-0S<4AFZ`I"@$X(H4A5=1-0AM%H;3%/LP"J)_LR1'.BC=EPCI
MKA5Q(@.1LY'[$5*+;(ALC^R/$)$&_H]93?^!/OIF#)%'/3Y7_Z2.Q=SH`[\3
MY*)VP#;F=@I019`M^O]S#=+&6/VKC^MH8+(91Y3/>F."'70$FV@LW)WE;881
M;6@;;\Z*MM<0T>C-F:#])/76H`\"$8J&RY,&B(1R$(P44@<`%H4@5R'?69FI
MY!_E,H^('!]_K@=O6=_5#FK`,;N7DSZR/^/7BYL>?ILX-!16TV0FP[8W=WS]
MB[]Z0CO:4A4.D@)B(GGA8WHO1*#M41:Q-\N"KGPV'(+H<X*"C>?P)&O)!"?@
M'(.9$(91N]<%XI=0C+.4G_8Q7I;V>BW*IH5`3+1]\)`1$!FV#-O]J$W"UKD+
M.YULQ5S%UHA!]B1+9:D"T\H9/D,T$GFYQ<@5.RD[4;:>I9ZA^[B5<I4:I`>9
MFG?0-Y@8M*K%+=1&>BLWDAB11TL[B9W43GJG=Q>WQ[<GL4O>F]RE?<M\G7B+
M>3-YP#Q@O5$\3!_GCHA'8L<3Q^2CQO?-H]84,\U.<].)*?E4<CIUTCQ'GV,N
M>!N)\];OK0?,`^Z+U`-MU8BYR1HIOL$27?)699OZS39B$[V)&6$]?6R_NM+H
M,XF:O,Y<8WD&Z`%FB/,0-.:%-BLIF2W)O%JD;8Y]C/H4)BSMEBTV27"AQ965
M!8;F`,?8.0'!'N)^F0M\!'W7L"#HM[+)),.RWB3T78K"8!0L!#$1ED7#S,N&
MX(-OR2E9.6<7NV2[L;#]G,QYM<;"-B=L,;3FX[@F&=XM)Y))A?5Z475$Y"0<
M2)HIAFFRS+!EF46*IM%,TBK"RZ(HY`S#M@4,Y[Q>YC^,EW]L$^<9Q]_W[NRS
M<Y?D?([M\X_$YW/N1W*Q[XSCQ.<8?&[XE<$@HV4#VD`F6!F3.I*P=:4KD&K0
MB#%I_%%-7:6MU2I8D2IUHUD6R#^1UDZ=)B3^`&G[HQ.54#=IBII)*=(H,7O>
M<V!9ITFSX_>Y>_WFDO=]G\_[?;X!-CCT<_^E`NS95;=4($=,Q0NNEK/[[<)T
MX6*!WETX5!@O3'@W=PK+A4#A;X&_!O=PR=\DN.N4C!+XOLNY_"A_DZ?Y7U:&
MYJEOO=<$[=[8TMVX<%<25E<\DV*N?O+8EWBA2=Y,VZDF>?^^")Q:Q^+_AG%]
MRPIMU0"\6:%*&'W$)YS_</B3JHT`VF$8T=9:%VED&YJT)'(U;P`Q)?MQ1%G#
M<8W(ICQX2(9U76N^UW6N<9HML:=*3W1UF(U7C,8?&S>Z&\_E^(XM0_B>5"KW
M8>YC0P87%X['PSV4T%WNSV$&4WV=46TC$*SU9\]^OD`??O`SYMG3,4U555O)
MGEYEJ9FIIS=HX58QX(>NGN*9U33U]Y?LF!%H\ZAN1\CW+E!=H_O6%"7$L%(2
MF)[U5P8-E<`M:*$,RC-:O$QI5#S@#Z`:O$@*>C(C/'@,N'`RA%OC0:V"7T#?
MR_A$.(+ON&WMCB5T.$+=-=TZ72>)\>-TMO]Y]$+H167"?#'WNO+3[&5\6;B2
MN:)<R5[.7;$6L@OJ@G:]/%?[4/@@^8'\H;-8ORW>EO_)+==3HB7(HB)WFT;>
MLC8*MFC+0YD!W3:WH581U>6Z7;]99WZ?P]_)O62=,\];S+"YG]^?H8/9>#:Z
MJ5;?D1C6_6)''G?GOY&YE+F49]8(5)A$W>T):7DJA#)Y)JF2I4@F_(D`68JD
M5M8(AAZ":X$LPB,-VI&7+9S+R):@A`1%K"&<$VM^@4WZ$S(\1<\9`&&MDG1\
MF$GZXJ*4C&L*>:HUF"SG%$%0<*X#XQR<G"*!;9-L=<BRE<^$$.,U6''*94@@
M*A&/^_V^P#=KN&8B#!93QC9^!H_C"?PKO(COX&7<@N>I^V[[9OE)^8A,RQN0
M\J9"*?/4[^;<^D\>@;4R!E8().P13J3U3I:F$?)(:EM#ZO_"9WW;#B]@"(U!
M%7T55@;`("CAR>%]<Q;N4:Q--'@=4F$?RQPQCUOC=>)]0`--Y%'6_JQ^K$SU
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M:H_M.D:X#P/W5SQ?<7O6A[#H5>AOUTJN?5`Z&!^UF;[8]V,GM9/ZA=AYW1_W
MQ?T4LB-LQ)#M4=OG\\$LC`C%9)",NUE#[S;4O&UOQ:[]%;R//="USQBU3_A/
ML">,$[T3]C2>]I]ESQK3O=/V&[UOX;>H-^WW.V]WWK'E<_X9=L:@,4LE<=,0
MIC4YF49&/HF:UK!+ZDQV=6M2+`8VMP/2GPT$"!Z*;L"=(6DQRV#M@,'JFN1+
M"QBA=+J+6,E8=/[A_5EB,>!BQ;,QY,)M]YR@X@:"E&<CH>^WGI-\1];)*HBM
M)5FW=5<?U2?T:?VBSNKSU&OO602:N+`R9B;`8U03TIK36,\-.0C(9X99*P69
M-?G!HK,&D+D.D>9U\_"9K6@5G8+4\F1G<A*!Z<!3F*!P#?G(,0H@8(,H#6DD
MDL(\J0M)(`G]:]XA.4H2EY2$GKJ`"GW!D9*T_"_M`:MR$_\YD3BRI]JXEM+V
M]*TN$H?:^-$3UI<Z-&ISE[5[(T[BEFKGP`!H3?ZK7U]=;;SSR*[B.E4^LB';
MHJI]?=T'&SOP+P[F4WUQR+*'GS:V,F+C=40C^1JB:-UM1>TT&O!1^"BS;;MD
M"I]5A17BUF#2F5*&$3__B,DVMCZ%$(5&'B[1Y^EWT0:TD1YI:I,KUURR4S67
M[&HDR>;5`,=1>U7//*J(+S9Y%ZF]Q2@9`O=_\8QLD6Q\A&QWT1M;=%@OLKD\
MV7(Y"+^2+Z(NIJ?/[N?=(#R4=SL[21N"K_CYA[?<+C*(YYDS$I:\7LD;(0EJ
M%UOM8Y"U5%N".F-,="QR5-RP5DDJW#)O8`MNO.-C<?$CTWQ?N'6C8)MFTCW.
MI7Y8I,0G![`HIYWIVMO!N19:-,53Z%3Q%72!NU#R=XK1BE";KC'!U$[?3O\6
M>8NRL^+6SG<&6MI8&2DC>$?+"#=2VC$X7!G9^#7N*'<N>+;E+-?^5/0'42I=
M.U2CQ@-%U%_-]^3Z%Z`TY!$/!V;0X0W.X<G<$Y62`'4718JO<9Z6O?`\S_!5
MR+$_N3V<LULZ)!V7:$LZ(U'2:4",S-BNNE4*ICV1F\Y1N1*LVSR]U0TQ7'XQ
MAW/C*BJV\GQ_/RS\`]@!_][B`CZ*NI%*_F*;@]2T.JU>5!E775:I:16K`AFD
M+E##B$41*"'33F0>'W6[DI938-TV1V9'V6F6%EB\S.)1\(+#FX:_+9F[`,C)
MJ2GSRTLK2Z:P:L*-65TUUPI#X=X89-?*ZMTQ86FRMC0%<F>&'#+&-*TF=U=I
M'@-U2[!79+L*]O!)=UMI*)7UA0?+`V7*'PRT!"A_1I$5RE_B'!F%.L,I)(;;
MTZTIK&2'?$X*E0/],B[U<V)*2.$V!9J*OYHB.,(_`4A"`S]F;V_ORR^_#%0#
MW7AR"A%EK(F>IIB(>+_9`LPT3V1,\,)<FS,HMQ&%(I3+I)KB0-EDSHG!)T6R
M/<&!*^2<08/$%H@M$(,0@P[Z@H3MAWFJ<'!G%:W43T0*T,\JK#\2ZVCV#10W
MQ**Q:"34$?T7U>4#V\1UQ_'W[M\[VV?[_.]BQ__N,';^V(D32""&,$R=$I:6
M)EM((*5N+(KH-+5J'#0TNE:XHPP%VI*M&NNJ(J"CW0;22($`J3;-72E0UDA9
M-W6L&B*:V+^R3*D&$Q)+L]_OG!;5UMU[[WS/]]Z[[^_S_3T-<;'<A]=K7&A9
M8&Y+EW"=+RY>MFKP.Y&ZW_YK8^_J>()+)^+IL<-//[0RY+96.57%USZTK7D%
M_5&JNZ._[<'GGW0%OOO-7'/'M_L7CVQ;M"BUHG%)2T/_:%WTON2>S][?O=++
M[.UM!SM>IOGV0*J063<(D3]_=_X&/R&^1#2RF'Y8B?RW(B)&L(JQ+'H5XK=B
M]/I!P'\S":^@S/"26<$X5_!^.]ZO*/XJ(G`6#^:R+F_6`K=Y?208M]B,`8X!
M?>![+3EC$MR,TVO)LGH1@A92VH7,$.R'\/`7T`_[8-^(*";BQ`\8D?K\'*H7
MAW/G#+:A\N]S>$E1$G&7"00(_#+6)A>>-XF/PYQYIYJ@QZ2STCC[)"J(B9P]
MOTQ/?(O?(7R/WRN\R9^062>C*V1OC7V-)^+M\%<I1`AJ1#7H%R-ICHJC(E<0
M2Y#*\^)-12/$OUA15'N/?<@^:A=*<!JS\\2NVG5[$U3+]BD[LT/TGVMOM1?B
MOWG`#"0,GO;UZAP&SEQ^>,8<Z?!J5U7F]LS_Z&TS-&H#.F]C"9V/Z+3:Z@^1
M@-^FA&1H105#IP%;,$3"4E`G%2_"((3*<\^!X$'CX&@#`Q1DIOF\K*(M=)]%
MK":^U.5"T2U;T"1=N>?5%S]\??^)GC?ZG;H_5.^@GH:E3V8V'SJTM;6UEOOO
MQ*>_N_7#THH5_/AKZZK5V-!<[=R?ERR]_.NQ7P6]D-^L!0UU@7L8]/8I6:"?
M^P=7+2FH"4E!C4BF!TA:W&EA!6/(X`Q8DG'4DQ$&XI_Q>+D^J%PYBXX2;N8!
M\8#O9'[UA1E3*),74"'N&&)T>WU#"XGAVZNR;Q2YD&>#T"OV2AO8IN"F$'M<
MW"&62,DX`YN9*7V:_%6T+*>=M-_?%QJ,%?R%T`[_<&B?^R7/J&O4_R8]QIV,
MG:;OT$OL4N"?\HW0)_HMZI>X+O=&]_[H?KT4FXTQETY_.3]-=#BB``P2)@C@
M)M!%P2@9'#%40S=Z#)S7J''$&#/*QI0Q;<P:=F-;^+J3.B]I<0L+8];KS6"1
M;7-G8)(VXX.H0KN5`PJGI%721+*D0(;(*!DC93)-+'B!(\>W5^^NYGJJZ>%J
M6GV>*EGWK$2)I$JZU"1E)5'*+<I-<-\GIK"&B^MG\L/%N6+^1M&453*Y>F:F
M:*+[AGLAQ*R]X<?"V\/\RV'@<7$`8J.MK8VVT6(>94,`V0A(HOHS0>#>64]&
M5-4,A:4'5@(9RV^I%>#1)$BL".EX;!'7VD),K4&]QDQ\D';>"MOXKOC5W:_]
M@](S>W_1G%H9<=EBL:]L7?6UHR-;'EK>0A\9?Y=*UZ]2QX'UB73"MR,:Z=IR
M]-C=7.-.F'W'_`U!!$)%20/WP(*V$NDL*JM.\INBDBL",\5&]+!F`DNSZ8@E
M%^I)5U!HNGDW7+V3-26I^[&''GJ;_PL)HU%#*QQU([I43];BX/H\7A*'%Y=*
M\6;&@>1*PT$7,HQKD%^437%"CO$YOK[NAEY$M_$\=@T-A6DV7`ASX:@-_L:F
MF0S3!`06C-"+I2XXG7#F\!?<A-:9]YB3D_HD*=UH4FTR68%;LCP).R0<3#X_
MN7H&R`:`@]B8(.GY\NG.SI8TALA]R<:60OH9X1EQGU!*GTR7TRR;+J4YDM;J
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M]]K1SI`K5GR?7NT8RG1_X_*5/X*B'P1>]O)CQ$O"_+,+BJZ5-?`[Q0D2)`ZS
M<)C`=/B:LH3J@`:.$!5.L%`F*[&2=;E<4".V8-S%"%,9Q_!G[,U,NL)]3#@_
M_Y'9`RI7SF$T",TVFPD&S*!!0:BJ?#YORAKL.#U9OF?&85^)'`$<\;I))[XR
MB,H397Q(=C%*6&4Z&V,\805('(\P@?U`>%TX)?#X*`93PTA,H)R]WF@$YHE5
MF"W('F<+!>RXX)+#$8U\V<*3DU/HXOD+^7QRB3E6&"G*/1MP#_KS@0(I>#_B
MQ8`>@C0ME-&RH4P41V7-=;7(4;2(J"FQVA;S<F]]8TM0"E@V>1[5!JL>]F^N
M9I2W2,PB*Z+OJ]((]X*T5]FG[@G_A#OA'_?\@?N3\V/U%O<?WN,NL((\!+,;
ML;S#+CMG&3@=LS_/\1:,$PGBI&N992W7:>F.;N`V6+9PP]R(9R3P8\\QRS'K
M>7G<,F:]Q/V=FU9N6;WR%*.$33&NB"6NW2@LVAB3V+."ES1I/ARJQYUQ#_IV
M^0[[KOL$GR_X>X'"&YP"`Q$P1?5@<36[SIW!-7XD2/&-L`]DK3:8<6KT*6V7
M=D#CM5M>;TFF3?*HS#7)!^3K,J_*61EF(H_)T[(D'W?X!#*"NN)367>3(^OH
M<?#$H3IT!S_KH`X<B076TI&+Y!8R%]@"K)\K8MI2S$,Q`WF^BD8SC))*#KO@
M%4&N_90/<FW8'L"F,P_6`Q9#\Z2MC13S-+?IC$0HQQ4'S,T!?LR,?((P>)HM
MEE&R#1D['#(Z3FV&50IDQ*E@I16L_+;0LE9:UDK+8K:R#DO&IP8R`=V5L<-A
MHN!+6?K`P(!'JL(\:'G5@H.YT<'B!K@7X$#ZF&[=NO?A/0U1WY57WKCYZ=E7
M+\[MI3\3_\]T]<:T<9[Q>^_LLWU@^_P'^PR'[8,[_\$<&+"-(00?A+#4A$`2
M$D@\$I14FEIIPJ`FJ_(EM%FV=9T&RM165%/(EV52]Z%IZC1.M31L0I6ZC2;:
MAVA_E#:=HG[8PA1U%9JV0O8\K\T4FWO?YWWN?=_S>SR_Y_?\Q,#IS.$+[*X_
MO/32Z9>]KWU!R)__02R_?Z=W2LT:KT`]-,8PW#GS3Y@$:ZVB6],I7^D&THYN
M(+`;$D1T\,3JB!,KCHD;WO7?#3<"U.&FT*<DY>"1GFS`28)5U8)^AG'&G672
M<-W-6YGVW,:JN)I;WQ`W*J2TBN7TFO@Q?M=0^.[0TBW&2=<PL-1HC/,J[&2-
M$PI$PB,"":VKZ<_XDU%#T4C],/X+K:\=#KUUAX(>8`./7U_'NA7AV/]Z>+EN
M.<(-<4.U^P(7N8NUYK=-I%T_KRSQ2Y85ZXKMLGC9=4VWB3SDJ9,M)Q.L;'64
M@M9+3:04M)0YJQ%J#JX$[P39H$O5_"0Q+A(QV1)WNWBK11`AP,ODT/N+('C+
M[.9UTI(H$]&PQ^+$[72)EYQ.HF*POC\SDZ)];V^ES^4JO=I!>\,G*ZDE!\$0
M/^DH.E8=]QR\(]#Z(<=SEDH%-5T)RM$-"%VJ;/N@^W+ZT3RP4`[(:&N^+[<%
MRA9>!.4?MQ;U^B):743SQ60FZE5E4F4=I!H&+BB27%Z(M*XZ)0WAEDF[FM-=
M(`&I!J054Z5@`N57UU5'KLI:_^&M!_'88.#Z]:D;<R],]::"_JY\*!1I,^3'
MW/ZMJPM-K:H:&SK%'M_7]]I'9X;T;#"M?-?CZ?C._<%]$'[,[NUA[J]0D^]B
MGF..<6\9K[I]XV]%EC,<HXL%]FS+V<,LT\*W\8=>#YMRW6.%V>XSD6)AT;1H
MON#_OK28_G'_A;V+(S\8>\/_AK0\5C;=,I?\)>F3U"<CJX5[A8>%)X6&^G!=
MEYCV9D(%\R^M^4RN@?%Q&27?P`3VN%VBTV&OK1%L-H_':[,N:,2ME9]^5G(#
M#VGX[_#6YK`W:MPUN17M7>V.QFEE<OG&5&(!Q!9,->PXU[VBO*O<43BENH;V
ML$2!N8:TE"=Y`[QY`USY5H1.?MQ+O&5B-3RS5G+>"H8+MK&F^>4]9$^9ZS!J
M`WFA/4#&`PL!-G";_2/#`[A&F3ZX)?"6P$%RL+75.?H1EP2^"T+;PXQR22,D
M)LEL<C&YDN22$O)KLA8AD4SWM'$+$V0"SV8'M(+QNY+HI<9G)9P"QA-#L`.0
M)K10C,1H#/KK4XLQ,A8KQE9C]V*FF`-GPJVO2PAY,/YIN#%AQ,Z$"\F"4;@"
M[]Q<P*5R36VJX%A\<Y@,B[AHN"/L(TY?T7<7DGWYZ5>&"]?Y:K$P\-'?Z"NS
MMPW/<H[D.I+<.,>.<X3A1([E\%4&&E.TAUTY?#R6R6C<Q#-R+QPO?$A>!ETG
MO/>:E$AL(BP@EV_,;U%C(S'_2$S,;=)!8AZS?V).?`2U&PA:<:-*"EM?(D7D
MQ(UY5+W3T.%\F`PL4;JK?*ZPP!/S7V]`499`C_:Y!IYY!)X+BEO(.'@1[.&/
M(N[<R&3O7C4M-_HE8HYHG1U=':D.CA^(C$7:M);(46U")O*NH,R,I$?#S"#)
MA9G=YIS,C.NC,G,H,1$F0]*P3(Y$)V5R=+*QMP&F-^QB]G?DPV0DG\X8[)XP
MY/%^4Y],#K0?E)G#\8-A9J]_C\Q0!A'[$OCS=AJ*]O]_6@#X^"'STTAV<Y3:
M#*%-A!A-B^Z>-@B(]]Q4/QTC$2A`,0L`[V`FL``/-5<U%(^5IY]^Z1V45>D4
MB*E,-UU%FF`"I:]T*AHA_+,C&*<GCJ]?N3#SVX2#X\V<,_&][-HOAK[5&E*2
M<O'3W=.S+_[\O[^Y.%+C2EM.IA(]I"[__%!J?/^IO5W;_VY/]CY_N_2KKM3;
M7Y`#\9\=^]&:8>9M_GK!S.\K+GS@C?1X76&+B3/;[,5#<Z<O379F)$D;M)T.
M=82:3[`_/'ON\N3@_+F5XX/?O-(UI275_O/[4CZ?"4B?L4-R^A>HN0R[6.7&
MQJR!P!4%ET")4)!4'$OU.)!`K%%,@/'0H`I/<F"02A%DRQ`Z(DHJ'=6)8JJM
M98\H=`]%EW`/O?ST/R7T@K%9PAOZ#L;`>&PX*2G3_70"*FQ``*IUPZ7!%8,K
MRJ2`>)UIPP9KTQDFZFIL-5D@K-O;40L"ZSY^#$%9U8.T:!77/NX4UQ(5SSH(
MQ+5GM.%4RHV03-,6GAA-P::XI2LJ4/H5*.4*E)8%B;HDZI*H2Y*RW42A;H6Z
M%>I6X#1/:+8!XZL2W@#CFYMX3]>SW576IJ1=M=>QZ()3@(Q<=U%<01`W&.U9
MHR4M9&>@;G9JSLA"=BEKNI9=S=[+<@F>C&=GLD5T&5D2MDKQH*O,.0U7DQX/
M1O--0CPHYIN5>#!2YAQ&6W,ZVC:0"J:'2#B:8>@IH:QRN40A(*FV)8%<$XA3
M*`HKPEW!)&"2TG1&4=M"^K@^HQ=UTX*^I+/7=`*,I:_J]W23/M-]%=2AN(D%
M)5:66Y4>>!F1"&?I<_7T4&&(+Y^F"F^];+;R6D-$-@=D8K'66QJ1G@&TE*#G
MYIEI`LDK@12-?(PP1*[V5;FZ&\B:BD/>0J4A>#N[,SM.4(QD=/;5@0/%!H]#
M2!K;_75&I\"%AI(=+^;K>H:W>W<W>R5GJ+ZNW4'<YI]NG3JW]^BWC7>V?ST9
MEF15C4;$`V3HS1/MJ;%M^41;2%4]0O8HM[NB'ADHR_N@L0!>:I@F]KD*8FXQ
M*A!!(X:SVT[#W:Y(&,F*A)&M>"3.!@Q"<SD8#VG@VU`%XFTP/OT`9]OLTD[&
M!^-OI2K<'N[`[?X-BK9P&1#@'U-FE?-`PTVS@.$9GO"TDL6*_"9NP#?Q'J@&
M[T-27Y\6'U2D)`19I05(0,Y,K&&,[2#!'J884&B+^Y1&1JK&P$#%,`+=W?P1
M@R<,?X5G\:$,$U::+!X\WJ8AXTJ;36VV4SS860Q[.\4#GJR"!PF!3_$#GIL5
M"*G-SV"@HC'AMS]8SZU/4SU2A4)@224S:E%=4J^H3U1S6!U760,;%0FSLS-%
M^VQOI=>3E;Y9H[W1%JA/`4`\^29[/.@&6$0#`^&@,O0_MLLUMFWKBN.\E$5:
MU)5(6K)(RK9(6;+U8$;)B6V9M591B6-UJ91ZC65;&XRX6[8,V".V@0$#TJW>
MAR%?AE1%40QH!L3`@*'?EKIIIF(8:@2!L0_+D&'O81B*K<CRJ-%@2(>B2^2=
M>RDY23%")`\O[[TB>?_GG-_!&@XUX55LAAG&?*A/:/J0SR8Y>.O(!#DY8FG"
M\W6,`UH@J3JFK9*VZ.13XTT5S:EH15U5F^JF>D_UJEN)K9]0=R"/O4M\`%+O
MKHNID'GAU:2.,]!7@@VDOHS60>L'.]@)>22TKVLJZU17UYGL]'0V6YS^GC96
M;A\Y8@WX^%AT,!U$8>]Y<J.8S4ZWXP^-!1N$'"W6T0NO'3`T,;G*L'M?;L^B
ME[TO@VHSZ%HGSOO3(5H$A72R?O<ODP!-C8X\W^O*\\].R-6GJVV!-`?TUEZ;
M#@'C`SH$C+_1(3H9XB-#=(;+I(A><1H:`)\RD8'?2$QN]WJ.1.L_7N_(TC2[
MPC1WH':Y\N,HXC1DDB]=*DP$S"T(?XXY9S;--X)O#&V:G`$7&Z9'@I8;IB?:
MFTX9Y50L/:.15^+JH:@OJPT8&<Q'6BCH!"2&P3S\LW@QA$(M=-HI9MUE=BH3
M'LM4E"BLKZO:'JK:7JK:I*XW#20::,78-.X9'L,@78S6WD=0,4('8RMK_C9.
MUMP\?I^26+$F$10K'I>.?F7F9NT^K#[`%N2G4LGULTO<]8'+5&^[ZPT)`J0M
M4Y3J,VV&:H,&26DP%A2'1@9%?1#%@@.$<E"W?H$T`07,IP33L4CY$CGT*=VD
MS6+1!'EL_&KSBTMC\>B`_$)<M2*/U/,RO9TUBVWCP5?OOG\XD3@8X!='%E]A
M?_@C,TX5A!B987HPQ+V"Y]V.?LPH3?\:/1J82$"F1T2/T$(4$"%'8(-;5"/$
M<$P7$B93EHXZ>-!#`R5'@<&B^=^*$'%974ZPNIQ@D4A*)@"C[4BT24*RWC,J
M*-&1-/TC@NR_`%H8929`>WV3E!8F"\RHANFC89#D%1\.4'E[_O&FP,$*F;MF
M!R(>FMO;VP1U'\,(<WL'HB;H$UR7<5V7Q*1W1%NWV3Y.0O![U?>:T/0W\07Q
M=?E"W^OZ1?LM0;`U.WI2.BF?U+\AG9'/Z!=8W]W8KLYN^+X?W/'LB+?9V^*N
M_&%?;TDNJ25]RBC9L^*Z\&VQ-\=F)6/$&,W94VA*XONE.GI>FC=Z$M(B6A1O
M2A])WL_)S^A7?5>%?PI>Q1>1]"%=/\H>%CF_+(8"43PDQH(Z=\)3[SGA;4CS
M\GR(T\2AH9A^@NWIA/W<I$HUC22/D)J`;_0B1O@L^(;`:2F,X:\[=(,IW<!'
MOTGC.(%F&L?!^(3&<<NRIQYQ#<4:PC/7(0%1I%$HT@PX=4E$K-P7"DF:'HUI
M%J!*:EA@?3&!D$HJ,9G*E2=BDS-,CO%#W$D:>MA`K*$#&^81&T:(109CZ"'4
MDV)%09)4H<`P2@M]X%15_&N_7^!`^9JF"OX\WL#L/8QNX/<PNXJW,8MSBG)1
M16I4MY$-:,,D<SG&DJQ+UK9UP_+.66C#:EJLM3)EM]!WWHK_]%O4M=?6E\&Q
M@2Z/2^O_(>;]92">?<PIDENEHD9>F11%(!RI6#P7M%0S^%WIVKG>CL%`![63
M`:1=)&V[QW/DWC6>;\#W65]?6UMFEM?1,MV8-68-BI5W&`G<)@SUBIZ&R@OV
M(0>$EQ9MEN0IO^TG)]D6W9///6$XO0G1A8BU*]D&@M`ADYIE8GPT-1'OYSB>
M#]&:AF2<25*L())_%)>K"H^#U7.WC^'>^"@Z__PWRW?O?FDXG]2>;A\9'4BW
M_Z59M;8UF^CWBT$CVI^5D>0]_V#U#S-]&(>'6,-@K>F_M/]T-IX+"LDDZ@\I
MA]#I]HW&E(J22=FOQ#_O.7RQ,B`G2*3Y+!"6")&F'[W2Y2L%\(+R51ASB$<T
M9B`:,Q"-&0@3S"9A`XP[M,+`783"!+1(P`#C[V^3,=C[2P@.O;#S3`@"A#\4
MIA$BW`\-)`0<)(4$ZE8,)JD9I)W'JH94B%)2.$QS#0QC&!Y1T$'461!-(N2A
M7.C!;O"BA@L]&"N1)\"_!#[B<L[/F\JV<D_Q*(1>2K/CY.P\94^/(V4K<&IR
M3D&.,J>L**M*4]F$CCS.Q/ACPR@3XU*)<"I0#L7",_!(/"<P*!G`G6DPQ9:)
MZ?$F1G,8K>!5W,2;^![VXJW(8]CBXGNI^`A4EM$:(M&.<LJ3;-)5QEEMO-(N
ME:QH4%>C:1G)WO/_+2],#5$.\3@7*BX]TRS"Y3T_8Q8]O^MD$:5!J\V&0]9*
MD>G2RO5JOAOO\V1!R?*1%D<D:YPW:2]SK##;[37;[45:G#CI-5NNE&F_,A5*
MF0JE7`V3?ZMVQU6[^:7:G0",3QR-]*T*9)JJ28>;=+A9@`5T_*2A()%A</U[
MQT_&%0;)Q'!]Q]%)UP)+[[-DCH),YY#I'+)!<B"=P\C31-G:N^K.863)''#]
M5\=/NAILY_X#T"C,8T2TW,&CSQ"@,BKS=8?TR=71<_4S]9?JGOH"5QE31P[X
M^>(!+T^88S=',MKR,H#5PVVR=1/:/G$]87:D#D?0NTG/.[1*,/>57X3I878_
M[^7GZPN\.E:1J>)EHX>F$9,C,C=IFUDHTZLRO2I7X3WN4/$;QA)\IX^I:U"#
M]`+CW_1NH;!4)3F>-%:['@3&Q_1NM=I8ZCB.O'^4X,GI#J_`T'>^7BJ1H`SJ
MO11X=G[I769V[Q9S%/8<[/F]6V]'54U5U2EW:PPX@^/\C<:'$<\&2+RQ`KAI
M!E"S@8Q>(Q-36^R#R\.%3&P,#,<_7,W$*L>&Y4Q,:7F"EQ-F)I9O>0*7$^5,
M;!8,Y^E$/54KS\?J,[V90LVQ,^E>AA^I+"R2A1DY@`4_S_5X^<KL6%Y5A`;0
MIR0GXWD#K1J7#-9HH0E'+&0L,SF5+Z#5PJ4"6R!MD=IB.5FMZK6Y&KM1:]98
MIB;5V!KX]95P9+RVLM1HL5^`G/62VD*G?D"1M$.D4(>`\?!]]U0\3M@4G)QL
M)?JKT01&D0<^+M/Q?9/67H"CX>$D%@,CB=$DC@^BH#@<'!F$D"`531=*F643
M`9,V$.0+8-"(XAXC_7)8<</%H6XN24'$@)2C/(HC^\T\Q___RN<0FCO5]YFO
M'5IXL?_T^6?_1W;YQS9QGG'\WKO+^?PC]OG7^7*.?>?XQ_GL)([M7,`)6XZ&
M%A(7DI9!$R"0HJC5"A-)$%`8)5%7Z(]U:K0_RJ15P+2Q39TZ@C16Z%:6M1U:
MM46PJ9K4_5'MCTD3*^FDJ=+&6LR>YW4<J!KY7K]^W_?>O&=_GN_S?0:G$W*S
MJ^<KM77!OD3$Q4>-[=:^AUDVW/M0K?APQ=V4:!_NL;9VM!2KM;[^DDI]KN$C
MH3Q[:]*7R4WN>;I:W=9[O'9XNRYKJ51$2OI'R$M3G;:UR9VO57=WPB!DI4=A
MK&C'VM?4PCMZHJE4M&\;V7VZO>&'/0S#_0>4K,RN*IE%E:R+^N$B;;VB3TZB
M)'3BIV0L98I4DD2J!R+5`U%.X6VRBA.R!^-<;L@3=#ZBJ@2=3^P,+I>9&+TY
M1C>*T2UBIH);F-0XFPV#;-8M&NW41<Y$;7/A'2;3RJ:Z4$B<15J9%4O-5R$A
M2G"UP97&F90O57*H[2S5DD(!<N*M6Q(89$#DB];X/OV04$"P0=58E8W=!1FC
M&+\:85N1]ND!BO7]?2F19D^1*H5(54.461R2Z9`LXI`L6]U,C*Z,T8$8G8S1
M!\51LR$7)HH)KC!-J_N>*:V[TM6<6X#'0F=:H<X4[7RO9><LT<+X[[)&K`EK
MRIJWFCIX8M/^''Q:L(0%ZX;%+EAD`@86+2XFRF;<=YGSV?XVTXRGAMI$,^X=
M2L;,>!($PNY,%HW<^JYX<4,KDRR5Z1.GDDF?S^N*R"G'O$@61.(3I\2SXG61
M%R^S;]M1LQQ+Y31SQ)PPITQ^SIPW%TR.,263-3&/.R'@S8EN"'5(VS3*(<;O
MU-\;KA0#NE)9#64:R`&EA1/X=`L7:25-@M*D-L(8HGA\&E[,.`$/@)'\I0!>
M\8(0D?</WC,!95+]P7>K^W79ZRX^4.L+VF47OW[SD<-N+P9BZ*&B3VO$X?([
MU>WKCM>./J:UM*921L8W3(X\,_UL+38NQR#2-DZ2KYW?I&*<L2#:?^>N0)SY
MF!CK68FT5K"!U-%YJ)VKUW22VPVMRF/LX"1V["`.\G09'TF+;BG-U#,CY7>)
M@@N^J\&I$^=QG8HW1Y$IE0]1XD(>B3HXB=HWGOH`[/)\W./1X@@6344(%^0B
M^D]@8_O!P%R8_$3^I?P[\K[SO=B'3B'P#Q?9Y'Q0?BQ\DKSL?-'W8=2AV26+
MUP8`N[,:N19^7V5MC0R*C=,$>/S1\^#_AP%%GMS`=H2?X*?X>7Z!%_A;'ALF
M;<]9*'$&X@-5);]%^G0FOWEY'#U==2&[M;HP\LB.BY[XX$6-'WQTQ^C;C.?N
M(L/#I=U=Q!0X,/IK1N5*#,^$N-)-Z6;TOH^0'<96'@@@ZB&Q0-J;8=.M&5=:
MR/A](9V)$54GLA-ZB@-ZP69))U$.FK`[HC,M3=#4"Y#5/T@;!/TF4$<&1FW_
M(?:0<,QUS'LL\+1\2#G4*HZ/02$$Q8_M;)7\E2A<8?C2+[HKN-,8(%H"/D."
MD&PS,E9W3T^D31#"H0`R"9F#96Z<V'?X^NSU8T\^\\>MUKX'SC[[^(FO;^0N
MG'G^PC<_GSO_[3=.W#ZROO_,\=_7/CKW[J<O3T#1<?=V;8A["U@SF`K;ML*:
MV6>CJI9<.7QS"8B22PFV,#IG!JD&!W69FC,0UU\T_!K571TA:J;&CLOF`[Q7
M4-\";8U@R0'VHS/M[1D3'`9588:J,$.`3E!8<&[+5'!I2B[4A79Q4;H&PEJ@
MQ#:D]0I3NOOY)02QY$(F%>RZ7'V]<#K*;9!J9%"OYP`!#_6)':5F38=56<%K
M,*3%"X=QXVGP`/A+]TMU921UQ03QO%$7SZ4\4GW"U8>T5J1!::?THI\_U4[Z
MVOO[JNT[VY_R/]5^4#SJ/]K^G'C><5.\[6SNZALMCW7O[^;M/E(0N:P9"(*M
M:CG5%@1S9209(S%LQ)D-;""?Y?A.J8?@25@'GJE%\9:*FFO>Q4ZXYEP77)SK
M8YT-7B9/VE%='TE,)=BY!&$24F(AL9BXD6A*3/2^4UTI9M9)5!5GEK&@68;'
MFO%'*M**(G)>"?T/)5HO6(YF,=V=\62ZTI:CI)-",S1E9X].BNY.G6%6T06A
MG)X99Z;'`4$N70ZCTT$.'91#HV%@RO*:>P524UTPP0)9*T:')6IFXRO#+^V:
M?F'J]:&>;"E2J=;TEC5&,"PEXTJ:=#N]W]@Z^=5'=MFC78445YGYR]'']S_W
MP?+W9\.^CMK-W>5X.DUD=W&2VSO6I7AG:Z\?2/:.;GGBRI^GMR@!8)G94!OB
M&6`YQN3)!RLLJQDJE9FPC&]A@3CBA"),O%B3^-%$>*D/\5(?`J-_HUH*G?]>
M0J2]34BP",1*CIC@BP>2:44PQP)NA[?.#2`#SGMYQ1XLY1<IL75H%J,YE-!H
M#CF,YI!!U:?&MTL<Z:"66U>,D0[6[ICK^%'V7`??I78E^G-K\\.2K=J)X=RF
M_*AO1!V+CR1VY/;D#TA[U;V)`[GCTK0Z&Y].S.9/JM_)O^9[57TM_FKB>[DS
M^9_*/U9_UOI&_HI\%4[PU_RM_&?YG-YQ,'TP^TKP=/!T:+'#L35(VD2O&7<8
M;<2,"T8RJOCB&I=438*/E4S'%(=#\$:CC*9Y$;L"HY%YPDZ0.7*!<$3$IR`?
M9XI2>"3,_B9\/?RO,!>6<#0\T#XP2Y4X/SVS>?E.?AS3,P81\KANN?\.\ABH
MK.1F)94-1E*1C,YD@]"DY:1.C)"IU]E#FPUZ"/"MS3,SJ(!DE;4290V5$(20
MH?Y[#5=G#Q01P.OA]BGEH5HIN#864G:^,'CR3R3T;F4BTVM]RYCLGSKWPX-]
MN[@+GSTQ6FI-IR5W!:SO_N%__^$F2>MZ:^I.@?P<\O75WUY9+#/@?)L!KS>!
MK"RYM,)5-D<U4M`B?H.:4T/1B)^2]87*5VOX6JWA2#54(S\BIH60/HU:6(U6
MO'0AD3A%;OD50*<P&<#..VP<,&8-SL@Z%`\'8K6$%>XRU+=?<J72>]<:3K21
MWY.X70;N/>"<=;).V$`1X*14*/VT@L4S_H\*)73^28M0[+R)<YJ6,^^92=B?
M*?0O+8VO>LBH?0#*-U^)+?ELUO8]RSOL'-F3(QJJ'*T73R4-0U^?B1L;&)<[
MYP_I$N&5.2=Q5B0/\8QQ'..`BG"/0.S_\UW]L6U<=?S>G<\^W]F^7[9SOVR?
M8SMGQQ<[B9.&BTKC;DV;_J)%(-H,O&3+)E$84YH!V[06S!\PJDTTT$J0!<A4
M"52$1+NP=F$H6SI%,-1EK<1:QA]E"$55D>HQIM(_J)+R?<].M_U#Y/>^[^[=
MO?=R[_.^G\_'C_RE5"?JI.1L*I6R4=V>MFG*EL`A+MF7;=8>+_SR<0*N>QYO
M:O7P%$&6U)AJU.2FE_.HC80'&G<*]!T09PR+.Z!.P$O+=;7TW(9):RDZM.>)
MIP=&^K*9`S$EUM6MAN_;LE[<WJ[S;#ACI!P>Q9@S;[]]O^ML&HX6'ES?N<<!
M\9:-$S\U\>*G+2S@`"^/W%VEKP!>>GQ]+;PX%8*72A6K,QII>/^1AO<;B:;!
M.2%\WTF+&^E'Q$3:B_O%G@#GB&F?4F31TRQZC$5LKHP0Z@SH3R;11!(E<[:!
MQHU)@S84@1I:KM5``Y4A0J@!F0YAB(#N6WEG17JGR:3WT-&;%AW.UQE/*B66
M[NP)-(?1E=TL^BK[#$NSN<[`MB1Z)/GU))W,*0+"*_RP:F"TB&*EU^`BQ,4X
M"@Z.4^EM,>9R,RZ#AJK5<)&6EVM#TK+B00<L"D.G$'1UEU:44E7PW+S@:='1
MT`,=L]+)+,L'^#Q?&*],5NH5OUA90';U64B7%\,7(\O9Y=Q?,E>S?W6O^ZYG
MKF?_Z0K*D%MS'^\ZZAY'Q^GC3#U6-^IFW3K6=;P4%I%(\TPPY+=X]\WV/V4X
MBXE'%2N>T`NF.Q.<X6?M$YD364$IAO/N+G=?9:SR5.$I]WN1TYDSE1O,=2M4
MX'J2U"*=1"E41C1:0,5Y:K&T@(RJW*DE]44S::0,)!DV?#G<J2_&<6>[HF0S
M8<$G.B2P2?1'JE3N[*$H_%&-;^FZML!LKT;C9?QAZ;<4A)1+Z??2_THSZ04F
M6A4F130N3HK3(B,NH$U5W3'T4HI#G#OGH'%GTJD[C.UT.[3S*K*I7F2_M'OC
M<.QM3-TBYFBM=O_!^;MI5!OURJ`KY^\B:((V:*Q"/U`7MDVK4E-RX0I4*0\^
M+1L6HN&P\&RD5(P<E99'-4JZ>:M1FT)2XU:CV2;-)HA>+MG!<!]5'"4YW<H7
M4K8D^P,I.6TA?X&SX`@G+2J09RVTD=BQ]X*Y@G<"MZ7;\IV\KS:*IB@XJG!3
MGT-S]!PS)[P0GHY-&]/FM#73_N/,7%<(Y'$1'<94`(\)Y4PY^YP[FYUUV=HH
M%LURWM:]8%[W4)7W:"@F6(AYWC.PD]!YKP2W7%*"7DA**D,1&U<@(>=-CP3=
MRX(HF%>]3#.$()Q7/5=3FV,IS;%$!:908`K%<VT%O_-!513A,=%CI##,$\8#
M?%!5PC!/&)Z!HLFD4,7_]P??9I2D*SG38K*V>%M;,V\1%961*UA5@:CJR!(+
M@)48]JGT=+KCR2]M_X*=&OO1Q<5O?/ZQ=*PMG$Y;/W]X^,!#ZW_KZII]9M/>
MBBPI(>;,^ILGOK*KZU/Y0FG'Q*FC,TG>0#N>_\%GO>$'IP>]`X=_TB9&-,AA
MT;O_IC?[+E`F6FOEL%RBJD`.2U1Q@A)"&F:O4$Q%K$J:*B$R%703(3P5,Q\Q
M"_A;A/`[JL"Y8CSJ6T#F/(7\P&1KEU?*C>46AUT#M5_^9'[2VT*8AN*DCGVL
M#?MQXV4BIS8:.M9S4=R:%)`@FBAV*(IV1A&9K@I0A+D%$['$'+`<ICF6L"`+
M"WR?#(%72O@/&O]]A5@)-6%]Q'_%RRO8$ZY=KM66I!5IN08$0U8.VVK^C@K#
M`K:&O#$T1M-#B1EY1G\]]GI\0;^A!^82Z)B!]H7VA<="8^'_:*Q?BVF.QL1C
MFFXP"%=1\T7$Q+I;JV6Z:1KY0_UXT?%+L?>(QGHT:KY%"0OH9M6U@3Q+Y<39
M!)V@$/+YV&QTOXKJ*J)423VK+JF7U;^K?G7<^O6Q#6NPAD_[9JEV"[1#`_+$
M9FIH;153I]2`KE4$]$D1==;3#6*?:/ZI(@9C)9:1B:8:J!#%U=$O9_HW`6\.
MH%U7KU;RZ2VRDZEO*QWL_.'`$UUM!=^%]3]O7_O-Z)9"_N&)RM@$_>5T_-!(
MQZ.8&>F[J\P:<Y+*T=TM5,6=*D8/UY+E@IW'E_8]/60G6PYSM:H28VF0!PW%
MPL\I&W!3-KPH-&Z=PP\JV0WK&=%R?L&.:/Z$&Q$"')SA<]AZ<CQ5OE9<@1UM
M2OB;31RN%$E8NE;\N(XZ$*ARX]PDQW"\8`M:))MK@U&;0PHM3<QC["`"*F0;
M/GQE$(EE\/B>H7!<ATV09_N),;4[8+4?$NPI6!_B+MP@V%,4IZ.%/1G74$DK
M<$&J)0S$(0`A$6*@!U<PH_8C![L*V\'\<-;Q]0D#J4%[)#5BLP:G[L/.,[TO
MF7,RG(.V!I+<-EO();@%-%Q5>2J7`TK"_T^$%WA!2-M8^T>HLPB):!+-H4O(
MAQ;HQ6I.T8VLHNQ7IU6Z#M59E<&@LUNP`]!UO/'M3^HTH"*`'Z"/PG@;:@*Q
M@5=^3ZD!=4BF)<J6:%B4))M2P@(;)VT&M@`/4"-`C!)+V<9F^C=P"+HMT)]N
MH1.NG'YF0DS'4TYD_?VN;QX9WGO8M09&T-;1H>+7=GL/,"?7KLSML.3,X3?J
M]XT^7T<S6WM-E%N;K>_?M(<.?&:`S@%&9<!H`S!JTQ>:&#T?#%*&XH^^!GB2
MH=A0:.8?+U&0PAJ-FS>'RL`(9=B`%E9Z-#YH<L%@>QK>$Z)QO+]1U2\3_R<K
M?IK<@?-MDX:-QUDI?O13B(XM7UN1KI%M#2J?XP]J7]09R''OS@O][9B%'HKU
M1_6HD0FV\VG95K*:K=O&8-#C!Q5/Z]<'C5W<SN`V?E@;UG<:A[B?<C/!GQDO
MF'/MOZ).<[\(GM)/&:?-U[ASP?/\>>T5_57C]^92^Q7M-G];NV-TS041GN6W
MO>-])!9[FC%9:,8=.YK1<9HQDVE&62:Q6M6M/K']"#6%INA)]HC]'?:[\O'V
MX"#7Q_=IGOD'_U+Z72/P??Z8]JS.#"@C&JUJT:1*F7:24G@Y":?@?VQ76VP<
M5QF>L[>Y[&7.[&UF=KTW[US9W1EG;_%8BW902YJ01C%5$TC0*DAM(4%(Q18A
M285E2XC8>4"6H(6*ET0\D`<$3>S4L;&JNI*1\I*2!QK12!4\N*45,0I10)&(
M'?XS8Y<4F-4Y_W_.S,[U?-__?>?=.IN3RY(LC[!<FF6Y?"ZGL`QD#!T)AT(,
M2+)4$F03%<G)46D907DZP2',*=Q%;HG[`Q?FIM@\6<38C=B7F!7F74#O%"N?
MSJVB/%6F6+A?/MEFR7W+!2\N-#LD7(]U*'8-[-(R>GL)#Z.98?]MP%$D+O&I
M=H40JXQK8'0?#`A?Y+:DCV18\]*#W":)D]*F;TV\M4[8==:74[-A2_*2&NBJ
M3837GNRAHH!JG]A5!-[2KZ%)T#=O<N5LO`_D]?%UB*P">AG,`J@4#H++I1RF
M##(%&O(K$A$3QXZE*AE?2*12H!ITD!6=2B8"#@A5D:;IFBZ@-X9T,_/>;9&)
M#K=1K9VN#FVOFMLK6:,D-(.OJEJY.K(="<1'"PF6CZIJ2"CN>_2W8+AK8Y8!
MM,0?;X2O`5KJP9L[:-$J12$1J"\3YJ5836)"AEJ*\!&RS/M]VQ8=O'4+MK4G
M,+-":5`]GR:\)PUYEL+KP2<!0!B_ES0V1!G>R<_549TZK2(U>MI`1M0_>[W>
MJ%2L!H$.<"6Y5G_0'^`/!M[%!,]U>&\U?S5ID44ZU.]D=3"8@JJ7K1/6*?8[
MUB?J)\9#]:$1(P<LI#K><3?RI7;%LLP7NP59+N6KV`IQ6D&K:XYV1+PL7I8N
M:TQ4W:OLU0]3SZ)#]`'F&66??L@X9,[1,WA&^)$Z9\R9,];/\:OD8'45KZ@K
MQMO6#?6&\;[ZOG'+*E'A$!W)A$16I776B)@=\2G\E#`>?HX^*CUG7HC.XSGI
M@GRA.J?.:3.6.,N>%V>U8)P]AL[@,T((,`%?4U4Y1`,JL"@4<;E:*98ILUZD
M>"Y1Y$MRL5@"4"TRA@[%=,IU)54I,S3#THIII$W3@-6@ZB,,FV88%M2)G%$X
M-<UQ:E511B0Y+4FRJ55E2>0`?QQ\AU5T%T!41'<72X@7R`A3"=`F4`4Q+I7*
M92I`)A%5AT,`I-(J^A:E4@SZI<L;+MRLHAC1\B/^)0X\U=5K:]1+9G49,6[&
MS=OC,KHDH[?DW\M_`M;[L6(#O//7R[R*,'QT`L5HK*VN(DQI5`80'G,Y^X2&
M7&U&"V@@D*ZQ4[K-_!9@SH"<XLJ4@6:,>T;`(+4?_FI<H@DQY,=--&,BRL1F
MV73-*^::><NDS:\W/E5-FP]J@PDYM[FU`:9G8@?;,)6#"=@M;>1`2I%&P$Z@
MGB-ZJM\C$JNW\_/S3=]G`?I]%D@`"S"[=,`\.5/[?\3POSV-F1[3\PAC`@V`
M*2:)A1C4"%=H.!WK$V.R"#%%>*+@B$^$-`GW%D1')2'CC:YF?.H@F\\<$9\X
M=,(3/FWL$LG.&%6#/H_$T0R4X?7?M24]VT/7]A?3S*UWTKJ#*E\QM]\U/]S^
MA[I]IS#:`SX)%8=*]:V_HU_/]L1$4%6#(JZF,UOWT;^ZY50QH*KQ4X_^&CBP
M=3T8.-"*$\V8IZC@7X!A1H/W=S1C3..DMA9J4'`J&WCF6B.%`Z.0+%&-HN`3
MC6T3EEGS.L_@$K)Q9Y-?Y-!\?#XQ+\QJL^W;T=OB'?U.B^4MC5.C2FR2.QW]
MJ$D/C5G\\6[(ZH?[N"^,:GW#:8^,'8@>QH>%?<4#VK/&P;8[=E0^JHZ/G::G
MH]-X6IC.3HNOT1?Q1>&RM*H5$V$>\P)?+^&24*J;G"G:8QP>.\(>[XZ/A7:4
M@@+W?6X4C9('^9Z-;$MK2UR(LL@S%*U"P;&L,6>7T&R[WR=/XC':FM^39_J%
M!M@4LUF]W>YPT5BL!?*#IF6MW6FW.FIR/FL+2.B`+,W&"E/R>!$5;?7EZG0U
M4)VOHJJL6I;3:MPW3;TU#F][JH,ZX3"MRC2M=-1TIZ/&LKH^THJE6ZT8?'F)
MC8DM796CH[8F<<%8F^[P0VBH!%_"MLAG@`(N"*0J6Z$&:C2*Q0(7`XGYYLM9
ME+749918+,M()KP:PQU7OB+_6;XGA\@$J<;R:J!+M2@:?7.A8^G`!XM4"[56
M`^]0#C46.+18N0G0K/USL/E@$V_5!K6)3?`S/O8&N]46I*;7X=Z`""G/V!#H
M):S:;&+*!QI)D)1TIFSI+MX8D'>\X;WHI#.P!S"#O2'^_EW(:`;W$KW9!.Y-
MK:^3L,ZLTQ`8F#T&")P<#$BIGJ`F`'PK5!0PQ3E1L";764<L%Y-]R#]>A)@A
M)I4=$OIQ-X_[$IF%`8EN2DSTPVXRVJ<EZ+HD&R-2!*)I\.1L]Y9X1RWSI.#_
M<8%W:`)DWFE"6(K#CK@WX_))1RN3)L"<0/X'DM$3"0M)/PB^9,C''0PO0(`F
MNDD'8]X1H-7=C)/R62'KAR0IA1DG!R,WE7&Z3,8Q1M*."4U@L@[KG2SKF*X`
M+>,T28,KB^3JT,C?KPK_X9;/;M1_C=%G=G@TY.F7K"CN)<2SJU_H5#8K9BJ=
M)IG5=4)-WIC8TKU$Y^31&V:E&LU^X>#^80UU]RA[CDQM/+_?V1YOR"GW_$^>
M;C2VWU/RVO&UWWSIRY\'8AH2I28>/GGRA5RF`+0D#4]>WEX^MR>H*.F$*`[6
MU[\F2'I`4<+IPIG'C[Z]%[`2V]X7?`#,U`P,[S`3J-/:YX+461WI!7`,$C&B
M:4),@I<*)`UX:8"D32]M+N^:B=IF[2[\^O;-P2YE[3!%D:U1A;00>*6)FE02
MZ*'Z"KD&GTZW**K=^E3T?#!8!U_H<0/Q5WM&KN"#SW_U+2K_^"$E/[Y'Y8#H
M.3P*V[&\^RL6P_)*U%XS`ZFVE7VQ^X/P#R,!E@TG&9G)L;5T3F.5I)+3:J.H
MF^SDGTF>9$]RI^1OY%[(GZR?9<YQY^0SN>_FS]8O<!?DUZG7V9_E?EI;I6ZU
M/_PWW>46W,1UQO%SSN[*NJ_NJY7!TNJ.+KNRK)51+=!:OH/M.,1DH(-JMZ%E
MTE`#AJ33,`SD2IN6D#QT:OKBZ?02>W"@0&+$D`YY<!](28=V:(9F.D,[X[1]
MB-L\N#QTT+K?KI1".Q-;YYQOC\ZGLRM]Y__]/D,$F"2=SJ129JR3.J_A?2;?
MPONX,<0'`KF4V0,+,NFT#O;I%+BD`B;:;,S`R`-I&",MQ$]H@F&'NTU(D=)F
MML!Q`5ZCA?:S9GS/_)F93)L/F_]IILPG*J;'3%,FRG0""EN[LCG]$1O";&@^
M1$)GIS)8RE0R),-W%1:%7T"5FAX'4A];K1U9;:S7UB&3-L8'OM[_5U09:ZRF
MFW*B_1"Z?!@?R=PP:M+RA8GZ87+&1S1I2'\1BNLLKI>S<J'8E>?T2K8;Q_6D
M:\7GO=FL<.]#9YLQG,:I6-)OXM7O%R\^WC/:G1-*27/'4+17O<H*O(/K@AA.
M;$X,J'G\[RU)E\EB`UCW"_;*@YE7OMN?277YV.U[Y\F5H!BQ.JP0O5L@KQZ$
MZ/7B145R&6D_/4_/V^;MBW2=;IOGL(U[UM99G$![V`DOU4YS=C?[%7H7>X^^
MS;:UHC*)*<Y'L<3.6'<R^#B#)YAIAC`YJZ&?Q<=8/,4>8@F;(V94:8!(ZIVF
MR,T*MP2E+;KO</1Z.Y"ECJ-*GF'>,7=8:#O+1BG:0U$T92$TBZUVSJ;M0D\P
MF,G9K`;'%(O9'"9F]CK9CNR()MN5#(7%>7@L<<*&<S;%=MA&V0(25^$>XRC.
M*EID1##A?=Q/FBED?/W(V/KJN*-V'P)@O;;J@'_((XW9LMY]?H_:;4*#VNWT
MB14_=JP!YOZK->C2CV;34*3INF_?N*V80.6I''2T%K`V,%A%NXKZ2FQ]XT_+
MOA*=]&CFW65/B3[LTLPWEETEVN_5S+\O>\%D=?,2^[^B"8JX%U."C(6P%C61
M;L&+A;PF>-0^RX.[9%J]\]6RNYU.&BC4^#$>?WHGY[!@7OU;E$KQD?P.-?;@
M3B03.H`V-M#HQBKU!#-#XF@8$*L-G4$O(H1XQ4HJ`A:<^>$TP<%KY&T($I#D
MFJSY#(#/-68K^.S2?5Y'BS`;5MP4.9PXE2#W0)#0;O"D2/2AZZPLPRH"O@W=
M=\\COJG+!$O:]^1V.@V[WY?P*6"@CI[A-"8D\_`C:FE91C3L_Q?F-O,,8E$0
M5=$HB2M7"HJEU`FM"UH26A::"$V"A-9LGI)?Q/3X2'!_D0Z;DS81%9#,!,6@
M1-@D*Q*3R^`S!$P=DBP5C[N?\QJ92#)"#O&'@F0J..V<YJ@)YP0WQ5/'$R<E
MDI'V)?9)U*PQ(8GBI63"DTPFDJ)$);+)3*)/JBZ%NI>*A26Y;TGZ+(=S.4'.
M+&5W_"CD$#`20L(-@1+J5*]B15E1+`9E_$N`+6VBQ^@81)1_T&B24<%1"!6H
MPNN=U5"Z.UC$Q8/E4U#N'CP%-'4P.(39(3QTR1'%IZ+ST8M1*EHG(<5#Y_KZ
M1D<=G;CSTC:I?+;\1IDJPQO+UDV#[].8KE,1Q>(9G+!BZ\C8_J?TXF:M48.Z
MI:8%NTY-((1KM=G5&J`/S*YK$V5(215MT6RYM:*LES$EJ:97.,T+5TL?FW35
MF?/W?4>9[!_!\8&8*V:/DUA'W`=T;8@'8OWQH2X\$A[JP4[6\R0*XDU/8LX$
M%M\&UF"LKPO%$\.1'3W8;7,<PYLIZ+P6_S'4SD#79`5'.?W_+/'""U`$P1\Z
M`D=Q%@1W%C]$"YRG75X/H2/A*)$+KB@7IHG7XZ*[\E&77"!11LC[O!X#``5`
MAA>(V.GS=6ED`2=+=NI"[<X7=?8(MU'F*WCRQGOJA7I=O?C>#3QY^:?J!Q?.
MX\+"`I;/7U`_:-S!+[XY=^#;OXMWN,-U]>-10[9/?3.7-+51;;'LVG/?^M*1
M/7&1>>:J>OY:7;UP_3K>5;^&=U_=MJ#>7%Q0;RTMP6<MXNZ%.R_51H\&U8]D
MCY42\`_5WP@=@L#Y'&/$LL/&\>I+XA/RXS,.1!`436WO,J.(0U7\<V7P!Q*N
MB5_S'_4?Y9_-/B^^ZG\Y^YIX3GPKNR!:^[(CXEZ>*HG]_H$`E?<7`]T9BO$'
MX\&$0W84H_YX("T:0RO5]CHVO1/>ME*M:D9$6*G&=".]4HWK;^56JD5]IKQ2
M[09#J82=*U7;F;!QI6H]$_'P8C;DYW.!4(;GBAG)3:)SL<1<+!XO0NC+<\7B
MUKGN;JL-0,[E<I]#%.#0]LO8Q\&@9)&_NFFNO;UWKEK%`8Q(=NZ;(A;?YOFR
M"S+AMG(F'>H'`$BG6!"K.AE9WI8[A\H8(CZEN(S4'/'-<45$BOBT,85..Z\3
M&^I#_?CC*\*>Y[7J`9+]JF-=BU\X!F4X!WK2;QX#+>.7I+&&7E5HEVOP@D'5
M7PU]@=1,?Y=9&T:UO>7FFI9S\TP\DC[^&Z4:#>A16G,+7`3"*N)L,2O$&:!!
M6R2&L>"U$V]K?CN1G3B"X<K7U8Q(+2`U<.@B=WUA\^ZG=B:KZFN]D=&I"39,
M?P,[L0ES6V.N^(@ZV[/%K7X84F\Y8XFH^MNM"9<SN949O3D\T/C59!:@UI#>
M1?HKXS<;*Z0<PY[,H)K9G:*C4>Q+]>)/&S/D>VI'_Q8?T&]J`/]^-.F-@7"C
M3VDOD9D91*&2PD)"Q2Q,_H$P\&N@.FZ\2[U,>)JI$],5X9.?Z5EV;+V%5-+8
M6JU)1#CB)K+ZQ_#3S(SZ%MZ+((9+]#2994K(`E$\`JF<GTSL+UJ5DR[L0LI)
M`S;PL`.EW#;]V41,K[#*E/>0EW@G_9-?]J?'09C&&O=KG^]3&UN3:FNP$QQ]
M[60WV4IXQ":&;*62S2J*>DNL*)FL4F%*2K8UUQKA:3?^@7]-.XD=GG;S-42H
MA&)&*,#@`_30,$CH)_]AOVQ#HLK"./Z_WGFYILV,XY3...9,.38[:EJ;6CJ6
M6=N8U329O5ANY=(DM:EMEBTA8>RF$!+M$K5%11A$143O5$209!^6/@GMAZTH
M"(*@8NGU0RVS_SMS6WHQQJ`/?3CG\COW.><^Y^W_G)E[;M#R4ET51W(7N74I
MK^_H1DE],]CNL=2G6!/,@VJG6%_=4CQ27S6%O"J'I:=\PSDPIR(ST<YSK]Z2
M:,/YH14VV4D!]*7FM*RT#IYG+DB^,Q9[AO.RY(,;_5(Y8F*_W<O1`ZQVRE(U
M3U4_C-13)__#8B*4\+1)18R&)XT>1U*R*<GJ2/%.RO*53OVQKDP.%Y07Y11E
MF<W&1'_^.&?.3[5M#90DFMH^1FJ.(1\&]*=C&(K))<#H![B(&*P?DDQ6D+^`
M9(4\`DR7`<M>(.4XD#H!L-%OV!$@C?7V2M)/`0\.3*87<,T"W->!46SKH=@Y
M'-=[%O`]`?(L0#['*_P;&/L//Y;H6]P)E/0`$_<!9=E`^36@X@I0R3E.<P+3
M#P#5?.$$UP"A_H&9:XHQGVM8R#[KC@'U[<#R>N"'>T#CS\!JKJ%I*=#">:[G
MO#8\`#:=!#:G`QV_`K^$@*ULU\6Y=7/,[<^!W_X`=G(M>[BN_;W`P0Z@I_T+
M<O(S>?0QAPKC<[@JQA'&X2AC?K3G*X)Z'[-^P%F!0"`0"`0"@4`@$`@$`H%`
M(!`(!/%``B2HR099M20',2!NDJ&'4<&0I.2A,%M2K*FV8</3TNV.#&?FB*A#
MMB=GM/<;7VY>_IB"PK'COAU?5%PR86)IF3_ZM!+3OIL>J)I1/7/6[."<T-R:
M>;7S%RQ<5+=X2?WWGQCQ/#EU&MT#/=L6?\*?2FO?+;1'\RUJIL,%YEZX:"G,
M1\(#'\I0AV78A-^Q&WMP`@_Q$F]<J2Z;R^X>&8FPA>J9C='(PQ1Z-M!SUT">
MD?OO7VR3$7D6N1WIBG1&MMX[P&O_W=5:;`:7Y+@>"E9J/<J,-S1;1]NFV09:
M7G4GZ!)9XX5?LQ-@P@K-EEF_3K-UM/=JMH%V;R!4-250F5N[JBG<&@QOK&EI
M:F@>;!T""*&*N@6X/W)1BU5H0ABM"#+?B!JTL-R`9EIA-&(#UK"T;M"MOK0?
M%3-LPU-JU`8C%;*@``L`_9_<!S++%$?:P9^)HJ.EEM[>L3+!2O'_3Q^&:3(3
M*KB3WBAJ-S<4D]RJ18LQKD[OU"\S^U\H=B7JW7,_LU>]7[QYSOMZ_;_=%B@F
M%M7X17O^3X`!`&MO254*96YD<W1R96%M#65N9&]B:@TQ.30@,"!O8FH-/#P@
M+T9I;'1E<B`O1FQA=&5$96-O9&4@+TQE;F=T:"`W,#<Y("],96YG=&@Q(#(P
M-3`X(#X^(`US=')E86T-"DB)7%0)>%35%?[/O>_-A&R$""29H+SAD0B91""(
M;&D82"9@(9`%=$*#S)"$)$C(L`H:640(#HO(AY1-E+(%J?A"`PT46E2T]&,)
M1:MB+9M8P$^$]BN"(O-ZWH`4.N=[<\^^W7,/"$`,YD*B8$1QM\QQ`6\B,&(E
M<X>7U?@#*%8'`OD:0%EE,Z9IJ]).SF#9EX"M^_A`9<W1625K`7LTTY,J)\X:
M;ZXK_P'(/,PZ:545_O+CJU-7L+\+3#]1Q8SXGO$F!ZQCNG-5S;29L8][W4R_
M!3BZ3*PM\X/B-[/]?YA.K_'/#$0-H0:VG\;ZVB1_3<4K6U-O<FJ6_<U`[=1I
MG+>5:JDE#TRI"!2%#ET&'N7XD::Z#TG\.=1M2%)2P769%_F[9)VA:O.2);=.
M\0U;-]_]@`:\0]5X!W_"^W2-K=[%7C3A,!*0B_6HPTK4PX;1S'D%10PJ\U=2
MDMF$;MC(^6S$,=9]&K.Q#^TIT;R,.5@@/V:K!=SI3AB(`M1B*0TSIZ,49Y3Y
MZ(UAF(0`S36]YC)SA;D96[!7'C9O(PH.E#$<,[]3/S>_1`9;O(XU.$,K6NV&
MFZ/,9<TW,`5KY1B%S$KS1\[`B><X!P7Y.$8'A8N]5^`B)5*=S&$OFTS#/,1:
M'3`&55B+?=2+!@NG6FKFF\?0GF/,9*]KL`M[&)IQ`%]0M'K-W&Q>0Q+2\237
MTX3C=%"&;L\+#>".J=REKNC+DEK\$7_&"=+I/5&K1JN9JEM]WOP$;=$#HSC;
M;6SY3[HA9C/,D1\I>>8@Q')?7K.ZC0]QCAS4C4;04Z*KJ!4;Y!1$<,0>#.6H
MYGZO9N^GR45[1+1HD9N4'<HMV\.ALV8LWT@JUN$-O$<Q7*E&4^DE^I2^$CEB
MK%@GSLN5RG;EI-W/53^#&BS%#MR@>.I#A?0KJJ(ZJJ?7:`T=HQ-T20P4(\6S
MXJJLDI/E`6400[$R59FO+E07VRZ%O*%#H;^&;IB9YD(4\CS,X^Q?QP:N;"]:
M<(KA#,Z32E$4RZ"1DT;1"PRS:2G]AAIH.S5QE!-TGB[3O^DZW1)@L(EDX12=
M&'0Q13PG5HKUHH7AA/A6_"`39"?IDKUDEBR1M9Q5O5S.L%N>4QQ*BV)RGS/5
M5>J;:H.Z0WU?O6:+MK\4@8BC/VVZG7;[=`BA1:%5H5VA)O,<VO$=.K@+'9'%
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M<<>;K:WR-A]9R@>XHNSGVHZSYYFV:)HMKMJBL8L@^G+,#V5WQ26/X`MYANS*
M1OQ=B:0$NB*VR0*>@@-*MNJ%4Z['3CF97L1NX>'M="MB"<_Q<'J;]\)(RJ2;
MTH04PWF*>LNO,!_/BL]QA=_Q(OR:RI5*+$-/JL-%;.57T56=9$NSM:._B&HE
M*!ZB)@AE.U?7ESJ35-OB91HCU]JNBE.8CA8E$J?E;SG[%K%3YBO7U"*JXA?P
M(A9BLCD/LU2O<I(J(>DII"AG>;O5R4S%R><<WBJEO-/V\.O>QWM@H,QG3B)/
MSC">BU&\(=8RK.8]H?`$5?,;?YJWV'$TV4:*9E2JL<1;!U".A(HPVMR*-68E
M)IDKD,'[H-ZL8X\-^!JOHH$6A%Y``(_PRSE-P]0\T:+FF1DB*$Z)8K'JP?OE
M;J=0(KYAV,E$MOH'!)7/4(P!YA+S;SS=77C#KL$X_!(7N,KO.,(0>1`]0\-%
MHYDG`USO&12:V\R.%(DJ<R)&8#^VV%7X[2YWSJB1`]T#LG^1U;]?WSZ]>SW>
M,[-']VZ/9:2[TKIV>30UI;/>R:EU?.3A#LF.I,2$]NW:/A3?)JYU;$QT5&2K
M"+M-5:0@I'OT/)]FI/H,)54?,B3#HG4_,_SW,7R&QJR\!W4,S1=6TQ[4=+/F
M^/_3=-_1=-_3I#@M"UD9Z9I'UXQCN;K63*,+O8POS=5+-.-*&,\/X\O#>`SC
M3B<;:)[$JES-()_F,?)F5`4]OEQVUQ@5F:/G5$1FI*,Q,HK1*,:,!#W02`G9
M%$9$@J=?HT!$#"=E./1<CY&DYUH9&#+%XR\W"@J]GMQDI[,D(]V@G#)]G`%]
MD-':%59!3CB,8<LQ[.$P6K55#19KC>D'@TN:XS#.YXHNU\O]I5Y#^DNL&&U<
M'#?72'C^0N+_2'8>G^.MOU^:+(.>Q&K-(H/!>LUXJ]![O]1I_9>4L`^V%2EY
MOF`>AU["31Q:K'$TL:#$:]`"#JE9E5A5W:FO0O=8'-\$S6BE#]*K@A-\?#6.
MH(&B6<Y=#H=[KWD6#H\6'.G5G<:`9+W$G]NAL2V"1;-^E^36DAZ49*0WQK6Y
MT]C&V-9WD>B8^Y&*>[(P%E:WL*%%]SI+5D;ZDSP0AE:F<29>G6OJ8_U5]$&P
MK`^K\:^$V,HHYQNI-EKE^()Q_2R^96^H*7&Z%KP.G@#]RK</<OQW.;:4N.NP
M4&M.[HT:RW_&#9?+2$NS1L2>PW?*.6:'Z5X9Z3.:A:X'XC0^N'THX-[Z2_IU
MX_8[G=8%+VYV8QP3QMQ"[QU:P[CD77!W<Y48PF=)#OXL^2_W51\<577%SWOO
MOK<+0ED(2X4,DA@^A4`@$[Z*9"400E+0D&RRB;2$CUKJ2J52K>V@+!-)PD(Z
MK6V8"$B3%`M-Z+#!6).,K<",IMA1IDZ#;:4??F2FFDZK#MH13%Y_Y[[WEMT7
MQE#;_M/,_O*[Y]RO<\\]Y][[_$&NB3@U\>Y5&8CD#N*GK#_FG1[_C?%-2%FU
M;6E,F?`IU5^QZHM*,HJ**T-IJZ)5MF^+2I,DJWYQO,XNQ5+R0EJJ:I?45$W6
M(B@WQ!NS$!H5$]/P,V10;^WT>!&54J.DY<=\5076_XJ1Z>DWV*G3?(][2;K6
MS38SMG1VLOR%)#G)O%%1#0;C&BPJK8Q&1R;5(=2L"=?8A(BGTE!Z6EZ,@LC,
M:?AUFF<6,RI28P&X+(\;(/XLE2TF-4RURQ7XX^C,G)./@RX:S<](RX]613=U
MFI'-&6F^C&B7>DX]%]VQJLH)G$ZS>W]J+/]`!7RU35F*I%!I17N&4E?<'E#J
M2BI#73Y\!]25ADZKBII7M:*B?2KJ0EWX?`E(K<I:5K*0Q@(5*5CD:=4KVZ=V
MX6LD(FN%5$AY2Z="4N=U=`IMZ50MG<_1J=`)2Q>0.O[C,R:O-)08/3(E*S+Y
M*L.7T_+!=93GHRNG!J?[I";QSX@:MHK?&39BZFOT9;&3_,`:SV3ZEEY&(:66
M*M56VL70)E-`G*0'T+85\AW@;NZ+]D'@S\`RH`R89.O6`IN`$I;1MHO[8HP=
M/([DG53IG4+WZV7F`.8[J/?0/<!1E%O$6W3"6$+;(1]#O^<%T2)N@SX'C59J
MA/X(ZK=`=Q0<@MR,\@;TR[++(SSU^%8#`P;TLS#.?GN],[2SM%#L--_`6BHP
M9B%0@SGN`N<#16B3`EX!U"H]5*?TF"VH!U,UYJ]E/;#2Y@*,LQ?UN>@W%7(U
MRI-@AP$>`Z0#,]63M$0=3\^!YV']Y=:Z@1[:QFN.KPGVVS8-A65C42(PYR^`
M#'6)V0<>D6";&]4NK-&R*0(.`ZE`L?HR;1=?)`7^>D+O(XWA)6(__0FX76RE
M=9`5V%FB=]`AEH&U$CO-`7&$FK3+M!AUWS$.8AU;X6^\?-6/:)[Z-\HTIM%N
MQ-=*C+\'.(HQ_RKC82N58OZYX&S1)V.H!CB`N?[A^(E]`WD/]G4]YOK$RS'<
M2B7`:NQ+!+B/[<'\\]CGO.]*V>`2M'T;;38PH/^\!-;.,<E]N#_&FF;'8<LU
MIA:TJ8=?_P(6@)]M<"#CS`;J7L0X$P$#F`S,!?J`%B`,+`6>!69B;L*\FHQ7
MQ`S'IHP/Q(;>`Q_"-AFSUAJ.ROVT<J;9'HOG23=.4MA&.H_)^<(Q"UO:G;$Y
MISAF');Q'>:X5][G=7),Q1FY)_II-=L@<Q"QY3#G'6SF?#BH!JD.?`AQ7,TQ
MR_8YS'[A6),^04[8O"QAK5DR1\`:488=Z]4..[Z(\S8ZAC&KC,TX4YJH0'P3
M;^_OTV;Q'JW49M%</0LZK`=M8VH_K??B78Z]O!/R$RYN9'AZE7OU,UAG&_S9
M2T_"I]\0O>JMHE?1]3;S'9V4\WJ;^J@L#V$WE#-6'3,CL>[?U7\6J!?U-IR9
M;>:[>J]I8CV/<TYX^I4L(,UAZ$\#$>`V[VRET1M6.CU!\AE$EX'[18"6Z@%:
M),Y@?_PXYY$+T`?U-^AYK9[VB5[S]TJ$(FHOU7C\M`G?3V-X+O4B53-X?/".
MA#A*BCEW+#GLQ*N;^<RW8VH*V$#^O6+C;1L?`1\BCGZL6',LXO-9W@\XHX$:
M*U[-*_'X/$]/@?<[\>F*T[`K/D>YX]+-\F[!^>[D*>S8YZR?ST<^X_B,Y'..
MSQFGO9L3^D?55L0QG\,O4Z6=U[?:*(2-;]JYCW,8^UUNFD:^>=SH,$]HX\P3
MQ@*4?P?HYG&L^^'XG1HR!^W[=)9SEUIZNLFY1_5LVFZ?9\?D>?,!_5#>HV72
MOA'&*=JM7\6^XPR4]C;9.0A_PNZPJ(+/#]$!K&.B5HM\A![8P#Z1>T%T,]\+
M?"=J#?`SWT7U5*V]CO<"]\VFL?*^R*5RV'Y>ZG"G,K-.+Z<6HY\6B"#.VC.T
ME?>*U\'V\-Y['Z317C_.B5Z:+WZ*-GX:B79-T@<!.B[C@ON&B=@7GBWD0<RN
M0QL>KUGV"=`XVQ_'I"]D?[Q%.+[8%QC3\--Z^9[HIQ_I02I'#C5[(M1L!)%S
M?CJ!,9Y"OR#;@GZ3Y'W=0'<CO^IP-M7AS"$9_Y7F5:T-ZWD8YSJ@1>"C-KI9
MC\"'8;GVE<(Z8VLY?[16FLXQ8C3@'.;W1`-%Q6Q:982I'KIZ'><DYMT/W6/(
MWRSD[C[TGV*?VX2Y]T'/?7/Y+<-O!,X73X!2C(A\!Y"T@=\IF%][AYJU0JI#
M'-_A;8`?]E(F[@L%L7<+,-^"E!^U<<""U/DL5M(U'STB]=GTJMJJW82XY3NT
M2^RAKXDR6J#-IXEB+&6*WR!7/Z;#VAC:*%ZBPZ*3#K`L4FBFAE>ZUH&W)>LO
MT%VL5U^%W$B58AGZU]'7Q4;:J;4C]GY+(\4]V&OTT[^+.)F*_A]@7!O*6U2I
ME2&W:E#^V#S)[>0<'68Y0Q10INR7`&FK`Y?-:A'\5H@]A;U<3K(7ML;M=&R\
MCGURG3PN^G$;<9B6$9F7@&D6#Q:K]=0&-*E_H#QM+7U;.6%V*T<H7^D#CMCX
M&15(;@>*<<?G*+N`N2*'G@7VH#P'_$O@E"7C[99#KP-[,?99\-/\7<!05]!"
M9NB.`HW`KYVZ1/!<U],G0D\UNY/D9W#7`,IEK.%R<IV<<P_>Y3G`[68W`[%8
MR#!VTWC/0S1>FP']+>CGDO54Y-,S-'4X>X:#<H&RI`\M!!+7Z.P'>,(-X%("
MIS';=\-_9-]G`?9W-_`EZ=^_D]^*(?J<<M&\!"Y3+I)/>Q`Q"$#.A)SB^-/9
M)^A_(/6N_4.LD$;F/]UZM^S>U^%D]6G:F`@G#N+Q\#@M9XA<M`?<LO<\+6<8
M+Z#NA:&R.#X,*NDV[1#;A!B<,50V[J09#'4J;)W$?9!S0%R^@#,"X+:R_VA:
MS9"Y"Z@=^%X#XO4YM(J1X->%[%?MD%7O[(^S+^[]@7T!\0JM`4\'+P&7@`L=
MCL>W?5XDQ7RQ%>]QF<^2/E>;:SEQ+3<N\%US_3'_GX#<>0GH`5[\7\^E$&(5
M\`'&);Q#<O&.[,7[Y&ZJ)AK`6?+)/.`G.(=*P:]!A]M[<!8P&N6QT'T5_"31
MU0]1?@#Z7@NF*E*IR7Y73H3NYW9?KSU>B=7_ZJ^(KEP&3EG]K[8"]Z+\/O`(
MRG\$GP4WHOV[Z/<8^)Q5/[`1\D/`<Y#[(=\'A%#^'M@/G@.D`./0_R"#WR-#
MOD/_ZWS][X\;9;Q9ML#.*>!N\"[W-\0-L[.?P[#[6\/9_^%8M[\EAK+E!WPS
MO8EW7RSQV^?3OG$<QGX.)D($S0&\*4?Q.YK?LOQ^EN_'?[%?]K%-G'<<_SW/
M&=L!@IV,)AEQ?'9>#,24,!<6()38B;T`UI0`*8NSC"1`-MXF6)V`5&EP3$,K
MZR"(26QC4H/0-$VK4"_.FCE0*9FR=6M6H-H8T^@;;??'^@=+J48[-#;O^SQW
M#A!`:;K],^WN_/F]/;][GN<>WSW/<Z:6WV]R'XMVB>9F-?J3(_:O8N\L]J_0
MHOYOV6?(_CR!?G7(?IGKQMUS*_L;/0O<H-C4NY!SB\_/7,3:Y,*<>A-[S1\)
MY-HFUC6`Y_Z2++^2&18YT!?@ET#?S*YIV;GUOCEVBC7MO^U/=XW\!&MJR*1]
M$@^+9UENLE8P>2V>+E.MW9]X+7_(&GWW.OV?^MEU/LM4^]+[]@%3^%/5-UU_
M\KYCVOZD?4G6G\Q]Y9.?O>Q^9A[-FV#2>S==Q+>%[84[>_]L'R:_QQ/O6_8;
MX2#%[@;SP`)S#3V#^6()*`%8HS(G$#O@O$TAYUD*P7\!8-W\UW7H;:(,NH\=
M)>(?9OX)_QOPW;8+,K?%9-M4S_/DYU;LS^7^$&,FY\'CHO]4!6I`/N@'7\W^
MU^(;$FW_B6/5%=^YMM;,3=M%,&D/.*5>1E\#9^&[X+OZFUV14J60QD$&**1"
M5H%&T`YZ01^PD\N,[`$'P3!X7Y:$E<+4B<?"::AGI!K8N3LDW4[#;?N2=`>^
MD##TY]<;.KK62%MII'UFJ1%>7&?H^8L,G5\1TH2>F1L:B10H!?0JX+07DO%?
M8N9GI-)IY1'2`5?L9B2LY`^4!T)]PXJ-F,(51MM(S8PH+)6;%XK,Y!D^3OE8
M\__*KQLE_/K`G+Q07V0=?X>>!\-`X>_@?)N_C0^L:]B[N2%K01\8!I?`.+#S
M:SC?PODF?Y-<_`VJ`K6@'?2!83`.'/P-2#=_77QO2BGL6L#YZY!N_AINZS5(
M%[\*ZRJ_BJ[]/E6](C0DC6"5::@5IE%8;!KY!:$T_UWJUD(US=\=\`75TY$E
M_#+I@*.QRZC\,OE`$^@`>X$=UA585T@#Q\%IH`,[KL&7(_#Q,?`*N$)+0!@T
M`2=_-85FTOQ2*E"G1@KX1?YK*L2@7N"_D?H5_I+4O^6_DOIE:"_T&'\IY54I
M,@OEA&O<T&[H*I3/X+\8*,]7,Y$\/HSA42&K0"UH!.V@%]CY,"]-;5/S4<EY
M&L,F5^4I>D_J'],9)X5WJN%`/9XQGQ"!E8_#@NCS]05X.'#R!W"%"!P[`4N(
MP#>_`TN(P%.'8`D1V+T/EA"!;3MA"1%H;8<E1*"Q&19$FC_[\_+Y:G7C+N:+
MN/A^C-)^C-)^C-)^LO']XJ1;-M&W'Z8J*S%BI\+!A96J=HYI+S)M`]/.,*V+
M:0>8=HAIJYBVF6E!IGF8YF5:F&GGV7(,A<;"/[O'71$N8MH8T\XR+<FT`-,J
MF%;.-!^K#J>Y/[7V,:EB4@U$Q'L%_?CJD`M]]&-$_7BL_7CMAR$O@8STPDCR
ME1K)G_8*73I066OXBU>&]D36\%%<.(J_893>`C;\0:-XC$91R2@J<$'6@G8P
M`L9!!MB178J.]TKI@JP"M:`='`3CP"Z[,PXX[3&[^+SL6)79Z4;A\5&<I3C]
MW!\N<7O<0?<:I=?#7%[6Z,UX>345%!!1?IXS+\UR!S_*_?M'N903R>''>"^5
MX(\X;NK>U*T2-<V^GPJ<5R./L.^1UX:GCJV@`*N`7DY)Z2\CCU/HI>3AST&'
M4IY-N,R5"BQ2S[$YXJI!]9;GS^I[GC2'^1?/>?6/OK2-I=0_(/+<H'K9<T1]
MN2KM1.3%0)I!G?/)U"'/<O7LF$P]A()3*?6`4(/JUST-ZBZ/+.@R"C8GX85=
MZH9`J[H&]44]6]1P$G4.JK6>S>HJ(VN9N&9078(N!`VS$IU=Z)&-EGEEA4]4
MI]GV\"+'24>+H]'Q64?(L<CA=ZB.$D>Q8ZXSW^EVSG'.=LYT.IUVI\W)G>2<
MF\Y<"P<)?]U<NULH\?'!R"9M-Q<20LYKS,EI'>F?4N(\OK&.Q?61K13?XM,_
MW%B69C/7M^HSRNJ8GA^G>'.=OCP83SLR&_3J8%QW-'VQI9^Q8PE$=?YTFE%S
M2YIE1.APL9Y?WS)$C.4=/EHL](+#1Q,)*BK85UM4F[\Z;\7GH@\0':8,WCF*
M[K%+])/QC2WZ3TL2>D@8F9)$7/_N1E];RQ#[@+T?BPZQ&T(E6H:4U>R#V`81
M5U9'$XEXFFV2>>1C-Y"')^:&S'-ZR2?RR.?T&GFGC+P*7(^\<J&0EY-#%3*O
M(B='YMF8R.M/EL>B_>7E,J?01TF9DRSTW9TS5H&<B@J94Z#1F,P9*]!$CKY:
MIG@\2/%Z9`J;1QZ9XF'S9,JF.RE59LJ1B90CLB6%W<GQ&#FYU[(YN=>0$_RX
M1U==,,@&:A);VV)=9;&.LE@7Z-"?V;>]2->V^'S]6Q.BP*<K@8XM6[<+W=FE
M)\JZHOK6LJBOOZ;M`<5MHKBF+-I/;;'FEOZV<%<T51.NB95U1A,##4U+J^]I
MZ\A$6TN;'E!9DZALJ6BKH?H!Q=6BN$&T52W:JA9M-80;9%LDG_&FEGXGU27J
MVPP]P&?-Q//:4>Q/U!6X]ZZ6#V^-O^A`\3EL2'Y"LX()?799G9X+1-&CD4<C
MH@COE"B:@[#++"HZ4.,OQF[=+'(CG%=61\'NGF0/%<5V1(U?$@="W3UBP`T9
M3#[L0%E,#W=&D]U$<;UR8URO7=_:TN]P(-HA;DE?F8W-FA5+9T:,X&($5XJ@
MHDPDBM@J$<O),1/O__][3%TOW@*-GQ]@82_KIF1"T;WQ9HZIH+D5]]K6VG(.
MVR6Q/"03N,$D"[)DM@[9;3)L$O>;I;O'M,QQZ#:U<14N26:'8^(0HR3F*<Q7
M,W!B<7$0^?/\>140F-/HMD\9N1V>0?\@GVV$)HY*"PL+"PL+"PL+"PL+"PL+
M"PL+"PL+"PL+B_]+.#$2QUQ2A,7F`3M->2A3I_QO'S9:(*5-CH\ODS%DYEUS
MO#[.$#CIRV:V0K,AF5GS;)R&;8=5)$;>EH-($96;-J<YM,JT%<37F;8-]A;3
MML-^JJ%I361M?3#RY([.W0^SJ8&::`U%:"W54Q#Z2=I!G;2;-E`7?85Z8'4B
M]K"LZ<9Q9_9O0]32/G+@3MQ419MPV[D80P7^OP<*T@D,K`P<H,"%!#&$9DAC
M$@(&$AR@!Z<]$#`X,"@P*'"`C#G#P<,\`QJJP+BP"9P\*9[?YBN'-`=8]:+'
MZJ#TS;#SZI9OO];_31=@X`#%`2B<P28#``.Q[S<*96YD<W1R96%M#65N9&]B
M:@TQ.34@,"!O8FH-/#P@+TX@,R`O06QT97)N871E("]$979I8V521T(@+TQE
M;F=T:"`R-3<U("]&:6QT97(@+T9L871E1&5C;V1E(#X^(`US=')E86T-"DB)
MG)9Y5%-W%L=_;\F>D)6PPV,-6X"P!I`U;&&1'011"$D(`1)"2-@%040%%$5$
MA*J5,M9M=$9/19TNKF.M#M9]ZM(#]3#JZ#BT%M>.G1<X1YU.9Z;3[Q_O]SGW
M=^_OW=^]]YWS`*`GI:JUU3`+`(W6H,]*C,46%11BI`D``PH@`A$`,GFM+BT[
M(0?@DL9+L%K<"?R+GEX'D&F](DS*P##P_XDMU^D-`$`9.`<HE+5RG#MQKJHW
MZ$SV&9QYI94FAE$3Z_$$<;8TL6J>O>=\YCG:Q`J-5H&S*6>=0J,P\6F<5]<9
ME3@CJ3AWU:F5]3A?Q=FERJA1X_S<%*M1RFH!0.DFNT$I+\?9#V>Z/B=+@O,"
M`,ATU3M<^@X;E`T&TZ4DU;I&O5I5;L#<Y1Z8*#14C"4IZZN4!H,P0R:OE.D5
MF*1:HY-I&P&8O_.<.*;:8GB1@T6AP<%"?Q_1.X7ZKYN_4*;>SM.3S+F>0?P+
M;VT_YU<]"H!X%J_-^K>VTBT`C*\$P/+F6YO+^P`P\;X=OOC.??BF>2DW&'1A
MOK[U]?4^:J7<QU30-_J?#K]`[[S/QW3<F_)@<<HRF;'*@)GJ)J^NJC;JL5J=
M3*[$A#\=XE\=^/-Y>&<IRY1ZI1:/R,.G3*U5X>W6*M0&=;464VO_4Q-_9=A/
M-#_7N+ACKP&OV`>P+O(`\K<+`.72`%*T#=^!WO0ME9(',O`UW^'>_-S/"?KW
M4^$^TZ-6K9J+DV3E8'*COFY^S_19`@*@`B;@`2M@#YR!.Q`"?Q`"PD$TB`?)
M(!WD@`*P%,A!.=``/:@'+:`==($>L!YL`L-@.Q@#N\%^<!",@X_!"?!'<!Y\
M":Z!6V`23(.'8`8\!:\@"")!#(@+64$.D"OD!?E#8B@2BH=2H2RH`"J!5)`6
M,D(MT`JH!^J'AJ$=T&[H]]!1Z`1T#KH$?05-00^@[Z"7,`+381YL![O!OK`8
MCH%3X!QX":R":^`FN!->!P_!H_`^^#!\`CX/7X,GX8?P+`(0&L)''!$A(D8D
M2#I2B)0A>J05Z48&D5%D/W(,.8M<02:11\@+E(AR40P5HN%H$IJ+RM$:M!7M
M18?17>AA]#1Z!9U"9]#7!`;!EN!%""-("8L(*D(]H8LP2-A)^(APAG"-,$UX
M2B02^40!,8281"P@5A";B;W$K<0#Q./$2\2[Q%D2B61%\B)%D-)),I*!U$7:
M0MI'^HQTF31->DZFD1W(_N0$<B%92^X@#Y+WD#\E7R;?([^BL"BNE#!*.D5!
M::3T4<8HQR@7*=.45U0V54"-H.90*ZCMU"'J?NH9ZFWJ$QJ-YD0+I672U+3E
MM"':[VB?TZ9H+^@<NB==0B^B&^GKZ!_2C]._HC]A,!ANC&A&(</`6,?8S3C%
M^)KQW(QKYF,F-5.8M9F-F!TVNVSVF$EANC)CF$N93<Q!YB'F1>8C%H7EQI*P
M9*Q6U@CK*.L&:Y;-98O8Z6P-NY>]AWV.?9]#XKAQXCD*3B?G`\XISETNPG7F
M2KAR[@KN&/<,=YI'Y`EX4EX%KX?W6]X$;\:<8QYHGF?>8#YB_HGY)!_AN_&E
M_"I^'_\@_SK_I86=18R%TF*-Q7Z+RQ;/+&TLHRV5EMV6!RRO6;ZTPJSBK2JM
M-EB-6]VQ1JT]K3.MZZVW69^Q?F3#LPFWD=MTVQRTN6D+VWK:9MDVVWY@>\%V
MUL[>+M%.9[?%[I3=(WN^?;1]A?V`_:?V#QRX#I$.:H<!A\\<_HJ98S%8%3:$
MG<9F'&T=DQR-CCL<)QQ?.0F<<ITZG`XXW7&F.HN=RYP'G$\ZS[@XN*2YM+CL
M=;GI2G$5NY:[;G8]Z_K,3>"6[[;*;=SMOL!2(!4T"?8*;KLSW*/<:]Q'W:]Z
M$#W$'I4>6SV^](0]@SS+/4<\+WK!7L%>:J^M7I>\"=ZAWEKO4>\;0KHP1E@G
MW"N<\N'[I/IT^(S[//9U\2WTW>![UO>U7Y!?E=^8WRT11Y0LZA`=$WWG[^DO
M]Q_QOQK`"$@(:`LX$O!MH%>@,G!;X)^#N$%I0:N"3@;](S@D6!^\/_A!B$M(
M2<A[(3?$/'&&N%?\>2@A-#:T+?3CT!=AP6&&L(-A?P\7AE>&[PF_OT"P0+E@
M;,'="*<(6<2.B,E(++(D\OW(R2C'*%G4:-0WT<[1BNB=T?=B/&(J8O;%/([U
MB]7'?A3[3!(F628Y'H?$)<9UQTW$<^)SXX?COTYP2E`E[$V820Q*;$X\GD1(
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MX0%LH'O@^TW%F\X-!@YNWTS=;-P\.93Z3P"D`5O^F+B9))F0F?R::)K5FT*;
MKYP<G(F<]YUDG=*>0)ZNGQV?BY_ZH&F@V*%'H;:B)J*6HP:C=J/FI%:DQZ4X
MI:FF&J:+IOVG;J?@J%*HQ*DWJ:FJ'*J/JP*K=:OIK%RLT*U$K;BN+:ZAKQ:O
MB[``L'6PZK%@L=:R2[+"LSBSKK0EM)RU$[6*M@&V>;;PMVBWX+A9N-&Y2KG"
MNCNZM;LNNZ>\(;R;O16]C[X*OH2^_[]ZO_7`<,#LP6?!X\)?PMO#6,/4Q%'$
MSL5+Q<C&1L;#QT''O\@]R+S).LFYRCC*M\LVR[;,-<RUS37-M<XVSK;/-\^X
MT#G0NM$\T;[2/]+!TT33QM1)U,O53M71UE76V-=<U^#89-CHV6S9\=IVVOO;
M@-P%W(K=$-V6WAS>HM\IWZ_@-N"]X43AS.)3XMOC8^/KY'/D_.6$Y@WFEN<?
MYZGH,NB\Z4;IT.I;ZN7K<.O[[(;M$>V<[BCNM.]`[\SP6/#E\7+Q__*,\QGS
MI_0T],+U4/7>]FWV^_>*^!GXJ/DX^<?Z5_KG^W?\!_R8_2G]NOY+_MS_;?__
M`@P`]X3S^PIE;F1S=')E86T-96YD;V)J#3$@,"!O8FH-/#P@#2]4>7!E("]0
M86=E(`TO4&%R96YT(#$W,"`P(%(@#2]297-O=7)C97,@,B`P(%(@#2]#;VYT
M96YT<R`S(#`@4B`-+TUE9&EA0F]X(%L@,"`P(#8Q,B`W.3(@72`-+T-R;W!"
M;W@@6R`P(#`@-C$R(#<Y,B!=(`TO4F]T871E(#`@#3X^(`UE;F1O8FH-,B`P
M(&]B:@T\/"`-+U!R;V-3970@6R`O4$1&("]497AT(%T@#2]&;VYT(#P\("]4
M5#(@,3@T(#`@4B`O5%0T(#$X-B`P(%(@/CX@#2]%>'1'4W1A=&4@/#P@+T=3
M,2`Q.3$@,"!2(#X^(`TO0V]L;W)3<&%C92`\/"`O0W,V(#$X-R`P(%(@/CX@
M#3X^(`UE;F1O8FH-,R`P(&]B:@T\/"`O3&5N9W1H(#8X,B`O1FEL=&5R("]&
M;&%T941E8V]D92`^/B`-<W1R96%M#0I(B9Q4RV[;,!"\^ROV5JFH&;[TZHV6
MZ)B-3"4BU2)H>@K0`@72BP_]_2XI2TK<.$T*`_**XL[.SBRY\:L+[SDP\-]7
MC`/%'_X)FD,A!"DD^(?517W(X?X0/U(XW/]:75PZ!C\.*PK^/CQ^KQ)(_4\,
MUXRP`GQS7&"4T"-JC'@A28G8M"`9#]BX2IF,,!A1%K%46W?V`QA;DX@B"*-%
M.6*+B'Y:>%T1FHGJR9:`5\[(1=R\-5;9VJ@6P;==OU?>=!8P`K_3$>D9H--:
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M:N5VL&V[+V@'+O]O9[;SVH'OX/5N\F?<7.J=L;!8S@-_,E-Y`GR9J7%%675Y
M_*A31LK$^G=IB85=BB/8&%</SH5S'@X0;FYC=2X)S;-J.81,S',3:R:WSD3M
MEJ9"U\9/4+UV0XNMC9<""E7(ZLE\SNXEB-+A%1"OFV.")+)BKQEG-M.2CZ5(
M0"Q"W`S*>H.2F\\Z<L.%=GH/"K2=&Y`OJ$TW>`CI*L7:(NFOM(?>N*M_>8+W
MSL0C?\1#H-X@%R;7`]Y9RNEQO&\&XV_!Z7KH43?M1N6Q9\;S4?D$-K?Q\C7.
M#;H?/=IN36OB0$UP_5&U*?<%W;1?_1%@`('8B:H*96YD<W1R96%M#65N9&]B
M:@TT(#`@;V)J#3P\(`TO5'EP92`O4&%G92`-+U!A<F5N="`Q-S`@,"!2(`TO
M4F5S;W5R8V5S(#4@,"!2(`TO0V]N=&5N=',@-B`P(%(@#2]-961I84)O>"!;
M(#`@,"`V,3(@-SDR(%T@#2]#<F]P0F]X(%L@,"`P(#8Q,B`W.3(@72`-+U)O
M=&%T92`P(`T^/B`-96YD;V)J#34@,"!O8FH-/#P@#2]0<F]C4V5T(%L@+U!$
M1B`O5&5X="!=(`TO1F]N="`\/"`O5%0R(#$X-"`P(%(@+U14-"`Q.#8@,"!2
M(#X^(`TO17AT1U-T871E(#P\("]'4S$@,3DQ(#`@4B`^/B`-+T-O;&]R4W!A
M8V4@/#P@+T-S-B`Q.#<@,"!2(#X^(`T^/B`-96YD;V)J#38@,"!O8FH-/#P@
M+TQE;F=T:"`S-3`T("]&:6QT97(@+T9L871E1&5C;V1E(#X^(`US=')E86T-
M"DB)K%?)<MM($KWK*^K0$0-&D'#MB_LD2^H>3=CRQ)`^M><`D6B+$S2I(2DO
M\_7SL@H+"0&2:'<H0BJA@*KW<GF9^69V]FHVTTRPV9]G@N=<,HZ?M%)<Y_CM
M<^G9[//9JXN=9?-=?(&SW7Q]]NKWJ6"?=F><S>;TZ^M9QD:S_YSQW&KKV`2G
M<,MFEV>9HL>X2::;)E+FRBO);,A-\)[>H9>YCR?1RM%Q?V37LZMW3.1L-#'6
MYR&[>']S>74SO;ID6$W?O[V^/)_AG]^N;\YO+J[/W[+I#`_>7=W,INQC]N'F
M_,,ECKC\.&*C?\_^<4#6Y<%'(G&AA`)5)TT>-''M,FJA=XTDE2+[.*%S+>.G
M0"]DPT/%0\[?`NZ87=]<Y.S\YI)-/[R97E]>G__K^FH:+YBH7!FEV$3DPBG7
M&,0V!X5XT,5FO2C7NW+!L-IM5LM%L<<_;PHZ1$@@TH!&)E\5ZWG)IG=EN=^1
M*=;%PV*)=\D4=*'+I3;FZ,+Z+F&2\3]FRS7[O%RMEIO11&7KW9B5WV@U+^_W
M;'=7T'I;LD5<[./OCZ..H6%9P85/J`Y,.I$A%][80P32Y\9913@RUC$\[$QV
MY0W2QC/51=CWH;XG]U*$WG-,KJ323YP3HG<#,TI2:%@'G"DH\N#H@S_H3&ES
MEZ6@ZH:$M[EF%J$MXV=/D@)0H75,%0J:R\;^>/E=L9W?(33''8`&`>?`H/UD
MD*S,-;UT?/RCH+HLY^7GVW)+=SUM"Y`2\M`6/$7*2PQB?*Z!YEF3R*@:QY#3
MJY(+WK&%SGDP_D6VT+D2KFOJ^F!8HGNPT*#8OMR&2F,4K?)@(S$E$S&81:M^
M7OU&T2[GNI$-$;\\W^V0L\=P9&X=-+$;M3"Z,,8=\3?"-U$Z,=P)R";<$^*?
MB:5?>,7DMO)6E\X!I`Z9J]F9<CJ'7EMC<R210U200;5GV_(,1H,IC&QV8</#
MW3>S`2,H3<&%&V/%X*8.3YF"Z^(!PI*;;+LMUVFU'T521334:Q"2DKQ`\3?Q
MAN<JD@RH,C(^D@"1]FS:LUR9:(\^`P".M\<&J'0K6J'+(<"RS$J0]7401.CS
MEDYD,4(`9L5(`N;NCA7K!9L76)3_?5AB2V=?BE7\6\97UOOXSPY@A4.^8_T+
MR`<AP$GA8386,M"N%E":[!<LE7/(L4R-J7SV4@-*;KNA^CPY:+CR#371<K.)
MV_1NLR6\)F/I#W'PV?;S2)"[V#(^7'\I=VF[>I[>6J=GB6FPL&/TGA$F,RBI
M>-HX4D<=RK0+_?2HBI_L.2YSTY`3C316;IMMBT6)^)V7RR_%[:I$#5R7^VAL
MD6)).*!.\:6=Y:`BQAIU[1!XY1DQ5MKV0P<*?2IT$T3N6K]H^@@W.B"JNB>8
M/)K79YOM,OXM1ZC',#8;(:RX@@I8*,=(\IJ$\"0.+K.R'RE=:D]&ZGF5XM'(
MOHT@E9!>EG^6R.]%#!69(<\ISN>;&"DR1DH57#+FD,F^I?2/3W;0@YC\PFKT
M<&T`"129G@`25O9S`\R34]\X?I3ZJ?PD=CJQ>[^/R7^'$CM_(!E+_S<,5&3@
MLX35F11-D8&4MH^!%*J?`<"<EN%1@@W4,W0J<ZKJ*"\\%1!KC8Q%0\J$H1\`
MZ;!_IGQ0+X]>?Z!\U+O/EP^!X`!X[?.GK#_;[!OMM=DJF?Y9/WATK6E99;6%
MX/J^K#9CKP:\H5T3]B_WA7*Y^FM\@9/:R.QXH_]N-!3F":%_NUE_^DF)#\J:
MN@@+GUE]9%*3"K,;L"?@J9/M*2!G#:>#PER)Y#^WF_LREB^;?1^AN<[&(TYR
M<K^*SXIUVHLENZK6-KN/!&U65KO5-^NR>ID*LU,4-X=U008Q4!<0K+V,`=Z<
MS)CKE,T#"7&]/DR(]:=E_.\V94;Y*!O&%:OH-,DE#XE@*M%2]^H31LM>/H#6
ME8=G^>B@#Q(\SAUH9%RH&\3?-YO%5XRI5-0J^72<4W)X2`G!`FKC*(<A/GVP
M=%"G)ZKV*B7J@)F;9%$Q#6R5+##CXK#:J53M1%WMZK?9H9.^]6J4J@4A^4+U
M5SM%0=='&OC%R:0AVN9EI:X'L437)`^B1^C^^JS[ZS-=?G+^:XM60OXE@DI'
M]:MI6]LT*O#@9%1MOK2R:<#3<GBF2)5-5U-%&A\:L^MH]A@=$HTU/YH@0IP@
M8A?1,T'XL?7]W1\A4L,.>&;<U2A((<V6[0Q[,.3ZW$OXIYEF,8E*HQM_&2K)
MU.<%+P<<U%[PA(?0+Z"K@AT0M`=N:+:I_C[>15<<9/-QKOMWX[>/-O'4UI_:
MZ-.^;?KVT6X=.0UHT;M;83[>M%#J0<C-;A]DC>F&MY!%CH&F;SM"[NXBGI\+
M!(G.)/JI$8]YHRA1.Y<%HA&A>)NT<;E:[I?ECE5/48FG=]5Z6]YMTFHUDMFB
MW.[^QJY0IO??8X2TX8522I,CI\CB!Y$;E0.ZBWK],Z'74'I9JZ6%K2:^:`(A
M:Q/(JB^Y>(`>(B^I3TVK_8A2EZV6Q6UZ4%GE=4QQZ46:&QR7*N5]*ZR6:S&H
M:D"B](E3C^:F&0/[I.E\/M\\K"L=8O<%.JM*IFZ33I6QF;">9!>ZI*'`V%0\
M'"M27</D0`T##',J=H5^PK?830->).S3NTWL!T.JP0$%F8;05+[Q\':SW6Z^
M+N/6^M,N30O&I!$TUC5K75]=L^@Y^U@0('<R"Z\I!^M27(=/[8"+-.`P@):Q
M1%#\[A^V*8\V?[)5;$_*;?4"FI+;/8&6J5FM&W33:=!1P5'1)Y-^(F@INOK[
M/!&G2&0J(IC\:B:N;BFHFZ@&MAC]M1H`F//!5\C(\$$.--A<#Y@>EW?3]MF6
M0D'R4KOXTRT%'57'XF#%(IL+.]14U+LO[2J4$4W?ET:[RMZAZ2J*U9"]K9.Z
M,]0$,V#SX/J'``+`[:DV5R$--3]O<IS4G4$>FUR''*$X9/)J]WF3)^PR'`PP
MW4Q]VY.(<>:B+)T_F<:4KA)U/*6K,JI*S<.$Y0JM26;Z^SD%:YX\^"CAV\'G
M<;X>\9&'T\XZCCCTL`0/@-X7W[H!AEY5)26-\N-4+YO0SP;`3IYH%'?M1#.D
M/JL.IZX*A334".>"354XRI&3O?.-'9C(",K)\XW$C2Z&515?)J7&!8J6SS:H
MP52TEO'W^E.YGJ<E#9D2I9G*L#004?\CO0-=;OISJ1\L]<F'8&W;.335MZ"6
M#EU":N9&\&G&2G1T>()ZG'U'X;79ZU$TL^28(5.\G(P=6)SGXN7V%EP3!V<.
MLMFU!&15>8%L0VVKRF+'(.H_FS7;$;G=&`W1EGTIJ!,2V4-ZMV3TX=]'.,ME
MOZ$3E9S=(_3B)V-D*A^C(QU+SHFVIKKU0ZPA6J=D/`2&.%O=IGR/TQ(O5CR0
M@]`^D:_^5RY^)2<IKL?"Z[%#@:G>H^W=[@&:4*"51[)(I9*(G4P'P,1I3DR$
MH)5FN'U5'-96$FV#J3%O'JIN-OT!\&5<0!B*](B]BRUA:G.W\SOHT9@A0/FO
M:9L$0&!"_;%H)7'_$:):'LM#:,GJFJP>PZEC&?B!@Q"2K8MD"/\OO6IZVX9A
MZ%_)H8<4\`Q+EO6!77O=9>NQ%R_Q@`"%'33N@/[[/9*R;"<*FJR7Q#(MF]0C
M'Q\+M-G"X;/Q$5(`E17>NSL8.'5.&S>$4JLU>42F`S*GD?!@*#9/W:YCG@[;
MWZ@?`4'F"J6KR-3<7(S.-1>ZF_,97[\B&Z[PA(;.6KBKZ_GD?9R2]IQ$CG@-
MOW(]]$P,R))C*W?V0@K?9-5O=NUQN:U]K+=Q!RDT$]Q*GS5VW822/FOJO#[3
M&A'^#S%B,9.$GZ.MTTSXSE2HA?,T>ZVY8!J.17-;:K;[S2!+5OY#W'243>@.
M77\ZL/VOW.HVLNQEF7;(VQ!S(&4XSV<JWY<U/,T>"`*[DV3X0!3FFYED%BP3
MM<7/1]+2Y&3@\"T?1>`\L!1,A:Z,"NS:MS[>DW$S-+Z2AAU1;@I\,8>R`<KY
MH,BY.PE%@O(^JS>>W[KV]/[VP3&E1M>*_`"()[GZ+NL:8X,NK#43G4P/_A!V
M976RY-`O-3WR^4:9(E0#(;>FFDO6)%HTA;$-B-'-44ST0U+\C'Z<@;X3IA'%
M^+*MK7UYI#`:R",!5`7')E-Y,N6B@7/G3/2I3%067*TEHB^/4/2RYI,)2D$F
M71V@HO'6D17^E5XOJ/2B83\/8TH<Q[QB8A*RE"QG,=E,8K)D.5F2H&2.P$=B
MQ%-56<!K<U75%*'*<R=YZNXH*0G/H&9,Q`:1>E&5C`U2M['()2!2H^SQKX*O
M/=_)?1^O0@/[!!IH":>O8A.M-X,#[>;,#$YETPP5$CCMZVIFHN*9T!%@W*3R
MQP\Z\4IJ_0%''A1E9$#]X^0+K9BZ429`Y&&&Q!?6YV=<\L_J>XA."@;M6X:Q
MBW)Q3C/)H4A2N3C7<,[1E>(L6_M"J>7YI=I&3V:0M>7F1!L6*$%P@+24*D$Y
M"R"2N4)8&3.-6#KM+DW>*ILOK!A`[;07-8!4RIEY\X5YRI_DM\I:)[?75AOX
M=M[K9,UZ;1S.8/8:OS9K%J_/S9F\%OQQ/?4,:=DQJ:-V^]5UFW;'4D,C4X^4
MGS6ZP@?)T'X8D>7C@+[7[Z%6T,1W#*^R984RQJ>>GR@'=ZF'TCN'_C2\'O;M
MB.?_'/JVWQU0.!"W([44Q+WM^O%4YE,+_AJ;TMRE),]DV#]=VS.A"F5N9'-T
M<F5A;0UE;F1O8FH--R`P(&]B:@T\/"`-+U1Y<&4@+U!A9V4@#2]087)E;G0@
M,3<P(#`@4B`-+U)E<V]U<F-E<R`X(#`@4B`-+T-O;G1E;G1S(#D@,"!2(`TO
M365D:6%";W@@6R`P(#`@-C$R(#<Y,B!=(`TO0W)O<$)O>"!;(#`@,"`V,3(@
M-SDR(%T@#2]2;W1A=&4@,"`-/CX@#65N9&]B:@TX(#`@;V)J#3P\(`TO4')O
M8U-E="!;("]01$8@+U1E>'0@72`-+T9O;G0@/#P@+U14,B`Q.#0@,"!2("]4
M5#0@,3@V(#`@4B`^/B`-+T5X=$=3=&%T92`\/"`O1U,Q(#$Y,2`P(%(@/CX@
M#2]#;VQO<E-P86-E(#P\("]#<S8@,3@W(#`@4B`^/B`-/CX@#65N9&]B:@TY
M(#`@;V)J#3P\("],96YG=&@@,3DT-R`O1FEL=&5R("]&;&%T941E8V]D92`^
M/B`-<W1R96%M#0I(B;172W/;-A"^ZU?@T`/4D1#B#?06.YF..VTR4ZNGJ`=6
MHF5V;-(C,NGCUW<7#U*6R([;)),)!6,![&+W^W875YO%J\U&$4XV=PM>L$*0
M`O[%D2P4@Z]CPI'-X^+5=6?(K@L+"M+MFL6K[V\Y.72+@FQV^/EC0<ER\_NB
M8$892]9P2F'(YLV"*IP&32)J6EMFA3+$>*:]<[@$UW(1#H)1(<-IKW^\?O]N
M16[>73/R^MT;<OO+U>W-FYO7/]^\O0V:UIIQY4$59]Q*DP\J_'"0"0==M\V^
M:KIJ3V#4M0_UONSAC]L>?AZKIN](>T?>EL>F;@X=V=)?FO+COH8EVV708YBV
MRB4U-JC)&KA&#1_HEM8->:P?'NIVN9:TZ5:D^A-'N^JI)]U]B>-C1?9AT(?O
M=KG\=?/#:0@DXP5WX-^H(GMT+3SC3IM@@=;!@N3K,.6M&:=&/PO+C'`Q$NC<
MY!T[>,<%%9O[8U61Q[;I[SM2@:?VY*?RN+LGDJ_RB:.!7AE.Q@//8K]6?/"5
M4%I/FN69,T*>F27Q)"H*7ISIE,QY)\Y4GI\)=G$C9HX$/+SXR+>;A=26.46,
M,TP(`IX/Y\*=CM4"7$!JLI#&,&_R$E@/X#M9HX1B4F2Q=4R>2J\V%UR#A:#0
M2*85<BV:(B6SIM`1#99IHU2T\]Q0"PO5A:'9QBB]M%$:!@!(8E@+JE]BI.;)
MR(!^AQ8)H*'`223";?FPA,1!JZ5@FG;D&T"ZQE1"^1)!05=6P,C"B"R%=)!@
M)+U<I+S,BY`CSW".F@5'S>N1Y!_H->A5%.A7,$^['O[2%(E]:-M]1X#V868?
MY>#$M8`X:9B27BS7!B?AIU`61E*K/#6HSW@^Q_R+XR3A/F8V3E$Z&Z<H?GF<
MN&:%*7B.E`ADD$RJ(F4L\OVQ[3JRE!(X*^G3L;VKP4.6]N$+ON!>.4WY2@J/
MSDAS6C`.DUP.DY<!^D\>6F?Q68BY&4/,$[@J""+%_V`J;0XK<JB:ZHB0HZ1L
M]J3</RZYC%+\(`SHL>S3CD^(+D4KO(@K-&0-JC#X%B;'X"L[3.'5-M^>8'T]
MUJ</]&?P%,](KT+.1"/VU:<JDJ!]0G.0#4T?)A!U7$!L#.7&9X1GQ5R94]`G
MQ1-0?QV.U;0]1IC7X?MW>?I7VR#XX[B)H(_B$NQUX+PH^BW2HNJ":4I)C"X?
M^."%B"9JYPH8V5-:9,]<!NH]>OR^.I+VJ1K=WQR@*#YA)0[:A./(6#7ZWV'&
MI.OU!;(^EWL:4&O='/>2=(Y[2?QB[FE9,.T&YHG1.S91#])=9-W[Y![`0QV^
MX*(TP)`YNFM#J$U`64I;A=<.HF2T1#^Y$P!IKO+4UR*EQD4AP,@>#'$=1@U2
M2T=[T5*T%X"SI2GBV^5W81U>0!J>[+;:B`LXJ:%!X8._N%8*%OZ(*>ON&)7`
M"7?ML:H/#=E]/!ZK9O=7*`$K=!VGI*GZ0'1HF0!-6QI8;2@V=1G.6\J+/)L*
MPZDI1>`\5CR=F$=NFKXZ5AV<G$RJFW1GK'GH@G!#99%(;KEVB3[`W<`K=TYO
MS@<=<DY'\F$D#<Q`[TA#??3Q-BJ6T2W5X^2I"I]5J)S\D:"P`^*W&K2`O\(D
MJ@$D>7":"-[AX0:Z\)&K_$LR$SP+[=$,,:-PCI=1^F):*@G9>NA<[,A*<<[*
M\!0(N1W?`[]5B#*2)A#F,M,R)G_(77T0EN&//R&[(>Z@]\9B8VQ(ZO*<IG'J
M:]'4C]=+C=E-DXR6P6@3C9;!:!.,AK`;XS'Y\$(.<3<0>+#9B"\?^@)^+COL
M'/LHG0U^%+\X^M)!T15#4AZZ(9>"_RZ`'\M0`D&50*`""#`#0>(%WT"OJ@0D
M8$VU12]A&QM;B5&BM(B2P5=22_DYOH)&F0E''#//;CM(!3XX+J3@'1BGO0#&
M:6G8>RD%I(J\5Z,+IZ1A[[DTA6BPV4X*D\G/A9"([*S%@W328J7"<VO&XD$Z
M:?$L:@R,34#-^$;\GY0<JEK*P5=E5^](@!DB##H!DBJ)HND'>KCNOCR&?E5:
M<)P.((.ZA`\E0>'5"Q4EU$?AL(EZ+M5)^N50".\E.X&S+(7PF%D4QKUS*(Q[
MYU`8]\ZA,.Z=0V&V>1*%V>1)%$Y;/$@G+<XXF[9XD$Y:/(M":,+UOU2N-[$V
M/83OQUBA^N%MHNB>5,\JV@`UK&#IYQ1J(C[R(IBP3O%X)G-^*&7/`'>Z!D%W
M5ML^&W8"^KD)8"4I]VP^]\6M<Z@+6^=`%[?.@2YLG<-<-G@2<\G>2<A-FYNE
MD^9F3$V;FZ63YLX!3G@HP:H8NR4W8BXUJ5=#QZ-I5X?'[8[\4<71X3X^=ZL]
M*3_!"^=09;P)FGXRWD)I%<IZ*KQ?>5>LG`T($K$/%?C<%-ZMM.,K$P$HOE[C
M=/)8TR?D4H%<*I"+QD8!J66!6O'.*MU93=Q9T?3S[,X\MEJRD"MMX.;>Q98A
MWUD6Q0J>6RLN]=A+8$/_1>Y9^*$<I9?-;561<I<JD*1/8`@&N/D+JA-IVAZL
M[ENX4K/'I\@>1UVPB4,>\#SJ']+2;LA5>';[4._+'C;=U4W9[.KR@70]3(`N
MCC!I^H[A,R9V7N?O0D@$_PP`BAA-U`IE;F1S=')E86T-96YD;V)J#3$P(#`@
M;V)J#3P\(`TO5'EP92`O4&%G92`-+U!A<F5N="`Q-S`@,"!2(`TO4F5S;W5R
M8V5S(#$Q(#`@4B`-+T-O;G1E;G1S(#$R(#`@4B`-+TUE9&EA0F]X(%L@,"`P
M(#8Q,B`W.3(@72`-+T-R;W!";W@@6R`P(#`@-C$R(#<Y,B!=(`TO4F]T871E
M(#`@#3X^(`UE;F1O8FH-,3$@,"!O8FH-/#P@#2]0<F]C4V5T(%L@+U!$1B`O
M5&5X="!=(`TO1F]N="`\/"`O5%0R(#$X-"`P(%(@+U14-"`Q.#8@,"!2(#X^
M(`TO17AT1U-T871E(#P\("]'4S$@,3DQ(#`@4B`^/B`-+T-O;&]R4W!A8V4@
M/#P@+T-S-B`Q.#<@,"!2(#X^(`T^/B`-96YD;V)J#3$R(#`@;V)J#3P\("],
M96YG=&@@,C@X,"`O1FEL=&5R("]&;&%T941E8V]D92`^/B`-<W1R96%M#0I(
MB;Q7RW+;1A;=ZRMZD04X)<+H=R,[6\Y,>2JQIR)Z9<T"`ILT,S3(`2C%SM?/
M?31`D!1E.N-*J4H`NINW;Y_[.*=?S:Y>S&9&2#%;7,DB+Y0HX(_?=&%R^!]R
M%<3LT]6+F\Z)NJ,%A>CJYNK%/VZE6'97A9C5^._WJTQ,9K]=%;DSSHLI6"F<
MF+V^RBP.PTZ*=YKZW"OCA"MS;XW%);A6*C($;X4F:R]_OGGW]EJ\>7N3BY=O
M7XO;]Z]NW[Q^\_+7-S_=TDY3FSMG8"O9VRC*P88C&S>;9AZ;+LX%O'6;]6I>
M[>#C=@>/3['9=6*S$#=5]U'\?;WYO1-WV?NF>IBO8-'=A#:1,B^\+-,FT\-=
ME,%=/F1WV:H1GU;K]6HSF>J\S)KN;C+Y]^R?(X!M+K7W`![Z>H29S\M`P-)+
M<+D1'L*@#4+/2X[C4Q9Y*7P!B]1^T1YD#=,J2`H#(IOP\0,^@7:??6QC%)\V
MS>YC)R)@-1>_5&W]46AYW5OL$P3R`>(E1@9#\'YT$L%1,397A7:`&)^X/^^)
MBSJ7IO1'+FI:J@I9'.T/L&HC1]L_9=/DLI3NC$F(VXE)Q.B)$_6'^6EVI4N5
M%P:R%4H!=K$R-P8W,$&T\6IQ]6KV=&R<+\$\QF;DJ?9Y$71(63!L]P%FI["#
MRB7MC)DSVAH2(B@(-OQVO+/Q.K>JGX9R*MUECD%@T*]I7R@IF24G,Y8#9K'+
MQ):?[62J(*DW_/7(C]5$YB&;\T><%.!Z^A#W_/PR4;G)H*8>^!O*,"U8-?P"
M-9:,;L=VVFK7KUBF7U3U;M5OO%O%[D<`3/I0!-QA,O7!A5SC6P`TU/@%L92Y
M+YT9-0H\:[T'`(_]-NXF)K>9B%7;K.BU679@2&D+<0C9#Y.IT4:!4>LU;F^5
M'`T:JR86XT<[SO[&3<WO]U&\S\OY;P\=;B6S3Q,)-0"'1IP:'NL$/P$7B2=J
M8[UIZA6-K>D_+Q=-Y(6#OY+\/?QUC:UMVVX>>0'6]Z+=I'WQ#$4PAH$;($SN
MD]/2]MFAV7LPC,AL^1$GL"KT\<*1)3_Z>.'[$"_EI;*Y/]GL)#HRX*X*:L79
M%)W7<0M(X"E45NWHP1^;1E@I)M`P2@_)80R,AL,@*+4/@D]!(`A<MFG1EB-;
M+ONC&G^!92`'?F_XH#Q=3;`:FB5/W:_I$2E5I(2J=YF4>$;M,08>LD(=987;
M.Y2*[O9CU<;I?854M:V^D$GT,8N8%UD'Q68S2D;EH.HS@`@Z!J.H-"T_W,(,
MG3[M,*L^B_O8Q,5JHNDH^!_M:BS1-C[&MJO6/`IUR6F">2^ZD6]U/[K%#(-C
M-UW%IM@L@(99I0L+.:H0A4);0.LN4^"DP8K_"A*OXR*V+6P%\"+NT&\SVE53
MYH.W"$A%KY\9=<VH*[G'Q+LC3-CXSYL.27Y9H;<00VQ`C>!SEV0?0@51K[HN
M[F@,$:(6HPJG`F3O728MGF+JK,8\T([;QD'=%(.8D2GCWE-#4P!TM5[]P9T0
M]JJV_)(>U&FAKNH5E-2&Q](/Q='GKJV2D54:6J:9+M8/R1S5'D;$&(,E?Y<9
MGN$3<,T,@\5Q=,I]=)+2>8<EH+./L;U.'8B:APH>%(?EB'/>8U*6Q["<DDVB
MFNJPWS,/=`-17$P3&+=.]-9ZOEFOJL1)JS5!`LZ/+>UZ^PMF.A$7BUB#(:@"
MGH#\*X[[RFF-W3]T7`9-J@[(MJK^[P,/=N/*Z\OE1WHBA`;$"'?EH^ZH@>C'
MW7'8U:;*ADR(2!1Q]5C=K[DF%+14"KC4)07;NM)0L*%''<69V5"YW$*6L,TW
MS2-U'HCIIF4VQ.J`0T#YD$'0>,:#EY`]FH@/%"\$^;C5G1+@.Z8H2*%49D1[
M$TGE.E76A<!^VL,DI4+S:9M1:4,WK^O-P\"?W#X]M0C#[1E(D_I$*='!N\R/
M"UB6M/S`[6+@/=D[C?[6#]"9FAWE4\HDZ@Q>)I>E._19J2.H1XU!CRVO-\U2
M[&(+>2;[C!WO8.$F!J[:?7V5;!?TGBDEBNW"^/()74[:$OJQ=52.YV6F\=#>
MS%F9F:8OD9G20N<4Q@'8I'\/*A]O3TEOL3Q)3`,UOHU4TDM6#T/OLB;83`=B
M/.TLG-V@E']:ZDWA-7AS`,C1;>M/B7!C2?^?18>G+Q;A1@-CA;T*#T-CU(<J
M/"05'I`;-$L[_'KDQXKJ9LX?),=D_\4R/)`,5X,,#[T,#[T,#T@&_>OC@:5N
MUX\OTT\&'1[&.KQ4BB/QK3K\"8;YUP/</T%K=,C#(%TA*9AFOA"A7$/#!C[>
MKFFL:A(%5<U<1&RT^+4E=9>T$[LC@;R1R.\R5QZ6J%5DE]L*,;VU!9?*V/6^
MGP5.E9<U;Z:PJ^/C2)."[T0&AAE;P@/(H.=,%AF4_=5@"#4/W2H@-2SUO]2F
M&-/I%+JL/0MM[Y\=%?X!E$GQH"\V8VU346:@D,6O^R2"GA0_DF4GMCC-7OFB
MX)Y'Y,`4\QQPIT1PY![=8![CLW<C;.*%]YBSF75'Q*9,SQ!?\:7P0S,*R95V
M4\<X[P;9"RT`5&'L*+'22$5H[!Z2JD*GR=\T'6FZV5'/TMBSK"I&/8L^GHU=
MR6Z%8,.IVIKP+\:B"VJI@/.2[`4-#+M3DKBA?4'(0%1\#W+0`#IX=:[]I>G+
MR4';$LWV['!,MT?D(-$[!OL)>NA34X=4,(4JD2SI/O"7DH2V>&<]CQ)/7TP2
M&DC?JCU)G*KG1!(ND83C"T29)=7ZF$0O9&;HQ3`KWEX9)UG\A<JLYPC7<X3+
M!@6.5\+^O2(3Z:.FCQ,AWO.$&_-$*`+WDV_FB6/-BPFR/2Y:@W?53;M+0HH&
MYO%^1PI*>;R2^I&*@%;VE8I4:M^TTCWNUT$+EQDJ30N_H5[E$MTXZNUK>B-1
M1V_\@S:M)*_2!16DNK,*RG@Z16`*;9&-H*W:_IKVC6VUIR;)U"0S;I[\SM3$
M(RT+Z5AU#RU+9H"O:M/]014E==7RL-V;"UML.43,G6FQ$/[X.;;UJHOH4[?;
MU/\!#0CWWH;J.C`49J1Y[;>PWZSZ+.YC$Q=,;P>,UOM0IB-/[X&'YNGJ8+,T
MAP'%'XFJ;:MF&?MAILUD$%V%2PO=)/3>5:;%<_X^UY@O[LD*#)KS@CU-7]Z3
ME?-Y2;5VN6:'GE`U]1G-+I4?5YOYJ]LQ%%9>GM?L:?KB=JSPOAOV^'"V?<A^
M6BQBG3(%$CE^!E4#V2+@,L.*BO(%!$.3)!]("GHAP8HK'JOU:.4XLXQQ$LX&
MLO6P#/575%=Q`N;_@Z.!UGD>1IJ]'$7E\N`&#,V08WOJG_#MA!XD6(%E6FA3
M\7#L:31#0C,0FI+1#(QF\!9AD]#7A[QT!DO5G"W5HJ>A/Y^1TW[MGM">8)8;
M"FE%1'%R+N0*/->>2Q+9P)WB/BYY0=.DYY+N3K'ESPW?*QP$(63Z&C=$U4R?
MZMJ8DJCFN?-_Y[(L3!Z>R2>>OCBA)#BK^WP:P6KWL&J"U3\%JTFP&H+5,ZP&
M88VP<@^C23`:."_@]@.T:!OP(J)A,+N6JF0M*D^FBK*8G&<"@E=:Z[\;O#+\
MK_4R2F$8!(+H57*!AD:M:<[1$X3$CT+00OSI[3OKJB31TE+Z%QR6#.HZ;S%-
MZ@;0K';[EV6)[2I4=<;FYUH*CHH8*@M-M4/^*PBWNU9EJBU5/O*-Y:J:'.]$
MU`SBK>.D5BW3C=%;RZ(J)\OBJVNH`4;A&O[TVE;>B)*A;L8@9Z?$3P^"?<RE
M]DD!;)U']GK73,[.QA+/X&MU3-2(=AQ#,,+M(?/(%8?-Y3Z/'D4QTL<%2(:%
M,'YUQ$)K2WBC=2#%CPQ_BK_\R^MYD>@O:A39]X=$XP;2O,Y+Z(47!)/:-`IE
M;F1S=')E86T-96YD;V)J#3$S(#`@;V)J#3P\(`TO5'EP92`O4&%G92`-+U!A
M<F5N="`Q-S`@,"!2(`TO4F5S;W5R8V5S(#$T(#`@4B`-+T-O;G1E;G1S(#$U
M(#`@4B`-+TUE9&EA0F]X(%L@,"`P(#8Q,B`W.3(@72`-+T-R;W!";W@@6R`P
M(#`@-C$R(#<Y,B!=(`TO4F]T871E(#`@#3X^(`UE;F1O8FH-,30@,"!O8FH-
M/#P@#2]0<F]C4V5T(%L@+U!$1B`O5&5X="!=(`TO1F]N="`\/"`O5%0R(#$X
M-"`P(%(@+U14-"`Q.#8@,"!2("]45#@@,34Q(#`@4B`^/B`-+T5X=$=3=&%T
M92`\/"`O1U,Q(#$Y,2`P(%(@/CX@#2]#;VQO<E-P86-E(#P\("]#<S8@,3@W
M(#`@4B`^/B`-/CX@#65N9&]B:@TQ-2`P(&]B:@T\/"`O3&5N9W1H(#0R-S8@
M+T9I;'1E<B`O1FQA=&5$96-O9&4@/CX@#7-T<F5A;0T*2(FL5\ERVT@2O>LK
M*GSIX@0)HPHKC[)D.^R8T72TZ)/4!P@`17A@@(-%LCZY_V)RPT;*'A\Z&$'4
MFI65^?)EUKO=Q=O=SBJC=OL+XSJN52[\N&5MZ+BQBOS0\=7NV\7;JS94:4LK
M7-6FU<7;C[=&/;87L-PU5NU2:KF>VCU?Z,M_7OW[9JT^W5PYZO+F6MU^>7?[
MZ?K3Y1^?WM^JU>[KQ29T`AMNU<8X)O(BM;MF008%Z9NZRUO5U>JJKK*\:O,,
M6VU=%EG200<E&-\)MC8&;62O&XY*;$F)#T655&F1E.JV@VW?\JIKU;W^4B5]
M5H"8^Q6KLG4B$X>GJKAF$&=\%'>G[W51J6]%61;U:F.=K:[:M<J_<SO-CYUJ
M#PGWFEQ)J\K4,6\6,YDT._FB'G_N/J,W?/;&QGA.9'W6*0A8)U*'+D9J6^OX
M06#4)HP<$T:TAF=<)_3#2&U0]Y"&0QR>G+VQGF-<$ZLP<+9Q/-S81F3\>VWN
M5[(A%G2P9=Q1#SYHD@A'VI_ZX@>./'>1R!5#F*UCC!?/3F8+=*?'VRCP>95N
MER)<QXNW5N;8X=8X0>3'9-V%Y8P3;4-_/D[^#_#@.WU9KCST=%T!LJO4`2R]
MF<;>W*_6*E&WSP6-M*U*Z^98-TE'?1[%K3*_,HZO8<.WE4$0)"OK6/VU;@@*
MJ*$UDSTIOLBA;L!@+%8^[._H_V45:%4_5V#0MG]H>2I;;8RL0MF1;GC97MWD
M+>\KZ?\OFE6WSJ6CU'7?\)[J47WNRTF\==UXS3A%^'@F.K/3J=/O-)Y4_J7`
MWYE*CL>F_E[@=4$AXWBZR\L78!BR@*:PJD`].L(`,$-_9H`Q&(?[JP*"^;($
MPX.=R8:^E@\,0;@US"`W]5/2=`6L_0C7N^S4=9[FLO`!`M,S:[S;=JU$6;[B
MH,#)%<_]P&8W0;AVHW!M0X_5\5@=;Z$.V/Z230IJ@S:?*O4YJ?J$/<..AQW^
M=G[Q:#K2\I'6->Y:+@;2V,N&$!5J(*2\264$-.-6-U^1)B5U^5_5Q[D4T'9?
M-P-&AD6($5__MHH!HR)EA`+I.[/39LH#=T!W9`5+&`SH#*LK@"9\I//(1K%Z
M]"6NE\]DO`29M*F/-=Z*P@;G<Q+;/((GV;ID1)]HS9VT$<OA"<]SBQQ0$T^3
M<!ZO>(2G:YG^@:TAWEN5R4C:MY.]18JJ:MZ5*]!V,!EK-T?6";7_@(9.0V!W
MR(E,?#S.ZHZ:.6@&L<[C@G.PZL"^*;$O3?*2#+<FLC=3>Q&(K$RMA.3Q#M7R
MNF&YB(>\2OV6C6^=,+;A#,'>J+BX05P%.8X\PL;'7D?_:%RKA<IP`*D,/MP!
M(/'U(IUC.D]KEL3_><HR>,$3;\QY[@5<X>GU"B`!XGG=059,OO&C[1FQ;<<;
MA'R#-U?,.9X^)M4+4+\"C*I^J"R0:62^[K'J&$C-BR([L\Q)V72GCX!T,"<B
M?,94X8*IZ*B'9!`9NOX\\<:CR(@`A4X'&W>`%5%.,#`KI3:>"Y"T9]<>'6?$
M<?LQ7;>4KE>&C(<W!'K/DZ:`:(8B2>(02C3?B\S/H`"Z_+:*G%AC@`,5EJK)
M(6EVJ/.'NJ'K1YA]-A\`FR4H_,RBH2X-C?E)Q5%T![KU%^?64;=Y"HFM*X1'
MWG]/#TGUF(^WCU^Y_KFR5P"9D$DATJ*:?!AOK0"6V'T(SXC98$!W/N%WN-TK
MX3E(%.@GLE<"-!H#E..!=W!X3HM%/(?G&%9X?Z0E":!E&#0Y]VN5U>.JY2U2
M/JS/`%#SR&.,[_[Q:L3HK&C3LFY[9/(F_V]?-'"7AQ>5I"E$")$>1$OLS:+C
M%'ZZ0W0=`6-I<2Q!SF->Y4U2EB0%RF]D7T8ZR0L="U7ACT/C#EX"%`]4>G)V
M)I-!5FF*-,'RCL#S\?+R]S=#D;ZQL1,:-SY#RW;*T_)>0$NWAYJJ*$_#=7.X
M>L(IPF-S&G+^U[Y*.QKDJ2%+<1KRV#L&*6O6XWB>K<)4&.H10Y.X;*@LMB:T
M/RFI_JXL`&3",..!`V:87-#D#Y@;QAEQ4"7-4UG*)P'&LJG.(.W_O]67UKUD
M0Q#-Q*B=T`R-"M=P>R0<#WM(.)*P7\G&)_E:0'].&/^BN@8CM$H>QWC$KD06
M8.XD#[W&,4<A@8HSF#I`V2%3*!LC456]C#QP*92/V=B-P$KN\C'CLG[SI\GP
M#N$Q(<JD;7N9("4"O7S-8##S"XC?+_-9"%;NUKQ3>@?NY8/Q%QM`\='?<1A[
MYW7E2"QVB#(HNS#_@,=12,8?51;)`S>+<B#^Y8KNP(U<R4BQ0L60I[C?]OR%
M="LC>_Q8C%GNBT0@)FX\BD0N,899$JM^6<].A*NC',^'YM+%[#^JWN80JR(Q
M69R:<F^>JUTT^Z!4JX9]"^(^(P6(G+WD82@9.T"@!G*"W#I2(Q8[:<>I>WR\
M>?/'FQN,3,Y"V[X$!8#YX5V8%?L]0';?U%1.D&.@Q@<`=X6,(#T/U3/4%`:J
MJ%\)QWCB!BFOX,&U>(Y(5$X/B:JCB$6N\"AA8HP>Y:'"G[I:*UYUX&=,KA:O
M&IZ3=PG/R!&G>9X#U$QOE=>S%,:7I1"Q5*T[4J_;D:GMR-26F#J0/<S4T_(A
MNU7<1Z:.D`3WO)QK9RP1N"]"DNQK+X(&`73&(&6*V"CVSUXM'+!W&@OUJBU:
M2N)U!4D;8KT29'FD=J@10E"H41D).;WII<J-YJ7!B"5"J"Y;2,T5E,IMFS0O
M$#U*BFBU3XH&SH%@X?(B"OS@)Z!$1F)@`N"IC"B@$F\&$*HCM.MLN"X4C:<X
MW"SK4"MR*6Y##&/+(5OQ`)0>W'!P!G*5^B-GR@%#D!:R42(5=Y`V4*X*.83@
M"M`#<"9K16*+P0^N1:Z0O;(`R0AVRZ!8K0`K#6>(A(+6I4E7/,E2)1+V?`\R
MUJ0L,U((4%/CZ*`KA"\<\%R4I7J8:PTNEEU%_C2?$!UF%DA&DMH,^55\)T&R
M[YDEX8P7>(?\<NI^N]M9!8[:7VQFB^,@'&!B(]P!\+7W*]D0\P98%WG1#)2G
M$ETGM'8>VI/6Q$?Z?=)4`/56_0X$>'M`;_&+9*8*'O&ZWOZ@QK@V"*;"*)S(
M3W#X;LS30&U`3#I5.2H`+=0!X`VTA%1%?(5%:$LJ/4.--LP<>Z`W3:4[,!NX
M""M0_81_&0N"4,0E"]'#8IP@T@01(!:G'P\B,'F"6AY>9%3'>$,5(YS_FALY
M.4EQ(I]!9RCF>ZXL6OY`+3/6&!3=IZ4(%S$Y%3%/2<7S%/)<PF3RH.NKIUQD
M@M(G!0P<#SHWPP+9FX[+?ZSN<](NWT]+<M+Y][2D:E@>.&E2IGT)T<E'/B1M
MD?*KQW=\?"^Y2_Z=7F)W&@P/5I^97-3RM'P65H2[2$Z/[)P^330!S([O'<QW
M!HP,UKKF=DG_/5J:'RJ&K`QX801`GS"`XY-*$\?:(#HK^OWQ2F:!@UC+9[J!
M)+=8DEO,56C,KD=6.]8\P$DQ)D_&%"5&\TZ5\1CW>MXX7XP50=]R6XK>V0'<
M;9"1`01)VS<8#<,S"G:G_U&B=DZGROXZ6R]%)7(!+)NHE:DZA6RI^.0]GZ!R
M$7;D136?EO^/\2I9;A0)HG=_!4<4@1341D'?>CP^=L0<_`,T+K6(=B,%X)[Q
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MK'\E#63S'28>7OP&4C?$.J4H(IH'`/?8-VS*['7EV4<)0O($^Y[)"OBKI(4'
M)B*#?]EUGET'K&SDC@^.4(.!Y:>1LW(27BRT@R'2*B_E4H#8>.`/=QN&=`WN
M$<F/5#>P4$0V[/42SMUD.<`IO(:71"HF5\8W+I7CHDR^"#^8JMI%:FZ]KHG#
ME]W<9NYU>5#67/=OZ3WFHSU<<)K/;!B6K@Y%;LL$@P)%+WIDB@[Z!CSR?.H!
M_WZ=N_$T)*'#.OJM[IM38E2V95-6VH198&$$(=DYH,.^B-98>S"N,JBOUJKX
M3%\CE'"M+\%`JG.5;Y0!X19#/1_VRJJ;DNT!>B]S1S!P@*U@YV#QAI%K^YZ>
M'XQS8$^B/1"`(E$%U!C2'[S>AX?CPU_/#T#R<V0<><(CKQ/M@+=K+,^_E@XA
MZ;JP%63!3N?`*+`(X(K!9,91;CT]%IT;A401UYSB4Z#SM6*%.8#PH@`'+/6R
M=KGM_U!M"YV>J$U94<TDQT86;1'+=XA/R*(16X7)&&$R)MV2*P%!LR57='C@
MC[`G@Q0"(@#/"2DS`*$N/?A!5U56E7E6>@6+7FG>-<I6@`^Z*C-7JJPH*[I<
M(L[`P%@:H,OR:Q2;D$,;-N[I>`2>Q$6:&(7!J+SPM'U]XX'TA,!7DB$TLMBW
M8QN&+_!3>",YZ>:-\A3!6=U2^8I'-W44J-9J=KN05I2+S^:)W.B0W>#;`7;C
MD#D2NZ$%8#?G"X];7ND&O.Q\:5D9HRN##LWRTF?:N*5^%GHHT$9ENE"9S>\Z
M\S9-G]6D9B[R$60BH%9]N?1(,QC&`3`AGSZBTT3N>^3J9`#`FD?Z-QF@,J6+
M3*EJ:8#''-GO[^F]E_]N&#4C!>FA/S)DKO""_6\=<0<VJ3BHSVR"L@(]%71@
M%$:D)TU8BD+C%*MM&0F,L9F&U%S8Z``4(0>MRXR]&Z%]5&?;/%RG=+3UD5(;
MJ@2E84S&('/NZW#42]I/N7X_QREPVAB"N;T%U`63K,I<OLIB6P$$Z13C693E
MAQFLE=N6F;DPJ:K4!>JZ@%150D$5</T(2%6I\',/2&7[#X%4N>K@[`RD>G:Z
M8VVI/;34'EIB%]0<6N(6?FH.K4"JO0&I-I7/%E(M0ZJ-D&H14O'=J-*M,-7D
M)G,%X&I5WL!4D^<9\*),$43<C`AY#Z8E&%P<-'C/'R`\"_=,V_Z@KW>M75[V
M\/)O[N+=[>8=OUL(OR6O?\ID([P*5:HX+H^A'^NV@_8&H!V0?N:.C\3SD'%K
M\NU[<JJ!)89CZ'N(#AXAIT`"*^W\`@>V*9<"#H;V,J)DP*],P9M'Q@GD)JN<
M382AECDX99:B)E4E;[^^-A!ZH9\NE<_\&NI1H,``IFL@=5LHN,:G;_!<"JKN
MT$L)021BANHAD<H0!BZ!<E\11JCT-W)C`()7FKWO\'UDNYS:/UKJ^`#?.?,D
MX=E)[B9?^39:Q%Z$AJ90_@Y#?Z+H+&CV;^;G(?D[QN-QAV7YS.N1H<NI;MAP
M].0?IOEU=TA0%1POG%M%`5&[?51OZU(]!4DHA<3B%%!H@>VEPBK6TJR3V4BS
M$\]"<N&S=9=0C]:'(R^@V^D+6,#)CK-AE-,O(O3'_`Y1M;E3JB;EA%7@!>I$
MJ7\=:7;B&<(,=`K=0/C>#>=7VN4;+WRFYAMPXGO-V_4.61L7M1!X>Z#'0Y:(
M[T2Q3WVW<E+#/GC#[N5#[P'/X*-\JJF_B_=`-X!]:@%I8^[RBE2$LXQQ<?XE
M"77?1<\.6+YCWU?SI>9-PD7GQ\6OP6V'"2C_'P`"F$?1"F5N9'-T<F5A;0UE
M;F1O8FH-,38@,"!O8FH-/#P@#2]4>7!E("]086=E(`TO4&%R96YT(#$W,"`P
M(%(@#2]297-O=7)C97,@,3<@,"!2(`TO0V]N=&5N=',@,3@@,"!2(`TO365D
M:6%";W@@6R`P(#`@-C$R(#<Y,B!=(`TO0W)O<$)O>"!;(#`@,"`V,3(@-SDR
M(%T@#2]2;W1A=&4@,"`-/CX@#65N9&]B:@TQ-R`P(&]B:@T\/"`-+U!R;V-3
M970@6R`O4$1&("]497AT(%T@#2]&;VYT(#P\("]45#(@,3@T(#`@4B`O5%0T
M(#$X-B`P(%(@+U14."`Q-3$@,"!2(#X^(`TO17AT1U-T871E(#P\("]'4S$@
M,3DQ(#`@4B`^/B`-+T-O;&]R4W!A8V4@/#P@+T-S-B`Q.#<@,"!2(#X^(`T^
M/B`-96YD;V)J#3$X(#`@;V)J#3P\("],96YG=&@@,C(X,"`O1FEL=&5R("]&
M;&%T941E8V]D92`^/B`-<W1R96%M#0I(B:17RY+;N!7=]U=@D065:M'$&YR=
MW1ZG.C7C5$UK*HMV%AR*W5*L)E6BY';E0_*].1<`'Z(HVTFJJT60P+VXN(]S
M#]ZM;MZL5H)QMGJZX5F:"9;A+XR$,&GFF%4F56SU<O/FKC6L;/V*C+5E??/F
M+P^</;<W6)YQP5:E'V62K5YODK>_W/WMXRV[_WB7LK<?W[.'W]\]W+^_?_O;
M_<\/;+'ZY\W2I%J8G"UYRJVT;/4^*.*D*/G8'*N6'1MVU]3KJFZK-8W:9K==
M%T>\D`:N4IT+!VNB;&9Z(W)OQ(=M7=3EMMBQAR/$7JKZV+)/R>]U<5IOH>;3
M(IB2IY8[,S4EXYTZKDC=8_(IV=;L9;O;;9O%4J1Y4K>WK/H:QF6U/[)V4X2W
M0\7BJ%ZS?74XFUG'X3$^R8Y_K/Y*T5`A&DLN4RM4L$GK8),WQQ_,FRU$JK3F
M;&ELRHWU:\),EAIE+%N2[<9_MOZ<@J<RTXH9TT^$]7Z;J,(?V-%>RR&>C\EJ
M4[&R>5G`,)'L3\>%PK,(CZW_17Q8\\36X6WG?T\+:!9)6%8M1*J3-7NMPI+G
MS=$?&X$4SJHAD-P,V_.P/6)>?*D.Q7-G1>)_FIH<>T"N-&12TM)/49,-2?W,
MGIH#HR\;,D,E%46"IIIURRHDUIK]"DMT4L`RF1S*#9/\-L1BR2G_I1N[YC$1
M&<\8]#-!.>:W6;.ZH3V8WS-L5.+TR6E=G6_^U-!G^F_"I]=HYDC2'^!P\H>K
MO%6U/]<M*]HS;21S0/)5AY*&+<[FCU;"%V3@J3Y49?-<T[=_X:!EXU6W\#XR
MT!]Q]>?9LGE,G@\5R@6NVQ0U?JK>]3`+05]P<M;G*D9/I(9GXS)T00L95%:4
M$L<N=T3*D_CH(_=3Y^\L=5RILU2<9#P,#@.LL;DY6RLS))'+/7HPOVC`-BE3
M;57N"X)2.]@I:2U\*;4)!OO@LH7-,SB8+98N=\A2'^EI>?8:D=V9-$&E44[T
M%C^2!@$CL]324*D<IPX#/%D_\JI_7MW('(=!;0J;(B*H4EBK'#M4-T\W2JO1
MG)'CN7>K"^RV@IE,IX`/`#<=5<BAH&)T'J@F;=*4GUFS#^-M^((RAN7*92*X
M02,L&"V7&`-7PG&$!8CHQ`IW*W/ASW"!(IGN`=3'\('BO6RKXW&'A&R/M'>Q
MWR-/MX4'=#A36#W"@4L8.FZ1.(<MH(.LY"JW672K`+J9A-]*G9T9BMZ4Z%O-
MU:VR/*9:W&@^?;KPL860G1.&0(X*A\N^<,0`DM734U4>%Y)64^[[D:]:2U5+
M;P<6GG7X"K2@MU,;ON*`K\TI?%NS#6J/_5%5-:HZZ`JKEI!-UF$<Y8.V\:(O
M<=MTL/M:20W5$N+HM.G"(*ROJD^)_+2(2UTD#:%A9GVQ7NA*C3AKT;W+N'=9
M<E>T&_9AU[RV[-_LX;3?[WR;1LM^OVW+7=.>#E54&6L/N*RY'NTY.LV2NU1R
MKL9MLVN)RDI.WS.1Y\/WP53PG?/LRVP?7M=7M'18)Q'H0P4X;.KCIN\D1>P?
M4ZSH%-/>ROJ]A4YS:_4DVSA8"&JJ!YL.O42*[B@'P[P//5J=>T:DY%6_C*?.
M66^_5\VI"*9Z`1#]^K':++^J=A1C0BQK@7E,4SDQ+O-43W#I.KNTJ$[%5(Y.
MX#J0NH"+^6R@HNJSAMW7Z/$O!<'"N=428=)2SN?)R/@,93U!U(BV<U,S8(MN
M(7`4AZ,,>#O@E@[QO0.V2L\S;`+;]P6!+<@#53%;GP[A%5S@Z`>$%SU=28FP
M=%QFF/1T(O6$(@V4PA,*K^8G_R2$-"*7?N@A.J6>@TR<<XH$$])@Y-E0'=3G
MC':VDY@%O?N(2Z`K(+=MA+[JZYYX^RVKJP$,"]_\`7&G*,/*8A^@*KS#01'-
MPE=B+CA$YG0&]_V)>J9TJ4MD`+;0`KB?0,*#2NN`\.`2.9KQ-]CSS&F'K%`F
MH\L/N.Y92G>S&JU<7,Z&!M[)IDK-S4;9BUE08]?)*D=M?F8Z"%],QX2-TOG<
M5)`\GS+R&_9VL_/V*J-&]FI89^:F@_#%]$P5\4QZ1$"7U:(K(VZ'.NJ3+5Y"
MN*?'2&RJ">XK2R5?*\]=A#'$9)`5,I>`N03\9Y0ITA'G-Y1",HG<Y?OY@KP%
MJ;J2+TA*=3U?I*5#7<N7*'LE7Z+LE7P)LE?S)0A?S9<@/9LO07(V7^;M[6=G
M[>T2(LA>S9<@_"/Y`HJK.%8KRI696^R/DQKU_Y,:U3>NF<[UKM@5->Y!#YNJ
M.H[[U<5-QL:+Q"5%BTVQO!FW%&(C/,\4[B@]]Z`T=QX6I:+L?E^5U<L?N,H1
M+P$75BE/KG)!@+T$2YHP`C1WKOC9#8D4<8!MN!KU7-LC;Z>$;D:"FV^UC2]P
M4'/8]LV#+KE']@O>C6]G^/R*XLX3V$]-'S=8AB:(P^+NZ0M:&1[9OW$.4O21
M*QDZ@\Z=&UVO0BWBLD<I-FGXN)N-YNP<D5%7B(Q@$JVD)S$\'R!+A8-^V/K>
M7X='NT%+VQ^:]:D\A@\36F8#!,WREA$I4Q.V*@/9(\Q3DKPBK;DD?(HX<.8)
MW45VJRZ[/10.B\Z4*RL(/*75$^5(`6GT]Y2C?^-:RGDH56ZOI\??D5<(?<R#
MP^?S*Q-YL*S:=LII3>JDN$+Z1LYS*7)CRGPU/R]ST/4`F]\ZD`$6@!]=>BO1
MV?^@;LX_/8\L.VY)_OFM>&5HA!E\5"Q`09,CN&*QFV:31EBR*[>ED4/`W9VY
M\`CP<GH&G>7?=PD7>M8E@(\?UC?V1`<D$:809&%BD&V*;AZ@G$V:LH3J^3JG
MB?^RR!'D5#@"X9<8$(_':.G:=7B\:H#W%_[/0<&_ZW^4IK%\XG_T&:5CN(>Z
M-G#54(A&3*L<-".SUDV].KOOV,F2@W_-=$Y)=TD<8="G4I.'X_O+I=2*0)JP
M5^1Y?]<8`B'`MW)UC1T))U&-U]A1)SO/CCK9>7849:^QHRA\R8Y"EG32M&9N
M-@A/9T&?C+AF=3\[:[5"^X$E41:=+7.STU[X8GJ>(PDC:!TUIZ&TLL@V[!F5
M_<\`URO#!PIE;F1S=')E86T-96YD;V)J#3$Y(#`@;V)J#3P\(`TO5'EP92`O
M4&%G92`-+U!A<F5N="`Q-S`@,"!2(`TO4F5S;W5R8V5S(#(P(#`@4B`-+T-O
M;G1E;G1S(#(Q(#`@4B`-+TUE9&EA0F]X(%L@,"`P(#8Q,B`W.3(@72`-+T-R
M;W!";W@@6R`P(#`@-C$R(#<Y,B!=(`TO4F]T871E(#`@#3X^(`UE;F1O8FH-
M,C`@,"!O8FH-/#P@#2]0<F]C4V5T(%L@+U!$1B`O5&5X="!=(`TO1F]N="`\
M/"`O5%0R(#$X-"`P(%(@+U14-"`Q.#8@,"!2(#X^(`TO17AT1U-T871E(#P\
M("]'4S$@,3DQ(#`@4B`^/B`-+T-O;&]R4W!A8V4@/#P@+T-S-B`Q.#<@,"!2
M(#X^(`T^/B`-96YD;V)J#3(Q(#`@;V)J#3P\("],96YG=&@@,S(P.2`O1FEL
M=&5R("]&;&%T941E8V]D92`^/B`-<W1R96%M#0I(B;17R7(;.1*]ZRMPF$.Q
M0X2Q+WV3EY[0A$?=,:)/]AQHJB2S0RIJ6)3;W3\ROSLO@=I85;3DPX0B1!02
M2R+Q,M_#Z]79J]5*,<E6MV=2<*&8P%]N*>6X",P;QPU;/9R]>E,[MJG3",'J
M377VZN_7DMW59Q@NI&*K36H)S59_G!47[]_\>G7.+J_><'9Q]99=?WA]??GV
M\N)?E^^NV6+U^]G2<:M<9$O)I=>>K=[FA20M5%SM#F7-#COV9E?=E%5=WE"K
MWMUO;]8'?-`*TG`;58`WS5SA.B=B<N*7;;6N-MOU/;L^8-I#61UJ]JGX4*V?
M;K98YM,BNQ*YE\&-71&R74X:6NYC\:G85NQA>W^_W2V6BL>BJL]9^2VW-^7C
M@=5?UOEK7[*F5=VPQW)_9+EIFH?FE_SX]^H?=!LFW\92:NZ5R3Y9FWU*[J2#
M);>5XL9:R9;.<^E\&I,M@COC/%N2[RYU!^KN+WNI-)="!N8LCR$,9D[NHPNI
MS3%@BZ665L3BG^O]Y@O3\AP]!NXJ,BD9+'?%VW)3/GS&J6%&IS!<%OF(JY\F
MY]`(@56ROT=-`R1W(NJ\IQ)2,%K=!(L/W"[:UG/;++ILEX#S2DEW#*;D?7.#
MO^UWN(S#G^?LM_N%Q@+KZL#6N*)W^#+%?YZVJ?>1H'+.KLH#=I)62P\CFM;X
M2+\RAG1<&Z-I?'BW.M-><X>8XL<;YAR/CN[`!+8OSV[/C-74;LQ><23-P/QZ
M-;C_<39ZA:M2U$(JIJ,EK"];G`[.MC#%GPN#2SA?"`K[XSUZ<$S\3R<MZ9`&
M1UQ(792IOQFY3F,VN_K0HK&M#98KH5US0Z/K&SAMN0Y1]1>IDI,?B[\!,P`D
M`JL6=.+BW!D_VL-QI;5-F*5BTNPSV8)[#23V@T:[X%ZP?+>+%9-=/##TW"Y+
M@Y,(:U(R.-DG@^GPU,3\8K-Y0B`5#\438(&H$ZQ"L5[@>HM#:I>I?<-NRL=]
MN=EF>S;ECUW%Q@$7W'MEGPLXLCA5@%'`<5M1Z;9DR7-M'2I,:ADWJ#5M,=`&
M6>-MRAZZ@YD]M>-!.9UW"A@><]R2<0!][5%/3D,_FW\<^A+H<`3]95^8D:<V
MM$5IM3NL[T?G0FF33CT;0Z2*=VX00Y_+C_$^Y-5;^)I"$K!T<:ZB9"W<=->K
MA1G?HP&S*#?&VZPC0]"AX)B^*/?K:<E%M&&PGD40J313`N`VM(D^%29IIW4)
M11K9&3GMT0>_LRJZM(DUH+*K=BZB,F]-<Z=6Q-:U<RU1S:PY39Z86\S,>]U9
M9[TV3A-T3GC=66>]-LYPTWGM4`'FS6GRQ`PHSP#81ER<(]P^#"O.$=OF+N+'
MD[1KD#_RF'B#3;2+]`4\1[3KQ7=)-P2GIJ3KK1R1+I']"=)-2XQ(5W1%4@Z+
MY--]$FZ_'K[`OS>[!]3"+Q!VVZ\ENZPVNX<2!>K]KJZI/BTCM$F",65^:L$!
M1[^(N^7^&-NX`0LXP!7BF&.4&%!2:T7=\>%'Z@Z(G\?O,.XONWU)7'I7L<W3
M?E]6F\R\C(AT3U7!@WGK1,#416-1[-<WOS_5])TI>$$UI)KA7%279RD78/1Z
MK)U2R3+:1BI.<<JTVDO]`J:U9L2T@\6#"UA<.3M9/`2A7D*PQDDY(5C=X5[E
M$'^H]N6:.-4GLO3%7P#1W3JW*Z)<7Y"FST.`GY(0A"`W([Z6]2&U$DM[BC;%
MFGJ@W:LR-]GNEATM"4#VXUD>!$XOON%5,CHQ""2\Y*8$RHD:)YS'79"ZQWC@
M2XO\'M$6;"O,_-MH*&<I.IO=7955*X7F<9?.:PE^R,NBS%_;H[YT-IO$'W6S
MSV55WN8AN:=>0`YF@;RC.;&@P";Y^+C?#OOQL"GW7W/7ILSB,:UP/HD3"-1T
M4#T9)V`V:-4*#7"$'R@-B@R>?'(2F=#G9B-\Z&H-/4IPM;E%FLP6W]K34E<V
MU"-/_8O4+L[3>]H+!RA,(O%&?$61E%=4GQ93B:<E*M<SNRQ-`Z]!E9VH@C8H
M7=)-`M=72A-1$LVI2ME8?[A2&LQPZO^FT"S>%1.JLD+:3J"UU0ZZ=U">A)Y6
M51#)B_586Z-.ZC$DM3V*O.5.!MWK,8<092H3@<<);QDON`HL<#^69&1T.)*:
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M'I3+`6L!3UZ.?!"NBV1,9S\2WLF?5-CF_,G!RGKZR"F#E(^>S0FG]#2T,05+
MR0'T?$][C5ZZ_K+;$ZO))$+Q0_(28I2D)G5N4V>61=1J^O.H*O?5/^<%TA."
MR(6:`1'#D'$!TY2Y\W326[UZYHD4!=,&UVUZ!NE"K!JQO=JO;_`(0@)LJ_Q[
MEW^@0#9/N;G?'K:DT)8*1(!'(3&#U9HJ;V@&(XU,E,F@\'A2N5NU5CK=-`>G
M<;[XNLZAO$__URE^G_-'N;S=[9?UNOEZ6<S3&R>BQLG"@H'QTO&>[`9U(J>?
MZ(5`BX'QHZX1`HUX4D'%60V@H5V<.WEIV?K\I44(5L>%:U](JH]24V!`^CB=
M2>'Q*51`4-U`U&2(FA0(WT#49(B:+ESYE=2-JG(?A4LZ`;X*F?W!Q+JP1@WN
MUW@?*8`^3@*HE38G`BA4C,\'4.!!@`C,D+86<-.-3$$-9DU)60TFSE&V#>U<
M<+*84'8RI\D3<WNE,_YVIJF_1,>G_>VLL_X2'??^.LBT"5OW_D[,,S##*E1Z
M9(LRZ7J8-:7A_:ZZ(RPEC.B,I(2C%D4)0XV5$%34_UVG!"9,)G3JE+S#U,V)
M>WH%JHDH4PEI0=,#T9GCZJ(`3M!*KBE=`3^)/9>IYCGL*1^F`&M-GH=9Z#63
M3D`OSSN!O&;J*>3EN:>`-^=L9YHXVR#KA+.==<[9!E?-U%.PRW-?BCKKL)^0
MSZO#U4^GD/E"U0;T->(A"3?'';11+]PF>J/1;`=0XA;0)P)LJ*_1:R0:VF7@
MD!=NEC`$&6V$5._.DHXGG(VSBBQ"`3HS?#_-U/UB=-!CG8/XJH@4^-X33+62
M*%7CX]VDZH*A)^*+S0@K"<+4T9[>\$A>*9DB)>EMZOVL)D04G`U^[%>ZI.*J
M/$R$G<`C<;`]MQ9/M-F5>1!A'-X<W^)=?=@^K`_ES7AUJUP<KNY,4+.K&V@Q
M:U_J-J@5*?ZBA54N:B.W];';DZ@$I_2LW$6M4RBHP)F"OO#,NV.=(MF6G6G@
M2'8CN#M2*UIZ*@/9&"CSAT;E\/1HC,;Q,%<1DU$>UYCY,B&#X3'D,O%=U`0N
MO`^#*"W[,'TL/E3[<GV__>M_G5?+;L(P$/R5'LD!%*^?^8'V#WKB$JFH0D(]
ME/;_.]ZU$V([$'HB>+Q^[,LSG8M<YT->C=E=:"$>-;PEB?2AMXNJF3H2)K^.
MY^\JT.2MW1AHYXS_]Q6,&FC3/GA9O'GJ"D[UX8%VFH7IW3#Y@^YM.YES^T'C
M>!O/7]>7(ZC']7JZ'KOE>>``T(!6M%+;J?SJR;AR3PGO^WCY/3VZ[SU7>D.V
M%+"RM%R"O80L]UJ5BE4>GMU\S;J(8XUL.P<WX2>N.!BG'H1TED)X[(*R@R0B
M]E:]QEL/%M@IBUBPG(4F-'E,60O&%N>%@0[$8^BCD(SXPNON&$U:-W4CK']0
M(;:COM5M$AQ`51?=QJ+399#'ZUZ4T)5FE/>E!AM*F-,;&I7VL1.B3>TSE9"4
M)I/56K>'VW<_XX6IA?P[?\GOI_PPV9#/1#FZO8<318C9`')'2)@X@W96)J(\
M]AX<WC-9)A7='-)RD2!Q+**UUL.-]3!;:PX1-@*G$<$7/&)*,H/R6LR>$D69
MF39AJ`]J*C])$.LH$G1\82W#:0&VXI2DA;,N3$O>I``4(MRU8*T3A)L7A)8,
MW5B5G'5"V;!&01Q"MG6V>,4FF(TK..>D6)<YF4&V74G8]IDGM'EF3:BO;(HJ
M#4V436LT)7O:EU_W%BP;5W"LXK!ZZHRV3SV(SDV>!D!-6#Q=PKD0&YDQ075F
M&+^X;:EF_.*R%<K**]E:*K5.AMFX@E>:@T(N4B5VYF):*AY4Q!^N4P;1"F5N
M9'-T<F5A;0UE;F1O8FH-,C(@,"!O8FH-/#P@#2]4>7!E("]086=E(`TO4&%R
M96YT(#$W,"`P(%(@#2]297-O=7)C97,@,C,@,"!2(`TO0V]N=&5N=',@,C0@
M,"!2(`TO365D:6%";W@@6R`P(#`@-C$R(#<Y,B!=(`TO0W)O<$)O>"!;(#`@
M,"`V,3(@-SDR(%T@#2]2;W1A=&4@,"`-/CX@#65N9&]B:@TR,R`P(&]B:@T\
M/"`-+U!R;V-3970@6R`O4$1&("]497AT(%T@#2]&;VYT(#P\("]45#(@,3@T
M(#`@4B`O5%0T(#$X-B`P(%(@/CX@#2]%>'1'4W1A=&4@/#P@+T=3,2`Q.3$@
M,"!2(#X^(`TO0V]L;W)3<&%C92`\/"`O0W,V(#$X-R`P(%(@/CX@#3X^(`UE
M;F1O8FH-,C0@,"!O8FH-/#P@+TQE;F=T:"`R,#@X("]&:6QT97(@+T9L871E
M1&5C;V1E(#X^(`US=')E86T-"DB)O%=-<]M(#KWK5_1A#M16V.GO;LXM<;*I
M;&4R56ME+_$>:(FV-2.37E).)O/K!PTT*4JD'&_M[)2KK";0[`;P@`?P]6KQ
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M"T6>,K942CC+`[PL?2$,V(0R+U&6P$BEH26W6A48SWAG2@\,6_:N;;H.33B@
M!]B98-EHN_7"D#?]UG2VXL$%_5\=K=WXZ$.,1K7,?3#F]%!T/GO;[;?WL8:.
MSP7(G9>SY^8&0JT!$JH/S)M1.*<N`9S"J-/K?<JR^Z;=;W]?>LBQ:BGA_^8D
M]PWWSAU'SX;YZ$T<Q92G4'^&.F^K<@=W.:ZS:GI-4$X_"R2X!CR:7*,GUX!+
MF]-2AGLDV/@T8IH+;2<9I@<"4L1GY;9EDX10TKJ3XT<L<8*>_RYZEBL!(!^;
M0GLOFFX_N?XD;\Z#%5-=35*=]KXKM_7_5$4>B.WT:&HE'Z"(JNG9P4.*/@T*
MG!II<M;@?Y6[QVIRJ+70>;Y70XA7S[U8%7E?G[')7-Y!@0`%RXS13Z1,D[5`
MH#H*MR@D8HVK)*==-<FZ'^F`)?01$0KDM-PZA3R;&^@LW*+(.A(-"P-A23H7
MDN[PG@S<X:E&2*3,W&CCH;HHZ=^N%AH4T"Z=$;Q0S(;(Q>">":RM%A`BZ%7*
MC=32C-5&:^[4H`:R=T?J`EP9M$!91V>_7DVZ0&P4LN`:6T#?R==#=L1P?^*7
MG-TV7ZJVQA85,)(0X#TKH767MU6]_L:Z:OW8;O?;F$@0+&,@(C\L<VT@2#Z3
M,(4L<\ANB,0/,2;*9GD>1<%!F*)(%;VH""32HHCLA^].6]_L_/%3&CO:_2TM
MRJ4`@]-#A0_Y=5*M?TWB#?VB#^G]WA,)`P0$,Y,D5VDG@A^A1HMAK?HU(&`F
MNZ/UJ[\13\A#/KN4SU4=4]9F34MA!(J\+NM?V8ZDRSQ:4$+YWSQ"P#%E(:>*
M+(AXN;8:H@IU,F-(X8\NET/`1`K81=,^-"UT.[:IKO?'*$HKH;'[3#EWZK"5
M%F8]>;6$>XP(@)*"AM1?->HQ>&M!=[W]#V`*6Q_I9[O_EB(>GPZWAL+&]-(D
M%_03+PTVMBEY$)QZFUX9=HS#?HBZ)6M^WN,4=P>3YQ97/6$8(@R#:>Z),$Q&
MID$OC28\@;\UA8\;,&&APLR8T."+P2FCAP9$@Y:`+HN,$E=%6CFEAD'KP!K0
M.CB,I^=8XZ">98U>/<\:O?8YK%$PJX$/3:Q`X@TUBK`GWU9-#)W#*3A.Q'$-
M4SZ1MR/R=ACE(I&W(_)V`Q8N2W+:59,,L5`PV``NEA(_%4&8)F<D7ZL-11+J
MT7EQU&049*^BV6N$B1*VP-*E,9A6!IA233'18),[C\F@GL<DJ<]@DK3/P(3F
M>2A9+MP!EIGV^:&I;_^4QAD*G98.1C/L<7&ETPIN3+$"$O'*GK*W'(:WWK+3
M3N/CU4_U&0FGA,R&I^BID+$1VV,B_"LZAQ4V?K;9[[8,I`Q[VBL&`^V(/9$[
MQ\PYNJ^`5@5PJ"C]WFUITRQ)C49CF"-@.(K?E2!WR9AANCR4@/&6NW"V!`[J
MV1+HU?,ET&N?1TL&]HDPD-*TV1(I622ED%&'[1MMJ@N+&1]275BJ"SO4A<V2
MG';5)$,(-$RWF0,H;6'D;"Z"_9G[/Y*1L9(_`42OG<>!M&=@(.4S4=""'R;*
M<`!!CT%0"()%$,"3\DNYQ=5NI+NFARJ_:=J\*],3HXT](HH048B()404(F)#
MH=(P&0=1Z`1!C0=178081>P;AU%4JCCK7V5Q\+*9BM#!%VH::&$HS6P1)A!J
M!4WF3X%0>?@.9`#2$0R#%FR;40+_]F_"T&SFE/'%B0XP\\.=)IS`.ZCCNU-M
MRJK!X%EELO=(!S6MW5E[>^VLP=[%;!SL=7/*9*V;2_+YZ`[:N>@:`QTLG#-W
MT,Z9:PSDI1K9J]VL.EFLYRJOMUB;.249?*RS(HPRZ=2F03MG,#`8MX<`P_@Q
MKT:#3[7`!L`>`<D`%QY\@S?@I$@&U#MBZYCY#-7@#S2BLY^AJ[L*FAY\*6D@
MW>F7$DJ!@N.\V7\IT=YN*>-$4K*'MKFINBZ=4)?T$OW_AD,^2Q^X)9:DBMAX
M2]WOS#!5PUBRZ6\[GI[2\VVOB,9IZC623-5H:IJR2IRR-A6[CK;X#!WKTJ#6
M'+U,6]O;JB<AV_?P\7R5."BN`K;T]?"M=]VT;?.U:COV]:[I*E9V7;7O6-E6
M[&%7;:)+9<?6S6X'N]MRQQEU_&$N.8P((,KZ:>"/`0!_4W[J"F5N9'-T<F5A
M;0UE;F1O8FH-,C4@,"!O8FH-/#P@#2]4>7!E("]086=E(`TO4&%R96YT(#$W
M,"`P(%(@#2]297-O=7)C97,@,C8@,"!2(`TO0V]N=&5N=',@,C<@,"!2(`TO
M365D:6%";W@@6R`P(#`@-C$R(#<Y,B!=(`TO0W)O<$)O>"!;(#`@,"`V,3(@
M-SDR(%T@#2]2;W1A=&4@,"`-/CX@#65N9&]B:@TR-B`P(&]B:@T\/"`-+U!R
M;V-3970@6R`O4$1&("]497AT(%T@#2]&;VYT(#P\("]45#(@,3@T(#`@4B`O
M5%0T(#$X-B`P(%(@/CX@#2]%>'1'4W1A=&4@/#P@+T=3,2`Q.3$@,"!2(#X^
M(`TO0V]L;W)3<&%C92`\/"`O0W,V(#$X-R`P(%(@/CX@#3X^(`UE;F1O8FH-
M,C<@,"!O8FH-/#P@+TQE;F=T:"`S,C8S("]&:6QT97(@+T9L871E1&5C;V1E
M(#X^(`US=')E86T-"DB)O%=+<]RX$;[K5^"P!\Z62>,-T#=9]KJ<6GNKHO%>
M[!RH&4J:>$0J)&6O]]>GNP%R."3'TB9.2E4:$`TT&OWX^L/+]=GS]5HRP=;7
M9X)G7#(.?V$DI<VX9T[;3+/UW=GSB]:R34LK.&LWU=GS-Y>"W;1GL)P+R=8;
M&G'%UE_/DO-?+WY[_XR]?7^1L?/WK]CEAY>7;U^]/?_[V]>7;+7^YUEJ,R-M
MSE*1":<<6[\*B@0J2M[77=FRKF87=;4MJ[;<XJBM][MMT<$':A`Z,[GT8$W<
MR^U@1$Y&_+*KBFJS*_;LLH-M=V75M>Q3\J$J'K8[4/-I%4S),R>\G9K"1:].
M:%3W,?F4["IVM]OO=_4JE5F>5.TS5OX1QIOROF/M;1&^FI+%4;5E]V5S)-G&
M81=_T8Y_K/^&T=`A&JE0F9,ZV&1,L(G,H8N1V5)FVAC!4NLR81VM"1*>J=Q(
MEJ+MMK^.(L<*3C>6(N-&Y<S:\1(QW)C'&Y]W[%6Y*>]60F8FN8)[*/&,27#P
M,U9\*7;[XFI?IM=UD[9T`V$R;9T8Q63FQ&)?LEWUI6P[T"I`:[GBF4\P-%]+
M=%O+KNO]OO[:O@A><5GN*>EHX"2S/L^\Q*2<NH23OSPW!U],\]K)3&JX=X[[
MP856<<K=CPEC*RFY-6`,6PF7<YW)A.:<H+D8HE@P"FQ7,B<O8_K'^QIR\YNF
M;ELZ_Q!3B*CVAHV6&X=^AN6L7QIUR\Q;K_Z2:F7'JH/68Z4B<U[KJ5*Z?/*Z
M[79W6%G'>G6,YH+>5/M,*,BZ4#640R-WSJ^D,O"HG![O@N_/[^JFV_VY<IF&
M?!#P?SNI")TY:X^]9_RR]V873?N4QJ,^5$U9[.$LFZFDG!_CI55/"A(<`S>:
M':-FQ\"5MM,"AW,$V/C]B*F,*S/+,#54E`PH5^P:-DL(*8R=J!\5RB1Z[M'H
MF4QR"/*Q*6'M1=UVL^,G>7,Z6)CJ<I;J8>V;8E?]5U7D%!3-1'5H,+]"$95S
MW=Y!BGX_**`5(7/1X-^+_4,Y4VH,]*/':HCBU>,P547:UR>BYN4M%,A*9R)A
MX:=<`?PG#6"HPLD=31*LTBC.AU55F&M?!`4KZ"X<,12'QF('@H&&?@-HC%/&
MAJEAH,$M469]E!WV"9]9TJJY(,A,M=(.JBLD_>OUF0(!X+_5D)?,>,1AN)WV
MK"G/P$/0P*0]2(4>2[52F96]%'J`/9+F<(]>"'!UI/CE>@;_.6<6FI^E[A&[
MTF9(#/3TA^PR8S?UE[*IJ.UY<B+XMF,%]/+BIJPVWUA;;AZ:7;?#'`(_:0W.
M^&F5*@W^<8F`OK!*(;'!"3^A.Z1)TA2GO`4/X4*72^`3*[`V3P02@-3G/LIX
MC@@H@-N0`T-7BQU^G!3O("=NP*#TJMA\!HP9&77]`+9"2"10!##>&333&\0\
M%\((U1YL`A?J!/HIG;7^^43;?A<I#YP8!@6U[?@1>GAZ%46;SW%Z&W[)LKB_
M=YHPP$!@PL8E9)3OC1H;:'3N#LM&5DIQJ!,;ZZ2LL!1,4C?!'>"6JZ+ZS/9A
M-CB\J$8>"L$32N!1"FQ2"0#2Q$<Z%XDP^G#\X!\3#KX`U2II[O%_&*+!*H&F
MRK;XC2YRR14..ZK*Z!0U=HE5T.<2C;,*_WW'*Q2V\4I*%<AQ/4Z7C\GK?Z&8
M#MIUWQ8.]4"B(44DSN9/.72\<AR-0S"B3WY#W-')+=#&'8UZ?-(!GS25E@OX
MI)-@C1)(`H1YS`I<,51'CY[P:+%2JZ';!5;'H:43?.$HCR,KY<#J#A`%N9:)
MTQAU$"^"5"]>1JE>^A28RIF1#EY(/4[)D7==N-FZ1K=9*$0LC#V-X9D1^H0-
M?<*2A_/8)VSH$W:(@TWB?%A5A3F*@P0.!7'0"$)]62A.8"<,(!=@%I8%1YS7
M\$`A/T+&6\>/^AGDEI:!YHTB(KG)J9H#XPXC+7)J'Y.((/?0IR,RB)<C$L4G
M(A*E3XA(>#<8#EKUT#SF??K7NKKY(1W:YRH.+7!`:J8X4G$$)T9/`0UUTDQ;
MA!A88F_9M*\Y//I[74V`%I]`"DX*<1S_7&#'AT?H_[MY0%NCSAGF^:,])$#&
M9/4I+'\4,O/05>4C:$F-2\Z!<MZV""G-@)1FR!,3\L10GOB0)R8B)3QR(!O\
MH;/+Q4OS26L8F.;D3:!A!7`0R'@0VNB.@58?"E)#N8"&4P5Y$"\69"]>+LA>
M^C2(!%Z%6OXB1(:?OD[_<X140.L3!^&U@F/XY;PX.-(M];_#1JUX9OWI4`SB
MY5!$\8E01.D30\%SR)X!&/TA%&H<"DFA,!0*N$[QI=C1:#^2786/,KVNF[0M
MXA<+"_NXR!`727$Q(2Z2XF*`ST0>C61<)8;S,1E7N4=7*CFFXUI(?.H$0FX2
MB?'SHB?UP,<3H_@LCDHJ_6/BR"T\:QG$Z2@0@]1DSB](H2WT6^'!H)>$M',F
MA+"YX53M)Q$>Q+1Y+H[)-=B\*.Q-/A(ZDRE[TN1>NFRSLYB4@\EV2=@;;)>R
M?=G'@W31QUH+4KEL\2!=M%CCHU2.3%9V4=P;K9:*L#=:Z25AM/E8:+@?Y=34
MJD&Z:#-`6F8.;M9(=I;$P>:I&*`!L,03,M#`2::@-;K`F$(WP68R`Q#.E/-(
MCGL`T0-]$1$_;DMHQ/"X4]`&YX\[F@501K#O'W=A;;L2R)D*=M_4UV7;1@U5
M$3:%_]_H`<*(&'G`(2Q/B?%Q)O3#$W2O`N*T[4\[YG?Q^Z87H'$J=!\13%5D
M:N2!!?'`;<FNT!:7T,7:2"7KH\UA:7-3]H!DIJ^^O@=&%WIJ\INZN:\;?(]>
MU4U3?RV;EGV]K=N2%6U;=BTKFI+=[\LM7JEHV:;>[V%U4^PS%CC`P)4.I`$*
M(+?SLV<,$,.WJ:NN*3;=0[''6PL`VL`#NYYTUM?4$O;%U1[A/_!;>-)Q'6G)
MC*I1AX#F0'XGI9KX)#XJX48=J?"9Y-#B^"ERG+!W1;.Y94H\8Y(#80+?E"_H
M?BF^**&_']UPX@-Z@0JG2*A@Z!W=G]J`XD;R`/X&"0&"/\[9@8$^7Z\E@PW7
MR,"4!KZ`*8:U$)U)UB:OVVYW!_'8TIFP2<=-4&A02X<=5@<F%(E;J@%69:Y.
M&!E7'8P`3N65GQGAPHW.[^!]N?MSY<C/Z.WM<(MH$&0C=+DCBRR7RV=E3G@[
M.BH]9$_R2[%K)G>%]>"['WE9J"<%43V^;-!X4;?=_'PMS1.O!DZ44R\2K"6_
M%_N'<A9&(`GY$Z]V1.%#$BJ7>4^@"O,N$WE^R$%KS"'=D'4`[8&B!669L\P2
MY1YW%PMY*`>QR<QC!!!P7CH)!8*ANSMP\,U`S+%6+\,["FHSEGL5ONKPTT$Z
M`>YMPU=<";4,V`V/5-;NXO*;\+.GY24B"98[(`G@R*#^6Z^'YLN?PP>]'+D#
M5Q'I,Q*1U@>9."SA3@3FIZU$.I@'D1]66,UI0.^J,33\N_5JV7$;AH&_DF-2
M-(;UMGHLT&///2>[;E+L(D8-[Z%_WR$IR<\$*=!+(IN62%'4<*8TAY?2,43>
M76FN9FAR^UZ"RX]G>1@.Q%NSVL10LO19L%(S5KJT1S+>9'"1OR\R&]+6`I#1
M)3`,*@:2-/.`MR%[0Y3^P+S4R.!7!"KQXYA>W>1AU]W:W9^#PZ?MJ:<(0L/$
M6^E&!"FI(WF8QD'=I,@V(,O/F1S#K:`U-:\I%G;>[/ONXW)%X8UVHOV@UF#I
M1NO1I<&>-ET"G<I>4W\2[X:]>_).RQ/_Y^7%=J4NK+)_-_V`_>,*JOWQ2#X%
MWV5\;\LSI?J5,RI[EWUUX!3L9+K)IHX.*<`&2'9&HCMJF==ZA1"37F4\9)II
M_@DF4'V8<1<FDOD)F(!.5!!?H>C$)4=AF0AV\-J>!V%X`A1]"_+R2K1D$(Y&
M)(B:3__6#G1C`XX<H3M7C\?OO%MDAJ1;M/Y1+W\:1H_YR^4]&H\V491OOS]^
M,;T<^!<'"D3#X7;R?&W[G=@S=[2B;2V70Q!M:UG;HL:A-96(UW3^QBS/OVJ(
M$3PN`N8,S]>`(DBY6P+)^F0%6%VYPO/]F"Y5*N!@F>,:8#Q(.3%"_+^7MV<:
M$C]D\D=C2F!.'R>/4V<X=9PX9>5&$J;C^B.=KM%SJ%>*+IJ+R^MT'/'2:"BM
M_Y-/.,#>(YC)3,<FJXF57AOIZNL\=:G<LI6GKHVATCY/=::*FV:>N[+F0]X.
M.5LW0[8>>O%>Q,FX&;`--461`P;.;EDEWH5QFYXH%2IG"^[X@CN1C_'3=]#:
M"\3<\7QZ>0/03,"'[NI)Q(ZM-/(\$1(+F;HGA;H2IUU6I)40N;S,(QA"]3K<
M;/:$N@P^CHHBU+5T=>X%NX/UQH[EFJ<N5Y>%48)_`52IO$8*96YD<W1R96%M
M#65N9&]B:@TR."`P(&]B:@T\/"`-+U1Y<&4@+U!A9V4@#2]087)E;G0@,3<R
M(#`@4B`-+U)E<V]U<F-E<R`R.2`P(%(@#2]#;VYT96YT<R`S,"`P(%(@#2]-
M961I84)O>"!;(#`@,"`V,3(@-SDR(%T@#2]#<F]P0F]X(%L@,"`P(#8Q,B`W
M.3(@72`-+U)O=&%T92`P(`T^/B`-96YD;V)J#3(Y(#`@;V)J#3P\(`TO4')O
M8U-E="!;("]01$8@+U1E>'0@72`-+T9O;G0@/#P@+U14,B`Q.#0@,"!2("]4
M5#0@,3@V(#`@4B`^/B`-+T5X=$=3=&%T92`\/"`O1U,Q(#$Y,2`P(%(@/CX@
M#2]#;VQO<E-P86-E(#P\("]#<S8@,3@W(#`@4B`^/B`-/CX@#65N9&]B:@TS
M,"`P(&]B:@T\/"`O3&5N9W1H(#(X-S<@+T9I;'1E<B`O1FQA=&5$96-O9&4@
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MYEPGP_@Q%8*&^\\X9/0K#.R3HX`/B'+HCPM^HO@6TV#V8;G@=AK#&5O%:8ZM
M8^\PLMBZHS5LP@:WWD4WPSD_8;^X8AU<G`\=IT[[^LM=_7$!<!_4B*HQ5=PD
M\$`@FHX-CV[=^*Z[\+-FX7<31[1A0AQ#G3)^K.NEJ0-64R'1<JG@Y;1/M^%[
MAXX@M:<#.*B+D)VE\0!1@INR#"AB$TXD5[I01_A1FEM9%NPHG6:*$($B5@^]
M<^QCUXX/`W-(\Y#6N-!*G"2C,'M7_USWZP>FQ+4?7W%55G*YV=Z3#.PE\\IZ
M1RDEYA11A@.^U9X\_,$$MU;)<"TR%SG.*0!Y3)&R``@D,0OP(!&+>*T_K:YT
MGG-0A`5C5LA?:2GS=(E$N+J[^G%U0JV%)*O-*4Q$K<>WH"J,TI-K5I<^<L@Y
MN)/!:7&Z-;BP8%8M-];89C89?>33GFK.>V<JQ7-/_.>8]7WRU[Y;.[<9V%W?
M$<J0'TC=@=5$=WT#UGT$[?;NL?[BS9YZ@55=%?`X>8;,T(KP:'*+;ED9()1Z
MJXI22:19A:/9>-(#1CH.UW3'^?YV]_>^F$;>E_,YBG".7_IN(,JJM\T_`<#[
MNFD'ALP)I\%56U'1S8LJS0S:29:E65FA8B07L^A['"IFA\JS#FWQY18>>9=P
M'_`#38MER1&@@HK`8>=W>F<*L_0N6`0O*JM_SVNDLF.M&]FNG1U_Z+:;IKV/
M$;TEN@TU&PA8E.Q0J.F,*()W78\RX0O$EJK"7`^>W##ZZ8I+JTR8_SX)R`*Y
M@6H!+Z!NNR,:096NU^N=-^^(OL'V7C9TXP-*L8],)BMN3!0@7X7(V@,<)/M(
M2TD4\`<HDN:)')MMY`4H@<XYT%'@`FH1;02?P4]R<>9],8U44V-)A,OUPQ]2
MBSQ@[A^[9OS"ZC'X6G(E"KU?052T0K8L(GM.]+Q%:?C*K1V\HPKT`:<.-@3<
MU\IGH%@:]$SEUU-`Y`E$L\/DER)LUKOAD4J;3=Q4_-'<?D$E?4LH"!UM^.F#
MQHFX"'WL(?QVX6?KZU.T-?XC3KZ/X^,OU5F1--$XL.Y@)S;V];3(T?RI>-NI
M>$\#@)C0B!.=WV%R<QK%7-VWE]T;4@0**7<7_>G9&`_HYI:O=:@FF'SH]>@7
M?#A<R;5?\>I`3IR!0JJQ8)V2:CD!Q0(!.@!``P!TH;A*3(2(\_^?2%=`;&W]
MUY>4E![W*N<BL5S@BF-13ERQ?JC;>W\+Q[2QIXO("6"^??Y3W56R.I__UWZM
M[HZ-]6>'K^^D`^2)K-32_2GU0^+K,XD?-]^G/47VAXL10M<EG05]@I*[T">X
M0X."_K_24,**XO^KH:"&-%,54$0:"L9O4E'*5ES_YRHJ;%Z@)#!3'FZM2T$Z
M*ACUL5>_IZ.4*7@YZRA1[K-5A1"]1&J)H/YE$K,"79+H@;IB<OBN8(C5U;<W
M<:ROL\MI4&)]Z!@`T2*9QVUV_=P>?2/N[>B9&DP=4)25UI/5,PJ60@5*C-=I
MB%30:66%D2J((7U6IQU"[GWR*QX@)4K&%K]54@]#XQMWX2<\7JHD?"'MZ\UO
MNR'T^2*+&I)2J6U#GU<+=&KZ\*<VR<`./N-.@026!F**L,CA^.Y@(]*K2@)'
M)KF%`$1Z(Q:E11K0M_]4>)(>'%Z*\%I:)-`9P;7`G$9,["GH@GB?K,?J_0+6
MJ(+;&6MZ)EXQ04T!"?ZZ[0PU%:H9=<6HE#/FJ!U&1&I>CO8L[3N65!U&>+ZF
MEH]GZ>,IPL6522#JL!&QM6_5?L1GK[GQS$3(/,H@=1'?VX3*8I4([8->Y'8!
M0C!*`&&YO`?<FS[W6+C,"A,IG+""J#C>E]7!]4RFDN-B#TT07/M90(<^:_43
M3ZV&0W_&N;KDN3UK]I-/S1$SY_R=3&?\C?1VP=_)>M[?4G*S]Q?/.7O6'/P]
M-E_$L<2+2\V4_F^\6N8Z.XDD,:="U$B4VJA=P-2+@4!X*)^OV;U_A2UT27R'
MD6*ZJYO>8P22P9IR^9HYUCKLJ=[N'&W0M)OFJ=GLZJW7HKT73!!U*/)Q_ES9
MC9\:9.JG9GPXXX8_OD+>@)I/*/<D[^\Q/609U$YHS"2`A\!15\Q,KQ';+GYM
MG)M2>1/'=Y$T/N!\<0779[%5M[$5,C_.?>QZJDK4'YB#=*5.(FM,@R+-]"'G
MW>::#;MHBS^!+/H]-7TX6.CK],/64S#NNS[.6RKJ?(Z?B/&C2]^Z]AY707S5
M8%62[*3MW<G%AGM[J.%4>/ZA?-BR^@I(G&N]1&5KR+BFW76[$^2QQV[`PEU[
M/2E,`H`H>%'(`_Q?5)P9Z:K2+"7AL10%NQB\\$B="'D936]\%0DAA6<C[AIZ
M;=*@8.]<^?22ADKJWD+5FH!(BCLK*--IF#;0%E6R\HM&2(VQ](1KV2LL):/Z
MGQT\.FU&G&A4Y0NQ%+X0"XU321.8Y/C$E@M1E8LC>VGFV4*"CVQDBY]K.)HT
M/7M'UT+M<#6I%(+\9FE!@)B'I9E-CH<BZKD7O,+D=&*6EA6)C,4D*@[R:.)Q
M"`2OE!:70X"Z)65.G`TBXPJ<G4MBWP7O*N4U]D6[UE`XY6P'UN6WZ0\!B6R]
MUOUJT`TORE!'%CC+@U#$HT=$8?PWHDZ\$\JB`N;DI#.H4!?6(I3S@-(<#(`N
M*)67;PHO%`*C(8WGA]/#`T\C@.Q-''P",6DK\XT0F[0>-\*:J",`88T<]X)"
MTHO'Q!>'I/PB>V4(VTLSK%4I?</2"(4W(4%D^M8H?42UDS*)-RR*@FY(X555
M+B](6NPT6?'^.'?[E^8J](M+<R,RHE6;8^!4EL!P8?)EV!@@PE+61>%:!"@8
M`6.@G`Z/E=0(DXS^M43DHY,>/*PX/>/(TGA+H'X=2HZ:A[:A;_C!_WC:D7F,
M\'_EDA9L>^DU]([?<';?/;F^/?N\H:I3W[MV'9XH_VJ\;%88A($@_#(]1&C$
M_)CHO8_1BQ8/@C>AS]^9W43!]M!+(+]LEF7G&ZG\(E-J($N:\D!%*5`S=/PN
MA0@!HC,5.4*(J?>8`YI]A(?+)ND!]+`4<$5LGF-."-O!.-U^-IS@D+@@W@X>
M?S*6RQ@0)V\&I`V+EA-]%7D;`7PFR;[K0\'X0.,D_Z`BC6@7_ZA7Y3A_B%'X
MS7&/Y:6@DLP,H5&@Z\8[I1H\4Z#F"^\4YV([9/!4=^U)1?I,I2]ZT_>T;M.\
M+18NU.[3MDB<=(.,\GPB:EM8I3`K.#1.<&0_!%%$5+,2`+6YC]?2\6?IF)MK
M:Z__`$886'D*96YD<W1R96%M#65N9&]B:@TS,2`P(&]B:@T\/"`-+U1Y<&4@
M+U!A9V4@#2]087)E;G0@,3<R(#`@4B`-+U)E<V]U<F-E<R`S,B`P(%(@#2]#
M;VYT96YT<R`S,R`P(%(@#2]-961I84)O>"!;(#`@,"`V,3(@-SDR(%T@#2]#
M<F]P0F]X(%L@,"`P(#8Q,B`W.3(@72`-+U)O=&%T92`P(`T^/B`-96YD;V)J
M#3,R(#`@;V)J#3P\(`TO4')O8U-E="!;("]01$8@+U1E>'0@72`-+T9O;G0@
M/#P@+U14,B`Q.#0@,"!2("]45#0@,3@V(#`@4B`O5%0X(#$U,2`P(%(@+U14
M,3`@,34R(#`@4B`^/B`-+T5X=$=3=&%T92`\/"`O1U,Q(#$Y,2`P(%(@/CX@
M#2]#;VQO<E-P86-E(#P\("]#<S8@,3@W(#`@4B`^/B`-/CX@#65N9&]B:@TS
M,R`P(&]B:@T\/"`O3&5N9W1H(#,S-S,@+T9I;'1E<B`O1FQA=&5$96-O9&4@
M/CX@#7-T<F5A;0T*2(F<5TEOX\@5OOM7U&&`I@*+S2KNN75[9@('F0[05I_L
M'&BJ)#%#%PV2LMOSZ_,V+MIZ"02(M;[ZZKWO+?5Q=?5^M3)*J]7F2@=^8%0`
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M5ANZ,>S-8AA*DG$)3=-V@*$#QA$0`!%^5L>W[L5V/:I6W;JR>;(D8O6W$[@P
M-(J76VH_S9-H,N`QB^Y!NNH7H9]XNP4`R3RKRI$0)1&"9BOZ7_.:@G?`BHY;
MP\#30AO\.NYW"[B:IYJ-LD7K6(3;@D7)%@9$!68.+AK!:0;7H)S,V]GV6CG+
MG>L%:!VD5M1SB"CQRIIZ^S5@VA8'4\A'GFVZSG;`A,8-FU&QU"+@</F%`=&.
MQSI5=(QT:4)PA"R;FXI,'\2C">Z]#5`6UGEU+8W7[N^\?[#5J9DD-("L*`5/
M-7X8Y^%$LS`"$B6A.G*;T8B:0\%JUUJKGAK7[SIEW5K<%^Z2ZQ.GTQ-F[X^B
M+7<JU->T/H?+Z71^V`1Z"5'*!'E"&)'Z$\;8CZ,HG\Q(;@":3T+#BC$!D%TM
M=*`SV&),"E8QR&[P32!![+&6?EM=14'D`UV3`)BB-,ZABT69:NW5YNKCZB2&
MI@9GXTS[$*8@AAZ[1)C[,XHE44:JN_<4X%D":GUR=IQK/TQ`Y.'9$9RDI]GH
M"-?,X\XC3"`"$D"Q6CE:$C7TF=VG0)ZFY&NI]]=(Y92IG(Y43N=4[F07<)=<
M378(M5.F-D\['@%6+W64YY'W"Q`U!P-FGN838OB8/`8GP"D=:S^"F!PF&#^A
MCUU6V$'8NO<^61:M]J[]@6N(!WX?9J@A`/N#E<!SYF[GC_HKZZ+KJDUEU^QY
MZ+E]6TBO<OS=RF1GRSTWVZJO+)YC$I/G<+EHL8Q-%D'&B'A%L%CF`8*>7=OH
M.#F7+@87"2;GF/$JBI`.EW@EL\>\NL`F3$QFI%.&.);SH([FB'S@`VH>&Z1Y
M,VB>1DCSV`+-A_#!V!>C[B-:"#H)302^/9(D]#2Z;`+73+U?T']TB)J)QL&9
MCD(31C^O(Q-@190?*$BF-$0G<S0%N*==P,WHW"QO/)V-<9/LC3(?TNZ9:=Y\
M.BU6.X=7IL[AA3"E+^.5V0MX,[#.A!>HF9R;%KS'TV>9I*(\]:$``AJ=Y"/R
M[BP>2QN34BIX\"`2R-)LJ#`H6P2G%<Z8VQ)S4$,>%7VS&O+6=7V[YR+RL(Y9
M2B'SC6)MMF)63>ET<@X)%K\WK44?T-[6J9M%Y.W1.4*O;:TKWV`"B/P9AGE-
M]Z?Z`QI0XX!_1)XKMI8<1I/#1.@PDD#R0$4)>!G<&[WA._HW(:Z)$DBGYQ+7
MK$)<:G@@A*F>7^U"G7=\^62ZO%14'U0']X*;X_\&_\H"?=Y3STW;\ZT]"!*0
M2+!'16$$1>$-A.3<:[B+"O">N5VX-U+/NT6&VE)ET>W4ID8IKQW&&JH"(>I"
M3=G01AQSLAG/@`0Q&U(;-@\:I]R33;"'R@Z]SE?J`\J&RA0T6PM>F<3@QO7:
M!77DDSKDO=&X;8-V#J$NG:!#%\%OK;,M0H0^'@'UK]JT=`D8&8!"$Z!VS;XM
M\4'%N_$ND+6Z_3.HE:M=>$M!DIE5NQF7(A*I.2I+]%U0QJFI`Q`5#W.$;B5>
M0W4N+?G,)0PQW1T(Y$[#N4!]\>]\M6[X%/XO^(3E8X'EO]2^`OQ8F2=%3&L[
M2_5D`0^RM7VQ4JH\#ZE=\KJ/!3R<KU:-XI$=UP467GK]6,O(ZN,EZX;%\C\`
M]EKU(A7'?EC$&@\Y4P??<`>@^67"8GMB+,WL0"U%1^+A3@%4Z[/`-E8EFOVX
M`(IV^[I'9WJUQ9_656#+NBDAU%%-#4G5Q%"/'[\`CR/DX`?`+R!]T5<O5O6@
MO!VIHR[@=83MFX;B(.3L_"#@IJ.E,KXU&42C!Z/?@`>_6Z24](O'JJ[Z-Q2^
MV8,5#TS:P!E\<XA'B=:SF#^\*P!K*Y"$0Q#0B]YNJU)5#HHMP@[G]*(`T&$<
MGG)K!!PSX(*>HE@RHG4"B$0]M2WQVG%'U;,Q9A\,TETATM#H&P:Z1ZM8DDP]
M%]QM.0W8-029U8Y#'KFR&5=BFP*>IW908EIF`E1C\"+2,Z*=)IV>D@GGD,>:
M.I)?%OA()5Z-$47/@I\DI';,1I)]+J<C7*>>VV;;%C*E>+#A"PY^+:A/WK03
M^Q*R*(CJ;=FK`HI)2-#JI4$*$D^`V$0YS6:<*)>,%LSY_JYQ2Z!4V5>-`_H/
MER/S0(BS?=&^@6=U%E(_DHV)ELV*Q:&^%6RD5Z^NF++H&KBMW!5N"^W*J4U1
M46386W#Q/<4SI)S)?9.$)SYW)C8\<F+CV+`O^Z%2D+3%B;*[E+OL5\:B6DYR
M0_[BBYWFIZ/\?_&I0\S$R(]>\,R/%*`D&+R2P:*MZC>U1Q/Q81#-0'&3$O/1
M.&S@OT!A@/RU:-<3;'`X<-VR)UV69&7(;":?"XI&:W#$:_:P!TWQNK.MQ9@$
M-H5&\5)4=?%86S8MF2&%LC!+O^OY%G`TXG[LIF7!GLW_XM'.;F26/[)&<60@
M'P:R;CK;S\=W.'X2#4I9`^3>L)B]#.W)_[E=#:YO3!K/7#\>#7DO],#"B0@2
M#P3!D6.*X!B21!YIA"8GSZ"I@J9:I"0];SL9Q_`!6%&O/+#CD^24=G)VPCE3
M-R;L>B9[#F$]9D6J^EZE[L(._ZMF+^<+/+>6BVXOW'$@&/**H;&B<TP[P!'K
MY@!:*@IGFNNG^C/VU&$/`Q3O%8E'JI#Z(&?WQ0&,6ZB7T<NRT<M"R3@<BAIT
ML`Q3`\51##<\,@2=-7<MUC0:P6)/=I$_)EXEHY`'9;4:AB`.R@$0#;E5LB24
M+6)ZSA`'![7@7")U$#4,H"IE(X3H=^#:<L;A`1"(#X8+'JXO0WK#O-B<GO95
M3AN/);SJ$+#<?'MN\)KKD)G,0^,<A\!R-X0]_F[Y8Q<!>4\EPY(!9"U-UGM9
MRKJ-O0T>/5X')S8R0VP50:6,B6"\(/.W&^5@:)E)^5&(TXZ?Q3DG:(P$I?F!
MH/%`4*IE?A#5H/5[;\3W?VO/5ML#G0E-XF\;[V>U/PA9GZB3U?/^1!_C$BA!
M,>P\SH^O#C&IYP/E-O/S(=38X524T]H!YH![G!Z5.>CW_/-I")OI0=C<%CSF
M^&G#58X\K&2HLV(ZJ/6RW)AO/GA>L3S!@F3')<N\>FEHW+;SDH8?F5*^J`?/
M?GVVKK,/"ZED_L=XM2R["</0_?T*%EW0F20#`1SX@"Z[:G_`%[@),PRDV"1S
M^_65=$1X))UVA3&VD63IZ)P]RZ`BR__!9>;6"`;S8;4_,1!0!FT1VDGWW7(2
M42%7@#OV4Z=<-Q1MRED6*1U=>>_TKJ[],).R*G@9!%!4?M-V^Q"&$$//R[35
M$DU*3\F3J-NHL"5UY>[J@^^BM))X%QRC.(*D6Y!8D@@4@JH>FIOEJ+*\S4D@
M_I6.D>A@H<B<?1CI%F,!WIC;%)7.Q=(W<LNW]>9;4%&G$MK'%CAF8-7,R??3
M?[?,K9AS+9TU3X)$@]I)<-\IA?S7:`=\KP>Y;/89%+Z_45AM<!YZYX*NQRIL
M9^T@@P#2)A'*B1DZXXN)S&$NLTT:OB#=&JOR;6GVI/U25%@!9I@QV8Z%ZGQ"
M8KT+?<HD$S.)7AZRN/7R?M'5>-L%.EA_)?RQ.,3*]JZD@%_J6M=6N@EG[R@T
M8Z<SPY7CQT.UIB3*!$MT\X`W4HQWBSC*M,/TN</S`X_2=M,_*=4P5.^W%FO9
MOPPF8UGYP#<*O%CE^;8GO<@Y)7[`!8'D'O>3'2*3%5NU%_(.I#WGL]N1NFBH
M4.XL,6S;!JT=J#!4H9Q,E"T+?S;HI##;=+8K&]*@7!B-'UF1.I5/,34!R"?*
M?DWWXI"38'SR]$GA_K@W_G<]M)3#._!QKIX+(<V>?!6="[7+5YV$?AS0D"@F
M,LTBA7+.>7$60$813])X$9%M?#4FTN7K0*--&-V[48"N9=+)`29C',')PWF(
M,#U_X=M^[=Q1D00]S(0,)1@)N<VE<2KO-=(:<Z8WCC$6<](\*6]</2U"8R2&
M^([GY]>C2+(+7NL%;S/"/&)E'F9B'@;,HYBX@5D;`&Y`UZ$G$IBH,;K:,0J=
M0HK_[7_^:?W"N(=C_<H_/T7HK/^LEF?Y6F'I1=EL4.I%95'328V`>QC(FF\_
MW_X(,`"\X-ZE"F5N9'-T<F5A;0UE;F1O8FH-,S0@,"!O8FH-/#P@#2]4>7!E
M("]086=E(`TO4&%R96YT(#$W,B`P(%(@#2]297-O=7)C97,@,S4@,"!2(`TO
M0V]N=&5N=',@,S8@,"!2(`TO365D:6%";W@@6R`P(#`@-C$R(#<Y,B!=(`TO
M0W)O<$)O>"!;(#`@,"`V,3(@-SDR(%T@#2]2;W1A=&4@,"`-/CX@#65N9&]B
M:@TS-2`P(&]B:@T\/"`-+U!R;V-3970@6R`O4$1&("]497AT(%T@#2]&;VYT
M(#P\("]45#(@,3@T(#`@4B`O5%0T(#$X-B`P(%(@+U14,3(@,34S(#`@4B`^
M/B`-+T5X=$=3=&%T92`\/"`O1U,Q(#$Y,2`P(%(@/CX@#2]#;VQO<E-P86-E
M(#P\("]#<S8@,3@W(#`@4B`^/B`-/CX@#65N9&]B:@TS-B`P(&]B:@T\/"`O
M3&5N9W1H(#0Q,S(@+T9I;'1E<B`O1FQA=&5$96-O9&4@/CX@#7-T<F5A;0T*
M2(FD5UMSV[@5?O>OP,/.E.I8#`&"M[XY=K+U3C:=B;7[XO2!IB")C0QJ24J.
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MJ[`(;'<IS'=N5V;7BVY3<J\UPK7L4NQ,.YE9NF;O?M&/?RY^P=O0?!MS&8>9
MTNQ3DK!/Y`X=C-Q6*M1)(L4\S4*99K2&9Z(P+A(EYNA[ZH\34V!E3">&O7D"
M0VDZ7H+GK(:SXXD_-JWH9W&8!YL9N)(&9MIMC1&/,PG6@L:ZF4X8N+.E^'6F
MPS@H9RJ405MM1"POA8ID='EJT:Q6INHI`DJ&N=8QW^E]T(EF)59-:VK:L;80
M[6I3VC7$T+0\>"C9G.MYH]RUW.UX2;MWOAIRRCG<B2?3FK]1F^]A[MW`Z+O(
MGD9_\5?7&*50J/),"[C2."EBW#2?PE*YJ-Z`[^!H#)Z5_-,S$/PH8!^0]M%-
MUBV[%86YBO3;,/W=P6J[-^+O9KEVMJUK>&.JB"?&YCY]JXLX5%FFV-H7LR4_
MXJ!'V&,#HQITFWK7"38F99@E.A$QY+0<T%2@*;;J//L$D%!!@Y<B@ZKL:X)(
M8_&:?RZY9V<01W\149@5Z=F193S@5/G,_#3#4#5=!\GTQ53-VB("LN#?,[CN
MI>".G46PR/D<YE*?1S-F@Q]@?8*W(Q$W9"NE[4FP!E1:'T29)^?$D7(,XR(:
M7S@<]V"&B($CJ<Y.(G9RKN#JL=G;WD7',EE%8:'![NB;_^OQ?P2F/WM\N)Z7
MCA_%:?[*\551:`&IHK/XSYP_.O+B&!'#QH0V0D`X%N!JOS$^<@I\.G,W&?*'
MMF+&0,1NH5YT/L$]*\=96$1:H0DR128*5:0#.=Q#>.<RTGD""(?#SHL,.#:A
M9EYD$8[.YEDVY.&'Q04L2$4*]3;/A918%Y&Z=2Y:<P&L4FBX\6$^*D((ZV@^
MAAUZ-`^I.)[6,41L-`TD,IY^OSBK_)#X:90`EV'9I[CDQT2.A[I@:DKF,2<#
M4S^5[=*!8\*>[DX]A590+=JRZCG"0!^4#-/UY]4(PZER""&AX6NPY3M>M8WC
M=:X5:^LA/L!S;/9$JMP'U;YMC:V>Z3R7,SAH'`AK>@+]@-="I_+$0T4,)\-(
M,^S00RFQCOR$]PT%%EU6@/10!S*#-AP3\E#,X@0`\(-%7P-9>#4P5Y"S1<0%
M)4[B'U6A29!Y2!XI<WQJ0OE]<$M%KZ`*J*!\=]P57ZC\E30Z7N$F:AKJOE%1
MUVZ=+=>&`N\7V]Y#NH@$J!90CA)PI]]"G)*T*$ER_$'4D5;QV2>5%T7P;5FH
M<08')RDZ.KV33:.RYL&,-[4`5KA&W&`IVG%=*^VS<",E<)T.GL6^`REA>X.1
M$BV(2(<'\$0EZJ@]X7:'''$UJ7LJ=\25E6E[")NDL.F@IC8I$[AZUSO@36#+
M]=>B!.'XT+1M\S0,\8H6$0K*P7:00*,]H(_=BL;9AK/$PV?QMMS7>%4W0VE$
M0-=$2P0ZN`H%]_%VUICONZ;;MRP(4_YF'@A?*JC'4P8^5'BLP1?;<CPNF#PZ
M.O#45FN6^\HXDSR%3H.OS<&T)2M&Q6+W>!/I\28<;VQGFOZ+JL$H!UA0AM!"
M8$,A"`X$<OJX#C!VB`ML`RX@1.#YL@$_;4,V$!EH%*$?!^@/E@V7N<ZI41!?
MD((($E9Y&`!N+?E'N-_&:<(9%@_X_&2TGU&DMN8P7@6^C+N#Y6?AMJV<%*Q[
M5)H\-K'0]1"`B*1RQ&@=?0UPYY5JW=?X4-LX-=N+)_>%/?]L:8<_T6XRYZQ5
M/@)U#R\U,-'6W3<>"3V1GU':N1I_07)>]:0JB;B8X-*3UXB7G21*`2+6FHHW
M#?+TB5L\NG$K2[Q^FN?,C`D*8)W2#C[Y4-IO?@WO@7L@S,++-=/%"+-3^7(?
M\!M)X[=4P,@D(RH@PM6(3,6X#,2F7,(-4YIH/`<SN*;\RGS>:9]W?EP@],2J
MY&VMHXQ#N:7^GC_LX)R&<2;C,TXXY[P-BB?1[!W#.-JSRX'"IN3'\QON&<ZL
M$9^56V:F73O95G%OYZ=+QW.H%7D$\ONG1`.6?+@5%-!7PCV--D1LAQ"(B:SQ
M[X$G_MB7K0MA.X='[E'Y3$/K^.0TMBZ8SILS;A@8%N.*7E&**2I%"3SFN&<X
MA16G,`A+SCV<X$2&VQ]5*\\O4,F9$[#H&RIRL,5O$'4'IW8+G?V6[?=FZ?9[
M\]Z!GFJ^_SHYV8K*N8F*:KQ,E%UG^HXBP^-U]Y;#[L,U&?!>V(F3SOAF'*G#
MV"/(4@J[)XAS*=MY'<N_*_ZI2L(2V#:K%?,!GMPB./9;ZO%8Q\D$B&MV!F&@
MR65ZYT)!YA8!%_8CX5"=4Q'H>`8GR*M"N?HUR24&T=;E@J_^AHIYZR!_Y)BA
MZ@,33.H^;]OS)'A_DH*_E!90C?4M(_]D>%2?Y-CKK/N2YGP!TA_+NA6_ER^"
M^:.'!%^EZU34J:$ZW+J1KF^="0_E\7I&13<2HUIF(11?J2$N;XG1&-=H">\,
M/6C1T:%1(459EO_7ROOL&7/5BU_+<0TB2-R8RKAGS(-IW5Q47-+[]=J_<$B1
MI$,A@2$%E2YZX3%['SS_99:!:%C5MK051K"V&#N*6D%TA;(=4[':[I<@8*JR
MVY`_U!@H*Y5I?O:@T_RF,'_L:Z@;!NQ`-24I2_9SLB\#&H?GWA)XDNLY:`^9
MCC4;03Z`"("AAZV!]655(9]W8E<^X]"EZ#9-VPO@BD<*=AK*"&XA>N6YZ#2>
M78.]+:40;N:7XM(\]"PY-T.9*^#^?X#B;!!M+C/A@#7)HPP4#_,C),\*L7W@
M#L#7,7;F09XAR"'A\#50,LPSE!O<</W>3ZS=7K#CIYAH=L<//#L?C%]QI%?\
MZO_E9;G=3@=Z;Q=D[\I[61[=@QP-&%_<]QF:!=[+TZ-T6'7&Y'Q4QU%!>"A)
M;`,H'\RV>8+#W>SAN='0E7DT$!8TW]@Q#=PCCV];TDM($2.BG._W+<M6(.TI
MW#V2&:4))%<:CZP>Z8QJQP38KV&7>0/@513G]'`N6=$=.AXKUQ]KR^%E"-(5
M\3W1I@:.TQ*I%X%?XV12[&52C"^.W:YMOO,*-\L*>?Q-@`R3#<7C-;+!2EVP
MW,E92F)_S]R.+[R>!@3_;-SXH+<4>8M_#W[JP=DHF:@JO'=CG)FEL\<LUCG5
MY7+9.?NV9$65A@41W([PM`<G*UW%9)B\48613%AY/H&4`:\90%!3TS29TIP#
MN!<?`.[&NA>NY<#Q0Q</57CQGGKQ[L<[P;T-;S$6A!=*KO]07BV[K=M0<-^O
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MWKM.LCD_'V7,Q[XL9**UJKX@URX6H?7SMV]V@YSS^`.T6M-@P<0KNEV#$5Y&
M8$TN.&3Q/`"7W#=\$:&P.3'[6!Q9[8K2G4Y&SBW2N`&6%H6>UUCY1-N-EY/V
M+@4[6,UDQX/9]A$9;#+9-(-L634.]>)L/G$7\]WKI+,06&OB^1`@WUH[C/<N
M*RZM!%'(\TM+3$-6117B!E38S2Y4%25)O*D2$C3L@':>L(Y=K#Q=(=PDA!DL
M7<9P@F!D9,3*ZS$.<:D$@`ZM2O%\Q&$0;%,C+!M;A[W#9];LP]`DJ!?(W:@A
M8P>1V#VD30W7@6$!:R?C,(W=U&BX"N-M&9^%"P72UOD6?OU+I`1MUB>S)?/T
M0`_!T*U'`T4-ESF/N\'Y4;V@#D^W7#\81R4O.7B_]RFEP2K.$G*Z?MTN)K&1
M"*`[X`J[_8J;_M9]F9!19S78.>[S\%-@!7$3=+;)6#I6)DI5;7GS?2-0XT9^
M]?6-D4<U?/D\$2(<6&C&Q^E"&O3ZM'S8R]_Z)ESX=L%-:I"@_6)3@F1B21JJ
MG?X0P<=RC^6%$WDA+UB<0&\CDWK6<I"(7-@]RKIGT>:HJ./3'2KRKFNYO>'A
M9,CPSVB"3`(0B9S"E<_$)B@N7FC(IUF8\".K["E_'8+0S/;&=60;O*5O,KK#
M-1VC(_,'R3#+X,FO!O=5^G_@/D+"G`/W=1J!0[B,H>TEZ&"KO:OI0JT!#R[H
M]1O&O5_\9FD&911=^B&C]/;\+AK5L=C`2"W+J=>!B75@8LI8T8%I0!I^VLA`
M(0ZU%$,07^3=A#ZNWIMFO*Q20.;4B7MO9YN0&$6_P!R,;.(UU)36HBIEUJ#Z
M&%'SSJ#6;L:5-9@!]L0;.O<5J(4D!7H512H4]:8GR-SY_'H\?;2G^\W#OW=_
MMB]/,(W'%[$QI_9.&AUEX^`PL=\&M$-P1`1NIL9N(S6J!BJ,FU*-)0]70]W_
M??O;R\@Y<4JB2DZ^IKS?=!_M:R<E(-;`,F52DR<U95(SF71<BDT#0:JWRJ&H
M0N+T.>T[Q<XZ7Y/II:J9<LOUK91[M7A>+(2FYGEV14SC-AX@3$A#P]3`ASRS
MM_ARIA8;5!ZD/,4!0R!;:JV)J'"-TWV:NLFM)K>L=X,HG%E@X.MQO@1I[IB4
M'_&VVY^()E14WG,-NFM?J?76UQ_JW7#=:3O80"Y'-.*)=#X&O>GS\662.VK0
M:[2^B08YDS[&&\JE89X\:)Q;ESNN0TKF6`.IB6,1,D[3QAK`/FM<A^QS1L%=
MDS*,QYVS/8WA)E36HT\H<FAO26HG)O/GYO$H3Z?L6I.XUL2N-137FL1ZII%K
M3=FU]KWJ6I.X5JHXN]ZV)K:MT+RO\M1*WR=H6I'!S8,Z9`?X`C"ND3?-B&W*
M">PT5C.A<Y$;?7!*U)MF@1M3Z,OT6$"MS8P>ZS`+0ZZB%H8,H5>1!+>OL@/I
ML:*RD%X]ODJF/_#O\66IW$PT!=8SGN[:2<%1^#CZ9+N@0PWVGG3+9PX'5O0B
MD![U=:`:'NPB$)WN59B`4%Q<3SG.`=:ZX[0H4$P5:R'AC"DEIR;#B?]HO)."
M$R)T>>1W`8:AF93=WDX2J+U"5O#30%9&.]PXW-M_`P#ZI1L!"F5N9'-T<F5A
M;0UE;F1O8FH-,S<@,"!O8FH-/#P@#2]4>7!E("]086=E(`TO4&%R96YT(#$W
M,B`P(%(@#2]297-O=7)C97,@,S@@,"!2(`TO0V]N=&5N=',@,SD@,"!2(`TO
M365D:6%";W@@6R`P(#`@-C$R(#<Y,B!=(`TO0W)O<$)O>"!;(#`@,"`V,3(@
M-SDR(%T@#2]2;W1A=&4@,"`-/CX@#65N9&]B:@TS."`P(&]B:@T\/"`-+U!R
M;V-3970@6R`O4$1&("]497AT(%T@#2]&;VYT(#P\("]45#(@,3@T(#`@4B`O
M5%0T(#$X-B`P(%(@/CX@#2]%>'1'4W1A=&4@/#P@+T=3,2`Q.3$@,"!2(#X^
M(`TO0V]L;W)3<&%C92`\/"`O0W,V(#$X-R`P(%(@/CX@#3X^(`UE;F1O8FH-
M,SD@,"!O8FH-/#P@+TQE;F=T:"`T,C@X("]&:6QT97(@+T9L871E1&5C;V1E
M(#X^(`US=')E86T-"DB)K%=+C]O($;[/K^C;4L$,+9(B*>;F'<>!@X4#Q%KD
M,,ZAAVQ)M.FFS"8UGOR0_-[4JRF*\F@28"%`[&=UO>NK7S<W;S:;6$5JL[V)
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M"U'(Q&#/O,A69%>Q&6M^#*`H9\W3M1CY"%.0Y<A33=/>3U&^)P,N=>!YAPZ5
MPK*QO`!>S@.E>[75=:?."#6#T`F5>O_RKJJ=&OE!,<#WUFF6G&(O2L;8$\_9
MU@L4VT*T@JE[FH#V497`;L>[)80);ZFGO2PMXF`/RH-;SLA>V0X-C2KU:"#B
MRKVV.R#<=J)5S\]$K3X9E6."@L#19">TT#,1)7I]IZW;FJX#BA#@8#?.+O$Z
M7UW)+O!Z9;KFF>_KLJ];"^3Z)V.L^FK;I\94.P->@=2RL,@AH9RHK4;.(M97
M`ZJ`7/&$Z<7N%+AA%*[!$"!1T'TUO3KHKJ_+^J`QB['8213&:9[.Q8[&S+64
MS/6$N@6_H7^R0A'PDN6).MOR!AJW2YX==$-?5#PPB*[6\@'']Y6NCL`?C?7.
MM(/SYU"0-0DB!^4[>]=[5YK$Q35MB7J,=D-G_,3V"LL#^/(_%W<YK.PQ'+(`
M`T0?==WHQ\;<2ACH9B"_?M187<!THR?1VW.5IF/V?0A`>K`\JJ0(CG!YV[4D
M):BQ?72F.\([M&F4K.M%C-')TL.Q@]PN(4\`-3"MEI.&3O(Q'G<N'-629\OT
M6M"AX.!J8Z"!X%..SD./GI8H/0P<:I"VX(YM)?!0:S3BVR!&X`G=GA1&7,U#
M[Z)ZPL,E>O867G4UV2R%9*D[S*M2IRGFB2\?IY3"*Z,;([$.I6N=+B>I!\.Q
M'$,47_H^$'QHV<J:`I/4FP1M91J4D4BAUZQ64U+IR#2%.+C-X=#4I@*7VNPA
MJTX(4AU-DC`KI$Q/O85RQ9W7`_+4+U:!*?>VAN_W`;C#@3VV#7R.1CGTH(0L
MG@0*%WEX-#A6[5;1OJ9%"Z$U.6Z1MC(./TB53_J9]^PX819/WI.?F!3WP03T
M9:AV2`'2CD'*\+V%:A!CJ.*$7`N>!J/L.F.0-4S=N`6I.UQ!\N:9@XC/`CAV
M,(CA^#8&VHR.N)&P-W>C6>23%TG*AJ@QMGPFA^KW!LLYIEK(B44R2=QGH>LX
MLKKA+-PLK[HQKUU&+*J&A\1XBD61II:GUPG_LEAC%9.]`U]I)D'^@XGQ\6=0
M4!J$'C&(0%/-$)8C%]S\:122$@"03E<K(/)^'E0HP22J5&=*K&#5"1F`;_M$
M$RVC];6X@#J)*B]'>%Y.X?FC;N!M\.J]P9<)H3#N%,JO%JQ2ZH/9M5*)_DUT
M\:GA0$YT5C>X+ADJ,A@S7*6VWIL)%%E?>IQKI:#Y5[#N7E;(^2-2$CE7@LG5
M@.SP1.J@+W=<F&8$^'Z'VN81KD-@':6L#G+.<;IA^T\,/'HQ:Z<8M>.]"#'J
MJ1:Q?[7L;$]&/%2\6);5GN_O]N/^6!!G[NXK5#N(5Z-^W?#XA7TFA8ZBF-3L
M2YN:DM7!PA^G*(0WGCE%_''V.3?-*VK74^Y`?)!.4I.(=H'9+[JEWK<74"G&
MJ#OO`B[ZA%NJN`"1M]*H-(T,GMR?3RXP:_XNVPCB:#WJG+J(X#<#P0`MY7_4
M!U0+5_?!ZNK+X"!0;Q65RDI15G6$?DML+K"]A">B.)LD@1F8?F!X$Q$N8(SJ
M*!?7F.WK$C,/L5^$6;J6PG,W2^H,I7]6]3$M88KA.@NE(H\N\?T%R!!8,<&%
MZ007OJ1-6'K!HAMO4=4_'R9MHN\JM_`)U/UY(RH'O>F?O2^4NNMJXST!Y`/S
MG&B"G7S3.W9BW&HV@V<"S6>^\TP665E-[?J1LF]3Q9AR5YA#@MU76>PQU5S1
MR@M@AMP*04?L/0LF3GT.6AQ0/`*`Z=1D!@T=^AH"&W(W&)0>!?&)$BD.6)`F
MBZ@BX_%+GL=3]#MZD6<+PQGJ;/1YP8JJ:=[3/[&!K8"J>+GC=+266YA[5H%'
MQ.O`7C\V`=70>)#;CSB&V'S%4P-T[9^B77#ZKAUV>ZBHT)$V`#8IWM-PO5Q/
MV]%9J#]@RGJJ^SU7H)@:KI0[1W!^[<-)=L<`H8D$"$$$CZ:JH6.@.^9!S\-<
MM&SDI)"\H$L`@=;UC(:H+"-,_661$RY<8N$AFOD$DXY(M!SA*>A)6VYZ,4LU
M]1:#&!-"?HD6?^Z]$X*)#VD#`4NY(<-0C<&"VC[_LLBX_V&C[(PUG6Z:9Q"D
M;-@M$?-`QTCAZ7N1*"I>!DH/`;>94*^Q5#^36QYU5[<#O-`>36>)CX)4A'!1
M`;1'3.M,.712'\2QY*U7M5^:KM?`:VV/4-//#*"V@ZV`(BVV*/HJZ/H=O`E5
MO_P*,EZ\BV4@7F53$YU<6?JMLFW`3U%=-:(T$BD)*"=&GG[[V-0[WW6=%Y8Y
M4@C([Q#+M)VI=U:9'^5>VYT9>ZX5%(,+##F6)]_-5$9:W:/F=E9FF`FP1I.[
M\YKE-3X&6`K"WO%$=?JTJEXC"=GT/3)-JY[S$5,G47X-'Z&$\D`J#\S`TH3G
ME'DN!!$Q\A6N4\^U7_\?R))CGL/0RGN>L#[WO&(40/Q@<+7=4=YJ']M.$\`8
M,Z6DGH024W9*3()U[UO9IHB,L'A*UH_S='75_2ATL?Y,L^AK\<N!.>9L>N15
MCRJ]+V`P0R5(`NI[V-R.0EB\!I(FQN&"2W@<G+D9._:9CTQL?\6Y7JG4<XL(
M_$OF\&]BDYK7J<1D89JM)PC^HF;YTO#3NL5V=$0)VH1<`OPA&!_IS+:!:JH$
MEFFI`*ME'D\>O<AG%M+'RV7D$5Q>S)AD89'&T25.'TME+"4`[M0$A[(`RQYE
MJC5A.>P_GO8\U[WRAQ9`*!+8!/6^5P<Y(AM4HV3)\A?[7B$\\*<AQZ]XHF31
M(05J7N2>)]TQ-T!8-G:RWPM[)SN<71@[C'5PAJ3])1$)`<#9/>,W//^J.I/Q
M##_/&])[PD$2"@7*2,"[DSZ55P%+\``C!4#4CF='8V<]Z:SQE!;7?97K=F\Z
MXWM06?KY3<YH!6<T[W%G%>TAF''(4U/N+2]]'Q@6_6$\R28WJ84TJ2_*/M9^
M8GF>H,BQJ>F!#!:T%8)R&(00&DG@4=MEIXBW_I\V\N&_G%=-C^,V#+WW5^@P
M0+W`S"#^BN/C%%@4/?36/Z`X2FR,:WO]D6G^?4D^RK&3V>RVET2R9)JBR,?W
M@M^!IE_X,_B]R(T_B[\1^RM$TG`BA*`64:#TLL.,.):\P^4;>Z(E;W,I$RJ*
M/)('!-862PS6,N@U/F=<8I@3S5[RX7NPKK^H2A+T7#?Z0A>A-I;0#.0M,5L"
MN_D$_#V=D^?,Z4IW("!GEN6CKW[>8=(,U9%V?Y1Y'ISQY[CJ*#2CE&7JY[II
M%'(/S-7]*D+S0%_H,+/ZQN7784:&?$:&A2+-19%>I6>.PH]4?5XA*O<01&8&
M4%O,]/N")U$`LFN+;WBJ1BHX3E_7W6KR1:3.[$FQ7AW]ET^KX*R"L0:G>`%.
MG<5U23IF`<K47^OK_R^3*X%+%\J";`OWU?1/)/TE^1-)?3J]B%K.0`+!V!PK
M&36V*3!B@I0%NJZ+9S"[Q!MULJ?!,_3U4DT>9I1+=NFB0#)V]V59(60\H6J5
MU*=L%G%@NKX]NF'`4MO86@;XY3A2C0C>A,QKQ.\3%=%>E]2BN,LCW>JP%<^N
MK"M-DOP.?)*9=:B&$KZPD["$\KE>R89IJ!,+C(#.(0['J6^JH03A&T;*JK^5
M@2^"<7MUE!1,4`I7G>G%8]]JG%'+Q32,[:%23DHGVD8[3^5G;]42M?VR'9S_
M<LBM3JV#_BA926'D<4Z)?H0<8J9YF(J1L;$@CGU@KCVV3,BH9'NG%&X7$\G9
M?"^8P="1"W1&G*OKF5Z<3-?6-%!U@8".%S68Q=ME%FGJ=)[PD5MRR`PP3WGK
M1J:R)$'K@6DP$T8]<@R">7OAV7SF'8R+;V5;\Q'%QD#U0NW'FU.M$.*3,1<7
M5Q:AY9R]G+CUQ2NO?),L*68T!T7Y("@I\SSF8LAH5,-JX4)LD^BS/=/9A#TS
ML:ITBR/!6OL)X1O?SGQT[\/MT=/9$^51"&:.DZ5Z,BYPH=D7OO"Z;=_)=-].
MIU(3@)PB\5!?^*-*"JE9R>$)^*(\?J"?`C%P8![,@V,E0$3!I@JF#,A?TVB[
M%`6W+OLLSY'E7(%=[SKZ/U"&S#>_2[?QYZ4>_.8*.U'%X'8')YIJ[&U%]IZ!
MOU3_89(\NL(Y+SC\$CVFXA=3U!20ZDA-3HU+<E6"4/[F<.OLO$*SB>>V0-\@
MFG7;%NZU5[B]PJM&YDUR]T_"O%2P,@[ZHC1Q^&RB3;AAZI2`:"1*G)0%"LC'
M?`@>2^<@+TUI!:&H\NDL3[O=,[L+&WK3XN*U5.?:]PXY95/"^?G,2I!W8$D4
M"788.\8O4"?2&=H]MF'IA,UV7#QC@,*\Q:J1$MW)P</@72YU^0()7IW[$DE?
MJ<>&=X!X1<1DV<Y#=,)4VWG*K@84GUHFW"MPAE1:Y2X`@T_A'G.=XMM4X47\
M81EC.LVK@!OBE8)]1CY>*>*50TV)$Z2F>H\V(6?,]1J6.DF$+$IEJ80^2#R8
MO1WH8DF"J(@ZJ0(YXJ^P-_+BJB":5E?:_>#ZL]U#];@;(3)#47B;TI_5-1>4
M%K85IM2_<[=E*51.G(E4Y0.=PUA3HV;\=@G&`A06NO&F=GY6?OS1</HTW+HH
M/A_56)(CN$*AD@VW^HA(]?.R/RR5A_&7DZ7)HIW=]QZBM)3MU8G)**.K=AHK
M%_7N-&^$!FQ>DSQ[U&O%-<]LI0`J27LY.S.`39+=M</HBB/I->%3,"FA$I3]
MB60.W_C13)W!(T[MP#PE<:ZY-'4B:'F-<29@[\M*YDS(LN#LO%69JFDV>IPP
MYD0/B%PHPF3;3?H(80SGA&68XT0Y*,TE4.@4#N:BUSG``)N<0,6@,-(XCRCE
M"F_,1SMA_X';L2:UNO9#\'#_,`$"+MQ"0M$[JTOWA7YL>_.&9W21U-G>L)7Q
M7>'F%MUYN9S?_Q&2</=;O4*]ZA'4?1#Z0Q1XU-)=]CO'HV`]9:'OR52-+^NZ
M5V;WE7*$=54J=[01L4C?:?&LP1^WS`@^<'L]?;)X4"/6=!CU:,IJ:(\_*WMU
M`HJS6AF<M[-VP%34KHM)+?=.'X^H"N;>NC9PI]L&0E;5/4Y27:U'NW[SO_GZ
M\N'\V<NEF=GIP@X^F`C[U[]^^7<`>N<5VPIE;F1S=')E86T-96YD;V)J#30P
M(#`@;V)J#3P\(`TO5'EP92`O4&%G92`-+U!A<F5N="`Q-S(@,"!2(`TO4F5S
M;W5R8V5S(#0Q(#`@4B`-+T-O;G1E;G1S(#0R(#`@4B`-+TUE9&EA0F]X(%L@
M,"`P(#8Q,B`W.3(@72`-+T-R;W!";W@@6R`P(#`@-C$R(#<Y,B!=(`TO4F]T
M871E(#`@#3X^(`UE;F1O8FH--#$@,"!O8FH-/#P@#2]0<F]C4V5T(%L@+U!$
M1B`O5&5X="!=(`TO1F]N="`\/"`O5%0R(#$X-"`P(%(@+U14-"`Q.#8@,"!2
M("]45#$P(#$U,B`P(%(@/CX@#2]%>'1'4W1A=&4@/#P@+T=3,2`Q.3$@,"!2
M(#X^(`TO0V]L;W)3<&%C92`\/"`O0W,V(#$X-R`P(%(@/CX@#3X^(`UE;F1O
M8FH--#(@,"!O8FH-/#P@+TQE;F=T:"`S.3<Q("]&:6QT97(@+T9L871E1&5C
M;V1E(#X^(`US=')E86T-"DB)K%?)DMO&&;[S*?H@5\"4"*$;>VZCD93(Y<A5
M$>V+E`,$-DG(%,``X-#R8_B)_6^-A3.<C)P4#^Q&__WOR]<OUXL7Z[516JVW
M"QWX@5$!_'AE3.('F4JCQ(_4^LOBQ6V7J+(CBD!U9;UX\??W6NVZ!9`'VJAU
M2:L@5.OSPKOYX?;'=\_5VW>WOKIY]TJ]_^GE^[>OWM[\Z^WK]VJY_KQ8)7YL
MDERMM*_3,%7K5\Q((R/O7=/;3O6-NFWJC:T[N\%5UQRJ3='#!CGHR(]SDX$V
M<C=(!B5R4N)-51=U614'];Z':U]LW7?JH_=379PV%;#YN&15<C_567*I2J`=
M.QTANP_>1Z^JU9?J<*B:Y<KXN5=WSY7]E=>E/?:JVQ>\:ZV25;U11]O.3C:R
M[.4?]?CW^GN,1L316.G03TW$.L4QZT3JD&&DMC%^%,=:K9+4UTE*-'P2^&$>
M&[5"W1-G3DB.U3%9#'>S&#XER91$ITA#UR`#R.3M81GYVFO.G3I;4+VG[7X)
M>H6>K=6FH@]=V9QJ/H/HG#K^6N]4\0"%:@LA78()GFJV9+T)()[9))XZ&=71
MK(Y*OGNNSGM@Z95P.?3VJ!'K$WE6W2Y#\&?#VR]+'7I'7A?U5Q"9>.J3!8L\
M9&")P1WD&>ZZI?9C3Q7'8]L<6_Q2T'D_4*H"0DF:KIRJ&!WQ/*N9NI0QXK_6
M@@(02Z^%/\]VMN8MY&-UQTNK&EYLD00\!GH'L"V6@=?^(C2]$C[TM:_*RNT=
M0U5TW8G7PD`H^DKX"Z6/26<\I=9[I\!41R'^-(J3976H^@J\!7*JW8RC!:(-
M+Z%F93'1]ZLH-!BONKZUA7SM(!_D8'>?W[9M9D:IF+??`0U'8_U7<7XTU&O.
MSF==(,-"_L_Y#ZY".'VE;FHYKV11@E:=Q"-"=QB4N.&MG9]NY53S-A!61R$F
M&6UIA7-?[*8'CDQX54OC.4)8=H-"JM_+-7=#E)*+G_BO(*:RP3A]';*!RD![
M<EMR(7+2NB6X#M+^+)_ER@&4$*M5:QVC0S_J5;B%"X'KD^5B6J_%YO.IZZ$H
M,U0#F@[5$G0&_J;XC^HU<;L][ZRR<K.:WB_X&W29N^)`RY.C;[9<OK_.+Y!`
MN45KOH;]`/1_%@:0":,9%TU6^VF>1--")_.RP="4#7U;J[*I:UN"AVMUKOH]
MN$@5Y7].55?1-Q@=)M#!<P@I]*F&M#,8%_R#]L0J0&-.XRB>#+6AI:!0%%5U
MJOETJ'8T"&%$$B<-=F*?^\6R4&(&!1/EZ8376"$4'X]56[7V0,S`@KZJ=S`F
M>2Z&L1]$:7YIO8X')WWPC@4Z,F9OYU#B/;7@CK3!D)R.JA^[,N3:,PWVG8X-
MNF=?T1'&Q7AWO(&I4=J6[Q1T(-_E?D=Q=Y?0&9_![?2)">^8$`$$[?>\;YO3
M;H\QB'SL?59M"Z9OL0@@&>^$\4GNH_8S#M"^U>/V%KR;505/7H>2J"_M[2PU
M$-.H<]%AQE=8KM@W);I]TP-^>0:C&<</$E5U>>!<$8QP'0"=-L`$KA00VJXG
M>^:B,?6=+UITP,ERZ,T$?\PF7#Y,.`%%HC.V$6<&-2(,'ER!"-D-[[ESYMQ[
M<M?;<AS;<B)\CG)?"+_^/GA&I'2.%8Y,G&4C*[G;\H&0S162G?1)$>)T',14
M<K";*W]/(N0$9"2H]*#DS\L59@OUA;GUXPB,O<Y7%[/L'I!X#<4B([&U#CG`
M#)3)>1J_/#3-28UP5&,8W4]&#138QT=_\70<X?R>CKAA`"-NX*0P<`9TL]03
M3/$$_JNS=9KNIRRLDU<6G?/G]B"\SO@'4'4^U+(1A88<BP$)&^X,9D#"9L2Y
M9D3"9H*$9Q2"A`WULIC:Y0!PX6M)7_?#9,@U/=%<&Q[ZB@/KV'Q25BD5,)QP
MVTVY7Z4,AU.!PR'#87+:DJ-I!!#C#GN:F4!B]K,1,4A+/0D@;HO`MK\@X`MW
M3ANP3<"S&/+?6XM`X=@5+J/A?$##0T6/@'CL&B,@ONPKEZ5(@!B:M[HII:@K
M>@QPF>7W.L&3^]9?.F>`T&$/YM6@BNLVT-]*:21/U5M06^X)]8&T=HU,B(2D
MY^>-,T6@[&C);&!=P(2AQVO"7Y#6DVDAGQOT88*/VWX/P.=9['\KI(H'H2QS
M/I4Z&5Z@]`2EP#`F^32'P7$M=H\[!C\&DC<,X^OUXMDSF&*AKV(*-RTR54?;
M5LV&WP:H*^2J,5)T*W=7]!3H]U658/(.RZ:F^3IXR["W..T!3.6QT??LOD`'
M'KNU;BA_F[(B%@0HD3<I!0[74?3(W&_::E?5@!N.IQ:40]C25J4E5Q;"@AZP
MP1314@M!/,)^+)L6X8,8)8@57Q($+<'IV;09W8?^-2/LW[%$<WSE05]GZ,U@
M'-M+2#VO`:\74ZS?U,-$1+^%X+BIWSYX[QK5G2!PSO/4D5'E7<T<?D/-:54_
M_+@H3VUKW3,$H\Z"-]?S]L5ZK0,%UFW',3V\`XR,AC<%5A38T:J?97DX\;]E
M7(0O#[BL/74K!+W=\:+AOY8])B\"$!L-4B]UNHX7%!@:1Q'P>5/5XXR490G+
M"O(#4LQBX5P,X^TC5PY5,1FTE94>!RV^<'.;YO,P:8M>ZGAD>7!P15VB$0RB
MX](Z+620J\FL[RH)>EF(^U*'"$AZ]=L@WW&90(S9?!\*VHWWGN8FOJ<`.1YH
M`U;RI)1YFGEG]0GJ:L,/&;ZQYQ.KYH3\C(4,%%;$]TZX8?I7M*J/)Z&;<2OD
M(Q-AS4#F=+SC9$^\+?^513WC(`I<:L?/G@3]1,SXV9/PLP<)J-`3BF=KW498
M^YB;H7>U2.#34"V&TQ9<:[C=9W&"Y3L02%[K%)Z9.E=`B&#KU3T.F1^D::96
M`X%KO^78D[GX$#=IL(SF^<]@&&Y/2PU6%31"_EE`0U2A?HX/P>"BP#1D1YBX
MD7%A6>H;HY/K2JZB1-3$P9/'?\I2:+`Y"!DM)?N&#(5Q1H;^@-`$``I&+/0.
M2E\8$OI!%F8/VS$*B[BQ!D^78_ZLG"S_)CGA-\@!.)%@S,;<2+2AH0J(;JX(
ML('(3/,(R0!J8.?P>FS'`*+FHHUO8-BRZ$%@.!7(7U^O%R:"2HE4I!,_2E0*
M<XLB&670U!80?%6I10AWA""#A)J>AR;!+W)*WR].4W<8I[Z>W\U@<`QW=92#
M4Z;G+]<+C74(=L`(HU4*ED4JS"$Z$(\O$[_Q\$ATFF,O@76490F^!&"9>-/]
ME36Y<.*0($+#D@0%3I6&<H#\D^,,S'O`&WQXQ1M\>-\;N4$W7),;):D?7E<+
M?#6FS!6O90`BV&DS1$@#!`=N49<X*V]HO,Y[0#)!E/=R&:P*`\PM+<F%72>7
MH*AEC,!^F7CN)04=.38I=IPP2L.A,PX#C<K+6[?%!K%M!Z.UY9&]4O^PFQW,
M@E.]Z5ATZD<X"^%>EF<7RCU#BMB/LX"[L*,0X`.EMEHA">10"E!D2I&G.N%B
M)":)#SRB_YE)GH*5JPM=O8ROQS#(_U^W.2[3WNX\?>4U<$,P!Y!_=6"<9*"E
M0-)X=K5M>-^N\)U'X9`/%)2_<51=4$<=AAP(!-H]E@@F3N-'1B16-A@`4_$/
MVJMEN7$;"/X*#WN@JD(6`>)!GK=R2%52.6SR`;3$M5VK%6U*MK-_G\8,`%(B
ML'$EV8L$LO%H#N;1\V?]J2[NI]=Q/J'&NS<CE4T4>E<TH0D/Q8`N:^]DO/4G
M-6L9OK*`J)55OH78?!A)46L08>Z&U]^X:H5N(D'[2[INEMA-H",X#VNT.S=;
M\&KG97+38J:\++D<AQOUKP]?G$76:$!C6')<8J$$-;;4;_`(=)CE?+GG`:0M
M))A_&.FANO/0_HM_?>#_8B?03Y9L;=HE6+N#CZ*.5I7+R;;!IY:"I]BPM-*-
M[#'B.0958#MG<^&Q=E=+=O&=!HA\&D^/U/%-,Z<:J..[X?2E./);3$-3>*:<
M0R2-#B0-I!4(]-:-M6X",2.%]N_7BGU)<.J:PL=I?IK02H[%8;R[K!,>)C00
M.W!LVEA;T6%CB3I^?2(`&8"UQ*5K"Q_\\[-3"B_49UR^7=U#N_)YJ2BL6O>6
M?LCLK8YG;:]@/7?UQ3)0B#;__4)&?1AG?SR;_O3JN@TWHIA6%-.68UJ5S$JT
M%J^8@6S:6I?BAHP6O77^<&WUA-Z>YK=A/A3C7_N'X81RLI]\]IB'/0_H2*%:
M$2QOK%0X\M;NAB]$_\-%_W*ZH.D[7PJZY//;\,39!1J-LLMR@$@?X+\)&@XA
M3OE2<%-"9N[XO-YT/I?],5V0:Y'-=\Y.1QJ3$27DG4)=1'PI9^&V+=R#5!H/
M<"+WI/FI<RV3+!EOH<Q*"*U;C2155_<JJY$\G-9('DQK)`_F-%+N7*^1<O`[
M-!+"I3:4]+ZF>H-<1W0E0_^[]I2M,T+GABOZ$<3]J"VJX1:=7PJ_2H.T=(O"
M&:1?JDTM3!*EM1LXW+6G;).89YST@R3A""8)MQ*1;G*$(YHA['TH:>,()FT,
MK5F+#..`)0FK1M9:Y0A'-$TX>'62<`33A!'P?<XI(IBF;*&MLTX1T33E]T0:
M,GVG.-*JT(?L8T:C3(V6!#&">NL:$QX=BU_#T$F,\O%(E8L":`G0#FXGTMV*
MA_[7R*U"0G"RP[8KG6GC-_GJ`_8DL"TQ_U:PO+;E7`S[9QZ^>'R'?%^>\7E^
MRHG_JGD\HHX<^`G5ZPJ]//K!/?]!CD6(-LPH)!&K-?>#L,;3X$2T=$79J8L1
M51(*N#SO7%DD;<*RP!6-QO:`JEU%)?.=<ADY23J_669HM`^FX]OX4.TTNBY4
M,-[/<)>05*_;G:#^E=9^IVY'!4^CJH6=Q`_?*:>H1;=(DC9*DO&1;'U_6G2)
MZV6FIPN]9W0Z!;$B@UB1)%8L:Y^UE)!I*2&_*R5TD!*]6*2$(HG//:%B';Z2
M$KCZCA4QB0<M2^FD@V;I8%5;0I:$8=_<ECIA3:V[K(3P<+IT>#`M(3R8DQ"Y
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M)0*Z.`1>IF(O9;T*\U;IF><@H?P]`$C5\G`*96YD<W1R96%M#65N9&]B:@TT
M,R`P(&]B:@T\/"`-+U1Y<&4@+U!A9V4@#2]087)E;G0@,3<R(#`@4B`-+U)E
M<V]U<F-E<R`T-"`P(%(@#2]#;VYT96YT<R`T-2`P(%(@#2]-961I84)O>"!;
M(#`@,"`V,3(@-SDR(%T@#2]#<F]P0F]X(%L@,"`P(#8Q,B`W.3(@72`-+U)O
M=&%T92`P(`T^/B`-96YD;V)J#30T(#`@;V)J#3P\(`TO4')O8U-E="!;("]0
M1$8@+U1E>'0@72`-+T9O;G0@/#P@+U14,B`Q.#0@,"!2("]45#0@,3@V(#`@
M4B`O5%0Q,"`Q-3(@,"!2(#X^(`TO17AT1U-T871E(#P\("]'4S$@,3DQ(#`@
M4B`^/B`-+T-O;&]R4W!A8V4@/#P@+T-S-B`Q.#<@,"!2(#X^(`T^/B`-96YD
M;V)J#30U(#`@;V)J#3P\("],96YG=&@@,SDT-R`O1FEL=&5R("]&;&%T941E
M8V]D92`^/B`-<W1R96%M#0I(B;17RW+;.!;=^RNPR(*:,A'B3<[.<=(]F4K2
M56-E-LDL:(FR.5%(AZ3L]M_/P8,/260JG>XI5UD`+X![<)\'K]87+]=K3AA9
M[RY80A-.$OSY$>>:)BDQ4E-)UE\O7EZWFFQ:MR(A[::Z>/GK#2-W[066)XR3
M]<:-$D'63Q?1U;OKWSY<DK<?KBFY^O":W'Q\=?/V]=NK?[U]<T-6Z_]>Q)HJ
MKC,2,\J,,&3]VA_$[$'1A[HK6M+5Y+JNMD75%EL[:NM]N<T[3.P)3%*5\11H
MPMY$#R`R!^*7LLJK39GOR4V';5^+JFO)Y^ACE1^V)8[YO/)0,FI8JD^A)*P_
MCDE[W*?H<U16Y&NYWY?U*N8TBZKVDA2_^_&F>.A(>Y_[65.0,*JVY*%HCB3;
M,.S"K\7QG_4_K3>D]T;,!#5<>DQ*>4P.CKN8@\TYE4HQ$FM#F39NC9<D5&2*
MD]ABU_UUA#,LT^[&V)LJ?-)Z6.+$;OL8%#82I,.0*CV>/^)DAB:2900+67JT
M()Q@J%"9<%#\`F?/P4_*^RDO&_+O?'^`T5I2[\CK8E-\O875!+LD'.X\T:J\
MHY(YLR"N<+%%0#$".C$FM;?B,--/W8I3EC$]N94S]9`#0OEX>5<\KF(5%2OH
M$M&>L!,O"V282.>O,2J3WIO)C^OA/ZLGS?Z0'O$']#!JM%9D$@>:<1^3Y`0(
MCH%GIC%CEWV*UL@ZX9(&RD]4<\I3I&DR>@L*Q52A__IF?<$EIUH2G2J*H#:*
M"N=)F9*FN(#S24DN!/:$!2GE?"H7*(SX$J3N^XG4]$*%Q#S>FPJ:#GN91.$Y
MTOUJ?5:'#6X&L%I0R6T='NWV"3>*F68FH]K:,)9I"FANJ*/I?&'L3#@QB!%4
M<%L2;,Y/0",=$']!G.)Z,];PP@5K>.&Y-3)4,+VH5Z*NB658K[[7O8+5%*-*
M>JLEDWAFXJ0]7+5MT;7'14#3C'.^$,RXED@FP65@A"PXA:P4:CI9Z6#AF`NJ
M%3>NXFBAEJK@NLFW975'VF)S:,JN1`.,R3^*[5U!=H=JVWK-ADK;;;$OS=(3
M;"_L"H16FC@O#"ML+OM4BV/?'[1)S/0,FAFF?3*^\$449\@_?0A<R$X/\6=P
M[G/4=I^_]HBQCTU+O9!&#(5M$@G&5[8K%#:!G,C+?7[KA_L58B@JXEWMYTW<
MYOO">2=\<#[ZNW=R[^,1R!`2B5?Q_;A09HP+8W<-0)]"HN,"E$4?Z0TE=_5C
MT51?5\Q^*8!31E6WDIB0''0CORNJS3/F)FA*7`L/%&%B`4:E03IY%:<7LSJ5
MT4@XZ_#I'<>S3O,"%S2(ZXFV"?,PF?>7`CL[.:+OW&E/-R:[YX)N=CN4:_G3
MRL=@X50()09OB"%-)\Y0G$7OZZ:[@ZWCVWSS!9QTDK<V7[',&,.=^6Q%YIRA
M3J/Z8ZP4(KW_#C;COY^Y:F2A`,YY8*'D?6"?4.\'^2JA:10FA9O$MT&T^1(^
M;_TO63GPWMONE-[;*7($;=VADB:!J2/FE^A^:ZP2GO7(I<[DS!I[B_7?+@8"
M$8\E;K3=35&5"%`9U8VW&^QWFU=?R-Y_Q;(HKP9#INCD/30%KF[5HK`?6Q("
MW@MZ$$.>G^B_=E2B>;#__=#"%Q%>"61KY]:*)KIUA,,E6)\?D^Q(0,N0<U/W
M2KM"V'_S;I[*`T;GVA[>FV]6YO24W?.1KZ::N72I[PYB01M8KQI,<>ZFZ=I3
M%UD(@X=^ZYP+[L&^O7KOJ.JQ:+W$U1WIZH[Q=4=&'A43!I^F`82+S:*QWR<H
M9DK>+W7SE#=;/*\V]WF%'KBI0XUK\HT?.*5,"C8X`4\FJB)]:GL?,?I8Y=A^
M0UZ]K;JBP25)8Z.@?<H??`T$L1R2V"M@\PJ85P#BB4+DJCI3P_,+#U6G+]-I
MJ+CKND-'0,]9"9RY=V-G1@Y.*M',841I;2P8L1,N%28*W6X4@:`XD<BL2&6G
MG$XE(%WI(J<+XGE.%X3SG"X(ESC=DM[`Z9;$/\#II*70GM.=OV26WF]'I/G/
M,V6)&,XDS*:/T`]20;/T7`HRBB`(>Q%2\U*W]UP*9_-^K]*4Z5FQVWPF#LX>
M4)M980`]%PD+F`?I+&;!#=5Z$?,@7L#LXVC!TH-TUM(@R)0M@>Z%LYAEPNV#
M80GS()[''()[`?,@G<>,G,\6HV.0SJ,VQCX.%U'WXGG4/Y)S^,&3`CD7'U,B
M'DJ9?4DA6]!`[7O*C_;D73^T7"0J]ZY]N50:4S5%\+'Y1U80_:4Y'/>EP;(L
M(R:$V`QW"@T(Z-U+P#CDS\2_`TS4D'SSS0\/0;Y"R8]:7"\LJ?Q/W!1[M)*M
MGZ&!'4F[,@SN_`\8QR!R!RX00C:T;/^,A34><LOVN>W,E@$5:)2@ZE&[LIW1
M,17/#5[87FPRB.)5[+KF#_)ZU"9NHV9<H1`0.O7>>!&O%%Z+:&+^/.V?,[,T
M^_PD/%.D4N$DLW*-#2UV.(G]WT]:I/[IR$K$P$J*TMGZKAJIB7UTU0^=^^ZE
M==7S%=[S%>[XBF&9L?:?L(FS%X%G$_R[;$+U;")C(YN0[BW@'Z_2$_8)FX#K
M4T^B[00](^(K7$Y%@4^(R+!Q*,Z:GI`4KY0E*A'$"PW$"^>I1!`N48DEO7T]
M71!;U+:A6EK.24:%GI4B0M)SJ74&[Z7GS3A(W<D*-N6GS1C'A<THMVEZ:BZF
M1UR2STH#KA,I5S352[@&J3MYKAV+`?09JB!=P`Q/L"53]L)92TJ\`HQ<0CQ(
MYRUIVRU+%U%)^#Q;]/`@G<>%I-"+'AZD"[C04)-E#Z.AGK=1(AFS'&V&MYY7
M>#W6G9#=U\AJF]OVC=K>NX*SR3$HOAU0<*+''`GO7F3"O<A0:NH=>2$N;5][
MPJO&UBJ[Y+`MMF37U/8-%Q&[\MYV`NQU$Z_@UAU&\MOZL:#CH^F<;K/$-W%(
M^YK<%ZNC^YP\M:)WQ6.Q)X+\FI=5ZR[SKFY;<(-C%I\@I5'/9\E!W$LGNKRD
M?]\-.MW#-KKJR/N\V=P3P2X)3UAR2;HFWY;5'6F+S:%QY`2V<M?0%!R!>\V#
M'S:#<W`<3-K=%Z2N]L^D>WXHK+UW8$&6_^Q)CMMT[CH,O=7`"4EOC"0=@!E_
MG;+:[)U?RHH$RU!"UCB]!^@NC&<NF`P_-:XUZ68PLXV5H^L`YT-3[XJV+>LJ
MWP,M7(^3X&I+`*K\SBKVG08EU(#>#E#9<'0?AM5CT7:.9:0NVG!`1W:':MM>
MDJ?[$M9%U_,4C]G<2:<7=[PJ*ELP(FNM^V*+UNDVNV!-PZ5W>=D0!/3!V=1=
M'<4I2^39U9D:@N)3U+D,<=&L$+REFSJ\;N1`9PXTCRK_+2A'8KCD@HG<8.=_
M@#)OO4/\:H'+'?QX2ZHZG'%;>`[%:"8DFQ@O&Y-8!IZV+6R/%@Z%CAJ;A)B5
M[EOE&1FTWC[[YAV^;XN'`O\JOY6$3;D_XDLXD=2W;=$\YG[F=X*#U`WQ7^[]
MZ4U]N+L/3+A'?&K4_S5>-3V.XD#TOK_"AUTMD=)1@"20\VI&VNMJ;SL7-S&)
M)632&'HV^^NWO@QVF&[-!;"-RV6[ZKU7L[C?%\O)5FP!5*J:/%U,+]UF"&N_
M=M1C\/(V(H]QBN8_+3W!*6Z:YN:XZVTR?D=7OTP465H>0(?L/\*1?]CTD4P?
MT?1WN+%7[3'`>)TC^PVWJ9SA#DI.#E'4%WE\9VO@1514#*^3(*7'N&BGP2'R
MHL:&1<*UG4*=`7J[!DV\.MU52J%3-7L)RIU#\O=-A0'03)Y'^XNEMW9P4.K/
M5DD*]CP+L2BVHAU@JN(ICKL\MZZ.WRV_&NUX(F+$O1^XP6,8/:W24%LDW0UE
M/:4!^#.0O^RN9]2C`3P5"$J"GY!!L$JY54_;-2XV/J`>Q;N:.2>IS/94;6:X
M)-UTTV'.MC;*5%Q"=^.-XYRAO-PGH%8M=RP!3BF54TH=,O?`??L)L(SW5I-R
MM^["*'G>U<=3&9.2(!%:>K>7">#_UG>(VYZQ%FD5=$[V"$UC1B"/@))E5141
M2I[FW9YIMP90`X@%BTNZ$=YF+IP`TKNLSW&4O23D5XAC$"D'/%Z$#C2!38.G
M76:=*K"UV[Q@M8083(.*ICA\=!OT^J$ZJU^Q;3MF%TNC0%[XND0FZ5N&5ZN5
MU$NA,<I2NGG##[)C:3&/^YT=>!E,IX$V:&:S](^\Q#6RSR[Q]T/=L:6E!:>_
MQ]/GJ<!8EVB]AA:'`.9%0@"^!`4AQ\FG:?3060`^7)X@!3="0.25=/7\&C<$
M/KOG6BZI0B-9,R\YAT$QUW=H\92-$%]7_L2PRC-VXH22CS\&O$F`CT[:J*S4
M-T`)W=G_<'_8"0C!'Z$]\=LE-I(IWS:J#4N@UHF=D$;#'LT*:+4*AQ!^AB!:
MDC@XYCEDL&'('L4,C?$YPZ(C!Q!C[0>J<PWF"-B.47Q1PU&G@HLE5,?<I04T
MA!MIY7OOB((SX;X#,M^62.60;<G-Q!)+:Z&Q_'"N/J,Q@[()*!Z)"P54WT6T
M=F$"$ZJ#/SQ_A0[B`G@[;@/TDH^\%>R!S0!K?"4MD#"BZ`#Q[UE7GF<O3\)4
MM\$8IAX4%^/-*Q0FEY6NAD-15Y+V2]0I'0X#[7UR%H#MDPNS,.2H6"%HBO4Z
MYQ-8JT!H)1JSF64,RO1(!X-D4]X"!;86B6\K$'H"&U6]VOZ33`>M`9ZAY/^#
M_2FR.^9(`?T/J/L:8]]AE\"CC3$@*H/;1:8\;SVO=E5]B)AH@14*SZPS?@'X
M\D?52=^&DJ(N3I]PAOHU/\"5_S6??7*H=#^AI#B<JGQ%'VOT^0!Q)&>G!#3"
M\/4I:0W"\9+5@^U3;."$DW_NB4GY\U^!C@T6,`3GM;@T&JAL<A[^C;-1YK2"
MAHL7K[$7U]BD2S`PZ0N;>8T/H@OPUI@(&C]&+[A1,?UDE2*:I_--/^/F)78I
M=,H_@1AH[(FYYB@N2DDO_+EFMI3=U\R0<(CV74;A,'7;FF;D4ZQ9.N14?>QI
M^SS!#)9J2BO]=[&W3+PGZPUZM#(@CGB6?%M@AC?NF?B%6Y7]0V-\/'O2Z'L8
M`[H9C.^3Z?);@Z7%SW/OC[()J!>R?H3R!@(8U@&@1;5ONOX[R$1,<BHNX4Q0
M\PZ089YPHKEI!P6N=2H4B*#4BL^@K]'#@$5$G@7@EHKHR+7'F6L/WS<V80!0
MP]R1X/LLO(]8NK9B4KLPF<)%QA<F`'&[(M)Z(=)R)E)`-N(Z$,<CM8:)='1!
MU2VLQ+V`$8!>_/M5<=^-YYFT*>2"%GJ9O#`,-"L2Z,<LYAH`.?;]R]^__`\2
M?+'E"F5N9'-T<F5A;0UE;F1O8FH--#8@,"!O8FH-/#P@#2]4>7!E("]086=E
M(`TO4&%R96YT(#$W,B`P(%(@#2]297-O=7)C97,@-#<@,"!2(`TO0V]N=&5N
M=',@-#@@,"!2(`TO365D:6%";W@@6R`P(#`@-C$R(#<Y,B!=(`TO0W)O<$)O
M>"!;(#`@,"`V,3(@-SDR(%T@#2]2;W1A=&4@,"`-/CX@#65N9&]B:@TT-R`P
M(&]B:@T\/"`-+U!R;V-3970@6R`O4$1&("]497AT(%T@#2]&;VYT(#P\("]4
M5#(@,3@T(#`@4B`O5%0T(#$X-B`P(%(@/CX@#2]%>'1'4W1A=&4@/#P@+T=3
M,2`Q.3$@,"!2(#X^(`TO0V]L;W)3<&%C92`\/"`O0W,V(#$X-R`P(%(@/CX@
M#3X^(`UE;F1O8FH--#@@,"!O8FH-/#P@+TQE;F=T:"`R.3DU("]&:6QT97(@
M+T9L871E1&5C;V1E(#X^(`US=')E86T-"DB)[%=+<^.X$;[[5^"0`Y4R:0($
M0/+H>>S&J=W)U%I[VLF!EFA+*9ER2'EF9W]]ONX&7Y+LF:1R255*52*`QJ.?
M7W>_65Y<+9=&:;6\O]!IDAJ5XB<C8WR2%BJW/K%J^7AQ];;S:M7QCE1UJ^;B
MZL=;K1ZZ"VQ/M5'+%8_23"V_7$37/[W]VX=+=?/A;:*N/[Q3M[^^N;UY=W/]
MR\W[6[58_N,B]HDSOE2Q3G2>Y6KY3B[2=%'T87^H.W78J[?[9ETW7;VF4;??
M;=?5`1.Z0=O$E:8`-^%LZ@<F2F;BAVU3-:MMM5.W!QQ[K)M#ISY%OS;5\WJ+
M:SXMA)4RR77ACUE)=7^=MG3=;]&G:-NHQ^UNM]TO8I.44=-=JOIW&:_JIX/J
M-I7,VEJ%4;-63W4[HZS#\!"^Q,??EW\E:UBQ1JRS)#=6>').>&)V6#!FVYC$
M.J=5[/-$^YSW""5-LM(9%1/OOA<G8\7JG"4V.DE=5BKOARU,%GV8Q.!F?CO<
M2_OS4JY0O&GT'`,[X'9Z31>TF=]-'6TV25X607LX5V1)$5UW70T[+&*=YIBJ
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M($&?)YN/PUK]\-RL.S[B$K*),HEW)N]](#?'/H`@@UWFH@OKT?7JG\_;#ASO
MFQ`[10J//98SY\V_U+L!?L!M[JP[`3"Y%FAUV#8/0)P^(E-G3_;RUH_55T&F
M8-O@WDX``*+E:3YW[ZEG<Z!;>'9^UK--BD@F3T6H%!)MO5\C,&V2T<@B+&8>
MCE,VDRBP.M-]9)SS=5#=RZXNU._P=*=\6B8E>3G[):LF[LU/\/$&3FFC>F$@
MQ0-YJ(N:)GP?U%VUXV'%]&95$[[D"'N6*S8N)Y?^TR+V.J60,(96<;NLE07V
MY0L\6$9ZX5CT6&M=)KW(Z10.X]$GF%LC+"[WA%LY<'VG'F18+5(D#1EW*M!;
M?"*U"S/`(66EMJYVVS_JM2Q>/<NWF9R8;:"<$0-<#7.:`L$23\,R3U,9S=B'
M#4MOIS*P`_I1S5IDN&E6T&3TO(:;0[O$@(;>55VU#<\?.G57W^^1QB;DU?X1
ML,C6@60'$"H>_@[1%"DX%WB-X:XZBF,:I?"@$F.H.SOA=_GG5WC9TP,;)-7P
M[).LM_4&I0)M_"P+K[`(GL0E_CV>D'-+G><#ODCV`.)8UCDR`R*)1D9#W\2K
MH.>I^N,YM)F@?L`1V=='S_+9`H2+B/%)%AKYQ*U`D<Q4M3IL/X<3DBM104@V
MG0E8B'=HV9I#%_:LF,@&B/PC,2U=@Z\#R)&(&<JOZ:EY4*!XY),?V_VJKH'7
M`-BNVH&W"B41;&$HURS(-(<^91`G.0CLOT7A`)LHNK1E9P^\LQS_!89'D\!F
M_I6(>-^LQ?$%9()G!XCQ`[L3B/%8,U$1O'6&,V6_7"SLF3`=@=6AO`4TOH2L
M/?F[H-66E/H(6R?I8=33*SEBK'V*/ER^E1&@["0O%/@KBBES`QF\F#-D)W*%
MTXFU9ZER^(1JJ%<)9SW4>9[,AT_(O4;E=''$UT#EPZ?4$FW,2UP/U+-<6\A4
M#OI"">R+LV0^?$(^8VO4/38OR5\HBX[U_`O8GPV1&M+7C]5V$7*.YG1%@;KC
MI7U8&E,5+\M^Y"3>^MR<$A"YB/N?ZL^U$%2F[L,K%3L.2EBN7;B+^PUA)50$
M611.S)DZ\*Q]9@#)"<ZC1M:Z^<Z5'`_)8T((J8Q7D,R0RI1<L!%Z/9^V=1U`
MW+B$"N8C/9H1,)SHD?(,(AP5()<LFT[5#7'Q,Z8EPP=N76U4IB^5276JOM3(
MILU>MBO*8/@^-/*]E\^J"M<E"XG('G2/NL(7C#W8FGF,K@_JYVKD(2TOU:%%
MX0^0Z\8*GOCB.]%@<@$])JZQ[L_E[<.FAJ5W7]7AZQ-&]S!S4\&:*(4J:?A0
M!M%=:&>,,7+7V"@&)G'3:B<F"UZCLD2IY9Y+JFK;((VT4OQFE(J]^8Z<N@NI
M\TRA1:DS9-1^_CS+LRB\\$XT.P*?O@]7MB2F#%'I(:&%R8HG$^&/7]EMJ[N0
MKT-WN]IAZ_9^.S+6D09D4O-]4$:@'3;AT8,X3\\$E#=[1\[U-_:[9AG[3,:;
MUGI\?3546ONF)C^,R,)]&7:IFIJ&E_S8K%+C'9)NB\3J<F)W/?JD#<_B%01*
MT\'\&'5[BF#'6.)(!DW1<^`9=G0RZA<8#_!M9-XM-//8QSHU"5W25V-^;&;[
M(#D*H[Z<.>H]4>/#SP_5W:Y63VW=X3FP<E?O]E]4QY@4\1_5-5G4PF<ZCHS5
MID(S2$XMH`=J\;HR5E7;?D7`ZZAG7WVN1"'/H@JJI+INO]K.]+!67V1!YAO9
M.R"P&Q`85U9-?YBKS$`/8(?^#_7`"9`4H[=DPBGADQ&+&\)GFC$^`]FYW'91
M(ZN=6@-:9/N#DK6-G*OG4P+=<,,^')[!*"<(7#R%,.#$B[W.J75E0`B/4F>Z
M5PB93S*#0BD=EZZ62R1QM41!D?C4<C9F?;R;5+[1M<1[.&#E`+J)'-EYLM_;
MPDB&%CXLMF@MY:C1?F#ZN[@10PVWLW4T7P]_;:M%3/H+`02(9R6-S,'H:;AZ
M\B0JV#*SK[",BL^"+_"<X6.-*M-OUB=$S5#ZY<<ERJL"HF9W/CL6D`(%QV_'
M=#77>8XGLW(BP/A:;'UBTM)/M7V&CU%D+I/C''HF]!PJWEY^(,_WRV^H&#<$
MM8^2I28%1"X1]08>[CATRNAARXU"TX1OZ$(XX1!=^A!3E*7E%L/EQ*/QFEI<
MR)F'@$Y/$^70JIE0`"XYJ^41)UL9(JM%DC:HP`IT),4,*2S,SJ35/+IZEF\S
M.3';P"V=*:!M`.41KR_4,*>)ZJ9944<6:KPQ[4P3F%QILX1"8@#<4/QZM(@,
M"Z:/0]EW_+2;=$S\**J8L;0LY6%@Y_[`4R1%R9ADH2>AM?4&J4VV?Y:E>GYZ
M.$&6-]PX>N.(PCWO5$/Q"Q@G7MR#2?I-K)D*F19##@I^^+'=K^IZW5$)WU6[
M6CH"9E)2'++,$'QQAH*+?.]3I)UC\^(5LL:13;'+GP-EJ-YI]P+38[09=*2(
M_6]&6\E4DQ;4=H58T^7H0B'/OF_6%%G9&%D91Y8?(LOFV1!99:2AIA=MD1E`
MYAG1_B-8,2D^JISUA#W%T6=.LFX\=-J(NLFY4ZI/7!&.HH&49')"Y;,GY/-]
MJ"[0`14!Y/[?B?YO=*(H<;G:;^NG?2M!"R\O4SNI4_/QC6"K`Q>I!%DV8A26
M+HCJ7^X0,!U[!$RH2S#_HKT*=AJ&8>BOY%@.JTC;M197OF1BA4VJ"-J"^'UL
M/R<C:R.X<%F6N&Z<^N793]7-:UAT!;\!/E_7)YW>6G6-X/=6W0\913Z5,_E\
MI.?TFD-J1$3J'PUQ;%1/PA1L19!5//,">\Y?-N3\49$_0L)8?;F/^0)[./)-
M]ZR`9)W99*)>F+^S%S&C\-VAG[6ZRB53RWV-P93:1]KWF4LFX:I['O$]<]K@
MJ!V'#2[Q'$=/:^O`71HEWS5CF%5]M_B$6XJT;\<Q;IJQ\;VY0BA<2B;KFG9E
MM>I,ASR?I+/@=+]C?,,P/^P@2VW9?6*TJ70F@M];;R(@L3?!-7D*X:#I(44)
M,\IE7@XQNT4SBBX3$7"-YV5QIR*.)3U\B'+1,`E%+/%<GL`=BW"BE*4]B@:0
MQ(ELO#W[KTABD;6%E60E:8-K2()O#4GPK2')]JTAR3;^&Y)H7,L//N*W``,`
MY$?@`PIE;F1S=')E86T-96YD;V)J#30Y(#`@;V)J#3P\(`TO5'EP92`O4&%G
M92`-+U!A<F5N="`Q-S(@,"!2(`TO4F5S;W5R8V5S(#4P(#`@4B`-+T-O;G1E
M;G1S(#4Q(#`@4B`-+TUE9&EA0F]X(%L@,"`P(#8Q,B`W.3(@72`-+T-R;W!"
M;W@@6R`P(#`@-C$R(#<Y,B!=(`TO4F]T871E(#`@#3X^(`UE;F1O8FH--3`@
M,"!O8FH-/#P@#2]0<F]C4V5T(%L@+U!$1B`O5&5X="!=(`TO1F]N="`\/"`O
M5%0R(#$X-"`P(%(@+U14-"`Q.#8@,"!2("]45#$P(#$U,B`P(%(@/CX@#2]%
M>'1'4W1A=&4@/#P@+T=3,2`Q.3$@,"!2(#X^(`TO0V]L;W)3<&%C92`\/"`O
M0W,V(#$X-R`P(%(@/CX@#3X^(`UE;F1O8FH--3$@,"!O8FH-/#P@+TQE;F=T
M:"`S.#<Y("]&:6QT97(@+T9L871E1&5C;V1E(#X^(`US=')E86T-"DB)I%=9
M<]O($7[7KYBW@"D1QGWD36MO4DJMO:F(FSS8>1@!0Q$.!'!Q2-;^^O2%X1"4
MM4FE7!8'@T%/'U]_W?W#[NK=;A>I4.WV5V'@!Y$*X!^OHBCS@T+E2>8G:O=X
M]>[]F*EJI!.!&JONZMU?[D+U,%[!\2",U*ZB51"KW?.5=_/3^Y\_7:O;3^]]
M=?/I@[K[Y8>[VP^W-W^__?%.;79?K[:9GT99J;:A'^9QKG8?6%"(@KQ/_61&
M-?7J?=_5IAM-C:NQ;YM:3_"`$L+$3\NH`&WDVR"S2I2DQ)^;3G=5HUMU-\%G
MCZ:;1O7%^Z73<]V`F"\;5J7T\[#(UJH$X2(N3%#<9^^+UW3JL6G;IM]L([_T
MNO%:F6^\KLQQ4N-!\]-@E*RZ6AW-</:FEN4DOZC'OW9_Q6@D'(UM&/MYE+!.
M:<HZD3ID&*D=17Z2IJ':9KD?9CF=X3>!'Y=II+:H>[:8$Y-CPX(LAF^+%+:R
MS!ZAU_0YJ!$&K$=`"HAP<D6!Y[:G2'_V_J';3>)'WJPG^FWH;]^IG:D.'3_]
M.D,X5S;N_GAA$FZAY-1ZGJ]0FVV8)@FX"BZ#>QJ0/I%T$CP#/DAX&/EQEL8.
M)"PN0\:EVO>#VEM<Z'$T@`D-06H;?=^TS=2`0%U5_=Q-A++,S_,B<40F5B1I
MYP$<4:B>U%XW@WH"#2'X$.8'TYE!M^T+HRPJ_3`!>*T]&K&-%2#TH1^:WT!>
MTP'TI\-@C)I>CF;\DU*/FS#T<T]O0F_XMYG8F9`"190Y]J[S\+.GC\>AU]7A
M&H16/4B)_,PSFQ!\J99W9'_5CQ-@EL2F?E26CLTV$S`R*%4^])7:'0RD)LE-
MO"/@V=,="0%K\S)C&=LE`BP%DI:DO*BGS3;Q8[`*3F1>._,C1)-^50.Q^<G(
M(2.'V/1M7/IQD":N.RTL*XM5B$_\7\1[4A\U13OU@R0L'<MMM!<L#N"O.+Q6
M40!)@H(BI)OCT)`/"D\/#41\'ION`4)H)%"0HA&D\0E%I96;L5SZ'%T1@I$4
M8C<\UTB&6K4&#!@6#T1L^0I0`:7H9\]\FX#PKDD)&_N(8I^>8N^SL->3\8(/
M`()EEKQEQD>-NF]B#-^-W+%*_-P/RK1XR\>"J\6C&S#4$[&%`UO(^Q$]3]N5
MX;CV?.I@%L>G:>`&])+`!C48IC`#-Z7>D^Z8R1235P?L`S^0Y*!0#*LUT7&B
M3XZ(6MV_P",HNWQ"VV0#2>8(0HU-DCB\B.":_Z9!=Z.ND/=&B.53WSXAO!HH
MC5-3`:Z!?RC`F-:8A'"7'M@!F5^4120.L'(ICSU]WYHE)T"$DQ(0@1/52K6-
MH-PXH3_EF3"8P\@5*-J,B#_UW$P'PN"K#+:-P]=9\40YR3F1(9;;N39*$)VB
MP6BW'M`<U/Q&R1M,IL+[VB^LYGCBE>(`2&BF%]7O2=WW[,^,_0DH[%[^L(%B
MX(WJ7K?`)V"FG#!ZG(?ECB3+0^>.PMJ1+]7BO%*`?S4`L)J'`6-ZK\%Q7##`
M-53-?M<USP:J#4@#X*?>S-Z`>X"#:`>)B!8'>77N'DFL,TY0'S>)U_/Q4=[*
M1V2L>21SL8W((K?^9*?L$NP:3"9O9-8A33$E*"%B20A/_3KW^&L(AOT]KC6D
ME]=A<1UZ^D+1D8.1=,7T$RGW^&B6G!*='*\1N:ZO'/MYJ`@N5,+`QI(M3OCT
MD=<0=LC8S%,UWE>KCK0`WR[9E>59YL1[G;J"^Y*<'3'RFZYN$#[8-B`(I%Z6
M21:N^XS/'H*"1!0D(H0T&["4G8.PD+BLT.6?B":+H.RZ4%K1O</RTH9Q,"%N
M22(%6]UB'0%/2S?V'8(O?.#WT"G]#J_?<B6*B2ACA\P1OPFC-R&&I0!CHX?!
MY4[26\CE2=B]\(O8XD]R>*)0JOW,"Y*84D-."(8H8VN'KZ!['V>LKR!3CP>U
M;QD%SP1#\5P.)2](+I+0LE\@[&?TT&&^Y9!O('BB)0$J!RO5N+QKZ==`W3*C
MZ?@87E?S@;$2]7*B"E(Y]^R>6QESFXO\L`@3080WY!.00V[$W0,KM-!%SN[!
M#=%/U(!N=-&!*AE$"AG*WK$T#=*W(*U'"Y/`:_/M:"I>BR`6B_5+W_>S'!.=
M^M%(N*P^-ER.[9BK/W[3EGJB*'0S3S!V;*G^(Y7L%;<&5,`S3PI&0=`+5]##
M<S.?T]Q!\+?BN4(@B"L"X;ED^;YV2(BT6Z,FM4D'BEH``%I9!8M6HWA_N;2D
M2Z]5?^1]WNN[+7<_,'UN(NI(<,V$04BO#8M%,"3>-35(]W*JET/\J$D`GZ9>
MP-GE.]V;*_.=*T3O`YNAQ3JYD3>K?CCV@[QR\^`U-]CF%+V7GXK+TG(`-,.%
M'6!%H:$N\,BO>%L<A4MT5"+;[*@8#]34`89D1>;9HB!%,/;DW)&?N"CDK"]^
M-O,^9`N#$UZ&1?9F7:S,,-D*1K6.J4_5!E6%+G3AP"=^@?%WSQTU"<!@/1]Z
M*H$<8%W].N/!$?^<B'0KT!3=SNHC5U36A?B65C@4=HN`[H$K.=S+%9%9W*WN
M\\@'B;(/HK6K\^O4#][^?V:02RK&8IXMW#L*UWRG5F6K@6_=L-EAI.I'9R1K
M1H=9#PM91416L+%4IS3-1#;DPL*@,!X^]W,+F6C(MH(KS$F%S*I0DBL&`P'%
MV@XSX&".K8;TH]&2NL34#XOTDFHNO`*#XY.0.UBCC[KB)_:/D#QPINYX).!Z
MLP'00AFQ39+UJ[#SD9\X(V)O*6/<*'$M6$YRP>GEX*H>H7OYO/4QMD>UZ&&P
MO(@@J53\Y5)6L>FAY0#[WF5Y`\/V<A;:)EYAS6K/Z]E66C=V793*[,$CDH8[
MH0?$/S0KX<+.2V]`>$%391%&S12HQFT4^O;)3EN+_<AD@[D8I7#89)*!KK(H
MWAQG=`M8TU5ECA.@YW3%,K=L`N3U0U_W;?_`4]\_-]L"HX)ULL'IL&T!:X.Q
ME8UO74^LA#9OI3I``*UI843%01/0B]*TC)-%DL1K[;W79E&T`/,*9P%XLS2X
M)";UTSART[>T;LXH!M0&7P-#XN1!^D$ET),AICSVX]B`:M>22H$?YWETD4J)
ME2G<W7<&=91VHN<FP,Y@_ULC(4(T]228&P`N((89R`7"\;>AWQM0<NEYTCPI
MWRPK?4=]-/Z7P<69?3K]`$XD0GXR([*TP\?,[ONYJT?W&Y$"^D`7*P1^SW3N
M,+O;L$.JV2Z(]/W=`?;U>?1:R?S*<ZBT;]`5T#$*H+"&,[O:B0X>83JB+G`T
MMF7,RO1-]U$9K4XU#X"#BXI<\<:0XOB1BE]??_'&+QNJA#)54BJ<PD)YO2$Z
MH3HYC.=E\]1(HL[K?%N7B-KLFZZAY&8*-]^:"7P`<R8Y"LM%IR>8%O`]52Q,
M-4`Q(A^3.HTNAL\E6$AE2SZ^`#AQ)*6\JDDVF(&I"`U0EKH9?<%X#UVS!RX`
M)L/Y8)B:D97[.M</%-L0^PFQ/([].,PO!Z_B%#.A.6SF(NI!@,BI5M+&@`GT
M/5;^WK1[!H:?*2!FV.X.NMONS"/VK<.+NGT\:@S=\"@M4;_'OS=/M$N=U#T!
M:;L_A7_8WA%XC+H])1]<5]@>ZKPQB0H_#/+"SK;_(;P*=ARW8>B]7^%;76`R
M2#)QXAR+Q1[VOK>>G$19"S#L7=N9=/KU?>0C;6O2F9XLR:)(2N3C8V+^RO\N
M;H=_C!TMUE?I8VR-#GQ'I+$3_=)QA"=8LZ)K<6SY?<.5OG(8]8K#?<A^<>%F
M6_]8Y_T8>A2;*&72ME>QD1HIPX:2JZNIZE=#A8H038<)H!Z!KID9,K'?HTHC
M/TPZBQ<3\`WQ"M7O[(>\D"83":G)$LCNH6^YS%:<EHHM(#^ZV6*Z6>=99U52
MY+U1@S];SLW?@AH+O<\CG?>)_;$#X(,T95ERY)N03SI[I+.^T=T539+D'`>6
MR]?DR!L1$57HB(!8S]YH%OPEA$GV[_.K4`%T9CQMG_NC[6DW2<3&GZVTJ6T9
MB=2PMQ$H]C,J^\UH,4'3UU/?&/^A+XJ4'(!_G^P`ZHR#MPXK]^3_T>*;MG+;
M7%-88$*2L,AM52"\T%(HK-<6*UT4W"ZU-@=*<I,"-@3[C'.>X$H4,"@(PM"9
M""#%1L"5S\6>X>J+A>!C!'Y`-C>%Y[ADM[*]G8:*\'30LMZ6Y!Z1G(WF>)3$
MEDACV)K*P_,&2C]I3NJ`3B:V^I:P>[QV3>SPU*!I=?7*)@7*RF*]J`TS`U!+
M\U,(K1Q2:<<9VUMW0\R`G0E%8UD3ZN<LK=SN'PK#8^,VWD,#`[PS:\>:S+)#
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M@WBVP0*O9_1WX.13R[]ZN3PXO`97,RU0S+3=Y;JL?*QWAV4_,J7+5`R%GA]`
MY?E5L!3.<8TZ;ZOVS!$P-F]T)!!PX2*%.`8$2,JVH1+PU$+=:VI#`EQ_^"FT
M_45Y@C#<5-U4)-3>AV2:H&/KE')@E.`Q^B<)$$!)(U]>:SFQII*!OV?:E5;:
MROSM=Z3WB6/29O]SX<?*:.EO6NJ;[OU-L<$TV;31ORX\F^''O-J"I,%4CO<^
M3U0,V=4.[2>KLLJ.)D\J<W._HOR(?BI1T,<N=<>F&NL;&!C=@,Q.<A-B,RM-
M,V+N.8Y\!>[;0>8<?W)8&2[MM#AO-')?T#)R#0V-[5,:@=!!^],'9O>.=[33
M:(;,6]8E>Y<'CC?[A9<#%G^[*N':Y&Z%;E)LW=AQ;BK"6&#ULE0U!NZ,MFER
M830+F&>^W>V2L^K$Y-58+PVPXU:T?PQ+$U/?P":>,A<.<U>45!*!)`U^[4\T
MMZ2GE9!!5P:G[K@.A&MVZ>XM;%^4P2?-3=90="9%<5C4T(D@&]!5K.PX4)X&
MM5-JG]XOZXA\1.TVOT2\-VKJ6/?=[4>=(?=;-)_#LU-RT_4)(_KZ_;=_!P!B
M_F%Y"F5N9'-T<F5A;0UE;F1O8FH--3(@,"!O8FH-/#P@#2]4>7!E("]086=E
M(`TO4&%R96YT(#$W,B`P(%(@#2]297-O=7)C97,@-3,@,"!2(`TO0V]N=&5N
M=',@-30@,"!2(`TO365D:6%";W@@6R`P(#`@-C$R(#<Y,B!=(`TO0W)O<$)O
M>"!;(#`@,"`V,3(@-SDR(%T@#2]2;W1A=&4@,"`-/CX@#65N9&]B:@TU,R`P
M(&]B:@T\/"`-+U!R;V-3970@6R`O4$1&("]497AT(%T@#2]&;VYT(#P\("]4
M5#(@,3@T(#`@4B`O5%0T(#$X-B`P(%(@+U14."`Q-3$@,"!2(#X^(`TO17AT
M1U-T871E(#P\("]'4S$@,3DQ(#`@4B`^/B`-+T-O;&]R4W!A8V4@/#P@+T-S
M-B`Q.#<@,"!2(#X^(`T^/B`-96YD;V)J#34T(#`@;V)J#3P\("],96YG=&@@
M,S4P,"`O1FEL=&5R("]&;&%T941E8V]D92`^/B`-<W1R96%M#0I(B<172W/;
M1A*^ZU?,(0=PRX`Q[X%OLIQU:2MV4BOZ%.T!(F&)*0K4DM0Z]J_?KWL&#X)D
M%%>E=HM5Q``]CY[NK[_N?CN_>#V?*R'%_/.%+(M2B1*_.%+*%640WKC"B/GC
MQ>NKG1.+'<\HQ6[17KQ^?R/%_>X"TTNIQ'S!HU*+^9>+[/*GJY\_OA+7'Z\*
M<?GQG;CY]/;F^MWUY3^O?[P1L_EO%[DKK'*5R&4AO?9B_BYN)&FC[.-FW^S$
M?B.N-NVR:7?-DD:[S7JUK/=XH1VD*6RE`K1):TO7*U&Q$G]?M76[6-5K<;/'
MLL>FW>_$;?:IK9^7*VQS.XNJ5(67P4U5*66WG32TW:_9;;9JQ>-JO5YM9KDJ
MJJS=O1+-[W&\:)[V8O=0Q[=M(]*H78JG9GL@6:;A/CU)CW_-_T'>,-$;N=2%
M5R;J9&W4B=7AB[':2A7&6BERYPOI/,^)DK+0E54B)]U==QW-AI45WQAK@\4G
MY_HI+.;E`RA*/C_8?A/E>=IMYF]G:6I(^(FV*\_O53@U]I:TT:C7+9E!9^T]
M_:_NUHVXW.T:>"I^7HKW&QKPWW*&2_GL"WQP;++"5\Y,+-89JQQ[=ZJ:DD4H
M@V&#$9*3@@RGO(,"Z?JAWBX>A):OA"IE*6:Y"U4H5/:N632/=_!R%`%^$^64
M*2KCI!@=X)4;.30"$<'FK;&DJU*2K2X#G*M5M.A4[Q(Q)"=JEY;FVL(&'Z+6
M[[>;W0YK<UGYPJ77F<9)A84I3.4='LH87<CL2'-7**WM"YK_.+]0UA4(%.=4
M(4$;N"\I9H+8-A>`AUB)"ZTE<4J<8JO)%$VF5$DJC2RJL?3M_(BB/"8;8#T0
M/_V1G625H'%HJ$"3%78R/AKJJMYNOZ[:>W&Y6#P_/J^):A"AQE?9%:P'VW43
M9I6$76`LZ*GC`!2"">.51X:L;/@>"'1P?0$"I0Q3Y/IX,V`H,=?EX^:YW0L\
MMOO5S,#/WV:A,%E-U])9^K9I<5OG8*UNP2Q4"G)<S\'F@0853*ZREW<ZNKW7
M[B48'02`[&C'N,`S?\T(P]Y5IB#`YOP'"BQ!H8+P;;4D'7@,5)<D5U8RRG-M
M:=HPB40>BD?`CP`,534>T-0=P%/IHI<BCL*!,"$[2L]".VUM"C66&J_&!_NB
M"A/DGT_3%`,EXM@113V>3H/$L.W]F%D3AI)O@"^@6(U]TYF\C/#YBXV==R<2
MR%/F8MSJJ+EQ7L>#;Y[O?FL6^QFR(3$59;HLOFT(;\/'^G$F%7W>1O&*_[_5
MX[=-^R9ME(/N*X;S7WJO^=]BDN10U7`FN8+M]Q.%A4.-P*7,3&O#P<(?F\5#
MNUGS<'/_=6:93G(5&>8'G%D%9.O,&`.2#F!6_FI,&9"'*1_*3%6>UR$IYSH`
MISQ#5V6F8>69ML'Q;152,`SP`UD`-];80%4N+84854.?`KK+Z!1ZO]2DKL^:
M&9)R'.YHGW@5&H$J5*:0=3HU*5P#&,KP.3A&]QKR"JFJ"D*)HN](1UZ+B&0=
M3;>6O'%22]>;7"63_[R?V>P!.9DT`Z_(04>IRI,ZLBE<I^-80_6"AI7N5I9\
MM0,=R]-T-L36B-.L\I;P1,@L5<6@Q%<'")#<R_@<$.E*9R.23].9M5#L')M%
MX1DRB\)S7);V/4UE27B"R4[PE]6FHRXU5%RI.IQO"&J47LCD:QZ+76(%?HD/
MHH-,$`L0^HD%Z.N*_[_5X[=-2U:CPH%=:%#=P)+!*'IA+N&!#9#?9D8IP*A#
M;22+N-8ZBD=CHQMB]F<INQ(KI>:5Q!H@&S4&PT!Z_PLP($;R+AW$Q*!26?"1
MBFIJ1&#2.+J+C]]P$6P)(Z,)BY_8N"@XL_2^I8="PH=Y5^E;&Q]O9IT^X,]H
M4.N-BM]Z&SNPZ^$':2IVRK%5G=4J,B^Z(I:-@E_VC5J9[O7+,^KTFJB6F-^2
M7I*6/VTWBP;%[[;9-5S*UV@O#K:JN@SD4DVX;/[3$.S0@#PQNG36,/WI(?=0
M4N4O.UR<S5]U\9]KCQX+#`+5.&\X(ML\9[K@%(,J#T.2GW"H-:4<S3_TZ_^5
M5TQ`B:_.$4N2GF&6)#U'+=W6I[FED_XY<C$.'E,]OXP(QH\)QC'!5%E,PR)F
MZY:2:\C&<I11_'87)S:B\[V#[Y/'*Y3=>!\R-[)/#_-IYF9^.9FYG0M'D?`#
M`Z:2`\&DS'U`,>PD6R`1&Q?M,#'52`K!D10F`QJ35!;&G)&6Q-WH0`_%AL9I
M,8*@#%-T#*L].?*T-.IU*-5H/,[J-9)BYV.I)"AV6H-FSDA)Z:FT\@4BZYS.
M@_2$SJ:T%!]G=!Y)22N/ENA0[`K;:X5J,!R&@QRY.)R78O&QM*)6XYQ:@Q0[
M.TE1-Q:'<K3UU%IGPA#5IHQA..KYJ`TYR(?Q$S2OD%RGS4$88C=U!^^>MQ2.
M"F')98#*'HCH%>+RX'7;-(*Y6R'[)\E.-.T2">(#5[(4W3:CC*#E*Z%*6;Z:
M[G@5&UN.,-1_5/KAAE`NJI3*3CY&9D^T2F=U^Y6W%_62SGKB0D2BA%8(]#:^
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MDEKN[%'*@W.JZJ15LYOF_A'EV^1PL+#54S,>[5L$,L%W;(NJP!G_PK9`E/3C
M;?/!,U2=4$6-&J2.SW4$XG`&/J)L^`.[#2>-+8BFQPZ.E?&P]SC,,L?Q8XG2
M#T=RG$U/I;RNPW"L1QWJTS8X5TO))2.ZJ)++]E264()'2%"NAAZNHJQQD/"(
M5WLQBA1WF)?<>+5^.>WH$EU<5_P=L\';>EVWB^:5>-<LFD0*=\TVT0!\&VD%
MQD"K0I<E7"7/:]H,U:SM>BFJVU#Z@:704@IZB^V,<A:-`K4?5!$&&$1E+@3Z
M-I1L>7<(H;ORKF<P/R2]E&$NF:4Y<\3'?I0ZP-*@1R9W>FUCBB!RYV.H_/8^
MG+H*L"')0G2$=`(Z!XFHS0".F<.BWHUYM\E45=V;-VEZS2;UV5.]H'R!Q`7=
M>HKG+ZP@!.#Q)GZY;T7S>YPDMG5<AWR)--E?`46QG5Q!V7B'TE!$TN&WF45A
MC"J9RN.(Q]NLHI>^%>UNP_OEZ7F"14=H3T=^']Q5X![D'-P[\1FX=^(_`7>%
M6LT,S<X`'9OPSDTJU3J>.QV3QAP#5`A5_^6\W)7;AH$H^BLLJ4(:O`FV3B:5
MNZ1+&MF68T^<R$-[XM_/72P`$0].G#0V1I<`%L`^SL8?BEKXGT$`@EP'@6N"
M8!)B.PAP=89VP?-XK?VZKZ6NR$E';H/1K'QHN_`&(''77CX`%?--U>1DU=.-
MM2JZ+97F-LU$4L/<7B."RAWG4K?DNG*8W,C))WCVO*6&R8TJR8>WK,YJUVJ#
M2'5Y7_2'RG7E,+F5HZM&J[L2FUPV$G8UJ[$HJ7U[_42M9;*7D*4KL[VUO!$^
M&D[EP#((H'?ZV:6Z<A]#34%*22%U(^GX;[M8B'UBL<!58I,)4-\4&K;,L2)7
M+AGB;/S\<%Y>AR^GY>=P=5Z6\QL@^85Y6QRL!KQ=YKJ<ED-F'(GBK\^`ZC#]
MX^FFQI8]WAI+,.5:VZ5<A*4!":\9L25.%)":EYIZ-F;PKMG)T#31VQPYUGI9
M,(]PNLL\DO&H@K;Z2D+YCX6_)L,.W*Y,V4N3^ZV->]`=QF=C*;O6%%P>FM=2
M.?7^];RHEM;8C=W$_+[=A%GW%,U!E4Q.GLP(P;*WB!8*D3!6>LXUEI*Q#UE`
M(BQMD[?TC-(7-0?D5$4DN^D@DS@3^)5QO'KK-J(E%=5<$/\AC%:HBUPO18&Z
MUGJS\@.^G_1=U>EV`.XZLAD@B'AH.=VM.0Z7IRQ*(U(,E4\O;2B?&B(EHCU<
M'U^19#V-%%K+<,MH/"\PO[_TCU_'#Z'4@^H)3L!D&B\3_X&L@/C++5E@0_'W
M@0SP=,_'9T0$K)GY7;63.\L&.F'P'3VSG"4,5=YE&S)PW"8((1,^+:&1"?L&
M1#K>WS\^/5)'BV6TY%.Y]=J.\^S$\\HSKM!FNJ`-'V`>?_T8SK]/R]URO*<[
M=6/80W`&UQ-.H<I3H/7$5T;R)J)P\CKQ)7<H72%ZP<K3J7"X+5=G<<O7H]IQ
M]MK%9S'`=-P^/#S[V&UVO+?<02ITD$_#RP./XT\+-7AV?!U>$0$[PH-QN"F_
M6.(`D<&#[_SOA9Q)QU=1\V&>30\-*5,[=T%#;BF<FW8HH.S##F^`_J+(%*A]
M\"M/UU=0;]+"O=4:7P1K#9-%,2S:B@Y+L88GL;XCAE4;T3B\E.G;FK2>K6:R
MA/1]6Y/(]N!O35-3.J7#$Q0>\D>``0#'4_`W"F5N9'-T<F5A;0UE;F1O8FH-
M-34@,"!O8FH-/#P@#2]4>7!E("]086=E(`TO4&%R96YT(#$W,B`P(%(@#2]2
M97-O=7)C97,@-38@,"!2(`TO0V]N=&5N=',@-3<@,"!2(`TO365D:6%";W@@
M6R`P(#`@-C$R(#<Y,B!=(`TO0W)O<$)O>"!;(#`@,"`V,3(@-SDR(%T@#2]2
M;W1A=&4@,"`-/CX@#65N9&]B:@TU-B`P(&]B:@T\/"`-+U!R;V-3970@6R`O
M4$1&("]497AT(%T@#2]&;VYT(#P\("]45#(@,3@T(#`@4B`O5%0S(#$U-"`P
M(%(@+U14-"`Q.#8@,"!2("]45#@@,34Q(#`@4B`^/B`-+T5X=$=3=&%T92`\
M/"`O1U,Q(#$Y,2`P(%(@/CX@#2]#;VQO<E-P86-E(#P\("]#<S8@,3@W(#`@
M4B`^/B`-/CX@#65N9&]B:@TU-R`P(&]B:@T\/"`O3&5N9W1H(#0U,#@@+T9I
M;'1E<B`O1FQA=&5$96-O9&4@/CX@#7-T<F5A;0T*2(FD5]MNW,@1?==7-!8.
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M,=M-!3(W"\=*$69QK@]9B>*17)P0N4_!35`UXDM5UU6[6,JP")K^7-BO;ES:
MAT'T]\;-.BO\J-F(!]OM[6S\</!?XN-?JU_)&HFSQC)68283QU.:.IZ8'1:,
MV98R3-(T%DN=A;'.^(S;B4)5I%(LB7<]BJ-8L3)BB64<1JDJA-;S(_$D<>0E
MOAC$>].5]T+%YT)&<70NAGL+6WQ9Q#),@X<%&"P"TSR+>[,16UBJW'8P4(D_
ME@DO)7DZ,Y*:M"K=&]4@#)14$LTXS`+_L8LXZ-AX#X84>&O*JJZ&BG$QF+IJ
M[L0K>9XE^;G3WE*J4.:P%>G,ZX/?R>A%5D8T/KE(PCAHB'D5E#7/``FW>B?6
MIOFW:!]MM^G,[<"KPMQUUH(UA0EPQ(O](@YU<"Z>W$VW>.^HBKV9.]`MP(4.
M``C3N6VW;D=-:9UD.U4=.M6G`*(O%"@PU3PP;B:>+('*-LXJ&E1IN=D[!)OL
M+8M'T[F%=ML+&*VS<!5W=$$V[4.OUK@(<YVK/;4>0''U%V93QCM-:P^@7K2W
MXOTB#<Q"XMD#+$'\-&A)+47@)NY8S6.Q;KNN9>VFL$LO;KN638"M#[9W%]S1
M/_B:&!49YZF>*3*=^/T4$-9(3GJ0_LF(22#Z[;IWRQM24!JX";$C@\Y-`#U2
M-3\"I<1)LGOCA.SBE89';(#=G5]T]K%U'#^.8GDU*QEFA3Y"+WEB.7DG%$Z>
M!9>9N0,4_"I+0R&N&O9.^PB`8I6#9!JJ7,F9_V43J')G0"/*>]/<6:)3MLW0
MM35[>6]'T!,=Q*-(SW5Z$"L"#JY/[;;>B*85=0N*G5B#QJ.I:K.NK;AM.Q=O
M98'44N1'HN83R8Q)F@TDK=H&,<`C`2`XYVA!$8?YDBY.,E^`\M`/V*[8B6L$
M?S(9G2M"E63J935\"ICSM2V=$\7L!<#%@WEFYA'Y35FVW8:(.I-1`E*RF!$]
ML-6GX*D:[MDFG:TY<0VVX_B6DW^)T?0ZU%&2?\?#?&R?IRE%2,]<RA2\O4OH
M2OD$"WXHDKP0#(,IOOOK/@,E84+7HE/,C/ZU(YP4>7J2"^BPR`YX.,K3;VUI
MOZP!ER,NTK#(\]E#!XPL49VD=,+I1']7)XG/]'O\C)DQCO8?E^&^!GS:]0[U
M`\(K3GVG'XN*'WDLWI?_6&H9IWJ?"\2=Q5)%.L\I-2"6I2FR*08ZDL`S>%RF
M4A440QE]/Z_.5`X`)B(M\)S`3D(\`X^=/8,%127.5*&A57\"]8;*YT>2#.6$
MWNVF\\TWWZHR<3'#Q2P*2<`OIR/>.\02L8+CB+=V/8A]O<'<B8*Y3]C#!_P?
MT,%RI'(0D>3.6\9JY0VG,E@V0(U0+U)$"LY?"HD%9&66RCAX!?H9:JL\@"X7
M2[A`\,I]=0![\9LD?_(MEP=_<:RF^G9F7V(?]I^8]P</PVDQN9E/2.]L/Z;Z
M07"8`]=<PPS;;LHE%+I]G*(#*"Q(Z2@9$4Z0!%DBG6HJ7)=+'PFGU#7A\5`8
M8";.?+[,0JGF'C.#(+(@_/,0@R/\W.Z+^)NV#P%X"+LB$BE&A9XP=Y0.WLVU
M$#LMG(O&#IPFYSJ,68?)3H>L$@5B25P0+F51[`,J"K,D]B4=H*+CB*A`F:\(
M(SEI?43)<J1#9:14R?^CVR@/"\A.JIKK=MS-2!]'NP4\9[P**9-3FWSS>!-M
MR?0JG"&1)[?Y\M'V:%)W^\"BTR;?/=K,PU2_Q/*T>Y+G)(_&BRF?.]KC:T=[
M)R"629%`LXH1M@OHT?>*'A^OD@3NM4+AP+U(W9KF7-QM36>:P:*,6#]S`5S_
MX7N?6+M$,5&=6H<19U39F:KIQ4/7/E8]JBHT$_>&,4P1P"RH!G^F(L?6MD/7
MP'33$#5$.B\#?#U-%1]7-NVZKNX,E6FHD4A$(##-_!57:/ADO*M-^6%.912$
M0>ZP9<MW58KGW]?[DNM]R?5^&OQYD<-7J()'=&^?&MOU]Q7O/Y";7KBS$!WE
M<CV[[6^LK9NV5/'+X`E!X4^^ZZ&.YJ42;)?.G#7S,06/_AW<!,7-PA_-QT*(
MB[;#!#^C%6HIYR94D[I=H7;5H#:U8F6^4HS92X++70!&JCN93?:`YS2;C@_(
M8^"AA(!^K;ALW0@H(7P\N)EIW/=9^&UTMMQ_^:G?ML"4G!9O_9D*?4*_=6MK
M]^DI@Z)OW;AIA=84,MY6-?XK3ZS<Y\33'LQ7MPQ''#S1SM_8W177*,3_8[MZ
M9-P_=`Z6")>CM!_#ZU#<VLV<_0[=QV?$943HD7[5CXR6P/V>R([B!*%3%;=K
M01\AXX*(MENH8^"A<1_+'4[K)O<HB]$X67?XKA&?M_YBOW'?$JZ`[,-C3[*A
MYN*?R"S<Q]*2)T9`5YX_B:0393/$Q5/A%?GVY=8^"?NUM`\#*IX<I.@?U-$?
M\I#I:8()IIGS(QUP5LP)*QQ8FF>\C:K+W2;7`P?4(GIJU"?VV_5G6SJBGK8G
M1J9S%WL?ZY8CX]^-I*,Y$<[0TJ(S')QJZ[:D!;2C3=LL^535^,9/<N.7,K(@
MN_&+0!+K#%JDZ!2]V,MP).PI0!,!LQWN6U\6P(JNID>LT2I]6>_!LS4=2%BR
MNT"KH&#-JT;\NFVLCYIIJ'2JCC3@\47=A3-1YDR4P417C5NP"V"Z,35/Q._X
M:%Y#8-Y:<6V[QXJWT.7>!#]=N0/7/]TLA-=0%O@/W6I*9".J?%D[*BQB[;N8
M3\&HO2QP%!O'BG%\N#6$9@3J`U8O^<W633V)!W^9T:00^3/"A//8/?(3E\2>
MIVPP_$H1@F=;=[!K^A%0GN_#+%3L/#?Q#@$;2C(ZP4@2T`9FAUGW#JP(ZHG/
M2X`S4C9/W2)YJ_;CA[U;4*0;M&X9`'`J5[NCM3O)-(;9>$,>U+L5PRM[C[HE
M=]G]DQ8+/.&_>U(@2U/\N86`"+4,O??8SST9?V4$V=Y%P(42ZC7K9QX%70TP
MHIU42=7`9<O51TKB43\!Z^)M5-VDB_U]KD9@UECJ;^3(NC)`I+CH^VW'H]^Z
MMJ2NYR;P&5--C6@6:3TO;(C`7^'<]F][N1557ES(V9NNFKF\^.V`8E@D.IX1
M_`%:)Q`&/T.%=M<9;WCA(5?X&&`:5(&3">+H!TRP1-\F(Z6/\#UI;PP<_[L?
M_I?S:NEQVP;"]_X*HB<%\&[7LKRVT=,&:`X%"@1)>DHNM$19;`3)(24[FU_?
M>9$2Y0T2Y&*+%$4.R9GO`1`YP4I740Z_,,<31_=VVAO.)6-E@9!NJ'I_9F6!
M,-\'.T9-[GP.=4@C7J&ZFW',S<H_"2!)0B]2+\`=SF"[B060YYGB@7U63#VB
MV8O[[1988\J&6".<#!G+@*@`@/P7G,(Y0:120#X_S$OC$"=[%-5151;#6@'9
M,9=("8="RQEGR-%"(<[RYP"2_@65_J/\">2A/!_PJ6.RT-6%BO/LA&K@=.4*
M3DJ?G#'A!N12D8F>WCXQ"75#()M]46QF/F,ZOURV['1)!N>!@!(-6R:MGA6=
ML[JUWU`FDKKB/Q*$+,1D],AM$)AT<:!@\L/FQN%0#.&PV[@1U#MH>EHS`+(!
MJ@]78X0QD<G)%RR/]D:*!1G$X@BU+#T@)*^A\.BV%J+LWV[^B:&1E7K/32V]
MK$M8HI'L2"9Q_7AJL#"+M%^^AMNX@.?B4MQG_*M$_W%H\\4=QR.C11!V/&,R
M3DH0-&14C_S>X24B3WA=+C1I*KIO#23[PN[2L^>[2/NDV%8V[`$1>DA"<Y-`
M.&?HR05ZB-(KQ=\/<S^)',S=%7_`#4U>U7$#'0VOS$,6RWLC'5>V1'W0^[GH
M_9P4Q%86YA[6^V]DWL3I<L`K5859;C=<]Z-+NM07H!CN@7PE'?"P6RT_"\?]
MLI?\D6]<&$`99J%"Q%HI#:@1NEOM0+U]X3?CW)WY`>(76P:?R'3PP8"B7P%H
MA#X>3[4G*_RM0UCT*C&M'IU"XA71B("0F`RGED""?0QAL,UES1_>Z4%=^R3\
M%E+F$.=.<G=!`Q\SJC+":<1_=@<Y^IVAB06:!^;DTMERSHJD^GI&XA,#LROR
MF?F8;HZ]!\8,T>)B<#ZZ@XR\XYWC65YMV[(N[<IV1+JWS#]W8>(%D.6[J*TR
MYG<<C3LE%15;`IWEA*>X<05[V!:H=8(H.'!E$HZ+*BZD+A]1,4/68U$0D&S`
MTR">%9RT!0EM$N<9/>"/IG&?89PSVO>=/N(,0$V]#^/P'_$%K$KH\F(1XP1L
M+@JV%@59BQH'MS&4:AX(W5H_QBBDVT"2./RD^A/?-/W5P,6O4MVQB]FQ%]*%
MG&CU%5#8F>#1UDSDH/;-5T(K/_K2G`=[;"&)>E79NC;.`AA8E-MG9P*G1G>+
M$Y.*P<1:6%G).]@!)0I&7:U4[<+B:K#R1*M%EX63+YEN&Q.$]<.!(/W`JN^0
M@69R>%+3"P).J-.66GCS<!5EH[G-OWCFB'5RD=@UGP*OD]N:!GX&/C[*3-S?
MR"*4='M.NFV(Z<PM3KMMMGKUD*FS#O4UB;J[5(CE4LYNL"6AP(%0`"9R[;.R
M'7<)9L`>5*D!AGINU?B'=.%8@\"$^\U^5L?[F!<[$8\>KA@U5DGW#):(!"-6
M$E7L!DIF4R32XR[-L#P!\QVC]([!?"=@#EI;-=(!YP#L5G'+R.O!UM9(G[*#
M5R,_R^O2N$%;:01TA2=91%;VR(8$JGWRM?2K$$N5?@U8#-HKQ.N2,!P@F[M(
MK$(B\`544++"$&([R5#89'C%K#_%#.[SR(^VE4*1R6"UN@4,ELO=S?@S2/0R
MRG:\/._[T@*)56KLG"G[4V>_H;F"0CR:SM2X`]']AX<B_SZ>?\JP0G_'"GY'
M.S8>933`MB[+WE4DQ&6F8KV1F;*K'1I0%!V\MLBC,';L!DRD]P/@B7:5%]P_
MW&_6N^*FK/.X(]%?KWOX"(7\FZ?WKS&$TVAY]6MCRV:EV!6"Y(%%>F:K]>X^
M<4B+S7W,&N)%",NO4"",UID9@1$7KKE@<RY8L5Y;#IHGCG-N1;M#J="'!8D!
MO&*<T0Z1_L1*3MBV`<K/'S>WM12K,M\$EX@)`"*8BNDQX_1"/<ZIO<^D0X4W
MRESXP;AG]1\ZD8)%!,AAZRM^LN7WO[\V84P37L%NO&BP/6NP?293\[YDH.3V
M/KMG.E'J'QT"QM);<UGLV5VM,]F4M&0DU@F2<S*RM7%;W!'$$AY%?#1(/1++
MNUBP9%N0[6IM$3H3]71C2CU[2,U_4$3'45SED3AD)]X3.(,$`[=D"#>0[_-L
M)A$(]P#\X42`8,3>2K]1_"U12%PW[0QC>FY*A*_RC*>06H#W4'3<`S(\(@'U
M$!S$[P(LS&*/0;=QU!`W6J4!2`OP<AV((]7W-YPP1UADF`0D5Y@ML'8I6.]<
M8(,2X/,92"P`MF_USV)Z/T?=`*,PG?MEUA!0GF@ATE!$Z0]QZG=SOO`,!=Z>
MDHDMQ5;;,L0^1&*'K6/ZF+`-.K@T<^=*J#(R_#I7+Z)*$AVD`&I%E_2=#/.8
M+@LAX\RY=XF..MV,XA>8."`_:QF&%##32BRPE!?]Q'\FJ#6)0&E_N[X?V]E>
M8/&`^8>`^?0!0OH+NT6(_R0-8(\?I&<UY<=E>FSE\,^)GHE*!6\U7#W&*\,F
M1-R]E-)XQQK@-VH)/2:)BU0=+YTT(E!2GL\X.[EYI:L+T2(H-]IL2<<>[TR?
MG%D>M]P8$/,?K&]=/*IP8)+RBTNI1S>=.I_I7Q]^^W\`U..P'`IE;F1S=')E
M86T-96YD;V)J#34X(#`@;V)J#3P\(`TO5'EP92`O4&%G92`-+U!A<F5N="`Q
M-S,@,"!2(`TO4F5S;W5R8V5S(#4Y(#`@4B`-+T-O;G1E;G1S(#8P(#`@4B`-
M+TUE9&EA0F]X(%L@,"`P(#8Q,B`W.3(@72`-+T-R;W!";W@@6R`P(#`@-C$R
M(#<Y,B!=(`TO4F]T871E(#`@#3X^(`UE;F1O8FH--3D@,"!O8FH-/#P@#2]0
M<F]C4V5T(%L@+U!$1B`O5&5X="!=(`TO1F]N="`\/"`O5%0R(#$X-"`P(%(@
M+U14-"`Q.#8@,"!2("]45#@@,34Q(#`@4B`^/B`-+T5X=$=3=&%T92`\/"`O
M1U,Q(#$Y,2`P(%(@/CX@#2]#;VQO<E-P86-E(#P\("]#<S8@,3@W(#`@4B`^
M/B`-/CX@#65N9&]B:@TV,"`P(&]B:@T\/"`O3&5N9W1H(#0U-S8@+T9I;'1E
M<B`O1FQA=&5$96-O9&4@/CX@#7-T<F5A;0T*2(F45\ERX\@1O>LKZC`.@PX1
M3>SDW#3JL4,.3WNBQ3ZU?"B!11)C-$!CT>*O]\L%($"I9\+!"*+6S*S,E]M/
MVZL/VVUH`K/=7P4K?Q6:%7XR"L/47ZU-%J=^;+;?KC[<MJG)6SZQ,FU>77WX
MVWU@#NT5CJ^"T&QS'JTBLWV^\F[^<?O/3]?F[M.M;VX^?33W7WZZO_MX=_/Y
M[N=[L]C^=K5,_21,-V89^$$696;[40@%1,C[5'>N-5UM;NMJYZK6[6C4UF6Q
MLQTF1"&(_603KB&-WEVEHQ`;%N*O166KO+"EN>]P[9NKNM8\>%\JV^\*D'E8
MB"@;/PO6Z:4HJV`@%\1$[JOWX!65^5:495$OEJ&_\:KVVK@7&>?NU)GV:&76
M.*.C:F=.KIGM['38Z9?D^-?V[V2-6*RQ#"(_"V.1*4E$)A:''\9BAZ$?)TE@
MEFGF!VG&9V1GY4>;)#1+DCT=GA.Q8L.`7XR[ZP1+:3H]$F1TAJ\!`?SDG7MR
MY2+V`Z\^?5M`JL"#%GG!U'LC([N`*-Z+*2>SYU8WCPN\(?*:NC\<S6]0/*_F
M\K&EDFJ,W2E]V:GDTPJ1QLI7%I^$)%2<3Y<!$-^8&R&IS)GK[TII89"\5MXG
MH2Q'G%ZP,&$K+`XJUEY?80==L/U6;"XUA:AQ/6`HC$2A_6(9^6NODD_NFLX6
M.NE>&4PT+%H@];GHCC(UC6M/,G1Y![_0Y6&?-:&4@:D5)"K-;C;OW'C:=GB2
M#%^-DMK3)YA2S)5>T[A!OO*5^!1/(U,]HIP*R*SD&B5W\^N-T=M.Y#C(3,]U
MA>V*>J:2ELYM/-A$YLJC7`1^.G`2=6__(GZ:C6Z_%ATWSN9'LX?WEZ2YNNS!
MI&*0F<H]&W9_,.C+G9@^A&#Z<>`3>U7NKIE'&/A9NDHTR(P!(1%&!I?HN%VL
M_,RK[,'I@I.%SCRZLH`+M08,BQ;2V+:N[",T>:K;MG@LR2PP"#-;#MPF,&)V
MZ=DO`X51U;B\9CAZ_T5`!`P9TA'P^N@J1P`E'X`Z`S_Q^+&8[0RM5X3RV,M)
M&C==83)'&3NHZH7F!L&=W`/^U8E.8C^*DN@<>(,Q4JXT4AY;\_@JG@'/C4B"
MDC_@J/-@]2>RR,ZI&,/Y^@G1,L.FA6^2^7JYJ==442K"1%%?/<0C"@ATK+=R
MR9RLD&7K)AR[>)W.ZEK=ZR*,Q%]6!@*ZD.AW;C??,'+\*#-GMO;%?,92S.`!
M@EU#%A]T10%V5%5XMJ1B"-'E`T2,/5:&1-MXB+:Q1ENQ(U@7/"%!//-D&YG6
M?0MC'6HY*6L$ALR;KB`\(J3P4):/3*6;''\YJY>DOHQF:F>5&X[)@?8HWUH^
M[/E@V14.T7CT4TX^G)S4:\F%<G(A")'$,=ZV/3K6[(9(!6KQ#4L6>B6/U6:;
MP68;-N2A@2N9LT?0NOC$^?[H%;0D&RU[NI&E2ECFPF>T^;BAQ(XR.]M\S5DB
M'&Q.J>+BY%N19P>L+C[7O?#>C4K[ZHD(2N`DX+XDX(S;[YUNR86G86>N@49Y
MB<37^L`]Q5M.,3/M79M=H?)4M?+-C[8Z.*/R"-DIR49N6'F(_)/[07V[7C>K
MPZ7X:I2F?>]UC1OYU:H_Q!88/5RA3C6&0#/H:WE1M:4"U-N:@W+DG20IV>KU
MSXN47`HQN"SR5PK,*#7STB(B[S&M.H>XT[$U3PY9A,",975I5`5!%$[JSLT8
M_I1E46E:B3@DI'@4\.)>3E3*JM2"6JO'"!WTK!EO=4;E=Y$45LGX4*X)SX+:
M/&]Z`!@!]&0;)LMP=0)2KIU1?:?KS>0-L;KCKF"#3VP=<!$1<`W1H)@N7UDN
MJ#^.LF"2!48M#-F1C$[V/I*185^,1GM2/.IFIKSIS"^V0>+69V>7,6A>4%':
MQ[.CX)H)7#.;?&P7\FF[\&A+-`(.1;ASR,,5W%P+:.I<SB^X[&(X#OR`T@VV
MKT&_055$]5!GRL*R'H&K]6:*A6BT"E?0WF-1%F(5&/2'9`U2=#'SPU4TR0MO
M4KRG#,L:&N2:/499M(G?EIACUQ-J;0`S0<7LU!#SD5"?>H,8^UKFC99ZJ00S
M&2I&=!W-3:7#!9>01N_NI6V1"G/8/<E$CW`5EW%).)2Q(-^B#>MEW'&J'(01
M@J]:4:;><&.^/TTJ\*HXS6;PN.B/EN\<>;_).>>@CWVC[<=AWKZXBVY&8!QQ
MUZ$[K7$5X>473%/M+PC.$X3.*=ZBN*IE,F\_$*%P,CO'9+I&&<T"C,E%.P-'
M;>"H>Y0/%_2?]2W=I)M9UOL]^=RT@`[B$?;!T/7M'7`NN6S-K`)JA-K6R0KE
MSLB;EVAK3_:(_*FIGPHY*1\J/K#^Q;_W)8BN_'`3Q1/'N7!L6.7H$-"..35H
MC</[.&Z$`+5])ETC'4+"28PY(3S5.\7',EC_(4(^;+>AP9/W,ZRLDW2LUE@H
M[\$+5@\+O;&6&[B0I>FD+[@D"9\(-NO)`\^)B8MD[Z>^+2J'''#O#M\04]J!
M0*P$6)HD^1ZXLTT:_U_@IJSSQYBC$-KG@IE6DM<41KIT*'E6([)*V?Z(UXCG
M*/SPL+G+U/WAJ$O/$AWJL48.LV2"!:D-M<YDPI-*C`BWT)@4!:Z:%G,_2@5A
M;J3VP%/,EVI:\TF=LC/W6AGIJD3GR:VQ#&;!WH3<<Y#7CO..`V5$H5='0U\;
M><,"HF3LE93HRGR^!2%E4`#1NG2/4,E%A\SSLI>![CNF!DW8TE'UHK?Z=UCN
M]Z)E&'N5*2"_DSF0)*R*`!OG&HS;3L.P9A77M$A+LI1/SA>:+2:9Y8LN%>=3
M^K"+5'(STBYR>SWH7T6^!/GZ#/)(!'<O.>$P1,8N^(N0\&OOFHXG#'@$CL\,
M/CF0UVP)'0M.8JYGZ9]PD@A.:&IU%6(CR.AL9*0#8<*%7S22T$V")WQKYQJ9
M/R%R[9OAZ+M4$4+W4Y&4Q/-T[2@\9P*8V9;[SL/F-?-82FK,$!M-H)H(I/">
M.QT,2$]&I(]G"';HV!0/R8#=1+";,';#"^R",BI+H^..F]WC]'AC^G>8[/<3
MR"8#9),!LHE`=D.0O6A&)[%T2(,7U=\T=/YLD<@U$J6BZ?4L$J4:B0!PG5M^
M0_-O)\L28EI7\DS^6ZZJR=(<<6=+,TZYS$YV>ON5#6IF!XU0.<J,JI0I<9-;
M&;A#K0P<2\FY>7;5`9-'75&N^BZYE_.]61EQ#B?4$)'^Z`;K(6(]_&B02!\6
MYH2*1;9RUW?P]Q(;)Y01>5.<`"8-O^A1+AJ,,>P..-TU_:%]6%SC?@C";=\<
MF)S[3U^<6-Z,[')NIH+87ZVC]>_4ZSOW5.2`Y0.%-MN@R+@V3T77N+IQ78$6
M2XA1"HY6?H+(>=FAO.D&4;P0G>+)04:Z_>!%&%&'T@]=8F/<*]H7JG7`>7C_
MO#MY\_R:(9=!C_(U)7_@XQ[*K5W!LU8^U=[I*:NW"&K`#PF4ZT5;Z>&#0?/$
MPY[PD'ER178A][5!8SE90A@/=)@O0AVA;/2$B.F4?B-N4.>];-AFJ-;DL9>1
M_G^T5\MNW$80O/LK>,B!"V@9SGOF&,=!X(,1(%)NOJPD6A)@[QHKRT'R]:E^
M\+4D;5]RD9;3Y$Q/5W=U]50(?)TV\@,W<A4!J@^0":"LUZPW7T0L]-)A733T
MO.N&/4BF/G1'K(H6D+]4:2"7^U-U/.F7?4MM\U3C+96TJ%^N3A2-R&1,E22:
M.QYV*1S(N4Y,)\G:K"[F^HJ4$@CAKCM/M?ALVTJ_$=/QY8/D`PXZZWL/8T-E
MA[^O&ADEU6\T]I[.GT_2HC!)5!]>CJH01?,A;-^EUR4]C/3Z*VYW>#I6$\*0
M:XBXOSL]DSKFHH"NL=.YP0RRNO6CZQR1P%OEV59?#^>GPY$*7+:#W?CI&)*&
M[53:44D"=AI^GAZ.-!.=N!/,<LK4+.!ON[O#RW-7Z=J)Q(U#,^K#'QKCTG(B
M7>H9%08'[M:**,N;\Z`/%IJ!<E?8?F3]B7"@`5&W53UT[N9:X7"L3L=.4QNN
MDF-CG!?=\<?:84,)#&4*\27-G/O-,O=CG_N33DJX2U>\FD20W+KD7#N1@<Q:
M]P.1G;N'GFR$A4YGJF<W;`\FK/Y^',D+?B$R^KVPW[`KX)\9E-@>Y:GK)<)@
M[WJ>N,BR07`I30RA,T)/3+"`Y]R1N$'N]:PT5&*G53&TMGU_RF5V+8#3C)88
M4UKS+\EM04+%Q(\A+)+E^_)J4:AC_;^]E\T"$UO@=M)8?9`BOOTH^4,.=_(N
M#JZK\3)AN$R0R]S^,QE-53IR?"?7P(['`:-B)^VVS8._2?P5'='S`;7O)PAZ
M2HECU7T]?'R!$D;"?7E$_75GU!N?0'5UUTTPHE,N,5K$1O58D-0J8VIMWF*,
MB4)A1#Y-C[I`!J8VZ7R5'+]B2I-=X:L#H&IG?$EMS?\M41K]0I9AK)1#?KZY
ML16\__#*I<8G5Q&-4<J]627]^DT'H7?W=&"9URLI;.)EDTQ[0/(->UQZ[$-3
M?)1;I1+IG;K?0QW!%5PH"T\XQ/4USQSS0T.3`VIC?NABUR9&GRXWG==Q_0=S
M,B7!VR,&P6YQ.T3;;]]N/`WUY>/B-(7EET^G\Y>G?W>)BV-/*3:JYO&T)'M\
M^UI['QO7!F8-ZTH8,E)5;+196>/FD<:)'1;`:Y\@/1^?^Z?N2,2H#^^8VO7!
MF2NJ\F0R<<UN'WV+6K:M:9%;UI)$H]5,[UK*$>17*OJNKN)=/%#FY2"6W")/
MEN^'X?V57?A="M!O-ZAUM&5;63B3;%4"9#R%VF<TBU?(9.>;''LSTMI/K:9Z
MJEXYCQWZ-Y#Y;KX!'3[L'RSM-C%[5YHPG!X;,_OX]<T$0PRO+7%26\DO?&`1
MRV`IX3XQ4M:.ZD&)ZJ\C*8)8?^&_&`=`%_?5M3P>=/69@&E#S##^A"RR")^K
MDXU8#R4#IG$5H67P(D(IJZ1KO#-8I$:QVZ=`$GG\P@5'7YA6]TD(B:T-B0'@
MO]L[Q[(6EE*`I;P";3>^8A)-)Y>0(:N\K=`T["QHR-(&XGLTIS5`Q7H)J&(I
MQB66.3:X?;\SZ&<%RN'8V<:^M$VQ6TX!YS5T6\0X3M!E/0K5%I+3<?(MJ#Z0
MX@3A^_I\/,CC$_\]84+E'U5!,>],:PW2N\Z.'\#R@-Y'1[@Y*BE0&!B_1L96
MNQ(S]76;`8^5\H&];5$]A$92-%KF"FN8?"U@+,5,QC0JOD#?\_[!9L/-P@0Z
M/-7:4J25A`ADTA+EUG\3Y<&\BK)8-U`6XR;*NO,ZRL.QJRBO.[6.LD&@9RAS
M'\'88VVOC:ZYM3N=5DDD/:...9(8@/!#%D]4+D$?#CM2]Q_Y-TJK&$<:U%PE
M:ZC8!0ISY0O5ID7K!_*Y>$H&YF%K"LV3";'!`U%#KGTKV<!5CN*F+1Q79QCS
M`:'UQO6]PYJ1D31GW^T"#S-Y'&:"#C-A-LR$6M9HF*$;^((;[/?X[4U!1Y/?
M3FCK?6T2.8]?.UHLLO1^QZ\$,A@O7$-4@K6$%*D-NV^FZ0RZ<O/6MY^JL3]Y
M3"(BC<O9A68)GEV(O@0LQUTJ>3#UBO-M#.)\0&S)$?:^12>P6"5`@9(I?`U/
M]5EJO07!CR4&SN],9)Q[V4VNNT%NZ43T^V)LH$20#-H.:XCD6!K"BN.PN/3(
M3/QQY(^[\">.H=1)Y_H1`GI_>WB&8H!$0M3JSR1H/4+W++(0H<N6]OH&[ID<
M]*.#`8O6"?)0V(CD?C_I,JZ85M8F;861]ZJ._A<B,PB)S9M$-IK7B$RMZT2F
MQBTBZW=>);+QV#4BVW!JG<C`%Z1*9[V*6$RSK[HY27,Z<*_2SD2Z0Z:)GV@"
M;(>V[VJAJF1)H2R-3%PQC2J$!L,8AFXV%3.4D@$QWB4>5D5@D!2,LIF=-CG;
M*Q!BJ"`OF&G/8T@Q=<4J8Y%`F>.I-NSOE[9,"(K-7(#9&WE3^AWG5E1>UD\!
M=7N11):^ZAV*><VH'ET:"RUON*3&#9>`N-ETB3(W;'BDME6'T#WHG'6'>B/O
MNC1"W/;.)DK&I7'P-5]6"O)4/LT4YQ4C?[HP%C!\WO)6C>OAPX359+L5/BI/
MXX?XN;QFU`!>&%'I6QZI;=TA[Y&N?M,A4$*(&X#VQE5$08TT56UXI,8-ES!\
M#,6T<.F_`0#ER?VC"F5N9'-T<F5A;0UE;F1O8FH--C$@,"!O8FH-/#P@#2]4
M>7!E("]086=E(`TO4&%R96YT(#$W,R`P(%(@#2]297-O=7)C97,@-C(@,"!2
M(`TO0V]N=&5N=',@-C,@,"!2(`TO365D:6%";W@@6R`P(#`@-C$R(#<Y,B!=
M(`TO0W)O<$)O>"!;(#`@,"`V,3(@-SDR(%T@#2]2;W1A=&4@,"`-/CX@#65N
M9&]B:@TV,B`P(&]B:@T\/"`-+U!R;V-3970@6R`O4$1&("]497AT(%T@#2]&
M;VYT(#P\("]45#(@,3@T(#`@4B`O5%0T(#$X-B`P(%(@+U14."`Q-3$@,"!2
M(#X^(`TO17AT1U-T871E(#P\("]'4S$@,3DQ(#`@4B`^/B`-+T-O;&]R4W!A
M8V4@/#P@+T-S-B`Q.#<@,"!2(#X^(`T^/B`-96YD;V)J#38S(#`@;V)J#3P\
M("],96YG=&@@,S0T."`O1FEL=&5R("]&;&%T941E8V]D92`^/B`-<W1R96%M
M#0I(B8Q7V7+<N!5]UU>@IEP5=DI-$^">-UD>IY1*-"FK_63G`6*CU4PHL@.2
MDI6OSUW`M27-E$MN+L#EQ5W..??3[N+C;J>$%+O#A0S\0(D`_O&54HD?9"*-
M$C\2N\>+C]=M(HJ65@2B+>J+CW^]D^*AO8#E@51B5]!5$(K=\X5W]??KWVXO
MQ<WMM2^N;C^+NV^?[FX^WUQ]O?GU3FQV_[[8)GZLDEQLI2_3,!6[SVQ(HB'O
MMNE,*[I&7#?UWM2MV>-5VU3E7G=P@Q9DY,>YRL`;MS=(1B=R<N)+6>NZ*'4E
M[CK8]FCJKA4_O&^U[O<EF/FQ85=R/Y59LG8ED(,Y&:&Y[]X/KZS%8UE59;/9
M*C_WZO92F)]\79A3)]JCYCMKA+NJ]^)D[.+-WEUV[A?]^-?N;YB-B+.QE:&?
MJHA]BF/VB=RA@Y';2OE1'$NQ35)?)BFMX3>!'^:Q$EOT/1F.$U)@E:(3P]XL
MAD=),BZAU[R=ONHL#N$LQA!C),1F*^,H`M\_][:L'T1W-/!GC1&/&ZG\T&OJ
M[M@*`]G;BW]H.IZ,_32+HBEA<HQPX")LBZ,(Y:50@0PNA=X_0?X,68P]RAXD
MH(0?MA?Z209YFPH@'#.FV%ZK*Z@C:TZ-[=#-]J7MT)[T4P_3XB[+#HL*ST"&
MMRKWHS24\SAL5R7A`G'=D(G0.VVVH2\]7;]@V=X;L&B%:;O2O8?Z$[JJFF=]
M7T$%F'U?="64M#C8P81@;\N:G%"Q+R.HQNET\?AQ+@+TM]!5T5<:38GF('11
MV!Z.8IL7776E:7TA=L>R%<51UP\&P\?Y=\9G!_SNC=[FY*TU;5]A7&"3%A]4
M!/F`ML$OP0F_^9P#+J`II2L@^.[=^:*!2&N*?UD7#:4S\<P&/R3V4_W`JK+9
M^RX'SO*\%%<-L/OSV)W%V+'+ZMR!V>L-])(''2OAJ_3Q#+.%=Y"M3>1'GBAA
M3>;5_+3HK85CGZSIZ+'^"4U^0A0"2*(GSIA[O5&0^(JNG9T'\2%:VN1#J=`'
MO_)9N%+TG6O+E6P''DGOB-M"#YIJ?NOZ"PL-^HO?C$T&MPDY$RW:2!P:*XJF
MY>78#!5=\4I^:NAZ/U2_\W*%`N=Q7@3#A>;(=U#L=3<+24%!XNLA^/P>7'?%
M"?5;-&Z7;3B@8L][VJ)OD0660:T;9T/(4.@AQ"H(DW=##)#<N.B916SXM^%@
MB[8_(6[0,W'%40,'_[3)?`6+[QMM]^@TN(BOK"G<?@M-3%>UL\1W[BN;J1ZV
M@[?K4,=CJ4-;/FF,1>[U%+&<HIA[W/"WS9.V\\=H/O+`1W?%>)Q3BI5G'^#`
M)]N<FM89)8`PK7$ESC&$:LCB]YH:.N'9`)/A-Q,^)N2XHKL>JU'?-T^KUPZT
M`S^)LQFL31P0L^T'4P-<H"WPOF@LY(`.'GEF[,,!),+P#,?6*`'XGB?1[U/:
M;[7X8NYMK^V+D-0[07Y)N'3=.$X[(5TSQNNZ;GK@)F0-W0$GB2%R4L5S33(V
MC71-4]:`H21B(`\/5A/B9AZI'5V5#TQP#C*1()[+[CCG)LB:4NJL9-9A-$]-
M]830:J!F^0215Q;88HSB`XO"R60:O9=M#0WC4%L3:MO_F`Y@YZFT33W`>=V-
MI72R;#E:<D.0CH8S-NS.KZCY@!LJKAT!#8D&H,]B.:_#%0)Y^G#`$]J!3;$C
MB-]"T(;I.82=9T.?(`L_2Y<$/!WTJ:E>A$H"8=SC4]6\`/)"TT#@AJ-!GN?D
MG(VNI>0:QI=*8TFC2"K`)X!XEA"/*C3V@SB<L\*H8P;$$A]D1D"^TEGI2F<-
MP#_*&`G%?Q8%=W:N\.?C'*&/XEFW*SID)*;4+.%WZM1LT:G9>:>^TH7G;,X7
MTTRRG>W*XE')*HHUJ'$I?VS<CLQ-,7Z2)D/)38IV,AGX4N;9.WF[@\R8[2?-
M(\<C'H+5U6#(*?3@/6E^IJ!E,I&0/,,;8FZ!BI=U[ZFW;8_\&2&K1DQ([OK(
MUT9<H1#P./$*"P49"OE)W``NT6:@'>]I6/]/?*WKRZ65:^82OB6+)[YF:90@
MDU!W+MC.<1TQG5-KKZ+LV5A([?;DM#8T?]W!`'4X@+42Z&+"WW0(!8`BS3K`
M&GF4O#WK?8?YRW8:>HS&!=>R+6GBTX!',!?%>?AV\@&0"`J0*1$*8H:".`HO
M80F.<%`:+4C[R@Q:*93<N[\#-!"PMK-E@3A`9D1?ES2,_O+U[EO[RX\-@Z?`
M._$$BP5`!P8)$LP1`%$6.(S8KH:=`4UQ!`F]`[(4U).&_?P$X&+[8C0P/]^;
M38`BL70;]OQSZ6@:^8:?`.(X`P=3=OU@#/#A,-K&.:$HG>&2,,34?`>TV,XD
M97"N*.<RA[4<3`2'GI4)_X]5&'L4$KI'?G`+W0,6-D[FL`@B@(J]5_22<>M.
M;+UA\PN-5#OS@+;#EW@2&"S9#20`,&[8-6RX-X#0('P!V!,%^7P7^98CS!G@
M?R7E!`YY=.X4LD4_!=_-RX@>\&.4?`HR;RDKS8-[^3]8#EUG!:^BYD\I<__M
M>07..ZVQ3^XC/(OQW.3BG7KKW<0+L*#EA<##CI)@LB"%P+M.=C2*!';%NQ"G
MWD6.<\"DR3%DD(+=='YH\'H):'N-MYA)J%](.($,//&AYJ7W1\GH#:_.]<,T
M:GYIN$OLH(VA8D==@7U_SP,*3&])K-+WV!ZY!\YUY,"Y`FB&.&J.(#&L>V8`
M\0=)/-A_GVI?'^BFT]P<Q$$7;L`#E'<C&BK!U9QWS=[Q+57`-.$1AP!QF>$Y
M:X6&'[?#<`<$8(T;_,0PQ44R5QPD4&EMVR]-SV=+DEJ+4507!:AS9Q"KCJ'[
MGEC]I/GSSN#P8>P=&M7F"F=$+_)F7:.3YHXX?H<>;<5>C]L!*,8^BJ&/VDO!
M;X_\%CJ(97G,AT(D:34O<7OJ048M=[I%:W/7-"0U'$``@BB.WQ/?3GC34!-2
MKJBL$#CLOA7NM:8ITKW;EY@JT<*44A[*`CJK<F\.MG$;0%`ZZG+!<YZL6^F,
M>]V8I=@C16/6$<0H.\0"&LT6O<5JH=`V>]_!+-;T&V5^KJ;',D?*9?W!K8:(
M,:^5$2#Y/18.U(A^UA@A9)23&<(MPW3>U'-JLPLB`J!<L)2K@H%^J,=J1S@"
M6+L>MCE<@9`<FCE%-FSGN?T+[QGC3BZ]3CR@4`,_#1(2U3/1&B1Q/CV:=',(
MZ!FD&>XB5?=Z44$\:31Y8RA9"&@8H;)`P=PY&(2/YVDXRR$C,>9)!M1\2LGD
M364/2BS/HY6#9,Y#*;GZ.N0Q"Q5]/'O39,0"?SNMFID$.7-F,DW5_#PRSR7;
MI:6_[BY`?_I`*V$0^U+D?HBVHPQ*_`("(DIQ$2:9GP\+DM17\Q51F/AR>)G%
M?CQ_^6F'`C=`S`P$7X$W*H/*2A#?'^=G!$/L+#L:1PEQP7?T=!OE$7-E&*58
M[E1/D_,J!]A,UMX[Q]W+,\^C&#UW;]/D#[F>0L8'UU^7!+L&J5T3V>-X<]Z[
MD8<KW(1%?0NHV^*S%@>#RDU)A;ZO)MF`C$'`':'\@8C$2J7081_@*HWR_U->
M+<N-PD#P5W(D5;'+XB'!.=?]"1*31%64:\LFSN[?;_>,!.*UF[T$T&`Q&9I^
MX!L#'/#1G4H2KZP2?5E><-4T;I2.61`\S(-+;B+OT2Y;Z#QDMOVI%WYH>P_?
MIE>@OL7)70^=N)JP-CP:U4!>7$FBL,_H*"^J`B\G.QQPX:RA>97S=:NYJ>R6
M8YCAI3X"5<V(%W>J)^%.8%(!`_4>3+2X!Q.M?A,F176T=0(3-\$D\/TS7R1)
MLJ"9*B7/1G_,*_IC/;OH7>1UDC:70N%]?H>:488=0*:DHH`13B<%ALM=A<4U
M'':\;JH5/[K;+22;5O3@%W+%I7M3$1CS2#3W36@^T9,]\4#5VH8?@F6/SM7H
MT>VW.,-"@`'L?5V6_P4#Z)#;0X'4]D`@Q6]@P$![,'SHTP2"W$P@L#%1T?3Q
M==79^?-UD.#GY:]F")XPV34Z08F=.D&>A@E6(/>1!\H,3+_B`:S:Y53#/`!J
MT]@COXJJG`TD%MW1V745XS*QB`=L%KGMNB9;:=%:*,%F5?9=E4LHKYL:=OEF
M,32\J%9%4EUV-5:E*\!H\=N**U-7ZCH2`$P"O4$'IK9L)LI=PF&34BLK4]J_
MD>O$EAI-'CDIER;=)]:<:D&M&7Y'8_C5DLG[U\\>P2_FF<;8//&'^>B<"GVB
M1+[V0=(>Z+OU<GS_T.M#+P==E`\=R061\J8K,*-W&'.]]R.69Y<P9@?J8)X!
MU`_W+CPH[/@^11UI]!]N/5/S3;M,2TXE]=30+E%@SAP4"38Q20P9Y0_^B1N=
MP]">'K[\\,'DUO7D7DXX[*X[H?,3`'I*6^+<DK?@+V=_]^?/MA_C2]<-'O]<
M$D?PM;C"K3AX1$#T%M?@_3FY&!4?N67,B_+(:Y<FT:OR1[>(ED]<AJ$"+,[=
M[?6J-[^`N-L7O+>CMC;!6O%9;TOQWV!<C3#>#SJKC-/[]L7W"7PUU_`=1.Q*
M*MC.-A3&RS+"<#(<^:!Q0&O;H4"\.2//B#]YV/+U-!.?E_I@<>`2B"YT@53M
MFY>CRGJ1O>F!,55.CC!+9;8;%\'1?P08``#Z#&H*96YD<W1R96%M#65N9&]B
M:@TV-"`P(&]B:@T\/"`-+U1Y<&4@+U!A9V4@#2]087)E;G0@,3<S(#`@4B`-
M+U)E<V]U<F-E<R`V-2`P(%(@#2]#;VYT96YT<R`V-B`P(%(@#2]-961I84)O
M>"!;(#`@,"`V,3(@-SDR(%T@#2]#<F]P0F]X(%L@,"`P(#8Q,B`W.3(@72`-
M+U)O=&%T92`P(`T^/B`-96YD;V)J#38U(#`@;V)J#3P\(`TO4')O8U-E="!;
M("]01$8@+U1E>'0@72`-+T9O;G0@/#P@+U14,B`Q.#0@,"!2("]45#0@,3@V
M(#`@4B`O5%0X(#$U,2`P(%(@/CX@#2]%>'1'4W1A=&4@/#P@+T=3,2`Q.3$@
M,"!2(#X^(`TO0V]L;W)3<&%C92`\/"`O0W,V(#$X-R`P(%(@/CX@#3X^(`UE
M;F1O8FH--C8@,"!O8FH-/#P@+TQE;F=T:"`T-#<U("]&:6QT97(@+T9L871E
M1&5C;V1E(#X^(`US=')E86T-"DB)I%==<]NZ$7WWK\!#9R[4L1@"X&??'"=M
M?:=Q,[7R%/>!IB"+MPZIDI0=WW_<?]&S6)`B)=O)M).,!1#`8C_.GEV\7YV]
M6ZVT4&*U.5-A$&H1XA^/M$Z",!-IE`216'T[>W?9):+LW(Y0=&5]]NXO-TK<
M=V?8'BHM5J4;A4:LGL[DQ=\N_WY]+JZN+P-Q<?U!W'QY?W/UX>KB'U<?;\1B
M]=O9,@EBG>1BJ0*5FE2L/K`@18+D==/;3O2-N&SJM:T[NZ91USQ4ZZ+'A"2H
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M1YZ*%D+NVZ*FN.[:JFE)Y`=;6MRH@UC>P7M&G0M--A1P9['I\>F%'>[ZY7`_
MN<Z[9<!$.>*$M(#`5#Q5_5;TL+#JNCW08D6S$;5]HH"UP."F;=PM1HH26*SZ
MJJD!*'<5O*A4[A'X59;%KNJQ5NS[;=-6O\.>#5D#X1=>!CR&K[A8BXL'R!-7
MN+'NJT?KE1]$3I3_*C\_%'4@Q$4O/A5MN?7>4.&YDWTY*+@C-"D7G&VQ%M#>
MMH]VS:JJP*3*3)(E'=V1^8`7NUW;?*^<-(A94+A[^_`L<#@5_K-#?\W:$B#"
M5$\B[3)P.60/264S2]+12/<'T\&W\`Z;;720IEDTBQF?KQ8&$!QBL]NW-.K=
M1\$_R$4%$/C9EF>#R_.YR]V6@]_=E&]X',Y]YDWD<:?;ZH^<&YQ:-/-)4IXF
M"4YF@S[^^AW/$)0%^$K^LLAD)^X:H)Z`MN;+6UMZ6]H.L>L(0FP-<.0&!*8C
M`XL2*<3>X9^I.3`1_X].-#M;"Z]7L="!ENV_K/<EE)FXIVS\-O]SB-GH$_*"
M&3&D.5HD+&4/I/)<%.XX/M3WHN&U+7+5CWA7Y2;U/:@4/.(F_*D#`+7<D-^,
MG)^QK,WRKJ#*0!S"(`^!(AU/\)@?\.BI!V33$O<XJ2TQB*&\A#<2"4#05T]'
M;LP+:[$'BDAQ^N:44!YBYCBKW99R2)'EH-,1&ZGTH)GWG8=D1$GF_CI(&H9D
MY!+;D8`;BT_X25P4(SGGA&;/6[K>GUJS.,2@\$L.5C3XO9A>B`HK[LC?J11^
MXZ#"Y2+BL'(28VG',P9V2L!&M.;0)@D.VDXXH/W4[-F4-5`^<![`M)PSDO8>
MH5I#T5Z$LL6M(4&C1YG@SR`_OR[\QCW_M%2B2K\(A(B&AQOZ#I;CV6ZRV6_X
MSC_5@C#F+RQPN2-!Q8L!D:R6J==A4(M[`H=DOT+$-_\RS/T9_W.TJ1OT1K(A
MW*O1QLOY::]^X<^!\OT'Z-O]P"&C`UM;=-,]S[/T/NZGODK/`<0LVPF=N%IA
M')E,VP'$Q_<#1Z4G'GL-%FN%:RYR)T?+WX!.M`;`D+MEWW<]@1CX'9N&07!J
MPOBM1F/67'3[NPX2D&0O=!B^#B%+0Y4=9ZM6AVSUS<.L(]FY=(HIEB'1N<N>
M<2I^+>I]T3XO8DI</I<AMO/Z,NGL\(D'A_8\="IE\=C.#17H<EO4]ZYI08/<
MMPUSN/C<-H^SXD"Y?=1DAM/N$A4B2B(N=-Q>!VF>1">\E1T\8=@37W;`0R'*
M41&0']F/ZM(\N%]1N9^:&$,SM6BF%DU5Z:FV;;?E/3M?B&@,.:@)^Z'5,BJ-
M)K&.1Z>A\]H*%,WKYK%HIT6P<RV,*[EN)/ASS?60=UI7!QV!H[F`$9VSX=IV
MO,[^_(_;-9'T0H'T?`]Z4^8$02_P_9!,WE[EBL:M]+Q)]R2RW'=4X3R!,^.*
MNF%&M4*9V\688S/WA-&88S[))LVB0I?BFL6$Z/N714*^FI74\F@;GF!(:KXJ
M"52>3MO[4],($)/&GK5UI6KM"XNO)<(.U81=T'`QL?#+SI<HOW.2H;$Z*:?A
M^/Y4'I7(<)]V/N-RM/IX=SPBL*)RUB72_Z#`P`/KJB"B#P8KT=?E;_;+XJ_-
MDWVT+7N6!!-'(9Y=-3;+13NR%1@AR282#V3E7EQSKN(WSHL6N`<<$=41S)9'
M<<]9:EG:!]O"--`VREC%K`KD[5"9Z>&Q0])49;5S21\'2'HU,7O44@V46O>$
MF`2(L<Y_,8+7//LAN3)#(W5X5WG$Q0REW#U/FO9`X$G\%FI%U0.9>QC1=7@M
M5'AOVM9CLZH+<A7=A")QP$=*)'T,$$<7>*+M.XL6J46?X[0;C(=5OL<K;>L\
M$0693J95ZZ0:]D6%3KEJR[TK@E2EH.:Y4P@K7?6=JR/1H4>``J>^7J_DEF"/
MNN2*'91<[UL:D:+]4R.>;8$FRL5?Y\$+5K[0[VX:[DCY;\.MZQ.WO]01GO*V
M\;QMT.N$Q'7B:C/M:_DL\5,V<)&1QZUQMV\?>>/CP-])BAP*YX7DJ_2EX1ZW
MM[NF+;@X\%=<QC$9M9P7DI-"<PZ%S4F!\>V^EH\%;R,JBJ4_._"V5_`8-^,3
M1WEN@Y"]'9J3$9F4$O2RZVR)F/45",RAE!HRA;[J#GL9!&F@0_,6"-"E]%6_
M)VAO@`'J(\?7EW^&X&;FUX#1,`B=*O\_]!3:Q43>2J515WAOQGM!DVDR:,U=
MPI$P\%&>O9[*\C-J2$6%`?W2YZ9#[]E7>']1-_;>UG9#B<[&'!J/U+QHRZ&%
MF>SU?<Q`5>5(7Q2TR\.[-.&2C=+6U/3>,BYNB&=M>2)VMJW<J%GS;XGPD89N
MXC>53>?/_HD_,(["MV)P\-;4R$D`N(SAR1BI*/8$./AMH<,(I5++P5M'W9Q.
M@R2/IB&:W`Q[TPAD%C@8?SC1!Z695I;CAI>P+U\)VU%(<"`SV<MZ*%\##]>D
M8::8">!!HUQS-5@V."O"4U=KEYO:F'C4+Q_#[)ORU;:U>$R`%L"DUC5UGPHT
M=8*Z]<4RB7,*O`Y5>.P\M'>YB5Y3.C%1^I;S\CPZ\IUSG:2B/?>.=IN.T^A'
M-QB\H-+C\`Q7P)B?NR+YP1740/Z?5CB*_XG@?ER=Z2@/<F&2/(@RD>#UE]'E
M&+?V#"@2E3BC$UDV[@D8H<,6H\:E%+":+>F8OOC5&&^'F7"3)0&"[9>5`?IG
MDM^O'(K)PE#P"-Y'A.C4ZMLKC=&-1<DKK6,&@$V9T*";DG]8+*,T17\N4VZ`
M"(B*NJ1A)9+QN)+'&>HGK62X3DNSH.Z8%D(J5KR@W,)P)`VI&\/`Y/%8SPX.
MCB$F(@?')\[CI=><QZNO.L_+1>+,EJ,X"<A9XW(8_81KX:ED=.T+#XJKV2.B
MI<<939F%(_:0RAAA*<9Q!BVU3,C7)B071^YA07,=P3X9O>:Y\*2I.JDF'[]3
M[PQR`1GNV_^27BV[;MM`=)^OT*)`9.#:L*CW,@BR3!"TZ2K=\,J*)4"05#U\
MD_YQ_Z)G9BB:EN6;`%V)XO`Q')XY<]AZ5-7P3J,"M@]4HC+LA"**&KJ/HR1#
M>[>G%P9ZR#?D.@\(X5+D2U^<0F^B3_%OF/+CZ-8Q5/"%BPO+S^3.YZ&&3AA7
M\$N.,;U<]WM:/@TRG)3;21"FV'Z_Q^X"QF.:8F\V;D9DV3BVO/C5_\3%$O,;
M_G!EC7T$8<03]JQK[FU'/LWBBKI>C+I>3``_8N=B@E<O1@52+54(LG'()4A5
MEC*]!`E*'4\*DEQEC`VE\O1(WU!E&R2D\NR@DLT<,:8'.6*LCW)D6?=!CES-
M/\T1C$RQ78JP)(3"AXE"]\+YP"*&6B1BZ&M%#/ULI$\<QCE`1PRC4J(GW+?+
M5*93K4@*B0OZ,KGED%28PY`0+,*')+6_:NY0$;7>W*M!VO^^7$P(E9<1P3A!
M7HRH>\F]$0>,HV4J%MVV\MQ[:TZUS,R-@U5ML6:>?&=FS,G4%#KJWL33[DR`
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M^=/M#Y8^7LU3C-%\*!`!'&.3-ELT_#&S7KI9_DF`%=VYE;'_E-X(768FR@CC
ME*PYF!UD1&M\D1'2AYA8M&>^6.C*4,)T>_**>9`^+0,:U_VR%1N!<#B7XQ-/
M<044O5(+^W*E$/;Z!\VFN7PM0]EHTI5]V8ZU=89T)2T30+`II:YXD/?9(@II
M00H-9:RGBZ)LRH%6.WC>1]WJ<XFM"'WE+O#;R0-B:M.#&/#Z0$^H<F?].X>!
MGJG2DX#='-2336L^2:^+R0")GE7Q!I!<&3D*:\@5YKZAF4(;4A&>^2$*4;HJ
M49J"KVP1GGP'N>`K-OB**>?\$4$=Y\:A+[I0H`CA[GJ*$'?*QL0RAL=DI?6F
MK*IXY&DU\*4ROC.K5E<R(B)<2)(8B!FT*X"E\6#N]9ZLKTR^B.^[]/M2_5J.
MF6[-*7`#?8/E>\,(Z)K<'(;RTA7ZN7'RR/N=MY6)S\^UFVF#O'3F<7)[C8<`
MYD)L21*E#K'="UFO*AN6IB>C(2F;1+RVE^7]5]HN.\B;VV\STZ@>!KH`G#^T
M+T?SC/2^X<$DS4IFE@O[(69)<`_:Y.I@8',7"W#80TY^P=0BLHG6&6H,HDA"
M@"$]%P<J#0R5D%N]&'7K3*)##%Y1\G!MA[9FG9/LTMJ(!E2^7HOH:>,!P$0C
MSX26RCJUJ*SC(*OPO%_.$/HFHKW\"=!2_X"R@VKJO3-+?^3H:`[[`+8(@Z=K
MA0E6M9;]S"S$4_%8'8,CZDK%=";E3-&V],&V=7NFU#KA#+ANM,:NJ4],H,^Z
MT6V!@E!)>*+#,<Y=9HLM<])6?EE.J(!%,Q-P6OQH%$7A9-I^&@!HE,M"CY54
M`FI0>NZ7I=>`R:_QCPQW_CU3J$/_HAO^$B03@224`>WU6Q3R\F/5#=+M3<[0
M@2,?BGX(;1Z8&]E<4$797SNS"-]EL+`]!$^6N]6$:DCQQI5EWDLYE,2?E,78
MON9/(7\(E#08%2;5$]F$1('DAQ):2DQY3#A'!'4\URFX0D@)XS]P9!E[N<;*
MJC+YY?>B["<G:30$#8&CGE!(QZL\FRK6Q^EK511H[TQI9+2EA+:WNX34`&`"
MF%W*MOCA=:+3(,:S`%+_E;KI326K#[]N-3ET`RP4:")ST60?OI?%/-472TBI
M++[&UU4+&G@1*4=4W(URB9G38V)DEJ]\#[&Y!_#+YX:_E.U?!N%K]+X[#^7=
M4%'CU#RAW`MWTA_?=6YJL:&'W#>S>_G3[9*!09BZ!'57T$R]NJT8Q.5K98G2
M.5BUI0MIS'JX47XWBO%4_E0'DNH"TNVZMARPVVOXI=;YC.&'E)[+Y5+U&4$\
M@X>(MH9Y2\]AI&X:*@:$1A!BEF<F%2UG%Y;(L<%4%W6O228"U[1)>:&9*9ZV
M8>8@;^785[I$'O]>^#,01#-M2[:<.]RIJU;DZ!^^O/EO`#E`I:L*96YD<W1R
M96%M#65N9&]B:@TV-R`P(&]B:@T\/"`-+U1Y<&4@+U!A9V4@#2]087)E;G0@
M,3<S(#`@4B`-+U)E<V]U<F-E<R`V."`P(%(@#2]#;VYT96YT<R`V.2`P(%(@
M#2]-961I84)O>"!;(#`@,"`V,3(@-SDR(%T@#2]#<F]P0F]X(%L@,"`P(#8Q
M,B`W.3(@72`-+U)O=&%T92`P(`T^/B`-96YD;V)J#38X(#`@;V)J#3P\(`TO
M4')O8U-E="!;("]01$8@+U1E>'0@72`-+T9O;G0@/#P@+U14,B`Q.#0@,"!2
M("]45#0@,3@V(#`@4B`O5%0X(#$U,2`P(%(@/CX@#2]%>'1'4W1A=&4@/#P@
M+T=3,2`Q.3$@,"!2(#X^(`TO0V]L;W)3<&%C92`\/"`O0W,V(#$X-R`P(%(@
M/CX@#3X^(`UE;F1O8FH--CD@,"!O8FH-/#P@+TQE;F=T:"`T,S4Y("]&:6QT
M97(@+T9L871E1&5C;V1E(#X^(`US=')E86T-"DB)M%?+<MNZ&=[[*;!HIE3'
M8@C>M?1QVD[.M,Z96EG%72`4+/&$(56"LNQ'/F_1_P:2DFQWU?%8!`'POW[_
M[9?UU<?U.E9:K1^O=!1&L8K@CU=QG(=1J8HT#U.U_GGU\=;EJG)T(U*N:J\^
M_OU>JZV[@NN1CM6ZHE64J/7Q*KCYQ^V7NVOU^>XV5#=WG]3]UU_N/W_Z?/.O
MSW^]5XOU[U?+/,SB?*66.M1%4JCU)R:DD5!PUPW6J:%3MUV[L:VS&URYKJDW
M9H`7I*#3,%O%)4@CWT;Y*,2*A/A;W9JVJDVC[@?X[*=M!Z<>@J^M.6QJ(/.P
M8%%68:'+_%R42'MR.D5RWX*'H&[5S[IIZFZQC,-5T+IK99]Y7=G]H-S.\%MO
ME:S:C=K;_N1D(\M!GBC'O]>_HC=2]L92)V$1IRQ3EK%,)`XI1F+'<9AFF5;+
MO`AU7M`=/HG"9)7%:HFRYUZ=A`P;IZ0Q?%MFL)7G\RN:#+CTRJ/*5=<.BS3H
MNP9^KQ=1J`/E#M5.&:?NNB?3XVD-_VZAPRSX\Z*$&[Q6N-TN0(,TP%MV$8<)
MF`/<MS_TU<XXJ[I'=6<=GB+]/^C&"8VJ^[G024`_78M6[`$8\-D-?@#2@3\W
M$__JX!`K,\ZJ[8BYTLG#(E1LZ(CL*C:+6--_+E*X;D"$.&C-U@)+](WEC6&1
MP(M"67%1TZ]<,;R'@*7%#CEG?EL9Y?CZMN7G(S\JXZF2D7'5\\GWPYP+Z,BO
M'=,]Y6+EM5^`W\K@(`*J8W=H:+51WZWJ[7\.3*VWFY"-L/X+0XHQH\-BE:<G
M=AG#D0`A,?"Y597MD0EH"#8O2<J,S4VZ'%H^[?G`0HSPQHZO6'4+KRFK(T;,
M@CV_F?8%_*`!!$68!TY9?]P0B8Y/+=AZ;T0*9E/-9/&T!M(3L)Z7$-YCGL!P
MKJ[F*+<*/RQ9B3Q0&_LH&Q;-U_K7@7X5"5."K&X$,+[S+H)8!X"TNTXY"U(:
M/K6TSZ9?QH"U,OO?UGXRK/=AU&C2&'#QV/7_%]M";*H=<W%,OQ-O5B(0__(7
M8"';LJG3,(FR=):2,\Y7^QXM`<8DB7<63&@P>1I'V(.$E:V2F8<N$Y'"*-YQ
M3%OD"VX"BA+>'/&4")[P9W,PC205N<MV3V"=I\7<\,NS7)\S/["-AF1D(.7E
MP6![K")0CU#VVTX.P:X)Z`]V5:A61U!H_B!64)U*G<Y-,:).DTH(D9NJZOI-
MW6Z;EVLD[<0PI-G06_`W%SH-P7EJU0IAN\$T3,*L$"+HS&:HEU:V]DWW`J6'
M2"*WM@6S>`26X6IU&>\7H2&YJ>1P+B4W<:25@$%.>B4C+@_D;<=OK-`8+*C5
MQL[#H2<(>FH2?AAS+Y2-7X\M9:"F,MZ2,([FEKF,(*@S_18HSGUW&A-@F:]0
ME=AK<5@D>?9>KN@AH0/1=DO5:S)/QR)>8Q[6YW;P\,O"59KK"ZM?PGT_5=:*
MJB*N]@Q_0R59"B151D-7!.D`Q<M-"1,H!72&U+:8F5*T-CXZ*9>&;^X(-PMD
MYI,H"*YGAEE-,HNIK\DQ9H-A")P'^N5UUV(\PH(-AJN>3Q!/\WN.?;^B@(<=
MLJ"FQ)9"(>[X%97@`-0<@/R);*/F>2![8H[S;8D"4>O<(<6D7,S*D5DXV4DU
MQ;>>FPU8$783M!\R*,#B]HB%G\ZV#:=6BDQ,&7O>Z/BNV)HT<6?5>=;PP18O
MIJZ=&YDR&ULXZ(>QI#\$V.[(W5(Z_#`O<A\K4^&?$0NU7I7O8?^WOMMWU(R/
M`0!M^>"Q?]G%3DW%&TWL&VW'I?V_M.IFW[,]V58JOU9Q%)77TD*.!Y@E4LX2
MOD6%7?X4HP;"P3[;ZL#[EFY3$,#;CMUHU6\'QCTD"4V#T=NQ*KTL\ONR]U$+
MU?EFVUMR>&`I8K'M=0>.WI.8.^ZF.-]=-L0>JS`21'E^6;O&L2<6@<P6"U,.
MZ+0;7D'ZDX6S3:/,GM_DT?,8(E>>^5%30P7B8UMIJ/,?;/.B"CY.A9Y<D*$(
MMUHYD==')JYJF+W<CO>XB3\]OVFJ,P+^75C(X^R2\YI5).*/<WWO9/$DG.E6
M/]1.U9X$Y'/C)8.J:V3?F6HXU\D,<'N,S]>1ZE%:47S\2:<0\*6?`7L+Y6:]
M.P&C,\T,B>H(-1VRI#M(KI"'H=-3S`+(?CWPQY)U"A\3[Z&_[8ZJ.V)!5D)<
M\E0GH@]SDA);YH<]2W7>#JQ]PMKC7`9Y&B<ST-[Q6TV_V]U`3]Y#ZI`R^`45
M@E[3*;Y!41A#-E1Q]L%/>TP5I\,$FM?NP%<=/PPU?SBI;1%ETAQ$<3K+=^2O
M3$*DQ[GDB%X'[%KIW""S4^N4$DZ*@"`"S`2;!`-HGW.459W<_)T!0K?Z>GAA
MJ",;>M)^PU[#I:6/^BFR4=*S)!@58_HM6>AC/>P@=O=]]UQ3&Z-I!$LY,#54
M`=FE:&Q)[-:;0X/4<;Z:=9&KD7X^&06@1T2HN%*+5CMH4$_8)L0V9[99C!YB
M%EF892<LQM2$S+B-'YLP9H`=Q@M.))J=Z@9T)7D1Q0E]YQ2'49F4)S:Z+(^O
MFTT!FK(4J_YZAXG]-%_7LTR-^D*NAAH_'&&F\:@P'D\%3#?OMD#SH/,]C:-$
MJJ0!<MW4`AF^`(&XERZ(A*KDJG1,W?ZT0U+2.7$X42RTLQ*!(IXCZ6ST^!:@
M%[X;F`LX24W.U93LM4_V@BDM&7[TLL[>[KF#&?(XT1];:NG%G)``_52S*J0?
M^4:NZ=@;?0VJC4#,_!1KR8X@,><]`\-,_^(57X6%CO.+/J*</$3Y*="8'W5$
M=K;/^QHF$DZB+RKA,XV3DF,1(622\AT\!P#8IA;MT*;#L5/8NM>877B@(VV(
M6A8F11&_,Q$Z!3TYP.\AJ!\6`J3:47V"HBW6@4$&J2T3[$SR^$+EBPGH^^%%
MX??0:2NPN1)S2HYX"*!!AO</P!&0`"[R3B;J[X0RN%+B%I(93"*4.V-"#X"U
MQ1@^@0'5SD?!$+2+29G,0)1-T?P,]H0BZNMGJ:?B27Y#0Z,B9`;T?)9>0OXB
M"YRFQDDFI/98]VZ`0F>@IYUQ/JO<UU,BH"ENLDTV.I(4`!G!A>1#22`8X#,'
M4A,&S\G%,_^P6LG%I$@JX,PJ*H"(V%-)R5J1X>/7#'_""!7VG6V>@IG>J0=6
M-=T1M$=<"`'T>$H>AY1&L'S+4P`KXZ-36)THLV>\(%8.LCA-16=U)@:0?5#F
M>_=D.=1VMEWZ:_T/.X`DWCUE$B?OQ)D(/#<2]@)UM5/'&CUA4;7JT)@!H`CM
M&/+S;B':YT$W6LZW%T^V1S"1?"FI`>6>A7R%N]H<^JE(SY$U4M82S>A=ABS:
MH3=4*S?F!?I9PD$6R,.2CS:U(>OYH(ZC)'\GGX%3(+]Z'C`E]54-.6P#1%!F
MW$0D^P14Q&E^ZE7&.%@36Q4?J)07YH%'M6<4*4FRMS7&A(\(!I^XKME<1BRE
M5LVCT91.DE$QZLH!RE7342/S=GR'XN,<0B_2[[4:;TRMEZ/AE[%00:F&SCOE
M\G,]=@DT*V*'D&'M;[L#U3<\V/%P:&A:Q%NTV)F-N`6_@ZO^1&AT\P%T/F/N
M?=LSHVTY>20T6U"#P;T]$P!;<?B^KNTK[>-;H3MVILEY9RK]`4.A"+/ROYQ7
MRV[C1A"\YRMX680&O(Q$62)Y7!@!<DDNR9Z\EY$XDI@(0X8C6O`GYR]2_1@^
MO5KL7FR1'#9GNJNKJW;YG;Z=R`B9)S=+XY6Z%!W'I8&6WFV+._)D1O+Y:D1:
ME6,O^*@(7R6[;9I]4U6`S+K6=\:)%U$34XN)F5J:I?X<&:21$MW06HV7H)-!
MCM'G!@L&9YC&^L^P>9H%HFZ=?C@@8`!?O]XS/T6WNA.?59)FPP9G%B^=U)F]
MX%?-:91E'Z9^<?P499?+F:7\)&86AU3A_P[VWI?]ZQXLH?=(489LI:!"_4=;
M)8>[(4W+?R5;9F@1JHR'"*>'EI='LKY]0"(P:9TWAUF$SI56_5R*%!+D!PAF
M`V`TAW+ZLQS;JL9?QY*-H/'7JO'[-'GNJ<AW^[_M09_(OUH3V-I3)SDT^H"I
M!\7EJKV:RR@0*7$9T+MDM9Y(R0FZQYG\%NY&&)(GG+.M+CB=D*2#5?!)`'GB
MM%M0`7?BUE2;A`AUF.N;M-A\G>1?8BH9CDH'K?BGEW_8>R2_^#.9U#.3_&?(
M_S,N=Y+$3("2D3VE*]A3MEFD?')(=":*CWM#Y&MNIBWAWN2[9F3#>*=SWA@T
M[DO\A:%38+Q=^']7ZO6)]U;(WC#&HU?J%;K3+Z#D4`XWK/I23C\_DE<BN!*^
MUO<`Y_[5Y>Z_/#S>C];:\>>YG&@+3E+!'$6W)0?<&M$1TN]9^D)"Z-I&KB2A
M"!QBZ*NUW+:8"(%VWM=6Z,X:&@#Z4LF2&`4;\=_+&4N3,*'85/@M97ZCJ2C2
MAN3'<ZT/<"8>=NY-I*.KH9D=H7QOG3U6UZC';K8>:]*TGVW:9,>V9N6&_J9R
M&(PB_^9L>ZK(IY`+!&EVEZNZ-'9?.X(XI@-H0)&WE3/?0QZHW;;^+.5LR.U*
M_FDBGTGLCI#PC\48*%^-5ME(9\X`ZJ5PM-?@+-;Y]HX:>XFE&<&M\;PQO27I
MK(U\A!R23@U]')X`Q0;UCGX/1!([;$X[E^(Z>2\J:Z3/U7K5^Q'>X(+O!NT9
M)(V[5H>J(?EK(E^=7'6L#K@)_>F,.U3FHK)[$S<8"2141=J4':E624<Z&P>K
M/AUK$:<,*<A3KQK;V[[T+&DP_M?9DP3XRD8]\'8PG;<#/'E3#Q]Y/`.>E;;5
MQPU(%_2TT'-S+W#HVA9=!?WF[*F^PDB0?&9A'P#Z:EU9M_X7WF66K++U2'BM
M\CY@Q@%]US27"MCC`3MDT-OV%7+,*V]3K*>D6`,KHQ,/6K"0$Y<4"/FFD\;5
MM3IQD7#0IKYBVWUII#!Z]'52Y.FB.Q;PE%Y,&6CSB40X:FN!84)DB*$5_5;?
M"+>/U/_&^Z[%T7`@0(6,B\8BE);8HV)Q,H)T7#VH8AP@'R#]W7IH:48^]202
MW`11R=*(_/R0JT38,J_#A#B2WN;P;\>K@N=0FZ&$A`M:^U_@@&V1YG<U$'TG
M#9I&G$@O)2>R4"].(WFHWN%Q=$O#(9(*H)$F#;J*:(]^-1Y`YE\3(3::WWFQ
MP,G<CT#%G:NVC!HDD$@:#4'-UV!GW'[0F@?;@4``Q6%H5:[L_+6E%\(J9&`=
MO_7B<94^C;J(J?LE!HR$:0H&M"T?H]NY.ISIJ[[6)U;P`PL3HA<</45T<SQ"
M,PH]0<O$@0[T@_.S+D;COO.5L^"H$DB_U(T.0+1:9#A2D6Q7XPDW\X<Q,G!!
MFSM/-%(W3=U>.U=1YA*Q6UF2K7:['YK;@F)0G+EX=*!S-28'('L]PR5B"$,Q
MZWZK*[E%\`:52KAZ7T,'A>1SX0?4]F,Z:&%">UFU2&5-1$:<U=0P"ZQZC+3Z
MC@L!K40Z`.OE,\R<O=Z>#Z#%F";$3(283%V55*%O!V'F6:)$TU5`C>6Z\UT<
M7&S*GS=]QT=!Q_&XYPU?1O/_AA'[F5^9S7P-*&]I#/^.-EB&#PGC=8_1N99?
M3.?+]^\K03&BJ@`-FU@,@73S8<BZ\(0`01ATF^S2/+LSI_`"O.`>8,7LN[:F
M1-[(UI2@EH.M7O&%)(_^X$&U3?)\-P;,=(]QP*5N@T!B#;IVM#ER801_#*<M
M$###1#K0YG9P8Y)$[(M)\XGSFTE^U8`]P8#M;3!10JA/X%"KUU'7D)@U&J"F
MGI0G9ZXV_Y*FP!DWZ=AW+4<+30)W`AT/+A/@(UVX8X<J!<4^F:_CONNDFW"G
M93\+MXH8D_52M%__^NG_`0#UW?92"F5N9'-T<F5A;0UE;F1O8FH--S`@,"!O
M8FH-/#P@#2]4>7!E("]086=E(`TO4&%R96YT(#$W,R`P(%(@#2]297-O=7)C
M97,@-S$@,"!2(`TO0V]N=&5N=',@-S(@,"!2(`TO365D:6%";W@@6R`P(#`@
M-C$R(#<Y,B!=(`TO0W)O<$)O>"!;(#`@,"`V,3(@-SDR(%T@#2]2;W1A=&4@
M,"`-/CX@#65N9&]B:@TW,2`P(&]B:@T\/"`-+U!R;V-3970@6R`O4$1&("]4
M97AT(%T@#2]&;VYT(#P\("]45#(@,3@T(#`@4B`O5%0T(#$X-B`P(%(@+U14
M."`Q-3$@,"!2("]45#$R(#$U,R`P(%(@/CX@#2]%>'1'4W1A=&4@/#P@+T=3
M,2`Q.3$@,"!2(#X^(`TO0V]L;W)3<&%C92`\/"`O0W,V(#$X-R`P(%(@/CX@
M#3X^(`UE;F1O8FH--S(@,"!O8FH-/#P@+TQE;F=T:"`S.#8S("]&:6QT97(@
M+T9L871E1&5C;V1E(#X^(`US=')E86T-"DB)[%?+;MPX%MW[*X@&&J,:V(K>
M*DU6:2<S2*/'`=J553P+ED17,5`D1Y3L>/ZX_V+N@]2K;`>S-PR7*)(B[_/<
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MBHLL]\,LISV\$OAQD4;B`F7/G#HQ&39*26/X=IO"5);-MP3IJ#%=4]:MT<U!
MM+>B/RIQ-W3E41K0#'0RLE:B[V1C9-GKMA&=JLDUX+3^Z.1+XI#]XREQU=[+
MKM=&M'?T@?JANE+C<8;<&?IIMBU><*=X4'4-N^&J4FFP-LC5J>^#[FQ$7,2)
MCZ&(1K,&(64*/(BL$5A/=NHPU)O$CSW9TZ/M'N%9>$+>W74@*"^:3>AO/5^(
MSW<@,"M`"WJV+/:J;+]MP&-N'DPFA9V1F\C/O*]MQTO\N;V+G![%''VCWAAM
MY1B!*"W$3J>.;;V)X;H*@@D4?\=O9=N<XU7@3[HJ]!IY4'9"\41/.T%,_D33
M+Z_=8Y;1^W$#5LO0'+1Y,:E8T@LGZMJ^^63?B"7^U!UD@QJ'WG_)PJ'';VU#
MI@T]\><F(2$2CUT1>JN-1J`G^*V"6*,!212[K<M)A4;!=S"*V+>RJT8+8S!-
M!LXF>:V%P:`5W`1Q4<*1$`V&_$<F97=EGF@;.-Z]<)R06'P_:(,"W[4(5O2Q
MHH^[`S@,S[[=P)4Y?#E9$\6:&?.+-[N40P8#9KS_=GG;1X#&.X7XB-/B_4(!
M<0D>++R6-].Y]./.Q'^EA&DQF]IIG85N*O,6SSRV#^I>=>=S:]@`&[?2Y:5L
MFI9&=Y"->$E)JS2UD+H=\-5>R4>P079_/W,I6HZUP#I'-H_BZ^8B]B,/H)L@
M'6Q=*K@*DJT_RAXE#"FZ,?(/QQ[B7>A&]UK2Z>'6CT-(K6`)=IZ%+-WTJ@/1
M`50Z`2A7UZHY@'>/@%?@4HV(Y3/(A%"YPG21!"MDAJ6\R))UG@3YF-A;UDR`
M4=($L6!W7/@3G(F>1#>VE,RA9Q^Z[\%M#X""MVUGYT`%*$QCK">A1=$O7H17
MP1ID1*,8IQ]T?QRQ^&^;'$QJ-@'&%UNKGG`>##^%*IZZ3OQ3I)I###B!GCR'
M00RQ4,_0QZS!IQ%1^BO'^0)^)K`3A(6@?-=:D!-7RLSO^8N.MB>T;!1;[2;?
M6Y@2"I$>4,T;"/AR%(R_S;T.;O>XOM&[IE_$)3.41ZQ#/$]2PI<,PWP$)?V(
M!OM'0GUG3"O-.CJL"6V5F<R(52;&(K2*$0;J][R)\IXTYLS/.?,SSUK)/GAS
M/_N%8()(AY2&&'(1%"?AS%A/E,\Y\*!BM[;N(=OBJDI5CXLHT04>*IH^V(P,
M_6([HV]/E!%;*F1ERX!!8.9APYCO(GM1.:RAX]2/H^+$T.'(ZYPZE!(:N"&&
M`T0"IHGC/#-$C_P4-$"00?>"0SXUXG?9#!*X@PVS)<2<%!I/1,$Y_(?PVY]D
MO&5!1;JUI&G\LAR/8_(R(0/:P#X8&;0Q`_H2M+%62'S@V>G/P6C"$\``R#&@
M/(`!G?J*P$$H.W$X=B#8-\ECAS7"H=$&@7Z6`;*VP5L^B65\`Y^8$7\+GG<5
MHO51G7ICO$KL);H+/#@S`9@G/0V$-<'\XDECE#%XN(<NH;K"4:!+A,-;A503
MX[GMG0GR;9(X$QQ!$*@C=(`!N@I<'ZJBD"4V!W)?,W6F8Z^<PG&6SI-M%"FU
MQ6\"ZI2`NK"&3DC[?*4]%@:\4H])`(9.BOSGT+V"W+U#5<&8T?!"/X/OSFTQ
M2T)*2LZ1AA%,+#"H07HS;;'58<UT#43.Q`Y691:F>#!UL0'IN4W'E@;Z0ZSR
M-UZ8W&SLWJWM>/TLSQPMI%WKP_PP+%[J+R$#O^F>VTK4&5I4S!0%*`@E:LT$
M7&NYT@+N"Q?29V$^)?^8I9&%Q'_KID4B!([7_:.XQK:2WL!L/*HK?D)87-9V
M%2KM.RS__-:(/^S\@QG&-)FZS^"EMC,X2:-B-$NVIC430HK$`=_8!R)E')I2
MV8S0/136/04)@QF#:C+K(BERH_&ZF*2R+2>RA(GX$Z%GH(2+IOP`D$,"CJYQ
M)Z\SX[0[6+-YCO:$8OW!$6I+<&WP)YPPO&1)^-A`$@G'I$B9&[MU8*P*,(88
M/%AE:+#7NZ8;C#GI*5`"9N0/XL9C]JU$&-]LL&&E;Q?$N[<-%WQ.1YF3AF*6
M:%;M"'R(WT1+F#F'QJ#&]'1EDKJA']IAXC;;SMG6=O18/CLY`NG1!+T24?PK
M&W7&\"@F9,='SCD)]EG#OM9E_2CZ3E9@J8=VJ"ML9)2&E@Q`QGJX\*.@..U7
MEQCKC0'IN"7$B))`\6;R^`YQG@"A5V[_RNU?N?TKMW_E]J_<_I7;_S_<_@5F
M_PQJ3%7UTM(9"$=&"&G!@[@9#%!:)#HC>)!8..#]*%8^$POGB-,<)9"(6][*
MTWQ/)8RZ5YUT4`KYL4CF,>0B:_9:E#6$'<2(I=X9FAH?HI9`O7F,L=RI6O:J
MLHN]W0PIR8-[?D@($7`-A@S1P8#<17,'W@'A,E9U$F^=%BLJYHW!!=8J5=<X
M,)#E]T$;/<$E`1A$=)%&SW=$D,.@"J6(I+C0="#2NY&R'57-B(O!0C[I'R>`
MF+=;8QB'UIX0^9"!$)D.<VJI"2"WE#T0AO?8:4@[U\+58Z)`V8M.$H6"RD-]
M2T`6<R[V`Z9760\5F*"NU8$*!N;`/X!CZYL-A2<@PP3DDX#>OB/:"/8":P(U
M+0$>#E(WIF<J^1;/T-R'AA!\699:2@LN![>V@V$5$8O`'<SGQK.(T\:!GT?)
M":=%2($.UETWZ[$J(E'U7WPYJC")>:NKH=1HLVK`TZ'*A064HI4/O![[67?V
MNM6RI0U:J?!YSN_-&[)S*Q))QUI!\$;1]F>%;*3JI,P]Z")UA1&&!\F]ZJF8
ML7XV8*,\G55M;!G+N>^56=OA"5VMOZ(X3E_H0Y]N/I_0-?#3X)1O/].4H*;W
M"Z==6[(/G9Y7P8IE,Q]^`+%O#B"O#16`@#3-BN>S]:5HH28(.#LE`=3%6ZGK
M`4I>W]K6RA[^!-$MQR($5U3:E#60K+'>/G+IE,P[H*))\<O!)40>S0V\*F->
MUPYW;W\A(<$F^FFC)&P4FZ;;/)FW!NDHG8O)$\N=V,3Y+$NR1:6]6&&4HQF$
M\%`L^#&9D]_1J':%3,MC1>CE/B%;V^W*%@.<UC4C@GUW`R4^^]<^6L!]I#F&
M5Y)\^,&#TG[GUA<R`//D5\10_M'0\QBC[7QS<CMMDO0U0!<TF5C.OO.JE0B/
MZ)031+LSQO+_)!UT[!\BC7A%ZE&'2R.>)4(#G`E"B">0;G?,Y?Q?!)CD7C4,
M[5C/<<?_B*^VW;:1&/K>KYA'!5"\D1S9TF.P[0(%>EFT!HI%^C*VY41;03)&
M<MSL9_0O^Q<E>2AI)+OIY66?+,D<#H=#'IY3PDZX)8A,`OJ301KV3G/3C7F2
M&3[O3WJN<AN\KP^\*&-R6$&N94&#3PYO&[QQC;[)C^:?VGT"P5CG'!L-%V%$
M60#S+>^>!!:KJ/'Z<2YA_(#ETKRE!JVKW"<>R(!(&LPYTA&&E0DW('%);@&I
M(`6-);O%6'I>-"W1XY:JXN!:P00H!=?RB:7)8HHL\Q/40VS/V20Q2R1FB<0L
MD9BE)&:5?[8$E'^16WS3J7TRY4;)_W!QN2#C&AES>A'=+3SH9>"GKF2VXRK4
M$NM(`"#_%I95Z]W&;M=,K*DAY?;LG<M9K\`[_C3_UNI#WW]MHR?7_F:E^1TV
M03^"*E2'LZUH&\)`8FF.)"9?<N$&>I4)O>H:EF`UBN8>43M#TYM\;\FO1YY+
MCW-[M1B:XSV8]D;,[FER@HFSU)$G4UFE\?#D\?O0O*PV,]4D`[-G34+LN1_&
M**<N[J=J:HM4NER320.<9Q0=QK\MCH,P,:12V**/=_BC]/[>/GVA+ZS>WB_=
M9U_#K`4?%#D.6DK6^5%PJFE;/9$(W_X`34.UNU:+26`C4#Z]V7TY$EM(.%ZX
MB*F>7M,+:Q619C2=HS0T\16)%2+MQWJ`XU-YI3XYDKF@AEPFME#IMM&:8/7'
MF"1O(55G')B5=<Y6(X-J)/6X3O#A>$&'(NSX^6BP[AYO^5GWHV:;$DT@*'&@
M5_88FN<T_.D&_V07CR$`D*I)68M0X8&U9#V@+L35>'@46U:.@LU[EU\27L/-
M?'85=[#<QP)N67*?D^RCDZ\?!=$1P.M#V1*?5LP'STM/B$_PBO@%A)'YVU9Y
MV0T13(M.#I`>\,[0D^5(R;+.E$DJJ$9X_1^K56P(I7;/J&SB9)GXYY#UG=DU
MS"[C"'/+CU-LNDJ6+J=91!>87%]3P;^MS,U^U#%$'E&IX?\!U7;C[T*Y/3MB
MOM/.DQ@4Q0C!_6/H&D9'II]WW>DTMG'G3\CW;<!$ENQ2258:?*4NB;J6X@^R
M]X+.+UB8<I7>P)2%T18?%5A3`=:JEHC2`/]5<&!AT`&44NC3G;M%RM*2>9H]
M(3]-WI%\;A20\B\0/$7;:,VF*=7IX&/@]IJ"0=5]P>W(=*18JU;T3=@1EV1V
M'67Q"5N;-,%MP&R>JL5@S"Z"O2T<LS+N)G^O=5$6[6,_?M.AL\_$&1`%S#_G
M;E,TW20?]&V]+K5W&Q5=61)'WZ&WK/9N2IFS5HNGINAH+G,@RUF6:KH"$`@*
MG8;B]B!G@&Y*9\OY(CG533UQC36WT!-</WM](%"/(#<6T#"3;QMYH2/A=7=Q
M&0N[ZQT)O\&++@G9)O)L2(T696E:^\G?P*BY+C[C2%49/7P,(CR1Z.0D74D]
MC*+V0N)LCAV]=7=XLO[9"A$H_]GIOC`JS;M<5QWP4XK]B7F#,1=2E'$?I<LU
M3+5]&!T=1?9B]>S;`+H#?%P*96YD<W1R96%M#65N9&]B:@TW,R`P(&]B:@T\
M/"`-+U1Y<&4@+U!A9V4@#2]087)E;G0@,3<S(#`@4B`-+U)E<V]U<F-E<R`W
M-"`P(%(@#2]#;VYT96YT<R`W-2`P(%(@#2]-961I84)O>"!;(#`@,"`V,3(@
M-SDR(%T@#2]#<F]P0F]X(%L@,"`P(#8Q,B`W.3(@72`-+U)O=&%T92`P(`T^
M/B`-96YD;V)J#3<T(#`@;V)J#3P\(`TO4')O8U-E="!;("]01$8@+U1E>'0@
M72`-+T9O;G0@/#P@+U14,B`Q.#0@,"!2("]45#0@,3@V(#`@4B`O5%0Q,"`Q
M-3(@,"!2("]45#$R(#$U,R`P(%(@/CX@#2]%>'1'4W1A=&4@/#P@+T=3,2`Q
M.3$@,"!2(#X^(`TO0V]L;W)3<&%C92`\/"`O0W,V(#$X-R`P(%(@/CX@#3X^
M(`UE;F1O8FH--S4@,"!O8FH-/#P@+TQE;F=T:"`U-30R("]&:6QT97(@+T9L
M871E1&5C;V1E(#X^(`US=')E86T-"DB)I%?=<MO*#;[W4^R<FU(=B2&7_Y>*
MW632:9U.K;33B7M!4RN)"4.J).6?U^B#]+WZ%OT`+"E*5I*>.>.QN+M<8K'`
MAP_`V]75F]5**U^M-E>^YWI:>?B3D=:QZZ4J"6,W5*MO5V^NNU@5'>_P5%?4
M5V_>W_EJVUUAN^=KM2IXY`5J]73E+/]T_?%VKC[<7KMJ>7NC[CZ]O?MP\V'Y
MUP]_N%.SU9>K1>Q&.L[4PG?])$C4ZD8$^23(N6UZTZF^4==-O39U9]8TZIJJ
M7.<])B3!#]THTRFTL=]Z\:A$QDJ\*^N\+LJ\4G<]/OMFZKY3]\ZG.C^L2XBY
MGXDJF9OX:7RNBN</XOR0Q'UV[IVR5M_*JBJ;V4*[F5-W<V6>95R8?:^Z72ZS
MUB@[JM=J;]J3-VL[[.V3]/CGZH_DC5"\L?`#-]&AZ!1%HA.KPQ=CM;5VPRCR
MU2).7#].>(^\\=P@B[1:D.[Q<)V`#:MCOC&^32,LQ?%T"YFM&$V)<YI6M69?
MY851_<ZH954TM2KAD;TAM_3LAL#561;^P`UJ7;:FZ)NV4Q!X[P2X[R8ORJHD
MKZC;YC%O^[+[=Z?V+4N,``U_(C`=!2:BUK[IX%3`H\^_#FKMV_*1Q#70M(6Z
M>2W.U:F;:B]D2UHKL4]9R\7@:'+O_M!VAQRW"AU%/W"R[V*<PPA%\VWF!P[_
MF)EV`_@UITTE;:Q5L^%/=O*)41\F1H*(&]I&1J#=K;J>!7"[E7\43)MZ^V^,
MJ]3'6BUQ+TPKDJ+]N=*>[\W5GN8YO:@')3:;3O&"U?I$'8;7ZO>7O7S7',AF
M-;3L^K8L>KK-K7F2*`.8HB"8>",:PT+,]H^F_:KRHB]AAL>F.M1]WI;5"[S>
MX58^+EKR\1BFL9Y(&N.+1$*/CL(<FI2M>FA-7NQ(CTVY/B"$VQ=6QG?C5,<3
M9<[OHM:'_D7E"+J\7)?U5H8/IN]IPH`(`C?-4OT*$,$H2LO%B@IN2LC,],!=
M-![=S'<U,+&URW77\]/"F,?R1G;.84F[1<3]=T:?0RM99!<E#J&8YP3EAR9O
MUW3YM4ABX-``(014'+UYQ@C6P1>@K7!*%(;PQ=]G8-[88ECE8*/BT+8"4P+5
MRRS$:W6H\P>:FI-(,,_[UG0=U%?-GL$VP+\^Q1L0Q4IJ<+0?3?PU&MD?C-PP
M2&"!F>]P&.U,!Z6JG,X15!5YAVRP/A@.>09(66]`[2_NP)LVBVGXU`^&G'!F
MG@F]AI$;ZS298F`TX;C9MT*]:698#`BQUQ!&^LBD@Q1%,#/(.=#72K%"+KCK
MJ(_O!F$23,E^<6:M].C'+(&#B/-FBX!X2!YS,GT*%Y7]3E:@4%Z=;C(SC]QH
M%UO*/O#U%YHR'=%J:??V".&G49@JD3J'(]EC_O`0H2WGV;ULR&6I/SFV1;+<
M3=]W".[*K.T!&RO\<*)<;XP5@@"S;T:=EH,&(*U\V':B0C]\W0/OP!?#93$Q
M]Y0`HM$_GSF$,^'2R-FT=KHUS`(9AX\F[J5E@BD/9!?JE($>,DL/V-/)_%EB
M.@-=&XXZ?@G(&'M&H=;M84NFYOC!8:%G<^'BE/&TK4J@D@<E]^)%L0-T,405
MB/8,][9NQ$G#P'#=$DC=(H.^;&1@)2@[W=`#G%7:]1ZIPIYU_@GJ&0];*[6U
MI\B\/IG!6=8/P^W.'7&:%\`1NYS(,73D%TQ!Q+LU`-3)"\G"-,(MM4,\,EHV
M/%J6?1B2P33,54YD=DR(G9C>=[W0SR;I*CO2JC6],5]!@!1?6_7)O7/5NZ99
M,[G?T%'+-:5UEQ,[;9('$$&/-I>G+(+E[IU?WMTL?T%QE._W+;))Q6\&6UEU
MSFV5')6RC$IB?:%L?,T:^/`,7;G]:N3M8!<:%^K1M)V,";LPXK*2-UQ6-4C`
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MK2H/@A3[M(J\R-74S8J__V,+W)/&-T@SP`-;/3?AK<.9BRDE*>X37"Z]\?N`
M:+-#"CQG^JZ84=V(@FDGJSL.;*G[SS>AP^7IX5Q(4[MJ<!R",/%>(_XU$_R9
M:[GF66)[(T'=/*/UXE$]5Q+7.^$*H_:6$@;2:*D:A%IV_[8U:QD:II/:DHE]
M;1GGE0=C*9Y^FP=UG+E)K,(L<*.?>%`GN':JPC0;_'?!-G.KM7":$MM80C0U
M=R(G/#JAQ`=KE;?4@[$A9$&,TJJ[8C=P*T+%1N21A-7R/7RY1+=+_0(;$$%@
MV0P)4B?1SWL3:0SZ2:/!`3H'68`%;,(<6@XH1NGRK.5H#1R>]W8'LU4DQ'CJ
MJ1/<6]13+?@HEPSIDDN!+<=Q"A[G5I1>U6")_A@7[22?A!>@$KEI%`=C^?ZK
M$!+">`$0DJ(._@E"0@T>P!=)X@8C1L::?LA@+A[-4%/$8K;4&8P6<\V021$8
MV]+!1BBD1Q>\F![-:8]`4H1;&%"IQ9@>K(A*09UD0,"R:><$.XNER)$/)7=.
M@*=/@#<D6@!OSL7)Q=9,RALI'P*YK"_MWW$JM4I+=5SHK.?J:2<KQ%XP$/6'
M=HL1!`3""H"X]K0WMVL$6%QW<OG,7CZ@RX],9U4\-^,Q187'S-S#56_S%\M.
M)'^PQ]$49(1<SEZ^)S=2`<[`3]PPBOQ)\AJK;$K82(.=>D*]CG*SXPY4=8>'
M+Z;H"1TY<O5.<F#@4E7^W10(E3@\?Y!*.4>2+,K/8?*ZWHN/&/+E]D,I=RSD
M',FK;V=2DVN8]853@>'Q$2A3F-B-L`R!#\2H.OF(ZE7'\!8^1;;QG%,+)Y8A
MK3B3BA$]J4>N7SX:V<&V/@_:V(6)PS"VV?98MEV.7"I;\%FH;2*_7)@#0G<'
M`9L`V)9E/!:@&<;L)?P=HSC5\>LV\17\**1^'?1RXL_%OLK+NB\W&VDX_&Q2
M2@_RB_%,6(3;2G24@J+65&C`'@T!AR#)J"+FKTR]I:/)?E-RS=S02_1OS,.4
M@),LR^")G^7A,$O=1%P6C974$;^^Q:^"Q9=4>43P3#3T.W!PE"*+_QS_T1SD
M`@PQ^HAMD%@(?3L9&^G,;N@U0UEBA4;JFB.D.;0\FPJX8<A*2#R!V0&H[X?3
MT`FE07J:NVR<T7=3*(@4S5``D73F7P?#:23CA)VQ>%AB4T[6#'^RQ@>R*ON5
ME4YJ1XZ2Q9W,P%*Y/4\^/K9,K.G$M(N3TE_;9%\@9W,M&A+G4R/;#ZBC-4(>
M/8$^F2YEN>+52]'^/]++YLE1(XGB=_\5=3/CZ";$AP`=>\?CL'=V9R;"XY-/
M"$HM/`K`@%K=__V^EUD@A/IC8GV1!)2*JJS,]WX99"'9.D;;E'Q/M0<9F@*H
MPRKU@ZG:K^K/D0_+<'!.@"`-3K)=\;G"!`7A*+]VH^ROU\GF9=D'9T&8*1T]
M3K(\LA5"M6TMZLO\8K?=D8@LYQ`F-V-X-_YJO;E6[FL&1=IF-V9[=!2X@'&'
MVGWKGEN\5W^=:,"`-EO_`P8U^8@!03RG<QCN6180TE%KINP/7>IIYCV,N:8W
MF^<342]EW1@CI92YR337-4&G=;]6,1,;R+H745YJYI^>VGPOIP@L:0X/`AWP
MVF$XT-8$ZMX14NJ!6L0<LI!5@E^'\_>G^DZ9%N=D2:9DV;A$_*,N;:=):&7A
M<%%.0V`87Q?*RP!&@X/UO/A6-R>DEA#ZWIZK5-ZWW."$J8$PI`=TJ,IJ>)+\
MM_6NZ0J;;ZL#;^'=6\`)W4D!9>UOTMD6KON*YYPK9?!GR-1KK>V.8].`CF5&
M/>?Z7"OT8$_=<I?Y8%BA8(6V8;.ER(,^YAG@6V73C.D<>0K3M'M,=9!5`I.+
MD3W,J3D>'.<&L4_R7M2X5]4[[M)J@-S&*`T\DCURA:NVB*;$+=&27DU:N9HB
M%V2Z)LLBJ>J_CU4/J4"$GDP!@Y<$8W'KEDW5XY"&:J"4.,[`+&GZ/4Y'EVJ<
M0<V0K?MFQ;\N3&]&A8P2'^6TM"7'G6G-M#+>O:`S\[?];MMAJH+-:G[:4\&-
MJY0D1TUM<>HQO1DG8(A7K'GB53>.X/(#T9%,'8QMU""7>[U$)3X6^L]CKP,?
MQB>R+1F;ZP@WJPXK9.Y9+7'5RQ!?M7P'Z>4J^62_9:TY:DU?MH`4,`4Z->O0
M-8,S`4LN!"QQ@U]H'IEX>^O>HN84HG&+HGF#=IT0U<0H/%I1Z?$&3X^/'\:$
MF!_G1:80?.5<N+3804TM&0&CRVMJXN1UQ!X39I/7N46^U>F*U8EJX$7%X5@B
M^S'M?_.NV)M$`"XCLU=2;>FLVIY36J\N+.NSOL'BN?*]:'MA*VI[;M"051CA
M%"_(UG/57D^%*U.Q@3L<FE/..3&5XVK,HYK@E`GZ@@[Q;63*6[*/?!RJ`J0D
M+%0+)ITJ!:51%]#@>3U/(1@1"A)QJM`"*G@I3=$S"9DC9(UT/F$]HI4&F^_$
M^DL>"U,0>F(BGM<%RI_I?XED8884S?"7Z`SUUS8RR0J:!4_.G;KZX[L4U=,C
M\T/O+/U.J3BRN/B?SZUCI)2&#NC[HS4[._-(:9F6Z3='&.;&EJC4YLH5I4,4
M6OV<4G)'U'G;'F:`4^1SW&EJ!YJ7?-.Z08HQCN5-OX<-Z3NQ?BEJN&FTFA?U
M-17*'K>*<TLFW"G2=;U#QK]1E(X..[H]Q':%.OI<F\^%WF\HP\%&2@R?B_E<
M&-VJ%F$,STN;&@)IE2@A'7;&']QQ*OOC%57<$T7Q15-^?)<A/KW9Y0]-)^6E
MC_03>7ZL=3XPQ<Y-4;KO>Z./N%@G4SJI&<%UH8_7H11%8W`$>NL+SFXT!L@-
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M.&MTEZVB*`Z<IJQZ]'UH(G3]I2VJOJ+J"`A$/C@@N&I1EH32<0^]4HZ6QPWI
M7_N2?N!A8&$3H\1)&KS(*`#_QN1EB>ZU5^"!D7I*//5P>%*`P;OZL>')PB1Z
M.53()\PQ`<Z678[%;N48(B8-T=D.;`+)+.<^)=Q$UQ"=SLSV3H74*7_H]5>X
M@MI.YJHM6?,,J)P)Y!)9@AC89,(H\0,)SP6V+&$EB-=^!&9!8YF,H[GDS=DI
MX@6PQ)3=2KYJQV;2_/"&RG`DG0W;&G,"@QI]MM?!KE\XR#U:Q,9SD]VC::`*
M$\\3]\B.N;T)P_!5)^O,\UYF'UN'!)9-Q&\[,ZN#"Y\[.?,RHX'>AAOXT>8:
MWJ\*61-8#!%>U+E,2<24Y:@E[?"6-`U?IG:0#=1_EGDW4FY8^/$@N::66;A,
M]-2F@+>7"7-5'$C4@?6IM;5ER]B*0E((R-ELM-H<!>VVG?E)O'H=&GNEO?M:
MOW<C"CJR4ZCC&:Z])0J^%Q=K]%("M6%)"6'6^A?4!F.1'V;,V$MXD87N73HK
M63GVE.BD,Y&[N?QC3IPE>QZ]9D^DJY4BQ,0?CH`2BT9.<4M&=2W!,3IWI$MV
MU2^WC>_"W5L)[]>?GC^EJK[MCU1`F&AIX3'N8*I:#PKG5M4`L:HTHXHE09*]
MC"?X)T(R[>V+BMGGW8ZMW^<6%*9I(;J0^*LLRE[1_B]=0\-`&OKL-^"F;C75
M\+2T@)6?,KG?ZGG_]+C78[NWBF6EPIN28T:^-!_JPZ0)X`-RY;_.18O[7>F0
MS>8ZDM7[V3&BH'T8*@CZ+FQ^%*?1Q=JFM/9D_>,!39#!P'*U[+(NZA,A`/*"
M=B6+J3R!*(]!+56CBL"\$KB7AE9VO*L.V(=RA.B#&%7U8"5)U8M1(FD<O5C4
M1-6!AW#7-H-]1,MEWN=U7E9Y?;O-::OC261)%EV=Q%4[.BI+V1WO1Z-+M2I3
M5Y61=^/:S7U>CGNHS=VGG^],L<]UKYF_29.Y42^"Z!T.MKZGEC6UP#8%CL'D
M<C=P^6#V9V9>\</<A&K044&%Y0RCT4-GKUTT\^,XFLT5SL7KBS@%9*)N#J]Z
M*3(%Z6*"-;+I#2>-4]AY`D/=^"F'O@"J")GBXE#=@DIL=Z^73TY[8=[K^!EV
M3,ZU,ZHZ#R71CDJ-67HB6)YT@B-B!.2@_&3HS%)&D<>A5GZQ__)8.&@[CFW+
M']7YX8WYJ.]H3KGY-?_VK3$?J[$U2K-X!IO/`$/G;!UZ+[6H]N_?F/\H#Y3X
MN6^4`TJ*>^,X`57QA_^[[_P\DM4DZN?(02"%3ES([3VRL3?C?\^]D"QOR:!7
MF+>UP!,DKV2ETO"P1]]1H(3$;O"R8B\,`1>FM/R,2G48N+5C>[+9Q*^P"=`D
MR*A!2!0`2$U2%>45(])42J-DYN#/=0JU;!3R<^Q8>*:O'F\=933U&4&Q\VAU
M32SS[&^AXNJ2:DN=\VYL\\*TG,4W]?]A=5JE^;W5\Y+YY?D>B2A16_E)&&8O
M"QPLJ]?#F*AG/"<#Z[(\=#SO+/NZ1G2$L9Q)0(!*3,/U/]6`]2KSU^O-Q@28
M\"V>7D.XR>`T9PY51[F-8W_%*=ZNZG,QSRNV^V;E5BL%*P<1(ZV&\X7Y]Q&"
MBAP+Q)[U6,9*KN7/_-CK:'EF[D:XCIEQK]5RZ^K+/DH6\B3D^C`O4!30=77J
M%2DM8U+<-B?BS%;I7H2*@]D#UN58O6Y!RV`MW,#[^`1=PAO9*FJ%LGX1@K5O
MG*_*I(HW$.;76ELW&3?7W+:'O*J':K?K;YS1"9GE]WGEVM$H2.<E/\WFDK?N
M1V=&O1>^K,-=OV^ZUJ>2R,(^?/WA?P,`YB*6R`IE;F1S=')E86T-96YD;V)J
M#3<V(#`@;V)J#3P\(`TO5'EP92`O4&%G92`-+U!A<F5N="`Q-S,@,"!2(`TO
M4F5S;W5R8V5S(#<W(#`@4B`-+T-O;G1E;G1S(#<X(#`@4B`-+TUE9&EA0F]X
M(%L@,"`P(#8Q,B`W.3(@72`-+T-R;W!";W@@6R`P(#`@-C$R(#<Y,B!=(`TO
M4F]T871E(#`@#3X^(`UE;F1O8FH--S<@,"!O8FH-/#P@#2]0<F]C4V5T(%L@
M+U!$1B`O5&5X="!=(`TO1F]N="`\/"`O5%0R(#$X-"`P(%(@+U14-"`Q.#8@
M,"!2("]45#$P(#$U,B`P(%(@/CX@#2]%>'1'4W1A=&4@/#P@+T=3,2`Q.3$@
M,"!2(#X^(`TO0V]L;W)3<&%C92`\/"`O0W,V(#$X-R`P(%(@/CX@#3X^(`UE
M;F1O8FH--S@@,"!O8FH-/#P@+TQE;F=T:"`U,S(Q("]&:6QT97(@+T9L871E
M1&5C;V1E(#X^(`US=')E86T-"DB)Y%?;<MO($7W75\S;#E,4%H,['F4Y3KP7
M;RKB/LEY@("1B`T,T``H6OF3_$2^,:>[!R!(RNM4[6/*91$8S/3TY72?[C>;
MJ^\WFT`9M7F\,K[G!\K'/WD*@L3S,Y5&B1>IS:>K[V^'1)4#[_#54+97W__E
MSJBGX0K;?1.H3<E/?J@VARM]\]/M+Q_6ZOV'6T_=?'BK[GY]<_?^[?N;O[__
M\YU:;7Z[NDZ\.$AR=6T\DX:IVKP5088$Z0_=:`<U=NJV:RO;#K:BIZ%KZJH8
M\4(23.3%>9!!&W?63V8E<E;B7=T6;5D7C;H;<>R3;<=!?=2_ML6^JB'FXTI4
MR;W49,FY*KZ9Q)F(Q-WKC[INU:>Z:>IN=1UXN6Z'M;)?Y+FTNU$-VT+>>JO<
M4UNIG>U/OE3N<72_I,<_-C]0-"*)QK4)O32(1*<X%IU8'3:,U0X"+XICHZZ3
MU#-)RGODB^^%>1RH:](]F<P)V;%!RA;C;!9C*4F66\QLL>\L_M`]VT\K$WBQ
M?EA!EUS#%!.O54#'X(UQ:]6OWIVGWM;#V-?E*)88R`WR?!&;?!:=L`FWW;X?
M2<+[MJJ+MM@AMO"F>_.4NAFF*)L(03E*FJ%F!&J%ZNVP;T;5/;(Z37$8]O6H
M'NNF;I_6O/;N[8V$.O0EQN17YS,6FLWJI2ST4`P0^WE?]T`;<%C9IGA118O_
MNUW?/0-3[KJ;';#ZA4`N5P2A%Y@X62B<SK(S\>ICUZO05^Q8H[MVW`YJWXYU
M`V$]_L*Y^1HKC1T&,:D>ZZ=BK+M6'2P`Q#Z^GF[ZABWWVA9]4R-P\%/7/,,@
MW$]B2XX!2X2)K$Z@NZI^?.'/H7\]K;4C7PG8Q%&T".M%WF_5,,)14)1</OD*
MX7S#P32>'X=+6$1S,`V?MV6Q'^SD6YP>;<EVBW\DAB$2/\O.[39L]_51F7O]
MP[ZU\*8Q:Q+U7*\B&%/!`0\O>,RT&GEE2]`.M,4EY;9H>$W^VA5!OWW"D1_E
M2'<HU*X8EU_E97TN3#P6>:$?1PN/<2(@)E]VI$ZH>Q86:GF#I60[/[,DHZ=`
MA/S9?:*:XDY4BL`J+ZT<*5$K`5[;+D47T#9ANT+MK7POTA..G(X+?][K37]Y
M2FT+N,[:%O5_:ZN]K,(W!.@?W"NY*=<J2-<.QP][T8+5W'7#A"2N4;[<)CMV
M70MA!2KF%EO;[B"7`;:7UU&F\+M3+4CH/N-/-CGYY[EQEHLHZ>625P[UN&7D
MW4&+[E^J+`#&"O?W]0/!QC;=X>,*<+YS%3CVE]DPH]D7-&^[?5--%6+8EZ6%
M$-0\5-6^[#YQ2H1>DF7+<A'/*<$R4,,D68',QC(4@3^$UB5#XID\O2P"Y_66
MO#K8<M_;D\Q<*U3*`ZO9=B,,5)!<CXU4/3;2>&&4AE^O9_K!/L&FP394;U6A
MGFP+<):J:[I=X=(^-O%"PGFU'8NJ;CG=JSTH9-P6DU)B(]@J"<(+&\^*Q[TF
MG^*R3.^(6!-M1RLAO6D0YN]6"9`YS%P+L##99EX>!,%1O2">F?9>_XW3,X?_
MNN:,I-$99=P-\8/)48Y5`DP$U"\Q6^O_L/EGK97),P^%,S&IE_+65Z(^^V+B
MV)8:%NEC)K*@ZL;R8R_QH^SK.+S7RF2<'H:@NR^WBCT5B*<,>ZH6>F&O/\P4
M`TUS<XJN6='8L<N7'6JT`*9F_T=Z5T#UH7YJZ\>Z+-JQ>7%]0>CYD5FFS$7+
M,:Y0WJ7VH=M0MWB-=">OKA79R1O8&*$Q^KM5"@L&-:!TTUF[(@@,7$C@QL>:
M5T7NL#+:<\9!TR2/7C'NV&-M_O1:=%`=$9)Q6_=S+M;M8P_T6[8_9Q4",(,J
MA+VH]*$?H>KV.%JI@/Y98W/T!#M6]X):E+_2UL3:2-"ZM,2M#E59YB]@:\)9
M0,`"?BG'[H'Z-:[$J:35FZ+OYZP*4W.15:_0Z$_%0]<[SNOZ>L%]W+&5'A/#
M8WU!G%3,I3/Z"J_*$:IPI]SY*L,2[BO;BP1AX_G\C:QREF?@@\LLIR)BHNB/
MIGD$.8F*TUC&HM])<P07(PZV^EX^I?DKF>D2'>C,0,OPN]$*Z=[P0LU__^ER
M5,FN[?0J,`8#1&E^$<;\&$:76<1#0J&N715BXR5B-T3YV:[582M+)3/_UG46
M`R?5%,>)=BWOD3B&%(>N/>D"SAH9`7[LA5FX!&XF+=&K05>_=2[(@HUQ@2+7
MQ'6'=M'2+?HT*@!'8%PT:)(*4N><3M]@4?B0_$;97#1#-W,R\=Z/+[B22E$$
M\+GR2BW-((453,C&@PJS9#FTSEEK)&NYG%`;2.PIQ"@S#)629_P\2;WA)%[@
M&RR0ADG\A_&=@I4R%<??8K$H"T!?<0203^@.CI!SW$!S'`4@H@!P/,3?$7+B
MM(._/O5WX#`+KZZN0RA^H!^THU)&90TME3S4Y!"W-F[E`7W.M,]26@7HM)OC
MF'KKY#H)/?T`74<Y[]V#DU$#_S'<-W6O/N7<$<+)T727V#31KB*J4)P[L58?
M]6'+LQ:6&(21EO$1[TA)[C47VW>VK>BU??JX(D"@G..-*WH0KH]]KO]*]E_T
M:$0`%`P`E_KI?3-.,U93'(8]'`B_`L8"M7<,<N[^?"].LN7$=MY8#I#W>5_W
MT@!4ML'X!V:>.\SI'LXV3A]JWT-?2&B2?X&$F7$#<2?R"9C1'+58M_(SKHAL
MM_(R4)03K?8G6QK>8H?!`0/M@6J0DD_R4B`Y3_:K`X7(%GU3P]%PE?O</+O3
ME=OGUGOJ-#.]D%ZZ+_N3#:,ZM<")J5F]QWH6>Y03RH,O/]<BYMMN4,.(")P9
M)2V_O.Q.]'(;G77%BA*E`5(VLQX,--<(!>:(<U<1I^$T=L-I?!Q.8QI.T?#P
M(U7U#$V-T$O,]`(N4^X,!8^3EIJ%CF<][A\814`/%Y%"9/3$\<G$\1A?_2#/
MS_GDI(.1D4288&9<II>#W!7@+C2RL@4`<%1T3AE(2<+SSUA-61OX$=TT#9YS
M1CIU+A#M@-S6W+1BW&&W&><VH[<#^F[D!A<(>J=+0;'":"DS&O,*'2)>X5VR
M5YZ99F2!O!UI)WFRS,"RP76_0;AH']&&;'K94?#!1LX1T0WEUE9[64".4_(V
MBYW+ZU#,G!1WGOP"+/VU.UA,O&OE3!?#)G\Y11;^NM=W=N<$.WNYZJ'XK*6.
M');&;ZO>'M1RA2HH*@%7&QY\]P^#G?B7F]ZO=LWW^O,>!(M&*]4-_WWA'@8M
M+L7'MJJJ>7E@AD^U>QO(-WWG%I4(X!"F""$J+"_(LB=\-#F`Z#3Z7Z:09%8U
M/XXAC]V^QX1[.8<$/(6$TQ0B\Q?`&>>_5\XOAI57QQ`W=IK0+`:8<]*YUYA6
MT*@T4$U]0!:S<Q!+JCP`-D<T6XXETL^"$L+LLJ']_YY+JN+E&W,)[L%/E*`K
MFSNW?[_:N:'[2B+\!%XP#R:7#0QZ#L2O*J@'H4Z&+$-2<5?3L2.X!(1:NI3%
M.)+F?G01OO1X@4NT8QTV2`G."+4YZ13J93:[4$W%Y;^D5\MRHT@6W<]7$+UI
M-.$BE+RUK'Y,1%7/1"]<M?,&2RF;;@(<`DKV?,9\\9S[R`2!W1I/;202DDOF
MS7///4<9[D$YY6')FJ\SH;@)ST'#+*"PK&?'O,CSOQ1X,]N1J^W(+VP':]Z[
MT+DLPCUK/G5:=YN;`)5VMHTF>")$_O8E(;"D[)E76`RS"@@:'M(QQ*$\LGQ]
M"FH>]?V(SU$JIF>M#/JY;X)$^"BQ:,TR@3-)"HE':#V@\,M'=@5FK#T&FI=@
M?@>.DZ2,BCQ($2FY@N,D!0,!SJ:,2H_C-<RH96D7T396739-=*C?CTOXR)`3
MC=8K=6PX.Z\"J[]9!M##+*(X*[*U&E`*$WH0)3&GEE[UQZ1)U-X>+A@HD(=4
M(8"N<BP9F7ME+.)8I#)@`66<9#E=OM=V^C64F.N2A@A7Q<%[&/(W62?5P:MD
M*=96*-M-D%4=-*2]#%FM,F%[77XK,URJ==%+*^2=A-;M+VADR!))9E$5`.]=
M:(]'BR[YS38O^!1ZZ0&U,;9#W02?I746"YY>>:P12T<T@Y*"RWJRA[HBKXEP
MBMY\FVI.0WR@K[OV;D.FC/LKL0;<[ED=;L"F#-V3O)-8I3)*S2Y>[2_V^V-,
MA;"]=F%UH1`HU"<8RJHE8UKW@;;P.$^RV9Z6R<+"/E?M6)U>@O*&%=C[7*0F
M>J263ZB>&40Y-;>$Y:Y*G]Q"R>^:GV1U$9.<?J2.W(CG4[=7J0"".H^W2>Z0
MC>TA%7.WUY#$04!Z<\^)<W$/-6R:A(3G\6*?PRV;7>I7;[Q]9;>%Q:E!:]64
MR:XB:7TN,+*2E7DY.YAX%J>0..2R.B?28*M@1%S:V4%IH#++9WIWG=B9R:K(
M6A4L4\0Q>;,$Q=TTKL.CBZ6)66W:^,BI1.:29:]I`[G@BD4S^1>+!X.,O'BG
M8#@',@_$!#:J>CO);M0(3H>?RIR#Q.+^E%%7/<M]&3_JERY&%@ZET_G/$O\N
M7`DR%&H9Y]\MR'!0J-8D0^.Y)LC,CK1;DL+5^D:V@M#=)E`I`<<$ZD+KM@U?
M=[2[/#Q3`O4Q4:H)Y3'G4(\.&B4KBU6U>1-D&&<A.D+P8@?)O#I`?)#I"`5#
MF8MX)_`3NZQ\VT^@_0:?CE*L_;C?6WOH*0R)B;VXI20$8P15PY7M0,NK?)MJ
MN3JA!QL+KW-0\].+U[/[D5H$E8'PYBXJLO0JPWB"@4T%W%%`E.``<>N!]CYT
M&#[4NNNBB.>TZ0_+&,D?EM$TO"]?25U##:]2`&3;F0N;*B?CUP\U6HFK//9'
MLAYZ=Q>59!??_#9<5\>L6X9/Q+IY:&&_SC4(@QO-CYN<U=\2]A^2+-J6R:I_
M_G_H-]N,U9PIKV#?T$I33$11>NPOF"3TN=!^^+6M!QS)[8!S[XE*/U/O-=RA
MF$?X2[LHV6;S3.4^[$ZV<SN",P6&DBRH<QPW&O,,`,]/$`8"@%IF5EB)U^JL
M=Y=4Z.O)\79/95F$#ZW\'^5O7[$8+[A0"^;"1"BK$,HJ0%D_8YA+C1>._Y]D
MA#;*KQ!IESC3OI)`4%RA5`,2I]^2J*3XXC#2.HN2M$@61D//.N0<?OF[[*><
M5+4*5^I61Y%A1]5K4GYR[]G=XP[]NA*$8."+8:Y%S_;D`\\5YR'XA[T_D1!Q
M!LU7T*7:CT6F!!<^;RG.OT:W$0222'=Y=I*1^E$137)Y&8E$E&AI5E(S)Z$^
MU2L#;KQ+9'BUYA)9/50UGW#;#_SO>E1./8I2>HN?[M\W)$\(BOQ(7OE&:RI#
M;@,YPP=G2Y8E"=]YPBLV%%%Z@E:N21&A(=1[Z[6@09:YQN`&#=?S&TQ&1W$C
M%$;;PHZH&1V[ING."/M3Y:(4VG#9G+2J([%]`9#C>KHW"6)TS60M'<UN`JL*
M$<%?PE#*!7^D<4:(_%/#@Q>FM9JO\8V/<I?I$K+[%;H$>^U2;/<[54*,7F>"
M.,GA7;;7=$(,BY/FF`V<N=FTX7S:L+8`<").ZP!DI51%O#T@B^"JMHL50L*F
M*YR:#0;19DN@#_Y)3_YTHK`D?/-9L-&52DJ=H$H)JGQ0]!+50>;J`+UR9_*5
M:XFG)6?:M7#$6"6OER)OB.?$9Z;.9\IW\54Y4#]+!L$?G<ZF2<,LV,L&Z^G.
M+6DFOOZ-?LEK47U]E$F$]SNH2K4)F9DU^'79.B66A_=:A-#1]Y`U=YN;`!`_
M:U'*+]V1PCV+9^T">4`B>!=JN?/U*9"P?3^*LID]:V703QQ#JUSB?PT'OW5&
M`>V7=SL[2(8$6B%DV>7YKG`/,BZWY7?C'AA&;XZIF_T/P$^*:`=:+^&V)MRO
M,416$!TRP<I'.53%B>"B:\F\,F`CAJS<[CFW1'$"HW<AT2/I=4@BRYV$Z=R$
MBB<<-)QU=9)'69;OKBL)YE)R5B1RP92_@*)5%=SC\""`MH`Q"R(20]H'BBB.
MB[EB72I^%HA$K4_V4%<#"5;[#%7=0PS=;9"WG_A@8&+A_>9]US.^8<$?VGTU
MPE=1*#1X*%<R'W@5"F47QW^Q`E`^FS@XC'8B>3KY/+TPFU!3$'[CT*$1I=D'
M0`V+/M7=X89?(^'/`K@(1])T$#T#G%.#:=!+;':EQLW"9:PM%]D!<B445ML7
MLQQ@%B3;@-,.^]4.CSUR/L(J-('//!&!UJE9N2X/V[V#,GT/ZR5OVLI?P[BT
M/:CC4>[8H($Z?9!!!9UZ,3^`,[/5J:D!`X!#'S;?]-V#SM+[)\H-S.$4>Z]/
MQHL)`VT3S2[4IQJFYL4=:SM?72(76_G[(`$N7]>U#ORZOAC@/%^"Q6;H&*LG
M&3Q=K$@GZKXJ]"M(12#TDWNU.EPN=9FH&\31_N3DCS\)\6_WBF(]]+H7/%NP
MYH&TB3VQ2^22@&TR,S[<^E9AM%7@[:KI.Y3#_1^6#%W'T8[U"<#D8.3)"D?K
M5,HFSF<1%XLSY99!;Y_WS=C7W^J!"D"\H3&[V5K,Q,VA%,CYL6;+X]SD!RB/
M,MNN=.K*T1XAAQ\!+"FD>NCU@"`<4"3(_I=3C6(A=0<B#5[L`/-D6_Y('(/$
M=V_[713T_M$>1JI_KGUD;%_UEL[TZ,Z@'_=[:P_,>=2FQ+81MX.2M<[T.]<;
MXCV+ED>N[7FW$^IGR619'[4/VH3]#;H4;P4XC$3"\T3@X8T(*(FK8@(R;W:@
MII@6I)6/3%5'\1OTG30\+2T+4;X8E6J8F0YJ,$>0L_05O,=BC>R?]#G$:^?S
M99;8ED"1A`&<UP]'C4\&(G>V:)(:O(>K,"$X_["`ID"/>@'C[EZH'<JP0#.Y
M%%G40$"C`T$!=7)O(?F1Z$;<0/!@6TNMJ6NHG8IYR"<GZ/S+WGL:RNVAG@2N
M6!%9AR+($+W0T=K!<OO1+4.AQ+LD?1U-JG><E/K/VB!`A,19O-1)[Y!()ME%
M^#4HZBORR*2P#SFF0MXY<;3=^31(7_89T.[ZM:T')/D6K52$A&]<*+O;D;]3
M1GD\[Y#;W`?=.=6N:90DHDH&HMMV.FK@%J0GQUG+S`JK4%CEKU?L2O7T)(J+
M\*&5_Z/\[2M6Q`6K[()=3A(&<HL+IT#A_,R:N9.A*J4G&4$/\"L_;J!.4#)]
M)8%0@EKC2)I^2Z*25HQ#9(C7_^N7O_UW`#1V8[T*96YD<W1R96%M#65N9&]B
M:@TW.2`P(&]B:@T\/"`-+U1Y<&4@+U!A9V4@#2]087)E;G0@,3<S(#`@4B`-
M+U)E<V]U<F-E<R`X,"`P(%(@#2]#;VYT96YT<R`X,2`P(%(@#2]-961I84)O
M>"!;(#`@,"`V,3(@-SDR(%T@#2]#<F]P0F]X(%L@,"`P(#8Q,B`W.3(@72`-
M+U)O=&%T92`P(`T^/B`-96YD;V)J#3@P(#`@;V)J#3P\(`TO4')O8U-E="!;
M("]01$8@+U1E>'0@72`-+T9O;G0@/#P@+U14,B`Q.#0@,"!2("]45#0@,3@V
M(#`@4B`O5%0Q,"`Q-3(@,"!2(#X^(`TO17AT1U-T871E(#P\("]'4S$@,3DQ
M(#`@4B`^/B`-+T-O;&]R4W!A8V4@/#P@+T-S-B`Q.#<@,"!2(#X^(`T^/B`-
M96YD;V)J#3@Q(#`@;V)J#3P\("],96YG=&@@-3<X,R`O1FEL=&5R("]&;&%T
M941E8V]D92`^/B`-<W1R96%M#0I(B:17VY+;QA%]WZ^8EY3`%`GA?GE<27&R
MCK-V>2F_:/,``D,2"@0PN"RU^:A\8TYW#T`0M&57I53B8LA!3T]?SCG];GOW
M=KOUE*NV^SO7L1U/.?@G3YX7V4ZBXB"R`[7]<O?V?1>IO.,=CNKR^N[M7Y]<
M=>CNL-UQ/;7-^<GQU?9\9]W_\/['Q[5Z>'QOJ_O'#^KIX[NGAP\/]S\__.5)
MK;:?[S:1'7I1JC:N[<9^K+8?Q)!+AJS'IM>=ZAOUOJD+77>ZH*>NJ<HBZ[$@
M"VY@AZF7P!OSKA--3J3LQ'=EG=5YF57JJ<=K7W3==^K9^EAG0U'"S/-*7$GM
MV$VBI2N..YIS`S+WR7JVREI]*:NJ;%8;STZMNELK_56><WWJ57?,9-5J99[J
M0IUT>_5+81Y[\Y?\^.?V>\I&(-G8N+X=>X'X%(;B$[O#%V.W/<\.PM!5FRBV
MW2CF/?*+8_MIZ*D-^1Z-U_$YL%["-_9<.\0W433?,=W7"26'5=[4JM6Y+E\0
M\[KIRUPK?/5]5@\9I\"SPSA(+REPPXN3[:MRP[7R*!O],>O54U87S7_40YW;
MR$)6JVR_-XGTX/`LD?'D2<*FRJI$_E2S5X_-2];V98>0';-.[<L*GL$4:NQ>
MDNDEB(8;<^1,5-BSA&QN+B7ZR<J/6;7"V99\ZA5N8]6'DE?U`3?E(WM>'U<P
MB$WJE/7S[;+HU(`Z;<70*SX3:S)S+]\BEF]6B>UC[YALUY%L>X[M>DCR%`#O
M$L9/UD]\8(J`-=6B3-";"?<C/_A.:*-DHM23EN6"L?[+(5YTMX\_?J*B)+93
MWDH12B\1,@6O3FU3##F=[UOVRK$#2ZFGDI=?5JA1WY)%Q9\90A)9K9+]#47,
MM<SJ*"NM[D^-?*._2M904,N`N+'M1Z'__P8D="-T=)K^H9"$Z`GW.B(4AGR"
M)=3A&H6LI<P"Y-C#AD69>9<8AN*MJ7J^*@4KL+J5"^^5*;_`DD^JI]B47R#E
M)S^\KD()8L!!G$IP>D46ZG-C7J5-_<PR&VC.-3IE]\H!\T**2S3KVU_)_=]?
M.<K-.4.#%5+&/I7Q6NT&22%A@CPLDGQY=R,'B\L^NQR)RWB+G=F,WBP[]H)'
M[)*%0FFJ!I:RHJSU6IV/97Y4FM*1+G&(\_#)^GHJ6Q#)!V`8ZI6.W@&+/0>%
M]FQ]/Z#!/3KG7/9'3NU)%T":MI0H.788>3.K@J&C?7B4`_U[T%/9U,\K6ZEW
M.L^&3K.I;BA[=9XPBHO&1Z/[\0TV.>%D5V)/_H!JV`R8:^@;@&D0;HKLE<BD
M;`JIQ.]04[@7E=-`5!):7:\*/7J?IL',^70*9R2G5+"6U?A_0IN_@"4)[&!U
M7K'[I@6N*`X>6KKNC\2@0]V7U9@].6=YI2473\$&<@]UI;N.SZK*OCQD/0*H
MRD[IK*U*)`@Y:RKB')S>'PW9D<UOW$:KO!G:?G*U*/>EED-\9W.Y`'N-D$6N
M,],.[I1:1U)[I,B_$CA1D,<0(<>22!_O1\G\UM;?FK-^T>U:(><9SBW;PL00
M!=`B:CN-I*('&Q0;H2``,#-W8R,79^)+-XHW>.U=UK;/J_68G7,S5,S):J<-
M%?MN/,_W$KP4Y$_94RU"5QE6Y\O)C8`42?B[:9QJ14J`HJNIR22%2!<*9J_+
M?FB9.S/E)@Z7K?Z:5T-7OO"%P5.N[\U\3:9C8B'\?BQTD0YRVYU6AS:K^;I(
MH!-\2_SU<E$3Z&>+7-V7+1I$[AO;I`F6F#,%;6S%?;GRP>85?Q)ZN1;2H.3;
M_0I)`I3+JN=/==8M=7^>H\;W@[QH=A`T`X.N]A,;``H)("]'U,86<\3R_/J@
M48?;5JQDTNVP&T3S&KK5.Z)#6#?MM*XAXH^Z&(SX*;C5[T]M.9-$RHO6C)9K
MIH"<)3C_(KL*$45&$<EW(YUO1I=^-\3G>3B.)D17*XCI7?.B-X7N<G/MG?FE
M$$'!T?E*H#M/Q;-UHRQ".PRC](\JBVL]X86IC:8/T\1.%FKB(D%N!JDHL".\
M`\*;E%8H[&1$+">C::$?A:$QU\C]4[E_.&(;?P49!A%F+IW2I<E&5KR4O*91
MZ3??I9:4Y+BI[7GN#><ZTQSGFJ(AH*A[=1IV59DS&VEF'(2>IBD8+.N>=NQ>
MU:-@*[H[G57B@MTLH^"I.;/\WT-)HU(%\AEZ6*]![0<:EHBVN=$AX0!LL\*^
MGE(^67!!)I6N;_)_2:6:N4#(("`IZEF,4#A4`N#C"EYR6YWS<N@(ST?`W;<-
M6TMO<B/+EK"`9#\M2`E[W+1CPGX$D>A=.V2M2;#GC:VU3)<TM&<GB6,P<C-O
M%\XF]!Y!(3T0*/@695T$(@E#NKA1X`%I0>I-BY0;EQDM$.6K%ZAS9*O*#AGO
MZ'AEKD_/QM[8W\;#90G=,#,8(]=(1Z=/&8A"5Z\CF@"/#3%3V'QVZJ@9A:H)
M>Q3T&`BG,$"'X/E7HNP6^$7/"?(#*>]5K<^3%?R\9UDQ"9T\ZXRH'XTOK[34
M?=1Q1+VONC=0JGL<]#3L/NN\IR(3U8()*0J3>2]P?Y&$;[JNW&&N!=$9V;5D
M2N%`TP-QZGQ#RUD7ILR9*;,\;P=]X;^U*O>3!`V"U+VI^V57F=@PC^FB0Y<K
M('";-Z:E2I,K,-38]:D?N.*C554:+,6RG["!TMWI?*"F'N447PQ#E._-YCPG
MGOQ(1K"HX/Q,`<Q5S$X?X-=XKSB*;@3,HI^E(^53.A77R-1!U[J5=8X9@Q\:
M8>2QEPNS':EKFV+(#:!>]:YY@7WE)RIR`QHGT]X&M=59[%V]3S,6^]#4;U90
M!FK)7EYB!_$->?T*;UWHZ)K!_"1%>##K)N"D:P9;\I8/QD(20O2$.Q'70B5C
M2KQ$(Q9=$XO*B24VL=PMQHT_UO*S?`W40GB>9)&9[[J%!1X:#%Y#^03^+5XO
MZY9&#&Y%C(93L9X(_S7JABC@4DE?3^A6J:1RVFEF)S^Y$JC3.6X@YV3H\ZX\
MU)@R<N`P,(VZX7W#Y!CRB9R0US>K"&39J2[#T,.=@)#MR[ZC66+D8L</KU%G
MJEJ+RWO[YU_'NBU-B&"IFO".9@W3<(OA,]OW(#)A25;^K,)]VXO#\!L3`TU@
M@+DRU\3NE>[)"B&HC+.H$S\*9]WK3NI!)*?UCZQ%&MR8@-Q)UX)0-,A,,T>:
MW&CP&W#[`>(/O-&TF.?6ZJ'.;4B>"\?_!%(!%YZ.ZN$7E6MHBSW?#V%-D,7?
M5`Y6+D,+DP7R<1EX"1#,3'6M/1R3?$*+7`$..YYZC`!YLXHYT\NN):V1QLX-
MYAJ'))$_W_]RO[U_O-:2U\WKHBP#3P6Q8SKRMYO7Q8CE!RJ(0M/G=/WT,A$$
MB^X-:`3!%>2)Z)_8V/PY*'HG^).27UGH!%;VTN#M3KZ#QB%AH-[Q"$"(&5G(
MLAB@"4=FF;&YPM`Q*"93B6\^-;]8'Z:#Q3I#B&L1<<]W-_+U>=I]ROJY&5ET
M2G;/??D?[U6VXS9V1'_EOH4"V`3W9?S4=B/(S,#MP=@S`=)^H21VB[%"&J1D
MH?-1^<:<6BY)D5*W,P/D1=3E4G>IJK-,7]OJ*AN)-I_R`U36DP4AG&J>Q=$\
MD6$VG&R@N/AVE3AM^X7+:5X/L":)'RW`Y?OK`%@1)Z""UXH@!9F@7A)<;!&$
MX5@$F2SU!VP8ANLW[Z-GA$A2/II"3A"/[EN`5>(F$*MHJ#=R,W'3*'`AH8=Q
M'A=N5H3C."]</[%C0K[4!;2X?AH"^_Z^NDDY*:DCT^Q$0)NSD3UYT%9V`?UG
M@/,`.[2IOAZT*PF1J2DSAW!`H-$UIUT-4`+XUR)<4H_B^-<LD$.B!2H#Q!*Y
MXE0DLL3K@1^X5ZF<"?P@OPZ(#PYFA=]!N#O`,'-.ZJR!JH@>DU1EB!9D4]Y#
MLP?1`B3/=<UQ*B9$O[-8Z?7.6UQR%3+<EOQ41<?,?G`=W*F95&NCTDBCO>-H
MHZD\#W>G(DMF.\'(&6R))/U$>YG(%T[@LCA?05>MU2*)9%SX65V5JJVC7%KK
MJR+_AD].*3,845]!CT\=W4F<"<?Y3,NSHI3DILVO5$<\,[,S!GYP1#MN+)0B
MB43*%)`F<HXD!&*<I-E6^Y*<S_-B)F9$9I\CQ.W>R@*9>I)XJ'(4-Y>-+9K`
MQ3<0%CT'@IVHGX35ZMY49;>O\1H*N-T3EULL`O,G63P@,,MX2J>LN-V"0"L)
MB,/\EYP#5N%GT]*>2<'KYTDZ1]D^S<-TP8+)T&\J:;!TMF3DLMA=H2>P@WJB
M/"+/CX/B.K4SI],&(`ZXQ,0&<=R>%JCX:B&9C%K@YW\<DZ,\XTM1"-;>C%MS
M_F.NZFNZ)`KD%_7UMNHWG8CB=46J=<__6Q'()ZHV?8Q^<^3A>'"C=(ZR)7@N
M.J/?[*KM4;V5BN?$]DO%S-E`"XJJ8U$G6GO'BIJK6/VBE%GL95D^M:WY,*-R
MS\Q6AFPK)Q@+S7!N)45!*QMK_'E!S46RP,A93;YF*>$4]R*2L:@D2,[WP!)P
M](T;<^BL&K(P(%)79M#-!6(*H#L.E8A.W89.,4]/-D'X6](P@1I#'--29$+,
MIU$R+^#OU!.1!Z:*TMC+7Y,4D!VHEBB%]+=%.VO@4552<BF),'[4N!\/R&!_
MYLV@B^50DL&="=H47IRB/OUKM>I<-'&TXMS+BE1K[L8RKRY/4U?SS$C'90^G
M39-Z>;R4>LL.)39,;4-RHC/:$XV`]2PF28/D8@'%YZXH@X,5Y'L'_B5Y&CJ>
MG@(D?!9]CRT<MQ@.MK"JGW:HL9<,H6J6(LR#ZTWJ?,1"VW^;=V53;DNQ7Y^Q
M-<1`K!KAJ5DU5!@DJ81R[M%G\&+]YQ5[2%#*5N6-1H*E%%Z`=2@6YNB"6YEZ
M!%'I4QW/SO1,U[/F&.V"*08;.I7X^I'1;8JS7'@2')G6)MF7*)]PST11)]JM
MZW57?:,@,<N@C!<:<Z@,H>ZKD[GKCD_HA#4J)L(C>;GOY8I#^NQ`$'S$X?55
M]47N$N0H?O'8XH<N:'Z`\9!'[<O'3H`H%\V7RPE`[+.B8P;!>2`WM<C%QKQ7
MYT3#1BZ]?(KJ0=;_5G%%Y\Y9/(W>ZDCGE.C=ETJ>#NC)HXT!"?3R7[3[K01F
MQ,M(BBX1#_X@"B<^*IQJ8G$R4(D-/*-^>1']8NI80)J?*J1=1[\XR+PTQ:N!
M`B4=<SJF?X9_J]CQ5CYY2I:$6F"45HLQ"X4W`O_-%&-J1G\"!YPG<2*/Y9>*
MBFI#WD&-M(T\(.R!&&@;;M`#W^,,H:9U>"*3!35!*#$-)H/>2*#I[-/7MD;G
ME*#S*=ZMI/IC*2EZAI+ZY=),YM=5K'=T'[V^U9E'J-99Y$4E)%X01]F?KH0D
M\8K8A!!FZ6N5``+,4[R*]`Z5P)-.TD^V!`6@Z=>4YU[N+S7+$D,TR[&SGT"'
M%4+36S(`7KSC9BWUL"WRV!.?OW_?>B9T@R)Q_2(&S"@`K8B2S3];11QK%T9<
M?U`LDV4]K^"XVE-#TI3__TR_[:D4T2TO$>;3$%0M86%(C)W@!ME_+_GA]7$4
M",N4;(/@FT[_.D'<"F+;^7Y^YKBTFHN(#DZ<L`BY`EJ((%7JR,<F3-2HRKN-
MD,8YA4!;5MNJ*Y5G*!&P43!4,C[_\E/;M8T\:6=45'756J=ES:H?DM(,XQMF
MBLBQ'^_(4$K*I^OE,[.Z8*"`0+S59T<,YGNX--E8$%#N1:=UU=-Q7Q[:#@Z5
MBQ[M$*3A1!K,E/6#8XVL4HO#<=[73=T?1H8X[%P5-#C=+(Y>T!JG74W:$#@!
M%'LF?=?OV@X*!@56BR6PFB$K_+,VNK%A)&"HT+F'K'Q:W3"_06#*OT8N!DZS
M*KM]C;6B)O7A_IM<X6+D+;W?X4(;U*=0L/+O.'E\(+;SQ:#130U1KT@.0@+U
MD^]#^1/+Y88^/_]85WG@C_4STQ^0N]DV>EW"QKY4?I4_7R=+TV]T<R5P:2_N
M$>G;C3=[HU';Z>SFN3J8M:Z\LO.>U5HQI#*=NTFN+YSUINRKT2\J'ZICG#E!
M4AV*/466SBN&>N*B/>2^[[EXH39(\8]?SD6RN,)EL6J%I9X/=[DPE_.*_3Y'
MJ?(XR\*I19NWI_K.,VO9[EMLK5022OR)\!P]$7.&LZU!]1?\)WU;@';"^/K<
M(!PQ9+D8LG1TJ2S:_[)*+XJP&W"OGT>+<_IC#!SXT'PF)$7&VWO9B_KP>B$P
M+/="^_9%W3LAY)S0F-6LBM.9\BW-J1+A*;]('O1'-=?+%LT"/YM46!B-C*16
M4[B:'%\DS(NN41I$6^I#&8%^Y$\CHHQ)T#7KHWX&$R5_UI6=/DG#:3GDX_21
M*GY:N\X7ZGRA(R.1V7*'-Q9B8\=&=4?HR"]Q92*Z0P4,>C-*H@4;C\48#UNG
MAD1;PPE6W-2)LZ:)"I)UV%U(6'`DO&_U\5=]C.:IL;ZAG00*D*,!"P;!O1E4
M.$V*O5:;@_1=S?4<82'<#A"DK1P<_&:4!2_UPGDGE,VS+?^^W`/#"6104X_U
MH??LL>#\P&UGQS)T@,,M:(%R1J(.B<.F;JC3[N]N+9!!G*!_RQ[2A7"D?"2,
MXE8$56TJ1A2<2)@E+R'*-WR*PJDW%?29V5<'BK(MZ82TI:(TF1#RO'F<GX[`
ME$`DD"N@\DO9*40"F_,E0B;#&K3[=V7'!PH`V%1'+(;0\L=FXYE=N;7[H[#E
M4U=^W9D??S>;JCO4CWCS4-O<O[)0*A="*^3$'$XMGV7/YH&0E#<;`:F*_"I^
M/CB$M^Q#VZ87#ZKV,[F"?'`,P6+_P9CW3[_>_G[[Z?:>II\A78@J!(8E:+(9
MSHW@N$"\,/$B/(L++[-P-W<.#E>GQK%KQ=DGH:WX(3W)V1K-/Y:K1)/.5WFZ
M@L:AGYZMS3'G>_&],`DFI7I!OEN8)DU+1B1W`!!4;?7DEE&`.A?SS=.@E6?*
M_+&=OMW*[=/PM@#T$$8G-_+V=-[I:]N7S<"'K@1@FK<"L^T7KL)%^:`<TR3/
M_ESYQ$#-_[E\X$']"6'^7RIHLM#3JPNUM31?:#RN5/W'#VS8C/G-^^BIT<V)
M;(G-90#V`4@G;A+X;I1';^1FXJ91X`*QAW$>%VY6A.,X+UP_L>/4!:*Z?FK'
M`OI(8>Q#@LRY<%":OBC-U$W\R(V+[`T?;<J3A4F$\K[=[YF&=U5?,?1S;V5>
M&J13[3H3U]A<#[C#MT3N'8,[,5R%Z(B&0X\1^T.C+B[.M?$<\],1MFK`<^$3
M06`F'+#U@.TLGU_9VH-S8`'%M4^FAA-Q5_/-7IYU,MK(B!57ZK3'3L?RM)$`
MYH[E%RLRYU1VE6O.)^BJ]3-W&Z0R]+M^3()99ROE<I0+O*R^K4]U>&RV($*X
M35D:)MO-)C)_!1>S+&&'%XS[,=O)&C4>)(+^43NP6AJD&>\_.))W1CAAJR-<
MPQY'L&&YY*Q%)B%;QP:RH^>WV<^6+(]J)26T=8HZG)NDT:1`%TU<[IY$`1")
M#13E0;8)J-K6:E$K$_DW]BXI$ZGW_]9=[CH(PS`4W?F*C*F$D)(4J,<._`%C
M%Y"8@XIX?#[7<5KET4Q=JKIUW.-SET+E4%3&_1)?#MWNM<*[<C>3W@#M;+E@
M)V8P]>V@I)EK<VB$<MW].PI\25(S%"+<0F@K=3C@!HRBHVRN%85,5+6UZQP:
M0R=%)F[%F"EQ/W[OFH'.GOFR/%]870&VK&'I8/(26[1M?M.`L[)IS=;B=H18
MV>>5ZB2A)LW[S.C;/._#R#+)QJ>7`/'X31UL[@.3]5\E1W2Y[OY@;HTQ"F5N
M9'-T<F5A;0UE;F1O8FH-.#(@,"!O8FH-/#P@#2]4>7!E("]086=E(`TO4&%R
M96YT(#$W,R`P(%(@#2]297-O=7)C97,@.#,@,"!2(`TO0V]N=&5N=',@.#0@
M,"!2(`TO365D:6%";W@@6R`P(#`@-C$R(#<Y,B!=(`TO0W)O<$)O>"!;(#`@
M,"`V,3(@-SDR(%T@#2]2;W1A=&4@,"`-/CX@#65N9&]B:@TX,R`P(&]B:@T\
M/"`-+U!R;V-3970@6R`O4$1&("]497AT(%T@#2]&;VYT(#P\("]45#(@,3@T
M(#`@4B`O5%0T(#$X-B`P(%(@+U14,3`@,34R(#`@4B`^/B`-+T5X=$=3=&%T
M92`\/"`O1U,Q(#$Y,2`P(%(@/CX@#2]#;VQO<E-P86-E(#P\("]#<S8@,3@W
M(#`@4B`^/B`-/CX@#65N9&]B:@TX-"`P(&]B:@T\/"`O3&5N9W1H(#4X,C8@
M+T9I;'1E<B`O1FQA=&5$96-O9&4@/CX@#7-T<F5A;0T*2(FD5UUSV[H1??>O
MP%NHCH20X'?SI-B]'6=NG<ZU?!]J]X$B(0LI0VI(2H[_5'YC#[`@15%*W$PG
M$XL?X&*Q>_;LV8^KJ_>KE6`>6VVN/)>[@KGX1U="1-Q-6!Q$/&"KKU?OK]N(
MY:U9X;(VKZ[>__W>8\_M%9:[GF"KW%RY/EN]7#G+WZ\_W\W9[=TU9\N[&W;_
M\/'^]N9V^<?MW^[9;/7E:A'Q4$0I6WC<B_V8K6[(D*<-.7=U)UO6U>RZK@I9
MM;+05VU=JB+K<*,M>`$/4Y'`&_NM&PU.I,:)WU255;G*2G;?X;.OLNI:]N0\
M5-F^4##S-"-74AY[231UQ?5Z<UZ@S3TZ3XZJV%=5EJJ>+01/G:J=,_F-KG.Y
MZUB[S>BND<Q>507;R>;D36$O._NK_?CWZI/.1D#96'@^CT5`/H4A^63<,0<S
M;@O!@S#TV"**N1?%9@V]<;F?AH(MM.]1?QS?!%:DYL3X-@GQ*(K&2]Q@.+%G
M]EE+6;%\%'C.V*K1`=UF+=-O32)\'HDD/B;",XE8]$'4#K?Y5A;[$JG;U`W[
M1];D6Q;/F<!.L'F_7W^Q*0T\7XQ2.N#*(US)O-.PZ+:2[>JV56M5JNZ5U1OS
MR$O<19&]4E9%PMW`(X39\%P\I/R6E_M6';0=9$K5!6QE'<Z]+PN6Y7FSE]C3
M^!=RWXN#D7\3C#CL8]8TP!C"LU%-V^%O*1LDN)%EUJF#[+W7YI!OS[7EY_,P
M$JFU;$RM_EC^N5PM[_1*%&%B"L]<!&[*$Q:E@DK3`,/Y;AR<5'&`B,:"14G,
M4[W4Z?>U.'.Y"+UP=)YT**'(.+%KZF*?=W.F-NR?&6"\SW,IBY:A$DR4_<"B
M\!AE2GS<6Q*"J@<U`U`[!_J1,]=I<OOLZPSNQJ@NNGVF'Y:5);,K-OAQ$#C[
M,<OM%9;(TZ^TX<(:V-E%>-3UR[J9A[\MR^Q]O[:5^9XN&U#/;S=+EMG/[4^C
M73@]A#9<(C8=>[$OK(G2;-*;7A\]8X,;JD,UV`5=?;[2'D<92]7@),AG$J71
MN:M1;%5.I++Z"^$S/M:D34@W"[BGC^7RR,D.-7+=TC-FTVYN6G@0P4=S@[![
MW'<RN^X%-6*N"I0+LNCC<D=+)"V1[$69BY/OV9(^`[>\FR5<8!-+@'U!G")>
M)(!9!+I*!\"/F/"L=R6F=T41.H19/U3J3XK*]_7J\0X.NUA3?N"!6([6WZHI
M03MG57%6]#S6=>8>V5TG*CRI?O:O"_7O@?%%[ROE-#S&Y/O$H3-2$"#LZ#0\
MGC\4OD5'#P$-*`T!X3!E;BJ=0@U:<[>E.\D>*GI-C^5,`!/W=)/99RTA<N&'
MW$W#Y(R9)^3SJ-OMC<PE@"4`FC7:Z-`PT#\,XO2+G6ZC@!IJ2M65`66![H36
MO$._0,]!?>F-<>XT!A!^2-^/."-L>CQT=ADZ3:N>*[51>59UY:NA[>NZ?T^M
M.ZM>W\TBU$?+VJR4FE8*73T;U;7<'A?--A+B]+@3!-LB/5,P*VP)YNJV6D0M
MV2[3-R!AS3BFQ>B.FFTZ1&99HIC09G*IK#H07AB-SCKM>P=\6M6=RB5;O[)2
M=MK*2%Y!142A/^KJ@P';U#_M*\E$H+NXF\ZI:9KV1XT!P1:)]U:2G=^S==UD
M7=TH"35U6^4<XJ+HCZ:;3O;<9+LMN_V3Y;+ID`_C'EJ@GXS=&^Q2`>49@4$A
M>$@&!5"+CXP]2V,!F$$W/XV0QD`E-7D>9--J`Y`6)K3O9K%)\Y2HX(>;6$DP
MT&L^Z>$4$A!''&/M%`C.A1J/8XX*B9`%(IGO4Y*)P]2>_C()@C$U1^@H4XF+
M8P,(3TL<W.KP&79R&/N(._#[3.B.US!E7NKZ3QTTW:PT]_17FD75,ZVIGAE9
MTHP`/MC4X[6U?O@RK-QEW=@$W;2,UH[W'"\KK#>:@)S3S3XW6?4LK?-U_1^3
MZ&FF?#%&]*_P+9@R#8[)L#3[!LM&0$8T3L"96/PK8P_\G@/CIJRI;#",N%$T
M+1LO.6:/E/!=#8()YZ'GSE$''W"9).G<#<4'%LVA[>=!&G\P=!3-DR"=B]`'
M<2ZUI-)BV7!$R*,@BL^Q:_6"%L>6<UH4$CX%HZK&\`59.">)41\"`6-W[`;2
M#K#WYXI]VI=6G?MHT<#GZ)B/CN?W7`)YX.N9"O6W4>:2'F@@Z,8"!C3WG?G+
MZ,8TII`:4TJ-*=2-28?XAI:T]*ZAN]Q^?HV?Q*GWS45S-Y+VSLS>+UDCYY,M
M&KE^!?)"$I'6.%">,;M?1C][^JF;?K5]:V_W&'4;]K*USIGMMM/3C#7=E-(?
M'2U;38-*M!(5FK`Z5F#T>`42\'^'DC]D93\O&;8VQ+BO.E7:9FM:)1`?)N-6
M.6U-?3>>XULTOM88Q#"FGHEX5<MDUI0*RR"HZU*WF]KVAM[Z%.33N=%H5#I[
MH$6_25'@Z".BS`O0@;/1?]!W3Q;Z[H*65.:Q#G1`88:0A6^D[BD6,^(^,`I&
MVUXFQ"(XZC*C1$80(#B@2[40&;+J9UL"J!UP#3G1\M&H^S.@6H#.]`E8GK5`
MF94/UIUIL,X4&R$GULC!F0?W4$0(_XR&"3OQ>"-55FB%?E1NV\OR#EWZ(!>%
M;/.&5J_MFP*LZ^L!`KLVC:W,WAA[<J8L+"+TI3`^$V%OS+Q^@EBR,!23B??'
M!.PG1B6'03R:`J;JXVEF*))&6Z@J^'NJT4.>NH'X56^#-.#Q+WD;I"F/O#0]
M]7?:LQUV88Q8!"CT>-(S?J&]>2+AH0X4R/Q_;F\>]%T0L!!:/AF&"$/^CWU0
M!^"E%MP%(=VRH2Z5GG*W8`E+CK8V3BHE)RO[0D[I<+FKK;5OTZ9P`7KX9CR9
M79@)CP>>P"^-S7%',>IS>I9)5^N,263.BA4Q&A>3U`,+%6E-A?5BQISU%VEG
M,%N0]>7RM(.5H`%GJKFGPF-7MZU:*[#U:]\*O,1=%&@3\EM>[EMUP"MSN(`G
M:3+&_[2"V`YRN2Y(_N=F],KRO-DC5;6I*ZNUXUB$[*+T>G+,*-.@56G5WR`T
M#5I6IP[&AO9N@G@T.(P65G3_%-NAE_#$E!5`'OT0W6_+Z1@%@E,$`Y,D0QSB
M$S4]9VI#C;7=Y[F41<LPQH(\&SNO"HRUT`;ET(4AJZGO`)XB2G_2<\M20N86
M@R;3568D!QJ@<1IYC]/1T.<=IR+*_+CSP5.,D29C:VE5F;BH/L]F1^RN.CV@
M(3]K^8P#MK(LS;DP7=$`U379H<9.+2E;+^9)XHZ1%`^^)2<1)"B18S9FGK/3
M<L9W9"=II!MF,G%A)O,B'@?)#^#V4Z4?AR#?T`VY^#^P$J!7(62ABZ53;NQG
MKK=U*Y4T""<50IQU_]-I]]%YJ%2'?-QW@(9!'&DY#=E!JAE&@1JQ00U,4!%2
M901;CX1>_\6!&'-E.(21-M2S`+B),*",Z$R=78;TM>JY4L9*RM,T&(\71QS]
ME_5J:8X32<)_A9M11(MH*![%[LEC'V;#.^N-L'WR"0%2$V9`"[0T^E/[&_?+
MS"HHH%LC3^REH:KK15;F]\AEE?NF++JI?>%"^$#GXJM6I)ZZEW<W$`NXW[%H
MZ]%B'$X&S[$-2.10I2E(J@Z$FQ0B],G$O^,-)1,"P8N%@8HSM>=-`3:Z6JNT
MMY7X%<>MV_H)A7`2!2TU*2KBF0&-ZJ.XGQ!\3E9O8,\5N?%8@%G`%'?6D%#N
M^JDIV6>U]40K5%C=5'@4)FZ%[Y@%25`_3G+W&=\]B73Q55Q9<QR3-,HO<04.
M0KP*2OW0#X\!PXSI^$=7!I"6E?D\/A+N2+M',@:UZ"0PI(<75*`94#IIO%&`
M=')@Y$B9"%R<RSN_4-X02,D*)]^FR9($7^K%<6JJ\DVR+,4#<^/((`*E6KBD
M6FJ*P98U&3FR$_`9HDVH`W%K^`79Y]OP:Z3Q<9?&8;ZL'<O:H`>8%&"?_-8W
M9.NZAX9;S"3.O]Z]](,ZB5WXG1$E!*)\'@K0!_1Z#-3L^Q^>S)$9Y#RT/SE[
M,,^X>TICY!O=:2N%..7ZIV5]`OV"^*KD[;H^H0N,U=&1R8MQ#$TN_>T&B)H<
MDO!X4%K]75JI"@^1SDQ+Q_DARR-N&:NE@SA4>[#=^U+,UOGAF&!V+*(\/6#O
MPS&-`"[OR552R;,[I09%4"&BI%%C=K64$@+]L;]VK]^"+X'WD?YFWSK06\E3
M/HA$)M6\6>!C3;L4O,MS,<`\NDL.]=T+PY^H!9Y(5,WKTQW[9_KI!SN*^TV#
M0W,%![_[YZX"PL!Z@E<(PTE@$/3X9R)L^@3HW!;"$G`^*P^K?&;9HU-]E6I\
M%E,,)6?(CM;[K1BP&0@M.J`'S##R8E"SS4/!5-:,7ET,;5.+^KRU6VSO=:8C
M>ZT04NQ8M/]$H4O)I/1B3;1$$UVD<@?IXD_%LZ\:;M_+`V2UF:*.MW9H9_ZB
M*-,+QQE7B'.[ZHS_"VZ0=2&PY.M)5J8J1967Q5@#AD?0==TM1DO[,JJ2;0O9
M`-_P+/VK0VV/^`L[BH()<AC6U[X5_93PI.WI'",YK;4^3X*U9[@"!=?,%KP(
M.2BEM8#N[9(5_G\O*JY0IT&."6H17(+2?-*M>X#&/:9O$8?7#AB!%6+G@(Y.
MW)XL2I-`Z>5H,'Y[%(Q2L$&\K'=95D:9"8OSE6$TWXPR]&]=9<JNLKB#]0`D
M?35]Q0WIM);?YPP2,03S&+H"_0(7>6-YJJNS8:**F>`W-#3G3>I3868'*S9G
M4_HF3V',KK5\&X]JQ4^J7%&ZE657G.Q5C\JKYD$TRU0KI,I97)$2Q)$8A'[>
MJ=X235V167_.CF&$/`/CI8CPAA]W%1`ASY!"R$RUI)#K6J(D=$.W*>FU?S5J
M[XJ#56L'*R@.S1.N4'Q[-VQT7W.P.V\JV`UYF8>K]/%GT_I&'\H!TT&2Q?EK
M$;!V];H/5>)#PPL^%%2WU41;_8DO(?FB@G"^3,=J[*1GDC$HQ#I(;;E+VKR2
M,<D1FR1YOMG&]RXF34(68=EAFS.WL6(@W^;NM=2A-*$:V'G1A;$W%I3BR=D3
M295<U0!;D^JZ3P,-;.4<;S4;HU`;\!*7&CHN=64_#5PI@<&M5MCYK`^,H3W1
M9^8;M_4H+6@=1DC*"RW^E<D5*M"7G!=?2GT3_Q*O1^1+?]:89O.QM!@WL9H;
M(TGVL;(8"B,4.BB_$4'^YW+JV37F*]>X<H2\4ASD:6Q6\O<>$9@H)M$:02EG
M)'6:_C]\#\OD?U]R*-Z_^@#Z/@S3@T[5@=0I]Y<\B)*/G":K=.JE^M54OWM3
M$P<9OG$)5C3?PG=?MH9.[B""[,R+<D&ADG7L17EL*ODZC"OXARS%T*.I7HI-
MML3&Y)[7T]E#OQ>'%C+]QG[5<*.#-J0$S/QJZ,N3&3K(GZP-$3`/QR[D+V]\
M'`J98(U0'E#9.)<TUQ1M/_+VK/$I;2=N-&(KNP!BM3;6,>*+2>1B(M]>1<17
MD>`JI$79C[W[YP[IPE8%TOJ][&&NAWSG4#R3X%;H+7B^N\4@2Q4R"]3U^-@Z
MYS*##MXG6;Y_+KQ?BQ\_>N^3###S.Y@L#I=\6G#P_BF[5'BE)'<7+>MNI+IR
MI'(X5U,BL0(S<4T>6&T5WE0/#!90_/4?(,&*/QD5^P!9Q;6?!&NFGI<,8Q'?
M$XS:2MYP@0(1&Z)1J5]3H5D4I]=K'8;'"Y-9KPEVG(K*&*V/0!'C6@@04$D&
M(B$F5+ZOX73)4[.\P0_REL:HWI/Y)*]:LU?%/5$'^UF*;O%4V`&>_8.R(_'9
MX-ZSXG"<[=LL[-9:D=O:K$,(A1#\BH]WCL3V:G-DDZ%LH.8%^`3K1-@0AD\8
M?&"BH;.("@4\"U+*T>36DB#2F0,Z8>*@3L4K&*1E6"4-KH[B1'.REZ<1]]?6
MH\&S,`NB8YZ^HF]I1>CLYJ$0CJT'\&LQM`TN'1G5MT^&/$C+QWFVNWB]7+Q!
M")Q)RN8D=533!P_296NXKZ2*[DV%5MLIZGAKAQH`.?&]4ID;D-C=+-7LS9$R
M"SRT7G"%->1<49+]<PTN.+QE9_(0`G$5RQ!!!=(B[K7O"'D\]0/*7#1JV3==
MV51&.U+<N6HE[I0@HJC%1D2(<JCT6K%:9ESI:-)8MEA1JM;.';/,F;VC$10_
M"O_(=8<]AQJ95"\*2RY<[=3W92`A,:/]C@*8$F:/]7_..!GWRG\$V2$[3XTK
MPCE`/&P>E8`#W&/=\V6\ET$"1J.!1EY"UI,B9P`MY0\`(3^?9"%IR&`S])XS
MDCI.,J;>LWT6I-`F;V7[#<?K%%(Z(A7(,?G=1#H1KM\HZQWMY\@U*(2C1JT>
M9^:/&$.LO-Y82Q4<T\1*9A'YURW?K<W(<EZ8OJK^X^:60U5W\E+)H[FA$)F^
M!WEX9WF:7B((HAIIW<FCEGL=+%'`DV;97DMO.=+PSS>0X4"I.`(NFJ$\&Z(<
MIZ(KZ_%@"$K2.PU2K5U46_2^9#>E]:<7XOFZ%:M`:(LB)%5*(#\%#+>0W^G1
MX=L=<%MB+-JQ1T**Z:)=EKUW1>\55<6.I6@!'%U%EE0*"MF2AN%.6LTQB4Q,
M8"60;11/)==#E,046O!?_-/"OV`7>N41(^4VZFHZ\>S)*U#1/+)?%C"+-0`1
MTAUM_>1LY6XT\22SV(5Z"9D,_EJYD+367JCS0&TD\2M5`EF:80Z0?];&>^KQ
M;+FPXA0NV,I."@NR0>BH/`]#;6!>4-V0BROUA#9<P5D9\=H):6PIA&C)B.DD
MR$*]QU"V/-_]ST,!*/=^$6[I?XC,W'H65@ER9&5TR16#9"5T#@G-!XC0G\;.
M15T0:H^T,N``5?B5ZX^3%EW(VX*5-,7!+UGGT!L0GGF<85WY5F@-%SKYU"+G
MQO%<VZB84VVCLC<[%`YF8VMSC%61:"#;V<]YTCA9>[/-UCP(8_47LQ7XY(5I
M$N06F]^2K=$1$R+,0YDXF+Z'%Y.O"/V7$Y.O47?CN2QKW";(?;3"<!9RP&[D
M+<&*JW\X=2@:9<_8F?DT@@6%!%T'21;G>_19X">U&@-%3Q$GI2&O#_)@C(^)
M*3CXCV:<]$YV,$&((DTO33O:ME^\WAUW6BT]",2APSP(YN[,:_WZCJ/`%?T_
M4=90^9N1+UZ#_#,[';QF@M:1ENEL>05[U+O5F;QYFV9J:SMF,@MXC=G*/-8Q
M:GA=*#7@[7K5!W>`V<`;Z[9MUC%?.PO7#Q3>`\3E0(HG]TNO;_FE?V2IE'/!
M0*7*WUT]8R,U/7EPQ22^F2#2EMXJSR113M?`%DR&D'KEE]5\46TYJ;9W-]H?
M]W0!7YM&^:8"+Q7?4E,;TD`))JBH&/"[*<,=560(+Q91VH#<[U=TJQ,131CE
MJ-BM7OS6N;JR9CE;>5\F5YK6(Y7QN3S9@@-C:1SD3^F^9*[E]#'<7D^-2^V2
MK)RJG*B279*FDDZ*!/$L#5CR"'\+C3?NXD4Y>6/S,*_>\(KWJ#,1`,A42_L?
M=B>3,2_O1F\LX#.EJ,UQ>,!`:E")YKB7]V:BR!CM%J@X4RODGS-:1*PU4^E\
M76Q]?'"3-SW7[?_X+I\5A&$8#M]]BAX51-8YP1T]>/`R!,73+K%;72]3NJ'@
MT_OKDLU_L!=(DY0DWV=A3YL,BT_\)]"<>L`5`ML5BFR+@\#4YD6EDF2IOU7*
M#&]T*&Q*=V=(=*8,8MD;%;(_(YQ>S25]7"*=?IK5>R"!L@C=5E@^!^SBZQ,6
M:A8J1\^$_W`4=/2'Q+_Y3,FB%"=&F&&W^]8U^0S*2D5?9<T]Z%R2U)X\73S=
M*I9'S&*4Q"-\O#LI4R*J98:$?SK/G`Q&EIE:I_$8YH;#(FP\P#;_2*.Z$-OC
MY"7``$K]UU<*96YD<W1R96%M#65N9&]B:@TX-2`P(&]B:@T\/"`-+U1Y<&4@
M+U!A9V4@#2]087)E;G0@,3<S(#`@4B`-+U)E<V]U<F-E<R`X-B`P(%(@#2]#
M;VYT96YT<R`X-R`P(%(@#2]-961I84)O>"!;(#`@,"`V,3(@-SDR(%T@#2]#
M<F]P0F]X(%L@,"`P(#8Q,B`W.3(@72`-+U)O=&%T92`P(`T^/B`-96YD;V)J
M#3@V(#`@;V)J#3P\(`TO4')O8U-E="!;("]01$8@+U1E>'0@72`-+T9O;G0@
M/#P@+U14,B`Q.#0@,"!2("]45#0@,3@V(#`@4B`O5%0Q,"`Q-3(@,"!2(#X^
M(`TO17AT1U-T871E(#P\("]'4S$@,3DQ(#`@4B`^/B`-+T-O;&]R4W!A8V4@
M/#P@+T-S-B`Q.#<@,"!2(#X^(`T^/B`-96YD;V)J#3@W(#`@;V)J#3P\("],
M96YG=&@@-38S-R`O1FEL=&5R("]&;&%T941E8V]D92`^/B`-<W1R96%M#0I(
MB:17VW+;R!%]UU?,VX(I$@8&]T=9RF:U=FFW(CIYD/(``D,1-@UP`5!<Y4_R
M$_G&G.X>@"0DRTFV7!8'P$Q/7TYWGWZ_O'BW7&KEJ^7ZPO=<3RL/_V2E=>QZ
MJ4K"V`W5\NO%NZLN5D7'.SS5%?7%N[_<^>JQN\!VS]=J6?#*"]3R<.%<?KSZ
MY7:N;FZO7'5Y>ZWN/KV_N[F^N?SKS9_OU&SY^6(1NY&.,[7P73\)$K6\%D$^
M"7)NF]YTJF_455.7INY,2:NNV59EWN.!)/BA&V4ZA3;VK!>/2F2LQ(]5G==%
ME6_578]C7TW==^K!^53G^[*"F(>9J)*YB9_&4U4\?Q#GAR3NWGEPJEI]K;;;
MJIDMM)LY=3=7YG=9%V;7JVZ3RU-KE%W5I=J9]NQ+:9>]_24]_K'\F:(12C06
M?N`F.A2=HDAT8G78,%9;:S>,(E\MXL3UXX3WR!?/#;)(JP7I'@_F!.S8P&.+
M<3:-\"J.ARU.4_-9Z.![%A*NCI+HZ%\=D8A[Y]>\GX50.R_SYXG>`$O*`.&%
M[Z>,(2]T?<(06^#\BX,W@9NO0S<,59QE;LQ;R>T)[6<KL(,CX"JUW!AUE]=E
M\T\"UJ6JH(OO=#/?C1U5;/(M/\M?,X./G/I1]M2/JN?%9@:W!HY1N[P_W2</
MZG-C]\NV_D2@V*M]-PIT)IY9'%%_[ZCF4`.>JV?L3AWU07Z;0ZZ@L;HD(=HI
MX.H'IS1=T5;\8D47:0<'\U7S9!YF<\'#`CF8Q''$*+`1'O!8C!BE>_-.'<QV
M%N`R^:OPIN?5`<*=1LGK'(;ZCGPPO&[A0'KJNCWN)X<<O]7RT)U:%3ID!KTF
M,V0#^S-V[%E5P(;V_),9`3Z`"Z8%011,T>6)/?\UQ((X<X,8N-%2IMZ`6)!$
MR"D5IXF;C1#+CA"S2:[63?MUAOP+G#W%*W!8E\"I^&]3`X._K)6\8_.`'_L(
M7WMN!&]?RDERT<X>)Y?&@K'`Z88(!\A5'_&<1C@^ZF5#C(-R78CK()YCR>AD
MT9!)2Y2C'11U6HH5$J+,CQLH53A1(D?=(D9DI6`/.UJE/1W`-IM;)WOKAB4+
M]"$HRD["]DJ2_H])R$F2<)*\GH]P8B.BFF%#SAM**]*<B[1[K"L(X^@E9RD]
MI)<U9N)\+QO3*Q:+KDU!WB(GKMA30/&#8]9K4_35D]D^XZ[>H%.5:E_WU5;]
MO(=2FKK9ZEG!+@-5V7T1JESFO]&S\KZM"A'754W],".XU>KGG""=N3H.3BJR
MGQZ=+WVWWN?ML]+)G)6<`XB$02H^7/<#>-K7\9G%8Y>+6,*'9XK$NMK"F&Y?
M]0H]KT?-_=&4ID4KO:XZ4K&7'ARYF=;ZQ)ZQ-/F,6^>JV;<LXZ8NJ[S.=^CA
M'6QZ;XI\WQD6W>VM+.U'L94UT0IZ'%#21*U#U6^L5AT:^[YO8',8+5`LK)DP
M+X!YT\!.G'WOH#-733D7`]%,*,C.GKHRT-^KTFPA,J_Q?[=KFR>8WZQYLV3)
MF!+Q:24;>8,7V9+"C0IU104>7P'I3=UOB(R<XT6#"NSKK>DZOF5;]=5CWE?4
MFT?$TEW?-:SJE,G;;06T`OW-]@ENP_TDM."(L*5-6:TK(W<%WD+>03%RJVUU
M@:N](#XQ;LKT*#W)=8.'$-N?FH-!"YBKE0WR4%/D)@2OM7@<Q$_+W\NRO);R
MNSVII2W<MS(;^0"$KQI;E-5[;JNY[&JE]^[L5_,[?$QONOWJ,_*77]KZW4@Y
MIXP==M>GQ5\DB@[*3SU"'/<I)&PAK_>=;'T24?(@,NQ6PIS<5C*:SAN)M;/M
MK&*OV3V?'D+L.%K+/WT##N>1I4#@YKI1NS9'!2N`:Y2)SK`0M+XT&W+:^6UO
MZL)07Q!W$2FG(.Z:KJM6%1#Z#%F6C\=>F+Y1"_B@=1M[#,YZ(@&2AOB<]Q87
MJ1MF+_-WQ)XOV$.4$"`0?%1@P'H+`E44[=Z0DN_SE@#"10/>Y-+1(O0M<IJ*
M]F#(A/2"AYX#_O_D)?@?9:F;?H^41"'QERC#STA*SNL'$-,VY;[HYZI:#ZET
M,"U;T.V+PB"WJWITG)]D9PDE:90.0K6EJL`Z$;0G^3'$7-`I"_L:@/$`M:J6
MQT?Y4?`TG&:/@&W+"F_-^48KKK3'=G:?O.V'S3V3]@[9*,_#]MXJH3I3[&79
M&EMDY-'^M/3C3TRQMVSA+C0-^\V*V?*-PSVK,V75J%;5H\M,=3G?;.VL6%X]
MJHO1<.HQ=>Z2^MS?Z/6GF>N?@LV&'3PZ<Y3\<,9'PK3Q\@#,\ZH$_+FQ9.0:
MVF)DBT&SY,79>:'P&?'3'V9$\*?LW,?@$:9_9/;3"1BTPOSX75ZN$\Q\2('$
M._)R+QES(+4]U'ICH".?ZJH'[N_0_TW'Y:G8#$[PR0E$U@Q"2<WSP+5A988N
MZF$0"-]B0?=H$SM4.]R`)*L@E4CR#L52==5CC:Y9Y'6/JC-43"_TLY,F>4SA
M<&#O`?S.[J>@7.$QE':3<7'&QYT\@6TP5?UAEG!R=/F6SQI`+>5D*<D7ZXK?
MBEP0=<>UQD'3.'O-.*DE%(%OM`EG:9MS;PRU"F8M8-QX$"9X9&#YN@>S$'+9
MDD@0DS`,3HEM,'K4C@7@T!71$(P356&DV/]]ML`T1H[0&`&*+YN\+7OK5$B,
M_5.)+S#QL;+A9B@\.!N3E[^!`$,W6Q)EQHI='2&N4Y(Q:BB#B\,,%1UBDY>#
MF;4X@0@G,OG7O,T?VWRW43=_$_J;@6=B`OHVG2],VS-:&(=$`5$03$T4@/E\
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M/^5?OC3J0]4B5:X:=ZX^]B5**94!<O#6<-ACJ2='C&>C,!OC^A'6VD)QJ$`1
M4#PK=&R(Q4P3023G.?%KSFP,H5YL)8Y)#TZ*RF`O1BCKQ[G:#(/$,-6%E"(3
MX_01<S8Z0+FX<(,B]8&B`&L7$A1&QBX_=7$M#^@>3\:Z&Q!ZT1)1J+Q0_]$$
MTRE&'A5F*-O?R2^=@LM1FHU=\65;8?RB\8G#.YK%KE%G;4=9P7SQN'\"Y-=B
MZ/CIG&+EH8J:]1J=#Z5Z2R0=02V-G=8"**WC[`6ZHK'4LZSSD=9''M!`95!<
M>^8[9*N>%LZ1GQ)6I0'C:JI\#S,`Z(K&$YI%T'3G`J=0VH8>$$2%,4!A?+1C
M3.+Z4?16;:8J7(R`XY'&$`C1FEJ3]]\8$!8Z<W6:A"]@^!_6JVVW;>R*_@H?
M"I0&));WRZ/A(!ATFG103UH4R<L114F<$*)!4G8\'S7?V+4OAR(I60G:/MCB
M(<]EGWU9>ZW_*AT"'VP0J.LKB+Z=#H&?@[4X<9HH,I._BW/NQQ=X"_7(L&)U
M:_>UTM=/5H&*@.Q43^KP'#HX_EZ4IX6OGT7$$GH(1"(`89#>HC[*5*8L9DM\
M8L)?'+,W,C[V^H9#'%B*9/M`)'V`9\H79\&LWE?;JE/*Y+R3J;IG)Z-2MU'$
M3+P\3R]`)<C.GE7^\G"'C#MU`[,SQO%`C(!#B3KP"W,T3VW#C_*B9X5`A?F^
MVG0@)^3`S'6"4`INY<B&K>YDGHTLE$WTZT&^5AQ/;%K)UV=]W1,[F,]T>AD;
M^3GI*?;XR%_K7NU1%XXK=`J9S)(+&?5LU!R<,],K"ZE*]8+I5$E;Y3FES4CN
M+"@K3FXT67]"F&VNB%F$72TQT">L;[>SGG)_VI_ZP0E74N20%T$1SC<JQT0D
MP@LGP]6G8U/U/==S`TVP%SZ&GE.9KJD))PG@4-I%>*5]7G0\8&W;$)D%H:,]
M2TH,ATU'&6W!^"HYS%XHD@OU`[S+THV\*Q4$03;S13!>0?%T$@3X\"?;$T'&
M#=/UK9!4HJP=\'M3'6I4ZJ;%>7(K/6&9XNDYQ0.YUOU3.U3?N-`?\:_]_<L=
M@RTH@"1H/+9KD534:!5LX[@(;H`MJ2^@=STTHJDZD0.S%+.ID>=^.&\-8U<A
MGW(F2`#A?G#J754/)^0&)2?W*?@[+*+IA5WC!+F_AFK%\K(Y]?5S/;S:!&,M
M8D4B&P'LB;(;_<EU(`2.J@_5;5\X_7=UA_SD8$!+\&81]&T\W6PLFX#SWJUW
M#LDKR!8`8UDB4W>GANA3/?266,G-?`^^N>@]%UD_-C4DS.-I\QL:NFUGJ,V^
MWM0-7;_=L7V)EQ1Y/K&/6QF1S9)DS_<<IWMD69A83L>N)*\@:+`$!*`LNU,U
M<Q;RU]*Z*`MFT5K/4R@,;">9NK:K&B0!(!#N=6EK>8)-]M62PA4>D#[ZGQF<
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ML2<<[SX9G,Y[Y%Y1Q++#>K&%6MO7^R-Z7FF(GK.]#RUOPZ8Q`SV^_ODN17`T
M$.1]AOEE4YIZOV<>5[!,HY64M_`+$\J"J6/!_"IV/:T(+XJS&9)((!AHE+)<
M8"7)W1WU[ZIBSB$U`H**-`1&$=QL;6>*TV"2TDOV8W8#.K``W`J<L/2H01(9
MV$HN.@_@APJ7<1P%2P+D;HWDOX+DP6SU?'.D)O\X(F:8P%,W?5=57\5/5&66
MPS'UV'62-TJ>"^&,X.;.`X8YJX70/9JMK,?1'U`$L:O;R4\O2W%?=-V?*MU[
MMI_NWDHB@FOF26K!RE$+Y"Q6)FR;Q0,>E0[PK)=G:O8[4B/\@<HZ1T90?4;C
M-E2D-/IC%$$T\NY\U[%XIU9\E^!14F@0V.]@BA9'";;:8S/R..8=E//#2\O9
M8^^;@!)-(AR.>1>)_$1O;^J>RDZ+G+)C6\/?OT@._@-XVE-*[91F"IW3G;]/
MYQB]V#<1^R:>>"8FOQ"C=W[5'H%7]%?)=&T7YQ?TB*[]H#E!V3'N[?RB,_7F
MY,9SEPW/ABELL^1`J_[8>F#R09&L_")&2Z_Y=7]'F.;\ULH0&@NLQY4E#?]_
MO4L0;J=].<+*C8Y^EE^2I@04]S*5JFZ,/=FU=-M"K[JT5K1&3W'Y`.(#"9$"
M<Z6$Z3N.HB).`3=!-$7&<XQM@WHQ*UCH#`*K:$X`R!I@7H.[<(-&9@%I`=LK
MQ3"(+S]-WTZ<SZ[IYGW7.&&\YOU3D1E;4*-7!$LXLP)N`+:0O='J)\3V_JG#
M&E)-%!!)S*[:GT"VH![/7!THHDY8-.EYG__LLF&$-=CH`Z[.&:V@,1Q6SLNA
MIEYFCN?[A_&-CN52\1'UZ`\M0)M2H-Y=4786*DF7+"]]T6^M#+PA[(*9L!./
M\]M1V-F&FV?QI$EDY_07^TG[";4^J[K'@_1L(0Q%DD_;S)@`?C33:98-SIE?
MRLQ/@QYY(6C8);<>HQ[JEL*:<Y>P0)X8[>1QK]^H$@-W*R/G2>?)V\%.'NXH
M#U$G,K2SB4G*8\=Y(,\U3Y:4D#<[^D'Y2WKH8J-GZ4\G<W3%\\P.RT_EI1[9
M\#'6E,WL.LYH.!>4SAG:JY/W4[./X]6(S,Y<18ULMO`X&Q'AY0@I*;D"WHS7
M[=,$PAEQT6[.$.[0/^ZVF,,OB/KA5TEQ1`ZCCQ7#,U@Q?B9K&"2UF\*JWK$=
M0W$\RHMPDH?%V<A8@9RLA&F3OH(1XWA$5R8&"%8!ILUW2(E5&*@9627_4<I2
M^"&T;7ZK<J``6])!6!;(%<!YI4OA!?6I6%H+!140SD^=?I;1V`VBU`N*;-8.
M2$$1U`.P3P,Q-UC&!_)>(DB"N,C>)H"=@(_R@=/Q4GKAB(^H547.-/:GNXU`
M9Z_+]9RY&[IJ1ER+8'G!_C.)<;9@_\!';7N9EQ6(UP4$C,8'RGDN54`D*D`(
MO03)]^(H"W[`:+4*Q)^C3#*,&)MP^HRBM6#T&;/'C!E]:!G]NO#\O,@O*+TO
M2$I^A$57(/[2KGLYF'IX/3G(48/Z%D"`<)?R$1#Z9(;1U*/:YIB]T0F]O#H3
M5NQ-1$J*!^HN+&;<8.R+:H^%UT0P`_P;A`Q<F&B'O'`>#O)@7QCT=)2HT6$K
M/P1N(+UHU_;#=KF^J;#RG[4>9!`BGYDY#[_)SQ\4L-#]<F==CSMD61[?\OWZ
MBN*ZK`O0?>P-THHS_PXAPPR#ZBQ$(UHYCZ]PX![I6_;.I\=[44XK("AGDN@.
MH%37]J=N#Y'9B(<3+PJ"^):R!0]ZKLM**B60G`PE)U=65SF(MR9VEH7)-&"+
M'ND^PVI#M*L[]8/3L)!+O"3Q+<L?SQ<T>&$-J12*O16C:\!?/T#=/WF/GO..
MX+HG1.[H22!?"#C1$AJQ,C@#>N4\MB<>5]WQ^GJ`T\?JQ?EWVWV59(XYE>?-
MI++'R'#:2J2@N<%O'=M/J)20;_UIT].KK4P]*X1.UJS&AC/O?@L._MG]F]FT
M'9<?LIR+B\HC(`21]``&OC*@2^KP!)E6RC3']'W5R0>"-'[@VQ6N;NS(`AT<
MS!;V2VHA/%$P1>9DS'OTH%W58<?F[*#$Q5D]<<>3O!7A*<(50`*JK')7P*9P
MY7_%JI6ZP^DH;\S+3K?X"_\_'7=&MNF`DZ:<;ESB2"U4M7?)<N,Q(36K*&1]
M>]H?!B1^5Y7$&J%-#F8@SE0V1F`_9U\'Q"*D-A(/13X!_0O1P"VG^L9L]$^!
M[W-\SE5M&J"K!D0Z7YZGX9N:@0-&1HGB0@,U>Z&YU$[Q"/XO[!ZYE107\+,T
MCRX^U&MMF*'`0"@-\[E"JSR8Y[KM8#30Z:\G4*PPLFHL7:3"I700$),>J9*`
M#XBH5!1FZH%Z7?^"%DXQ*.W>*;3"#>G40L"!U]NX('\43;8"6KD7%L44`M/1
MN((=V0]@FH.H&`^%,\*0GQ074O`*WZ*[L<5X*%:VOD4#$#V0@6'FU<D`64G\
M9\[1'HC+RH"P1%P4B(LP$UUT)ZN;"96C>I2WLENOPH)!BTJ_5Z[W*'LH%)S)
M7LG;]`R2UUFB;B2V[/0&X&MJY(W)RQLR8$]![2(6[VJ-Q@-KRITJS(\0L8S6
M7!GAM)]<I3'OE+P(^[#$0[D(//]K]<WTRG".PL&<]VVG$_YUMTXM;&&UO#U8
M.(W$AS8[$U"827)=P(G4-J<U5^S8:7.I@-3]SX`I-Z^D&&B\(["35)0)21N0
M8'(-X0(`@67<?0IE;F1S=')E86T-96YD;V)J#3@X(#`@;V)J#3P\(`TO5'EP
M92`O4&%G92`-+U!A<F5N="`Q-S0@,"!2(`TO4F5S;W5R8V5S(#@Y(#`@4B`-
M+T-O;G1E;G1S(#DP(#`@4B`-+TUE9&EA0F]X(%L@,"`P(#8Q,B`W.3(@72`-
M+T-R;W!";W@@6R`P(#`@-C$R(#<Y,B!=(`TO4F]T871E(#`@#3X^(`UE;F1O
M8FH-.#D@,"!O8FH-/#P@#2]0<F]C4V5T(%L@+U!$1B`O5&5X="!=(`TO1F]N
M="`\/"`O5%0R(#$X-"`P(%(@+U14-"`Q.#8@,"!2("]45#$P(#$U,B`P(%(@
M/CX@#2]%>'1'4W1A=&4@/#P@+T=3,2`Q.3$@,"!2(#X^(`TO0V]L;W)3<&%C
M92`\/"`O0W,V(#$X-R`P(%(@/CX@#3X^(`UE;F1O8FH-.3`@,"!O8FH-/#P@
M+TQE;F=T:"`U,CDR("]&:6QT97(@+T9L871E1&5C;V1E(#X^(`US=')E86T-
M"DB)C%=;;]LX%G[/KR`&"ZR\L%61NC]FDNXB19H.&O>IW0=&HFT-5,K0)9G,
MCYK?N.="69*=S2X"Q"1%'I[K=S[^NKWZL-TJ(<5V=R4#/U`B@#\>*97X02;2
M*/$CL?UY]>&F2T31T8Y`=(6]^O"O1RGVW15L#Z02VX)&02BV+U?>]?W-EX>U
MN'NX\<7UPZUX_/;KX]WMW?77NX^/8K7]_6J3^+%*<K&1ODS#5&QO69!$0=Y#
MTYM.](VX:6QI;&=*''5-796ZAPE*D)$?YRH#;=S9(#DID9,2_ZRLMD6E:_'8
MP[&?QO:=^.%]LWHH*Q#S8\6JY'XJL^1<E4".XF2$XKY[/[S*BI]575?-:J/\
MW+/=6I@_>%R88R^Z@^99:X0;V5(<3;OX4KIA[WY1CW]O/V$T(H[&1H9^JB+6
M*8Y9)U*'#".UE?*C.)9BDZ2^3%+:PU\"/\QC)3:H>S*:$Y)C0TD6P]DLAJ4D
MF6^!>(\.3-GBHAEL;]JBUM7/E52^\KI5X*>>T&"66R%?**^O($!BU]1U\V)*
M7[!),O;#,`YG0<I)CR]67!_;JA8J7`L5R&`M^H,11]WV%43>X*UCG&.VDT1L
MSB*3L)X:TV-70:KT%&[3][4!_:0?>@8T3CS;D\[W58'IQ,IM0K`E#R+RLO,@
MR8]/\EG\];XU+"[WX`I(S+T!=5OQ4O4'H<7C<#S6K^)Z/]JLDC">V9R>_)JQ
M0!:G?(GBP%??(,M;\H#>+[Y!@K',T%?@A7,_CFF/%5<7C06%ZAJ\^"K^%BH!
MV6K^*`[:[@T$IN5D5YD?!_F%R:<"EES`+TU;ER_@4=%6^T-/Q=@9$/[X:DT+
MYE<`!JX,DUBE[Y3A$6K/8M4^5WUKFA;.6@C2L6W*H>@[,'][<))D(.<%[;QE
M3GO9OB<CG(?T2OJ19X>=+OH!$^;IU846S$SC*)[;N5G&0BF6#@:M-E!NF"A>
MNW=CLD^[+R7_B&[@P7'Q4U=FW-`W;H#1X*$3X7.5D*U\`X2:1QQP+"OC-H.A
MNNY&61UE,ZR`SR9-EZI5X(C374ZNJ*N^<F/=5TM]Q-,DJG\QX\V7BE\X@?R[
M_<>[GEM#[O&TJ(?_K:C3Q5W<TY;#Z-+)7Z-W((V<T&X%0<V\_D+)Z91SF48[
M3_ZE&][US]K%ZURP$]?"SZCO\]RR<O((`,,;NPO3(4RZ#V+G+.F',1G$PE.=
M$S',-8>B-&-ZC/X]-V!,.(8//XS2<%'T9]T$`NH`KSAA(%8'`/6M*1B1(N\)
M4$IFB-@!_/^DW;)A5<5G7SQ4INZ,7</XUA>[JH:B!#]H4D.%?IQ&\PJ/3K#C
MH!:A`I)GUU:`6@2Y&8F7B.#=4$&H][JR'9L%U2]#-<F[X"$])32H<V<+GSH`
MXR1!89AP<[IP"TIR]M_KIS%X&$8%#47W\QFT*Y2.*W`#I;U+/PC3-__1%[=5
MU[=5T4./PM5A=KCG3/#:TXD'GKOIZ#6*WJP!3FCM&G5+48=PGRYK>&&'%\6>
MV")/P04H!)AWKD#Q!`"+'MVIXO2=QN4A6-^VIRB+"H"JZPPT;;MW/H5V$$"(
MS_J+G!(KXL`<="\.<)Y<]!NU"##>%_%:QMDZ3A60`-<5H$6K=]H_`@*FV2^?
MA[JO=DT!S>7.]JUNBH$D@,%R;M5Y>Z]U*^Z!%OR"]CP9M&7,0.HHV)=O&M?_
MC^Q0;5__OL*<'YF;#!QU4\!79*[^BP>X5Q?MZV.S0^6`7F=$J6D@`RC=2,1Y
MYF?(NBD=O;^<%0N"+H/,3Q+8&ODA;76]NSCU<RSMK^9Q^^4KGI_(Y=F547QY
M):OYESLWFG:A0APL5&`DF2X*()WFCI?$#$XQ1-=7JP@!"[MX#\,6\1S0&")7
MPU2OL$A:@6-#8\MT`9EB/RWB<"U>#BBMH*4#,)\C3I$4T%8'A.`T*";6Z3O=
M>>#K#>1;*9J=^%+@:H-0!S"7@US=`0$QSRBN&3I4YG4%:>Z17G0G/U$<\TC\
M-$SB,U0A;%N%D$`-W@<5>5T^P^L$CGT&86R*\LJ*]D`*TZ_X<N1#;IGV=`[-
M`,IX%?!LQQMXP8D2O,8".F)*XMIV+V#8)VT'W:(5H(A4!.BY\ZS;PH<M*UNP
MX*$D-*=7`=_4NB^:MU,_R">.,+Z>BJMYT)&+:E$:.IMYNM4]#1K2"+3\?2CW
M)"I##DS?!/]0L!)/O[7(21%2PU#4,&BRJ>C';J![T,B=Y0GZ)1PG]EFS2CPM
M62ZU#=LLCEG^!"#!TST]>=!]A8;GQ4$CD`!``G?C8V@S#RG'<W>%)DWK-T0O
M?7A9.=?#?N@H\0'0I4>/*,P)*W3Y;%I0HAW&_`1`>W(IN\AX"&0[$\$%-!6;
M.#9=ATM/M`:5T)!(]@;$"8@XE)FA@H',H+IAV0*/00A#8/_T69"@O<7_.ZH9
M364[JZ:%:@OKSV#MNW<#GDKXKI23CM@XS@"805SH`3IC>$5'(45&!I5#H83'
M!)5+2IF04@HH#WSW_W(ET$1>=KC+$`%WF@H-#%2NT-;B(Z&;%;\==$M>8J3#
MMG7R?FL)MPAUX+V$/KS'!4BT;G#>?F'^VR!N+=QW,T'-&`<>LWL2<$\&(0?W
M#$\4F9(_5Q/JXA"YS35>39R)X`W<DYQQIC=#!,2IX<(&8M]64PP67(R64?A7
MBBAM,+HM#FLTEL*1^%F@HG?93\E4QE]/K(8?`.IM#@;K`_^TW,T=#\.%V4F^
M'Q`I#>6LBYU1F>_>1]VAG3'`(;#EBH9NI>59P3,,$Q`Q``=>IE('N'P\F):R
M.*87+6#`VGD[A-1,X_C<W6K*-<=3,4%\*B?72^!U5=$$V0P/X#9"+%Y%=AV>
M-F/B8=UR(ODNM2#U*%<I<;CGGI_H!$3/:ML<=<LK?$%!FT9]'(^56#BS2":L
M/%T)[BL.MJEIV.Q?5S%BT@]O)(B\985-P?($^&*'A%'EV5HEBE(J7D<J7V>1
M^K'RQ=B1W<4S)VZ61-#E+.$W$KV`B1[&J(;71B\*^''K].8<\1E(4ZX6Y/14
M"#)S71^9[HQ"2I8<,H5,L*%?D,C4SV4R?]=D,_+X9P.DX((ZJ@22-A-1#DJ?
M4<>)D9TS.)5DOA)1EI\89#YEELMNQ,MR0!!'A`(?KZ$O\,Q8_JWH/^)&0A$/
MW7^$FAR8F=L.6;X0UE&N"SY-M3#F9XCY*=PI_C!.*2\A05PVAI02B><TZ4Y!
ME[D?9\$E3%^P$0SZ#<,4=U['/(Z.:EA'2C3Q(B1`D&8C!<I&"I0Q!<K&TTQ!
M2BR.SR?O2,_)FE&NC^ZT/2,S5CA)S3.!/1$D1PU*QUW<#C?K1`$OL1FM6/()
MJNP%75KTV)-;XJG%TKM7L4D1O7S8'=1<\1&I=]1)@6:[/03XD<>+SWC``-';
M(3_N%HZ+1L=%[+AHO*5;89$Y,L6X`90R"N8(?&H`6&VCLC&[QT4@X?AE+G[0
M$9"3D;8)\2UL-@B^&$^AW1EX`E"`B0'/U4U&=1-6-QEOP1R6W@@T3M,WGW[?
M/<C]9P;^_W!>+3N.XTCPOE_!PP"C`JH,6[8DZ]BSTX<9-!9[6&`/VQ>61-OJ
M%B2/'E53GSQ_L9D928F2Z]&8BV6^DDDR,C*R5/X_FW/GK$\>=%/XBR2`.34R
MQS-:&+]HWNA<+^I+9@SS'>2^I1,!\(,?U%1S10L7M),WI?,L4Y/[8PPWAF./
M\(FYLI%@EOW]527^JA)<5>+WHZN*WA')"43R^\(/>J+C3`9)04B/H"(DSF+I
M(/U@XAV'&/$M=OP!Q4C.P-(L5IX(M=CRHG/1,J%^E(/TWC/-=$E^/*[Y^R&$
M;$N/OXB,2MR7>X^Y,&4)<L?WUI2]0;O%(-;Y%1AB')+/M31.Y@ECY[9#Q4K_
M^9#'""7"E!?%S0\I,JPHYO+(5Q6'FSH,=05WW3-;4WQ<VF='-NYY"#9*L^!+
M*1.D"NK1SZ4"?T_X2+G`?[#Z]7U_@,89Y?E4%GB>7A8&OD1$;;B9RH*U[EV5
M!0^OUP5)D&:@`(1*)?_CX0>5X65ENXK1T'$IVPW\?VB--4_</[P$=)@&=+C-
MIO<2R1$1T[<#)]O:G6W-QRJ<*ZOFS*;94_8AS4(3^61")%E4]33=M.,@:8-<
M;SLR0)4,3KI/-EFZO9&E:VD<,1`(-V3C<22+KN]9HA?UR-YXQ\2C9+--DSSP
M:-91,3QB]SM7VX&7TK6HDC!U91^KNAIPF6*,"IPX/BXE.[\!20:2+.0!J0P(
MX)U`@"F\&3Q3M-K/^0[(\?&2;]+C,;W1D?.Q8Q6TCW</3*D.&KJNW-.BHY<B
M@SM(&E:#\0T_^K1HUU6)MBD75H@#T.Y!"\(CZ/$+JLE6)5@^H]'BT[$./?C6
MN#!6O[RU6QD:U#ZU.QW+T:L,U=F?L=(M=+:Y+BS_@%WK357+(_/MS?%)==I[
M\4E['?(WDG,H>/][]Y#1%IH[PRSL(%A7N96R\%@'29+SG%=;P31+V<UI*G2:
M*6&\;1PKC44?P;,IJF!74G?6QW^6IDF`[G1.+@KTIF')S1F-PH1"_P[UV)Z3
MA5#>GOCWF;NY0URDV2(?#R(>1=,C&6$.LV=*4IZ+1IW16-20:K#1'2G;R&+T
M<@;5Z*&2+8WSV^B9@B?Q!1.]<21%$_]QAI$9U0,*,!YQ$O3<*X%/G'("]"/Z
M_US5M9$&HXZ<E[/!)@-NS[KT`/!Q06.\670,KJN(-"W#<3&3B<R=3J2WC!B6
M+28?_RE]:NHJF\&AG^GAYOD]BAGI0%SS<>1+XK0)G)3_!?ZS0UX7/7BBUTM3
M.2$UI50(R%P/K*(KB3PM`B2Y:E,B?R<"<D1/34E(!T\ZJ$VU[)#).[NVJ7L1
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MO.F%^5USD&<2%6,'29NKI,TA:7,O:<FR^_.*.H#J'^+K)^<'\+G`$O3M$?I6
MJZH<^C91?<LU5-?J"*&YOL,M[#61Y2S:\0>F>["C:JF@*RB;/MJQO;K.8BUS
M?JPUY'0#!`+?48X])G;\P)#Q2;2,E73*Q[GD[G[L"W<=JL?:L>SK*[K&4\67
MIVY+L)!CON!Z@R%#I3A!*0WHZ]\W@O)VFFJ-=),=#X=PNWB2JQFV$Q')Y2B#
MZH4SL>U[2K"4ZNV9=$P_B*Y6M1D#=[&HS:J9!6>6Q;<R.P3;"B*G$1TC.B@^
MJ78(WG5"0:L36:G,B%,\L'R0P>]-^]PH#!4%?P>4]G4\$];[%=;AGYIQ[VN[
M=V7=]"#;?5"`06_Q_EIYIO#UJ+[&/FK2Z/10R;?IQXX+,6E<,+EKQ_.%^.2*
M7DQ\PI@SN@Y-6FV;PJ'"DX$2`VC8.U:''1J<[K"Y^J:>]MC&#^*7'P[+,-I+
M&<,Q<64=QUUZ(JZ+"MN/NCP<NY]8+<O3P\?:3$37&"@9:!8J[`S^D7SJ9%PT
M$)2_2B4((FB=A7XS7=5_%YNK1!B(]UL'7W_EWYKE2SG"<J>WB;O6VUN6IN&+
M296Z,O(CP+G8W@#-K!U4JN^3_3Z0ZF'DDC!?$N4RS#@V;%=<Y/E*"E'0>'OU
MP>$#QW:$L+/SW4+!/IQ9Y,]LKX$W"_+=(<_".UW1215R=6FNM@N#U)/]8HF/
M],[],>IR9]2U*LA&NEB/W#@Y9=>"+ZP,UH'GRB-7BS^K*U#6\G=^S`[[D)MW
MGBD/N%R6[7/9X\(&%RYRWLR?-RQF>E1IZ.(*34J>\=HV;]9.0L@'T/&![P)<
M>Q"?YZ=0IS^$=QWP3?.=``2X*3#7J.W'HN#0U&(T&'D57*D'5QIY''/%TRJ;
M]!,;WX3B*E@UE>_RN3!5K?KK2%1WX/+F;&)*TO?FB[MP$4E=)!-^D4B2!Z"W
M&F3FQ76]^:U!@]\AC;K&H@E;;4/,QG_,U^CSR/SW]<Y\\6A(XV,V1V`\NZ24
MUC8EO=^)35%-)K^\"P.`CDZ%H+@G;TZ_#3[]()_.XHO.EG6.3&)Y:CXW9YBC
M.R9Y\0E3#3[\$I&NGN/Q$"?Q&@3;;`+!48%<R2OM(G<_:PAN$R/%<I$O/]]E
M$IM$^Q?/_Q?#,?ED:WI<INNB'DM"T$\9[4`(P7VEFVVRS^?[8N`5$QAY]_Y"
M@##$\R)<,DZ8I'&I"*#L=7%UJ2"ANC7.0^J3**1\82RM.'?NS(6O*4@1MJ44
MN`2<AWVZV1_W-W>P2^=GTVBV!3$X`I"<5Q0!0Q-I98*A`$$:Q\`/O9IXFFRV
M::)'_I^":0DE0.1*"6.TV#+D$BO9(?<QWLM8R41%\?.)3NK$-83]YD[J4?,O
M)_-XJ[_$)R.D\=3RIY#`#AA*D[1ZN@;()'6WJCT5$#$`,8G*7UWA=.#1=1)_
MC(U['J-&OD#38G'G*K^0LZ:'RDRTKRKW4DY9_W6/0"+U/M`[TVO]E/"6)T>(
MN=JJ-(\O.A,@\)8_!L&;E/Y[&W"PO-@GB6-0,__(]4O\>@M=_W>0A+O8;=(D
M#FAF=YQ]5>J68(^%*F)/6?%K./NJ<QK//7Y1@T\/0]W*(!GH'(QR%F(YP?^=
M_!<\\30^:AQIZX*6QY<_Q1I?AXD"=EZYU,Y"/#%BA!$>/",<5XR`(#ML\HQ>
M;?LVJQ%S$"C8WLP)&N12C%8DCI7G)/"U$"-V/P1F\\EL"K/LI""-UI,&_^:H
MPJ,RTI;?:!>QQUEEQ_ETT'O8TZ4D67*CAK?))(=AN^2:C0H9BFDMX'RC04,G
M5"(\M>^,CVGQU5XZN*ZG5*1]5DS5)#K0[@>H;/Y?C/AVI"*]!9U&US\,M0LL
M6ITBM6R^=`>-?B`X52N7M'EB'J!7I<A8F+%^WB^=SAS$UB6\"(D7'76=/]AZ
M*W]2#@8]%S;5:8N[):#CH3[_YQ__'P`J2OXU"F5N9'-T<F5A;0UE;F1O8FH-
M.3$@,"!O8FH-/#P@#2]4>7!E("]086=E(`TO4&%R96YT(#$W-"`P(%(@#2]2
M97-O=7)C97,@.3(@,"!2(`TO0V]N=&5N=',@.3,@,"!2(`TO365D:6%";W@@
M6R`P(#`@-C$R(#<Y,B!=(`TO0W)O<$)O>"!;(#`@,"`V,3(@-SDR(%T@#2]2
M;W1A=&4@,"`-/CX@#65N9&]B:@TY,B`P(&]B:@T\/"`-+U!R;V-3970@6R`O
M4$1&("]497AT(%T@#2]&;VYT(#P\("]45#(@,3@T(#`@4B`O5%0T(#$X-B`P
M(%(@/CX@#2]%>'1'4W1A=&4@/#P@+T=3,2`Q.3$@,"!2(#X^(`TO0V]L;W)3
M<&%C92`\/"`O0W,V(#$X-R`P(%(@/CX@#3X^(`UE;F1O8FH-.3,@,"!O8FH-
M/#P@+TQE;F=T:"`X.#(@+T9I;'1E<B`O1FQA=&5$96-O9&4@/CX@#7-T<F5A
M;0T*2(ED5$UOJS@4W>=7W-V`%%QL@PG+-.V,\E1UI!>Z>ID%!;<PHG9DD]?I
MOY_KCT2T%0M_WNMSSSG<VV9UTS0,*#0O*YJ3G$&.7Y@Q)DB^@:H0I(#F;76S
MLP(ZZV_D8#NUNOGK0.'5KO!Z3ADTG9_E')KW5;)]V/W]N(;]XX[`]O$.#D^W
MA_W=?OMS?W^`M/EWE0E2,E%#1@FM>`7-74A$7:+D4<_2PJQAIU4OE96]FUD]
MC7T[X\)EH`4I:[9!-#$V%U<0M0?QYZA:U8WM!(<9P]ZDFBT<DR?5GOL1TQS3
M`*4F%=V(KU!R>DE'"Y?N5W),1@5OXS2-.LT8J1-EUR#_"_-.GF:P0QM61D*<
MJ1Y.TGPZZ>-TCJ/#\4_SPZE1!#4RRDG%BH"I+`,F#\<7YF$S1HJRI)")BE!1
M^3OA)">\+AED#KNXE,,]L9SYBC%V4^*6$,LKWU1\0/:U(@![!=KT6`9*8F0G
MQ]]8G\+:3](SB9OSV>"E%VBME1$>*VFYD&=SS5X%/E&-04X]/'_`@QS>4HHA
M"::]-7H>I+&>%(H,4+Z0^2I+7@8R]FJ61K7SJ!5*?4SNST:?))+J]?+U<DZX
M*+FG,U+E4_%K+A8@M;V'425CB@HD*@QV]H-IPQ@VM3JF:]A.?M%I!4-KH7TU
M$ND(]]`E%`='CE^?PQIY:M5'6A">>+;"H4TI5A^,P/":$`ON:.6`9DND[\.(
M*6C2I>B#9,`GW6IP3_!$P@\=CE78"*>P=>5QG,7#,-APZLISHPXAQD(OPX[T
M;YC/L9>7[*#/D]_J0>GXT-"B0WPMV:68+]Q_M\.SE`KZT3Z?C?OA43OD9IYD
M-(9$@LI$S6C'9D#[Q6U]5K/WG?J`E[/J?=L(+')2B(HN6/SJ[V<9C2O[-8P^
MQQK>L9S887(B:+[L,,6U)="`V4A[GF9X,1KA4+))`)WK>),F;HS!F9$,7I"\
MJC;?C!A%Q3_!Q:-X6)07BWJ_,>]%.Z-$&G69AW8."9&"F@JV@%A>(<:?#/.9
M\77`G\VSY'\MZ*9V]-GKI/7&P_?&"!)%SLNZ7N2LK[P)SYO+>3*Z0ZN/ZC6(
M?7)]`7MU)T'_=IT"[X1>4Y*Z$G19<O:Y7;,(=>=(S)&S4YIQ(K`5?/R18G1B
M+WC=(7%-$RT6P9*"5Y^2?^V3]\WJ?P$&`*VQP)\*96YD<W1R96%M#65N9&]B
M:@TY-"`P(&]B:@T\/"`-+U1Y<&4@+U!A9V4@#2]087)E;G0@,3<T(#`@4B`-
M+U)E<V]U<F-E<R`Y-2`P(%(@#2]#;VYT96YT<R`Y-B`P(%(@#2]-961I84)O
M>"!;(#`@,"`V,3(@-SDR(%T@#2]#<F]P0F]X(%L@,"`P(#8Q,B`W.3(@72`-
M+U)O=&%T92`P(`T^/B`-96YD;V)J#3DU(#`@;V)J#3P\(`TO4')O8U-E="!;
M("]01$8@+U1E>'0@72`-+T9O;G0@/#P@+U14,B`Q.#0@,"!2("]45#0@,3@V
M(#`@4B`O5%0V(#$X.2`P(%(@+U14,3`@,34R(#`@4B`O5%0Q,B`Q-3,@,"!2
M(#X^(`TO17AT1U-T871E(#P\("]'4S$@,3DQ(#`@4B`^/B`-+T-O;&]R4W!A
M8V4@/#P@+T-S-B`Q.#<@,"!2(#X^(`T^/B`-96YD;V)J#3DV(#`@;V)J#3P\
M("],96YG=&@@-#`S,2`O1FEL=&5R("]&;&%T941E8V]D92`^/B`-<W1R96%M
M#0I(B<1777/;MA)]]Z_`0SVE[E@,\4&`Z)OK.!EW$J=3*0]WZOO`2+2LCD*Z
MI)0T__Z>!<!/2V[2Z;T=SU@D`"YV%V?/'ORX/'NQ7"K&V?+^C"=Q(EB"/_\D
M$\V,TG&:L>7'LQ=7C6:KQLTGK%F59R]>+SC;-&<)6Z[HW^>SB,V6OYW-DSBS
MF6!SD\0ZRS1;O@PS22QMB@F83]PP/4CZ/)*2%L`9X9V9"Q%G*2:UC=/$MHN3
MS&U&3X9V_#6Z65Z_92)FLWFJL]A&;R]O+U]?O[V^77Z_8"]O%E?O%XN;=[=L
M]I_E3V<<QG@*_X,Y+CMSP@5P>?N2P<";?R]N%NS=*_;JYO;R]NKF\@V[>G?[
M\F9)EFB-BY.G2)-B<QYS(TWG8F>3>YN_7"_>OUDZ<^]^OO[EDHPL6`@WY'ZN
M8F6Y,Y6FWM0DJWUJ$K<L2[L,4BI677IHQZ(Y[/8-J^[9N\>BSO?;JFPF.R9_
M<3/.N\V4^V#Y4!<%^UB5^X>&%>6Z6+.W>;UZ8))?,)'PA*VJCX]YC?%]Q?;/
MKTYL_"U^\MA8[4]`F^X$<,)8]BL\*]A]M9M)P,+_KV98FD:?M^ZMW+"U?VI6
MAZ;QCU5)_LZXP/.C7P[?D4N72+>D7=C`>LW\V(-?6G2O!#=@.-7"#O#FX#MO
M84+X=>F8<1D+6-S/%'[[S.#51/D,9J)11OTZ%XV(6M=H:.LG.M><.;^L\"4P
M%RJ6J95/DF9]TN@;Z;_AO7,R."?'SF7..1U-#I#V6?[K&*KX"%;#JG&PBA;Y
MKOASI#YW^$G:E9]/,*'@BDZ4^Q.E9.;EE^]G)FK89E=]R'>L<=MNRU5=Y`UB
M0V7+<X+K=_S"GR2HC*.Z3C+'KY$1G#G<F&B[VZ'B_!%@]X!Y/_=,G83S$;%*
MC'@25PCGOO;HS"('M<P?E<;Q-GF8*'`F/&)`Q=:MJ-;,/Y1^:3@F1IDI[N^+
ME3=$='&??ZKJ_,/.#00[Q1\MF*W1?09:`*\>\G)3,%\<\&-&>6[<CMKOF$5M
M7C<[-THY=P^4^-%7:9R>P[/K/U9^_+`.=C;,FW_P!HL^6>3440)(O']=A-9'
M6-6%+^!-B=""]_>>'PYAX2$4_J3>+WP`M@W`M@%8ERN!`#Y7AUV7KDP\6_IK
M]I!_*MBFKCZ7S,;9^07S]5OZBD4.Z(URX$8W+(G%N8-5O@Z#X[+/_1>L.=0;
M/[9JA_I\94^Q->FJD:^'YO"A*7X_%.7>,W?!?LK+0UY_\7#-5ZX*T]AR'0*-
M?C]LFRVU&]][]E59[=B;_=JA;0M4?'3?R#BUV:":GA3M8UU]*D+-$C80_9X]
MUMLPE-?;W1=6%_<['"UP]:G:'=K5;:2^U3^'#$K\B+U97JXO`H-7[1`;'7!3
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M]CE0,K6=&74LET?2*`37I].H?:6.-P^]SSJ'"1RA?\T%TH?\4']ADP.VL51&
M#N(]*3G![T#3--ZPIV[QZ(&$+:5)40P!5_`!8M5CDB>&`!?2CY691#N[B_*[
MV<0W;D)W/^7<]?),2+0?Q93-8LFL`8V2ARH#"YW=G_VX?')]0@M71L><+D]'
MT#D^TOFDZ*P/\B[:ENRCDQ,`'^JH;.YFT\P:(`=9.0+:P'-CY,X5P.%*DBL)
M04*ER2WW.4LA=&QH%H.@4<RXL`$TI+?ZJ`7&K1A,F^$L9UMV)A4N9>T*X'TP
MKQ+(BZS[&GPWGM8Z[FV#32;Y'F3S2.8U:D!0ZH^Q6?2ZJ#9U_OBP73&G.*<L
MH$3*0W>:WCB`(2>#CE($DHNS(-'TUU+>QS0GQ2E$-KI^C2JT)<ZP[A]QZ)AV
MN-RMT/[?EUMJS(M]OB^:'\8N9UZX'\\OJE]H^3\*9Q3$4!:HEEV24'D_/^1U
MD-/YJCCLMQ!2,&93KF#M.T=U*;:4Z$'.%5R-W"BVQ2AR070H)2X2$2B1G6.1
MI@**YO/6S7/ZDB>D9VE)Z^IYU\KAF>AXS_NU",K.!&7G@N4*$@Q9019H5YN2
M;A=IYNE0"OB`O`J7-(V59N`$C2E).75+QOEJG>BE:QK8U]T%T7P.[GJH(LBB
MZR\STC)^BB2*@91Q/)QQ4BT\(?,JT5",$2Z@LSG2[46"L(K\M[$9CBI!JL#Y
M.E?:T+'C(55T`GXIY_#<!&>=RA$D^IYM+QT$.HA-2PIG)J3Z&A7P5[@T0;I4
MSZ4@JQ&7=M-F./LLWZ'G<B8SCL84"._(96.)8^%>U>+6T-X*4*;A&H'%.+VV
M8HD6W01IW!3W&AP+5"(NN=HE0),ZU6DV57'X1-KT9"]Z(FUP$4BUG?1ZH0/F
M$VN\\XA3_AEZ:<D3\E(M>>$V@$Q0\*2ZCG9)I`;,3FDXP3-N,Y$Z'/;G'3:$
M&$ZRH'2/'KPT."9ULHGVT^9;&IU,34P!?7R.C&_*?5&7.=W+\MT/7]]`^LS\
M7>DX2<"F(V`](F"2;$,"YL(3IK2\ISH)O=13'>ZXVCF7X-2)*?@1M`!X)[CN
M6PB71%SGA0+S#`@7ISKRP@R]L)*JT9PD7-[7K^X95_6,F[:,"S.><_VU,)MP
M+C+3U2LR-R)=I2B[$+_9<%AR:>`ENH$]PKNI&_VG>7<L3>"J%'9TUSNFE,"F
M/!LHMS3.$FD[\X@TZ6(:E"W\YB?INIO]1K86=(/0"?]FPNY*V;V&V;*=/<+:
MJ=`$/YOV.,AD^O_B;1M4QS-%`&:>7L=4#+#98_?7H3>C2VR`G\0M4V2=6N0H
M=^-Y"T=/98DG860@^3`T&.$(RQ4C^KK+*)6)I[Z9@+ASG7T,$%1_;$XW]'[Z
MZR&"17`IU@.`'&&$I6<$ZMPV``0QO/:_U8=V8!$>"L<.A(G,<^!WE!\$+B+N
M;5P8001A40?MK![,*BNGL`$;(#M_/VS2T.X];%+BZJ>PF8J/KX1-.#F@1&A8
M5\S&_E[:'5R8-:"5[.FLXNY8_2QX_^BLMXST86(T#<AVIA%'JJ>0P4CGEQ+'
M9EN_)K/`F=`G_0JSI_RR=.<]Z1?`>@RB*=U:")\]VR;3QNX52707Y7>S@`4=
MCBM&%\D&M\"G?*UQ%0P+B"-E)VY$VQ-1)-$#D:")\G)3L.V,4%+Z$0;MT^S=
M"%IC5/I'MCK4=5&NOKA["H-G#:*\+QR:@"&H6C/8]"DQT\<0RGO'M`^>@>OJ
ML'FH#GYL/.69NIDYC];A;75HFD#AY=V,C=<4^P&)>Q'4FBF]36S_@?S/*,:P
MX-%/Y758N6'Y^K=#$VRM@_YJ`QP<TWR84I'P!.EXK.J]ZS_DA(K6+`]:K#J4
M?J*Y8%X0\6AU\+^Y6SO^[N#"Y.2.^&_E5=/CJ!%$[_D5?=@HK#1!8`_8'$=1
M%"G*:J.=V=.>VKAM4!#M;6`F_E/YC7E=54"#9S/9B^6&INOKU:O725*H\1@Y
MI>(OKRRL]+-Q&E4T?Y<5E=/I\#28[.>AN(UD5?'**%WR@T'\8HNO!!-*K5M4
M^5#]Y95"]8CI8D4LZO_C"'"HN/?]:.,O?*$!D];*'LT>;5`3#[@9?%F@PC_'
MC['Z[>'A3P#DY,\IHA9E)6>+R.AN@/*S)\3[;-K!J+.S+SUMHP1E$:+XA?T6
M*2[FUE+\)B'?'V8IV?+(&'?V0?ZZ139'3W=C*ZL7-BD/?5^1D<4F"<.K_<VB
M8\.D<9XD1Q</$+_V:3I99_CMN9T!=VKHT2`;!\Z<YA5O1_C(Y(=)<7OY=39C
M&?B!F)$\BX=K9KP?\YS*5>-@FAK%ZSC%NNVGK/J$&4E4I>I.Z5;5,.EO0D`W
M)P)\F6V"1"2;R8`P%YU)G^4!8/H*%P@KC\$B7B;H]OK3^]Q#5=D+FM)?'3MU
M,*4>.N"^#VYSWN:;$+HX^\PU/2(.`11"Y8I:UZU*+CC0JA2@:(?[SH7WE+QI
M='\)BA)U)=X8\>7WO(4WV<Z_#@\%\P=!GC[,WXM!.[8#`:=;<<'0AN&H9\O?
M#T(MV+_@H'3*U[UP4'M4_I.,[101=U2V:#0PW,75]+@T,TEYJ9>2U`MH*F/7
MBKE_`6O:UO;CP2,)[9/-_3?Z:;*=17?O$R2N6[*1]_OB3&>D!;@?9%IEG+N)
MD/R]=0L/+"_'+I6>:P,S\HK;38Z:2(S<#1#X)6)B1:P'P_,Q/-=Q,4??Q"7Q
M074+QN`%;V?C;DFXW3A>7@M6O*B`W!LOVCKX!+63Z1SOBGP13*",!"Q)/H&E
MX*(\-*BI^MS6/2KPV.O>=$(8=5LZ.(K'4&W;'U5OU;L=-)5W)JJ;IAXI--ON
MBZ#DNUGT2`/#`!B3N**OG#'!(*\Z9=HC;'S0KJS4-KU37D7<J9.SLDN]@^B8
MZ9"LK>FPF,*2^PUE;$MN!M8EDUMFJI3K:11(JK9'!$Q#'[WPA+T^_)$;BY3T
MZV@MF[B1C?DLJ1?`F7B0\.#55]<W5W7$-$7FT,2#O#43%;>J,UZU-#,CDJ4%
M'B^5=O*E+LW0U^AFM(D]8LY@5O;F;%UM.NH>G%BWO=,6LU,[U9BV,Q`^'`:D
MW':;!6'0#`&=7$Q9ZP:^VL%!]SUKD:B`#2J/NU,X%U8`BDQ9M;:QY^OKEEF4
M0Q:2*O\9MX/M;K>YX?QTOF@]E.[Z:$]+.9_']WNZ0-"?-`$?X@U*N9GO$/^(
MPXNK1IKLXQR7AF07[_S6:.T2KK!9FJTO"M$G\_CT\=-_.G&?_6\GLF3AQ&MC
M+O(%7/F&CO8)3U9IFJ@^4D&REMZAB>(B7WG'"7[5Q4V2Q_O]TL6;6JLG0*U<
M)@6B."V"YD@G93)V!XV0/8^0G(;:WH_)Q`/:LLC;$T&F($A>&5IY"$V#:7S8
MT4@>W)E/+>6E.LLY@_3X>.38*O36:V<HS&XX=.;KP'-FSRPNDR0?5Q6O1KV;
M9DA/\BW@SA7Y7;>#=E<B,=PIO@YU5WO]X[W^>.&>@G/Y9ANDC+06V-`VZH_^
M&*,'/2..I.N)BQF#F(F.R.-TF^[6O1SJ0<@;HI9FUGJ044;^^R&/!/?*EJ0)
M,'S/NL9L)VO"1ONX*.[?BAC*4Y=_'9V]^!#IGE$9W?15J;V6,J!>J@=&6F/H
M8*0RS1?.W[#WN>X:DHUWZJ6J,1?@X>!)B<X71O0\[AF1#P7JBS0X<W(S%3>9
M.'FT':[J7<9LG<F,H-Q"''/POS[]\"^A\]78"F5N9'-T<F5A;0UE;F1O8FH-
M.3<@,"!O8FH-/#P@#2]4>7!E("]086=E(`TO4&%R96YT(#$W-"`P(%(@#2]2
M97-O=7)C97,@.3@@,"!2(`TO0V]N=&5N=',@.3D@,"!2(`TO365D:6%";W@@
M6R`P(#`@-C$R(#<Y,B!=(`TO0W)O<$)O>"!;(#`@,"`V,3(@-SDR(%T@#2]2
M;W1A=&4@,"`-/CX@#65N9&]B:@TY."`P(&]B:@T\/"`-+U!R;V-3970@6R`O
M4$1&("]497AT(%T@#2]&;VYT(#P\("]45#(@,3@T(#`@4B`O5%0T(#$X-B`P
M(%(@+U14-B`Q.#D@,"!2("]45#$P(#$U,B`P(%(@+U14,3(@,34S(#`@4B`^
M/B`-+T5X=$=3=&%T92`\/"`O1U,Q(#$Y,2`P(%(@/CX@#2]#;VQO<E-P86-E
M(#P\("]#<S8@,3@W(#`@4B`^/B`-/CX@#65N9&]B:@TY.2`P(&]B:@T\/"`O
M3&5N9W1H(#0Q-S$@+T9I;'1E<B`O1FQA=&5$96-O9&4@/CX@#7-T<F5A;0T*
M2(F\5TN3V[@1ONM7X."IHE(6!R\"Y#'K.%OKBK.N6#<[!PX%/1*9').29_WO
MMQ_@2Z,9SQYVR^41"8!`]]=??]WX:;VX7:^M4&*]72B92BTD_.,G(YWPUJ59
M+M9?%K=O.B>JCN:EZ*IZ<?OS1R5VW4**=85_'A:)6*[_MUC)-"]R+59>IB[/
MG5C_(\[(U!093,#VDH;QP>#GB;'TJ=9IGL&0*]),NZ)?HS2=`4^X_&'Q*6G#
MYER=EB9UR8'^-K7@AWJY4FF>5$=Z.V_"1O"Z/4^$N.[+4FGXN2_C-J+9BGTH
M^;/9%U79!M&&;=/&;P0O"DN5%LF.M^N.R_^NWRW``6_S#"#J3;>#Z8I-+W'S
MG,S.T>PVW,6AL-2I2@3/D!\NJ=I0=J$3L+`CX_IEG2!K\J2DUTT0FW,;/]T)
MWG#/>P2Q;<[M;$B0M:O>7!A3SOO>:#D8K<CHY.NY;$^A18RTE(4X[<N3>`B`
M2W<Z'(_B4,-0$`_[YAC`S"#*>@..G<K#D2*/<<V=9EB2S:$[M8>[\^D`7E7[
MLJ[#L1.P(^Z!RY5*I<N*"8IJ0-&207=A=ZCK`WA*)BGY6I0=6`2VP"]QR9@4
MV*8N?5,>MR(.`LDI(@BL!0P16,O`&G@MZ;4'%A<0L/A`*!H`=O;:AM!_V]1Q
MIA.A1@Z^AU<7MVRKO3#J-=F=<B14Z@MG9[9>I-7Z;^Q_/B#AV?J_'RN`\9<:
MXE.7"&EY1*H`9PXULV<C5)'J&W%JQ*NBR,!&HBJ<52CW-,B?$@@MABA&][2/
M#NHT0P='W\JI1Z_%MFWBJI%F19X_B@1E]:?D56XR$5-K?F)7QF%.-7$?VD.S
MZ5F8"K&&16&[#=4)![?EMZ9EWVQJ<?_!-Y:9_E3`M+P#EH;?D'T[R.[R-,4K
M<C!WN8F4%4^CS&1S*>C5HT1ZG/U%ZF_`\+>_59S,Y\U3.<M^T1@YU[2!E^[J
MT?!MW"4N///'9:]%9-,8X'RD?M119*E.#O2WJ;O7X"<]1V?I&=,B2]#MV>*2
M5P(*S&#(`.O->)H>#\OX,/S`TG8>LNRA.?/`1NS+;T'LVN:A%B#\-Z\C;2"#
MG7*/>5.,.T>BWE."FH2RSR1E?#W2W^_P%\@#"L[OB"K^\AH`_EO#$^?X.=O"
MBR@<(,I1`TRO`<-,(%;22+.!R#)JL`G'`%R0-G\NR0A8`P@?Z"\!BP]1[S,B
M?PZ`[=KP@'6@%!"=CK\I::[F%U&=VS;4U7>2'G%7=KPE:&O5-EW79V.TZ9'8
MH'DQ5"4(Z7W;8)$5QT,=.O#LP[[$"J@@9&450+VK,0>(`1F+V-.J3;#N,;O?
ME?=E356B"BV4B5J\/;?-?2AKRKTL5=[X2?JZ8:>")9&3$`C;G=O=Q)+Q",Y+
MF19>/BX"@QST-8"/)XL03,_A]4F(8?#(VR3N/UU`Y=ISN8:W0(H%J]M=G-B)
M.`3BG[3_#_QUQ^7SXJS)ROFV55/STI;'H7C2;]-V<8\FKISMR(L[((DF]>Q[
M&#BBK@+$]./,.9`9@I.&JCC%P>W+3S$`YQBXW;$\5ZSWAN@(S45D3@>[W77A
MZSG4)RP^ISWS!-(C,Q.E&&E"[`,<WI4U=!S?J9X`>;^>#]V!NH5FVVNSU%.F
M7<0S$;_>GYJZ.8I_G2`I"6J9JAOT$`L+LR1ECFBTIS#/%=]57Y]EZJ6;M;29
MR0O\E!J681S::AW;Z@S:D%Q1UXNUYXEZM*;B^I[+ZELLJW&;V)T7J;6%$I--
MG-)F,/-3(L1R!6Y@1R@X9*,-/LT@L2\LH#XH^2>6E5T]/PQ$$"(4X:5ET5GK
MB]$$\+GPW+Z+"Z>A9BOH5.8GHK9@O7_#I0M95@#!HZGQ:)MBSS;YKE#>3\Y8
M6<-U&:.%&C$W<8)[GAKE[54;DK%CF3ON4PEWEVLH_PA@I3,_/8N.>=/K\>P0
M$&=E\KZQ8&#GQSZ+;&ZMN?3*\7%8%DH0BHOC=`XXO`12S1>T)R'UL)6ZA)3L
M-*G,<A9YREFZ)<SMR!&CJ]C&1+L\+06S]<5A6K&G1*%+T@(P5S/D"HA:`V9_
M8&N&\%$^X%WU95'SQF7/\L,R]A-6HTV\W6<05CQO2OKD\_("X"A?%V?0HK=K
MZ$2@[%N1>3@H%X6'CASM@3Z@#8OMXJ?U`BXC$EMF*?C)^Q366U@#VWVYQH;"
MNJFP#2U9-?1IJ$R?$ZC&7ZBSAPR"[J'NT/9YWL-93KU8W_#9Z@R[G.4*+K#X
MHS-%-XZ5R64.I^"3S.@!CYI`D$F$P-J4%;V'0.<N+?1DVD]GE3B(A;%Y6O0K
MC)O.6ZE3:+#[K^'&,Y]V13K.NO02_`FN5\.@\S2S&(;K[<O/7*N;N[YH?XC-
MV[S`7X`.M<D!LW^`NO;0167TZ)+I^\7S'XW(JC]^4G@_X2)EO7.X[$\\//8S
M6C.24*[B!>V7>LL7!$<7!`<-^>WD#1HR"12DJP1<M.C&X)+X`WT;E+3YQW!N
M!NH*#=@K,$KF.*J-%/@&)1W6:P@B>IT;;*%@HT+<D+$^L7Q:*J-?-^@8KX,O
M!Y=N9BYET24)&=Z3`V]`L4_#JEL")S1!;<!SH(<!(1-D']`4[#,3BP!D21!+
MC>:ZP1H<4PX[/FBAY!,`.ZZ><*_,$OP?EGC%:G??EUGJ.-HNR\$$K(FC"<I&
M@Z0$`8%;#$H&="5]),D4R+B)*0;&#"R&?6FQ_%&H?YU&JJ+8W4Z#7'8EAYFL
M!(K"(Q0Y(A<)D7?3P`$7Q=0V-['-.=S'3V(V;ZLO[C=HVSZTXIZO7'J\<'6W
M;;@K3WCG6CFH*>2Q]I^7?-T$35&%YDHUDV/ML30-*8WV%_AE#E`1SE8G_[Y]
M3SA&D"&]'!C-HSENS3![!8?RJ+.(4W^OC(=#.FOL-Z_J"<!50/&-*0V"GG,_
M-6FM5A9$@0^+\%GXA)/[NJ+;S$%S,2JZUS-%'Z?]=/99U2V@$176`*\'U=5J
M(%!4W36PP^+-2V+:$UG07DRI//F`L>.XT7@US*^<ASJ2)5Y/&>_TC$TN-1,V
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M_S![R?T?")%Q8)`>LL`.%;X8A<ASW%T4HGP0HH_G=G>@D6J8614%*(Q*O-=3
M"?+3NJ_0S"D5BBN8YQ>Z`XTOY(>_=MV<7O/&.^>U"/UIP7%PQC/1&:9?)$W&
M%"D6[AB4@?MF3'4##>")4[[BWZDL6<H,#\+4CVX.--SQ3]^)PM=QEVZI(!+@
MG[?&@Z=*9=.>25(%T5C!#<0FFV6,?Q0]0\G]O()=".[OO%=-<]LV$/TK.#0S
M](RM"B!!D$>/D^DI.=1N#VDNM`1]-"KI(2TG_E/YC7V["_!+4IKVT$-B$0#!
M??OQ]NUM*X2[Y_\WH%WYM0*_[GOR%<Z-H.0-7[7,O@8:`987>E3J^;C4#97(
M8'BY,*?<:YF0+\I-+@W7BSR0H._[`7W(YH4AU6K'=)-.?.<FOLM.?(?8GF6;
M_U?XI$37EX7/L/TOA0]ZX\)DQ.)AX+12E@\-R$7=-75W_`LN???JU5W5$H7;
M;.G06H"0^DSTM'%+8B1=9I/5#-6O9=(9+:>D)AV:K>$N75I9SHPCZ(X2>,8U
MA*Y,1UQ#5B9,,#BEET$*97:QA)<E/H[C@S<SDA6K2$AT/G@$.G998!BY&7'8
MB)G.1R^:%KV*0(,(6(>#<<O2]6]C'C42Y#R5,IFB@ELP%^JSJ(;(&U3\\G+D
MA^T?CSR3FLESR+,A\G,">)"QECJ-"YUFJ/1?Y+%YG*W?5X,*(Q*`\-5PP4\T
M?V),TW+;M4/RT%I>4@W&U:R<-"4[TR?VI#1+HK59IH0,F/HT-*218Y$2)D=N
MY@JC9#[Q:]PE=CK9S#0[G3>I`9[=Y'LQ4F%CL@TQ$R]&0MA\'DZL]$9EYNRN
M&#7;A!=-?LFHN'G!J-+1;1>,.M<0<=@ZY*)DCC@5FJVT!97=TI)2>3M2B3*<
M!H[^\#-GU?LK2V1WHSXT(A25K/BJ%LE8;S<L\?-+[6I9#'']E%2?KD)IYR'C
M%UJCL)>G7!%K;X$L"67+O)</MH8"N/=>\=6JJ=53ZU]@6M(<.P636<RGR2-L
M3/Q";+PA[Q7EQ-)9\J%W]3_Z;Q%;\`AY!2Y)$QDD2<"%#@"/ZQ*=-%/4$LT_
M"!9-K($8@8Z-Z,@!_@V$8`:"&EG8F\-.$`:`67;H919I6Z+@J=955QTP6C4;
MU1Q;]21&&Q8]P6@XJED?5\^=VK;^BZ+A]@T#0;.W=EF./)[V7PLCDUH?VWV]
M5<\[CW\MW,^W.Y)6NT[Y>NW7ZGW5KG;H=]>`",1*/>"T^#]^8IXJ-GZ(`YOX
M#:DM`K&I7IJV>CQXY;^N=E6]]:JMG@%P7Z]:7W7XW';`S8D>16^/8NZR'_0.
M6TQ-FW1Y?QN,C]?E;"LJX`TPOONZ.AS7T3<!`$<4(L:FQ0EF/=B5\46$%@/E
M?EL/6#<'F'*D:S3+V6)DB.O?+P17];R'&+AF:'T6]!CU98P.\PR,N!CWY$MS
M/*S5KGKQR)GF2ZU0!HY0W\?/?/:O@M84BRP%MGF$0\6&+U]![K*`3A.UYX<:
M>4Q<PK86U-3HL9.3<95*6B=_-JV2]9V<\FWU!&B\)+>M^*!:5;+HMTTK&YXW
M.M3FYB`+P1@DTDLC2\?P-8"M)L9UJJK7JMN1RB(_3(Q8#-IW1BGP54G"8!;_
M<J"S+,ACRLFVZ9YY6B&P>;(]R$/-XTB:U"@)V(>T3&1!]E^OB`(H$O&%XZH)
MY^2B&'3>)=<7Y'J^D@#H9"4O'M>^ZUMVE&TH*@B1<1GH`>3#K[>_WS[<?IC2
M=TX42*3'/](<#:E0FBX:<=ZWD-H3?DP=[$6*%:27H_31@[?RP$7-TX[08*)@
M26,3QFO9+Y93`!"[1O:.I&#*1%Z0$TU]?0(4PX;)[*@K1<4]PJD^?@^I!:':
M%"UVP'HSXCB^Z9LZAYNZR#)':Y@KOIMQE0?4+J!V@MJ-9K^`V0EFEXRG1/1)
MRN$Y;,@W8T;A-8.M;X_-0UN]?`^RP;A!QH,5=#3^<G@-B@OE,(>JW0#53".L
M`U8M6#5CT1SA+*+5A);X1%Z0$TT-CKHC32![X?5'>9(SM3R@_KOP$<_W]ETB
MU%N\4\Z\BJ;&D3.EHDN7__=2R8J4_OR@-[,"A'N:-Z>Z;E3_8#)`-$D419B/
M;'[:H(KACE3N8,%@(%#?4*LBE85;F/\,V'+R&+0!A#II`]GI!0([CVC))F.I
M<"VT'+1(FMOT<D_Z(S"W8\9WD*-1BN#>I/WL93.R=15.D7$.L9T\JL=&3N]4
M^"OK7OU6RT%91F(D:W4O#U58DZ:@HA3\>P``&<(P"F5N9'-T<F5A;0UE;F1O
M8FH-,3`P(#`@;V)J#3P\(`TO5'EP92`O4&%G92`-+U!A<F5N="`Q-S0@,"!2
M(`TO4F5S;W5R8V5S(#$P,2`P(%(@#2]#;VYT96YT<R`Q,#(@,"!2(`TO365D
M:6%";W@@6R`P(#`@-C$R(#<Y,B!=(`TO0W)O<$)O>"!;(#`@,"`V,3(@-SDR
M(%T@#2]2;W1A=&4@,"`-/CX@#65N9&]B:@TQ,#$@,"!O8FH-/#P@#2]0<F]C
M4V5T(%L@+U!$1B`O5&5X="!=(`TO1F]N="`\/"`O5%0T(#$X-B`P(%(@+U14
M,3`@,34R(#`@4B`^/B`-+T5X=$=3=&%T92`\/"`O1U,Q(#$Y,2`P(%(@/CX@
M#2]#;VQO<E-P86-E(#P\("]#<S8@,3@W(#`@4B`^/B`-/CX@#65N9&]B:@TQ
M,#(@,"!O8FH-/#P@+TQE;F=T:"`U-34U("]&:6QT97(@+T9L871E1&5C;V1E
M(#X^(`US=')E86T-"DB)K%?;CMM&$GV?KV@$,$PM))K=O#]./!LC`6($.TH>
MXN2!(EL2=VE2RXO'DX_*-Z9NI$AI,O8.%@.,V-W5U=UU.77JV^W-F^TV4%IM
M]S?:<SVC//CC+]^+5!Q$;IBH[<>;-V^[2.4=K7NJR^N;-^_NM3IT-Y[:YOCO
MX<91J^V_;S:>FZ2)49O8<Z,DB=3V3E8\UT]#6`#U'DWCAX_;'3^DK<:X20A3
M4>J&)DI1AJ11/"=QH_&D#TY_7&U\-W*L^K[FK]ZV\I7U9<-?X\3*<[53J1T/
M!_[I5J`[=DH1LEVG.GO@P<<5&"%Q[*B[6ZL3?[:KC7%3I\RM&G?FK<TZVTUC
M=;[<S_7J]^T/-R9PPS1)P'+R:GXV?FE#IBM[6ZC[/NM!3U87H,(JN]_;O.]4
MLT?C:.WZ6@=G'3J<+/_!4?NFM>7*AZL=:I4/;6OK_'$%YSHJ/V;UP7:N4G29
MC1^ZJ08/;[2KHSB>]*6HC^T=L-:[H2U!A^_4!]73![P,=L'+%L/66@4F\V&F
MJ66E4[8NX%$_PC`!%Q@T7GY4OEXKXVEOS;>!`-2>1"!X/0C2V0N3<VS=_M&<
M>K3#.6(C-T@H'.G#I.!-%9L8HL[3&+,4F<Z?9+R+X#9IZ$8&I'U7C])XX.06
MSXA=F].Q![/&SC&KZ!?>:3!L:)"OC*.ZH3O9NN.9IEXKV8"VB<%4;U<8#`T/
M9?N)1UG]2-9ZO8K!2)WL;$ZB78Y4>=;NFEHFQ8N0*[Z.@RLO)F<O^OR&K#X^
MDA.*%N)4H4>-4Q_Y=\<_/?VG.QJG75,,7OHG==,HT+,@CF;N^?7V7^]NG_6/
ME\)%5:PA^I(ON4<'KI>`K,:=HW.NXY.]0^$&IL)?B4*.VIR"[NR?@.(3'J?R
M1@1W',`2Y3S(6.4HCZDET@,?<BG0[-6N7:CXHQ%)NL'B4H7E!)^I&%.']\B/
MY,<&3*'C-+KTLQ=.",*V.#4=8D@&P.WZK_B%&N!@AX`5`LS!8I=5A%.,6"KK
MZ`@=NSI(XYEC`W(-Z&IM-U0]/A`!23:6@`99GMM3G]4`@[`H?I\2.7*]6*<O
MC90@,"[DI@<12<[?G-_K_*F>BI<@2%Q(A2A-W?@<+U,NAV,>%(K2+P"_8/:U
M_[&]ZHY9:T=DC!FG+W/J`A:<0U;6'<;%Y<LA05,O>"&":1_*'[["2-%])D,T
M7#6.%!183)3QQ6PCE^MPZ&H3QHNWL%NE%H>I?Q54EV7IG@+FVL.^"T`]@P(S
M*T6_8%`'8*./S><10IY^;^2Y!MX`U5Y_&;)U!`]*0#HX`_S3>#>B@A%4,)Q@
MQF&H0U2`JM@UO#8PYO$&ED",:(96L8#-"H%,"/MZ+K=!!A'*H&8]6+)G(I]X
MUJJ]G-:TS7\'V2$W:&JKBG8XK-5"$R=IH:`L!J\D0%/7I.DUYL^9`"4^4A0J
M,:$#T5U074D9WN'IQO/2->3VOJ)IO#'^,GV`5WYJ>&$0358=VN:!A8ZB`Y/I
MU/(6Y$*\EQ>%$`'A^)%"H?G,RW)>\SG+1_F+$N,#8B6&XPH1<)$M8&MPL3>Q
M0AU,K#`]LT(\T");PX\6B1@4:^1S8(E'XF@4G8MU6_"PM++<K[0SR5X5P@TD
M:I"$EVYX61)XD,@J"L(1N9[)`'`&D!:HP0*,9(3X'/_"63B.-!!<C>6OH@%/
MY5`'+1<?S>'@.^J6)7*H9#LD"D`XOET%5+L"AR<L?;?J/C_:EE5!G/P$T$FI
MI458W;X;6>;,7$:[2>*9F>>\^`R+[__YR^W[V[?/`:,?1ZYOOLY(?@+6"2Z,
M9/392-$2)$(!B9!!@K,Y))!(%M0AQ$K/'QVR/@2(NJDW4CF@78C,`E#YN*D*
M:3D8JG1+[0GZQ"`AX`$V*1$T*5G-X[[<E/*YKS(JYL04--$*E.U%#82UZ*#F
M).`&1SL'_E&_.=^\O[_]_NZ;WU90LT12FA2B\I"NO6BVW*]`<D)U\9YI#83F
M8VTX90ON0]"PF-D+&1*>(S_,C48>1$0$VK0PG!,1,UF/L!U=D'5=DY<9<IV'
MLC\"-^ZS-LM[+GH^A";0XJO"EDP5/"9%W=`>;/L(T?IW)2YV@;%&+P]:#:49
M$AMI^A<3._4IL8&()>?$CLXV%XH',&P?%-3!\!4:F,T+60<V9%P.N#$;!V-;
MQDW9LB4+R?[^HB53S2?;+K5UY#3*?W#VB9+?:0IBA',YX:H&K!]?6?^ZK>+*
M$8]-4:NX#;(9M![%8,<^B%>5]$QP8:)LW!,Q;P,F1L.:1;NU>C@VW#793MHG
M)MRM;$0MO$>:J],`-LBD?0-4.V4LR/\M'EIWRYY.)-2#A2M`?1UR6ZC%1:3&
MCN_,Q4+;?\#C%X)2*^F*U73!H0:@[2Y49D51SFXV]IM3D]@,-:_(H5B!QU.]
M<^PR@W8#/];7<#655"TE]2<"$XBE3CX0>RBS?:J3@(2,0P'V"R<11AR"&\H"
M,"E[F.^N5&?[OK((.F#A"X7<H/&8)$2K[<M^TB@?>SX):MBX0Q2]7D58`E65
M#8OYG$X[BD8:%-/U#_/I>CYHRUQ]6DQTY?+`K[[1;F&C3%:+IVYT13RNW38C
M0N3=;;-KLSO[^5EHPG0*5!CY(]X\1SIB-XI4&*8CCCT!IU).H9)2JD*"Y5/I
MQ*I94_OX<UTB:M_W`-Z`N+7Z(:N'C`N.9F+K_6W+!46.4,I+`;._RRID*\@_
M\,ZI&\7>O&Q<M#$?N&Z"L7,[]&6>51T3_(.M+7I6:C@`JXG2*^L*^IZ8[0"9
M.>N!5^ZZLBB!6D+45EW#JL`&B8G\V7.6O:@#48D97F#,R1T`>LE8UY4(M'FA
MG\ZT_8_^]B/0`/X.S=<T6GX4N5#XPB!>-EK7'&#D4+YPJ*FT<_7/J<#/.116
MHLGQ+6)^"DBY%ON;].GHIF#[X(CO[X9V:L>DRQM[K,5P+'[48,G*O``2T$(9
MG!?`M:+N"??L6,NB(X.=G724EO8R;[BDNRFPU"!XN;L"B#%X=!AX.'K>68$&
M4%$AA&Z:_-\]A35)4@-F`NT_VWA^EW%[A\K0YJ]7"1B(PYL7.,:Y!ZR?,AT\
M''JYJTC_*JL9(*T&PM8D7VX2#`BAA4T@3<+4&N13OT!F(R".',M56D9*\V_,
M/RX"N79D\A4`.'#@`X^J%<)%PX,=_V0D456`&">>H5*0<I>*Z-*6U2.16U[F
M-@#.'2<02F6IGR[%L+I6<M@G$:7#VME68G1X#"^-S`VP+XF2*]Z<3L!%[8N#
M#)#IGZ3C]EAVJA`#`1?:5S;'2Z'50S=)C9GA\F1@+V4J@F6!L9""K2B[OBUW
M@*T,ZVF8:-[^`2/F5)YL5=96[<NJPCMP'7B]BJFP7B*IE!T!%[A,Z%U'<'S.
M%:D5/;6WA"+^&46TH(A>HDA$*!+,4(0+U-"*L&W'[:U=JX5N.Z(-,1SJZ]IL
M5Y&():U"N'$WMU2:H<AG?@GVHKD"&E'63`Y@!;G,7!RY'WB=_RN[WT^28T(B
M73S#UJS_0':9L*J(;E^/"9V@>WBYX65U(5S-%X$W"S5.'*3.$TC`$!8:(-2\
MO5OAK9'4R^K8GF)5\)YQXE^L5\MNW,@5W?LKN!@!%""UFV]R:6<,)XO!&)8'
M"1!O2NSJ;L(-LH=D2Z/YD_Q$OC'G/HI/6;:#V4C->MZZCW/./9)U\B[UV\4N
M7"BSC?ISX:;.8O_.^QTT)3.P>$SZ?U[?IH!_.6ZV<WF.)I\8O%+;D1AK_S@+
MS[1&B$J^*(6G]./=V;/,6T=2L(H3`:89[[?-W8:[EY&@E/B0%D);0GG3%3ME
MS4;O6+$9F"&>BJL?%A\1Y)D7YX%CJ!>41XR^%)R698[X5&&6@^K$I3=<U57=
M2YZH9J+FB'Y#DSD<T$3J6$_=A@")(DMG`##(Q$0"00CM/UU'OO0?(AMC[C^&
M[@/*W]-Q0O+,?T)-\3AC+,,J=;0M([//4VC_FN&#T1Y70$IPWT=CO)3IP$WS
M^KW\KO"&O=R]C@_*(IE)S1^-3Q(08<;9=L:%B83)>S9.2;Z)$*<T<51+G)D,
M1:AP4;&^P_NVR#/65QM7#^DF@T9:QV)L4+$I2HHU7N=CJ6OUO)?4;NY5FCVG
MT4CLZZ#9#?)1UTU7MP=2I;D_H!!-$0IE_LU:KN0+N1).]=`'KL0"'5YS<CN?
M5RY%OLE1(G'Z[78LVD8<K3B<M&/AZ!-I+T2Y+;H(L&D8?,O6G7EZT=8H@9'A
MRM;_/-](1*2RYK:*9'2*E*3@474CMXY001,1Z76-S%T(G1)?-C@%";$#X7&:
MC-6R#$B/FZ^\V:"GM^F2L>?8)L6ZY_O+90$E/XDE7DL)!8I\-)T[19;/^$D8
M^HE;%6]WL9XC+*9`(&623I7R-)Q"?O3<UI1SI[WL%*&0UG:E:O;S<X[W-&+R
MUW*HI'!PHH;1R.@7*ULGO80S?>GR<,!Y+6R#\-(5Y$QD+[N"ZI1^[\2&U)>_
M,B@V4-I`C.I34WEJ+D]-Y:D0OY!,[7RDK;VC9>M37W9V9\@WRW'3?`':1F&D
MO=V0'N60,V0V"_+0]0R>J'<8Q;X5T*?`GV68.`2PTU<&'8&(]]#?[SO;>_?R
M\01/YMI1A$(/B:\+'^DK]47=._:^=59^T\/-15S0R7MW=NFDWVJ9Z2=>WJ'5
MD*CH:`</C<IQ@>/@R2@+5J8$@RG:H=YQ/!.^(U?0[GFDXK\EC[_FWQQ1I%BG
M>R:2,:':\KUJNDZ;-T*EY&H^Y<F>HWS9X9-CC2)$_S(IL37W##@0*@Z$<QS(
M5'%-<<!KH)I5=1U%=6E7%@TTY(1_Z$NSI7%%(H3IFA,'7ZJ,(4E(V-B=T1\R
M%A`,3%HBSO*8RRKC&H6\@+[M!]'D')!'N9,6<ZWD]Q3U#Y!9E.'B8>1TTT&$
M/2@91&DRT26CF0&'W+?(]ZK>GRZVIAY`*H/>.N>MVPA`LHW256N:CIGVMW]\
M^/CKS^_^]9+."?`<)J7XVT(T0+=8Q%B[G0K18O!S*OG-#NLNW=G6U'#"(9_]
MA?50LL6$=+]F]$(0)-OO-C5,XKFIOC?W`F1=@IB-)D1#')39*JA0R-5#U?6`
M.S0$K=E9EKA(W_8+Q>2M>;*<$Y2C<9*\7!3>F_<W*K<DB4LXR"X[C3>R`NGI
MW:OH>LL,)R4C0ZK*M``BF)3$R;J1TI?<E4>IFX#DW8>C:6?T"KLVGZ^7*J[8
M!'$Q;7"*\44*3LAT%D@1Q!P2_64UMTTW`712I')Z`HC/!S"0O(SSB9A6$:]E
MPR;4"G=P4W=N#;DG'H@^9Y3,I<N5`78S1,;!Z)1^<^WG[)'`\3.="6=9;[Y4
M5<NJY0@6I1VNE&3\'8Z*TU`4Y<Q3SSLI3E%(2Q\M.(2?6N/]II8.`HUGG`9K
M[@E%@5;UKBJ-@\6?;>G(_Q[P3!#*H.BR?J1]UXJ60WN*N\\XR-;HTU+OR9J6
M@<P<T/8!5D\['$AG$?3RZY)-LHV^7I*@E5-E]W2&*!DTM9`'MCT`;]IC50-D
M(7X?CQ5H19K;_'EF&`YV%4(9E'&R9/X7"G/F6QE[XOSVS&ZG*91)"F724-$W
MBA',?&B;1YD_ROSF!\E_.R1WH,E-^JH\FOI@'4,U^--Z9ZE@8GY3V@O@UIRZ
MUZV]-SVXXH1HPZ_"5<AFW/45/2RN)TX%G2H[FRDGWZ"05+BJXC6,A(TG7#KH
MJB1'Z%?PD[H'A8'3!?N3+9$.K-I246V%J+:45%NDF@U59OJ^K>[EXR+_>A8[
M1@=/T"6Z4]5DZC2-CG:]Z6=;F]FU3T!W/8OD9N!#%9SL@XQ8'CFI(!U,T*V=
M?AJ]MQ]-<0_0KL%]F9.;*`E1X`EG#!R\):@Y6?5*)5KO1$4H(WK+#5T>^&->
M/:=R5'940'IDQJGZ4VH91</V'$AFU:IT+"L=0"57<[I)TGS2.VVSX>Q<T18R
MZ-`:WHUVC;N78W6@G-1$"7S]1T=3HP<![VEF`C/?"*=VEU-/%AW9+8-#6MVK
M>>4,6M;)V%HPLR(1P-$G,U5R$.B])45.]P(2%&#`@$66KG2'JAA&F+(YU-6?
MV(NG/E2D7SK$MC>GBD^`*6$RJ:=UT<+O/R6>EF=U.I%5A')`D(I,'/V!*RI7
MQFUUHG3$*^S0$";?V:Y(O]%H/_<+\[SV)-*FE$8;F:]#DF:3.,2_NQ"F`MXP
M\^[3JPQT'&TWF1=%FSCT;EE3M?;5_M7;3VN1N$UH44BB9,)?`LBPL,C#Z9/F
MUR^UY/M3<P^'#2*XN;10EF*<:V\(>NVCA^!F5U2&."Y$027IA$K63O-^RO`L
MU]=*F#1Y^J/V+S0%(3&V+@MP'-J/L%C'R5&+%D8F")HI@LZ(A,`4Q4%P;_=[
M6\HLO7=O'IK6W(\\X]D_E!%:T^NH`CTY=GSP2BEU<Q7CNK^#B"=RLRH>_6&O
MI<:G7N>)TJT<V\N<VDNB2?0'5TX:W:I-R_R=,M"[/THZK/`OG*H%54_//X["
M-Q./%.*1IK6R]%"/SMCK*;KPHF0E7[(<A7S#+Q%_(9/3+'C186M'?)\3'IN+
M3`(<S8-]WN]0)A-/J37?+/6_2R$SXHI]J98ZVR>SM2"!P$)+'U#Z37F1Y8:7
MM]YT,]H0.,=T`$H9EK\T4AHYQ[2F['44J/\@5\WNL`B-#,SL4#,GGDK94\#Y
MSS[$FD#4<6Y\*9LN.SLX/56GXRC[^T5&SEJEMI9SP9!;"H&#.7]G'ZK2"E/M
MJN[<=*@FJ[8PHJ-ZPV#*"4L,ZKO/UW!.63:7FM#925;T&!`8=>^5E[:U=?DD
M$O"(J"K8Z='3J*Z48%:D:XA?<OH=/]SQ]1#JF+P5<A!B"4(T!#KF0&<:Z('J
M$>CI5I>-0;:)KJ83GAQZI-]V^.#*`;;F:?ARJROX&5%;6TM[.X(H/C-M9J=P
MZI$P\70QO84N[HP>(PTO:U5>`<$J/VI9.D)."L6_<F@ZFJC5K9C+`!0S_,0"
M/K'<#H]1/W8U0G#,1B"Y%)'B"1[%#HT<N*2H9W61W/=#,*58*-,RVU)FYT-X
M"_9@J.$MV#0XHU-4<`.=`Z/"@=$`.&SAQ$__]F>W#IFQ%4A_+Z<H3Q3^ZB+E
M";-[,'6I%(?9\E@WNO7PY+R3!6'Z(CDOP6D!#FI;7`!$YU.>X,!1ONS\<T[K
M,N/2<O`+V[;(GS`<\R<3$W^Y3@A6KZD;F*4Q(0T[/2;%)4XG8*B].-ILK[S'
MBF=Z_GML+O+#TV^),J4>7B;N2J&JBN(K+=Q$(+A0_)6,.3*46C%+F+O_)P5B
MJN-YTB*^;=-9<@T-SP2`]Z![+]J(PIMFEJF=(/)<-;#5KS]]0D!0\/M78;Z!
M1IOR/8.L_Z9LG^Z:/6$Q5L>R."5]2XJ6?T0%$B7UB@2X-^K9_S)\+[1O5.2;
M)/<*`#$O%9"?F+'=A`GB-UH1\6$?[=VG7S^^9$0<)=]K1!QO9T;<SCN=4`'0
MT[Y3.]E37[F.E+1UY1K;UKA1M]"TFA3H#/XW`)O92*$*96YD<W1R96%M#65N
M9&]B:@TQ,#,@,"!O8FH-/#P@#2]4>7!E("]086=E(`TO4&%R96YT(#$W-"`P
M(%(@#2]297-O=7)C97,@,3`T(#`@4B`-+T-O;G1E;G1S(#$P-2`P(%(@#2]-
M961I84)O>"!;(#`@,"`V,3(@-SDR(%T@#2]#<F]P0F]X(%L@,"`P(#8Q,B`W
M.3(@72`-+U)O=&%T92`P(`T^/B`-96YD;V)J#3$P-"`P(&]B:@T\/"`-+U!R
M;V-3970@6R`O4$1&("]497AT(%T@#2]&;VYT(#P\("]45#0@,3@V(#`@4B`O
M5%0Q,"`Q-3(@,"!2("]45#$R(#$U,R`P(%(@/CX@#2]%>'1'4W1A=&4@/#P@
M+T=3,2`Q.3$@,"!2(#X^(`TO0V]L;W)3<&%C92`\/"`O0W,V(#$X-R`P(%(@
M/CX@#3X^(`UE;F1O8FH-,3`U(#`@;V)J#3P\("],96YG=&@@,S8Q-"`O1FEL
M=&5R("]&;&%T941E8V]D92`^/B`-<W1R96%M#0I(B:172V_<1A*^ZU?T(<+V
M+"R:;+Z/B3<($NPB"VA\,O;0XO0,QQZ3"A]2]*?R&[=>))LS8]GKA0`-N[NZ
MNIY?5?VTO7F[W28J4MO]310&H5$A_/%7'&8J3[(@+=3V\\W;=WVFJI[.0]57
MS<W;7^XC=>AO0K6M\-_SC5:;[<>;NS`HRL*HNSP,LJ+(U/8?<A(&<9G"`;`/
M:1L_8KRNXXRN&A,4*6QE99":K)QHHH3>@*\PPH<^Z-,F#@KM-B:(=-.K@9;U
MYBX*,FUYI:JVZUS%BUX]=JY_>-DD0:+;QR-M6F6;G>+OAN]6G;.]VRF[:Q_Y
M)A^WC9++JA^[@VOAT7:_?M>IS7^VOZ%%HY!-:HJ@"$T"!IL4B19C_5AU+_?M
M'O5>G)`%24$6IH^X-$&<J#PN@YB\0+;6?^&="W>5>6#`8W$2%$3+-O>D"0.3
M1BD+H[=M=ZS4^G$3)%%I%FG9-R2W(9&/S=#9MAI/ME,GAW:O[3#9N6?OQVD0
MQ5&NP"11EN?(BQP>9;/J'[3MA^-A<Y>`U3YO2G3%!HA*/1Q[7@=DRB@.2C8'
M?T40'QG8P\1!5&`H3!91URQ2@`U5'D5HR=D>V[_/"E6SDBC2?8LQE9&_,[U#
MEU(,-?U`.W83@8`-+U0U@LY-A2%A("0LWW5$TZM#USXS83WQL9\WD:$@V7>M
M?"OY;9E('E*M7'7=1,!O?VP[B.)V-U:3$)8_W`&<N1+@F9<K&7BK$8%61VYF
M93L[<<?<("\`21+GD>_1)98_Z"=DG-);J>Z0H=&N[1QO\"&]6FHR4PKV<@?2
M+-6N8;)^$^E`J7NA0#TP:27%4A:TU*YWE'_,M9KX+59A3N``]ZSZDR?!H>9C
MWD._`=G>]KP+IH8,M[.[4S)YH44ZW]UP[<'VS+17*_7.9&7K2<"%Q1QP.0?<
MK\W@NL8.Q[:Q)_4P]L?&]?UL&X.V4;O1J:'E@*K1'(^UK5IB;"+&V25=2W8(
M(U3WHHZ-<L0K!@4/Q^:@9(7*9;K[!#ZB-(N"V)2QQVG&VXCP5O=O@-F,C57E
M'@?;5`X%XJ2/`V/R]'J(3!R!C]T]X;V=&EQ5-^VI/;Q,SF/X`/&2)(X\Q#2L
M%$;C*AM0>M77MG-B'0X?1T&#%F#5TJ#(C*]:-HM4LA^.$$;J<+)C17E)[&.]
MB#6T@SVA\7Z(20)]/)W`9Y(;`/%QF"87FL^OI&S`\:%W?XSH4G#G4#OUFVU&
M"TXR(>"SK4CY.,A-D@E"_S$>^R-&!RKT^^/0@KW4/P<D+`'IR]13*I^?*^BY
M7:">'5@&G'8:=V!O"(6A/O:8YX@6+V`L]AQ$49I"I?7E/ROH7X3,+:BQ0A6.
MD/6>ZMQ^!A4^>9I0YQPW]X!P9\"T6G;.S9@I2%SWRC6HX;\H-R4VJEK%T1NV
M+;POKX@00/P^N`^^`;7!\"8/XMO7<9`BZL[O3ACB.8@@VL<I1C<)LTX(7=^H
M=L0M`)-$[U#5^=BI]PWNXA8V.;'>J7M<6,Y8`ZU5DN42`?RH@R3=VZ>VLP^H
M5TD7H3B!4=V1-@Z`!W]6M6T.4(68AE$3?O'=E%NG4C,Y8"&%"<>YO'@>)^L0
MF1N&T+!0[\B>P&DDO^6(M#\CC`(DJ7=26`TXEE[Y>7N3&Y66,13N`A_$7A&J
M=^=N]C<_;2\J?)12/Y"6B=3XBUZT",(D7T6W]`K777DA_^]C!]@`<N:Z?;#\
M057"T\=-^E0(1KU0@?41-I'V2!M0F,`=`WWS#F`*1%C%H9QK3!)RKH%>IV#?
MWDT8PF*)5-A\;>ZXV@$%M0+X=,N;IY%_`3SX8TW\1MEN..Z/U1&`;W"VZR$:
MF6+'/TKN#909-2_<!AI(#>;PE\WJ#/A)M(!##+;Z:_N>XQ0$[8N8;8);O]!@
MTW>+>/F#,1$G?C2A+P&:E%AH!PF#EZ*1>KWF4,^P@3$]+(AA?9Q`5PG1HR1#
MAX4*7H_*9-(KOHKV7'FG\H*/2J%="^M)$G]1DK"$I$-D=?N]FR(B"<HDC%X!
M?`RD*?G=DN4=P'WO6?1PPBC&&.4ZR25`N'\U&5I(AE=C?^G#IG"'.<;<@D(_
M_UEQ6HR[.?:9CA`/>$WZ4H;!6$1ZIY"^4>DY]A)K!=^2<W1+"-L21C8"SD0C
M&<B/P-M1HD[HVDLBDFK8+4W^%@'.37,QCSH>#B_L4)`=H!(\MR//K#M5VR=W
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M+?=!F&$9`=USC7L5$<!05-%TAH9.V)J)_M9>"G:PQ_E1/;;=`A`\=OH,L%TD
MS;4`Q$4_1UUF0CUFHBFNO/N=\Y"H(_[S;,@J(P7ZTY(_.3)\#W?]WS:081(R
M3ZYA\E;"C(EZ);L2:U/-XR7@4M-VLL?O\`O*?^C)\0J3,]%?J(FK5WA5\\H)
M,SE\?HWW.C'.V+R64=B64QJ]AFS?!VK0&=$V0]$>&Z92%A51\C>C"W,0T*`^
MZ@KP7P5Z*+F9(/T9Y(C>WP[O4ED+J:S%5%D]GC`NWB[EM=#_ZSB#O<5W%-F+
M`CL9F&G(N+E>4AF_+",9,,O]LE\N,B4LTXE0GI`F7ML>-]#VA13=A#)>BBXN
M"+EB#?1/V&2F07(+EU=G5I9\&Y$'@9>G.GQ6$(W%/#=@@<)^T(R41I#2>$AI
MV#5&DT"&/0JKAU9.U8I*`(R&!_R/%DT%Q&!I99?Q^=?&)^H:.>7[;6-9IKE@
MI&E6^I.&E(F'L6?8;P3#^U[U[C!A?L,`CU;.M(>?7K40#/7+`!\)#[+^Q`]D
M!>AF<B%CWFHW>N6#A#VWMIDS.Y9^OV7@P\D2QY?NDQM47V-?1@ZH9_A]N]U"
M6P!!OL?),IV'KB4-!)WO7WHJ&(V;[B5\+<.Y$^=1^C!A$1292B)H:)=Q5/]%
M`^?9Z&I`<R!*PCPP1,MXY8D$$U4*38;G'!))OS\-G15:$<.P2<(OM^Y*NN^'
MCMOORLK0N73PNZY][.=^\2[*@C0KRM<ZQNL`$A;SX_F,M6X&@!8F(7^,,#Q&
MG(V!R\S"D0K!;#(/$7CB`KT*;)EI1$S5]PQ=<W"567*)A<6".Q)=<S<YH8%9
M(S%E_$[R^G">R`EBC2`QY>$"K;`B<)T&OLP4OD<O"M@"P@3^`NVCM+9^%9O!
M^$J]:Z54K%Q2S)-=LG1O(I%G(9#A_QEV(.INI1/&IP>OL#9^G0+?Y^`<SQ;1
M;`LI!M0`-M7+!"``%?Q:N?359*A4<PU,L45C.,9%S;3KFV(R(*5BPB:K1MZS
M\X0HTGV]BCY-32AWMM1'4LO*P`V-58,PV[F3%$BNG/NEL)%Y4_UZW^/EYY4*
MOZ",$92ATSQ>TG?&CHBP0_\"`UJO_MVU^^.@UKCC\4_3JR+\E_%J:6X3!L+W
M_@J.[HQ#S!ONZ2]H>NI)!MG6#`,NPDWR[[LOR3P<FI.-L5:KU>[W.*S0H?*7
MEW-=./Z5X_NQ#P!_9+*C?1)7CX:;VP,46EQ&6Z,R`X'R`0@LAAK_A-M&2>76
MR+;^SI,\2S8=X4/7-SGJQ.,],H)-H*`M4/W53NMC_W%+?J;WBP*%WJ:LGCWZ
MFE18$W[C"T/3SS;A88FJW=W#P.'CZ-[P<K%%SNFD/%.HI%TAOMK!3KZO)O[E
M-AB$USG`9Y\!/(B\+)8>N6/X/E#-7]756A9#I9%X"!BATDSV$6#*H9@H`Z9A
MU\N8#`XM"B#,R()4H'@DW>F+&4?(YF:QF;F!DB@\Y-D#;I4N(@FF81G`L!T-
M1&%UK0/5MOV;.K9`UQI!`9K2RI60I[)$M4)]M6KKFU-Z991.,'0YY2"H%0;#
M)E-U/=P@XZ'_4.UHM"64-C80RH'H/JN"LO(D2IO\=^(';6\MU@0B*6#N=#'<
MJFD,)0,%.T_1H;G?^E4[HBQ@%B?3O]*#@^D;X9E!SY2AZ3`:[\!W?0C+#-;=
MR^2Q)!(LD4SH\"7%B7;#&0Z"#`/D`J?"].2>H>W*O%Q5Q.<848X[5@3$,&!$
M:NUAT%\E.(!1D^9*P[(JXRVX(V=`9"K.%.A?8$SH]7923B\,WC1"$H:K`-E&
MR;3C,Y\OI5L;(%N#85MUO;H;L1KL+$X3]LEPAMQ!V=";DQDL4\=3G(=X14OD
M+.[@(>WXYZ;$4<`00%T0.(@GO^8B;##S+Q-S&#&QIWZ%#20`KWC?!V\7_EK3
M^XN80[^IDD<.@J(#9/2;!BG4GTY6RR9'>;$P0;RHYT=+5\X-Z(+3GM!1L_0=
M]0@>KJ?7.HD]]L=!R6A^U*9[;O2[>];C1=F^0[TEOQR_/X%^@4'@BR_"[#`5
MV2LESQCA1;KC`@"[L^XTM"Z'QE^N&!HT[^A'>>6YBC"ILG4K4X^]XCE>0`[/
M!,?<;Z5YC!]16859BKVYZ;C2O`@A3)F%!_GS;H__6\:L0$_,8HK9688K@$+G
M\5RE:E\].$AC8+A1G?(PTQ0D55@6Z;:`8%N`G`RV8")P@=/UNR#QH,:I'-C+
M@##_"^^5AS+=(B^G-P9]!"CW=[JCR=4=``4]:E+VW8@]YD(3>W^&$K]WO\*?
M87#1P"$7,@J`D/U`C0="H-5G8YES0L<?%2>[K0?XRX_7;_\$&`!)HCZ."F5N
M9'-T<F5A;0UE;F1O8FH-,3`V(#`@;V)J#3P\(`TO5'EP92`O4&%G92`-+U!A
M<F5N="`Q-S0@,"!2(`TO4F5S;W5R8V5S(#$P-R`P(%(@#2]#;VYT96YT<R`Q
M,#@@,"!2(`TO365D:6%";W@@6R`P(#`@-C$R(#<Y,B!=(`TO0W)O<$)O>"!;
M(#`@,"`V,3(@-SDR(%T@#2]2;W1A=&4@,"`-/CX@#65N9&]B:@TQ,#<@,"!O
M8FH-/#P@#2]0<F]C4V5T(%L@+U!$1B`O5&5X="!=(`TO1F]N="`\/"`O5%0T
M(#$X-B`P(%(@+U14,3(@,34S(#`@4B`^/B`-+T5X=$=3=&%T92`\/"`O1U,Q
M(#$Y,2`P(%(@/CX@#2]#;VQO<E-P86-E(#P\("]#<S8@,3@W(#`@4B`^/B`-
M/CX@#65N9&]B:@TQ,#@@,"!O8FH-/#P@+TQE;F=T:"`S-30V("]&:6QT97(@
M+T9L871E1&5C;V1E(#X^(`US=')E86T-"DB)K%?;<N.X$7WW5^#!4Z%2%H<7
M\?8XDTQ2NU6[4Q4K3]X\0!0L,^&2"D'9X_GZ]`TD1/DRJ=J:&ID$0*#[=/?I
M@\_;JX_;[4;%:GM_%4=AE*@(_O%3&N6JV.1A5JKM[U<?_V)S55N:CY2MNZN/
M?[^-U<%>16I;X\_35:!6VW]?K:.PK,I$K8LHS,LR5]N_RDP4IE4&$[!]1,/X
MD.+G05K@`C`F3MB:=9*$90:S>15F2>Q6QQLZ#9ZB&(^\"[X>S:#'51J604._
MW2H*B^"@OL!;$7P[FLX:J]3J7]N??6_#35K$:AV'<985M/W"#[`VJU):D1>%
M,R":#(C%@%O3MDUWN%$'TX$IK=+=7NG][ZLX)IL2M*FQ(UC9/!IEG$5-5P]&
M6[-GT\#?"'`#<)VKDZ<9'[0)DP]J[-7UIDH4;)^$FZ"!L_L.]E+C@X'_@S%N
MJN_&!ZM,MX<3?M%#_<#GK!,`J<R3I6-Q.IV7\'EI?*.2*([4_=#3GD4`9Q=R
M=N&=G411=:..0R,S>FC:9[4_&33WOA],<^C`<?8S@ZQ(<O9S[2(ID.9\<OV@
MNX-1#6&8!D==CQ;VU\/8Z+9]IGTP2>/$@RN9[$\YB/W]O36CVCVK5A^/$"+"
M"&WE/$W!DFJ3^T#@R<,!@@-&*ZT&LS_5HS@)0[4)E?K)^?O$P1P:T^%^21P6
MY68S6P3G.(N<7Q`*M*'IUOA=OU=U;T<+EJKKBF%-':PO6"#QDW.6\5OX?Q<\
M]?]Q-D..0C7D`?\V].NE++W/>9O,:_B/'>D/UYF;>URM,<&]C-Z;>N`8;\(T
M@=HA*.X"SG)MP1]PNS8=;Z-7<5@%$&=PWXH1AL:LXA4]'Z&2,LP_3&D(IJ8Q
M#HB-LDC0D:.7Z.2(SMHG#@PB0/.I76V"$?X_]*?#@Z(GW'$3&.OY-O3PUL!D
MQY-4&3=JCT.VQM\C3^!VWCK#,7:P%)@+T>MLQDE0`C9)&`>=/A@9,#S`1`=;
MRM/0M_27?WG17O$<N0&0,BT.RM$CC3+WR,J>QY2_RZ/A-[O"$E0[>96E3S/<
MY-*2)<O)L8**$>(+(!Z&_FE\`-"I`#T*=I\N*'C[YVF/>MH78?H'Q(8H#7-V
M;\#6_DA`Q0%DUTL<&V=AB>SIN#;+H#Q?YUIU'>?5@F1_"Z`D*]R&$];8WU9O
M,._$ME597J1C.:>C5*M/U`OF3<,$#0*JDI=S@Y@.JS#:Q-5;['-AN%3`EAA)
M$@*&A]?`30E<]LN=MW3L',A@KA]SQ'V[$9F`\K?I3O#<=(^&DB'C=CO;/_6C
M6/J1':D?%$@24`E*UU"45AV!LF5"U^8T-K5N;Y0]#0=\8G-A][S(O<J[3"ET
M%LRR)Y='@S+/1M5Z,-#9>J1A!7W>V%"TQ!I(*`*;WR?BK6L[@@:BW9XPW->Y
M<GS+(84`87-@H\LPW<0^)`ECZG4.[!)3C\!\5T_]@+1/F&Z\5NLRH9ZR`[:B
MYO!F_+E3IB`(+SO.!7M1LC!-'!UO.<J:,D$+K_0+0N)A@J5?:CKT#:#I3X/Z
M<LLEG(9Q?":7+AG^,WQ;!9]6J$B#K0&/=LC,/7(\OB%5(]&FP:['\V!JP`6&
MQD!QZ/J_)QP8,%$][K\U1]H#RS'80:90)4T%3X9Y8*40QZ3TN.TU^GLA1'?!
M)T02+!N;[WJ<<F0$A=3LVC..0VT(JI363^)L$I=)5;VNEH#Q%C26OR`@'2_=
M^+WXNECD\(3#)G_!/RGFAM0Y`5H$9TSD3TA2:NJ^G@S5\@"HT'+^Z+OVWQBI
MUANI)0$[[I`%)D'7\XK^\+S:8*,;#`]`8@2R"I[<%[T8_.7V,XF/3_@>4W*Y
M=,%EG#"^AP2*]+.XFE-UXRX1F%'(L$3Q<U;=D+E?9;9'<_%ARDUXENR$IXZM
M43_K[J0'=*ABH1(*#?YHQWWAFB6:`LRZJ$Y0UE-U(R&=RX_S5\PO1\E9F7L%
MG,R@2!,F**B=@B<@RZ9D),>P<@%IOUU.38;6&SXG7YP3%_-!DHQ[I`+D_!6V
M[X/F-T(>R0*>T6_2<?AB*4GP2=,'H_<Q)@J^4:*D3I4"@>9Q="D#L@G^.TJV
MBF'*`#7=\4!#OS5LGLCSD9=HGD>!R=<ER';1A97H0HC^GK^Q]<E:2<J*\R0+
M5-?+'@K:##_V,N5HH\@A&F_0!@OU!W<7``/VF`C<2WO_OK'G-7*'@!7WHM]U
M5S?>A4!N(W+G<,N%8MS=`57I'"$R`2(DS"-6+\&^C+L7T?.HV=/QB-Q":?")
M8PT._6E50A2LVO5ZV"/>*/]A:C"U?#]8Q4.=[,1O<LJ*5+9YE`0[:1[G-<Q7
MO_:/>O"'^2,YF3>@NG`)!]?5`07*L;>R+5YJECE!5O:2USX715.EQU3I<&L\
MM2#1ZMJT6.:&^@(XV!^ZQK6?V@RCIAZ6AVE<O'GG!4%1]R(?(7-9HEON9(XU
M;D01-<`D]L'10UE"G.0*"2ILO:,F=]3/LQAE,L=-4/Z$KMJBRP2XY#E^^+C=
M0E*#Z_=7:X\>B_3UN\Q7XC^T]:<.7#-NGPUOX^V292\>'KVCFN^\(YI.T$,^
MHTXR]_ND"*,/U/7S+%U<5KA^`8@T]^O7)YS+JTOU1L^?VB^0RG4&#6(J-@+K
MG0L@D7D2>KID[OD-U(S,0AX_&GE&=S/4^;26V/V^A4)#H0-F6^UT(+"[+Y(7
M"7T7S#?/&_I22@.V-79LZ.J`M(1H#_VS;L<&,[+5QR,.36J&CGE7`B]Z'\E^
M.!"JE'NC%KE^)F[/E3"NJ\T-4S<(Y9K_'GFV]1NO'(-LZP@[+=.I:JQH;]'B
MV*V`F?3!.''.`[)J.H];!9=A!-JU2-_LGGH'0:-"!,,-L]8!JOXT#*:K4844
M4Q\$:DXOJ?FBQ,PW"=)]"UB=B"WPXG7[X(B`V`<:5CQSQ-X13<)$D\Q$PY<E
M0GZZ7C2.9["KO='A_"+,*2NA`G;/(+7+A?!%"*Z3]&4Y7(95DB0_)H=9:S[P
MFSE_G8JU"+C9%^?"*"'E>E:Y:!=K25!'1U/[*OE1#F'1RQHXQ!M3$OAP3]@6
MG(<%8WLNMZF=XK-5_Y\_?D/ZPV6@<C(PK;+D%2J$6A_Z;RR.A.0T*2[11_3,
MB@HA`GV49!^P$RY$6]</9Y^+"+.7.$XRSN'HE-[<%A>*;"<XK9TK[]P<`VG:
MWU'V,=7?G]I6/1L]R"U.0__DNRA4099Z]T.L2-K"GMJ16C[5HW4[/2)U0F7`
MC%1B492>#KCH:/@1)^,3:">LY<^FUB=K7-\"-R%MC<S/50-T=DF[?NR>#'PE
MD$%M=XN8,*H#=`"GJ-5>^V%=:.*_F=T@EZ<LD+(130+L>H[2)5E<Q#GG.)=3
MG)T<GNLEEWK)V8:2Z\43U6>O4_WG4O_Y7!%32R8SEZ"5<V6)M;\0-V.J9EX%
M0?KX%9003AG0JZL2'*.B3.1;?UE+SP@?.))&4B4X1@[`L@G.-(SR[(^#TY6-
MY#T-?Y<[SZO80DG0@-PZIFY/EKV/(/O)%85RAKEF5H"ORT]7'+6K%]SN4PMJ
M7?T3E#;8?3N"_(;+QLDVG;%667,@L5*A\E6N>V5IXD,X%]Z&M^POI61&7:P\
MDY(@!%A*;M)8R2IN8#<*9$M6A1L*)5PR6*_/9%054?P#PNA<:I8_(C7!Q.O4
M2=O2MX<3*`OCN"K?\CZ#J"[L%MWY@L2><&%>Y%20,Y;^4:K>!;!)[>ZD<@S?
M5TDFN+K^7^55S^,H#$3[^Q641,I&`1L(M]456VQUS75'8X&7K(0@@B3:^_<W
M7W8,Y*)+`S8>_#&>-_.>"UUDM\MXY*0X$3&<)!C_/=]UX/[%T1%FMF%,;T$-
M\A*UG:_%EPU>6&#`$>+9ONP4PDN6FT'.D6,(YI=Y`4KESD=(ZF@II!J("/<;
M?D5'?HM51\Z7L4_JB'TK]F)XXI?=[%'5XB7.S>S7'3NQF9#;``F!R`.6*Q_/
MGZ;K_@#9-&>(C&=!O*B[#L7O_=F./?%/TRU1G!*&U]BDBU:(3)<BTT.A'T5X
M@.!4$)RK.PC6^2Z[B^`4:D"J5YP\47ZE]"Z"B_]!<($(+DKWA]L/'T[O]FD9
MD@X*FQ@WFX7I)D#M>R_4!3=S<Q]>QXN;;WF0M6)AC4*1KF)RO((^UB]-8@E[
MAGIC.[.-N"<F@F<S"71QZ$Q/!UWMIQ4)2E^./-F6]))C%HDNB^">\]NF$[]I
ME%6!-((/J"3AB1-J1*<F,Q!+6Z_?BC+7C_5;W]P]%[N7!L0)K:^Q7LZ5.I^!
MQ,]<^^4H$R`.$&S`MSI[Y18"$XB':</N,S74^Z?V3L/%?A+PP?,^-R2<&Q("
M%C7J@=]4416M#9GC0[Z.$%\R1X1HYK;\"O69&U"E715.<Y4%3EX3!2SGK,Z$
M+$TDRWXP79)\$=`HS!S49;J%.80:F$AX4>"GV3XL_2O`SD18D'M(O8E2VR`E
MBYH!]M,/_&TNWFI6AI?&?N?1*DZJC0L`^#M+UKEC';VU'3$Z$56*8K3GF"6X
MR>?^\F$XGD>R:)DA(WBJV.[:W?:QM0M8P4`$76HUMWG0YP_GN!IJF;ZV4[5Y
MA2:LG<*!T?](;N.96ET['7DSY4)<JK%7R_X;3@O/._8/=Q")XX]VC*3%OC<]
M9);VPC,8'AI(FBCYWQ6)),N7>?1W/+W"'P<\@((#T`U@'X^>4'`<^!:PLO(0
M[J"U/;BQXU_K83P-H^%1+[/<Q'C$*M8^'-Q.ELJT]$X2A$['%;-76*YQ8\3L
MH4H\DPBX\?;KVU^/I6!D"F5N9'-T<F5A;0UE;F1O8FH-,3`Y(#`@;V)J#3P\
M(`TO5'EP92`O4&%G92`-+U!A<F5N="`Q-S0@,"!2(`TO4F5S;W5R8V5S(#$Q
M,"`P(%(@#2]#;VYT96YT<R`Q,3$@,"!2(`TO365D:6%";W@@6R`P(#`@-C$R
M(#<Y,B!=(`TO0W)O<$)O>"!;(#`@,"`V,3(@-SDR(%T@#2]2;W1A=&4@,"`-
M/CX@#65N9&]B:@TQ,3`@,"!O8FH-/#P@#2]0<F]C4V5T(%L@+U!$1B`O5&5X
M="!=(`TO1F]N="`\/"`O5%0R(#$X-"`P(%(@+U14-"`Q.#8@,"!2("]45#$R
M(#$U,R`P(%(@/CX@#2]%>'1'4W1A=&4@/#P@+T=3,2`Q.3$@,"!2(#X^(`TO
M0V]L;W)3<&%C92`\/"`O0W,V(#$X-R`P(%(@/CX@#3X^(`UE;F1O8FH-,3$Q
M(#`@;V)J#3P\("],96YG=&@@,S<U,2`O1FEL=&5R("]&;&%T941E8V]D92`^
M/B`-<W1R96%M#0I(B9Q72X_CN!&^]Z_@80+(@:T125&/O65G%\$&"!9(G%-/
M#FJ9;FM7(_6(<O?._OK42[)D=\\,@@;:(HLL%NOQU<<?]W?O]_M4:;4_WNDD
M3HQ*X(^_;)*I/,UB5ZC]I[OW'T*FZD#R1(6ZNWO_]W]K]1CN$K6O\=_+7:0V
M^]_N=DE<E(51NSR)LZ+(U/XGD22Q+1T(0'U"T_AA<7MD"UP`QFC#UNR,B0L'
MTJR,G='3:MQ7\U=)1_[2C7[P8515=U"_CB<_J%^ZNO_DU<?HYS^>?!=\^+A1
MHGVZ:IS:7*N=CK5S.>F^ND1"PBS/YX/S^>`"E]U?3F[PO(TVL8[\!E1'ZN#K
MP5?!'Y3)8_L7-?;J7:%D3=.V3=_!+C6>-O_=_^/.)'&.%TNFL[2=SS)\EH>U
M@_>L(H_Z;CP%Y;L#G/#/:JA/RNJM,HE.U''H99%ZI_6TX7(FG8C.U18N=W5)
M[68WW$<&7+Q53T.SL7$9D:(RJF38TO\OFS1VD:J"JA2XXLRS(_U7_5'QN-_`
M,2YZ@="$4S^(F'_\QL0F&D2[8N4=;UBM`$?SOJ%BIYDX2[.<G7:_6AO`ZDJ.
M8845S;>WEO?'8_"B^$'F3KSG$5/IH6H7"KK:![Q67843Y1M]S!XE>Z[3IIQ#
MF5%V^<_GYKEJ?3<&#`?&+%9JSB4/*8OYIVV<IX5;Y(2>%:4<'\CL1:*E(.)$
MLQQTMTJT50*YKR407V<Z?W&=^VC*+7#2.W=["B<,Y<'8=(]JL7RV<TKX1)O+
MW1+'A??0#T/_`EL#>;?M,66:R35#-?H0,\3H(G9@W\K;5Q6\_RO[+9W]IMEO
MOV*\BPC"NU6=Y\%V`Z"D.?\*SK\LJEL:G=%)C]5*%`!=6-H'!AAT`:]XYE0M
MN&0*2DH==3P7U.0!G>E\$5[*D]TROL=^@"))8QN=\%"-(+`<2C@MS$`X63+'
M%(8%96T6K:*+?L4X8<U*XD*IE<7*E;LI*#,6'*&&+02R;>7C)?S`^Q=0N@S$
M'`/I"8MEN5VT!,!D`7PKW6+'R?$&[$9[3N/7$_@*Y=,X+;5:Z"M=F2W2A$U+
M'=@$\V";,9IL,R5T*CY:5BWL-%(9*SNYBW$!K8Q(8UVX;&E$GAC]JN8T3C)7
MOJ$80G:C&*U^Y7:B^.?]G<T*0"65)8!AJHQ+\BZ4S>#OP#VJ47<VAQ6R(+.Q
M-LL5::KCW(BT@%Q:27_<WU`&6.P*V(.$89$&"^=!6MK"+NXXIWP]UP$FW,<(
M`.4380LF7`IHAUT<,V[%6&P*S?(;$;XXPI50O-F-)]@)(KSU@H/$F,6YC2$3
MO^V&/"$GO(I`_P(HR"-?,8(P;/SYG2`39!>C"G:C[X2=G=9IF4?O-CMG;08]
M#9K]QD#R`SRS,&8IF`F'?XP0$LO(9NCW789T+.(`)+=8<1.__W0<-D#]MH&[
M\4@]\F^U@<A!A'E$]Y0P3Q>5H,NV:>4S_WC:'D:XJ9:!+!@WT/Y5W58A-,=F
M/A;`;APJ&4W*Q!85?'T68YNQ\>BJPF2@$Z_M+/*25)9>_`6$#9R$*Q+K+BN2
M:>&N=`7&AQPVM:("O02,4">YFWH1L@S0FT`[PYC`9VZ=I=--EB8YT`X4`VC"
MP;L=SG*H%K$PVEW#EN`VJC:SOC*#^L.=I@"H)?M!FN8L+5*K9Y,7-9-"9S%O
MU0P+WZP9%G]/S92)<I!C4#I0-KM+W1CPKI6ZV4-:I!CEJE6<Q^@(PY,)_Y"#
MX$"Z7)J#E2EE=9$B#T[G15`+R?JNIE!.EW%JT*+5;28I=&U;W$KS/,ZS61JG
MZ6M2T7PC+4&9"#,HL>(5*2N^D:8.ZG-I<O:*]&+R6IHE:,D;-D]2,2N]V:S1
ME(5=W^H+11:#N@1?<G-K>.NQM69O^846R5/H;RUP&QW5@(5(9AH:C?0_;!"Y
M5#@_!)X^()`"T-``V1#6.`V@S/F#<1._F,T?67W_HAY]YYGBE$P,OD;6@)P2
M`_-$N0["?:GN^B<_21OZWW=!F%S/3$X=^1R(DK4+SL\\87=Y/=Q'9[ARWSWV
M#;U5@&3/VETTSWEY]VZ%X@&U*DIC;MXFV=R8!+6!9WLB4^C9@W_V;?^$[22"
MYXI0<E`/?)PF5=T/3SW2<M4VU4/3(GPRO86>DQF[8/@%'P#\7>U/\@S!D$#J
M1;_U`+Q?L)7A.X44E+$&OOBUU\\1/!&`OWMD@/#LJ>IZ>FU,;YP#6B8>``1*
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M7YU[['EYNUST,EN^].B"=DF';`C.D!<1`]3$`)6,*QH/O_L1'F_JV/P!E0/Q
M(N@!X'1F47#7[Z[[*3Z:U`IM8L*T516,N@;>JS0):A^J[G<`BZJ35Z;.@9D7
MFO53[2*<;*EP5>N!]0W@GA%@9@N)?B:U`A7T1@-FD^FDN$8P9/UBI9T0C+R=
M4:@S8M6(6^?N%0'3[8P3$#DR(=PE[`6Q423=LDXH=L;ID)$G2J;8R-89^@!Z
M]`+#;]G_BN,KYN<G'OGUD%ZZS.9[(?*71R]E8$4D'Q';ZJVBY^?@C_)"J'G+
M]1&,B&+G#2+.'L76B^8^]VTU(JY]@60AA'XZ/[1-S5EE"'L<9]6<338VI4T7
MV327OI;2!\SLO'IIQA/KP=+AW`0EAZ:F\(NIF+PNLZO@7S&(M^D"IM"'3<H1
MM1$U9<V%;*60H09/U4&)B&D"4P*_I`P5,X-+&1_.(B%`P8\3JX4B9L$P48O/
MYVH0E0,V.H,MER?$L!L-/1_7+A>]S.==DQ<QG@WNY-35C="WS))^8*G8B"@@
M?HZAY^J;&IOSUTT8(U"04@'D:R@X^<,C6(_=>?LM5`":D!JG%WER!6B1Z)D@
M@2H4*UG!O:&[8^@Q.W2Z3#9JZO?8BV8P+,E4@V`X#N<PSN#"[,`!\2I?*89B
MI@<"+Q^H`1;<)S.F"0"L'?]^44'D[8%_5<-508-G_O'((S0_7XE0\%@6C<1A
M+YN6U_U_-.%]>4S\I8Q&PFNQ7,P=\`=8="/CZ6P9'EE,EX&VL3I\OJCLJ=<>
MDE64`G+6%$D>3ON_UZ05HW"+IR[21P"ZDDL(.0]F'\W<I"#/\CK,1B:3P&59
MPQ&-!DMX7;-<K7C4R>CJQ"-+A\#S4O;X>2E[R3SI1Y-Z[$<KLZ;6$V095C80
M(%`R>>!>MDYMJ>2V-"WM>"Y\W>+5<.XWI?2;<MUO4H(2L^@W@&+2;TKI-^7-
M$;<W6"\(?FVB7&8XOWJ=+2#C`/R4M]0D.UT?*3O96GQ>D)@7?:%7TII'S76>
M4-.+Y"G2]A2%%^"R1'Z!9Q*A",PG"'U<;%UIWR9.44M[1!4$=!RJ0P,(?@%-
M:B1([5!?]C_6JYRY32`*]_D5%/*,/*,0;J0ZX\)%TL3IW*S16FBB`85%EOSO
M\ZY=%I"/(MT"RQ[OO>]X8526Z[<I$3J?O:F`$EZA4\,,K*6@OK=B\P!':$Y`
MVP)U,*WEN#?8O1@4,[86ZN^)9`7L/5Q[JU%&6#%)%['/A/K`1.((WYA;P49F
M)8D$B5*7DAQ1'6:<8C"/GDK(>]&#.(VM"Q6C0$6&O#_)\9.4%2>YJ295--JB
MAI1M=>4#3J9INZ[%]V)M#9(<YB,Y%"G<'PY["(KJ@Q_*]V.A&.!Y].<6A@??
M'A[`)<$^SR-)+M.WSW"/DJR#!W4)[N`VZ?)RU(T1>8/U,EXNHH7R_.K^U^MC
MW@?<-]-.H(=MM>P(Y@"083"L;;"(P?C)7(F/6$AH3"GAH,S)VC,`\Q[1<5*)
MG#30T2C(V,#*I&!1)/:'\9XNK6F1I[-[2O$;)89;D[,.CKICO]YN)P2NGY^M
MP^89+V,/S];\$G2*GV7!,Y0BD$9RX]H%<!Z)%X$Y('W@()1J'FO_0<*4$G%G
M8]K.Z2SIJ$U8!91%AVO5$1+$)V?+H4N@XTU!,/?9$+3HQMK2ZY9V]&@/C.96
M_.KHT(6UK9[6N);@4VBZWB!BZFKNYW8U=ITVC;8S?.'6C].(IT#W:--H>SX2
M(7Y1C^?+HRO;0J2TH.MQSJ,P+4L_Y_-POA,'V^-1-U%)5[$-MAQ[N$ZG@0W-
M)!?'KMV>9#;1J218W/-'++?3[:Y3QQKZ/M"=!N3*!);YX';9\H*N<I'DP9@/
MD1NJ6G5(Q9UM&P8X)ED89?'&D[N)%$,D]/GP"H6AJAYN"==XV1M8V2`<?X>_
M0B!Z=>CK2I%(0UYHD\15L.PPO:!O'7TA.9O@<;EEC3#$;]7)()\]Z9$_.S_>
MKJ[)$A"AF$#5^_:QF1L?/GZGC16_*"LE%"/\:^(ZW`M9%GO.F;HJ3Y?IF3Y!
MZ`'65J0#FC1F$,";1VL#1=))WH&7IU&1KTY\[HUKFS*^P4_=!W<*'3S$!8N'
MA]"1Q,O_(5*SHL$-79T.FI04X?J&E"DO19F2:RH!J(@!HAY"G0NS2>EK!_'U
M9Y0)6I=%EB?VCV%31[1YF<W+=(I#)T#[X5Y80J<#HL.#&&T.UAN(8->UY[Y>
M>==+PR3:%![J'$W&0I.`V6:'<HZMYYZ<)3!1CS:U:U\5LW`4)IM--JG8RLD8
MFE_TMRO@)E/MCX=]`V>L6M-3+K^F:9A'\RO/0BTA8T%MU$Z/)+IA>5V)[-96
MA7$?>F.L=Z<G-.,\:G@F&TS+Y]X"`)V3$WC1ZDV:^6YE,_"V5#KF%#@VY=51
M[]ON#RP.]A0!S-](]T!Z@<LP:?*#:BH>X46+Y8'&=C5VU<._FN8T_&ZH(3K?
M-*#Q`*).]Z>N,:'32/S$T+I[^/)O`+4W,2\*96YD<W1R96%M#65N9&]B:@TQ
M,3(@,"!O8FH-/#P@#2]4>7!E("]086=E(`TO4&%R96YT(#$W-"`P(%(@#2]2
M97-O=7)C97,@,3$S(#`@4B`-+T-O;G1E;G1S(#$Q-"`P(%(@#2]-961I84)O
M>"!;(#`@,"`V,3(@-SDR(%T@#2]#<F]P0F]X(%L@,"`P(#8Q,B`W.3(@72`-
M+U)O=&%T92`P(`T^/B`-96YD;V)J#3$Q,R`P(&]B:@T\/"`-+U!R;V-3970@
M6R`O4$1&("]497AT(%T@#2]&;VYT(#P\("]&,2`Q-34@,"!2("]45#(@,3@T
M(#`@4B`O5%0T(#$X-B`P(%(@+U14-B`Q.#D@,"!2("]45#$R(#$U,R`P(%(@
M/CX@#2]%>'1'4W1A=&4@/#P@+T=3,2`Q.3$@,"!2(#X^(`TO0V]L;W)3<&%C
M92`\/"`O0W,V(#$X-R`P(%(@/CX@#3X^(`UE;F1O8FH-,3$T(#`@;V)J#3P\
M("],96YG=&@@-#(V-R`O1FEL=&5R("]&;&%T941E8V]D92`^/B`-<W1R96%M
M#0I(B9Q72Y/;-A*^SZ_`(:E06R.:X%,\VL[N)B[G8BLG>P\0"4G<HD$M0(X\
M.>6G;S_`ARB/4[LU52,`Q*/1_?7W-=[L'U[M]ZF08G]\D%$8Q2*"/VXE42Z*
M-`^SG=A_>7CUUN6B<O0]$JXR#Z_^^5&*DWN(Q+["?]>'0&SV_W[81N&NW,5B
M6T1AOMOE8O^S_Q*%29G!!]@^HF%L)+@\2$J<`,;$;,PVCL-=!A_S,LRB<IP<
MI708M*2D$]\W_QF:NNF?A3*U>*LN3:]:\4&[;K"5=G[3\89)N-O1'7&[M=GC
MUZT,9985L]FP@?1F1?2U2(K1()GA-I^"MQM8':@-?,X"=WX4/^M##V-E0(:]
M;Z@-MM)OS?.XP].>-W$8PWG_VK];6!PMK2&+V209%F6>TL>\F(V1HW?03U<P
MZW4O?E.V.HM$/HHXDM&CZ,]:O.V^;&0,%ES0D#)0YEE8?>ELKVM1*7<FHZE!
M!L5)&)6`@VB*0\;[:[C1DVJUZ9WHCN*'Y%'&I:#-TZ!IVZ8SC[0##$2I+.<=
M9#+9&O->PIW!`-%K2^N+0!PZ:[MK8TZ.S=@F>5@FJ?SK>Z/Y?8=0J"$.9%H1
M2^%OS8;Q'3OCV,`L+"2`=;YB/FU:\J9=V]0*/>3.RNISU];:NI\V12@#@8X`
M$,)!XW4!2NGBNA-P(\F[_9`_IGG.)NV\2:$0KYVX*$LF`X07,=C&NS"+;^Y.
MB33=/?8Q@1TC\#Y@$?(M,)OMU#YA6W/;S]*+6?U&PHAPO85;TEP`98"(H76`
M&OSU"R^T+ZU[%K='-KR;XE\G6F7Y9'%8&-,JAE8<YEE<+#R538GY*3"0P^B*
M6TSJ,8\`>O2K*7D,9Y(3_-%PDHF/UV6>_:$MKU&\IJ9MO8>]+6MXW<7N#>Q0
MT*DRL#Z"0ZT>Q?7<$!&T])\GB)XZ9S0G1S?2XHZ[?O&%>Y"'FQ0<B:#"B]1,
M(KM`\+8.(I2,>0%`Y%'#BX4;#HY':AYI/"F1F;RSZ"X:PDL?_.H3),':C&9A
M/P20>M[BRJ^&XS5_</IZUE8#>,F-^[_=<>L+='5'`:\%<A#YIV$O&8P^CY`#
M"^_`G,TI`L\5%^ZQ`Q-R(!@FE'.:5Z/K@%^ORHDSV5VPEPHF:#[./&G7,RQE
MN$MVR0S+&&W=WG`?4`SY%`T+;#><$**P$XY9JY^Z2AU:ZJ$CX:`/9)NBSN'`
M$_T>EI-B<-SUNV!DT3XQF.-@:CT!%1R0I/=`+68CO4>5M<J<-'@I@5"B'2GF
M28JX/'96<)-<FX!K+PK]1UZE^>-4",)!&WULJ,N#Z-$\\#MTO`-Q%PWPS(H.
MY/:%IRASLQROQ1Y/PSA)LA>(`)A0VWZ1N+<Y7J-I-``^\I;..2\NVC@>`$!=
M?/X;-V*K9`=D'EL>ZAECJV3#,X^M+`@W42#&0'BCUX&()V0GWQ5B5?G<R_F4
M'9[24$J"7T9IVH5EL52F*6\D11F1B#HVZ=-!M0J8$W1*ZUXTIFHI"0$T,E^)
MN-^'MAD08`964-:P=\#&W@(JQ>>`I0@KI01$M(QWZUM'N^G6Q2S#$V,OZX0T
M8>&+2?CXEDD89\4R_G=.])I]6R<`AAK*6]_3&ZQH#*>Q!(SEZ4)=U@7DIX`-
MBM,=6B0G*?Z\@<NK7ER!V:`V`E%L*O1MWY%3(%'\=+C3#(8RCN,[MY33/7+R
M,YQ'@(3K,%3!*?IKI2\]90-#'=230-#T,,\]`KD#>("\,`!PD(RDC^1V!8D=
M7VLJ\R2G7D*I]_S3)@>G@T0B7)[([MT:%G>%CS85E#9V=#D(O$*K;@`2CB5:
MS'74T@G_EQH$O\(!%MT!+K>ZTLV31BK47R\:O`*AL+H?+!"N@80"4\$:1=Z!
M4B1-Y.)"=[AD?(,.0*X\B_?Z[,$(V[^QG8=.M(8.Q3$`J7/B5P.^8"]`C?DY
M^/M@05@!,V-^E%%Z!X1OT/-[B#`X\K.G2,!W[:G7#_"/8\I$X9ZYE3`*B*C]
MG&J`:]7"+_1\;#I>H@54,;=4O:+^J=!/LF69?E=:>V::.`<(DU\R&0LJ,&M/
M/9AQY'$#;,0MM9&^.LJPT.0Q/]T7Y]IP'_0!:L_7/!>.$F?E9ODC*]>)MN(S
M=;*:,]8C!9\YGML(A_!0+=*%QD?%=%F?15#/0=HAR-]U#23ZZYJLE'1A#`\5
MRYW%4FTD)/AHD'N[H64@E6$4E^4:2#,A?`IJC!-<$!!^T-I`2-UAL!1-(\#>
MOF7O),1N.;!;."E0^6VL+<5SCTKCQ:P;?)F,^8)%A?,2Z#4/#$!WT=#`0Q9$
M]=$7U4>L4W98D[`8/J(87O&J]*Y%IO1M?\K1=O[DM=36_A0NWJV?=:/KBF=,
MTGW@0]<[06R6J_S)/E;3EOSC^*M5-[>V[G9/_W5]T%3??E-);',ZL[XI".<9
MB;Q5C9<)1#X`!N5X5"8H')*741&PSMBN`A!C24#PN"`30OZ!NGM-3^)RN<N4
MK]+G:_>$%#JK089J$%,!1&J0@QI,=F)ULZ57X*QIQ(+_$YWS^*O]'B0<[#D^
M;!=SBB1_26F"W\./H?A%J[8_5PIT]X.&&O6+N#M&?M,0.##E\R*:EF7?*4U`
M7;@@FXNQWPW)RL<>BB@G3N@XXX4!TR[#Z&FCJ`QH]?1ZC=+=R_X/3HUK62VI
MG&@<"5C5H\%8UT7RY8HG8/:BP!^5A>12U1FAP"H#L2]`-1>._T18]Z]**"E;
MZO$8O]O&'E"WK_^Q=^;:4X,D*EYS,TZQX'6F'AQ_L_A-!IB1,:(&GR]"(-50
M%'_6]!0812652U')9R'TN8.J1TR0T/.$V`F!`$WLGCTJL?S[9:#)BB>+C]H^
M@>8%%<0,)>)@.U63*((D(I/1^P/98Q8/M&;AMNTJGWW9TW=8-N%CS'`#&/["
M+=AWK-+\'`<Q;?P"/^;0*<!6?O2(:5=@6G-?.RW\3+U![UU%JZY0ZBD_6ONM
M?7?@'\S30-ON9G`\RNK3S7B[@:+F);LPJN-9?5,U_F[XA/`G3QXX^D;;^L8U
MQ%A[ZZER#KK1-3<T>5_%.T;2R?#O<82G85R)ZHPO5D>QOH4GS[1"NR64/=@]
MO"%E]/&("980M6'BW6+\+544'7?O'E\$9TH-)`8RXCCP#@-/@@OR+*U`-M")
M-1LR5F`'S3GDCT!7S2Y9<]8_)%-6,CVIZ$&)+/JG)[7<DUJ8YM*SQ9KPUF+R
MC0Q[,XEM`J0$&6$,_3^)=\H,RN*=P/OS\W1..RTP#Q=+'?;5(K5H)YX,.:><
M=K?K?R/=YATH-2N%_R%/[7`"U!YH,_XN*+UI1_Q'O8$WHC8\GFREB268`TZ:
MXD4NCNX*H0E^V0@_<VJA/NL&V(7BVQC3/6$5QV]22IXX:/OF,L]#.]U4S$!&
MC/0/5!)_[\TJLU#^B"P.O`,-+`Y`5]1)BQ&W_%X=CB`L@P6MOL!+4X]DY0]8
M5[K^^4#H!+M-9[:K6Q3LL^*[]P`VDF3=S-/%LE!=%=1")C^&S/&MGH4-H0@U
M;IY]I\8-CH.EDDA_[345G>?&3:\E*9/=7P9NAHI&?PY]TS9_L`4^*.C*(JCA
M\W^)KY;>5HTHO.^O0%?WJHX46S8V!B]OE"ZO=!?=I9LQ3("6`F%,TO37]SN/
MX>4FZ:)JI2B&89YGSOD>1=?T>1%TI?MM?48Z0K_*$0%\X?'TGC?\!K6%[,P"
M[PF%^G%C<#Q4[6UE:L=AP`G:IN,=X%Y)0NBMZ2H?.-P'-D(QI3V5%3TZ:6$L
MBU?2AME-VS+82',C%TM*?8`ZW_E9OEDRAK0G;BQ\8Z83TXKTF=4,MV@ZT(=:
M6F!*OS',B4K:"R[\<J,)4$Z'M7Z:JS7U6(AAN!I`<#TW6Z&/AI`7#=IQ+#QS
MQ<)<F/ZEK*K@+"^6K,=%.RA'QPH_E"?R;M"+Y%P[OI:9CM$NKP([7ZMTL9K1
M!]]?Y]!>%]ZEU3Z7TE35:^"GZ.6GDHR<C^^GXWTCY!0$D'/Z$7FVV(R^/H^'
M[[#B!UPKR,J\R#"#.!@AJTS(2<E1J6J!26/.-UUNE*__7.K(?T1O$P?PK_#;
MB`YJ<^X`2&"TD<Z4R?"_+8RX2_BZU`(WQ(`=-^$ABB90,)3G3A,R-15+&\Z;
MW02CG6_N1=,Y,@90A\A"Q5(R9G$<OHFE#\BNO+.6YP$MUS".+^6E$"-"`EJA
MY+0YAN$U.)Y&?M<`#'X%*S.3'EE)4V;+3R."G2PE"69B8L!$$&V_L%K&NTN;
MWH\!ZJ0T(^F9S@AXXL1Q&+VK,D!(M9F(^;]C?N33=_(&8-%[3TB@+5NIGLB%
M[.GQ+(^C_!A&:GAT2\OP7!7"/2ZH:T27R7\+4%!/,RN%02?R\8FH<]-ZUIN4
M4JZB3]H610'\>>I5KEHWGUF[+I?C2Y^83K^.E\7:J")4%?`@A:5BSU/#1Z"[
M6Q6XXBE&7.6A9F"3V6J9DIR191WLDBVHX]4-E.&[2*HGFW![.DY2_3A$7YT4
MIB*IX@M1RU#+BRB6Y]ENPB0^3-)KP9>S`G1%TU=9X,I<!,@Z3#:'4_RABL!U
MM$*9!X[3@1`U),+4LY.0L+5T</!E)V(=?I.V@KI+0TV/P9Z#<S/TGG1#^9A'
M>;>,]IW6]>ZTB9)C,HF95C&G&?N)R)<C/[+/L'^D%;_V&<K2BS@XN4]WLH:3
MWL'W3F9([:=1&J_]HDLQ>85[@P12M=7V7=M`TWOJ5_`CUA=&3DT/SOU:>9C8
M)OOD'2V8DBEK`)9*UB7`3Y9R$#4>QY%XA-^T:*-7K#-_J*L6L@>:<Y`]7MVT
M,XTU^0(<QK51V&S>R%=L!B&`+W7#^WP%:1Z4-\V625NJ(RPY4>CO^;A7P5I;
MC_LCP%UL7V38=-(!0ODH]W,1<`W*4R2;&3OV<JQO/2O`'HFC0^Y5[-!0,/S$
MJ#OQ><"5WS67W^-EX(K/2LE)'G[R.FW6ADU8EVKNMM(F8Z4)8N,V,%("TEZP
MS#>Z@`GD6R-#<8]#YE\E_4+WK]AUL91!IOV'2F99?:NENS*5:Y#!K1'71+,1
M1E'W-VTGDL8!Y&CX_K"]8Y(%J@B@T%7G'4B:9HHFVUDO]I/(Z6U5YN499NOR
M2E5+`J7I+ZB?DBA""C/>Q/OC%0U?<8VSEPM*FXGDJ3=5^5B2PBS**NML_>,-
M55_1N+:\X-2W0#AKU^YB/&3NH]-[D:LS@HW4H,ZZ(&5!ADF03T(U)DVAKZ?S
M=STDM)S`S[X\`0>66./1=M09!$21*"UE(BC--14I!4;$XTI_^IIB-2P4O'CO
M.;NTT0!M)=(D_W!)N!YUE82]KJ!BY[M"6ITTJQY6)ONU=Q<&G!V3RX%8MK4=
M'1RU[C3U]_"BV]FYUO.K4<BT3V0L(C$G$?DD8$ZE_BI2^Q&130E)*^6S5VM(
M_"(Y96RM8Q+Y_<)S,7E(0^F$-L2]EL_2:F&?2AVJZ*!?=.V*-8YN$"<GMK7C
M#OWR^NYN<%"(J,F5!2_:A0#^Q?HS81?='$*3$4)5/U:,P>:&Z+;+T9\E<SA*
M9CS^'T:(8#8=H)=VNL0/8>MDQ0P.B*R;>@WYT"/P9^2N:C(6IJ,Y`M,>]X?X
M;4W'WJBL,^0@K-:CM;<J>;';!&"PG=J$:`@&*HEJ%(X"M</)>^*@AC-M-V0N
M,.6Z).>@L@(DM>85Q8@_&+^*-D/:@7#*Y'FG@'G<'B:29"$+5S:G6@,J?<8%
M!P"[BD-7JX,$*QD*)Q%_$WP^;':+/HE*([ZMGW[^X:\!`-9(?I`*96YD<W1R
M96%M#65N9&]B:@TQ,34@,"!O8FH-/#P@#2]4>7!E("]086=E(`TO4&%R96YT
M(#$W-"`P(%(@#2]297-O=7)C97,@,3$V(#`@4B`-+T-O;G1E;G1S(#$Q-R`P
M(%(@#2]-961I84)O>"!;(#`@,"`V,3(@-SDR(%T@#2]#<F]P0F]X(%L@,"`P
M(#8Q,B`W.3(@72`-+U)O=&%T92`P(`T^/B`-96YD;V)J#3$Q-B`P(&]B:@T\
M/"`-+U!R;V-3970@6R`O4$1&("]497AT(%T@#2]&;VYT(#P\("]&,2`Q-34@
M,"!2("]45#(@,3@T(#`@4B`O5%0T(#$X-B`P(%(@+U14-B`Q.#D@,"!2("]4
M5#$R(#$U,R`P(%(@/CX@#2]%>'1'4W1A=&4@/#P@+T=3,2`Q.3$@,"!2(#X^
M(`TO0V]L;W)3<&%C92`\/"`O0W,V(#$X-R`P(%(@/CX@#3X^(`UE;F1O8FH-
M,3$W(#`@;V)J#3P\("],96YG=&@@-#,X-R`O1FEL=&5R("]&;&%T941E8V]D
M92`^/B`-<W1R96%M#0I(B:Q738_;R!&]ZU?TP8&I8(;F-Z6C/8Z#7<2+#2)@
M#W8.+;(ET:%)A4W.QY[R=_,O\JJJ29&:L1T$P0"C9K-975U=]=ZK=[O5F]TN
M4:':'59AX`>1"O`GHSC(5)YD?KI1NZ^K-W<V4X7E]X&R1;-Z\^>_A>IH5X':
M%?3O8>6I]>[+ZC;P-]M-I&[SP,\VFTSMWKLW@1]O4[R`^8"G:1#3YUX2\*=A
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M90X'LH?#D+V[UKV&[W0$W3RIAW:H2W72B.7>F&8\B=OM^B39%+JM[`GO+6SK
M1KT*`\XT#V=!3!!(9ROVTVVT-'4%&6\^A`Z#_'R;);0TBN.4D>-?O&"WRV1%
M(``17%!EAF`^/II?=#AYFXBW.P2!<C;E--IXQXH?K,SIGG]D#B&3`5]WZIU;
M2WF@(C_^@S*/A?O2*/E(L[U'CC1/<&DB[>F&W8X.8Z)-F,R<G)<\5=*B7DHI
MID*[2BO-O9N!,Y\)(DKC"H[@SXVD4)4UQ1P5.*/#S][I\_J"0NS,[&H^><_!
MY8,I33=Z\*%MRQOUOAN.7!1WF-V,T&!'W^?;%GP0]=;Y\GDMT++T5=Y)B)![
MVR1P=\QD,4)!4^*,A[93)RK"&/E+P+`[5>N$X3QE8+GG1_J'$^^!!+R6XAE[
M8T7@)2VXI]T3'''*>M[Y^_4+]H$+#A<.("#UWA2&*VOK[?$8AS<4Z8@#Q*5=
M5_\P]1-5.`J4TR#R`[#D]T")$HYA2"N'.,!<[TO;5?T3Y0G;V?I1AD)9ALKY
MFCG*NA1^3(4?@XM0^*_7&4YN`3G=L4)^C<6*56G\0PCK@+W-`,@@(*,3HB+J
MH30N+.0>85;L)T$>S4Z93*<4.X2IQ!*W\/*V:(>&PHD[+(>B)]^`D&PH\<&6
MLZH))D40QH*I5A5MTX/:5&T`R&5EJX9N6C>]O1%A$H$_8ISDFG09U!:)IKLQ
M0PZ4K3D/"\X@&FD>U1@I6F=TARV8(HJ!9G6G.`G[:2VG($UQQKZ;*!09*9<\
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MSV7#!928B+V/I@3F5*6"BCM6^ZHF3(/=,`:Y$@&=)M91OQ(^X/5?`#E\+C!,
M&EW3PQSSO!HU]E.O=&U;.1\%")EGS5EW-#@97?<G)$P#]NP=.CB[U^BPO=2@
M4Q'`.N37$3A']1(+489>UP['DRNLF`LK0V')$V+$O_?R4PY<P3&7&KB0"MAR
MY8+4Y(W\!\!:9V&4#TF^_9[$P17"L0+Y?QXZ^(F\*"B"^F@0E;\.NIFKG`.Y
M'K'.#]T4[G*A8)S068?>1360#]?%1"V2N!*Y)HV*'CV@D,[&(VQ&S];(4RL_
M/0*0@;87D]96>QG5_!JY"5`YR11,]*-EP_0_S2^M=,)U?>6>W<;*/1[D]627
MB\R9XEVEWI;?EHL=#)%#Z'WC3,?%),K4O1TGG#8?%COT5:U^UN[!O=*R3?>T
M:)2B^)*8W)UZ(CL25M[(:+=N7KKJA\`E^/8_HM?+U?BA:G1=/]UP5<^!;*JB
MTR@6\CB<X6`^Y;:<CQE%/J6.<]C;JJRDVS/5/7AT_^0,;:+`@1<TM6'2"+US
MW3Z9#BQ(,KXS=JA[LG,8'(!)<N=^M(V39RB07X(]ZC.8*+J**X=[P9CY-O1D
M"DX22CJ,X2EY;24[2$-V9OY%1]>,G,:)X!)TD+P\B6VC/N(Q8\Y/O%(^*71G
MU*\_=(35^D^,+U@"A6S<6(PULIQ1:)YAS[N]CRW\:JK?Y1+>%AQ`2)*8Z]`0
MG$L+V$S7U)\J*]`%U0^Q.KO?20R&3G9-@"RW0PT-Y"\:L:;J*U#!JRA5+"0V
MKLFD%.J.S(+N^MPFU]<W;[(6C4?1+OHMU_IH?GC$32P[JJO&R'5>G95Y]<^!
MA"-W,IU$)@PXJK*.;A[2"YPY-F8XH0Q<`Z5T6=*!==,,8\/UW[L+H!\]&?L#
MW.3MLKV(-D[B(E42D5+TPV"9D1_T]"@_A(.AQU@;"@IE7D^-S"MYG\B/<BN<
M>A*VDC>$VVZJE!]GYNFUI6IVRXB4(8P7(LLAEN@*/]U&SV7%51/PR?MM?4NH
M'%`(0'1549V)[EGHL#JB[M!6I(4KD92'"K?'=P04<FDZDTTOP5#5`6F&NC:4
MH"0HCIT^GUA=0T6QWBB-DV32#D$HO8J"268$>;A]EJ'368)XU*,A*0B7Z`07
ME$XW)/?0:1%BO4K5<E$GFCJ=X=]+@M(4[1%%+.5U"0)GK^G\$>#ADF.)Q">I
M3![G\:P#F%W0A4C"+)QI@DG-1TZ>W+4BJ'$YS5&&S**1UQ2$Y=_,@0OC!+Q-
MFDZQB\(+.+NFX8X;F1-91GF`9:@B[EPC1'"70J[5O->?=BNTJ'&V]6.5)WZ>
M*7R$9J$SJ\/JW8ZT<$`M;*!D%"89+8IS:&0DQ->7/!TCEPMQDK^;-'N9/J?`
MS4X43M`X=J1OJ:5=LS@J!DM-HSPQ+H!.FK9?BXI!+<BP=:_DZ21/I`9!+@U9
MP,BV]5H4#_TO98UVIAP;4,:&WVW1&`=1]!IWR"/-'%?S6#$FQ6(5/.9:.-/(
MLT6U;KP;]4M[+^`9>]7L!5H3=(N/IG.6QY,3Q\U6%5HV<ULZ,L`IPN0YES]7
M].U9E+Q(;6J-9"#"_J*DE]H<*?4+>MO9U+]9]+]>;Y!G3MH7DF\QY]MEI1/U
M1]4^-!`EKFDXPZ;$/"842E]LP,"3;X4;8-L1+UWEX*C!_0@I"!\(ASA"7G*8
M/++V@-)LK"ZN/AFUR.*K*<#LY8_%TG\8KX(=1ZT@>,]7<(LMS5H&&XR/J]5*
M2:1=1<GFMA<&/]M$ENV`&>_DC_,7J>KN!P^8G=F+,?!X--W55=6:X,"2F%\Y
M',U[5*$W@K7[FQ(I=_1P46.#KCRT)[E2V(V:P\L&?'\ENQ>G8"-+3F\_0E9\
M`08^B\20G\:DHB-TW"^M5G%G0)'TK6W!X8!\E9A9Y^MN`S_#*9[4^+(8$W2$
M/F8YA6Z(`A$S-1:^6&_XE0\]+Z0>)E<]*\[/PHK`+N:9!K;*O7LLV&W%O:AW
MF*T4<C`G7[V#*O52N[/SP_A]3ZX)P42T[S4SO6L9!GQI]9X]!UWN'@UC&KC4
MB8W4B+_.'^1=!40.1KNJG5E',`^^!E`7484@F6ANTR0>BZ;(<*QI2C1-D?.7
M.$]`LF@>+I#1.H(3</XNWN(=#054V#VLYD@T_+"6]Z`T'_#7%8@KIIA)##.)
M-D^B.4RT81(M0H(B!`23",&0/?@?^SQ8;\"7)FGP\5,WPGIDNFEN2$H52;EW
M*E<]4R0E0-(&;3G$DMG7;BUTJ-"=*_GEERK<X*G.>L?-F<Y=0#D)!LMQ8\1:
M+0P"*C!I5YYK7:',N/%;`5-=/T?Q`T>6;737PF>+>(6-EM]WE71TA')426VS
MF1W4:.ZJ@IX87//+Y>Z>7*V#[I/SN$K234#DR[Q+[4:W;VB%9**5X8D]<2KJ
M02+8AGMX,TO""E0(M$[\<-Q%+H0VFWPQOZ0H2W=R=-S1Y0PO7^TE7HQ<'$LJ
M6%AX6K'.Q&4"RT0X+'O0&@])IYUO/\\S)+NQKEA+VNTO\[.!T\-[;T=YB:8$
M5[,L3$DWG,2)=XFRQ4;;;B-MAR)6-\"I1?Q-P[/&IR/5-(S3,1E?D<%N/$5*
M&18(!^:A;=P#7P"CWH<).L[25^=5GRBDP632$TY9U65K?-/<X(M<8[U&O&T!
MX+[7NJ_W8LFXL$=3?5-_OZ%G/1+)KG3B_!'JKJWYSS*P7*1I-ATJID*LHGE4
M-74FKG?*%]X2J92ZHB8WJI*>0OF]JTSCO2\04FR$%,\6<QKZ*/K5N"8FUPPE
MGGY5J$=GBSX;61^R99E!:L2`%.I?0_76LR>]P+\(I[S4UTM-2R!7.MO2A2GK
M]!&+5Z.=/<R7YC+Z=QC5]&//JT.G^Z>MX#LH*SBTDA*BJ$,J6T28T)4HVHUC
MCC%((0SRW#F4Y2K=!KGH^ED-RNR1FSZ"+VXM\4OY>G]B:H5C&V_5\&XECX4-
M9_DB`5_\@/Q,R8G^2=RFZ$7T\1N^X2:GE?P^L4$I,W_@-!:R3F?A@MK,@%&;
MVGZ`XW?=E#+\I6X;N_K>%%27^O%CE:^2("W?0W6DCHA_=T[5?03W#\2&GHB_
MBU6(5B9:F[';W".CXSU0P]H9X'NDQ!CCWH8*S#4(N2I.X-V=4SHB#JHSRHGV
M;D(0>?W(ENO\^_HQTWH?D+@#.1WT7K?<#=I:H6*/[NSV)$Z6&>33==N[48BZ
M&["+Z**`V1H^&.KC6&4B<!5C@/8A>N%/HFZ5+[(DG[#R=+2EE]CX:55JGVM9
M,BL+6E:0?;C0;8V)AY:VMC%V02)#6:)/G?<&6Q4'9]LZO:`/1>I.<P%J[M]<
M&"^EB]4R?9V8$$U`&T(^"*\AU1S._-WSIRR$;3K6X;7'-F"JFP?E>D1#LERI
MF0V"VSIXP`P]=B1E<;XXX]J@4).A=,IP._.D$-=MMIY0PM",F@76L<&)7??>
MW6QY]-?BSP6@O+=SMS/`R:FN[4>'QE<LV""HIO>B&TIWG_BI)9X88-_X"4<A
M'C@*@7^/0S-<Z-E#U`X\]=`^OV6O.Q^ZW@[`K2STP\9;HBN:Z#-FUEJ?M"^8
MT_A@#D.]]/\P`%W+:J0S=`4ZO:T]40Y=_'+3M5IN`^X1-IR1?`;V3__1HO.%
M2RJR>?-X9H=>5B1R"9K-_<&O$V\FU.ES8@&,L3@9)M3LVRA@![/Y>LN&`G>2
M@\X3"GZ>[V!6RPM;C&?_0A3A7.U!71&%HT-M;]`59YM21F-'A]K,1AVF'DQ2
M:&K1`&FV>E6#H!20!M6%H@J\DRE-IQDH0GV@'^3@>"U4>$:+S"4A\[737<AE
M:Q,Z)_^-XU6PSCTN)=(WI:C3!:95"*4?#$`2T:?">+.?=,#N@(T?@K`._'?T
M?(EY<)4$YF6Y[:J>F8\3R-O7VVMUXEG!29>Z#[:.XVW^BD1QHPK%WU=DUM-S
M#TIV!T"IMN*9K@L=Y!WR>I&ER52-IJP.Q`O)DG`;L3,LP^7J0GO9#`SE@+6Q
M4-;L!DON1]&".3_V^()[-C<:74J`J#&2_OCEI_\'`((+H#X*96YD<W1R96%M
M#65N9&]B:@TQ,3@@,"!O8FH-/#P@#2]4>7!E("]086=E(`TO4&%R96YT(#$W
M-2`P(%(@#2]297-O=7)C97,@,3$Y(#`@4B`-+T-O;G1E;G1S(#$R,"`P(%(@
M#2]-961I84)O>"!;(#`@,"`V,3(@-SDR(%T@#2]#<F]P0F]X(%L@,"`P(#8Q
M,B`W.3(@72`-+U)O=&%T92`P(`T^/B`-96YD;V)J#3$Q.2`P(&]B:@T\/"`-
M+U!R;V-3970@6R`O4$1&("]497AT(%T@#2]&;VYT(#P\("]45#0@,3@V(#`@
M4B`O5%0Q,"`Q-3(@,"!2("]45#$R(#$U,R`P(%(@/CX@#2]%>'1'4W1A=&4@
M/#P@+T=3,2`Q.3$@,"!2(#X^(`TO0V]L;W)3<&%C92`\/"`O0W,V(#$X-R`P
M(%(@/CX@#3X^(`UE;F1O8FH-,3(P(#`@;V)J#3P\("],96YG=&@@-#`T,R`O
M1FEL=&5R("]&;&%T941E8V]D92`^/B`-<W1R96%M#0I(B;17RY+KQ@W=SU?T
MPE6F4AI>OA_+Z^L\G$J<1>3*PI5%#]F2:-.DS"8U-9_LO\@!T*2HQXR]2=VZ
MFGX1C08.@(-O=D^?=KM$A6JW?PH#/XA4@'\RBH-,Y4GFIX7:_?+TZ8O-5&5Y
M/U"VZIX^_?7?H3K8IT#M*OIY??+49O?3TW/@%V41J><\\+.BR-3N6[<3^'&9
M8@/B`UZF04R?>TG(GT:A'Z1QJ;+23Z.LG,^$(=^!49#013]ZWW6J,L.XB?W4
MTYO0+[R&Q]WF.?1+3U7]U,GN(!O&;I4L'.6(45\P3;Q>IK]LP@B;)YGI[FV3
M^*'W]2;W,\\J,V^W+**776.L.FFGA5Q3K72998V;_^[^_A1%8HU@>52R/"J4
M1QE%'Q;RB,Q3M=F[!5.K%]/-TY%_%2M30%>K^KWZWEA9E]7?-A$T])7ZOE?6
M0$LMNX;7%:OT'"5^4J0*MX59GK]O[;.6=T_+BRXO[CNU[X?_BVV/&O_E%BOR
M>^?-RBDDO_(%+&0Z,77BQT&:7$P=I`+/TT"6@#%9XZ.!"6&]K=*6T`?8QVD9
MKSR4D2&>UR[".Q-Y9>(9NA=N@D35];0!_R5>5]/OF7[J"7HF'OUW9YWA8TRR
M)%];?KFF6NZF"V&<T(^!<023-YJAT:T:>U;^2^\V8=@8!H!A%;VK9RRTO_%5
M8>(78;*VQ0*[D-]$&/E<5?U0-]VA?=N2:.LLPT\;!P.'DWU@Y;S,KLU:$6YK
M6%"Q,B5AA+S9CLVS<4NGMG\S@XBDV[H.=IDA6/AEF=Q!\"XVJKX3``\2`R^3
M3&760U>9]RYV9':4F3QHB19Z56W6\3`P!F=I+OXHZ,AM\.O#X%*ZJ^454>Q'
MP=HR]R%4'?5P@,2U[ZZ#`I;YH:N->"WR\SA+/TH6@](*0KN#H>B_F*<7%;<;
M`"J\M<,,O]0ODRR\L_H]WCF])1Z!N<*C8QZ=!/^ZHRV+C)=ZY'U"*1UQ4`<4
M[Q==G+P8V2-I!TI-"5F;_O0B&[;EDT?&S88NF[,H%`]7ABDO.CM3;]DQNJ8X
MQ,TC_\JX[R@@,1"#T6B0'<+3^IP5WY<<\5AA"X:<V1(_$C5#BLY8`C"4`)1/
MW#*]///<FC/'[;*+`O>L6X?DE\=%\C@VBV0[-9A?IX9GE--DQ-B-R7YT00Z+
MFU=EW=ZAE=S*D4DIXR0+O9QUMN:7(%`%B3Y"_CH^;^K][D^B:[0@-!95?SBA
M-L#.=F*L9Y[[0_6Z],8&NT#N+8H!X*UZ->JU:5O`1;5+]<R#?)5[LN6Z4J[K
M(61P97)4^X$CS&.:H)M.V;?.#(<&906Y2L-V=FI'NK2?AE4YS/)[+Z3+BW'+
M*\18KDI(;`*2=$D0)2>(DA-$Q)E5YG@85S,YHWGW9],!I&?=N44Q@4P8;2`M
MT'I.,$F:KF%_9VU^'3Y&E+-]K9(9`P)LP9JS&;AL(@SW4U>-/)1#'!>Q*V::
MDO1_-L\Y085EJ;KGR)43W?K+B@_(^"17:=F?D\VL^QV$G&E)>0V('KIFWU20
MKO9-I[N**EW#%0091U<CI<[/+5E2@)GZ69`4'Q2V>C)SNFU[RR1):ML%"B^F
MTA/7MM3/\\@E7`]G@$`J$]4T#*8;VS?$T:$?&SVB2@*;XU&X;HQ@PX>WD+E%
MIS>C\&RZNA_L)SN=3FT#)'&NNCS8&M8&K#M/RM7;%G>'SMW#N:F(?@[]N:E)
M#E[*QH)CQN:@1T,I0)WZ$>HW6DR6^2&T_2B(Q.21&'R)H0<QZB]4!J4JC+([
M"Q0B\&_]*P%O2Z&LK9T&/!1ZP\^N"%`EI8P`M@25X>5C@\<T;L>X-(3P1\7Z
MG33D^H\'9Q\7BG^YU(ZTX;)ZMRX">#"<PD/#*=NR*G_>/<'A:1ZH`D]/J)T!
M#`?SM'_Z9G?7185I0H?2')T--U*W>J,!0S!S!_9<^%&:"Q_/X_S2.*V:-#].
M\IA/I.F5L9T?<WD:AV_"X9L*0]6O]$L)EXKCX&Q/;VY&T&J@NH%[X)K!'#23
M056U<,/,;\+TP]YE;B]FI$#*Y!C7+5&;J1LRXMFXO%)XKO>I'5/IUE_MB<R4
M;B*,K7;G'7$CO/+<7G)YFD7E'Z`X5(90`OJ3$2)"G*27GDJO&0R3%!X19?"8
MV:N./YF$M`PS6E<^#=;>?.#[9'ULY=+0<6L%T6E"5.&S1=H>7'T`9&NI0;::
MK#5BCE*R?>HYJU(G!E?)L'=;-Q4&\5R;CB14XFOD\ZA8EYK%U>EL,,LD,V&'
M).2R2+S,+&XOJYS1>$31G7ORA;)R;C[.[DN<NXE,DI^W2F9'$BR]9$SJ1YX[
M?N(;B>$("9=[UB)F%+C'W":G>$FG3*L\.[W8IF[TP/P`P4&\E\;(JEJ=:7U\
M8[(PDNE;A$A+N9><B#N")"_?-1AROZ%P(L&-I;CJI]$5([!"SO>AM(-2?7!8
M#V]PS#18CMB7"9\9BT95:LX[&;=<[N7>T6NZJITXD*'IHL1@6BEB>!K6ZPF)
MWM6<O+AJ%&^,A.+0Z)>F;6`),OI)4VE13;>G["&]7DX9Q^M&5(?=<>X_+X7U
M^4:NJQ%+*QM**QMS*_MB4"#/Y(,CR@(H'1&HLVZ;>JX\`'":787X\Y7](P=8
M`)1"%YNQMS<=S:RC\U1_:<Y'D`'5F08-UZ,##7OZ&40K'D^KST$+'LBN+R)X
MSG+P"CZI6BK/-(076""?4:>5G`^D:/FT63^"C#.7XS].U^\Z5,?XCM*04DBE
M'+0I5Y%"$D<Z[QMAT+PD&V@$O9G!KH[I?3\8U^Q*F*=.>-]1TNFOUES-O=Q*
M5&'N`/(L2U=A=I_*NTM[>4)+=.E:+[F[!GG;)+QP=*TF<3-*Z$M_V\D&+4K;
MNEW7@4XSV&,GL',WMJYTR"KA]MU"]!BE`A!F0((41EK+5"C@E$G@T2^,"XK"
MK6KV#KX82[^T0'9DY"B1*;`ZKR`FI8W%RL)H!N*?FF&W/DDYR.SW!FEB!==9
MQR^\YD0QAIU"7\-QE_,.J;R``):'&@FZO8!9K[!?R9@48B,"L\_7/"=R-)CS
M14&"N?@[GL"110N=_%%NRG$,E!)T9:4=[;RY=YMNZB2S%4)OT+<RW5T(O'](
M1`O7N;VYNIZ/C1L<KL2[Q4IF<Q&:E7R1/S_!-%0KN16:Q1_=Q0_%*O>EEJDE
MBZ_M,2MIS3BVAKV8W:A$.`+S5?,%]<V[IBO+CHN_5A7))6'#<1U[5OZ`1?B7
MTW3PAL>_1Z+>0<(7[?QR5']IG7*O3'^M6EC90[9UDR`?I-"'^?+;B5DS5?'Q
M.!A'J"FMC4>KT.<AN_U3#]51Q>%614$8;/DP0L;EL[!8<VJB[M55[^1Z(&([
MKB8B.Q)+A62AJZ2`Y'UHF\2KUBY<.L;`&:C2,,V^[5\I27\5%X4HC'ZQ;9N^
MV\Y5-?5#="&/WP\IO7OF21(\<%H3E?@J@;?=E@@$,\"K@Y*Y@%'P_V`TD@F6
M6?FYL^!;/FA)^9$7Y4^#=*@@4RB_@Y'G!RL"]:@C\O8MXH9H<B=JH`[TP\]L
M/^94@$L<Q7=9.D@7G,U6Y,2`1X[(3H/Y56:36]R0308))50_<-%((BGE2`)=
MOP']HP[V0^1?'!NY7N^[#M6&K$3Y(?+4YVILSLW_"*^6W;:-*+KO5W!1(!2@
M"!(?(K4T`B]2%$U1%\C"*XH<2VP8DB$Y5O13_<:>^QB1$BUW89GSGKF/<\\A
M^GH3]LD*!"]4(]T<_G&[BM;0M9/$D`$`<;P+9V3S<HN-AM<?9A`O658CY'Z]
MEI==+D3]TX3A$`#:A-,0V%P(HC/Z_93R3B"%".9$8B^Y!+/&:2)QFESB=-0%
M8?2F+J#S?MT$F^OL(*K\6M+Y^[.\3.(.X9Y$$^X_EO5--`G?:PM,LD*);RQ)
MON,D1XG@O;?B^+N$W'>17`[]76NSD=C!0;I*HC2>O?DFX<!#NL8>CD!\;/7#
M0K(,;%'R6VMA_$Q425D/67TH]Q4X'A3HT+,8@CP+XLW]1'P6Q985_]A^8!,'
MS/1`_0:66W2,/.9FU&N;;GAIX`W8SOE1CWN'[X(&A<G,T\'('95^?0+3$XJ'
MF`&1$P*XBK2KXF_/_&P1AM-A9#[H`1F;F\0=?;'ZH3,GKY>%,G@XRAKI.R]B
ML)^.(H"$JPL+5QT`PO%[2?'%=DBXEJIIPA0\H:LR94_&BXZ#5A*!KGHRG7$)
M0VL*XLLRMY99N;3:3+:3WS.;R)/M&IGH'!&NMKMHIDDWZ6AGS2U<C`,`?[8]
M=!G.AM!E@@UGD['A;/N"*);Z2A,E'Q*1O>\(5+S-,#S0H@+BL6I:ITL10-B4
MB#/3*R=.TV`;3JP<C]&#+1H$8\<*-^N'SM*5##ST65)XJ:4#-P[3W2RO;BO0
MR7C[KOEF$!>-K1F,]K:L8`IW,4I][PF/SA#J1G3OB;,*<(5ZO1[+T@@S6WDZ
ML7]^*L4PT3AG0[CVF'5N*#=V*/.LHE03$U#A2Z<FN"$ZK*:*$N\O]Y8JJ.)#
M8P=]?TQ&G!$F)7^*,!<Z$U+@$*OI!P*1A[[,8-%/8(-L8():DH1E;8US41)>
MR;[;D/(+AW-+]COLW%8`+^A.!I,0M0)S!0QPUTT4O8.I_0]+U/NE:8;1+>0J
M]-D*C$/>O%[%\7KF\V`SWDT?_6+KG)(^9@@@=IA5_.%)NQ890?</E!J\@5AS
MIL!73L;C`L<%O-^R&D^@7$U\-0M,PE"./L*JPOO2#OS=U$W%'TOO=^DI5DO1
MAD3G2<M&?B'K\DRF(K$<=5MOX]W]R'GV7PE%8C\WWHPVUF?9;.`91^V5EJ0N
M?S9MOW2T,D,A2#6N>=`2EI'+KR9TWXP,]PZ;8.?UC,%0?<XO-9MN6S=R*M0-
M;YCZ);=J^<>72^E0"+/N()UYIBNDJ>M:Z<QJ6=(O*/>$&$D/@^?6]ZIIZT18
MLU!=1ATRMY,(R9K<ZK8+RI\.D&WZGJYSM<AK]:+2:WBRNXAWDEYI'G7%0?>U
MZB5W!!+SZP+$T.UUO>JJ54X?.M6`\T+K(C$B)3C64?DFHO$@Y1$PX(USQZB-
M7-1&_H=%2GYF8GW1>*B\S':1Z^$N#F;2@M/H\>?'/_]Z?'I2NJT$&1R84';M
M\4>P35=;\/`(Q`S/^*XJ]5\&$FP8\%3Y"A)$''8)4Q`2GOLF28;R.0+6*X9C
M6"V'[=7LU";DWG'XE[EAAECVGHX9'BL(O'4"G`G0UQ@'B<;A_T?NG'X3N@DB
M8KAEV&^HD`\5K/YAD1`^N[H1C%6#6'`!E%;RFZX"6%@,[$NY@D+CBCET'*_9
M-$IK-ARHSD[YX3,':VF(^9W*X3@:(^!<#H4KZD8J3U',P_6<Q=[B^/$,C3F8
MNF?NRG6!K`48SXH"'.#54`6D"T5P<CJEV<G%9JEZ;7!,G;*"31<2@I&A`A@*
M!?V$VS<M,51;,\-0+'_\^Y?_!@"A66_:"F5N9'-T<F5A;0UE;F1O8FH-,3(Q
M(#`@;V)J#3P\(`TO5'EP92`O4&%G92`-+U!A<F5N="`Q-S4@,"!2(`TO4F5S
M;W5R8V5S(#$R,B`P(%(@#2]#;VYT96YT<R`Q,C,@,"!2(`TO365D:6%";W@@
M6R`P(#`@-C$R(#<Y,B!=(`TO0W)O<$)O>"!;(#`@,"`V,3(@-SDR(%T@#2]2
M;W1A=&4@,"`-/CX@#65N9&]B:@TQ,C(@,"!O8FH-/#P@#2]0<F]C4V5T(%L@
M+U!$1B`O5&5X="!=(`TO1F]N="`\/"`O5%0T(#$X-B`P(%(@+U14,3`@,34R
M(#`@4B`O5%0Q,B`Q-3,@,"!2(#X^(`TO17AT1U-T871E(#P\("]'4S$@,3DQ
M(#`@4B`^/B`-+T-O;&]R4W!A8V4@/#P@+T-S-B`Q.#<@,"!2(#X^(`T^/B`-
M96YD;V)J#3$R,R`P(&]B:@T\/"`O3&5N9W1H(#0Q-S<@+T9I;'1E<B`O1FQA
M=&5$96-O9&4@/CX@#7-T<F5A;0T*2(F<5]ENY,85?==7%(P!P@Y:-/?E<3P3
M.P[@!1D%`2+G@<VN5M-#DVT6*8W\)_G$_$7.O;>XMC0Q#`$BV;7=Y9QS;WUU
M=_/EW5VD?'5WNO$]UPN4AS]Y"[U$I5'BQIFZ^^7FRW<F4:7A<4^9LKGY\IL/
MOGHP-YZZ*^G?TXVC=G<_W]QZ;I9G@;I-/3?)LD3=O;<CGAOF,0:PO<<_TTM(
MRYTHX*6![T9^&*@D=^,@R<<Y/D^B-]B%@^Z=N[-61_U8[4(W=4JMY,7L?#=P
M5#ETG6YZ_JGF_\^[R`T=U6F9]\O.#_`X#)W11[NVV=WZ>"A9=I8OK?[A?E`'
MN_P[/`)'[_Y]][<;6.HE<8Y8C#8F9"/[YOEBY+':14Y9=%H5S5&U/;[.NE.7
M@O9+G);.B)S.['F<)M,4?B%/8D<5-;VWJKA<NO81MM)$/O\V"-P8P<,6?I*F
MHQ5>/D4J$2-L,.IGQ5Z'3H&M$Z?[J'ORO5%_&;KVHO?J7=$4QX(W]V,WB--X
M=LZ+QFU]]LW9J[>#Z;NBK@JVR>A'C2].<^X&7IC(8J?MR>6R'9J^J[1QE?I*
ME\5@M,*`@E?'H>Q59>!JIXOCLT`HB-PHP5$;[UZ(\109BEHC$54<:7E'!ILQ
MLGI'_A_5!_HH^!>S3@U"1`&B:3^WJT^*%^5B/^=)<!"Z?ARG"QQDLXVAV'C0
M#T6#&`"2!*"NXL=AD$_Y:AXP@<[#NWV0N;'3E3*AX*^:W^4_H2ACN-!Z<C=@
MU_$XRY=6)QGMC/RN?AV*3E[A;7L:L62=V(0[2&=J!QY4@9.#J(;I.C5,81Z\
M^_,KA/VVV3+K)+PCT^AI3:-7,8U.W*LG321@<K?J,G3EN2#.EMK.15B<-8%7
M7_.DYD$&#K(;MC5&]PO9`#1)5?[H\O7"4J8-1]BZ\5M"?AW%>WN:+L]-*\O;
M!ZL\!%+Y:52\Q@"[LJ"UCEM58VN'4U'*Z-"!VXLA!C('7'A;+V12;$-)\#VI
M"1"9)(\LEP4([['A;[`/R9YK1^)&&1<&?@E#V!.I!"KN9T347RQ$_L/XV=:9
M,'-]3(8DCI,)0>E,(PLAU5[.A%W?.9,NXLE$\9E!OE."(&"ED2FZ:^7GHSJ!
MR9?6_GZ[PYZ)8X;NP2ZS>ZFV'.2M((F60<YFZ(PT03&,496VJA1/-($>-5)0
M<ED;.Z>:OPI.0>[8![$YX(3GCDQO&P#PG[O;A"#`H\`^2L?0%`?90BN9W\K&
MHA>TV45^L+,6.]M]BHDXQ"L9.LN:<<\)=+D%72SXZ,2XA[-,,QL3MG@);82\
M=3UR_O7MW[]Y^_WG,!.EH0O(Q"E]?!XP49J[:8*Y\#V;\!),BF-5ETU%E;U4
M_"Q91I(QEY$GR-[63W\J=)%L0Z`#WA!J\K@JU8.N&5*H%Q?=XX>/J'Q]U5=&
M:B<(&^3AHB!L+'/4<>@JZ#T5P%,%_1/IFU5/=/86N<WR(+A2VD6O!;F5%\I!
M('%=2DL:\K+;M28'F;CV==44NUL2F*:$0?*JWI9]]0AWM!FS:Q.6N2&R-&G!
MNNFS@W0H51),0;BB))+2\%KA>#%Q[^?P].=.:U$O9++IST;IAC3UNP*`5J&_
MG\M$U92=E&04RL`7.^\=S?6B'3IESFW7*\39[J<.;=>U3SC+H,53;Q)O/*FJ
MZXKY^`.6324RC[-KZR?C8S%^?4BT.H0ZP6-ERL&0278"J`11!A*&&CW:`._&
M_M+WTFS!I"MD=NJ+=YT^5CTS]5UK(6H?>H<^G+H'=&4_%A>@Z^NBK&I.[!?J
MH.OVR1UK4>XFJ9?^'Z"]HLHH[%_K0P<$/]M<<$OVJ;+B;#M*J@C9LJ.<TN[;
MM/<:_D-M%3LP)D%I^WFIVV=@P9P1Q5N4WKY&#$W?EK(_=,//@\7^V929E-WX
MR'9IQ*.G;;L*FF;8M\Q=6Y9.*[-9TV>G`G:*>DNV6$(8YJZ'6\^5G&RLN'?\
M)-OCB]TB<1[=@B,?4>#(-J`1+;(=UTI_TH)K/W.#,%Q:.C':YV0X9650++3M
M9&@A?J$NN\(5"1XP"\&.),@_!ZRZ*FD;U;=$0D/40J\_K(#5('A/A1G=]]PT
M!]FW#:0_PX6O(\X;'U/C1!$>.96PU?)]!1ZV%,4DSQ84N"*;I1!E(Y5L)''$
MX5W'DPNI_C3>;?PL3A:[3G<;N5,X$K7CGFXGC]61;,-;J?71D$*_B6*1/.IR
MLNC*Z>N<VU1:0$M4A:^,``@`]??-L]P#ET@+V+=8?`OR5'Q#W$:A0WU8@GY[
M35LS94,!CC%LS]-%-+QDLC[G+2Q1;`AM;&R%"B&669#\'N'@'NG>63<XJT9I
MV;(TQTVC(3.-&;1J]-/<^M@'O&$T&77JQB&Z<!UEW;K/*J3/465Q60Y+2V;'
MJ,!O&B5Q7NS@1LI8$P5HJR,,N@/9Z6@=.-BFZK7N_V7DK%4"W=>YZ"45#UW1
M]'3M;4`<B&DQ@CN*8W\![JN+&$*+!2&P1DFM:WJ2MR*L!ZZ6Q5/1`>SC&<6)
MFI/WNM3V'G'`I]1>+YV*2.1Z?O9[H+#AV[WS@<(&28%(D2][CGPFD4\0^7?S
M-2>1C&?2\R;$&L0U<OZT2[D]/;2PG))SE#V!=MFL[9`3N%H,=O.VDQF_V1O:
MXKRY6VZV0^U%-\J:0(#QQ_M4YM"IP\4NL,:J(/ULQJ^;GU4'HM[6`/&(]L29
M&J$1[7V+/$Z_/J@6RC+5BCR,/B,-P/>9NI*],I`#<WIF59IJ!IS1MESD0;9`
ME&>9_.M0]<];I$#;I%[G$V1M@?#=(/"OVNW5U6G%MT*^N&<RY5D?!WN]V2H#
M:N7(>*LJ2Z+.=Z>5UC!RUP3OVN'A3$4H<$5<8_2O4?XY*J',MKQ)*INDK!+R
M`VQ!C>1790;TJIRQ"5K2##:MG=%IA)-?T="-':<U8"L2&X&^=XB]S,RQF9"D
M[#FA0@@>I5(2.L\H9JCIS=0VI=9'I^<%HXYB4ZY$C^@?`8:R`#WK>E$YDDV#
M>AV?PGIW&N1ED"!U]I`S7SA3YZ@[0_P%A:R^:"T+)"0`*;H$BZ/0C;/DJL_R
MY];`]C!W9TGH"Q>%<N!C8K$G=\BI1RJPY^)QRM!88-,PB:>KQ+HXQQS1S!9G
M*"_,IU6YF^?1FC!DT4N4CL869J:T]9-.QLIM\J]ZTY\<W'OJ@;N4UWI42;7G
M^B%VFO.5S,V9%6(5)U.'`5.XMOC>3SM&PYM@GV(-M?7LRUAPT/?YKW=3]^3:
MTL@W^:B?-B#3*4CR"/W(39+H=UU(MBTAKB-3H8JX4('J&5>[`C0S0]T3G`GI
M/XXR3UW7#Q=!-J<]=!&IX/6FZ-YY^X"+*;-*-STTJ'_2*`S?:]/7_^7]O@=Q
M.NCJXL)7-;-[F7_=.+Y0JZT^:(6Q?JZ"X-1&=JC7T0V=@C=CB27T.<H<2T;,
M.%E:@='RAD+FU%:J9-8X>>2C53(#2`7.?GLXU>=DM,PNN=A3N3Z'CM1C[`#S
M5MP>K*`OMIO+[PELX;%R3`W2?N]8\DQGS>2QF[X<H[EVB\NV<F/B@.!![N2L
M,1*LUYV>K`&W4.;L>E*DO[9/^E%W?R@<UV$P_V.\6GH<)X+PG5_APTHX4B;$
MK]@^HA4C0$)(,!*'/;63SL00V98?R>Z_YZNJ[O9K$KA,XHZGNKJZZGLL+M@>
MUW;=T74B0^L1A-$ZM+Z7_06*\^3D+[;0YDMSE4F%+,D.3YN:"9N0./"=$&#+
M,]>&+EQRB":#OY(RK`SZL1@9'1L%,VL76=,E/]E50JW<_ZJ["1JDNS0.D_^!
M!DN1`T3#)F!1A'S#Q#?J&ZN3C*>652(,GJZ0)R:U&XJ_(1>M05,W55Y5(8@0
M+)T6"Q=`&(D@!&IUK\H*Y=&JK4A6>77+++G?97D6/O2PODL!2H7:K=/M#467
MCK0F*POW:YO)1.?_>2^[SKNJN]`]FK2I.U!V@;2&UNEAS@58'4VQ>DPF,*R)
M;$@Q0RR+%P5:EEPQ$F1$<UP8*PN<Y4BCX`FO^*@/Y6))G_B>\J%KS9+'`L)'
M"[P._8`VMT4R%<EW09*D_TV.<M]$AKAOFA+8G9-N*!`P`P!=U@.DCI(3RW$.
MN_@0F./`=SK>HA-4NG<7O`6.,H12(;BZ#R^9$`M6E`AF"R'5743OM9:E](8F
M'AEN22K1>9UHYER>B69<1=>(R2'_0Y=6&UV+!J*CB5J&_3D)8XF(;HT_%<U\
M4Y71V]:G3IM'P#NW9DJBS?7T3$IK\[KK1@D]E92R,E?R\Q@S``SRL:=,JSH)
M27A*+85N^;WR7G71#JJE4V`#4GRB^WZ4%W$1WV\RU'QN%>FGUG)_D*>'9[)6
MJI!R%6ZUH]4Y?,O1]6)UI7M7W*>$(!;$2VDJ"X<FPV57K.4<'<R_T1^>'<3X
MS"7^>8/7,O_5PT/B->@39E3>-7)LNO7L?7VE$/P;6=X(1BWFOHG`E;%/"</I
M?D*>^X?!/$7_Y-$?/FO,5@G$6KT#]=08T:.]*GG%T^<S%3N>L^%:[&.7I<[O
MZUY=6117'E294^SD4C\%VP!T99:,#"5<D`Z(E[BTD+1^)8!0S4[`C&4@?PZ(
M!LU^.4\0&EDX3`/U"*PENS`,UA>[(%9?9@@1BF^C8S.X*AF$NWV83ZSK&AD5
MF[T2%UQ5`Q#L75>ZQ:>%2]V;(_ZFX&WL%`E"YD+'^RD335G7)Y.EOS;,I1?L
M5/8"O07U=\G86UMR0]NGX<KGA,'8S%;Q%#5L)&/3KT.EO5QRVHVML=8$\N6'
MMS?4$!'/^)DV2B/>Z&5>W3"5C3ZKS4L,3&SDH^S-\]7[0W>U?(<FM%8-T>-I
M<"*F#Q3*?L56F;N3=*E5_MJ\I(87$M^5LI;;">EV&)^/0]N2D+G7[3]T74?5
M(-LKDX#UK_%^9F0<F`72E-<21'0B$5-I?0(!C8377[B7H/BC:'K;J[SUS'B&
M+.$2-IZS20OMI!ER@]I#<D_)S;*2\,F1J4J^-\(22G[G:>)O-_G@N1(L37Q+
M>I;BC,[[B((F^$Q!,!Y6_B6';#)003KVIV$%2VPQQF>[V2-3C'K)CX2$^%#F
M4=ZAW-BCT`-C(BBH'MXOHA#H#OD+*05^QP8GG`1$RC]VVWD$*QULQI/JODRU
M.86B6M)?V2#T3P3#;I6&E)1_W<JJ)Q^T>^*W?*20T1H?%22K_&S6Y:U*UD1+
M;DT`+K4+=Y$GPHMI?/.?7F7;.`^S*:*N_)#&/'9$^W1Q6TG;ZW5KS5!1MVU]
M)]T&E.;QBGB\#JOQBGB\9CK,[K^<X,4P?9E,TRCPF-<W`<D[C)2(#,!6&"2'
M)Q3#C0##"F*1R48GG*_U710>XO`+D/X#)*AF.0U</ASB]#$N?V$9P>Q,%L@Z
M(50A\%O6L8TB_A;O0<P"^2@.Q]0AAX5$OR]'-AN'P;3727?'5GJC(*+2U^G=
MWPG^:],`V.JD"WG8+KM"I`1%D173;O+P0;O>+_)TY"ZZ@(@LI>_S)'M<;Y2F
M8$&<,;YDW(88.0UL'62=3@'H.)_EA:-YCT$EP\3C_`&:Z:8K3WXZTU(N2EHT
ML`T+)Z+'YC*Y?6#OYI>G3C<0/*&J8EF$NJINO$X@8HAV!GZ=J)>EJQ5YCNXQ
M1_[T]MV_`P#40D_E"F5N9'-T<F5A;0UE;F1O8FH-,3(T(#`@;V)J#3P\(`TO
M5'EP92`O4&%G92`-+U!A<F5N="`Q-S4@,"!2(`TO4F5S;W5R8V5S(#$R-2`P
M(%(@#2]#;VYT96YT<R`Q,C8@,"!2(`TO365D:6%";W@@6R`P(#`@-C$R(#<Y
M,B!=(`TO0W)O<$)O>"!;(#`@,"`V,3(@-SDR(%T@#2]2;W1A=&4@,"`-/CX@
M#65N9&]B:@TQ,C4@,"!O8FH-/#P@#2]0<F]C4V5T(%L@+U!$1B`O5&5X="!=
M(`TO1F]N="`\/"`O5%0T(#$X-B`P(%(@+U14,3(@,34S(#`@4B`^/B`-+T5X
M=$=3=&%T92`\/"`O1U,Q(#$Y,2`P(%(@/CX@#2]#;VQO<E-P86-E(#P\("]#
M<S8@,3@W(#`@4B`^/B`-/CX@#65N9&]B:@TQ,C8@,"!O8FH-/#P@+TQE;F=T
M:"`T,CDT("]&:6QT97(@+T9L871E1&5C;V1E(#X^(`US=')E86T-"DB)E%?;
MCMO($7V?KV@L;)@*1C3OI)"GL1<.8L!.$`N;A]D\M,B6Q"Q-RMVDM//)_HO4
MC10E><8(!*B;?:FN>YUZM[Y[NUXG*E3K[5T8^$&D`OCQ+`XRE2>9GQ9J_?7N
M[7N7J=+1?J!<V=Z]_=N74.W<7:#6)?Z=[CRU6/_W;AGXQ:J(U#(/_*PH,K7^
M578"/UZEL`'D`UK&28S7O23&`\!,&#$WRRCRBQ1VLY6?1B&>IGLAG<=95.";
MC]Y[:ZK%,O%CK^Z5YEF[6$:>K*KW'4^^?C6VK.5$H_XILP,/9@'T,\^J#[)>
MUDW=U\:IQ7_6'V=Z"M0R],,TS4F"*^%Y,\OS4;QP9#=(F5VU6(9IDO@K[\&I
M;JL^:5ON51S>JR@(@WO5[PUP_'411GZ"O$6>;I_47E>J!$%1Q+9BED!#61[D
M8`YY*YAT`UJDQTHD%/JY)X-9A![JH%$'?3!6;?4D9=_UNJG;G=*'@^W^K.6&
MAAN]:9[4J\A?\;O+\>$K45'"<A0:%+*IFZ;N6J6/NF[TIC'JU-FF.M65N5=U
M6S9#A>^AVL+4!YVL9J)$$ZV81='(0:!&HB)9YLE@%@&H]`>R/1'/\$`1)LGY
M@3##!\BEF-U'SU?JQR9Y%6>A@G?`P_AQ5D,<^G&ZBF\L/EDA$"L`R7X1@S+W
M8'NT`G,?L5TBLDN$O-,A#?.&9B+(20-7`U-P/(`/\&&T%R^!7X"F6=B57\1%
M/--F/K%$0>,9JW<&;-`;:UROK.X-"A[XX6NU,=O.&K4UQOD<T".]N:!7?K_^
MB^CR[(+%M;]_AJ>:[VJW6,807@,/&NR6>%:W_-DO(C_T#/KCGE=063PC2X?C
M8/@B&WQ.2SYD?W(#-3Y1\:"T<[7K'6A!%FKX$.),J9V3W<W)7O!PP?J]V@J[
M8#@1H2YEHD[FDM<G)4H9F6/7`FV2,K/);"M2M6[;`<0%TZB-=J92X(N8+_21
M#0I>XGHM`96$<31S@=5$*V/#M!1]XHFQ)P-D",R"LSC:Z$:W)3J#^KNX/E"/
MTC"=44\FLW/LZPI2%83*/8FLSW(2\^!@[%DQI-PLN<DDX13]`46_YXP]4FYR
M0&$W:/"7'FA@<@'^VC]4TX$&46YPM+0(+Q,)N2&^^5$?=&N<44^F5>DLF_SN
MO4H3,#X)EURK[BIZ'B4-_+Y0I#1TEQ",V0\6>:Q%23E43KCP?,;Q/FHPIWW"
M+!,J;4&H'=B4%9.!'%#VKA53G&E(7MP\+1*_\-3#.QA#[[-Z^`23W/L7??Z#
MJQI)WPU6N6'C:MBAZAC"P!^0<_S4LT**UUH^P$H#XZ,%::.A_^]TY<VB`*=Q
M"TQK;!@N3;&_"H.9#L/)0<9LVV+:*BC4P<M(D857TQKOJ,$IGG7("0C1;?A;
M\[%6R2W9QZ2ECYV%4L.D*2"5'.8S_6P'4Q^_9/5\W=V/=4ZDN#;";>G@:!P.
MX$JL)E02J2@F%86DHM3C&@Y;>(2>3=`"D,:A\,-(!2*!.)=R`TN[/9WM:-O8
M$ZXQ,4@"AG22H$9([1CUJ[G:KP()U&XJL.6_%\N<\E<(>1G(H,(RTGXFBT=#
MRL^8)=`Y?T&B>B+S4WV`R.8[%1]2&]D4TV5L&MCXS+K./'[I.S\L:A:NK]6<
MG]4L08Q>7)-?]_3O*%F-"8&6GLCYL9@QI[DG-]K*;/B(J2`'0$FU%!6\1E)B
ML4&]4T0C_&HAJ<J"X85^=.\L+?(7T82BJC^95&H^Y=F8J,54\1-Z*B9_D80+
M\&MG.15%5_:\17A:<!KD#Z,FN(>X$6&")=C5=U0E!+5D?I#GQ0UXNTER6Z["
MN@?8-C05.AN8N\+\AE##2NY[L\C!XF[9F';7[U4/EG"Z[,4A`?*G<?Q\&?(Z
M3"UKX`XS.`C0]KIN,<L?+.5S*1#!U`#,D&$N\.I8NYHJ(?!*"HBHO*907G59
MFL80OIFI(/0QD\XTL#P;D7H2L2$U#IFWX:&I=SS14-EXUO+@&-<1E,!O`B\X
M,<H<929;_;0'S')1?..FNE/,:FJX.OM4,OK4J376[=&CH7%!%WMH:`Z*@^3'
M<_['V"@XMO&3`C'T3BH-7X/&61'RY,NX;G3J<DKDE[!N/38LF)/(\5;4LNC&
M==2WG/'_"!ZH>SK[Q!7,D;8E(D@"31T-INT)F[_*4\7K7+D'B&L+_\Z4`^16
M9<VQ:P@K2+LT:W%.-3BH2"Y,7$?!%8YY]"9\5A$^U-LM4`-W<G\%X'W;*63L
M@`6Q-X9`MDJRF5W/+6$B(3!"?`!OC,I8*O!8P"H4!M$,T2^O+")X[D9>[&<:
M<(PWBPP2D!N=/_;3.%K=2'Z--0DI5+6VJ#DT8[^O;;4\:`M8&AI%0^;@1Z_;
MN2C\&3XDT-8!;*VLWLZ9OJ=&E&0&?\JB>4]83"Q*Y%_UJQ$%/KHA=ZQY4BA9
MOFS<(FX&KPO.M6'8"J<]X'>T!218M!,FO]W.FATU3="7,=Q>15'TDD]/MA4\
M3<X<!\&%-Y-+C5&2Q\$\'4P$4V)N[GA@Z4\=]'%8<B`:Q1,82$*%3*-;1[\I
M)-=Q,G-\LKQ"R[,O(#8@R(9)SU$5;;"B0@)NV>>A[N9%\KPZ().UB,*UI0<@
M2]MAUH^*^;,\&^-FXI:%!SUI[EK!O[&-@_0@X2WH.4G3&_1\PT73E=#F;#IK
MNQ.:!BE*GS.9^%["<*8?2FK0V)"K0W(-TN2RX1!>N7>I`<&9:NK1)B'Q,2EQ
MT"?,**",4Q(&DX*WOKY--KZ("HDLC(N;'#ZE;YZ\7:_!T.!#6]C&LWE\+GSG
MP(H$)?ZFL1TMO&:0"54\!MTRV>(`\/I#W<J9%II&N08:=+T=OE+6)I<`!I+Y
M^YA\?U!O`(0E>7QCN'32*?.'->>#KJWZ33?@.)^,=I#]R2-77"K0K7ZM7=ET
MN./4NCO4)6B3_1-P51R&+^.W"_#VX>'+.T"NJTLT_U"6W=">0;SZ0F"\K;2M
MG'I/%SK"^UO\*R>\3RWG+P]?^,@O@``S#]K)J>V@Z+DIRY/_/R+@1A090`!N
M$76,'Q"-J)8CKFA::0;:O5?@<WJ#\Z9V^_D-K;:6860B:Z>.<U#F1Y`H7VHG
M[!\4_I1E`>2@&;@C`&5LI3FP##W443/X'[@G8)9H15,[L)EW(:AA@.6&V/L)
M(;67SL5BA$@+PBT9PL)Y&S-"P%&TF8X?Y>7V,/`5!VT,D+AL9.:2FI]SAFYH
MVCTF?*<J$:V<@$%12()[E,9(GB'BUGP;A+P9GR5%M2-_J/J?LG#!\?@QDB`M
M3WAP9.D%0/A,@-Z4NPD51HP)$\*$>ZB?4$P,=A%'L#Y#NP6V7FW/E5#SEQX]
M,(NB8M31#L`O=C-\66VA0$,/:FN^:&LH^K44>6C:@BP5]``N#ZJL[I7;=[;G
MX@6R9/XJS*+G`88'O.[VRV^#AL3_I+;UG\`X9]W<7Z51>--"G+NH2,HJ!2>$
M5-GQ"*QBA$&<<;N`:T<><(U4,AZ0[7[!=58H6(Q=9;[QU\`#\H<06(Z,^&^]
M%]+_[UO83>[/1YN*YXH*[XX_&CHK7&UXT'A8C7RX7G;E>DTW=#L2:R]VU6$F
M8/T_PJMDR54;BN[S%5JD*G95M],,PGB92K++,E599(5!;O,>#QP&=_R^/N<.
MD@%W=S8V$N)JNO<,I?/=/M@61YR'`]5%L)V2+?*]JV&)@N#T>%Y.##8Y`S+]
M%RU9UP/7``[TTDMWN257*\\`,2X8#.9>"=#30@XZY%\JLVSS1#)Q]OTYQ/,!
MM-GP+V%4B@20621$*:^F"DAQ[+NOKO^9.RI7R!MHT7^F3M:`,8N/(:'DA?1>
MI=<ME]]_=3)(4L-]M&<%S5Q`$V&&^^$^+_E8L]RGGM74D]RQ3$$QTJF59B=_
M(Z.8.4K+.7UKBDH>OFR?4ZQ'(T+<:;__XH;E6G_S"`"@D2?.Y\/FHI-KW!MV
M^]?V.9=<)FY8K.ZJ4>05_*.T:UZD>PN3ZQQ^GP1JX(-7:38\6H<<Y^%]-5A?
M#793S6?PJ_QI,)=%Z+JL]97.889WEU`N,_\!Q,ZU\N*36IG*C47=#&P5+KT[
MN9X`&;E0D@8>NJDOA;A8WV**0_ZILYF!^'CN*F8E5V"B8AC<:,H&_[B"WR#4
M@-TT:UN,1'!J5Y1[=**U*5O:GK\WDK,04XPE\AR63?:1>W##,24&&@E=2RQU
MF#(9$15!A#$;<=6!G(9!0IWD3WG?!T(!Z$Q7T2RIC^=X&:WT`3<'XV3D_//>
M_.&N3F:"".X6[7@G)P`L(J)[,?RPCTT2[W<I"NS;(PGC0&(>*T^YW5D8@VQ'
ME__M`P#\)4"&`B#)4<:2:H4EK0<9DRD0=/IF"0MDOBK7DD@B&]8U,P2J9,Q]
MBI/.`2DD\@>M-$T^9E_18R((+.,FRI,//Y:P.%B^A%CE#("&U>N3S!7S7._$
MX+2<C:<B&'P(QR-AUZ2I\BH6>66]O(JI!GEFG[VP81`3#]E[3]]4]D1U)0</
MR'GM.)GMYCL9Q"%D!>9)X"][.N'^TO5^O)'1/@FM)*'E1>>2A(`9XSU.M#]D
M,_&^OWL<A>TS9B.DY<M*B(^HU6K+RZONY*@ZZ%77%O*%_!*-[5D3DQ4DDD&%
MP.16YJBO-"(OF)YTJ).ATG<'`%[P6EJ&1(ZB@#<1<QII5YJN5SY#E?()XO!@
MBNCRBT9N>Y#37'P)-D21=SX97VQR\#K3M,`M0:\K&4PH[:EO89M8N"()B]%I
M+#:;O2M=?:4D[SOMOWLY#KS>U$.NTV$;TBB0)T4[$%9WV(^?2K.<ICHU(G#M
M+LVMZEM7RDJ+L48A<EU.Y4A)!8?:5X3K@%Z&#KM+\N03/`>&.SA(E,0%4;$K
MSH-`#Y>NP0-.1'0P%%F6)P\Z.*1];'W:@],ISU*M/S/>+M1R)*:2C1>KJ;)Y
M*ES.>)WJUS=#W(P665K\R9>L#E)1`RDC-7]"(G*7*(FF1*'I1MYP=-T$!QKK
MIOZN48X\T38.\8Q\?YVO==2U:9L'D*9)1<+HZ)I[!IX.MF5^`M?9^IN:^PJ_
MCP67)R'WM6)+UX.\6X*E7G)3DGI_]W?<0*HHK;QCV%9LXB5S'!(A"8P1+.LT
M#,H3F0!$[GDB"SP1[*NVSMZ"OL,3V49B53*FT$B5E&.TB[/$SK"+$PJ%>5($
M5&2W7,NBJJVR@]UXN/3HZ(%Q&X$;-`!-"PV*];2NE/?R!N+W39ZD]^Q'XN1G
M,R[#!`3+(I3VNMB#6E8`*TJXT:'F6GUB"?2KP`9+UYBEZ\T4K[UCA$+-C7*5
MV2Z*6"3XR*'.(J47[)5`#]L:4:UHF4MQX]A\#H0K]0AEUFIRP(8<]K.`#V`+
MX*X];!*@S!(/\NW'//>@6C<-]O.D1P%@R*+LX2@>5<ET>7`;`"WU4HY]R=4]
MJXV1FT1^86J]#^]ME@KF-,F[2=J`?J)X4L$L;"NPA,?]V$;6X[X(F.ZRGD[;
M<P<G2_.6LG54X)48-LB[3Q<'B^%:.K_C%_>N:R,P#/3!ZUOCZ^SB,SE'H;_9
MO3=U<02PC;>0`8DPB.@*$N7UJ?:ZPTN&E=9?>PDA5_`!)"WE[2P;@LW@$^9)
M^$5EIH&(@_GB`Y&_JI!-50]E-[4CVY+NZ#?RYNK7,^$D\5B\.[RD<6#LLAC.
MYM1T;T8KJ:M<XWTNU!V5VU6\*9+',RB3U\L=%&D%REBTO9#\C,^#MR\XNDF[
M'2O(^3*9&^7RX#CWL?U?1U/@J"HQ#7.<32EAXLW<AQ3R;(9BX3X4B-'<W>EC
M!?*___G#?P,`*L$S"PIE;F1S=')E86T-96YD;V)J#3$R-R`P(&]B:@T\/"`-
M+U1Y<&4@+U!A9V4@#2]087)E;G0@,3<U(#`@4B`-+U)E<V]U<F-E<R`Q,C@@
M,"!2(`TO0V]N=&5N=',@,3(Y(#`@4B`-+TUE9&EA0F]X(%L@,"`P(#8Q,B`W
M.3(@72`-+T-R;W!";W@@6R`P(#`@-C$R(#<Y,B!=(`TO4F]T871E(#`@#3X^
M(`UE;F1O8FH-,3(X(#`@;V)J#3P\(`TO4')O8U-E="!;("]01$8@+U1E>'0@
M72`-+T9O;G0@/#P@+U14,B`Q.#0@,"!2("]45#0@,3@V(#`@4B`O5%0Q,B`Q
M-3,@,"!2(#X^(`TO17AT1U-T871E(#P\("]'4S$@,3DQ(#`@4B`^/B`-+T-O
M;&]R4W!A8V4@/#P@+T-S-B`Q.#<@,"!2(#X^(`T^/B`-96YD;V)J#3$R.2`P
M(&]B:@T\/"`O3&5N9W1H(#,U.34@+T9I;'1E<B`O1FQA=&5$96-O9&4@/CX@
M#7-T<F5A;0T*2(FT5]]SV[@1?O=?@8=F"MU8#/$;[%MSUW;::5YZFNE#T@=:
MAFPFBNB2E%WWK^\N%J!HB;PXU\O8(P)8[.+#XL/NXMWFZNUFHYE@F]V5*(M2
MLA+^J*5*RYRVA?%L\^7J[8^]9=L^RDO6;P]7;__RLV!W_57)-EO\>;KB;+7Y
M=+4N"U]YR=:N+*SWEFU^2I*R4)4!`9@OXS`V%*ISK:.J%(6!$5L51MH*I\3)
M9177@);4N-`'OKE?K551\<!^;*GU906P#7^@7GV@[_/O>[9K4J=>@37)4V]+
MO:;>L[KOP]"SK'1+'[9OZAMJ-OMF:$+/DO4./Y*'/B2-(62=>F"[NNG8XXLE
M]\<,]WR-;3V$.VJW+XPW_SW9[-G?0S(8DD&F3L*DN"-%]K[NMLD]>9:@S_5J
M+0L-A_&OS=^NUJ)0VBD&7V&=R^<AS'B>'[@L10F0;]E/81O`PQ*,W(2.*7'-
M)![+4^@"ZX])E#[U2@*.+NX`5Q)5(8QQP)NT1JGS>0I!Q&D.;+@/;*AO]H$]
M=.A9\"F["?OVZ0]$*^$*7WK]`N\Y]2ZWE)E7:E=-QZ4KRLH1^5B<`S=!TDV0
M56&%]9&HPH^@1Q(B>=$[T='1%ZNU$%84#E9;6^"AQX90`%GSZ+KLM.B/R9W3
MA:NL9I.%K)!JLBW:E]:%%DK&#3CUU0TH0""T/MM`G"L+97!H/%VV$DY+N#F`
MV'OD5CS8<Z"J,)7WWP)42J325X"J`A8W$Z#K,WY4!/4C!X9\:?;[)I)=\T/_
M<74!$D"YTGT-Y)\V5PKBFM#,.K@5GGF!`+1G7;C:76EE"N=/LD+9J?C=YB)2
M.HE2:\"WX%*,EA_0F])J;W#-M56F*A0T8[LR>$L)?'EQ_>3(,D5;AZL?]BM5
M6+C-%*EBIU^!8EQ&>/"ZXK\#VTX"4.Z!>T3!"F*PB!)I%,R1<D+0<7TEE9J[
M3N`(K>"&QGOK"Z<BM@^(W0NXU"X9F3A4^4*"TPJKISX;I0[6NI0:'1U.NJ+0
M\]*H>RFU0+2L"[NMY*PX*E^(\U'/HQZELZ@U4ETNH1ZELZBU-@4DQHQ:X.^<
MF%"?BY<9*$QA+?(O,LGC::VG5-JTPTH#^3!`&[Z/[40I;"*E8@B3TEE(_$@<
M747J5D@IR:^E4%-:Z2J2V2>I!=3S_-*_$;\@#LTQ*$LE7M8E?I'N$K](=XE?
MI+O(+U)>Y-<\ZE$ZBSHS:![U*)U%G0F44"_Q*Z%^-;],519NI-=%H$)V862J
M@4853R%KU\3OH3YLFTOI13B+%83EH>Z/'>3_>DA6:E+ND&@P[;$F`T>*=`$Y
M60E,7D!*XR"M:@[;FU+5.`/U)S>F^KX4-=[/DC!+H2188FA276`HJ2X0-*DN
M$91TE_BY`'F4SD%.!%R`/$KG("?Z9<@+[$R07T]."V@ULI-"GAN?#'+,HU@Z
M."BARUP_.S[6_O!/Y3U-Z+94VSL^4'WM8GW-V9!ZP^G=`"34"IRE8(V^AT*6
M9M3)`!/T?0-F8:YZU=2U*OE,B4![\^/>U(N]>7H>B+P]/[.]<4[>H<\[]/2"
M$'F//NXQO9X\/64$3[TM]2:OI_@`HZM+4SJR1L\8'Y]&X"FH.5-QXITJJ>Z<
M7D<X\*K2%V61&*-->@%22#`4$F0."89"0A5#@JR,]?CZ>0,=1W67!M=*CPKY
M$72QW"^%`."RTV:,`6MC%'!BY:T\F<P*YS9_.W.1!<)FER@Q88'&,\##J8@%
MV$\O66SFERQXH=36Y>I0EI3&<4KZG)6/$+ZX(XD8)_RZ./J*74_B::F+:C&<
MEE"D+\?3J+H43DEU*9Y&U<5P2KJ+\706\BB<A9PCYBSD43@+.0=,@KP43A/D
M5\=3[25.3=F>'H\Y[Z=L#W<?B36AE%"^HB2L*XO4D#`(\>S::7=6-UH8'J7P
M`ONN25F[:I8G6>KC4V^>14EW@49)=X%&27>)1TEYB4<+J$?I+.K$E074HW06
M=>)*1KU`I8SZ]50R\2$SIN83E_R42Y!IL$H\8Q6D%2SY3A4A%(.4*`!,)26Q
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M,):EWKA8[WYC+2K'.)/N^3<\4Z4OP96>BUB46@@C`$F45)6*[UR5NFJA*(4X
MIIVZV&@R^>>V@Q/;'3O<9L7O0\=NF]CLM\>^IV9[@#MT5W=)`H$VS<:]@[OQ
M("06YC&0Y\Z!)K%V1S`EU.ZN%+\4U'>X@.,Q5\16O9)\'ULLB7!)Q_LA]KIC
M7`R?=9(?:*R_9GT([-!2-S#+J-62:NK=4R^P;7NX#8<>\@\Y4ZI""3=S0,EK
MB!-T^G;?W-8#J)UR6S_`0$QJ&K??%^,MFIPN]*CQ=K,!ND%]OTOO0*=>'`\H
MO*^[SV%@_VCZSWW6T:12Q4`&1:%D"JI#`$P1+"]S&>R8K.!&6#B!,5N/;!<N
M:O[U`%DM]+`B;(2615N0JJ*Z+.!YZDQA[5<BJ]`.)TT7/"?YVA7&E"](F_GJ
M*GMQ,<OQ100Z:.1=V-;'/K"GP.[KQ\`>NO#8M,=^_TQ61`$O'S\AV]DKD].Q
MA=MK5A]N6?C/0]@.$)&0#\E_>$VC/A^:`U0:($Q*UZP]=JQ]"%V=YL:]Y,G`
M#M8<V$,-Q<APW[7'N_M4FL2=*TA@5HOYV/.!4\`)*WSJ=I'?^,J+@RT%F_H`
M)(>-UUU`X"V2=YA.8!2K#M1[83#T*:!U]72<=:0")UXP]L>!;BPD#&7-R8D1
M(5$GW03V?@6[P7N*UW%[SY2X9K(4Y34@@FP>[QE%"`4]FO>IA=502%.>5R9&
M"?1I*J+B.%12L$O88_1=',IW-`$[3[AXM(G0%>&C*DWP:[;;MY@=$$.)>1+S
M#7;OZ(/^"&R<DX0]G%\:&=A3L]^S&^J&;9H9K8=H,M:S/(W'HZ'F0U*)D[+A
ME-<>DXP]I75"FL`ROG0C$5X/IP24S^!NT\Q]Z/O_<[&\R_`,B6Z_!PKDR$5^
M=6,ADR+U/R&O8I!?E9Q%78S5)7^D9AQ^.`UW`US+F*T=A]1]ER1#N*566A^$
M<8N?T^@-?9]7L6HFA[CI&OV0!^_.#(6\'"[_B6J;ED1=,SRSU,9*A.?.,<GC
MV+;NDZGD;\<SV(DH_/N%:K,2)X"X\CXDW2%*^DM;H1OJO`F6[;83)$-Z:91C
MO8GY!"D^DATC;'P3P17V_/!(=]SS&#P\)L?_55XEN6W#4/0JW!15@,2(9=.R
MUUEET791]`"T1"M"!=$0K0RW[_L#9<E.FW216!S_Y_0&R(].ZJ+17H0-I&M:
M+@8GS=I8*SRDP>934^/:X%YLSJ.\J*1M-LQG&_7`\C[_.T0+%%JA:MPU0W@/
MG&BXMI-:Z4(@MDW@9A.XI7H37]PQ,LX#LF5XJ.2WY`QM)O_?@#+(CP+%`6BF
M<*.97@+VE7YQ=>]]DB1)CR"%/+O0(-J'Y$WG:L_0-Q,X*E[0KHLJTJ*D5O`:
ML_\V4&?1BT@"A<EO92J_/_VG<)K)E?)"L]S-Y7%>R(H?>GK#+,I%IT@A)HL+
MW;#<;M@1[A8?&;(E-AJN<%N0D7M/,ZQ%07Y2,UR+^<<.`$':,/&J8_)K0?I#
M+Y>+26B(30=0O56K8*%[=A,M<8;#>_9U&;BXZ4J,++$=V`C",+,_*Q3_>O*X
M?)RJ711%KIR*&]Z[RJ=A$!@4'L+[%#A!,$NOKZK0VSQR(&SKQFZ+:PZTXQG)
MHO=JBF[(*[6-?YZ6%3`M\5OZ]%$RDI(N1PJ1-<>+!Q&F9M[!V9Q];`Y-&GX+
M]Y,@U&9:*8AK!38MX5S.JD5[`?#T2T3UX6!<>6I2D,0E.Z;R/$M]N5!/,XFS
M-4V6@3W]D8(+48U9I"3*YCB=MYUC[Q5403:6\N2M>,0\4PQ2O($FQ/6:=TA'
MSY4*7;3!M>\@+=\!II=I5\5%(SV<0&#M&><$86%EMJLIPF[.`FXY6JZU&BZ1
M9RM$7/,?Q01#Q#!@PC+TQT`(M,ZH9R`)RA#IHFG'H12^]Z>QW.A47EKC.;>[
ME-S<9U%*=1]`BQ0=VU$^.76="%CU0PWQ$EJN\='IATY<AV?<G.0_$5*Q#1=%
M.AI@K5A+&HU+\*@>52VOO"^QCJ@=NB$.:>@A]/PZ#](7ED,:',?!PJ..HN?+
M7R%ETD<-P"!LA0QV<GZXFA^P^J].R'?*H)7Y*<7$J]'(1U!:[ST,4?3*S!><
M+Y5/4L)]J4%;=9K)N..Q#Z_-E.8=!YTF(+3^)J)\67Q)=WLR;1A4%FBF736*
MB[W*`ID7#R<A+XX>6M:5P.-1KTQWA_"V'#&8=J?WI6^>W;[U.,[OP0"YZ]9/
M,#3'_H\S,IQO%F0G_R$[0)]TVCS<RI:2<P*8N`Y4)8L%CSP$[7*4+D`Y#@":
M6L'?G?EBC+#4"&]?;S;DMLAMQM`V%6EA$QV/+Q9K:]/P<20;+@A*MI84'<[2
M>W64V\5J9Z\$2C[Q:[I=[,/@$[L3/^XG&(>N0NAO-Q8G0>>QF]DXU01@\C])
M\Q?E"F5N9'-T<F5A;0UE;F1O8FH-,3,P(#`@;V)J#3P\(`TO5'EP92`O4&%G
M92`-+U!A<F5N="`Q-S4@,"!2(`TO4F5S;W5R8V5S(#$S,2`P(%(@#2]#;VYT
M96YT<R`Q,S(@,"!2(`TO365D:6%";W@@6R`P(#`@-C$R(#<Y,B!=(`TO0W)O
M<$)O>"!;(#`@,"`V,3(@-SDR(%T@#2]2;W1A=&4@,"`-/CX@#65N9&]B:@TQ
M,S$@,"!O8FH-/#P@#2]0<F]C4V5T(%L@+U!$1B`O5&5X="!=(`TO1F]N="`\
M/"`O5%0R(#$X-"`P(%(@+U14-"`Q.#8@,"!2(#X^(`TO17AT1U-T871E(#P\
M("]'4S$@,3DQ(#`@4B`^/B`-+T-O;&]R4W!A8V4@/#P@+T-S-B`Q.#<@,"!2
M(#X^(`T^/B`-96YD;V)J#3$S,B`P(&]B:@T\/"`O3&5N9W1H(#(Y-C$@+T9I
M;'1E<B`O1FQA=&5$96-O9&4@/CX@#7-T<F5A;0T*2(F45]N.V\@1?==7-(P\
M4,&(YOWR./;N!@X0!_!HD8=!'CA42^*:VU38I,:S?YR_2-V:(B5YC<#PB&QV
M5U=7G7.J^L-V]7Z[352HMOM5&/A!I`+XQT]QD*D\R?RT4-O?5^\_VDS5EKX'
MRM9F]?YO3Z$ZV%6@MC7^>5UY:KW];;4)_*(L(K7)`S\KBDQM?Y(O@1^7*7P`
M\P$-XT.,R[TDI:51Z`=I7*JL]-,H*]V<,,-)M"X(<:=G[Y-1=6>,KH=UXC7P
MOS/J%7_Q_;C>A'[BJ6[LE:U:&-'KR(\]J[J]LF-_P(DU?5#Z/R.^G7Y?A[&G
M#2Y_6`=^""[_>_OW513X>5XD<&;TA?=^U6K?PSJ<'?NEU]+?MW7BIY[:-_1F
M*E-KQ=_)G=33ZC3V];&R&MU`WVAOG(&[1_#K+*K*['C_313Y:9Z4"DR$69ZC
M&QR(E.(.3Q%[I<UZ$\,V@^Y5XYX[_E6MAFTMF.7WG0S+YV$=LIOXHN'TD=?#
M061R10/R4M-+4[5JZ)TU6]5#(Z;<T!J<S#Q(R7!<[C7R3[_>1'[A@AS[89`7
M$F1,>.0.A_C`T]6CQ=!D7D>ARCS=6U\I@,%!&]U7+7U\P&UC3_%4BGOA:0@X
M?^YXH#*6`MS)-`@8/_7X/<3O<"(::7@=+)!LB*>S;)"_^06@D@Z(SD$K@!88
M-&@7W-J-?370"(\#9O<]'BA&O'4&`4/C,G_/T\Y:(;AR3U<]>[XT>^K)N;#T
M\PQ@,44QNCB5LE.X+J%U7LW/)V0!<J4B-X!'(W(`1_@$SD$8^$N8/H`MQ=_1
M21A+@P`'(1?_6F\RP`92+?>0G;NQ%E,</.?@5?!8`ES:*=F]WC4#G+1JWQ"V
M0)?AJ!5B`)T),100B:%CPV'"JC$=/"@G^&1"V2/C!J(%[-7?!@U1G+;9*:OK
ML=>T"YM,_;0L9H@,LLED25K7=@Y&PBV$.AEP+-^Q'$:EGZ51/C_ULT<B!`I$
M$D#L1^Y#$/]Y1C2"E;:R@_@2^WF:S/)Z!VU1/(/(`Y[Q6)U19_8:#NF`A*(D
M3X<)-:F?I&DXLYY,)Q6M[0Y]1=$K0$'W72\2&L-[3<0K/"=EA4A9(5)6L)3Q
M)()UYEF,EM"I]*.@S&[H=*OW=!S3H3RK%ZV-(KVN2-:'2>![E'+6=1SL9G6@
M.VDBGQ0+$8^:X<X+P:U9]8#)HDUQ448<GV=OOB]&/$-W("`OOW$I6NQ[1*N'
M(]*5R9IX>W1NYL?#?$O-D)0JIL@I^]4N;+Z2T9H<.%Y4B7R\#N-$+`<3P$75
M(_Y/'>*SK@QZC]G)\4Q>?P#TN83E&%3(%B`%G<(!V-8;IMDO,LL7G/IYF24+
M)ZY:@^U?V:_BDEZ1=](.SF(ZUX[(4Y;U)W(?I7:^C+:A"118^&HI3O!TY(&^
M&R'T>-1>+#D(8`&COZCK%6<Y\8LP268LN(4@A&4>O'E2)A@)).ZE$0"WI=S9
M-78#;EC-AB2;F9^%0?'CB@]Q":!N-T-SD$H]:%?97_CWC6/FBK!6XZ(^:Y`*
M]PF.5IWX67Y:4"BQT\),*>![J=RM'@94X:MA/#J/@+36RZY`YC2]>,ZMQGV7
MVZH_.*>=&5FV6-W7V(R\W&E5OBY;$=?.J"=0ZC]TWUXW0]?OE`V!+&*@GN01
M\(P2_:MI(.#J:8"X@YXXA-^"?GJ@/$ZF(JG*'R$I@)T>.SBD-O4P;^I+8[_B
M@"5'?MZN\DBE!;!,99$?8AN=%*K7J_WJP_:F>P]CD'F8#K68^O>;+CWSPS)?
M*"]_N,/BNT6!&%L0*:$-6!)C)O9*RD%%\_JO6JI"S]4"\,\-!F/GB"V'5?S-
MB`6HS!":FGD:L5N7NBQ<0.)!<=??V(9"HD\2IOB9A"'WY`N2E@5LIUC=R(T<
M6J):9J#.]-K*-!Y$JD:D0I/V0KS"FX#=:MQ]^3%2G:.I.D<4+.`<JQ8$E4>7
M2UW#A:(I=3Q*PWF7<*/^2@Z(VFTJ"!+=03!KU/O0\3J.T3)BV$%3%ER[E61Y
M^&=]IJG?UB)Q_E3"?*YS(LP<V\/([6=U*=!^XMK4PZ5+R,/BMDN8SD>[>AQ*
MBB(LQ3O)&:21;CT[U#EH&JK3J>^@\4&<YWX`]]09DO+)7D'V&J`UE.<C^XN$
M'_GJMM-]<Z[`O*;]R!I$'YJT90O*D4!Y:HP=^I';O#7V[&:PG,`<59B&R#IT
M5[HY&#EX#$4^2^,?DU$H\L;=-OI'##I7S#9Y8SYIOJ(6@K=X(J=T<@OR63;`
MOD]TE]8.(FMG1%XP'?%U;XU3AXYWL_]W[W"#:F)!241?A-#%!`=>JWZ'7<4P
M4:6,Y\5^B22\O-6#W!%/<+4U=->@XP!4UT@)X@]BX@PG$5:$<(89`J8LA2'C
M<VC:9GA#!)G.;/:CJ=$VP&-RM:[LD>4Y!I7)RIN[4IA.87G&7A+$Q^M>[:12
M):E421DOD4%.7<NENI:<X/1&,2F0(#`(SU\PDC3F$`GR6Q;1]V]%%R0NHB[A
M!)$Y]0VQH.J;]@W3M</('O7NH!W9>8OK<T?31K&[RL:`3SI%08=F'I70$/")
M,Q!R\R8:*E<RSJFE2XN;;ZDQF\C-IHYL%X6/V"2'SXHBNZT]9ZDH7$7.HIE,
MLWRB&>LNEQ(I.(:G6EXN)..:9:3:J(I7M'-UAH2/]DJPH>T::Y;T#NZ0BV67
MT-(!_EQ'G[U%2:`F-[K!24+1`],$PL0;:QX=<;+,:'BY@0NIY6=3.Z-'G*?5
MH9(/^#HUXU#](,T+)DD#CINE?.:2+Y*=(8LIIZR\I`S'.#.I)V\R@Y4`1WHN
M]=`DXA7.\C,2O/#,?"4/\>;\%X$58ANPMYIG7H*,SE_%^)HH7MM9!T>(@>%S
M``HK&!;I:9OJ!14#2]B+QII&/-EQIPE]1YIFY;+BU--F5.\?E6%,Q=X+7.P0
MW4>JY0M.ZF^Z'K&1=:7NL[9#^]]+?T/[_)"03)R.B2,TJHAA7^%8NW-E9.Q`
M/&/^\A#V5"%"#%H`'FEFXYJBH<%I1^QF3E\T9FM':?_2MG^O#W^_W4)_K+9[
M^(JG*M+LNSW`9_VJ'FNZWF$"H-4W.U`UZPPE<T-I>K=R07%/\MLB?LVZ3T8]
MZ=.@I<Q@PB)(Z@/!XI?'IP^JL7:$-"W\8<($?I$5\?>QX#FW?SWMH*M1GSN?
MC&_"^$&]^\?8#LVIU9N?=-N@=KRTFJL0@#D*TUO%N&E`OKAF&_)UUF;4ZK'O
M42[N]@V;"B%HM;&C=9I;,(&Q/\'#LF[][);W!VE+#NH3'SGQLS"8M6^W@,1H
M6;6MH#6!2E9K_QT*_1Q9:L1PS,`$]:D[\XP=LE/PILUN>EH@5B@BOOR`\T"1
M3CT^?53;[M34*@M2B/T7S>'Z`O@^P'T2&H)W6#LIZ]PP5M:I8I+/^5Y,YG,V
M#Y)-;D;H)L:U%^.C`454\@T5&GXDY;M9RMWT2<APO^O4W_1?U2S1R]KE"JL$
MF3]*Z9-KE-[O=7VW>D(F[.G^-RYJ<N/#6*'C#A5QM.CL\LO=1/S%$UY\CE%@
MUD@X,Y"D6Z7EB8>AKJJ&WJE:QQY_[/A%=117M%+1],527E>U],-_T>O<<VNZ
M'4_9\\_U5A=\T:EFJ7AV2TCY_E=WU>P@",/@NT^QFY!``@0)=^+%LR]`%)3$
M(&%HXMO;;_TF/XDGUG9;?VC[=0Z*].:F'H$6-][3\WL#OHBM=;LRT)Q>?6-2
M2<0L21/^KRH$YC/ERJ1<AK.8P\G*AR?!`'ME-';S5A$HP+IW',+M7G\:L1R#
MRAM\::S@WI4+#E+BX&LR=R9*"-#[9723D1E,HPI4YAB_9'66+D(4KQMAQB'B
M&L8ZY8H\"Z9F%`<2`'U/`3=(`9)A.FX9E"'`&9FN%<N4_D3FJ:L6'Z0XD)7W
M4,2S4M^ZX%FS(6>E%24;W5[GWDJ05V>M1-)K>W34+LW>^]-Z#VMUG=1%*;Q2
M[50[^(&^AN+)_D?4XWGW!1SGI=D*96YD<W1R96%M#65N9&]B:@TQ,S,@,"!O
M8FH-/#P@#2]4>7!E("]086=E(`TO4&%R96YT(#$W-2`P(%(@#2]297-O=7)C
M97,@,3,T(#`@4B`-+T-O;G1E;G1S(#$S-2`P(%(@#2]-961I84)O>"!;(#`@
M,"`V,3(@-SDR(%T@#2]#<F]P0F]X(%L@,"`P(#8Q,B`W.3(@72`-+U)O=&%T
M92`P(`T^/B`-96YD;V)J#3$S-"`P(&]B:@T\/"`-+U!R;V-3970@6R`O4$1&
M("]497AT(%T@#2]&;VYT(#P\("]45#(@,3@T(#`@4B`O5%0T(#$X-B`P(%(@
M/CX@#2]%>'1'4W1A=&4@/#P@+T=3,2`Q.3$@,"!2(#X^(`TO0V]L;W)3<&%C
M92`\/"`O0W,V(#$X-R`P(%(@/CX@#3X^(`UE;F1O8FH-,3,U(#`@;V)J#3P\
M("],96YG=&@@,S4U,B`O1FEL=&5R("]&;&%T941E8V]D92`^/B`-<W1R96%M
M#0I(B<Q72Y/;N!&^SZ_`P5L%I48T'^`KM_$CJ8G7NY49.3EX<Z`H2**M)162
MTEC_/OT"14H[8^>4U%2-`!!H-+J_[O[ZS>+F]6)A5*`6ZYO`]_Q0^?#'H\A/
M5&H2+\[4XO>;UV^[1)4=??=55]8WK__Z&*A-=^.K18G_GFZTFBV^W,Q]+\NS
M4,U3WTNR+%&+=_+%]Z(\A@\@WJ=E'$1X7)L$-X`R(2LS#T,OB^%CDGNQG[O-
M?DR7P2C`"S_K^\7[CRKRU&P>)YF7Z[]_NOME<;^X6]S_X[VZ^^6=@H6?>3[[
MU^)O-V'@F3@.X`E.8CA(C.@-[]6[^\>W/__Z^.GA_:.Z>_/KIX7Z>/?PX?U"
M/=P_?E"BIW%ZBL!YX`5QG)+8"X.<7^73MBQVCP]",]Q.#])O#VUKZ_*D'JKN
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MBN[--6F3ZWU1R@YT1VL[V<:+W2Q`;=!9>^ONX?--S=X@#>=.Q>^:;RVO+L`'
M-&*3[=A>8%I>9?OQN*D]I?XYFR<PMK1[:NZZV%C2GEQS`(].?<.S+<\L(-*%
M9QR%^<BHA#K*&+YA94<^R<F9!F#6?443XXA$@KN;PV8KYMN`^0B`8-LPD^#_
MK(O6&1#/L9QZ0_9;RXP,(NMLTPB0D`37@98--DTIT,"#U;'J*PX/@/76UJK8
M[]MFWU80$K>JW[*._9;1'F1>`#$\BKAH2`XA/QTC%]R^LFUU+$"^!45)QV('
MX=3U[0%\$'@I>`0\T'>>*!TD7NHGR43IB_RQ^--P4SG<CG>"CTD>&AOOOXC9
M$RX\%>U*E6QC@VEM](B+#/09D-.W8!T&:K/'Q`.^:Q@^`<`'T4WPZ;<L,O),
M%C]O%VW5L=F!/795?T+[U$T]7Q_J$D6#909-*:>$4"8B,W'@_*(0I*PHV3)$
MQ$;P4_./G?D0P'W1GE31=9:>P5]6_*-V5;'D(2J$`,``YI5=7\GNC>R&%,0C
MN0T2$<^+Z4:^%_*3+$-<\>#%_9B&+,!`_45N0=]-W@/6D2]@(Y%(1]&Q\@7=
MZW9/K=%3=A-WMA+$`B4L$^50.@2^*P7P1T]#]%6[$_I]:U?@ZZKN;5M2.H;T
M5Y^4*QDF225B0?G2`O"7.ZDY^^)$$WC?`H)(HH-B*>8RZY^A+AD:]8"(Z^QW
MH\B0#5.,(Q?[0&CB,+W*IP,>?8G3`C-GJOD_9;Q4/W6@(*6]80F`L3J4G":;
M(V2B\;%IXCR?<45(*@S&II0C/WBQ7*LU"H[T@6H+_,[F%&\\J^@_A.*MZGA<
MEWPUI53<:=6FD$^\P%Y@J8TL=>`;8!(7!]'6M'*<7'=TWX=ZA6^X3*V7X5X.
M&:0[++L>"`QX;H>1OX:`5+N&E$#50%_(+9)<S8MY2:/2"*(:=-V=*BP$$M]T
M'KBK2:/1^2D3U6@("'P7\DN+$@C:*T\23^I%06!^(`E?%1-$][JH6G4L=@<"
M^?-9>#!.!?9!H<"DJ6(]__3#\HLM>XS%@075TZP)X9#GYOG7CT%)\>AX)M.X
M&#J",+R*FS%A>K)"D0I.*1LK#`AMR.0&#+H;<ZI+4E5#X^+_A-894818^![0
MIJ]$+I=V-R),0_#D<38RT35%.MHI92F$3$*J8G+(L3%01XB"5NW&E(=0.25!
MY$5:&;F2Q3E_#I%!"EY:,#FS(]$3_3\SE)+AIQ/R:#3.@,J@$9GU1A>IQ)!9
M(TH3AI*$P12!>;!PA[%2/S4D3S0#Q8"O18Y2[9&.:9)>T!"WXHL2+>$Y$U,9
M-I1QAC)L%#/*((9M#8I)5`ZRW$/(?`:--YB)M+FJ[><V*W<D$@N8&:J>H:H7
MZ:&J-_(=,U1Z+NK&%77`^(/=\%)!1[E&P@81*!^EC)JA]!HM&]3S2@QG7.DU
MKO0.IZ'T<N&]%09BM')78U*476Y@2;*(D'N[V9Q(0L!3GW]^HIW`57FZGQC"
M0I4$6C5]A[MV4OZQH940$N*.V(_9ISER-BIW,8,,%UQ:H]515TAS9*`95AR.
MLUA#H:9?=2'VD_?HJ57#LOE_06=;!3@FS`+,\WA4"X+L'$;">M5'`%I*R2C6
M;;E547"K0C_P!?_(]]2V.&)I*UM;(+.A;J=HZXH^UQNL`O@@!TZY]K*\7=&D
MJA8>A&\&3_3%-ZPH)VX?O@E]HF^]A;KW*@F(/`,T=\!X/69.J9<`=1JE;*'?
MU+6E8E'P&>3#RF)VVQ8]%%1XJA10?*A$.9#Z.$SR9_/_9[VTKOPROT-?,,,#
MO;D,2X$5*@5U/XVNJ!0'JAX5X:M"Y^*S'==;+K'PGB@-?J3+2<\.%\IVAUU@
MP'Y/R.]FXO=;<B_UA<'0%P:R<<=GY2,B$3I2%DAD,D*20SMK7@7K6@!&T<'[
M^##_;_CL4_=GEBCMVW??]0<[V#?EX"Y\Y*LX"[G/,@(69?]]`!:\LW4/;1,U
M3.SQT,L",Z[X$L0[59"`6#<'./,B%7$4/C%^.I54#BF"F)=C+-`#@.=7R$0<
MFAI80GXW-&^Q,?D5;*Z:3(I##$&[7EN4S44O)#>=6PV84K-!G06KF[`IS\GA
M*H^-.I!=4P"R?],K6S=B%F@E>G@",*AC,01/GF4O\*^V:J`U<.G.=K_-@/5`
M[&'(J\>GJNN$1P6>'\7Y=7E+1D2*6\U$+_F'<GRJJQ5/*VA</885G,SR[`I5
M+S)1@)``*/P>@"#E^IEYR8[_8RA!#HRR*RA=-W.<TK'3.N.)IF=0I1C[M(.;
M-->8084NW8X],T7(Y]"VT@!RAUYRLV<G($KU1)KK\U:.<:4FC%^N7E*"\'RH
MSR41%_F_%#:!&M<SV;U$[8#98K[[``X!7HU]5C7>5(V%\'[OS,&2.+S*[".R
M#R5H#+&K1O55*!B+OI^DJ*/Z_\58YODFN,;8N/%Q\,JG\,I'\,H97CD[--;]
MJ`MR`,L=P(`1<8/3N+9H@BW7^(BH0F2MIC<H>V@;!PY<7\GZ4JZXXV7H-GXP
MF_#@]6(1*C#C>E+4LC@9LY1QPM'WF*QMUZL'2*OJH>J^=DZ284D^R8CC_Z(P
M7G(N[=I5Z`^)U.U;>\2DO#O=LAC(9JF)1DB;EE:-Q<!^VX/O$`W8A%7UP=[B
M9%TA7;`43R0K]J(DCBY+JV[VMD5N70.CA^JQ+]H>SF_;YK#9<J&A_K5`0BG@
M2M(D^6,*-<(KJ-5TC-+*&;-%8[9D3.)])2D&C:@9/_(Z^Q,EK*0`["$*Z%74
M8R(G6ZOS(U3AX@G"*7S><F`XMA!&#6A:X6GHKNYZ];&8,C!^=NZ%,43051$<
M$G<@'*#?8LV+H"<@0AI0GV;T%US-N16"KJWJ3TK&:^QQL%/EZ4%VR.J2I^Y<
M*X,G[GZB_S!>+3MJPU!TWZ_PHB,%B:()CQ"VE;KHJ%6E:I9L#'A"1!10'$+Y
M^Y[[<$@"G>F&D&OG^OH^SQ&^-Y.!"US-`,_O^Q^)*N2(J]2FL7DK=%7,JP?Z
M)%;M'EVDN*FD-A>TR6">V^I.U>]8:?!`L,,A6>7O23_C;67O"GD3_'<)GM0-
M)MBHZ=3C?<IBR&Q/.>9:?AJ8+-"35P-:?BG\-/!7(:9BP+PU8*X&0$4=!.C?
MMB@FS&I0$*K'Z++EMZ9[A#EUEZH:%(6<$R'O,ET!?AL<D_--#BK=R/,ZXKS(
MU:;>*;X.8E4J2367I)I+)@`V;*W7(\9"8#N2OEOO*0M-1:8)&(W\'%`,ZDE^
M?ZR4V=2=/962DD!9&J=TY3%9Z1$;)*QP%2O+NIA1HG:.Z*EFX`+,DZZF[Y!(
MY8U$3`%>:C]1KKI4D7&XZ9G*@8@D]6MTG'Y/\Q=[DILK&M%#AQ-XVG8AA4SH
M6S0!D^BXD^?6%OR4WRL#'C[3G]&4;%8YQWT0*5?6(X':L?B9U9"STLCH'CNB
MFY4V<T;4E[(NFQVOTBWXE3UYDQNUS!\,L)!W8I'`A(1&]\YM],.>;M7&#'3:
M:@O&3F[I]7]D<H"M,)G-BRW/(!1HS\\Q#R?'P2#V@VEC3?S\Y:HC;S5-.Z2J
MTZRG,J1L]2"2Z&PU?,V@3R<4S>Y_,BD,J-(&R!>WD&]A-@HD7RQ0DD,0KZX<
M:XK,4*]+P/[.?2.!87GCT!TPS!M7H9XS'G9]96Q5`I2W7'7,$E`1#L)\^R,^
MZ5QO'<63Y&D]TFLM`0G>P9SFN"GRC`>K8<]B:%@VB97]^/[UU^]V/"XQQ3^F
M->L(]WXR=CAF`?KRTM>:-<)BRIH'L@ST9`B0[X)P-[BI7-]L7AFJ7ZY:DCR*
MM_7F<VPT?N+G$*=P\/!FK:]"&]E8@COP%*M)F:;$475PE/DHR9V5/R+GFDFE
M9E#U!;^==RK-C.S=RS)`DY,=CC]N;*E*>UKJSA:MZC14-<FY'8*\K!9=8)3<
M.KS>!%Y_A:.DT4N;9ZTS;LT1U04>M$9Y3Y)316]LQCS:TO^3+%!-S+@B^(U_
M?S*6MZPP!$S;IAKW8191?"5JB[D)Y)7#IOWE03,9M)MOKY_^"C``4T'F-`IE
M;F1S=')E86T-96YD;V)J#3$S-B`P(&]B:@T\/"`-+U1Y<&4@+U!A9V4@#2]0
M87)E;G0@,3<U(#`@4B`-+U)E<V]U<F-E<R`Q,S<@,"!2(`TO0V]N=&5N=',@
M,3,X(#`@4B`-+TUE9&EA0F]X(%L@,"`P(#8Q,B`W.3(@72`-+T-R;W!";W@@
M6R`P(#`@-C$R(#<Y,B!=(`TO4F]T871E(#`@#3X^(`UE;F1O8FH-,3,W(#`@
M;V)J#3P\(`TO4')O8U-E="!;("]01$8@+U1E>'0@72`-+T9O;G0@/#P@+U14
M,B`Q.#0@,"!2("]45#0@,3@V(#`@4B`O5%0Q,B`Q-3,@,"!2(#X^(`TO17AT
M1U-T871E(#P\("]'4S$@,3DQ(#`@4B`^/B`-+T-O;&]R4W!A8V4@/#P@+T-S
M-B`Q.#<@,"!2(#X^(`T^/B`-96YD;V)J#3$S."`P(&]B:@T\/"`O3&5N9W1H
M(#,V-38@+T9I;'1E<B`O1FQA=&5$96-O9&4@/CX@#7-T<F5A;0T*2(F<5\V2
MVS82ONLI^C!5@;9&-`&0()D]V8YWRZDX2=G:7,9[X%"0Q#5-3DAJQK,/LL^;
M;C3X(VHF]J9<UI`$T+]??]UXM5V]V&XCD+#=KV08A`I"_,=/.C201":(4]A^
M7KUXW1DH.K<>0E?4JQ?__"#AT*U"V!;T\[`2L-[^9[4)@S1+%6R2,#!I:F#[
M@U\)`YW%N(#B0_>9'C0=%U'BCBH91%(K,%D0*Y,->Z1R.O")MJ.BESV\R]OB
M"%I>@PIE>`W-J86R[FUKNQ[:G,1)'22D*71R!A$R=B)Z"YVMN[(O[\O^$1[R
M#JJ\/=CJ$7;VSM8[ZT5$6>(ED/YDM"1U8NH>FAKZHX5]4U7-0UD?X#:O\KI`
M^4=K>XZ)2@.CHP0V,I`F24;'DC%X-Z)H/J]1GQ1W36WK?AWA8_>]^P/K?V]_
M7&W_QEYP-/&-'S"%RJ<P#=)014Y+&H\A)E.+T7PT^NT0I_<YAN'#+`Q>GH?$
M9B[0R&2*XY3N2;LR@5$J=?FEC`UISP*591'',`WB,(K9B:4R'0>94NI"V1-Z
MW/I2#ZHWT3Q79G0[8WM?UO4IK^#7UO;Y%WB3MS6FJX,W^[TM>A+Q9KN*PA#-
M`&-TH$'J*$#345-FH+6K_>K5]J)08C0<88[*`^UJY8D0#3YB/:E,GP7TPCU$
MK0[CF7NN8,*Q!F3">/E'OM[H0(FRA=_\8W6R+Q@K66"RR$S!D"X8+$GR>1F&
M\&JM@TS@:2P\T95K_('U)HI-BI^?W4`*YHG#(E'Q9>*>1HD*HDC+F7O.O&PR
M+V+S?FYZ5!=HT=1YY1[@Y>?FA(7!_L498FU*=CR&AX__VB`;=/"#+5J;=Q:]
MDAGF2PT+;VM>N'!&!:&.LV]T!LU2.EHX$SIGQ`=[^(QUO(``@CQ!&Z<#3T$<
ML9=JM12[X)X;4=98P>N-PMCT]B(OJ$E'2TU/NX'X3?5?4K>),)^)"Y=2\GG*
M^2UOR_RVLDPY;^NN;T\4G<Z778(E)^,@24'**$B_5G,R-;3)2$.E]Z<U1QR&
M28(%6\R#'<99=E%OT0BHC-W_2`'X7%95V5"U1:+N/JX)5UIEA$X7#W1%98J(
MP"!/(7>D&%R2':7LC$XCK)9A%;U)HOFRA!)6V"81?,.>A-`PWQ,E"05J6L80
MS)9?_5E7ISB'<:`<48UT,(3N9=?9'GO.$AVI4;,NNHRP2H(H3-2,;%PQWA#%
M;](4\QGYZ&QT./%?EICS/CCR'$7[-5)-OE;$.D?(ZQV<?7CS^ZETG?'><8,4
MUJT,71,V0(!S+XBZV0YX/XKIYY^=>0,W4:2R<?I0OA"26&NV[6J]B<,LQ--Z
MC49K<2U5AD#`PR@+5PTV3:2:CV*-:1%:(D[H#*_[,Y(C,O+A+"(++&LD<XD5
M-9GE)ZUA879V,Y']C?@)2P[9/#"BK+##V^Y[]O-2X"RO3TE]DF$_')NVAZUM
M<6R1V"20:V]['_FIU#FP:9!D6%&+P#J>I`HVOL2,20@Q(8X)(H&/(OFX]E'R
M`I:>7G;%MS6WPK,)YR&_XZ\=_(\?O)6^;9[9FC%$OV9K'(VF2C15CJ9F(\15
M%,?_3T*1/'2&Z4H!H1+$EZ4=I8F;.-PJSAM&+0K_B7*/$6%FJG9'S,@HD3;L
M!_Q,0ZJ#A40R4O'2\W2$OQKA[P`N&>"Q4'H&<"T4`5PASKGDO52,AW85])?B
MH5"/N0S(L"Q1PO/AXL,7\1J6W>%OC";>!HAT,9S^3C,?Z<?!_(P$D1@H89EX
MN=N5;ISJW2\_N^F&'OCW$4DI%M?`6XXT=\7"(OFA;Z+A5ZPWA8MW_);7?`:.
M#8O8=;!GV5_L#OBIYKWNBD%GB?6P".ZP@MWZGE*&"JJY97RF@X>YU=XDN"=^
M==M.'72\UN;\EZ4?>-UVUW#F(C1[>#CR8N%V(L&W%O)B'I=[[_H\+-,UZ"D^
M\C24K['P1)T?T/F'LC]BT^[N;%'NRP+:LOL$=WF;^[W6[46JZ`*`+5[BSF2T
MG[`RL,&<F!>0NXV4LY%3CP;XPK#D&MT%7S=.4$(Y4O@'<_3=&LE#4&I<5NJB
M<5))7>KG6.]"0F9Q;O!.638=%%7>=>@`'LR'N0LO'5&4R>6-D@GQ1N3W>5D1
M"V_V3;OI<J2XLKY'1G0J#*H("18X"#^@R)QMP1BKN8/9.,1YKKB[:YLOI<.0
M=D$R&+SJ$:YB$X/_[`:D&O(>WN5M<00MK]EDG-7P7A/-QH1QQ!I2J$(9_MWC
M`X]>X2V6Q::#V`>D=?A7\"&8!HI4&7T1AL7\>2,.S;UM:R=,N;S'Z+T;+!`I
M=?$(G2U.K>N2UW"5)>"WSO7FN*DN1S3@V!L^.\&(IF61F+3;O/X$59/7F/Y3
MO;LFEL`LA":>2Q@MCCTQ7TEO171FA?^$Y8D0[0]H_L;'`O.'F/AZ+&[SXA.:
M=>:Q&C)X[G+1M`A$:HX[ZN[NR!"`,$GF-["I%?LQR8EV(;Z2X'%W)MNV?5[6
M#`YD)1G.9LC+ZP<T6%KM!&/EIC?IQKZA?L?:H*):Q(&GHLT<;RZ=T66JUA&S
M'XZ*/F=`^SH'&X0!EL'>8DG2/G<[%?2?2,H(\E2[$5,C"PUSI3:QGN4ZG4SQ
MP2*Z&A01?Y&3[LF_'X8%L@NINW)O#;^1E:26'E%Q+'86;LF<5#B/.NCGV_UA
MWMH>AK`-9B[QL\B$F#!QV[1M@[E$%CDV'1:(NS\X-K^K[.[`A%4T586[V[P*
MQ@:YF`#PTWBKD/[>P:TUT<ESA"OH%M`_.H3]XK"!C$.<_9YH_OR.PL+B.'EJ
M_@@OH#)B>4C/U,7?\:UB37V"NHQ#HG%()$+%=H48:*V]=TW/B%/.WWC##OC-
MM='4=_:8$Y,*+^N.W[BS*_'=&N][V#J(P;Q0_G7-W7BLT-.3MC`$L22P?4T0
M5!,"/=^X88#N:GN^H#25>RO=+QDHH.,-U.?I+_7Y1!P>UU04F`0'P>'$%^)Q
M?AS`'`F_@P_6_*T;=CD5<Z6'(^\@21ZBWHUEOB;RC,9A@,!-:4JYD1=-O4-&
M:K!4"(W((Z`0T4@<;VN\NA36'[E%'-'"M>ODMTT^T!W.^K/FM615T>[(S%W9
MVJ)OL"+R4X\7I/*_=N?H'F^+!OD\G*XNH\URF,1GHX,6[L8B"030-U"5B/7=
M>$G9:)R*DO`R$(N6*G`HW)7UH2-WCU21CF28E5N+:"+;]*(5A:,4Z8D2,($<
MM'&&2!W,)'71OCUUO5.1UV#W>[H73A.%R8;Q!OU`CCT5S\D91QZX;S!'=&E]
MY/SX["=!G*E+8K^8(W[,ZU/>/C)X,)D9#]0IEYWQ99=PV?FR2;GLC"\[/-BY
M<3@5._[NJBT5+(A:@1X^#068#I((WY(+,!TW>2DNZN[[<"AWN_F93WZ;7/[3
M4K5FXM3-#?/M\%N\W+.N:J:>H+&SY_M9.N]MZK-)_&)R:>WO?U!>+3UNPD#X
MWE_!8:NR4A+QAAQ[Z+%2#ROUL"<O.(FW**1`LLV_[[P,&))4O20Q,>.Q/?,]
MSAHK`O4W5;5H%FS'G%`3&D2T\K(J2VTL;9+$?2!(+\`P0WPK2=^A[8`6)/Z)
M]0HT8!2`YQV#94.P+0=K2JTKFQ>PF3T$5O&)S^`A_0<XFT;YHA0'B@K$$U0@
ML8"\L0CA4GZTLLBN92N6^[*8-+A5RGF1/`";5\F%,6S+<JK5W%5P)*?6B)93
MK6W$/(RFNW?=$^BR*T8K57=8T:<'=VB`PS1Z!+P71(IU#)IHN]CU,KV)2!O5
M]GK?*A`F2P<417GZ2$@ZGN6.C[$5W\@?=&?$H9[^`_ZO[P870IKBWDD(2D$-
M7D#/5$P9JD;)-[TY)%@JKP&9$E0-LX.)PI%E,]L;Q($I=7U!1)<B-N`V9+!W
M>D*J$%\Y\;2>IO%DK`(L,?LF.JC-V)U+F36(SG)0HJZ^^?F\+B`6'BR@`[%0
M[)_YJ\5#S?SRP$,%=:M_.S.P\5!+RWQK`7A8\9?7\'=/8".Q>#V4]SR^3!_+
M=8<R/$[?[U!B2IJ*@_1VA1WG:X?N+NQ39R406/7_YP#""/7PGI]=2=UX.XG?
M@O207Y)FX^0QD+K`Z9)]&1OH+-TR+[C,"<V_/&=P>]VD=FZS+,ISAE?`XFV0
M/()7/3@=[`&`"`=G$<<K]!G2QDD>AY;JH<M;F2PT4#=0GN`"Y.FH8Z(L3O]-
MZ2?=@JX03E+'$O$.C$B%)_(5;0=SHG`K?PKQE6I&7J)5HX%[B9$\6L*JO;!(
M)W!YPSNV[/,P$_0[-&K(3O:C?41+V>K]&>VA:D>3B$GC-.\[-2Z[Q;8\>'&X
MHAY&P9*P7`&Y;%%&TIK#[P(P=\JT'H#W65L6O(&+6#!H*S2[*,L3,RFX@';L
M[J&O*P>JB(:>XM@3X#=U;2SH9H5#/S-/^6JOY:G@ET-ZN3FNX/@ZA&^`X_HJ
MU2^E$VSRI'!*YZ:P]F6#D\0IT;(&NVIVADVJNI`43C=!]$CE*U.KMUJOH1;7
M';#C"IROJ?5"R7QH"I>!:W#BS:[*7^0!0(*"?9+MQEK9B*TLDC`<9DP;QW*X
MX6CO&-^U>_91-`?_%T+C'"KNPC\`4?WZ+`\[ALP<<35&^K//M4!F[LMK@)$,
MF($,Y.^>!&!''=-)V#?^>G]>)PBV)?@)6<:3`)A$^TLB]PSV.<(G\$TYI"HO
MU;3$Z![&+>WLC%I^?-BL][)>K]ZF02#'@Q/[@SU9-V[=)M-,]Z?M;@T(!RK6
M8-&S(P/+)1AJT-P_*3H!JJAY'YN./)*QO1IN\RE(C4(\&9I*^G\BR%*B@L(U
M7%""9_D789*TA&W=*([3^\I1>8?KJ8$U>E/"=LN#.NYQO3%OK0#86#X"<\;A
MPK7.I;C%&-+PRJMT69NC)GP`@PG*$3Q41Z'#X#.W!W)9ECB!9RWQ[>73WP$`
M0#6#_0IE;F1S=')E86T-96YD;V)J#3$S.2`P(&]B:@T\/"`-+U1Y<&4@+U!A
M9V4@#2]087)E;G0@,3<U(#`@4B`-+U)E<V]U<F-E<R`Q-#`@,"!2(`TO0V]N
M=&5N=',@,30Q(#`@4B`-+TUE9&EA0F]X(%L@,"`P(#8Q,B`W.3(@72`-+T-R
M;W!";W@@6R`P(#`@-C$R(#<Y,B!=(`TO4F]T871E(#`@#3X^(`UE;F1O8FH-
M,30P(#`@;V)J#3P\(`TO4')O8U-E="!;("]01$8@+U1E>'0@72`-+T9O;G0@
M/#P@+U14,B`Q.#0@,"!2("]45#0@,3@V(#`@4B`^/B`-+T5X=$=3=&%T92`\
M/"`O1U,Q(#$Y,2`P(%(@/CX@#2]#;VQO<E-P86-E(#P\("]#<S8@,3@W(#`@
M4B`^/B`-/CX@#65N9&]B:@TQ-#$@,"!O8FH-/#P@+TQE;F=T:"`Q-#$X("]&
M:6QT97(@+T9L871E1&5C;V1E(#X^(`US=')E86T-"DB)M%=+C]M&#+[[5\RA
M!:0BGLS[<6R:-&F!`@5BI(>D!T4K9]4J=FIIT^Z_+SE#:6792H*@Q0+62!R2
M'S^2P]DGN\WCW<XPR7;[C11<*";@+Z^T<,P;QVU@N_>;QS_TCM5]D@O6UX?-
MX^<O)7O7;P3;U?CS]Z9@Y>Z/S5;P$(-B6R^X"\&QW5.2"*ZC!0&8%^DS+C2J
M%R8D526YL#HR%[E5+J8]29XM2^ZC,PR>TGF/4H"J98AY3]H$`2D*2'$I8TC^
M9!C]062(%U92)]"OJNZN8<<]>]G4=Z=V:)N>[!`Q(<$5$YA9K!"J$H;-'&AK
M`FYZC7"V-C@>8.O6.R.XA]7ONY_G$"6/WGT&X6LT(%60W%P%2R8)+3"G@9`5
MN-$(.8?KK%$S\K9&<]BA$L5>?YYBP.^,7`;@Q@!$3,Z?MQ^;`WMQ_^$XW#9#
M6U<=6U*,%?-@9(%[YI#+<\(,-U"DY^`FH\$8O;!Z:3#JE0#`EW*.,I!#**54
M%O)X'LIY`H`OX^,UDBFBKV7:&>=G0%,;0?&-M1(S4EENP7(A\N/;4GKN"O:T
MJ;OVT+#VP'X]M75S430J1O-5"4@HY(3"/%2LL)''XL>JW"IXMB?VBI98PK3L
M2U&P8U[O\:&*)9]7T[B"[5HN[81M@F8#-&XA!;`3N"W83X?ZU%3]*CW_4TH5
M]]K9BY0^M+]/UJ';O^^ZU>/)<>^#N=[P<&1H.6OX+\IF\K\=N1NS*;6'PO^E
M.M6W3,M'3`DI_L-470T]>PX1R^*2A:7OJ)1:H\%:=S5_5U*GE+2+U*7#/`:M
MH*-@H<*\3"DB!=/&Z)4&A7"%&^OO3='B21*%`3/OVZYKC[E9#_V;\G.4PH",
M4D_Q)632VC1;ML$:`XW$2@#")4%\MMM([[DUS`7+K8/QKGD>BS"J3LT&L`>/
M8Y[DT>#O3`Q3>R:&LM5G8LE:MC'"PW"93`14F.UYLKNX7WC%G`,D>+M(5,G4
MJ9XK+.<4V[._RBV`*>[R(Z6=?0-Q.@TG5J'S9Y$?K'0*/ML"-GAEW2C6K+16
MX`&#FB$8X(I$;M)TD+YQ/(OY!2,UA'SH")H'+YJ;=PW;WQUN>BQ1*T*$$\7#
M.JJ(N0RE31F`QG$V@.T(:V<77J#4TD5(045&)Q=I%;E$6!FL5BFO"NI)IM4B
MLP:.6O6)S&;Y:F9)?9G9,:FD_85)A?;0"K.:N$NC-'"#_8:![8Y#:8NJU%P7
M':PHG\@6=$_IT:>B'&*HID2/,-8LSC'(%%XK*96X,A:4?!2I-2=BM=)ZG=@H
M(2),A%1>B&17!B-C(EO2X/H$VW`'`)H]UV=TS*3(Q%(*A1?5J`L'LUF1@NZE
MU&%F2!=R)MV*&)0OQ&,-D&>)*;TN1M<7XHAW\37<,^D5W!K(C1-NN,#*L"(&
MY4LQ%>>$.ZR),^YS,=:1<6NX9](KN(V`:3+1#1<H=5V*;"^E*TT!G0DIPJ9X
MN(6>'33Y>`GC`%2SJW\^U7^#LZ6XQ4D1BK:#&U0]W.6W"EM$%AU[#V<&5#.]
MG_[,XF9@'_+JA`]9P`6G9_LC?8-+3U[=D.T2KIK%Q_D+29;N>IC%9"0?S61R
MG]VP843;L^&>(#19F=45>65OSP7DF$QUR7\U0,"/YO;ZAM1[5(LX&D;$PSVK
M^IZ`$2-DO)],5`.K.KJZ[[XC\OU$/IU58X!^##!3Y<?0?-%D:GW&ZQ/#Q;"G
M-YKLL+_Y)R](#6GUQ5MZ&6;F^BI!AB7>C#^>&>^2%I*!0=;TE2#5L'\$>VKH
MX]#=<Y;N3%,8]XP<5*"02\1/)4(!I`*I"5-%MM[15L0U\5"-UL;XFPD7"<AN
M-S(P<9Y&OGN8K'0]VE?];5N:XGA@`SP`!/[?6QW8AU,#6<=O30F#JKB!R*:3
M^=\!`'3OHN<*96YD<W1R96%M#65N9&]B:@TQ-#(@,"!O8FH-/#P@#2]4>7!E
M("]086=E(`TO4&%R96YT(#$W-2`P(%(@#2]297-O=7)C97,@,30S(#`@4B`-
M+T-O;G1E;G1S(#$T-"`P(%(@#2]-961I84)O>"!;(#`@,"`V,3(@-SDR(%T@
M#2]#<F]P0F]X(%L@,"`P(#8Q,B`W.3(@72`-+U)O=&%T92`P(`T^/B`-96YD
M;V)J#3$T,R`P(&]B:@T\/"`-+U!R;V-3970@6R`O4$1&("]497AT(%T@#2]&
M;VYT(#P\("]45#(@,3@T(#`@4B`O5%0T(#$X-B`P(%(@+U14-B`Q.#D@,"!2
M(#X^(`TO17AT1U-T871E(#P\("]'4S$@,3DQ(#`@4B`^/B`-+T-O;&]R4W!A
M8V4@/#P@+T-S-B`Q.#<@,"!2(#X^(`T^/B`-96YD;V)J#3$T-"`P(&]B:@T\
M/"`O3&5N9W1H(#,R,#8@+T9I;'1E<B`O1FQA=&5$96-O9&4@/CX@#7-T<F5A
M;0T*2(FD5UUOVS@6?<^O(`8+K#Q(5/%;>DS;=">#:2?;N`]%LP^R+,<>.%96
MLMMF?_V>2U*R'8N=S"X,V#0/[R5Y[N7EX>OIV:OI5#'.IHLSGJ698!D^OB4S
MPZPRJ<[9].'LU9O.L*IS>,:Z:G/VZA^WG-UW9QF;5O3U[2QAD^D?9Q=9FA>Y
M8!<V2TV>&S9]&Y`LE84&`/>9ZZ:&)/-$%30`BQ%^,1="I+D&:(I49T4_F,PJ
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M'RW`'3:7OPA#PHX/'>=I(94WR+6)';HOR9^<-BQ-<J%32P=`&4L9YSE!ADAE
M)<T@!`\SZ$+)`T[(/,LET8RFT1Q<N#Y>\-10'S:5^U9N5$;34&>_ZZOIF>6I
M-<SHC(I7EJJ<:@Z^V_IL<0Q*K=/B".9LQ<Z4L*E5_:!"I4H=CM&H3CR/34"H
M_)_`_=)XP+CK\0O+\Q^@PHA4QT`I39AT!*2]BJC?_7I'P-?3DUO#BE2`.)$3
M?[@W7-KH/H'X/L1<(4,H,2XLSVR:4TL7PC>LC_6TV99K]F'W,*M;2GT`0OG(
M%T)*.B4'1D;XQG$2R!PI%V<S`@<Z(VC@,X+VA$;@P&@$C5/*#65J3ZDB2E_`
MI"ET#O#65ZN;4`+G[D!9&OR^_+YZV#WT+.,@Y44J7D"L,/L4'B$V`@=B(V@@
M-H+VQ$;@0&P$C1.;:12C@=A\*'9VGZPBDYIN\<-\1&D#VXXIF6-25ZZD@>L\
M*4%UV6XI9V]VL_6J6C]1M8(4P-VQ8"$:4[H[WI=/H%K(%W'.50IE%>4\`@?.
M(VC@/(+VG$?@P'D$C7*N"YDJ0YQ[?F6&I,L/J$&?,MQGM<B4!?F77^NVQ#U'
M'8(NNLO-IMEM*B3SS;K<>!M;))_K+7M='Z6ZS8RO&G]";R937'91>B-PH#>"
M!GHC:$]O!`[T1M`XO3D&#1DMA^I[($N%3]FC@H`L]S1Q3\]-NZI`9+DB5+B:
MGD!7W;3-?5L^$.$"T@E!VD'=M9!"]3X27!7^_O\QY1IU7D89CZ">\`CH^8Z`
M@>X(ZMF.@"-D<Y1DD3.--THQ7':<#P5$!;4$'=P0A28K-"BX2\J[R5TRHZ_J
M;N+X+L*UQBUDHTX@G?U)<"4E)[5S:B6YM,\B<I?,`=TEM1^0OZBJ:(LW5OR*
MC,$A"A$TA"&"]G&(P"$0$?3UCUZMX0!H7&WNLH2^SVQQI"_9A+L$I_3DT*E.
M;4^LQH&`")\87VZ`9=IXNKA2N?:_6I_0!X%KQY1D$)$!1X0AJ4^48$#'E2"!
MAZEX')=1,$1E%`LQ&<7ZB(R"^Z6>8O$BI`Q$,DD^?S"$'AY\00;^6FYV9?LT
MT10`[EZ4[OE#)V#_#D36Y@9B*5'GTA1>N."ADOP-K5S3;<M!O;&4Y];@\A\&
M:@)LPL^M+LZ-(5<2SX_PL!@]"N0I2O@H&`@?Q0+AHUA/^"@8"!_%XH1+14/=
MI?JNGK5Q;D4^<*MS0R\MQ<^YU715NOI#I5TIB=+.<9(@ITBB&!+<P\`]N3P_
MQ_$@$YW)%Y0;^"VB'(^"@>-1+'`\BO4<CX*!XU$LSC'5C4&%"[M/Z7"WO@?C
M)BDGT#<)KE9'/:ES1[T\2&NBAS0]TC<[A\09XYY"(_?<#P/WW&?YN<CYR[F7
MV$64^U$P<#^*!>Y'L9[[43!P/XK%N<<?IQDYBGLFBV<UW?JR@)8LK''2,>_?
M,CPS.!RNX$N16\2&#$16N%N76VY]ZY@L@7"<5.:>+`=:14^'`S0PXD#H"*5&
M*OZHV_V463Q`XVB(T#BX7]`(V,=H'-TO=P2,1DD5.0Y4?T`,!8F+M!#A-84G
MU$2[\R&3-5HH<N<6KB=<\,+Z<&1TVW*\6R4J%$HZ::-^F/$W]X=7L+UD$_C5
M/II"XHDF?2OSK>-H9O`W[`.J]8AX5>"%0(K.CL4Z8LHINU1O:R5Q>6`=XA(Q
M)A1Z(1CG]!PZM+59:D6/&DTU^#3-(JX)M8/KXGFJ]5&/6`?9TEM'9$O$V*/!
M]OG$(SF3FQ13X1N;I9P9SC3"-_T#S0L\`HU%\KP-751M<Q):>\")[9Q,O4JF
M85"()BC$E',)A>5&ND$L#`@2,D,<A,==*<^*7L&+H.!?TPL)XH'*2^-_-^%O
M5V^WZ_H!28L"75.1%SVVG9"R['J+JMKY1MNNPHC[X.3;:KOTS1YA?4?-@N_C
M>;WO,"9%^7>'@!(>33PSCOEYQNKTYX/;*W%OBA/*K+0_H(Q#5/,B#`BW7S6\
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M,MRJ2FBQ#X*/YQ?D6DTG9-FP;=TZ&X&J4)+'.OP-+G`9T\';%RXNA\(5<@X4
M*<SY!))MX@H)]T7*4#P(HD+"^PI$':QO@.9@'@P?_;\R6#Z%C)4@7MJ3`W!Z
M-F<UR*K95U#D3I4_<0AP:%`($8MN!]GLR?O+AV(H:?/_OZ1I'X_?-^RV?MRZ
M(/H`%-A)RRSI^`S?EVN'5<WF[Q/4$39KRG9.N3!?.:"M*V_=M!TK=[Z];%J/
M_@=Q#5VT?WUPFMA_2Z]RW;9A,+SW*;A5!HR@E'4^0(-,F;)U8F,Z%F)0@F39
MR2/G+?I?I"CYZ)`ACBSS_/E=Y!:.WR];R5*0-&G2OUO^&><=.VG;2D_CK@#\
M3T($9S,AZ^$^SO!^5+J&H\._:(=*1*Q.Y!^\\D>E7O;,S,I/+&TZ_L;<A.5T
M/!R(WF*=XV"7NV3^<AD#I>:](H.82:-78;*%C\X2*7<C4E79#]N_-H.-Q'ZB
M%5S=LCIRF4LI1X[.K,"<X<RQ!H^]5WEU;.3)BGO!-7!3EG'0T'Y@+?IR;+F;
M1OZM@8I(0OG>H=EK+*.2-V:%1/Z<`"-LJ2`M%I<)Z9::-8XF:COKE(B462$5
M$54/4V47E+O&RMB7[/=]*=3G5Q9L"4A7K94!*J'8CHBEG!"<$_CYB?"#X<F\
M]9;/%]#DI-E?RP]G;`6%AGT_LRCE"8_WM:+LP4JM'U(-&?B>71JW5<_MR?3>
M+<76Q`['8>F"KL665H%DWW15X-L60D)(&GXA4<%Y$2%\Z=)'#3>TAV9+KK$#
M]W"OC3FHX0@O"#LI%F/P<$^+31[!/0_#\6@S'-8<7XC.:F\..`/^'##8[GC8
M#.Y\E;Y;-126;)*5#5MYD)1;L4&@&L"N:UU<N$^P0JP.3D8@*%$OO5J6B:1`
M4KPRX4^>'+`5=@0A\:TWTA])_M2>[<EZ<!2;+,*LS[_]6G+LGG,L2V/N8RV-
M5K`T5B*-:0(%'?#8N2>'9#>*0TR1V(LB,#1$Z@`16LZ2D\LC1;N'V+V5)*-]
M0*'S/5`$^;F"6LQTD@6/3[?B2]B="T`LC%<C_;P\LA]YB_I38TZ':D=;J]+B
M/R&`'WZ__/@';?:Y/`IE;F1S=')E86T-96YD;V)J#3$T-2`P(&]B:@T\/"`-
M+U1Y<&4@+U!A9V4@#2]087)E;G0@,3<U(#`@4B`-+U)E<V]U<F-E<R`Q-#8@
M,"!2(`TO0V]N=&5N=',@,30W(#`@4B`-+TUE9&EA0F]X(%L@,"`P(#8Q,B`W
M.3(@72`-+T-R;W!";W@@6R`P(#`@-C$R(#<Y,B!=(`TO4F]T871E(#`@#3X^
M(`UE;F1O8FH-,30V(#`@;V)J#3P\(`TO4')O8U-E="!;("]01$8@+U1E>'0@
M72`-+T9O;G0@/#P@+U14,B`Q.#0@,"!2("]45#0@,3@V(#`@4B`O5%0Q,"`Q
M-3(@,"!2(#X^(`TO17AT1U-T871E(#P\("]'4S$@,3DQ(#`@4B`^/B`-+T-O
M;&]R4W!A8V4@/#P@+T-S-B`Q.#<@,"!2(#X^(`T^/B`-96YD;V)J#3$T-R`P
M(&]B:@T\/"`O3&5N9W1H(#0V.3$@+T9I;'1E<B`O1FQA=&5$96-O9&4@/CX@
M#7-T<F5A;0T*2(F<5TN3V[@1OL^O0/E$I48T'R)%QB?'Z]W:9&.G;*7VX,H!
MHB`).S2I$.0H^O?I%RA2FGB]*56)>#3ZA>ZO&W_9/+S>;%8J5IO]0QR%4:(B
M^/$HC7*U7N5A5JC-UX?7[URN*D?[D7)5\_#ZI\^Q.KB'2&TJ_#L_!&JQ^>UA
M&85%621JN8["O"ARM?E!=J(P+3/8`/81+>,@Q>-!%M'1)`F+#);R,LR2O"0:
MVJ?SH&O"ND9J&8=QD8U<HI*TP%%.JKQ[^\_-SQ\_J'<?/[Q[_^G#SQ]^4C]^
M_/3KVT\_+'_Y^/%O./^\>;MY__?W'S:?/??5E'N6K4?Y$_-X,U^OO>@X'D6O
MD.P+T"WC;+4*RV!SM$YUYM1VO:K:IM>V<6K?=F?=[99UVS[9YJ`6_]K\]2'.
MP6L)^M];E'BV<<IL7:][\W41QV$>F*9WZFS[HVU4?S3*+^L&.;9[6&2VJS`I
MTY6P'3EFS-&H?W3V&;BJSZ8:.MM;X]0O\#GHWK:-^F1`5V*]"EC-92I^OW5"
M.CHA8=YOJWZ1ANL`E8G+,@N5VAR-,U?S:1M]0`-0V_$)S1\T-<%OPW.WB,,D
M4*=.Z,')\*EX=M+,CO\OBU68!N!XGNI%$@A/&"D>MGS^^X1VY@`JCXKRWI$Y
M&&7^<S+5C`U3MG#98'T[=.R\S9_80W*?)"H'[6*(E$8?C"P87D!.>0"73%^>
MD<@"]7$B,F=[<K:G\#,A!&\/O##P0F?4R71\JR2\J0SJ^*P[EM,.3NDK\]&`
M[>"8H!'.SHTWZIA6\V<T0RQ`%\:!DM//;4V#9S/S29QC_!`R1#&[YZEISXW2
MS4X-#8]!Q57@GMPCK%2FZV$&5PLWC>NDURK`19P:VG!TOL7%H^G47E<X;#O(
MG2-2541UQ/1)A1?&#CBUT@-8AI;SF0$";$6.'W"`2VA8%CQ>'9J*.R?7S:;H
MZHCFEZ15`K:3B_R4_%2"KOREB\P"M:6L1C)-9/V$0\?L*.C+@/]1<3BVXZW]
MWG1X`P0"69BOHC6#`,#3OFN%,[A'CG&<E!PG&<8)FXIKHM\"_?LXC9^2#'9H
M\7>:"*D"?)W9X1D^((0GEC5ELA/,\?K?8LX(.0)GVPM=V"V^>MQ,0'W$38C;
M7Q?+-0@`5X,O=TZYH3I"V*M77TEB`@D8YU,P'N$M)G@+].7QE7IUMG6-7W=L
MAWJ'H\H/SG[`X("C4ZT;^'*A$PD3DY:^A(B@D@2]TDUO*WL"$Y#'UM36/-/0
M-KUI6(3K[5=D"XY:KXO55>_[VD1)F@7$X=2UOW&B0QC3W%#T9,%TL943#7^9
M`$&KH,#+@E=P67%`F>9XEYSM2>O)@<X'`&\A0&H(-9Y1!G.T902"1=#L(%)X
MH>7=:TB0I;<A047S2\!@LQ.H$B#BQ3TNQI0M`.S38I3[8I2/Q>AW0.V/(6!G
M]BSF!KE'K'YFX>8\HN[WE0A-]#?,=EX9(KTCL%/-/%Q]";A7^?\JSWVI@4B=
MNP!C!"]\JPD"`-Z=&SCE``/253P)W6QLO+Z,&,'@U$^0@D(((V_82BR7P0V0
M"EA"X9!J0K4C'8&5MYM[WHQ";M2Z:84_QZ!7^28&)RE,E2S@1,5`;M7!0N$#
MT"7#.RH7<'M]2]F["@'EIJB3C]G+8(`N'CPT$Y#]!/RH`X0@9,.TL$IBZ-*N
MK`JO"K1XC^K2#HI!"XU2@$P5GM\-R+NVI!?C5!'F25+<Y=EHHZ_6<)?HG((#
M!<+NIM,K?'(58W(5G"^%Y(M/U(*")<7D^E%7O((5>\9>3BHYR8P/1UGEXLWQ
M6'`\YM.25@130<*Y93(NH`454"4*\T[%1X>=>81V2$1=XP(F3,"'9IJ)G024
MN[F\QWD?-(UZCK8C!R:Z<UKN);K/$KV'/T]#?SRS@Q04^I.OR%*,$1(JWPC,
MJG57V4EZO-!C/,O^MI[D"73F[6ZHILW"O(&1P]/4>S)*M&L.X&Y,M*IUHI\<
M;L>.9&:;;JY]-ZBP>S-)37#FTD<]AVDB/7<%IRGR&OX>^&,60!]#JEM9AU"!
MDAK#"S;8\LK`GPX_0&ED5T[*L7Y!(72:T;8\J\SN)4[0/HF$"[NQ%Q5M)_1+
M)A2FF@5V_47-5RXBIW-OP(D\%B6%T/3PM),=;Z=0>!ZJ-EK$(BKQX#QR-J-V
MWH%P"3SP,JK>VZGVWIMZYJ2*9U;7\]`OKT\`:5:JMH%LQ+=<3_\\;OE5(*WX
MN.FH8Z#*"2VJGI]P;_A)")!D+#?%>9@4\;17NG^"'##&JJ.&X%3$49X5:H]O
M@($?!OSNT/[A@07I_CG1&!:Z"LLDF4#\/9`>!-H8.)X%31E9D!EDE09L$F#D
MAE=@"F";1YJ`IA8P)"=>48C'X$2N8BD\<*,T?[F3NCY7@]'EO;OZV*)GX44`
M$@#5H:7?#[X/S?.,S62/CNSBM8`;%K(:`O)`;-!GH`FH'D%R7\!AN`[@=5%6
MMDY0#=!>?WUIFJ63"K<>%2ZD6%KR"(09N8"DW%A!-2X%9T5Q<=^+W^D\-7JB
MNC-]7QO1TI`!\,SX`Q;Q5210M*-R6K1O.XG?L8A<GX11F17SRE^-'D*_W-P>
M'`85\!G'W@#'1ME]9WW[V(+*TO;<U``'HSM\08$N5'&DV-![2_DW:)QEZ_]M
M'#5Y,04O]>?4F%RLP1;%G'UQ@3;@J'MZ;1K/-TGBW+]MH;NBFA8S^%$K3/PZ
M<AN\\\!0!$A*:L>=@G]GIE&8KM?)74.7\:,"GI>=.0RU[MON@L%.`DI2&(KF
MD^D17M"1%ELRG_`)Q.DWPM2`:18/G;$_J0PVB,"&PL(;_0;9<5[EZVCJQ/%:
M8H%,(\&527#MJ=O<<Y,-;]YU-H$\MDRN%W2AG*2F'=2Q_5$B8AW&ZS*_SX^Q
M/4VN-QC1#2*^]Z9#EU.URQG[Z?4E-1UG'<\@?(SL*RL\3CP'&Z!=M;);U<)M
MQQ_+CT2>'/CSB#SAJ;'EJ1SHN3@(:3M;K+U,*Z4K][4/NS/H8!_].3%,>'9@
MW4P1IQT8#?K.S5-HA%\3!R@@[#R9=:+`F]%2+>I;@)G+J,VL7MXEMN[[#N_\
MWX.N[=Y"6$.6N[9I3`UF'"TD:$4M/X52'L9I_,U0N@.L[`I8>NLU4X>N/5]S
M/%I_"WOPZ'9PMJ$DW-G]WE94,8HP+F;OE=NG3XW]3@>(4_54:A`T*3C+<)5D
M\7UPEF-PBCGLVA+BLJZ!R\`S:DV@R>5FJN2N+.$(*0-9-$R$/5=G#[QV%&X+
M]`MG*-,J.5M5(J+KC(BNQLT]BU%^YYD_EKAU0B1[%!S0S'O](>S@B;:5$UB'
M`#TT1)&W4#14>\](.'CAP\Q4];*M6EK%40T'K0A$J`:@TD]"*UNW@F=A.EX$
MWBE!%!0O?G=`>R0AR2T-%`]9U]1(0SFYAT(9(5CJNG9<.J$*9''VK6A&P$9,
MVW7ZK&NISAFE=/%2=9X$^[7L<IWPTF[J1!)?&\A\WL!FU*-F`8^A:H,ROG_U
M>VZ1S+O7*SEUKW!_A_9YK'IKJ-*3/G)]E9VP[*[!-A1?&`NLQ`VRC`,N8334
MO&+IGW7B#3YPX`WW,K'PUD2*?>DZ8!].R*AY3;%YQ9D0\98<1Q>S6M+'XIC[
MV-7(G8^+[[WE=_F>SCV>_)?W:EE.W(BB^WQ%[R)7V0IZ2TML4S.N,(G+II))
M>25`!L:,1-3(QC^5;\Q]M=02##.513:VI'YPG^><2U'U'7[N1]RLX<20]&/>
M':"80T:,4N#O);J$0QJ]H7V1<U!;Z^V-?PF#+*(N'H46)O*8\^0,!Q3%3_0#
MX.V7IN8/6B:@!=P>.^</`<A;>]<H*5"286QU,]>\N.3-_)+33ODIE(!<X&+T
M4`,&;2M+C>6@%^#F+SR.)!@7_%?A3[1O\!O.(>?G#:]3_?BR]LZC6;Y\!;JB
M22<QWWB[[*5BH5]IAYZ$BH4##:P?VX1V8IZT?>;1$2D2((;*$5;*12&#HFYV
M.]Z"IB")0R#--KJ@;)ZY>@/'Y`J(2;*EZV8WS!4B'6?`A%E,'H;Y>!"5SJ(!
M\Y4'3NPJ,UWB9YHYN9^Z;C*]),,H'I%Y,'2Z@=7J#?JJB85H/J+(0BZS47AN
M:)7^L<=+Z!\:/S%NO+*665950(U(BDB'I$]YK.5YM>)=6D,U`H%1[N$:0'WX
M#;Y(]DL0Q;HA(+0$X,O`DD.7A%C]&(-<-_A`[!^@N+A4*_Q0\(?2>JY;O@U9
MCETJ>J8+M#03']!:\1.J.UK?T1LR:<B7*MN,@IY?Z>8+3&K=;23.#AW>LA_:
M`#I$OY`!D,_6FBU=PG?;+JPL7X'D:`6(3DBW.T^*(!CP]V!&.#6#S@N:HQ!O
MH(&?KS:D,*$TD]C2=(,1TBDUCAOY*M^4>@_ZJ8(;T"V<\>JJ6:U;E0=796EZ
M1ATN\AV2-T0?[L0N9KQ;;D`6%=I5ZJ^J8;WH9VX<A\<]=\R?>ET)42ZA._*E
M8J9:,ZD).9),@>5=50N1O?%*;W/_:*&:<@E0M[<XCDG+0P3I[<TM>C1<V>2&
M6?H*_@1N4,,_-]C4#<-&79QJ=0(/Q@B!E'EA?\2M!3W5A"9XW,(?PA,H)NAI
M@A_NVP`)B6"KHQ6R^/NQAT)BB&"/>P*B..P*B00D]L^+JQC%,4611A]+@#QC
MR<?FH"R)G$#61Y2L:ICPEE?\M:I>-H9-TA2LZ4KN2,9"JC3B$24)_QGMBE;C
MNR9IJ>;O%R2*^>.:QU,8>0&$&OZVH;]5F=>R]4?N!=\GAT6QXV]R>\6W=_Q"
M3@SB/6KAV^.6WJ\+B.H>[H?:^+O9U#`Z4HDJ7'DNX`G:71>0$AXVMOF;9F!?
M8U/Y\--I9@7+ZUI=F!>JKMD6?(C$$8X7P(D[0?C($;T$SUZ2V9/@T%I@0K!O
M_D[&/79&X=4\$D9N%*?9#Y09!)#4G;I!'N2.$V4J_Z3-M=&]EXAQ%!OIWI="
ME96JYG;9K7J]VTIF?I6?4;NF=V9A>CJ,$X^][^E:EIA8R5!2S6XI:K4@S<D$
M_LH251="J2D5.>];LV[%LK,KWN>*)V6[ZKJ4;/A.U0!`[B$3-"NE6)L:8K,N
M("E0-A68\[Q%<BD+D]8L#KVS8/5&.J9DG!)1YN1]F3+$LN*5(<=(EEJ1W*D7
M#9U&C"55IW&IPC>P#R%:3A2NF2O$0-MK<IAJC@KKE]G,5V#K,WS$;6D4]PO>
MF3V,;R>?Q@^_/IH#H7T@BKI[^<K149%&/!TH\#`*47C.ZGS)")"!W`9R!*+%
M\N>)<+PEQ``J5OEN5^0U2>:,HQ@Q+&2<_<CA)4TBP7!68+1M"WM1')R3>BCY
M!WKNA#9#=`7&@KU;2Q4NBK(U'C>5)`#'O`5\^/DB00,M^$)CCD:]5I$8IFY0
MMT3.G/]I1OW-DE];#4"W0DZ\$2<E<L,DLUK-#]N$/SDW&Y!ND4N:"%NL,J<E
MH[%+0]U(T8,7@;12?@(]%F.@ODJ2_R'U`I?[M)>?H`Y<WU=^'+N)V<W.+#H'
ML>@,HEDV>VX6^=Z1$J+]-W?W#[_?3C[W2Z]OJ`]8G?ZHH;Z?NLFQH0-%",6:
MDZI8;33H7LCO7DK6,R4+2;[.WP$8&`M@!@HBN\C2SG6!N_&'2\4`Q>@DE<-@
M5C&88>'0&BI0`;SK5E-%`I:,D+5Z7$#G#Z$N<[,D/BXPJ:O[=5X+#[!*4^,/
M4$>?2/14!]$8HAP.^4(DW.50[NUJ7C%WU2)(C.2#F/$CJQ@1/699^&)8O3#W
M].6U;U7O'QOJL%7^M3J<+=P`T#Y3?I0!97ZW'@*(5PKU`/4[LNKA!+%>JIX^
M[A%=E\F.#,>\H\UD0IF4J/,'CHV51Q++QRF2S$9N$D"A#N#5][IVP5RBESCG
M=(@,;V?1_FK`A1D[?#>;?%(1`D[HN.@4H*J"5KSRL`8_WEW?S1[9-+XM";Y%
M,88QW"@:9;V]K?V.-_+<N]^89"(W#5)H)I?:Z/9TAWZ^?IBJ.QBS:#:ZK8@>
MT<CB`CL)A!^'32X;L)L5M2?Z[<<;*J^/?.J4!5[6U41H;*#F>Z"_TPOHWUE^
MJ$J:%&3N@*!-#E@9`:4[AA%Q0V]0%YAWV9K3FG$CZ';ST;.^<+%:OJ#T&R-C
M),[T__3GALZQ*UOZN*#GAE]R/M9NG_)3^3+/=?'?7#]*XW1\S43\;;>/51JX
MC9KA@?Y.H7P2VW$S$9+;,C*2T^1#/B]H(IV2T.N[8C9;\^()-SKC[Q](-4S.
M&'^,2Y@SS!@9GO8RULZ7G+$6C%OIK^YKD,\"S@PV`X$_%5@:Y&B(ZV><ZX'!
MT"?^ZL5'0I47)K.?_AT`,9;^L0IE;F1S=')E86T-96YD;V)J#3$T."`P(&]B
M:@T\/"`-+U1Y<&4@+U!A9V4@#2]087)E;G0@,3<V(#`@4B`-+U)E<V]U<F-E
M<R`Q-#D@,"!2(`TO0V]N=&5N=',@,34P(#`@4B`-+TUE9&EA0F]X(%L@,"`P
M(#8Q,B`W.3(@72`-+T-R;W!";W@@6R`P(#`@-C$R(#<Y,B!=(`TO4F]T871E
M(#`@#3X^(`UE;F1O8FH-,30Y(#`@;V)J#3P\(`TO4')O8U-E="!;("]01$8@
M+U1E>'0@72`-+T9O;G0@/#P@+U14,B`Q.#0@,"!2("]45#0@,3@V(#`@4B`^
M/B`-+T5X=$=3=&%T92`\/"`O1U,Q(#$Y,2`P(%(@/CX@#2]#;VQO<E-P86-E
M(#P\("]#<S8@,3@W(#`@4B`^/B`-/CX@#65N9&]B:@TQ-3`@,"!O8FH-/#P@
M+TQE;F=T:"`X,C0@+T9I;'1E<B`O1FQA=&5$96-O9&4@/CX@#7-T<F5A;0T*
M2(F\55MOTS`4?L^O.(\)6EQ?XV1O&QO3)H'0&IX8#R'UVD*7C%P$X]=S;*=)
MEU%I$A*JU)S8W_G.[;-SG@>+/)?`(+\/&"64`\6?MP1-0,N$J!3RAV#QMDV@
M;-T^A;:L@L75DL&Z#2CDI?W[&800Y=^"F)(T2SG$FI(D31/(+X8=2D2F<`/I
MJ5NVAK#NH6(6@,EPGTS,B59209(11;,]EFH'7EY??3C+/]U>+F'P&DH0A"NM
M(&:$*:6=EW/PT=UZHO644/YF;L1<$*&$.,1.D9V5VE(_(SQF2DJ2A1_[INV+
MJH.NAFYCH#$_^FUC'B+&"0M-Q(@,JZZ%^MYM+TW9-]MN:UJX_%5NBFIMHB_Y
M3<`EX4(H[.X0DXTAE>_N6=E9$I8)>3)$6F_;KL'8-G<<6TJYG`BL7[FGL@2;
MHH55OWN"LNA;LT*.;8LDCW73^>J%(E2H;%X]2RV1FYN=ERV_BS#=L,8FX`.^
M&FBW;F5=(6]=@7_SJ!9;H"UH4^S<PGV$7`I7GO`U#<'#-I[,0%^M3'/`=S(#
M-*:OAOBV'&<-3$4_0.O&^_\V*P*NOSCCN50/YZ]1\TI:`,X6A\MYRFR.SG<2
M)NI#2L&<B&U;_BZ/\&Q7UM4)7%<EF6DT'ADFE?K.NN`NC;W$#M-($DF2\"Z\
M->LH1HK03][;W5T$$<=3-^3[3.M39?0HKU6SSI*Q8&S(JW"2",;D*_1R4?C!
MF(@[YSCE"1'AV>,P)S]%X/H$.&44`5IG%$L[QPVV'^_>#18'PO(VW-1%51GP
M>%-^]PDR@E<0?W&<Y7@RV'B<!^HHS@15&!FM!`\#KGTH\#`CDSO,+#P=8XUA
ML%_Q?OR>F(M7$.?;;F=.X<JX.5I^9&%A4^S@?3&L%7YM_1SAP\8)89E._M>T
M_U$5>E(%/U0%<ZJ0+U3!G"K8$54X3>C):>&P5A+)8,-R8+\O*JL+;*4-TWI6
MT\`QB8PYEF/BK]6(5;B]VTXQN(];M#O3S%22>>J4IWH:4BIU9K..8H5?H+TV
MHJ$E75=;!61A4_FG>8JW@QG;!P_?%?B!&.\Z9-?I3`>S$+:?6>9:=4Q.!Q_0
M\;:\S(,_`@P`6)+3]PIE;F1S=')E86T-96YD;V)J#3$U,2`P(&]B:@T\/"`-
M+U1Y<&4@+T9O;G0@#2]3=6)T>7!E("]4<G5E5'EP92`-+T9I<G-T0VAA<B`S
M,B`-+TQA<W1#:&%R(#,R(`TO5VED=&AS(%L@,C<X(%T@#2]%;F-O9&EN9R`O
M5VEN06YS:45N8V]D:6YG(`TO0F%S949O;G0@+T=02$5)3"M!<FEA;"Q";VQD
M(`TO1F]N=$1E<V-R:7!T;W(@,34X(#`@4B`-/CX@#65N9&]B:@TQ-3(@,"!O
M8FH-/#P@#2]4>7!E("]&;VYT(`TO4W5B='EP92`O5')U951Y<&4@#2]&:7)S
M=$-H87(@,S(@#2],87-T0VAA<B`Q-S0@#2]7:61T:',@6R`R-3`@,"`P(#`@
M,"`P(#`@,"`P(#`@,"`P(#(U,"`S,S,@,"`P(#`@,"`P(#4P,"`P(#`@,"`P
M(#`@,"`P(#`@,"`-,"`P(#`@,"`V,3$@,"`V-C<@-S(R(#8Q,2`V,3$@-S(R
M(#`@,S,S(#`@,"`U-38@.#,S(#8V-R`W,C(@-C$Q(`TP(#8Q,2`U,#`@-34V
M(#<R,B`V,3$@,"`V,3$@,"`U-38@,"`P(#`@,"`P(#`@-3`P(#4P,"`T-#0@
M-3`P(#0T-"`-,C<X(#4P,"`U,#`@,C<X(#`@-#0T(#(W."`W,C(@-3`P(#4P
M,"`U,#`@-3`P(#,X.2`S.#D@,C<X(#4P,"`T-#0@#3`@-#0T(#0T-"`S.#D@
M,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P
M(#`@,"`-,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P(#`@,"`P
M(#`@,"`P(#`@,"`P(#<V,"!=(`TO16YC;V1I;F<@+U=I;D%N<VE%;F-O9&EN
M9R`-+T)A<V5&;VYT("]'4$A*1$(K5&EM97-.97=2;VUA;BQ)=&%L:6,@#2]&
M;VYT1&5S8W)I<'1O<B`Q-C`@,"!2(`T^/B`-96YD;V)J#3$U,R`P(&]B:@T\
M/"`-+U1Y<&4@+T9O;G0@#2]3=6)T>7!E("]4<G5E5'EP92`-+T9I<G-T0VAA
M<B`S,B`-+TQA<W1#:&%R(#$R,2`-+U=I9'1H<R!;(#(U,"`P(#`@,"`P(#`@
M,"`P(#,S,R`S,S,@,"`P(#(U,"`P(#(U,"`P(#`@,"`P(#`@,"`P(#`@,"`P
M(#`@,"`P(`TP(#`@,"`P(#`@-C8W(#`@-C8W(#<R,B`V-C<@-C8W(#<R,B`W
M-S@@,S@Y(#`@,"`V,3$@.#@Y(#<R,B`W,C(@#38Q,2`P(#8V-R`U-38@-C$Q
M(#<R,B`V-C<@,"`P(#`@,"`P(#`@,"`P(#`@,"`U,#`@-3`P(#0T-"`U,#`@
M-#0T(`TS,S,@-3`P(#4U-B`R-S@@,"`U,#`@,C<X(#<W."`U-38@-3`P(#4P
M,"`U,#`@,S@Y(#,X.2`R-S@@-34V(#0T-"`--C8W(#4P,"`T-#0@72`-+T5N
M8V]D:6YG("]7:6Y!;G-I16YC;V1I;F<@#2]"87-E1F]N="`O1U!(2DU0*U1I
M;65S3F5W4F]M86XL0F]L9$ET86QI8R`-+T9O;G1$97-C<FEP=&]R(#$V,B`P
M(%(@#3X^(`UE;F1O8FH-,34T(#`@;V)J#3P\(`TO5'EP92`O1F]N="`-+U-U
M8G1Y<&4@+U1Y<&4P(`TO0F%S949O;G0@+T=02$%'02M4:6UE<TYE=U)O;6%N
M(`TO16YC;V1I;F<@+TED96YT:71Y+4@@#2]$97-C96YD86YT1F]N=',@6R`Q
M-C8@,"!2(%T@#2]4;U5N:6-O9&4@,38W(#`@4B`-/CX@#65N9&]B:@TQ-34@
M,"!O8FH-/#P@#2]4>7!E("]&;VYT(`TO4W5B='EP92`O5'EP93$@#2]%;F-O
M9&EN9R`Q-C0@,"!2(`TO0F%S949O;G0@+U-Y;6)O;"`-+U1O56YI8V]D92`Q
M-C4@,"!2(`T^/B`-96YD;V)J#3$U-B`P(&]B:@T\/"`-+U1Y<&4@+T9O;G1$
M97-C<FEP=&]R(`TO07-C96YT(#@Y,2`-+T-A<$AE:6=H="`V-38@#2]$97-C
M96YT("TR,38@#2]&;&%G<R`V(`TO1F]N=$)";W@@6R`M-38X("TS,#<@,C`P
M,"`Q,#`W(%T@#2]&;VYT3F%M92`O1U!(04=!*U1I;65S3F5W4F]M86X@#2])
M=&%L:6-!;F=L92`P(`TO4W1E;58@.30@#2]82&5I9VAT(#`@#2]&;VYT1FEL
M93(@,34W(#`@4B`-/CX@#65N9&]B:@TQ-3<@,"!O8FH-/#P@+T9I;'1E<B`O
M1FQA=&5$96-O9&4@+TQE;F=T:"`X,#(Y("],96YG=&@Q(#(Q,SDV(#X^(`US
M=')E86T-"DB)7%4+5)55%O[V.?^Y%\$'@G#)%S]<>2@7`<,7DI*7BRB^%06S
MY"+R$A/-3!U+C506^"@7^9BEI&.$1=G%1D-S)G32&35#\^V4Z$KS,:,Y9BYG
MJ??,AFEF:NZW_KOV^?]]SO[V/OM\!P2@#99"PG_Z_'GFCXZ+R_C-9L!Z.+^T
M8-:?WNO&'CYY@"6AH&1A_M:]Z0N`_@\!"BZ<X<YK>JY;&3!A*L_I5\@O`GX(
M>`"TW\CC'H6SYBVH'QI\E,?[@<[1);.GNV$)*P<&^O/8,<N]H+2=H-_R_&3V
M-TOGSBB].J#J72#Z*M`A4*T!U$B$\M-55J$+H*_PP]_T#>\(_5C-A-U;K"_+
M0)[]T<\/$('U>`<]<)<2<!"-&('W\"S&H@K#T(2/T1X+Z1@,V)&*'8B@4`BD
MP48*FW`!4S$7UW`9T<C`)0K@=5PH13`&ZIO\GX%RO9>]?.'$3NRC$IJ`.+;3
MA8-B./):W0@;HO5Q?9Y'6W"->NAZI+/U/3HB"DOP%@)0C*/Z<4N%D(M:6DPW
M$88<5!J)1H6>B4'8C3.4P=8H+%3GV^Q&"<_:3C9JU,WZ.OYH$&;P2J^CG!GO
M0J/H+9UJ*TQ$XAF,AIN__@87*)`29(J.TD/U)GY;BWLB1AR65N81@^&8AM78
MQM4XBZOXB?RH+VVA.L9)NJ/.,[<,O(Q%W!=;N'JU^!![*8$2A$W8N%HV]$0F
M?UN+&H[_"4Y0!F53(QV0-2K>.T1WTD'ZNM;HA2QF^`X.<(S[%,\^'$&&RWE&
M=V.>ZO-D&6>8Q[UV`B>9QR6N^T]X2+T85\1K8HF>K'?H:\S%!Z$8@'&8@MF8
MCU?P.][5@_@"_Z!'H@U[-AF'U")U5Z_CVD9B*',?P]X3>.U*WJ5=:&"<Y2P[
MDLE9#*#1-)X*:"VMIP:Z0!>$182).>*6],AC\ANCGU(ZB5<*1G>.:\=D%/(.
MO,;57L?Y[L`A'*$@BJ18SN@LSW\@!HE4QG;1)"[)Y7*M\5BM\%[V_LW[2%?`
MRETVC.OP,C[@*OQ`P<RA)Q732_0=,W]3_%ZVE_[2+OO*9^5$F2W+997\B_S*
MF&O4&1?5<.56=5:W]T7O29VAW^!:$"S,*PH.)*(_]T\^=]-,YE?*F(O%6(8*
MK.%^68>MJ..\/\<1G,&W^#OO`"B,.1=Q]%G<=<MI#6,3?4@'Z!`=H2OTH`4B
MG!$M^HDAPBG21(%8SJ@2)\19<4-VE=/E$KF442WWR`L&#,/0J@\C756J6LLQ
M:[0UW9KK\^7CVT]Z/<E^<LD+;V?O<][UW@/>ZWJ27LC\(Q"+WLQT);/<Q#U8
MP_B`.W$/#N-+G&OE>H\$*>[X$+)S-SAXUX;0,!K.&$7C&)F,R32%X:9<*F0L
MH:7T.I71&[2:WF[%1LZMAMZG/8Q/:1_C##73]W2+[@EN8B&YFR-$E(@3`SE3
MIQ@FQHCQC`(QFU$JYHKYO$.UXA.Q5YR5@3)"QDJWG",WR9WRH#PM_VD(PV'$
M&<G&)*/`*#.:C)/&>>.1"E4N5:BJU4%+%TNB)=-2;-EH^=ARP_+8:K&.M>9:
M%UM/6[5/!*O5GSGOW?CE+\[21"^I3L8"T<SG(D26JI64R16SB(FR1*Z17ZM\
MNBM-ND@5LDC.U-MEFG@H9],D\3F%RU"5)/.Q"IKJQ!5Q7UPW@FBBN$G1QEOT
MJ9@MG<+2$D2=,H*,,G4#$.>0)%ZE1G%(ELDR_0<DJ6IJ5M7B)$SCL@A$,Y_J
ME6(#3_I*%(E*9!F)ZA&*N.[OJP5<[\&BG'K)TT8UKDF[^)'NTGI6C>,TPN@A
M7A`#J8X5]PEUQVV:@U)Z&RGT&7U+#2#:(6MII&C+N^41[:@_7S+'91B=EK[(
M;N%(D2*(QHJ[(E/NMYR0?8E8);[&(I(4S[WSGY\7+_()J!)1K&DN5I-3U`<A
MV,!Z?]^[OT6QU7E5R7VV33HP'O%X7AQ#$I^-:XPLK$`?[.,>+$>\V(C%>BGE
ML>Z/8OT4:*!BQ)$?JZ6-N2WA^R)8A+,63N.H#UG_C[+J9]`=O$(FGZQ&1!LM
M7U89+E:F'-;?2D8>GN?19JRS[%:G,(9L@&%ZJ[G+O\$+?.=\Q_$[(YGY3<$V
MP\&L35;F.3QCLS<=*8P5.$8"KS+GP7S.QQKIK+SK=3%G6,1WU$B^$X^@2&^`
MD_=NO"[3E9BFM^FI*,`$O8/U=[[>A7Y8J;+%)!5C)++&'J$O^#[Z*U6R;J?C
M(NM1!(7@%F,G\Q^L/D.%<8ZU<XA>I<\@B.L1SA7*Y5OT*F;A#M<M73;B:>]H
M4:_39"G?4,T8IVMU*/FB4)>P\NY'C56Q]BQ%=U7#O8N4H9D34X8,?B9Y4-+`
M`?W[]4U\ND]"?%SO6$=,KY[149$1/>SA869H]VY=NW1^*L06W"DPH*-_A_;M
MVOKYMO&Q6I0A!<'ALJ?EF)[('(\1:4]/CVT9V]W\POV+%SD>DU^E_=K'8^:T
MNIF_]DQAS_S_\TSYMV?*?SW)WTQ&<JS#=-E-S_%4N]E`4\9EL;TZU9YM>FZW
MVJ-:[3=;[79LAX7Q!-,54IAJ>BC'='G2YA=6N')2>;EZ/U^GW3G#-]:!>E\_
M-OW8\MCLI?5D&TRMAK"YDNH%?-HQ*4]G>ZK+\Y0]M86!1T:XW'F>L>.R7*E=
MPL*R8QT><DZWYWI@'^KI$-/J`F=K&(_%Z;&VAC&+6K)!I5GO:*Q8U>"/W)R8
MMGGV//?4+(]T9[?$Z!C#<5,]MD570_XWY,4#_L5ZU<!&<5SAM[-[>Q>"\6&;
M/Y\A=RQGRW^8GQJP*>:"N8O!-,38F#O7:0XP$>`VH>(G0HV"4<1/EM"6M(T(
M(@BA-D6X#6M#6IM*R*A"**THK2J#DM`V):4M;0(1@E80R=OOS=Y>S@<MM*KE
M[][,>_-FWKQY;]YL?7Q7IC2@FM'QZX+<-<U=0>MP4SQ3&N+?1`)S6"(<2YHQ
M+/PJ7-C8',1:8D<B;BD[L&"0]\%[<G:WQH@R)[D^:#UB+##6FNN3.)A"TZ)E
M6T.]A861?OM#*HP&S9:X$;+F!XS$RH5%/05D+MMZ8D(D.&&XI+*BQS_:<6O/
MJ-Q48V1.9F--6B9;<CBW&I>E_:JP1<8BA(,57!V$)7$#>YK#/VOFD+EZ#H;A
M+Z%`R^K`>:RS'JE/FOY:\/VL;WG"?B-HWB:<O_')Q\,Y*U,</>R_3=SD*$D'
M&N1NVRHOM\K*.$"\]3A1V%@G^]65%5OZA&5L\`=!X#YZ"KY=F:BM@O-#(3[>
M/7T16H6.U=44=_I!6A7HI4A5><(2298,N)(QRUG2Y4K2ZDD#<7R2^/M@C.4K
M3O_G^L?F1]?66LK8_R!>X\@;FXW&IK9X,&HF4[YM;!G6<^1STK)42W$$<+BE
MA>&I109";UE;G!GX]X1C1G1=L@&I!ANM_/JX&A`)IR4"JIP*\=N>GID[\9$\
MEQ;69?QW]'E]"&#)48(QRY]L<'X3(T*AAU3JLS]E+4D^5TOMR:HM']Z?.ZP_
MS+R1I@J#M6+1V-)FFB.&R6*XK$PS9@1C9M)<V6=WK3*"?L/L5^-JW-P03;K'
MWV>?VA.P8J\FL(FU2BU"6]""'D/9W=03478WM\7[\<T5W-T2[Q6*J$\N2/1,
M@2S>'\3]++F"N<SD3I`[J&_(BE[AD^,#_1&B+BG5)$/V5_<I)'D^EZ?0ZC[A
M\/PN3X"G.;R(Y/$?WQ3U+?',&)")E:B4#P!\@8:&HK3"3Y]M&BKV2T[FGV[J
M-4H1MX0+O+#5A;1#PS<@\%7]&#7H-=C%UZD)LA9@*OC[M)<IC/'/H=\,ND_4
MD`K^8N!3H`)H!H+`*B`.+`%>!)HPU@*^R7.X4/=2N_<KM-)SCOR>5IH,+$;;
MT#ZB,FTCA=!NX#[6FZE.I#*T)T-6ZIV(L>?LJRS'N,ER7"OT-E(7Y'7H/PKD
M>?=2`#07R`>_$/,<99M!&]4SO%?[!MI;8,<BM#\#C<'6A:!+P%^*]CP@!SI?
M%#7V:K1'HST/OAF-]D@@"KT[K(/Q.;"Q`_("]`6/Q;HYH`$>BSE+U4M*0#F`
M-]4EZM%:J`#R41+8-^_9W1/;SS;]&\38ODPX]DFPK>)SV^Z!R,(:=:8\J^VI
MO1X4YVF#>MB^B;:A%U"4X;U$D["_CX$:K8,F>"?:?X6-BSPGJ1I]'S!>@N<\
M2#O56Q2!K%Q_'7'3075B.@35]EWQ#9JHA^D)[!?^IA+8GN#80RQ,P;AFJ=]!
MD[2K5(AVA.$C^G/:3_`-SKX1M!Y^O^XC^Q/,4<_`//W`&>B/P_I5[`,^=Z5U
MJ!MCKT'V`K`1,3(!&`?Y'AG#T&%]K/,XK^&<`_EE#`(<>\`,%ZGS<?&H"^G_
M8Q)C@7'`;(#7?1WX&?`D\%T>@WG'8OPDV/$2QPS')L<'QX:,?\23C%D^QXWP
M#<>8DS,_$,_2;J``J,!'R<X4RC!6Y@N?(]O,N<!S<VQQS+@4\F(G[I4;O$^.
MJ0QJ>"KDVC('.;8R:"G'/E,U(O=0*@9H%L>LXVN72ANBG(^<$RYU[>'\E#D"
MJG92/ON.S]VEKB_2]#"%(5OB>8^>T*;3"O4LXK\=[:=`9\,_AV0.WM"^1W\2
M.TAX!Z@"9\FY^T86W<_P#BKK,=\`?%FLG:<W)!T4D[5!Q>/IMJ]YNL5+#MQV
M)LV&,N#(F#(R9?\M_W^!N.CIIF?1_IMGT+:U07H->R7OWY5I0-"EX/<"74"9
MKUS9[^M4^KS+R8^XN04\KT7P_1JAV=H`S=?&R+P+@[\<<U=IG307>BJ^U%Y1
ME],1O9N^H`[B'+&6N$@O,WA^T`WI.,J.N7MC25(W7N]#.0=R7"ISJL;^O<RK
M&OL/,B=K["&'4@W7!KZ?97T@>3>/=N,U'9=O4K%Z.R,^L^(T(S[G0L^?'9<9
M=!335&W)<?,4.F.YUO#^Y?W8*O-)WG.0];KCLVE:_QCUB6/V!_(>/D]M;EX#
MTX$PY#]/W2.XAW'>7#/WVNWZ"W:[NMANQSY_HN\"O6F?$"5V3[JFAFE&ZBXK
M=&LI^\ESGHK2=31,2U/W69CKJ784-=RIH_FR?OZ%QGMNRKMMAK27\Y!SL`KW
M7@GJ^#_LNUH>/:>^0J0B+YF/&&EBF>:C,>H?<><NIDWJ(?NWZCYY!T75(4JH
MY<AAZ,)GXSV"BCP+J1$Z).?C,:#,8_MU#?')=T$#^C@K]U[FL]?O4@Y0XKF.
M^Z@58X[)O8;E/;Z?IK`?I.YFU!7,Y2VG/$U0>6I,6.I\#>\%Z0_<@1F^2-7F
M.IY37R9C-E?JS+3O^O*HAN%YBV9A_;!<JX%J?354[&FUK\MW11X]J9ZC:6H#
M/89VH8S[7:A1I:B7#:B/@/H1,(38]#M]6:LEM>_(>K]-UO.1GBI:(=\3+--I
MDEY*4QF:`5F2*M6W,,_SB*N[:+]MV_)]\#L:S6N#'TN]3_B=(&2^_`9Z[U(E
MYQC;(.L-VW,`\7:!'N.:Z#T"'X[@'%04^+LH50?ST!>@W\K`MU.\(H<J(?$>
MM4I9"WTH3HOCXK3=R>]`]7UZ1OT^SN\XA=0VU.^SJ(US4<,7PU>_IKCZ*[0G
M@W\(V(*WWR;*U7*I0[V"<3,@VP"]\YCC".2,G="Y#/HVS5-_0>O4`;P/KO`;
M@4+:9M"G@854K_R(.L4=ZM1GH2;/M=^4\S,VV5^6.(*Z>26EFX*TU<7];-Z*
MM]U][)6V9MK)-M['/IZ#YY5Z&*-IE$MD7P;"#AUJ$GNI&S@LWL?8+]%6Y:A]
M2CE(,>4J<#"%'U.#I#U`$W*L6GD1F*I5TT^![6A7@)X&CCM].@!\`.S`W&=`
M3^CX5&"(!8AG4/`.`?N!7[JR3/!:]^-GPA.P3PWKOX-:`RBWL(=;PV5RS>TT
M"^O-TN;9IQCJ-=000-]&!=XM5*"6@#\)>EE]3P#WW#LTY4'V/`C*!9HF?>@@
M\C![?%AP[G)]_G_-][#`^6X#GI8V7,=]+&.(1BD7[<N@K<I%U.W-N$L!]"O1
MSW?]Z9X3^-^1_*SS0ZR02O8_L_G9_>QS?5!?G*!G,N'&03H>7J,ZAC8?XX'L
MON]=JF/H9R$[>V]?^^$#T(8WR@&V"3%8<F]?7THE##$%MA:R#G(.2/<OX%X%
M>*S4ST&]!&3N`N(D:C&0EE?CS@?^Q7VU!T=UU>%S[KFYN\MRL\L2*"3`2=@L
M)&1IPB(-C[6[FP9H'M,$01YQIAMYE!DHDR#8CF/2@(H%+286+!0L29%HQR1F
MN4OH\E`RX]A..RW$&4<=9X2@./[A.*8/<-"$^)VS]X:PP*2I]1]WY_M]Y_<X
MCWONN>?\SJAY?4S,*SN6]%OOQWHOJ>\'XPNKEX$:Y+.721%X-3AB\<CZ-O>+
M>];\JN1Z']'%7O*7E)B[W\3=;P/?RL/:_'\"OIUW@;>!M_[7?5&"M0JX`9FC
M+B/+M47(/=<27%>'WB-D,`,\&><"OKS!?I1_@_)&H`#E-V$["MX/QE8S>`?V
M89PC#'Q"S43^3LA^`&W<J4_6';H%/)]L8^@"(?_^O8G=R?J#+P$KX$-F-G@&
M>`/X&5"*.E8[WX>^$_Q+Z"N3;0VB/'0=>!&H`(XD>?`[@/`[T,?O1#[R@'OH
M9\H/NW]\4C;O&4&+[[M#C(>7?2*^Y\YAO?^QV+I+/(#E/)CCUT:-YV%WG'L8
MZ\<Q&LBEO2*G%'FTR&73D#^+_'&$Q;WM2<F3S78L=HDS4.3.(G]-6XB<.7G/
M*QAU'UQNG1NC]U;Z,3D!N($LD[<CYC;N.I=Q-KFPI][$\YT2D&>;.-<`C/>*
M]/]V^)*(`;\/?2;XIG6F67OK?7OL&&?:9ZV/]XS\%&=JP$0T!0^S6UALHDP@
M]2P>+\8ZNS_U6?Z0,WKT.?W?ZM8Y;V&LO/2^/&`,?:SVQJNGYAWCUE/R$DM/
MQ7W^U+5GY3.9)',$*=_=>"'N%FK/W=S?&D/J=SSRO5EWA":<J:.`?2`/9U8^
M<!+[11$P$_``+\/V@GV0!.Q=)`"]!S@+V]_!FX4/W$H/8G.[-3P$_1O0W>K[
M,G:]B<UCK>?4=2OR<YD?8L[D/M@BQD\*@66`!S@-[+#>M;A[HN^_*A<)$?=<
MM6;XIGH92,D!Q^1%9"?0!=T%W76>K!GN9=?CRY<'P@EPP:.2C;S\P#GA,#)G
M!'[.KBN=9"[A,%PSIF9)SU6CI,0L/+8X68C/FQ^X%IG`KI)_``J[RJYATF6M
M>-ZC@8&(#@-E+V"GIH23-O9'$@,4$F9_B.?.";1>8N_!_RY[AVR6U=XQ]$D!
M-/@V>Y-X"&=G68_IZ8FG3PJ0R"X<*93T0O8!_<``H)(Z]A/2!#0#W8!*7)`<
M*`2JA(5UL`Z,LQWU79"%0!W0#*AD#?LI[-N%9&^P;60VZK[$#I,IX.^R0Y)/
M@3/!)V&?!7X=NN!64S\.%OYCIOU5Z%/!1TT^`GL6^!7H@G]@ZL]A68MZNTUN
M8[N,6=P=F05_-E`$,)0.HW084W<8&H&D[)OL6=G3:7``O"/)F*Y&(\<KWU%C
M_)'I@39,:2.FOA$SUXB9:R0J7`U63$,R9CYK0$P#8AH0TX!9*6*[T-\ND2Q`
MNH%L@&'>=V'>A3T&V0OT2?NW(%N`-J&QYS&/^1C5`;;-R.-89%OC2\*!T`7V
M#*8ZS)Z)3Y\9:+ZK.2:(A0A.-]DE8K=([Y:X8Z*P;HEGSDPRHK9'TMDF\G5`
MP=:XB>0"GP-*`95M,G(+^7GV%-EA)^%TWJ0TL2:U*4TM*J6>2RQ`JI%)<^)A
M\TD0`?D\&J3%M8YZQQX'<SNR'46.L*/:D5;'FE@S8YP5LA"K8E&6EACN-6Q+
M%X+"*[6E"UN<;<Z8L]?9YTR+:;U:G]:O#6AIV5J1%M:JM5JM7MNCM6AMFJ-%
M:[$IM<YZYQXG<SNSG47.L+/:F<9MM"VRCVW$8Q)(-U`/M``JYC@*>S9[&HCB
M;40Q%4_#3B`)-#?0AW(_.`V:"W$NQ+E@=<'J@I5`"D\U4`O4FUYMQ&/5$?$#
MP@/@6L#284W'W/9##H@24`Y-AZ9#TQ'5IPQBA&[(;*`:8-+6#V#50%J^(M-?
M"VC2/R!C+%]8U%4&PU^>VYM/8_FT+9^VY--P,!0)A&=#>#R>J#?JB^9%V]4Z
M;YVO+J^N7:WR5OFJ\JK:U9`WY`OEA=K50F^AKS"OL%WE7N[C>;Q=;:[LKKQ4
M>:52C5;65395LF*\NKA14!20/-LGN,>8GADH=D66*=UXG"AD*W`-8(1#%@(A
MH`Y0E6Y(KG3!V@5K%ZD"HD`::G2)[062FSYA;Y4^41)^Y1X_PX-W&DL75D7*
ML>5&@5:`H>U.^#ME=++4+>TQR'YIKS+CVZ2=0UIU&#:X&KG-U>#SJR$A(`K4
M`VGD"EM'K@%H&9(#]4`WH+(:_->Q=4H7_IU*)_.']053.)DZE1#BF61W1]S*
M1*P!'8>KD$>E/"!E2,K<<'JY?JM<_T6Y_NUR?2X*2AZ)P'%8RIRP,Z*?B>A5
M$3T_HJ.U1T@.T94I4FI"TK])^924_G!&CGX[1_\H1_\@1W\M1]^9HW\^1]2;
M@6]75S*D=`I)7Y&R7,HY82?7W^+Z.JX7<SVBTQ,4O9,2*6=)F24D_?",J]1%
M'!?HAZ04+5$CF,\3"I%$AXU@!'3'"*X$#1G!$Z!_&<%#_"*]3>611F\9N3=X
M9`K]F):I0O_(Y`]H&>D`#X"W@G],@M0'/F4$]XKX'Z'^,>@GR6R[B'^=5,MZ
MK;1,VE\SZ_W0\&]$K\<-_]?0ZS'BE[T>,?PW8#UD^`^`7C;\SX*:#9\8X#8C
M.(]')M&M)%<1L9N(3Q$CJ31[?!(M/PM>F:R\W/"+6J6B@P1]PO`N`,T5H[Q(
MO:1:=L<-KWS(F<0KFYA!O'+06<0G.9VZY.!U,ENRW?#N12O:&=\-_L_@!?'@
MY"9U&2?XGR_B^=9"_1,M,SKXK\^)Z3+X%7^"^L[RR]X+_%>Y";K6X+W^A!V.
M2_Z$0GOX:4QR#+$*/<N[_5MYEU=ZV[WPXE6W!N?SX]X:_JH/NL'W^B^*89`=
M>.*U<&_P/\XK@QU\A2]!X0X'T5EX`E_J_0I?`O/B!"V+=_`%N0DQE"*TT7&6
MST./<[QR*%\L/J\L(C;ZU;#?MMNVT;;6MLJVS+;0-M^6;9MIFV'+L'OL;GNZ
M?:)]@MUNU^RJ7;$3>T9BN#]<0/`59FAN09HJI"K+;D5("+'K*]2NX-N)3685
M2L7J$AKS5)"*-26QXH**A&WX"['%!14Q>_67UI^F]'L;H,64_0E*UJS'`A6F
M?5DQSQ/KSQ%*"_<=S!+<L._@A@VT(M:[B51LS([=6HWGF+"J)I;F+9E&ICX7
MFA;R/#YIR8K2!XA:4Q;<_4TK^`_[91/;1A'%\3>[<>RD<>P0"`YQ$GLW3@+;
MB-81"5*7Q+%WH<BD*DV%O%7:VG4,K2J4E/7FT$,-0AQ2J'JH5'&+%"2K@D/7
M,45)D.HJW'JI!.(`RHDB#D@(B:\#33#O[49)*^4`$B<T(__FS<S[[WNKV9G=
M\<,EU&U?3T]E[(^[#3M.C7JWD;9?FHI,9U:%"\*LKJT*<V2,S"J[*%S0C]$X
MNZ@9.S*0A#F4@4J&9%602`82JSJR5QP9+E-)URJ2Y(K6V<LDPN6S[HC><&/U
M80J,=90,RH0>Z'-B]0D]),/UX`8+/!RL!5C`"19H`2=8F$256`PE^V,DJ8S&
M4%")C3KN3W;=<LR]'0-B3IX8,YP\C.UJ!ET-KH)MC>!#C?)?ED+R7XA9-;<Q
MD]<+LIZ5]0*2M=^?/QNRWSX3B51F-L@1L<7^[)G\6;*Y@KTA%S1[1M8BE5Q^
M#W>>W#E9JT!>/YZIY!,%;3F7R.ER3C.JY5(J_4BNA9U<J=(>P4H4+$6YRND]
MW&ERERE7FG*E*5<Y479RI8\E6?IHIN*#I)&:=FU5V->,^R';%362'<&Y,6=S
M'(J&+G6M-0!^MO8IAMTB)VT_0JZAB:$)<N'N)%<K#@>V7:%+AZ)=:^S&MBN(
MPVUR$A0(Z>>TG9]IFD7"LA2LBU;(&2OBIHU.I>T77SV1L55;U>U$5C,8/0YK
MNZ0RB6!-O:<*LVI)O:HNJC=5CV49./Q83;HG":>E6:DD7946I9M2(SFF,Y\E
MU$7I9TFT<#6Q(A9=<W)::/%'W:)E4@%,8")N.L524ID)"?)XVF5X,A^"=D1&
MAI$IQ`-?8/T5<A_Y%6F`=[&^AGR$5&E$'!*']-`YC3(:"KUT0F*\>N"Y^/,K
M:'.ONW;JA&OU(ZY5)^(AM,OCP\T3`3QX,UC#^B[R+?(C\B?B$>-BW`ENN:O6
M,,%4&-X^8*=(E:D4F8(-1M-=-!4%"%K@^`10JK!'USTPTP*<"GP@:%#DC)IT
MF45V5XCOX#"`)TRG9?#"9$5@GPNW\9CJ%6K+X&E8$6Y_*D*SEQJW&'3Z&CTU
M]`L@LJ>AB9UGIR"D!/]0M]0CP=_4R2T5QK$=W,3JX(%H6[0MAA4+-\!F1+RS
MF?#``X@TW,&96!!E=LUS'EKA8**YG_7[A>N,M<(*.YX(-HK!Z:8WQ;'6#^&]
MP)>G*,%/FUL_P#@%96^=;&\?&1T9&8YW//&XM]$K+O3Z_>VZTO=,L_^%RQAV
ML+1_;'2P]\FN@7?^^@;J=5@295'`7/WL2B<P+[O"9O$#]%25X<MQA<TF6@X/
MX!WU+!T>J/4R=I*F9;O,<S@<#H?S#_D._]MT<#@<#H?#X7`X'`Z'P^%P.)S_
M"0R@\3+\`BK,@Q<$",*S\!J`YVZ]#B+VT8\6)L/E[T\'U-]]G3Z@LG2_>YWL
MZM>W!A\4MSX(@J\5NTVHIRO@[P$`,^%E#@IE;F1S=')E86T-96YD;V)J#3$U
M."`P(&]B:@T\/"`-+U1Y<&4@+T9O;G1$97-C<FEP=&]R(`TO07-C96YT(#DP
M-2`-+T-A<$AE:6=H="`P(`TO1&5S8V5N="`M,C$Q(`TO1FQA9W,@,S(@#2]&
M;VYT0D)O>"!;("TV,C@@+3,W-B`R,#`P(#$P,3`@72`-+T9O;G1.86UE("]'
M4$A%24PK07)I86PL0F]L9"`-+TET86QI8T%N9VQE(#`@#2]3=&5M5B`Q,S,@
M#2]&;VYT1FEL93(@,34Y(#`@4B`-/CX@#65N9&]B:@TQ-3D@,"!O8FH-/#P@
M+T9I;'1E<B`O1FQA=&5$96-O9&4@+TQE;F=T:"`X,#8S("],96YG=&@Q(#(R
M,3,V(#X^(`US=')E86T-"DB)?%4-=(QG%G[N^[W?3$02$2&92>@W&=)L,J')
M%@E!?F9"5D4(FOCISDBB"2)II19;4A%K=^B64MM=:M$J]=/]0K:4(NS1TUI_
M.535:INCU$_E;):UK,I\>V>H9<_9ON_YDOO>][[W/O=W0`!"\0H4%(PL[),Z
M^5R1#1C;QMS\DDI/-0K5+*#0"5!&R:P:[>]/K#S*=^<!\X`IU<]7!EW9DP`$
M10/JY\]/GS,E+'%.%R!M&\M,+R_SE!Z_8-L,C,OD<[]R9D3,CS#8H%]_S_+*
MFMGK3*FK@;!(P)HPO:K$`W$H#4AG?59'I6=V=6@]K6`\)UE>F^&I+)MW9.M0
M8,PZQM.GNFIF#>/F->85_WWUBV756;92YB1D`.%5ZA[$!KY-B)7QB`6,BS]\
MO@KCHO_._U]<8VW=[W\/U@YLP^>40!IVTEU$X0Y9*`5YD+C-%O^$=KR!2(S!
M*HI`3W3#6.219)DD+*75QBSC*@;A=6PP=E&=L87O7\/'N,,(OI*$_LAG^;$H
MPU7E$HJ-/R`(B]$1`S&:NL&#,[QO,8856(G]]+)QAZU&HH[U92`+6<9!XQX2
ML50N4\]V^#.68R^9C!*C`CT0!Z](,LX87R,>Q7@;VQA3$C7)8;!A&A;A3;(H
M'S/U!MZ!CT+$)"5'/<"6\C`.,_`+>+$%1RB""M2S:IOQ2^,R3.B"!,94@:O4
MET:(C3+$&&R<PP1\B$_87_]NDA/D)G6";XCQEG$(7;&+@NDC.JBFJK]M7V"L
M-]Y'".-)X8CDLYW)6(B#^!3_P`U1:]1B&`K9\F'J3AK%<\3/"(N8+^8KI]";
MO9W$:%_"'Z%S1O9@+_9Q;/Z&%ERB2(JAG]%D6DXW1(@H%2>4U4JC<EJ2?(_C
M;4<OCE$--N(#',4QG""5]3]%!325JNAW]!:U"%U<%[=ED%PHOY?M:KROQ?>]
MD6_<0C2L>`9S4<NQ?1L[T8CC^`PW<!/_HG!*HW):3SJUT'710<2)D:):K!(;
MQ78E7UFN')1]9;:<)H_)<^JOU"5FC]EW[UW?"M]V7[.QRVCFV@EC_?'(Y8@N
MX*K8B`,XQ=J_P)>XX*\?UC^0QM-S;&4F_9I6TG8Z3,UTC;U$8,>)@<+)5JO$
MBQRG.K%"K&3K)WB?%.?$E^([<4M1E3BEG_*"LE[1E=W*2>5;&2[C96^9(D?*
M\=+@S*2J0]5"=;.Z53VDMIDR3*6F:M,5<YVY/NAH>V+[5S[XRGVZ;R?7;A!7
MTER.Q%ILX+IOY!P<X8@>9\0M^"=GP4HV>I)QIU,N#:<1]"Q-I#*JH\7T.KU)
MJVD#O<\>L`_"S-B31)8H%!Y1)NK%8O&J:.2]1WPJSHBSHI611REV)4E)4?*4
M\<H$90;[4*/,5^HYLLN5+<H)Y91R6;FBM'+6HF0/^9*<*W\O-\E&V:P^HU;R
MWJ`>4)O49O6>>L\D3%93K*F/::IIL^F"V63N9RXP_\9\VGPSJ)IB*9&1:WAD
M"0OW8`^Q143*6FIE1G>2Z,2>)W$>"KDK;F*(XN.\A/GO&5M789%=_"]-F5+G
M]S6T%WWI,&I-0N&I*ENP@\Z+%OD7,0B?D9LL<I,R0STB;-C*TVB9^$CLI6PT
MB@PQ3JQ10)=H,RYQO<_&2II&,[&56FD`S:/^5(O3HIM22/7(,#8(21THC]K`
M"+!`EN(Y_.BB=)[65WUK9:A\F>?3;JSBC&[#U_0>[I)J7.?IIO`T\O"46<KU
MO@C^J3>)^ZR6^]'"$V2ZZ00:R<03O[]IL)R+-OP;5]4]7%'9/$DO^RKD6OF-
MT=](Y@[C+L-F[KMR#.6.N<15LH_/_M-$[O1@GB6IW-4%&(]2S..IM]S0C37&
M0F..486_\MN[Y*"[M(X[8C>_R,`GO%_#%[2$^W#HC_OY_Y:O%$VX1M'4BU*Y
M'UK56>HR=8O:J.Y7CYE2.-KU6,T5?8&K.9@]*$$SKN$V!7%N+'#@:<:;QMB+
M,%T4*_N00U94<\\F\!S/?N#)3-92Q]%;P_V\CWNCC>?$1.S'61(4Q1Z5L/T@
MUC.<X_QSEGZ7,[B0=C*GE*=V(KYCO\,H3=2PO4S6M(JG5A-C.H]O.=I&`)>#
MYX*3QK&NVW@6I6RA'PJH@3/P`=)YLCJ5HQSOGA2.;(JC=_B=FSLT#-V1KGY#
M`@Y?OI$F*I1]_!MC,'\=_WK%8!"]P"@ZL1_MZ$HCT=<WFC&<`C*SQF0.&3PH
M8^"`]+3^?9_^:6K*4WUZ)SN2$G^2\&1\KY[V.)OV1(_NL3%62W14MZZ172(Z
MAW<*"PWI&-PAR&Q2I2((#I<]UZWI\6Y=QMN'#4OVG^T>9G@>8;AUC5FYC\OH
MFCL@ICTNF<F24_Y',O.^9.9#20K7,I"1[-!<=DT_YK1KNVG\J"*F7W7:BS6]
M-4"/"-#+`G0HTS8;/]!<T>5.32>WYM)S9Y5[76XGJVOH&)QCSRD+3G:@(;@C
MDQV9TJ/LU0T4-9@"A(AR#6@0"`IE4+K5[G3I%KO3CT!7>KD\I7K!J"*7,\9F
M*TYVZ)138I^LPYZM=TH*B"`G8$8WY>CF@!FMPN\-EF@-CB;OTMWAF.Q."BFU
MEWHF%NF*I]AOHW,2VW7J47,O1O_WR,HC<HH6/WH;HWA=T16:_^CU+M;TIE%%
MC][:_'^+BUD'OQ6]<MW>7#:]E(,XO%!C:V)1<9%.B]BDYO?$[]5]_\KL+C_'
M/573.]BS[>7>J6Y.C=6K8_0<VPZK-?-#HP56E^8=4V2WZ4-B[,4>9VQ#)+RC
MY^RT9&J6QV^2'0WAG>\'MB&LTP,B)/11HNSA78`*B/NIX:,?1I;\B.QY7!"Z
M5J(QDB+[?[BO^N"HJBM^WGOWO;=$JFMI4DA&V;@FD@\:0/D*%#9D2*D9(X$D
M;`*C(7Q4H"W4C(QTQI@Z;8D;TO)-@$"I5M$$VTWDCR6A[5(ZC<&F.J.Q#G4<
M&HH%`ITZ0K6)\/H[][VW;!8HM4[_Z4Y^.?>><\^]YY[[NQ\/<YK&_U9,H]"R
M:6B&7Z4"K_!RK,BJ\(C"ZI`WG_7L']8SO'Y?Z#*!`?Z+%X9KECH:(\-[F;C(
M/(E1#7:W',[)"6=G,T7,0JPI8IPEZY/'YZZ/J%/\Z[P^"*2/YB.W2ROS\Y#^
M]'1>X,9(@&I0"=>7!NVZCVK2.BB0EU,95JO9$G4MR>5LJ7<M,?=J/YA\F/A1
MGQSV9,;^[O"FC)K[6'Y82?DWYA6VO7BAO[BT*NB;&ZIV<EM<-JQFVZ?%;$XI
M/*HPJ*6I3DE-TZ05I%P2:\R5X,BPR,"?(4F]/*R!E%*A^(K"WNIY]O_*I/3T
MF_I$3$^<4\3Z.WM)<<W-B3*<GS.\/F-8?5AT(T,:XA69:G%952B4-,Q6A`,H
M%"KR^XI"U:&E$:N^QN_S^D-'U(/JP="ZN=7N@D:LSL:T<-&F2DSB,24?9%5I
M3KM?:2AM#R@-"ZN"1[SX4FDH"W:HBEI8/:>R_5[8@D?P%`E(K1K3<LW'-2I6
M0/0.U2--:4?P,54OK4(J9'U91"&I\[@ZA99%5%OGE3K\QA.OO3GK:@D5>FEP
M\&JF5VKB?T;(<%3J=`>M%-%>IW6BEKX(%)EW4:7>357*7VD);&N`0NTN?&,=
MHG*T?P+U6LAMZG3K"MI7`,\!]P,/`9G`8F"1@X5``7QZ@%;T\2CW(^5I6FWV
MTE<Q%@$[@:7`=KV"=L"VRYA.-:S'6)O0AQ_EW=#O,UII"\K-L%=R6RG9OX(>
MA#T7Y6UZA669361"1RA?@3X%XV_EF"$S,7ZMJ+4NHIR-OK\.^T;(<L@R)][1
MLGR:?>1<>8[/<AGYJ8-^"[``:`06(S_L/P%^8U%O0ODVQ#4"<B1PNR"Z!VUF
MXJT8AAR/\0N=>9.<-^81FQ/BES'=&)S3@G@@)I[7.:`7>#,NMD0T#4,M7A7W
MR_7C.7\!F*'VTASDY2K/2S]C?<SP$+V+>74!.MZC$SUDM2+.V?IA:D9]$C!3
MHI84T4)KM4M8@\/T76,G_11Z4B<"_Z`,]0*E&ADT%?D+HO]%P`KT>5SR83G'
M8%V`'"O.4"KZJ@968^P>-T^<&]3G85V#:/LIRGC4TO>!5<A!,_`XQX?Q\SCG
M6/>/E8JK+Z/M*8Q3S,"88R4P=WM=Z0GX?P=]*7(<>QUL"<"^&CG].?!KX!C'
MX$+RS('LJY4TM=7Z"'(4D`KT`EN8;T`U<(#;8/PDM$^2?`5GF)O,#^:&WBVY
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M`/A<"7T'4`]D>W*49L\:)6*6DQ>??)>`M2)`^7J`IHHHS1;)%$">,J`O-[XF
MS]W-Z+];&:`FK-</S63R:^=P-F(L]1W<#P#W#_E0'(^&<2Z12ZYT^9HHF3-\
M[D+JD&.P[SJ!+N"D@S\#_>#CM^7^Q=W`Y[.\'W!&`TTV7ZV+,7[V4`ODCUQ^
M)O`T.X&?9B(O$R7?+7R^R[L%^Q1Q-+GSY_.1SS@^(_F<X[O/;9\HX_QWX.SX
MHSR'>ZG*V==9P`0@#WT<=<Z1+BUB7<(>/6N\9769LZTN[8359>RV7C376*\9
MAZT6S#LK=J=&[;.,]Y-[EW*>^%YT[U$]DU8ZY]D>V1;CRWNT0IX#9&S`_EM-
M->CW]WRO\C[46K#OD$_T]XQXB;XI^FDS8K]#^X6M%PNIA,]$L1YEZ'&FL_TV
M;;.T+Q`?T7J1A?)+D'OI3L.D]<9OV,?JE;K3MHUU>A7M`N_RQ+/T,[V=@KQ6
M/`]ULG6"UQY[/M533_M,`H?[:8\8Q)RCF&.WE'LEG]CW56N0YV?.H"_K&N;'
M;0#VT?>1S\G'3IF+J,S1#LEAY(+[--Z6[PW2WT7[G]!3GB3:X[D/Y]-E2C5Q
MELBQVFF1)R#S+N1]_2'VQP`X5DX-^I>L?TK^'[(L;1![:`#[BX&GG9Y,8_0!
MVHN]U"#S8\M&WC_:`"4S1S"_,OF>&`#'7Z#'C3;:9$3!NS[<!7U8MP',90U-
M0WF+:+.&T'8N^B`>&_I2^3[A>RI@O<G[Q8S2:#.`\=&&8Y#O/XRKG4&\VZ@!
M9TF!9X">-WS\KE$4<.]N8*(-67\:J`,VV9`ZKRV5=/3QE-2OH-?45DT%O]G>
M(U[&WMM+!=I!2A(K\7XX3\^H>;11*P'O+N+.T."'NLBE<=I%*M8^D??/1CV)
MILIV*;C'S])\40G_*"T7';1<LU`>#>P`'^&G1ZA*7X9WUB/HQX$Z!3XC:+[1
MB'*>=8C;R3$^L5(88@--DGYQD+&ZX)B?BXMY!W+[/?"!XT4Y/EZ.-1:G$^.-
MXI/SY'[A)]O\B0J(K/>`#%M>+56;J`TXH)[$.SQ*=<I.JU-IH2+E#-#BX!6:
M)V4[4$I%HDYI`.8#0M31?LCQD.>!/J`%.`K\34RF'Z#O8Y"O\G<!0_T5SBY(
MV%\`?@F\[]KBP6/=2!\/\8'5&5_7)]%TAIJ+,SUWN$VVWT\/B"=Q#D^P.AG:
M>DIB&+=3ENFA++4?^@KX)=3U<;1+K$6[6\1S*RAOT`290QN!^#FZZP&9\A_@
MO3CI8XG]-9[OY\\;XV<%UO=IX!LR_P?H*Y)#9_$F-ZWCRE%Z1#EE#>(\-QAV
MG5)E/O?3G>XZ0=\@]0GK!ZY,T1:0EJA'>2;#K2>NZZWJZ'=5/%P>N#`G48`A
MWD=[(+&.^R#`,)ACN=?78^/>#&7T`/)4),H02__U=<-+>0QU'>K-L']`]S%B
M]3+*8G!;!G+K9R#7G0RUG](9V@+8%LCVLQAQ>0UR7K4H^TI_N3XNSQ/7![XD
M?HOSZ"]X,Y=1:J*,\=LY+X9QOM3F>ZS.9\F9A#;7]L2UO8&]<K,^_Y^`O7,"
MZ`9^]S\=!SQ7"%P%O(0WW5MX;X3Q5GT>WYBO4Q/1E0:BH6-$GSZ*<V@BY"O0
ME:.<"?DA,!JZ59"XC89.H;P.MK>!7N"`2*,GG7?E&-3GVKY77G3ZR[#]V6\0
MKYVA*;;_T$9@+\I_`,"RH>.0V_]%>_G&-GG<<?S^&#]/TB0V(9B4$.YI@F/B
MD,9SPPQ#2AX#I5JS*2ZD*!E#]6@[:9M6K)&4#5J2,D4B:4F]59/6=6J\28N0
M&,V3QR5UEK"XZRJA5@RO4S68-,TOV(MI5/"B;)I$YWWO_!@A4YJFVV1][WOW
M//>YYYZ[QW>_@]]`?0O<`/P8KAV'=Z(<@W:A_'N4NR"&_!>@OT'HYTV$,3<[
MP+\*/2WCD8\YA_YO_2[GCT_KZ.,WH?TJYD1_R\\0G]I+\[F$EY\U2O._E)?.
M$G>X,PZ(^=Z1NNWL\XEGG))C/O_EZ$/HFFNL\!%B2DW%T8AE5<PMXT?'5;S]
MOHHGJ8HI'<=XRGY4R=A9QJ_PGZISWD7TYQ#Y$OJU5_6KM(_<MK:R3>1)R.<(
MZQ[9@3KOH3_7Z2GBH:<*-Q!;)J7DWJ;V,0C[[KMP#];<1;I0N`&_@'(C]K**
MTIY66EOO6&/OW-/^K^7E[I&?84_M=?2-,I6N?]U1^?T.1TU2Y7OQ<K74WOV9
M]_*[[-&W[]/_;;FTSY>T5%Q:'@<L55ZJO>66R^..V\HS4I]P7Y7+XY)2N5QW
MW+_SVRO&,VOQ?RNI['^W7.%_NMUUL'"Y]'\M]:'\?WSK_U8Z(PR3G="#)<?Z
ML1'K2"OT@G/N:D8>>V#AB-S?])LDK)\A893/0K-RS8$/%/>^P@OT=<32_T1@
M3_X]BK+FNJ#J]CL:6.I[+O]N97RNXD.,F>I[$G/Q(>F`MD&UT`ST[5MSC3,D
MGGV>8^>5YUQ^I7`#;=VX6RQX-\<Y[SORO(>R!V7/KTD?_PF63DI$(<M_G/;6
MA<T,?SGM614VHU[^(Q*#&+'XETD68N0@_P$9AABJ]]CMGPO/R4RZLB;L1?WG
MB0&-0)RDD%)5-B%9__GT*I]L_ONV9Z7BCMJASF(F[:T/QZ)U_+N$\B?Y4Z29
M"'X,OA[^.+P1?H`_0:I5/\VTQQL>P?.Z4;V;KR:MN!WE/LR)X#OQW36H:D-V
M3?$Y0_;&8#A:R7?P>E7%PZM))USGFAT6QCPWT5.3GTA7W"/[=\+VK@Z?XZ-<
M(W6H-8)::X3G'*\D'9!\D[YT174X&:WB?7C-/@R+0!\IF52IR9^RT1">]R!?
M1WRX]RW>2%;#=_'U]FJ1G><OJ6H_E*W@>5VV_H"T='5-.!NMX%VX:_$)C/B$
M>EHRW;(E3*(M?",)00R#.HS<,')>/H[<.*9I'%,SCJD91R_&$6L2/H8[8ZC3
MP8^0!#],DM`D\BXTN=K&",ZIS(:-X3E^+Z_'2'CG,7845]>F*VIDS^KMVE6J
M6GVZJB;<?8X?(KT00^<'TVOJPP?G>5"]RJ9T?8,$$G9%%89N37$N`/KD')SC
MZ_AZ-1*-:@2LJ$"9$@\7A+)W6$Z.#OL#>U_.+[N(LO1W';_@^.^*7LBR7!I/
M,3/L/>GYZ#KV5S3V&/LSF42.L7GV%@D!^!/+R%ZPRVR.=,,OH?P$?`[^`/Q7
M]GWG189ETC#T_16[VB=?EKUEMW4X&>%W,FL:G$RM+QSUL]^P-\DZ-/%'^`;X
MFRQ+FN"+\'IXE@V2\_"S;#/9!G_=\=^R!?E-LS?8+-D"3]LUL@N6K4F;MMW2
M7K-)L13K$`OL-7::K$75,W;+6EP]E6[9(#SS:(^R7[!!NU'41BO9SV@_E@O!
M4N22=%++?FY'9"-)>\$0<RS)DF9]Q/2;[>84#_E#[:$I;OB-=B-B3!E1+YL@
M*S!X^,.RYY%&B,'P]4`FE&1CMBMB13_".\GW8F0$:4KEXD@3*D>0>F_=O:YR
MW6P4(<<H<DEV#!J&1J#GB`OI$>@H]`STK+HR"`U!A[%\)$`D0"1`)!21`)$`
MD0"14$1"/7T(DD0<1!Q$'$1<$7$0<1!Q$'%%R/[&0<05$0,1`Q$#$5-$#$0,
M1`Q$3!$Q$#$0,468($P0)@A3$28($X0)PE2$"<($82HB!"($(@0BI(@0B!"(
M$(B0(D(@0B!"BC!`&"`,$(8B#!`&"`.$H0@#A`'"4(07A!>$%X17$5X07A!>
M$%Y%>-7\#$&2R(/(@\B#R"LB#R(/(@\BKX@\B#R(/#L\PW/1MX'D@.2`Y!22
M`Y(#D@.24T@.2`Y(SGGU0348#)_-,6@8&H$DFP6;!9L%FU5L5GU>0Y!D+1`6
M"`N$I0@+A`7"`F$IP@)A@;`4D0*1`I$"D5)$"D0*1`I$2A$I]>$.09)8_D>Y
M[*EAS]%^'9LK&Z&MRH?)5>7'R"7ESY(9Y<^0*>5'R7'E1TA$^6'2HASM*1\D
M0J>VB'BB/BP!O=!CT$%H$IJ&%B%-Y2Y"?X$*;+/9Y/)HO=JD-JTM:BNFM;S&
M/.Y>]Z1[VKWH7C'MSKN9$6U@U6H=Q=)"7E3I,-)K$#81I-TJU\TZ\=Q.K+.;
M\>MDG>;*#XQK07HQ2!>#=#I(7PS2:`5[B+K42F>0"$/':;]9U=(E+D&1ED`7
M5J:)V:MKA-WR>9&A"T5K-=O@5Z$9:`HZ#D6@,-0.^2&AK@51O]]L<II<@`+0
M?9`A'T%\/L1JM2MU<XY5TZGTV]6D0CXGL!'<O!T(P3)VH!?VAATX(*(5=)8$
M9!A$SV+F3L.G;7$%M\\4[9>VF(>=LD4G;+\=N!^VSPY<$-%J^B@1+HGV.;X'
M[RU]MRWVHMHCMFB%M=F!%ED[B`?Y<;>5]I,K<+]#;2@^J=D6VV!-MM@J:^LD
M(">>NDF[ZMX*2#I/HT/7YFB_BYKWB`_$2^(J\+]C8/%Y7#8R+MA%?X;N-2O%
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MG5JU/:2G;[NUI:TGHQ5V6Y&V'DN+[>N?H71B`%<M=B)#25]_AA;DI=$&JW8'
M;I+1DPUSA-)[1T\.#)!ZW]/=]=VU72NW[MKY,4G<2?_#?M7\ME$%\7F[ZX^X
M)+%IBMP$R^M8-H&M,0X*.=3"'^RJK5RJM`%I%U7";NNVD2(EJKWT9N``$G#)
MB0,GPR%4G-8VH*8J(I*O7)%R+^(/0,"A)#$S;]=)`$M!@@OBS?KW9G;F]]ZL
M9I[7?MJA1(^:,>?CRK+I?!&SG'DR!C&KXKR[K%XUMZ1):=S0MZ0)4I:YI:Q+
MD\85\BOKNH6T'S@-=_,$TN`94D@+ED$E&KY/RD3#'KF\-$Y'7H(4\D+CD.:\
M=&B<\Q1&O,Z.:N@=5>4</$;M<,Y."HYP<,?@7+V33G-64F4FL9B95/F#/<L7
MBL>1DHES"L/_=7RA../)G.PA)>51%@XH"SR7S`XY<9<S-3?D3,TA1_N'4B]K
MK)>S6WVCGC2J2:..J#H?O74[ZKQS354[+9L"JB.GJ]>NWR9=JSMVLJX[K:2N
M=G+]$>$^A7-)O0-]XS6STR_6]6ZNF#.2-=WJ%?)FZ0^Y/CC(9>9'+):GQ4S*
M52B-")<H7*!<)<I5HER%8H'G,E9HWR^9G2"4K5>NNKHGG0CA'J[.)*SR4^'U
MEVE#;YU-1%LS#Q1@]^"$9CE/),O..()"F5*F1"'\GE%H`MV37BC:.IN8><#N
M>:$PNB/),@Q+"T2J.`N7*TYB^0V3MHI3K(WN68.$AZ-@K.CXP?LF!UY'F=`8
M*<U18MMV@P9;:P!4G.>6*\Y+E_%)`@%,5=4M]#T_],DR]W7&QHS[@VT,:O@0
MK$GIR-*8AA4LAO#4%9#:_G9`HJ-"LS<=FU_[!G_!WT;@.4ZZV\WF^"GB;F\V
M1>>79B^[X&H\GY+N3B?F,4-O$:>23KFZ&,F@L9':R&PLME/M3'O1C]ZO-]$9
MWZ2?TFYV4X:FUA@6`LVFA<7&QZ)\GW:?CO'$;3(TS=(:C-?KK\5FPZ(?%+;A
MK=K@RS>'#7']#7#);E"SAY-L;PH/VGP*3XBO7GP%^_#"?U,!*'\IL7U_X+Y4
M*)X$G[(O0RB@[#,X'?3[]B7Y(4O#&'-8%*):^-?\7OY2^.?\JWMY**`=WL4A
M]T(BDHBD<,`7/>RJ\O9NT0>_@:IL@R>K`@("`@("`@("`@("`@("`@("`@("
M`@("`O]+2,"`9`IDLM@TP@_'BGP\Y;\M"LSQ4>'U40<#=QP\\NKU=TH0A)L>
M6X8(CLQ;.8*7:_O1FJ7**V/HF847/5N""7C=LV7T7_=L!>WW/-N/]N?GELX;
M%RYJI3LKM=4SY;75&\<[X!PLP7DPX`)<!`U*<`=6H(:;X0R480WU#;@"=;@%
M-MHUC![/_S<85!'_A_`3Y-'AQPJ$(8LU`/\EK+V,]]2*#?!!D)KBML;5<%-Z
M$J<?R)_;4$"!(JB@!FF9[X*G%,GKAO3C+=^WG[S_YF3^E^#I(&=_]B@?([WU
M_5<G'S_>W0M#\!3>4G_XRK\/`&&ASLH*96YD<W1R96%M#65N9&]B:@TQ-C`@
M,"!O8FH-/#P@#2]4>7!E("]&;VYT1&5S8W)I<'1O<B`-+T%S8V5N="`X.3$@
M#2]#87!(96EG:'0@-C4V(`TO1&5S8V5N="`M,C$V(`TO1FQA9W,@.3@@#2]&
M;VYT0D)O>"!;("TT.3@@+3,P-R`Q,3(P(#$P,C,@72`-+T9O;G1.86UE("]'
M4$A*1$(K5&EM97-.97=2;VUA;BQ)=&%L:6,@#2])=&%L:6-!;F=L92`M,34@
M#2]3=&5M5B`X,RXS,3<Y.2`-+UA(96EG:'0@,"`-+T9O;G1&:6QE,B`Q-C$@
M,"!2(`T^/B`-96YD;V)J#3$V,2`P(&]B:@T\/"`O1FEL=&5R("]&;&%T941E
M8V]D92`O3&5N9W1H(#(S,C$X("],96YG=&@Q(#,V,S(P(#X^(`US=')E86T-
M"DB)7%8+=(U7%O[V/O]_;YH0T9!XA-RX>9"'1ZAX1D@BJ305Q&JBQN2*/!I"
MM*&)D=9C!A&O*O&J=O1%A>8&\6J-C,=0:BQ5A+&4F:%4*5J5)<D]LW,[:U8[
M=Z^SUC[GW^><;^_][7TN"$!KS(-"VNAQO:(GIV2<`I9GR.J+V86.HC=G-]4"
MY5\#]&'V[&*;3GA_G7R["EA+<HOR"FG"9ZL!CW3`/),WK32W^.^']@)AGP/C
MIN3G.*8<;[?&0\[;)GOZY\M"JS+KJX!WL,R#\PN+2]JNRYHE\V09SFDSLAT4
ML,`%_,$F\SV%CI(BCRNT3/8/$'O;=$=A3F'$XX-`Q7K!L[EHQFO%^B?Y@HJ2
MEN]%K^84E79*.@H$-`">1\T5@NH%!,H(4#/1`=`W9-QN&:Y1NLF<"KLK7_]3
MQ<KNM?\=O_Q"L`TKR`ME6(!$1.-#G,)4%&$,JC$$#^@2DF"(U>OH@3@TPX\<
M&$DQ,EL!?WU*OKRL[_`M,#9@/AYA%BXB&W^#!1NI+X(Q`%]BJ,Z#KUF/_EB$
MM?H?L!K]\!'J]57M0C+>1ST-H7%JGAF+ES`'<[&,_"F<!M!<A`J&$AQ"'?L\
M4XM62,6+2$<&\K#'(+G31!JJZ8**EYLR4$'/49W>`9N@"D44AE-_CM`'T17A
MZ(?!&(8_80W6XQ+UI*&JCW$`_N*3`P?(F_RH&QW6[R!0)!43!>DR5&([3N,T
M!5(Z]U)9YB>NV_#&#$%8A@I<P$/RI)>HA/>KG:YAND#OUL=D=XS<DX!1@KL,
MZ\2[K=B+.OQ58E)/72B-UM%]H]B,;I[O.N>ZKOWT0[01K..1C^EX$^62FW=Q
M!%?P;S2001[4EHYP;[ZBO(UW37\-O;B%`>B%X1*M$BS&$I$#LN,XV:@[]:5B
MNLC>W(:G\1M<Q=^K<E6C_F5\J^/U-GU48GX'5MA%0C%6LEHF65LIN=N!3U&+
M_3B)[_``/TDD"ZB":JB6GG`[WLD7C":SWGR@-^LF>$FT0Q")WB)])8))>%ZP
M3,=&R=07.",U\Q1/J3,-I#=H,2VE%;26*ND;^ID7\5F^IBK5)\JI3AID1!L%
M9H5YW3+&ZG!5NC;J%/'.5\[N)[R)E1CF"!=?$TZ\(W'<A7TX+-B>H%'BXBO>
M!M-@&DLE-)?FTTKZ,UWF9"[@&5RD2'51=A6FEAB!1I5QSKABSC$K7*&N3-T3
M+;SQ%#8,%MP9(K]'KMPR1Z1"XE"-SR5;)X2U=X3-C]$HM['DV8O:4Q"%4:+(
M>,EZ!DTB!^53&7U`572%[K,/=^!NO)+7\`?\%7^K9JJWU2:U6YU7+D.;7F:T
M2(J9*?Y6F8\LXRWEUA'6R=:M'E\VAS>?;+[F:N5J[PISC7/]T?69SM"S]>MZ
MB]ZJ=^IJ7>>N5"7<[2+\LHF$H:=43@I>P"3!/Q4SA9-+L0IOB6P5'W9C#XX)
MX\[A*US#-R*W<%LR>]?MTV,TB4\=R$Y]A"\Q-)$F4RX5T1RW+*#UM($VD9,.
M4QV=HO-TB>KINLC/](0:^%GVY5X<PPF<Q*-Y+&=S#A?QF[R>-_''O(\/\G')
M\D6^Q#?9I0(D$XDJ6?U.39*(E*KY:HO:I[Y6%U2]NJ$:)#:&Y"C(L!LAQB`C
MSUAH7#>[2YRFF`7F>R)'+%Z6`DNU9;?EM.6VU6+M;DVVIED_MNZR:JF4:JR6
M*OW53QBWC7KPRX)2T5'>0V_3&=YEW&-ORJ0Y"AQE1`K'4W&+RU4(Q:H2ZBQU
MO!S/LY(8>O-F3D*P^ZBQ4L5]A8?IYGFC/6T%>!'E2[\Y*_Q)$9LE.(@078^V
M>$M/12WY2T7EZ`U2"_,HA>JDAO)X)G]G-"D?8>@-=5EX<TMJOQ]56DYC(D<(
MVX;B/?AAH.3S&DK)QCTQ`1O4$LET$#HBW)AF2@^G1VH7MG,EE_,>_04#WTO?
MFV`D$8SKTO?#$4AW\:E@.\7GN9QJ#0MMH=&"(4!Y"#].()@W(T?-(H/G\8]&
M/2[S0)Z@(NF1T4?):RAY6HA,NDL>V$&5W$!!6$OSQ/N;=)=OHA@_DN9FM9+S
MZ22=(#^.H!&J-UQ\@R8+FF#<-_W)@V.DCBS"JUN\7>72)IPWCZBK1JK:"X/^
M0C'<I&R<0*EJ@+Z'$$N#:NVZH..1P%JO-KR:?Y#HS,1E?4Q%&0YC5&-MXUGV
MI]6JT,S0CUQEYD*.1:YYQSH4I1PO'>*LO$75"*<?N)/$/5!6!DFD_(U5C8T\
M!EWX`3U&":V4Z@@63]*E<U0CC[:)K2EOTS!Y!9YRE73-5#5+^LQ>'!.VSY7>
M[LO9\L[DTUBPO!*&^SW8*&QX:+R"4OGWD(9#\II6B=;5_"AN>'K<L-BA0P8/
M&C@@YKE^?:/[].[5,RHR(KQ'][#0D&![MR!;8-<N`9T[=>S@[]>^G>^S;7W:
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MV7Z?_]!>-<!155?XO'??VUTQ0"C_"3\;UX1*2$.:`B%"67Z2`E$12.(FC703
M`D6"!J45H073(H59_A$L"#AHT782[6PB(QLL,8`DT#90L)$9+$P[T%%*`Y0!
M*C;F]CMWWUMV@ZW8F6;R[;GWG/MS[KW?/><^*O.GQI5[RDM+?$%16L1S]$C%
MO)."?9=>Z'>[BL&_-M&W*MJ:*`(Y_9YP<S406.4.[I[NB[8F\6]1$<9`7STY
MUQ_(Q=1K>1/[I<,1=I^7$E[4'$\.:_SSW<%[/!,\\P+S_3B/A$"09BQ)JDM(
M\-;+/U-"CCN0[_,D!<<E>HI*)PVH[46!&4O>[N]U]X^UI`VKC>\1WLW:;MVM
M0ES7Z,*<B$V55',NY<V(;*?&'GFF@`5!]VPW//%YL)`L_IF318'966B&OR(-
MO8+E.(8G@O=,]`?BLUG/_8-F<KS'';A!.'9/V]]C-:66QI$<?X.XR.2(\`MV
MNQQ,30T.'<J\<$[$0<+';ZOZB+1ASX;TRYZ%\6X(;!\]ZD.WHNQT['E2$I_J
MFI"7RE`)5DWWA>MN*DNL(V]Z:E%0][.ET;;T+F!+E6V)=/=[0-^]Q%\!O8.N
ME,A_]_@^/7/F90>U/O_%/"=LSYOIR9M>['/G!/S6WN;EQ]3"]JR(S2H%>T[T
MB43=*NF)0EG!Q))(8Z[XXH)&,OX=BLGE(:<+5%0:S9T;C/=/#O\6=4E*NLM.
M(7F5>REQNYOE9C`[-;;^8$P]QKVX@(##1HJ>EU\<"'2)L>4B[`0"N1YW;L`?
M*`W)JC*/.]X3J,<;+QA8F..W3S0D]Z])#.:N+<(BYFG98*M.$VH]VNKIM5YM
M]<QB7WT\7K:K\WUUNJ9/]$\HJKT?-E\]/I&\2JM'M%QS<XWR-#"]3G<I4V*]
MEZA*60VE4/79(8V4SF7K-)H=TL.Z>*7#7YIZ/N!K+ZDCAQYS5;2;[1VNF_B6
M<D:_+\2;CM':`"[I-JKI95&BI1A$+P*%CFK:Z!A-9=H[6E?8UNK5,LD@[3YS
M+C7H)"]!-Q+]<O31\EVT7PHL`]S`),`+3`%^`GP"/`(\B#Y+@?LQQDO`49;0
M-SE+J-0X+W<")\U""IC-\C#*IX#C9C.M1_VWF+]1K)/[S4)YS%@D&QS5\@#*
MS;`O1;L3D#S&28S7S5A$&U`_8YS7".NX!?UBZ$+HURX&4E=]-)T1`V6F\%.6
M0?**7JW-0[_AP$BQCG4T!-*KC^[8`?LQU!]`'Q_JNZ'OA?(TC._A=L`8M!D$
MF8:QAV+<-MCS68^VP[`>#_P.`26P-8M,6J=G4IO(E-\W\JF7M>Y7>-V\9GM-
MRO^P3W<`X_+8WFB$_;N-V[Y]*<["IS]"/@-D8"WM>@N]9:33`H,Z]CEZT1J&
M\S3.O5K;#L09Y=3?.5!N@8^3S;TT`G7&+*`8_:\9.^4I<9V\L*4Z7J+-T$_6
M,\"Q$52G_X@N.)+INUAO&N8SF2?8MXV*"^5JWW3(0<9?Y?LH<SW9.5#K8NW3
M3MX;YSI*0_^1F.LR_&@S%FD!X(?PK0[8Q/Y@_G3LN1_GOD\K[*C!.#W`O1\`
MW\"ZEH4ASX/#FZ`;CW:#7$3/6_.<BI*GF'O1L,['QAD;:N^K\:*LIB;@)GQ)
M`0X"R]#O(\ATZ!^!G`$N-J%])O,5O+@:YJ9\B[D!OO\!^E'LNUH#^,T<"]\;
M;:D^EWX!5`(O.(A>M?!3M%'WA3G+?EICMS&WF#.VM+AQ1*_!.Y[7R;RRI+I[
MYVB(\@%K9VY%).X=<U_)B[C3++?2%.8LCQF1S2H>C.'[B+--B4C+'[Z?B!MG
ME;Q(A1;7Q]C2VHO#$;E.O@/;,D=?VF5D@OLAW($AU$=<0PPZBSU\DJ;R/3:V
MTLOZ2NKEO$3I.,MI&&M[)[F-X6S5YF.\1NQGD]%"VR&W&:WZ?4:K9IHU\J+1
MIC6:-?IR+M\I.\-NRY(1;?NJ^O\%^H=F#;XI:N3?S%8IC5;:C+62\Y(V''#;
M$OHZH`H8ZDK5MKDJM)"S@.+!F^M`I>&E;-,+SC72.*.WBM_)T!<X"/NO49[Q
M"BW2&K6NHD!+<=30`E&`.XJY]`]I!8/'AUP8X5&8:]FVO(-+EK3YVDD>Y9C/
M<=>6ZNXAKEK2%U//IF]Q;N#XS/F!8S0CS%?Y6H27FY%#/KK-SUB>REM1_'P1
M8V9TYF64/,>2<PO'=\XMF'\6YM^%L5[G]:OXB!C',9+C'.[\PW;[SC+2OUH[
M@/BP3\7A%BJV[S7`]_P3V!ZRX@CB,.U5\;"2'G<44I$810^K>#299IDGR*UR
MD)53C3KY2Q7+<)_L7*KR:*O<$,FC`^6U<#R31U2\.2CK^7ZJO(G\:>[6>IK'
M*%'%E47T&W4/^0Y^2MF8JT"\B9C;+A=#ER'&(O9"+RY3L;*=IL%B,?H9<@OG
M1/$D):O\>%I6BG$T3O5=*;W&I\C;;R!76..I-I#F5G`2;P&'GPZJ6%#,'*%N
M=CSFLW=6R'>=L^0A1SDUF8]B/67T%ZRE1>U!2#:I?>"^?64:[X4S7VX4-V4'
MVOQ>@?M4R'JU']BCZ+U0N9G?%!C344E;U7YPGQ7TL<LG+S#,>?2LXS/,@[G,
ML<@E$V2#.4%N4K'5@1RW!.L<C-P61V.9]\ZGI12#Y7$[#XL&2A;+Y.MFHMR#
MO7O`T@_AN,]O$GYO\!O"_#7G?AE2?4[BG=:%O`QC"'A907/%'F`5=3?WX"T2
MDB^HMT(K?5T8LEHLP_LF_#[A-T*!NB^5\@VSCH;R'5,^8`Z^^SB/PXBEA8@E
MXYUKY*\,G;X)SHW`?D\#Y@`Y5OV0A<-A:"?";30=]GS]G]2&<@G*W],;Q(_U
M!AK%[T#Q@6P5S\LC^B:Y7#Q&!\1Q>5(?0._I+OCQOOQ,?$!%VA5J$E5T4$S!
MNVDA-8NC\H(X+,_I]])4?8S<)6JI0JR0+>(9FB:>PG@;Z8CXN;PJULL-8BLX
M>H,.B=_)E486O6?<B['.49/V,]JA_X-V.!ZB>,PW7HU?11LP?A^%%>`)^D5#
M^6KC3I_+]&2*L_PMCO&7?;7]M'VT_5N/7&;YQ^OF<54_M#$FTU0B^2<@.2P[
MIN-,BCFNJYB5@]CC0BQZG,;`GD#T^35@+\J;T/8F<`'EYX``RJN!?P&O`4^A
MW74,,P(8C/IWC`1ZSHHSE6B?"MT"`/T^/X7Z()2S4&X!^A.U?PSY-#`.Y5L`
M].VFA0*@._J@G>2Y,BS=%;3?"9Q!^57(F6%=^]LH=[7D?F`+L!P8KMZOG=XE
M_P?YA?GH;F6G/)31.:=\)9ES5S(F!]GG_V72RBTE=TAK'^QU1/GSGW)>C`1_
M&J+!L97C&\=5CFT<3SF>1.2_6:_6X":N*WP?DE9^K"T+V98QZ,J6=OT0LJQ=
M83L&6RMAF3:J>9ETK/`P;0,-)30DMC--`Q&$>*9A"OQ(IP_:0)-I9BBF\7J%
MC8PI>*8SG<D/AD[_=293:.K23%M"VDDR;H*CGGOEAC;3:?]T5^=\]Y[SG7/V
MWKVZNPM[JMC7^/,$/D"+6+C%]U*^G_&]E.]G]N/B>=]D/PU[Q$E4_\_KNH*V
MPT8_ETNE-",/&&H3:#6W:+/"L5+5CB96T#ET#F02Y"8(KS0'#Y\Y1.@<F41-
MB`%YUJJI%U%Y*YE<;G1T%1NYUK!V*U$*KYCW0`C-TUG47(S*-;=I[R7*P(`A
M[66$02C\)QF=H<>L;E:9J*4YY*(6\H-L`3D$<AO$`1>30[=`[H$40&S(3<];
M;[_$KM%S^``^`TF^CUYV8J.<96U9.\F2+"7#<\1$N#"/:ZVZ?5J^,)_;NW(?
M7.91/,(-/Z<OXEI>'^[@I!75C3Q`FX`<3(M`M:F(#4H15_D%6H$BNT[_\568
M%A/D-IF<I@9M:(%"?\MUJSW:5?H"/U&W$TTS0]FI^_(PSIV/`>'=G-*F>Z#+
M[\/^:_083,D)H2NX+:*YN&_K#JV<XZ:M6B/'C0-:!4_1KY<"&"7J1LVM;!@2
M)$O3>8S5JKLYM;-'<\]!PAZD%]XWJI4>W:NLW:&Y%#6F.916O1SJYPN?&$$E
MK)=W1W3M!\H%Y8KRIF*S*QW@U;JTNNZ6[JYNZE5J(>&E9J5+L5VEQ_B)%"<R
M7*R2\8MGWV"DC+7K,*J_YI@8]E%^(@:D:M8Y+$U*9-@QZ2"-%X%?<C$"A=\R
M2B^R1JTQ$-K&AY2U6G0!C7Q2LI;/#]G^>-D7TC4?3`9?6-F9+VS6-'6-GB@M
MO$NS"#[]"HN`(<`_04BW[H?(7+Q?\W&,=&MNGJE-%UU8E"*_JMMX]_,/QSC"
M1`IHT+T`1OEJO5%MU[1&5>^"^HM&J0K%2]3Z!NW$-2B%:9:?2(6!M;%.YH@X
MX@YZCDR2Z^0FL9VCD_0ZO4EM3P+K-*6,1FB<;J;#U%Z96$ONPLT=!GT.Y!8(
M11'0<9`G16\2UA!&FT%#1D3`.PE>WHKS52P\PY_Q\/\'IA:UR%TX33@AB[&R
M$Z-V;&"",2K!!#E1;2UL,>XJIY$H(\^1`(HA&?<(W2ETO;$R)I^.R2_&Y,=C
M<B8F;X_)GXO):V)R<TQ.N,A:Y$<RJ><:WQ?Z%T)O$7J-L=(OO^>7K_GE[_CE
M9_WRU_SRE_SRL%_N\\L)&??B+B2C'J';A5[--5ZZ5#E0B4JNXR4T@&0Z!5-;
MC1BIMM08RQ./I<8!G)9OCB7JB`->"3%X[2`3(+9EI(C9N!VC*-\%\,<H@+\(
M^(:EMK(\_ED1)GC.1#4^CU0>A5]'/JP`_@1-B/YK*"KPU65\Q0H\`6$_XI`H
MP3^$;PPH`@5T4>092VT#]Q-6]&F6J,('H"8W/XZ"@I:")<(QOAP6L'QGV57<
M@'R$=]$E]5FV!/&*Q3[2\TYLL;\'\V3"8N^H>0R]/X#OC,46HM`SRMCOHPOL
M[>A+[-=JGN`9]BOU!KNAY&U`O!P5Q#=4D>2B#XS`/QO=S;ZGGF4O%W.?"`K2
M<9C,"6,%>P&&-!988(<@S6.!I]GN8JI=`7$%C]P1O4&X'H#-NC!N4GGB%6QC
M]*NL7YU@&Z(W6&]@-^MF8)]A#P476&=`U&H+B/!6'PP.KJ0E,,&:HA/LD<ZK
M^)=(PB=`0D:;E)6>DO9+^Z2T9$A=4H<4EAJE!LGC=#M=S@IGN;/4Z70ZG#8G
MO,PZ/?G";0->JS#R.%P<'#:N;:+M(ER#XH\4@IT$7OS,%31-TH-)LS.4SDN%
M;697*&V6;-DQ-(7QJ0Q.F_-?0>DO^\T/!P-Y7+KU4=,>2&+3G4;I[4DOD$WR
MK3Q&VX?RN,`CQNM-]X8A>&9A8_QD/<?,^,E,!M4\$_?&W;U5#_7W_0>U9UF'
M'AS>T+\?WM7F=].#0^:%U1E3XXW"ZDS:W#CHWSDT2XZ0YU)]L^0PA\S0+.XG
M1U+;N!WW]V4^I<&".@PT6-2'B[0L\G$:K.ZLH.TNTAA$`TWAP&GG$1,TAL]S
M&BPSSIN:8*F^*<8$QW8(30C.A.U0D:,(SIU_X=A=Z([@W+&[1+E:00D&@1(-
M<LI48Q`(4\%&X=[ZP!THNH\4W4>$^^L/W'K1?:'HO@#NT/_IV)O\7XS4_L$D
M3F\9FG*B9&;#SB+6N`[UBG50-=USM/X*7D5_@\I"&;,TD#3+`DD4CWM#KO4X
MLLM1;CK`)H%P^KH&[_/U5VP(IIS3R\$L+[O"B7""NV`Y<U<%F"N77=[GUS5`
MD?/++A>8JZ`(K..V05B7!U)FZQZ`0%\&>5/[^^"W#"-PC(V-C8R,CO$#`M3!
MM-FS]=&A*55-F75[^C*AE'=_W^A_&3]*FZT0%.=!DI0R#0@:&0F)N%!HK-B`
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M=<TM\6^/_ZXQUJRX*YWM)54UH=ZDEIG18`/KP-\D>W$!QK8JAXX3G*=5,W92
M9SMXBE=9&'`MH,A2M!U+#9UD;\O21RVX,#X.<7V%=^BK]L=1&[HQBSR%>:._
M:E5\5_A@>%0]$CX5/A-^O?2GWLGP')F3IDMGO=?#%;O1,"9[/6,>8B<EE>4M
MU$%K:-#S2OA"^%KX@VK)YOD'W64?V\1]QO'?[\[GU]@^G^_BE[MSXGNQG9SC
M<V(3X\C%%S)>1TBGK46EN"V%E&ZL0`8-A36\B)90HK(UTH"U:QEBA4%73042
MTL#>H)VV:>JZC;5:_U@[*:50"&63QS\09\\Y@0'59.E>?CZ=K>?[>;[?Y\>R
M!#M*[@%?+9_`V".-DAZ4@,#CW:XS>!]R$C!6P*V'TLQ<"Y!N1.'HL.'#N@_[
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MY%+R85!4H\LEK:QIUS6M?$$K^9A`WL?D2]!O-'R*!5-<N.CWI#1['_T.G(.:
M!2Z"B![']*]O'^U7;M_9/'3!1M&%@JT`W0H64BJ54`D!&YBT<FR@MC8#K9!I
MR0$FN5S49H7%V@`LM;;FX#]&+76K[%Y_>Z=KXG-7H+U!I%U.NO+L;CV8+;@J
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M/CR)=E[%!_ZZXKNMP:#22*VN+%A3>&1._/&^L3._>??RL]M__OK`S9?^@7]R
M36=9';KC'+CP(6H1"J,F]/';2)B\:&1\>5U;PF^*;]8&XD,1JYOUB&[,P:C/
M"T*$Y<!1.#GE3J8PX;:SJ03'T@VC,/%;@;%8H&@=Q0&D@W<Y_/EU.M;Y\\(H
MB1%'SCG)>%G,CN#UPRD'&V!3SE&\'MYK$E?0S,KT=)@C#CNYS7P/3(O;3B2"
MU;/A:H(%(YAG#5]>FTJ6SK&)L<5T"3#MO&2^`%@K%L?I<9-+ZEX<`3IPH5RT
MWL)PK(>PR-$J:JTY?]66*%P%#FJKY%J9JE'A9`U^"_NQX[6'UU^M?/[^Q%EW
M%Y_PB\HU(;L(=U8^BG),N.U5['YP\^`G'\Z@XNJ6RK]>>?[&ON$E*E'C$QNW
MDMGEN7AC[*;C.SP=H1SM1@G/??_RIV#$DW^!JGNAZCE\U#ALA$Z&B.=#/PB]
M'B+[A9WQO<*^IB/\D:;3EB%F2#C5Y%PE]`H[$>P]6>^"$)DQ^+Q%XO(AR<_-
M"O/8"[[LI6ED2WH\C]I%FZB`M:2RN=PO=3%EG4\0RRG1RC\7"%P+B[PEB9.J
M)B8134?`7A1%S:621,KC]7))(I`2[<K,A*K0UJ,V0V:*N@W;A*.\$0AF>2#[
ME#@ORP^F!IO@VJ@-"]D#35\T$4WA/'$,ZYYCWJ/HA[0IM5J56L&*^9R+#605
M4&V;>0_2SW0H`65F5?JV.Z2'IIA27P&*!%]1&9FB0)FFP#P/`P0*0'`'`.4+
MY0N+(7RTSO)-31O32]K8+1;&BV!4A2\#44J-7T'T?_!=I^HW4Y=5G^J'Y[$Y
M`YCC3M6LH#.KS4C*U8R2Y2GCRDPMWHV3G(M6'XO#Y"`3^U[9NFMS4AU(,/)]
MCV_?X0_YOO+,N<LE==N-B^[%?(+AU:O"C$ZNAGSO&ZHM++6GWZ3(B8M?7U=A
M9R6U;*A2;)?"K&?W&Y5^`(L1&G:0+2NR,4VMO)VJFZ&D@HQ)U'M`U$-`E([G
M#W&2US>KV2S^#D@BRL-Y]L6.Q'YA&?*=BMFPQX,PZ`V\N-TF+[5B0*R-/ZGK
MRQ-B_!8OG)<5.8N*U8@BJLCKC8@15A0C>DHE4FZ/AU.)6LXNIA,1$5A!L/<C
M_F3[V$;8XH,HEHX9L?MCZV)4+-R,SGM-(B+D'*.&\8IUHBZ2VT0LFB2D'?#+
M:2=<OG7S#A"F,!"GY!>GY1=OF8`(^HOWFL#UGDZ0ON>V](7_)SVZ0^<O*]\/
MRO>]8Z,+5;?0[A)\2N^I3/J?TK%;2E>%?OG'QY_96(R]F/!^;>W)WOK<ZIH)
M4#B<\//J%V(XLZC&(JR,N1;D$P.49>*SA9LJ3"%^7T=EU5.*FK"I5==HV$8V
MKY@95AFU<G168G8G[82TVC/Y"?5'2*M6=,Y8Y(<X4=QY-M^\H'DI\T3=!L<&
M]Z;&7NVYFKUUPVC(,<I]Y/P@X>.C@LB'F9`83K<0+L;GBTA15O)YI2@?#NNJ
MEZ@C"&*$)(P:6R8SV*J3GI6J@S=3;#K,6G>ATV#D,V'PVVIX&^!7&\PT:^C.
M=2^KQIB98O1U,\7,7BM<F;@`HP*4O=^>TCQF^\!=_AX31J8+3Q>TGK3Z6,8L
ML;_:*F;70/!#\)'F5*@0$'A0Z-N1=[8[YGAS?^7W[[YZ]@\M#RU=P84;'Q%<
M1-;9^5_*JSY&BO(.SSNS=SOOS-[=SKQSL[NS\\[LU^S.[MW>L7=[D,7S;HQ\
M54#;"B*4PX*`%#1*"%^BW!6M2DDA6E*";1.+:$M-2^&.XS1\M1']KT5KVU3;
M!EI,:Y2TM@FMX6[I[YW=`U32I-G+^YNOG<V]O^?Y/<\S*Z9D5^[\T<!OJY<'
M]_YQQ_#99S=VZK&T">JW<&YFQ;[J'_Y:_?.IZD>JC0;FM&4(S>50*A_?43UT
M2^X'"#_Q,W3K>_V+II!(.V/2&8@D<X!)%OKV"$JU5'2(.)[70OHXNR7!+XSL
M)\-Q82B!>"Q0'JM(C1*JHAC(HR*%J1*-Q2PL:1A+JL+S2,2V*^%P]`1/N!@P
M0>*)IZ@MV,:=>!#OP0UX*%K!P-6C;3VL'._NP5XV5V;'7L3M&<)G\#E\'O\#
MG@388P^HC1E[;(PCV/;G*+EACL*T\JG!6.2U8D^5^[&GA6#1FV")-/?[;\8P
M8K%GJ?[9<(*PZA,.UPGG7V^Q_'HT5ZE]J37=CX=:8K6;LCI9^_R:]L^'/`PL
MQ9ZK^7>/:)6;Y-(:;Z^SU?>2S3>QD-<YRR@YL+ZMS?D\`8-9!AN?GCKZ1)YX
MNWE!O+TUF?[(,GKFA_B0[-G%3N?#1&R:XY/,ZMPJ=*TN&QGB.*A%NV-P_)?K
M[5B:0.]/05;HA-Z["'O=F$1=7EVH[\GNRNUR#W+'N=%X,.<BD:>UIBNXWF\1
M:Z*(TPEW##5ZR40'@M8CT<VEN4!!S+M8#'.'.#?L)ES!?;T0.PDXP,),3H7@
MM6$TC\6(F/?'X.O7^^@/0;'6$Y%M+_1$K&N@.%330+:-EVK3K[:7"*PZF*#>
M\*5+2N5_[*DO;`/P$\=`F;6^V-C5OQU5*A`E_C0,.&>`/PJU]A,#R4]K6RH'
M.YZJT;0N@#77WBV\,DZ:OQ@O:';Z[]:T>8H4XO/BP)V&FO\P'E=ZG]BSH*]L
MSC:@![)*.[8(E=53L@7D.)E\_%OCOUF:B>HMF?A4:W.1L?`DQP570B=*O#D<
MXQ%B^.L%'-^#EEB\FA)[Z.SX+'JON8@^P(TD?T?_3:6<^0;E5].GZ"@5LA05
M4V&ECYL"B\6.CC3RMR^XU\M)[=U=<5H*(1/!CUL!9!6%*531,CF:#4RA)4*S
MHE#B?5CVAB?.PM_9LRP#L>GFS[2X][52$9X4<(`*Q-`HR;;#EU5)H:IC,[U$
MR-=+Q%,8!9)EQ#7#B,,_D3;CFFG&B^WM:=O2;-M2"3&SCD.I*98X@><YGII(
M,&RCRXT;EAT&5!P<,8#W!J/E[3\L&PP*45KVSZWI_OE1K<?PG5:S4DX8@\8+
MAF"<Y'=QW;"/\[EVM,&3;2^LE&TOU%2VZR^PZR]DU5/@3?;V+B-B1PR[2^I]
MV,<A`#$\X?/UTD7?H/F';2P$`M;.((6!K9X)P_7/).B>#D`H;)A,A_X5L7[E
M)GC\_+KXFO-B,/5:S"CTGJ9@X=C"D,F!E`R`04^V-D[RGZ&QGB,!KB@M7--L
M'Z0HF\U-XW<^+A`T]T&2G):XHL>S7X[BB;-2?)YKE]K/CW_@#O[3GKI&KMXF
MQ^]O3Z11+MG[):EAWI43@1E.,-ATY\/C!^>VY33J.'IX\7Y!O7(D<-?XJ^L<
M)P<*WI79(OPK%0TZ#,%O7KW0&`4$Y]$*;V.01%17FZI.S\[B9JJS6]?P6_F#
M47D!V10=B0I/("2K(2K[UCWON#0O\9A*IAZG)@,3RUR(UUH9A(BJ$<01U<ED
MTCH;>:UY698DAAQ1(U@G!5<EK7H8=9(QH<_3-&^:"=&I*];O:8]H0]H+6D`;
M$XK#F-O/_+@GZ^P!G3V@,S`1)GAGAO/%LE]IQJ]>S.CIU^_2!_4]^F&]0=]>
MP"2B1XA>N&%P`6#:K@$%7;K8=IFYJ.K%:Y#Q2=7_::"(_R<^:CP>00G<7.;:
M`"?<`"@#0C=,)]`#^*`T^HQEJ_5_+GKQ+V9Y=JA)1B.A&<G.2")9_7FF>NO'
M\=)2J7H/3+"\1C.H*;=XF0R-_[U@K)CJL#F%6EJ3G1NO'`AL&1_^:G<VYULV
ME;9O%P[W%@7H.<\]>O5"PREP:F$NQ?WT6"(%`AMA]F$.')1CT\WIJ1FQ.>;<
MU`)^4?/=VL+6)729M:IUK;G6WD0>-1^SOZ'MIOL:]Y+OF<_3D=;3]*05#S:+
MA%>Z.<'H%G%D#,R8$@(S%O*6]H2\V2O+H57I!+L:#7C)V_H#'FAT`.X%V+V`
M%^L)C*'(Z",0OIAM"P]<]IL#QHVMS+A=`J:M9WWJ`BAI?""=RF:9\\I$4LR,
MP08R]S55A=T5/G[ZW*:)ZIIWO__K5<>K*#&T\O2)N4N?V_>5P_=M/O!<P[J-
M[V][MYH<WW5QW2FTX9.GO/LOC)Y_<_=[2Q[:B0Z-/?,6QU_]%>CK?X`3)BAL
MV8LU\CH_._F,LS?Y7>>EX,N)T>"QI-0HH0)#W'V07<1H/GE+<E;#(G>;\R+_
M2G*TZ;7D*4?64^&*DFH)]U%7DJCKRJH.<LQ%3,HI,FBR*\N6'@%N1"21VMD.
M3NRV;87C5464:%K/NQ$]G'Y-&.0"*#)<<-^164:)\&1$'=*1/N:+LA[1:Z+\
M]1NRB:_*>DV5];HJ0QTZ#JJL0S)AUXZI%7TRH%Q/*/,_F)3H2J4>4""?*!6U
M\IF,<N,:;`92!9M[_6$XT,:M'T#)+NA2(W0I=PW<=0>=S1'6JAH-@LCC];?/
M/5D=W[?LV0>S4U=+$^_+:^^><MZM+']C_<R'AE<]MGW&\H9YQW8\\(NMJ>KN
M)PN)0J/C?.$E(;"K,]W1,/$3NF1D^:I-"J#ZZEO0M0/0M2Q70M_T'A=UG.LM
MS.'F%>YH6\*MY;9QF^VMQ>\T/E_\<>'5R.G"Z0[EY<:1(-]HZN;.HB#D2J5`
MB#31D!R0J&QHD$FR*8=F2X&`132-$"V92ED<TF!J)E&^L\/(=R#$&7PV%))E
M3DPE$1=H)UVN1L+MK&L6V_ABV6(-,*U:)5&H#.G=J+OT3H`U5./),<(,,*E[
M6^+;4V@9^2_A51_;Q'F'W_?.'W>V[WQW_K;CC[O#\5=LY\-.,#')42H*@;:!
M%!8&AG5DXZ.@4!"4?@18*23T`[95:`C"*).ZMAI;ED"H^>C8NDA=-_;'JDZH
MFU31C:G:1-1I@TW:$K/?>W::EFJ;+-_OO?/9;W+/[WE^SZ/9?1V.FGEUU/!S
M+/`6R+4+4@$LNKXDNSAJN^@?P2[['=A!.J09!-#1?*]M*WW6YM:PUSDWB__L
MU*SU@/2I5=.'Y?_4P$&24&N:)].F6'7JW9-*S6W5+C$[@`%F3+JBVA1TSP?+
MNG=Y@NZOLM-_MW;Y$XZ(.NE=NLB&+WTX\>[(<XU?><PZW:LUG_W%P$"D@7H9
M"Y6O=[<EO1(3C=*03K-/T"TKTAD-1U\_?."#8&7GMWM-4>KW[-4C_;L90`_Q
M=S\RK`+]:\<KM8,'&[Z1I=9QZ_AU]BU</]]O[Q<&N'W\/OO3PO[T_LPP=XH?
MM@MQE.1RZ4?2&^6^]#/,T_R.S&'F4/)0^J3M!']".-;R.OJA;80?L9\57LV\
MD;V(?V*[PE\5SF4N9&]G0N[,<FNWK8=;DWXD:S(Y/<XNVV*^2W@N8[*GN8S!
M'`^6Z9!FB?>YU$]DV453EW$&(52`BZ*Y)9=#K)"2+&<CC8V-5"/<.JX.*9$A
MI8SO&P_+-V1*KDY$4L[Y`CE2M8`2RV7E3GF_3,O^^:FSDI;)2]>H(=P^A,D7
M3Z,;,`E(E(,;D>;)HTNX%15QZ^B`MY;0P+8+D[=3Q+N3AJF=ET@KD-Z8O"5,
MD@(+8CP)W#MP"3V.'_<X6FJ*G,_%ZLDKGVMM:88.@!?1Z19:K6)-;D.D"4P@
MZ#$"/K]=,8^\=&`HG+VVH2[S_O?G-H=7S#/Q8C!95[]),;QR8-.S/3C5N^W:
MD\5-.V+^=CF,_[FD\?#9,YOOG]OSF[ZFY:N/_-)J4CP4'6JJ=!2C3YYXJGO1
MOLI'9]9L_-D6=\K>#?@?1<C8#$HAXY2FTH1['$CU.(=UFRQ9P2$;Z2$J,B13
M`C9A?)EFD`7)Q+R*!5E`C6@[>78THPD!P0(J7K7.;)TE4,;#FA-1\EL841:'
MQ/B5>$"POB?ICAB@U&LJ4ZUJHEI#D5S5&GO]N7W^T_X1L,9E*O2FPOH]?L6R
M\2+=A6KDK4*12I%4Y-?`8^K6VE/PU[(MJ6]*C@X_<4HU;9],U1)LJK,X!6&A
M6"S.J'GJ*>&O)>S-ILCJ!BSFIB8P0#I=^"R=20P#G9!UU``E%>OPSII8K)(I
MK.(&@ZF_WI%67GJL<KM%6YZQ38]9_0\E@]DD]BW?=;2W+FI<5CG^<,>2:-W4
MEW^<J&^*1GWBZF_2/R_NV`RX_`Z\Z`'`I1GW7$3A:LPS$F.R#1;'U/.V<>ZR
MV]!C7!'>R1U4#4R&R1:D]IB!K4O%*&R"P!N(U`4#*-T<1+J`FU@VE$P[D\ET
M1%%4R>F4)&?`[P?9IOB^*&L7Q#FJ44I*+?%TTBDH0Y(&LBOI0NWK(%7CQ$*C
MI$G=$BU(6+I"/X18T.PD/'-?/JEC%\_I-976JR8US<M%DCBYIX5->B0/_+:E
M3'>.]L]:SRJ"&)A4TI/*YX+*Y#V^<R:7_%>IK05&T>EEQ9Q$#DY)B1AX'R*D
M3!'KB4D^(?B9>0H"2,TM=5"U>0Q6E*!'\Q1P,)^;D><8ME'SK;U+\\$7HF;;
M^>]L&.Y?J^Y)SR]9\8AUV<+F\,L/[/UD]-J_K$SX4%UAIW%9E`IV]54B^^-:
MVY.O+1W\>#?^[LFLG#5"<%RZM<+>^?.ICX^U+VS8BG_=EXTF3)`8$/C0=W4>
MEC0-L<AB$1DG$S#))I>H"90T5YSO:O<5(@5YL;!,'!"?<1P1C[I..8==;[GX
MKX7[(M2P^"/QBDA#`E()"!$E1^I8,*^?^@/ZZ;G,/+UJ#<D\:[<$67\D$/0S
MV!QD?*(WZ+,+@C[7!1%A41!4.>*4Y4CY[FY-$I`<\?M\+,M0,F*S(A;+U/-C
MPE[Y$MT!_\!]XXAT#)%130`C:$<^$(?]R(!\"ENFEX^^[9V9MS!E_W'[9@G-
M)(L49,_/1XO_!S&[07Q6_)XX)AI0J18\/XV>.EW&X%&5]4*\QJBS4,V?N&2L
MI@X5D"9FV4QC&,(UZ/54BG';=F;AXCD6RF/]T@*'Q=I-B:O<]DRG#1^W-`7;
MMNV>-H0-FU>%TD4(&$K"O7'J.O7>KDS8$X@;HE&#W;_ES+__!FGR"5#624"T
M$Z_5_(<-)PT_,-!>]RIAF_Q:RWB+D6$8=YN7SA-.+[(7%FB^QIQ&#O`W>#QN
MK]?H\7CC\5@BX3:9C&90EGR>C<<38!?;VF+8"`RWNX6@/9//!C-V%"8JC`/:
MAD)G$/$L%^1E;R0HHS1.)QJ"Z4)K/.HQF19HL/"8C$C)@QRX$V"X$\:V6$SU
M&IVP8UL^X?.Z62.S0(,E69F1$GU#S2J9-.@$C%I%MO/,)?P7R@<J#``6BV3P
M%8LX>_NFSC),#H2R@_Q`E;(`Y^PG-6!+7T#VSA<O_=0L,$6F."@P`Q/\A+ZH
M'HO,1!7S4@D@U8'$#K<G1-5<%0@SC75NSQHM3-?/T!LN.VJWU<<,"OZ5]=%O
M#51>V<#7>QN7=%FG;UE7S`GXUU?>+DG6$/^`I3+?NK+UX1?P\UN;EJRQX#_9
M%F9]WK6_W9L5'8$NX#J_^F#E>.58;MNB>6$:;%>=,U*W'J^L7%T?DL20@V&C
M42:<?1&_B`?/]X!E%U6WM[<R]O[>!P,N#R?1T"M3X-?_"+WBP!Y-E>9R2[@]
MW&G3:?,QRZN6<<L[Z!WQ.KHNVB@%/#&[R6@LXP:MP`191X/=_J@4=!AHCJ+I
MD(USVFR<C;92G%T%P(RJE39D+%;&+D@"AY"%HCF7TW$)+T(VW'K>R;)[*:(1
M:D$O_CREVZ9Y.5+';6*.FG*5P09-$1NDY]`';Q(.`X'!^$`2*D`1]7@TK3?"
M=)%<&30"_`,3%&0A+\Y,WD+"G5HAL!&.:FZ;$BIPBE*PP9M6O%"]O@[8]L,+
MGH(MY"G0Y;M_&'459HSY:BR[,,E*X)?D/):K,_8_?%=K<!/7&;UW=ZV55EIY
MI=5*LH0DZ[6[MHPEVY*,;-G:^)&QC8T!8P@8%TK`!0(D)DDS%$AA$L8#9$@*
M<1XTQ4E+TW8H";$#%4U)()`?_.@TG<FT0YKI8\9M(1T-G0G)M`V6^UVMG$=_
M5*/=[^[CWKUSSW?./5^:/GO7]H/B;X_&Y4?O-M"WBW_//_=`-`R8?.YIW+>[
M..5C_A;<,@85$4K,WZ2OT(>A(DKA&YK;5&V$89[$3]9.XA>\)VI?J/]YTX68
M.4'8Z+(X<J>=IQNH=&U?-64)5:4LUI":M))G&6CD7(.N#2ZZ+8$M&EQ:M*K4
M1><-^:9,8XIA$#CXJ"Q+%MZIQ!OEJ)-ID.J:?'*>GM1$I$1"(<2JB&$"DNR0
M)#F>G_]HQF_/Q?-TO<9[/()92JNR)/!'+)=P)V(H&DDP?_H7\EE)@_<DHJ_6
M<#2))$%*2/0S$H9;!Z:'4M(E:A+5T0>1'?F(T">3/O*N2U:2O@-#J2G?;1_E
M:TQ++BG--5[5/52Y_BFI)NFT7,V13C-@F$K17;Z6PGJL+-^'B?AT:U"*;[B^
M!&K@UIW8Z'@L=@><TV<%O80J6>38PD8>@UV">.59;"OGCRT#"I'!PO4)\APX
M;A6N$8J/(N#X[A+3T=)SM4-+S[6L6'??.R@U_P%*PJ'.WT3*_,TE\`-QC^%1
M3.NL)U:LV55RTK"+-X,6E%KV9K#>3E<S&V(-5&GG+VD_?>6JD^:,%EY2[@EU
M'V^/Q9S2$[L&^WNWOW/BX;&V%5+D/:UG;*JK;N>!,QWTX;EU([Q)L)@$WXA[
MZ\Y83</RI6>Z&O9LG\+?W+Y*Z]N]*#M<G)[H&GSE=W\9[B>YER:Y5W$,N5`$
M5VC"B!<;.<R:5J`U%6\M8N1RN4HB;`">I*T"XW#$[4:N;NO'JC/A&G#S..C!
M5H14!'?=`=[JX'EK,.+/!!6&Y6<]$;.9CZI67O#GZ8-:)0MX/\W^AJ4"+&8W
MN7\%2>3"$<3#AVH329YP74V5@EP*Y/-\R77#YR_S[_/_Y&D^CUO/1WD7'^7R
M5."-<L(L>.[9PASXJ%L+\!8*.1U?HXXOMI<0M6<^+<3NXD\!SVQV/T%TG$`)
MD-)I@H3DH)AP2,&ZE0ZQ*9J41':]'&*IP?<V/KULUU/YXL<3ST_A1%AP+99B
M-9O[[[MT=*1]=%JN.#8WL+GO^/Y7BE>FQQG7'LG#VUGY/_]J/H@;7UJ_=?(0
M^.@LK/T.X+V*>>U>J.VL.96<ZE$=CBGU:CMJQRT5[4J[^A1U-'A8.4.=CIP/
MS$2$`/)0'J:JPJ,$5,,A&7]'.:*\&J2=%9A8VVE;R?%..TL!^)B:4E]7*140
MXJML><R\Z8MP;!048\8KY"!^I('>117:C*X['JI2>``HSN?X07X#SU3R`9[B
M/;4A@IW?`(]RAD'#!L.#!N:`X67#.<-EP_N&"D-536QUJ1P%=@W<6B8422P4
M9F'U8S%``!-)%JZ/ZEOC.&%,$!A3#XQY"RS13>0G3%E+BE+`,%HFASU2PJ%,
MD'9*1V+!&*>;:>_6#[Y];.H,#A[=N4->5!.HJ8QSHB^UZ7+7RD<V#SS_C0_W
M/_KRQ(M8O3C2T5X74OUB]6*'6;(ZCGSWY,FQQP:V0/X#19E5D/]QU(K?U4ZQ
M?NP(557FS""<'!QF+9U-<N1D=B=32;/6V`27C:FDE_.8MW';S'_B_F@VY*1!
M:8,TW,1\V2W4DDRG>OV]K</U$ZGG\/<=)Z57T06<Y\[[WDS.I*RK$)8Q_B2%
M+6YXE2/OESJU:=%4FQ:.0&-1RN&0PA%9%G=PF#/'BW(>?Z+):GTB/A!V-&42
MLK<E'7;0(N$>C>)T0)0=HB@W1:K93'[^PVE_)D.4V^QV6\UB5I5%`>5I>D9^
M7323S.#2,,_&4TGS$8Y4HVF8>>>I))?'G1I'S\8GD2B(E*@+N/A+$/`TY(#5
M"SG@A4EZ-5\DZ=7I2H)F`U6_[<7>JJSH$K-<XT^^SDJ0WO'9N<]()143[GQ-
M?'.%K])3W[UM.DO+)(74*?'4N/_:@J.&+!HE&AS;C7<O"#PX+KWD_;\2*Y;]
M58G4A,ZHU`4QJXH_760S\?;0\E#/"2U4YU>^]]C*I?WC;[^T]UOI9?(F,VNI
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M1@G9"*W+AA?I%8X)A`6F8B("8^-RQG)D2319VLGU-$1]1R9EC[C`9]?_T)XU
M*`!56I?<.^SCZWH./2$5?G_\V3QVGM@^UK'F9P]=>W9T[]Y4P]A?\9[&X-K]
MK5M\_\@_.(F7G%W=.M1_?UN-QU;3_&)W;?(&0K@X5;R7O@Y<[\1C%Q$-TUFW
M.$>3-12'8SF#YKK'U9%!C+U;4VOT0M13%4XB#4[=0/ENS0F'&PZKD.PFSH)/
ME4L^2Y!ANKMP6(-QPGG\@"9$(LC0--D668R$26_$5(ER<[/DGQ7F8EFR>/%?
M>[58,*0H`9KJ[&#"$29`=2H=X+T"B@,.Z*;W_\JH(AF5C!;H4I6`D&[)-"3R
M5'':U<#G*5H3$J(&A#W;%7`%NKC&/Y3Y=V=TKC!7^()P!7T.,!EA=L'U8%O)
M+6<FKD$Q,U$A7+-FOZA<%RP8`^L%$R$V6/-"@PEE_3E*RSIRH=#B=;D@.75K
MXH+96HLA=3`;IBFV1#\%@$V7<=5=4)J4/F*X66^4]UP]`Q;H"3U9ZG[[\5V]
M?=OVK%^?K0TT1;U126!-8FQ#7]#:]MIKUJ&.YKK6=-^/>OK7UT<"BN>_;%=;
M;-O6&>819<NF*(FB:%&T;%(2)8K4Q9)M4;9(3Z)OL119:6HY3I5%:;(MR_WB
MIFGBI-W0K6N3%$V'%2V&M0D0!%VQM%E:)_;<9I=@R`)D[;`"!?8R8!DP(VO7
M&GG)"A28U1U24F(,>R!_G2.2(O3]W^5OMS&YOE'9FT=G1VK%VIWS=S8-!QG1
MEPBXW2Z[!8Z-Z7T[(Y^;WARAARO'1RJ54IQ/!ADBT6:W8*(\J_X+ML;MVCIS
M%+(S@7P#F028EOG)Z`7RDNMM]\71RQ/ODK]CKW-71S%R+[&W.$?,%7]6?*?8
MZG0XN.QZ*IM=[W!FUYNS?H^0.=.VA/;/QQ#(LU<T+G&K/QBSC`<]#M))Y4T)
M<YN03&?].`]>->=[J=^@?4@7DH0IV8SV:NT2KO#[I6&EZ]<P'D'I122HM1%9
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MS[$GA9/AMC*R3S"593T9R"YX`&"*1&,QQ$6EQWNVB'(R70)\'/0@B`7'.:^/
M\GI]2`Q)Q[AX#Q6/]_"]9DL\AGFLW@'1Y^V)$]09%W39J[@EY%L"P7D\Y-7M
M-69"Y].?Q(TQMS.EUWDZ8Y0NV=B%J<"HD911-5*1[\5!G!GPTG':.X#U/5^G
M?%.X=>U>AI##EC"FG88"Y(:@X;;4#1?V@"<**_(@%S<-]P7"_LQ-..\8.@"M
MMOAN'TQL:9C8WO,%!F$KP);1VH$'S_3``R:(ORVZJ"P5J"M`!0"R07?TH2/;
M375'=M4UO=Y&%@L/!HRE1395:O]<_*B:U+I.T$ZKS9D9Y`)SFP.A!'_$S5#=
MH;&*YU3$J[T&"GR4(T,=+6?_(P/RVLC`R+9:=;+-3MIB&USR]WL3H=AQ\.-B
ME/*X(T]P?UU7_I/Y^-.=8BL:UKWWL:\_-?6TN!$K(H&@%J8/*K+[*44FHQHI
M1S7&FZK@@.&!FY;&_5M$,2F5<.1PZQ+ZAM:)6T3<@4L.CO53+.OW6MF(Z&<)
M^HP;`GK-T7X8Q9?`Q#RZW;$$^%])^TE6\\JL#IJBIM@&>'K5VB&:K,;YZBN7
MRYU*LB^S)I:)L#0;P8XUL'P(I?Y_6UG=H5G-!D_ZP]PVHS9FW$II>77Y+M%`
MV\!Z3;!"OEPAFN#JTT[5>.0"K>%4SF;`EZ$A>OK'!4>&UAR9AI!#'5\CS:XU
M>#:#U0-`9?#'B*)*DJH,W*)<-D='1N''MHYEI13S`Q_G=8^WN)6(I*I21*D=
M61V=L!,4$2_3NR?DWE!H!MPXV.7NLD*,`.*!S/P<,K,?+&A)/$!E9,WF2,E:
MARQKA(Q9,=QC9?`IY$?.-PG+`)V3U]$SM-D;8H3..-JP90Z$83(6.3@80$,!
M`F46\;YD?PE!\%81"U@A%7*Y?Z\X23ICY)G$%_UZ\6IAU&0V`Q=%>:!,!<-.
M`,QA,>P4$9:S.>U)&VZV)O'^6G0)=&D=HO%(RN/A@@(5#`K`#!"S;M=]SC#E
M=(9!&/XP'@9P`(-OTP]?)TI)4M2&MTHBQK[:&0Y8HQ)AZY39,]P2>'_1LQQ<
MHI:%WZ()V*LO(:()1:+@^GS?)Y*A#-Z45)<$8PF3BM3H*L,8,$66F)1$&^D;
M]DY#!)97[WX)96!U90-Q%[8&DBOI620WU)2!.OTA_^NN\$`9='OP((VV08@5
M`'O*.!.W+6W$4-O0"_KY&3TUV(F;-RM&7QG]"L"`$;,%@><'_)96@^ANW2X>
MAO.P@%I02/YF\Y@VU):?N#Y(XGR,MX(%K'B@?Z=OQNU+NUR4DTZI_($GDQ%:
MK)[>]0:8[&H)\70?%`!IQ_E)QM9.8()@#@O%[LG\LW\11:=09DYO]JO@M6.U
M<^:C.QB7QX?Q>F<]`MF_`W96-Y"T]>T((!$.<%JG/(U,=]WCOJ+-F,^:M&K6
MC5:SM7N\8XO8E>R&+0,GK&Z4(SLHDNQP6$E6["")AQ?NQSX`U^$C@QJ.ADB$
M!#?(CTD3N014#6/;29IDL6.3#776O=J(5"0$CK;G2$,.^I@<J8F4L;H:<M=W
M77P'W/7#74V_4".\]>\=3.,N.PUW;?6K%SP94G,W`U@SAJTLW_^B^K]R`/%N
M8EK5Q:`:!;.&OECUW\'T$X`Z\!Z?:=@^^#^D!P]PVU&[Q+CL4,(R[.,;55GH
M]P&'7Q#I!!R/ME0H!^649KCG92$5"!Y&+QUQ>CA+""+!?_UIRT&8LLJF<>TY
M!CK&8!Q4VK^)/V[;3&T=K"I5==O0IJG=KCWNO;$Y?,Y](G9\Z#3Z8NS%H=.C
MY]#7[:^GSXV^!=ZV71CXQ>"5S!7EBOK+H4MC%\<7!A>5Q7QH7WKWP-XQ=`JI
MC$U-H:?3I\9^.H[NS)Q('U5.CCV5OYAI%4$H$YY(;#HTW>(/E&M%G<_3XE2R
M7$)LB@44AFV8`I!BJM?I'.ZU6,JW$`O%,)R4A`1.8HK"J5E*5;-('BGGN4*1
M*A2*@K60SZNJ@DG3T#BR:K%`!,[X=;=GJ%!R26\0)B1I=GF[=$<R24NFU.(A
M!5Q1@*)'^`Y5XV55\W:E#JE`W8@!+)2]K'X`;B!Y$WJM>'GJ=J$>"XS"RT;A
MC'(5WF0LF?HR$C.6&IU(I0X5[A5,!69:HE6Z0$O3#Y/"&G_196+E_OV5*@&3
MY$IU%NZO20Z-!C(^Y1ZDAY:&1JR)$<M#Q'_Y+ON@*,X[CC_//G>W]\;>W@N[
M>WO<[>Z]P[URW(&'((LB"HJ"!!P$-%&CJ8-)9&K::!HUHU:HUC06C1T=2'WI
M1"6V6AN@MMI):FLSG3K33O_H](_^09/:*;73L::=C$>?W3T11UN&YYZYO>,/
M?M_?[_?]?#%CJ@'1KA$%_IUO//WJC]9O]A+,#G7X`+\UWXKO:N4_L.5M*G7F
M==H%M(>=VL464</O=\[O=25*(C5):-A!.FKF`0C[%('4S`\9@3DBP7$%!9R/
M5E($7G]K;?V&=;G:S&)VV9EW.E8G%SI>#IH,9K,[GY'<>]:%`ZGR7H%`%JNM
M(C7\U=5+3UPL8V@I5/>3K'O]MR<Y,BJ4+#2AH4+]:/L;"T0Y4[FZ`"MW-S4L
MKFTL[-Y#46;2&5]>&CV<20?2WX*-KUB=#C=%Q?;\^<3?B/Z-DH?G(K-@9TWA
M]\2AYYPF)F!5)B>"W7$<3TXU/*HQ6*+(8/*I(H094PSP$)Z4KH-<8UKCZQ!?
MA[L30[[SD;/1*6(J;.F#?=$;$*TSK?.M$U7DW>;3@-?07=&1&PCCN7D2>&,J
M[R8TWL6Q-`Y!8C0`,=SJ`#D/?&.@.B;$$ZYX/!&//8+>1/P9T*OHV9?S3!`C
M5W*W$TK,B6&SBZL-'M<^5*]:]5(\+E[$X+AF@7%U1V)8OA>'<06#X_\#@V-M
M,]/3]V-/D_`S.!@W[R`LMB[]!`W_'QC&S:<$,.Q[Z!G<^Q0G:78XUW6XSSX^
M\.-?]&4:O;M*:9/5GFL0^CMKDZ&X_\L,[RR+M([UI(3,\1^)`=[J"QMP.^4A
M^_W%N;K-A=X6FG*65'0[#^0CB7!Z)WQG187+S25^\U[7B^>(P1TL(^D,04R]
M=;AGKN*>*0%N,"XW&@D3,IC16><'W)CGBN,*\U/.T,OUN`\X#W,CSM/<.0=9
M[:QU+W.VN-<:NQW/.4FSU6H/6DBDU[-!G<4U@?;)#G+OBLXLN7=)[B@Y2A*D
MFZ>4QQ&@.`B0\6=`7I(#<@8?7PX`$:2!#,:`'GSDB7W$884>:`JUW=7$:KN+
M8ZJR8I07;5G@TKH(G5H_1Q"75HV4A%I;![HZ6I@^.#3^/O3LWW_Q?._R8Y\_
MWW+D<Z+]>.$/ERY_XQB,7OJ@N7]3H??.AJWP#.:I65^A%?T25R$`,K!37M$%
MCUA/6\>MUTOT^=(5H)EJ+EU>T65XD=I)O<Y?BDX:KY=/5MSFJ27^=M!-H33(
M^F6`8$FP,D-1@.'9-%-*N=*E@:6>"?@]F8KZTX$V$(2I,`2>U`0Z(ON5\8@"
M"@0H@?>X>-X3#IHM^*]L/.2KHAZ>CD^A?8#$#9W,D4I?EVM71+WD4C%'RD)N
M-0EELIU\E1PC;Y)Z<@HMQ$02^Z$G$)C@\=<^S.1XV>=HX-5<6(;?>+S9>SST
MN*MXEJ\R3Z#:'W1K8U$<BEU_X5+TS$.M:V-W-4+8`=1P."\T%%>Y,@SY9W`@
MQKXZ_/.UC^>T(JNU_@=8L8@Z`TP5*=545S\."4XLW2*DOC&0\.=+MU_LZ7FS
M\)V_9]K2+0R;;3,5RLW]C<&'K"!ZLR\O^E)V8.N:QI;*@=]6HJ%/]VXYLN./
MA3Q35BBL9!G!'@KI%NQ!`YTNCX^,/'2VU@Z._&I3>]>_SRM)+X'5_@2K+8$4
M;);-!H^AK#[1FM!%E#+U8YHR>K+$:_""_7W'N/]\^&SD0N)B\EK$,A(^E;SH
M05O@OO#A)%KN;O5T0Y1/+$PU0Y0P)U+5$70"P)0HT6;:DC:;H#%MLHNAF&BG
M_1*73-!1:0*-R$X0"GJ]BOP0"K3DHFDI-H&2LK748C91=#HJT32XCG>>!`^!
M*!X<YPWZ'DW0>SMSM!S&1_!G:6W5*9<L\O@9CX7E(*>HS6%LY7#`Y`;2-$NG
MS9E)^"DHJOP`JUK<?OUW[\\%PJ*\U&-YZ6DU_"A&G2_J/%]?3=L=FFO'0!$%
M64U45=9'VTTS7+9&'5!07'X.]$EADF%=0L9<D,P;N7"E;WC_8$?SYBU3[[[V
M_+(^5EBV*K^K\,\EZ?JVG:?1T!?'5S&L9+2&0D:3K6D[G/G9JIHS&T[`E=LZ
MEZY\];ORFD+?U(I535OA$H7EPW@(\EC?<O`?N9'`'BCATP&[T'K3>O.:\@OH
MDNT"=XXW'>!'^-D8&M*=U!$^08!@J?37:'D:M$'")1("`:54"2R9@*.RWQ4R
M&"`9A?A+@B!*+E&41,$<E40Z;9)-[29DFB)D@!W_2OEM41$ER>9%.5N?%>5X
M3I2#^/CQ$43\H,R;!2($XJAX0[PCWA-G10/VOD/78B*;4=/`_>+XQ6+3#Z=5
M2G]L29H\^+&*4O/MZ.N*>I5IQ7.PPLX0FD,=18A(>`YK'KN,^F@K['G[\M&.
M*BGLYQ*LI"-(H\5NXW.=+U3X*@SBR4G1YI)*%Z".!04>QK[2%`DMKDOX!*?!
M:*3DC:<6=PZR;Q+;!Y(.*VW"U9^=P4GJ,US]-/A0#F8@9/T>NL%HT=DX2ZFM
M-J*/6@*VDPBE8`-<#3=`'9R`.MF<O`72I#Y83KHGX#4Y6WJ+8RW>H-U"#(-;
M4'98&MHAA+>IVCOBG\1_B&B/>!37[Z:H$\>,M>$1?MA]BU-M/XM;/XV/Y,^.
M<3<Y@GNC<@HVP<UX`.A_*9U_']O]_?[^AWC?3<]@6VFHFY[17OO5;:4T,PJ$
ME2VD=C0NH!I*<:4"SBJ\MC)*X9)$+HNKRRKO:XC/ZD/ZE]H6M7@KWUHYOG_Y
M>LF18$/U(</@II4]=-G5JB.OB#RUU1[S8HO^]<%=36FIKOJ;;\LOO>>W)F'3
MNV]V+8KZZWZW+??"03V*I'`'K\4UW*+;!WS0,`GT&.!V8/J5;?FS^GO$%Q3J
M\@R#!Q`%O;6@ET(VT2L2>W`C$3Y`V:!.3Y+`6^;S0+[,Z^/T;ATT8D]RNW4Z
M=`R,$=#@M&`T$Q@W7L)N1HBZ&9IHL2$!$;,(H@$17"9MP]04A(#$X</J8.3J
M?/8F<X<A&#6Y"B9<%N&)Y!I3L-W&*$F5D<OL^`7OH?^R736P35QW_-Z]<_QU
MY]@^G\_GB^,[?UYL8_OB[^1B/\)7OD@8L`%M4UB[KBNK5H6N[>A4B6VL&IG4
MHC*$)F!EZ[K1EJZ#0/%:IB+!F(!5,`E-ZBI5=$N1)A&UTZ"JNL;9>^=`09I.
M[]Y]VWK__^_+#(GSGV(J(1T]V^8:0C.6MJ7":SYO)@?<RF([$]1J9A=;#`.X
MS[=S`>$88J`*UNC_]4Y1PC:T.'[0<^!(E]LI]036J?>MK=8R5>6W^QS?>>$>
MY@>M3QKSQS9W>;Q1W\/2LY5$)5U^C%Z6['YJ#V$+XH#.XGXUP#ZTT]8G]='>
MDKY*7V]L]6\7GO8?$?Y$?2[8OYI=W[_5#D>%]=0]`BQ3AD"K6D^-?LT.:HF&
M-J%MUFX*G_IOUJR^?L/@[8Y$LEKK\XN6@F#PB:0\D"T4%KUPVFI0'12$8=[P
M\;P1<#EE?@"[88-W.Z;M6R")?++Q.H\]$H\"4I%'0BG,3_";^>?Y%WD+C],A
M8@MQ&65!-J[L]<IM-TRF&?RX.?N$]IPIFC.2HEHQ+R/YD`QE:<`NB[R(?]3Q
MU!FSAG=%/ES*$S**>AOF!S#RR'S47S/+N9HDP3GS21P+;YMF(B%W5!9GP44U
MN24BN,"DH,08M#FJ+1VD;0)"P%D3%M->/QYY/+KQ6$QP`..Q7?@[ZXYK?K=[
M[K`FRY6[37:=KE3@V=\E.:>G9UWWQ+I*(9GAW*.O?O1`%F4V*!Z'D!H)CZY'
MY7A.NS\I">K6HX\O]<.I^2,_CGH]X4?%9_H3F6BD.O)9ZU]7D#ZZ'Y0>DUE/
M]Q;_=ROI7+S\T]8?=T9Y<?"??WYOC'12!G?2-.ZD!/5?M/0D`!IRES3$XN$J
M;:(WPC>9]U2FIZN_:YB&U0BPV1V`Y5S6@-4*E!CF.0%8PXHS[,UY&U[HQ;IS
MLC,9()Z94-NQ5,ED.#E1^CBP$*"5``KL".P.7`I8`D$M/*U0PPERG_65&HF)
MQ.;$.PDF<0I&"8@IA;1"MJBTOV,*E!3OP5J$/[Y&V:'L5@YA*E7R"E*@TJ2[
M9I*]'P0(L,V6F,,`GW7/C2^>K\;J0RR#<6-.PJ7-`5S<MAG`-ZE)/H[I`6_E
MBKGAXIA4:0H1D9XH;9)I!JAA7O;87,\$=OI4SCE9B*:0._C<+WP7XH$QJ4_*
MPM'ZR.JI_>-?3*LSX9+6+0>7IY3>%85";NS]IOA7>OO!@AWKS2F\ZCOQJJ\$
M-O0@1Z3"2EE3U`"H^R@_3H]10'S:+NDE\(KT:NKPP!L-]Q`NC%M\4'U</2]=
M5"WV*)M:&X6,%`S2J52ZCNH&TM0('0R&->33-%1/8?+TE`:G5YZC/,3"A84^
MAX.REL[5DMELPLFDI+HZ_6+D4H2.G.?HV15O@544PG$V^$.-V(>0-%M'_:/%
M.@J5ZO55"H>XY[DW.(8+#O5*JYK`=_0#DGIFW=<F\7J27(HUZMH<1N0<P0]>
M;*SXYLY]8XZ0Y6UXN<];;6[#AL'G/FL":Q)@?P?(^A->_-(`+*H_[[^30),)
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MC_C$M'JS5&/^.D&6J8GM4:.\9&\J(W/6:+L4L`WX_2)_&V2+AH2X%0KCS*3&
MMD%I5Q5OT*QJ$HQ&@ES&V%;YBN[L</4G\[%,_='67][?]T(QG%N:\'$VWF:Q
M=G16AK=DJZ[JH%"VPUU]#_VLY1LZ,/:C-8K;XW3Q!;6G=QA-7&S=]]EKFW+A
M)+);<C:+(S+R0)U^^N#RCCBIWQGLPZ-PBO*!YXYZN>;"/Y`WTE=D"41A-S[B
M.M02;"Y<1RFU5*8O@DOT1?AW^#GLR,!^.,QM9#=RC]#?A-^CGX0'V8/<R_0O
M(7>T@UZV?B/B[#Z_P"IVL<A")]U<N(I$?$QS%'0Z3G.7.?HR!ZYB\XZ%MO'N
MY-2VQKMX!=-DF(HD([^]Q3#7<4#SK7"YKO-Y'^=UA2FZ"21DQ\ZG@_'",(O/
M9AQ.!XX`4>2R-VDP[/?MA>;_)Y=8UHEDI=AP`N<>@:#X!"[L_&3:F,-T><,@
M]M*X-H\U[@\4Q`2,)16:VLRV9_,S"Z=/8M,$D<=7;\L=YE7W-3=Y"PDN(L,N
MA%]PD1]U$7_E(AS^Y=,@.W>=<M]<G#:9/'Q+QI$78L\(42A:AT@@.Y\IJIMX
M50!J+T9Z`:HEH$8(,4</T]^?'P/Q;U5SH?B&^2?HXZVK]_)=E5`"3DGS>7=Q
M>>N3$'W9TE'HIRB&6K'PH>6RY=M4)Q6F!JDQ(*(BFX`%6.0+?-%R43N3H^D$
MJW5FG4-[(K].O*Z],G0J>4IS]"33VD!R0&LLMQC;0^4FD$]$!K8/AG`"DM^,
M+=$RH27ZVW`9%:)*0)Z))C5,H"^A<C;GRV9SV5Q28V)ZME1:4KYB&WE94:]0
MN64_4?(@GR^I[@(%`P6;?5P4@UV%JPQ@FM!V;-616),VCAEC^MLT0PU0!K[F
M*[`$I:YXB44>H9AC`2NM'F^"O\VH'Y[%CFB<&!Q,P@;VI_/8[<R-KWAH^36J
ML1HG!:)XDW,&KB_F9^.6>[U%R+@!YH#[=#J-"[%M:A(;G5[&*_AH)AJ)881Z
M8V*$H06?ERGTQKRE_[%?+C%-1%$8_J?3EB((!0H$B6`!>5,JT`(*`7E3H$`I
MB`@Q#99'>$5!,,:XD$03XP(22=BS*8]4XR.4@+*5QT(3XL*P,-&XTT2CK&#J
MF<[X%DAJ0F(R9_+=>^X]Y][./>?.G4Z6+$ZA]3RS=##3D1T:R\0&T0D=JC5D
M\$]U4!9_$H=0ICQ_<7S80P\9Z_(2YW2YN'M+RXSUP12WZIQELAP.QC#KY%9W
M-I@;XY.=(R_BHT)B7-RK:F5:,3>N3_3U87V.I[T?[CMYL3E>I^B9YV877)QS
M<9&QN!:8QOE\![<R[>#6Y^9HKFDFV[$QVE8]&,V]-&C\62TSP:UIH[3:\#!U
MC<S/=#@\@AO5-1CJ^]40I>L?V*2C0O-W9%W>(;\FH+@)*+<!7S/@EPSX3PH$
MW/V!.@H(?@UH-H#0ST#XC$`$M2.)H[U`="N@U0G$M@C$+>U.0@Z0^`A(ICKU
M/J"CUYF>[B'#"&2E`H;G`CET3[GDE_<!*(@!"A.!HC"@>`LH'0+*7$`%C37U
M`U5O!6J>`K77@?J6_X^&"Q(2$A(2$A(2$A(2$@<+9&`\WZT:L+S&'"&4V%?8
MG_1`M:<*^\4A#O$)B4G)H&^\=/V)C$P8C-DYN3B%?,%>4EI67E%IJJJ&N;:N
MWM)@;6PZTWP6YUK;]O_Q/^2V%V/V$3G&J(R"FI8:@&-(0R9.HQR5J$,3FM&"
M;@SC*IQN-_D=HW7R]F*R5\/BL=O0@RN\W?UFUVM3C/Y>0J%V?]S30X4.<1X6
MD50RX@HBZ1)T)6E&/L-R7^HQHE[49;2V6Z+.4O^$J,M)7Q-U)8P,4UY782HI
M2K%V]]D'S?81RT"?K3^U<LC6V]WNG8E"68<*F%""(J3`2N'L@QV#,%,Y0B$<
MH+8-_1382@R1UDL>[=1O1R<N4\N&2U[.<9"CA&RP<_B$/'1!01%7(QV-E)Y1
MVCDLM2G8S!A95'+2^-:W&AVR8!K^77Y/>P$)"FGO.57\-.LJ/3LH9E_VKC,Z
MQO+L?&#>%U6$RN,]%>UZPM>/5V:2MA4[=U1;*CTU^?W@F?FK``,`?*(O:`IE
M;F1S=')E86T-96YD;V)J#3$V,B`P(&]B:@T\/"`-+U1Y<&4@+T9O;G1$97-C
M<FEP=&]R(`TO07-C96YT(#@Y,2`-+T-A<$AE:6=H="`V-38@#2]$97-C96YT
M("TR,38@#2]&;&%G<R`Y."`-+T9O;G1"0F]X(%L@+34T-R`M,S`W(#$R,#8@
M,3`S,B!=(`TO1F]N=$YA;64@+T=02$I-4"M4:6UE<TYE=U)O;6%N+$)O;&1)
M=&%L:6,@#2])=&%L:6-!;F=L92`M,34@#2]3=&5M5B`Q-#(N,SDW(`TO6$AE
M:6=H="`T-C@@#2]&;VYT1FEL93(@,38S(#`@4B`-/CX@#65N9&]B:@TQ-C,@
M,"!O8FH-/#P@+T9I;'1E<B`O1FQA=&5$96-O9&4@+TQE;F=T:"`R,38S,R`O
M3&5N9W1H,2`S,S<Y,B`^/B`-<W1R96%M#0I(B5Q5"514YQ7^[OW?FQEPPRB"
M@CHX,$0!%Q2CHH`R@^(6C-H#(LH@"BX(*C6(MHU*/%1)(JD;B=&JQTJJJ4-C
ME:8D+HD:6US01(E'XUZ)!C1NL2G.ZV7B:9/./?^<?[GK=Y<'`M`&KT$AY>6)
M?:*SQJ3N`E86R>WX&7FN@KF='V\'?M,`4,F,Q856S\BZN_)V"3"7S"K(R:-9
M[[X%6#(!_63.O"6S2OH=E#?[(V!T0NY,5_;1Z1N;1=_G(C,P5RY:'[?X`&W[
MRCDT-Z^P:-M;(8URGB3+/2]_A@O/'MT!%@R0\[X\5U&!93.]*?*IPF^=[\J;
M:?JJ?WM@>9GX<Z(@?U&A(9;D/*_EO6#AS(*T/^9U`[IJ@,\]723UL>@N*UBM
M0Q!@7)-U4U:#9[31K,^%S3/'N*HZB'3S\_7C+PP/R8KIF(P[B$8A3LMN#/92
M/'SPF"RP"V(!-`F,3JC&.:3@/FS&)[B,[Q%C?(/VO!_)>)^2*16]$8M5(F-#
M/`9C",;CAN@91KZB:P%9/`;&8@4VXSCJX2_O>6J"7H\7A;;JU:(Y6VXO4CHM
M,XX8]1)OA6&@*Z+P%053H98D^A9"+/O\!8/$QSR\1X$2ZU!,Q6P4HQ+'J(?Q
M0'*\"C<X0G\%?3$2Y7BDD7;"V&L<-KY$I'@8BSB1GHL*[$0U'>(0E6B48;C<
M3<<[^`,^(5^ZI+JIM4:.H-,/&9B/_3B$,S@G+RE4PX6\E"](3`,Q2B*:BGR4
MX'=8+[*5V`,W#J`&ATBC@?02.6F=VO]LN2<>9G26F&.1+C@>Q34\I4X43I$T
M@$8*>AE4HQJU0CU:CS-@;(0%[41S'@H$L=]B#7;A,)Z(3$\J-A8:I<]S%X<T
MX5D@N"P7JI&L?$T=R5^\W$SG^=>:I@4;2V&5;"2)I^,P!;F8)]RO825VX!3J
M<!V-9*;N9*=XFD-7U32U0^U2M7J]?M]3;Q09?S*N&;?%\U!!:#)2Q=8*P;<4
M:R7.O^$(/A-<&J46GHK50-$32=-H&6VB[51+9^D'CN`\/BUT1?57Y>J&MEMK
MUCQZJ7[;=-!39XR6*$@Z4D.`6!@J'OY"HL[!JX*D6W#Z%,?P.;[!73P6"[[4
M6A"+$1HLWB;3.-HHEHY3$P_C%$X52_F\CC]44%U4+^52&]0VK;^6H"W1+FH-
MVK_UI7J9OMOL\F1Z*@3C#D8?8Z31B$#)<;R@,U>JOPC+))?KL%&L[Y<\UN.B
M('03M\2#)MR3#/Q`)O&BO5!'BJ4XR6^+'^F43?E40N7T(?V5ZN@:W:)[K+.)
M>_!`CN4X'LZ9O)C?$7J//^,FU4&%JPBU2)6IC]01=59KI[VN^TOVH_5DW:6O
M-U68*LWAYE'F+(N?I?99KV=?>VP>AR?'L\&SQP@UAAM3#9>QQ=AA')!>.6K\
MW;ALW/?6A)+*\9.8@J4+(Z0#XB3S8_`*I@G-ERY9*IE_':NE+][&)D%YK\19
M*Y5P&F=Q&]_A@41(9*%6](+41+A0;V\=#_)&FR"1SJ$"*J0EM$+B+:4WZ&UZ
MEW[OI=U4335T2#)_D2[15;K*Q'[<D;MR3^XKE,A)/)N+N837\P[>QX?YB%3&
M9;[&W_)]Y:>&**<J517J`_6Q^D)]J6ZH.^JA9A>:K]5I5_4.^AA]L;Y#/Z`?
MT9^:8DWIIFI3@]ED[F(.-:>8WS=_838LX7A"=HGC"G[R4R6\EQ]2->M4K)4+
M;:&M6ICW7Q878P+M89?JK&(Y6,52$Y5R$?M2DYRW2EV&LHNV2%TO@(.2N005
MSU>8](23-XG6$YRL.:A4<[18X[[Z.<U?9=!RV&@^8K032-<W:.4(XRR^3&>T
M`<I7;'53A[4M>H.:*A(KC'M:&W6*?:2VGO!$M9VO\!GXXKQT&Q!-/M)/>^E5
MUKB8MO!=0?Q;'J_L6KIJ4I]J=AQ065+%+R/<:*)0;%`YN*!^R>7*KNPM/M(%
M%++!.[D3;Z5B:;A@F;8'*()R\2_THTH:@DJJE2]!&#-"L(B.FQ0'T0C2I9)#
M50POI#(MD6[Q"FK''L%E-!^5S([G7KR33LO<K.)9ZL\JE?SQ)F7P3M1YKI-;
M:FB*6B\3ZGOS2A6$-5H&MI%#/L/KL,]S4!U#@SI%B]0_J3?WT-;+C+()]M62
MK?M29Q/5/JK4FTR!=`R_PDG4J652MQ^CMGED<Q5*>%?S/[1L_HAR5`0*:*",
MD6CDJM8T&4&>?.,8)U,__LZSQ+.O^8$Q0GW0W+;9I7K)/"G'-IDN8\$T33I]
ME71)!L;(9*G&*N.H],-"F6UI\D6JH!CY&@V3>50LD^>\3'NS3.3K,J=J:`X:
MN1#I+5:Q6V9IBKX3:Q.&3TJ(CQLV-';(X$$OQ0SH']VO;Y_>49$1O7J^&&X/
M"[7U"+%V[]8U.*A+Y\"`3OX=.[S0WJ]=VS:M6_GZ6,PF75-,B'3:DC*M;GNF
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MW`'%-P/_=Q3E_V&]:H"CJJ[P>>_=]S91?A8PE"1$-K,D_(2(\B,D%K(D9`<-
MEB0$V&08ND"""(.&TEHIHFG]@5F2MH!::!5DF+%,8G6#F-D(A`@X2)6QCA,I
M%L=VE*$6:;$-/Y9D;[]S][UE-]`6.\WDR[GWG'OO._?<[YYS,[@DL"'1FFF$
M2H<]Z.%N*+3!$WZI(I!HS>:_U=58`W/U''\PY,>G&SF(P\;#$7:?MQ+;5)VW
ME#7!%9YPJK?8NSRT(HCSR`B%J7)M]MZ,#%^[_"-EE'I"50%O=K@HTUN]>.;P
MUMLH5+GV]72?)SW9DC^NU3TH%LW6`0/M1K_^B8VZN$VUU'!NE57&PZFQ1]Y[
MP8*P9ZD'G@2\V,A4_E,WE4)+IV(8?JHUS`K7XA@>#*>6!$/N0NC=/#]LYKB]
MGM!%PK%[SW^9K%EL:ZP<]T7B)I,CSB_8G78X+R\\=BSSPE6"@X2/TU5_<OZX
M1R+ZI]YZMP<"X:/R`*95%XY'S+.S^50W17RT!)UP0T4@UO?0DLR]Y!N?5QW6
M@VSI="QI\]C2X%CBTX->T'<?\7\$:>&4W/CO0/?0(:7+"\/:T/]@KHO9R^9Z
MRRIJ`I[24-".;5E54B]FGQJWV:WPD)*`D:G;+3W34%8P<6%\,'<"_<(B![^6
M8G)MQ)4"*BJ-YO&'W<%9L;_5MV1GW^2DB+S`LY2X-LUV,UR8E]R_)ZF?Y%Z_
MD`&'1:Y>5E43"MV29/,C[81"?J_''PJ&%D=DPQ*OQ^T-M1L'C`.A^M*@<Z(1
M^>:FS+"_L1J;6*X5@JTZ%;=ZM8T5K3YMX]R:0+L;_^=LK`KLQ1NB)%A<W3H2
MMD"[A\BGM'I<RST/]Y#'P?2]>HHR9;;[B!J452B%ZB^-:*1T*8Y.HZ41/:9S
M*QU^\DF]2\F5'2VE!:GZU9T]T=27\:IR);TJ7K$*M.&JXMLPLFBU6*U5X)^R
M<F".U4R?6`6T2,=[56^F!_1FF0[])?$S*M<)5:J9^D.>T0MD#?2K@3N!%(#'
MC02^`ZP#O@)F`PLPIQ+0>(TXB-ZP]L@KYGS9"+QGSJ=GS&.R#>T(VF0>HY]:
M!;+#R)(10?("]!WB,]GARI+[,:X#]E7H'V$)VR&Q1GXH/J/=Z'=B_C]<6=0#
M_5/0\;QWL(^W]0)Z"3(+W_\=UIP-G[KAQVA@B-%$=T..@<S7FZ/\S>?%&DK'
MG#%Z0;0-MGYHWX[8W`9]!OH3,,:"'(48>N&GA'T4;'ZL40`?"F#?;31)'VSG
M]..T0#M"._7C<@:^/\K>=Y/:-^_9WA/[;_MT';!N(7!7(O#-_$3@^T-COO7!
M&BI.`E&K,9'V0:X"[H6OG^LGJ!;R]X*BN\U_TD.,%)*]>K.V!;%J%[4TP=4$
MGX_1/',?7HFU=#OK%$B>%R_(!J.;YL"69SV/M6IIHGX7>)9-C?HR0HZET9B;
MB^^-`%(1M]'B%+Y=2U68+]4Z9U1LYP(#4HA>L^/4R+%Q-=$3D'=@[%?PZTN,
M^3L#_GF!7)Z/[X]'S&?RN6OSHQM@SX;OCP(%8DUT,_!SS.\&]W\%W7"TC^([
MD^SO1!)DA+F7"/M\''0Z4+%OIE\`;<`>^#(0V`24HW\KY`CP;@[:GRHN%A`Q
M7[%F#_<A_\S<8`[`WTGL>VP/\BW%L5,T"YSY)6*X#J@#'K:(UMK`^<GO\WUA
MSJK[$EO[*G.+.>-(YK<@3=-;M+_Q/IE3<<EWKY?&*![RWL$M1]H^9[,4>3%I
M$(U3_H)OUZ3BT@2^CWPG'.GXP_<3>>,R2^'C;X'KX*(C[5B<C<LN><C*I'JK
MG'XL5H$;Z91CS*)!HIR*X=<D\:JZ8[--/_U`?X=279TT$F<Y!SYL[R.W,5Q=
MV@JSDTZK_'."MD/FBBZ\Y+LTTVR17XCS6J?9HC_.[>ME7SAC63(2;=]4_[]`
M_\ALH65H_\7LPMWIHBW8*[G.:7<"'D="OQ=H`,:FY&G;4E9J$=<\<H,WW<##
M.(="TT=31"<5B33R(4XYT,^SG@./5E(9XE6C^[0BL5*KL%IHN[$2.1[?TC^B
MA0Q>'_+^:WQ27+O[FE0<RK].VGSM*SGG<]YU)/.9[]<-Y'[(;W%M0'Z.J/J`
M'*V`.@&>+;)YF6&5ROUB+@V+\S.)I^!9C)\2O-R)-87-1_\-Y%&6L=H"[L7N
MJ8_K!>=RWK^='W,Y1W*>P]UW.>/[RFOSM3KDAN4J#Y^@&OM>/P0T`D=A&V?G
M$<[#?HZU-85\KC$XKW[D,T^1#^-\UBR:CGU?C-=4(7=PO/D^.;64XP2LC]=1
MO_R`XP$[CSLBNE'W^'["-ZZ?UC*Z9%Z1?U5YA6LI[J&Z@\BUZAS.P>=T6654
M49&Q`?F4<_@HJE"U:!IE8G];$=^?<$TTMG'NAGV$#!J;42<QUXC("C-`:\WC
M=`_FC%7K80Q+UK'_UB;:PKG`+*8:^ZPBSKO`-5-N=+TO.ZSUM,5<A?UMIG>Q
MEX,J!FGR#QP'-?>',HW7<@5D@Q@LW^,Q:AS/62\W<#PX1HFQ8`ZK-P6O>8*V
MJG@48*T>NI2JRX,,*XU.N]Z2'YN#Y2ES,J6DK)&OFT_*'ZEZ':49QE::I'?+
M<\85NH-Y[]HA+QLCY$GFD<(`O)LR<4[KY`ZQVGY7J/>%M/C^\'N#.6*^&7M/
MJ#D3:2G>:?<QQ!3ZMME$U<8>H%*>-4]BO1$JWOEB/`TS<N1IHU+=%QE[R_`[
M(=J&<W\1=3J=[QC[@&\4H3W-.()[U4U%R"4S7)7R-V(1#0?G)L?JEP1/9:G=
M/VSC2`S:^[$QF@Y[%>K#2;07HCU=[S`>TSMH"K\#Q4CYMG%0OF:8<IWQ)+6`
M.Q?U1U$WMU)$#"-#>&B9/AUODV=IC_&,?,-HI!>,C^6?Q&3YM5Y/W]6WR.>,
MEVF!<,L7C;/TN+%+'A#+,?Z,_`3M?48GO6JNH`/")9\6%ZA-M%&K>(Q:M0^I
MWG@$M62PO(SO357K/TL/&-OE8:-1'L9Z^WE>(MA7!S?PN1X^S[+]79+HK_+5
M]M/Q,>[?+MKD^,?[5NOR/-['/'F)2)X&<F(RRN_R:9S75<XJHPG61.2B=\D/
MVP=$O6W`+HQ]`OT>X!6T)P.8$L4K(_HTL`#`F[_W$):I`'+1_Y[(H,%VGJG#
M>*BC$X`E&-<"^5O(SP&LVW,&P+J]BX'[T?X"P/%>/1B#:N_$G*>P3B-DEJW_
M-<:CW;L=[3F0MT)N!4IL#(+N/J!_3/:<87Y>]R[Y_\L;UZ.;E';]&1.3\NOK
M:LHWD64W)9-JD'/^_TTZM:6O=.+@U-$$?_Y=S4N2($I'(CBW<G[CO,JYC?,I
MYQ-'JCK.>8UK!][TD&'DL1/J?S/DLW\17_5!45U7_)Y[W^Y[?#SW`P0L92\;
M%C$N7[*P"RR1M[";-%E?,6@4-(#1BC5J,8).-3-!8_UJ:G4FTZ:),Y*OJE.2
M87F*+"(?IFVJMAOM'\U,:JU,AYG^T5+3B?6/1J'GOJ5Q.M,_^E_?[OF=>\_Y
MW7/..^^].^^)O53L9Y8'>/_COH=YMF.?Z;_K&ER]/Y2*#W4?R@#*#11I;I)-
MGH]$*K0X:F^IJ8TECU>,"(?QM<458VP27PB+"$?#N)&5:WK&C(:&^8&_.CDX
MO[2DX@[&'R-W42@;8^-D27+5^26E%9_'V?@0G+2>E.G(W'YZU5CFT^+TZOFO
M^RKLH5S,L`%E)PHC-L0!%$IBB%/FJ`/Q;7-4AEB/TD2O:N<8$,*T1'6P0M,1
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M(.TB!Q&S!4+/\$'UBX/JGH-J2*55Q(..'!.90'C!Q`PMVZ.>\:@_\JBO>M0N
MC[K>HS[I41_SB$5/$Q?2%PB$*R:^9^)WM3R7>M^E_MVE_LFEWG:IG[C4W2YU
MITO=[%*;7>HHS20!Y+VMI074+P-J24#-"ZAQNO""+6PC*:-T(0ECX#I#S^-Q
M6FOH'%7`T)?RR[2"Z!1[2TL-_CH/I=!BPJ$0YU[4:U`O->TJ70(:V8MS#CM,
MNXOX)+$NS_!-8[1<PQ="E66X2W@<?F[H+E03AOXZJG%#3_#+,)K,!,,&WX(1
MX2)&/(9S@_A%)!@D?G@+=<SPC^*J`</?CP7!A["#;$'S!ZAWH3YCN(O1_5/#
M787J?<,=1/6NX6['%._@VX((];)(?!GV$MV,O$<4$%H(NY/G!MV8>3OJG?,9
MNU`+^[;D.<%6PW=`I.XD;M.^B01-_92A/R8J;\2QX`6)C_:CKB4^<UYC^"JQ
M&+_A+L7L/OQ\%=8*(]B/4XY)#^!T4;)%V8;[*50.HRJ!2C'TO:BL!N]'93'\
MNU"18:3\`Y_6>R.@*:!E\+N^8OXW##[C7L&G\)SNZ'$`@_\!R85#_!9/\-^;
MU(O\,_\Q_JD[#FL,_KN@J1*ZJ7ZCCXI:R770C-/\VHBXG`;_E2^."=+X1[X@
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M6C'!C2;3:A?**@F4S+&="D1`)!042IXA?6/T,&[6A\D$"HMEL"B-KFJ(!;S1
MN#S7'*OV1F/RRO4M@P`_;(5H;'(3B6[,C]U?51"'U&?7Q2P%#1!S1DET=4,.
MDF/T*-X5JUOB,"=6',J-.1M;1G"WJCET/%?HND/'6UL!PW>3K#WU.?7.Y8Z:
M)\/_!3;,H_?1D>/]CR/'FQ?[<7152^QG>:VQ"C&8RVN-QHI6Y3_?,D*/TL.1
M\`@](E1KRPAXZ-%(L["#)]R*M'*3!CO0'!;LHTG:1M@A:'C/;31IC28-=Y$C
M2,/MX8A)H^V$"QK:VP4-KW*2YS?#D=KY<,H;Q&_R_,H;)D^"9%J-U$;"@[6U
M)LLU!9J95'--F4G3!6DP&$2*+R@H@\X@$@:#3M.][)';G72O3+I7FNZ:1^ZJ
MI+LMZ6Y#M_?_<FQN^)^ID:VK&B"ZLF50(0VMC<\G=99]YW+S3G*<>>)0[B7(
M99^1-&]K++6@(996T$#JZW.\]CHHB\;4U>)VFXM5BS9^-;:FQZQ(E5%$E*`[
MYY7<2Q*!<V:4=#2K\ZZ24$E(N/"I$:X%:+;-NW)>";HQ][EYEQW-#LR=$]D:
MQK]0W7CT>"/AGI[=\P<1T(/S[FYO)&<K>I)H,KQ>0B+AB%C6LYMXO=UHZ?ZJ
M$;N]XAD57SOXPY<#F>B#%$;!1JQ$IKL,8I'B8+O`2*HL!D-`%BE6RP3Z*6$0
MQM>#?/`2[,O]NH=UW[3?J],?UI%Z'-L?("PK=SO<CD($W!S(@WPV^4"SD"])
MOC2)F\.6V7ULGV4;L9,F+3-3*E$J)09*"G&D9$!9.1+&`2\`46`S%I,"W5J:
M=6U'6E<:35OD>'8$MF-:S-BFS\S8I^T/VZ;Q`CEK:I:50QO(5ME*'9G9,G%4
M!OP!/]OG/-%^<JC),?O%NA=O]EFV!3J/W'S8/_O/LU=JX=O0^<GUOP[CAQ3,
M+9K=1XNQ)@>):K9<J2`E*+$42"49J8Z442Q$)JG0?3$=RNJQOCC=."RO;4J'
M].,9ER`!GXM&W&N;P5KL6-.C>EC`[W<&G%6510'BR!3%_=G9W7>N*MQD!W7=
MUM_VS>X+-/\"UG\,,'7VHYK9G\R>NG']+\F*/IX=Q@J7$2<):7:#QAC]I1/@
M`S*\7P4USKX_1,KR`2`.F[6T5(O%'DKMR&CO%U=DIJ8,J\$RVA[.B"K(2ZP(
M>U%5N;AH<56EWU>1M3#36I#]9F'>%H?Z0J1QT\3L\-*U)04%11WN146A]A>;
M_D5V^<<V<9YQ_-Y[[Y?/CN_LV#[_R-D^WYW/SB4^)W'B./'PH5%,8!EAHZ4)
MN$DIBXB@"Z'M*(&L41&$=FWIAEJZ40;_;-7:TDV"@,NVDFI9.ZV;5*U:]T<U
MP20JEFDNB*5H@\;9>S9LK2K+[_O>:]EW_CZ?Y_D^[]0-ZPD^7KX"4J`%A2)N
MHJ>@[/`R9P/CMB=LN"W@R+\)CM^)Q$1_!2N@6S76?SEFW>6I>T8>7+5J9`2T
MC%@3>F.X=68E_H!4EE`O^)'Y59WM97.!KN!:MJ]AB-W!/MRPESW,OAIT`%R1
M9>AP-8@.Z1MBZ*<Q.V1%N_<Q,;A9ABX0`HJ*Q239[7*5X>AY*'L@E&.*M<:`
M)8I=+N.FZ7;#4##H<-@97T1R%QLCLNL"/(E!F#8=\D!LP)`*TA,2E,K0.*.>
MNFI)5UI<O%GAERH\^D-Y'KT*%7>N9""D9YPI?8:8F@<N=PY%%T-3#GVC`OBY
M^CC#3\T[\^1\C4.)MH+M]?@$KV1QF`4=L'9)URZ[LME&`%=4MVP<:6I@.WJK
M.]BNYNXQ^'9K*\R:[-*L?5-#4XJT!:LS8';[(VI8$/Q)J*HV,3%%[+O]ZB;W
MJA6DJC*4<_#;R^!"=36"\M#RW\CYFK:G9KDHZ\C0Y>4/3='FR"2YYD`7^$@B
M>IAWHSB'5`U'H@09`G@9O#.+21+9&2HOSYT36S,AR+O*@#C7,.VQ\45K:39A
M;+\I`"$0P_$B`+Q43&,FJ@)!>?*B%?Z;*/KZY/O`;TPN^`V$PT3_`K^(]%M:
MS!?T"M)P*>]R"SDD6%L:*X&2K@,HQ^-RC*@IU-'>E>V@$#589\:M=+0+:"=+
MSF_3Z)/33U<_&>[_V=$]\]O2^Y?.?UK]\R?@XE\W3IF!]@YR1W7#+T[_\U^_
MG7M]=OMC%UX$R6N7P;';BKL+<78.U;43Y-<P#Z9B\^93M+_!5?#[[5Q!;5#<
M.3IG[_9F??EP+E(D^NBU]J)OB-YB'V/'['O(&?*4=I7T`-,M9.PFWYBQA^UR
M*!R2"1O=$!$C$".`B-E)BT>?+T*0'M+T.`H$039IF%>SHU,3$4^0!"_]$>-.
M<A<YR`4U0B#B;/=1U&+P>4NR4O^"M>+G4*E`K"&V@*Z34_R\'ZNQ5!\MDI!:
M)?29G$4J-=92."M%:[6$D`!`^M7DZG+7DGNM8^NWI)O^[D<<X'TP#NY9=[2Z
ML_H;(%0_]`KAWF?'GWOAOJ&"NF$<;MK8E6JAU>I?JHN_GKYUF?CL]F?%2)-+
MN'\"?/=7AW_?J:#L+R,-=R$-T^#U-S%I^88YYN`+C3$D8I2,4@9M,`/D`#5,
M#S,,WPZ$V%X2-S0CD<-R2K=62!1=Z[7UB2%E6!M.[-1V)O;$9F+OQA:P?Q!7
M8PO*3=J76,U[,@$MDL!MF$VQ:5R"X.@(/4Y#NHS+IH-G1!JC>&J$@E1M`Y`B
M909"KL2`II5!]FQ,'`B'+4*]T@CJ7`%M4`7J"'62ND1=HRBJ#-L0MCS@71CF
M<D6DF"=F!4J28GIS&8Z=2283H94.O!L3,0V>P!)8&(T"'$77:3AZ-L'Q.(\J
MBAD'!K@$K@'(H2,,FH"8P$5&:DO$I"2O%YM-M[W0_$83>B+3'2P^'SH5PD-S
M[9(@M;'=4_6(HX!7KBP"O:+/WXVZ.S=1,JSD0(:!?,QZY?EJ_O\DT/F\[D>U
M-5\"1G"2_[??N%(?41X%4Q6,_[0$ZE,=D]+$;LPB!<!:0D&Y7N]1&;T#B8(V
MI<]CA))00VD(J6.I<Z_TJ"_)MI69V(ZO/^GR10=?`ZG'D\_>?MPQ^D!\V=LU
M8B=RFQ0BU/R]ETFP=&-D<NEZIY1=S;'57%X4G)[O'ZT^H_8?@&-]S?$DXNKT
MMJ39BQAZ"S%T"#&D@Q^;.]Q1*HJH,6P;J`UTB2G9&+X5V*ATZW0K[,%ZH@6Y
MH*S!BOQZ>;UR/[&)&HIND;<H#PD/^<?E<66WL-N_)[Q?WJ\<:CP4.19Y+?#S
MX%SK`GFY-:RL=GDR"")4VY@(,\Y`IL8+9Q,9C.;ID3I1YP$ETOX!04"1FN5-
M94"6+8K"@8%@L$:1.,*D&<`8=($^0I^D+]'74`V_2Q&'CC@\'Q'#GK!%D2B&
MM?A*%HZA`B,C;E1,1^0H&`='9P'P*[CP2[3KQX+PA.D+!/R,V)((BRJO%>,6
M+^DXB)?A5M/6*@IB"]M]^BXG$Y^'I,8&(L5`4[[R!3IF\O-?IN,Z&N]<?`F0
M.WP`U/.:SL88JH>U5!8\7`YU@X,`UESI#C9Q#=9*<\VN:L1DXW5B4K@,B1=_
MF%HWF=2.)]B.@;.3?C*4WVA?VFS?.J3<B.-XOL02&S>K5,_!'Y!8%<-9[L'[
MEA8RD15K0T1U\-Z`7TX(0%7[]L$5!U2YC5"K/]KU\%>L0^-SR,%N(0<S`&6F
M8B#AT]5$/`NZ81?3PW7[>IK6.==P:YKZQ&,^CJ(]M,\.53:NOM,*6>M<FA+U
MC*])$'U>SB-ZG3Y'(I%LUEM:4S2I-8EBQ,EYG&+8R5EE6\-!&5^%;,(PR$X-
MF9_)(??3H*,S8G.F4>Z+9;SE#.8$SC*^P8R"FO6]810Q+(KM0NURL<W6+P?2
M3L&99F?^5]<7D?,ME2J3U^M>:*WU>B@K=2=$S3%*7R,_PZ1T)PHC9AFCCK:^
M4/<QO6Z4I;L^B==LLIZX<E:B*=1;T-!JM/!.7E4DY)EUU[SU0)PY_LSSU<OO
MG=W;T;<]6.AG\3Y;IM?%>O?]Z>]G;O\$W`OLX)N][6HI[VO1D(?VO_7*>]7!
MA=]]((+1H2:U(QZ'4K1Q?75XX$D0/`NF__,V10I<6SV7J8]1+F=PF_F!NY?H
MUON(HK,HKM$'B4'D`H/ZH+&=^0[[J/=1>4_R"'.0/>`]*,\D#Z=FVJ:[7OXO
MXV4>&\5UQ_%Y;_:8V=VY/#,[Q^YXO,?8>P36&-OLAHUVTS38!!R[0*@-+$<A
MF'(;D89@HO3$35*)-JDX6IH#132`*.52'&A*JR1*2])_*E5MFH*02M,2X2KY
MIPI@K_M[L[8!B4:UO._-S,ZNQ^_W>=_?]\N\P+ZH'@B_F-B;_DEN;_/>&<>8
M5]F?<Z\JQ[1#\2/.X?21W*'F4^RY\)GF]](?BO_,S&!9MAFS-)O%S>U@^4P3
M4]'65HOE`A8;-J'.R91C)9M;9UC-#/9;C,I#V1-6W$KDTM.M',?SMHF5.G,/
M1CE<PB<P;>(])NR7DGG"I%N!B%1:29/=#*"`J0>M;X]$HVIS+L>R#'&@X;#*
MI,RV%#;3*=$L2X&2J:7(9)O(3J&49J;:`OF?NN4O9BM$?LFANWU_,VD@W9$4
M?6QB_Y+"5P:&*@-P!MOQ+":/8`*#IQ-UM3FDU&8UX<ZG!*7DAK8^W?WPW;#\
M'^.06'SZ'3\\(RC!0`6>DZA`4"2&R"9#:'C\^BFA,!.F<E`H>!2QD(67-3S^
M&=Q64$`DXO!*#(^_<U(N3&5(D(W89#/QQPF1I--,:D9LRO#>T7/(;7@5^G1S
MN+T_B`\%5Z]-CAJ1Q++`V`9AY=+&)ZIUVXT'E@3&M@=7]C6.AMO6!/$^8=GR
M)OPW-/AH.I7Q.\ZB7:,''W,<V<2.,^\[Z,?5C0M3R6GN";UF7C9-[NG^%E5S
M,/2O@%B=^L<9OEXHH.'QOY1A;C![3+S51)0YVU=4.OP=RESUD7"/^4V3Y4%(
MWA"D5M0`PTD??FA1+WA`V^\W#9JR$.9$2V"HTF@1?DD2R%V/E$O81UM8D.$M
MI,!-O)^S>$4&AX:$E,_OMV5%44B-95G!"`L\(QLI1>R1D:S)1B#_)MU'U12D
M,J$6`,UM5+)$(_YGR?N@I&`1MPV0UG^O,I"%1Y$@WLLM69'\/!)-K@F,K0@^
MOKSQII;W-CE.SS.C!Y?9284L9]>WZ34]:2<#:_<[2&H'8.TBU"?EU76.@5)F
M@2D8G;ZYS-S0$J8O]*1OR#<D[?,=".WGCN+#OJ.AU\US^")^SW<9AUF&Y5C#
M,.:`G?8A+[80)_$6%_(%K9!45V=[?8J/K(C7Z].:$!?"D6&<+_-0-,8;3?EL
M+_**%'%4O-E!15#$M+R:-PI+A:91=YCHD:M9L3+9*Z^3?GE[V>ZQ8JY1HFKT
M!Q0"/@.4BT#]R5H7C-W-JJ^VEC7OY*%OO1M<!5"JQ=X@?CZXO)+\^+YI+8=1
MVX8,0:^_,YUJ]C@.[AD<_?O^F)+8OX\P>)ZB_._#.J;1!Z<-!:4)@B_`7\,Y
M+B<6<=%?Y$`>E)EJ6SCO=.%._SQNGM`M/J+,4><Z_=0&_`0UB)]4MV:?QT?P
M62IJR"A,13A#-<(>%K$XR+%A#^WW6+0+H)UL@$;'`(#U.G@4)ZEKBLSXF90-
M&N?H%$)V6%/""`,?#$/(=*%$1/QX=8)3556<9-*]!!_7R"5=UT#QAL'-Q"D:
M8PK;]?6@CJH`-.MR)J7(FJWG]&Z=UD7F/+X/$J(,B1*LC@V80W'/(E;M:$##
MZ.0;N7`IW!VFP\-T<YG-R)JNR7HF,(R;3DXJ:=:`ZNHCIC&2!8^#LLC41TBE
M[Q+6*7$=D0JWRS[D@2.]YI'XZ36]A&Y;NT)V;.&+]U-MG-CYP2`ZIAS7SBMO
M:5ZJTN?R0U0>&)+1U%Z;VFHH0:/)<[!3LQ`T[UFT?PW^'OHH]+6UR9MZL9<=
M6QK:M"XY/OIY>F=U3'QX8:!:9K^2G1]'3N:A[I!W_N@R^C57XQ:D'*)J"P?I
M+;=>\NP8'9SEM#Q`.PYMY[?3GTR/.J0GCW_F>QKH2J`-Y04"6HSPET64$7+Q
M7*)`%?%L[_U<N]1>/]LNQHL):-=21WU77!00ZRDAVJ:T0*(G'O^SO=+MJ7J]
M8>EN)]6DL*5-4!'E.84C"/"(XCD"D"`J`LB8"`B0&T*2J(CD!DD2XX202")!
ML0Q#85UC``^)3Z8X7I1$H8.GSN,;E`1?(I;9,H^Z^14\!H?UAS.O.,B!;WNY
M;.:DDM0M/2/MD;S2NTF6UR2-EY*!_,%)-EPD1L3*?RH#R+BJBU?%D3M[;FFB
MX]ZI!5,`P`&AXPN;Z(2#)JZLAL&9``H!\A/UIP;`1=\I$2B!W*K/)!00$XV(
M5\9_1:]?$$I=0?2+P((-3O5LX]B5Z@VNXU&V.H<MZ)D>`]EMG9U!*/@._,/V
M3$O1ZSC>!;MN_<SSW='!G-/^H.,$Q*6+Z0]G`QH4A:E-XU>\%[P;*9&*48/E
MH)4)A%JC9%"'QS\]'0RU*L/C'Y0-N-`;Z%76X1W<4+U7:F-HLXUBM2Z/:W*5
M6*GL01XC;G>50RA$3(89:25SF=7TUI"9V+E1)^*:S0YT70-'"WVEZQKQKR-N
MBH`?;[RQL:VUCIK9`@*@4'Z?'.?QA$-MKX-UP>77+CY>12?^.'AIL/KKW^\_
MT;UEQZY-ZQ=N[CKPV_Z&W?_:?!F]C81=EP?&JO2VQ[SW%W;?J"[:L_/IN3_"
M,SYZ=A#^U_&W(3<V`M?UH)MR>74Z$!)+?N)`(HEH7IH=SZ<[T-QH9[S?OTY]
M2OV!>I`]J!YGCZMOLN^SEUB9LM-IQ/"0__PD]+EY`/$6(Z2;[!05LRA;2`/(
M$`@$EVQ>:'H+XIM*V6@%90'3+;&87\6@FWPF)?!BLLMT/1J);F:YOJ6U@9B'
M!K/9+)M;S5?,*Z;?)/`&LCV0&#0^`YT*BQ.=:AO$@($LD'@M.YGKW$SW\22A
M-64J%"`,N%F@0%[WP'/"P!&7B:9TIYT(S22.D`.@(HEX$]3"S0IQ/WYXLU9<
MSXVM#RZ:HTGQ6^:7OAK$QJ55>ZM_&IO?]V#VN9?6+I&C>$MU=T]L>@[T!MD)
M[1MT9;'CS,1.OO>71ZMC%6;TV4H_B/[X!:B+!75)0D;[?GE'W;_C-^,X8<3-
M@C##F&'FH_E8/M>!.F.=N3ZA-]:7^KJP3EX761_=%'M*?DY^63[&'I./ILZQ
M%]D(]5_"RSZX:?L.X[^?9%N1+=NR(EE6+/E-L2W;26RP8Q,(M@MM7@CAO4`#
M(4"!`&FW!6A#LQOC.B`<Z5;:7LMZ[1W=5MINE/<NRR@=N1U<N^T/>J7];VW7
MN]Q>[NIM[3)VM+&SK^R$P&Z[7<Z6%,NRK>?W/,_G&XS'<14S(U*UE5.J?;)7
M\6%&]5OC]1I2@_7A8"TB`QBPW.L/\'Y_((X9*]:G/=$336$O,QU.#&.5_>Y`
M6*U_&X2L1F&2S"=5G[I"W:R2*E5-^'V^*M`SX'>3"5F,,@G-RK#13E&75-0E
M/2E>%0EQE-R:9^:L`&N(S.QDMP?J"!2\71%0;Q&HD!F^YYJZXP4H(1"-FRXB
M'!NZIX"P7CFZO"#P_]9WFM7A_++,_3JG_!)"_LM+L/K!HN4M_/9;%QU-]CO0
M`A#^WT![+JP$&!*KG4Y1\)/4/4MBZ?Z:[%9;<2^S=0/@3*K'3,S]XMJ>ME\,
MSFE_L-0UYK?0JNO9*]M6\6[BA=+V=9%0`ZR+I8?('>U1G<#?.#3\K99D:?NI
M^\D@\0*1)=[[\>9M&+[HS:G/#*>-?2B%/LRWI)A<B+"$+&%WB*PS^)SUH7HM
M$F^+MR4WA?I"N^)'K$=L[\6M)BZ,@C@`>!)*IE`C;G;_)O3;L*5&<4\IBBR/
M$E?S+O=M)&)QDD\I:(I0<O@&)K`70SW!BUYT>\YDR!^V,J1"-=:3_D;>#?Q"
MUQYB:]+F0]%1(G*I\9U_N6+LK0+$6F>A(AODF4,$.3Z?*'1CMKLP44#LY]T3
M(`#L3L<^#4MZ)O:1WOND&@I#I0?*MUL//Y-)#=3",:56)SU$Y0:C,*1C.@E6
MA..,X72_WR)'AU<N>VSEB2=6[_OXJ;6EKV.!M!9^(F1=\_*VAP]WE/Z9#/YU
M;-T/5@>4!J^QKY1ZY+Y-.P8ZECQ]?.]K6QX=W9X4/(3QZ-6^[ZWO.(:K=G:N
M._'[L"A!^Z.?@!N'P8T23N:;.$O5?")GFE\U7P!$%];1O99>^X!YGVW(\CJV
ML;Q#8>VT#:87FO;R`B_HKN%Y@9!T\EZ$JH1?(8*U5_$UFL"S9"MQELOA,?P^
MGL(&'T[@'GP07\7&[^*3^&^8Q.BLJU7*9^3<9@D?E(Y+<)FIL;=JE)1$7P;Z
MXXG42`W-BWR->1373',=/&[A0CS6OP?'"A/Q;MCJ)&['^E?!NA&Q?D5]24\4
M9K.RV,Q.-L\FI>L_B;YBDRJPAX7+00?^^9+54=[F!?"+I8SY:;9)@`?D/9N=
MG5U)M6P6?)=],!2ZBML,BWMKB<%G2A](V1ZZV,/T;@KCAI<_6!<V+BT]ISAW
M[JV:)!^,A'0^ZSQ"%HT'G@/61V-3GYGV@QYQO#B_@>9-?CJ6]ALBI@8FPD64
M6&0!FL_/<V7\S75+48L-$-_?'MN(UO-=K@VQW:X!;H@[ZCH:>LGU&G?:]2[W
MQVH%FV!RDI0:14*1N()<G*BX8*#4J2N@1?B(?N.`ZQ6/Q^O@>*X"89SD<F&,
M"'44]^89,ZTY$EI$XQPLI5>4(ZX]K9W4SFDW-&-<.ZX1VF4R@3Q$75ZZX<`Y
M1]ZQPK'987#L3=`:H!>\V7SASH!:IB^=NXKP=#=U%2I9>!=QV?X_:$U#-F/1
M9$V.1#5#1"7TD)P&+0!L$_R1A$$--!"-J=FY+'!G+ILIOW!(-9S!OZ.7QQX(
MO+6F](=/#HQU);0WQ::=%N)59FNO>B9VZ/%'3LQ=E+I@K_-N,2X-FGS)QXK/
MEC[^4UO7X?K686+5BG`(LBVX9K!X]OFN58/+6WLN$+V-:M8O@K+_`&73H*P,
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MGKJ-DXS7\(V'C9D4H._Z8\6%Q(Z!C0$I;`X&&='?]_4NG7JUJ7'R(_(D"J(,
M%O,;B#1NKEW0T%$[HAKH#(ZBF$5C8K71T$*T,)@+93-+4`=>%MIEV<4<%8ZF
M?QA\/O5B^F>>GWJ%=*A6,`2Y6K_$4`:[F;EYWH(MKR*#(<8%>8X+!D?)"R/(
M%&WS4W-'R0?RG"39+7DXY_6\W<+-TX)L\!W<CPSX(O(A;FKLY]5-YSC,C1)+
M\DZ9CM=Q"1G_7<:R.H\3N7EF=6<E\^#>=_>7$TH&UO;8<S($Y8@$VWRYOA_J
M+,^XL9K">*R<>*Y<S>!?NEWQ2DGEQL%)%4)TW>HN`#V@,C^4B:),"0CL2%*F
M:?[.B'HG00-E,G#WRWM<!MK(*68HW24!RC2#ZIDT^=&O>=)!"T$`Z]8?=3<U
M^US[^K(M&U>]^=3>[?/N9VM72YS7ZU_\DBK4-RQJW$0^4^Q=::<8SF==SCTY
ML*`^O'OENZL3)WJ^CQ_]YL;[UG[[_,I:R9,M'3[6&$\MZ;NBZU<-^HT!$SA1
M"$WF>ZPLAE_`9OFLT(Y:C.WV#G:S=I`_*+QH.\X?%]ZPO<*_(ISGSPO5-*)9
MP@ZKGL4A4?>@B`UB0!*B/+^/%1&*L=;*V,G"SDWA@-.)4$`7+F$P20LL%FM8
M8ZVLMX[2SZ'T=OF4FJ(('Y6@>JB3U#GJ*O4I15$U&GN9B,/%+^8M5BEL%:UA
M\[99[3H+X\O*B1>+==[II$(Y[R8*0\:9N,.#[%<P,^KIY2A[B[)!6@[I+UVK
MA!F(E-9U$%A=EC`NAQ:5"6)=BRQ1(3,310R=6;X[NW_@VME/3HWBN4Y>;K+@
M9:4K\5!C;=-WUN2C+2DU8NPKGEK;=*:_].6';V\Q!#MDEXTGM05?O>\1_LUV
MM<`V<=[Q^^Y\L<]V[//K;)\=^^R+'[D[XP3;YW=\Y$'BA)0`";2`*86.IV`+
MCW:CA4:,%AABI)-*2QE:*O$82!-1J(H9D^@F;9/63NJ4/23424S*JJY@:6RH
M6C<P^SX_>%352??Y[GR6_/U_3__L_?T#0WW2">1'&;CWDY`[8>RDPH[KH2F0
M#H^%96B+I97$L`OD>D]OJSI8!BG%1.JP.0"W(`YN+V4`DZ%1-0Q;"VA5:'C_
M)_1E^@9-T*S`2Q2Z:8!/;U`?4CCE[."WU50&5I,1E+)06!ZIE.Z)E=IFL?OH
M?SBB<%>B:&NPNO2@;0G8ZR!%*&U'FV-M@+<NZ8_`*A.DYX5U^]]8?:QG%K0?
MG]BU,K$@+P>,5FYL:,.6;47EK;NN/?+@R+'B69"_]N)0[[I<AQQVV\PZNF]U
M]<ZK&_;V("QV/)Q7E2`6)2P'__+;T$"S^?@OXN4,&03MNG`DB\F@$"@(!7$0
M@_TRL!4[;#LH'!2/9(_FIH0I\<W,>7#1,BU,BQ<S97`5OV:9$6;$:]G?66[2
M7Q@K-*\/`"H'>#^4$T*K:]&VYB(++%!T=',GM&!&"[1G"5$0A#T!`N(W8+8&
M$#8#`;,P)QZ0)`SK[/6J4PC#C-VN1<\*6D6+:R^TZLQY)$!ET#-+7#&7GU8?
MEDI(+%23?[*`Y?-0??)/J8_84)BFP!1@XA6QNKI\(XH1WBO-QI(6TX]A/`%S
M,`!/:,W7I4:N2TVC:$!TQY^2'+.J5+WNI2D3$TBT'[^86\1Z]J]=W#.\^=#/
MSBP)Y4-#KG:/P:8%Q>JA3HX+#)SVVWA^_!RY_7_O;65TM,G]C.7+0E=TU::_
M%N5]>]\"_E^MX*2OUH8=?B*4?_!&/N53JOL/=2[@EH#=<-Y=$/]'(?[=D`%?
M*+F<=XUW5?C/896N56W5<42+%P35O(:G8IH8-42WX!J<,FO,E(K2Z-O\>-N?
ML$Y,P3[!"$P?*./O7U4L:HWFPGH2\<6FUVGF*,07ZK;>#_QI\R1D#:(%!>\Q
MVP1<,B(&^:P%M"I&1!8CN&4$1K[)EHE2354@7\1&B&40K>`K#)H]@S0+_>0L
M?%>L6\5$G5+0(1S1`ENI5<\FI[HZ84F9`/!7F]FHZ04-;JEAMFT)=1,-K0%]
MU*KBXN,ES^Z;ARY,W@#%\V,KA<S,CN*N9U\H]7D=G;F=X.5%PO#JOG'7L9>F
MMYX%@[\9S1?[U^WV6(76R,:W>]Q<[SZH,]5R=;'*"'F5`AEEQ8<9H'&U>=NX
M$!:2A[F6]F1[BLND0);(.E*N`="?[$\]ZQI+CJ4VIEY73VH.&TYAIUP_=7V2
ML>$)<P+'<`!DDT$#@X[#P`9CBB25\;\K6CDE8TDZB2>39>"X(J^'W1`X8#>4
MX==9E]6%MHQE71WG%O;R6`H^W*(XVY*RW-:"Z0`'??R<M9<TLNFPBZ4Q^.H'
MP#7+:M*&,J%<8>5SH$PL49P%=BF+'V.GV&GV!JMBG6G6SJ:U0RN>\/*1!\YY
M!RR3]#P]WS2$!_.EB5JT>@#KROSCK@()];DCRM;.)7-Z'_TO>%6IZU_#),A<
MS1]@%R)PO#XNN:Z$-GO#II,6/LG`57Y"(>6F8<34N&/O\A__X?#X:(\<Z?20
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MSM")T.40$3K`S1HCW@C.190('MFSXL[GCEJ%F9\O56AXE![;^WSIWCQ=07D+
M"1X,8I5"H7(/C2M:JK$LW6!:T[Y*&*(P)L*FPJ/)H-&$6E`6LS/HJ$\KA,:5
M##86=(:#M#-J.+VFDJ)I@L95+3P'"0?0<C_@-O[R)>^PU&/2&]G8QXN>6_/9
MW7_O7K'C2M[6MOW`AE5;?__Z>(__;)=?7I86.CSI,;DZ^7S_T9/[O[/Y1WW$
MAIW9Q)IWUU(:O]5@-+?:=9(KL&?Y_NNCF='\EK#?'>SHW;0P],KR56<V6+16
MKNNSS5UI=_+N!DF^OR6P<N&BK6OR<E_`#'.$[>$]%0[YG0#KE8]D7[>PG-O(
M?4]U1-.B]H&5PK@XFB0PA\Y'.]H=(6?8E\:RT4*L$!_&BMR`T"\-15936_W;
M^7V^[_J/Z([Y)F.3\=.Z=[C3OE.1J=A4_")V`5SR7?)?C+R7O&J8B<W$;R7#
M:D#Y-)'6:&?R/#:35"^(2%)4$$4,IAC19-`Z7(ZY&3NPGS7$A5AL3Y0R&&0/
M;^414CP>7L0P.2I9H^@R&I5B<_$#B02&!6,M:DG4V@MVQ8[;$;H,)I?.(X=Y
M3U2B#1<\/R=@I8!9L#7Z-\DI>^R279*U+UXCBEA=`NI="J)"1$6J1OY]]"T8
MUPNYI^P4`J@F`XZO&6L%,T-'Q6H1OFZLAPUU<YTH[4)P`H^(WNRX-0EX%.LM
M3>83!/\H1.)GJO</Y]=\/Q<K.EXS&2B]GFNGK*&5[_9W+W:\JC?IV@L'#S[W
M'S!HM;*R&HR0V^^_\MO%WQH84>1EU94I"V74.I,&-_/#;4JGM`Q<DJPZ4^Z5
MZE?5OZBV#7J=!@M,E]!/(P_G\8T0!SKHIW]\7Z\UI5O+#[]4$K2IF[!;[+R]
M(`QX7_:^)KRCOZ2?9J;MEX4/O/_U&.QF(^/4$I].48"BC&[[W!3R2D)1NHPA
M(1C<`[5)+_K<5A^:EL_G;OD4@W'F,D0>%IP+'0@ST`N9*6::43%E7%1L3MCY
MU.Z.L(\>A87+[NYXE'<F&A$G5ZAWJ'N5`@P^WY1P&K063;5&]7_&JSVVB?N.
MWRNQ?>?'G7WQG1.?$_MLGWUG)WX[?E^`V$D(>38!-@(!,5JV:BW3)CI6&'15
MV99-8]J`C?X1RB@115-9"DUX2*`);4C3*B0CK?N'K5L[:8)HTIINW;HX^_W.
M@21"DZ;(=S[[ETCY?C]/K>HJ"KI&8&VKX^>P];,'N>9><6R\D!\?^\9O&2O)
M,.&2Y_1;75N8*=;OMC29T-&&+XT7"N/P54LL90HVRF;Q[69K_^KM]&70!]VB
MW8,&TC"C&Y?_3K2`F<;0[ZC5(,A`6_W7)((4]3Z]3(8(I441%%='I"/:B438
M3KD4*46U<,J6I1ZY/](?W6Z?B$Q$GX\\'ST<.1P]Z;_"SMG?]<T%!$O$$FV-
MM$8).1@,`7-!6;;)+TD,BF)20&("",.2'ADQ!OP8ZG((..GQ(S)NI'A$`I\0
MB3@PXCT2PTHH(C%1.1)Y&)I$`@$E&&)#<%'@KTH8BE.>2#5Z!$$"IJK12%95
MJC$8(`,"(M!"FX`+D&,6QZ2'"@5I5U503;)1N(YN0(Q8URPED_/8QRHU&9@)
M.N)!;F^!KQ-LJ;FVN/"(_K"9ACQ#2M!!P3J5$GR_`**K4D(6M8CZA&TH./,I
M6.UQ?5V^4?@MLV*T4+3KLJT\EO#C>CJOA^2K7[57W8EAQ$U#TD$A3KN!Q\(?
MG<W./4Z]6MJ5)%V=@7Z_"!CX>NW11_UNDSZPA4)/DSUA,=[O#A5$AK*($9W1
MMWEG*1[?Y(E]>>\RVM_$B@D#^@Q@X<#]31[>8FIR-OC]C)V1<FW!VJ.S#LL(
MQ7+?ZXWVOO[G/;6+Q/X>!R>8?5F(%S?@X!3`BX!\HFY"5,99NL:@!@Y%*(.=
MIFBCC_(8LT@:S7*%EH*SU-J']*`5MK?I8-,W6R\A,TUOMUY'WL7F<!X6%`M5
M)6$ZY:Q\@E0M+*@;1K:DDB?(L^1EDB`A1RNX4VYI^2H'*PMG93FX>HZSME2=
M1P0!04A84>KG&\@9"V5U!3@:GR&'0#MQ!>"5L[I6^3F@T/<.P$:RHIU_U:3S
M?[00\($"!1,HIM8^P&:4=?5CI7:D5X5PJG958$@K'<E)NW:4*AL&>-1L;W)F
M*'08M(@S>QTFJUF:L/ZD*U2)^4;P,_T.WLSB_AR8++?\2<-[(.4,H7?5GUN+
MW8<LV/;PUO;M^;'RWT8:+"-_&,$0+^WU>_V^-)]*IWLJ?-E;[BQW5WJV-4T,
M3`P>-+Z4/YXYOND'(R?U)]G3N3/Y$R/G]1>-%]B+X8OY.<>_\Y^6W=WE,F)$
MD8I7:!8ETI@V9%&D[*T2(GI'O"]BXOFFYN:4W%%W+EGN,&2S2J[(%N%C+E=$
MRF6ETL?VP<=*I6^@.GAD*'X#[,:*=.&(&K0V#C4BNDJYG,MER8!8$E7QA'A6
MO"PVB#,2)0\'.N1BKJ]"C\SCO2K5/$/(Z&WYOHS)\[BL&K(S1`Z]G4-S\,E>
MGJD,R@,/^V8KCF&9RW$53AY>YX4:5Q=A:`*Y&+Z6_J/9(KUFN8J6B_,E)`^N
M,'&M=<@G!KG6*_EZ_<QHY;,NSQIAX9<:#+Z":'5)-86!`Q5<3*:/I3.5^>5'
MLW2&GU]^?];"%!6M,*'XJIOJH(W^/\YJQG4Z\8G-`I+;GI!</'HLM_5`IBO;
M$GXELZTK'$]67"\X3'I*[PT8K)[N-\N%/L<!SJPSF6R#/\XX"TLW+":=;^C0
MWN'EFT[:&R?1,7RZ-O*K[B\4!SJBN]ZXNV&?M[F24??5ID9YO5DG=!H=]F,O
M;0PK6]'7AEF=J9%\YO>'=K^'?3_)ZHR[3U5K'V#?VA6@.1.`+,"L'20S'"9S
MM*B>MA:"7R>P;6VC\E`*I]JH4"3U8HKP\6ECQ5@.[HCMB#^K/Z7_:>B"_JW0
MG/F/*1/!LSP6E&4D'%*4=C/73*)!-(C(?)4[#_.4X&$]$&B"`'P"2;4K;#M\
M;&]7?/'&1B16C1]))!"=(M<#U0GN+$=P,\V4D`QXA'8%Y*D[`BI`+%F5N!Q[
MV#ZK.)("IW!"\JE,!6&T.+$V5M6E01,'\.&Z7,4_E@K^'Q`I$"(0*1I$UBCY
M"E"N`9/]TSL`%*T`(ZH%O'$#T(1==";DLF2>1LIZ=#P=NU;QT/KRX>+G7\TF
M^OBCM$5/4B)(7?X?G0.AZ[#):O2GOGML9/E&"^V-`?D!>Q^]V;VW9TNQ<Z@V
MULF0M%Y(FIW</]6(/(I>DD'D2KQ:^ZSV.^R570%&6S"&Q)8_Q'\)]FL!S69.
M=2=L.2<VZ3GJ.>NY[;GG::!SB([/Z2E7UDJHL62"`&+^CH76[JJ+,B6FB5L$
M1CSG:<I:*36>3$Q3MRB,$MU0CV&;5>!\KE*P65'P=]UL_1ZHWV=%:TD;SY8%
M6)/`.^T\`<\3*^>)E?/$^O,(B,,+VAI`J`)3Q0AMD$6,`T/$'O<>*Y@D]L;@
M5.5J[?U3WS[YPJ4'`TFQ?+G3+[E"1T=B^'3O*X/G:C=OG/O:U,=7#R1;2[7H
M]?8\[_T,[3B2R"`(MMQ8Z\-_`R8D`@YXK]A!;A3A/[_-DMF,HV7;N&W</L0=
M=!YG3]ETN#=!TQA.>Q,,@R7B7IR(2`DOC1,8P\EV^T.&EQV.NTY$%L6'`L8P
M*:?`"A#Q3J<@5I$C(#E%YO'N*XV-F(Z>QV?5E+311#FJO+W*<V9G,B`XZ7#(
M`'_#`$<T;4#;#!&#:I@TO&B8-KQMN&70&YY+8=?1&XB`]UQ-@NR:!";;\XL5
M>X1$6%@MI,H*%:!NEI8^`E2`3%A<T-12::A[)0P]:Z\P]R!:-`+9)I\_?$>G
MW>$JH'\J-E]<5T<Z7<\QL*_:.9T;K".]`FV;':RGB#^6P)?1S?GP_M<V[-SW
MZ\OW?(F.A#,T;%CZ"ZF.^19;Z+;.&5>DK:WPN=%86A);PP7\V<Z?36[\X?[:
M!P_NF/DK>^)M/I//APT<PWMW2@Q'+DE1M_C%"]7)+65K<P6@7`([?*#M,(GV
MJP<-8(DA:RCJC?5[WK0U7$Z#*;:1"DC`23S5$#/\E^YRBXWBNL/X.7/V.CN>
M/3M[F<O>QCM>LSN[MG>\ZUU?V9&QL;%E0)2+,5F@2>.XY,*EJ;B8&J>$$(5<
M+*&6-%%#^@`N/`1B!#5N*E!)(Z16;21'D=*'0A-7(D(6;451I<2X9V9,\$NE
MT9S5F7W8/=]\_^_W-=(Y3Y.WE&IN[`5=J,>NNW5ZD!JA#L*#U,G<1.EL:MIW
M)7=5N\O>+D6'?$-:)8^V>9]G?\*^Q9['YQ4'3BB^A*+X?(E@HJ;>EU<PK;K=
M!JG&D4=EF)L8(%3$2VT28Z6F-^Y4@"-53]37_4$/P\QZW.Y9#\UB4ATQ1K^%
M4\2CF+QX#,N7XQC&\2U,D7<DJ>.2>[P$U:RH%#&/B[1R%;X-ELE=R>`Y0V^(
M'^M]Z&NAX1`FM[)!NJ19_A_%S=EG1:6A\G&6R`WW+I5)"Y8,=7E3WI54R6\2
MTPKB0\[*0K[D-`0VOV,8TO`C^MO#+V(.MUC=XUFX1[>U9"/']NSL6[,FV[;_
MQE.-Y94#WMK)FF1GUX80%A5EXZ]*Z.BW52/A;"P>"#N227=RRPC\P_6>8K%W
M]"48_B(O]6X8JZEN^^#ST4(T*/?#[<]WKS:R2P$`-1/5JV&KWLVE:"C'<\H@
MVB*.H.'`<&A8/(#V!Z>I&^!&=56(!Q#R4CB"1,#S14$,B(8T@B!6.X$SSC0P
M908QTRBCU^-6>WS6*\?E"1G),A"J[4Z!%@7,G7;!':YKKENN19?-]7<`Q]Q@
MBI^&4WI`D-5<7(]3\;OB&4%,"%81P??G[E?F\,)<9@Z:$AG,$7#I=7S9I?ME
M<F.-3]&X"1M;S:)2;K=J)9Z?KY3+C\N)S^@B@%C2(A@KE<#BG4NU?!E,DY4,
M3F`.;]%:6=Y:/4O[Y,\:ZQ5_2UCW8@MOK-SB'D&-8>8E?GD<4?`?IV:VESK4
M0D,LF4IA-^T)]8RT%OY]AO-7DPY2CTXO_!F^NZ.YH_G[G6I?E8.I_/749]2I
M/B$<8Z.=`"Y^0_K&`Z)2'CKTUQP>1Q6=<F1L#91JJV54K=W6EFS7^FW]VA.V
M)[1G;<]JAVV'M9]I9[3+VG\T__4F*-8JJ!9GLZW97%-?=A*X5B1IQB:'-:C9
MZT(RM\*E,JPB<N$(B."('$&1.DA17-[>5N>45W&>/)F[7BI.-5"(FH5C2@MF
MU[$4.PW_I&=5<58:B\R",`Y3X;NN%J_Z%Y7RJHO&+:[F5%V]1G9NJ4Y5+,R@
MLS`+K-3;NV^`T.H\X8J%RORW\Y7[5EJU$^G:?2V5!H(@\'%Q)%>%Z&<(1TRU
M%R+%.&9S:!K!YC`=13;(J>=C5+[1[(VUALF(,*:MJ`?9I.MH?WV[5/=>U_K3
MFULW-4?$B"^IR4K'<$.IMV'3CY/2+]]<.5077B$03OCC@=>*M7)S[OSXFG5O
M;.*Q5X`#!Y_IZ,XU#%:.=#?JSTV$/-7$02K1YB7;21"%SUP%]L4OI_PM]NG%
M+_7CWI:T5)0HF9)1@I6]"5P3J8GFJ!PJ89W249=W%5XGKI,ZHUO`H+!-W"9M
MB0Z#IZFGT6YQM[0S,AQ]D7H1C8JCTI'XR]3+Z)CWA'A"FJ`FT"G[.])Y=$&\
M0EU!GX"/T2?163`;_8KZ"A6AS>D$7IKEPD`2A2@(BJ(Q4;W"3K3>"[VS^DGV
M?4,X4BECSIU.TB:%8$"P7!PLLSH[09[;V$E.G($C`,&1*1@%T[!3QY#SD-(7
M2PE!;+OIG`P:?N!B9;+>OE0L%8Q5]\:T0G`FY@[RP<=M,X,?$&+)0&+AI<E:
MQO=)B!)[5I;U34G`#RO20J51.H3O"`V6Y);V+<>-F?OQ=^$)4=ZIH&4-]!$>
M*D9Z4FO7'U5>FL2<Q\?5=RC=9]=W]4OOO1H8OWC8=O+A/W^T\%$Q4N5GE2VA
M`WNZFUJW4=&^AK'7C5G8N3AGDTV7'=!?X3IYN!%N9:@$K&$5(9%I\12:>F`/
M.T0/R;OH7?(H/2K_`KQ+_YP]!\[39]ES*V8BO\E\SGZ&O_;,><.Y)NBA@1"E
ML6`3_)B7$..4@43+L;C'QD0-NL>-JK9#VZU1VEBF"N-BE`DP%NDSI$MF,JE`
M9GKQ7WHL5%7."&2?[!#$-P`?$<#79AO'\GE`YNV'.E\%2$MQWDPF)4\J6D@Q
MT4P*XTF3^C&:3,T4HGR*CZ8*M'+'5,64A7CO$>D;>4?PIHSG3+8AL4>XWU)G
M>35\E'WDX1PVJ)\WD7_)IBVF/:W4,PA5%L@O3Q`O7/('5N)ITQJ0T#^!XY6J
ML4U6UMA^5!6-2?I="I;\I>4:6Q*72$PN+P-F`8C\GG6Z//4#+QS<MG!=\+K8
MJIJVQ(G)E3VB]M.VH='FI@%Q;P0G&\W>MS#8P+GMK@W[;\%&]\)S&QF7CXD.
M"M^4\\7OG?M=YU.=:]OSF^'$DPFO2?\0=!#Z?]/DHO_JO5R&RU3W<7WR>/)"
M<L9^,?EITJT$`XB&F`4*#S#T\S$ORT(6XPQT!"#V00<S6W578IW0LS,&]1B,
MM>J\0<<<D73<E/,B?X^W`Q[RQ)>7<=41!C+3\(4IQQ@VDI&7UT-(KAS4R;('
M7H>?PMO0"6?0.E!#U7ZX2\@8L+I/$N>%N0>5=A$_V$ML(@GS1`D2A@157?66
MR0Q'+>FU-%6MD6JE*F!)@P#&&P@,<`:ZC[:*A%TA9TT9XY0D6U.20T7S[)=F
MJS%]G0X8JT%*R!?QQWQD4/X`G=S=[>LJE&*JMG_-*Y$-ZCYXH;=)P+::K0_O
M/=S\^@>M]3M20F&UHJWJ/G:Y[U7#?RV+<_:UY*15N$D?X<*A0)KR^#TA6QK)
MH=J$G"ZDQ]/OIQUI*NW/\/5"775=HD[5^#:U'_7[5R>ZTP/J4'J[^D/UH'J,
M/Z&^3;WC/YW]M>T<=R'[D7HM&_&H,"VH#J?-YJ/?"*E`5D,\.?(G]92@!@1!
M#05#?#`#00!"P*<E%?R/_6J-C:**PN?.;'>GNRVSVW:VT^UCR[:=:??5=K9E
M=X=M=]C2[?L!M%"@&RA02('2EH<$8K%J+($(X@\"*F(CQ`:"$41-)42),1$,
M_R!1_Q@3"6)(C1+L'Z7US.Z61C%"@M$_>R??W'/OG7MG]W[W?'..&5)U\V_8
M[A;H^,S,#(-M/K*BF'C%1$RR?E!/CNA)FY[HHU+(5^A55=63?7"1VZ>8B7F"
MZE8,3E$>M(Q8QBRT19VLS^<'^1%^##4!FQ<=C2IYMR-3&*Q@F//@_MY[CNV1
M(;YT,F*<"J@^&0C>GPS.?@CWNQV,ZHQ);MZQ?_AS1U0A_?LU46E$;8Q$8C%-
M"9ZN5*0Q4^4R0XE*!Z!SI<=X$^>8HT@!30HPX!2%&+=FM5='Z*'&8]T9`8TN
M7%EI==Z<'BVNGFYWL":])\^81;IR]"8->1&=*73T7=GL;-6G9WOJ"BL6#TP?
MGYZ@-CYXG9COG0R7V#5%JUMK-Q^2-E(VC&).H;Z:D%^%&#\&>>:.LCW5%*PJ
M;!+;?,?@A/"F?%8XX[LL7/9=$[Z44\S@!2H;4\.`&/#6<TV%+4*+OUOH$KM\
MW?XN^8!PP'=<?BUPR?R%?'7A-YF<CC-SE"S(/L'!T1F<('(TS<F"AM@"LD=@
M.9HP!C!=0F6=1S1*"L,0Y09@.JG+S?V4\)!%QL$&940#%30H\^QVFR'H>LY%
MN:XJ=IB@-RL9AMP;>?L,JF?D&Q3#H($V6$(3Y/<+56H\,X4>UZ+&,O=O#46U
M%,V]^!T+[OT9V32J'60N*61B1$9S!%"=-1TW'I.!6!"I"EPTY4O+G%6_6%PI
MSJ.BVC<;TN`,+Q5UR@B)K!'7234KRKT+%SKSEQGM0D5SIR?/:DG/#11V=2C5
M2F?(M>NE+JFB*N3)MDGFW,P\=T[3V@6VBFR17A\X>O%5N;4TX"FKRLPK&9V^
M&1)3N0[NL.SR/W_XZ`%[H,P3,O(IK&3M)1O"+@;97#P=CNJB#[Y3*FT\L2<[
M>#E9YOT6O[N%#XNKF%5\']\K[N%'Y/,RF\QRKA(=3XI\-^!N&M$5C9=,D''%
M:F6S=`:.%8MM&'+2FB2MMKRLU*W120I'.">K"J49#W"0;6>I(/L*>X0=8\^S
M5U@MB^[V@:[-1FP3U)22Y;)+X#NM&V>E]R2J3!J0!J41:4Q*DE0_\Q?$17)R
M"C]OMR*J21R3$96,3-6SXL%&<')2U4NU(\VO.ETLYE#9P2L=]_NA[JD\Z2B=
M-D;-GSA!;Z)C6NDC%45LMH%CMART]_`-%=XE30<OG.T?K7?8_4L:RJL\-EPV
M;X&6,247YKA,'%V[REU2-SPU_>.A.^%J,2Q:I<8.?\V%KZ8GKXT,S4]O]WJ;
M%8P5Y&%E^0DRW.>VX7&.EF>>'$2/.#$'*B^.P7\/]/48-%\#:',`F+4`^L,`
M*4YTOV\!C)8YF-8!I%\!X,X!F(\#\&4Q6%H!LC\!R,7:6@R0__:3PX9K%N![
M"G\"$+`NQF37+@`X$6XW0.D+,92_#^!)`:C$]WO'`'R?`<BC`(%G`:IM`$%\
M_R+\.-6<!*AE`,)W`.H_`FA4$D@@@0022""!!!)((($$$G@2``4$U)(!M&H1
MS`.)%AY;9M-=`^9L+)@>?:`0!+&XQ.[`/+.TK%SR0.4"K\\_-[ZX-EQ7W]#8
MU`RM;>U+EB[KZ%R^HFOEJM7=CW_W?U(T,(AW,QCQKVHA'TK`"6Y8!`W0#LNA
M#_;,S.!X/A3'^VN@&99"#VR9F9GY_M$KOLM_5W`K9W[YQ]_"P,;X?!JL>"?Q
M7VC%*V9KT:I6&=0D8T\U1.(V!?/@C;A-8_^9N*U!^X>XK85J4E377M_8TN[H
MZ.OOW=':NWOI0'_/-F=H8.N&AIT]6_O6/]TPU.&FU4,CM&#M@`[<OG[HA1W0
MBO?=N&T#V.Z!;;B5(;2WP@;<YIW8LQ6?7(_CO;`)=F&K![8_Y5K_Y^P8<_0Y
MN`<!V`Q)R(X12J$3J:S%TT1C&XDA1W"$T:"EMF9KV$BEX?2'Y:]')(@%%#R/
M>QAUF>M,B-X1/RG4[4WFW)7,&C;P*Y/%1)\^9;U\6JT_O':V\+>W'KR<_`X3
MPJ9Z=J(K_S$`KA^5VPIE;F1S=')E86T-96YD;V)J#3$V-"`P(&]B:@T\/"`-
M+U1Y<&4@+T5N8V]D:6YG(`TO1&EF9F5R96YC97,@6R`Q,C@@+V)U;&QE="!=
M(`T^/B`-96YD;V)J#3$V-2`P(&]B:@T\/"`O1FEL=&5R("]&;&%T941E8V]D
M92`O3&5N9W1H(#(Q-2`^/B`-<W1R96%M#0I(B510NV[#,`S<]14<$W20K:F#
MX25%`0]Y($ZS*Q+M"(@I@98'_WTEQTG1@0?PR,,=*7?-5T,N@CRQ-RU&Z!Q9
MQM%/;!!NV#N"4H%U)J[=@F;0`602M_,8<6BH\U!50I[3<(P\P^:[_"BV((]L
MD1WUL+F4/]=$M%,(#QR0(A10UV"Q$W*WU^&@!P2997_<90X(:NG+U=A;'(,V
MR)IZA.JSJ)^`9/_/7HI;9^Z:Q7-3%4K5(NVN;%;E4]X!S,2<LBWW+A&RN2-\
MOR3XD+URB5\!!@"%R6A:"F5N9'-T<F5A;0UE;F1O8FH-,38V(#`@;V)J#3P\
M(`TO5'EP92`O1F]N="`-+U-U8G1Y<&4@+T-)1$9O;G14>7!E,B`-+T)A<V5&
M;VYT("]'4$A!1T$K5&EM97-.97=2;VUA;B`-+T9O;G1$97-C<FEP=&]R(#$U
M-B`P(%(@#2]#2413>7-T96U);F9O(#P\("]296=I<W1R>2`H061O8F4I+T]R
M9&5R:6YG("A)9&5N=&ET>2DO4W5P<&QE;65N="`P(#X^(`TO1%<@,3`P,"`-
M+U<@6R`S.3@@6R`T,38@72!=(`T^/B`-96YD;V)J#3$V-R`P(&]B:@T\/"`O
M1FEL=&5R("]&;&%T941E8V]D92`O3&5N9W1H(#(R."`^/B`-<W1R96%M#0I(
MB520NV[#,`Q%=WT%QP09Y$>&#H:!(`$2#VV"VNVN2+0C()8$6A[\]Y4,.VT'
MBB`O+WA$?JQ.E=$>^(VLK-%#JXTB'.Q($N&.G3:09J"T]$LUO[(7#G@PU]/@
ML:],:Z$H&/\,XN!I@LWY=CF<#[NFR7?)%OB5%)(V'6R:??;U'3KUZ-P3>S0>
M$BA+4-@R?GP7[D/T"/RO_U=K)H>0S76ZD%B%@Q,229@.H4C2-RS7A$;]UU?7
MO94/06R=SI(\+UF87OK1%W_XPI$C42"=SS"#1`1M\'4I9UW<%H/]"#``6W)N
MP0IE;F1S=')E86T-96YD;V)J#3$V."`P(&]B:@T\/"`-+U,@+T0@#3X^(`UE
M;F1O8FH-,38Y(#`@;V)J#3P\(`TO3G5M<R!;(#`@,38X(#`@4B!=(`T^/B`-
M96YD;V)J#3$W,"`P(&]B:@T\/"`-+U1Y<&4@+U!A9V5S(`TO2VED<R!;(#$X
M,2`P(%(@,2`P(%(@-"`P(%(@-R`P(%(@,3`@,"!2(#$S(#`@4B`Q-B`P(%(@
M,3D@,"!2(#(R(#`@4B`R-2`P(%(@#5T@#2]#;W5N="`Q,"`-+U!A<F5N="`Q
M-S$@,"!2(`T^/B`-96YD;V)J#3$W,2`P(&]B:@T\/"`-+U1Y<&4@+U!A9V5S
M(`TO2VED<R!;(#$W,"`P(%(@,3<R(#`@4B`Q-S,@,"!2(#$W-"`P(%(@,3<U
M(#`@4B`Q-S8@,"!2(%T@#2]#;W5N="`U,2`-/CX@#65N9&]B:@TQ-S(@,"!O
M8FH-/#P@#2]4>7!E("]086=E<R`-+TMI9',@6R`R."`P(%(@,S$@,"!2(#,T
M(#`@4B`S-R`P(%(@-#`@,"!2(#0S(#`@4B`T-B`P(%(@-#D@,"!2(#4R(#`@
M4B`U-2`P(%(@#5T@#2]#;W5N="`Q,"`-+U!A<F5N="`Q-S$@,"!2(`T^/B`-
M96YD;V)J#3$W,R`P(&]B:@T\/"`-+U1Y<&4@+U!A9V5S(`TO2VED<R!;(#4X
M(#`@4B`V,2`P(%(@-C0@,"!2(#8W(#`@4B`W,"`P(%(@-S,@,"!2(#<V(#`@
M4B`W.2`P(%(@.#(@,"!2(#@U(#`@4B`-72`-+T-O=6YT(#$P(`TO4&%R96YT
M(#$W,2`P(%(@#3X^(`UE;F1O8FH-,3<T(#`@;V)J#3P\(`TO5'EP92`O4&%G
M97,@#2]+:61S(%L@.#@@,"!2(#DQ(#`@4B`Y-"`P(%(@.3<@,"!2(#$P,"`P
M(%(@,3`S(#`@4B`Q,#8@,"!2(#$P.2`P(%(@,3$R(#`@4B`-,3$U(#`@4B!=
M(`TO0V]U;G0@,3`@#2]087)E;G0@,3<Q(#`@4B`-/CX@#65N9&]B:@TQ-S4@
M,"!O8FH-/#P@#2]4>7!E("]086=E<R`-+TMI9',@6R`Q,3@@,"!2(#$R,2`P
M(%(@,3(T(#`@4B`Q,C<@,"!2(#$S,"`P(%(@,3,S(#`@4B`Q,S8@,"!2(#$S
M.2`P(%(@,30R(#`@4B`-,30U(#`@4B!=(`TO0V]U;G0@,3`@#2]087)E;G0@
M,3<Q(#`@4B`-/CX@#65N9&]B:@TQ-S8@,"!O8FH-/#P@#2]4>7!E("]086=E
M<R`-+TMI9',@6R`Q-#@@,"!2(%T@#2]#;W5N="`Q(`TO4&%R96YT(#$W,2`P
M(%(@#3X^(`UE;F1O8FH-,3<W(#`@;V)J#3P\(`TO0W)E871I;VY$871E("A$
M.C(P,3`P-#(W,#@Q.3`Q+3`U)S`P)RD-+TUO9$1A=&4@*$0Z,C`Q,#`T,C<P
M.#$Y,#$M,#4G,#`G*0TO4')O9'5C97(@*$%C<F]B870@1&ES=&EL;&5R(#4N
M,"XU(%PH5VEN9&]W<UPI*0TO075T:&]R("AU<S`S.3@Q,"D-+T-R96%T;W(@
M*%!38W)I<'0U+F1L;"!697)S:6]N(#4N,BD-+U1I=&QE("A-:6-R;W-O9G0@
M5V]R9"`M(&%C;#9K<3$R,#$P<F5S=6QT<RYD;V,I#3X^(`UE;F1O8FH-,3<X
M(#`@;V)J#3P\("]4>7!E("]-971A9&%T82`O4W5B='EP92`O6$U,("],96YG
M=&@@,3$P-B`^/B`-<W1R96%M#0H\/WAP86-K970@8F5G:6X])R<@:60])U<U
M33!-<$-E:&E(>G)E4WI.5&-Z:V,Y9"<@8GET97,])S$Q,#4G/SX\<F1F.E)$
M1B!X;6QN<SIR9&8])VAT='`Z+R]W=W<N=S,N;W)G+S$Y.3DO,#(O,C(M<F1F
M+7-Y;G1A>"UN<R,G('AM;&YS.FE8/2=H='1P.B\O;G,N861O8F4N8V]M+VE8
M+S$N,"\G/CQR9&8Z1&5S8W)I<'1I;VX@86)O=70])R<@>&UL;G,])VAT='`Z
M+R]N<RYA9&]B92YC;VTO<&1F+S$N,R\G('AM;&YS.G!D9CTG:'1T<#HO+VYS
M+F%D;V)E+F-O;2]P9&8O,2XS+R<@<&1F.D-R96%T:6]N1&%T93TG,C`Q,"TP
M-"TR-U0Q,SHQ.3HP,5HG('!D9CI-;V1$871E/2<R,#$P+3`T+3(W5#$S.C$Y
M.C`Q6B<@<&1F.E!R;V1U8V5R/2=!8W)O8F%T($1I<W1I;&QE<B`U+C`N-2`H
M5VEN9&]W<RDG('!D9CI!=71H;W(])W5S,#,Y.#$P)R!P9&8Z0W)E871O<CTG
M4%-C<FEP=#4N9&QL(%9E<G-I;VX@-2XR)R!P9&8Z5&ET;&4])TUI8W)O<V]F
M="!7;W)D("T@86-L-FMQ,3(P,3!R97-U;'1S+F1O8R<O/@H\<F1F.D1E<V-R
M:7!T:6]N(&%B;W5T/2<G('AM;&YS/2=H='1P.B\O;G,N861O8F4N8V]M+WAA
M<"\Q+C`O)R!X;6QN<SIX87`])VAT='`Z+R]N<RYA9&]B92YC;VTO>&%P+S$N
M,"\G('AA<#I#<F5A=&5$871E/2<R,#$P+3`T+3(W5#$S.C$Y.C`Q6B<@>&%P
M.DUO9&EF>41A=&4])S(P,3`M,#0M,C=4,3,Z,3DZ,#%:)R!X87`Z075T:&]R
M/2=U<S`S.3@Q,"<@>&%P.DUE=&%D871A1&%T93TG,C`Q,"TP-"TR-U0Q,SHQ
M.3HP,5HG/CQX87`Z5&ET;&4^/')D9CI!;'0^/')D9CIL:2!X;6PZ;&%N9STG
M>"UD969A=6QT)SY-:6-R;W-O9G0@5V]R9"`M(&%C;#9K<3$R,#$P<F5S=6QT
M<RYD;V,\+W)D9CIL:3X\+W)D9CI!;'0^/"]X87`Z5&ET;&4^/"]R9&8Z1&5S
M8W)I<'1I;VX^"CQR9&8Z1&5S8W)I<'1I;VX@86)O=70])R<@>&UL;G,])VAT
M='`Z+R]P=7)L+F]R9R]D8R]E;&5M96YT<R\Q+C$O)R!X;6QN<SID8STG:'1T
M<#HO+W!U<FPN;W)G+V1C+V5L96UE;G1S+S$N,2\G(&1C.F-R96%T;W(])W5S
M,#,Y.#$P)R!D8SIT:71L93TG36EC<F]S;V9T(%=O<F0@+2!A8VPV:W$Q,C`Q
M,')E<W5L=',N9&]C)R\^"CPO<F1F.E)$1CX\/WAP86-K970@96YD/2=R)S\^
M"F5N9'-T<F5A;0UE;F1O8FH->')E9@TP(#$W.2`-,#`P,#`P,#`P,"`V-34S
M-2!F#0HP,#`P,#DP,#<P(#`P,#`P(&X-"C`P,#`P.3`R,C(@,#`P,#`@;@T*
M,#`P,#`Y,#,W,B`P,#`P,"!N#0HP,#`P,#DQ,3(W(#`P,#`P(&X-"C`P,#`P
M.3$R-SD@,#`P,#`@;@T*,#`P,#`Y,30R.2`P,#`P,"!N#0HP,#`P,#DU,#`W
M(#`P,#`P(&X-"C`P,#`P.34Q-3D@,#`P,#`@;@T*,#`P,#`Y-3,P.2`P,#`P
M,"!N#0HP,#`P,#DW,S,P(#`P,#`P(&X-"C`P,#`P.3<T.#4@,#`P,#`@;@T*
M,#`P,#`Y-S8S-B`P,#`P,"!N#0HP,#`P,3`P-3DQ(#`P,#`P(&X-"C`P,#`Q
M,#`W-#8@,#`P,#`@;@T*,#`P,#$P,#DQ,"`P,#`P,"!N#0HP,#`P,3`U,C8Q
M(#`P,#`P(&X-"C`P,#`Q,#4T,38@,#`P,#`@;@T*,#`P,#$P-34X,"`P,#`P
M,"!N#0HP,#`P,3`W.3,U(#`P,#`P(&X-"C`P,#`Q,#@P.3`@,#`P,#`@;@T*
M,#`P,#$P.#(T,2`P,#`P,"!N#0HP,#`P,3$Q-3(U(#`P,#`P(&X-"C`P,#`Q
M,3$V.#`@,#`P,#`@;@T*,#`P,#$Q,3@S,2`P,#`P,"!N#0HP,#`P,3$S.3DT
M(#`P,#`P(&X-"C`P,#`Q,30Q-#D@,#`P,#`@;@T*,#`P,#$Q-#,P,"`P,#`P
M,"!N#0HP,#`P,3$W-C,X(#`P,#`P(&X-"C`P,#`Q,3<W.3,@,#`P,#`@;@T*
M,#`P,#$Q-SDT-"`P,#`P,"!N#0HP,#`P,3(P.#DV(#`P,#`P(&X-"C`P,#`Q
M,C$P-3$@,#`P,#`@;@T*,#`P,#$R,3(R.2`P,#`P,"!N#0HP,#`P,3(T-C<W
M(#`P,#`P(&X-"C`P,#`Q,C0X,S(@,#`P,#`@;@T*,#`P,#$R-#DY-R`P,#`P
M,"!N#0HP,#`P,3(Y,C`T(#`P,#`P(&X-"C`P,#`Q,CDS-3D@,#`P,#`@;@T*
M,#`P,#$R.34Q,"`P,#`P,"!N#0HP,#`P,3,S.#<S(#`P,#`P(&X-"C`P,#`Q
M,S0P,C@@,#`P,#`@;@T*,#`P,#$S-#$Y,R`P,#`P,"!N#0HP,#`P,3,X,C,Y
M(#`P,#`P(&X-"C`P,#`Q,S@S.30@,#`P,#`@;@T*,#`P,#$S.#4U.2`P,#`P
M,"!N#0HP,#`P,30R-3@Q(#`P,#`P(&X-"C`P,#`Q-#(W,S8@,#`P,#`@;@T*
M,#`P,#$T,C@X-R`P,#`P,"!N#0HP,#`P,30U.34W(#`P,#`P(&X-"C`P,#`Q
M-#8Q,3(@,#`P,#`@;@T*,#`P,#$T-C(W-R`P,#`P,"!N#0HP,#`P,34P,C,Q
M(#`P,#`P(&X-"C`P,#`Q-3`S.#8@,#`P,#`@;@T*,#`P,#$U,#4U,"`P,#`P
M,"!N#0HP,#`P,34T,3(U(#`P,#`P(&X-"C`P,#`Q-30R.#`@,#`P,#`@;@T*
M,#`P,#$U-#0U-R`P,#`P,"!N#0HP,#`P,34Y,#0P(#`P,#`P(&X-"C`P,#`Q
M-3DQ.34@,#`P,#`@;@T*,#`P,#$U.3,U.2`P,#`P,"!N#0HP,#`P,38T,#$P
M(#`P,#`P(&X-"C`P,#`Q-C0Q-C4@,#`P,#`@;@T*,#`P,#$V-#,R.2`P,#`P
M,"!N#0HP,#`P,38W.#4R(#`P,#`P(&X-"C`P,#`Q-C@P,#<@,#`P,#`@;@T*
M,#`P,#$V.#$W,2`P,#`P,"!N#0HP,#`P,3<R-S(Q(#`P,#`P(&X-"C`P,#`Q
M-S(X-S8@,#`P,#`@;@T*,#`P,#$W,S`T,"`P,#`P,"!N#0HP,#`P,3<W-#<T
M(#`P,#`P(&X-"C`P,#`Q-S<V,CD@,#`P,#`@;@T*,#`P,#$W-S@P-R`P,#`P
M,"!N#0HP,#`P,3@Q-S0U(#`P,#`P(&X-"C`P,#`Q.#$Y,#`@,#`P,#`@;@T*
M,#`P,#$X,C`W.2`P,#`P,"!N#0HP,#`P,3@W-CDV(#`P,#`P(&X-"C`P,#`Q
M.#<X-3$@,#`P,#`@;@T*,#`P,#$X.#`Q-B`P,#`P,"!N#0HP,#`P,3DS-#$R
M(#`P,#`P(&X-"C`P,#`Q.3,U-C<@,#`P,#`@;@T*,#`P,#$Y,S<S,B`P,#`P
M,"!N#0HP,#`P,3DY-3DP(#`P,#`P(&X-"C`P,#`Q.3DW-#4@,#`P,#`@;@T*
M,#`P,#$Y.3DQ,"`P,#`P,"!N#0HP,#`P,C`U.#$Q(#`P,#`P(&X-"C`P,#`R
M,#4Y-C8@,#`P,#`@;@T*,#`P,#(P-C$S,2`P,#`P,"!N#0HP,#`P,C$Q.#0S
M(#`P,#`P(&X-"C`P,#`R,3$Y.3@@,#`P,#`@;@T*,#`P,#(Q,C$V,R`P,#`P
M,"!N#0HP,#`P,C$W-3,P(#`P,#`P(&X-"C`P,#`R,3<V.#4@,#`P,#`@;@T*
M,#`P,#(Q-S@S-B`P,#`P,"!N#0HP,#`P,C$X-SDR(#`P,#`P(&X-"C`P,#`R
M,3@Y-#<@,#`P,#`@;@T*,#`P,#(Q.3$S.2`P,#`P,"!N#0HP,#`P,C(S,C0U
M(#`P,#`P(&X-"C`P,#`R,C,T,#`@,#`P,#`@;@T*,#`P,#(R,S4Y,B`P,#`P
M,"!N#0HP,#`P,C(W.#,X(#`P,#`P(&X-"C`P,#`R,C<Y.38@,#`P,#`@;@T*
M,#`P,#(R.#$T.2`P,#`P,"!N#0HP,#`P,C,S-S@P(#`P,#`P(&X-"C`P,#`R
M,S,Y,S@@,#`P,#`@;@T*,#`P,#(S-#$P-2`P,#`P,"!N#0HP,#`P,C,W-SDU
M(#`P,#`P(&X-"C`P,#`R,S<Y-3,@,#`P,#`@;@T*,#`P,#(S.#$P-B`P,#`P
M,"!N#0HP,#`P,C0Q-S(X(#`P,#`P(&X-"C`P,#`R-#$X.#8@,#`P,#`@;@T*
M,#`P,#(T,C`U,B`P,#`P,"!N#0HP,#`P,C0U.#<Y(#`P,#`P(&X-"C`P,#`R
M-#8P,S<@,#`P,#`@;@T*,#`P,#(T-C(R."`P,#`P,"!N#0HP,#`P,C4P-3<Q
M(#`P,#`P(&X-"C`P,#`R-3`W,CD@,#`P,#`@;@T*,#`P,#(U,#DR,"`P,#`P
M,"!N#0HP,#`P,C4U,S@S(#`P,#`P(&X-"C`P,#`R-34U-#$@,#`P,#`@;@T*
M,#`P,#(U-3<P."`P,#`P,"!N#0HP,#`P,C4Y.#(W(#`P,#`P(&X-"C`P,#`R
M-3DY.#4@,#`P,#`@;@T*,#`P,#(V,#$U,B`P,#`P,"!N#0HP,#`P,C8T-#`U
M(#`P,#`P(&X-"C`P,#`R-C0U-C,@,#`P,#`@;@T*,#`P,#(V-#<Q-B`P,#`P
M,"!N#0HP,#`P,C8Y,#@V(#`P,#`P(&X-"C`P,#`R-CDR-#0@,#`P,#`@;@T*
M,#`P,#(V.30Q,"`P,#`P,"!N#0HP,#`P,C<S,#@Q(#`P,#`P(&X-"C`P,#`R
M-S,R,SD@,#`P,#`@;@T*,#`P,#(W,S,Y,2`P,#`P,"!N#0HP,#`P,C<V-#(X
M(#`P,#`P(&X-"C`P,#`R-S8U.#8@,#`P,#`@;@T*,#`P,#(W-C<S."`P,#`P
M,"!N#0HP,#`P,C@P,S8V(#`P,#`P(&X-"C`P,#`R.#`U,C0@,#`P,#`@;@T*
M,#`P,#(X,#8Y,"`P,#`P,"!N#0HP,#`P,C@T-#(R(#`P,#`P(&X-"C`P,#`R
M.#0U.#`@,#`P,#`@;@T*,#`P,#(X-#<S,B`P,#`P,"!N#0HP,#`P,C@V,C(V
M(#`P,#`P(&X-"C`P,#`R.#8S.#0@,#`P,#`@;@T*,#`P,#(X-C4T.2`P,#`P
M,"!N#0HP,#`P,C@Y.#,Q(#`P,#`P(&X-"C`P,#`R.#DY.#D@,#`P,#`@;@T*
M,#`P,#(Y,#$U-2`P,#`P,"!N#0HP,#`P,CDT.3(R(#`P,#`P(&X-"C`P,#`R
M.34P.#`@,#`P,#`@;@T*,#`P,#(Y-3(S,B`P,#`P,"!N#0HP,#`P,CDV,3,Q
M(#`P,#`P(&X-"C`P,#`R.38S,3@@,#`P,#`@;@T*,#`P,#(Y-C@Y.2`P,#`P
M,"!N#0HP,#`P,CDW,S<U(#`P,#`P(&X-"C`P,#`R.3<U,S8@,#`P,#`@;@T*
M,#`P,#(Y-S8T.2`P,#`P,"!N#0HP,#`P,CDW.#<X(#`P,#`P(&X-"C`P,#`S
M,#4Y.3@@,#`P,#`@;@T*,#`P,#,P-C(Q,B`P,#`P,"!N#0HP,#`P,S$T,S8V
M(#`P,#`P(&X-"C`P,#`S,30V,3$@,#`P,#`@;@T*,#`P,#,S-SDR,2`P,#`P
M,"!N#0HP,#`P,S,X,3<Q(#`P,#`P(&X-"C`P,#`S-3DX.38@,#`P,#`@;@T*
M,#`P,#,U.3DV."`P,#`P,"!N#0HP,#`P,S8P,C4X(#`P,#`P(&X-"C`P,#`S
M-C`T.#$@,#`P,#`@;@T*,#`P,#,V,#<X-"`P,#`P,"!N#0HP,#`P,S8P.#$V
M(#`P,#`P(&X-"C`P,#`S-C`X-C(@,#`P,#`@;@T*,#`P,#,V,3`P.2`P,#`P
M,"!N#0HP,#`P,S8Q,3$X(#`P,#`P(&X-"C`P,#`S-C$R-C<@,#`P,#`@;@T*
M,#`P,#,V,30Q-B`P,#`P,"!N#0HP,#`P,S8Q-3<Q(#`P,#`P(&X-"C`P,#`S
M-C$W,S`@,#`P,#`@;@T*,#`P,#,V,3@Q-2`P,#`P,"!N#0HP,#`P,S8R,#8W
M(#`P,#`P(&X-"G1R86EL97(-/#P-+U-I>F4@,3<Y#2])1%L\,&%A83%C.3-F
M.65D93AA-#@W,#@W8S(S9F,R-3(Y,S0^/&(Q9&$S-F$Y,#=E-68U-&$T.#0X
F-3<U,61B9F,T,3<W/ET-/CX-<W1A<G1X<F5F#3$W,PTE)45/1@T_
`
end
</PDF>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.INS
<SEQUENCE>3
<FILENAME>acl-20100331.xml
<DESCRIPTION>XBRL INSTANCE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?><!--EDGARizerX:  Instance document generated by EDGARizerX, version 3.5.0.0--><xbrl xmlns="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:asi="http://alcon.com/20100427" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-gaap="http://xbrl.us/us-gaap/2009-01-31" xmlns:acl="http://alcon.com/20100331" xmlns:dei="http://xbrl.us/dei/2009-01-31">
  <link:schemaRef xlink:type="simple" xlink:href="acl-20100331.xsd"/>
  <context id="c00000">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001167379</identifier>
    </entity>
    <period>
      <instant>2008-12-31</instant>
    </period>
  </context>
  <context id="c00001">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001167379</identifier>
    </entity>
    <period>
      <instant>2009-12-31</instant>
    </period>
  </context>
  <context id="c00002">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001167379</identifier>
    </entity>
    <period>
      <instant>2010-03-31</instant>
    </period>
  </context>
  <context id="c00003">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001167379</identifier>
    </entity>
    <period>
      <startDate>2010-01-01</startDate>
      <endDate>2010-03-31</endDate>
    </period>
  </context>
  <context id="c00004">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001167379</identifier>
    </entity>
    <period>
      <startDate>2009-01-01</startDate>
      <endDate>2009-03-31</endDate>
    </period>
  </context>
  <context id="c00005">
    <entity>
      <identifier scheme="http://www.sec.gov/CIK">0001167379</identifier>
    </entity>
    <period>
      <instant>2009-03-31</instant>
    </period>
  </context>
  <unit id="u000">
    <measure>iso4217:USD</measure>
  </unit>
  <unit id="u001">
    <measure>xbrli:shares</measure>
  </unit>
  <unit id="u002">
    <divide>
      <unitNumerator>
        <measure>iso4217:USD</measure>
      </unitNumerator>
      <unitDenominator>
        <measure>xbrli:shares</measure>
      </unitDenominator>
    </divide>
  </unit>
  <!--Document fiscal period focus-->
  <dei:DocumentFiscalPeriodFocus contextRef="c00003">Q1</dei:DocumentFiscalPeriodFocus>
  <!--Entity Voluntary Filers-->
  <dei:EntityVoluntaryFilers contextRef="c00003">No</dei:EntityVoluntaryFilers>
  <!--Net increase in cash and cash equivalents-->
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease unitRef="u000" decimals="-6" contextRef="c00003">122000000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <!--Net increase in cash and cash equivalents-->
  <us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease unitRef="u000" decimals="-6" contextRef="c00004">641000000</us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease>
  <!--Proceeds from exercise of stock options-->
  <us-gaap:ProceedsFromStockOptionsExercised unitRef="u000" decimals="-6" contextRef="c00003">45000000</us-gaap:ProceedsFromStockOptionsExercised>
  <!--Proceeds from exercise of stock options-->
  <us-gaap:ProceedsFromStockOptionsExercised unitRef="u000" decimals="-6" contextRef="c00004">5000000</us-gaap:ProceedsFromStockOptionsExercised>
  <!--Net proceeds from short term debt-->
  <us-gaap:ProceedsFromRepaymentsOfShortTermDebt unitRef="u000" decimals="-6" contextRef="c00003">78000000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
  <!--Net proceeds from short term debt-->
  <us-gaap:ProceedsFromRepaymentsOfShortTermDebt unitRef="u000" decimals="-6" contextRef="c00004">113000000</us-gaap:ProceedsFromRepaymentsOfShortTermDebt>
  <!--Share-based payments-->
  <us-gaap:ShareBasedCompensation unitRef="u000" decimals="-6" contextRef="c00003">18000000</us-gaap:ShareBasedCompensation>
  <!--Share-based payments-->
  <us-gaap:ShareBasedCompensation unitRef="u000" decimals="-6" contextRef="c00004">23000000</us-gaap:ShareBasedCompensation>
  <!--Diluted weighted average common shares-->
  <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding unitRef="u001" decimals="0" contextRef="c00003">303569998</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
  <!--Diluted weighted average common shares-->
  <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding unitRef="u001" decimals="0" contextRef="c00004">300015135</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
  <!--Condensed Consolidated Financial Statements-->
  <us-gaap:QuarterlyFinancialInformationTextBlock contextRef="c00003">&lt;div&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr valign="top"&gt;&lt;td style="WIDTH: 18pt" align="right"&gt;&lt;div&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;(1)&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;Condensed Consolidated Financial Statemen&lt;/font&gt;t&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;s&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;font style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;(in millions, except
 per share data)&lt;/font&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;/font&gt;&amp;#160;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Alcon, Inc. ("Alcon"), a Swiss corporation, is a majority owned subsidiary of Nestl&amp;#233; S.A.&amp;#160;&amp;#160;During July 2008, Nestl&amp;#233; sold approximately 74 million of its Alcon common shares to Novartis AG.&amp;#160;&amp;#160;At December 31, 2009, Nestl&amp;#233; owned 156,076,263 common shares of Alcon.&amp;#160;&amp;#160;In January 2010, Novartis exercised its call option for Nestl&amp;#233;'s remaining Alcon common shares and proposed a merger of Alcon with and into Novartis, as discussed in note 13.&lt;/font&gt;&lt;/div&gt;&lt;div styl
e="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The interim condensed consolidated financial statements of Alcon and its subsidiaries (collectively, the "Company") are unaudited.&amp;#160;&amp;#160;Amounts presented at December 31, 2009 are based on the audited consolidated financial statements appearing in Alcon's annual report on Form 20-F filed with the U.S. Securities and Exchange Commission.&amp;#160;&amp;#160;The interim condensed consolidated financial statements and notes thereto do not include all disclosures required by accounting principles generally accepted in the United States of America ("U.S. GAAP") and should be read in conjunction with the audited consolidated financial statements and the notes thereto included in Alcon's annual report on Form 20-F.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISP
LAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Management of the Company has made a number of estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities to prepare these financial statements in conformity with U.S. GAAP.&amp;#160;&amp;#160;Actual results could differ from those estimates.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;In management's opinion, the interim condensed consolidated financial statements reflect all adjustments (consisting only of normal recurring accruals) necessary to present fai
rly the results for the interim periods presented.&amp;#160;&amp;#160;Results for interim periods are not necessarily indicative of results that ultimately will be achieved for a full year.&lt;/font&gt;&lt;/div&gt;</us-gaap:QuarterlyFinancialInformationTextBlock>
  <!--Amendment Flag-->
  <dei:AmendmentFlag contextRef="c00003">false</dei:AmendmentFlag>
  <!--Diluted earnings per common share-->
  <us-gaap:EarningsPerShareDiluted unitRef="u002" decimals="0" contextRef="c00003">1.89</us-gaap:EarningsPerShareDiluted>
  <!--Diluted earnings per common share-->
  <us-gaap:EarningsPerShareDiluted unitRef="u002" decimals="0" contextRef="c00004">1.51</us-gaap:EarningsPerShareDiluted>
  <!--Cost of goods sold-->
  <us-gaap:CostOfGoodsSold unitRef="u000" decimals="-6" contextRef="c00003">392000000</us-gaap:CostOfGoodsSold>
  <!--Cost of goods sold-->
  <us-gaap:CostOfGoodsSold unitRef="u000" decimals="-6" contextRef="c00004">354000000</us-gaap:CostOfGoodsSold>
  <!--Sales-->
  <us-gaap:SalesRevenueNet unitRef="u000" decimals="-6" contextRef="c00003">1721000000</us-gaap:SalesRevenueNet>
  <!--Sales-->
  <us-gaap:SalesRevenueNet unitRef="u000" decimals="-6" contextRef="c00004">1493000000</us-gaap:SalesRevenueNet>
  <!--Property, plant and equipment, net-->
  <us-gaap:PropertyPlantAndEquipmentNet unitRef="u000" decimals="-6" contextRef="c00002">1291000000</us-gaap:PropertyPlantAndEquipmentNet>
  <!--Property, plant and equipment, net-->
  <us-gaap:PropertyPlantAndEquipmentNet unitRef="u000" decimals="-6" contextRef="c00001">1304000000</us-gaap:PropertyPlantAndEquipmentNet>
  <!--Entity Well Known Seasoned Issuer-->
  <dei:EntityWellKnownSeasonedIssuer contextRef="c00003">Yes</dei:EntityWellKnownSeasonedIssuer>
  <!--Acquisition of treasury shares-->
  <us-gaap:PaymentsForRepurchaseOfCommonStock unitRef="u000" decimals="-6" contextRef="c00003">-9000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
  <!--Acquisition of treasury shares-->
  <us-gaap:PaymentsForRepurchaseOfCommonStock unitRef="u000" decimals="-6" contextRef="c00004">-4000000</us-gaap:PaymentsForRepurchaseOfCommonStock>
  <!--Purchases of property, plant and equipment-->
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment unitRef="u000" decimals="-6" contextRef="c00003">-69000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <!--Purchases of property, plant and equipment-->
  <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment unitRef="u000" decimals="-6" contextRef="c00004">-52000000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
  <!--Other assets-->
  <us-gaap:IncreaseDecreaseInOtherOperatingAssets unitRef="u000" decimals="-6" contextRef="c00003">-15000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
  <!--Other assets-->
  <us-gaap:IncreaseDecreaseInOtherOperatingAssets unitRef="u000" decimals="-6" contextRef="c00004">-36000000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
  <!--Inventories-->
  <us-gaap:IncreaseDecreaseInInventories unitRef="u000" decimals="-6" contextRef="c00003">-9000000</us-gaap:IncreaseDecreaseInInventories>
  <!--Inventories-->
  <us-gaap:IncreaseDecreaseInInventories unitRef="u000" decimals="-6" contextRef="c00004">-43000000</us-gaap:IncreaseDecreaseInInventories>
  <!--Amortization of intangibles-->
  <us-gaap:AmortizationOfIntangibleAssets unitRef="u000" decimals="-6" contextRef="c00003">11000000</us-gaap:AmortizationOfIntangibleAssets>
  <!--Amortization of intangibles-->
  <us-gaap:AmortizationOfIntangibleAssets unitRef="u000" decimals="-6" contextRef="c00004">7000000</us-gaap:AmortizationOfIntangibleAssets>
  <!--Proposed change of control-->
  <acl:ProposedChangeOfControl contextRef="c00003">&lt;div&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr valign="top"&gt;&lt;td style="WIDTH: 18pt" align="right"&gt;&lt;div&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;(13)&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Proposed Change of Control&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;(in millions, except per share data)&lt;/font&gt;&lt;/font&gt;&lt;br /&gt;&amp;#160;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LE
FT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;On April 6, 2008, Nestl&amp;#233; and Novartis executed the Purchase and Option Agreement pursuant to which Nestl&amp;#233; agreed to sell approximately 74 million of its shares of Alcon common stock to Novartis in a cash transaction at a price of $143.18 per share.&amp;#160;&amp;#160;This sale was consummated on July 7, 2008, and Novartis now owns a minority stake in Alcon of slightly less than 25% of Alcon's outstanding shares, while Nestl&amp;#233; remains Alcon's majority shareholder with approximately 156 million Alcon shares comprising approximately 52% of the Company's outstanding shares.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New
 Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font&gt;The Purchase and Option Agreement between Nestl&amp;#233; and Novartis also contains put and call option rights on the balance of approximately 156 million Alcon shares owned by Nestl&amp;#233;.&amp;#160;&amp;#160;The option rights commenced on January 1, 2010 and expire on July 31, 2011.&amp;#160;&amp;#160;As outlined by the two parties, these rights grant (i) Novartis a call option to buy all but 4.1 million (or 2.5%) of Nestl&amp;#233;'s remaining Alcon shares at a fixed price of $181 per share and the 4.1 million shares at the first stage price of $143.18 per share, and (ii) Nestl&amp;#233; a put option to sell to Novartis all but 4.1 million of its remaining Alcon shares to Novartis at the lower of Novartis's call price of $181 per share or a premium of approximately 20.5% above the then-market price of Alcon shares, which will be calculated as the average market price of Alcon shares during the five trading days immediately preceding the exe
rcise date of the put option, with the 4.1 million share balance to be sold at the first stage closing price of $143.18 per share.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;On January 4, 2010, Novartis announced that it had exercised its option to purchase the remaining approximately 156 million Alcon shares owned by Nestl&amp;#233; at a weighted average price of $180 per share in cash, pursuant to the Purchase and Option Agreement.&amp;#160;&amp;#160;Upon consummation of the purchase, Novartis would own an approximate 77% interest in Alcon.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inl
ine; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The consummation of a purchase and sale transaction under the option right is subject to regulatory approvals.&amp;#160;&amp;#160;The consummation would trigger certain change of control provisions in the Company's share-based awards plan (including the vesting of certain outstanding share-based awards), certain retirement plans for Company employees and other agreements.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Upon consummation, the Company will no longer benefit from certain synergies as a result of Nestl&amp;#233;'s ownership.&amp;#160;&amp;#160;Alcon has taken advantage of the synergies in several functional areas.&amp;#160;&amp;#160;Management does not anticipate a significant financial impact to Alcon due t
o the loss of these synergies because the Company is currently negotiating with certain vendors/suppliers and financial services providers to mitigate any potential impact from a change of control.&amp;#160;&amp;#160;However, no assurances can be made at this time.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;As a result of Novartis's planned acquisition of Nestl&amp;#233;'s remaining Alcon shares, Alcon's relationships with third parties in the pharmaceutical and other industries may be impacted, which in some cases may affect Alcon's business development and licensing opportunities.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" ali
gn="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Novartis also announced that it submitted to the Alcon board of directors a proposal for a merger of Alcon with and into Novartis to be effected under Swiss merger law.&amp;#160;&amp;#160;Under the terms of the merger proposal, holders of the approximate 23% of Alcon shares that are publicly traded would receive 2.8 Novartis shares for each Alcon share.&amp;#160;&amp;#160;The proposed merger would be contingent upon, among other things, approval by the Alcon board of directors, the &lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;closing of the purchase and sale transaction related to the Novartis option exercise as well as receipt of required regulatory approvals.&amp;#160;&amp;#160;Upon Novartis becoming a majority shareholder of Alcon, management believes that the Organizational Regulations provide that the Alcon board of directors may only approve the proposed mer
ger if a majority of the Independent Director Committee so recommends; however, management cannot predict the outcome of any judicial proceeding that might be initiated to interpret or challenge this position.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font&gt;The Independent Director Committee was formed in 2008 in connection with Novartis's initial purchase of slightly less than 25% of the Alcon shares from Nestl&amp;#233; to evaluate transactions such as the merger proposed by Novartis.&amp;#160;&amp;#160;The Independent Director Committee engaged independent financial and legal advisors in connection with its evaluation of the proposed merger.&amp;#160;&amp;#160;On January 20, 2010, the Independent Director Committee issued 
its formal response rejecting the Novartis merger proposal.&amp;#160;&amp;#160;The committee rejected the merger proposal based on its assessment that the price offered and other terms were not acceptable and that Novartis's merger proposal was not in the best interests of Alcon and its minority shareholders.&lt;/font&gt;&lt;/div&gt;</acl:ProposedChangeOfControl>
  <!--Short Term Borrowings and Long Term Debt-->
  <acl:ShortTermBorrowingsAndLongTermDebt contextRef="c00003">&lt;div&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr valign="top"&gt;&lt;td style="WIDTH: 18pt" align="right"&gt;&lt;div&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;(8)&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Short Term Borrowings and Long Term Debt&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;(in millions, except per share data)&lt;/font&gt;&lt;/font&gt;&lt;br /&gt;&amp;#160;&lt;/div&gt;&lt;div align="l
eft"&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;March 31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; 
FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;December 31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2
"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2010&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2009&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM:
 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&g
t;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Short Term Borrowings&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; F
ONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Lines of credit&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/f
ont&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;263&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: tim
es new roman"&gt;273&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Commercial paper&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ti
mes new roman"&gt;361&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;286&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"
&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;From affiliates&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;6&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DIS
PLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;7&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Bank overdrafts&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valig
n="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;37&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: bla
ck 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;41&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: 
inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bot
tom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Total short term borrowings&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: in
line; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;667&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;607&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISP
LAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&amp;#160;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;At March 31, 2010, the Company had unsecured credit and commercial paper facilities totaling $2,748, including bank overdraft agreements, with third parties that were denominated in various currencies.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;As of March 31, 2010, total borrowings from Nestl&amp;#233; and its subsidiaries were $6 under unsecured revolving credit facilities of $75.&amp;#160;&amp;#160;In the event of a chan
ge of control, these agreements would no longer be available for additional borrowings, and any outstanding balances would become payable in accordance with the related terms.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAM
ILY: times new roman"&gt;March 31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="left" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;December 31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bot
tom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2010&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"
&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2009&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;
#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Long Term Debt&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign
="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;
&lt;div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Bank loan&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;54&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FON
T-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;56&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font sty
le="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left
" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Less current maturities of long term debt&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" 
width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;54&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bo
ttom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font
&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Long term debt
, net of current maturities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY
: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;56&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style
="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&a
mp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font&gt;The bank loan, guaranteed by Nestl&amp;#233;, contains provisions that may accelerate the obligation in the event that Nestl&amp;#233;'s ownership of Alcon falls below 51%.&lt;/font&gt;&lt;/div&gt;</acl:ShortTermBorrowingsAndLongTermDebt>
  <!--Document Type-->
  <dei:DocumentType contextRef="c00003">6-K</dei:DocumentType>
  <!--Entity Public Float-->
  <dei:EntityPublicFloat unitRef="u000" decimals="0" contextRef="c00002">11324474690</dei:EntityPublicFloat>
  <!--Cash and cash equivalents, beginning of period + Cash and cash equivalents, end of period-->
  <us-gaap:CashAndCashEquivalentsAtCarryingValue unitRef="u000" decimals="-6" contextRef="c00001">3007000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <!--Cash and cash equivalents, beginning of period + Cash and cash equivalents, end of period-->
  <us-gaap:CashAndCashEquivalentsAtCarryingValue unitRef="u000" decimals="-6" contextRef="c00000">2449000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <!--Cash and cash equivalents, beginning of period + Cash and cash equivalents, end of period-->
  <us-gaap:CashAndCashEquivalentsAtCarryingValue unitRef="u000" decimals="-6" contextRef="c00002">3129000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <!--Cash and cash equivalents, beginning of period + Cash and cash equivalents, end of period-->
  <us-gaap:CashAndCashEquivalentsAtCarryingValue unitRef="u000" decimals="-6" contextRef="c00005">3090000000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
  <!--Other operating expenses-->
  <acl:OtherOperatingExpenses unitRef="u000" decimals="-6" contextRef="c00003">4000000</acl:OtherOperatingExpenses>
  <!--Other operating expenses-->
  <acl:OtherOperatingExpenses unitRef="u000" decimals="-6" contextRef="c00004">0</acl:OtherOperatingExpenses>
  <!--Common shares, shares issued-->
  <us-gaap:CommonStockSharesIssued unitRef="u001" decimals="0" contextRef="c00002">304184709</us-gaap:CommonStockSharesIssued>
  <!--Common shares, shares issued-->
  <us-gaap:CommonStockSharesIssued unitRef="u001" decimals="0" contextRef="c00001">304016290</us-gaap:CommonStockSharesIssued>
  <!--Short term investments-->
  <us-gaap:ShortTermInvestments unitRef="u000" decimals="-6" contextRef="c00002">542000000</us-gaap:ShortTermInvestments>
  <!--Short term investments-->
  <us-gaap:ShortTermInvestments unitRef="u000" decimals="-6" contextRef="c00001">479000000</us-gaap:ShortTermInvestments>
  <!--Entity Current Reporting Status-->
  <dei:EntityCurrentReportingStatus contextRef="c00003">Yes</dei:EntityCurrentReportingStatus>
  <!--Entity Central Index Key-->
  <dei:EntityCentralIndexKey contextRef="c00003">0001167379</dei:EntityCentralIndexKey>
  <!--Net cash from financing activities-->
  <us-gaap:NetCashProvidedByUsedInFinancingActivities unitRef="u000" decimals="-6" contextRef="c00003">127000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <!--Net cash from financing activities-->
  <us-gaap:NetCashProvidedByUsedInFinancingActivities unitRef="u000" decimals="-6" contextRef="c00004">114000000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
  <!--Tax benefits from share-based payment arrangements-->
  <us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities unitRef="u000" decimals="-6" contextRef="c00003">13000000</us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities>
  <!--Tax benefits from share-based payment arrangements-->
  <us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities unitRef="u000" decimals="-6" contextRef="c00004">1000000</us-gaap:ExcessTaxBenefitFromShareBasedCompensationFinancingActivities>
  <!--Proceeds from sales and maturities of investments-->
  <us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments unitRef="u000" decimals="-6" contextRef="c00003">520000000</us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments>
  <!--Proceeds from sales and maturities of investments-->
  <us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments unitRef="u000" decimals="-6" contextRef="c00004">420000000</us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments>
  <!--Other long term liabilities-->
  <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities unitRef="u000" decimals="-6" contextRef="c00003">15000000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
  <!--Other long term liabilities-->
  <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities unitRef="u000" decimals="-6" contextRef="c00004">9000000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
  <!--Deferred income tax assets-->
  <us-gaap:DeferredTaxAssetsNetCurrent unitRef="u000" decimals="-6" contextRef="c00002">163000000</us-gaap:DeferredTaxAssetsNetCurrent>
  <!--Deferred income tax assets-->
  <us-gaap:DeferredTaxAssetsNetCurrent unitRef="u000" decimals="-6" contextRef="c00001">162000000</us-gaap:DeferredTaxAssetsNetCurrent>
  <!--Financial Instruments-->
  <us-gaap:FairValueDisclosuresTextBlock contextRef="c00003">&lt;div&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr valign="top"&gt;&lt;td style="WIDTH: 18pt" align="right"&gt;&lt;div&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;(6)&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Financial Instruments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;(in millions, except per share data)&lt;/font&gt;&lt;/font&gt;&lt;br /&gt;&amp;#160;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGI
N-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="DISPLAY: inline; TEXT-DECORATION: underline"&gt;Foreign Currency Risk Management&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;A significant portion of the Company's cash flows is denominated in foreign currencies.&amp;#160;&amp;#160;Alcon relies on ongoing cash flows generated from foreign sources to support its long term commitments to U.S. dollar-based research and development.&amp;#160;&amp;#160;To the extent the dollar value of cash flows is diminished as a result of weakening local currencies relative to the dollar, the Company's ability to fund research and other dollar-based strategic init
iatives at a consistent level may be impaired.&amp;#160;&amp;#160;The Company has established a foreign currency risk management program to protect against volatility of non-functional currency monetary assets and liabilities and changes in fair value caused by fluctuations in foreign exchange rates.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The Company primarily utilizes forward exchange contracts in countries where they are available and economically beneficial to offset the impact of fluctuations in foreign exchange rates on monetary assets and their related cash flows.&amp;#160;&amp;#160;All outstanding foreign exchange forward contracts are entered into to protect the value of assets or liabilities denominated in currencies other than the entity's functional curre
ncy.&amp;#160;&amp;#160;To the extent hedged, the changes in fair value of the forward contracts offset the changes in the value of the assets or liabilities.&amp;#160;&amp;#160;The changes in value of the foreign exchange forward contracts and the assets/liabilities that are being protected are recorded in foreign exchange gains and losses within other income (expense).&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The fair values of forward exchange and option contracts are reported in other current assets and other current liabilities.&amp;#160;&amp;#160;At March 31, 2010, the fair value hedge derivative instruments have settlement dates in the second and third quarters of 2010 and cover a gross notional amount of $606.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: bl
ock; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The Company believes that, at the balance sheet date, counterparty credit risk was not significant due to the credit quality of the counterparties to the derivatives, which were all large financial institutions primarily in Switzerland, and the short-term maturities of most derivatives.&amp;#160;&amp;#160;The credit exposure related to these financial instruments is represented by the fair value of contracts with a positive fair value at the reporting date.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&amp;#160;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New R
oman"&gt;For the three months ended March 31, 2010, the effects of foreign exchange derivative instruments were:&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" width="19%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Derivatives in Fair Value Hedging Relationships&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="2%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" width="18%"&gt
;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Location of Gain (Loss) Recognized in Earnings on Derivatives&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="2%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" width="17%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Amount of Gain (Loss) Recognized in Earnings on Derivatives&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="2%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: 
black 0.5pt solid" valign="bottom" width="17%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Amount of Gain (Loss) on the Hedged Items&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="top" width="19%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="2%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="18%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="2%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="17%"&gt;&lt;font style="DISPLAY:
 inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="2%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="17%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="top" align="left" width="19%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Foreign exchange forward contracts&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" width="2%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" align="left" width="18%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&g
t;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Gain (loss) from foreign currency, net&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" width="2%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" align="left" width="17%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;17&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" width="2%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" align="left" width="17%"&gt;&lt;div style="DISPL
AY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;(19)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="DISPLAY: inline; TEXT-DECORATION: underline"&gt;Interest Rate Risk Management&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="
DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The Company may use interest rate swaps on certain investing and borrowing transactions to manage its net exposure to interest rate changes and to reduce its overall cost of borrowing.&amp;#160;&amp;#160;The Company does not use leveraged swaps and does not leverage any of its investment activities that would put capital at risk.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;At March 31, 2010, in connection with a long term bank loan, the Company had an interest rate swap fair value hedge outstanding in the notional principal amount of $54 at the respective quarter-end exchange rate.&amp;#160;&amp;#160;Th
e fair value of the interest rate swap agreement is reported in other current assets.&amp;#160;&amp;#160;This interest rate swap did not have a significant effect on results of operations in 2010 and 2009.&amp;#160;&amp;#160;The long term bank loan matures in January 2011.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="DISPLAY: inline; TEXT-DECORATION: underline"&gt;Fair Value of Financial Instruments&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times Ne
w Roman"&gt;At March 31, 2010 and December 31, 2009, the Company's financial instruments included cash and cash equivalents, investments, trade receivables, accounts payable, short term borrowings, long term debt and the estimated fair value of certain contingent payments.&amp;#160;&amp;#160;The estimated fair value of all of these financial instruments is as noted below.&amp;#160;&amp;#160;Due to the short term maturities of cash and cash equivalents, trade receivables, accounts payable and short term borrowings, the carrying amounts approximate fair values at the respective balance sheet dates.&amp;#160;&amp;#160;The fair values of long term debt were based on interest rates then currently available to the Company for issuance of debt with similar terms and remaining maturities.&amp;#160;&amp;#160;The fair values of investments and acquisition-related contingent payments were determined as discussed below.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&
lt;div align="left"&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="14"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;
&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="6"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;March 31, 2010&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="6"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-I
NDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;December 31, 2009&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Carrying&lt;/font&gt;&
lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Fair&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&g
t;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Carrying&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Fair&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;fo
nt style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Amounts&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5p
t solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Amounts&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Value&lt;/font&gt;&lt;/div&gt;&
lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Assets:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td v
align="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZ
E: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Short term trading and available-for-sale investments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE
: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;542&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;542&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;
&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;479&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" 
valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;479&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Long term available-for-sale investments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: 
left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;64&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;64&lt;/fon
t&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;73&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10p
t; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;73&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Forward exchange contracts&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10p
t; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;5&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&g
t;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;5&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;6&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;t
d valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;6&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Interest rate swaps&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign
="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;1&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;
&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;1&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;1&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT
- -SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;1&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="52%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="
DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" va
lign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160
;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Liabilities:&lt;/font&gt
;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new ro
man"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style=
"DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt;
 FONT-FAMILY: times new roman"&gt;Long term debt, excluding capital lease obligations&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;54&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-A
LIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;54&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;56&l
t;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;56&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="52%"&gt;&lt;div style="DISPLAY: block; MA
RGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Liability for acquisition-related contingent payments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;88&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style
="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;88&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: r
ight" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;71&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;71&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&am
p;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Forward exchange and option contracts&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new rom
an"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-S
IZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowra
p" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="52%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;
td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&
gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE:
 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Financial instruments, such as equity and fixed income securities, other investments, financial liabilities and derivatives, were presented at fair value.&amp;#160;&amp;#160;Fair value is defined as the price at which an asset could be exchanged or a &lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;liability could be transferred in an orderly transaction between knowledgeable and willing market participants within the principal or most advantageous market at the measurement date.&amp;#160;&amp;#160;Where available, fair value is based on or derived from observable market prices or parameters.&amp
;#160;&amp;#160;Where observable prices or inputs are not available, pricing for similar financial assets or liabilities, dealer quotes or valuation models are applied.&amp;#160;&amp;#160;These valuation techniques involve some level of management estimation and judgment, the degree of which is dependent on the price transparency for the instruments or market and the instruments' complexity.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font&gt;Financial assets and liabilities recorded at fair value in the condensed consolidated balance sheets were categorized based upon the level of judgment associated with the inputs used to measure their fair values.&amp;#160;&amp;#160;The categories, from lowest to highest based on the amount o
f subjectivity associated with the inputs to fair valuation of these assets and liabilities, are as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Level 1 &amp;#8211; Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The types of Company assets carried at Level 1 fair value are equities listed in active markets.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div s
tyle="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Level 2 &amp;#8211; Inputs (other than quoted prices included in Level 1) are either directly or indirectly observable for the assets or liabilities through correlation with market data at the measurement date and for the duration of each instrument's anticipated life.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The Company's assets generally included in this fair value category are various government agency securities, certain investment funds, mortgage backed securities, collateralized mortgage obligations, foreign exchange derivatives and interest rate derivatives.&amp;#160;&amp;#160;Foreign ex
change derivatives and interest rate derivatives are valued using corroborated, observable market data.&amp;#160;&amp;#160;The Company's liabilities generally included in this fair value category consist of certain foreign exchange derivatives.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Level 3 &amp;#8211; Inputs are unobservable inputs for the assets or liabilities.&amp;#160;&amp;#160;These inputs reflect management's best estimate of what market participants would use in pricing the assets or liabilities at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY
: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Generally, the Company's assets carried at fair value included in this category are various hedge fund investments.&amp;#160;&amp;#160;The Company's liabilities carried at fair value in this category are acquisition-related contingent payments.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The Company's Level 3 financial investments are held in funds professionally managed by investment managers.&amp;#160;&amp;#160;The net asset values are furnished in statements received from fund custodians whose statements reflect valuations conducted according to their respective fund pricing policies and asset types.&amp;#1
60;&amp;#160;The complete details of the fund holdings of several of the Company's professionally managed funds may be unavailable at times, limiting the Company's ability to look through to the underlying assets at the date the financial statements are prepared.&amp;#160;&amp;#160;Because of these constraints, the Company classified these fund investments as Level 3.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;As of March 31, 2010, the Company has recorded $88, as the fair value of its obligations to make contingent payments related to acquisitions. The fair value measurements were based on significant inputs not observable in the market and thus represent a level 3 measurement.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;
/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;In connection with an acquisition in 2009, the Company is obligated to make acquisition-related contingent payments of up to $439 based upon the achievement of future research and development milestones that would be expected to create value for Alcon.&amp;#160;&amp;#160;At March 31, 2010, the fair value of these payments was estimated to be $71.&amp;#160;&amp;#160;Each milestone was assigned a probability based on its current status.&amp;#160;&amp;#160;The resultant probability-weighted cash flows were then discounted using a discount rate of 6%, which the Company believes is appropriate and representative of a market participant assumption.&amp;#160;&amp;#160;The probabilities assigned to payment streams ranged from 5% to 39%.&amp;#160;&amp;#160;An increase &lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10
pt; FONT-FAMILY: Times New Roman"&gt;or decrease of 10 percentage points in the probability assumptions would result in an adjustment to the estimated value of approximately $30.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;In connection with an acquisition in 2010, the Company is obligated to make acquisition-related contingent payments of up to $145 upon achieving certain sales objectives through 2014.&amp;#160;&amp;#160;The fair value of these payments at the acquisition date was estimated to total $17 and was included as a cost of the acquisition.&amp;#160;&amp;#160;&amp;#160;&amp;#160;The fair value estimate was based on the Company&amp;#8217;s estimates of the probability and timing of these sales projection streams.&amp;#160;&amp;#160;Each revenue projection assump
tion was assigned a probability and the resultant probability-weighted cash flows were then discounted using a discount rate of 6%, which the Company believes is appropriate and representative of a market participant assumption.&amp;#160;&amp;#160;Achieving the Company's most optimistic sales assumption would not increase the estimated fair value more than $5.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The fair values of these contingent payments are reviewed each reporting period.&amp;#160;&amp;#160;Any changes in the estimated value not associated with the original purchase price valuation are recorded in the Company&amp;#8217;s results of operations.&amp;#160;&amp;#160;No such changes were recognized in the current period.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPL
AY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"&gt;Fair Value by Category&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font&gt;Financial assets and financial liabilities measured at fair value on a recurring basis were categorized in the tables below based upon the lowest level of input that is significant to the fair value measurement.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="
left"&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="14"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Fair Value as of March 31, 2010&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: t
imes new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: center" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Level 1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 
2px" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: center" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Level 2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: center" valign="bottom" colspan="2"&gt;&lt;div style="DI
SPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Level 3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: center" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="
bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline;
 FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#16
0;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Financial Assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="
bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt
; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Trading securities - Hedge funds&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMIL
Y: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISP
LAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;8&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width=
"1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;8&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Available-for-sale securities:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&l
t;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-A
LIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&
gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="MARGIN-LEFT: 17.25pt"&gt;&lt;/font&gt;U.S. government and agency securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISP
LAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" 
valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;185&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#16
0;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;185&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="MARGIN-LE
FT: 17.75pt"&gt;&lt;/font&gt;Mortgage-backed securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" wi
dth="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;17&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td s
tyle="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;17&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; T
EXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="MARGIN-LEFT: 17.75pt"&gt;&lt;/font&gt;Senior secured bank loans fund&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt
;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;97&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TE
XT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;97&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new ro
man"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="MARGIN-LEFT: 17.75pt"&gt;&lt;/font&gt;Corporate debt securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font sty
le="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;265&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" val
ign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;265&lt;/font&gt;&lt
;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="MARGIN-LEFT: 17.75pt"&gt;&lt;/font&gt;Equity securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10
pt; FONT-FAMILY: times new roman"&gt;33&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;
&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style=
"TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;33&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="MARGIN-LEFT: 17.75pt"&gt;&lt;/font&gt;Other investments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new ro
man"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;1&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DI
SPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bo
ttom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;1&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Forward exchange contracts&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" v
align="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;5&lt;/font&gt;&lt
;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-
FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;5&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Interest rate swaps&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="
1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left
" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;1&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt
 solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;1&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-B
OTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;fo
nt style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;33&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;571&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;
&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;8&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font
 style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;612&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="52%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new ro
man"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline
; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&
gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Financial Liabilities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="b
ottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&g
t;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-
FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"
&gt;Liability for acquisition-related contingent payments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%
"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;88&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" v
align="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;88&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-
INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Foreign exchange and option contracts&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/fon
t&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160
;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: time
s new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM
: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM
: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;88&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTT
OM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;90&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&l
t;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&amp;#160;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Cash and cash equivalents of $3,129 were excluded from the table above.&lt;/font&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&l
t;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="14"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Fair Value as of December 31, 2009&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; T
EXT-ALIGN: center" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Level 1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: center" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Level 2&lt;/font&gt;&lt;/div&gt;&lt
;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: center" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Level 3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="b
ottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: center" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign=
"bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FO
NT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Financial A
ssets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bot
tom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;d
iv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Trading securities - Hedge funds&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DIS
PLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" w
idth="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;22&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;22&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&
lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Available-for-sale securities:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;
/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160
;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline;
 FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="MARGIN-LEFT: 17.25pt"&gt;&lt;/font&gt;U.S. government and agency securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" val
ign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;179&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;
/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10p
t; FONT-FAMILY: times new roman"&gt;179&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="MARGIN-LEFT: 17.75pt"&gt;&lt;/font&gt;Mortgage-backed securities fund&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign=
"bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;82&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/f
ont&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY
: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;82&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="MARGIN-LEFT: 17.75pt"&gt;&lt;/font&gt;Mortgage-backed securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&
gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;16&lt;/font&gt;&lt;/td&gt;&lt;td style="TEX
T-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&
gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;16&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="MARGIN-LEFT: 17.75pt"&gt;&lt;/font&gt;Senior secured bank loans fund&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font sty
le="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN:
 right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;154&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;154&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="M
ARGIN-LEFT: 17.75pt"&gt;&lt;/font&gt;Corporate debt securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bot
tom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;43&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&
lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;43&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT:
 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="MARGIN-LEFT: 17.75pt"&gt;&lt;/font&gt;Equity securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;31&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font 
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALI
GN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;31&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&g
t;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="MARGIN-LEFT: 17.75pt"&gt;&lt;/font&gt;Other investments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: i
nline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;25&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" wi
dth="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;25&lt;/font&gt;&lt;/td&gt;&lt;td s
tyle="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Forward exchange contracts&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&g
t;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;6&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY:
 times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font sty
le="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;6&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Interest rate swaps&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt
;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times n
ew roman"&gt;1&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt;
 FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;1&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLA
Y: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;31&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&
gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;506&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt
;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;22&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt
;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;559&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="52%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline
; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&
gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TE
XT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Financial Liabilities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&g
t;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-
FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT
- -SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Liability for acquisition-related contingent payments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width=
"1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left
" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;71&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font
&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;71&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Foreign exchange and option contracts&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inlin
e; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;f
ont style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bo
ttom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valig
n="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE:
 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-S
IZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;71&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10
pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;73&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Cash and cash equivalents of $
3,007 were excluded from the table above.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"&gt;Level 3 Gains and Losses&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;At March 31, 2010, trading securities were the only type of financial assets included in Level 3.&amp;#160;&amp;#160;The trading securities were professionally managed investment funds, which consisted of hedge funds of $8.&amp;#160;&amp;#160;The fair value of the investment funds classi
fied as Level 3 could not be determined by independent market observation or through the use of other observable valuation techniques. The valuation was based on the net asset values as furnished by the funds' custodians.&amp;#160;&amp;#160;If more than an insignificant proportion of a particular fund's assets were Level 3, the entire fund was classified as Level 3, although many of such fund's individual holdings may meet the definition of Level 1 or Level 2.&amp;#160;&amp;#160;The only liabilities included in Level 3 were the acquisition-related contingency payments, discussed earlier in this note.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Total gains or losses (realized and unrealized) for financial assets and liabilities classified as Level 3 that were included in 
earnings were a component of other, net, in the condensed consolidated statements of earnings.&amp;#160;&amp;#160;For the three months ended March 31, 2010, net gains (realized and unrealized) from trading securities were not significant, and the Company received proceeds from sales of Level 3 trading securities of $14.&amp;#160;&amp;#160;Realized and unrealized net gains during the period were approximately 1% of the beginning balance for Level 3 trading securities and did not negatively affect or materially impact operations, liquidity or capital resources.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The table presented below summarizes the change in carrying values associated with Level 3 financial instruments during the three months ended March 31, 2010.&lt;/font&gt;
&lt;br /&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; F
ONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Liabilities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style
="PADDING-BOTTOM: 0.5pt" valign="bottom" rowspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2" rowspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Trading Securities - Hedge&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;Funds&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" rowspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt
;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" rowspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2" rowspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Acquisition Related Contingent Payments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" rowspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td vali
gn="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE:
 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Beginning balance&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;22&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; F
ONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;71&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman
"&gt;Total gains or losses (realized/unrealized)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style=
"DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Included in earnings before income taxes&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bott
om" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&l
t;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Included in other comprehensive income&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt
;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; F
ONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style=
"DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Acquisition-related activities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="
1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;17&lt;/font&gt;&lt;/td&gt;&lt;td style=
"TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new 
roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Proceeds on sa
les and maturities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(14 &lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline;
 FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&
amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: t
imes new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Ending balance&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BOR
DER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;8&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;88&lt;/font&gt;&lt;/td&gt;&lt;td style="PA
DDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-
FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT
- -SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Gains and losses (realized and unrealized) on Level 3 financial instruments included in earnings for the three months ended March 31, 2010 were not significant.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;At March 31, 2009, trading securities were the only type of financial assets included in Level 3.&amp;#160;&amp;#160;Total gains or losses (realized and unrealized) for financial assets and liabilities classified as Level 3 that were included in earnings were a component of other, net, in the condensed consolidated statements of earnings.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" al
ign="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The table presented below summarizes the change in carrying values associated with Level 3 financial instruments during the three months ended March 31, 2009.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;
&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY
: times new roman"&gt;Trading&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; 
TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="88%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font styl
e="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Beginning balance&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;261&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="88%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISP
LAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Total gains or losses (realized/unrealized)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="88%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&g
t;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Included in earnings&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="88%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="lef
t"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Included in other comprehensive income&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="88%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp
;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="left" width="88%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&
gt;Proceeds on sales and maturities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(155 &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="88%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: t
imes new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="88%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAM
ILY: times new roman"&gt;Ending balance&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;108&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="88%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times
 new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt;
 FONT-FAMILY: Times New Roman"&gt;Gains and losses (realized and unrealized) on Level 3 financial instruments included in earnings for the three months ended March 31, 2009 were reported in other, net, as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="88%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Total gains or losses included in earnings for the period&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td sty
le="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="88%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="D
ISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="88%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Change in unrealized gains (losses) related to assets still held at reporting date&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: tim
es new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;1&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="88%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT
- -ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&amp;#160;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"&gt;Valuation Techniques&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-
LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font&gt;Valuation techniques used for financial assets and liabilities accounted for at fair value are generally categorized into three types:&amp;#160;&amp;#160;market approach, income approach and cost approach.&amp;#160;&amp;#160;The Company valued its Level 3 financial assets and liabilities at March 31, 2010 and 2009 primarily using the market approach and, to a lesser extent, the income approach.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Market Approach&lt;/font&gt;.&amp;#
160;&amp;#160;The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities.&amp;#160;&amp;#160;Valuation techniques consistent with the market approach include comparables.&amp;#160;&amp;#160;A majority of the Company's balances measured at fair value on a recurring basis were valued using the market approach.&amp;#160;&amp;#160;Most measurements were market quotes or obtained from other reliable market sources.&amp;#160;&amp;#160;The Company did not use market indices for valuing material balances measured at fair value.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Income Appro
ach&lt;/font&gt;.&amp;#160;&amp;#160;Income approach valuation techniques convert future amounts, such as cash flows or earnings, to a single present or discounted amount.&amp;#160;&amp;#160;The measurement is based on the value indicated by current market expectations about those future amounts.&amp;#160;&amp;#160;Examples of income approach valuation techniques include present value techniques, option-pricing models, and binomial or lattice models that incorporate present value techniques and option-pricing models.&amp;#160;&amp;#160;The Company valued certain derivatives, in part or whole, and acquisition-related contingent payments using the income approach.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font&gt;&lt;font style="
DISPLAY: inline; FONT-STYLE: italic"&gt;Cost Approach&lt;/font&gt;.&amp;#160;&amp;#160;The cost approach is based on the amount that currently would be required to replace the service capacity of an asset.&amp;#160;&amp;#160;The Company did not employ the cost approach for determining fair value of financial assets and liabilities.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font&gt;The valuation approaches are consistent with generally accepted valuation methodologies.&amp;#160;&amp;#160;While all three approaches are not applicable to all assets or liabilities accounted for at fair value, where appropriate and possible, one or more valuation techniques may be used.&amp;#160;&amp;#160;Professionally managed investment funds may 
use a combination of market, income and cost approaches.&amp;#160;&amp;#160;The process of selecting which valuation method(s) to apply considers the definition of an exit price and the nature of the asset or liability being valued and significant expertise and judgment is required.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"&gt;Other-Than-Temporary Impairment of Available-for-Sale Investments&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The Company reviews quarterly its available-for-sale investments to identify impai
red equity and debt securities. An individual security is impaired if the fair value of the investment is less than its amortized cost basis.&amp;#160;&amp;#160;Impairment may be either temporary or other-than-temporary.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The Company normally reviews securities held in its portfolio that have been in a continuous loss position for twelve months or longer and securities whose fair value is significantly lower than its amortized cost basis.&amp;#160;&amp;#160;Impairment is evaluated using a combination of quantitative and qualitative factors such as considering the length of time and extent to which the fair value has been below cost, the financial condition and near-term prospects of the issuer, as well as the Company's ability a
nd intent to hold the investments for an adequate period of time until an anticipated market price recovery or maturity.&amp;#160;&amp;#160;If impairment is determined to be other-than-temporary, the investment is written down to fair value, and a loss is recognized immediately through earnings.&lt;/font&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
  <!--Entity Registrant Name-->
  <dei:EntityRegistrantName contextRef="c00003">ALCON INC</dei:EntityRegistrantName>
  <!--Current Fiscal Year End Date-->
  <dei:CurrentFiscalYearEndDate contextRef="c00003">--12-31</dei:CurrentFiscalYearEndDate>
  <!--Other, net-->
  <us-gaap:OtherNonoperatingIncomeExpense unitRef="u000" decimals="-6" contextRef="c00003">20000000</us-gaap:OtherNonoperatingIncomeExpense>
  <!--Other, net-->
  <us-gaap:OtherNonoperatingIncomeExpense unitRef="u000" decimals="-6" contextRef="c00004">4000000</us-gaap:OtherNonoperatingIncomeExpense>
  <!--Interest income-->
  <us-gaap:InvestmentIncomeInterestAndDividend unitRef="u000" decimals="-6" contextRef="c00003">8000000</us-gaap:InvestmentIncomeInterestAndDividend>
  <!--Interest income-->
  <us-gaap:InvestmentIncomeInterestAndDividend unitRef="u000" decimals="-6" contextRef="c00004">11000000</us-gaap:InvestmentIncomeInterestAndDividend>
  <!--Operating income-->
  <us-gaap:OperatingIncomeLoss unitRef="u000" decimals="-6" contextRef="c00003">653000000</us-gaap:OperatingIncomeLoss>
  <!--Operating income-->
  <us-gaap:OperatingIncomeLoss unitRef="u000" decimals="-6" contextRef="c00004">514000000</us-gaap:OperatingIncomeLoss>
  <!--Short term borrowings-->
  <us-gaap:ShortTermBorrowings unitRef="u000" decimals="-6" contextRef="c00002">667000000</us-gaap:ShortTermBorrowings>
  <!--Short term borrowings-->
  <us-gaap:ShortTermBorrowings unitRef="u000" decimals="-6" contextRef="c00001">607000000</us-gaap:ShortTermBorrowings>
  <!--Accounts payable-->
  <us-gaap:AccountsPayableCurrent unitRef="u000" decimals="-6" contextRef="c00002">309000000</us-gaap:AccountsPayableCurrent>
  <!--Accounts payable-->
  <us-gaap:AccountsPayableCurrent unitRef="u000" decimals="-6" contextRef="c00001">321000000</us-gaap:AccountsPayableCurrent>
  <!--Commitments and Contingencies-->
  <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="c00003">&lt;div&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr valign="top"&gt;&lt;td style="WIDTH: 18pt" align="right"&gt;&lt;div&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;(14)&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Commitments and Contingencies&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;(in millions, except per share data)&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; T
EXT-INDENT: 0pt"&gt;&amp;#160;&lt;/div&gt;&lt;div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"&gt;Minority Shareholder Class Action Lawsuits&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font&gt;On January 4, 2010, Novartis announced that it submitted to the Alcon board of directors a proposal for a merger of Alcon with and into Novartis to be effected under Swiss merger law (note 13).&amp;#160;&amp;#160;Under the terms of the merger proposal, holders of the approximate 23% of Alcon shares that are publicly traded would receive 2.8 Novartis shares for each
 Alcon share.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font&gt;The Independent Director Committee was formed in 2008 in connection with Novartis's initial purchase of slightly less than 25% of the Alcon shares from Nestl&amp;#233; to evaluate transactions such as the merger proposed by Novartis.&amp;#160;&amp;#160;The Independent Director Committee engaged independent financial and legal advisors in connection with its evaluation of the proposed merger.&amp;#160;&amp;#160;On January 20, 2010, the Independent Director Committee issued its formal response rejecting the Novartis merger proposal.&amp;#160;&amp;#160;The committee rejected the merger proposal based on its assessment that the price offered and other terms were not ac
ceptable and that Novartis's merger proposal was not in the best interests of Alcon and its minority shareholders.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font&gt;Certain Alcon minority shareholders have filed several class action lawsuits related to Novartis's merger proposal concerning the acquisition of the remaining 23% publicly held minority interest.&amp;#160;&amp;#160;The claims vary among the cases, but include allegations of: (i) breach of contract against Alcon; (ii) tortious interference with contract against Novartis and Nestl&amp;#233;; (iii) breach of fiduciary duties against the Alcon board of directors, Nestl&amp;#233; and Novartis; (iv) aiding and abetting breaches of fiduciary duties against the Alcon board 
of directors, Nestl&amp;#233; and Novartis; (v) breach of Section 13(d) of the Exchange Act against Novartis and Nestl&amp;#233; for an alleged failure to disclose that they were acting as a "group;" and (vi) breach of Section 14(d) of the Exchange Act against Novartis and Nestl&amp;#233; for an alleged failure to file with the U.S. Securities and Exchange Commission the materials required in connection with a "tender offer."&amp;#160;&amp;#160;Seven cases filed in the Southern District of New York have been consolidated into one class action case.&amp;#160;&amp;#160;One case is pending in the U.S. District Court for the Northern District of Texas, Fort Worth Division, but the plaintiffs there have agreed to join the plaintiffs in the Southern District of New York action rather than pursue their claims separately.&amp;#160;&amp;#160;One case, which did not name Alcon, Inc. and its board of directors as parties, had been filed in the Eastern District of New York but was voluntarily dismissed by the plaintiffs
 on March 18, 2010.&amp;#160;&amp;#160;Two cases filed in District Court, Tarrant County and two cases filed in the County Court at Law, Dallas County, Texas have been consolidated for pre-trial purposes by the Texas Multidistrict Litigation Panel in the District Court, Dallas County.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&amp;#160;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;On April 14, 2010, plaintiffs in the Southern District of New York action agreed to dismiss their claims against Nestl&amp;#233; and the five Alcon directors nominated by Nestl&amp;#233; in exchange for Nestl&amp;#233;&amp;#8217;s and its directors&amp;#8217; agreement that, without impairing the directors&amp;#8217; abili
ty to exercise their fiduciary obligations to Alcon, among other things, during the pendency of the action, they will take no action to (1) amend the Alcon Organizational Regulations, (2) remove or replace the Alcon independent directors or (3) facilitate Novartis&amp;#8217;s proposal to take Alcon private other than &lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;pursuant to a recommendation of the Independent Director Committee.&amp;#160;&amp;#160;On April 21, 2010, plaintiffs in the Southern District of New York action voluntarily dismissed their breach of fiduciary duty and aiding and abetting claims against Novartis, Nestl&amp;#233; and the Alcon board of directors.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Time
s New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font&gt;We are currently unable to express an opinion on the outcome of these class action cases due to their infancy.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"&gt;Other Contingencies&lt;/font&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;/font&gt;&amp;#160;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Alcon, either
 alone or jointly with its commercial partners, has filed fourteen North American patent infringement actions against six different generic drug companies.&amp;#160;&amp;#160;With the exception of international generic challenges, all of these generic drug companies are seeking U.S. Food and Drug Administration ("FDA") approval to market generic versions of Alcon products, under what are known as Abbreviated New Drug Applications ("ANDAs").&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The first infringement action was filed after Alcon received notice that Teva Pharmaceuticals USA, Inc. had filed an ANDA seeking approval to sell a generic version of Alcon's &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Vigamox&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SI
ZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt; antibiotic ophthalmic solution.&amp;#160;&amp;#160;Moxifloxacin, the primary ingredient in &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Vigamox&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt;, is licensed to Alcon by Bayer Schering Pharma AG.&amp;#160;&amp;#160;As part of its ANDA, Teva challenged three patents covering Alcon's innovator product &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Vigamox&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt;. Two of the patents are owned by Alcon's licensor, Bayer Schering Pharma AG, and the third, which expires in 2020, is owned by Alcon.&amp;#160;&amp;#160;The two Bayer Schering Pharma AG patents were also the subject of another Teva ANDA seeking approval to sell a generic version of Bayer Schering Pharma AG's systemic moxifloxacin product, Avelox&lt;font st
yle="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt;.&amp;#160;&amp;#160;Suit was filed by Alcon and Bayer Schering Pharma AG as co-plaintiffs against Teva relative to the ANDA challenging &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Vigamox&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt; on April 5, 2006 in the U.S. District Court in Delaware.&amp;#160;&amp;#160;Bayer Schering Pharma AG subsequently filed suit in the same court relative to the Avelox&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt; ANDA, and the two suits were merged.&amp;#160;&amp;#160;Trial was scheduled to begin February 26, 2008, but the dispute between Bayer Schering Pharma AG and Teva relative to the two Bayer Schering Pharma AG patents was resolved by settlement on the eve of trial.&amp;#160;&amp;#160;Under the terms of the settlement, Teva acknowledged the validity and
 enforceability of both Bayer Schering Pharma AG patents, and further acknowledged that its proposed generic ophthalmic product would infringe both patents.&amp;#160;&amp;#160;Teva has therefore relinquished any claim that it is entitled to market the generic ophthalmic product prior to September 4, 2014.&amp;#160;&amp;#160;Alcon remains the exclusive ophthalmic licensee under the Bayer Schering Pharma patents.&amp;#160;&amp;#160;The trial relative to the Alcon patent began on February 28, 2008 and concluded on March 6, 2008.&amp;#160;&amp;#160;Since then, Alcon has received a notice of allowance on a related patent application with claims that will cover the &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Vigamox&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic"&gt;&amp;#174;&lt;/font&gt; product and Teva's proposed generic product.&amp;#160;&amp;#160;The issue fee has been paid on that application, and the patent should issue by the first qua
rter of 2010.&amp;#160;&amp;#160;On October 19, 2009, the court ruled in Alcon's favor on all counts, finding the Alcon patent to be valid and infringed by the proposed generic product.&amp;#160;&amp;#160;On November 19, 2009, Teva filed a Notice of Appeal, but that appeal was subsequently set aside by the Federal Circuit Court of Appeals as being premature.&amp;#160;&amp;#160;It is expected that the appeal will be reinstated after the lower court amends its form of judgment.&amp;#160;&amp;#160;However, even if Teva were to succeed in having the district court decision reversed on appeal, it would still have to address Alcon's recently allowed second patent before competing with Alcon's &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Vigamox&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt; product in September 2014 when the underlying Bayer patent expires.&amp;#160;&amp;#160;If Teva were to win on appeal and overcome Alcon's second pate
nt, the resulting generic competition would be expected to impact significantly the Company's sales and profits.&amp;#160;&amp;#160;On a related note, Alcon's European counterpart patent to the patent-in-suit was determined to be invalid in a European Patent Office Opposition Proceeding.&amp;#160;&amp;#160;That invalidity decision was upheld by an Enlarged Board of Appeal on October 22, 2009.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&amp;#160;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The second patent infringement action was filed after Alcon received notice that Apotex, a Canadian-based generic drug company, had filed an ANDA challenging one of the patents covering Alcon's &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Patanol&lt;/font&gt;&lt;font style="DISPLA
Y: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt; anti-allergy eye product.&amp;#160;&amp;#160;Alcon's raw material supplier, Kyowa Hakko Kirin Co., Ltd., holds another U.S. patent, which has not been challenged in this case and which expires on December 18, 2010.&amp;#160;&amp;#160;In addition, Alcon has secured a six-month pediatric extension to the patent coverage, which means this generic challenge poses no threat to the &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Patanol&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174; &lt;/font&gt;product market prior to June 2011.&amp;#160;&amp;#160;The patent that Apotex has challenged, which is co-owned by Alcon and Kyowa, will expire in 2015.&amp;#160;&amp;#160;Alcon and Kyowa, as co-plaintiffs, filed suit against Apotex Inc. and Apotex Corp. on &lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;November 15, 2006 in the U.S. Dis
trict Court in Indianapolis, Indiana.&amp;#160;&amp;#160;As a result of the lawsuit filing, the FDA was required to delay any approval of the Apotex ANDA for 30 months until April 2009, unless the litigation were earlier resolved or the court were to modify the 30-month stay on FDA approval.&amp;#160;&amp;#160;Because of the protection until June 2011, provided by the unchallenged Kyowa patent, the expiration of the 30-month period was inconsequential. &lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Trial had been scheduled for July 27, 2009, but was postponed and has now been rescheduled for April 26, 2010 (consolidated with the Sandoz case described below).&amp;#160;&amp;#160;Should Apotex succeed in overcoming the challenged patent and secure FDA approval, it would not be entitled to begin selling a generic olopatadine product that would compete with Alcon's &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Patanol&lt;/font&gt;&lt;font style="DISPLAY: 
inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt; product in the United States until June 18, 2011.&amp;#160;&amp;#160;Such competition would be expected to impact significantly the Company's sales and profits.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The third patent infringement action was filed after Alcon received notice on October 1, 2007 that Barr Laboratories, Inc. had filed an ANDA challenging the patents underlying Alcon's &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Patanol&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt; product.&amp;#160;&amp;#160;Unlike the Apotex ANDA described above, which is challenging only the patent jointly o
wned by Kyowa and Alcon, the Barr ANDA was also challenging Kyowa's composition patent on olopatadine, the active agent in &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Patanol&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt;.&amp;#160;&amp;#160;Alcon and Kyowa filed suit in the Federal District Court in Indianapolis (where the Apotex case is pending) on October 23, 2007.&amp;#160;&amp;#160;As a result of the lawsuit filing, the FDA was required to delay any approval of the Barr ANDA for 30 months unless the litigation were earlier resolved or the court modified the 30-month stay on FDA approval.&amp;#160;&amp;#160;The 30-month period after which the FDA could approve Barr's generic product would expire at the end of March 2010, nine months before the Kyowa composition patent expires.&amp;#160;&amp;#160;Trial was scheduled for late April 2010.&amp;#160;&amp;#160;However, in September 2009, Barr withdrew its ANDA and subsequently has b
een dismissed from the suit.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The fourth patent infringement action was filed after Alcon received notice in late November 2008 that Barr Laboratories, Inc. had filed an ANDA challenging the patents underlying Alcon's &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Pataday&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#8482;&lt;/font&gt; once daily olopatadine product.&amp;#160;&amp;#160;The Barr ANDA is challenging the patent jointly owned by Kyowa and Alcon (described above), as well as two later issued patents owned by Alcon that cover the &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Pataday&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICA
L-ALIGN: text-top"&gt;&amp;#8482;&lt;/font&gt; formulation.&amp;#160;&amp;#160;Of the two Alcon patents, the latest expiry date is November 2023.&amp;#160;&amp;#160;Barr is not challenging the Kyowa patent on olopatadine that expires in December 2010 (effectively extended until June 2011 by a pediatric extension).&amp;#160;&amp;#160;Alcon and Kyowa filed suit in the Federal District Court in Indianapolis on January 8, 2009.&amp;#160;&amp;#160;As a result of the lawsuit filing, the FDA must delay any approval of the Barr ANDA for 30 months unless the litigation is earlier resolved or the court modifies the 30-month stay on FDA approval.&amp;#160;&amp;#160;The 30-month period after which the FDA could approve Barr's generic product will expire in May 2011.&amp;#160;&amp;#160;This case has been consolidated with the Apotex case (&lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Pataday&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#8482;&lt;/font&gt;) descr
ibed below.&amp;#160;&amp;#160;Trial has not yet been scheduled in this case.&amp;#160;&amp;#160;If Barr succeeds in overcoming all of the challenged patents and secures FDA approval, it would be entitled to begin selling a generic olopatadine product that would compete with Alcon's &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Pataday&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#8482;&lt;/font&gt; product in the United States on June 18, 2011.&amp;#160;&amp;#160;Such competition would be expected to impact significantly the Company's sales and profits.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The fifth and sixth ANDA patent suits were filed February 2, 2009 in the U.S. District Court in Indianapolis against
 Apotex and Sandoz, respectively.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&amp;#160;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Alcon received notice January 12, 2009, that Apotex has followed Barr in filing an ANDA challenging the patents underlying Alcon's &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Pataday&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#8482;&lt;/font&gt; once daily olopatadine product.&amp;#160;&amp;#160;Like Barr's ANDA, the Apotex ANDA is challenging the patent jointly owned by Kyowa and Alcon (described above), as well as two later issued patents owned by Alcon that cover the &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Pataday&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-S
IZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#8482;&lt;/font&gt; formulation.&amp;#160;&amp;#160;Apotex is not challenging the Kyowa patent on olopatadine that expires in December 2010 (June 2011 with the pediatric extension).&amp;#160;&amp;#160;Because the suit was filed within the statutory 45-day period, the FDA must delay any approval of the Apotex ANDA for 30 months (until June 2011), unless the litigation is earlier resolved or the court modifies the 30-month stay on FDA approval.&amp;#160;&amp;#160;In addition, because Apotex is the second filer, it is also subject to the first filer's 180-day exclusivity period, which could further delay its FDA approval.&amp;#160;&amp;#160;Trial has not yet been scheduled in this case.&amp;#160;&amp;#160;If Apotex succeeds in overcoming both of the challenged patents and secures FDA approval, then after the expiration of Barr's potential 180-day "first filer" exclusivity period, it would be entitled to begin selling a generic olopatadine product that would compete wi
th Alcon's &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Pataday&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#8482;&lt;/font&gt; product in the United States in June 2011.&amp;#160;&amp;#160;Such competition would be expected to impact significantly the Company's sales and profits.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Alcon received notice on January 15, 2009 that Sandoz Inc. (an affiliate of Novartis) has filed an ANDA challenging one of the patents underlying Alcon's &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Patanol&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt; product.&amp;#160;&amp;#160;Similar to the Apotex ANDA on &lt;font style="DISPLAY: inline; FONT-STYLE:
 italic"&gt;Patanol&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt;, the Sandoz ANDA is challenging only the patent jointly owned by Kyowa and Alcon, but not the Kyowa-owned patent on olopatadine, which expires December 2010 (June 2011 with the pediatric extension).&amp;#160;&amp;#160;Because the suit was filed within the statutory 45-day period, the FDA must delay any approval of the Sandoz ANDA for 30 months (until June 2011) unless the litigation is earlier resolved or the court modifies the 30-month stay on FDA approval.&amp;#160;&amp;#160;However, as a third ANDA filer (behind both Apotex and Barr), Sandoz would not be entitled to receive FDA approval until the expiration or forfeiture of a 180-day exclusivity period that would be granted to Apotex (the first filer) if it were successful in its patent challenge.&amp;#160;&amp;#160;Trial has been scheduled for April 26, 2010, and consolidation with the above-described Apotex suit (&lt;font
 style="DISPLAY: inline; FONT-STYLE: italic"&gt;Patanol&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic"&gt;&amp;#174;&lt;/font&gt;) has been ordered by the court.&amp;#160;&amp;#160;Apotex has advised the court of recent public statements of intent by Novartis to acquire all outstanding shares of Alcon stock, and filed a motion to sever Sandoz from the trial.&amp;#160;&amp;#160;On February 22, 2010, the court granted the motion, ordering the suit against Sandoz to proceed separately and confirming the April 26, 2010 trial date with Apotex.&amp;#160;&amp;#160;A new trial date for the Sandoz case has not yet been set.&amp;#160;&amp;#160;Subject to the possibility of the 180-day exclusivity period that could accrue to Apotex, if Sandoz succeeds in overcoming the challenged patent and secures FDA approval, it would be entitled to begin selling a generic olopatadine product that would compete with Alcon's &lt;font style="DISPLAY: inline; FONT-STYLE: itali
c"&gt;Patanol&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt; product in the United States in June 2011.&amp;#160;&amp;#160;Such competition would be expected to impact significantly the Company's sales and profits.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The seventh ANDA patent suit was filed after Alcon received notice by letter dated March 17, 2009, that Barr Laboratories, Inc. had filed a Paragraph IV certification with its ANDA for a generic version of Alcon's &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;TRAVATAN&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt; product containing 0.004% travoprost.&amp;#160;&amp;#160;Barr 
is challenging the following patents listed in the Orange Book for &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;TRAVATAN&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt;: U.S. Patent Nos. 5,510,383; 5,631,287; 5,849,792; 5,889,052; and 6,011,062.&amp;#160;&amp;#160;With the exception of the '383 patent, which expires in 2013, all of the patents will expire in December 2014.&amp;#160;&amp;#160;Alcon filed suit against Barr in the U.S. District Court in Delaware on April 30, 2009 and thereby secured the statutory 30-month stay on FDA approval of the generic product.&amp;#160;&amp;#160;The FDA must delay any approval of the Barr ANDA until September 2011, unless the litigation is earlier resolved or the court modifies the 30-month stay on FDA approval.&amp;#160;&amp;#160;This case has been consolidated with the Par and Apotex cases on &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;TRAVATAN&lt;/font&gt;&lt;font style="DISPLAY: i
nline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174; &lt;/font&gt;described below.&amp;#160;&amp;#160;Trial has been scheduled to commence March 7, 2011.&amp;#160;&amp;#160;Should Barr succeed in overcoming all of the challenged patents and secure FDA approval, it would be entitled to begin selling a generic travoprost product that would compete with Alcon's &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;TRAVATAN&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt; product in the United States.&amp;#160;&amp;#160;Such competition would be expected to impact significantly the Company's sales and profits.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The eighth patent suit was filed after Sandoz 
Canada Inc. (an affiliate of Novartis) notified Alcon Canada by letter dated April 9, 2009, that Sandoz had filed an Abbreviated New Drug Submission (ANDS) seeking approval from the Canadian Minister of Health to market a generic version of Alcon's &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Patanol&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt; product.&amp;#160;&amp;#160;The Sandoz ANDS is challenging only one of the two patents listed in the Canadian Patent Register for the &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Patanol&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt; product.&amp;#160;&amp;#160;The challenged patent (Canadian Patent No. 2,195,094) is jointly owned by Kyowa and Alcon and expires in May 2016.&amp;#160;&amp;#160;Alcon and Kyowa filed suit on May 25, 2009 in the Federal Court in Toronto, thereby securing a 24-month delay (until May 2
5, 2011) in the regulatory approval from the Minister of Health, which can only be shortened if the litigation is earlier resolved or the court modifies the 24-month stay on such approval.&amp;#160;&amp;#160;Trial has not yet been scheduled in this case.&amp;#160;&amp;#160;Should Sandoz succeed in overcoming the challenged patent and secure Minister of Health approval, it would be entitled to begin selling a generic olopatadine product that would compete with Alcon's &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Patanol&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt; product in Canada well before the patent expiration in 2016, but not before expiration of the unchallenged patent in November 2012.&amp;#160;&amp;#160;Such competition would be expected to impact the Company's sales and profits.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&amp;#160;&lt;/di
v&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The ninth ANDA patent suit was filed after Alcon received notice by letter dated June 1, 2009, that Par Pharmaceutical, Inc. had filed a Paragraph IV certification with its two ANDAs for generic versions of Alcon's &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;TRAVATAN&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic"&gt;&amp;#174;&lt;/font&gt; and &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;TRAVATAN Z&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic"&gt;&amp;#174;&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;&amp;#160;&lt;/font&gt;products.&amp;#160;&amp;#160;Par is challenging the following patents listed in the Orange Book for &lt;font style="DISPLAY: inline; FO
NT-STYLE: italic"&gt;TRAVATAN&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic"&gt;&amp;#174;&lt;/font&gt; and &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;TRAVATAN Z&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic"&gt;&amp;#174;&lt;/font&gt;:&amp;#160;&amp;#160;U.S. Patent Nos. 5,510,383; 5,631,287; 5,849,792; 5,889,052; 6,011,062; 6,503,497; and 6,849,253.&amp;#160;&amp;#160;All of these patents will expire by the end of 2014.&amp;#160;&amp;#160;On July 1, 2009, Alcon filed suit in the U.S. District Court in Delaware, thereby securing a statutory stay under which the FDA must delay any approval of the Par ANDAs until December 2011, unless the litigation is earlier resolved or the court modifies the 30-month &lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;stay on FDA approval.&amp;#160;&amp;#160;All of the cases about &lt;font style="DI
SPLAY: inline; FONT-STYLE: italic"&gt;TRAVATAN&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174; &lt;/font&gt;and&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#160;&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;TRAVATAN Z&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt; (Barr, Par and Apotex) have now been consolidated.&amp;#160;&amp;#160;Trial has been scheduled for March 7, 2011.&amp;#160;&amp;#160;Subject to the possibility of the 180-day exclusivity period that could accrue to Barr (as first filer) relative to the &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;TRAVATAN&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic"&gt;&amp;#174;&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;&amp;#160;&lt;/font&gt;product, if Par succeeds in overcoming all of t
he challenged patents and secures FDA approval, it would be entitled to begin selling generic travoprost products that would compete with Alcon's&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic"&gt;&amp;#160;&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;TRAVATAN&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic"&gt; &amp;#174;&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;&amp;#160;&lt;/font&gt;and &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;TRAVATAN Z&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic"&gt;&amp;#174; &lt;/font&gt;products in the United States in December 2011.&amp;#160;&amp;#160;Such competition would be expected to impact significantly the Company's sales and profits.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;
/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The tenth ANDA patent suit was filed after Alcon received notice by letter dated June 24, 2009, that Barr Laboratories, Inc. had filed a Paragraph IV certification with its ANDA for a generic version of Alcon's &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;TRAVATAN Z&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic"&gt;&amp;#174;&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#160;&lt;/font&gt;product.&amp;#160;&amp;#160;Barr is challenging the following patents listed in the Orange Book for &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;TRAVATAN Z&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic"&gt;&amp;#174;&lt;/font&gt;:&amp;#160;&amp;#
160;U.S. Patent Nos. 5,510,383; 5,889,052; 6,503,497; and 6,849,253.&amp;#160;&amp;#160;All of the patents will expire by the end of 2014.&amp;#160;&amp;#160;On July 13, 2009, Alcon filed suit in the U.S. District Court in Delaware, thereby securing a statutory stay under which the FDA must delay any approval of the Barr ANDA until December 2011, unless the litigation is earlier resolved or the court modifies the 30-month stay on FDA approval.&amp;#160;&amp;#160;Trial has been scheduled for March 7, 2011 in this case, which has been consolidated with the above-described Barr suit (&lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;TRAVATAN&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic"&gt;&amp;#174;&lt;/font&gt;) and Par suit (&lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;TRAVATAN&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic"&gt;&amp;#174;&lt;/font&gt; and &lt;font style="DI
SPLAY: inline; FONT-STYLE: italic"&gt;TRAVATAN Z&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic"&gt;&amp;#174;&lt;/font&gt;) and consolidated further to include the Apotex suit (&lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;TRAVATAN&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt;) described below.&amp;#160;&amp;#160;Subject to the possibility of the 180-day exclusivity period that could accrue to Par (as first filer) relative to the &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;TRAVATAN Z&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic"&gt;&amp;#174;&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#160;&lt;/font&gt;product, if Barr succeeds in overcoming all of the challenged patents and secures FDA approval, it would be entitled to begin selling a generic travop
rost product that would compete with Alcon's &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;TRAVATAN Z&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic"&gt;&amp;#174;&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#160;&lt;/font&gt;product in the United States in December 2011.&amp;#160;&amp;#160;Such competition would be expected to impact significantly the Company's sales and profits.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The eleventh ANDA patent suit was filed after Alcon received notice by letter dated September 11, 2009, that Apotex Corp. and Apotex Inc. had filed an ANDA for a generic version of Alcon's &lt;font style="DISPLAY: inline; FONT-STYLE:
 italic"&gt;TRAVATAN&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic"&gt;&amp;#174;&lt;/font&gt; product.&amp;#160;&amp;#160;Apotex is challenging all five of the Orange Book listed patents for &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;TRAVATAN&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic"&gt;&amp;#174;&lt;/font&gt;: 5,510,383; 5,631,287; 5,849,792; 5,889,052; and 6,011,062.&amp;#160;&amp;#160;Alcon filed suit in the U.S. District Court in Delaware, thereby securing a statutory stay under which the FDA must delay any approval of the Barr ANDA until March 2012, unless the litigation is earlier resolved or the court modifies the 30-month stay on FDA approval.&amp;#160;&amp;#160;This case has been consolidated with the Barr and Par cases (&lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;TRAVATAN&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: te
xt-top"&gt;&amp;#174; &lt;/font&gt;and &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;TRAVATAN Z&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt;)&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#160;&lt;/font&gt;described above.&amp;#160;&amp;#160;Trial has been scheduled for March 7, 2011.&amp;#160;&amp;#160;Subject to the possibility of the 180-day exclusivity period that could accrue to Barr (as first filer) relative to the &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;TRAVATAN&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic"&gt;&amp;#174;&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;&amp;#160;&lt;/font&gt;product, if Apotex succeeds in overcoming all of the challenged patents and secures FDA approval, it would be entitled to begin selling a generic travoprost product that would compete with Alcon's&lt;font s
tyle="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic"&gt;&amp;#160;&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;TRAVATAN&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic"&gt; &amp;#174;&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;&amp;#160;&lt;/font&gt;product in the United States in March 2012.&amp;#160;&amp;#160;Such competition would be expected to impact significantly the Company's sales and profits.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Alcon received notice dated October 19, 2009, that Apotex Corp. and Apotex Inc. have filed an ANDA challenging U.S. Patent No. 5,116,863, which covers Alcon's &lt;font style="DISPLAY: inline; F
ONT-STYLE: italic"&gt;Patanase&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt; olopatadine hydrochloride nasal spray solution. The patent, which is owned by Alcon's raw material supplier, Kyowa Hakko Kirin Co., Ltd., and licensed to Alcon, has a term extended by regulatory exclusivity that expires October 15, 2011.&amp;#160;&amp;#160;Alcon had until December 3, 2009, to file suit and avail itself of the statutory stay on FDA approval of the ANDA.&amp;#160;&amp;#160;Had suit been filed by that date, the FDA could not have approved the Apotex ANDA for 30 months unless the litigation were earlier resolved or the court modified the 30-month stay on FDA approval.&amp;#160;&amp;#160;In this case, however, the 30-month period would be shortened to coincide with the expiration date of the challenged patent in December 2010 and therefore would be inconsequential.&amp;#160;&amp;#160;Moreover, Alcon has regulatory exclusivity for the &lt;font style="DISP
LAY: inline; FONT-STYLE: italic"&gt;Patanase&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic"&gt;&amp;#174; &lt;/font&gt;product&lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;&amp;#160;&lt;/font&gt;extending until October 2011.&amp;#160;&amp;#160;Under these circumstances, Alcon and Kyowa elected not to file suit.&amp;#160;&amp;#160;Alcon also has additional pending patent applications that are potentially relevant to the &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Patanase&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic"&gt;&amp;#174;&lt;/font&gt; product, which are not currently listed in the FDA Orange Book, and which have not been challenged by Apotex.&amp;#160;&amp;#160;These pending applications may or may not issue and may not cover the &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Patanase&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTIC
AL-ALIGN: text-top; FONT-STYLE: italic"&gt;&amp;#174;&lt;/font&gt; product.&amp;#160;&amp;#160;Should Apotex succeed in securing FDA approval and overcoming the challenged patent and any other applicable patents that may issue, it would be entitled to immediately begin selling a generic olopatadine product that would compete with Alcon's &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Patanase&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt; product in the United States.&amp;#160;&amp;#160;Such competition would be expected to impact significantly the Company's sales and profits.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&amp;#160;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The twelfth ANDA patent suit
 was filed after Alcon received notice on December 15, 2009 that Sandoz Inc. (an affiliate of Novartis), had filed an ANDA with a Paragraph IV certification directed to the Alcon and Kyowa patents &lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;on &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Pataday&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#8482;&lt;/font&gt;.&amp;#160;&amp;#160;The Sandoz ANDA is challenging the patent jointly owned by Kyowa and Alcon (described above), as well as two later issued patents owned by Alcon that cover the &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Pataday&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#8482;&lt;/font&gt; formulation.&amp;#160;&amp;#160;Of the two Alcon patents, the latest expiry date is November 2023.&amp;#160;&amp;#160;Sandoz is not challenging the Kyowa patent on olopatadine that expires 
in December 2010 (effectively extended until June 2011 by a pediatric extension).&amp;#160;&amp;#160;On January 27, 2010, Alcon and Kyowa filed suit in the Federal District Court in Indianapolis.&amp;#160;&amp;#160;Because the suit was filed within the statutory 45-day period, the FDA must delay any approval of the Sandoz ANDA for 30 months (until June 2012) unless the litigation is earlier resolved or the court modifies the 30-month stay on FDA approval.&amp;#160;&amp;#160;However, because Sandoz is the third filer (behind both Barr and Apotex) and subject to a potential 180-day exclusivity period of the first filer, the 30-month stay is of no practical consequence.&amp;#160;&amp;#160;Subject to the possibility of the 180-day exclusivity period that potentially could accrue to Barr (as first filer) relative to the &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Pataday&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#8482;&lt;/font&gt; product, if Sando
z were to succeed in overcoming all the challenged patents and to secure FDA approval, it would be entitled to begin selling a generic product that would compete with Alcon's &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Pataday&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#8482;&lt;/font&gt; product in the United States.&amp;#160;&amp;#160;Such competition would be expected to impact significantly the Company's sales and profits.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The thirteenth ANDA patent suit was filed after Alcon received notice that Wockhardt Limited (headquartered in India) had filed an ANDA with a Paragraph IV certification for a generic version of Alcon's &lt;font style="
DISPLAY: inline; FONT-STYLE: italic"&gt;Patanol&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt; product.&amp;#160;&amp;#160;Wockhardt is challenging U.S. Patent No. 5,641,805, which is jointly owned by Alcon and its raw material supplier, Kyowa Hakko Kirin Co., Ltd.&amp;#160;&amp;#160;The challenged patent will expire in 2015.&amp;#160;&amp;#160;Wockhardt is not challenging, however, another Kyowa-owned U.S. patent covering &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Patanol&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt;, which expires on December 18, 2010 (effectively extended until June 2011 by a pediatric extension).&amp;#160;&amp;#160;Consequently, Wockhardt's generic challenge poses no threat to the &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Patanol&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;
&lt;/font&gt; product market prior to June 2011.&amp;#160;&amp;#160;Alcon and Kyowa filed suit against Wockhardt in the Federal District Court in Indianapolis on February 12, 2010, to avail themselves of the statutory 30-month stay on FDA approval of the proposed generic product.&amp;#160;&amp;#160;That 30-month period will expire August 2, 2012, unless the litigation is earlier resolved or the court modifies the 30-month stay on FDA approval.&amp;#160;&amp;#160;However, as a third ANDA filer (behind both Apotex and Sandoz), Wockhardt would not be entitled to receive FDA approval until the expiration or forfeiture of a 180-day exclusivity period that would be granted to Apotex (the first filer) if it were successful in its patent challenge.&amp;#160;&amp;#160;Subject to the possibility of such a 180-day exclusivity period that could potentially accrue to Apotex (as first filer) relative to the &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Patanol&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SI
ZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt; product, if Wockhardt were to succeed in overcoming the challenged patent and to secure FDA approval, it would be entitled to begin selling a generic product that would compete with Alcon's &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Patanol&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt; product in the United States.&amp;#160;&amp;#160;Such competition would be expected to impact significantly the Company's sales and profits.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The fourteenth patent suit was filed after Apotex, Inc. notified Alcon Canada that Apotex had filed an ANDS seeking approval from the Canadian Minister of Health to m
arket a generic version of Alcon's Patanol&amp;#174; product.&amp;#160;&amp;#160;The Apotex ANDS is challenging only one of the two patents listed in the Canadian Patent Register for the Patanol&amp;#174; product.&amp;#160;&amp;#160;The challenged patent (Canadian Patent No. 2,195,094) is jointly owned by Kyowa and Alcon and expires in May 2016.&amp;#160;&amp;#160;Alcon and Kyowa, by timely initiating this action, are entitled to a 24-month delay (until April 2012) in the regulatory approval from the Minister of Health, which can only be shortened if the litigation is earlier resolved or the court modifies the 24-month stay on such approval.&amp;#160;&amp;#160;Should Apotex succeed in overcoming the challenged patent and secure Minister of Health approval, it would be entitled to begin selling a generic olopatadine product that would compete with Alcon's Patanol&amp;#174; product in Canada well before the patent expiration in 2016, but not before expiration of the unchallenged patent in November 2012.&amp;#1
60;&amp;#160;Such competition would be expected to impact the Company's sales and profits.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Alcon is also enforcing patents against generic challengers in China (Patanol&amp;#174;) and Chile (Vigamox&amp;#174;).&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&amp;#160;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;On April 16, 2008, Synergetics USA, Inc., a microsurgical device company, filed a civil antitrust lawsuit in the U.S. District Court for the Southern District of New York against the Company 
and its subsidiary, Alcon Laboratories, Inc.&amp;#160;&amp;#160;Synergetics asserted that it had suffered losses resulting from alleged unlawful/unfair practices and sought a recovery that it claimed could exceed $100.&amp;#160;&amp;#160;Synergetics also asserted that Alcon engaged in allegedly anti-competitive behavior.&amp;#160;&amp;#160;On June 23, 2008, the Company filed its answer and counterclaim in the district court.&amp;#160;&amp;#160;In 2008 and 2009, subsidiaries of the Company filed suits against Synergetics for patent infringement in the U.S. District Court for the Northern District of Texas in Fort Worth.&amp;#160;&amp;#160;Synergetics answered the complaints.&amp;#160;&amp;#160;A series of &lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;counterclaims and motions followed.&amp;#160;&amp;#160;On April 23, 2010, the parties entered a Confidential Settlement and License Agreement together with a Supply Agreement.&amp;#160;&amp;#160;Under the agreemen
ts, Alcon will pay $32 in exchange for worldwide rights to sell Synergetics patented vitreoretinal products.&amp;#160;&amp;#160;The products will be manufactured by Synergetics and supplied to Alcon.&amp;#160;&amp;#160;The agreements also settle all pending litigation between Alcon and Synergetics, including both the antitrust and the patent litigation, and provide a process for future dispute resolution.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;On December 18, 2008, James M. Nielsen, M.D. filed a patent infringement suit against Alcon, Inc. and Alcon Laboratories, Inc. in the U.S. District Court for the Northern District of Texas in Dallas.&amp;#160;&amp;#160;Dr. Nielsen is asserting that his U.S. Patent No. 5,158,572 entitled "Multifocal Intra
ocular Lens" is being infringed by the Company's &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;AcrySof&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic"&gt;&amp;#174;&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt; ReSTOR&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;&amp;#160;&lt;/font&gt;intraocular lens.&amp;#160;&amp;#160;The patent, which expired at the end of October 2009, was previously licensed to Advanced Medical Optics, Inc.&amp;#160;&amp;#160;Alcon filed its Answer January 12, 2009.&amp;#160;&amp;#160;The Answer included a counterclaim for a declaratory judgment that the patent-in-suit is invalid and not infringed.&amp;#160;&amp;#160;The case has been set for trial in August, 2010.&amp;#160;&amp;#160;An adverse ruling by the court, while possible, would not be expected to impact significant
ly the Company's sales and profits.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;On January 22, 2009, Elan Pharma International Ltd. sued two of the Company's subsidiaries, Alcon Laboratories, Inc. and Alcon Research, Ltd., in the U.S. District Court for the Eastern District of Texas in Sherman, alleging infringement of two Elan patents on nanoparticle technology (U.S. Patent Nos. 5,298,262 and 5,429,842).&amp;#160;&amp;#160;The complaint claims that the Company's &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Azopt&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic"&gt;&amp;#174;&lt;/font&gt; product and, potentially, other products infringe the two patents.&amp;#160;&amp;#160;The Company answered and counte
rclaimed on May 12, 2009.&amp;#160;&amp;#160;Elan then moved to dismiss certain of the Company's affirmative defenses and counterclaims.&amp;#160;&amp;#160;The Company has filed an amended answer and counterclaims providing greater detail with respect to the Company's inequitable conduct counterclaims.&amp;#160;&amp;#160;The case has been set for trial March 21, 2011.&amp;#160;&amp;#160;The Company believes that it has strong defenses and intends to defend itself vigorously.&amp;#160;&amp;#160;An adverse ruling by the court, however, could impact significantly the Company's sales and profits.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The Company and its subsidiaries are parties to a variety of other legal proceedings arising out of the ordinary course of business, incl
uding proceedings relating to product liability and patent infringement.&amp;#160;&amp;#160;The Company believes that it has valid defenses and is vigorously defending the litigation pending against it.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;While the results of the aforementioned contingencies cannot be predicted with certainty, management believes that the ultimate liability, if any, will not have a material adverse effect on the Company's consolidated financial position or results of operations.&amp;#160;&amp;#160;Litigation contingencies are subject to change based on settlements and court decisions.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18
pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The Company may be subject to future litigation and infringement claims, which could cause the Company to incur significant expenses or prevent the Company from selling its products.&amp;#160;&amp;#160;The Company operates in an industry susceptible to significant product liability claims.&amp;#160;&amp;#160;Product liability claims may be asserted against the Company in the future arising out of events not known to the Company at the present time.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The Company self-insures through captive insurance subsidiaries almost all of its property and casualty, business interruption and liability risks.&lt;/font&gt;&l
t;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;In the normal course of business, the Company has entered into research and development arrangements with third parties that require milestone and royalty payments to the third parties contingent upon certain future events linked to the success of the research and development efforts.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&amp;#160;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="LETTER-SPACING: 9pt"&gt;D&lt;/font&gt;uring 2008, Lehman Brothers International (Europe) London filed for administ
ration in England.&amp;#160;&amp;#160;At that time, the Company's cash and cash equivalents included $707 of short term securities held in a segregated custodial account of Lehman Brothers International (Europe) London pursuant to a Custody Agreement.&amp;#160;&amp;#160;Nestl&amp;#233; invoiced the Company in December 2008 and, in 2009, the Company reimbursed Nestl&amp;#233;, for a total of $5 in fees paid by Nestl&amp;#233; to the Joint Administrators of Lehman Brothers International (Europe) London (in administration) related to the release of the short-term securities held in the custodial account.&amp;#160;&amp;#160;This amount of fees is subject to adjustment depending on the final costs incurred to settle the administration of Lehman Brothers International (Europe) London. &lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;In order to receive an expedited return of assets held by Lehman Brothers International (Europe) (in administration), Alcon has agreed to
 return any assets which the Joint Administrators determine should not have been disbursed in settlement.&amp;#160;&amp;#160;The amount of any funds to be returned, if any, would result from the determination by the Joint Administrators that the rights of another claimant in the proceeding have precedence over the Company's claim.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
  <!--Other, net-->
  <us-gaap:AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesOther unitRef="u000" decimals="-6" contextRef="c00003">2000000</us-gaap:AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesOther>
  <!--Other, net-->
  <us-gaap:AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesOther unitRef="u000" decimals="-6" contextRef="c00004">3000000</us-gaap:AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesOther>
  <!--Deferred income taxes-->
  <us-gaap:DeferredIncomeTaxExpenseBenefit unitRef="u000" decimals="-6" contextRef="c00003">21000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
  <!--Deferred income taxes-->
  <us-gaap:DeferredIncomeTaxExpenseBenefit unitRef="u000" decimals="-6" contextRef="c00004">76000000</us-gaap:DeferredIncomeTaxExpenseBenefit>
  <!--Gain (loss) from foreign currency, net-->
  <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax unitRef="u000" decimals="-6" contextRef="c00003">-2000000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
  <!--Gain (loss) from foreign currency, net-->
  <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax unitRef="u000" decimals="-6" contextRef="c00004">-10000000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
  <!--Research and development-->
  <us-gaap:ResearchAndDevelopmentExpense unitRef="u000" decimals="-6" contextRef="c00003">169000000</us-gaap:ResearchAndDevelopmentExpense>
  <!--Research and development-->
  <us-gaap:ResearchAndDevelopmentExpense unitRef="u000" decimals="-6" contextRef="c00004">146000000</us-gaap:ResearchAndDevelopmentExpense>
  <!--Gross profit-->
  <us-gaap:GrossProfit unitRef="u000" decimals="-6" contextRef="c00003">1329000000</us-gaap:GrossProfit>
  <!--Gross profit-->
  <us-gaap:GrossProfit unitRef="u000" decimals="-6" contextRef="c00004">1139000000</us-gaap:GrossProfit>
  <!--Common shares, shares outstanding-->
  <us-gaap:CommonStockSharesOutstanding unitRef="u001" decimals="0" contextRef="c00002">300232045</us-gaap:CommonStockSharesOutstanding>
  <!--Common shares, shares outstanding-->
  <us-gaap:CommonStockSharesOutstanding unitRef="u001" decimals="0" contextRef="c00001">299550733</us-gaap:CommonStockSharesOutstanding>
  <!--Total shareholders' equity-->
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest unitRef="u000" decimals="-6" contextRef="c00002">6466000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <!--Total shareholders' equity-->
  <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest unitRef="u000" decimals="-6" contextRef="c00001">5905000000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
  <!--Goodwill-->
  <us-gaap:Goodwill unitRef="u000" decimals="-6" contextRef="c00002">700000000</us-gaap:Goodwill>
  <!--Goodwill-->
  <us-gaap:Goodwill unitRef="u000" decimals="-6" contextRef="c00001">688000000</us-gaap:Goodwill>
  <!--Investments-->
  <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock contextRef="c00003">&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr valign="top"&gt;&lt;td style="WIDTH: 18pt" align="right"&gt;&lt;div&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;(5)&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Investments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;(in millions, except per share data)&lt;/f
ont&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&amp;#160;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 14.4pt"&gt;&lt;/font&gt;At March 31, 2010 and December 31, 2009, investments were:&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td s
tyle="PADDING-BOTTOM: 0.5pt" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;March 31&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;December 31,&lt;/font
&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px; BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: center" valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2010&lt;/font&gt;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEX
T-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: center" valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;font style="FONT-WEIGHT: bold"&gt;2009&lt;/font&gt;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10p
t; FONT-FAMILY: times new roman"&gt;Short term investments:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&g
t;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Trading securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;8&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;
#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;22&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;A
vailable-for-sale investments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;534&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZ
E: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;457&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&l
t;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; F
ONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Total short term investments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style=
"BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;542&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;479&lt;/font&gt;&lt;/td&gt;&lt;td st
yle="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt
; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 
10pt; FONT-FAMILY: times new roman"&gt;Long term investments&amp;#8212;available-for-sale investments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;64&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" w
idth="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;73&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-
FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font st
yle="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 14.4pt"&gt;&lt;/font&gt;At March 31, 2010 and December 31, 2009, trading securities were:&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table style="FONT-SIZE: 1
0pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="6"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;March 31, 2010&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt
;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="6"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;December 31, 2009&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMIL
Y: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Net&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Estimated&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: lef
t" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Net&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&
lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Estimated&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt
;Unrealized&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Fair&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"
&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Unrealized&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Fair&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom
" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Gains (Losses)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FO
NT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;t
d style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Gains (Losses)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new 
roman"&gt;Value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new 
roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="
bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Total trading securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: 
times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(5&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times ne
w roman"&gt;8&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(9&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: time
s new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;22&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="52%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font
&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&
amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY:
 inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10p
t; FONT-FAMILY: Times New Roman"&gt;At March 31, 2010, available-for-sale investments were:&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr&gt;&lt;td valign="bottom" width="52%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT
- -FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Gross&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT
- -INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Gross&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Estimated&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 
10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="52%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Amortized&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bo
ld; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Unrealized&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new 
roman"&gt;Unrealized&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Fair&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bott
om" width="52%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" width="10%" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Cost&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIG
HT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" width="10%" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Gains&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" width="10%" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT
: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Losses&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" width="10%" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" va
lign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Short term investments:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td vali
gn="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&l
t;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;U.S. government and agency securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td sty
le="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;128&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font
&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FA
MILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;128&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Mortgage-backed securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT
- -FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;12&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;
font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td va
lign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;12&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Senior secured bank loans fund&lt;/font&gt;&lt;/div&gt;&lt;/
td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;80&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new 
roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;17&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style=
"DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;97&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline;
 FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Corporate debt securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;266&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: le
ft" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(1 &lt;/font
&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;265&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARG
IN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Equity securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;30&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT
- -FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;1&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;f
ont style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;31&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt
;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Other investments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;1&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="now
rap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom" align
="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT
- -ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;1&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="52%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt
; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" wi
dth="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" 
valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Total short term investments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times
 new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;517&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE
: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;18&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="
DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(1 &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;534&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&
lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="52%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"
 width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;
td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY
: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Long term investments:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY
: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE:
 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowra
p" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;U.S. government and agency securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;58&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign=
"bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font
&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(1 &lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMIL
Y: times new roman"&gt;57&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Mortgage-backed securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt;
 FONT-FAMILY: times new roman"&gt;5&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;
font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEX
T-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;5&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Equity securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE:
 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLA
Y: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;fo
nt style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="52%"&gt;&lt;font style="DISPLAY
: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;
font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALI
GN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LE
FT: 0pt; TEXT-INDENT: 27pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Total long term investments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;65&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt
;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&am
p;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(1 &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;64&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="52%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="
bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/
font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&
gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Total available-for-sale investments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN
: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;582&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIG
N: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;18&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(2&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" v
align="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;598&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width
="52%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" v
align="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;
&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div
&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The senior secured bank loans fund is a professionally managed fund investing in loans made by banks to large corporate borrowers whose assets are pledged as collateral.&lt;/font&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;At December 31, 2009, available-for-sale investments were as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;
&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Gross&lt;/font&gt
;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Gross&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/fon
t&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Estimated&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: 
bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Amortized&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Unrealized&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-
WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Unrealized&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Fair&lt;/font&gt;&lt;/div&
gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Cost&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;
font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Gains&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new
 roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Losses&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold
; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Short term investments:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FO
NT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&
lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;U.S. government and agency securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-
ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;129&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/
td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(1&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new ro
man"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;128&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Mortgage-backed securities fund&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: time
s new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;75&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="D
ISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;7&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" 
align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;82&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Mortgage-backed securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valig
n="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;6&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160
;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; F
ONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;6&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FO
NT-FAMILY: times new roman"&gt;Senior secured bank loans fund&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;131&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bot
tom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;23&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&
lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;154&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT
: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Corporate debt securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;43&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FON
T-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt
;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;43&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&
gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Equity securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;29&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td
 valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&a
mp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;29&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: in
line; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Other investments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;1
5&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY:
 times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FO
NT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;15&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="52%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&
lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: 
times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inli
ne; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Total short term investments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM:
 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;428&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORD
ER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;30&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;
/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(1 &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;457&lt;/f
ont&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="52%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DIS
PLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&
lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-
ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Long term investments:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-
ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font
&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAM
ILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;U.S. government and agency securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inl
ine; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;52&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="rig
ht" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(1 &lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt
;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;51&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Mortgage-backed securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt
;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;10&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; F
ONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font styl
e="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;10&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Equity securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font st
yle="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" 
valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&l
t;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Other investments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; F
ONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;8&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font s
tyle="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom"
 width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;10&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="b
ottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="52%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/fon
t&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY
: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Total long term investments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times n
ew roman"&gt;72&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt;
 FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(1 &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10p
t; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;73&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="52%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font
&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAM
ILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY:
 inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Total available-for-sale investments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADD
ING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;500&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOT
TOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;32&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOT
TOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(2&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;530&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 
4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="52%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; F
ONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width
="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The senior secured bank loans fund is a professionally managed fund investing in loans made by banks to large corporate borrowers whose assets are pledged as collateral.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The contractual maturities of available-for-sale investments at March 31, 2010 were:&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TE
XT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div 
style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Estimated&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Amorti
zed&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Fair&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-
FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Cost&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTT
OM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" v
align="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Securities not due at a single maturity date*&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&
lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;81&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right"
 valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;98&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Other debt securities, maturing:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: righ
t" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp
;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Within one year&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;128&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&am
p;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;128&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;After 1 year throug
h 10 years&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;322&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline;
 FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;321&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;After 10 years through 15 years&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style=
"DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" val
ign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Beyond 15 years&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="
DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;19&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;18&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1
%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="
bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Total debt securities recorded at market&lt;/font&gt;&lt;/div&gt;&lt;/td
&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;550&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new r
oman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;565&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-S
IZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING
- -BOTTOM: 0.5pt" valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Equity and other investments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;32&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"
&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;33&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font
 style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" wid
th="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Total available-for-sale investments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;582&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new 
roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;598&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="
9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td
&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" colspan="8"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;*Mortgage-backed securities and a senior secured bank loans fund.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&
amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY:
 inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&amp;#160;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font&gt;Activities related to available-for-sale investments were as shown below.&amp;#160;&amp;#160;The cost of securities was based on the specific identification method.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&l
t;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="6"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="6"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt
;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Three months ended&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;March 31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style=
"BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2010&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2009&lt;
/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160
;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Proceeds from sales and principal repayments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/
font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;506&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;1&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt;
 FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; 
FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Gross realized gains on sales&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font 
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;19&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALI
GN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt
;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGI
N-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Gross realized losses on sales&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SI
ZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;fon
t style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN:
 left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The net unrealized holding gains (losses) for available-for-sale investments included in accumulated other comprehensive income (loss) in shareholders' equity at March 31, 2010 and December 31, 2009 were $16 and $30, respectively.&amp;#160;&amp;#160;Net unrealized holding gains on trading securities included in earnings for the three months ended March 31, 2010 and 2009 were $4 and $40, respectively.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; T
EXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The changes in net unrealized gains (losses) on investments, net of taxes, included in accumulated other comprehensive income (loss) were:&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bott
om" colspan="6"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Three months ended&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;March 31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: in
line; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2010&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align=
"center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2009&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td
&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Changes in unrealized holding gains arising during the period&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style
="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;5&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;3&lt;/font&gt;&
lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Reclassification adjustment for gains included in net income&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-
BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(19 &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(1 &lt;/font&gt;&lt;/td&gt;&lt;td st
yle="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-
FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt
; FONT-FAMILY: times new roman"&gt;Changes in net unrealized gains (losses) on investments, net of taxes&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(14&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width=
"1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY
: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="D
ISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign
="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0
pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font&gt;As of March 31, 2010, gross unrealized losses and fair value of individual securities with unrealized losses greater than $1 that were not deemed to be other-than-temporarily impaired, summarized by investment category and length of time the individual securities had been in a continuous unrealized loss position, were:&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr&gt;&lt;td valign="bottom" width="25%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;
#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" width="17%" colspan="5"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Less than 12 months&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" width="17%" colspan="5"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;12 months or greater&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &l
t;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" width="18%" colspan="5"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="25%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="5%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FO
NT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Fair&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="8%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Unrealized&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td 
valign="bottom" width="5%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Fair&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="8%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Unrealized&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;
/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="6%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Fair&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="8%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Unrealized&lt;/font&gt;&l
t;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="25%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" width="5%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/
td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" width="8%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Losses&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" width="5%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt;
 MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" width="8%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Losses&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td sty
le="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" width="6%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" width="8%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0p
t" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Losses&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="25%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="5%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY:
 inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="8%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="5%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt
;&lt;td valign="bottom" width="8%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="6%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="8%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-
FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="25%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Long term investments:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="5%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" wi
dth="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="8%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="5%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&g
t;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="8%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="6%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="8%"&gt;&lt;font style="DIS
PLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="25%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 7.35pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;U.S. government and agencies&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 7.35pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="MARGIN-LEFT: 18.4pt"&gt;&lt;/font&gt;securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font styl
e="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="5%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="left" width="1%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="8%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY
: times new roman"&gt;(1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="left" width="1%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="5%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&g
t;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="8%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="ri
ght" width="6%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="8%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="left" width="1%"&gt;&lt;div style="DISPLAY: blo
ck; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font&gt;As of December 31, 2009, there were no gross unrealized losses on available-for-sale investments greater than $1.&lt;/font&gt;&lt;/div&gt;&lt;div&gt;&amp;#160;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"&gt;Investment Income&lt;/font&
gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font&gt;In the condensed consolidated statements of earnings, other, net, included gains (losses) on investments as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: in
line; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="6"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Three months ended&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;March 31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline;
 FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2010&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&l
t;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2009&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td styl
e="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Realized gains (losses) on sale of investments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" ali
gn="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;15&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td
 style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(36&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Net unrealized gains on investments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td
 style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: 
times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;classified as trading securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;4&lt;/font&gt;&lt;/t
d&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;40&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt
;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: tim
es new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Net gains on investments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width
="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;19&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bott
om" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;4&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
  <!--Net cash from operating activities-->
  <us-gaap:NetCashProvidedByUsedInOperatingActivities unitRef="u000" decimals="-6" contextRef="c00003">388000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <!--Net cash from operating activities-->
  <us-gaap:NetCashProvidedByUsedInOperatingActivities unitRef="u000" decimals="-6" contextRef="c00004">409000000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
  <!--Tax benefits (reversals) from share-based compensation-->
  <us-gaap:ExcessTaxBenefitFromShareBasedCompensationOperatingActivities unitRef="u000" decimals="-6" contextRef="c00003">2000000</us-gaap:ExcessTaxBenefitFromShareBasedCompensationOperatingActivities>
  <!--Tax benefits (reversals) from share-based compensation-->
  <us-gaap:ExcessTaxBenefitFromShareBasedCompensationOperatingActivities unitRef="u000" decimals="-6" contextRef="c00004">-2000000</us-gaap:ExcessTaxBenefitFromShareBasedCompensationOperatingActivities>
  <!--Depreciation-->
  <us-gaap:Depreciation unitRef="u000" decimals="-6" contextRef="c00003">51000000</us-gaap:Depreciation>
  <!--Depreciation-->
  <us-gaap:Depreciation unitRef="u000" decimals="-6" contextRef="c00004">44000000</us-gaap:Depreciation>
  <!--Other long term liabilities-->
  <us-gaap:OtherLiabilitiesNoncurrent unitRef="u000" decimals="-6" contextRef="c00002">723000000</us-gaap:OtherLiabilitiesNoncurrent>
  <!--Other long term liabilities-->
  <us-gaap:OtherLiabilitiesNoncurrent unitRef="u000" decimals="-6" contextRef="c00001">691000000</us-gaap:OtherLiabilitiesNoncurrent>
  <!--Long term debt, net of current maturities-->
  <us-gaap:LongTermDebtNoncurrent unitRef="u000" decimals="-6" contextRef="c00002">0</us-gaap:LongTermDebtNoncurrent>
  <!--Long term debt, net of current maturities-->
  <us-gaap:LongTermDebtNoncurrent unitRef="u000" decimals="-6" contextRef="c00001">56000000</us-gaap:LongTermDebtNoncurrent>
  <!--Earnings Per Share-->
  <us-gaap:EarningsPerSharePolicyTextBlock contextRef="c00003">&lt;div&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr valign="top"&gt;&lt;td style="WIDTH: 18pt" align="right"&gt;&lt;div&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;(2)&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Earnings Per Share&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;&lt;/font&gt;&lt;font style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;(in millions, except per share data)&lt;/font&gt;&lt;br /&gt;&amp;#160;&lt;/div&gt;&lt;div style="DIS
PLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Basic earnings per common share were computed by dividing net earnings by the weighted average number of common shares outstanding for the relevant period.&amp;#160;&amp;#160;The unvested portion of restricted common shares was excluded in the calculation of basic weighted average common shares outstanding.&amp;#160;&amp;#160;Diluted weighted average common shares reflect the potential dilution, using the treasury stock method, that could occur if employee stock options for the purchase of common shares and share-settled stock appreciation rights were exercised and if share-settled restricted share units, performance share units and contingent restricted common shares granted to employees were vested.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 
0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The following table reconciles the weighted average shares of the basic and diluted share computations:&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" width="20%" colspan="4"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-
WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Three months ended March 31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" width="10%"&gt;&lt;div style="DISP
LAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2010&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="2%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" width="7%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2009&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td 
valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="10%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="2%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SI
ZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="7%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Basic weighted average common shares outstanding&lt;/font&gt;&lt;/div&gt;&lt;/
td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;299,980,871&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="2%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="7%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;298,581,689&lt;/font&gt;&lt;/d
iv&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Effect of dilutive securities:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="10%"&gt;&lt;font style="DISPLAY: inline; FO
NT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="2%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="7%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt
;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="MARGIN-LEFT: 17.5pt"&gt;&lt;/font&gt;Employee stock options&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2,087,235&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="2%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 1
0pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="7%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;1,261,409&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-S
IZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="MARGIN-LEFT: 17.5pt"&gt;&lt;/font&gt;Share-settled stock appreciation rights&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;1,126,119&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="2%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="7%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEX
T-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="MARGIN-LEFT: 17.5pt"&gt;&lt;/font&gt;Share-settled restricted share units and performance share units&lt;/font&gt
;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;334,272&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="2%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="7%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;45,349&lt;/font&
gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="MARGIN-LEFT: 17.5pt"&gt;&lt;/font&gt;Contingent restricted common shares&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td
 style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" align="right" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;41,501&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="2%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" align="right" width="7%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;126,688&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SI
ZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="10%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="2%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt
;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="7%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt
; FONT-FAMILY: times new roman"&gt;Diluted weighted average common shares outstanding&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;303,569,998&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="2%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="BO
RDER-BOTTOM: black 4px double" valign="bottom" align="right" width="7%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;300,015,135&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="10%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="2%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="7%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 
10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Certain executives of the Company had deferred the receipt of 119,188 and 141,954 Alcon common shares at March 31, 2010 and 2009, respectively, into the Alcon Executive Deferred Compensation Plan.&amp;#160;&amp;#160;Alcon common shares held in the plan were reflected as outstanding in the condensed consolidated balance sheets and were included in the applicable basic and diluted earnings per share calculations.&lt;/font&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 
0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&amp;#160;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The computations of diluted weighted average common shares outstanding for the periods ended March 31, 2010 and 2009 did not include the following instruments, as their exercise prices and unrecognized costs were greater than the average market price of the common shares:&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr&gt;&lt;td valign="top" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" w
idth="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="top" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2010&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" width="2%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="top" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="top" width="9%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: 
bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2009&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="top" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="10%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="2%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt
;/td&gt;&lt;td valign="top" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="top" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Stock options&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" align="right" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/d
iv&gt;&lt;/td&gt;&lt;td valign="top" width="2%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" align="right" width="9%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;728,392&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="top" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Share-settled stock
 appreciation rights&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" align="right" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;1,350&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" width="2%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" align="right" width="9%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;5
,514,471&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="top" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="10%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="2%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="9%"&gt;&lt;font s
tyle="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The effect of their inclusion would have been anti-dilutive.&lt;/font&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
  <!--Current maturities of long term debt-->
  <us-gaap:LongTermDebtCurrent unitRef="u000" decimals="-6" contextRef="c00002">54000000</us-gaap:LongTermDebtCurrent>
  <!--Current maturities of long term debt-->
  <us-gaap:LongTermDebtCurrent unitRef="u000" decimals="-6" contextRef="c00001">0</us-gaap:LongTermDebtCurrent>
  <!--Total current assets-->
  <us-gaap:AssetsCurrent unitRef="u000" decimals="-6" contextRef="c00002">6128000000</us-gaap:AssetsCurrent>
  <!--Total current assets-->
  <us-gaap:AssetsCurrent unitRef="u000" decimals="-6" contextRef="c00001">5833000000</us-gaap:AssetsCurrent>
  <!--Trade receivables, net-->
  <us-gaap:AccountsReceivableNetCurrent unitRef="u000" decimals="-6" contextRef="c00002">1456000000</us-gaap:AccountsReceivableNetCurrent>
  <!--Trade receivables, net-->
  <us-gaap:AccountsReceivableNetCurrent unitRef="u000" decimals="-6" contextRef="c00001">1346000000</us-gaap:AccountsReceivableNetCurrent>
  <!--Cash Flows-Supplemental Disclosures-->
  <us-gaap:CashFlowSupplementalDisclosuresTextBlock contextRef="c00003">&lt;div&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr valign="top"&gt;&lt;td style="WIDTH: 18pt" align="right"&gt;&lt;div&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;(3)&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Cash Flows &amp;#8211; Supplemental Disclosure&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;(in millions, except per share data)&lt;/font&gt;&lt;/font&gt;&lt;br /&gt;&lt;/div&gt;&lt;div al
ign="left"&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="6"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Three months ended March 31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: 
times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2010&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0
.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2009&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Supplemental Disclosure of Cash Flow Informatio
n&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&
lt;td valign="bottom" align="left"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Cash paid during the period for the following:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT
- -FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&
gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Interest expense, net of amount capitalized&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style
="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;3&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style
="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;5&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIG
N: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT:
 0pt; TEXT-INDENT: 27pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Income taxes&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;23&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style
="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;62&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&
lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-A
LIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:CashFlowSupplementalDisclosuresTextBlock>
  <!--Repayment of long term debt-->
  <us-gaap:RepaymentsOfLongTermDebt unitRef="u000" decimals="-6" contextRef="c00003">0</us-gaap:RepaymentsOfLongTermDebt>
  <!--Repayment of long term debt-->
  <us-gaap:RepaymentsOfLongTermDebt unitRef="u000" decimals="-6" contextRef="c00004">-1000000</us-gaap:RepaymentsOfLongTermDebt>
  <!--Trade receivables-->
  <us-gaap:IncreaseDecreaseInAccountsReceivable unitRef="u000" decimals="-6" contextRef="c00003">-139000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
  <!--Trade receivables-->
  <us-gaap:IncreaseDecreaseInAccountsReceivable unitRef="u000" decimals="-6" contextRef="c00004">-117000000</us-gaap:IncreaseDecreaseInAccountsReceivable>
  <!--Basic earnings per common share-->
  <us-gaap:EarningsPerShareBasic unitRef="u002" decimals="0" contextRef="c00003">1.91</us-gaap:EarningsPerShareBasic>
  <!--Basic earnings per common share-->
  <us-gaap:EarningsPerShareBasic unitRef="u002" decimals="0" contextRef="c00004">1.51</us-gaap:EarningsPerShareBasic>
  <!--Business Segments-->
  <us-gaap:SegmentReportingDisclosureTextBlock contextRef="c00003">&lt;div&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr valign="top"&gt;&lt;td style="WIDTH: 18pt" align="right"&gt;&lt;div&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;(10)&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Business Segments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;(in millions, except per share data)&lt;/font&gt;&lt;/font&gt;&lt;br /&gt;&amp;#160;&lt;/div&gt;&lt;div style="DISPLAY: block; MA
RGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font&gt;The Company conducts its global business through two business segments:&amp;#160;&amp;#160;Alcon United States and Alcon International.&amp;#160;&amp;#160;Alcon United States includes sales to unaffiliated customers located in the United States of America, excluding Puerto Rico.&amp;#160;&amp;#160;Alcon United States operating income is derived from operating profits within the United States.&amp;#160;&amp;#160;Alcon International includes sales to all other unaffiliated customers.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font&
gt;Each business segment markets and sells products principally in three product categories of the ophthalmic market: (1) pharmaceutical (prescription drugs), (2) surgical equipment and devices (cataract, vitreoretinal and refractive) and (3) consumer eye care (contact lens disinfectants and cleaning solutions, artificial tears and ocular vitamins).&amp;#160;&amp;#160;Business segment operations generally do not include research and development, certain manufacturing and other corporate functions.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font&gt;Certain manufacturing costs and manufacturing variances are not assigned to business segments because most manufacturing operations produce products for more than one business segment.
&amp;#160;&amp;#160;Research and development costs, excluding regulatory costs which are included in the business segments, are treated as general corporate costs and are not assigned to business segments.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font&gt;Identifiable assets are not assigned by business segment and are not considered in evaluating the performance of the business segments.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new 
roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign=
"bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: b
old; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="6"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: -0.15pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Depreciation and&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt sol
id" valign="bottom" colspan="6"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Sales&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="6"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Operating Income&lt;/font&gt;&lt;/div&
gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="6"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: -0.15pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Amortization&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td 
style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="left"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Three months ended March 31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2010&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: time
s new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2009&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5
pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2010&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2009&lt;/font&gt;&lt;/div&gt;&lt;
/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2010&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bo
ttom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2009&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="28%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;United States&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom
" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;726&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;
&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;658&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;431&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: tim
es new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;353&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FON
T-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;12&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;12&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"
&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="left" width="28%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;International&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAM
ILY: times new roman"&gt;995&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;835&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; F
ONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;463&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY
: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;379&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&
gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;28&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" v
align="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;20&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="28%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&
lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMIL
Y: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="
DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bott
om" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="28%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="MARGIN-LEFT: 15.75pt"&gt;&lt;/font&gt;Segments total&lt;/font
&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;1,721&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt;
 FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;1,493&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;894&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" w
idth="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;732&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td sty
le="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;40&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roma
n"&gt;32&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="28%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Manufacturing operations&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY
: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(17 &lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bo
ttom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(17 &lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;14&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt
;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;12&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="28%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Research and development&lt;/font&gt;&lt;/di
v&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: 
times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(150 &lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&l
t;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(119 &lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="b
ottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;4&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;4&lt;/font&gt;&lt;/td&gt;&
lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="28%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;General corporate&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;
&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: 
times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(56 &lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISP
LAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(59 &lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;4&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="rig
ht" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;3&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="left" width="28%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Share-based compensation&lt;/font&gt;&lt;/div&gt;&lt;/td
&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&
gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman
"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(18 &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMI
LY: times new roman"&gt;(23 &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 
10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="28%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-F
AMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT
- -SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap=
"nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-AL
IGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&
lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="28%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="MARGIN-LEFT: 15.75pt"&gt;&lt;/font&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTO
M: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;1,721&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;1,493&lt;/font&gt;&lt;/td&gt;&lt;td style="PADD
ING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;653&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;
td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;514&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td sty
le="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;62&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td sty
le="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;51&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&amp;#160;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font&gt;During the three months ended March 31, 2010, advancements in its sales reporting system permitted the Company to better estimate allowable deductions from sales in the calculation of accrued royalties.&amp;#160;&amp;#160;This change in estimate resulted in a $24 addition to U.S. operating income during t
he period.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font&gt;The Company incurred pretax expenses totaling $4 in the three months ended March 31, 2010 for costs related to the anticipated change of control discussed in note 13 and other costs to support Alcon's board of directors in its evaluation of Novartis's merger proposal.&amp;#160;&amp;#160;These expenses were included above in general corporate expenses.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;On February 11, 2009, the Company an
nounced that it initiated programs to align its operations with the evolving economic conditions and market environment.&amp;#160;&amp;#160;These programs included a staffing reduction of approximately 260 employee positions that resulted in a pretax charge of $18 for the three months ended March 31, 2009, which was included in general corporate expenses.&lt;/font&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
  <!--Intangible Assets and Goodwill-->
  <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock contextRef="c00003">&lt;div&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr valign="top"&gt;&lt;td style="WIDTH: 18pt" align="right"&gt;&lt;div&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;(7)&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Intangible Assets and Goodwill&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;(in millions, except per share data)&lt;/font&gt;&lt;/font&gt;&lt;br /&gt;&amp;#160;&lt;/div&gt;&lt;div al
ign="left"&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: center" valign="bottom" colspan="6"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;March 31, 2010&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman
"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px; BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="6"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;December 31, 2009&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISP
LAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Gross&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT
- -FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Gross&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style
="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Carrying&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;fon
t style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Accumulated&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roma
n"&gt;Carrying&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Accumulated&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT
- -SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Amount&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;t
d style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Amortization&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new ro
man"&gt;Amount&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Amortization&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td
&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;fon
t style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: tim
es new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Intangible Assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan
="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; F
ONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Subject to amortization:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&
gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DIS
PLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="MARGIN-LEFT: 36pt"&gt;&lt;/font&gt;Licensed technology&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="
1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;444&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(297&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: le
ft" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;332&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&l
t;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(296&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="MARGIN-LEFT: 36pt"&gt;&lt;/font&gt;Patents&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt
;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;278&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline
; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(29 &lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;111&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width
="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(24 &lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="MARGIN-LEFT: 36pt"&gt;&lt;/font&gt;Other&lt;/font&gt;&l
t;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;120&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&a
mp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(96 &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: time
s new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;121&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SI
ZE: 10pt; FONT-FAMILY: times new roman"&gt;(93 &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="52%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowra
p="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-
ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160
;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Total subject to amortization&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times ne
w roman"&gt;842&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(422 &lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inlin
e; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;564&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="b
ottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(413 &lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="52%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="
TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;
/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FON
T-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Not subject to amortization:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10p
t; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font styl
e="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right"
 valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Purchased in process research and &lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;development assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td styl
e="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;104&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font
&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new rom
an"&gt;104&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FON
T-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="52%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT
- -SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="
9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td
&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Total intangible assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;946&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" n
owrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(422&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right"
 width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;668&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valig
n="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(413&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;During the three months ended March 31, 2010, the Company added patents and licensed technology throu
gh a business acquisition and an asset purchase.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Minor changes in the carrying amount of goodwill for the three months ended March 31, 2010 were as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr&gt;&lt;td valign="bottom" width="64%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10
pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;United States&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Inte
rnational&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" width="64%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" vali
gn="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" width="10%" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Segment&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" width="10%" colsp
an="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Segment&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" width="10%" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Total&lt;/font&gt;&lt;/div&
gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="64%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Goodwill&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FON
T-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 
10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="64%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Balance, December 31, 2009&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;423&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE
: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;265&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font sty
le="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;688&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="64%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Acquisition of business&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font styl
e="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;16&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;5&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" va
lign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;21&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom" align="left" width="64%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt;
 TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Impact of changes in foreign exchange rates&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(5 &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/fon
t&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(4 &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt
;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(9 &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="64%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width
="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td st
yle="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="64%"&gt;&lt;div style="DISPLAY: block
; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Balance, March 31, 2010&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;434&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&g
t;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;266&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;
/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;700&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
  <!--Document Period End Date-->
  <dei:DocumentPeriodEndDate contextRef="c00003">2010-03-31</dei:DocumentPeriodEndDate>
  <!--Effect of exchange rates on cash and cash equivalents-->
  <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents unitRef="u000" decimals="-6" contextRef="c00003">-6000000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
  <!--Effect of exchange rates on cash and cash equivalents-->
  <us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents unitRef="u000" decimals="-6" contextRef="c00004">-3000000</us-gaap:EffectOfExchangeRateOnCashAndCashEquivalents>
  <!--Net cash from investing activities-->
  <us-gaap:NetCashProvidedByUsedInInvestingActivities unitRef="u000" decimals="-6" contextRef="c00003">-387000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <!--Net cash from investing activities-->
  <us-gaap:NetCashProvidedByUsedInInvestingActivities unitRef="u000" decimals="-6" contextRef="c00004">121000000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
  <!--Additional paid-in capital-->
  <us-gaap:AdditionalPaidInCapital unitRef="u000" decimals="-6" contextRef="c00002">1563000000</us-gaap:AdditionalPaidInCapital>
  <!--Additional paid-in capital-->
  <us-gaap:AdditionalPaidInCapital unitRef="u000" decimals="-6" contextRef="c00001">1535000000</us-gaap:AdditionalPaidInCapital>
  <!--Common shares, par value CHF 0.20 per share; 320,254,200 shares authorized, 304,184,709 shares issued and 300,232,045 shares outstanding at March 31, 2010; 304,016,290 shares issued and 299,550,733 shares outstanding at December 31, 2009-->
  <us-gaap:CommonStockValue unitRef="u000" decimals="-6" contextRef="c00002">42000000</us-gaap:CommonStockValue>
  <!--Common shares, par value CHF 0.20 per share; 320,254,200 shares authorized, 304,184,709 shares issued and 300,232,045 shares outstanding at March 31, 2010; 304,016,290 shares issued and 299,550,733 shares outstanding at December 31, 2009-->
  <us-gaap:CommonStockValue unitRef="u000" decimals="-6" contextRef="c00001">42000000</us-gaap:CommonStockValue>
  <!--Share-Based Compensation Plans-->
  <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock contextRef="c00003">&lt;div&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr valign="top"&gt;&lt;td style="WIDTH: 18pt" align="right"&gt;&lt;div&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;(11)&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Share-Based Compensation&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;(in millions, except per share data)&lt;/font&gt;&lt;/font&gt;&lt;br /&gt;&amp;#160;&lt;/div&g
t;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;On February 10, 2010, pursuant to the Amended 2002 Alcon Incentive Plan, the Company's board of directors approved the grant, effective February 17, 2010, to certain employees of approximately 543,000 share-settled restricted share units ("RSUs").&amp;#160;&amp;#160;The RSUs vest at the end of a three-year period, with forfeitures if the recipient is not fully vested at termination of employment or at retirement before age 62.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Restricted share units are recognized over the required service period at the closing market price for Alcon common sh
ares on the date of grant.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font&gt;Forfeitures were estimated based on historical experience.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font&gt;If factors change and the Company employs different assumptions to account for share-based payments in future periods, the compensation expense that the Company records may differ significantly from what the Company has recorded in the current period.&lt;/font&gt;&
lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font&gt;The effects of share-based equity awards on operating income and net earnings were as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; F
ONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="6"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Three months ended March 31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&l
t;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2010&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-F
AMILY: times new roman"&gt;2009&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FA
MILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Total share-based equity award costs applicable for period&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE:
 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;18&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;23&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt
;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Costs capitalized in inventory&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt
; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: i
nline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font s
tyle="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Costs recognized in operating income&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="rig
ht" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;18&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/t
d&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;23&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Less tax benefit recognized in net earnings&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" widt
h="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;6&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: ri
ght" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;7&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#
160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="
76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 36pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Reduction to net earnings&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;12&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ti
mes new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;16&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-
LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font&gt;Compensation expense for equity awards was calculated on a straight-line basis over the three-year vesting period of the applicable share-based awards, with acceleration of the expense for individuals meeting the requirements for retirement, as described above.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font&gt;The effects of share-based liability awards on operating income for the three months ended March 31, 2010 and 2009 were not significant.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt;
 MARGIN-RIGHT: 0pt" align="left"&gt;&amp;#160;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font&gt;The Company intends to satisfy all equity awards granted prior to December 31, 2003 and after December 31, 2007 with the issuance of new shares from conditional capital authorized for the Amended 2002 Alcon Incentive Plan.&amp;#160;&amp;#160;At March 31, 2010, the Company had reserved approximately 21.7 million Alcon common shares for issuance pursuant to the Amended 2002 Alcon Incentive Plan.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font
&gt;The Company's board of directors has authorized the acquisition on the open market of Alcon common shares to, among other things, satisfy the share-based awards requirements granted under the Amended 2002 Alcon Incentive Plan.&amp;#160;&amp;#160;At March 31, 2010, outstanding authorizations by the Company's board of directors would have permitted the purchase of approximately 1.7 million Alcon common shares.&amp;#160;&amp;#160;The Company has purchased treasury shares on the open market to satisfy the majority of the outstanding equity awards granted subsequent to December 31, 2003 and prior to January 1, 2008.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Change of Control Pr
ovisions&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Upon a change of control in the ownership of Alcon, such as Novartis's intended purchase of Nestl&amp;#233;'s common shares of Alcon (discussed in note 13), the Company's share-based compensation awards granted to employees prior to January 1, 2009 will vest immediately.&amp;#160;&amp;#160;However, the vesting of similar awards granted after January 1, 2009 will accelerate only if the respective participant's employment with the Company or its successor is terminated without cause, or by the participant under certain circumstances, within six months preceding or during the two years following a change of control.&amp;#160;&amp;#160;If Alcon is not the surviving corporation under a change in control, the equivalent valu
e of the successor's securities may be substituted for Alcon shares under the awards.&lt;/font&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
  <!--Acquisition of business, net of cash acquired-->
  <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired unitRef="u000" decimals="-6" contextRef="c00003">-157000000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
  <!--Acquisition of business, net of cash acquired-->
  <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired unitRef="u000" decimals="-6" contextRef="c00004">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
  <!--Unrealized depreciation (appreciation) on trading securities-->
  <us-gaap:UnrealizedGainLossOnSecurities unitRef="u000" decimals="-6" contextRef="c00003">-4000000</us-gaap:UnrealizedGainLossOnSecurities>
  <!--Unrealized depreciation (appreciation) on trading securities-->
  <us-gaap:UnrealizedGainLossOnSecurities unitRef="u000" decimals="-6" contextRef="c00004">-40000000</us-gaap:UnrealizedGainLossOnSecurities>
  <!--Selling, general and administrative-->
  <acl:SellingGeneralAndAdministrative unitRef="u000" decimals="-6" contextRef="c00003">492000000</acl:SellingGeneralAndAdministrative>
  <!--Selling, general and administrative-->
  <acl:SellingGeneralAndAdministrative unitRef="u000" decimals="-6" contextRef="c00004">472000000</acl:SellingGeneralAndAdministrative>
  <!--Other current liabilities-->
  <us-gaap:OtherLiabilitiesCurrent unitRef="u000" decimals="-6" contextRef="c00002">921000000</us-gaap:OtherLiabilitiesCurrent>
  <!--Other current liabilities-->
  <us-gaap:OtherLiabilitiesCurrent unitRef="u000" decimals="-6" contextRef="c00001">1047000000</us-gaap:OtherLiabilitiesCurrent>
  <!--Other assets-->
  <us-gaap:OtherAssetsNoncurrent unitRef="u000" decimals="-6" contextRef="c00002">143000000</us-gaap:OtherAssetsNoncurrent>
  <!--Other assets-->
  <us-gaap:OtherAssetsNoncurrent unitRef="u000" decimals="-6" contextRef="c00001">142000000</us-gaap:OtherAssetsNoncurrent>
  <!--Long term deferred income tax assets-->
  <us-gaap:DeferredTaxAssetsNetNoncurrent unitRef="u000" decimals="-6" contextRef="c00002">363000000</us-gaap:DeferredTaxAssetsNetNoncurrent>
  <!--Long term deferred income tax assets-->
  <us-gaap:DeferredTaxAssetsNetNoncurrent unitRef="u000" decimals="-6" contextRef="c00001">391000000</us-gaap:DeferredTaxAssetsNetNoncurrent>
  <!--Income Taxes-->
  <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c00003">&lt;div&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr valign="top"&gt;&lt;td style="WIDTH: 18pt" align="right"&gt;&lt;div&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;(9)&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Income Taxes&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;(in millions, except per share data)&lt;/font&gt;&lt;/font&gt;&lt;br /&gt;&amp;#160;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0p
t; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font&gt;The Company or one of its subsidiaries files income tax returns in Switzerland, the U.S. federal jurisdiction, and various state and other foreign jurisdictions.&amp;#160;&amp;#160;With few exceptions, the Company is no longer subject to Swiss, U.S. federal, state and local, or non-U.S. income tax examinations by tax authorities for years before 2003.&amp;#160;&amp;#160;In June 2009, the Internal Revenue Service ("IRS") commenced an examination of the Company's U.S. income tax returns for 2006 and 2007 that is anticipated to be completed substantially by the end of 2010.&amp;#160;&amp;#160;In May 2009, the IRS and the Company entered the Compliance Assurance Process (&amp;#8243;CAP&amp;#8243;) program for 2009.&amp;#160;&amp;#160;In January 2010, the IRS and the Company extended the CAP program to 2010.&amp;#160;&amp;#160
;The Company also currently is subject to income tax examinations by various state, local and other foreign tax authorities.&amp;#160;&amp;#160;In addition, in June 2009, the Company and the IRS signed an advance pricing agreement ("APA") contract memorializing the mutual agreement letter between Switzerland and the United States for years through 2014 that covers all material intercompany transactions involving the Company and its subsidiaries in these two jurisdictions.&amp;#160;&amp;#160;Finally, during the fourth quarter of 2007, the Company submitted a similar request for a bilateral APA between Japanese and Swiss tax authorities that would cover the tax years 2008 through 2012.&amp;#160;&amp;#160;The Company expects that the Japanese-Swiss APA will be concluded in 2010.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; F
ONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font&gt;The Company believes that it takes reasonable positions on its tax returns filed throughout the world; however, tax laws are complex and susceptible to differing interpretations.&amp;#160;&amp;#160;Tax authorities throughout the world, from time to time, routinely challenge positions taken by the Company, particularly in the case of transfer pricing issues.&amp;#160;&amp;#160;The Company has identified its uncertain tax positions and prepared its reserve for contingent tax liabilities to reflect the associated unrecognized tax benefits (the "Tax Reserves") in accordance with Financial Accounting Standards Board ("FASB") guidance which, among other things, requires that the Company assume that it will be subject to examination in every jurisdiction in which it is subject to tax.&amp;#160;&amp;#160;Management believes that the Tax Reserves are fairly stated but believes it is reasonably possible that the total a
mount of unrecognized tax benefits related to transfer pricing, currency translations and other tax positions reflected in the Tax Reserves will significantly increase or decrease within 12 months of the reporting of this financial statement as the result of, among other things, (i) developments with respect to currently active audits or advance pricing agreements and/or (ii) the further development of tax laws through judicial or administrative actions.&amp;#160;&amp;#160;Although tax laws are complex and significant uncertainty exists with respect to the actual date that any of the currently active audits or APA negotiations could &lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;reach final resolution or a new audit could commence, management believes it is reasonably possible that unrecognized tax benefits could increase in the next 12 months by at least 10% or decrease by over 70% as a result of actual payment of amounts included in the Tax Reserves and/or d
evelopments in various negotiations with tax authorities.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font&gt;The total amount of gross unrecognized tax benefits included in the Tax Reserves and the amount that would impact the effective tax rate, if recognized, did not change materially during the first three months of 2010.&amp;#160;&amp;#160;The &lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Company's policy is to classify interest and penalties in income tax expense.&amp;#160;&amp;#160;The gross amount of interest and penalties accrued as part of Tax Reserves did not change materially during the first three months of 2010.&amp;#160;&amp;#160;At March 31, 2010, the condensed con
solidated balance sheet included $23 in other current liabilities and $58 in other long term liabilities for the Tax Reserves, net of deposits with statutory authorities.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font&gt;During the three months ended March 31, 2010, the Company recognized a $25 tax charge for the write-off of deferred tax assets as a result of provisions of U.S. healthcare reform laws enacted during the period.&lt;/font&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
  <!--Document fiscal year focus-->
  <dei:DocumentFiscalYearFocus contextRef="c00003">2010</dei:DocumentFiscalYearFocus>
  <!--Accounts payable-->
  <us-gaap:IncreaseDecreaseInAccountsPayable unitRef="u000" decimals="-6" contextRef="c00003">-7000000</us-gaap:IncreaseDecreaseInAccountsPayable>
  <!--Accounts payable-->
  <us-gaap:IncreaseDecreaseInAccountsPayable unitRef="u000" decimals="-6" contextRef="c00004">19000000</us-gaap:IncreaseDecreaseInAccountsPayable>
  <!--Interest expense-->
  <us-gaap:InterestExpense unitRef="u000" decimals="-6" contextRef="c00003">-3000000</us-gaap:InterestExpense>
  <!--Interest expense-->
  <us-gaap:InterestExpense unitRef="u000" decimals="-6" contextRef="c00004">-5000000</us-gaap:InterestExpense>
  <!--Common shares, shares authorized-->
  <us-gaap:CommonStockSharesAuthorized unitRef="u001" decimals="0" contextRef="c00002">320254200</us-gaap:CommonStockSharesAuthorized>
  <!--Common shares, shares authorized-->
  <us-gaap:CommonStockSharesAuthorized unitRef="u001" decimals="0" contextRef="c00001">320254200</us-gaap:CommonStockSharesAuthorized>
  <!--Common shares, par value CHF per share-->
  <us-gaap:CommonStockParOrStatedValuePerShare unitRef="u001" decimals="0" contextRef="c00002">0.20</us-gaap:CommonStockParOrStatedValuePerShare>
  <!--Common shares, par value CHF per share-->
  <us-gaap:CommonStockParOrStatedValuePerShare unitRef="u001" decimals="0" contextRef="c00001">0.20</us-gaap:CommonStockParOrStatedValuePerShare>
  <!--Treasury shares, at cost; 3,952,664 shares at March 31, 2010 and 4,465,557 shares at December 31, 2009-->
  <us-gaap:TreasuryStockValue unitRef="u000" decimals="-6" contextRef="c00002">-366000000</us-gaap:TreasuryStockValue>
  <!--Treasury shares, at cost; 3,952,664 shares at March 31, 2010 and 4,465,557 shares at December 31, 2009-->
  <us-gaap:TreasuryStockValue unitRef="u000" decimals="-6" contextRef="c00001">-408000000</us-gaap:TreasuryStockValue>
  <!--Retained earnings-->
  <us-gaap:RetainedEarningsAccumulatedDeficit unitRef="u000" decimals="-6" contextRef="c00002">5104000000</us-gaap:RetainedEarningsAccumulatedDeficit>
  <!--Retained earnings-->
  <us-gaap:RetainedEarningsAccumulatedDeficit unitRef="u000" decimals="-6" contextRef="c00001">4533000000</us-gaap:RetainedEarningsAccumulatedDeficit>
  <!--Long term investments-->
  <us-gaap:LongTermInvestments unitRef="u000" decimals="-6" contextRef="c00002">64000000</us-gaap:LongTermInvestments>
  <!--Long term investments-->
  <us-gaap:LongTermInvestments unitRef="u000" decimals="-6" contextRef="c00001">73000000</us-gaap:LongTermInvestments>
  <!--Earnings before income taxes-->
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments unitRef="u000" decimals="-6" contextRef="c00003">676000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
  <!--Earnings before income taxes-->
  <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments unitRef="u000" decimals="-6" contextRef="c00004">514000000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments>
  <!--Treasury shares, at cost; shares-->
  <us-gaap:TreasuryStockShares unitRef="u001" decimals="0" contextRef="c00002">3952664</us-gaap:TreasuryStockShares>
  <!--Treasury shares, at cost; shares-->
  <us-gaap:TreasuryStockShares unitRef="u001" decimals="0" contextRef="c00001">4465557</us-gaap:TreasuryStockShares>
  <!--Pension and Postretirement Benefits-->
  <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock contextRef="c00003">&lt;div&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr valign="top"&gt;&lt;td style="WIDTH: 18pt" align="right"&gt;&lt;div&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;(12)&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Pension and Postretirement Benefits&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;(in millions, except per share data)&lt;/font&gt;&lt;/font&gt;&lt;br /&gt;&amp;#160;&lt;/d
iv&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Components of net periodic benefit costs:&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="6"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="ce
nter"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Pension Benefits&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="6"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Postretirement Benefits&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font
 style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="left"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Three months ended March 31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2010&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDIN
G-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2009&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DI
SPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2010&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0p
t" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2009&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Service cost&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&l
t;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;7&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;5&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY
: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;3&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; 
FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;3&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Interest cost&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10
pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;7&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;6&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" widt
h="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;4&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="T
EXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;4&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Expected return on assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td 
style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(1 &lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt
;(1 &lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(3 &lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FO
NT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(2 &lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Prior service cost&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAM
ILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font
 style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign
="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Net losses (gains)&lt;/font&gt;&lt;
/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#
160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ti
mes new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;1&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SI
ZE: 10pt; FONT-FAMILY: times new roman"&gt;1&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="52%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom"
 nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style=
"TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&am
p;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 27pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Net periodic benefit cost&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT
- -ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;15&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;12&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: le
ft" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;5&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" va
lign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;6&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="52%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: in
line; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="botto
m" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&
gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Ce
rtain U.S. defined benefit plans contain change of control provisions such that, upon a change in control in the ownership of Alcon, such as Novartis's intended purchase of Nestl&amp;#233;'s common shares of Alcon (discussed in note 13), the Company immediately would recognize special termination benefits and curtailment charges, and payments of related pension benefits would be accelerated.&amp;#160;&amp;#160;Management estimates that such charges would impact significantly the Company's results of operations in the period in which a change of control occurs.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The Company maintains an irrevocable Rabbi trust to be held and invested in an unfunded arrangement for the payment of benefits to participants under certain defined bene
fit pension plans of the Company.&amp;#160;&amp;#160;At March 31, 2010, the accompanying condensed consolidated balance sheet included net assets of the trust (cash and cash equivalents of $43 and short term investments of $248) that were restricted to the payment of pension benefits except under certain conditions, such as the Company's insolvency or termination of the trust.&amp;#160;&amp;#160;The Alcon Executive Retirement Plans Trust Agreement provides for the Company to fund the current actuarially determined present value of the aggregate accrued pension benefits of all participants in the event the Company undergoes a change of control, such as &lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Novartis's intended purchase of Nestl&amp;#233;'s common shares of Alcon (discussed in note 13).&amp;#160;&amp;#160;Management estimates that a significant contribution to the trust would be required.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT
: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;In certain countries, the Company's employees participate in defined benefit plans of Nestl&amp;#233;.&amp;#160;&amp;#160;No separate valuation for the Company's employees has historically been prepared for the plans, as they are not individually material to the Company or to Nestl&amp;#233;.&amp;#160;&amp;#160;Accordingly, these plans are treated as multi-employer plans.&amp;#160;&amp;#160;Annual contributions to these plans are determined by Nestl&amp;#233; and charged to the Company.&amp;#160;&amp;#160;Under a change of control, the participants may or may not be migrated to another plan, and additional contributions by the Company may or may not be required in any new single-employer plans.&lt;/font&gt;&lt;/div&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
  <!--Purchases of intangible assets-->
  <us-gaap:PaymentsToAcquireIntangibleAssets unitRef="u000" decimals="-6" contextRef="c00003">-113000000</us-gaap:PaymentsToAcquireIntangibleAssets>
  <!--Purchases of intangible assets-->
  <us-gaap:PaymentsToAcquireIntangibleAssets unitRef="u000" decimals="-6" contextRef="c00004">-1000000</us-gaap:PaymentsToAcquireIntangibleAssets>
  <!--Net earnings-->
  <us-gaap:ProfitLoss unitRef="u000" decimals="-6" contextRef="c00003">573000000</us-gaap:ProfitLoss>
  <!--Net earnings-->
  <us-gaap:ProfitLoss unitRef="u000" decimals="-6" contextRef="c00004">452000000</us-gaap:ProfitLoss>
  <!--Total assets-->
  <us-gaap:Assets unitRef="u000" decimals="-6" contextRef="c00002">9213000000</us-gaap:Assets>
  <!--Total assets-->
  <us-gaap:Assets unitRef="u000" decimals="-6" contextRef="c00001">8686000000</us-gaap:Assets>
  <!--Supplemental Balance Sheet Information-->
  <acl:SupplementalBalanceSheetInformation contextRef="c00003">&lt;div&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr valign="top"&gt;&lt;td style="WIDTH: 18pt" align="right"&gt;&lt;div&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;(4)&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Supplemental Balance Sheet Information&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;(in millions, except per share data)&lt;/font&gt;&lt;/font&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt
;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;March 31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY
: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;December 31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;di
v style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2010&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2009&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEX
T-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Inventories, at Lower of Cost or Market&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="b
ottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Finished products&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="D
ISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;376&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;375&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowra
p="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Work in process&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;51&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap
="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;50&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt;
 MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Raw materials&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;185&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDI
NG-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;201&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width=
"1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td styl
e="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="MARGIN-LEFT: 38.15pt"&gt;&lt;/font&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" wi
dth="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;612&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" 
width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;626&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;
/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&amp;#160;&lt;/div&gt;&lt;div align="left"&gt;&lt;table style="FO
NT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;March 31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roma
n"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;December 31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY
: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2010&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2009&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" v
align="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Property, Plant and Equipment, Net&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font st
yle="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Property, plant and equipment, at cost&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="D
ISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2,647&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2,650&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" n
owrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Accumulated depreciation&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: i
nline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(1,356 &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(1,346 &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font 
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&l
t;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="MARGIN-LEFT: 38.15pt"&gt;&lt;/font&gt;Total&lt;/font&
gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;1,291&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&l
t;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;1,304&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bot
tom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt
;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&amp;#160;&lt;/div&gt;&lt;div align="left"&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;March 31,&lt;/font&g
t;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;December 31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY
: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2010&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: bl
ack 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2009&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Accumulated Other Comprehensive Income (Loss)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="
bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE:
 10pt; FONT-FAMILY: times new roman"&gt;Foreign currency translation adjustment&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;197&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" va
lign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;265&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Unrealized gains (losses) on investments, net of income taxes&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&
gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;16&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: t
imes new roman"&gt;30&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Unrecognized postretirement benefits losses and prior service costs,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: i
nline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td s
tyle="PADDING-BOTTOM: 0.5pt" valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 9pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;net of tax benefits&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(90 &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" widt
h="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(92 &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DI
SPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt
;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="MARGIN-LEFT: 38.15pt"&gt;&lt;/font&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times ne
w roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;123&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY
: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;203&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bot
tom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</acl:SupplementalBalanceSheetInformation>
  <!--Other current liabilities-->
  <us-gaap:IncreaseDecreaseInOtherAccruedLiabilities unitRef="u000" decimals="-6" contextRef="c00003">-116000000</us-gaap:IncreaseDecreaseInOtherAccruedLiabilities>
  <!--Other current liabilities-->
  <us-gaap:IncreaseDecreaseInOtherAccruedLiabilities unitRef="u000" decimals="-6" contextRef="c00004">-22000000</us-gaap:IncreaseDecreaseInOtherAccruedLiabilities>
  <!--Total liabilities and shareholders' equity-->
  <us-gaap:LiabilitiesAndStockholdersEquity unitRef="u000" decimals="-6" contextRef="c00002">9213000000</us-gaap:LiabilitiesAndStockholdersEquity>
  <!--Total liabilities and shareholders' equity-->
  <us-gaap:LiabilitiesAndStockholdersEquity unitRef="u000" decimals="-6" contextRef="c00001">8686000000</us-gaap:LiabilitiesAndStockholdersEquity>
  <!--Intangible assets, net-->
  <us-gaap:IntangibleAssetsNetExcludingGoodwill unitRef="u000" decimals="-6" contextRef="c00002">524000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
  <!--Intangible assets, net-->
  <us-gaap:IntangibleAssetsNetExcludingGoodwill unitRef="u000" decimals="-6" contextRef="c00001">255000000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
  <!--Other current assets-->
  <us-gaap:OtherAssetsCurrent unitRef="u000" decimals="-6" contextRef="c00002">226000000</us-gaap:OtherAssetsCurrent>
  <!--Other current assets-->
  <us-gaap:OtherAssetsCurrent unitRef="u000" decimals="-6" contextRef="c00001">213000000</us-gaap:OtherAssetsCurrent>
  <!--Inventories-->
  <us-gaap:InventoryNet unitRef="u000" decimals="-6" contextRef="c00002">612000000</us-gaap:InventoryNet>
  <!--Inventories-->
  <us-gaap:InventoryNet unitRef="u000" decimals="-6" contextRef="c00001">626000000</us-gaap:InventoryNet>
  <!--Entity Filer Category-->
  <dei:EntityFilerCategory contextRef="c00003">Large Accelerated Filer</dei:EntityFilerCategory>
  <!--Entity Common Stock Shares Outstanding-->
  <dei:EntityCommonStockSharesOutstanding unitRef="u001" decimals="0" contextRef="c00002">300232045</dei:EntityCommonStockSharesOutstanding>
  <!--Other, net-->
  <us-gaap:PaymentsForProceedsFromOtherInvestingActivities unitRef="u000" decimals="-6" contextRef="c00003">1000000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
  <!--Other, net-->
  <us-gaap:PaymentsForProceedsFromOtherInvestingActivities unitRef="u000" decimals="-6" contextRef="c00004">0</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
  <!--Purchases of investments-->
  <us-gaap:PaymentsToAcquireInvestments unitRef="u000" decimals="-6" contextRef="c00003">-569000000</us-gaap:PaymentsToAcquireInvestments>
  <!--Purchases of investments-->
  <us-gaap:PaymentsToAcquireInvestments unitRef="u000" decimals="-6" contextRef="c00004">-246000000</us-gaap:PaymentsToAcquireInvestments>
  <!--Loss (gain) on sale of assets-->
  <us-gaap:GainsLossesOnSalesOfAssets unitRef="u000" decimals="-6" contextRef="c00003">-15000000</us-gaap:GainsLossesOnSalesOfAssets>
  <!--Loss (gain) on sale of assets-->
  <us-gaap:GainsLossesOnSalesOfAssets unitRef="u000" decimals="-6" contextRef="c00004">36000000</us-gaap:GainsLossesOnSalesOfAssets>
  <!--Basic weighted average common shares-->
  <us-gaap:WeightedAverageNumberOfSharesIssuedBasic unitRef="u001" decimals="0" contextRef="c00003">299980871</us-gaap:WeightedAverageNumberOfSharesIssuedBasic>
  <!--Basic weighted average common shares-->
  <us-gaap:WeightedAverageNumberOfSharesIssuedBasic unitRef="u001" decimals="0" contextRef="c00004">298581689</us-gaap:WeightedAverageNumberOfSharesIssuedBasic>
  <!--Income taxes-->
  <us-gaap:IncomeTaxExpenseBenefit unitRef="u000" decimals="-6" contextRef="c00003">103000000</us-gaap:IncomeTaxExpenseBenefit>
  <!--Income taxes-->
  <us-gaap:IncomeTaxExpenseBenefit unitRef="u000" decimals="-6" contextRef="c00004">62000000</us-gaap:IncomeTaxExpenseBenefit>
  <!--Accumulated other comprehensive income-->
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax unitRef="u000" decimals="-6" contextRef="c00002">123000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
  <!--Accumulated other comprehensive income-->
  <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax unitRef="u000" decimals="-6" contextRef="c00001">203000000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
  <!--Long term deferred income tax liabilities-->
  <us-gaap:DeferredTaxLiabilitiesNoncurrent unitRef="u000" decimals="-6" contextRef="c00002">73000000</us-gaap:DeferredTaxLiabilitiesNoncurrent>
  <!--Long term deferred income tax liabilities-->
  <us-gaap:DeferredTaxLiabilitiesNoncurrent unitRef="u000" decimals="-6" contextRef="c00001">59000000</us-gaap:DeferredTaxLiabilitiesNoncurrent>
  <!--Total current liabilities-->
  <us-gaap:LiabilitiesCurrent unitRef="u000" decimals="-6" contextRef="c00002">1951000000</us-gaap:LiabilitiesCurrent>
  <!--Total current liabilities-->
  <us-gaap:LiabilitiesCurrent unitRef="u000" decimals="-6" contextRef="c00001">1975000000</us-gaap:LiabilitiesCurrent>

</xbrl>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>4
<FILENAME>acl-20100331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by Fujitsu XWand B0126 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:acl="http://alcon.com/20100331" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://alcon.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="acl-20100331.xsd#ConsolidatedBalanceSheets"/>
  <link:roleRef roleURI="http://alcon.com/role/ConsolidatedStatementsOfEarnings" xlink:type="simple" xlink:href="acl-20100331.xsd#ConsolidatedStatementsOfEarnings"/>
  <link:roleRef roleURI="http://alcon.com/role/ConsolidatedStatementOfCashFlows" xlink:type="simple" xlink:href="acl-20100331.xsd#ConsolidatedStatementOfCashFlows"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:calculationLink xlink:type="extended" xlink:role="http://alcon.com/role/ConsolidatedBalanceSheets">
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_Assets" xlink:label="Assets" xlink:title="Assets"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="AssetsCurrent" xlink:title="AssetsCurrent"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="AssetsCurrent" xlink:title="calculation: Assets to AssetsCurrent" order="1.0" weight="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="CashAndCashEquivalentsAtCarryingValue" xlink:title="CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AssetsCurrent" xlink:to="CashAndCashEquivalentsAtCarryingValue" xlink:title="calculation: AssetsCurrent to CashAndCashEquivalentsAtCarryingValue" order="1.0" weight="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_ShortTermInvestments" xlink:label="ShortTermInvestments" xlink:title="ShortTermInvestments"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AssetsCurrent" xlink:to="ShortTermInvestments" xlink:title="calculation: AssetsCurrent to ShortTermInvestments" order="2.0" weight="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="AccountsReceivableNetCurrent" xlink:title="AccountsReceivableNetCurrent"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AssetsCurrent" xlink:to="AccountsReceivableNetCurrent" xlink:title="calculation: AssetsCurrent to AccountsReceivableNetCurrent" order="3.0" weight="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_InventoryNet" xlink:label="InventoryNet" xlink:title="InventoryNet"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AssetsCurrent" xlink:to="InventoryNet" xlink:title="calculation: AssetsCurrent to InventoryNet" order="4.0" weight="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_DeferredTaxAssetsNetCurrent" xlink:label="DeferredTaxAssetsNetCurrent" xlink:title="DeferredTaxAssetsNetCurrent"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AssetsCurrent" xlink:to="DeferredTaxAssetsNetCurrent" xlink:title="calculation: AssetsCurrent to DeferredTaxAssetsNetCurrent" order="5.0" weight="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="OtherAssetsCurrent" xlink:title="OtherAssetsCurrent"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="AssetsCurrent" xlink:to="OtherAssetsCurrent" xlink:title="calculation: AssetsCurrent to OtherAssetsCurrent" order="6.0" weight="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_LongTermInvestments" xlink:label="LongTermInvestments" xlink:title="LongTermInvestments"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="LongTermInvestments" xlink:title="calculation: Assets to LongTermInvestments" order="2.0" weight="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="PropertyPlantAndEquipmentNet" xlink:title="PropertyPlantAndEquipmentNet"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="PropertyPlantAndEquipmentNet" xlink:title="calculation: Assets to PropertyPlantAndEquipmentNet" order="3.0" weight="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="IntangibleAssetsNetExcludingGoodwill" xlink:title="IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="IntangibleAssetsNetExcludingGoodwill" xlink:title="calculation: Assets to IntangibleAssetsNetExcludingGoodwill" order="4.0" weight="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_Goodwill" xlink:label="Goodwill" xlink:title="Goodwill"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="Goodwill" xlink:title="calculation: Assets to Goodwill" order="5.0" weight="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_DeferredTaxAssetsNetNoncurrent" xlink:label="DeferredTaxAssetsNetNoncurrent" xlink:title="DeferredTaxAssetsNetNoncurrent"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="DeferredTaxAssetsNetNoncurrent" xlink:title="calculation: Assets to DeferredTaxAssetsNetNoncurrent" order="6.0" weight="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="OtherAssetsNoncurrent" xlink:title="OtherAssetsNoncurrent"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="Assets" xlink:to="OtherAssetsNoncurrent" xlink:title="calculation: Assets to OtherAssetsNoncurrent" order="7.0" weight="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="LiabilitiesAndStockholdersEquity" xlink:title="LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="LiabilitiesCurrent" xlink:title="LiabilitiesCurrent"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesAndStockholdersEquity" xlink:to="LiabilitiesCurrent" xlink:title="calculation: LiabilitiesAndStockholdersEquity to LiabilitiesCurrent" order="1.0" weight="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="AccountsPayableCurrent" xlink:title="AccountsPayableCurrent"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesCurrent" xlink:to="AccountsPayableCurrent" xlink:title="calculation: LiabilitiesCurrent to AccountsPayableCurrent" order="1.0" weight="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_ShortTermBorrowings" xlink:label="ShortTermBorrowings" xlink:title="ShortTermBorrowings"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesCurrent" xlink:to="ShortTermBorrowings" xlink:title="calculation: LiabilitiesCurrent to ShortTermBorrowings" order="2.0" weight="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="LongTermDebtCurrent" xlink:title="LongTermDebtCurrent"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesCurrent" xlink:to="LongTermDebtCurrent" xlink:title="calculation: LiabilitiesCurrent to LongTermDebtCurrent" order="3.0" weight="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="OtherLiabilitiesCurrent" xlink:title="OtherLiabilitiesCurrent"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesCurrent" xlink:to="OtherLiabilitiesCurrent" xlink:title="calculation: LiabilitiesCurrent to OtherLiabilitiesCurrent" order="4.0" weight="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="LongTermDebtNoncurrent" xlink:title="LongTermDebtNoncurrent"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesAndStockholdersEquity" xlink:to="LongTermDebtNoncurrent" xlink:title="calculation: LiabilitiesAndStockholdersEquity to LongTermDebtNoncurrent" order="2.0" weight="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:label="DeferredTaxLiabilitiesNoncurrent" xlink:title="DeferredTaxLiabilitiesNoncurrent"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesAndStockholdersEquity" xlink:to="DeferredTaxLiabilitiesNoncurrent" xlink:title="calculation: LiabilitiesAndStockholdersEquity to DeferredTaxLiabilitiesNoncurrent" order="3.0" weight="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="OtherLiabilitiesNoncurrent" xlink:title="OtherLiabilitiesNoncurrent"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesAndStockholdersEquity" xlink:to="OtherLiabilitiesNoncurrent" xlink:title="calculation: LiabilitiesAndStockholdersEquity to OtherLiabilitiesNoncurrent" order="4.0" weight="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:title="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="LiabilitiesAndStockholdersEquity" xlink:to="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:title="calculation: LiabilitiesAndStockholdersEquity to StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" order="5.0" weight="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_CommonStockValue" xlink:label="CommonStockValue" xlink:title="CommonStockValue"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="CommonStockValue" xlink:title="calculation: StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest to CommonStockValue" order="1.0" weight="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="AdditionalPaidInCapital" xlink:title="AdditionalPaidInCapital"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="AdditionalPaidInCapital" xlink:title="calculation: StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest to AdditionalPaidInCapital" order="2.0" weight="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:title="AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:title="calculation: StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest to AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="3.0" weight="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="RetainedEarningsAccumulatedDeficit" xlink:title="RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="RetainedEarningsAccumulatedDeficit" xlink:title="calculation: StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest to RetainedEarningsAccumulatedDeficit" order="4.0" weight="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="TreasuryStockValue" xlink:title="TreasuryStockValue"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="TreasuryStockValue" xlink:title="calculation: StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest to TreasuryStockValue" order="5.0" weight="-1.0"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://alcon.com/role/ConsolidatedStatementsOfEarnings">
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_ProfitLoss" xlink:label="ProfitLoss" xlink:title="ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:title="IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ProfitLoss" xlink:to="IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:title="calculation: ProfitLoss to IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" order="1.0" weight="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="OperatingIncomeLoss" xlink:title="OperatingIncomeLoss"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="OperatingIncomeLoss" xlink:title="calculation: IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments to OperatingIncomeLoss" order="1.0" weight="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_GrossProfit" xlink:label="GrossProfit" xlink:title="GrossProfit"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="OperatingIncomeLoss" xlink:to="GrossProfit" xlink:title="calculation: OperatingIncomeLoss to GrossProfit" order="1.0" weight="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="SalesRevenueNet" xlink:title="SalesRevenueNet"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="GrossProfit" xlink:to="SalesRevenueNet" xlink:title="calculation: GrossProfit to SalesRevenueNet" order="1.0" weight="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_CostOfGoodsSold" xlink:label="CostOfGoodsSold" xlink:title="CostOfGoodsSold"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="GrossProfit" xlink:to="CostOfGoodsSold" xlink:title="calculation: GrossProfit to CostOfGoodsSold" order="2.0" weight="-1.0"/>
    <link:loc xlink:type="locator" xlink:href="acl-20100331.xsd#acl_SellingGeneralAndAdministrative" xlink:label="SellingGeneralAndAdministrative" xlink:title="SellingGeneralAndAdministrative"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="OperatingIncomeLoss" xlink:to="SellingGeneralAndAdministrative" xlink:title="calculation: OperatingIncomeLoss to SellingGeneralAndAdministrative" order="2.0" weight="-1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="ResearchAndDevelopmentExpense" xlink:title="ResearchAndDevelopmentExpense"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="OperatingIncomeLoss" xlink:to="ResearchAndDevelopmentExpense" xlink:title="calculation: OperatingIncomeLoss to ResearchAndDevelopmentExpense" order="3.0" weight="-1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_ResearchAndDevelopmentInProcess" xlink:label="ResearchAndDevelopmentInProcess" xlink:title="ResearchAndDevelopmentInProcess"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="OperatingIncomeLoss" xlink:to="ResearchAndDevelopmentInProcess" xlink:title="calculation: OperatingIncomeLoss to ResearchAndDevelopmentInProcess" order="4.0" weight="-1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="AmortizationOfIntangibleAssets" xlink:title="AmortizationOfIntangibleAssets"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="OperatingIncomeLoss" xlink:to="AmortizationOfIntangibleAssets" xlink:title="calculation: OperatingIncomeLoss to AmortizationOfIntangibleAssets" order="5.0" weight="-1.0"/>
    <link:loc xlink:type="locator" xlink:href="acl-20100331.xsd#acl_OtherOperatingExpenses" xlink:label="acl_loc_OtherOperatingExpenses"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="OperatingIncomeLoss" xlink:to="acl_loc_OtherOperatingExpenses" order="1.0" weight="-1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="ForeignCurrencyTransactionGainLossBeforeTax" xlink:title="ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="ForeignCurrencyTransactionGainLossBeforeTax" xlink:title="calculation: IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments to ForeignCurrencyTransactionGainLossBeforeTax" order="2.0" weight="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_InvestmentIncomeInterestAndDividend" xlink:label="InvestmentIncomeInterestAndDividend" xlink:title="InvestmentIncomeInterestAndDividend"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="InvestmentIncomeInterestAndDividend" xlink:title="calculation: IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments to InvestmentIncomeInterestAndDividend" order="3.0" weight="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_InterestExpense" xlink:label="InterestExpense" xlink:title="InterestExpense"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="InterestExpense" xlink:title="calculation: IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments to InterestExpense" order="4.0" weight="-1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="OtherNonoperatingIncomeExpense" xlink:title="OtherNonoperatingIncomeExpense"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="OtherNonoperatingIncomeExpense" xlink:title="calculation: IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments to OtherNonoperatingIncomeExpense" order="5.0" weight="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="IncomeTaxExpenseBenefit" xlink:title="IncomeTaxExpenseBenefit"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="ProfitLoss" xlink:to="IncomeTaxExpenseBenefit" xlink:title="calculation: ProfitLoss to IncomeTaxExpenseBenefit" order="2.0" weight="-1.0"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://alcon.com/role/ConsolidatedStatementOfCashFlows">
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:title="CashAndCashEquivalentsPeriodIncreaseDecrease"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="NetCashProvidedByUsedInOperatingActivities" xlink:title="NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="NetCashProvidedByUsedInOperatingActivities" xlink:title="calculation: CashAndCashEquivalentsPeriodIncreaseDecrease to NetCashProvidedByUsedInOperatingActivities" order="1.0" weight="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_ProfitLoss" xlink:label="ProfitLoss" xlink:title="ProfitLoss"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="ProfitLoss" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to ProfitLoss" order="1.0" weight="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_Depreciation" xlink:label="Depreciation" xlink:title="Depreciation"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="Depreciation" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to Depreciation" order="2.0" weight="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="AmortizationOfIntangibleAssets" xlink:title="AmortizationOfIntangibleAssets"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="AmortizationOfIntangibleAssets" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to AmortizationOfIntangibleAssets" order="3.0" weight="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_ResearchAndDevelopmentInProcess" xlink:label="ResearchAndDevelopmentInProcess" xlink:title="ResearchAndDevelopmentInProcess"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="ResearchAndDevelopmentInProcess" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to ResearchAndDevelopmentInProcess" order="4.0" weight="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="ShareBasedCompensation" xlink:title="ShareBasedCompensation"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="ShareBasedCompensation" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to ShareBasedCompensation" order="5.0" weight="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities" xlink:label="ExcessTaxBenefitFromShareBasedCompensationOperatingActivities" xlink:title="ExcessTaxBenefitFromShareBasedCompensationOperatingActivities"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="ExcessTaxBenefitFromShareBasedCompensationOperatingActivities" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to ExcessTaxBenefitFromShareBasedCompensationOperatingActivities" order="6.0" weight="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="DeferredIncomeTaxExpenseBenefit" xlink:title="DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="DeferredIncomeTaxExpenseBenefit" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to DeferredIncomeTaxExpenseBenefit" order="7.0" weight="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_GainsLossesOnSalesOfAssets" xlink:label="GainsLossesOnSalesOfAssets" xlink:title="GainsLossesOnSalesOfAssets"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="GainsLossesOnSalesOfAssets" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to GainsLossesOnSalesOfAssets" order="8.0" weight="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_ImpairmentOfInvestments" xlink:label="ImpairmentOfInvestments" xlink:title="ImpairmentOfInvestments"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="ImpairmentOfInvestments" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to ImpairmentOfInvestments" order="9.0" weight="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_UnrealizedGainLossOnSecurities" xlink:label="UnrealizedGainLossOnSecurities" xlink:title="UnrealizedGainLossOnSecurities"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="UnrealizedGainLossOnSecurities" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to UnrealizedGainLossOnSecurities" order="10.0" weight="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesOther" xlink:label="AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesOther" xlink:title="AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesOther"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesOther" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesOther" order="11.0" weight="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_IncreaseDecreaseInTradingSecurities" xlink:label="IncreaseDecreaseInTradingSecurities" xlink:title="IncreaseDecreaseInTradingSecurities"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="IncreaseDecreaseInTradingSecurities" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to IncreaseDecreaseInTradingSecurities" order="12.0" weight="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="IncreaseDecreaseInAccountsReceivable" xlink:title="IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="IncreaseDecreaseInAccountsReceivable" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to IncreaseDecreaseInAccountsReceivable" order="13.0" weight="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="IncreaseDecreaseInInventories" xlink:title="IncreaseDecreaseInInventories"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="IncreaseDecreaseInInventories" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to IncreaseDecreaseInInventories" order="14.0" weight="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="IncreaseDecreaseInOtherOperatingAssets" xlink:title="IncreaseDecreaseInOtherOperatingAssets"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="IncreaseDecreaseInOtherOperatingAssets" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to IncreaseDecreaseInOtherOperatingAssets" order="15.0" weight="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="IncreaseDecreaseInAccountsPayable" xlink:title="IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="IncreaseDecreaseInAccountsPayable" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to IncreaseDecreaseInAccountsPayable" order="16.0" weight="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:label="IncreaseDecreaseInOtherAccruedLiabilities" xlink:title="IncreaseDecreaseInOtherAccruedLiabilities"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="IncreaseDecreaseInOtherAccruedLiabilities" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to IncreaseDecreaseInOtherAccruedLiabilities" order="17.0" weight="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="IncreaseDecreaseInOtherOperatingLiabilities" xlink:title="IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInOperatingActivities" xlink:to="IncreaseDecreaseInOtherOperatingLiabilities" xlink:title="calculation: NetCashProvidedByUsedInOperatingActivities to IncreaseDecreaseInOtherOperatingLiabilities" order="18.0" weight="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="NetCashProvidedByUsedInInvestingActivities" xlink:title="NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="NetCashProvidedByUsedInInvestingActivities" xlink:title="calculation: CashAndCashEquivalentsPeriodIncreaseDecrease to NetCashProvidedByUsedInInvestingActivities" order="2.0" weight="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:label="ProceedsFromSaleOfProductiveAssets" xlink:title="ProceedsFromSaleOfProductiveAssets"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="ProceedsFromSaleOfProductiveAssets" xlink:title="calculation: NetCashProvidedByUsedInInvestingActivities to ProceedsFromSaleOfProductiveAssets" order="1.0" weight="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="PaymentsToAcquirePropertyPlantAndEquipment" xlink:title="PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="PaymentsToAcquirePropertyPlantAndEquipment" xlink:title="calculation: NetCashProvidedByUsedInInvestingActivities to PaymentsToAcquirePropertyPlantAndEquipment" order="2.0" weight="-1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:title="PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:title="calculation: NetCashProvidedByUsedInInvestingActivities to PaymentsToAcquireBusinessesNetOfCashAcquired" order="3.0" weight="-1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="PaymentsToAcquireIntangibleAssets" xlink:title="PaymentsToAcquireIntangibleAssets"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="PaymentsToAcquireIntangibleAssets" xlink:title="calculation: NetCashProvidedByUsedInInvestingActivities to PaymentsToAcquireIntangibleAssets" order="4.0" weight="-1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_PaymentsToAcquireInvestments" xlink:label="PaymentsToAcquireInvestments" xlink:title="PaymentsToAcquireInvestments"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="PaymentsToAcquireInvestments" xlink:title="calculation: NetCashProvidedByUsedInInvestingActivities to PaymentsToAcquireInvestments" order="5.0" weight="-1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:label="ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:title="ProceedsFromSaleMaturityAndCollectionsOfInvestments"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:title="calculation: NetCashProvidedByUsedInInvestingActivities to ProceedsFromSaleMaturityAndCollectionsOfInvestments" order="6.0" weight="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:label="PaymentsForProceedsFromOtherInvestingActivities" xlink:title="PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInInvestingActivities" xlink:to="PaymentsForProceedsFromOtherInvestingActivities" xlink:title="calculation: NetCashProvidedByUsedInInvestingActivities to PaymentsForProceedsFromOtherInvestingActivities" order="7.0" weight="-1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="NetCashProvidedByUsedInFinancingActivities" xlink:title="NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="NetCashProvidedByUsedInFinancingActivities" xlink:title="calculation: CashAndCashEquivalentsPeriodIncreaseDecrease to NetCashProvidedByUsedInFinancingActivities" order="3.0" weight="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:label="ProceedsFromRepaymentsOfShortTermDebt" xlink:title="ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="ProceedsFromRepaymentsOfShortTermDebt" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to ProceedsFromRepaymentsOfShortTermDebt" order="1.0" weight="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="ProceedsFromIssuanceOfLongTermDebt" xlink:title="ProceedsFromIssuanceOfLongTermDebt"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="ProceedsFromIssuanceOfLongTermDebt" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to ProceedsFromIssuanceOfLongTermDebt" order="2.0" weight="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="RepaymentsOfLongTermDebt" xlink:title="RepaymentsOfLongTermDebt"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="RepaymentsOfLongTermDebt" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to RepaymentsOfLongTermDebt" order="3.0" weight="-1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock" xlink:label="PaymentsOfDividendsCommonStock" xlink:title="PaymentsOfDividendsCommonStock"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="PaymentsOfDividendsCommonStock" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to PaymentsOfDividendsCommonStock" order="4.0" weight="-1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="PaymentsForRepurchaseOfCommonStock" xlink:title="PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="PaymentsForRepurchaseOfCommonStock" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to PaymentsForRepurchaseOfCommonStock" order="5.0" weight="-1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="ProceedsFromStockOptionsExercised" xlink:title="ProceedsFromStockOptionsExercised"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="ProceedsFromStockOptionsExercised" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to ProceedsFromStockOptionsExercised" order="6.0" weight="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities" xlink:label="ExcessTaxBenefitFromShareBasedCompensationFinancingActivities" xlink:title="ExcessTaxBenefitFromShareBasedCompensationFinancingActivities"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="NetCashProvidedByUsedInFinancingActivities" xlink:to="ExcessTaxBenefitFromShareBasedCompensationFinancingActivities" xlink:title="calculation: NetCashProvidedByUsedInFinancingActivities to ExcessTaxBenefitFromShareBasedCompensationFinancingActivities" order="7.0" weight="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:label="EffectOfExchangeRateOnCashAndCashEquivalents" xlink:title="EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="EffectOfExchangeRateOnCashAndCashEquivalents" xlink:title="calculation: CashAndCashEquivalentsPeriodIncreaseDecrease to EffectOfExchangeRateOnCashAndCashEquivalents" order="4.0" weight="1.0"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>acl-20100331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by Fujitsu XWand B0126 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:acl="http://alcon.com/20100331" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <link:roleRef roleURI="http://xbrl.us/us-gaap/role/label/negated" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2008-03-31.xsd#negated"/>
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="us-gaap_loc_AccountsReceivableNetCurrent"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US">Trade receivables, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_AccountsReceivableNetCurrent" xlink:to="us-gaap_lab_AccountsReceivableNetCurrent" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="us-gaap_loc_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US">Accumulated other comprehensive income</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="us-gaap_lab_AccumulatedOtherComprehensiveIncomeLossNetOfTax" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="loc_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:label xlink:type="resource" xlink:label="label_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_PaymentsToAcquireBusinessesNetOfCashAcquired" xml:lang="en-US" id="label_PaymentsToAcquireBusinessesNetOfCashAcquired">Acquisition of business, net of cash acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="label_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:title="label: PaymentsToAcquireBusinessesNetOfCashAcquired to label_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_PaymentsToAcquireBusinessesNetOfCashAcquired2" xlink:role="http://xbrl.us/us-gaap/role/label/negated" xml:lang="en-US" id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US2">Acquisition of business, net of cash acquired</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="us-gaap_lab_PaymentsToAcquireBusinessesNetOfCashAcquired2" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="us-gaap_loc_AdditionalPaidInCapital"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="lab_us-gaap_AdditionalPaidInCapital_label_en-US">Additional paid-in capital</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_AdditionalPaidInCapital" xlink:to="us-gaap_lab_AdditionalPaidInCapital" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_Depreciation" xlink:label="Depreciation" xlink:title="Depreciation"/>
    <link:label xlink:type="resource" xlink:label="label_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_Depreciation" xml:lang="en-US" id="label_Depreciation">Depreciation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Depreciation" xlink:to="label_Depreciation" xlink:title="label: Depreciation to label_Depreciation"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="us-gaap_loc_AmortizationOfIntangibleAssets"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US">Amortization of intangibles</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_AmortizationOfIntangibleAssets" xlink:to="us-gaap_lab_AmortizationOfIntangibleAssets" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="loc_StatementOfFinancialPositionAbstract"/>
    <link:label xlink:type="resource" xlink:label="label_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_StatementOfFinancialPositionAbstract" xml:lang="en-US" id="label_StatementOfFinancialPositionAbstract">CONSOLIDATED BALANCE SHEETS</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_StatementOfFinancialPositionAbstract" xlink:to="label_StatementOfFinancialPositionAbstract" xlink:title="label: StatementOfFinancialPositionAbstract to label_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_loc_CashAndCashEquivalentsAtCarryingValue"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US">Cash and cash equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_lab_CashAndCashEquivalentsAtCarryingValue" order="1.0"/>
    <link:label xlink:type="resource" xlink:label="label_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="label_CashAndCashEquivalentsAtCarryingValue" xml:lang="en-US" id="label_CashAndCashEquivalentsAtCarryingValue">Cash and cash equivalents, beginning of period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_CashAndCashEquivalentsAtCarryingValue" xlink:to="label_CashAndCashEquivalentsAtCarryingValue" xlink:title="label: CashAndCashEquivalentsAtCarryingValue to label_CashAndCashEquivalentsAtCarryingValue"/>
    <link:label xlink:type="resource" xlink:label="label_CashAndCashEquivalentsAtCarryingValue_2" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="label_CashAndCashEquivalentsAtCarryingValue" xml:lang="en-US" id="label_CashAndCashEquivalentsAtCarryingValue_2">Cash and cash equivalents, end of period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_CashAndCashEquivalentsAtCarryingValue" xlink:to="label_CashAndCashEquivalentsAtCarryingValue_2" xlink:title="label: CashAndCashEquivalentsAtCarryingValue to label_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="loc_IncreaseDecreaseInAccountsReceivable"/>
    <link:label xlink:type="resource" xlink:label="label_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_IncreaseDecreaseInAccountsReceivable" xml:lang="en-US" id="label_IncreaseDecreaseInAccountsReceivable">Trade receivables</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_IncreaseDecreaseInAccountsReceivable" xlink:to="label_IncreaseDecreaseInAccountsReceivable" xlink:title="label: IncreaseDecreaseInAccountsReceivable to label_IncreaseDecreaseInAccountsReceivable"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="loc_IncreaseDecreaseInInventories"/>
    <link:label xlink:type="resource" xlink:label="label_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_IncreaseDecreaseInInventories" xml:lang="en-US" id="label_IncreaseDecreaseInInventories">Inventories</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_IncreaseDecreaseInInventories" xlink:to="label_IncreaseDecreaseInInventories" xlink:title="label: IncreaseDecreaseInInventories to label_IncreaseDecreaseInInventories"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:label="loc_IncreaseDecreaseInOtherAccruedLiabilities"/>
    <link:label xlink:type="resource" xlink:label="label_IncreaseDecreaseInOtherAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_IncreaseDecreaseInOtherAccruedLiabilities" xml:lang="en-US" id="label_IncreaseDecreaseInOtherAccruedLiabilities">Other current liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_IncreaseDecreaseInOtherAccruedLiabilities" xlink:to="label_IncreaseDecreaseInOtherAccruedLiabilities" xlink:title="label: IncreaseDecreaseInOtherAccruedLiabilities to label_IncreaseDecreaseInOtherAccruedLiabilities"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_IncreaseDecreaseInOtherAccruedLiabilities2" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="lab_us-gaap_IncreaseDecreaseInOtherAccruedLiabilities_label_en-US2">Increase Decrease In Other Accrued Liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_IncreaseDecreaseInOtherAccruedLiabilities" xlink:to="us-gaap_lab_IncreaseDecreaseInOtherAccruedLiabilities2" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:label="us-gaap_loc_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:label xlink:type="resource" xlink:label="label_ProceedsFromRepaymentsOfShortTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ProceedsFromRepaymentsOfShortTermDebt" xml:lang="en-US" id="label_ProceedsFromRepaymentsOfShortTermDebt">Net proceeds from short term debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_ProceedsFromRepaymentsOfShortTermDebt" xlink:to="label_ProceedsFromRepaymentsOfShortTermDebt" xlink:title="label: ProceedsFromRepaymentsOfShortTermDebt to label_ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="IncreaseDecreaseInAccountsPayable" xlink:title="IncreaseDecreaseInAccountsPayable"/>
    <link:label xlink:type="resource" xlink:label="label_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_IncreaseDecreaseInAccountsPayable" xml:lang="en-US" id="label_IncreaseDecreaseInAccountsPayable">Accounts payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInAccountsPayable" xlink:to="label_IncreaseDecreaseInAccountsPayable" xlink:title="label: IncreaseDecreaseInAccountsPayable to label_IncreaseDecreaseInAccountsPayable"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_IncreaseDecreaseInAccountsPayable2" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US2">Increase Decrease In Accounts Payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInAccountsPayable" xlink:to="us-gaap_lab_IncreaseDecreaseInAccountsPayable2" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="loc_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:label xlink:type="resource" xlink:label="label_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_CommitmentsAndContingenciesDisclosureTextBlock" xml:lang="en-US" id="label_CommitmentsAndContingenciesDisclosureTextBlock">Commitments and Contingencies</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="label_CommitmentsAndContingenciesDisclosureTextBlock" xlink:title="label: CommitmentsAndContingenciesDisclosureTextBlock to label_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:label xlink:type="resource" xlink:label="label_CommitmentsAndContingenciesDisclosureTextBlock_2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_CommitmentsAndContingenciesDisclosureTextBlock" xml:lang="en-US" id="label_CommitmentsAndContingenciesDisclosureTextBlock_2">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="label_CommitmentsAndContingenciesDisclosureTextBlock_2" xlink:title="label: CommitmentsAndContingenciesDisclosureTextBlock to label_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="CommonStockSharesAuthorized" xlink:title="CommonStockSharesAuthorized"/>
    <link:label xlink:type="resource" xlink:label="label_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_CommonStockSharesAuthorized" xml:lang="en-US" id="label_CommonStockSharesAuthorized">Common shares, shares authorized</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CommonStockSharesAuthorized" xlink:to="label_CommonStockSharesAuthorized" xlink:title="label: CommonStockSharesAuthorized to label_CommonStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_loc_CommonStockSharesOutstanding"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US">Common shares, shares outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_CommonStockSharesOutstanding" xlink:to="us-gaap_lab_CommonStockSharesOutstanding" order="1.0"/>
    <link:label xlink:type="resource" xlink:label="label_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="label_CommonStockSharesOutstanding" xml:lang="en-US" id="label_CommonStockSharesOutstanding">Beginning Balance (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_CommonStockSharesOutstanding" xlink:to="label_CommonStockSharesOutstanding" xlink:title="label: CommonStockSharesOutstanding to label_CommonStockSharesOutstanding"/>
    <link:label xlink:type="resource" xlink:label="label_CommonStockSharesOutstanding_2" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="label_CommonStockSharesOutstanding" xml:lang="en-US" id="label_CommonStockSharesOutstanding_2">Ending Balance (in shares)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_CommonStockSharesOutstanding" xlink:to="label_CommonStockSharesOutstanding_2" xlink:title="label: CommonStockSharesOutstanding to label_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_loc_CommonStockValue"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="lab_us-gaap_CommonStockValue_label_en-US">Common shares, par value CHF 0.20 per share; 320,254,200 shares authorized; 304,184,709 shares issued and 300,232,045 shares outstanding at March 31, 2010; 304,016,290 shares issued and 299,550,733 shares outstanding at December 31, 2009</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_CommonStockValue" xlink:to="us-gaap_lab_CommonStockValue" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_CostOfGoodsSold" xlink:label="us-gaap_loc_CostOfGoodsSold"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_CostOfGoodsSold" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="lab_us-gaap_CostOfGoodsSold_label_en-US">Cost of goods sold</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_CostOfGoodsSold" xlink:to="us-gaap_lab_CostOfGoodsSold" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="loc_LiabilitiesCurrentAbstract"/>
    <link:label xlink:type="resource" xlink:label="label_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_LiabilitiesCurrentAbstract" xml:lang="en-US" id="label_LiabilitiesCurrentAbstract">Current liabilities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_LiabilitiesCurrentAbstract" xlink:to="label_LiabilitiesCurrentAbstract" xlink:title="label: LiabilitiesCurrentAbstract to label_LiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_loc_LiabilitiesCurrent"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="lab_us-gaap_LiabilitiesCurrent_label_en-US">Total current liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_LiabilitiesCurrent" xlink:to="us-gaap_lab_LiabilitiesCurrent" order="1.0"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_LiabilitiesCurrent2" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US" id="lab_us-gaap_LiabilitiesCurrent_label_en-US2">Total current liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_LiabilitiesCurrent" xlink:to="us-gaap_lab_LiabilitiesCurrent2" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="us-gaap_loc_DeferredIncomeTaxExpenseBenefit"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US">Deferred income taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_DeferredIncomeTaxExpenseBenefit" xlink:to="us-gaap_lab_DeferredIncomeTaxExpenseBenefit" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_DerivativesPolicyTextBlock" xlink:label="us-gaap_loc_DerivativesPolicyTextBlock"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="lab_us-gaap_DerivativesPolicyTextBlock_label_en-US">Derivative Instruments and Hedging Activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_DerivativesPolicyTextBlock" xlink:to="us-gaap_lab_DerivativesPolicyTextBlock" order="1.0"/>
    <link:label xlink:type="resource" xlink:label="label_DerivativesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_DerivativesPolicyTextBlock" xml:lang="en-US" id="label_DerivativesPolicyTextBlock">Derivatives, Policy [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_DerivativesPolicyTextBlock" xlink:to="label_DerivativesPolicyTextBlock" xlink:title="label: DerivativesPolicyTextBlock to label_DerivativesPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock" xlink:label="loc_DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock"/>
    <link:label xlink:type="resource" xlink:label="label_DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock" xml:lang="en-US" id="label_DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock">Impairment of Long-Lived Assets Held and Used</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock" xlink:to="label_DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock" xlink:title="label: DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock to label_DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="us-gaap_loc_EarningsPerShareDiluted"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="lab_us-gaap_EarningsPerShareDiluted_label_en-US">Diluted earnings per common share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_EarningsPerShareDiluted" xlink:to="us-gaap_lab_EarningsPerShareDiluted" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:label="us-gaap_loc_EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="lab_us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents_label_en-US">Effect of exchange rates on cash and cash equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:to="us-gaap_lab_EffectOfExchangeRateOnCashAndCashEquivalents" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_loc_ShareBasedCompensation"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="lab_us-gaap_ShareBasedCompensation_label_en-US">Share-based payments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_ShareBasedCompensation" xlink:to="us-gaap_lab_ShareBasedCompensation" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_GrossProfit" xlink:label="us-gaap_loc_GrossProfit"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="lab_us-gaap_GrossProfit_label_en-US">Gross profit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_GrossProfit" xlink:to="us-gaap_lab_GrossProfit" order="1.0"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_GrossProfit2" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US" id="lab_us-gaap_GrossProfit_label_en-US2">Gross profit</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_GrossProfit" xlink:to="us-gaap_lab_GrossProfit2" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_ImpairmentOfInvestments" xlink:label="loc_ImpairmentOfInvestments"/>
    <link:label xlink:type="resource" xlink:label="label_ImpairmentOfInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ImpairmentOfInvestments" xml:lang="en-US" id="label_ImpairmentOfInvestments">Loss on impairment of available-for-sale securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ImpairmentOfInvestments" xlink:to="label_ImpairmentOfInvestments" xlink:title="label: ImpairmentOfInvestments to label_ImpairmentOfInvestments"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="IncomeStatementAbstract" xlink:title="IncomeStatementAbstract"/>
    <link:label xlink:type="resource" xlink:label="label_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_IncomeStatementAbstract" xml:lang="en-US" id="label_IncomeStatementAbstract">CONSOLIDATED STATEMENTS OF EARNINGS</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncomeStatementAbstract" xlink:to="label_IncomeStatementAbstract" xlink:title="label: IncomeStatementAbstract to label_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="loc_IncomeTaxDisclosureTextBlock"/>
    <link:label xlink:type="resource" xlink:label="label_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_IncomeTaxDisclosureTextBlock" xml:lang="en-US" id="label_IncomeTaxDisclosureTextBlock">Income Taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_IncomeTaxDisclosureTextBlock" xlink:to="label_IncomeTaxDisclosureTextBlock" xlink:title="label: IncomeTaxDisclosureTextBlock to label_IncomeTaxDisclosureTextBlock"/>
    <link:label xlink:type="resource" xlink:label="label_IncomeTaxDisclosureTextBlock_2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_IncomeTaxDisclosureTextBlock" xml:lang="en-US" id="label_IncomeTaxDisclosureTextBlock_2">Income Tax Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_IncomeTaxDisclosureTextBlock" xlink:to="label_IncomeTaxDisclosureTextBlock_2" xlink:title="label: IncomeTaxDisclosureTextBlock to label_IncomeTaxDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="loc_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:label xlink:type="resource" xlink:label="label_IncreaseDecreaseInOtherOperatingAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_IncreaseDecreaseInOtherOperatingAssets" xml:lang="en-US" id="label_IncreaseDecreaseInOtherOperatingAssets">Other assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_IncreaseDecreaseInOtherOperatingAssets" xlink:to="label_IncreaseDecreaseInOtherOperatingAssets" xlink:title="label: IncreaseDecreaseInOtherOperatingAssets to label_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_IncreaseDecreaseInTradingSecurities" xlink:label="loc_IncreaseDecreaseInTradingSecurities"/>
    <link:label xlink:type="resource" xlink:label="label_IncreaseDecreaseInTradingSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_IncreaseDecreaseInTradingSecurities" xml:lang="en-US" id="label_IncreaseDecreaseInTradingSecurities">Trading securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_IncreaseDecreaseInTradingSecurities" xlink:to="label_IncreaseDecreaseInTradingSecurities" xlink:title="label: IncreaseDecreaseInTradingSecurities to label_IncreaseDecreaseInTradingSecurities"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="us-gaap_loc_IntangibleAssetsNetExcludingGoodwill"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US">Intangible assets, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_IntangibleAssetsNetExcludingGoodwill" xlink:to="us-gaap_lab_IntangibleAssetsNetExcludingGoodwill" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_InterestExpense" xlink:label="us-gaap_loc_InterestExpense"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="lab_us-gaap_InterestExpense_label_en-US">Interest expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_InterestExpense" xlink:to="us-gaap_lab_InterestExpense" order="1.0"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_InterestExpense2" xlink:role="http://xbrl.us/us-gaap/role/label/negated" xml:lang="en-US" id="lab_us-gaap_InterestExpense_label_en-US2">Interest expense</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_InterestExpense" xlink:to="us-gaap_lab_InterestExpense2" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_InventoryNet" xlink:label="us-gaap_loc_InventoryNet"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="lab_us-gaap_InventoryNet_label_en-US">Inventories</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_InventoryNet" xlink:to="us-gaap_lab_InventoryNet" order="1.0"/>
    <link:label xlink:type="resource" xlink:label="label_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_InventoryNet" xml:lang="en-US" id="label_InventoryNet">Inventory, Net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_InventoryNet" xlink:to="label_InventoryNet" xlink:title="label: InventoryNet to label_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:label="loc_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:label xlink:type="resource" xlink:label="label_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xml:lang="en-US" id="label_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">Investments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="label_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:title="label: InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock to label_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:label xlink:type="resource" xlink:label="label_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xml:lang="en-US" id="label_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_2">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="label_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_2" xlink:title="label: InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock to label_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="loc_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:label xlink:type="resource" xlink:label="label_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_LiabilitiesAndStockholdersEquityAbstract" xml:lang="en-US" id="label_LiabilitiesAndStockholdersEquityAbstract">Liabilities and Shareholders' Equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_LiabilitiesAndStockholdersEquityAbstract" xlink:to="label_LiabilitiesAndStockholdersEquityAbstract" xlink:title="label: LiabilitiesAndStockholdersEquityAbstract to label_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_loc_LiabilitiesAndStockholdersEquity"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US">Total liabilities and shareholders' equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_lab_LiabilitiesAndStockholdersEquity" order="1.0"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_LiabilitiesAndStockholdersEquity2" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US" id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US2">Total liabilities and shareholders' equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_lab_LiabilitiesAndStockholdersEquity2" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="us-gaap_loc_LongTermDebtCurrent"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="lab_us-gaap_LongTermDebtCurrent_label_en-US">Current maturities of long term debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_LongTermDebtCurrent" xlink:to="us-gaap_lab_LongTermDebtCurrent" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="us-gaap_loc_LongTermDebtNoncurrent"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US">Long term debt, net of current maturities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_LongTermDebtNoncurrent" xlink:to="us-gaap_lab_LongTermDebtNoncurrent" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_LongTermInvestments" xlink:label="us-gaap_loc_LongTermInvestments"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_LongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="lab_us-gaap_LongTermInvestments_label_en-US">Long term investments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_LongTermInvestments" xlink:to="us-gaap_lab_LongTermInvestments" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="loc_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:label xlink:type="resource" xlink:label="label_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_NetCashProvidedByUsedInFinancingActivitiesAbstract" xml:lang="en-US" id="label_NetCashProvidedByUsedInFinancingActivitiesAbstract">Cash provided by (used in) financing activities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="label_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:title="label: NetCashProvidedByUsedInFinancingActivitiesAbstract to label_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_loc_NetCashProvidedByUsedInFinancingActivities"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US">Net cash from financing activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_lab_NetCashProvidedByUsedInFinancingActivities" order="1.0"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_NetCashProvidedByUsedInFinancingActivities2" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US" id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US2">Net cash from financing activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_lab_NetCashProvidedByUsedInFinancingActivities2" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="loc_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:label xlink:type="resource" xlink:label="label_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_NetCashProvidedByUsedInInvestingActivitiesAbstract" xml:lang="en-US" id="label_NetCashProvidedByUsedInInvestingActivitiesAbstract">Cash provided by (used in) investing activities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="label_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:title="label: NetCashProvidedByUsedInInvestingActivitiesAbstract to label_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_loc_NetCashProvidedByUsedInInvestingActivities"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US">Net cash from investing activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_lab_NetCashProvidedByUsedInInvestingActivities" order="1.0"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_NetCashProvidedByUsedInInvestingActivities2" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US" id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US2">Net cash from investing activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_lab_NetCashProvidedByUsedInInvestingActivities2" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="loc_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:label xlink:type="resource" xlink:label="label_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_NetCashProvidedByUsedInOperatingActivitiesAbstract" xml:lang="en-US" id="label_NetCashProvidedByUsedInOperatingActivitiesAbstract">Cash provided by (used in) operating activities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="label_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="label: NetCashProvidedByUsedInOperatingActivitiesAbstract to label_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_loc_NetCashProvidedByUsedInOperatingActivities"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US">Net cash from operating activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_lab_NetCashProvidedByUsedInOperatingActivities" order="1.0"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_NetCashProvidedByUsedInOperatingActivities2" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US" id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US2">Net cash from operating activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_lab_NetCashProvidedByUsedInOperatingActivities2" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="us-gaap_loc_CashAndCashEquivalentsPeriodIncreaseDecrease"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_label_en-US">Net increase in cash and cash equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_lab_CashAndCashEquivalentsPeriodIncreaseDecrease" order="1.0"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_CashAndCashEquivalentsPeriodIncreaseDecrease2" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US" id="lab_us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease_label_en-US2">Net increase in cash and cash equivalents</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:to="us-gaap_lab_CashAndCashEquivalentsPeriodIncreaseDecrease2" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_GainsLossesOnSalesOfAssets" xlink:label="us-gaap_loc_GainsLossesOnSalesOfAssets"/>
    <link:label xlink:type="resource" xlink:label="label_GainsLossesOnSalesOfAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_GainsLossesOnSalesOfAssets" xml:lang="en-US" id="label_GainsLossesOnSalesOfAssets">Loss (gain) on sale of assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_GainsLossesOnSalesOfAssets" xlink:to="label_GainsLossesOnSalesOfAssets" xlink:title="label: GainsLossesOnSalesOfAssets to label_GainsLossesOnSalesOfAssets"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_OperatingIncomeLossAbstract" xlink:label="loc_OperatingIncomeLossAbstract"/>
    <link:label xlink:type="resource" xlink:label="label_OperatingIncomeLossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_OperatingIncomeLossAbstract" xml:lang="en-US" id="label_OperatingIncomeLossAbstract">Other income (expense):</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_OperatingIncomeLossAbstract" xlink:to="label_OperatingIncomeLossAbstract" xlink:title="label: OperatingIncomeLossAbstract to label_OperatingIncomeLossAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_loc_OperatingIncomeLoss"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="lab_us-gaap_OperatingIncomeLoss_label_en-US">Operating income</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_OperatingIncomeLoss" xlink:to="us-gaap_lab_OperatingIncomeLoss" order="1.0"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_OperatingIncomeLoss2" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US" id="lab_us-gaap_OperatingIncomeLoss_label_en-US2">Operating income</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_OperatingIncomeLoss" xlink:to="us-gaap_lab_OperatingIncomeLoss2" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="us-gaap_loc_OtherAssetsCurrent"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="lab_us-gaap_OtherAssetsCurrent_label_en-US">Other current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_OtherAssetsCurrent" xlink:to="us-gaap_lab_OtherAssetsCurrent" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:label="us-gaap_loc_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US">Other, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="us-gaap_lab_PaymentsForProceedsFromOtherInvestingActivities" order="1.0"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_PaymentsForProceedsFromOtherInvestingActivities2" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US2">Payments For Proceeds From Other Investing Activities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="us-gaap_lab_PaymentsForProceedsFromOtherInvestingActivities2" order="1.0"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_PaymentsForProceedsFromOtherInvestingActivities3" xlink:role="http://xbrl.us/us-gaap/role/label/negated" xml:lang="en-US" id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US3">Other, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="us-gaap_lab_PaymentsForProceedsFromOtherInvestingActivities3" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="us-gaap_loc_OtherNonoperatingIncomeExpense"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US">Other, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_OtherNonoperatingIncomeExpense" xlink:to="us-gaap_lab_OtherNonoperatingIncomeExpense" order="1.0"/>
    <link:label xlink:type="resource" xlink:label="label_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_OtherNonoperatingIncomeExpense" xml:lang="en-US" id="label_OtherNonoperatingIncomeExpense">Other Nonoperating Income (Expense)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_OtherNonoperatingIncomeExpense" xlink:to="label_OtherNonoperatingIncomeExpense" xlink:title="label: OtherNonoperatingIncomeExpense to label_OtherNonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock" xlink:label="loc_PaymentsOfDividendsCommonStock"/>
    <link:label xlink:type="resource" xlink:label="label_PaymentsOfDividendsCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_PaymentsOfDividendsCommonStock" xml:lang="en-US" id="label_PaymentsOfDividendsCommonStock">Dividends on common shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_PaymentsOfDividendsCommonStock" xlink:to="label_PaymentsOfDividendsCommonStock" xlink:title="label: PaymentsOfDividendsCommonStock to label_PaymentsOfDividendsCommonStock"/>
    <link:label xlink:type="resource" xlink:label="label_PaymentsOfDividendsCommonStock_2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_PaymentsOfDividendsCommonStock" xml:lang="en-US" id="label_PaymentsOfDividendsCommonStock_2">Payments of Dividends Common Stock</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_PaymentsOfDividendsCommonStock" xlink:to="label_PaymentsOfDividendsCommonStock_2" xlink:title="label: PaymentsOfDividendsCommonStock to label_PaymentsOfDividendsCommonStock"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_PaymentsOfDividendsCommonStock3" xlink:role="http://xbrl.us/us-gaap/role/label/negated" xml:lang="en-US" id="lab_us-gaap_PaymentsOfDividendsCommonStock_label_en-US3">Dividends on common shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_PaymentsOfDividendsCommonStock" xlink:to="us-gaap_lab_PaymentsOfDividendsCommonStock3" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:label="loc_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:label xlink:type="resource" xlink:label="label_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xml:lang="en-US" id="label_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">Pension and Postretirement Benefits</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="label_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:title="label: PensionAndOtherPostretirementBenefitsDisclosureTextBlock to label_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="loc_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:label xlink:type="resource" xlink:label="label_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ProceedsFromIssuanceOfLongTermDebt" xml:lang="en-US" id="label_ProceedsFromIssuanceOfLongTermDebt">Proceeds from issuance of long term debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ProceedsFromIssuanceOfLongTermDebt" xlink:to="label_ProceedsFromIssuanceOfLongTermDebt" xlink:title="label: ProceedsFromIssuanceOfLongTermDebt to label_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:label="loc_ProceedsFromSaleOfProductiveAssets"/>
    <link:label xlink:type="resource" xlink:label="label_ProceedsFromSaleOfProductiveAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ProceedsFromSaleOfProductiveAssets" xml:lang="en-US" id="label_ProceedsFromSaleOfProductiveAssets">Proceeds from sale of assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ProceedsFromSaleOfProductiveAssets" xlink:to="label_ProceedsFromSaleOfProductiveAssets" xlink:title="label: ProceedsFromSaleOfProductiveAssets to label_ProceedsFromSaleOfProductiveAssets"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_loc_ProceedsFromStockOptionsExercised"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US">Proceeds from exercise of stock options</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_lab_ProceedsFromStockOptionsExercised" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_ResearchAndDevelopmentInProcess" xlink:label="loc_ResearchAndDevelopmentInProcess"/>
    <link:label xlink:type="resource" xlink:label="label_ResearchAndDevelopmentInProcess" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ResearchAndDevelopmentInProcess" xml:lang="en-US" id="label_ResearchAndDevelopmentInProcess">In process research and development</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ResearchAndDevelopmentInProcess" xlink:to="label_ResearchAndDevelopmentInProcess" xlink:title="label: ResearchAndDevelopmentInProcess to label_ResearchAndDevelopmentInProcess"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_loc_PropertyPlantAndEquipmentNet"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US">Property, plant and equipment, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_lab_PropertyPlantAndEquipmentNet" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="us-gaap_loc_PaymentsToAcquireIntangibleAssets"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_label_en-US">Purchases of intangible assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_lab_PaymentsToAcquireIntangibleAssets" order="1.0"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_PaymentsToAcquireIntangibleAssets2" xlink:role="http://xbrl.us/us-gaap/role/label/negated" xml:lang="en-US" id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_label_en-US2">Purchases of intangible assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_PaymentsToAcquireIntangibleAssets" xlink:to="us-gaap_lab_PaymentsToAcquireIntangibleAssets2" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_PaymentsToAcquireInvestments" xlink:label="us-gaap_loc_PaymentsToAcquireInvestments"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_PaymentsToAcquireInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="lab_us-gaap_PaymentsToAcquireInvestments_label_en-US">Purchases of investments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_PaymentsToAcquireInvestments" xlink:to="us-gaap_lab_PaymentsToAcquireInvestments" order="1.0"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_PaymentsToAcquireInvestments2" xlink:role="http://xbrl.us/us-gaap/role/label/negated" xml:lang="en-US" id="lab_us-gaap_PaymentsToAcquireInvestments_label_en-US2">Purchases of investments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_PaymentsToAcquireInvestments" xlink:to="us-gaap_lab_PaymentsToAcquireInvestments2" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_loc_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US">Purchases of property, plant and equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_lab_PaymentsToAcquirePropertyPlantAndEquipment" order="1.0"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_PaymentsToAcquirePropertyPlantAndEquipment2" xlink:role="http://xbrl.us/us-gaap/role/label/negated" xml:lang="en-US" id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US2">Purchases of property, plant and equipment</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_lab_PaymentsToAcquirePropertyPlantAndEquipment2" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="us-gaap_loc_RepaymentsOfLongTermDebt"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_RepaymentsOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US">Repayment of long term debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_RepaymentsOfLongTermDebt" xlink:to="us-gaap_lab_RepaymentsOfLongTermDebt" order="1.0"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_RepaymentsOfLongTermDebt2" xlink:role="http://xbrl.us/us-gaap/role/label/negated" xml:lang="en-US" id="lab_us-gaap_RepaymentsOfLongTermDebt_label_en-US2">Repayment of long term debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_RepaymentsOfLongTermDebt" xlink:to="us-gaap_lab_RepaymentsOfLongTermDebt2" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="us-gaap_loc_PaymentsForRepurchaseOfCommonStock"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US">Acquisition of treasury shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_PaymentsForRepurchaseOfCommonStock" xlink:to="us-gaap_lab_PaymentsForRepurchaseOfCommonStock" order="1.0"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_PaymentsForRepurchaseOfCommonStock2" xlink:role="http://xbrl.us/us-gaap/role/label/negated" xml:lang="en-US" id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US2">Acquisition of treasury shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_PaymentsForRepurchaseOfCommonStock" xlink:to="us-gaap_lab_PaymentsForRepurchaseOfCommonStock2" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_loc_RetainedEarningsAccumulatedDeficit"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US">Retained earnings</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_lab_RetainedEarningsAccumulatedDeficit" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:label="us-gaap_loc_ProceedsFromSaleMaturityAndCollectionsOfInvestments"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="lab_us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments_label_en-US">Proceeds from sales and maturities of investments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:to="us-gaap_lab_ProceedsFromSaleMaturityAndCollectionsOfInvestments" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="us-gaap_loc_SalesRevenueNet"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_SalesRevenueNet" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="lab_us-gaap_SalesRevenueNet_label_en-US">Sales</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_SalesRevenueNet" xlink:to="us-gaap_lab_SalesRevenueNet" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:label xlink:type="resource" xlink:label="label_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xml:lang="en-US" id="label_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock">Schedule of Business Acquisitions, by Acquisition [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:to="label_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:title="label: ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock to label_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:label xlink:type="resource" xlink:label="label_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xml:lang="en-US" id="label_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_2">Acquisition</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:to="label_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_2" xlink:title="label: ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock to label_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="loc_SegmentReportingDisclosureTextBlock"/>
    <link:label xlink:type="resource" xlink:label="label_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_SegmentReportingDisclosureTextBlock" xml:lang="en-US" id="label_SegmentReportingDisclosureTextBlock">Business Segments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_SegmentReportingDisclosureTextBlock" xlink:to="label_SegmentReportingDisclosureTextBlock" xlink:title="label: SegmentReportingDisclosureTextBlock to label_SegmentReportingDisclosureTextBlock"/>
    <link:label xlink:type="resource" xlink:label="label_SegmentReportingDisclosureTextBlock_2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_SegmentReportingDisclosureTextBlock" xml:lang="en-US" id="label_SegmentReportingDisclosureTextBlock_2">Segment Reporting Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_SegmentReportingDisclosureTextBlock" xlink:to="label_SegmentReportingDisclosureTextBlock_2" xlink:title="label: SegmentReportingDisclosureTextBlock to label_SegmentReportingDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_ShortTermBorrowings" xlink:label="us-gaap_loc_ShortTermBorrowings"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="lab_us-gaap_ShortTermBorrowings_label_en-US">Short term borrowings</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_ShortTermBorrowings" xlink:to="us-gaap_lab_ShortTermBorrowings" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_ShortTermInvestments" xlink:label="us-gaap_loc_ShortTermInvestments"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_ShortTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="lab_us-gaap_ShortTermInvestments_label_en-US">Short term investments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_ShortTermInvestments" xlink:to="us-gaap_lab_ShortTermInvestments" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="loc_SignificantAccountingPoliciesTextBlock"/>
    <link:label xlink:type="resource" xlink:label="label_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_SignificantAccountingPoliciesTextBlock" xml:lang="en-US" id="label_SignificantAccountingPoliciesTextBlock">Summary of Significant Accounting Policies and Practices</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_SignificantAccountingPoliciesTextBlock" xlink:to="label_SignificantAccountingPoliciesTextBlock" xlink:title="label: SignificantAccountingPoliciesTextBlock to label_SignificantAccountingPoliciesTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="loc_StatementOfCashFlowsAbstract"/>
    <link:label xlink:type="resource" xlink:label="label_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_StatementOfCashFlowsAbstract" xml:lang="en-US" id="label_StatementOfCashFlowsAbstract">CONSOLIDATED STATEMENTS OF CASH FLOWS</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_StatementOfCashFlowsAbstract" xlink:to="label_StatementOfCashFlowsAbstract" xlink:title="label: StatementOfCashFlowsAbstract to label_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="loc_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:label xlink:type="resource" xlink:label="label_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_StockholdersEquityNoteDisclosureTextBlock" xml:lang="en-US" id="label_StockholdersEquityNoteDisclosureTextBlock">Shareholders' Equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_StockholdersEquityNoteDisclosureTextBlock" xlink:to="label_StockholdersEquityNoteDisclosureTextBlock" xlink:title="label: StockholdersEquityNoteDisclosureTextBlock to label_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:label="loc_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:label xlink:type="resource" xlink:label="label_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_GoodwillAndIntangibleAssetsDisclosureTextBlock" xml:lang="en-US" id="label_GoodwillAndIntangibleAssetsDisclosureTextBlock">Intangible Assets and Goodwill</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="label_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:title="label: GoodwillAndIntangibleAssetsDisclosureTextBlock to label_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:label xlink:type="resource" xlink:label="label_GoodwillAndIntangibleAssetsDisclosureTextBlock_2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_GoodwillAndIntangibleAssetsDisclosureTextBlock" xml:lang="en-US" id="label_GoodwillAndIntangibleAssetsDisclosureTextBlock_2">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="label_GoodwillAndIntangibleAssetsDisclosureTextBlock_2" xlink:title="label: GoodwillAndIntangibleAssetsDisclosureTextBlock to label_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="loc_AssetsCurrentAbstract"/>
    <link:label xlink:type="resource" xlink:label="label_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_AssetsCurrentAbstract" xml:lang="en-US" id="label_AssetsCurrentAbstract">Current assets:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_AssetsCurrentAbstract" xlink:to="label_AssetsCurrentAbstract" xlink:title="label: AssetsCurrentAbstract to label_AssetsCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_loc_AssetsCurrent"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="lab_us-gaap_AssetsCurrent_label_en-US">Total current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_AssetsCurrent" xlink:to="us-gaap_lab_AssetsCurrent" order="1.0"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_AssetsCurrent2" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US" id="lab_us-gaap_AssetsCurrent_label_en-US2">Total current assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_AssetsCurrent" xlink:to="us-gaap_lab_AssetsCurrent2" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_UnrealizedGainLossOnSecurities" xlink:label="us-gaap_loc_UnrealizedGainLossOnSecurities"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_UnrealizedGainLossOnSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="lab_us-gaap_UnrealizedGainLossOnSecurities_label_en-US">Unrealized appreciation on trading securities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_UnrealizedGainLossOnSecurities" xlink:to="us-gaap_lab_UnrealizedGainLossOnSecurities" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="us-gaap_loc_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US">Diluted weighted average common shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="us-gaap_lab_WeightedAverageNumberOfDilutedSharesOutstanding" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_loc_ResearchAndDevelopmentExpense"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US">Research and development</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_ResearchAndDevelopmentExpense" xlink:to="us-gaap_lab_ResearchAndDevelopmentExpense" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_loc_Assets"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="lab_us-gaap_Assets_label_en-US">Total assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_Assets" xlink:to="us-gaap_lab_Assets" order="1.0"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_Assets2" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US" id="lab_us-gaap_Assets_label_en-US2">Total assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_Assets" xlink:to="us-gaap_lab_Assets2" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_InvestmentIncomeInterestAndDividend" xlink:label="us-gaap_loc_InvestmentIncomeInterestAndDividend"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_InvestmentIncomeInterestAndDividend" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="lab_us-gaap_InvestmentIncomeInterestAndDividend_label_en-US">Interest income</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_InvestmentIncomeInterestAndDividend" xlink:to="us-gaap_lab_InvestmentIncomeInterestAndDividend" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_loc_OtherLiabilitiesCurrent"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US">Other current liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_OtherLiabilitiesCurrent" xlink:to="us-gaap_lab_OtherLiabilitiesCurrent" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="us-gaap_loc_OtherLiabilitiesNoncurrent"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US">Other long term liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_OtherLiabilitiesNoncurrent" xlink:to="us-gaap_lab_OtherLiabilitiesNoncurrent" order="1.0"/>
    <link:label xlink:type="resource" xlink:label="label_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_OtherLiabilitiesNoncurrent" xml:lang="en-US" id="label_OtherLiabilitiesNoncurrent">Other Liabilities, Noncurrent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_OtherLiabilitiesNoncurrent" xlink:to="label_OtherLiabilitiesNoncurrent" xlink:title="label: OtherLiabilitiesNoncurrent to label_OtherLiabilitiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_DeferredTaxAssetsNetNoncurrent" xlink:label="us-gaap_loc_DeferredTaxAssetsNetNoncurrent"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_DeferredTaxAssetsNetNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="lab_us-gaap_DeferredTaxAssetsNetNoncurrent_label_en-US">Long term deferred income tax assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_DeferredTaxAssetsNetNoncurrent" xlink:to="us-gaap_lab_DeferredTaxAssetsNetNoncurrent" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="loc_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:label xlink:type="resource" xlink:label="label_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xml:lang="en-US" id="label_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">Share-Based Compensation Plans</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="label_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:title="label: DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock to label_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:label xlink:type="resource" xlink:label="label_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xml:lang="en-US" id="label_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_2">Disclosure of Compensation Related Costs, Share-based Payments [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="label_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_2" xlink:title="label: DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock to label_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_DeferredTaxAssetsNetCurrent" xlink:label="us-gaap_loc_DeferredTaxAssetsNetCurrent"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_DeferredTaxAssetsNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="lab_us-gaap_DeferredTaxAssetsNetCurrent_label_en-US">Deferred income tax assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_DeferredTaxAssetsNetCurrent" xlink:to="us-gaap_lab_DeferredTaxAssetsNetCurrent" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:label="us-gaap_loc_DeferredTaxLiabilitiesNoncurrent"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_DeferredTaxLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="lab_us-gaap_DeferredTaxLiabilitiesNoncurrent_label_en-US">Long term deferred income tax liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_DeferredTaxLiabilitiesNoncurrent" xlink:to="us-gaap_lab_DeferredTaxLiabilitiesNoncurrent" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="loc_AssetsAbstract"/>
    <link:label xlink:type="resource" xlink:label="label_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_AssetsAbstract" xml:lang="en-US" id="label_AssetsAbstract">Assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_AssetsAbstract" xlink:to="label_AssetsAbstract" xlink:title="label: AssetsAbstract to label_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="loc_FairValueDisclosuresTextBlock"/>
    <link:label xlink:type="resource" xlink:label="label_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_FairValueDisclosuresTextBlock" xml:lang="en-US" id="label_FairValueDisclosuresTextBlock">Fair Value of Financial Instruments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FairValueDisclosuresTextBlock" xlink:to="label_FairValueDisclosuresTextBlock" xlink:title="label: FairValueDisclosuresTextBlock to label_FairValueDisclosuresTextBlock"/>
    <link:label xlink:type="resource" xlink:label="label_FairValueDisclosuresTextBlock_2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_FairValueDisclosuresTextBlock" xml:lang="en-US" id="label_FairValueDisclosuresTextBlock_2">Fair Value Disclosures [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FairValueDisclosuresTextBlock" xlink:to="label_FairValueDisclosuresTextBlock_2" xlink:title="label: FairValueDisclosuresTextBlock to label_FairValueDisclosuresTextBlock"/>
    <link:label xlink:type="resource" xlink:label="label_FairValueDisclosuresTextBlock_3" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:title="label_FairValueDisclosuresTextBlock" xml:lang="en-US" id="label_FairValueDisclosuresTextBlock_3">Financial Instruments</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_FairValueDisclosuresTextBlock" xlink:to="label_FairValueDisclosuresTextBlock_3" xlink:title="label: FairValueDisclosuresTextBlock to label_FairValueDisclosuresTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_QuarterlyFinancialInformationTextBlock" xlink:label="loc_QuarterlyFinancialInformationTextBlock"/>
    <link:label xlink:type="resource" xlink:label="label_QuarterlyFinancialInformationTextBlock_2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_QuarterlyFinancialInformationTextBlock" xml:lang="en-US" id="label_QuarterlyFinancialInformationTextBlock_2">Quarterly Financial Information [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_QuarterlyFinancialInformationTextBlock" xlink:to="label_QuarterlyFinancialInformationTextBlock_2" xlink:title="label: QuarterlyFinancialInformationTextBlock to label_QuarterlyFinancialInformationTextBlock"/>
    <link:label xlink:type="resource" xlink:label="label_QuarterlyFinancialInformationTextBlock_3" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_QuarterlyFinancialInformationTextBlock" xml:lang="en-US" id="label_QuarterlyFinancialInformationTextBlock_3">Condensed Consolidated Financial Statements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_QuarterlyFinancialInformationTextBlock" xlink:to="label_QuarterlyFinancialInformationTextBlock_3" xlink:title="label: QuarterlyFinancialInformationTextBlock to label_QuarterlyFinancialInformationTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="us-gaap_loc_TreasuryStockValue"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="lab_us-gaap_TreasuryStockValue_label_en-US">Treasury shares, at cost; 3,952,664 shares at March 31, 2010 and 4,465,557 shares at December 31, 2009</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_TreasuryStockValue" xlink:to="us-gaap_lab_TreasuryStockValue" order="1.0"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_TreasuryStockValue2" xlink:role="http://xbrl.us/us-gaap/role/label/negated" xml:lang="en-US" id="lab_us-gaap_TreasuryStockValue_label_en-US2">Treasury shares, at cost; 3,952,664 shares at March 31, 2010 and 4,465,557 shares at December 31, 2009</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_TreasuryStockValue" xlink:to="us-gaap_lab_TreasuryStockValue2" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:label="loc_CashFlowSupplementalDisclosuresTextBlock"/>
    <link:label xlink:type="resource" xlink:label="label_CashFlowSupplementalDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_CashFlowSupplementalDisclosuresTextBlock" xml:lang="en-US" id="label_CashFlowSupplementalDisclosuresTextBlock">Cash Flows-Supplemental Disclosures</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_CashFlowSupplementalDisclosuresTextBlock" xlink:to="label_CashFlowSupplementalDisclosuresTextBlock" xlink:title="label: CashFlowSupplementalDisclosuresTextBlock to label_CashFlowSupplementalDisclosuresTextBlock"/>
    <link:label xlink:type="resource" xlink:label="label_CashFlowSupplementalDisclosuresTextBlock_2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_CashFlowSupplementalDisclosuresTextBlock" xml:lang="en-US" id="label_CashFlowSupplementalDisclosuresTextBlock_2">Cash Flow, Supplemental Disclosures [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_CashFlowSupplementalDisclosuresTextBlock" xlink:to="label_CashFlowSupplementalDisclosuresTextBlock_2" xlink:title="label: CashFlowSupplementalDisclosuresTextBlock to label_CashFlowSupplementalDisclosuresTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="us-gaap_loc_EarningsPerShareBasic"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="lab_us-gaap_EarningsPerShareBasic_label_en-US">Basic earnings per common share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_EarningsPerShareBasic" xlink:to="us-gaap_lab_EarningsPerShareBasic" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities" xlink:label="us-gaap_loc_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="lab_us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities_label_en-US">Tax benefits from share-based payment arrangements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities" xlink:to="us-gaap_lab_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities" xlink:label="us-gaap_loc_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities"/>
    <link:label xlink:type="resource" xlink:label="label_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities" xml:lang="en-US" id="label_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities">Tax benefits (reversals) from share-based compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities" xlink:to="label_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities" xlink:title="label: ExcessTaxBenefitFromShareBasedCompensationOperatingActivities to label_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_loc_CommonStockSharesIssued"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="lab_us-gaap_CommonStockSharesIssued_label_en-US">Common shares, shares issued</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_CommonStockSharesIssued" xlink:to="us-gaap_lab_CommonStockSharesIssued" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_loc_OtherAssetsNoncurrent"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US">Other assets</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_OtherAssetsNoncurrent" xlink:to="us-gaap_lab_OtherAssetsNoncurrent" order="1.0"/>
    <link:label xlink:type="resource" xlink:label="label_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_OtherAssetsNoncurrent" xml:lang="en-US" id="label_OtherAssetsNoncurrent">Other Assets, Noncurrent</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_OtherAssetsNoncurrent" xlink:to="label_OtherAssetsNoncurrent" xlink:title="label: OtherAssetsNoncurrent to label_OtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_loc_EarningsPerSharePolicyTextBlock"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US">Earnings Per Share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_lab_EarningsPerSharePolicyTextBlock" order="1.0"/>
    <link:label xlink:type="resource" xlink:label="label_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_EarningsPerSharePolicyTextBlock" xml:lang="en-US" id="label_EarningsPerSharePolicyTextBlock">Earnings Per Share, Policy [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_EarningsPerSharePolicyTextBlock" xlink:to="label_EarningsPerSharePolicyTextBlock" xlink:title="label: EarningsPerSharePolicyTextBlock to label_EarningsPerSharePolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="loc_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:label xlink:type="resource" xlink:label="label_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_IncreaseDecreaseInOtherOperatingLiabilities" xml:lang="en-US" id="label_IncreaseDecreaseInOtherOperatingLiabilities">Other long term liabilities</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="label_IncreaseDecreaseInOtherOperatingLiabilities" xlink:title="label: IncreaseDecreaseInOtherOperatingLiabilities to label_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="us-gaap_loc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US">Earnings before income taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_lab_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" order="1.0"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments2" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US" id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_label_en-US2">Earnings before income taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:to="us-gaap_lab_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments2" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_loc_CommonStockParOrStatedValuePerShare"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US">Common shares, par value CHF per share</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_lab_CommonStockParOrStatedValuePerShare" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="us-gaap_loc_TreasuryStockShares"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="lab_us-gaap_TreasuryStockShares_label_en-US">Treasury shares, at cost; shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_TreasuryStockShares" xlink:to="us-gaap_lab_TreasuryStockShares" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="us-gaap_loc_IncomeTaxExpenseBenefit"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US">Income taxes</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_IncomeTaxExpenseBenefit" xlink:to="us-gaap_lab_IncomeTaxExpenseBenefit" order="1.0"/>
    <link:label xlink:type="resource" xlink:label="label_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_IncomeTaxExpenseBenefit" xml:lang="en-US" id="label_IncomeTaxExpenseBenefit">Income Tax Expense (Benefit)</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_IncomeTaxExpenseBenefit" xlink:to="label_IncomeTaxExpenseBenefit" xlink:title="label: IncomeTaxExpenseBenefit to label_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="us-gaap_loc_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_label_en-US">Loss from foreign currency, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="us-gaap_lab_ForeignCurrencyTransactionGainLossBeforeTax" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_ShortTermDebtTextBlock" xlink:label="loc_ShortTermDebtTextBlock"/>
    <link:label xlink:type="resource" xlink:label="label_ShortTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ShortTermDebtTextBlock" xml:lang="en-US" id="label_ShortTermDebtTextBlock">Short Term Borrowing</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ShortTermDebtTextBlock" xlink:to="label_ShortTermDebtTextBlock" xlink:title="label: ShortTermDebtTextBlock to label_ShortTermDebtTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_LongTermDebtTextBlock" xlink:label="loc_LongTermDebtTextBlock"/>
    <link:label xlink:type="resource" xlink:label="label_LongTermDebtTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_LongTermDebtTextBlock" xml:lang="en-US" id="label_LongTermDebtTextBlock">Long Term Debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_LongTermDebtTextBlock" xlink:to="label_LongTermDebtTextBlock" xlink:title="label: LongTermDebtTextBlock to label_LongTermDebtTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_Goodwill" xlink:label="us-gaap_loc_Goodwill"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="lab_us-gaap_Goodwill_label_en-US">Goodwill</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_Goodwill" xlink:to="us-gaap_lab_Goodwill" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_loc_ProfitLoss"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_ProfitLoss" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="lab_us-gaap_ProfitLoss_label_en-US">Net earnings</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_ProfitLoss" xlink:to="us-gaap_lab_ProfitLoss" order="1.0"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_ProfitLoss2" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US" id="lab_us-gaap_ProfitLoss_label_en-US2">Net earnings</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_ProfitLoss" xlink:to="us-gaap_lab_ProfitLoss2" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:label="us-gaap_loc_WeightedAverageNumberOfSharesIssuedBasic"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_WeightedAverageNumberOfSharesIssuedBasic" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="lab_us-gaap_WeightedAverageNumberOfSharesIssuedBasic_label_en-US">Basic weighted average common shares</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_WeightedAverageNumberOfSharesIssuedBasic" xlink:to="us-gaap_lab_WeightedAverageNumberOfSharesIssuedBasic" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:label="loc_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:label xlink:type="resource" xlink:label="label_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xml:lang="en-US" id="label_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract">Shareholders' equity:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="label_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:title="label: StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract to label_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="us-gaap_loc_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US">Total shareholders' equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_lab_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" order="1.0"/>
    <link:label xlink:type="resource" xlink:label="label_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:title="label_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xml:lang="en-US" id="label_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">Beginning Balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="label_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:title="label: StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest to label_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:label xlink:type="resource" xlink:label="label_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:title="label_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xml:lang="en-US" id="label_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2">Ending Balance</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="label_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_2" xlink:title="label: StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest to label_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest3" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xml:lang="en-US" id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US3">Total shareholders' equity</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="us-gaap_lab_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest3" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_loc_AccountsPayableCurrent"/>
    <link:label xlink:type="resource" xlink:label="us-gaap_lab_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="lab_us-gaap_AccountsPayableCurrent_label_en-US">Accounts payable</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_AccountsPayableCurrent" xlink:to="us-gaap_lab_AccountsPayableCurrent" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_CommitmentsAndContingencies2009" xlink:label="us-gaap_loc_CommitmentsAndContingencies2009"/>
    <link:label xlink:type="resource" xlink:label="label_CommitmentsAndContingencies2009" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_CommitmentsAndContingencies2009" xml:lang="en-US" id="label_CommitmentsAndContingencies2009">Contingencies</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_CommitmentsAndContingencies2009" xlink:to="label_CommitmentsAndContingencies2009" xlink:title="label: CommitmentsAndContingencies2009 to label_CommitmentsAndContingencies2009"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesOther" xlink:label="us-gaap_loc_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesOther"/>
    <link:label xlink:type="resource" xlink:label="label_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesOther" xml:lang="en-US" id="label_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesOther">Other, net</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_loc_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesOther" xlink:to="label_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesOther" xlink:title="label: AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesOther to label_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesOther"/>
    <link:loc xlink:type="locator" xlink:href="acl-20100331.xsd#acl_SellingGeneralAndAdministrative" xlink:label="SellingGeneralAndAdministrative" xlink:title="SellingGeneralAndAdministrative"/>
    <link:label xlink:type="resource" xlink:label="label_SellingGeneralAndAdministrative" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_SellingGeneralAndAdministrative" xml:lang="en-US" id="label_SellingGeneralAndAdministrative">Selling, general and administrative</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SellingGeneralAndAdministrative" xlink:to="label_SellingGeneralAndAdministrative" xlink:title="label: SellingGeneralAndAdministrative to label_SellingGeneralAndAdministrative"/>
    <link:label xlink:type="resource" xlink:label="label_SellingGeneralAndAdministrative_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_SellingGeneralAndAdministrative" xml:lang="en-US" id="label_SellingGeneralAndAdministrative_2">The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc., including expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, services, costs of public relations and corporate promotions are typically co
nsidered to be marketing costs.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SellingGeneralAndAdministrative" xlink:to="label_SellingGeneralAndAdministrative_2" xlink:title="label: SellingGeneralAndAdministrative to label_SellingGeneralAndAdministrative"/>
    <link:loc xlink:type="locator" xlink:href="acl-20100331.xsd#acl_NotesToFinancialStatementsAbstract" xlink:label="ShortTermBorrowings" xlink:title="ShortTermBorrowings"/>
    <link:label xlink:type="resource" xlink:label="label_ShortTermBorrowings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ShortTermBorrowings" xml:lang="en-US" id="label_ShortTermBorrowings">Notes to Financial Statements [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShortTermBorrowings" xlink:to="label_ShortTermBorrowings" xlink:title="label: ShortTermBorrowings to label_ShortTermBorrowings"/>
    <link:loc xlink:type="locator" xlink:href="acl-20100331.xsd#acl_ShortTermBorrowingsAndLongTermDebt" xlink:label="ShortTermBorrowingsAndLongTermDebt" xlink:title="ShortTermBorrowingsAndLongTermDebt"/>
    <link:label xlink:type="resource" xlink:label="label_ShortTermBorrowingsAndLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ShortTermBorrowingsAndLongTermDebt" xml:lang="en-US" id="label_ShortTermBorrowingsAndLongTermDebt">Short Term Borrowings and Long Term Debt</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShortTermBorrowingsAndLongTermDebt" xlink:to="label_ShortTermBorrowingsAndLongTermDebt" xlink:title="label: ShortTermBorrowingsAndLongTermDebt to label_ShortTermBorrowingsAndLongTermDebt"/>
    <link:label xlink:type="resource" xlink:label="label_ShortTermBorrowingsAndLongTermDebt_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_ShortTermBorrowingsAndLongTermDebt" xml:lang="en-US" id="label_ShortTermBorrowingsAndLongTermDebt_2">This element may be used as a single block of text to encapsulate the entire disclosure for short-term borrowings including data and tables. This element may be used as a single block of text to encapsulate the entire disclosure for long-term borrowings including data and tables.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ShortTermBorrowingsAndLongTermDebt" xlink:to="label_ShortTermBorrowingsAndLongTermDebt_2" xlink:title="label: ShortTermBorrowingsAndLongTermDebt to label_ShortTermBorrowingsAndLongTermDebt"/>
    <link:loc xlink:type="locator" xlink:href="acl-20100331.xsd#acl_SupplementalBalanceSheetInformation" xlink:label="SupplementalBalanceSheetInformation2" xlink:title="SupplementalBalanceSheetInformation2"/>
    <link:label xlink:type="resource" xlink:label="label_SupplementalBalanceSheetInformation2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_SupplementalBalanceSheetInformation2" xml:lang="en-US" id="label_SupplementalBalanceSheetInformation2">Supplemental Balance Sheet Information</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SupplementalBalanceSheetInformation2" xlink:to="label_SupplementalBalanceSheetInformation2" xlink:title="label: SupplementalBalanceSheetInformation2 to label_SupplementalBalanceSheetInformation2"/>
    <link:label xlink:type="resource" xlink:label="label_SupplementalBalanceSheetInformation2_2" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:title="label_SupplementalBalanceSheetInformation2" xml:lang="en-US" id="label_SupplementalBalanceSheetInformation2_2">This element represents the complete disclosure related to inventory. This may include, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the major classes of inventory, and the nature of the cost elements included in inventory. If inventory is stated above cost, accrued net losses on firm purchase commitments for inventory and losses resulting from valuing inventory at the lower-of-cost-or-market may also be included. For LIFO inventory, may disclose the amount and basis for determining the excess of replacement or current cost over stated LIFO value and the effects of a LIFO quantities liquidation that impacts net income. Disclosure of long-lived, physical assets that are used in the nor
mal conduct of business to produce goods and services and not intended for resale. Examples include land, building and production equipment. This disclosure may include property plant and equipment accounting policies and methodology, a schedule of property, plant and equipment gross, additions, deletions, transfers and other changes, depreciation, depletion and amortization expense, net, accumulated depreciation, depletion and amortization expense and useful lives, income statement disclosures, assets held for sale and public utility disclosures. This element may be used as a single block of text to include the entire PPE disclosure, including data and tables. This label may include the following: 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive inco
me. Components of comprehensive income include: (1) foreign currency translation adjustments; (2) gains and losses on foreign currency transactions that are designated as, and are effective as, economic hedges of a net investment in a foreign entity; (3) gains and losses on intercompany foreign currency transactions that are of a long-term-investment nature, when the entities to the transaction are consolidated, combined, or accounted for by the equity method in the reporting enterprise's financial statements; (4) change in the market value of a futures contract that qualifies as a hedge of an asset reported at fair value; (5) unrealized holding gains and losses on available-for-sale securities and that resulting from transfers of debt securities from the held-to-maturity category to the available-for-sale category; (6) a net loss recognized as an additional pension liability not yet recognized as net periodic pension cost; and (7) the net gain or loss and net prior service cost or credit for pension plans a
nd other postretirement benefit plans.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SupplementalBalanceSheetInformation2" xlink:to="label_SupplementalBalanceSheetInformation2_2" xlink:title="label: SupplementalBalanceSheetInformation2 to label_SupplementalBalanceSheetInformation2"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/non-gaap/dei-2009-01-31.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType"/>
    <link:label xlink:type="resource" xlink:label="label_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_DocumentType" xml:lang="en-US" id="label_DocumentType">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="label_DocumentType" xlink:title="label: DocumentType to label_DocumentType"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/non-gaap/dei-2009-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate"/>
    <link:label xlink:type="resource" xlink:label="label_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_DocumentPeriodEndDate" xml:lang="en-US" id="label_DocumentPeriodEndDate">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="label_DocumentPeriodEndDate" xlink:title="label: DocumentPeriodEndDate to label_DocumentPeriodEndDate"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/non-gaap/dei-2009-01-31.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag"/>
    <link:label xlink:type="resource" xlink:label="label_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_AmendmentFlag" xml:lang="en-US" id="label_AmendmentFlag">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="label_AmendmentFlag" xlink:title="label: AmendmentFlag to label_AmendmentFlag"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/non-gaap/dei-2009-01-31.xsd#dei_AmendmentDescription" xlink:label="AmendmentDescription" xlink:title="AmendmentDescription"/>
    <link:label xlink:type="resource" xlink:label="label_AmendmentDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_AmendmentDescription" xml:lang="en-US" id="label_AmendmentDescription">Amendment Description</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentDescription" xlink:to="label_AmendmentDescription" xlink:title="label: AmendmentDescription to label_AmendmentDescription"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/non-gaap/dei-2009-01-31.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName"/>
    <link:label xlink:type="resource" xlink:label="label_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_EntityRegistrantName" xml:lang="en-US" id="label_EntityRegistrantName">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="label_EntityRegistrantName" xlink:title="label: EntityRegistrantName to label_EntityRegistrantName"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/non-gaap/dei-2009-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey"/>
    <link:label xlink:type="resource" xlink:label="label_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_EntityCentralIndexKey" xml:lang="en-US" id="label_EntityCentralIndexKey">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="label_EntityCentralIndexKey" xlink:title="label: EntityCentralIndexKey to label_EntityCentralIndexKey"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/non-gaap/dei-2009-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="EntityCurrentReportingStatus" xlink:title="EntityCurrentReportingStatus"/>
    <link:label xlink:type="resource" xlink:label="label_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_EntityCurrentReportingStatus" xml:lang="en-US" id="label_EntityCurrentReportingStatus">Entity Current Reporting Status</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCurrentReportingStatus" xlink:to="label_EntityCurrentReportingStatus" xlink:title="label: EntityCurrentReportingStatus to label_EntityCurrentReportingStatus"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/non-gaap/dei-2009-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="EntityWellKnownSeasonedIssuer" xlink:title="EntityWellKnownSeasonedIssuer"/>
    <link:label xlink:type="resource" xlink:label="label_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_EntityWellKnownSeasonedIssuer" xml:lang="en-US" id="label_EntityWellKnownSeasonedIssuer">Entity Well Known Seasoned Issuer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityWellKnownSeasonedIssuer" xlink:to="label_EntityWellKnownSeasonedIssuer" xlink:title="label: EntityWellKnownSeasonedIssuer to label_EntityWellKnownSeasonedIssuer"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/non-gaap/dei-2009-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="EntityVoluntaryFilers" xlink:title="EntityVoluntaryFilers"/>
    <link:label xlink:type="resource" xlink:label="label_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_EntityVoluntaryFilers" xml:lang="en-US" id="label_EntityVoluntaryFilers">Entity Voluntary Filers</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityVoluntaryFilers" xlink:to="label_EntityVoluntaryFilers" xlink:title="label: EntityVoluntaryFilers to label_EntityVoluntaryFilers"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/non-gaap/dei-2009-01-31.xsd#dei_EntityFilerCategory" xlink:label="EntityFilerCategory" xlink:title="EntityFilerCategory"/>
    <link:label xlink:type="resource" xlink:label="label_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_EntityFilerCategory" xml:lang="en-US" id="label_EntityFilerCategory">Entity Filer Category</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFilerCategory" xlink:to="label_EntityFilerCategory" xlink:title="label: EntityFilerCategory to label_EntityFilerCategory"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/non-gaap/dei-2009-01-31.xsd#dei_EntityPublicFloat" xlink:label="EntityPublicFloat" xlink:title="EntityPublicFloat"/>
    <link:label xlink:type="resource" xlink:label="label_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_EntityPublicFloat" xml:lang="en-US" id="label_EntityPublicFloat">Entity Public Float</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityPublicFloat" xlink:to="label_EntityPublicFloat" xlink:title="label: EntityPublicFloat to label_EntityPublicFloat"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/non-gaap/dei-2009-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="EntityCommonStockSharesOutstanding" xlink:title="EntityCommonStockSharesOutstanding"/>
    <link:label xlink:type="resource" xlink:label="label_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_EntityCommonStockSharesOutstanding" xml:lang="en-US" id="label_EntityCommonStockSharesOutstanding">Entity Common Stock Shares Outstanding</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCommonStockSharesOutstanding" xlink:to="label_EntityCommonStockSharesOutstanding" xlink:title="label: EntityCommonStockSharesOutstanding to label_EntityCommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/non-gaap/dei-2009-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="CurrentFiscalYearEndDate" xlink:title="CurrentFiscalYearEndDate"/>
    <link:label xlink:type="resource" xlink:label="label_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_CurrentFiscalYearEndDate" xml:lang="en-US" id="label_CurrentFiscalYearEndDate">Current Fiscal Year End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CurrentFiscalYearEndDate" xlink:to="label_CurrentFiscalYearEndDate" xlink:title="label: CurrentFiscalYearEndDate to label_CurrentFiscalYearEndDate"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/non-gaap/dei-2009-01-31.xsd#dei_DocumentInformationTextBlock" xlink:label="DocumentInformationTextBlock" xlink:title="DocumentInformationTextBlock"/>
    <link:label xlink:type="resource" xlink:label="label_DocumentInformationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_DocumentInformationTextBlock" xml:lang="en-US" id="label_DocumentInformationTextBlock">Document Information [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentInformationTextBlock" xlink:to="label_DocumentInformationTextBlock" xlink:title="label: DocumentInformationTextBlock to label_DocumentInformationTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/non-gaap/dei-2009-01-31.xsd#dei_EntityTextBlock" xlink:label="EntityTextBlock" xlink:title="EntityTextBlock"/>
    <link:label xlink:type="resource" xlink:label="label_EntityTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_EntityTextBlock" xml:lang="en-US" id="label_EntityTextBlock">Entity [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTextBlock" xlink:to="label_EntityTextBlock" xlink:title="label: EntityTextBlock to label_EntityTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock" xlink:label="ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock" xlink:title="ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock"/>
    <link:label xlink:type="resource" xlink:label="label_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock" xml:lang="en-US" id="label_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock">Deferred Compensation</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock" xlink:to="label_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock" xlink:title="label: ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock to label_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_ScheduleOfSubsequentEventsTextBlock" xlink:label="ScheduleOfSubsequentEventsTextBlock" xlink:title="ScheduleOfSubsequentEventsTextBlock"/>
    <link:label xlink:type="resource" xlink:label="label_ScheduleOfSubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ScheduleOfSubsequentEventsTextBlock" xml:lang="en-US" id="label_ScheduleOfSubsequentEventsTextBlock">Subsequent Events</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfSubsequentEventsTextBlock" xlink:to="label_ScheduleOfSubsequentEventsTextBlock" xlink:title="label: ScheduleOfSubsequentEventsTextBlock to label_ScheduleOfSubsequentEventsTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="RelatedPartyTransactionsDisclosureTextBlock" xlink:title="RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:label xlink:type="resource" xlink:label="label_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_RelatedPartyTransactionsDisclosureTextBlock" xml:lang="en-US" id="label_RelatedPartyTransactionsDisclosureTextBlock">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionsDisclosureTextBlock" xlink:to="label_RelatedPartyTransactionsDisclosureTextBlock" xlink:title="label: RelatedPartyTransactionsDisclosureTextBlock to label_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:label xlink:type="resource" xlink:label="label_RelatedPartyTransactionsDisclosureTextBlock_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_RelatedPartyTransactionsDisclosureTextBlock" xml:lang="en-US" id="label_RelatedPartyTransactionsDisclosureTextBlock_2">Related Party Transactions</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="RelatedPartyTransactionsDisclosureTextBlock" xlink:to="label_RelatedPartyTransactionsDisclosureTextBlock_2" xlink:title="label: RelatedPartyTransactionsDisclosureTextBlock to label_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="IncreaseDecreaseInOperatingCapitalAbstract" xlink:title="IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:label xlink:type="resource" xlink:label="label_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_IncreaseDecreaseInOperatingCapitalAbstract" xml:lang="en-US" id="label_IncreaseDecreaseInOperatingCapitalAbstract">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="label_IncreaseDecreaseInOperatingCapitalAbstract" xlink:title="label: IncreaseDecreaseInOperatingCapitalAbstract to label_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:label xlink:type="resource" xlink:label="label_IncreaseDecreaseInOperatingCapitalAbstract_2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:title="label_IncreaseDecreaseInOperatingCapitalAbstract" xml:lang="en-US" id="label_IncreaseDecreaseInOperatingCapitalAbstract_2">Changes in operating assets and liabilities, net of effects from business acquisition:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="label_IncreaseDecreaseInOperatingCapitalAbstract_2" xlink:title="label: IncreaseDecreaseInOperatingCapitalAbstract to label_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationByMajorCustomersByReportingSegmentsTextBlock" xlink:label="ScheduleOfEntityWideInformationByMajorCustomersByReportingSegmentsTextBlock" xlink:title="ScheduleOfEntityWideInformationByMajorCustomersByReportingSegmentsTextBlock"/>
    <link:label xlink:type="resource" xlink:label="label_ScheduleOfEntityWideInformationByMajorCustomersByReportingSegmentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_ScheduleOfEntityWideInformationByMajorCustomersByReportingSegmentsTextBlock" xml:lang="en-US" id="label_ScheduleOfEntityWideInformationByMajorCustomersByReportingSegmentsTextBlock">Geographic, Customer and Product Information</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ScheduleOfEntityWideInformationByMajorCustomersByReportingSegmentsTextBlock" xlink:to="label_ScheduleOfEntityWideInformationByMajorCustomersByReportingSegmentsTextBlock" xlink:title="label: ScheduleOfEntityWideInformationByMajorCustomersByReportingSegmentsTextBlock to label_ScheduleOfEntityWideInformationByMajorCustomersByReportingSegmentsTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:label xlink:type="resource" xlink:label="label_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xml:lang="en-US" id="label_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">Adjustments to reconcile net earnings to cash provided from operating activities:</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="label_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="label: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to label_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/non-gaap/dei-2009-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus"/>
    <link:label xlink:type="resource" xlink:label="label_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_DocumentFiscalYearFocus" xml:lang="en-US" id="label_DocumentFiscalYearFocus">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="label_DocumentFiscalYearFocus" xlink:title="label: DocumentFiscalYearFocus to label_DocumentFiscalYearFocus"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/non-gaap/dei-2009-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus"/>
    <link:label xlink:type="resource" xlink:label="label_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="label_DocumentFiscalPeriodFocus" xml:lang="en-US" id="label_DocumentFiscalPeriodFocus">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="label_DocumentFiscalPeriodFocus" xlink:title="label: DocumentFiscalPeriodFocus to label_DocumentFiscalPeriodFocus"/>
    <link:loc xlink:type="locator" xlink:href="acl-20100331.xsd#acl_OtherOperatingExpenses" xlink:label="acl_loc_OtherOperatingExpenses"/>
    <link:label xlink:type="resource" xlink:label="acl_lab_OtherOperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="lab_acl_OtherOperatingExpenses_label_en-US">Other operating expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="acl_loc_OtherOperatingExpenses" xlink:to="acl_lab_OtherOperatingExpenses" order="1.0"/>
    <link:label xlink:type="resource" xlink:label="acl_lab_OtherOperatingExpenses1" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="lab_acl_OtherOperatingExpenses_label_en-US1">The total amount of other operating cost and expense items.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="acl_loc_OtherOperatingExpenses" xlink:to="acl_lab_OtherOperatingExpenses1" order="1.0"/>
    <link:label xlink:type="resource" xlink:label="acl_lab_OtherOperatingExpenses2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xml:lang="en-US" id="lab_acl_OtherOperatingExpenses_label_en-US2">Other operating expenses</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="acl_loc_OtherOperatingExpenses" xlink:to="acl_lab_OtherOperatingExpenses2" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="acl-20100331.xsd#acl_ProposedChangeOfControl" xlink:label="acl_loc_ProposedChangeOfControl"/>
    <link:label xlink:type="resource" xlink:label="acl_lab_ProposedChangeOfControl" xlink:role="http://www.xbrl.org/2003/role/label" xml:lang="en-US" id="lab_acl_ProposedChangeOfControl_label_en-US">Proposed change of control</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="acl_loc_ProposedChangeOfControl" xlink:to="acl_lab_ProposedChangeOfControl" order="1.0"/>
    <link:label xlink:type="resource" xlink:label="acl_lab_ProposedChangeOfControl1" xlink:role="http://www.xbrl.org/2003/role/documentation" xml:lang="en-US" id="lab_acl_ProposedChangeOfControl_label_en-US1">This element describes the impact of a proposed change of control of the reporting entity.</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="acl_loc_ProposedChangeOfControl" xlink:to="acl_lab_ProposedChangeOfControl1" order="1.0"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>acl-20100331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by Fujitsu XWand B0126 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:acl="http://alcon.com/20100331" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://alcon.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="acl-20100331.xsd#ConsolidatedBalanceSheets"/>
  <link:roleRef roleURI="http://alcon.com/role/ConsolidatedStatementsOfEarnings" xlink:type="simple" xlink:href="acl-20100331.xsd#ConsolidatedStatementsOfEarnings"/>
  <link:roleRef roleURI="http://alcon.com/role/ConsolidatedStatementOfCashFlows" xlink:type="simple" xlink:href="acl-20100331.xsd#ConsolidatedStatementOfCashFlows"/>
  <link:roleRef roleURI="http://alcon.com/role/BusinessSegments" xlink:type="simple" xlink:href="acl-20100331.xsd#BusinessSegments"/>
  <link:roleRef roleURI="http://alcon.com/role/CashFlowsSupplementalDisclosure" xlink:type="simple" xlink:href="acl-20100331.xsd#CashFlowsSupplementalDisclosure"/>
  <link:roleRef roleURI="http://alcon.com/role/CommitmentsAndContingencies" xlink:type="simple" xlink:href="acl-20100331.xsd#CommitmentsAndContingencies"/>
  <link:roleRef roleURI="http://alcon.com/role/CondensedConsolidatedFinancialStatements" xlink:type="simple" xlink:href="acl-20100331.xsd#CondensedConsolidatedFinancialStatements"/>
  <link:roleRef roleURI="http://alcon.com/role/DerivativeInstrumentsAndHedgingActivities" xlink:type="simple" xlink:href="acl-20100331.xsd#DerivativeInstrumentsAndHedgingActivities"/>
  <link:roleRef roleURI="http://alcon.com/role/EarningsPerShare" xlink:type="simple" xlink:href="acl-20100331.xsd#EarningsPerShare"/>
  <link:roleRef roleURI="http://alcon.com/role/FairValueOfFinancialInstruments" xlink:type="simple" xlink:href="acl-20100331.xsd#FairValueOfFinancialInstruments"/>
  <link:roleRef roleURI="http://alcon.com/role/IncomeTaxes" xlink:type="simple" xlink:href="acl-20100331.xsd#IncomeTaxes"/>
  <link:roleRef roleURI="http://alcon.com/role/IntangibleAssetsAndGoodwill" xlink:type="simple" xlink:href="acl-20100331.xsd#IntangibleAssetsAndGoodwill"/>
  <link:roleRef roleURI="http://alcon.com/role/Investments" xlink:type="simple" xlink:href="acl-20100331.xsd#Investments"/>
  <link:roleRef roleURI="http://alcon.com/role/PensionAndPostretirementBenefits" xlink:type="simple" xlink:href="acl-20100331.xsd#PensionAndPostretirementBenefits"/>
  <link:roleRef roleURI="http://alcon.com/role/ShareBasedCompensationPlans" xlink:type="simple" xlink:href="acl-20100331.xsd#ShareBasedCompensationPlans"/>
  <link:roleRef roleURI="http://alcon.com/role/ShareholdersEquity" xlink:type="simple" xlink:href="acl-20100331.xsd#ShareholdersEquity"/>
  <link:roleRef roleURI="http://alcon.com/role/ShortTermBorrowingsAndLongTermDebt" xlink:type="simple" xlink:href="acl-20100331.xsd#ShortTermBorrowingsAndLongTermDebt"/>
  <link:roleRef roleURI="http://alcon.com/role/SupplementalBalanceSheetInformation" xlink:type="simple" xlink:href="acl-20100331.xsd#SupplementalBalanceSheetInformation"/>
  <link:roleRef roleURI="http://alcon.com/role/ParentheticalDisclosuresToTheConsolidatedBalanceSheets" xlink:type="simple" xlink:href="acl-20100331.xsd#ParentheticalDisclosuresToTheConsolidatedBalanceSheets"/>
  <link:roleRef roleURI="http://xbrl.us/us-gaap/role/document/DocumentInformation" xlink:type="simple" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-roles-2009-01-31.xsd#di"/>
  <link:roleRef roleURI="http://xbrl.us/us-gaap/role/document/EntityInformation" xlink:type="simple" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-roles-2009-01-31.xsd#ent"/>
  <link:roleRef roleURI="http://alcon.com/role/Acquisition" xlink:type="simple" xlink:href="acl-20100331.xsd#Acquisition"/>
  <link:roleRef roleURI="http://alcon.com/role/ConsolidatedStatementsOfShareholdersEquityAndComprehensiveIncome" xlink:type="simple" xlink:href="acl-20100331.xsd#ConsolidatedStatementsOfShareholdersEquityAndComprehensiveIncome"/>
  <link:roleRef roleURI="http://alcon.com/role/DeferredCompensation" xlink:type="simple" xlink:href="acl-20100331.xsd#DeferredCompensation"/>
  <link:roleRef roleURI="http://alcon.com/role/GeographicCustomerAndProductInformation" xlink:type="simple" xlink:href="acl-20100331.xsd#GeographicCustomerAndProductInformation"/>
  <link:roleRef roleURI="http://alcon.com/role/ImpairmentOfLongLivedAssetsHeldAndUsed" xlink:type="simple" xlink:href="acl-20100331.xsd#ImpairmentOfLongLivedAssetsHeldAndUsed"/>
  <link:roleRef roleURI="http://alcon.com/role/LongTermDebt" xlink:type="simple" xlink:href="acl-20100331.xsd#LongTermDebt"/>
  <link:roleRef roleURI="http://alcon.com/role/RelatedPartyTransactions" xlink:type="simple" xlink:href="acl-20100331.xsd#RelatedPartyTransactions"/>
  <link:roleRef roleURI="http://alcon.com/role/ShortTermBorrowing" xlink:type="simple" xlink:href="acl-20100331.xsd#ShortTermBorrowing"/>
  <link:roleRef roleURI="http://alcon.com/role/SummaryOfSignificantAccountingPoliciesAndPractices" xlink:type="simple" xlink:href="acl-20100331.xsd#SummaryOfSignificantAccountingPoliciesAndPractices"/>
  <link:roleRef roleURI="http://alcon.com/role/UnauditedQuarterlyInformation" xlink:type="simple" xlink:href="acl-20100331.xsd#UnauditedQuarterlyInformation"/>
  <link:roleRef roleURI="http://xbrl.us/us-gaap/role/label/negated" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2008-03-31.xsd#negated"/>
  <link:roleRef roleURI="http://alcon.com/role/SubsequentEvents" xlink:type="simple" xlink:href="acl-20100331.xsd#SubsequentEvents"/>
  <link:roleRef roleURI="http://alcon.com/role/ProposedChangeOfControl" xlink:type="simple" xlink:href="acl-20100331.xsd#ProposedChangeOfControl"/>
  <link:presentationLink xlink:type="extended" xlink:role="http://alcon.com/role/ShortTermBorrowingsAndLongTermDebt">
    <link:loc xlink:type="locator" xlink:href="acl-20100331.xsd#acl_NotesToFinancialStatementsAbstract" xlink:label="ShortTermBorrowings" xlink:title="ShortTermBorrowings"/>
    <link:loc xlink:type="locator" xlink:href="acl-20100331.xsd#acl_ShortTermBorrowingsAndLongTermDebt" xlink:label="ShortTermBorrowingsAndLongTermDebt" xlink:title="ShortTermBorrowingsAndLongTermDebt"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="ShortTermBorrowings" xlink:to="ShortTermBorrowingsAndLongTermDebt" xlink:title="presentation: ShortTermBorrowingsAndLongTermDebtAbstract to ShortTermBorrowingsAndLongTermDebt" order="3.0"/>
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://alcon.com/role/IntangibleAssetsAndGoodwill">
    <link:loc xlink:type="locator" xlink:href="acl-20100331.xsd#acl_NotesToFinancialStatementsAbstract" xlink:label="NotesToFinancialStatementsAbstract" xlink:title="NotesToFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:label="GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:title="GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NotesToFinancialStatementsAbstract" xlink:to="GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:title="presentation: NotesToFinancialStatementsAbstract to GoodwillAndIntangibleAssetsDisclosureTextBlock" use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://alcon.com/role/IncomeTaxes">
    <link:loc xlink:type="locator" xlink:href="acl-20100331.xsd#acl_NotesToFinancialStatementsAbstract" xlink:label="NotesToFinancialStatementsAbstract" xlink:title="NotesToFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="IncomeTaxDisclosureTextBlock" xlink:title="IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NotesToFinancialStatementsAbstract" xlink:to="IncomeTaxDisclosureTextBlock" xlink:title="presentation: NotesToFinancialStatementsAbstract to IncomeTaxDisclosureTextBlock" use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://alcon.com/role/SupplementalBalanceSheetInformation">
    <link:loc xlink:type="locator" xlink:href="acl-20100331.xsd#acl_NotesToFinancialStatementsAbstract" xlink:label="NotesToFinancialStatementsAbstract" xlink:title="NotesToFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="acl-20100331.xsd#acl_SupplementalBalanceSheetInformation" xlink:label="SupplementalBalanceSheetInformation" xlink:title="SupplementalBalanceSheetInformation2"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NotesToFinancialStatementsAbstract" xlink:to="SupplementalBalanceSheetInformation" xlink:title="presentation: NotesToFinancialStatementsAbstract to SupplementalBalanceSheetInformation" use="optional" order="1.0"/>
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://alcon.com/role/CashFlowsSupplementalDisclosure">
    <link:loc xlink:type="locator" xlink:href="acl-20100331.xsd#acl_NotesToFinancialStatementsAbstract" xlink:label="NotesToFinancialStatementsAbstract" xlink:title="NotesToFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_CashFlowSupplementalDisclosuresTextBlock" xlink:label="CashFlowSupplementalDisclosuresTextBlock" xlink:title="CashFlowSupplementalDisclosuresTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NotesToFinancialStatementsAbstract" xlink:to="CashFlowSupplementalDisclosuresTextBlock" xlink:title="presentation: NotesToFinancialStatementsAbstract to CashFlowSupplementalDisclosuresTextBlock" use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://alcon.com/role/Investments">
    <link:loc xlink:type="locator" xlink:href="acl-20100331.xsd#acl_NotesToFinancialStatementsAbstract" xlink:label="NotesToFinancialStatementsAbstract" xlink:title="NotesToFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:label="InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:title="InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NotesToFinancialStatementsAbstract" xlink:to="InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:title="presentation: NotesToFinancialStatementsAbstract to InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://alcon.com/role/EarningsPerShare">
    <link:loc xlink:type="locator" xlink:href="acl-20100331.xsd#acl_NotesToFinancialStatementsAbstract" xlink:label="NotesToFinancialStatementsAbstract" xlink:title="NotesToFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="EarningsPerSharePolicyTextBlock" xlink:title="EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NotesToFinancialStatementsAbstract" xlink:to="EarningsPerSharePolicyTextBlock" xlink:title="presentation: NotesToFinancialStatementsAbstract to EarningsPerSharePolicyTextBlock" use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://alcon.com/role/FairValueOfFinancialInstruments">
    <link:loc xlink:type="locator" xlink:href="acl-20100331.xsd#acl_NotesToFinancialStatementsAbstract" xlink:label="NotesToFinancialStatementsAbstract" xlink:title="NotesToFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="FairValueDisclosuresTextBlock" xlink:title="FairValueDisclosuresTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NotesToFinancialStatementsAbstract" xlink:to="FairValueDisclosuresTextBlock" xlink:title="presentation: NotesToFinancialStatementsAbstract to FairValueDisclosuresTextBlock" use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://alcon.com/role/DerivativeInstrumentsAndHedgingActivities">
    <link:loc xlink:type="locator" xlink:href="acl-20100331.xsd#acl_NotesToFinancialStatementsAbstract" xlink:label="NotesToFinancialStatementsAbstract" xlink:title="NotesToFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_DerivativesPolicyTextBlock" xlink:label="DerivativesPolicyTextBlock" xlink:title="DerivativesPolicyTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NotesToFinancialStatementsAbstract" xlink:to="DerivativesPolicyTextBlock" xlink:title="presentation: NotesToFinancialStatementsAbstract to DerivativesPolicyTextBlock" use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://alcon.com/role/BusinessSegments">
    <link:loc xlink:type="locator" xlink:href="acl-20100331.xsd#acl_NotesToFinancialStatementsAbstract" xlink:label="NotesToFinancialStatementsAbstract" xlink:title="NotesToFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock" xlink:label="SegmentReportingDisclosureTextBlock" xlink:title="SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NotesToFinancialStatementsAbstract" xlink:to="SegmentReportingDisclosureTextBlock" xlink:title="presentation: NotesToFinancialStatementsAbstract to SegmentReportingDisclosureTextBlock" use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://alcon.com/role/ShareBasedCompensationPlans">
    <link:loc xlink:type="locator" xlink:href="acl-20100331.xsd#acl_NotesToFinancialStatementsAbstract" xlink:label="NotesToFinancialStatementsAbstract" xlink:title="NotesToFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:title="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NotesToFinancialStatementsAbstract" xlink:to="DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:title="presentation: NotesToFinancialStatementsAbstract to DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://alcon.com/role/PensionAndPostretirementBenefits">
    <link:loc xlink:type="locator" xlink:href="acl-20100331.xsd#acl_NotesToFinancialStatementsAbstract" xlink:label="NotesToFinancialStatementsAbstract" xlink:title="NotesToFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:label="PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:title="PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NotesToFinancialStatementsAbstract" xlink:to="PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:title="presentation: NotesToFinancialStatementsAbstract to PensionAndOtherPostretirementBenefitsDisclosureTextBlock" use="optional" order="1.0"/>
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://alcon.com/role/ShareholdersEquity">
    <link:loc xlink:type="locator" xlink:href="acl-20100331.xsd#acl_NotesToFinancialStatementsAbstract" xlink:label="NotesToFinancialStatementsAbstract" xlink:title="NotesToFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="StockholdersEquityNoteDisclosureTextBlock" xlink:title="StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NotesToFinancialStatementsAbstract" xlink:to="StockholdersEquityNoteDisclosureTextBlock" xlink:title="presentation: NotesToFinancialStatementsAbstract to StockholdersEquityNoteDisclosureTextBlock" use="optional" order="1.0"/>
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://alcon.com/role/CommitmentsAndContingencies">
    <link:loc xlink:type="locator" xlink:href="acl-20100331.xsd#acl_NotesToFinancialStatementsAbstract" xlink:label="NotesToFinancialStatementsAbstract" xlink:title="NotesToFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="CommitmentsAndContingenciesDisclosureTextBlock" xlink:title="CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NotesToFinancialStatementsAbstract" xlink:to="CommitmentsAndContingenciesDisclosureTextBlock" xlink:title="presentation: NotesToFinancialStatementsAbstract to CommitmentsAndContingenciesDisclosureTextBlock" use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://alcon.com/role/Acquisition">
    <link:loc xlink:type="locator" xlink:href="acl-20100331.xsd#acl_NotesToFinancialStatementsAbstract" xlink:label="NotesToFinancialStatementsAbstract" xlink:title="NotesToFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:label="ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:title="ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NotesToFinancialStatementsAbstract" xlink:to="ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" xlink:title="presentation: NotesToFinancialStatementsAbstract to ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock" use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://alcon.com/role/SummaryOfSignificantAccountingPoliciesAndPractices">
    <link:loc xlink:type="locator" xlink:href="acl-20100331.xsd#acl_NotesToFinancialStatementsAbstract" xlink:label="NotesToFinancialStatementsAbstract" xlink:title="NotesToFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="SignificantAccountingPoliciesTextBlock" xlink:title="SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NotesToFinancialStatementsAbstract" xlink:to="SignificantAccountingPoliciesTextBlock" xlink:title="presentation: NotesToFinancialStatementsAbstract to SignificantAccountingPoliciesTextBlock" order="1.0"/>
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://alcon.com/role/ImpairmentOfLongLivedAssetsHeldAndUsed">
    <link:loc xlink:type="locator" xlink:href="acl-20100331.xsd#acl_NotesToFinancialStatementsAbstract" xlink:label="NotesToFinancialStatementsAbstract" xlink:title="NotesToFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock" xlink:label="DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock" xlink:title="DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NotesToFinancialStatementsAbstract" xlink:to="DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock" xlink:title="presentation: NotesToFinancialStatementsAbstract to DetailsOfImpairmentOfLongLivedAssetsHeldAndUsedByAssetTextBlock" order="1.0"/>
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://alcon.com/role/ShortTermBorrowing">
    <link:loc xlink:type="locator" xlink:href="acl-20100331.xsd#acl_NotesToFinancialStatementsAbstract" xlink:label="NotesToFinancialStatementsAbstract" xlink:title="NotesToFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_ShortTermDebtTextBlock" xlink:label="ShortTermDebtTextBlock" xlink:title="ShortTermDebtTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NotesToFinancialStatementsAbstract" xlink:to="ShortTermDebtTextBlock" xlink:title="presentation: NotesToFinancialStatementsAbstract to ShortTermDebtTextBlock" order="1.0"/>
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://alcon.com/role/LongTermDebt">
    <link:loc xlink:type="locator" xlink:href="acl-20100331.xsd#acl_NotesToFinancialStatementsAbstract" xlink:label="NotesToFinancialStatementsAbstract" xlink:title="NotesToFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_LongTermDebtTextBlock" xlink:label="LongTermDebtTextBlock" xlink:title="LongTermDebtTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NotesToFinancialStatementsAbstract" xlink:to="LongTermDebtTextBlock" xlink:title="presentation: NotesToFinancialStatementsAbstract to LongTermDebtTextBlock" order="1.0"/>
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://alcon.com/role/GeographicCustomerAndProductInformation">
    <link:loc xlink:type="locator" xlink:href="acl-20100331.xsd#acl_NotesToFinancialStatementsAbstract" xlink:label="NotesToFinancialStatementsAbstract" xlink:title="NotesToFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_ScheduleOfEntityWideInformationByMajorCustomersByReportingSegmentsTextBlock" xlink:label="ScheduleOfEntityWideInformationByMajorCustomersByReportingSegmentsTextBlock" xlink:title="ScheduleOfEntityWideInformationByMajorCustomersByReportingSegmentsTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NotesToFinancialStatementsAbstract" xlink:to="ScheduleOfEntityWideInformationByMajorCustomersByReportingSegmentsTextBlock" xlink:title="presentation: NotesToFinancialStatementsAbstract to ScheduleOfEntityWideInformationByMajorCustomersByReportingSegmentsTextBlock" order="2.0"/>
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://alcon.com/role/DeferredCompensation">
    <link:loc xlink:type="locator" xlink:href="acl-20100331.xsd#acl_NotesToFinancialStatementsAbstract" xlink:label="NotesToFinancialStatementsAbstract" xlink:title="NotesToFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock" xlink:label="ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock" xlink:title="ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NotesToFinancialStatementsAbstract" xlink:to="ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock" xlink:title="presentation: NotesToFinancialStatementsAbstract to ScheduleOfDeferredCompensationArrangementWithIndividualShareBasedPaymentsTextBlock" order="1.0"/>
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://alcon.com/role/RelatedPartyTransactions">
    <link:loc xlink:type="locator" xlink:href="acl-20100331.xsd#acl_NotesToFinancialStatementsAbstract" xlink:label="NotesToFinancialStatementsAbstract" xlink:title="NotesToFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:label="RelatedPartyTransactionsDisclosureTextBlock" xlink:title="RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NotesToFinancialStatementsAbstract" xlink:to="RelatedPartyTransactionsDisclosureTextBlock" xlink:title="presentation: NotesToFinancialStatementsAbstract to RelatedPartyTransactionsDisclosureTextBlock" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://alcon.com/role/SubsequentEvents">
    <link:loc xlink:type="locator" xlink:href="acl-20100331.xsd#acl_NotesToFinancialStatementsAbstract" xlink:label="NotesToFinancialStatementsAbstract" xlink:title="NotesToFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_ScheduleOfSubsequentEventsTextBlock" xlink:label="ScheduleOfSubsequentEventsTextBlock" xlink:title="ScheduleOfSubsequentEventsTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NotesToFinancialStatementsAbstract" xlink:to="ScheduleOfSubsequentEventsTextBlock" xlink:title="presentation: NotesToFinancialStatementsAbstract to ScheduleOfSubsequentEventsTextBlock" order="1.0"/>
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://alcon.com/role/ParentheticalDisclosuresToTheConsolidatedBalanceSheets">
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="StatementOfFinancialPositionAbstract" xlink:title="StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="LiabilitiesAndStockholdersEquityAbstract" xlink:title="LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="LiabilitiesAndStockholdersEquityAbstract" xlink:title="presentation: StatementOfFinancialPositionAbstract to LiabilitiesAndStockholdersEquityAbstract" use="optional" order="2.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:label="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:title="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" use="optional" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="CommonStockParOrStatedValuePerShare" xlink:title="CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="CommonStockParOrStatedValuePerShare" xlink:title="presentation: StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract to CommonStockParOrStatedValuePerShare" use="optional" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="CommonStockSharesIssued" xlink:title="CommonStockSharesIssued"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="CommonStockSharesIssued" xlink:title="presentation: StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract to CommonStockSharesIssued" use="optional" order="3.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="CommonStockSharesOutstanding" xlink:title="CommonStockSharesOutstanding"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="CommonStockSharesOutstanding" xlink:title="presentation: StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract to CommonStockSharesOutstanding" use="optional" order="4.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="CommonStockSharesAuthorized" xlink:title="CommonStockSharesAuthorized"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="CommonStockSharesAuthorized" xlink:title="presentation: StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract to CommonStockSharesAuthorized" use="optional" order="2.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_TreasuryStockShares" xlink:label="TreasuryStockShares" xlink:title="TreasuryStockShares"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="TreasuryStockShares" xlink:title="presentation: StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract to TreasuryStockShares" use="optional" order="5.0"/>
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.us/us-gaap/role/document/DocumentInformation">
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/non-gaap/dei-2009-01-31.xsd#dei_DocumentInformationTextBlock" xlink:label="DocumentInformationTextBlock" xlink:title="DocumentInformationTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/non-gaap/dei-2009-01-31.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentInformationTextBlock" xlink:to="DocumentType" xlink:title="presentation: DocumentInformationTextBlock to DocumentType" use="optional" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/non-gaap/dei-2009-01-31.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentInformationTextBlock" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: DocumentInformationTextBlock to DocumentPeriodEndDate" use="optional" order="2.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/non-gaap/dei-2009-01-31.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentInformationTextBlock" xlink:to="AmendmentFlag" xlink:title="presentation: DocumentInformationTextBlock to AmendmentFlag" use="optional" order="3.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/non-gaap/dei-2009-01-31.xsd#dei_AmendmentDescription" xlink:label="AmendmentDescription" xlink:title="AmendmentDescription"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentInformationTextBlock" xlink:to="AmendmentDescription" xlink:title="presentation: DocumentInformationTextBlock to AmendmentDescription" use="optional" order="4.0"/>
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.us/us-gaap/role/document/EntityInformation">
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/non-gaap/dei-2009-01-31.xsd#dei_EntityTextBlock" xlink:label="EntityTextBlock" xlink:title="EntityTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/non-gaap/dei-2009-01-31.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityTextBlock" xlink:to="EntityRegistrantName" xlink:title="presentation: EntityTextBlock to EntityRegistrantName" use="optional" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/non-gaap/dei-2009-01-31.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityTextBlock" xlink:to="EntityCentralIndexKey" xlink:title="presentation: EntityTextBlock to EntityCentralIndexKey" use="optional" order="2.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/non-gaap/dei-2009-01-31.xsd#dei_CurrentFiscalYearEndDate" xlink:label="CurrentFiscalYearEndDate" xlink:title="CurrentFiscalYearEndDate"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityTextBlock" xlink:to="CurrentFiscalYearEndDate" xlink:title="presentation: EntityTextBlock to CurrentFiscalYearEndDate" use="optional" order="3.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/non-gaap/dei-2009-01-31.xsd#dei_EntityCurrentReportingStatus" xlink:label="EntityCurrentReportingStatus" xlink:title="EntityCurrentReportingStatus"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityTextBlock" xlink:to="EntityCurrentReportingStatus" xlink:title="presentation: EntityTextBlock to EntityCurrentReportingStatus" use="optional" order="4.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/non-gaap/dei-2009-01-31.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="EntityWellKnownSeasonedIssuer" xlink:title="EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityTextBlock" xlink:to="EntityWellKnownSeasonedIssuer" xlink:title="presentation: EntityTextBlock to EntityWellKnownSeasonedIssuer" use="optional" order="5.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/non-gaap/dei-2009-01-31.xsd#dei_EntityVoluntaryFilers" xlink:label="EntityVoluntaryFilers" xlink:title="EntityVoluntaryFilers"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityTextBlock" xlink:to="EntityVoluntaryFilers" xlink:title="presentation: EntityTextBlock to EntityVoluntaryFilers" use="optional" order="6.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/non-gaap/dei-2009-01-31.xsd#dei_EntityFilerCategory" xlink:label="EntityFilerCategory" xlink:title="EntityFilerCategory"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityTextBlock" xlink:to="EntityFilerCategory" xlink:title="presentation: EntityTextBlock to EntityFilerCategory" use="optional" order="7.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/non-gaap/dei-2009-01-31.xsd#dei_EntityPublicFloat" xlink:label="EntityPublicFloat" xlink:title="EntityPublicFloat"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityTextBlock" xlink:to="EntityPublicFloat" xlink:title="presentation: EntityTextBlock to EntityPublicFloat" use="optional" order="8.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/non-gaap/dei-2009-01-31.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="EntityCommonStockSharesOutstanding" xlink:title="EntityCommonStockSharesOutstanding"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityTextBlock" xlink:to="EntityCommonStockSharesOutstanding" xlink:title="presentation: EntityTextBlock to EntityCommonStockSharesOutstanding" use="optional" order="9.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/non-gaap/dei-2009-01-31.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityTextBlock" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: EntityTextBlock to DocumentFiscalYearFocus" order="10.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/non-gaap/dei-2009-01-31.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityTextBlock" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: EntityTextBlock to DocumentFiscalPeriodFocus" order="11.0"/>
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://alcon.com/role/ProposedChangeOfControl">
    <link:loc xlink:type="locator" xlink:href="acl-20100331.xsd#acl_NotesToFinancialStatementsAbstract" xlink:label="NotesToFinancialStatementsAbstract" xlink:title="NotesToFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="acl-20100331.xsd#acl_ProposedChangeOfControl" xlink:label="ProposedChangeOfControl"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NotesToFinancialStatementsAbstract" xlink:to="ProposedChangeOfControl" xlink:title="presentation: NotesToFinancialStatementsAbstract to ProposedChangeOfControl" use="optional" order="2.0"/>
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://alcon.com/role/CondensedConsolidatedFinancialStatements">
    <link:loc xlink:type="locator" xlink:href="acl-20100331.xsd#acl_NotesToFinancialStatementsAbstract" xlink:label="NotesToFinancialStatementsAbstract" xlink:title="NotesToFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_QuarterlyFinancialInformationTextBlock" xlink:label="QuarterlyFinancialInformationTextBlock" xlink:title="QuarterlyFinancialInformationTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NotesToFinancialStatementsAbstract" xlink:to="QuarterlyFinancialInformationTextBlock" xlink:title="presentation: NotesToFinancialStatementsAbstract to QuarterlyFinancialInformationTextBlock" use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://alcon.com/role/ConsolidatedBalanceSheets">
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="StatementOfFinancialPositionAbstract" xlink:title="StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="LiabilitiesAndStockholdersEquityAbstract" xlink:title="LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="LiabilitiesAndStockholdersEquityAbstract" xlink:title="presentation: StatementOfFinancialPositionAbstract to LiabilitiesAndStockholdersEquityAbstract" order="7.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:label="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:title="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" order="5.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_CommonStockValue" xlink:label="CommonStockValue" xlink:title="CommonStockValue"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="CommonStockValue" xlink:title="presentation: StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract to CommonStockValue" use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_AdditionalPaidInCapital" xlink:label="AdditionalPaidInCapital" xlink:title="AdditionalPaidInCapital"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="AdditionalPaidInCapital" xlink:title="presentation: StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract to AdditionalPaidInCapital" use="optional" order="2.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:label="AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:title="AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:title="presentation: StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract to AccumulatedOtherComprehensiveIncomeLossNetOfTax" use="optional" order="3.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="RetainedEarningsAccumulatedDeficit" xlink:title="RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="RetainedEarningsAccumulatedDeficit" xlink:title="presentation: StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract to RetainedEarningsAccumulatedDeficit" use="optional" order="4.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_TreasuryStockValue" xlink:label="TreasuryStockValue" xlink:title="TreasuryStockValue"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="TreasuryStockValue" xlink:title="presentation: StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract to TreasuryStockValue" use="optional" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:label="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:title="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract" xlink:to="StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:title="presentation: StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract to StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" use="optional" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_LongTermDebtNoncurrent" xlink:label="LongTermDebtNoncurrent" xlink:title="LongTermDebtNoncurrent"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="LongTermDebtNoncurrent" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to LongTermDebtNoncurrent" use="optional" order="2.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_DeferredTaxLiabilitiesNoncurrent" xlink:label="DeferredTaxLiabilitiesNoncurrent" xlink:title="DeferredTaxLiabilitiesNoncurrent"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="DeferredTaxLiabilitiesNoncurrent" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to DeferredTaxLiabilitiesNoncurrent" use="optional" order="3.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent" xlink:label="OtherLiabilitiesNoncurrent" xlink:title="OtherLiabilitiesNoncurrent"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="OtherLiabilitiesNoncurrent" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to OtherLiabilitiesNoncurrent" use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="LiabilitiesCurrentAbstract" xlink:title="LiabilitiesCurrentAbstract"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="LiabilitiesCurrentAbstract" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to LiabilitiesCurrentAbstract" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="AccountsPayableCurrent" xlink:title="AccountsPayableCurrent"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesCurrentAbstract" xlink:to="AccountsPayableCurrent" xlink:title="presentation: LiabilitiesCurrentAbstract to AccountsPayableCurrent" use="optional" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_ShortTermBorrowings" xlink:label="ShortTermBorrowings" xlink:title="ShortTermBorrowings"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesCurrentAbstract" xlink:to="ShortTermBorrowings" xlink:title="presentation: LiabilitiesCurrentAbstract to ShortTermBorrowings" use="optional" order="2.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_LongTermDebtCurrent" xlink:label="LongTermDebtCurrent" xlink:title="LongTermDebtCurrent"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesCurrentAbstract" xlink:to="LongTermDebtCurrent" xlink:title="presentation: LiabilitiesCurrentAbstract to LongTermDebtCurrent" use="optional" order="3.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="OtherLiabilitiesCurrent" xlink:title="OtherLiabilitiesCurrent"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesCurrentAbstract" xlink:to="OtherLiabilitiesCurrent" xlink:title="presentation: LiabilitiesCurrentAbstract to OtherLiabilitiesCurrent" use="optional" order="4.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="LiabilitiesCurrent" xlink:title="LiabilitiesCurrent"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesCurrentAbstract" xlink:to="LiabilitiesCurrent" xlink:title="presentation: LiabilitiesCurrentAbstract to LiabilitiesCurrent" use="optional" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_CommitmentsAndContingencies2009" xlink:label="CommitmentsAndContingencies2009" xlink:title="CommitmentsAndContingencies2009"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="CommitmentsAndContingencies2009" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to CommitmentsAndContingencies2009" order="4.5" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="LiabilitiesAndStockholdersEquity" xlink:title="LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="LiabilitiesAndStockholdersEquityAbstract" xlink:to="LiabilitiesAndStockholdersEquity" xlink:title="presentation: LiabilitiesAndStockholdersEquityAbstract to LiabilitiesAndStockholdersEquity" use="optional" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="AssetsAbstract" xlink:title="AssetsAbstract"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfFinancialPositionAbstract" xlink:to="AssetsAbstract" xlink:title="presentation: StatementOfFinancialPositionAbstract to AssetsAbstract" order="6.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_LongTermInvestments" xlink:label="LongTermInvestments" xlink:title="LongTermInvestments"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="LongTermInvestments" xlink:title="presentation: AssetsAbstract to LongTermInvestments" use="optional" order="2.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="PropertyPlantAndEquipmentNet" xlink:title="PropertyPlantAndEquipmentNet"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="PropertyPlantAndEquipmentNet" xlink:title="presentation: AssetsAbstract to PropertyPlantAndEquipmentNet" use="optional" order="3.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:label="IntangibleAssetsNetExcludingGoodwill" xlink:title="IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="IntangibleAssetsNetExcludingGoodwill" xlink:title="presentation: AssetsAbstract to IntangibleAssetsNetExcludingGoodwill" use="optional" order="4.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_Goodwill" xlink:label="Goodwill" xlink:title="Goodwill"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="Goodwill" xlink:title="presentation: AssetsAbstract to Goodwill" use="optional" order="5.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_DeferredTaxAssetsNetNoncurrent" xlink:label="DeferredTaxAssetsNetNoncurrent" xlink:title="DeferredTaxAssetsNetNoncurrent"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="DeferredTaxAssetsNetNoncurrent" xlink:title="presentation: AssetsAbstract to DeferredTaxAssetsNetNoncurrent" use="optional" order="6.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="OtherAssetsNoncurrent" xlink:title="OtherAssetsNoncurrent"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="OtherAssetsNoncurrent" xlink:title="presentation: AssetsAbstract to OtherAssetsNoncurrent" use="optional" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_Assets" xlink:label="Assets" xlink:title="Assets"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="Assets" xlink:title="presentation: AssetsAbstract to Assets" use="optional" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="AssetsCurrentAbstract" xlink:title="AssetsCurrentAbstract"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsAbstract" xlink:to="AssetsCurrentAbstract" xlink:title="presentation: AssetsAbstract to AssetsCurrentAbstract" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="CashAndCashEquivalentsAtCarryingValue" xlink:title="CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="CashAndCashEquivalentsAtCarryingValue" xlink:title="presentation: AssetsCurrentAbstract to CashAndCashEquivalentsAtCarryingValue" use="optional" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_ShortTermInvestments" xlink:label="ShortTermInvestments" xlink:title="ShortTermInvestments"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="ShortTermInvestments" xlink:title="presentation: AssetsCurrentAbstract to ShortTermInvestments" use="optional" order="2.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_AccountsReceivableNetCurrent" xlink:label="AccountsReceivableNetCurrent" xlink:title="AccountsReceivableNetCurrent"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="AccountsReceivableNetCurrent" xlink:title="presentation: AssetsCurrentAbstract to AccountsReceivableNetCurrent" use="optional" order="3.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_InventoryNet" xlink:label="InventoryNet" xlink:title="InventoryNet"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="InventoryNet" xlink:title="presentation: AssetsCurrentAbstract to InventoryNet" use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_DeferredTaxAssetsNetCurrent" xlink:label="DeferredTaxAssetsNetCurrent" xlink:title="DeferredTaxAssetsNetCurrent"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="DeferredTaxAssetsNetCurrent" xlink:title="presentation: AssetsCurrentAbstract to DeferredTaxAssetsNetCurrent" use="optional" order="5.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="OtherAssetsCurrent" xlink:title="OtherAssetsCurrent"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="OtherAssetsCurrent" xlink:title="presentation: AssetsCurrentAbstract to OtherAssetsCurrent" use="optional" order="6.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="AssetsCurrent" xlink:title="AssetsCurrent"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AssetsCurrentAbstract" xlink:to="AssetsCurrent" xlink:title="presentation: AssetsCurrentAbstract to AssetsCurrent" use="optional" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://alcon.com/role/ConsolidatedStatementOfCashFlows">
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="StatementOfCashFlowsAbstract" xlink:title="StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="presentation: StatementOfCashFlowsAbstract to NetCashProvidedByUsedInOperatingActivitiesAbstract" use="optional" order="8.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_ProfitLoss" xlink:label="ProfitLoss" xlink:title="ProfitLoss"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="ProfitLoss" xlink:title="presentation: NetCashProvidedByUsedInOperatingActivitiesAbstract to ProfitLoss" use="optional" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:title="presentation: NetCashProvidedByUsedInOperatingActivitiesAbstract to AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="13.5" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_Depreciation" xlink:label="Depreciation" xlink:title="Depreciation"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="Depreciation" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to Depreciation" use="optional" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="AmortizationOfIntangibleAssets" xlink:title="AmortizationOfIntangibleAssets"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="AmortizationOfIntangibleAssets" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to AmortizationOfIntangibleAssets" use="optional" order="2.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_ResearchAndDevelopmentInProcess" xlink:label="ResearchAndDevelopmentInProcess" xlink:title="ResearchAndDevelopmentInProcess"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="ResearchAndDevelopmentInProcess" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to ResearchAndDevelopmentInProcess" use="optional" order="3.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="ShareBasedCompensation" xlink:title="ShareBasedCompensation"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="ShareBasedCompensation" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to ShareBasedCompensation" use="optional" order="4.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities" xlink:label="ExcessTaxBenefitFromShareBasedCompensationOperatingActivities" xlink:title="ExcessTaxBenefitFromShareBasedCompensationOperatingActivities"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="ExcessTaxBenefitFromShareBasedCompensationOperatingActivities" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to ExcessTaxBenefitFromShareBasedCompensationOperatingActivities" use="optional" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:label="DeferredIncomeTaxExpenseBenefit" xlink:title="DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="DeferredIncomeTaxExpenseBenefit" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to DeferredIncomeTaxExpenseBenefit" use="optional" order="6.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_GainsLossesOnSalesOfAssets" xlink:label="GainsLossesOnSalesOfAssets" xlink:title="GainsLossesOnSalesOfAssets"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="GainsLossesOnSalesOfAssets" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to GainsLossesOnSalesOfAssets" use="optional" order="7.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_ImpairmentOfInvestments" xlink:label="ImpairmentOfInvestments" xlink:title="ImpairmentOfInvestments"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="ImpairmentOfInvestments" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to ImpairmentOfInvestments" use="optional" order="8.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_UnrealizedGainLossOnSecurities" xlink:label="UnrealizedGainLossOnSecurities" xlink:title="UnrealizedGainLossOnSecurities"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="UnrealizedGainLossOnSecurities" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to UnrealizedGainLossOnSecurities" use="optional" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesOther" xlink:label="AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesOther" xlink:title="AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesOther"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesOther" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesOther" use="optional" order="10.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="IncreaseDecreaseInOperatingCapitalAbstract" xlink:title="IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="IncreaseDecreaseInOperatingCapitalAbstract" xlink:title="presentation: AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract to IncreaseDecreaseInOperatingCapitalAbstract" use="optional" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_IncreaseDecreaseInTradingSecurities" xlink:label="IncreaseDecreaseInTradingSecurities" xlink:title="IncreaseDecreaseInTradingSecurities"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInTradingSecurities" xlink:title="presentation: IncreaseDecreaseInOperatingCapitalAbstract to IncreaseDecreaseInTradingSecurities" use="optional" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:label="IncreaseDecreaseInAccountsReceivable" xlink:title="IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInAccountsReceivable" xlink:title="presentation: IncreaseDecreaseInOperatingCapitalAbstract to IncreaseDecreaseInAccountsReceivable" use="optional" order="2.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_IncreaseDecreaseInInventories" xlink:label="IncreaseDecreaseInInventories" xlink:title="IncreaseDecreaseInInventories"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInInventories" xlink:title="presentation: IncreaseDecreaseInOperatingCapitalAbstract to IncreaseDecreaseInInventories" use="optional" order="3.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="IncreaseDecreaseInOtherOperatingAssets" xlink:title="IncreaseDecreaseInOtherOperatingAssets"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInOtherOperatingAssets" xlink:title="presentation: IncreaseDecreaseInOperatingCapitalAbstract to IncreaseDecreaseInOtherOperatingAssets" use="optional" order="4.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable" xlink:label="IncreaseDecreaseInAccountsPayable" xlink:title="IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInAccountsPayable" xlink:title="presentation: IncreaseDecreaseInOperatingCapitalAbstract to IncreaseDecreaseInAccountsPayable" use="optional" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_IncreaseDecreaseInOtherAccruedLiabilities" xlink:label="IncreaseDecreaseInOtherAccruedLiabilities" xlink:title="IncreaseDecreaseInOtherAccruedLiabilities"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInOtherAccruedLiabilities" xlink:title="presentation: IncreaseDecreaseInOperatingCapitalAbstract to IncreaseDecreaseInOtherAccruedLiabilities" use="optional" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:label="IncreaseDecreaseInOtherOperatingLiabilities" xlink:title="IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="IncreaseDecreaseInOtherOperatingLiabilities" xlink:title="presentation: IncreaseDecreaseInOperatingCapitalAbstract to IncreaseDecreaseInOtherOperatingLiabilities" use="optional" order="7.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="NetCashProvidedByUsedInOperatingActivities" xlink:title="NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="NetCashProvidedByUsedInOperatingActivities" xlink:title="presentation: NetCashProvidedByUsedInOperatingActivitiesAbstract to NetCashProvidedByUsedInOperatingActivities" use="optional" order="14.5" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:title="presentation: StatementOfCashFlowsAbstract to NetCashProvidedByUsedInInvestingActivitiesAbstract" use="optional" order="9.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_ProceedsFromSaleOfProductiveAssets" xlink:label="ProceedsFromSaleOfProductiveAssets" xlink:title="ProceedsFromSaleOfProductiveAssets"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="ProceedsFromSaleOfProductiveAssets" xlink:title="presentation: NetCashProvidedByUsedInInvestingActivitiesAbstract to ProceedsFromSaleOfProductiveAssets" use="optional" order="1.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="PaymentsToAcquirePropertyPlantAndEquipment" xlink:title="PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="PaymentsToAcquirePropertyPlantAndEquipment" xlink:title="presentation: NetCashProvidedByUsedInInvestingActivitiesAbstract to PaymentsToAcquirePropertyPlantAndEquipment" use="optional" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:label="PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:title="PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:title="presentation: NetCashProvidedByUsedInInvestingActivitiesAbstract to PaymentsToAcquireBusinessesNetOfCashAcquired" use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets" xlink:label="PaymentsToAcquireIntangibleAssets" xlink:title="PaymentsToAcquireIntangibleAssets"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="PaymentsToAcquireIntangibleAssets" xlink:title="presentation: NetCashProvidedByUsedInInvestingActivitiesAbstract to PaymentsToAcquireIntangibleAssets" use="optional" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_PaymentsToAcquireInvestments" xlink:label="PaymentsToAcquireInvestments" xlink:title="PaymentsToAcquireInvestments"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="PaymentsToAcquireInvestments" xlink:title="presentation: NetCashProvidedByUsedInInvestingActivitiesAbstract to PaymentsToAcquireInvestments" use="optional" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:label="ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:title="ProceedsFromSaleMaturityAndCollectionsOfInvestments"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="ProceedsFromSaleMaturityAndCollectionsOfInvestments" xlink:title="presentation: NetCashProvidedByUsedInInvestingActivitiesAbstract to ProceedsFromSaleMaturityAndCollectionsOfInvestments" use="optional" order="6.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="NetCashProvidedByUsedInInvestingActivities" xlink:title="NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="NetCashProvidedByUsedInInvestingActivities" xlink:title="presentation: NetCashProvidedByUsedInInvestingActivitiesAbstract to NetCashProvidedByUsedInInvestingActivities" use="optional" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:label="PaymentsForProceedsFromOtherInvestingActivities" xlink:title="PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="PaymentsForProceedsFromOtherInvestingActivities" xlink:title="presentation: NetCashProvidedByUsedInInvestingActivitiesAbstract to PaymentsForProceedsFromOtherInvestingActivities" order="6.5" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:title="NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:title="presentation: StatementOfCashFlowsAbstract to NetCashProvidedByUsedInFinancingActivitiesAbstract" use="optional" order="10.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_ProceedsFromRepaymentsOfShortTermDebt" xlink:label="ProceedsFromRepaymentsOfShortTermDebt" xlink:title="ProceedsFromRepaymentsOfShortTermDebt"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="ProceedsFromRepaymentsOfShortTermDebt" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to ProceedsFromRepaymentsOfShortTermDebt" use="optional" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:label="ProceedsFromIssuanceOfLongTermDebt" xlink:title="ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="ProceedsFromIssuanceOfLongTermDebt" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to ProceedsFromIssuanceOfLongTermDebt" use="optional" order="2.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_RepaymentsOfLongTermDebt" xlink:label="RepaymentsOfLongTermDebt" xlink:title="RepaymentsOfLongTermDebt"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="RepaymentsOfLongTermDebt" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to RepaymentsOfLongTermDebt" use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock" xlink:label="PaymentsOfDividendsCommonStock" xlink:title="PaymentsOfDividendsCommonStock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="PaymentsOfDividendsCommonStock" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to PaymentsOfDividendsCommonStock" use="optional" order="4.0" preferredLabel="http://xbrl.us/us-gaap/role/label/negated"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:label="PaymentsForRepurchaseOfCommonStock" xlink:title="PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="PaymentsForRepurchaseOfCommonStock" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to PaymentsForRepurchaseOfCommonStock" use="optional" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="ProceedsFromStockOptionsExercised" xlink:title="ProceedsFromStockOptionsExercised"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="ProceedsFromStockOptionsExercised" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to ProceedsFromStockOptionsExercised" use="optional" order="6.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities" xlink:label="ExcessTaxBenefitFromShareBasedCompensationFinancingActivities" xlink:title="ExcessTaxBenefitFromShareBasedCompensationFinancingActivities"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="ExcessTaxBenefitFromShareBasedCompensationFinancingActivities" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to ExcessTaxBenefitFromShareBasedCompensationFinancingActivities" use="optional" order="7.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="NetCashProvidedByUsedInFinancingActivities" xlink:title="NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="NetCashProvidedByUsedInFinancingActivities" xlink:title="presentation: NetCashProvidedByUsedInFinancingActivitiesAbstract to NetCashProvidedByUsedInFinancingActivities" use="optional" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents" xlink:label="EffectOfExchangeRateOnCashAndCashEquivalents" xlink:title="EffectOfExchangeRateOnCashAndCashEquivalents"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="EffectOfExchangeRateOnCashAndCashEquivalents" xlink:title="presentation: StatementOfCashFlowsAbstract to EffectOfExchangeRateOnCashAndCashEquivalents" use="optional" order="11.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:label="CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:title="CashAndCashEquivalentsPeriodIncreaseDecrease"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="CashAndCashEquivalentsPeriodIncreaseDecrease" xlink:title="presentation: StatementOfCashFlowsAbstract to CashAndCashEquivalentsPeriodIncreaseDecrease" use="optional" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="CashAndCashEquivalentsAtCarryingValue" xlink:title="CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="CashAndCashEquivalentsAtCarryingValue" xlink:title="presentation: StatementOfCashFlowsAbstract to CashAndCashEquivalentsAtCarryingValue" use="optional" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="CashAndCashEquivalentsAtCarryingValue_2" xlink:title="CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="StatementOfCashFlowsAbstract" xlink:to="CashAndCashEquivalentsAtCarryingValue_2" xlink:title="presentation: StatementOfCashFlowsAbstract to CashAndCashEquivalentsAtCarryingValue" use="optional" priority="1" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:type="extended" xlink:role="http://alcon.com/role/ConsolidatedStatementsOfEarnings">
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="IncomeStatementAbstract" xlink:title="IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_SalesRevenueNet" xlink:label="SalesRevenueNet" xlink:title="SalesRevenueNet"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="SalesRevenueNet" xlink:title="presentation: IncomeStatementAbstract to SalesRevenueNet" use="optional" order="8.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_CostOfGoodsSold" xlink:label="CostOfGoodsSold" xlink:title="CostOfGoodsSold"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="CostOfGoodsSold" xlink:title="presentation: IncomeStatementAbstract to CostOfGoodsSold" use="optional" order="9.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_GrossProfit" xlink:label="GrossProfit" xlink:title="GrossProfit"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="GrossProfit" xlink:title="presentation: IncomeStatementAbstract to GrossProfit" use="optional" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:href="acl-20100331.xsd#acl_SellingGeneralAndAdministrative" xlink:label="SellingGeneralAndAdministrative" xlink:title="SellingGeneralAndAdministrative"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="SellingGeneralAndAdministrative" xlink:title="presentation: IncomeStatementAbstract to SellingGeneralAndAdministrative" use="optional" order="11.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="ResearchAndDevelopmentExpense" xlink:title="ResearchAndDevelopmentExpense"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="ResearchAndDevelopmentExpense" xlink:title="presentation: IncomeStatementAbstract to ResearchAndDevelopmentExpense" use="optional" order="12.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_ResearchAndDevelopmentInProcess" xlink:label="ResearchAndDevelopmentInProcess" xlink:title="ResearchAndDevelopmentInProcess"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="ResearchAndDevelopmentInProcess" xlink:title="presentation: IncomeStatementAbstract to ResearchAndDevelopmentInProcess" use="optional" order="13.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets" xlink:label="AmortizationOfIntangibleAssets" xlink:title="AmortizationOfIntangibleAssets"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="AmortizationOfIntangibleAssets" xlink:title="presentation: IncomeStatementAbstract to AmortizationOfIntangibleAssets" use="optional" order="14.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="OperatingIncomeLoss" xlink:title="OperatingIncomeLoss"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="OperatingIncomeLoss" xlink:title="presentation: IncomeStatementAbstract to OperatingIncomeLoss" use="optional" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_OperatingIncomeLossAbstract" xlink:label="OperatingIncomeLossAbstract" xlink:title="OperatingIncomeLossAbstract"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="OperatingIncomeLossAbstract" xlink:title="presentation: IncomeStatementAbstract to OperatingIncomeLossAbstract" use="optional" order="18.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="ForeignCurrencyTransactionGainLossBeforeTax" xlink:title="ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingIncomeLossAbstract" xlink:to="ForeignCurrencyTransactionGainLossBeforeTax" xlink:title="presentation: OperatingIncomeLossAbstract to ForeignCurrencyTransactionGainLossBeforeTax" use="optional" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_InvestmentIncomeInterestAndDividend" xlink:label="InvestmentIncomeInterestAndDividend" xlink:title="InvestmentIncomeInterestAndDividend"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingIncomeLossAbstract" xlink:to="InvestmentIncomeInterestAndDividend" xlink:title="presentation: OperatingIncomeLossAbstract to InvestmentIncomeInterestAndDividend" use="optional" order="4.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_InterestExpense" xlink:label="InterestExpense" xlink:title="InterestExpense"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingIncomeLossAbstract" xlink:to="InterestExpense" xlink:title="presentation: OperatingIncomeLossAbstract to InterestExpense" use="optional" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense" xlink:label="OtherNonoperatingIncomeExpense" xlink:title="OtherNonoperatingIncomeExpense"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="OperatingIncomeLossAbstract" xlink:to="OtherNonoperatingIncomeExpense" xlink:title="presentation: OperatingIncomeLossAbstract to OtherNonoperatingIncomeExpense" use="optional" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:label="IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:title="IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" xlink:title="presentation: IncomeStatementAbstract to IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments" use="optional" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit" xlink:label="IncomeTaxExpenseBenefit" xlink:title="IncomeTaxExpenseBenefit"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="IncomeTaxExpenseBenefit" xlink:title="presentation: IncomeStatementAbstract to IncomeTaxExpenseBenefit" use="optional" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_ProfitLoss" xlink:label="ProfitLoss" xlink:title="ProfitLoss"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="ProfitLoss" xlink:title="presentation: IncomeStatementAbstract to ProfitLoss" use="optional" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_EarningsPerShareBasic" xlink:label="EarningsPerShareBasic" xlink:title="EarningsPerShareBasic"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="EarningsPerShareBasic" xlink:title="presentation: IncomeStatementAbstract to EarningsPerShareBasic" use="optional" order="22.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_EarningsPerShareDiluted" xlink:label="EarningsPerShareDiluted" xlink:title="EarningsPerShareDiluted"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="EarningsPerShareDiluted" xlink:title="presentation: IncomeStatementAbstract to EarningsPerShareDiluted" use="optional" order="23.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_WeightedAverageNumberOfSharesIssuedBasic" xlink:label="WeightedAverageNumberOfSharesIssuedBasic" xlink:title="WeightedAverageNumberOfSharesIssuedBasic"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="WeightedAverageNumberOfSharesIssuedBasic" xlink:title="presentation: IncomeStatementAbstract to WeightedAverageNumberOfSharesIssuedBasic" use="optional" order="25.0"/>
    <link:loc xlink:type="locator" xlink:href="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:label="WeightedAverageNumberOfDilutedSharesOutstanding" xlink:title="WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="WeightedAverageNumberOfDilutedSharesOutstanding" xlink:title="presentation: IncomeStatementAbstract to WeightedAverageNumberOfDilutedSharesOutstanding" use="optional" order="26.0"/>
    <link:loc xlink:type="locator" xlink:href="acl-20100331.xsd#acl_OtherOperatingExpenses" xlink:label="acl_loc_OtherOperatingExpenses"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="IncomeStatementAbstract" xlink:to="acl_loc_OtherOperatingExpenses" use="optional" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>acl-20100331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by Fujitsu XWand B0126 -->
<!--Created by EDGARizerX-->
<xs:schema targetNamespace="http://alcon.com/20100331" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:acl="http://alcon.com/20100331" xmlns:us-types="http://xbrl.us/us-types/2009-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="acl-20100331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="acl-20100331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="acl-20100331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase"/>
      <link:roleType roleURI="http://alcon.com/role/ConsolidatedBalanceSheets" id="ConsolidatedBalanceSheets">
        <link:definition>001000 - Statement - Condensed Consolidated Balance Sheets (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://alcon.com/role/ConsolidatedStatementsOfEarnings" id="ConsolidatedStatementsOfEarnings">
        <link:definition>002000 - Statement - Condensed Consolidated Statements of Earnings (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://alcon.com/role/ConsolidatedStatementOfCashFlows" id="ConsolidatedStatementOfCashFlows">
        <link:definition>004000 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://alcon.com/role/CashFlowsSupplementalDisclosure" id="CashFlowsSupplementalDisclosure">
        <link:definition>006030 - Disclosure - Cash Flows-Supplemental Disclosure</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://alcon.com/role/SupplementalBalanceSheetInformation" id="SupplementalBalanceSheetInformation">
        <link:definition>006040 - Disclosure - Supplemental Balance Sheet Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://alcon.com/role/Investments" id="Investments">
        <link:definition>006050 - Disclosure - Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://alcon.com/role/IntangibleAssetsAndGoodwill" id="IntangibleAssetsAndGoodwill">
        <link:definition>006070 - Disclosure - Intangible Assets and Goodwill</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://alcon.com/role/ShortTermBorrowingsAndLongTermDebt" id="ShortTermBorrowingsAndLongTermDebt">
        <link:definition>006080 - Disclosure - Short Term Borrowings and Long Term Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://alcon.com/role/IncomeTaxes" id="IncomeTaxes">
        <link:definition>006090 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://alcon.com/role/BusinessSegments" id="BusinessSegments">
        <link:definition>006100 - Disclosure - Business Segments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://alcon.com/role/ShareBasedCompensationPlans" id="ShareBasedCompensationPlans">
        <link:definition>006110 - Disclosure - Share-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://alcon.com/role/ShareholdersEquity" id="ShareholdersEquity">
        <link:definition>020010 - Disclosure - Shareholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://alcon.com/role/CommitmentsAndContingencies" id="CommitmentsAndContingencies">
        <link:definition>006140 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://alcon.com/role/CondensedConsolidatedFinancialStatements" id="CondensedConsolidatedFinancialStatements">
        <link:definition>006010 - Disclosure - Condensed Consolidated Financial Statements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://alcon.com/role/EarningsPerShare" id="EarningsPerShare">
        <link:definition>006020 - Disclosure - Earnings Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://alcon.com/role/FairValueOfFinancialInstruments" id="FairValueOfFinancialInstruments">
        <link:definition>006060 - Disclosure - Financial Instruments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://alcon.com/role/DerivativeInstrumentsAndHedgingActivities" id="DerivativeInstrumentsAndHedgingActivities">
        <link:definition>020060 - Disclosure - Derivative Instruments and Hedging Activities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://alcon.com/role/PensionAndPostretirementBenefits" id="PensionAndPostretirementBenefits">
        <link:definition>006120 - Disclosure - Pension and Postretirement Benefits</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://alcon.com/role/ParentheticalDisclosuresToTheConsolidatedBalanceSheets" id="ParentheticalDisclosuresToTheConsolidatedBalanceSheets">
        <link:definition>001010 - Statement - Parenthetical Data To The Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://alcon.com/role/Acquisition" id="Acquisition">
        <link:definition>020020 - Disclosure - Acquisitions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://alcon.com/role/ConsolidatedStatementsOfShareholdersEquityAndComprehensiveIncome" id="ConsolidatedStatementsOfShareholdersEquityAndComprehensiveIncome">
        <link:definition>003000 - Statement - CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY AND COMPREHENSIVE INCOME</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://alcon.com/role/SummaryOfSignificantAccountingPoliciesAndPractices" id="SummaryOfSignificantAccountingPoliciesAndPractices">
        <link:definition>020030 - Disclosure - Summary of Significant Accounting Policies and Practices</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://alcon.com/role/ImpairmentOfLongLivedAssetsHeldAndUsed" id="ImpairmentOfLongLivedAssetsHeldAndUsed">
        <link:definition>020040 - Disclosure - Impairment of Long-Lived Assets Held and Used</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://alcon.com/role/ShortTermBorrowing" id="ShortTermBorrowing">
        <link:definition>020050 - Disclosure - Short Term Borrowing</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://alcon.com/role/LongTermDebt" id="LongTermDebt">
        <link:definition>020060 - Disclosure - Long Term Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://alcon.com/role/GeographicCustomerAndProductInformation" id="GeographicCustomerAndProductInformation">
        <link:definition>020070 - Disclosure - Geographic, Customer and Product Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://alcon.com/role/DeferredCompensation" id="DeferredCompensation">
        <link:definition>020080 - Disclosure - Deferred Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://alcon.com/role/RelatedPartyTransactions" id="RelatedPartyTransactions">
        <link:definition>020080 - Disclosure - Related Party Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://alcon.com/role/SubsequentEvents" id="SubsequentEvents">
        <link:definition>020100 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://alcon.com/role/UnauditedQuarterlyInformation" id="UnauditedQuarterlyInformation">
        <link:definition>020120 - Disclosure - Unaudited Quarterly Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://alcon.com/role/ProposedChangeOfControl" id="ProposedChangeOfControl">
        <link:definition>006130 - Disclosure - Proposed Change of Control</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://xbrl.us/us-gaap/2009-01-31" schemaLocation="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-gaap-2009-01-31.xsd"/>
  <xs:import namespace="http://xbrl.us/dei/2009-01-31" schemaLocation="http://taxonomies.xbrl.us/us-gaap/2009/non-gaap/dei-2009-01-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.us/us-gaap/negated/2008-03-31" schemaLocation="http://www.xbrl.org/lrr/role/negated-2008-03-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.us/us-types/2009-01-31" schemaLocation="http://taxonomies.xbrl.us/us-gaap/2009/elts/us-types-2009-01-31.xsd"/>
  <xs:element name="SellingGeneralAndAdministrative" id="acl_SellingGeneralAndAdministrative" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration"/>
  <xs:element name="ShortTermBorrowingsAndLongTermDebt" id="acl_ShortTermBorrowingsAndLongTermDebt" type="us-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration"/>
  <xs:element name="NotesToFinancialStatementsAbstract" id="acl_NotesToFinancialStatementsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" abstract="true" nillable="true" xbrli:periodType="duration"/>
  <xs:element name="SupplementalBalanceSheetInformation" id="acl_SupplementalBalanceSheetInformation" type="us-types:textBlockItemType" substitutionGroup="xbrli:item" nillable="true" xbrli:periodType="duration"/>
  <xs:element name="OtherOperatingExpenses" id="acl_OtherOperatingExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:balance="debit" xbrli:periodType="duration"/>
  <xs:element name="ProposedChangeOfControl" id="acl_ProposedChangeOfControl" type="us-types:textBlockItemType" substitutionGroup="xbrli:item" abstract="false" nillable="true" xbrli:periodType="duration"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R19.xml
<DESCRIPTION>IDEA: Document Information
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<InstanceReport xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <Version>2.0.0.10</Version>
  <hasSegments>false</hasSegments>
  <ReportName>Document Information</ReportName>
  <ReportLongName>995200 - Document - Document Information</ReportLongName>
  <DisplayLabelColumn>true</DisplayLabelColumn>
  <ShowElementNames>false</ShowElementNames>
  <RoundingOption />
  <HasEmbeddedReports>false</HasEmbeddedReports>
  <Columns>
    <Column>
      <LabelColumn>false</LabelColumn>
      <Id>1</Id>
      <Labels>
        <Label Id="1" Label="3 Months Ended" />
        <Label Id="2" Label="Mar. 31, 2010" />
      </Labels>
      <CurrencyCode>usd</CurrencyCode>
      <CurrencySymbol>$</CurrencySymbol>
      <FootnoteIndexer />
      <hasSegments>false</hasSegments>
      <hasScenarios>false</hasScenarios>
      <Segments />
      <Scenarios />
      <Units>
        <Unit>
          <UnitID>u000</UnitID>
          <UnitType>Standard</UnitType>
          <StandardMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/iso4217</MeasureSchema>
            <MeasureValue>USD</MeasureValue>
            <MeasureNamespace>iso4217</MeasureNamespace>
          </StandardMeasure>
          <Scale>0</Scale>
        </Unit>
        <Unit>
          <UnitID>u001</UnitID>
          <UnitType>Standard</UnitType>
          <StandardMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/instance</MeasureSchema>
            <MeasureValue>shares</MeasureValue>
            <MeasureNamespace>xbrli</MeasureNamespace>
          </StandardMeasure>
          <Scale>0</Scale>
        </Unit>
        <Unit>
          <UnitID>u002</UnitID>
          <UnitType>Divide</UnitType>
          <NumeratorMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/iso4217</MeasureSchema>
            <MeasureValue>USD</MeasureValue>
            <MeasureNamespace>iso4217</MeasureNamespace>
          </NumeratorMeasure>
          <DenominatorMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/instance</MeasureSchema>
            <MeasureValue>shares</MeasureValue>
            <MeasureNamespace>xbrli</MeasureNamespace>
          </DenominatorMeasure>
          <Scale>0</Scale>
        </Unit>
      </Units>
    </Column>
  </Columns>
  <Rows>
    <Row>
      <Id>2</Id>
      <Label>Document Information [Text Block]</Label>
      <Level>0</Level>
      <ElementName>dei_DocumentInformationTextBlock</ElementName>
      <ElementPrefix>dei</ElementPrefix>
      <IsBaseElement>false</IsBaseElement>
      <BalanceType>na</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>string</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>true</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>false</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.</ElementDefenition>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>3</Id>
      <Label>Document Type</Label>
      <Level>1</Level>
      <ElementName>dei_DocumentType</ElementName>
      <ElementPrefix>dei</ElementPrefix>
      <IsBaseElement>false</IsBaseElement>
      <BalanceType>na</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>na</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>false</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText>6-K</NonNumbericText>
          <NonNumericTextHeader>6-K</NonNumericTextHeader>
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>The type of document being provided (such as 10-K, 10-Q, N-1A, etc). The document type should be limited to the same value as the supporting SEC submission type. The acceptable values are as follows: S-1, S-3, S-4, S-11, F-1, F-3, F-4, F-9, F-10, 6-K, 8-K, 10, 10-K, 10-Q, 20-F, 40-F, N-1A, 485BPOS, NCSR, N-Q, and Other.</ElementDefenition>
      <ElementReferences>No authoritative reference available.</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>4</Id>
      <Label>Document Period End Date</Label>
      <Level>1</Level>
      <ElementName>dei_DocumentPeriodEndDate</ElementName>
      <ElementPrefix>dei</ElementPrefix>
      <IsBaseElement>false</IsBaseElement>
      <BalanceType>na</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>date</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>false</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText>2010-03-31</NonNumbericText>
          <NonNumericTextHeader>2010-03-31</NonNumericTextHeader>
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>The end date of the period reflected on the cover page if a periodic report.  For all other reports and registration statements this will be the filing date. The format of the date is CCYY-MM-DD.</ElementDefenition>
      <ElementReferences>No authoritative reference available.</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>5</Id>
      <Label>Amendment Flag</Label>
      <Level>1</Level>
      <ElementName>dei_AmendmentFlag</ElementName>
      <ElementPrefix>dei</ElementPrefix>
      <IsBaseElement>false</IsBaseElement>
      <BalanceType>na</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>na</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>false</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText>false</NonNumbericText>
          <NonNumericTextHeader>false</NonNumericTextHeader>
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>If the value is true, then the document as an amendment to previously-filed/accepted document.</ElementDefenition>
      <ElementReferences>No authoritative reference available.</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
  </Rows>
  <Footnotes />
  <ComparabilityReport>false</ComparabilityReport>
  <NumberOfCols>1</NumberOfCols>
  <NumberOfRows>4</NumberOfRows>
  <HasScenarios>false</HasScenarios>
  <MonetaryRoundingLevel>UnKnown</MonetaryRoundingLevel>
  <SharesRoundingLevel>UnKnown</SharesRoundingLevel>
  <PerShareRoundingLevel>UnKnown</PerShareRoundingLevel>
  <HasPureData>false</HasPureData>
  <SharesShouldBeRounded>true</SharesShouldBeRounded>
</InstanceReport>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>9
<FILENAME>0001167379-10-000075-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001167379-10-000075-xbrl.zip
M4$L#!!0````(`"=TFSS!C)JS+<0``#?K#@`0`!P`86-L+3(P,3`P,S,Q+GAM
M;%54"0`#ZBW72^HMUTMU>`L``00E#@``!#D!``#L/6MWXCBRW_><_0]:[O1,
M][F\#(2$=#I[Z$[2PTYWDDTR.S/WF[`%:-K8'LL.87_]K9+D!]@0("]">\Z<
MT\3(4E6IWE421_^\&]ODEOF"N\Z'DE&MEPAS3-?BSO!#Z=>;L\I!Z9_'1_^H
M5$Y//G>O^'^9__LA(3U'!-0Q&;%<,QPS)R!#YC"?!LPB_2E)QI:CN4FSNE>M
M5^N5RO'17=^W":SKB`^E41!XA[7:9#*IXN.JZP]KC7J]6>-ZB9(:>6ASY]N2
MX?AUGXIX^%UF_*0I1QN=3J<FOXV'"IXW$*8U:K]__7)MCMB85N;AP>7Y&O#3
MU"K4-EVG:KIC&&K4ZZW&?GI6*QF8GK)=4U]&0[EP6PUC?QD(:D3T0B@J0TJ]
MV<E#4=//\9U.I6Y4FD8,LVDO@KF9C+(8S\P)S]+S'?_];X0<(=$/A23G%1L0
MN0F'P=1C'TJ"CST;:26?C7PV^%""U2O16M4[895J:AJ`(V!W`>'6AY)9Q__4
M_/`5<"(/IOHO^)M;^&3`F4_DNFR&6H*9U:%[6_O4^Z5T#-,81GN_N=\YJB6O
M11/79F8^\IC/72NUCMSLX!A0/J@8#4#YJ!8]BV9(O7-4TS@L0,C8)H0ZCX!0
M8XL0,NJ5>O.A"#5?'"$`W0].0.-JE`SX_ZB6/(T',L=*#5.81\\VP+RU59@K
M#7,OYCCLP9COO3CF,U*Y-A.'#E?8A&F5.694A#X[UL;B\-?KDZ-:]%#-@B]F
MIS`R4TB3>"A&U&=BM3D2O6#Q6R!'@BJ..@?7`GP*UX\?KP*O(D/^^W+:$^:X
M8^XLFG@Q%LG,V2F.:BD,TNB"ZW02.4D#+DQJ$[5%9`"/!?A#<A@8S,-HW)D<
M=BE'G>$@HO?Q"LUBI'_^#9N_]*UX_5/)5.0_KATZ("53<L9M\,K22ZLA\0@U
M('?9<U<MF_M&O.0Y@SUV3!^HQ^`#,:D8$>I8Z@/[*^2WU`:@8R"T$W+X";[O
M.A;^<YJ,4ECU](0G3$^,5);`28XF%C/YF-K@55;:I5S@C49#.@SUH]HF"VXU
M>J"8VRWC4="[]%V3,4N0@>^.";MCOLD!'G=`1.":WXCK!>#29Y"+7CN#MZYQ
MX(4:=ZHGL-;?L-;>/$+W+K)M6,"^/``)Y#1O!A$Q<OV`!,P?P\K]8!GX5\RC
M4]0-XF)PC:_=P%LG\-+Z&[%_L`R'A0MM%QZP%8;1?!@BUV@8*AAJ6B0:.P^[
M'/,1AWQRQQYS!,7=W4!=98B>/_/S`P>4;&0(>0]P)]P.,4$P87PXP@_T%LSS
MD,'LXS%`H$SN/+B_Z=%=-1AL>I_Y%P,]F5Q27(0!.D&8M)C!PTCC4<^G<;/>
MW&MW.IV#!(\UE]QF!%N(((S;,YI[#T?PD^N`RXK,!9^$:W-+9GS.P!-R3`Z>
MS74`#W*Y[M\AN.?,MZ?QX)XS</VQ9)$;@/FCC3HY;X=^M(/WX%S].`S>X\>`
M]FT&*GQJ@YM]=G%^4[GN_=_I(3'J7O">R`=GW:^]+W\<DH"/F2`.FQ`0;>H`
M?9AM"X^:,KM55W][U+*BOR?<"D8?2F!%WY3B]7P"5I,/G0^EP/62QU8$PV^]
MDYN?8?T#+R@1/=)'`L=C4]`/`,'HQ9/>]>67+L#)'9L[3`/_VVGO\\\WAZ3O
MVI9^M!#!&XG@.2!X)1'$5=X:[WZD8^_]_QCM^OO4)UB\AJM'D-124-4"*\$K
M!74$Z=?NU>?>>>7+Z1D`)L&X.?W]IM([/SD]CY[H,5<*^GJ*&'^&`L*<:6EU
M&JR%\/IDE:^MS,PSE`LV7$UDZ;_"9M0"/_F(?)\W/K5/,3!]E*;L+N72ZW&X
M#KS@,;=M]&+*X&R9S`LPT%%*CP!MZ;L,UGV?U-;$Z!Y.1"%<QHHV&^03X9'X
M,$%O5O!>/7)=3/^6"80,5?*V)/\JO2L32JXG7&"DZ'NN+Y5YF7`!S\?T3]?'
ML-.=."!6(NP+;G&,/L$!/V<BL!6)&LWF>W)=[5;SE-9)Z*/)^U=H3PGF5LN9
M-T%PP<YZX%K>@1D,&`S<;T6<B$OQ0!`)[JP5)H%+SMU;,$H`;?=S[NK=@$!H
MQ-`XDJ911@@Z60@4?L9>NUS?;Y<;[>;<0@"#7#]WB9Y#_D6=$,F"^;ER`A.+
MPPW$`")[6P<L!,SF/!`_">*S,>4.4BL/6XQ-@4:>BQ/"YC!_"$A%H('="U3\
MRIT476![!;&X,$,AX7"(XP:,&,WJ4OVUB3[:+4UP,\*L`+@[?(P>C38S9MK,
M#&(S(V*?*=D/N17P()8:#FN\-5W;9F;`;X'+RR2`14KH:%-G6GI'4,N&#@TM
M#M/GL_/8#7$5#Q@"ED-&R&%P.9&*(``07$3/N0+\((>,2HD%7I&8_(2L!_QM
M`W]Z&._!G&?@]L%2E3.8Q$9W&9D/%_JU>ETEU\P$H0^X9MK3.W-$'?"A`=,Q
M:!J^0)`V)3FN@5PM$`*?`?=;+C[`](X=6H`]"![*@.UB'A#E[*^0^ZK.24T3
M28H(>X"VR3T;1JA2J&W+[\$,*M&1"#J2D-*Q4+L-@LA-"AI5XOZYV[W$K028
M(#H.0;/U&2Q(Y02`RY^A8TH5$)-LC;V!2?&-660UEM9J&U;(_7*Y_TH="*=D
MJA<V%ZFMY9.,0)..*;(3<62TA0-`ATN;I3:'"A&.51H(:&]3R5:P13B-V@M\
M`*_!0*8WU.:TS^U$6G!LPJPX&`,J>`]!6O`>+`$:P4.QA]<%RV<?Q8`8L:%-
ME_P7LVR^MC$#Q44BM-&`27:V^&``N,O\3S`"8Y30H."MY;P%GL(X9B^04M<#
M:X_>5K"AYO/9`*V)5'#4PAA-/7^+KW*AN,VQI;_F8*2.FPFZ6>IWT&P^;*]X
M!]&UR81`!T8QDI"%#LHAU->LJQ@`O98TJ*H(DK)&N5QTE7I[_DWD6-34$00<
M5N2.!?H4322"':T=C,#2P:?(0YR`>XBJE9HCSFZ10#`])8,0'D_!@BWFQ22'
MLEI"(TZ=@*9W+*D9SFPZ3)=>XF_PB]P$R``(S535969P)O$$H*,'*&3@E78`
MY[,QIWK@)?-EMB>:()U;:JR0/#.J!YV$)`MF?6$P,>E;W3-6!_.3*Z3^'KK(
M91A@9*HX,.)B\!F_O\;X8^W$;K.3K4/-SOELT&"&<*^U*C37U,YF,.7#*Q`D
M)V28YU\_S[W?R!2NYB9]2@B00UJ=;#I[`027$$<Q/P`7W+,IVE4PJ.@4>BB7
M95!'>;4,^<8ECN\ZUFDT>GU8&UC$[&2HM6R%[0#<`,";]0RCK02X+F#_QD`_
M_^)`P`U1`A4NQMT]\)J8GRUEXU@Y-!JI!N:RWQ]8Z+_WU425FP"CX(%.,`2^
M;!&8+DCO7^HR##C15\P+?0AG!+L8?))J3];^UI>72B=#QGM7V1;P0=@J62Y8
M'?Q+_:V,G[QE'+T(E1M7DL!G"WEO@QUI+]R2^Y?;9MQPN_8RQFH#W"XPY-0Q
MR#ST\XT(/4>.OO"P?0=,=5=%+NOOBI&IO*^VU,M!C?1NMA\(=<\!HQ6XF#6Z
M'^C4X,?01$L7>&X(I;+)&/;50.R.,>3^+XT4)80?U!GR?H[[D1YZ,>C%`S?E
M6R-CWY>O\.(P`YWW-P3Y,LI*ZSR?SEGXKAU!3$W[,!KU20Y"RR"'%/7BQZ@7
M-U]_P?BA1(BY\%/,A9K%MJI4NV*Q.;?"^_3EW/S:[HX50B\<TO5\;I-V>4%)
M$AVU=!G/E#D+S'U%_IT<HEK^2'?H,Y4R!K]7A.CI!2Z9C+@YRLZ,8RW\7F`H
M=%_9<ZX`&:=:I->>KG_"9E/5NAKXU!%4%1DH^)Q8US"E./Q@M)I5XR!A@@5E
M&)A.0.!,)E3V#XMP/)8Y2)A0EG'W([+-D`G"+2RDRL(Q=U3A6`3T&XL+$[)O
MTT8U"9.`/9-9/8<T]M[$"&)6--4HI=`O(RT!GGE:JGJIB-^,Z]7RM1&($B"J
MZJ(S9#;VVC&=%6":S$!=():0V=&9-_8:;^;*`;F`OH8$^#UZ^ZF[*])3SD`J
M;6E&#=W<*W)]%DP8<Y:+,+@]KG0T)+]X8:`[O9.*O+3>(JJ7]JDMST9BJ68U
MUE$M!/WI/!P+*YVSZZ)<,UA1"9EN)Y#E7*.NPL8[CV,Y2(N@*O4:1G[=1O(F
M[I*$"!$*)B[QD!8H3:I&I%<>^JBOWO)W*6K-4`:T3#^<RAI#'PC7JAHQ!=ZZ
M/FE4]]Z\RVD(R>EGB!H94"D-^!TVN":JZ<!(&:>H$)9>+'D;OQEP7R`C86_F
M8@6G5-1;CMC-\X=D@P1'J8[3&C4/8:V5%R`V\[8"TW8GJE`8??&3;@19A+FL
M8GBP``_'6?9KU(':A/;=6Z:V=<2<RICZWV1KMIXQ#5-9FZ&H7`)KFZ$MM3D5
MJORL&UR7S4(LU<2C"(]K^U2J/8M.P?0`ZUI<`0B0`Q-'8^.&?:QA10HT(7LY
M*8)G-CH6060_IGN$LEN/95)=NU]HX[9?)[^P,Q3IFU9YOH.).HX;2K4DZV\\
M("-JS?4U)2(49?UTT3"2D0=J4*4O,@W9:0&JIP1('^4IS_AB]WINN7KT5T]Z
M7-H!BI*MDH755"E*361Q'//:X-&D,";[^V]4V1.PBCVA@BGO[[Z:)SQ-^$MV
MUZ"'FO9U0P?=O6#.M&(GHPC[?V*9'!C!9T-4?RYPN]PD"//%0A,]`X':X``F
MQ;8[D_GH2V0S'ICSO>5"MH#HEJ'$8Q2ILQUT0GVLG8.6`P,E>W@BM7G+1-0H
M$JV3\35G9GE7C@?Z+``_004C,+4JNT<M+&SLV>Z4Z4X35R5&(Q%X%=[K2S)E
M1AV49_J#I(EU7##Y#G)(GSEL``I3-LI$NR.F#O.'LM4'W2S5W)#O/*$Z],6(
M>_DNGM2<V)*$$19H'.L65!T=QE8V60F79:@T;3+0S6?PD6+:-'?J5`>4Y6(N
MS45O.>`F]U"?42*`TGS`32J/PT9M*1RHH&1,P6:%+-*\8*.%ADND(>LSDX;:
M7$14!''%!A58'6R%PX9NP%4;E705(CK>,L=R?5$3H>?9',^Y(D.G>F28?POF
M02AIM'``P#+F`1]*'&`ASPWPI'8"N=PHFI7H7"+]#'X=T+2,&XY=7S[Z*NC:
M.>BMJ#8Q]%8`'<Q(%J)U3VOZG#0DSC(J,?0+Z&S)<]5@HQPG!U0_'D@OB)2(
M'$_N6U%8%&EK#]X;4Y.%P/$H)[&BY(X5BD!6,,9TBMNL&(=9D9.-DN:.T<D6
M>A`=#-#P1##T0W!6,>]A`?/8KBKFJ68^DSG2D74];!/$U#U_'?F$EV2;V?@^
MZZR"X0>9#U2^#3=7L4;?!:.)7&2!J33!&1`RYL+T,2I)&8*MUEZOHQ,FMUEV
M-:$/HLY3Z!EL.LEW+F-W!<_/1OHQ>BN"IDQ4&BO^/NU:-IIO,I&:1!W]8"_L
M`U=A!Q_$:MBB+?T7#,\P@&M4#Q(D]*N(.*/`QZD)%_I&\4D$#?`DZG5.=:N&
M'MI(.G:1KZ4,@<0Y0SR4H'VO*#VQ:%^4A<U(P2.S411$SGGW^6ZFU",)1\5$
MU$YG'/*":9[(#*]01/<"U<ZH6\]7=D2EUQ&O`B83;ZT8ID_GI+.=$3N44YVF
M\)*-/9*:.1#J"W]('5W8@UVX4L!(IU5;S&3L0IE!!2>[2Q4"RH[/\P4?S!PD
M4A3N`>][#/M<`W*BYU.G`T!8,=A'DLF,F"7>@P1H6YM"R41AQVP%L[BIX`07
MV43MBZ$"V/<_P9^6OH`^LJZ<:\!I+,,"5-^H9*.]E"$:3!=@!@:VW[89N@'2
M@@-"TO"\!G7\^M*[]S`#%B&P*5<=<,"Z@VYD=UCJ($7*8U#;:B=BO+3JD'!X
MI`71#9Q/00"#,)#0$+5N2AE@:`GZ4F?29E2W3F5HL!:JT7N0!QX$CD?,DV&)
MERL]!S;$3Q;$G"B3.:3!'(T&/IW"F)737``OTB?;HMS0"O++L=E.)8<&4=>Y
M`#6&26>&D7@4Z,9J;<[J+8G(HS741+HH-_=Z<O8)0<#.'R&DUHAU6I0\&C#4
MQ8F/ITSQA.FV='7X1S8?J(PTO)[BM/EED575N2-51%`9'Y7ZR3D9EE3)$@6^
MQ.4[JBWIHDA='X$G?O#*"_+1]7UW(KNT<<DO:(;E%R>INSIPSOB6C.2-KF/A
M^/B2CJ))X^%-&@=%C\:JW%ET;#QEQT:>+_#\TIL2V$B.^VX0N./'\$_F89PE
M2C:BF!&TS>%91SZ6@[@>A*"?<0?@0:.T`ML_3&V8>-;+?T:J?*7@R6')>W5=
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M#[]V'EXS(&QY=\\9#C[7-3=Y]+MQ`[S32K;>X0EUTM^D]6X#.KXJMQ80(98;
M]FVV%5[MBM7_M5!YL:1J>\-X$!!YQ:YL(32%T#Q`:.K?I="L>B5#SHRO_CZZ
M;D#BL^JIZW*27Q#&&^($_@(K_EB.["%5%]'/]>>0`363W_8%XX\7YOS0*.^W
M#LHDN2NV/Y,G3MWD&E^LG;[?4-Y>(Z^VL9B#EXA1_;/6M]3G;AC=NVD6]P[>
MO\^R"3BSU=)-2WRS_*ND<G\77F[+#VU]?V#"(SZ[=>U;W&O-+2G&P*NO]_=R
MKTKJJ0N(\'<O`W5U<N96T^A7`!*FT5?XI6^P)?26<EO>#")O1;0LKF^,2[!4
M5^PC>Z?O*-:WMXOX7D!Y-9M'IW(R_+$2TW1]2][P'E\"'U^MA[<P;04/;C17
M<;W*>JF*U>$I+K0HKE=YKG:*9SY8]RC@/BN?/C.!BFM7ULF.%=>N%/=1/!OY
MBFM7"C;_+MB\N':EN':E.(^^5>?1BQW>]1U^CFM7.AGC4^EL5?2SV?7(A7#L
MNG`4.[SK._S<I_V>7!6N?Q3"=JFSN<K;]KK\ZRF[;T-5?:_U1$*^18Q1,/`N
M,_"NGU`M#@#LIHP5S=-;+'0%#Q<\_-IYN#@1OCC]@S];J'\7FXQI$/IQ#Q@V
M:ZE3`=9ZF:&-R+JM/FAQT'7K([)=.^A:B%`A0H^$5:7R?8I0$2H6;G;A9A>A
M8L'#+P_SJ^+AXJSXTD:!.!PLP[?R!%`V=GQXI%@<@GT:G';I$.RFGNWK/@-;
MR$PA,T]?(=PMF2EBP<*/+OSH(A8L>/CE87Y5/+SJA2.+@KEGO+/BF2J(>5=6
MS$\Y`RD&K/&HF,XW(Z:N&,'^RS(9AM2G3L"81?K3^6LMRO)>"<H=03S?O>6"
MNXZ^<F1,IWC;`[.93P,F+WIP^X`PQ:LD\"J(Y*H*.7YNYI\$<2<.\\6(>QC)
M=FU8B0RH;0O29[8[(7O&F\6711S5J&D?RI\MQ?;YY$=+NXZ%L3(^Q);ZX[__
MC9"C?U0J)ZX9XGT8Y&;JL4I%/;<8/XR^P.<26W877+'!AY)9A_^:I>-VY9>C
MVOS(>-Y3)^#!E%R"G\E-<@8T#=*SJZ_5M_)+$CI<S1_"]"4(YTT^IK905T#,
M+]\H'1M&L]%J[;?:G;H"(S-E#,LG*D;JXAG\P/X*.<BZNCBFSX;<<?`*#Z"U
MQWSN6N1_R9(7&#R-AT88A:(RI-0[Q/>`T/C/:?)2-_A$?7\*B_R'VB%;C&FE
MG8.J43INUNO[=?G?46VMI7:#`O72,>QTYSNF`+![TVA\SQ380RG0!-B8`A>@
M>GWB>JB9$5EVYS%',!$A@*I3CKF(AISJ$6M""]JQ%8&Z>-+GAZM5.EX-(OP%
M/3`[8D1]!MNM_B5<B)!EMUN.O0[`([B6XWIRV`QHQ@H*O5EO&0>M_7HGM;WY
M4[\<F%(9M^I&N]&IKP[F=7*5*7=NP=[+"ZCF`8R-=B\9L[Z>V&LUYH4D;^+G
MAPU(U]K/J+"EL&D?XI-.YE\Q#P:C@%P'-`A%UI_0(^.!:ERN?/[!1-IM^/_V
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MO,$AL*TB:&D=1ZQG*4_'9[T2`7O*"%S_S?`!P.-!^)CQ`'R36+M3HP6M,[1N
M-H#^/+S^NWGQ&3T>&8;"0PKBS]WEE3*@X+P]X54M\=U]FC2L^-EZ)VT<N*(T
M.0QXQ_:M')_>;>0I`2AZ)\Q_;Z-15^QC\>H2$GT^/JL%/N?6;&"1)IR%92;S
M3G2%4KKSJ^[)F8!RXG$L)H&7/0EB?Z,?0!M@78^%W;#6Q81RG3'^3JEM(;43
M3N,\U%KEIQVB.%%II3Q_X('28=B[(/9"&:?@']\#`6\PA5B)8IMTS'.V6^\E
MFJ>"$UF<AB]2QW_>OKO_S6811S>S2RG3^?.:B_3*J$IU'E^\JFJ*.W_!2T6B
M=[7$[E]IG`3=YP5RNZORH!*)\W)@8QGUQ>9=^=H2<`@B-@C"$*U5@PGP9(8)
M)FJ,$\9\GO!7DYPI_Y!O!-2L7?F+0VI*W[U_^_GKS?WMYT\_FO[4^#<#,JD$
M$&GC4>^9?0WB;^QW'G'CQL[FJGO;,SMM*<YB^$;0#3P.X^J@6T;H&98:R'\?
MVQ@QE(^8U1EOY-ZUZU%NY%ZA",T.BA*A]CWA(U%/ZA;CQ=@]</.5'M;$HW;@
M6*;*TSWI69P.D4C=RKSPC+"1?6!]4'CHC]=WKYD/SB)7-M@!6R=TNV%T@7WQ
M($(YQ,<K";V79F_H*3&;0\*.A>8H-<W,1]D1`#."N`_?X>!DX\?24)<_/@K^
M3>A\+@`!E&+!(=-T/'@02&_QB<88WXT?]8P/=4$(1N<AM7\X,D_0N<"^7N#!
MNH#_I;\`HR38BAWT4!#K*87(`+U!UA$L@&\%X&!4LV+D&H&8@<<-BMG.=7SA
MGYE"01SD@HA[<CW%!T@^_#,!WYWQ'N[6)>Q!XOSUY(!1D8Q.8(*>;?.>#SB0
MD4BX>K;.EYYVR0TV67'=8S[62(29V%7R>!J;+<-NF'I)JJ/$N`Q74,FF.SVR
MS(V^[PXKBC(2A@K\6!6$SRS%)?P''@:F/G+E%TS5_?ZYEVB6>S*%G_2-`WV\
M<@"`"TNJRHW^<24%O`2*!20E?+:9"^U+`'QDMPL`T-*!@/6T>,VWLJAKJG`$
M8P%:LN;_A4A/45[AR$4#$Y_*&%#,&^>G>X5J+8EB7D@!SB/7)I8FJ4:@/:9D
M2ZK#R'T"WS5Z2F<M05E4"-`<^@U$N2=\HWBJ1<E:@\D9EA:E].;(W/"'ROE-
M53>ED<8__R+'S:K:#_Y0YJ;>XL<5Z0A</KL.J,447@"!ET*,&K/\,UI?&<4C
M8]SJP7LCX$&S"C8^/+9;1:](C;RL1@IHZ1S4A.K0MFVH'9%1:5)Z5\"LDV%_
M=KZ@)-:C?W@)<5.NSBFA7\L'2*,*'HS!#HK(!FPB_`(^G83&X/E:X5@AB%&?
M^1:5>"7.WRD'\I6>-7[+7L+S`/1RUE,`+S"$5H+Y`'6FOFWEHGE!L)K?.G70
MPWRP,M]`YR?1%47Z9AB(OH0PZ]0P9DDHO*GH.;OI1KLPCUROQ(AO[*>YKV8?
MA>7,_!?]VV(T<X&2\>MRX.#U2/T`H*9OW0$;Q\!O0SV6Q\R(K"!)C3TKC"S`
MZ0Z4SC\0`@%@&KF:TS<SGF@'>#2K.Y#@8)4^/%W7FHF`\M+YH.(F'&FOZ1FE
M+4-]@.[K$'W1*#$^UIC,9/?]:,G5]^QPB"WB0,M/Z3F[-BK?4,1U61KK:\/G
M!N+M'9;@0;BLN9STE1#H"27]&`M'8.6J5)_H=H4Q[I.V<(H61$#_Z(*&6F:L
MW:4W)S.:BW>^ST:^7L<!0M<ZW[\K5!@J0<Q@,U.T]!L89=077W44#>JR'PP7
M.5HXA8UM!PYWK`R%JSI"X:/T>)::^A4\<G;\$=RE5P``3X*-_L<XA>^YBO05
M>/!@"3P$#`V,RSH"XR;WDPD6!(L78"%-8/:;3GFPVT0,EMF<JCPGB%N45=9X
MYX<$RX2Y@-=*AETY2IBS#+MTE#!BV+('C36U5<U!MN+;;[(WR(<7,[=+6&*G
M05>YC-OPRS>YC,:0AMJ0CFS/9IL-NNO+02SE-ERF32[E=Y6%2C7Y5^N2,$@8
MW.V_CEO7%<5=6RY[V];%\_NW7?3BD"]4H-WJ;?TX85_Q:#F5GZUEWP[KD=(8
M=Q8L<_6Y_?B1#W7BQA,*#_K;(POZD%+DLTYVL)Z!)QG%W)P.P`TL4X:D"\6P
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M00=DW/RV>3U>=3REZB/RPM3/2B6K^U&4SA,VT"+[NKA.P`/@U\*ON*>K9&(\
M?8J_:I@B%BO)>9.<QMCU(GG)"UK^@2D0'ZTVL<X!9I1@`%U[;,ZW3B]^F386
M6GRC-F<5P)@*(:Q^P69`E1]Y5U0,E68Y6JHS@Y=SL$^_.86#NB3)MM^P-@:H
M'@Z5?-+3'BG#F[0ZD_52TSDY5M`WMG:ZW,F4I\LQNXE.C<@22$GX7*H'MHS+
MK&Y7*MU/0M,$WS`CH\F.@T&`Q?GX0>-;*3$`+."T"U[/2WL)P'HL[L&28.&2
MC$[R4N%)D)E)^@*)`%G5!P'\(/;2."X@LDU=5:5<=EKALNWK@A?LH;EQ>A8C
MI[B^N'6V<]J6[=2W4[K7<JO7SE&Z(6I7W5U?]W4XDU#*\7]1P^*$49]L@6SU
M+#@LT8/97<`0X&L%^(F(@S#_DIURS1*Y+WI3):I=0XG*&BLN+DA[+S$$1M?`
MB%D[`B(!<>=`)*U(8'0&C`>J%2GQLO,E6$L<6D>1-*="UG`'85VB3T)Z39&N
M]]`)YX3SFN.<-#HA_3"03AI]E;SYQG"PV1Z[E2I/5V3.[K>RG[4.[9V3MI>E
M#K3"M,*TPK3"M,(NK_""%XV?M[=POG-QYV4AQI3N-,-BYNS,5E[D>]*5Z@2O
MIBF7W2[OUXS>`>'*/<%.W2C]W>*4[NHBZ?.S]H;4@$/((`03@@G!A&!'$7QV
M65&I20@F!!."G4'&`<85'_,#AA1*[$P)K$+RKK3!Q5G-E0$AF9!,2-X]+`C)
M<]-\>4I(=H5.0C(AF4*-L=[%4^XUI.#"49)WENZMN?03D`G(!.2=HX*`/'^0
M3$!VA4X",@&9`HL28VXGNUQ31.$HR;L2^U;-Q9Z`3$`F(.\<%01D`C(!F8!<
M)R"O$%%LC-X%6RRZPDJ2->?8[*C0$88)PX1A%YCK-,F$8<(P8=@5-CN*X7IL
M":S:Z^5CP#M!J&\P6J'ABRMK2M+O')L=E7[",&&8,.P"<YTFF3!,&"8,N\)F
M1S%<CTABR0/2>$]J`T\OA*GNOY3=&A\*'@LF.T".N7I[A>B"=@CKJ!_.Z82I
M,W02D@G)A&1W2-X9DNM>"$Y()B37`\F'&'78S8IGUI6*<>_O-(@##"Y.E`AY
M(GQ]>!JB$`&?'?)GZM'D,LF[T@Q75S77#(1D0C(A>?>P("3/W]FF[N7BA&1"
M<CV0?(!QQT2/)KQD0@XQ\J!V3:0)IM!,O?F=H9.`3$`F(#M#,@&9@$Q`)B#3
MX6J2->=E[6#*&`G#A&'"L`O,=9IDPC!AF##L"IL=Q7#)@?\AP>O3\I]*2?$9
MVP'CR?]\-AW%?EAPK!>V%EI7L_<6--_7P,Q[S<Q/P,ROQ<9"$/'("W@(8\2)
M2G7!4H/%J==G/&;B[Q2+G7"WH1L\"1^>\N1`L%AXJ=)GMAM,)GVA6.E.N@8\
MFXT:%J>[]2B^4,$#3X('?/-1*,&&2L3P%HS-$];E@4*$I>)U:9GS?WW(_\R"
M&,:"[^![,0,28*#`$SC(8S]`ZB/X0RP2YLDT]%E'Y)LG/L/:K<EH:LVL#?-:
ML9R"1/$H[@JE-">11*F`(^&S^0OW](9.1R2/0D3L&XA4*/R>0/AJ[CT&88A'
M7`9<?1-88*:2P`N&')@.?TOZ,*;E1(2_#G&B`QDGC/L/\!#O"9G&V=O`*7QX
M('B<*H$KQWR>5#/^SSXN57X58:.T4+@2'1XC5W$Z9H7AIRY(+).=6*@'37]&
M,ZY2C`\"]7P@$J'B&9\L#5"\&43#%&;,X>^13,IDX3/((*S.BX,!_%J5P*CQ
MH$<HP;(!%/,0$/QW*A,S/LY+'QD"YODB-%_BPV$8"+^2UOL^8+CT6B*\?A3\
MG<)P(!<R?`")0;$)Q8.`1>D",R)8#,USD)I@8%[#)?XK]7OX^X9>'%_TE!#X
MA@&U1OU01#Z^*:,2[C6`@*4B\DQQ(OZI)-,:"G;AX3-C?_T>,#H8AN()X/IZ
M4JTZIS)?V(W=I,8<'W*$4E3E^5,Y#S^,(Q!7H*P9E?!0$8RI0&;%V9.XWK$I
M+HUE&/BZTK3#0Q@5D-47.*96IA[\I2=5\(_^.[Z2#BU,<NQE"$-B)%"%8Z'R
ML)C0HI7BJXG,E`/^":@J2*L6V?M^00$*EE8!H7S$'N`P6!]\'OQGKBWP@WP@
M4\1R%VQ.YR\!&O!!6YSIM,%(.2%&;N#E1$M@-7L;1GYC$(L0J'FAS<@N`&X\
M`%<0_E$CI<7,PEZU6ZU_L]M"Y:81]['<0?@-HS/]3#6C2<,%S)1]K!51@,HJ
M\*;IW^EVB%9IUBJAL"7/0[187?86M#>/GC,.>UR!!&IUDBUF2:W@(FK'#KD?
M!KB2DTM'[)]'2-I50G)L/.($G,T)`<%#RH;==F%>F>4(]"M^`)8@`7=0.SG%
M3X43E%GV:E%*^DJFO3[8":7/(Z!RU.K36GZ0*SY-WHR3;X?W4Y6K5L'1\<A]
MA>]1OQJW$V<6!ET2U3E$U4HH<L\L74]$0O$0EK>,"O#AX[*L6G/ZK%'RP%6`
M#GQ//@@5&1O>TPY?.1[SA$HX#%5$9*R;1C[\92!5TH,WP`)[W^![(V^!;81O
M`47:><@?+9V?;R`\!'"K*$,KA7,:/\'(E1^EOU:'<TL/9]D!'`(/)]:G_@'R
MLB/Q0;!+DW$'0G^JTU(L3EF:%EPA=,Y`F:+(9$LPBU\D-/,HV-/I7DAIC:UG
M.%,YS@C<[.M*=$-0N*7@#`#10?C9&,T&8CRI#L!UE)_J\?)`=+JNGN;V`!@!
M1P`4HX`!;#V`2X1N+SZO@O@;?`"#8WC#1@@5D6<>Y56^4+C2F@:,<@F/L_'X
M:Z8-3&0^H<]+/M=("#>F.2H5>A^S/%I+E_-H"ZJK:014?'?.@XON0<*MY.GH
M6F0*JUM*J>9KJ=G>%Z$&@C;'H")D5\0QK(&V,4;K0-C^7+;<YK=34F3X_4@D
M-L]I`G/]H6ZJHB#N&]C%":RO(0+\25$DYS3>/(CDI!_P"!187X+R&GG<*,1<
MO<0Z%Y%Z.EOK8<Y"ZSAI\P-@JH?"1!%Z[$P)#F4(_[`VW1"K(Y?I202=C-(F
M'^QH&-L(WXS:ER%^5O\R!IXK'F9_+Q9C"G,-YP?\&;.Q$,AFF4.MC7&%&R!2
M@R#)5'=)RFTN%R8;2ODM=[6M"H5Q,8^+[V5)"*/?M6NM:<]A4>(P-PEPS-M5
M9Q;?"(^C2<E3'.AE)`J<"\RSETAD7@@?#KJH`<R3X^H$,R`6HR38LP7[1H/K
M=ZX@\CEM-5B[V6J.<KO/2UF[[ZZN&MDN1$GUPA`!VOW"@]8I-?Y-5"E;EBEB
M>*:DG^/7['YTV)+'8+-^>4(M!LX`!#RN+;TV\9@@'_&4C,4O9X)3_+;=AF'<
M)@I/R]\AO,S&RZT^A1,)KXBX<?NI6$7D>[O9O!X%49"#PV9;$1ISVF9$5SK$
MM[X[.[T>3_9"R![`,FH3`@]VTP2SN+C$&M-F)PZ660Z-E0E"T!(RTBD$W$$K
MMLQ0H1OJ/"50EQD0HJM]$P)=E5KK)JD4GE'9,%HJG\\C;C=:/UM_#S[_W66K
M<OSWF)+(B=:OHO+KZ=U`U/V=3%WGHH&2"-&N=H)1`:?3K0^P*0T3E*'22">/
M`K?L<3%XW&==3"0;Z8-Y1,P/8@\3V7D\RO-?F>`5)GSQKX;=QBF#H"-"7*H8
MT<"'\$6PFEDZ)A=+'3+B&+PB],"YIP-]&&SJG(J9:#N<,0O8;!<`F`+K.P!5
M8+9(M8=P_B]\XO3Z7]6KC+!&5,`R;GHS56\LVF\!&UI--A3*$WI/$_P+-(<L
MW_TLEK_@3!:?F<6UNZ\FD:VG;^UX@<`<IWI1GO1OP9/X[K1)VG`MVG#<I*Y)
M&[;.SHT>-#I0YX9L.B;F(:;+[393*5\*Q)Q-%9V96LMZ>>7):8]O0ILE$GM2
M?M>Z-!OYO)0,1NT%DS*IH['1*JF:@](\8X%?&MEPL^S.TRJ7_RXHS1WM$1E"
M)P&<8F!D/G_#27CJ+[O*5GM,U]8*=%R4BO([A7#.TN!Y'J-F6ODFA^=HH*'K
M-?!H[R"`5?$LJ\N\TGH,_;I<^XYJKK*O*#4K0/R^.R>U]7(T7]KA'@FY)O0-
MU^[40R`>@>'"`'PHE0X<P3(%LCJ<N\%`3:>"<W,U;G%T14O%[K=400]"R)`-
M4_"L<-5-X4>1^S,TV9@DF"[M1I+T!.70YAFK)?>3-)5@&<E:LO`3$&;\4WPD
M\ZNRB;N/LPWG$>_N_^\C_`;;$`?>/%5X"+O_Z.7O/+.W-E5'?-Q&'4YUK:(-
M?L>SJ2AE*```>)1T,*Q!1>6-%0M==HH["&"5)JIQ3%5,7I2CHW43?,&(Y3C>
M.J;5"0`G9&VIL:H0HAF6?66QPF#P\<(P'G+,-_Y\U#0_#[GO9S]G9<G-9E&8
M/'*RSW[VR\V[=[>??CUY\_G^_O/O,)_7Y\/)JN<U8'JULWX;HG;5RYP6+2]_
M\_GKN_=?<_([(?>^F4DP7>@V66[N25QF^$7K;/-=73#`%&J+_"L9`EZ1@YPI
M[?,#Q#)AD;)^UR`T[7SNE&FWAT][(\.KT>J:!(]BS0K4=*EN;TZHM\=#6]JU
MNK0"%&H@JP3UND.]HAL$09V@7D>HGQ+4">IUA_H];E80T&>'&JZ%$]NF9S%R
MJB1DW\ZV[YIN6F%:85IA6F%:86=7>-Z^@57;'ZYLPZV<Q,YWU&[T-ML"CB1)
M1ZVE@U:85IA6F%:85MCE%5[&A]GJ92OK*BNJ3'TIK@^U%6?CV0G[+3^?29>L
M;)+D[Q:G=%>-%$].-B3Z#@&#`$P`)@`3@-T$,%T]Z@R=A%_"+X4191;=9)TE
M3KI2G>`9KE)$,;L!)35BWR;)U(B=+A,@#+O"9L(P89@P3!@F#!.&*:088]'8
MD*,'GB]?M\^KSCS_\?KN]4C#8&S!-]XT>(5XA%(2==0HE!QVATY"\BHTMZ[.
M"<JNT$E0)J5,2':'9%+*%*GL(%*YK(Q4?K=7CIQ,W$Y"X8FC)),E)$M(2%[)
M$EX2DEVADY!,.IF0[`[)I),I.'$E.+D348!WBF-,HN]6CKZQ4.*M27@JA`(4
M1TDF8TC&D)"\"LW7=3>&A.0#03+I9'?H)"233J8`99T!RENIAM)>D]Y):/.$
MM`?904)RO9'<OJA[&0%!^4"@3$K9'3H)R:24*3I9:W3R_N\4[W*EJ(34QA2:
M3RLNUJB5UB`D'PB2R95SATY",B&9D.P.R>1=4$SB2DSR.>D+!5]]$'&"1^,I
M)G&59+)_9/\(R2N5-!.07:&3@$PJF9#L#LFDDBDB63N+/DCUR)7/Q)/7YU%/
M,`_&5]RC(,-9DLFBD44C)*]"<]WW_0G(!P)D4LGNT$E()I6\>)!AZ?AR\^[=
M[:=?3]Y\OK___#NX_Z]Q)^`P0I#;*!%*Q`G3AT+B1SY<)/98BH&N*H\WG[^^
M>_\UGT0GY-XW,Q46RS#P[:+MEWI9;%*NF])*H,VS+HXJ)A(A$J'M)@I)@DB"
M')\4&2$2(1*AO12A`S5""\:79\.G;4:7K:O=A9?W,N'AZ@'E+([ME1J"B3!?
MIIU0.*&%YKP'=Z&IN%Z\6X&M/58])#,D,RLD?B^7M-@D-.[,@81FNT(SYXWL
M)#(D,B0R9BX7K?8A"LV\Q8T5X=[&Z&4O+(3SF1`'1',?]_@/YO9?PC!AF##L
M`G.=)IDP3!@F#+O"9D<Q7+?327^^-T-T9.@OP[4/0<0C+^`A^QCP3A"NVJ3-
MD64FA>`<FQU5"(1APC!AV`7F.DTR89@P3!AVA<V.8KANP<5"+,KBAV?6E8IQ
M[^\TB"&:D-&)$B%/A*][(0113\!GA_R96J\YLM_H@HJ@D[?NT$D`)@`3@`\-
MP%=S%D$1@`G`!&"7HHM91W`.I.?!!ZD$?*1HN\8CG\DA1A]+=6!;BJ6NJA$Z
M/>>\5UBWXW,D0B1":YK5DF7&)$%NS8(DB(P0B1")T'Z*T($:(>J"0%T0YI-8
M.FGGG/G>[X-V)#,D,UNWUR0R[LR!1,;-[1.2&9(9DADSE^OF(<I,*2K\(>&P
M&%7AS\:V$?]*XR3H/E?1NXW/KRNHO-?L_P3L_YJS_RV/^WKGTL-_B+_3`!"!
M59),=MEWIXU6^YH]"B5PFS-,?>&S+JP=2_J"Z75@O",?Q.N)M>LH]L.":S3.
MDJ-YQJIBD2',?F4Q1#)/A&$\Y%X0]7X^:IJ?A]SWLY\S>6@V"XE8?F=\XS+U
M4I^.#5&[Z@G!=6?T)O6<)W&9X1>ML\V7(7@"[T?8(O\^\$"Q__`P!?G4DOQ.
M>&+0$8J=MAJLW6Q>KYY'6C;1Z!J*%DPXMBM\-%?%>#5:71/B4:Q9F9HNV.W-
MR?7V>/A1/(B05;177%1:VTNY?^Z"A:!>3ZA79-$(Z@3U.D*]HM,T09V@7B^H
MKVG3NAY`G_.L[L[#B6W3LQ@Y51+B_*F9I9&Y%98Z1@ZM,*TPK3"M\$&O\#*-
M/3:>R=Y9I\";.!:KM.[8-01).DC_T0K3"M,*TPH?S@H?='.R>\6Q;(3%PDN5
M[G',3MAOPN\)UDTCG_J0.5#RYT)%'[5Q<H=.`C`!F`!\:`!NSWEVAP!,`"8`
M4R"QY4#BYH$'(=:TGW2E.HDY%K?G,<6/*X01CBRN4U)/S<X=5@.$8<(P8=@%
MYCI-,F&8,$P8=H7-CF+XH$.*\2%'*&U=OFZ?EZJ$<P[^\?KN->O)!Z$BO$E%
MGQOF/1%YSZ6`9(5XA'(2==0HE!YVATY"\BHTMRXKSDT3E)W!!4&9E#(A^<"0
M7'^E3)'*C$CELC)2^5VJI`>AR4F'>]^$7Z[!PMHKBE$<)9G,(9E#0O)*/37K
M7@I`2#X0))-.=H=.0C+I9(I0MA.A4'#B*,ED",D0$I)7RM5=$))=H9.03#J9
MD.P.R:23*3AQ)3BY$U$@E8E)(#;I\.@;"R6/:/?$:9+)&)(Q)"2O9`S/SPC*
MKM!)4":E3$AVAV12RA2B.!.BO)5J*!5/!/-%)Z'M$U(?9`@)R?5&\EG%E3&$
M9&=@04@FG4Q(/C`DUUXG4VRR<&SR_N\T2.A,/&F-J32?5ESI6BNM04@^$"23
M)^<.G81D0C(AV1V2R;N@F,25F.1STA<*OOH@X@2;=U%,XBK)9/_(_A&25VJ'
M?TY(=H5.0C+I9$*R.R233J:89/TL^B#5(U<^$T]>GT<]P3P87W&/P@QG22:3
M1B:-D+P*S74_.$E`/A`@DTIVATY",JGDQ8,,2\>7FW?O;C_]>O+F\_W]Y]_!
M_7^->P&'$8+<1HE0(DZ8/A02/_+A(K''4@QT57F\^?SUW?NO^20Z(?>^F:FP
M6(:!;Q=MO]3+8I-RW916`FV>=7%4,9$(D0BM:59S%B^0!)$$.3XI,D(D0B1"
M>RE"!VJ$%HPOSX9/VXPN6U>["R_O9<+#U0/*61S;*S4$$V&^3#NA<$(+?;>!
MJ;A>OEN!K3U6/20S)#/+S^6\.6?JEX2&A(:$QM9DS7DO"<D,R0S)C#4TYW->
M-UHOH9FWNK$BWML8O>R%A7`^%>*`:.[C)O_ZV>RHT!&&"<.$81>8ZS3)A&'"
M,&'8%38[BN&Z'4_Z\[T9HB-#?QFN?0@B'GD!#]G'@'>"<-4^;8XL,RD$Y]CL
MJ$(@#!.&"<,N,-=ID@G#A&'"L"ML=A3#=0LN%F)1%C\\LZY4C'M_IT$,T82,
M3I0(>2)\W0PAB'H"/CODS]1]S9']1A=4!!V]=8=.`C`!F`!\:`"^K'NS7`(P
M`7BO`4Q-#V;U71/PD:+O&H]\)H<8?2S5@FTIEKJJ1NCXG/->8=W.SY$(D0BM
MJSB?)(@DB"2(C!")$(D0&2&7(TYJ@T!M$.BDG2OF>[\/VI',D,QLW5Z3R+@S
M!Q(9-[=/2&9(9DAFK,R<'J+,E*+"'Q(.BU$5_LP(Z\8W#?/9=!3[8<&QW-B2
MO->\_`2\_)KS\BV/^WH;TL-_B+_3`)872QZ9[++O3AO-YB5[%$K@GF68^L)G
M75@(EO0%TTQEO",?Q.N9,>:6F+S%!=MT3']W_W\?X3<!1.^!-\<J?A0/(F2G
M[%<>1+%>SH\RCE\X(7<8K)S%MIN$_<Z5UV>GK09K-UO-!DL4]X.HQV+AI4J?
M,C3P1\#+*'QFR?-0H&QT\Q.)'#@-\A)$5D""B-GU>%W25/F_[E%TIGQEJ&17
MQ'$@(Q["MX!.WM,C9O=`LVX:^7&#/?8#(-N341S$6+,,!/6%WQ/F[UIVKZ9^
MO<L#A5H\U1/!F8U_@'DAS"KH!C`TC[/IP/?2T`=]G[".8+Y(A!H`YWW6>881
M?#$4\/]@B`%7WT3"9"<6ZH'KZ@:IX#M*IKV^_EX:ZT]+?<NU?0Z5"1)E7DB$
MUX^"OU,1OV9(<_&71R"HPV.<=*0'B^!;>@W,G&*DN)NJ*(C[AC9\2$_K>^:E
M<2+]@$=Q)7=NNVP@]6KS",0(9A4#"($/'L=J<"6'4IGY=!EG0PX_>&G(E1[^
M^SB#@EY+R[2&_CRP)5"&"CV!2OXV`/-)7S,)5OX9/Q*GL,QV<&!Q\!#X*4"N
M+T/$3PS/`4H$3!T_X@L`99#19P9M(>O-/]M3`:&!'18':ZNP7(C!S)IY[SDO
MFF\P/XB!X;A4@JLPT#>:PQ!!C!ARPV@XK)UT\I;UM$J'10RU1F?'2L"W_T'@
M`);2*/OQE3[/,*&5\*'RRE8+-N`],0M<7GE8M$BC3/^%PR(/AC)""<]DMX'"
MUS"KJF^1!/F/#1STMHC&1IS`?P:93Y$-6@G&#UI/(,R4$""*4=*/&6H5?T)1
MH]0;WLS@B'95INA:5&,EZ6[HM_'C;V&:*'Y*>")X@&%![CTA0"OJ\6+PC^)"
MP$ZK/H#ZMW56.<6OU<26YN/#*#`<DC(4*I"^Y?\0Z'@*!L!,D-;6OS+=W1&]
M($*6@E8,8?&%!L(,XO##?F#T>"1ZH%4?<$3>[0HO0:3A)U2@+5``K,!?`B%:
M^X)0AZ"5`Q\/T,"C'A^BDP*\BF6J/-#6)-2SA3IWG(?`,Q`*-%$BE(^@Z@=@
M.`$+L1$F4R$(HN5QI9YQ#7/S%DL0<7SS,4CZ^5(7L@\H2E1J1*Z$IA>E:G+Q
M9C&_BEMF:I9=BT5VS!-A&`/<@-R?CYKFYR'W_>SG+*YL-HO(<OD*TXW'IB_U
MN]L0M:MVVECWSOADOL"3N,SPB_;FJWD]E#"U1?;=:+.[^I;KLGOR[@*%@%XK
MH"_7AZ?F:%_+V8?]LDSPA<=QE+NR'&L2WJHIUD>0[VV$<%=$""?L-TPF+>O*
M[QD#2N$G)HEVI\WV0Y1(+1R$6K@ILGSLJ\WRO95Y9XPOBW?&."!IF;/#RFXM
M_5X0N0-Z%B.GRLMW_D#VTF[T5ECJ&#FTPCOL-W5YL>=GOM^,I^<7L)A[5M>U
M/V5;+E1ES7N=T]X68!&`ZPW@@^UD<A!VZX7J@Q]*^^PK6#1'5MHI%4"]4QW6
M"81APO"^8WCW=FV79Z)OJRK<.J(K3?6;'&"!SM-*MXN0FUM'_4"]4]VADY!,
M2"8+-X>%,T<LL');B;Z(XN`ALW)DWQPEF;0"V3=",B%Y#?:MPJ2YLHWO"BM)
MV)QCLZ-"1Q@F#.\[AG<?&.UP2^NFXN`R]Y+@8=7;A,F+K*-2J+T724@^$"2W
M+FN.9(J'2-A<$;:#\24)PX3A?<?P0<=#7[*^-C*R76VP-<R`)_8<*$5$CI*\
M*[5PW#J;\^RX@PJAHDR5('QP$*Y]4+^>ZS=="I26HGS7RT#W(3D@[&MI;;#'
M+;!)>&HP*1*>O3"D<]\JMO_UA>\C?[GSS$NPSE7WF^ZPV*XVNEI.">WW%18D
M,B0R*XC,0<H,;052LLF59-/!;*,0A@G#^X[A/;HO;)<7&!173+UX(8F,7KB;
MH/*RD>Z\=X!47N-!]T_,7KZQ*Z^:UUNY\JKF-]D0Y/;TRI/FM1.+M]1852M'
MUZ_0]2L'?2L%7;^R5#9DY]+HOKP=E!C9.R$6EZ/:"@P9-S)NNY;*XH86,G`'
M8^"HQ7W=6]Q?7>WY.0)J<>_@%K4+>P?M"VH17F.YIQ;AM)'HD`/@"MMWKQ-<
M:3Z9[9"0/^`HR3MS#$@%'(@*H/ZSI!3H:.9B6J%"$;B2MW*%E21LSK%YSX1N
ML8.1M8S?U]C_8RENNFJ_Z=#I#CN,G)^OLKGIY,&5F9U'R"D@IX"<`K>=@KG/
M=N]_[$YGN^F@ZK;53JM))U7)\I/E)\M/I_P<.;/CRBF_YK4YLJ7$4*JDM*5@
MSVMQ'"D,Y6/\XTQ?Y5`/WVS9<W6N&&4F]H9"!=(G'Y=\7&=VO,G#)0^7/%S7
M:*Z%T!V\A_`V/UY>N*_683@V[L(KEET+ELBL[4"<!&'(^B($SS>Q?BAFR+`C
M`+D.Y#IL(3U&K@.Y#N0ZD.M0@^38*!EK29-MV*.XN_^_C_";(('QO#DR9__A
M8<KQBE%V+[Q^%/R=OE!(XT:R<4M^617'QH<<H123H/E3.0\+)B<YDUF*_9KF
M:AW%/4^FN@\1/@YN79<'RO0:8EP)UA.14#P,GYD'7EY/*NTJ!A%XA29?B1VQ
MXA^K6ET-N/HF$L:'0R6YUV_88N?\%YH63\;%(]4=L_J"O96#(8^>#5WP^22N
M2+1.FV$RWBP-G]#YU*$*L.D23"Z-LS9)8U3CPPWM`X/^@@\H)IX2$24-_?#8
MC)SHH%0K=,])15DQZ4%^-ZMX8Q=F9,RI*!M?^A33IH`1SY8#F@)^B(O$`P>2
M@@A$9F!DSXB);N?UG(V3*![%>*FRC##[^B##!P19X`-\`@\`*\UI`*YTMMS"
M%Q.V!7HK::T4>>S.%L0(3=,7K`K+-@5<^FKU!V[@S;]`U)-G;.Z6%`+X?9R5
M0\1L('B<*N&/*0V@B@./O%0I4ST!5)F-"RN\4T6MDI3?43_83YD]%#V6??7O
M5"9"\TQV$@A?48V!I2]6*M"LM4_',E7>E"F7M8P?^+J7(JQ_]FH0^1H&J"1Q
M'C@%6'JA4/&\P!+2"JYHA5NCKN?7"K=C%NMABN0]"`4KGB8IME0<H$&-&RQ.
MT7S`WWG<9UW<F$.@9ELOUJB@,!3M`/$!/X@SDVR&FJZO"K%@`4HF6GUIVC8:
M8=2PS=02BB0^:B$MGH;"2[A13[PC4]!8?0F0'YU'Y=??/\$_L4H:U,.X5:_D
M4:9YLGD:\HH'&DP.]67TJ&ZU<$E?A/!KU+N=()*#P"C,D">@/(7]N^EQB12H
MH43]._4#1H%7?6->I\.#-085PWP0^@>8X`-2#3^#)M7K]MB7H3`$<^_O-(@#
M_;$LC08HP609TC;DST:5%:J0'`E'5<9;M#^+N1$C+NV$8!JQ,L"U$@G^YZ-,
M0VP%"C8+H*-,VE6)8<@]TWT6/,\'Q+W'<6O<&&8>&:=A;H,F0&CELVWK6B82
MS9HOP)P-`MV\I&S/*YK=CKG8A-9UH_7>:G"C1[-E0BVFQ(2G5X1H$,R)(2J;
MXMV!`*7NRU#VIGF3?_8#]#[#T`9T8U]#W,"O0!ZT*X5&*PRKG=59P60#]*-N
M.(RC@P)&78TP&LHX#CJH.&4D<+R!5*+:A@SX,TH(QK:5$_FB9!="-'A+,P/8
MSWLZ5@5-G6@CV4TCWXR#KIWN?0RVQ7P(<&X,8Q&GCH>G,US'(9X?BK4]C"$^
M\/2^R&,_&+&'9BV.XU>:B\#39[.68%%,UU]?@*@%&3D@WN(I2$P$HJG!9R*N
MK;/UR_4ZE)<!691W"S852J66X-KHJR2(S7A_I7XO\QXRQ4/"O'">ZS-&&R?W
M?1Z=W(.*!4=$/;-;4+V!&MC&VC<//`A1@$Y`,D[N.$C2;8[+?4B*[;IK=F;*
ME'@(!'C2?Z?@=@D%(H3)(#["7CS`5Q+[&,7-1-U=>%RO"X@&XAW$!>7`%YVD
MU//]-;N)M.O\$/@I6#W[EV<4D_SUP`C@J*4TKERN;^!Y3!JAL8\,G0/<,OU'
M6,6B@^/JP*-`CU5[(M`Q;9(##(->#3P<_23__3[(KRM@BC!_@[8B0U6I[[_>
MY@[,LN%&=U>&@31N6Y\_"%@2@2#15@0]^U2FL2ZU0Y-F=+@NKGL4X4->U:FK
M\2`(4$8QEVX9,)%7`2:`3DEO`XD0/^+RKX(D&%,8:Y2G829L(,@5S";1\8TF
M$GX19C]WN9=(L%5Y9&NM5Q;%A"+J@4."@A!8`VJRI2B!QAJ.R4P?1M&<-%WP
M<2XFLUKXG'@!@>$GCA=!_'R"CBJ:W!@CV#@7O#A.L1J68XY(^RACJ:O,0N(X
M0931!6&;/R:X)L^#[K4/6D*'E;H^,I\9.#E!J!_`5%XPU!RU<;4QUTIX\D$8
M,;7'B)^KUZ=K=4JV1)D?;F(`D/PJ*6]4J)I'^`9,BOGR,<)7R\Z7CDH-/+6M
M]R1@2V?R!P/AHS>&EUOTE4Q[_3EN<_CIAS0^Z7$^_/$#?`3SD>)=$'LP/O@F
M\3TL^AM4!+_\]W\Q]M/_G)R\1TP]LZ^B!XZK0D?D$Q^(DQ/S@"^"'\T3Q0/X
M=RU9,-97T?WYR&O"_TZ/?KGY^/;S)W;[Z>U//TQ[+__L6YOQ^`"T`9+^#R;&
MW@,GWL%\RQ^WSYG'\"EX")^I).#DI-4^.6V9ST][,R?A<UZAG7TPXYS^RR<9
MR2%FCH'?)MGT'CRT*$:(!>:[*7SV"%#A!:"KXI^/3BZ.*NEJ-\W_BK69_85M
MDWAV],O9DA3>8G=A0+KUS,?)+#PI\WKV^`VL!=IPH<OT%V3GU3BM<WQE=P0#
M<UNM52C^G*W`%)(_CZ[01]0D"_/TXOQT`@&3XVZ1)F#;>6L2E3-HNNN#W67:
M`'6D4O(1%>4X8?JA>WCF3?[(@H2U@5D7E^.$58R[;<):0%AS(<)N3%(@QK2G
M=M'':,K^_L7\.=/9"_/KM'D]3E;UT-NE#!AVVIX0S1<H`Y]E$%A7!$WWVRQY
M[(&S.$YFZ6&0[)%'"Z.<V^1*P;3N?%Z_L_7C.WE94"*+]M5%&=&?M^_N?[/)
MLM&:T%(P,G_`L$@_]JH8XKAU]JK*EYL9>HW41U7$4*OE//Y*8PQO%XB:5F7"
M3(S.RXF-E5DM-O_*UY;`!<2#@R`,<4NM`:$/9F,Q=&!Q'U.I/D]X10.4M<7J
MLRK*7$NZS8.^1?-POP>1*5JX0W9C7`>L?XMWX[$;78;!/O+'.`WV(N&V7QL6
MGR/VOSQ*,2]U9JJL&NR3?."8:P;M$(&Q\S"@U=NU,'#:&6"PJD-<C&1O0C!+
M``:N=)#M!Q"BZE0#QSA_*&,(WW1,S@9"8?X$<ZKZ';T%8B-Z67S3A,ZBVX5Q
M,-L1(1;N'H,XSD8(^2,[CB1$>:W35Y6A^1_Z)7TT%UR;/,]@W\_H:C"#M/SO
M>KO@*<#R$-8^_5=!JM8"=L\:]<$P[0"P,?!6'`]FFDU`F+G`9$O[]54Q'?MJ
M5Q<0>/WR@/N0\-LO,&.*\!;6?HB'L.'-=Q:-S)B\1`CVJ$];JX$Y3@NA]Q7^
M%]8D$D;3:%AFR_<]%D`$"6:SAJGR^CS6V>(X1!<&<WMYDKA]_J\,1B.8T55-
MGR!V"PT\VZ>G_T:,9_F\T6*S+#\W@593")*1-74WZX7)BZAG=]:*QTI[Q+@Y
M+'KX+_\AB%&(*UB#.4Q1;(W9.>=4&JHK"2RIFG8STS7)RU3K]*"I'=5U>R%(
M6CR4F,A0XB^[98?CY$(W)N@S-ORS;YB!A%^E)XHR`)V_Q4-6L4[=:7U@9H^9
M0PDZ2]FM.VES_JA]\BM^S2ZOJ1F,K$XM(6W\LPA5?,W>Y]HQ:0F3"8@+Y:15
M*/QBD!G1N#"BM,._=AWSUE83&>97,MWL,W2#$*_;%0^XQV]N^F5&SM&":6^F
M?%1O!A#@0Y[0F5UCIHHBI4S\E!AP4P""=BLW3WHK)"<QP\YT<0AY`'A]0`GE
M`VD_YP'ZP2GNI$E>#,9#U!-&9<GNC^PX>,4Z2MLW(`CC5`4S95P?3$P,J_X-
M3P6X@0Z3Q!T730T*#,S-:):)]TI^B#^N0_5P(Y_M!GX*>@QH]U-3U&"'F>6F
M-"9TL_Z6_3!^Y.$5XX'N)Z93\1V1:'UCOFL*Z3;SY8?RY.ZL"FZ='F.[$K/J
M[Y_L;<,W<S(MWQW!]<-B#QZ$6),`\/--PD'D2NW9WC-MU"M'A^ZHIV0Z_/>1
M'OKX(:@D\&Q#!*(X%072?[R^>\V*N^3T6/G7M.G0]22V6MF4^Q:E$E5V#::7
M".TW:CW^^JA*2NY`FB,C$5:^K7*^DREJ_`CL5YR`-="U`ZAK_D^J;Z5]QY&K
MN+7CB]4S(\H!1Y]B/XTPXD80FDN37RW8D7_ZK4RQJM5V"/D$$C=!VKUXX@#!
M#YAZ_!,?8)A81I892==6#=0!;KUWM3^BA)D&[REA--9?TGZ]].!<[+`35=P8
M272?P+N*4UTP%ZA,#\4":]UQ@VLF.QIV@S*KE8MP`TI+70,\"^]U;B"K@I18
M5X$&J.#ZW#=K-+*P[WF<3)T(<@JM](,,TR@Q!U)`D!!\QF$;XPY,VIQH:5T9
M_Z=:%3_*<8B-+FV#W7.E-^/>8B[2[(LFDV^9353]A($$2#8$T@WV#N0+R#9_
M:Q@P3`,IPFBHQ$FBK!>,?EZ<3<Z\^GL:)J`C+8T?022-=6!?>"3"C)3Q28Q0
ML;2CLB[G8I>G^JHRDJO\:_V.$OCN-^#EAJ#?,\]]2:DO](>5E%&ASZU$A7$T
MY04/F4TMQ!BKS*.L6G[\3>R:E%D&!//8W\V_KMJMRW_'N:K(AR[]U5">._X-
M;3:P^-Y4`63>6?6KMH`!`[\GH;P@SG1=X3M(<-HRIPJ>LQK,^&$VG.B;\P=^
MFG_-A$U>?MS',+EA#3AV?4CX-XP^,O;#R,<M<&D&PC+4\/*SZO$H^$=_'L3\
MJ^BEH:&EP8[;V%-B(!]TF6>YMMF\6XXFBS6!1X]/7V'E2:#+4(KP;(3CN9.+
M^20DU8PYU*7Z(I\XF(AEJL(7@;@V0=R4ENB#4.!%P*Q&PMS9D>JTJ-=(3KNU
MHN146QD#HRENL#$-5?[KN+C9M:GV2F?YL;,5]^+);'<"S\5W9C8=>_YICO86
MIP_2**OM%D]X@`8U&)-#"`41LP9;`"U=%6T@'%=XFZ#O4F$3NH"E(.IR4"E.
MI`[<08,#VR2ZZ.:%[;IU\G@#@"]H7<;?VAJE:W'#,A-N"X!Y:`]*8-RDCPYE
MZ51M:93.P6(T$@FEPY',D^^BNXQ^N8[DV`T\B[6E#(L7S6EF=`>,9Y(EDC.]
M'@=/H*IU8A+^J@^<!![S5=HS9XFCJ8=+LDC;;(9:&ZB3-E'F)63#@7,58@4I
M1E%XQB37--7?TSHL%N(;VB$=N7Z0TJ1-W^&#-SX>9L*J0/W9XZ,/[VZ.7IG=
MF0?C*=B*S6S\!^"834;E_H,$,XB'.<T&TF.V=?,MPB)+X.U-IX/%P]IKQ-4W
MGS;G90P/CX]N/KV[B8]>.:$)':_,[@8JKL2BV7'10.9=0(]=(+M9ID/VP+-I
MIWOQP-F7/E<#\#!3?=8^9G_<W=A`'B-T.Q(X5;`V.8K*V(AU"?$X-G)H?!^S
M.5DP<:3P/^"?#^33TH[H9?-?_V;_>?_U_O;MS<>LN0Z6])SDQ3-&_B[/1I6E
MKE;N!,@IL.Y]X%4X@']"D)XBBZ><OW\*NJ%\PH*>1K9+,4"_$!BFA!\8W;%_
MS&CHTQF`F2@V<:3U3)_9&_Z,>\5>WQ2V&R"QFU^K6R7$]@!P5^M@A%/#`#!7
M9[X]6&<4+>KI!S-R!J0@B@!UB<Z0:'VS?]Q\S3#=E.WBV8FBH@0U:>+I;+*&
MY5(UIO*YD0<+$*DJ/TO,@6L:*'V4'.(?W/F#]1L=?>J.!":UIGTMI];DJ</8
M%"3$:0>W\LPY/!,^ZE5=0E],^S(P(WZ.$X$R."B)68:"!KMY$*%9S<TO8&6>
M.@V2DN+-^*S79RH_];F0DU)PFCD1FG]ZJPJ3+UGA!_(S$Q4<:.^@CP&2"<W/
M=9OVBUG9=$S"`@<>==U&!<>G<A7P&(N_4Q.OV3U!7!W[K=@<E\!/3'!X>R"R
MZB\77Q`[LT%I>K;@?F3UT=U[G15&I,4P=3\-L\,O``GV0724V>Z_T`R^*O86
M_"`>I@GFFY-'=&VG@Q)(JL3??*J!XZ8/V,D'(P6Q2)+0>"<V.A8/)C+&>2Q2
M2U2,9*T&]]"UA/GW;!4!%L;ZV:DE@2V'/)'E`6&0#NBF%R=@EJ2;*A-!C'Y"
M5V3%1>E%IL%*'D)FEDR!4N:=F6_;3U0O*\ZHS^W&3U?JVPL`;KCQW-?^U[/)
M(.6%87A$#4_T6`!DG93Z8A99('RX2279'9Y^'W1@CB:]?%9MLJWG.-#];FUP
M$J;Z/N;2Z-8W$-;UQ^>J^3R3`[C@&MP38FD"#!-\`="YSK046+\R6+>GT+/>
M_?G6CQ6%:K4=1":S"AZ;^4Q?`]BZRCQSEM&VX841V+PHZ]MD"@DL6;R(8^S>
MNDGWZ=72:6'MR^CY.*FWIWYUF@++()7IB^\K!,,^,W6]=:$1ZXK2Z<8A#VP#
M$#["U4)76H['?2-B>@B[.69B(GO@&1=MZI;?YXA]]A*)`M"Z-G>&-&RW#VT9
M4KNCE_EB7?Z`IXCU1CGS;-NB;F#VA"=`:DHJM3ZR!9=&#Q1;E(MPZC,F(AZ,
MM!;$:HUA@S/X>P93"*@%5EH:O6]X*#*+4;:,V`V!XYG4C*8/PM>%,V\#Y:&]
M-&8X'U+OW9J."4/4"-A;H?J8IM%-NF=2IC9ML:<F!(5!MV]!5T?+D`E3];%8
M?737K('>,8GS*C2D).O"4/G=W^#=!SR>ITL&@J[AD+:GZ'2F'EY;BVO:YP_%
MWI'U.<PG\8"*]D45CF1KT+CE:)!I==O<FQL-Q7U?YX$SI*#RT`S6"D,7).&Y
MW$)_:>6.N1EA6E^@MMC?0#E3`\#7PJ:@0<$N)L;B:ZL0/N-DC5FPK+!ARK2S
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M.TH&GN`D5>^9B6<QTUKG=H`_%GTOXQ0]&31._^\9O$CV&__V3;+_AT4,H%A>
M-]C'Q']MCD?$>19%1\69.C.9G;ZM4#950T7:3,>V06RJU5`SC2:"),;2GO4@
M9E5"W6(C!]-#HNP0Z_8;VM&(@Z<3W:&##74S!`2(;EP1VUJ'DH>F5Y[W\GJQ
M`:BGV-`YL9'!3)%39'HE\UP/[@-81@LE,H-8]+@P$=?_IB`;P/C6],Y8U@(4
M4JF97RQSQLA`YXU&,WIZU36X&L;%,FMO<H"M\QGA7>G%\814HYP_R8N+#6EY
MI9_]^:U4P]>(M$V7C12^\'Q9I-L(E1H?RA"K+>Q/TS+4W/H,F1:SA>/(!]!A
MQJOX`$K/Y#F*!H0^&/IG':7GF<[L<(IACU:56`UUVLQ:W)C6*+961?OT:63/
MM\"'BYH^[0,)KE"!%,D56VQJ'-?,31I('SLWX1].FU90P<E^U@$S$)`15YU1
M$QY/XT*!*R#<F!-#:8[@!OX-NR+D\4P:E92147%E/TQC<:2N)Z?.MHM!?F+K
M@L@&*)@<VCB23"XM+T,M$FJX3O^;@N/7OLS"K:SR%/14,I21/75B]/&C>1^6
M9F0$N[(7MI?Z\4B59UY8?0?CR'^,YO9A!!5TD*_8Y*?ZK-V="7PMKDIQC?6(
ML]BFM")9DB+KI"1&P%`*;8QM&4DLF<PBYNQ-%Z0\NQ1*&!8<ABBWAS;;H4<R
MCK983WBS.]-?"F^TBHD"7+P[C%OCLEA8JUJMW._PD-F&(H^]K07;M1.M=\Q6
M]Z%+,8^Y>_;22,$;KA3[R#O8:UDJ7>\^94N][#^7'>=2V+SW\C,ET1\&W\2$
MD2R4('#O092=GI%(PTJ'7<&LQB?WBHP5T@Z*J0HR:6E8%?T57%V]A5D>5+_S
MO:X/RL-F.SZ:KD+C-?+:7WU`8\6=_9TMSSQ>8<466I8IG.UKL6/3Q[:TOF.'
M:5Z-9`Q.C?ALSS,KP##NERWIA6GO*["[48O[7_<5?I%1/45#0!S$T];##&5F
M\7T\GDBV)L8&`38#BQ7H,'>S+6(JHR,TWW;>-C6)3YJ5KQ"#63F[JJW)KFE$
M+W(W=TK@F2=OQ_*(Z'KI=4(_PE>@Q;/:$>/-E#/:^1Y"4:NM#X.;(H4@H:JR
M.:K*$,C]U<UB$)EESX,UO4/GIF7T^?/&5>_5V55[HAC"PT8W>+B@PI>>JB$*
MK35F$1<PANQXS,B^&NT%^BCUZJFL$T#&^+&4@^G,O_*^Y@[7`#>6[+F;ZB1^
M-R]]*&_PQ0UK@A)L$:!UXK.^VQ77I`3Y]NF4TA6%K-71UO@*EH/G,:?#\+M4
MW)7G]$Q\:5JX@!3"RNN<G*_;N8R$[CJ%7Y6[JXXUU^8+R*(5Q56V,[":G1^D
M<;(VXXX;EO.8]M@)TSZ:WON=/\_**V99X=PZ5J<ARA[:\?Y)\JOQW,D,#R5+
MHC^+9#SQ4\ZC3]N7U,BR:9=X+.]2%.-/IE_B4OXEGI:`<33YLB/U/#/[@BK%
MV=0+>9/FC$+7MAR+@R>$(NKCK'ZG*'<T5J4HZ#(&8H&T_OC>!'[1Y%4;NG51
M9A9I-WK-BUSM_&>6OM4N*JM&][2ZTA;'&%<HLM:=//]IGO]'S)19?\"4#H^G
MS2@:V'@T8-F]?L^]<,]S?VQN%SW;M<NR'*4`'0?+JM[!9J80;C^SL_,38*]U
M0N=VIZ?O8AZ/11BOIFUC;MK''JE=Z%BN%$N6%(4SR!W5L$74.@F<G6&Q50>F
MCE0_!O+6NFIJEF6USU@=E;'/N._&;<^JQ@T7T;J]'!>LPR$=W0D<=TEUZ?DR
M/BE619=*,T?W<*TJPB_KS=J<24<EWAU5LHQ\W<5]W2!ZH7[$L2W&LBM;)\^F
ME,:PU2?7!HMV%U\G,H^QGUH7/1K=4*6;]_IX53IC/F?U7.TW`>^"01!RE9_U
M*-D9N8<[:HUR34>57[;XOB56GJ!UR'T,6_DU96-RM/)O[QR-,NM><#1VY&?D
M6U6Z1:,I(S#DHLUCQQT!O/"-W2W%HV@QP3>R\YM:;I/UM"Z389.XXU98(8.Z
M(LANN>0S/)6RQ80O]K"9G3W,;4@\'O-[7N$)BL!6EFG7(HZ[J6XMI\_`V1+/
MS*%XP;NIJ*\:K8YJ9*>W;&HR/T>E]]DQ*#DI@I3<X0'Z5LI5;DQ%+'J:ZE7!
M):E\W=2X\UQ`=E8T@B_J]M%VW]G+CNV8@RBV-ZV62V&NH+!M1?`PRO-(&WC=
MYU:9&VYEFL`KYGR3[:Q==&=/P'K;DY+V`-)`9LW.=/_=#.;Y_NOTXYZ?RT?Y
MVN4NU68F.53[PGZE87B4Q5TCQ:GVNT#'T!QW*#6US"`&*,^+Y,9J],P!1+V3
M8_Q)S>-J]NNK7$HO9.T_RP5]DY[]E#NH[T8#$'/7;WYT%7_UDFS;K0//4Z:U
M5%;7#V)L*9H2(+Q4*[AON6H'"P6===\I36W.TSR(J"(]/6>M0P>O)4CP[V9/
MS7:<O1Q)?LY1]<"^@*("=3?LL]O_,`]OG^Z.G"G.2U_,_1X;:+AS__7F/S?W
M-Y]V*$#8E-RV5F^^;C;/_H47-CQ(O,.T6G5FN^GC^3B38];G56TP%>)=\'FC
MWL]*=RA](^4WS=#]X]F/9F_$GOC[)./7[+QQ#N;S].KTW_#/B]-6HWUUB?^\
M.KMN7%ZW]3^OKAO-\[9I-'G1P'K^YD5[@9YD^(OOX1-C9Y-&NLZT3LN=R8KV
M$*-;U^7H9%8'@HI3*-G&P8P=HJQ]2-%VY+1I8W9[EEP)W:+"'&X:C5YFQ@79
MM.8]Y[Y0O8)Q]D<.T[9VE5.=NWP`5%?Y,)!I<KE"`+]5H1H]:+)8(<%89`-6
MVK2Q!;M@[,#EK-UI<Y2C7%&P9$'!BCY:H6(W[J(Y8&*J?#1RRYQSRP3>^=2?
MZ9#9R$:?7.8O9E_17]/UV<:JV+?&W3=C*JY'O#?[G=$2U:I^EG=X79NY">,8
MM/G=J\D.:'E,G)VW9K_K[INF8\EO@H>H4_../AOQ\W8>)TTUE47^[ZXR=5K*
MD>/&=+5KEW/6ND;FTG.A\AB]?GR;C."/Q[GP2;YF[4;K^KS1O#Y[A=Q]L3)`
M=](J_#I;:GBQ:*VHM*^>CU;VY!UG,H_M7BJ8KVR,^F;&5+7/K/-B?"B;#2Z&
MQ82P'5>99OKHQDU*W:2PY;NXNK$4L`/T>XS7-`OD2M!=S>G*Z<Z<+G/EW&9W
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M\^*%)G.D8=>^^:XSNL?:>RM5U(PW-G83S&YX%;IP`6&QDY-VT_/B\4M1Z];6
M8=WROV4TL>W`:<\]K\K>@ODMAA-5)B.N@5-;&M2+:E8OJG66GYA*H[,]KCYQ
M)=+9BMLV*['O2FF+*PNR1.A9"C*7BBS7$E>>NAE8CM><;#*PG+_D9&Y??F0;
MI-PA>4:=RG@IN2V]6*60W"UO_)5&MW&<ZS.K6B707HV==1#%T5%TO<P%-N73
M4"ZOY.R)SE-+M?[H&]&_\>#;%31MTTG10;D+_6]V4*]VB.N]AW$F!92Z="Y<
M[Y&&HAJYU:KJZ6*:_Y<*@*=T=-S3@PL+NRLS+PC)6U*4PSK4G-W@(2]N*X=P
M-KC+U&A]]D5_7/-Y!;?#J[SO;MOY<GY->A9(F/VW_?`_)[;>G+7[,QWGK1CY
ML:Y/M+/FFGK<X,[:[)Y![KKQM+OFU.[:2W%"8?(H2'`J2*AV^XT74'4Q[LNN
M_H.8T=EH-$>/*?I6ZZ)Q=7%:=%##8&`]E=_@KNR@DJ5<X-Y_]I7T^J%4>+\N
M$(17``X5F#GPM5+=7Y#=YWL+I1M.1ELJ+GF+(*Z-O9+;='@Q?83ZIE^-4(.B
M.SA\J718HFR#1SH6YH@XGV'KL^L"_?'=A'SW`VA!B-B#O$`E?^#P((BK"+OY
M/>^C?O>4D[>(L.KN/-RZ_MI?,8CLV.D@O(M&1%[>@D>#US;=]LN)5X<N![D=
MV>OH9SV(1@;+[E++E&AQB$4?2PTB#^'X6!SJS@\8^/:L7/69D(F&E?GQ:7U0
M(?_>^`5N5?/X'=Z0FO3R?>N5$%S+8:V-*8-EBS?6;(&-**..-5*77Z<S34S_
MT(&LJ9GU\*KO`?;Y\;`D8/P$EPB-#489*<ONK.-?V$W3M"0RK3A!9.UM/_D)
MH^)2=UM,A6?T\TZ2(:JD4#R`F5_+):"[!$!E4BA3]SAKY"PXTLI<8#.ZB8\J
MH90%:I3N=;7ED9/WP*+EF-ZRZ-X42MOE&%F'`:HAI?^#X^I.O_J#V6_6T]C7
MO=58[(K%/#\T8I-*UY'//EB'62)SMZ]E?B<L"@RT*""[-?.G!U/!8*!;]@E]
M4M&1TW:[\;GJ<*"?CL7-J(M[!,=P^5V,D6NOEVC76G7;N1:9F<5R/KC,&9*T
M+SEF53-Y7UI>YF3@BNU3=],&>8Z^`-3J?G4V[^CB*[N(>W'UU>>BU;.Y!1K;
M4J[K/JQ]:+#;WGF#W:R)?P$;C4G=<;>BV6Z^:96=(K(W1&8[$+RB77W%MH/E
M4VE_H5$QD4`?=HZPSRA>C.C!F'GPZTUIRK#R9D@Y2-KNQLCN&^.7.YEFU]U/
M[YDU8^M"]ZA=0\^L`[V+P"F_FDZ5S/*>05$F8I4R(`WM/V&N?:[\A'T,!AH(
MQWW!_;_!-":Z4W5FVUXMY2YOK"1HYUU@JEMJYMP<\V(GMT@NSEJ-J^9Y:7M@
MPKTM_!$\G;/X9L$T;WLR?3'6N1/\@_.7YS?FY97RUK`R.@]2OM!`<R!K+(_Z
M'-FR=ZL_W@YU)`B]:FS.87V;Y][#YT8AM:4+1/-51=]#X/*`A"O!UY-HW6G#
M)=LL;PB^DJZBG]UN>X8;G_67+>%XT8MN\W;VK:*=O;1[73#2`%R)!]-.?]2?
MGZOE+/R$B^?/V7L6UG9B>Z@DR3=I#Z,%0^?.RM*6O%'#.(.O2E@_C&LU9L<1
MIKW<G'55Y8!B_.J`S083.U47.I8HH69F.#$]G;]/D<3.^^&Y'4A0Q'"OSQ6G
M6<0P,UBP5XOH]'E4V51W],+7T:C@;K,]<3.T%]OP+_5.+:H]-MES=G&ZG.OI
MVM"E-``>&!_6!PQ'8C0DWJ/IF;MY<%N[K/2F=6ZU-^_H/&--^K9.W3;>JZZK
M4W'*J*OIP5H'HPBRZW)%!&OIE?M/9&'31*BIM))Y"PX\9\<3T#(Y>OAK*-CQ
M?T!0!_*I]%?:5%_S,G[.;D)IZ1O/FE<-=O<,*]8#$?)B]L?=C;'J#;S2+?"4
MC%/5TYL;OGC`C*!G1*B1=XWQ(+3`"A@0086A9,@?7SIYE5^4)E/,`47%WW'S
M'>C]/ZF^Y8@J"6Z>Z(K33AR`&53/V9;<9&^;2HU1FBN/8Z',Q7*@#X-$NREQ
MVNWJG&8(097`RL0X#;6-TW8(,=W3B1J8)H1M/Z11EP<JVP.R*B66::^/3@H$
MG:CYG_-/>"&'1?%M\(67ZL`/W[6:S9>I1;$;)=E,'&2,]XR5L=3IB^Z2X"37
MC!"P003-'P*IIK<IP73):8:),L_-0@=Z\R1^%,HV+P`C#C8-YY,MM9^MXO0K
M"V\C_0$]A"D)SE<R*#(BHU]&-!7ZI<P3Q%%N+[J8+=07',X#O4]234+O7CQQ
MK:T^P%\A/(1'7EX7S1.17;TX&`)'HBDM<6_`0&?SW'3Q1WF!#"K-W8FQ[1TT
MI9%BKA\,%K*;&(=8#P/?$)')^'-@9]0-?+N9>B<2<$0&F2/ST=2>LYN>$N:W
MB01V8;K7;@?<86[ZN7A@=J$J++Y]+J]1U3FL(?AEWYVV<<5`E/JZ4A(7^%&J
MT'_$4F>%-XC$)DZ'%\H+9X`#<WD`Q27`,P$IQUK563V-[_NY%V7[`8&O`1Q/
MNR#^J;VT<Q0=?I:'+RKQIPY=3-->2J_9JK<SLYK-DC?;$<DC5G\6+GKIRPW;
M1B2_`%ZS,5?2MGX[DYYBU$;F$ST@^[BY1#,VHM9-=48,Q'R8)L*XT.8L`VW1
M+6F+QS8&4/7^+\<G?W_-/@4BC`6LR.^OW[W.S6V5OAO)6]O#'CHT+V*^BM9O
M*VO)=P!,7BTH[U1.O_89M=TRT0\8+HP6*PX$G5\USB_;15AS]#N:WJY$[^,V
M2A277HHWA7\$Y7*$PW8$#IFQ(K\QM_#RE\V7W7CJ^4YVW2A47G82[*NXN__\
M=?M)OS4?<`A*2P\1Q0S-7'$;(8B,\2!MJ[;B=`0Z'YC7&N(=3C*-=?E]Z<R4
M_X"'(GSVN_"U__MY:/3J-->RW'I`=THTSE)60F:V@IK7TW-0YGG;_4E[UF4?
MR^R2^P)^4B9#\E?J]XQQ[=LY&@:<!-&)\<!12A^`O;Y6!+JL/Y.5Z2FGD>8`
M8(&,,M`[RB#S9K_(N`;5;(CP,FJ(^L!`I#H94;['6B].F&U9A-BT;63#AE*\
MF[8X>4EC.SN4]S[$;**^&P35+*A[;L_M8($`TV6PF/4<=<Z_CT=<]^EA6,D(
M?16QP//`V3G%.2S0>XZIL"D&Z`YL$TRM80*?LBW0<H$$`]UZ?GD=;\0B'DGM
MSWHA-E[U^I$,9>^9'5?TD6Q?7S7:%VT]A_/&6?NZ<776KMY]OR_[_\SZW;EH
MKL$F_2.'B1L6*<\'`EL:Y2W$ACW<4FI3;-9C/'4^E8-%H&_#JO%@$U.V)F<]
M4Z/J18>/1A#V/!B%`GXKWLRGJX]X$$WB&<\``)YTO.R++IJ">.+[+Y/>+S9+
M0!<.3&7'E-`YMJZV;CF.A1C8<$DD6"B@(R7PL8>EG=Z"5EC?OT''Z_-#(%KV
MXN1YR)REX.UI_=:,0[[EF78$Q#4/(BYE4$`K)$K";$88"!(!;-!QF/Z]GQWY
M?0AZ4FGCNY0QR:N)3#Z%3,9F=@6G9M\P):#/;MKT@-[M><#?FU($HPU`-YO`
M&K-=L(CX3A#KS;4TR<10*O@3&B9<VEAOMW52>`B"SW(L6Q[%5"-@4"%SC10&
MW%9"Z#6>#):6`[7QHD8Q'9?0:V&=[>^4HO3\L*4-S_#P+"%N%N+^U!ZBV0[$
MY&N>%N2X?X1K"'S5.=0(5U]$'D(/I-TZD>#0@\>>=[.RZCX!XP1?X-8W&%UE
MO0L%L2;63A80TD4B.M>M4SU%HX"BQC+33J::C\EH3-V,]G@%@`.Q*`LR#K):
MH](DY5"8G;%J[?VQ0-7HW+DN)<IK@FPFK,-C8RSC/#N7FS.%!T2\(#;?(CS.
MJP'Q=&YGA-DV*5:2>&/P2GZH,<A%HQ.]\9H?],F&-IU_4U4V7SH@TAH',]U*
MMW0<S9#CID2VZZOKQUY*7V9O&JR9"@".N[4^Q'78<R.-/0&A+CH6F#8M$3.I
M8V>X&E^F/)RQ,-_*J-KFL8&!Y>V8M=!<,*7%WR+Y&(TY1UG`#^R*-;M@20GB
M\T,<_;(36!'=W2OI*]S+`K@.M5NL?X]YD3$?(!Q@"R_;-<SB$`!FS3"XG"D/
M4:%F)EU[A$JEPUQB"IS`:G\CI?3"BMT:"8DD!"QAI<^4C(4DV=8-<!ZK84TD
MKEGO@T2%<FBV;Y1N.#&P-Q[HC0.LQLT]/#27"F,/$,P!&.HXP>(H'$;)9UQD
MW)4QKUNY'!T@MUP)2X=HR6PT9F7="C>PY5MQ@-J6R69^P%3BP0I+12?QUPZV
M\2$_OK^_?__UY.[+S=O;3[_^R*ZMF+T;8;SIDV$V-3Z*/@S&WB@=$<1C>:;C
M]RFJBU?L(T2R>1)59SS]@:Z&*FJ*WD<]".VK\Y<W62X4YM`8]\1XW,^449\A
M@,&GUUC+,Z[?738O=0$UEI"9/EFFW8<&;E^$9I,=?@FA>D^[=!X83>EK3]#3
MX3>^O]ADAR"ZJ>UUP]E;/>!+.Z.?0.QL$4W[]/3?F.:5@6<WH4M&M'1(VFRZ
M-TQ9EFGI5CRJ1##HH`KQV=C0#9MX3F1BCB!\=XY#=(7`'=1`[[F,4V.E]G^Q
M#I'=%"LH5;PX>XZ1Y2,HL&7HA7K`;D$\SBLT]?*=3%L^G3T87[7IO7+Y(%M5
M/>4@'CE/[/\%(VG5XXLLT+,Q0%?O)GM@%F/CUREAZ\7UGJZ.9T;!O2AK7F^\
MAN`6`Q3?W$J1G9_@D79*?5W'K00H;4TYNG.)Y3)`8LZ)5"QNN2V8W@^WIS?T
MA[1[9[Y4-&*NQ)DO$`!8]1CW1]N\Z;27'\06[T$Y/IJ^,Y_#0'O=J4UF=82E
M3/BE8%%_SX1U1?5J1I#=NW^>3GH>D=KB!?U1DTG1+C0O*ER*;(B9VQ!7R<?S
MYRSO35%2@?CV?'OU/_V0QB<]SH<_PNN#0&,\OHG\M^6X\UT0>R$6B(E[\92\
M03/VRW__%V,__<_)R6>DM\$BD9R<F%]F`][D0A-_DA%JX]M$#.)[^57`NGN@
M^C^)Y#;RY$!\E#'\_BT\\L44)/AOGO^`1;N-/IM(.>K=X!DZ+>'ZBRR-@N2K
MZ/Y\E#:;S2,=Y(*#%/]\=')QI'T/H%3_W8._-T^/?FDW]?^*"6^4OCWCS]G1
M+Z>[X<\[T17*N*LX$DOXDXC'694]9+YVSY_>FW#YC8A$-TB6`$-K?+8O?&*7
M],+B7%XL2^^OZ',?8Y'C*Z.C,+<&CJ1M1N<]5V+S@WGHK7WF'F*%V)3]XWBX
MW&]TD3=\=W'FGTR(X@*?<W9BL$HG%E4KSNSKE+!G?"[9<Z"NWQ5/61PLOBRM
MB^MQZF=^8:?T`K=;9Q-",1^]ORI@N]T6&J=1_^V+_M,2'#QM3["P-."&"4"6
MM$[G(@!M/>:+^USA[KWY+Z;=L$$H>AGC5)D7[A*P_'?ZX<_%LR-DMLID-BNH
M;&M+TSYM-\_.1YV/:>.[0'4+3,;U]?EY\_+T=$&J[W5`I8GMRQ"<[/A['94F
MS^/DZH'L,^_U$[?9=M@7B'1`9]PDB0HZJ=X-OI=HE8%0)7566'O>V*MK,=3`
M>ER<74Q(TGIHV1<FP/*>7S?/-\R$7Z7T<8-I0N3M[Q=?N<OFA,')!MO45X%5
M%U=7+W[U-GH0UGD<_W#I3[?1.]%)0%O_KD][(A<-G^_R>!YC$9,Y!-N)G+_1
M86%%2%*IDI=-(IN""_O6[(`ZT0%U!`&UT@$U\T08QD..IZ:,-H&?A]@EV?[\
M&/A)_^<C<!;^57Q/Z:UG3/#E19?X:S^CX<_;=_>_F>Q@G@K4<>-1*>4X?WK@
MS_<FL]@!="^3,3@^?U450L^..1._F%=%HO2%Q&AS=EX4@Y6@^[Q`:G15'I2`
M/.^\?TA4\4^$V+HV/1:;;>5K2X``//`!2#UN+C?T(:=A@JTGC*+';I'\U21G
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M($^&_6M_<+EQDK];G%++S2FD7F^,U*L-";M#N"#\UAB_[7;-`;Q@<F=*5K">
M9NT&KT+`C9Z3KE0G>":_[-^O*4$XE9FN*I#%`O8=J9C-3FI7VNC\]&RY+,*R
MJ6CW%HIDB&1HI5F=G5\>I@S-&Z)6F.^=U0XXC_D]%%,7A'#CR2"'V+Y7@"`,
M$X97#!'/7MK_7V^`V+[<8=[3'@RHVOY9/3R<Q<B]<FQA(LR7*0323OBU<Z:?
M%IK*SB+"LSD35!7@VF-?EH2&A&:%$/"RHC*C_D)#`2`YS^0\4P!(&-X]S7N%
M8;<#P!T6_GW$%N(3@9_FZ56[U?XWW_`&(CF[Y.R^-)>+);<,]]O7)9DAF5E^
M+I>GAR@S%!^2;TV^-<6'A.'=T[Q7&-Y87Y@EFN%OL;%^;=NM)!/'.7;0=66=
M8U$'%^K@\G)]XHQ3Q1>;SU/MK)F+T06K)Z/JTNZ"`%]3P$]8.L+\@J'_SBV1
M^Z)W4/V2/HG)JWY?E*&]%Q;"H6LX?!^;2S%]0B.A<>=H)*U(.'0!AX>L%<FA
M)9%9@BM_1$K`M_\Y2)DA.+H&QP\\4`1$`N+.@4AZD>#H$!P/5"^NI5?3SEU>
MVERIHTCBA9`Q.\8[(45<<6_.H>ZL$.!K"OC_\#`5A'/"><UQ3HJ=`']0@"?%
M?EB9=&JPOP\-]FF%:85IA6F%:85=7N%-=8HX;^]YIPC3*7#R8,WJ?B:=9]_,
MG.ITGOWX?+E(UM7S[!5I"!(5$I5US&7."XOV15*H6PJ)S,:M2\VZ:9)U(5'9
MT%SFO4YL7T1E(XV%RL&>*^ED5UA)35F<8[.C0D<8)@P3AEU@KM,D$X8)PX1A
M5]CL*(;G;?"6_7/]O=:V=0UP5;.UB;YI#3:[L3=U2UMOMS2*$]=I=8#+==CG
MW@-.+T+9S@Z*O0"+^M1U_JIDO,1^^W:`N?/EWRMB":N$U7TAMO98W6:;&8<A
M<*B;'"1@F^;0S4"J9$N]%_83`GM%;.WQNM5F(?N)@;TBE@!+@-TK8FL/V"WU
MOW%X]=?2"L<I7WPIRAU<F57.E1^,`+^5\1(]@M=UQ'POT$."<`B"H+N+D"20
M)!R\))@&.R0*)`H'+PH[[L#C,'SFW62HY1GZN[Y4"0,H#LK%5K/KK*A8AXIU
M"`.$`<(`88`P0!APRI?:5E%[Y9[7Z[O7K"<?A(K0C=)7@?.>B+SGY;H3[=G!
M=P=.O,QYKMV%@RZM]IQM4?96&1""ZXW@DQ,"L"MT$H`)P`3@0P-P_7V(PPXH
M?I<JZ4$$<=+AWC?A4Q3A6%;!*550<TU`2#X0))-7Y@Z=A&1",B'9'9+)NZ`X
M8P,\NA-1()4)+R#,Z/#H&PLECV+63:-%#O"0-C@$;7#5K+DV("0?"));EX1D
M5^@D)%.L04AVA^1=(?FZ[CKYL&.-MU(-I>*)8+[H)+2E08I@ZL4>%Q<UUP0$
MY0.!,GEG[M!)2%Z%YN/6G$TW'(3R2Y>0$8(/`<'MBSEO;G40P11@O,RC]W^G
M04(G+D@#3*7YE/8OG*&3D+S2_@4!V14Z"<@4(!.2W2%Y9\Y%W77R@FU"VS.N
M\*Y9Y/$YZ0M5[J.S0.2Q!/=<51PO=>%RX@;TS4[*<7^P`F5[?!4Z20])SU:=
M4!(?$A^')T7B0^)#XK-WXG.0OMNAWO!&F1OW,C<'TZ6/,$P8)@R[P%RG228,
M$X8)PZZPV5$,K^?2N,WM![4O=[<?="\3'K*X\HJ%29XN=14')1CV;U*[TDGG
M\YYVWNFE+UM-T9$,[>FD=I:DF[/A)HD0B9#CDW+^!-'^R-!+!XM(=$ATUN+!
MG9[5371HF\CAG(/3)%-JA]*3A&%7V$P8)@P3A@G#A&'"\`H._.8V@IJ[VP?Z
M**->3>_8)O%WB\V.BC]AF#!,&':!N4Z33!@F#!.&76&SHQC>?2A!=\P[C%JG
M2=[9QF'=[XDE)!\(DJE1E#MT$I*IDS(A>/<D[\RKH)M:ZAQJT.WSI`GFU00U
M5P0$Y`,!,H47[M!)2"8D$Y+=(9F<B^U&&5/.<AQ00^55KG)9@GNNZ@TZ<;6[
MRZ+FFTR]FO*1])#T4$=8$A\2'Q(?$A\2GST5GX/TW>BD/"5N7$G<'$Q)*F&8
M,$P8=H&Y3I-,&"8,$X9=8;.C&*:&RB\U5`ZKCM-/LI3Z*5-^8:,JZ6+.C>FZ
M->,C$2(1VG&&FT3(K5F0"+E_C&A_9(C:*9/H;,6!HV[*M$=$>1W*ZU!NDC#L
M%)L)PX1APC!AF#!,&%[`@9\2KYQM]\30[G>(^`,/0MX)Q4E7JI.8AV*]6T6S
M&+I7>0:8"/-E"IQR(LWPW0:FLKN6:TO6GY[M=?TI"0T)S?)S6?9Z39(9=^9`
M,K/E#:":V9DE=W](5$A47O3)K@_2OM!^#^5H*$=#>4;"\.YI)@P3A@G#A&'"
ML(ML=A3#)0?^AP3W-?*?2CL7,S9LQB_"S&?34>R'!<=RI%W<O6;F)V#FUV+S
MIR]8+*)`*M,R3OBLPZ-O+)0\BEDWC7P6Q(RSH9)=$<>!C'@8/C-XG??@6?.`
MWB<*HA[\R[XXX+Y@G6<]5LP2R4*N>H)Y4@VEX@G\32HE'X6*V6-?QH+Q.!8)
M?$@)-@R%CV/S&)X/0WA:\?#UY%J/\KZ>RW.3L'?"$X..4.RTU6#M9O.Z\<)>
M'0.V(D-9%[@G'U^X-75+(K#46%4,UK*<?64QY<$\$8;QD'L`U9^/FN;G(??]
M[.=,=36;A?*:%?V[%O'OVF:,FP807V`W_**]<]*6-6>[IGOI%?[SO=%4'1GZ
MNU[TC=U`[8&^$VJ+7/E5R7B)8H@-PFY7Z^P^A81$0J(;%-8;B>_!]Q^`E^X?
M(!KGW";:7T>11&837+D92)4$_QRDR!`:74/C'Y$2\&V"(\&1X.C<8KM/8;WA
M^($'Z@"!N):>:COW>S=$[=8D;5:E8*DWQ"2Z:BV2;V6<+"Z2ZVI)X2Y,".:U
M@OFO/(C6U:21<.X0_83S$?9]E'&\CGOJ".BNT4]`'V'??WB8"L+Y@LGSRC*0
MC8%BDR?M[_I2)1-MF&?7YU#!!Q5\N$,.K3"M,*TPK?!!K_`R?DM]+AC_X_7=
M:]:3#T)%Z+XP'OF,]T3D+7GI^)Z=/W?@W,F<Q\M=.&[2:E]O2`,XA`Q"<(T1
M/.]U"P1@`K"3`#YN[2V`7VIK0[BM,6Y;[3D;SS@(7(HC7N;1[U(E/0@<3CK<
M^R;\4O"@3Y52!.$HR;O2!Y=S7AVWM^J`D'PH2"8@NT(G`9EB8T*R.R3O"LGS
M-A[?6R13K%$=:U"8X2C).[O@L.:*@(!\($`FY\P=.@G)A&1"LCLDDW-!4<;Z
M>70WLX\F11J.DKRS#<[3_=V9)[OF),F[@G+[E)#L"IV$9(HU",GND+PS]^+\
MK.90/NQHXVW>2]\7G82V-$@33*/YC+PS9^@D))-W1DAVAV1",B&9D$S>!849
M4WCT_N\T2.AH-RF`Z<E?.N+M#)V$9'+*",GND$Q()B03DLF[6"*\L'3,UP*V
MIL''YZ0O5+E7Y@+!QU+\<U5YO-1(=YYNL'L^J=WMH\XWFW5UZ75OG4B$2(2V
MXHV2")$(.3XI$B$2(1*AO12A0W7DYMV_JH@:-T;O@O<5N\)*RN8XQV9'A8XP
M3!@F#+O`7*=))@P3A@G#KK#940R[OD/4OMS=#M&]3'C(XLJ+U29Y2IM%E&/8
M;#'LO$W+ZY9D(!DB&5K3K$Z;)$(D0B1"*\SJN/52@G7O9.BENV!(=$ATUN+!
MG<_9GG]_1(>VB1S..3A-,J5V*#U)&':%S81APC!AF#!,&"8,K^#`;VXCJ+F[
M?:"/,NI-;`#].,FNN7L5.+*H)/[.L=E1\2<,$X8)PRXPUVF2"<.$8<*P*VQV
M%,.[#R5VV77@C]=WKUE//@@581C!>.0SWA.11VW02#E,I?F\[E?($I(/!,G4
M/,H=.@G)6ZF#<A#*+Q4\$8(/`<'G=;\C[K!##;J8GC3!O.TKYBR+WUM-0$@^
M$"13?.$.G81D0C(AV1V2R;N@.&,#/*);7$@!O-!GO>;R3T`^$""33^8.G81D
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MS1B;2Q:@PD3V.+=`0D-"L_Q<3I?<#R*9<6<.)#-;W@"JF<PLN?M#HD*B\J)/
M=GJ0/AGM]U".AG(TE&<D#.^>9L(P89@P3!@F#+O(9D<Q7'+@?TAP7R/_J;1S
M,6/#9F1[!K=BLG<ZBOVPX%B.=(^[U\S\!,S\6FS^]`6+111(99I7"Y]U>/2-
MA9)',>NFD<^"F'$V5+(KXCB0$0_#9P:O\QX\:Q[0^T1!U(-_V1<'W!>L\ZS'
MBEDB6<A53S!/JJ%4/(&_2:7DHU`Q>^S+6#`>QR*!#RG!AJ'P<6P>P_-A"$\K
M'KZ>7&M:Q[%U]&!(Q;TDY2$L0&([D3/9?6%SC_&$_<Z5UV>GK09K-UM-!BLC
M?MPJRZMXI.4V^\IBBH)Y(@SC(?<`EC\?-<W/0^[[V<^9FFHV"T4U*])W+;K?
MM7T8-P,@JL!N^$5[YZ0M:[IV3??2*_SG>Z-L.C+T=[WHRZO/YFSMZ8&J$FJ+
M7'D/-@W4J/!GZL%M0V\[:SUG^G-_E2*)S":X<C.0*@G^.4B1(32ZAL8//%`'
M",2U-,/8N6;?$+5;D[19>[RE4WV3Z*JU2+Z5<;*X2*[K,*&[,"&8UPKF_^%A
M*@CG!Q--4(JE[BD66N%]6.%5+B&]O%C'09X7+-$FS_'<Y9>/PIHDS$\%)O8Y
MBX.H%XIL1^"9^3P1_]\"QFG/"D0=V!B>L_[3A?W@J]:&](!#P"``UQC`UW/>
M/;6W`#YHFV8NM_-%)RG=K=VPMBSJS=ZBIHHFJFBJD2(@#!.&]QW#NS=FN[RJ
M]<\@Z0<1DY%@SX(OLC=%+NPAJ(%6N^[.+$&9H%P3*!^V*;OI)A"8M;0=8TE?
MR;37AW?USXMT"R)M<`C:X+0]9\.%O=4&!.6#@7+=,^9DV%1NR0K3=DZFS6F2
M7;]V?&_5`2&9D%P/)&_NEL#]-WMOQ+.,_&7,W%+<<U5UT,TRN\L87<\WF[K=
M+$,B1"*T+A&:,^=:-Q%:L%E?V5J[4FON"BO)BW:.S8X*'6&8,+SO&-Y]JG/W
M%W^,%5<R)3RI?.R_E+`!5]_$(@<V]\Q7)?VP7$_H\SE[0N^M8B`H'PJ4+\YK
M#F4*CDC:7)&V@W$L"<.$X7W'L.O;93L\EO;^[Q1/4O/(9U*?4%OK58F4]]_3
M2>W;%7#[GO<G$2(16I<(G1ZF"%%T2)XU>=84'1*&=T_S7F%XP>APUE6CM=Q6
MFWWEQNI!(MW=NIDYU>KNUJN:W7-,=X.3T&Q<:.;M*%8OH:%`D)QH<J(I$"0,
M[Y[FO<+P4C64>:/KJ_W>"/S_?I<JZ?&>..F`+R/\<B$E[@[R%R[7G'VMY0%U
MY":W@E0RJ61R*_:%9,+P]@S'&N_O'OWT6FY]WI+W<:\Y^4F4+WT>'W*$4NPF
MD#^5<_G&2X*'[*`'WJWMX^W<+]P/C;=!XW7<<5\^1JPC0OGXNL3*_%_F$NHX
MP2NG2X[0([S:X3%\2D8LP0O'A\(+NH''`A_&QW_Q)("_#432ER_X1'3O]&Z]
MH5WKM7'UE4<2%SLGK58.^D*%53L'Z8:HW:-K]`KXU^<:O?N^$H(-X#O]F(G(
M?^%>X?I,_'>NO#X[;3463P\<VAV"I*?V2T_5\;K/=K-5<2#V4"658%Y;F#<K
M>G0=*LSI4MOUQF]TY>F:6.H8.;3">]:DQK0A';%$)[ML3?I%24\(/V9=^!W#
MY*396QVJ(/*"(0^9$D/^O&A=[9Z5`3JP7[)'MX*>-R\VI`H<0@8AN,8(IELF
MJ#!D'T6,-M4=%CK",&%XWS%\Z.'0KTK&6+P!G_I'^*S'@RC&P@H=&%'\XRC)
MKM^JL+?J@)!\($@^V.N)*"(B82-ODB(BPO"NV>PHABDB&HF(0OA)4$A$>N%0
M'4E",B&Y'DBFD(B$S15A.QAWDC!,&-YW#&_F]'`X^RCI<E7>VXJ<J@X0XX'=
M2"0LC?+HJ2]#/*MJ]Y6.33#UBG6E>NF4<!!Y88H7QP41XYZ7#E)SOMC<D.#)
MP5")OHCBX`'?@Y^%&?X5OA#W.?P5OBU4_#T3]GZ%A.4GH1@>LM!U?^^$)P8=
M&-+\MGEMSB=_U[K0?_[NM-F`8!#/&"?PJ?"Y\JCRIUFSQF/*BNM?E(XQE^<G
MN(K@S['F"QYI3B:.JE617J+VS!![-D'LK'"5$*N/F/=YU-,+,@[>,=#".I8`
MVM!/RRY+^).`GY;'*Z[@CRXL5#U.O-,1OD][=;:)CAK7:.)TU'CNK`/IJ?W2
M4_4\@TE'C0GF!P!S.FI,1XWI(*I3!U%IA>N^PH=>2?*VR"Q-30YR%<3XDY\J
M_`\F_X9"!7)VP$C;\P=S<O-\0YK!(5P0?FN,WSEO0MU;_+IUK[EK)O"K\$(>
MQT537N[_E9H=%+W998Q@>>\$=U7,_LB:(K9Z7-%%]S9O0UD=MZY7280Z>6'7
MJW6FO$AVG)_4[F3GL$2'JDGKZ5M3)9[#WC9AF#"\[QAVZ:YSU^+%M^LHQEL]
M<*2;G7>:M]J+FYV/6V?+^;NNWNR\9*!(LD*R\F(!1KTDA8X;.NSU.4TR.=<4
M(!*&76&SHQ@FPT%"1T)'AH,PO'N:]PK#+IU3W^()XA>.&[AV9W:,B<K1X]P-
MUM-=QTKY3MMW#(]U=WF@$(*IP#>#"#@5^"D/1V[%#I)^Q>L]^$4B\%`YC]AW
M+?QO8HZ,1S)AOA`#<V5W1YB#RB?XX$DB!D.IN`K"9Q8,AO!YX3=8G`X&\#L<
MO?-<RKXR#S[1D^I9$QN*J`>D8"X6^*4+6JLI[G,81XA('YAF'G`GB%*93C"!
M#64<8.U08[]/2N=ZQJ'KP+,7VN<.N)!+GUW*9GWYKU+-_OG">R'NGV/Z*$`<
MM"BWVO9T\4QI<,:]H:5?=>GS!6=8-6FT.JV]GL-5W=?^7B8\K,%B+YC7<,(H
MN<K+Z:25N%8?$?@`/F@-)&`O2;NJ(Z#^R(,,@A7I*=)3-2"-]-3^KIW#I"U1
M5>D^K$A/D9XB/56G0'7E-$H-YE!+E_(_N/%3`Z$BC-97^W_4NXT$TKK,@10I
M8=3U.9`B)9`Z/X=:)@](D=9J#J1(70;I/N8B7.7E7)M1KI'F,-<<)NW*7=(<
MYIK#I)&$UHPTDM":D7;@QQ#K1QI)Z.IN>56CIO8VTJN;[-+T46*K>J$&Y1Y,
MLP_F[,>JDOMQ,*21<JL9:22A-2.-)+1FI%&`4#/22$)=#A"J^KA>OCX]WU*0
M\,?KN]>L)Q^$BG27`&P.P'LB\H(7]F7V=L;C0XXU@WA]5M4.HNB(L$+\Q%]H
MM[FQ*--\<4/\K.B`N1I'MA%W;Y0C%_6,L:MTX#;0NTEEL';P;F.;?J/@/6ZM
MSI):0:2BX3)I?-+X(QPY.:FURB?\UESI$W[W:;76CM]MU+^2QTWP)?5+/O=Z
M?6[JI;HWO53?"4\,.D+9=JK-ZP:V'54B:W0ZM;DJWD?\P(,0E_>D*]5)S$-1
MKFD8[Y_Z^J7$Y:A6WIMEN;O_OX_PFR"!\;PYENJV:/YZ^_)=S83LQ9%]&^G6
MN9Z,?!'%`%GXES[&`7#$(Q_P'X-0P+_@*@JB7MPP/7SU96@-EE^J/?/F-,9C
MUI5A*!]?*.!Q6=55+>%.V^S:S\YWI_+.G<,-4;OJ$9YU7Y,\>0`J[QIZL7FG
M9OM=0_M*B*QIK``U,KLS2WTFGK=67\#UG24"2UQ!YIJ0+'CE*.DI1_54NX9Z
M"N\_($DEF-<>YLUK@OE+!LDUD[-M>A9,XU9(S*Y(LY_<(#*WPE+'R*$5WHZB
MJ<QU7RZQ>V5*$$<LT4E56>*V\MU?LY3G9!9()SOUA5)Y-F@!`[7HCI+SJ'7E
M0F\7;LQKG6](%S@$#`)PC0%\?%JQ<;\G"*[8HB1[EC'GDTC*&WG&JHUN::Q@
MQ$CJUTLRW?BZ?3OF#F6$8;?8["B&U[(Y45N#YX4\CH-N`,:.QRQ1''>AV5*G
MQI9BJ*O^\$OIY7F2I'L^J5UIIK/Y)K.NW+5[RT021!*TF@15['@>@@@MV,SV
M\L`[1I!_3?XUQ8A[0#)AV*T8\6SX=#@1(J9$5\R#+L'&O?)J82+,EVDG%$XX
MM7-NI"PTE9UM%594-<V)K3UV9$EF2&:VGD#9;Y%Y\4#E3S^D\4F/\^&/Q?&R
M^#9Z)SK)3>3_SM4WH=][_W<:),]W>084_OA6J`0LX+W)CM[$L4CB=T'LA3).
ME;@73\D;-.2__/=_,?;3_YR<H,GT>-QG79@%DT.A>()I5>XEP8,>].3$/)R1
M!&^\A1>^*/D0^,)_\_Q'+/S;Z'/VZDW^)DNC(/DJNC\?I<UF\XCYP@L&/(Q_
M/CJYP'JN*`%R]-\]^'OS].B7TZNKIOY?P8'Y/^?BG,Z.?CEK7J]A3O?\B75$
M)+I!$K-C)1Z$BN&SK\P<XSY7XJ3#S?&XP5!$,0PDH_%YOG_R1!S#6&_,4!_@
MY3M\]PV^^K;TYEJ6LST^\96^O\>\`!B<;(@9[\10P<<KIUC^V^*K=]X:I[@\
MWJ8)0,DYFXN`SWC4DX5Y)_8PX)T@K)1S_>C'XN^?9`2Z4^'IW<6H:Q_]<MD^
M'2=O^O`[);9U],O%]<1BSD%LT=W>!].C3]-BF61&Q8`GUO",DXXOWL-[:+%6
MX7&)W.HA'2$5.'Q^,<[@%RA^;\\JLR\`""WW$QK*/@$/Z+]_D6'@/><VO%)H
M;?B>NU!;/_N;.V&)+`J>"T_NS]MW][_9H][5?3]*U*_WC$;5>?3C]JN2SS;#
M>YN6,*A(F:QV'.>O-$Z"[O.&SJE4\6`2B/-.?V.=01:;=/[:",WE,=:#E2!B
M@R`,P?;$#2;`>@\3!I;9>!S,YPF?+%C,#^MOH!7&ME)M5<P`'R7P\GX+F@W@
M;`VPF%YS0S<<0?<KQ2X-G6<&TPQTP09JYOP]^`,V=W@4J`*PL`-\.=X3+$IU
M&Q/4X*518R;3)$YXI`?J2J5?5B(4#SS2:Q%(_W650-_#<ZF.I>`C0ZFT0P*C
MPYB)"KS$^(JE#SWR&)?8](T(;`L*'GIIR+-W.YH%$Z1/);B2L'=!J#GTPC!*
M=$/A)9J,H4S`C@0\!)["RT!-@Z4Q<@3_FBC!(=1[AK5&&S$025_ZV`:&0U`D
MT]!GT@-3Q((N$X-A*)^%L(_*(8X5YWP=ILKK@RLZN0K8P-JXV1!>)J%NPX$C
M\&')W=-:/39`$$]">0%ZY/@J?'KT[=(J&/2@]049@P4%8@!RGBC_00^"Q@_F
MC+9ZZB+V%,`"?IO(?*Z6((.$%YO8+*RXUM^L99="CE)C6J)H=&E?`A88?)D@
MA(<K)3?#?5?_V<@(KI=O@6[6T6@&#93M=EO9G6-$F_QKZGJP]/7.;5B/XACA
MV<+;7>X?K9[L=,*6Z0'B,`:(M(W=OT%::"M:J-5<?*/=?<VS8.^2:1K:@?6M
M,?0NZXF\A=J).+R\1!K9-C=):[I+&YF,94B[=)<TA[E&I&U$$V_,%UE\+V4A
MSKQ9,`%<3R^ENJ)O&T'.1N\+:%]?-ZZOFHVKRU4N#B`CM39(;2-XV3"BKAKG
M5ZW&Q17%*X=*V@%:R??=+NY<RJ[=KGP0I3/[L_=^]F--*6ZJFY12W$2DD478
MF$48'W+T3.&E;B&1LR=CV_O*8I5ZFH^ZAE2-YM5EHWU:T5*3`BH*J!8_<-EH
M7[0:9[3]<["DD?&<SWC>S5>L64\YJJDU;35:[8M&J^K4.5E3LJ8+\Z.N]Y,3
M:6LSH^OJ&[,P\#?9-&8-!K7Z_((N>Y]RA*&>HE932WMZ>M9H7[;)SKH`I[VW
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M=R9%2SB&79OT&]A$IX$;;4.!+>9%^-R`F212?\4,\SXCB[W+2"CWJ&=?0AY5
MMCBMHJ(OPKRMZA!>-%TY;9=3<\%ON=5KUH!51CY\3^\#1GI[@NONLCRT]35"
MV+(;/5P0C?9OY<-A&'BZ\>-D7\J15K:V2671[S6>;!6Z2_#5K)GP?7^T(VA^
M6'2AO$?1N%;W`9YH@#B*=OB`SR*99"C1;Q;-3H,H3E2J+UYIZ.NF^R)0>1];
M-E2!9QOAIA&V1.U%P3\:EW'6\[:G!*`3*>(6?G8"`WU_BQDBD_"126VU(>HZ
MQ\IMD0O-5;'_O)/.?9FPG=OF97:"1R9`W0RK5]:%X&.UE=WW"5S7$YE+'7=S
M:F%?RLR0YEZ%+I<2,JXIQ'U:R&W<E;R7_)I+?=3RJ,K=BJT/G%K&*2M6M\W9
MI8[5D=Y<%X"VX01N%#^7[:O&Z?4RAX^<6JP#5MH;.WOOU`(?B#IO-4[/ZY`:
MV%\,[;U&/V^<M\X:9TOUE75JN2B.ISC>';I<74B*XS=4%N"&RS=M/U/D;6_-
MUJ'>9HS1WWO4MW#V^8-@'2$BQJ,D.,EZXTZ_DK)T<?SL>Z'S&Z;?3EQ^C>2$
M(S=ES[H.^^VRUW:?3US<7C'LCLEL3;U=?)R^>YGP,+])G,?@RD_<(GZC?[LT
MPRY:[:MQEHT,N35B\";SJ].)F^VG$*.X;XM0'E"`8WWO^@0YGB?3*(F_YL]]
M$LMCJW4V>=/ZK"_LCEA@9>OT;#EBW_*XSSZ$\C$^N4N'PU!@)0(L_+L@]D(9
MIVKR(GM\!=\H/U]ZG*Z-7W(7KDK!'Y_2M?$%1)GAP%6[U?HWFP+7>5GCVI7R
MY=>6P,DR5\;/7656Y<GLM/1FRC$!O5,_<5!@YT[QAJA==8=_ECI93P>'_`KD
MBQH62*SI"N19X+`<N/EX^^NG'YG)5H_S.)*/B@]_/C+_=0X^"QZR)0EV5(+;
M-93@!8OO:BZI!//:PGRA2KZ:PWR9%K2NY0A7Y=24T`FS87FPQ6XCW4\6=XX7
M0,^V+?><^>@9@KXKTNPG-RA06V&I8^30"N^E?MS6H;`JOFB5-^2!S_Q4X9&L
MXFA7?M(K/Z^UPCV"NX8C20KI0EKA#>C"G:<G"(:UAB&M<-U7>!VM"#=7T]R^
MW)US=HO)$A$G3#QA!PBA]](Q4.4#W-QF'A\&$,7BF?C5<QRS^#I67[R%FJ85
MDEU%<[=Y,C8;G]-W&YB*78\I<]E<+=SI<CE4F,82R3/WX$8B0R*S<!WZ(8H,
M=07<B5?G-,F[$L"-.\\.L7VO`$$8)@Q3+#A_+.C)@6`)?UKH2B[R7,ES77(N
M;8KV2&9(9A::RT5%"XGZRPR%>^0JDZM,X1YA>/<T[Q6&7SR'5ASHG/?@97ZX
M\ZL8\F=\[N5SSOFC\>=N^8SR@D=13T<..T\;=(<$GAW]<M(:/RG[(IT31WK'
MJ8/05`D>BW?"_/<VFCQ]NS@K3UJGU^.TSO.EG=*M.=RZ7(GN-[IK_DBG_'+C
M\O%9C/<I,*^7R6Z7R6Y6<[OU^KHUO?>!'G.'!)XA@>?S$YC&H+;BF-V)GD;V
M.$GV]P!]J?#^\T*1T`'N=1[@;C7I!/<$&.>=/1W2GG)(>P/W<NRPC<WXD".4
M:DF>X,9]Z;8:O*TE]9*8!?!_O5!V>,@Z&>22OI)IK\^21UG\,K8X_''Z-3)_
M@'(6/KM+>&+OWS"_UP5)D3X6P\,9U]",OF_O_H`O<[#"+)&@_'FW&X2!OEC&
M`Y&4`Z%B<((\_1M[D\SH*.`DW<!3@<<U?&!$+%?_D@H%`WX-/#DW/1)@QQ-S
M_XA.J@<QV!\5/,`C75#/I0>&2G:1L8]!TJ^B:L8W1WA5P0,>ADS"@&H*-Z;W
M*%I6[M=_E\Y^B<U[[O4GQ,!>%&-0'J-1QD4W(C54L&S!$%;JV6`2#[W;OS*$
M:D\JVT@)D2&'_:3/PP%X-V;0']EQZQ4;@H(;<$^D"6`W9,=#"%<\%>C^TLQ7
M:2]^U6#'[5<,_(^>?D3\G09#39R^.TD\Z&MPCN&+7'$O:;"'(%%"*@$8A<?Q
M(26Z^"?`\"O]\_'I*WU]4PI08N(9KUD"+7N,3@T\!E%B!)@/@!78/XM'=OY>
M*#CZ57A4-$V,JN;@(74#+X`/)>#SF0<E7MFDD`X^"*+X5:4<O!EGM94KO'NH
M)R+X-S+6ER,7!`%SA.XD8*<N0JE9T0`/R=S<!0A(NS`)<UY%4Z/%R),*W#E8
M%=9-(V_*?5(D0ZO)T-O*13`7,N%2C/[^@:L`+PV#OP'Z<)EY',.T\&*U"HO$
M.L+C:8R-)>)D;*@2=HP$BD).\:#2`,3!W`(E(S$Q="4^OTZ!FIE.V<HHT<,K
MRJ1ZSNZ>Z@?X7L7U9Q.3:NC'$GU/E;YRS4*_A->"?7.QB5"];E3?^L!7T'(Z
MGC/MWB:7HO,\:3S*:X;J-@`_PF!!0*26&B?"'JG3)XJCXC:R':^K<WV-Z&`1
M'3NA@T6TPK3"M,*TPK3"*Z_PUEHO;;OUWTGS=>M\EUV5WHG2S2K@`\^?T-\"
M"JFW'_7V.^SNG'>88UY<)NO:]8QP7E.<?\[W:<SI"((\0?X`O*^;`5:M_+-H
M=\*:0WXM#EFM.U]NH6GW82B6>C;*I7[0!/,#@#GU@R:8'P#,29L3S`\`YJ3-
M">8'`'/2Y@3S`X`Y:?/5[B+(;P^_6D>[HRW5<%:Q:.20Q0*8V+/V+`Z<CY^S
M^XH+Q^(OVQ?K8JNCY^$)P?5&\,7Y%2'8%3H)P4N0>G;:(@2[0B<A>`E23\_G
M[&M(""8$.XG@UIQ-!@G`!&`"\"Z`L?Y:I-ID=D;:8JPIVU>/MKREQ*\3?7DW
M.ZE=Z9[KZR5O9%DVK^S>0I$,D0RM-*NK4Y(ADB&2H942:1=+7J]`,N36+$B&
M=I?*NZRH%R`9(AG:PTGM[):?.7<D281(A!R?U,Y$J*(X\Q!$:,%K?\JIRXW1
M2]?^[)9DNC*%KOTA#+O"9L(P89@P3!@F#!.&"<.$8<*PH\QUFF3"L".)E%H6
MA(T/.7I=P_GKR_.J&QNRR]18(I.%ZLCV+*U+JF.Y"M/&99L.JCA#)X%Y-3"?
M7=.9%6?H)#"O5#MX?490=H5.@O)*_0A.ZWZ.A:!\(%`^F[.$@9!,2'8;R;77
MR0>=+/I]RIVPE`!RE.1=J8&3DYJK`4(R(9F0O'M8$)+GIOFX=3GG?70.8OD5
M0=@AD@G"!&&"\'*[291_=X9.0C*UD:)43S6+OHI8Z-OI>.0S7SR(4`ZQY(=2
M/8Z23`$R&31",B&9D.P.R;N+D\^;%"@["`C"\`(8;ET3AAT$!&%X_KJ>O<4O
M.11.DDQ`IE3/VEGTJXB$XB'SI!I*Q1-!.1Y'2:;(F`P9(9F03$AVA^2=Q<?G
M%Q0>.X@'@O`"$*8,CXMX(`A38$Q`/BP@U[W#`=T)-Y6!=WVNQ$F'Q\)GGAP,
M113K8UT+I(&6XJ*K&H1ZN3L?GM>MESN)$(D0B1")$(F0"R)TW+J:,R^Q/T+T
M4KJ"9(=D9RVRTSXEV2'9V>M)D>M&KAN)$(G0'HD0709'6PFN;"4<S,4!A&'"
M,&'8!>8Z33)AF#!,&':%S81APC!AF#!,&"8,+Y!(F9(W.AL^'4B5V/B0\UT4
M=[_@_7!+L'FOLL`P$>;+M!,*)Y+`WVU@*GMPZ5P%O/8X]TMB0V*SBMC,?;T=
MB0V)#8F-F<O%.0D-"0T)S4)S.9^W^S4)#0D-"8VU-'/VV2:9(9DAF<D,S2'*
M3"EW^4/"83&J\FW9/T='''W`[>SDO6;0)V#0USFSDU=5J<EWYA;#I"_@_Y00
M;`!_Z,=,1+[PV>^Z^?UIJ\':S5:SP;C_P"-/8`O\&.AD`?PGYB$0HL10J@2'
MBI_C1`S84*A!D"0P"([]5@Z&/'IFB60=`;]53,2PQ#P1P)=0/N(Z,?ABZNFK
M%%D75MV.#)_!$3P>>FFHC^0RV67<\U0*@ROYS,,D$/'KTEKF_[KO!S'S^CSJ
M"1PG_Z82<1HB;?!+SKYKG\',_$"/#13^\?KN=7:O(TPHB#PY`.H*3L&?`NF_
MGIG1G0&@<;CDJ])1[(<%QZH5&.]+2`&NITK!$@V52/@3$T]X)!N^DF`R'5?B
MN[,,&R\BEW6E8IZ,$P0J@`A1*?6K/$H"+QCJ7UF@`+H\&$K)D/E![*5Q;(`2
M24!.ZU3?!2'AW6Q$&"E.APA_=A/"F]_'K".Y\G$@/U#"2Z3*I46`%DUS%'^2
M#QRD)H97!D+U8,BADD,)P)\"9Q&+@A./0B&LO3#%&?..?-`H[XUW,LS?V`?$
M(C)V!=G/$?L@.BKEZIFU-'2:UXT1_<6C2*:@`5&K\016%+X&>D/#!Y:NI_A`
M`T(3JQ>\N!\6#&32UZ.)!QD^((0%P$4.`@\!9_1/K.$UX.J;2`#*#X&2$:K;
M&7C(OUM``7C"NUW\@LITJE::0WCV2:O`\)FU+YI,#(:A?`;A`=#9[^N)C2I(
M*X(@'\K(QW>M*RU2<P@?<O"Q'\#/C[Q$XI(X_>F'-#[I<3[\\4[TD"]?,[OS
M#D0UE'&JQ+UX2MX@UG[Y[_]B[*?_.3FYC1*0[`!MS`U(<V*8_*N4_F,0AB<G
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M`_8F<V5)"";<C%D'+7=NF]R7QJGRU*ZA//VJ9!PO+D-[+RX[D(S58;=OM=.[
MIIMT#>D:)]?9,<$@74/.EYN"4F^%^)8K]1Q$/=*)!,:=@_'&\])!JG=B"8^$
MQYWCD90C@=$9,!ZV<ES+'14[=WXW1*UK^V(S-@1J*9D#F0+'%A;*=35:=!<H
M!/2Z`5TEP3_KO`&'X.X0_01WTNL$](,$.NGUP\NHT\;./FSLT`K3"M,*TPK3
M"KN\PO->,E%UJ,"5@YRKNE43AU46\"5)/&HM'K3"M,*TPK3"M,(NKW`=G)B%
MV'*7=OX27J+/YI=R8#^2XT(B02M,*^P$.;3"M,*TPFMW7+)^"^?M.M\^<7I1
MU5+K8^!A2QV?)<+K1S*4O>?E71[7&TSN3_](%]I#GIW-V8=X;UM!$H+KC>#C
M]O7EWD*XHG,1(?=0D'MZ.F<_:P>!2[J7$*QU[\7>0GBF[J408[$0XPM/L!\T
MA16.DKPK#=&^O-I;!4$VSDF2=VCLYCSPYR"6*=!PB>2=W7#8FO,V$`<13-K8
M29)WIXW/:JJ-UW+VG0(3R]S/>$G'`F')4EQV5;<LUM%Z3[3/8I/:F:EM5W3+
MWN1Y.O<6BF2(9&@U&W]]L4J+%2>%Z*5`C&2'9&<]]F?)BQ_=%1VR/R1#6[8_
MIX=E?^;=]:J()S<&J`7[(;B']3T43Q>$;^,EK`ZQ?:\`01@F#!.&"<.$81>9
MZS3)A&$Z&;.YW:%[O!2>Q=6'?">Y1I5I3I"\*YUP=4;5U\[025!>*4]UUF[7
MM!B",'P@&#Z_H(.(SM!)4%Y-';?FW3=P$,RT04!BMA=B=C!!/6&8,$P8=H&Y
M3I-,&"8,$X9=8;.C&#[H#8)/,IFV/;!"#U!7EI:4@'-L=E0)$(8)PX1A%YCK
M-,F$8<(P8=@5-CN*83JM/I6!7U+E]3GVW0TB-E32$W',E(@%A]\S'OF3.Q=K
MIL`7#R*4PX&`4?FB=S0MM8*N;F72*:K=G41LSKFSOS^'J.@D(LG05F7HY(1$
MB$2(1(C,$,D0R1"9(4>"7"I[H\P2998H.TH8WC6;"<.$8<(P89@P3!A>P(&?
M$J^<#9\.9(_*G)D/HH1'O:`3BK5M$\UBX5YE%F`BS)<I\,:)Q,*<MT,M-)5=
MJ9_KLSEOCZH`UQYG$TAH2&A6.^Q?+ZE9LB4R"0L)RTMSN;B8\_JQ?9$5LC`D
M--OH7U`OJ9FWI\$/"8=5J(IY9@1WXZ%</HF.8C_L<*P7@L[6U7:BSGN]'I]@
M/;[FZ_$N54'48TE?P/\I(=@`QN_'3$2^\-GONC[RM-5@[6:KV="/O96#(8^>
M&??QB:&Y;5374(:!)R(LLDR$UX]D*'O/.*A,>WW&62>-@<88'O7^3H,XP+->
M^C4>F5"7#6V5YNN9,2^MV>]!)!4#5D4]^%L0Z67QN%+/N)1\(%/XG.RRGI3^
M8Q"&K`N/S[7"[%$H3#S`&V$H'^/99_%<EL2J9=`J)?O*8JJ+>2(,XR'W@,,_
M'S7-ST,0@>SG3'$VFX7JG&>#^N*L)AO4?[XW0M"1H;^3##@PGGD2%PG^V-Y\
M+A!T72+4%CGT1Q0D(+%W":C<)=*"VW$&=@Z#O2*V]IB]Q>]%^EPW#PFSSNZ$
M+0A0VOS:Y1$MEUR'I2AW4SKGK/^</JO::_,[T<,#;(OK\9U6H6X;0"0+)`LD
M"R0+AR,+NG2%)&$!AV^>BJ:R?^=*1=.J7/O5IB07``L%30<>-!$&"`.$`<)`
MW6SI0BQZPT,>>:+!W@E/##I"V3V[YO4*IM3Q:I/]*29QH5;DK#UGJ<C>*@!"
M<+T1W+XX)P2[0B<A>)DBUZLYBUSW%L$'[83=E"K79#>O:",/S%&2=];@:,[#
M5'NK!0C)!X)D<LB<H9.`O%)LT:HYDA<L+6K/>ZY^[YVVV\&0>[H>OE0QWY5*
MP)>9>#*_9&JYHMI%V.JJ1J$N?KL[WW6^9'U=>Q^/=Y'8D-BLZ5@DB0V)S=Y.
M:F=B<WU(8K-@IU@GJNF=!_H>RJ8+DG<P-1J$8<(P8=@%YCI-,F'8K6S@W%TV
M]SX;F-?1C3:^6#WS1^V<-C.G.K5S.CM=\N(;5[LY40\T$IK-5P52:UH2&A*:
MA>9RV:QP:19HM/?3#VE\TN-\^&-V8N\F\F_SWN0WNC7YNR#V0AFG2MR+I^0-
MNGZ__/=_,?;3_YR<O)->JB^[_2)4('WV/O+9.YZ(DQ/SB"^"'[-GS"/P!#[`
M/"`9AOLJNC\?>4WXW^G1+^BBG31/3TY;/_TP]<W\V^^[76%V?$>W=YF,F,=C
M<^&O_H?X.PU@;;"#7498-F\SR.?N>SO$5QCA<_06W@).X'_>%^^R-`H,P2G0
M>\1\X04#'L8_'YU<'%5.Z.2BJ?]7\'F1[^W-3,]@IJ=KF>DGD9B)=`'D(!@/
M(DYTMSLO"1Z")!`3TX(W<+`O2CX$OO#?//\1"X#P;?;J3?[F$LMW>G4Y/JWY
MO^?BI&"E6NW6&N9TX_N!:??$ACSP3P)$XC!(>#@^E^+)+_#@+2!`/[8@X6T@
M_/QB`F13!M\9F2TD\_1\43+?RL$`9#GN<R7B!I"JT):D@KW][0-KOFXWV5`H
M\^=_L]-VL]$^/VNTFTW[!N-ITI<J^$?X#7;:/&NTKLX:E\WK[,]!'*?"UUH"
M.-AHG[8;S;/S[*\R36+0^+Z&9#(6,?];C]=L733:U\V*\=K7UXWS\V;C\O1T
MRG@3)]G&.6\F?Y>`7?F/GO3"R#AKCS-\?$SB]!HXW5J(TW=(X\D;CIUBL9FL
MB&+=((Y]"7DTH?$*)^-SM_ST5Q&"W?#?RCB)]8AZP"_\&?V".'=(*M6WS5[E
MOMW6^X+F#F$BAT>3+N:?M^_N?S,]9L<\^U+N;7[/<9&F#57]9H];K5<EAW^&
MZS\M:5:1,EPM1?A7"O:G^[R`^[PJ$Z:A=EXF;*RW]6)3KWQM"4B`O1Q`5``,
M`&4)SJ<8)H6"9#Y/>,7F?/F'O'GO*)SVOCGSYXA]$!V5<O7,L&6V:9P]3%6<
M<OA0(G4GYIN!:;\,6K/-;D)04NPVPKX]P8/0>G"DU_;W,:P=5SXZ^GZ@P'N6
M"BS.<`A^&;;;AB=["D:'E="^-0Y2$'&9=^^6H)Y4PF'MQ&`8RF>!IJ)K!GH"
M!9^(\)F=GYTVFIE=.X$X+PGA&V!5$A5XV(#6+#%:B)@='WV]^R,^>O6Z2C_<
M`UWX9X;>(MHA)!3FK;]IFE&?/`LPM$,=QC5`629]+,WMBB!)M97KZG=@QL$P
MP&@R`.4K$]9-0Z`4AT4;"`,+-0A,FU$=#.G9Z?!3*OR[$@FP3?^B([#VEW$(
ME2[:U&E\-IB_5J\Z_@O61/8B]'<8@%#9=8+(3>'#0CT$GK`+FRT]VG'T2`9<
M?<-V[PH?P=[D1@"\L@>&$2R^XV-*`'N9([[W8;FVM+=5M5KC0XY0JIV)"4W\
MH21LNO<[QG6H"'S6T:8.EJ$?Q*!O`@]B'O&$*RI`4]%2K'LI;KNLRXUFMZD<
M=.[+-RX8M1:#"0`MKU"9<8@"!D-4>S%J=^YYNO<_RI11WV81A]8KUB<?4EQM
M*YFQ,3->V0O'-8YBO"S`BFWV>91XY<<@OL^6!!8#(X,N0"-*0!_K+,;C^&M]
M'MM7@9+LLH)4:?H-%82E=6,)+:]Q!;2!+V,!573RS/@CQ[5$>PF+P'7:*8@`
M"`9V$>AGL,P1_#JF2R$V=BG$E!V>ZBZ9&]_*66NOY\U$9KMIY)DW\;K8?/'+
M]IMWSK@49OX(?R8XEMB&=0T^:^G<3A*\<PFN8_O=]12PU452">:UA?E"S0YK
M#O,YCS?MW.1LFY[%R*E#?]9=TTTK7.L57J7CV^7%GA\7T#<;3,V?`+;B1&_$
MA(&G\PB8>3-)K04LU9[5<NY/J:8+E9BMNG>$)`#7&\"U;RN]GDOY:FG^='55
M5ABI]WJ#2->I1HE4SVL*QNIQF(%:F&Q#&9V<K)#ZJ>5I(!*A/9T4B9`;9G[*
M`I1MMRO),U=8Z90K37TH'!8ZPC!A>-\Q?-`)4!,!EHI]@\F*,4IU.DHRY3PI
MYTE(IN3G'B<_MW7ZI8J#'T4<LX0_L8Z(1#=(QLQ@N4::4J&4Q]FR:EJR*]*^
MIW%(@DB"UC2KR\.4($J$DG_MBG]],$DDPC!A>-\QO*FFTNN)%$\O=A<I?A5^
MZNG3TXE<<UQ(W3XW,Z<Z=?MLM9?S9*E#KCMS()G9LLP<9%?IC74A._2.&V^K
M6JC@:9#1?AN/',MI0R_5S0NQ_0:'CRB.0G""Y&+;G2`N6BJ5NF1EW6%M4R5I
M>F.5#I^4CZF8[]F66MSS1*CW;$U_+-V'JT1C$,$R!7[*PY@-A-!?*?5S,KUC
M\,&BCU8#&X+X(O94T,'/=8!BZN.RQ3XN8<`[0?A"*Q=<LQQ%4WH\Z.9PII%H
MLWEMFKU$,BGW]EEZ8=>U&!OH$;A_0,@:*@51`DNH&SZAOHF[`($P'%,TNE\:
MMGX"7:'PT?$>L*=ZR7DW@5^-_^W2J`U$#O:9Q0MS$'YH<&QW-MWJR9-1WD39
MGA$HM<'-P?=BK\/*YH$WXVUP&V-=I71/0J&P`>)H`\-VZ_5EUIRRLK6<5GG9
MO!;NS$A:;H/@KNYTB2W$2L#29L\#N,>!L6BFJ1AHORCK+0BO5ZU\(L%NP<\]
M)N$-A"<&Z8U<CG"822LZ:@<SR4H!)FL&^$C;9CM?;KJ[=9Y?;@CZ*-/0!V8]
MZ/9N@R!)++,`XQ[P4$PV^WQ!5*:V]2PW=\M&AV\IP>-4/8_U<"PO3$EIX9\&
M_"^8)*@MZY64.5"MT.*T$\-?A)'8:JV6*[W_Y9'I@:K_>.6$Z.ZM&EBU@_);
MT]405OHM?$O)D.E[!6+$MPL+XT@E2A7K_ACJ2,'+.>A9#MI^BO(Q$BKN!\-<
M\8%.2T&W@'A^D@]<@<1]'UO/`;V"DD+X!&%%:*2[?7KZ;WALK!%KIDJ/_2#V
MTCBVU2\R$:QU^FJ\47%9?8[TE1R38Y#.H@GQ%($%;Q1TDVD?'`P&P@^TUJK4
M2K_)1P%!DR$G"Y709PY`OT'T-/9YX_A4?BZ/EH`]$>C(O`EQ/+2]E8?(4"^`
M&2<PXU*WX=QMRO0C>AI@,V`M/!''VN_(FQ4#%?@\J#SPGM)8-/!IJ^=+7["&
M)NO<[`7*2P>H)#UAXSOX;1P\9>[]$,R!T`H4AO-3E05SR:-D&$=F?1RUD9F$
M5"5S;S,,V/[+VDZFZ@&B1AC%DVHH;71IB,W'18+-N&9ABFMH[.T*5N_G#$($
M"0^HUG>88*O1CM`Z/PF2-+%>I:'%XK.PPV:)IROYXFZ"%2\5*&X1*7LA7=9)
M8Q#P&)8E,CZ(N8/',UV1QV\VR(>5-^:)-_9U$7\2"1"&-^+8=Y>XHJ9U/G%%
MS2)?='Z.9T>_K#JU/R)P6,RY9E^@W`0&Q,?H)&4_O=)NC.):I`ILCL^T&.M7
M$-./,HX_1W<%DA=?O[/QU9O]!?<G=59,:O%9W0EP4J->@_4$F#H,-#%Z]4&1
M!I@_0[6<$<^]\$?[^*_FX9O(OQEY=/'E.+O.+SB98WPWR`:&GUTN1?9G'1UE
M79JS5%,%0/2#'XN_O[6O+'Q3S_7DY5-3QMX5D7B#4_-L0J?.1R77%^95$F;N
MTOLD(V]9WK7.)JZ_JAQY:S0AJR8O!)I-TT>,RM$U@L&[0BGM9>HD)E9@5]/Z
MSCYYSY_LN")9A9&GD_>(S?Z$.]0#RT^O)T1H3NIO#:GPU*3PF+_!GRIN>Z3+
ME=9PN=(UW:U4QM^\$Z?[E+9WG]+>II,Q!):1CC)-&-Z)`S_@"IW7;A#B#4.%
MEE8B256D+\FX@[#Z'Z%"\-9,W/K'Z[O7K"M\[</]!<YI[`>ZX*NA/;H'&%*F
M\($$LP;X&Y-?QJN&@$4C;U0G5?_45Q_!U,W:&QR4,PDZ\F8AV!E$1=KY"R]^
M3222BL%8F<!&B0Y87_P%\"&2T8E^JC1E\<2S>Y-,BAF-E4D\:P<?@VV3,[#7
M)F&*M3I#$+'_32/]P+4A_!;;`^/6T%?Q("((]>_LI4#'1[=?[XY>Z3037B6#
MMQB6*<ER`D5.:9SL;*60//C@1;9[>6DN+0%6\<BD3VRFJ6/N.`E%ED%.\`&.
METC9A(N]E@KS\-/F]SM_+D_OZ]WD!2TX95'\#GQ2W&("TYLJ_:\O2F*:@QV;
M@:_:9Z?_?GOSI?33*S94LJ?X()O<]51VV]Q5L3=62=*33?GI7]Y\R8<'KDR=
M;%F"P.60F9,=:AB6P#<#2B,BT3`XK)",,<1-FRRW]Z0V4#K'@)93:J>.;,#-
M:P,L[C^8?3X5>#KEU5/"W`1V?'3SY4;C,(+X!R8T$`,@`X/1+&<V2),4R<[?
M`01AWK`CDD<A1O1$_OD_P&^#3]\E^B+F0H*2OI)IKX]</S,X];#*(]:;M[@=
M@Y_6*5KEV1D!65',C=;`MFLR?,@H*T]Z0K69K'!L<GXOZYX/L&X@"HURMK`K
M4P4:Z6^`&$Y8BT;S<I3A\$V[R<3S-"MNE6&Z%N?-&01%.#&8%[`ZY]K_<G@=
MR4/BM?Z:4#R:/V8_RRMJ8>`APTO<S"DSM/TBC+'<!:LH\EN-,B).#`%(G\[^
M:E41>6%JKRLR0N+^]L3^VNB."`,P$79M`E@>_DW@IBN/9:2CAZ$T^4>]HXAH
M'S$"0:C5FP8#)M-Q=1^E0E>TGV\*P`LA?S17UQE3\*3A%Z>QMK?X&5!HYEXK
M4T$#P!W"1_ATP;F?0.TD$0U3*X&QC2XQ@/\V(+Y)$V`VZ%.O#Z(G,%5>3!+G
M'XWM^#;LED`*0H9JV-ZC9?=PM*+`"[DR+:>O!YYO^S;P<:>Z&PBC2-(HVVE`
MGA5$F7U5`538!VWUA99T5*'P6;TIBYPNTB$X9R6ZH388F*./8XDY2)WN+9VG
M+AVS!O.(3QXA=[^:C\2@IH$BO-],^5J=ZYT65%R1AVKSQMQ\AE._P_UCO=?S
M1F^1'Q]]N+E[`P/TTL"^VP^\?G4A@-WI+^F)7-'B56LBQVBF*TK&L.S"X!6;
M`+SG$>V+O]7?Q@%&#2E,OW*Q?N<1[V475Y;%!$DK,T@#N\L#!(<VN3[KI*67
MS!=SF7K&E8T-ZK/A$MWK&KB"5\@!J*:OCS+;))KP,>0UK*_@6>L5\@(^EM4C
ML++8**Z&&YF4YO+H)7/@<N`LA-[=$O;?=A>LU<XVP62V9S>4*ML)A$=06V20
MT5P:F%OTL@V^-,295T/C.'@%'WP0H1R:0A`-0;LKJ.]6S9TD;K8)>>HCM]`2
M3G-"-&-^@">.`QA>&UZTNT*5/Z6)SQ189O7^@L'U//3P(UEB/L/6WX2XXPCO
M3]>(!;L+99"@!0WBBEF;8ASM)NF[.C6<=.C5+5_U5\45M+F1Z,DDL"#QM,&?
M,+9K-E<`&1!!!$*($Y%A:J(.=%@P^:0)M+1D,4H#/+1)27Q!J*8+D!D\A[*%
M?@3.>@G#8``X>IP<W*E6\U\C@(>_:;?H$GZ/Q5$%>+/%L'<^ZM]HD=:Q;N[6
M3.H/@\,1A,-SF1L_LDYFFWO<<R<?:?T^TKA.[BE`V`Q@O;3$1ES-<"4?.P`;
M9PUT<8.T=K)T\!9T2ZU/($P(?%T%8/?XL]@%\%\.(`(5)Z.%Q[/B:YSLI@6_
M2"@,91AX.IA%O1V";0^ZIK!6Z:NJT=<1H!\2&TV-Q+FZ;G[J),P*%2LV95!P
M952*D5.L'3M\<F2M-L'C*26U6,:+4T)M%^GV#/;^WU#;K+@O1%(`Z[OVJ>X!
M-VWS3<_SN_.KXJ$PWQLI/Y95!Y=GG=<4^$)["%;3H*5.L>$XZ9M-ZIMWI5JA
ME\X+C"8"2MJ(`T#.M:``<E6O.(+P",LF3F2W:];7;I(5NV/C9FR8UP;B3SH#
MV!<@/'W/W#X.XPZ,`P,RI1W(DF"\=*]PL4,V:WLKWQ][)[U4&],N/`3Z6!_'
MZ<(O\]TR7P0_9D]]T`_]'SSS`1^IW"1#'O[TPXRW2N4WGK'>8-`Q&*[8G],N
MP3OK&MQ&V1M?S`M+E)Y,;'*_^)&=D7MV]$OK>GER;S/M;-7Z)+GF[^_M::G%
M>3FQHSPVY)9(P>*;\WE)>5LN`&UDA79%!?XX:>;YNP1D1E?-Q3=%L7Z9S%:9
MS.:4/?AVLWV.Q0,%F3.&WSW)K761/.3*UD2^_>U#L?<W@_`O7'U6.L_L_P=?
M_"*4_MC"/&^^;E?3/NT+KLVAM<H<[D=/+3283LW'8&5/&]?G[<;%Q5F.IW$/
M2GL[9XVSB_/&^?EEZ;'Q@PG7XSS(OJIIU(0M7J]R<GIQ,2[3D^/N^T1;NF[P
M:H&)?A68L\#+VFP;CG&:L@?>V[^#>4@'YDSN.PBDO&")XJ'S5G.B9//E[^R0
M9N#KV?GIA'U:@.:BZ@GO!(H3G348IQL?NH=G;HM'%F?NQ01K*X;=-EW`P,L)
M]LVB*V-IMIM>A)73ZJZP'O:#DH.W.L&>PLN?A_8@=_Q&#Y([L"+^/8CT8:K,
MK-]$_N@H[_6)JM\%F")_^6F#5W-Q.:%WMDAOS?AYAKIC`M^[X.=T`V%^,5.U
MWV7',1;T]\#R@.&9HM?-H+LC$'4DV#PP>?,1^`7\:'W8":SE%R"L:)C`WM@<
MW<01"?,*+)8ND!U]*WN)BB\W4WS9:E/UY1R8I:+,71=EFM.GFP72PLET&6ES
MIUM#)#;I%GAYNW1]._*/6\W35F56MZ\$)_7>?+VJU[!4J[79W1"UBVBH;;2?
MGFS7E5\2?[&&3I0O"*:GRT2WR+Y,P2^JS=??`MM=R!#DZP7YU?R8^B-__?>^
MN+9=NBH?[V?L@:X)1X>A7]HUU"^8$B=E0C"O/<R;UP1S@GGM84[:G&!^`#`G
M;;Z>:YW/VWM^K7-V%AM3M`M`8L_N5-B?*Q-<N!%ASNOP]O;N`\)OO?%[3OAU
MA4["[Q*DUOVJ<<(OX7>?\7O0`4-^.H4B!H=)IM"!3!<!>06:Y[P4D(!,0'8;
MR&<$9%?H)"`3D"FJJ&31>]V54?BVF9^^#U5W@Z`(PU&2=Z4&CEMSUJX[J`@J
M#HD0@@G!A&`7X$`(GA_!IX1@!^%`")X?P>V:(OB@HX@O^O;0F$J:2/"GT7QR
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MWWO6G<[+'0DR%V9O?MOG7C/SDQBY&UNHA`<1^^/UW6OFBRX,X^?;/\.01S'S
MX(OXB-?G44_@%=KX&R5#-E3R(<#[>F,6IUZ?)7V>-%@ZQ-YHV>/XHGT<_IGT
M88#'2*BX'PQQJ)L0_MHPKW,@3CYPE03Q]S$\G9BK+(>I@K%B_>5/(DY"`X#V
MZ>F_OT?J!@/XGK[G/,Y'9,=^$'MI',/[\-E()H*U3E\U-`%X'SB/GEDP&`@_
MX(D(G]FC3$/L[>;)7A3\(U@\%%[`0Y8(-0@BGN"EQ)8ML;Y^WDN1<:&^LQ7(
M4ST1-_0?AOQYD-TUKD3(L6?<T%YKG(]@/M<1C'N>"(7"IUZ7@)W_ZW<>\9ZY
M&1:F'@S@P5CSV;#,?MF.%\"\//@+H";H!AZ/$IA9:<;`+F!2&AKBY!"_JU?/
MKHS9_\.?'OL!+DC%FDL/9AZ_GA0]$JN26-V78#8`X4$!0MRP0"GQ(#U]S_M7
MWND$+%%IG+!$(AKZ`E81011$#[#<!KSP5AIU4RT+7"E<$(V'KE1FU0S@<)%R
M?,%P0Q0D+P`2X&=\6S'/"ON$G%MX&GF'<4J8J43E35)<,,OP2CHC6`!F\U(0
M]1`P/HP+GX%_Z=)E+0H=#A_Q0,#Z0B0P/2],<6(1_&#Z*6;?-WPY]GC<-P*'
M_Q!_IP$8H$R^OCL[U7^+^U(E6E8MYW()_*Y]=O7*",RC4`+QGZA`-W($'HVQ
M;T),Q9,GALD8]W!B@9:;0F^-"EF`\WT0D??,<(U**J0\MTK.(G",!GO_)+PT
M"1X`)\7MT%_T"MUKUMSTE#"_U7K8!Q!FD,B@!U-$X.C?@=@J?!@T1,H5Z#;0
M#;XPQ*&*`L[@GX&[J<CHY#WX1@_6#9=6I56:#)Z$H4;19M6)>,`!R_1H1O8D
M4%JA6@IN3BB7-4OGAJW,@HJ<EQ6V84;0235<+$2-*.0V0Z$4*#08I(1G+?-M
M5)+9%-F*-GI45,5@&,IG`>_F"$ZTTU+M"TV"HW*Q/TD6"Q@0QT*!,L(_)ITC
M7P?HL7X0)Q*4DQ;-CA`1"B6,`E3DNAZI:%B-\PSF0"#J@%Y8H<!/]9L(+:5]
M%SDB?#B$G(O\&]#CR@<E'CYK?L7VP_I[B1):D0,-`W`E@A,["66>J1XPBH"V
M$6S'EKR1L4OZJ/,\3JJQ`MKA\<?F5OG1/[36KE0T1N^7--:`:_[@?Y"?(&2#
MH*>],OP2A]_U[02-D\=]8P(F)M49<;@JQLV$UUCV9QW;Q,AJ,<'(:=+]TP]I
M?-+C?/CC%Z.-;R+_,Q+X18)QRXW%&ZNBWX&."F6<*G$OGI(W*+:__/=_,?;3
M_YR<?+%:3R,;W92H%Z!K8DSQR8EY,/^<=6WOY8VG9W&;OW%C;'<:!<E7T?WY
M*&TVFT>PGAYHNC#^^>CDXDAS"BC0?_?@[\W3HU].6JW3IOY?:58O?<81\L^0
M_.6)QXH[P54$BS])JI*P=!]EO`1+SR\G.9H/M]FO`T?.SMMS?/U>)B`ZU<NT
MU%JTCWZY;D]":8SE:_]LZ^B7JXNKBQ<^>Y<.AZ&62?CZ&^L`WVD'^#8"U3[0
M]B$CB'OAC^4W[`OZ^=+CE6MOC76>Q]%QAK6HBV5:P'2&>,&P!P#Y^:AI?AZB
MWK,_9WF>9K/(]"0J3P\ELKA'MT@G_7G[[OXWXQ6,U1F47(WYW8%%KM^M\A".
MSUY568Z9?M5(FJS"05JM_\M?X.D%W><%7*)5>3`?..=ER<;2;HLQHO*U)?`!
M1GH0A*$)]FPT.`0+K0,!!A$MK^BA4_YAED==Y0)O7V*G)_U=*VC8C$RL=9ND
MUI>RYRF?^?7CTML([J^U^Q36&XWOA"<&'=#%APG(M?2YV[F&WQ"U6Y.X676<
MI:8=D^BJM6CBCL#B(KFN9B'NPH1@7C.8-Z\)YB\9I%G'9S>.B06W%U;EU&V$
M6U[2;#3PA'V4C^"@R"Y[*^,$$\'@0G\3*]SYL'&#O;J'N6\%2[NFFU:XUBN\
MRG4WEQ=[WG'Z0Q`%<5]7%T@_]>BR3!<.G;E0AGIZ2=>7.T,G(7@I!,]YE'AO
M$7S0ENM/J;YAB088+D_$9+=<)7EG?03F[("[M])/2#X4)%>D:FN%Y,W="+3W
M5NXK?\S+11>Q<4NQSE6]06WD=]?!ZFK)?CS[WDB>9(AD:$VS:C?I,H9Y6O24
MC;4K%6VNL)*<:.?8[*C0$88)P_N.X4TU`=_[<'!\R!%*3Z]>M\Y+!?DY=_6A
MFM6#1VI%N9DYU:H5);4\)J$AH5E0:-K4P97"0W*MR;6F\)`P[!";'<7PO$>8
M*T:D`[XKV;OYZ:$CE73`UYU*?$(C'?#==9:2#OC2R<>ML8\.^!+,#P+F=,"7
M#OB6.?5%8=?LY+FA._$FNA?D^[_38(C]LQKL$YWM=2JEL&NZ:85KO<('?4*J
M4(7#7!6*0A7RA6\/W[-M3`?2R'MT7++=N#B[W)`.<`@;A.%Z8Y@.2XW&-NV#
MJ8V[\;QTD)KK?'PQ5'@]T"*-<9?CH:N*@\Y[[$P+';<:I^<72^9=VXZ6]%1T
M42;1(='9@.B<'93H4!%</;UF*B!RV(<F#!.&]QW#=$9J&OO&AJ0S4G3<PZGC
M'JU&^WK)C@#[?>"#Q(;$9A6Q.6V>':+84(A([C6YUQ0B$H9W3_->87@S5SW2
M@2HZ4%6;`F(Z4$5H=`>-=*!JD90F':BBDR9;8Q\=J"*8'P3,Z4`5':B:5E;Y
M.>F#<_)6#H9*]$44!P^"W4:>'`AV_%'&<46E"YVM.LR3-[3"=5_A@SY;]4$J
M`1]A7JJ4B+QGEB@>Q:$N.&?<_RN-$SQEM;P^='WWTX'<\QX=3&E=T]$J9^@D
M!"\3&%S0;8HUMF=_1$K`9_X!)[_'@RAFQR'X\R)^Q<">!=&#,/8L;L!["=Z7
M'ABW/^%/@NY>=)7DG9D[NCO8&3H)R:O0?'JHQXD/QNIYLA=INS>4<:)$$BB!
MEHYU1"2Z01(S8PAU]XRA"J1BL5`/@2=T]XQXD7VZO9(X4A+NY'D<8OM>`8(P
M3!B>U^`MM)^Y07-XO3MS:$,[B.ERZ[>`=5N*@:ZZR]0#8'<]`*Z;JY38.'G0
M8\GN&20[>SJIW<E.^[!DA\Y&D0M-+C2%@83AW=.\5QBF]AG3V#<V)+7/H#X`
M;O4!:)\NY^+N=Q<`$AH2FA7*=YH'*304'I)K3:XUA8>$X1UIW>J^$S_]P+WP
MQ[MT.`QUL04/W_"01YZXZPN1W$9=J0:ZE/Z7__XOQG[ZGY,3<_+(5-LG+`QX
M)PB#)!#QR8EY)HU/>IP/?[R-/"5X+-X)\]_;2+]ZXWDJ%?['XD661D'R571_
M/DJ;S>81\X47#'@8_WQT<H&'0Z)$/)F_>_#WYNG1+R<MF+C^WT\_+/PY=V9R
M!C-IMU>?B`[YRA/0)3)QGRO1EZ$O5/R]OFXF>1Z?66FTF\B_2R`BMF^\U\\O
M.*'VT2_7[=;I^(Q>^HI[$VD=_7)U<36!L;DG<@N2%/4"[+;"XUC8:MU)7&5/
MW>B'/HGD_9,7IMA3Y5<I_<<@#!=?@?/VV22D7O[0[FD'IK?/SU>B?52D#?GC
ME!MITG]Z:Q]<F,?M]@0V)H?=+E7(O4G1FT'5;?0`/TI5J?#,GYZ!V8LSYZ)5
MH=.*`3=,`/#A8G)U*@EX'R6H&CX$(9ZEY8GHP0,9*;X(?C0/Z+]G?ZZT1Q^Y
MZ@D&&EK`D_I\KG[GIQ^F##).P5LY&,B(:87"[E#=Q>QSFL2`?(3Y)$GF!?V\
M>;ST]`B_6F5^-:O7"T#3/FTWS\[+],[ZPBBP*]7#%_ZL3RE\D.J+DIX0?OP!
MG!?]PJT^Q`#CW'A)\+"D"]`:7^$%O[CS.8#Q7P/U7U+E]3E6Q>J3(/GID&ES
MN9<W'I@J)6Z+9Y?PO\XOKJ?QO^H+NR17.UEG$PIA+G+Q)#T[QF,X^O1-S,$F
M`N'5&OQ7/*WS49<H?X[NX-'X<]=HWF4<W`D[.'WX'9,+##Z=8.\<U+[A<>"Q
M1X$!%&A,_@"JLX>UW%H7:J=O@N@_[=,WYN%/*?9H^MPU&NHVCL%!-L,NI`.!
MX>WKZ^NKYM5EJYC"O-]R<$)G.*&K\ZO6Q=7U"A.Z+9TLJXB)X&_W_.G]TU!$
ML7ACRA274>033LN4L;=(UQDZ$8N25>[/(8W+-]*?PQS4&R>X]);6]B,]/<PG
M48[`;_G<A6\O[HZUVA,,7O";3L\0_=Y)""T[PX\2'*A$J`%\MBO`8?9+YRMG
MY0C>V<=AL%*4^$E&WK(QQN7$I%[ZAG.S@+4YGW`4YIZ%R0;,D9\I#;-T1->Z
M/I]P*2?'W0%M+:3M<L(=F$+;?__73S\\=11&Q/]_4$L#!!0````(`"=TFSPL
MLU/+5@T``":Z```4`!P`86-L+3(P,3`P,S,Q7V-A;"YX;6Q55`D``^HMUTOJ
M+==+=7@+``$$)0X```0Y`0``Y5U9<]LX$G[?JOT/6L^S(CO9S*Q3R4[)5TI5
M3N2RG-UYFZ))R.(,!6A!T);FUR]`$3(/7#QD->V7.!+[[H]@HP%"GW]=+Z/!
M(Z)Q2/"7HY-WQT<#A'T2A/CAR]&/V7`\.Y],CG[]]]__]OD?P^'@*\*(>@P%
M@_O-X"KY(V1Q,OCMOQX.!F?')^]_'@R'@C0*\9^?Q#_W7HP&7`6./ZWC\,O1
M@K'5I]'HZ>GIW=.'=X0^C-X?'Y^,?OMV/?,7:.D-0QPS#_OH:,#I/\7IE]?$
M]UAJ7XY]?4\C*>##:*=+2R$^#2794'PU/'D__'#R;AT'1YF)GA_M='B13_`[
MGRPY^PFG_G`BJ800!U,D^;I"GWE^<GIZ.DJO[DBYH-`@>A<<'N/!8!ME2B)T
MB^8#\??'[41AO[@R.B<X)E$8B-R=>9&0,EL@Q&*N.Y7#-BOTY2@.EZL(R>\6
M%,V_'/&H#&4,1+1^TLL:M3-LQOB_2X19/)U?>A1S$+:U3RFR*S.G\W,O7EQ%
MY*DS,_,B\V9ZU)>69O_-&[N#28C9*`B7HXQF%)"E%^+A$BWO$;7;J$'>QU1!
MP,1M\S&UO2@W;ZC/`Y=$Z?UZS3\75*(U0SA`@50J3*P/V%295!<1OZ`B$F,%
MH4JWF+<FF"Q#%&^]2^)1$@\?/&\EG#P=H8CMOA&NG@Z/3[(1XJ?LZ]_'<9R[
M:2+O'O$AH_@E"YEP*_MR!,#<\X12CBVEU:5K!>/EM:(/N0R/:=$=#CLI*$.@
M8323&(V3Y3*5-@SY/2#YYY0L*Y$E9JMSEGT:;`D'C`Q*+(0&B&;/NB<4/BS8
M]L-A,R5N^S$.Q)_+_R7AHQ>)06O,SCU*-WS4^H\7):B4P5H\68S<>`Z=\7)^
M23-G%8#()`M<.$J$B9?9@E!VA^AR@A]1S-)'7`D>)I(L0$H2@,EW<,6<:[6`
M++7O8:5V[/LDX?;=(A]Q5-Y'Z#MBFC'<@50.Z292@"FOX9HY]69!&00^P(*`
M0"GF"C;<U%+*59>R.!0N`4RIP71S"HN,6<K^"2ME%VB.N,'!G;?>VJ^]:1TH
MLZB8*`'FU]TQ<[J-<K+L?X25_2E;(&JJMO4$64@4!`!3;'7#G%D5>Y;0GV$E
M])K@!W-Y9:#(8J&B.'1.\\FT>Z"942D98193-Y2L$&6;F\C#C%?[HM)?"8NK
M3U87TBPN1E)(*:[ADR;79@E0RR?FX8>0EWJ[Y\?EVH\2T=;^2DCP%$91I:QR
M9]F56PXLD,#0P$<-*-PDP2S4-`#0!`!D(NLEJY(08+63JMS[3K#O7#Q7B0WU
M<XX84DIK^:5)M$T&S$HK5Q-JLVZDJ1;00'/LXH4FM1K6+*._P,KH=>C=AU'(
MN!!>,,P8\?]<D(A;&HOB@6W*A;0CN:RJ;>1@G%?/!/4$50<//Q-T3@YQ\*P`
M;IOD=**AD`BS'R^[C#?>1K08S>U:-5&I45LB`@$!0Y_6Z),N\8HV;5D.S'3O
MUA/."*7D*;]3H;SZ4J4H+[[D**!FV>Z-0XJ50F"V#62'XP+=:[JX!HI2^R=/
M`36_=F\<\JL4`K-#D-93UD>UA2I?>$)]:.MZN(V?U>5NKN$1#6SBGX>G=J9A
M)E+<V2#F&K6J-!</ZU=J&JDPA_?<3#GGG$O3P4A>;3NHR?L!E)I>UX:,77X_
MGAWFKH5+Z`R$_8"*LZ>U06*2#/,Q4_5C@K/6^`VO?T7J&*/A?<+$/.>."(\(
M9CP?W)Z'"6:(HK@,I6Z%R@E(-T+[`=&]1+`VG+NR`F8G_YPLEP2G/BKWJVHN
MRZVIY<N'`U;'8"%6WPM`ZD9[NL6UHA5F.V4<!*'PRXMNO#"8X'-O%3*OO$1G
MH9+],PW5:T*36R3V!"JM<IBU_MCWDZ4(`PK28H+?$RN*%@C'X2/B,2!+=$UB
ML58VG?-2M-JR;<+]W,NMQ?VJ,-HJ<OO";EVC8$Y!;A'S0HP"^4I;SBT^JPK]
ML%P_NC-D\7=@>$U@K1V?/>'3Q0Z8TYX[BKPXH1MM]:<GR$*J('A-$+/ZOR=(
MJ?2JI@_#9PQ]'I7C?<T_[_DM3^6KNH?>.SH/F7@>E*!<O?"\+U1>./0.2/DH
MN^)PYF%F(4YX1*<K\?X^3UM\AN:$9H\\_J1#\;<0$YKB;(L=/H<M2MG"\!MB
M"Q+HMT4?0/-N/^;+:3[<P*3`'CEDU`NCUK-QVUVB+V@4S(EMYJH8D:47Y2:Q
MGD)VAQ44A\/?(9!&7,)4`.(+6IEVJ576P43D5\J-V]ZG)20JKLA-T+DKAT.>
M"0+$9'X!&0HIZ2;I/#?,S,V\",6WZ!'A!%7?7M%<E:W^TM7#95&5)F(SOY#!
MG(2TI5[FA)F]<Q*SZ5SLQ8]GO*ROM,:55W>=\>)5<-DSFV_*7H53U40<-DQ?
MY<P=_L7O,Y1.D;9'645\E!\'RQ"',1/#PF-YUNI(+6\S"S78P;.>FRX#JE5B
MEXGNM+46(QY0<3+(!1]4(I*^[':Y7B$<E\'A1+MKJ)EHP0*CCHLNL+#(4[5;
MP8)B@ODXYJ-*2>](;03&,W7/H*%SLSDX<A)5K4\`\!@O14ONK]2YZ;S\<F1Y
M1<F)6"X@F8G!8J.6DR[0L`FT=#3;EPWI<M'.N&S`*N=6$'*1.F*PZ;+8K2RI
M`=QW5WP&'S[@[;YC?W-'/1Q[O@C!5R_$PLGM++^ZK-N`,P-K'<XWUZ5I'M9#
M=F]J60USD\.S1UNO<V&X"!_#`.'RC+,&1^YX*1O'FT-\_3`>$NE.UL+<\B!-
M5<_$-%>?3^HH7'V#*#6%Y["(+%D&M,1/*Z/O7$RQD%*CT8TXO_E?3_SFL%HK
M>`==]+$8"G./]L[YS,XSA%%U+<A"55AQKU+!7!VW>6-=R58(L#0Q#[N1)G^8
M/,##K6\0#<5-Y8L-2N@";?^6%T8:L!J/NM:P'O:F%`=<<C,YZ$01%IQM?L2(
MV[B;B8_Y;.0Q?;.D%)[ZC%EP:C`>[FYNE'S2(BJ%(:".=C%(U-$*<XVRPPUO
M+PF3!NDF!I\*('"7G1V6N),),\47:$61'Z;>E9*LNK1[HSEWJ6^)-OC5(M5%
MJ3"[0F]P7:(91)HO5]0#C>,J!K#6R]M<_6R&I!:+HO6@U&BM]/!8FBT\BLYX
MQ12(5Z_X7$KU)#(3[8[/4A+U#3!.OK;`B4X^S.[$Y5J`ET^TLQFV:,&H/;#/
MC3J1E26@G:R^8;++R+6`;DLS8!YW*T^]<>O#.5*7#AZ"UY=K6KG7\;Y5,6]1
M!/.@7;$\'8O9)HJG.-T'/9TK:WL[H=SIKR?L&WB<?6Z!&Y..##+_@@69R7+E
MA73;'3:\Q&>FDNU_#57?D.+F;0N8:!5D&#F%A9$?F"(O"O]"@=S_PL&-_(2J
MJBPWXBR&%N*^`:>6[RWP8],C6XW'L'`T#OY(,JB+U].YOQ,>^/B.W"*??P[3
M7^)[7FZ](XXA21=>R]VKE]"U.V%HG[KZ=A.\9.3;M-[V:Z:\!8&U^\OK5!-\
M1SUQB(1V/*_!\;P+P,K1-U#7CT*;\L!%F008L"6&JNW5WUNU(DS/HH68@J7_
M&+/&H5.0J;1)E`%;@:@:+W\2UF4`4]!J<96G[3^@])YWBJ2"&@DA8`L/5:N+
M+[LH^R;UF+2@4C+U'UT.L>@49FI]$F_`5C+TXVWV"S?.3\42O?61*.G[#S!S
M!/;R,-RIDK`"MGR@N2NX^31!0>X(:K>13,]G'LP4?/V'FUM$NA_25"HE_("M
M.-@&Y=H`-'$Z/D]?(0@=HK+')ZL2B,#6,30>;[OK#79,&QC-.Z95C*]FQ[0]
M*OO8,:W4"G.'9;K;"@7IJT)B_6\ZY]\$B;!;O<O2G>%YA[6-`=R@9X(-:1`#
ME[%.H3/;D6W5!7.G-J]$TV[U'1G[_&:BB!O.1VBVN8D\+%Y4$[=8NNFO#+':
MC!)J[HR]@US3F+2!7@V=0`_#JKAPEL0A1F*_0WI$?CK@;Z^4SQ=HPJK#H8FU
M]TATCTN76#1J!7H*5\4)RQL-SO0ZW,%_KZ$NV#IXM<$58=JW&Z"]VJ^P7+<O
MRH54#R;`.Z3JXZC--BEW"%7W2G5RPM<>9P#?/";6;#=B'D2B"*7G",6FS78M
M)&CF""X2>@?!UE'J<!;AI!SF_G-YDUT1FO<J[0#9NR<-N4MCHBMW[S#:*CH=
MC)S.BE7[V0$,IAJOKT+L8;]!5\_`:.[JJ1A?35?/'I5]=/646F&^\)J_AV[1
M*KNYIO/9@E`F?^7<\!2W\BB>VWH><*.@"3^D621<QCZ%VO*SV:`.:),O9_PD
MCA/N()K.KPE^<("9F4&!,0U#GP'F%(..T*73!7-I(G\O&`!E(]N]IZ\AZQMX
M'/UM`1F]!N!]M>E<'@(:YWXX6C,#,!.7"GX-<=^P4\OW-H..10_P1AJ?A?![
M(*'^@E>$T[D=2W:&Z@12Q]!73#G'H`-<F73UH<TF+)VNTI[+Y1I1/XRKRT^N
M]*H6FI*^=\"J&8&.BB2-*IC-,/<3)NPMB$YDU3YN!%:CHAE2NXQ<"Q2W-`/F
M$1&7\SGRV73.G5MX^`'=>@Q-L;JE4P9T`U:)WSJL_>NKM8A,J\Y:/;WF`\"T
M1Q-G%\0_]UPO_^;_4$L#!!0````(`"=TFSS\-98CHC```+E7`@`4`!P`86-L
M+3(P,3`P,S,Q7VQA8BYX;6Q55`D``^HMUTOJ+==+=7@+``$$)0X```0Y`0``
M[7WK<]PVEN_W6[7_`];W0^RJEJU'G%EG)KVE9Z):6=*UE,EN36VE*!+=X@R;
M[)!L69V__N(`9!,D\6(39$.VO\11\[P(_,[!`0@<_.T_GQ<1>L)I%B;Q3Z\.
MWNZ_0CCVDR",YS^]^O5N[_CN]/+RU7]._^W__.W?]_;0SSC&J9?C`#VLT<7J
MGV&>K=!__^;%`3K9/SC\`>WM`6D4QO_Z$?[SX&48$15Q]N-S%O[TZC'/ES^^
M>_?Y\^>WGX_>)NG\W>'^_L&[__YX=><_XH6W%\99[L4^?H4(_8\9_?$J\;V<
MVL>Q/S^D42G@Z-U&EY0"_MHKR?;@I[V#P[VC@[?/6?"J,-'SHXT.+_*3^*V?
M+`C[`:$^.BBI0(B!*24Y/`T5]-P;,_J6_**E#CY\^/"./GU%VA@AULII$N%/
M>(;@WU\_76X8J9)5]FZ5[<T];_D.GK^+O`<<O8OQ'+J0**02\O42__0J"Q?+
M")>_/:9X)K8Y2E,FJY`"3?D?>Z0U65/^WU+X.\Y&JO:*_%]-(W[.<1Q4=H!4
M13NQ%]B\_49VXM>D1@"6)!6^2.X])W&R"''VMMD\1,6'=SC*-[_`>WW8VS\H
MWZOX^?=CWT]6<9Y]PCX.G[R'"%_C_'25ICC.2Z7T?7]Z5;(0D]1L[^IO!-RU
M=TIQEJQ2'\OD>P]&9ADU,(BF4"1:(`;@>._7NU<H#$C3$CTFS?`[%?([XYS>
MIUZ`4;JARR8HQOG?WE5OTG[[X[3>J5[JER]!_E?S'@7%.^*_/E[F>^4K4?99
MFBPZ]$QI1=*EM9,TP"D+IN]VC=758A6!/][DCS@]31;+%#_B.`N?\"4)\PM\
ME609L?UF=N\]J^';29(=1&]CO&60=S&ACGN.&27`C7R>'864WRD_V*:]!:[1
M38PSWG+KK1?$?[/[Y-C_8Q6F^&25A3'.,LRL/?6RQ^))T,`MM%\G]BW]@P%L
M&T.[N`6S(\R!8RN-$K_J*FA*_R\+(?=#R0P]%+1T`($??$*-O()\MY[4&0&<
M^VS?JWPG_8BZ2$!Y@K;0:R&N=]%W*(2O46JKB^U=S.`#^^%7`\L>G>9,3#\.
M`MI/7G3KA<%E?.HMP]R+5)F.A,-&1J,VQFKF(E;5R%`V1&A)J,C<FT"7TCF4
ME:C;K)5]R,B=0>09)NF0'](%C0961(^*"%][U"MY$"GIEQPT),H'_QKAE/]K
MMW@3MGNB:K#ZN,M35..JJLO&CH*+),W#/ZDI-[/+."?]$Y))ZS&)WWFF"H9J
M1ALQT<@TJZ%1J;$1(3E:&-G##77F4(@T:L)6I-1P.1,P[W*2T4'R<3.["&,O
M)BX5W28L_3I^R/+4\YL+;]`J1FR](FD7P_I%6$--\LAK)&!Z>G-]=W-U>79\
M?WZ&3HZOCJ]/S]'=+^?G]W>[SV*[M'85O#MQU8*Z"6<5[+=!V\A^1%/T.(!_
MSDFB_N1%D-`?YZ=>FJ[#>/YW+UI)(S7I`#-^"T-")T-MC@Q&BNL#Q"F=ZL4!
MF_/ABLN=X:%3<S9'"4-F^6#1+:1:[_HE3L,D(-Z9YE?2\&JJ51Y?S23(T3)!
M#W@>QC$AA32#6?V"(;1%;]:CKQ%K%7X'C4T=5/PN7K!2@O,\#G8.36*W"IR8
M_/J5P;+JR?&!.7)B<!G[*?8R?(;9OY=Q^_.F(,$V8NOE<ET,ZY=@&VJ2>YF1
M@/:G\-VGU5W:N'*A3EPU_S'AK-QG&XSMW'LNXR?BY$E*Q!JY#4]OV5\$IMAV
ME+J*+A["<TZY/UQT"D%#JKQ!1*YQ`XY%A7\%6'8.?/J]GSAHNL+!5>@]A!&9
M_QHZ@8S7LD-H3#1QCARG&99G;%UT=O$6F93I#=M;PC8?H:AZY*(?:=I?Y5,Z
M5HU_2=A5OF89D_R\VEA9IPF%Z4*'L?;&A^^2#Y6,I)T1PU_!BZY>//ZV[29G
M%LQOT\3'.,@N2#M\PLOBR_W-[.XQ2?-[G"[.\(-JJZH9?[\=3%U,[+EUR5"5
M8L^2D83I-<[1LB!%@$&4`0$BX\4"!83$G8ESI^;G=BAU8JMO33)AY?8D;0/!
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M]E-1]O9@C0G]G56N0.V9,KXI>TCFP?!@4OR+O`W%;OW-I%N3#AW0]B$)0]UA
M#/&R:^^X6>5P3AT*`Z@VB:G8;.P-,S#+ZI8PA;[&3C`AUI.*W)WE'Y-&;&T$
M4_)8V_]EJ7O-MGVIE76(>3SC]&2SD^O$BZ"P`WH=EKAX\_)`8-XQFOC'<2@"
MH(5XH9=L?YO6$%""-/:<M==7@B15/FH72[L;3;7;K)ND=D?-X39/-W0H1\>E
MEZ(GNE/N])<+M/_V<!\V%[+'?T5'A_N3P_??3X@1[9R1/-[_?G+P']]/_K+_
MH7P<9AE\?(2)WM$^83XZG.Q__UXP"",O1Q\)OA_1T<$$064?)F__X(?)X8=]
M@;S##Q\F[]_O3_YR="21=X9]O'@@YC.1^Q^<=$WU-N\6G4-KA%E^,_LY28+L
M+HF:4[/ZR]8IK3B.4+E=OZFI:+I-1D^4S^$QRLASE[`E;)LVM!IDSB"+^WQ?
ME.Y1'"=3$/=*4_1&])O7*^7+\Q(%V_2TO=7HQ]VOG.D;LLI!#&AK^8><OLH^
MS`&R<Y@K8JB`V$(8E9M@,Y*VM30*D26Y%[FW44[3_)*P*J+L/PM7:^@T:\JA
MM:^L=-WA%]]W+GV4/<,S3(P*6*VN>^_Y_'F)XPR?X!C/0E7PT'%:`*6A<3;#
MBD9E/<:4Q$5U-T0ZQ"6,&C9?$[!:-H?`FX9/7AX^X>PVB4)_+=L]4&\5*9,5
MR.I,ZKQ'0`]9F<HF6DLZ=!F39&55?2_]!0=SF-\>^^2Q8Y%6WZ)M`,LY;*U=
MV^EG>2:OE*\JNB-EX_H_FR#VU*'OX=V[W+0CFN5[9/1\,1_3$#%ZP,N],,IN
M9I>+I1>FK`3%51+/KXBM`2OF\@N.@N,X^#7#P<F:_J3:4]578D\GLO(Z?3VM
MKQ$J=^PG>UKQP<(0<.Y15L1X$3#3"`[LNY^66^I0WKOM"&R$@%Y"^3AAU7E&
M#B;G7@H?+K-;G-(O*&=AM,I;VV'XN"SCL)`W:8RQF>)+5#62)?8CP@4Q_6+A
M<]\UW!DM-4W7S(ZDY,ZD]>>S&?:))YT_^X^D(_$G+\<WL;BX@@JM7<38@/`6
M9EO%=0?]=;`S3AAA<,&+X-J/#"5Q4=[6Z9I'VS1\RRLZR7#&5:@'GWAD<('*
MZV26+JHTRK>5A,$"_-6FV`2Z6%,=TI1F#VYF"5!YHLP=Q*K;JHE-&;4S*/PY
M3;+L-DW4"X8\E06\"93:!!DGOHXL^@#.?I(G[B!*T!I-&-5(['X]X$0/]]E`
MTB.'7T:7N/11@)_.0`F2C.WR%RP?R"C['595J^]9TT8J7'$F5<(SA;M-($D*
M:]-T[XG,"N'TW=XL2?<RDC2@#/NKU(&%556?M2;?.L+ZX50Q,7<DU0PJXY_K
M3A9X4]!5LB=$0U6=X192]3VYK5+=N\"31+CR@+:0IUY0^.Z>_//Q_/K^#MU<
MH//C3]>7US_ON+"PKA<3PS9OG<H6$=?.8IO`8B?`O_>>S<[>*LDM`%QMB)VJ
M!"HU.KQ+&*?L*;K?_9=?;2])8*ZA%F!=S-$$_-A8L760=1"@_'[(0\7=$ZGV
M`"3;W6\?0CNO!$.K1-TLX:K<,)X+K]F(Y/6IFHQ#U,"3&&>[.J1$5^?"=TT1
M1=4[C_[EA)-T:&1ME3L9GTF)NP:OMKZ=!FP[=R6HF4NLN]M,EXS\J,UEV8FD
M9MGV()&B+N[3YI\6/[DU!35O897[R)DTOM-B5#F.%EVC>TW]]IYKG)\_^]$*
MC(23%Y_#2'7EG1&[E>I0YF;:K0^EUUM?T:TXBB'&L3NKN[1DNT*4":\[*X\Q
MF<;A+"^VG*IA7*.T@UB1<LO@Y%6T<$@?(LR>.H5`4<L(P%8GL_N5H2%^P.MB
M%=UT^.7UDU.?'HJ*YVL2J)3>SY%9@59;K?6-VKR2IN<[4@]?VL92)/$TMC97
M;]L;JDR[)E&54G.$FWY93]"U6QF!N&ODS=?,B"L*/O65.]4.PD#Q@>@RAO*_
MQW'PT4O_A7/XK@9[<?)UE9##%AV<YEY8YNHLUS%=V1Y(56\7&+(!K*RH#V:B
MVC\'43KE)+LP01ZV^^O!8E!-K<`SA+9Z$/MZW-G>1X\OR)?9QY9J"T(8(UIP
M'G:Q5O(14X"X1:#7M'8H4X+*=3.FYHW+WVQ>>JR0?ROZ4J+%[JI`$)MII9_'
M)"+)><9>R:STB9K55B$4(P.ME471:3,JDJ(6,N4O'(*(0O?O%K3?%6%G]V&C
M:Q<("ZJ8<<K*JRBYA<56.D'2,:=3+&=H6>U6^%":-U"1%J%.4<F6J.$]6<U[
ML`/>TZGG)`LG>K[!ZKL(]8U2[46+@<-O(&ATBC,+LW"LM;R+R:"RE(#:!HKE
M1E@-6VTUC4I]16FBA9>7<X=DAJ($"I2Z=P&8HM5:B!21.HG!:_+NG6#(,5A&
M8MN4H<!8::KC\:J&//KY&@#IMV#J)BC;#:C")4_M'#3EQV5$+V_AR(RHE7H>
MFC%%)*=&!L?0E4557>MK<%<C=09TUSB'H\FW:?(4!E!?`JI,7,878>S%/BQ/
M;,HY*2;\6PCI-?7?WNA^BP!;Z94O!VPA;@H,<$R1<J"'-7J]RFCUN#=H5O(A
M;\/H0)W5[3NK6B[H(:.V<-!=3K6$T!_DSKJV8ICI(,3"Z-/=9)N#DKGV^E@%
M7\!I:0MZB:_(#=T9N+JW<',\ZR+![@*$N>;AEB*VP\CA-Y`HNLKU9(AE;CV3
M(960(9(A`Z,'28;4>CLG0RIQJF0H+/E>1#)DT%G:9,A$ADDRI)"C388Z@-Q9
MU^Z>#(F$##?<*4P>(1D2:%<E0R(W='Z<4[2PX3@GE#!*,B30/'HRI,%(*QGZ
M!I(7E`Q5QS][)$,J(4,D0P9&#Y(,J?5V3H94XE3)4%+RO8ADR*"SM,F0B0R3
M9$@A1YL,=0"YLZ[=/1D2"1ENN%.8/$(R)-"N2H9$;NC\.*=H8<-Q3BAAE&1(
MH'GT9$B#D58R]`TD+B9#XBJ^M_2BW^9Q?T7,["3&QG646YAM,VYVT=^.G&%!
M`;OO7T`-Z6T:NW7Y92<9=H-H%]W#A=%M(7/X#3-F_>9,3/W9"^,,RI_B[":^
M(U9G-S-AY2N^P11,O2:.>F/Z31"5\N43004;JQS[>N[1&5Z,:)%8*!WK0(DK
MPQYKS>8,:&NS-CE]-3LS1\S(^-^D/*Q2'9BH6$E14?="OH$9_:"O5B#'OHJO
M*.=67)KXNJBB\<:!10V#YJSP;D)<`[R"H4)\!ZCL'O**6"^BMI#G*(RPF?L*
MU-13W`U!`6-W0K:BA9K)AY#4;EXJ4#%<^JGIM<,OM]M<2@UI=&>#M/Z@B(#8
M!NJD)E@-$BTMC1A!A[ER$[YKJ9V\C5IX$U`Z@[;;XG*?BR2]31,?XR"[(.]*
M;>ZV0:"K)`LXW=)XZY6I.MHA@+EC)1.W;-@F\CN+L3MX=E2_52V0`:%!QMN2
M&Q%V5/(C$(!8=-R(</+NZ=W`2#F8CX"C(R&.K!16[(&FHV^1IM9%SHS`U,9K
M(J:>ENI+N&H8;>6!6M.L#Z=JM>Z/GF;-)DP3%5RVJD/:ZU3%LI=.AV+E2\U:
MS`IX@N).#/2ZH'GS$I'0I6\:RV)*'FYEK%.XV-$TY&9V%L*W\3C(3NEMT;2J
M@V!)6,/0RT/,C+%0`E*K2.XF&M;IYE=Z"3%W\;8#U1G-VK?R"D/ZFE>H>2JO
MV!V.;-4>'`Q$O_,3D&2&*D@Q(D2IOC0XR8KI[190HEQ7K&&$V8>DX>J3C2\C
M`'5J=V>F%+=D1`^3^#@.Z*!_FV1YBO,PI1<HGN`8ST+3\LY;B^H7.7N^0,^(
MNKUV1:S=5NBTX*2[>>ILJ.1SP*5Z]A@7GOM*JH?M+:5Q`=V2!XP=`[AED,LL
M6WFD^VYF?"$@D;?KF?KYM;%1/3W81(_"5_7LT\UJ+#O&55"Y5L?,L%/;3FC.
M4W<W+1_G6)W!MD,7@LU3-S/R2[""540LO:;2@,F:"ZF-LN="4CUF+B1A;[B0
M2WOX##M2Z38:'JG;B/G$;F,&L%VZ#:3&-\N<#*#9^3-._3"C4PW9FK:>U\8$
MRM1`JQ\"=4KKZ]IUW\`%$?A'1N>;">-V9ZG3N%%;TRH]HS,3JT\XPZ1=8,OY
M&7["4;*$)/`RIN_0VL\'S:+CZ#46&)K3;R#0*Y&/`CK>Z64,QW;A_U%:T-)Y
M3E!1[WXD,&SF:A@P9:B-`1JF:@#H"*GQH_\2I_GZED`"KH.`8QG40/6-=$HV
M.S%?:Y;E<"_5UXKTE'*"ED!+X8]+:L>^;)JTHB"^*WB<">WEZMY]<NP3"U/<
MO/K58.N;G-?BLJ_6P"&V+TF5-K!,WN'1RU@][[!Y+[!#.#9M2]D:L()QF+U'
M4H4#7N/:J?,/O_5^[M0^<H&Q)K6UE6S#`'K0:MLJ?<K@Y6#E;9.V,\"L42UN
MVWT[;IP2=G$[1'T%?>QT2)+FAET"E%S($)#6FCQH\))J5X2RI6J"X3#PM2VM
M=0.%A($#GU3SF&'0""S-H/@-+:(^<R:$?L++S384Q<=<OJFD+!:`KS/'9C"4
MZ:J'O@V5:Y]BC;I$@E4YO=TX)M,S8-0RZ=7#KZQ;70HXW,D:8FXQ4MS,Y+NS
M):=[9,QVSV=I3!SH9)]$:STPT5$F"^';%F`XAYI$JW3MQ*;(CGVF&5%5G(.=
MS)-H'"'?,@/`X3<$%/WA3&C[A.$N<AR<>VD<QO/LV/=7BU4$W7^&9Z$?JK,J
M+;.5`=G41+N9EDYK,^=B]`@7#.Y@V;P!VX.SGM,9*#<W!7UD5U:NH39>$D78
MIULJ;F:&:\!;2+.]+Z?;2PRV4\?,#-7>'=C7QFYAKE]WZ^;JX_9=H-S78RK*
M&8>BQ?(^X2<<K[!ZYT*3TH(C2)3;!'E#11W`]*$[H)0T1Q-P+3)WP.0_XF`%
M6S5/5AD94[*,2P6SDS7WE^PL3A\1Q3ZCK43TVI_6Q^A^F]:VU"S?R;:5P&G)
M!?&^Y$,\XP0NJ^#G!?\`;D39_W>W'M@+<8D-"-3WQVTCJ=HT]S+`W^U,L.9T
MN1,^\'M]WONU0EIVJGCWH!Y[*,1S2/4^X6620A$*LU.H)ES]G-7<+!N>::1-
MX8@&_-/->%-0.W"DID,K<^[6@:GN6WI&SI4<0)BMBA`CP`O">D&&-G2H(G0H
MCQD2>-*P/C#TQ@[:C\0R^#AUDJ1I\AE6PU038@&UC4FQW`BK$^.VFL;D&`C8
MU\>'#8E#DV5Y,[4FS")2=R;-I75F:Y9"<INP&WC54:1'"CPGUPY5+26%GJ.K
M?^$\#F>A#QN!?#]9Q1"7;Y,H](E89:)JQM@OD^AD7,]4PE27(ILP$S&]6RT6
M7KJ&I1*.!54\J&1BE5#@2H?0W_4Z98=.;R<8W?CJ&881+Y=D;`7,L=TN]W):
M5N5F!C<Z743)9]6U,$KR?BYF8$A/QU)K4+B3BG%Z>G-]=W-U>79\?WZ&[N[)
M/Q_/K^_OT,T%.CV^^P5=7-W\=N>`QQBT+^<G)M1U[U!P<#[1`3^C>P+QQL<D
M(N-A!OM0\_5UDF/#Q1)CWIX^TM'$O@YCKD[E/:922+KEI;@@_0XQ8A<\IV.K
M\V[4E;7A4X;LO(-MB<2Q;^-+DN!S&$7'<=`\T6?F<AT%]+NM;RMC+:Q:=E:L
MN-JOFZAI182*<CB0`I92=N^5V_4)=_??=OSU^P`[R>#N"'06N[;60W<&7%@E
M+3DH8MLX=G;)=%Q(RQ92=P/JD8>?VMU0BOF.F*Z70RI5]_,ZF6BY<XDYIJ>U
M&\`<N.92V6B5!ZC):C`7DE9H-NKX78)6L2YK_7*ZP>^E4UQ)=P_7*3I[)9W1
M;73&%]'U[IOA+JJ4]M#AE]=%+AV8^#5.L1>%?^(`+I:&BS-OXCOL%YN:%4%`
MPV@!>6:FV0P3:HWUN%'1(F^Y3+$?>NP44(Q(+`]@<3O;L+J#5K-&;<)7Q^4,
MG'_#X?PQQ\'Q$TZ].;Y>+1YP"M7]HQ7YE:[_9#>K/"/Y(W21`M]=)5D`_);&
MV_2`CB;47:*@0I\+(<AC4ERZ*Z)/%TN<H[,89[Q%7'92?TV=FL_*&3D#P^P>
MCU,H;)Z,<[&HJ7GW2%"L87(&L]K*C?;*,PY7@U%4:)%EN6YFM^JT=I@IQ]!S
M#>$DXR4VOTO3B6KO#[N*\#+.,>EQJ+U3WK"D<%T3;@OXZF"D3:<W4%N/""4!
M"BF].ZCLT(!-R!JQ.@-G>CW05>@]A!&=Z>C7QF0<MJ[NE1MC$ZH258)[>C?+
M,E%%[0Y0-4TFO*]71.XL(*]).W3&),<T`"S;)G7^4-T5GI5*$4*KTE(O`J/M
M]M/!E.>P>J5T[UZ5?TI2RM=<)2UF*WJ;>SA!U>.7UM^FO2"X.%I(W[@TVB@:
MC!S;SO`,$SN">^^9);;7.#>*;QI&"S'.S#2;([!:8SW,77&U\QA7D3$BTBW.
M36G,VK(9\W1<SHS0U5X$6B0+ED_HAX%/F-89.DVR/*-K@B=>AH--Q5+%3K2^
M$GN-`Y9>Q\)>M?Z6R(>5OK+9SM(]^A3Q`A!4GG7@/(.E;JQ&)EL":\-73Z'5
M&/>27<;6%CF'_04VT7&[Y))9W6<**8B*F2#F6P_4MS:7U[NUL\XU]Y+MO7/5
MP1S(-/5+.RJN@7+,`9=X%.H:7W5?:$ZI6>M1LKB33596=EWUT;+:Q:RUM8(.
MP#58`E+/C9Q<$#)M5`6B.R\.[>0CKG9?M,T-T4/LA.ZP!;K:^WSL0.P4-'$K
M!9$\%VQRENUN=F1;\X47IG_WHA5W2DTYWU;3]X*BD2D6YLHZ/7*TJCFG\!C1
MYY"U7X2Q%_NA%Z'+F'3URH'J%?H.;`'=C+R&>R5+Y0:[0I*M*>1`,(+I'P<D
MCL2Q:9U-(,FF9*Y#Z:@+E)YP^I#L(#`1*Z=?03"J.F-X#(T\2/^_E9>202U:
M;[KQ,IXEZ<)355"&]C5D[.4A9CIL15WCII`[B['!TPUE;3#?T#H6D+NAI/*J
MKAU8=R\S[LK/'()DI^BM22K'PR6)YJ=)',#.8U@%CK,D"@.Z)%R!=%/IQ8$8
M/S`L)5%_'%B./`[<%S<HT3HC=+!2+'$)B"TL:LE-L+F,U=;2V`Y>OTIJ@KP<
M^4F6_Q4=33Z\/YS\\,/WQ2-X\I&>2#@ZF*##_8-]>C3A^\GW/[R?O'__%X[L
M#/L83J<4E/L?W%GUDK=Z<YU+1&EW`WI;PX!WCJF!</@-"5V0X-)>^+(`V=UJ
MN8SH4.5%ADM0QJR]<HBN!EK((3JHE&<1QD*F0(EH$;@]GIA?<MA]]M"U&ZK\
MH3-G+7\PY:XR"+=@:6N^-2HF8<ZU0>4$R5#IV+QK>(C*YE[C@73DT:&\@_`6
MI^5&B=!7Y+IB>@O)CM(0FQFO4%$]Z:4_;:Z<1$LX7\*='7<G1U$V6C--D1`[
MDZB</_LXR^Z]YQ,<XUF8T^O]-IMW^.T]Q<PQGA_[>?BD*Q'23ZX-:-MX,:LN
MT,>@QOS0>T8/3$IY*R6W3ZZ\6=U+4V*/"^LD]H`A\[)^0E^@-]Z0^.CE]KU1
M)+=71F?EE?HE>7U-D&=^_237_?AUBI_(!,J+LC=MG_8Y42_1EQ5]6^6+=L35
M4LA>(JN\TJK_C+T44=W6SNK17&;9"JN.XLLX+(S*&F-LCK<25?61])2O3C0I
MU\A"2NF.GVE:K3D:2LF=&>?H.<1BZZWQ*>86O:T#S#)#ACF[W-0F.K;LVAYK
M93,)CRBWB:V>3N[39?)$029:<R:YQ5'T(OO=X9/(JAXU:&S!^>,F:>/HL<Z%
M=[P.0R_06<L6YU5K`$W.`=9F),99#U(:O?5P51(C0LT.:[D#<<,&U*W8M-AL
M!3*+':R8^VB5*&8W&EY![T_8K5YKA]:PMX1$ISYJ3#K43-RTHEL4&;V>EP_?
M6/$99O]>QC2&;V8XW$$3P6?,+MR]W&@+,_NY5#>%<O?J(L?=<C9=^[KE8MLP
MU]RM@X#*]7K`<WPW3!88ZB[#JL-I`E?]K8B%A:EP,SR>)2EF=/?>,\X^AG&2
MAOF:*[!6E\)N;_J(\\<D,+N/=4PKK)3Y&[W1[)8+',U\23[W0.5SYR5W'6=V
M!49)ECBJ"79WN(UH^G!U7'?D(8??7,1%%W%JZU^U^GKKI3<IW:P>T!V*99YO
MMO8NY;:[#J\S<J`U>9E:Y?K\TDO1$STX>/K+!=TBXMC>D`[MJEBUE[,Z@_+:
M]EOVE4&!:A&U[;W:=2,&VZ[/U)CNUW?MV@M%BRDW6)>DSN!O,V@4MQ04'V:U
M,Y@VA[6,2FJ,]25:B;YF!7%W\Q)I4XES"`&YK458"UVG7"F2"%>N"@EYROZ$
M/2/%(_2Z>/CF1?6O4<.WEGA$Q+7E'!/G'KOZ",ENPWG,2DOYZ_O4BS//A]2W
MO$J+9<#$;D7@ZB+%0C#;PFB;@VT']<UJ3UFQ&7+&1!3EZ?WU!,78H4^O6S1P
M,RQV$N',F'WWF*3Y/4X79_@A5QV!DA#V"O1JY?WBO%2V/,Q+6*;T=P0/T$F2
MILEG,F'>_0*_NO&JH*ZAJ\5T,6T5TLU`,#*$H:2<"8+%=+T`K%3=#[\RT7+X
MBCE8Q3T*7GBP>]PJVZR"K9JLAEHA:05:HWX?&;/EY>F*%&-#8B%_:*JSF1R4
MLNLC?_FK.T-\LPV:XW?UW)G!^39-2,(,J8,")QR1!:2T5=K$2B6]CI9KG&].
MF;F#F'9;-#'#4]C](%1)'NY[C;@W#K^$[G#IXX/D/EI^&[CNL*FQB.%N/9::
M:S,^F.H6G5)]X;<<2]O7\'IC`;\S'D"7JQ^3B)B3L:^%E[$?K>#VY5LRH2!3
MY.,\3\.'5>X]1/@^@<W(29R35B7VS#<?'N7EB2TKZ#>I'>1E>TZ&;=NDF$3;
M5<5N<BGD?8<PE?CC[F<QP_0R-VL?1GY]MF]5![=*,*@WOLC8I1C;+2FP,/+;
M?56;>8$=RT3W>V>"\.).KF"W1YJ9A"WIMK[[C8^_)4[#)+C+O32_&GCP'&'0
M))DPGH<Q3-O0B4=4^0[MPK$/Y2%`,\0`:7M@=,')NM7Z8FYV'@=?@)-!P3#R
M)M]\K`=FOF0OLS_`=JL9W64!T'Y:=?0MK[+8[<XLX!S[?K**\^S66X/)^KOY
M)`P6?$IMBLU)AUA3?1)1TD"!+R!R!^+J=FI"5D;M#`)A)W;(#A8<QP$[N##'
ML4^$`H<"BCK.?K51S<SJMWJG5Z*H@ZKAG=9^<@>^A@W+%38U9*A7,U4S<45,
MNX%H[/`<_'-5G+J!L<3+'B]SO,CNDT\8FCN,\#7.JT,[]PG49+U-DZ<PP,')
M^M<,!Y>B*EGT^*TJR@^JM]\E@V,T23^W'MI$Q16(@VIFY^(=V^`Y"AZXRQI'
M45>_^W%(E=Q5DF/ZO$D<]?QH#ZY6V#\JHB+YX?<[3'/IGW%,%$4D9!\'BS`.
MX8L"4=@,&8;417OKJ/LMSYB9TO-SH%:)8A5%PSLM""9HSDCHE1=>C6BW8<&T
MMY..?=)8U5`S<<L5.X13MV6\(/'I+7[TH/#8P()UM_M'C+SY/*5WN2"ZU$'/
M]&4H9??<0ZMF3`[RT"Q,%]^1J5F:!"L_ISC,</H4^O0X8(8^$TKXUR/_)#3*
MR2&+,#O$DKU%9V&*B;A23_D`O9XE*?G+6RPC/$%^BH,PGZ#/M.1SOIX40I]P
MFH<987R#O+02B_)'.*#HQ>@!HX!JB-8(6IB]%3$/95Y$KWG-EM@/9Z%?OAFQ
MZ3(.)%8)E<1)OHV>">)>$>4XPLO')*[D3Q!=O"`#/WO;)>D;Z*)'+YU#R_VL
M;UXXNA^M`FJ$ET)Y&&)(G,1[8!2M0)\E<8RC"8()Z@2M\J(BS(3N]UG%H4_A
M.4$X]]]."G&;%B%=0J]S@/=8$B#2;R5@#G[&_@I&)-H"1?2@<I9IZ--X1EIA
MD;#?@",`XV$1!Z[E(T:2\<TC5LR3)("JI1N@,8`2@N7J(2*-2:$*)^VI%#])
METD*<-Z(9WU&G)N\2D0ZAQB3$>$IZR#2;0LO_1>FME+9;[^L<"I=)AXHH&Z=
M8UPG.2;YS>;VMNH&/,E.I<WIB<TIDF;U)!&%G1,V;966CM?4!!N<K>'HI[0%
MH>-$UPBB?Y3-N.-B=:IN:Y^RD?9M">,VH>!\C;S_MT^)V[*);_"'(_1PE3#(
MT=MDL`UFB4'6L=W6TPGJ37;AD3(V(+AT7*<#`E2.H$:-W"\:?$HW&1EHUA/G
MH2''TN<P0YC=P422B#7D$BNXR0!R8`0Y*<GJ'NCA*9*NY%`LE#0Y)I/\9;:*
M:,I-<B/"3-)&2'^**YQH,I6!!7NT#.)#!>@J^PJ\W*/XIM^\2"XXI#%0DK&#
M+5^BDTFSJ$'=;/O!B;L<K-A6<?>(82%I<R-N<W32<S2;P(BE7^#H8%3/,<I,
MDR)DF`B8UN[#*\@0I>-O)=^Q`W5!0K)-5S5<R("3<R(G0&=]O!H#?JTQ*\5+
MTA)T<L!FZ;`.D=?"/[<0%,9/A#1)U\5@`X-,L;HP063>CLAOL!`2A8N0L4RH
MV`<O"^F$/<OI&G4EB#U?T$IW0!!@&&3"N$9$)^4%I?=/,AKY$5P=025RDNCX
M0VAB#U8DZ!A'7RG+R]?=K(4$Y'_XM[GD!,%+9+0J&?(>DB=<:/=\/UV1WV+B
MJ*1EJ/J8+HBA)0'2HY>Q\U'%-TTZ:E8RP;:"B[3W*J*M0,MX0*&W^MMZ.34\
M2C[C="^9[8'^O23=8XL4M-&]**/K%N7KO$471-W5Y<4-WR!`670D&]N]!6Q)
MH,:P+@$C^2:G"0"]!0B:CX`C\GP&%&CUXK(#VJ*D8=*RF:A>5K"N[`,\FV&?
M+=)X[/D?*X]D%K0\<13^L8+;[F&9AZZ?A8NE!]30MJS0Y%ONJE`00O./*'S"
MP00M']<9+.04]X<P$;#`0Y.=,&8@`,S#6F9,5RJ)B(<528'@S0B0V?(;9DM+
MM65,^@=@.(QS'`-2H(U(GWD1,>J<+=15:VK$S0*`?A@%Y;I7L;0'+P>;M);0
M?(6_<%[%N0YP+'&:K^GZ&>N>#2?@#CH-I"^A<'I8V,A\)HF2.4`?9?XC#E9L
ME;&4-Q$*G*<$AX0E"$*Z-C8A""`^S_XWAQHK,YPR'6P)EV`[GF-*1X*%'Q:K
M@>0OQL86'Q>P#^M/UJG%TB/]8$D]9[58L2#2501]0/IUMHH0='\V*2N19N6R
M!M>J=!&:8N(11ZSGZ,HK[1:V5LA6-]<\T[:9<]E]7-9\>WO.29YHLW4V+O%8
M`&&S)(IH<O@C.GC#.RZ-=V6]LTT3D;<LKE>#=7=($%FTQI[_2"-Z$F/&7/0G
M^2G%CX07%OF80-Y4TD$07V&=FO6%5WV@G*!#9I&*B*UI4^UU&J4)M'6.WA3-
MR=R)0\X#&])XX?RKB22^A=THC"23T90-_R-Z3=JZ65.)^4/4>L._HM>D'>9>
M6*PY<P."4`*K6L2%J@!GA(H-,EGQ(2,MPR98![_"Y]]D04!+7'N.BV#*8F19
M$Q;"G;=1"BC,U\2X([%Q$--2:`4O7IM:2I5NIG][G&HVSD[09]*B&R<HZ\_#
MWYQ`*@J6W4D("^"UZ<>%!Q*0R?^1#BVB7!%N']9,'MWI668'16`G@Q*$"?C\
M`&^S3,,,?T=0L5GOW`0&Z*7OWQ3AJV0O!E$V6M%WFZW8!PRZ892>NH-7)\-5
M1(`+P19B`.T!2A^S$%/8`?V7HYD7%A5;B<KW;]`J3C%A_Y,\A4VK8*RH.[PG
M+XP@'.R1EZ:?8\@P1+J#-2(;2KV\F3!4(9KF2P\YS\0HR'M"`-S+$Y(TY/",
MY%"D5>:07A2=(U!>DI"7^.%-`36P%IP]F<?T?:`UXLW@09H;8A!T<'E5PYJ.
MGFO:0CP7"&.G%N#S5\'$RH?"F[[^"_-\((.V0G31(2O&8^`EK&DY3!<Y2%I\
M$V0?GPJ9,.;QPQ=\,DLQA&>*VC)44K)=+U0,-L^2+E8,/M.RN%$//E+2OP(<
M-C?JD9]^/RLF5?=$4V,>)WI4M$3M4:]IHDA)OS6(AD3Y9*]&."W_0O#G;B$M
M;/A$U6)U@/(4%1!5?;8#P-V6IZ_.2,24($](TX!@G<8*%H5J[8"R*5J/SCI'
M!5/V.R(/$#QQ`['B#FM!5]6O#0S72-M@5O;^B*@^)L8$8-!%Y,T;X!(^*]ZV
M_JS?WF*1FIY[@1LB%7MW:Y33S9\(_MXM-L7-GRB;K;&'E2?A]IRJ^FX7V#O#
MF9^&2\%G"15)$XD\B1U`"I1:PF5=L@$\>08.I=S/CH!5U%%MS,J[LPE=CE*`
M8$6?CPCD<SKU_H3G=%=4G%][BR:R5"3%FPM)^EV_J5#:#\@2R8J+-D4,4_8K
MJGY&\/MND:SLJ<2D:1M790HHN?LQ#3I]="2?8E@-B2[C`#__%UX+H2RAJ6&Y
M26,!S!*U-M#<%JV#<Y.CQ'/Q.Z(/$'GB`J)E'988-;`(TPW2)J@UO3\^JMDG
MK$_E&B+LC5PU2\&:D-8Q+B:U`76E$580+].@!;Z8<8/_XF/AYCEB!$ZX@;IK
MF]Y@`H2Z4P@Y6KYAA)K17>0W'$7_%2>?XSOL94F,`UH`LWEFU8BVYB0R6@M>
MHC'#AIO(5>C\1,99.@H\1Y0`E12(D;C@*KH>3CKUA,A9)"Q-;S&$S^CN\O<D
M6L6YEZXOP@BGXJ%$0E-SCR:-!;>0J+7A#FW1.C=H<I3PW_R.V`,70"_KK\2H
M?44@;Y`VP:WI_-%!3<TX+;X&"B$MI*@!NDYA`<Y"E3;`W!2L@W*=O@0R_165
M/[L`8W$?)0:M*H)PC;`)8&5GCP[?6[K5YR)*O.8!'.GS&G3YYQ:`*U!G`[9U
ML3K0\M0E9-EOB/[H`F!%_9)HVU($5HZL"55%YXX_':TNPV7%YF]6>99[=/.3
M>%)JP%"?FJH8;$Q0#0RR,DU5Z]%.5E7LFRDKN]V`4B%&AC@Z%SS$J/^;\U=S
MS-1GL0J^UERV`\Q&]+)BBGT19KX7_0_V4O$G>QU9T3I2LG[USC3*>Q8ZDTM7
M5#B3,4W+51WV",$S1[[B:_LP,6WPNB_(J+E"9H:PV,$^%6Z?ENP:/Q/2QJX5
M(:F5S2LJ(^SL89%HT&]E$3)6.UJXQ^@?0(`HQ8[/V1MU;FN'BP$4"N=0<;3W
MNYC@9O043.87DJ>UY,H2^B6J;*1-9AAOTI8)D3M`EO5&HFE#45XC0*BF.\>^
M'Z4XRG,S.\,S3`:7`(XQX#BCKG,,Q8_F=%/N;V'^"&6*GL)@Y44T\3KQ,AS<
M>FNZ_UV&[>$4%.T]@()^YSD'>^&>1XZ'L$MQ0M2^NFDI"?&B=KRK?CAX)\,C
MJAZR[.OA=O</[J4["YQWJX<,_[$BQIT_F45"+4<KM,DY+,4JK4FV@H]*D4DT
MD?-/JT>(/7,E-.C[6^#KIB!I.:^44>2-QL`:V;T^L4(`MUY*<B7NK&!U4EOF
M9EMP%BW9A;.7VVUA8C_WZZ90[H9=Y$P+8D2I$4_.G[=W)^_?!CA)CRZM^V\'
M`94?NXC8;K5*<IQF^,HEX$+9$CETOPZ(RDYTC@W2D0>=R]A/,4DVSS#[EZMT
M?NHMP]R+)*5!NS,6[=J!L9?_=C>PWX#329_<;3N(F9:TZ'5)_0;.X6\84,'A
M3&'2+4"3;-^?=4<VYZ_\V#VL6AUJ1H<L##2GK-P-`#79`+4H*T/K-Q2%#FB%
M;*A,D,PVY8YH^85-H2'/_V,59K10PH[OUQX'U[(A:EQD[VS1H=BH&@:8^])Q
MLOX()<M.5UF>+`C:3];5AF\\-URFM2:YM8C17[*EQ0YKKVAK4<2&02:+)_WU
M3'_&R3SUEH^A/T$E"PU5M\4]#>X4EAP`TH)U&MO^TEK/Z:U`M.YCW1=W=V=:
M[[N+)$G]D"J*OAY$A:V+UZR_M+7[UFQ:9G3-FCV%4TXJ^&5:RJ79'?;2N+Q2
M`.[F@NJ*5#1+]K@4<2-YQ\G>H$XBNH]M*%<LPNX0FH2WKPWF[SO8^E5M1[L@
MOS3/)6FH&AN^FE16]GI)5-O9YM46KM_AU>2I-G?QNQWI,S=V=<DZK[6A2]W+
MC;U<#>+V-BX-&G:&=59.28]V`9T0[SR=1<0+U-O$?%V\*>IYKA;NBVI=SB%?
MU)$2[,O[7(A^CER&?P4ZMKZR@5[8N1E6SHO[VQJ8`D(B4D:\)5*I5.]!8T(7
MH,KN@I>_:/T>>'9):I5>E=?9[1:!FM;G8*AK4?D]\';Z[*!+IS6O)^C7>0?L
M7DEVFV15NCII]"BMX<IN"F2%K$.X]G;')5EM=?#!\#V\_4I[O^X]_-*=\U#5
M=UM'=S)_6"9DYL"^+]S,X,I[\D:2\"ZC[HDDC1&V`KQ$33W"ET1EA6Y:H9W2
MN0$C35OQ.)*2VHL!$A6#A7F#+CQH7"83T$I\#YC=)<,N]6`UUI?2KBZO::F5
M=0_SM2/#0'\,B`8"_MVNR/^1'\N?R'\>O`R37_X_4$L#!!0````(`"=TFSR4
MCM#G\QD``&JA`0`4`!P`86-L+3(P,3`P,S,Q7W!R92YX;6Q55`D``^HMUTOJ
M+==+=7@+``$$)0X```0Y`0``[5U9<]LZEGZ?JOD/'O>SXSB9V]-)=:;+:]K5
M2>RVG4[/4XHF(8OW4H0N0#K6_?4#4*3$!<L!!(D@HY<LXL'!6;Z#]0#XZ]]>
M9LG!,R(TQNF'PY-7KP\/4!KB*$Z?/AQ^O3\ZO3^_OC[\V__^YW_\];^.C@X^
MHA21($/1P>/BX"K_-<YH?O#O;T$:'9R]/GGSYX.C(TZ:Q.EO[_D?CP%%!ZR*
ME+Y_H?&'PVF6S=\?'__X\>/5C[>O,'DZ?O/Z]<GQOS]_N@^G:!8<Q2G-@C1$
MAP>,_CTM?OR$PR`KY*L5?WDD2<7@[?&J+BD%_]]117;$?SHZ>7/T]N35"XT.
M2Q&#,%G5$20A3E^%>,:*GS#JMR<5%6<"$*4B?^G0EYJ?O'OW[KCXNB)EC&(%
MZY5QF(T/#I96)CA!=VARP/_^>G<MD)]_.3['*<5)'''?G04)YW(_12BCK.Z"
M3[:8HP^'-)[-$U3]-B5H\N&06>6HL@&WUI_DO(XW$^P^8W_.4)K1F\EE0%(&
MPDWE$[)T)>;-Y#R@TZL$_W`F9IVEA9AG.8U31.D]>BJ4MA"KP\+&6I4.]_F<
MU<CY!,E%3,,$TYP@&V-I.%JY=#:+LT+'TS1BWL@8.%CC%R,[;\JYV>$M0BE%
M41TE5W'*@BT.DC6J[7`'8VTA]@4B\3-KK)_1-6NK2%[9X^\H>F+V.`W9ISBS
MLS"<MX7@5=MPB\C]-+"":(>%A1A704S^%20YNIFL/%+3UD(J'4<+(:_9`&&&
M'H(7*S?62UM5SKK`I_@Q0:>4H@(`'S&.?L1)8B6,G)N5<,^(9K:NJI>VJ/R6
M!34;)3$5;C'S+\IB4@3R&1NS36(KB;0L+<0L8N,L*-J?V9Q54(SM;MDPPD9"
M%3=;X:8XB=B(^/+W/,X6MC(UF5B)@DGV@,CL#!."?_"6A?GA$TZ?^(\7Z#&S
M$DW+U$;46I]<'Q!>IQ-,9H5';&0%<+4)$^:<-)LR+(?U$01]P`]3Y'*8;%D1
M1*5B6I#3XYP>/07!?*E8A,.B33^^*/]A9/Z2<Q:\X!3/6"_ZJET)FX*\.T9)
M5OS":Z1\&O7NZ/5).8WZ4Q0[D/Z2C9RRQ<YE9U7;H.DT9`%.8TN(UTL[G#MU
M&Z!B2#J;LU]YB\Y'4+P3=CBW`E=I-:B<($*:+;S5^%'`QD*<CP@_D6`^C</S
MG&9,)\+[1X*C/-RPQ8-RMAF9S.9L(+B<8?+F_A/S2+0<\_P=)1&KYROK0VT&
M+3#&%B)OV-5MVJG=H82#G+7BV>*!L/%$$'+CV_0$4E9.A@5.A@%VW?YL%I`%
M"_[X*8TGK)M+L],PQ'DQ][UES02?_180Y@J'5M,%BTHL5/F:!GD4,Q_],V=.
M0B0QZX`Z4JOY67>22?"(DN,4/7$X@?O%QD)B0LB25\F%]X-_.7K]MNH'*^96
M>'BDZ/><-067SY93H`X+FP$>P7/,)P13-K5CTUZ^%L,^V(S@))SJ0K$.CO(A
M*G?L)_9#HQ;TDJ$T6KN*R[?!>+^HMJHXP6&CKH2ODF.B48G]\/T+SO@H5+#D
M<_K(9GDLC"HF!=X^'`I$6UDSSKA*(HIC1^+")T)R<64S)ZGTXEF1R.FGI*E8
M0,**/?MGP^/=%?V2XGA>S!6.PFF<K,`R(7BFMCVVT+4N^OL#??$*$@<9!E`?
M'F#"AH`?#M^^>EV%R;$P3K810JK5G+YB!UZ@=!"@@$5D&4Z1^"_M&5+Y\_?*
MI,RZ;8.O9[D/S&]G3)+?6N:P*UR:QK!P;S%KX'.\H4F:X:ROF(>Q:84Y917A
M.:\B2%817NP5L^J7DZI/2_=*C598C`V$*"HH^V@;ULO.^[;`55NPLJH^\B&D
MI=I*TH%$M8&Z-C&L9C^*B(6L__[DD2P>+\-7XZL!L\'Z?3EBUI=X,Y1(-=?>
M)F!!M<CC=N?1ITNX^,DCSV$?6EE:;&@JZT]-BY7F`!<;2/1:FL$FA.%5C:+_
MK:<C[*/=W8AY9=7KM%A@2://`?D-90&;A2VWSNY1F),BE8EOHB&2!7'Z0`*>
ME`N=9V^[FM5(?4O5#*3UV9&9[68(VQ)M%*U;)UMOW\2Y:N+:IBTVZ1:RE@I(
M72JOHQY(NV&FM$WX:VL8113KLEOW0>TJJ%>6!DQ-0+2EXFK:@82SB<(VP:SA
M[RR4GQ%YQ+T%,SS!?Q_6KL)Z;7.J[J;UA*7*"L*!1#-859M05C$?19?<.3^V
M#U97P5J:]`[-,>'9;_IE`(,2U<H^H,1`XMA<>:N%?4@MHXALU5F;?9`[ZY%7
M^.$)AVL[ETG$YYAF=.V)VV!1""_MMMUPJ_KV#;D-I.%P:S2K4<*F$HRBP=$>
M/]RW.JY:G;6I;[(I(F)[Z\<;F[(IS67-9B`-C",SV;0L]E5[E)P@.&&[;PJ<
MS3(RYNZ&<;G(@+F&:;EJQ@$N-Y#HMC6$U>P#7I='\:NZ+&4?R,X2B^16UD>S
M7>$JR<BL\$#B>B.36"4<&58XBD%__4S\OBUPUJF'4Q3E"9M.5NNS-3O3LT7M
M?]+^?0,655=OPV(@K8,#\U@-`*RJ'45+87$T?-^@.&M05#:7-B%&A:I&`U9H
M*,V$C0FL&@9@17W.`X"7A^RCUMUV?Q;$";V9P"S/N@_^DSPGP`FW5>+`9MP&
MT@"X-9I="L*&$O2[]->YNF;?/#CKU"OC\GQQ:2>N)&I?J=$D&DB,@E2TZI0E
MC/N,*"^NF!E?+-7-*@LE)4VIJ)AF(($$4=`FCB1\^PPCZ.5]^PASOZ9U6=P9
M^BV.4,W29XO/P:^85-Z@9XM5CE:5FZA?ZG+&N;,"MCGG@;0!VS/F9NME#J0I
MVYLW?;0WPNM,]XV+^\9%9.A30OB5@%S@;W$VO4ZC^#F.<J8'.#-O>Q5TFAIG
M%0RNQ=F2:3=K>-P)U>=X1WJI[;X-<M4&R4RLW[VW*%D:Q:3D0)H#>V/8Q+E1
M;4/=>&O=TKL/>??#CK:1]>,(;8G.P$!>8B"A;:[\9EVWHI8^^V++IT9Z3C,-
MJB?O5N:_Q<M,!=D]U`9%5LFE@"(]+Q3&P6.<5+>P=!,Z)<8P+58M)T*+]7?C
MM8F7L;4A6A=A`RHM%A[!E8E3;-9+!?ZD=U^G89)'178`*?3-,A(_YL4]00_X
M"T[#Y;WW3)ZGZY0-/!#-I!&Z#>;21/&-F/<&<&/`"G/*'1JV&0I0\<3IYYN)
MI<M1[S.5&J>%MJROO2%%<Q$55W*T7XRLY4\#2]22IG4E>FR4MX(_;&.H=LOM
M4K(J[5HKT0"06DA*KRG-UZ/(+CI%5%U$-JC&C4*%07:(O*848K2]]0]M-WE&
MLR"-:N]2R2`G()7AKD[Z,X!/;IJ=([`ABAB&_^T?#$_S;(I)_(>^X>M2RD!8
MH_P9,"@US,XA6)?$UUG5`T$!S<FB)G8+>0J*TK`BBA$B36^(;2-,*($86;_L
M9#G/_#W?K8$]Q>GR?Q&*.^_[HOB[0!AI>CB`M,K]5I%N+[*ARCZPFB3*U3^U
ME"D^]1;`(.MCI2+-.%0Q+-+*&XSZF!]!W<EF<3&.+M/H@DWL)'X5TK0<W*09
MC*=5JMFYO,6QCTY:Y_M3)F?$9;U*@O;41/BM-$CSF_<^5JEBYML6ISYFH&"?
M7B`:DK@03N9:`4G;PW62X3A:KIBEOQL,=3.^_D9%ET7ZIA=CHJ4HT@ONQ5^K
M"^U;7_N+IJ4D=^@IYB/E-/L2S-J=HXJDH4^+I+=HDMD>@W1I!E"+5W')OI"'
MCT.?I:3G3!O";\B/T,L_T$+H70E-P[UM&G_]J]8&Z.`.$Q\'..<YX5:ZBFD8
M)/^'`B(>W^K(JM4O&9F/K@;JI/6VG(^/HY\2FTN9UZ<4F'YY>^T)0MH,<#&I
MC\XWT`T:[A)>?:Q^PT#P#27)/U+\([U'`<4IBHI](R)$@8:V`0,9K;\X@&D'
M!(*4F6ZML#\D_`LG.5.,+*[B!!%Q.R"A:7B^3>.OQ]7:`#W=82+V\)\]\'`A
MX3GKE9XP$8_@A!0-[S8I_/6M2A.@9ULLQ'[]'P_\>IL_)G%XE>"@G50G_=[P
M:?V[OQZ5:P'T9X.!V)M_\<";!HD1\`+-(9J721+Z@9IMKH-\N&:1LO#.BWV(
M]43CBOW2[JPU5*V]B#:5CPB`::1UNY1-M=+RVB/O+K=&]/X5T`D]7*?SW\=R
MK0R]W&!4^;F?LS8$SS%_`V?*#^SRYSF*7(.?_0R<4!F9K9H:R*@&<@9-H^0&
MY\ZDG'7KCSN]RIU1IL6;4.MC9@*]?O;X<)AK]L\\(!DBR:+VY*TV&<>L4&D*
M8*&!!*J5"6SB%EK1*&YAWA\OW1\O71MD?[QT1\=+=[)RM3]/NC]/.NCSI#O9
MF3$\H5(<)&SORDL^=\^B+#^/\%B`Q@0[/'525N]L=);4!F9]X>\TBN*E)K=!
M'%VGY\$\SH+V3%Q#525,2JA&"$J80;:-3:D4OIZ&.@W#?)87]V`5KTSRF^X(
MFO*G)Y\1LP:>H4^8TB^(C8<>@I<V"NU*5^@T+#U&U&YDP*VCV50Z7P\_W_%W
M%%(4708D9;K2FF(7:!*'<7LT"R^059?Q:0N,$+[&9MHV8B$"^7HTNG'6433T
ME!.(CJ6.=OBI-<-.#Z4JAZ"_#',(ZL9D6UD@V,K"P!BC9"OFWG9DN1):GA-H
MNER/V>C]DP<A67]&@VN]3'QNKP0KB:IU7S'1H-;$0(K:KVW)V/LZB:NN*6=C
M\)J:4IA`R:NL%AWYH*!CJ+P]B/05^3I;*N9Z$"#I"4LK*@@'!1ZPPO:P454A
MG[ELN@OMP99G>99'O\DI(>QN:[8)!P4UL,(;='.**KRY);%\$9?>!@L^YCL7
M-D1JHO5RHXC(!U3(/(R!JDDQT&)<+NH)&?IZ36;W&=%V>JZ"HIHF"B@\][M>
M*1.G"[GY.IRM#[_%\:Z@$,QR!A+I>J5,/"[D-I01I]CK&BK)6',@WH<I9X(`
M*4=?%\"U`-":9WAN=^IQN+,M%J:]60KC^1]QMDSE37DR.S_YC]*0,>4E!/DZ
M`.I:^HZ*V@<T@:<09JK;SR.T]:Q:F%^&N!NB,X5A.JYA&NZP(&>HO).YJZ2B
M\>T!G%**I(=GQ!^KJ6_SXV`RNI5*V>5MMUGNY+X(DUG/=?J,Z+(UE<QZ!!2M
M64^=HC=G2YR'(8HT?=OD5)_=-#CX.I_EAP,1R1:W2<#&:VG$6Z@YE_D+:D<Q
MA+0TD9+40Z<;J*;SOIJ5KY/<:Z91^A0_)FBI$1/V\J7<W?Z(<?0C3MI9OB9%
M2MN!BG@(#PM5=3"!L?1U-BR!A,06/KO6TGTZ%_5_5*2VQ;M"&&3774'<W7,7
M$7OH9"/U=*[7,>OCSB_P.F8IL7+37$937\/LT'CH=8@R.F=+>,CO_QKJ9O=2
M1^&\33A?\]'A0G%U'JX*R2\!&_:47)VZH*1I.-R;A`6=_TTR$F1P\#?EX#R@
M4[Z0R?[B,XOG("F6-K/S@)`%&SL*CX6:E*D6FT%E>@:!8N_"1F<1-@0[&4#6
MWN<LR!=S5"3MK`6/EG,@&0MFRSJJ;(5!+.]4"35W*$0,J6RZR4:KZCPE%6DK
M6TE(ZB\(##0$@D'-T=_%GF<F'R:+[AJ?Z--J\:;VR5\G*S0`.K7)87QYK:()
MK+A)`%`JU@3\;Q#@^@&AHV3HZTI1;8ZKR&T2$G27!/QWNE8;H*]%?'Q=^U%Y
M5V6*H?C4@3M!GK19X6DO!_1TJ5YM#YK/7*X2_,.?N_56$NGOU).2=N_2ZY+V
M&X6\,V`BW1+\'#,/GBV^4A1=IS=S1`*>EG0:9O'S,FU$<@FI-8/J4E)S!C[D
M8\A]CAT819JKT:F6MQ,VU?7QP`!P\W\29_R:E.Y6?^O#>F._^M#?=:WV#L<*
MU5I7M!I74F[^KYC[NOYS&OV:E^L6#YA-7'$:QL6\=7UIS@/>K)W:9A6KV\.V
M4,5`(;T#<[L(CNV(6<75VV$F\%X@)G,8%X;MS+Z[GU;3[=JG_H;EV\0=5AJ@
M-:C?@B#+Z7Q=`&\;]!F_?N2/0LJ;23NQJ-TT@XBK1E9-/%K@&1EI-U#4B>3K
M!L0=,PYS*-\PNT#/*,'SY>OA3/T0=<:=0.K5O79JZM'BT\Q,NP&H5B9?=T.*
MU[[.@N+MD=D<I534%ZN)5GNB0J+1PA!DE-V@3R:*KPFTER\\*!Z"ES.4(C9E
MO&(.$^L@4+R%32>\JD<!-^(U6J2[-/%N`F)#B4=U962U*[<T*;/)Y0O7'I6F
MD6QZ:JA;&Y\RZM&&A)F9=C5?T\CDZ_[<QR!.*5<;T9OT/DC87Q/A]$U/6)VY
MD!..%I)@X^P&C2IQ^GA`&I0:-)L',5EN?\CS`S545<*0A&JT^(.993?@D\KB
MZU[4UY2@((G_0!&/&ZXW"QH4YD0TY(41EP;7$(\6CD9&V@TJ=2+)G]D>X+"S
M9D1^=HA9ZSI#L\T-6B0>R7?<ME=7=^MM"W6--AQWZ:(=K4EO5R/)?LMVGV6'
MY4^'_)4%=(&6?]>4*-]4DNR+FQ=<Y5Z#"XXV?JR-MZ,!EX%X$F2[>++7GYAX
M(`&_S$`ZAC,H(8V";HG>X&\!3R&H=49HHAE>JQBC@MI\W>;N"M\]?:.%F+R(
M%&."(H,'F=8,;E$FJL[7#>NN]-5Y($@3)J"5`JM..WA$R15W"Z5&/;YN*0N4
MY$/:]0A"M+1K5D@^,!05&CR\`*9PBS-QA;YN)\N;W/(F?7#'V*+7]HH5_>`1
MIC;`=OK#55WN+D+V=SZP/"\7AB1GNJQO2(6U@O)RZH904&[P2(499`O-H:A.
M=S?9>H[<E;V,L:LJ">S&QX=?@%&VV:$#,-S_9BS\F$4+B.8%C<\'#O6LC+5I
M7)R`,:E<L@QC<4^]-Q>22=1?;D]O</X5P$"-;Q6#H9Y_A1O%R?E7977R;=W>
MS[^&"$6T2(X,$G0S8;]$.==`?'H&7F!]7E97P+>&%`(<;&$*4`.JJ+P\7ZNM
MU-?U:S;9*W>=3L/?\Y@@Z4WA;=`9%ZS`!R\X5!#:FL8)&`TJEZ]V#S"QI:/X
M64[C%/%$1V;)9;]1?HET6`84E:%9570L>(:;9RN(5E8O7WT?`Z8UYVC!]#+T
M^G.:UC%DC8[+.L(I]#RLQ;5]GH)3EIH-(95#TH,D;>=HA.5A.P.B-M5ZH(>H
MVD/OST'&4T86Q:MZ28)"KB95G1K8@(-D-@7A,%0@;VRL;<RW0%+X>L@*;@+K
M92?KY::APM3:-"[0:5+Y]NYS['M0<(5)/4R+?0X]IBU+MX8.T-(#1?=F1G(Y
MP`!+L&IMS;<)?-F`E5BJ?#G3?IL`P$#=;JL8#'6;`&X4)]L$RNJ\/?!1#[T[
M-"]C\F:R>@OB`CT*7LN$EQ&,;^5E?&M,(1#"=@8!-:&*^MMC6$6]\FV#@4_6
MKBG-F7W0S:1ZF%:#5G4!`50E!4:`4Y`I7(-45JFO&?/UH%)`3$>VNM1-0C90
M.`'5=@$B>56C7*J_F5S$W#QI1,_Q;(;3^PR'OTGF.6KBUK1&0CQ0!!J9P$EC
MIJG0?&V^C94U%H]3],2?-_`$DVR>QJ(P)^$TH*P!U^-27Z`[Y985&#@^P:9P
MB5%5I>-=O^?ZW12*T<L71,*8=G?JH?2BM7DA_5#A:6@(U\-!29V^KK+#+QX4
MV*"%02>\C&^V%/$:*'9=&M`%KC>49V")^GJ`FQ<T7J$<*G2M3>,"IR:5RR]4
M&^K.TN5D@L+L9L*B=1JD3^B.#;!OTG/AL\?M%MNB:-5`FQ3U?KE]`T.8+;2;
M5:2X><;'=\UO$8EQU#[,U<*<35'E*^>2HMYC;@-#F&'.K"()YBR2G[UI(<4&
MD+PNKX2I^D5Z6)F!`E.MN@M$=FJ00-%B(71>@)V)1;)1`_+[FY\8DAWE=P'*
M.0,6S[%CN*P?^[1$Z&4:^?3X+&4#E8"D3/F>'Y]=WO:WDDM^8:.*:GUZ7TC5
M\[LV_,;Q._2,TAP5+]DW-)-\K5ZR:7WM\\X!I0.P3I/.)0(B=L4+,FTVOEZ4
M?8XI:W`^8AS1>YRTEVTE7ZO&N_759[^J-0'[M</&U\/('PFF]+9X0+;E4\&7
MZI6'VA>??2G7`.S'!@M%IMA.IQ1!F#!WGC!NI3/9#]_O4<)(GCZB%)$@80.`
MTV@6IS%7A9]3;C?$,.JJ8=90^PP",TWA#;>.K;=K'N(G\\HW:SK9,P!:Y;N(
M%:W/$#'1$@P0#5/%\H2/\!CYTYG6((&]?FD,$^T#EB?]7S?Z\ST`#$#)!F_X
M*D!B]PSO2?\WA*[NF%I?<]\"AH*BM)*(PF<(Z#4"^UW(2N+L(1\J$^@I61H!
M4,IAT_^Q&3OX@([&F,%(>_RE_Q6'*TQ0_)2>YPS/:;AX($%*@^+H;_6*TQF:
M,)J'X*4%$HN2I4E-2O8&(@A"\"96:`)+41T'EU$UH\H(7Q\_7UJ&]<N(68[?
MP51E('<6=L$E5HN\^A*^`]%<:R,`@MC[>X7Z4ECQ]%OR=86-YE?_<:#2QM#G
M+5:C2IHNSEE_86R:1A!C!$9<#8K4Q+XCR$A7(T#I.(_RPO'2#CP=]ARG3.N<
M*5X:"J=EO[UZU1K1SW%:[!'76M@F%[[?G"T^HVS*,W*D[_CNON;&ENEN:O9Y
MCM&?!\!SEIV**)D#6;P`Z\V4>F67]F/T@E"44C7"IDOE/\1UFAG"4<!.<CS:
M9D_0EYYAN=TI6*OK?EB?PJH^^(P)J?Q@&-0Y2#QO\YRF+XU&E21UBTAU/B8.
M6R!0TE1)]4(:GZ$!T0J,$@DS"6#ZW_)KRWL1)WG6.9JIH9*XOJ(:DO/%FEF[
M?\5.`H#^M_*^H?AIRD0\?6:#JR?T)9\](L+OJF'24WXQ"(I$38%IL=*0X&(^
M8\92=S"(X/PEJ/K%5U25X;#4Y";/:!:D_#5@&+ATI=48DY8>(-2`EM@4<?)J
M),"S/`PN3&IK/I]5CKW;PU).R%C*B'UVK49TV<34Q;J3/">__,+_>`PH8K_\
M/U!+`P04````"``G=)L\,:B*]/4'``">/P``$``<`&%C;"TR,#$P,#,S,2YX
M<V155`D``^HMUTOJ+==+=7@+``$$)0X```0Y`0``[5M1<^.V$7[O3/\#JI>T
M,Z$EV7?7V'-.1K9DGV9\EF/)Z?4I`Y&0A`0$>`!HR_WU68`$"9FBR/-=.YD.
MGT0!BP_8_0@LL$N\_VD;,_1(I**"G_>&1X,>(CP4$>7K\][#/!C-+Z?3WD\_
M_O4O[_\6!.B:<"*Q)A%:/J.K]#>J58H^_0OS"%T,AL?O4!#DHI>2.+G)^'IT
M3_]#Y*>L=JO.5+@A,48:RS71MS@F*L$A.>]MM$[.^GW,0L&/0A'WCP?#P>#D
M9`C#8B0F7%\)&8_)"J=,G_<^IYC1%251#X$>7)UM58'Q]/1T]'1R).0:0`;#
M_J>/-W/;JY/%(3O882:5JD`_)Z3$W2XE.TI5WU48]--@,`S*-HSRWW?&8=OD
M(SGIF^HE5J08--1&>K>#7/AM/ZOT1>D!:,J5QCPLH2M#R4TR/#T][=O:'E""
MD"$%<RXTUO`FV**\,$DH7XF\!,I,FS.GPCU9(8MR9FQQWE,T3ICIW99M)%F=
M]\#.@;/JKXDD1S`T)R$%(P?4,=5]:**`>#NPF[)?!X%E6$&I*`D@(B%24^"K
M,'__6RD58O:E2D&3,&5_8IT87GZI3M"$L/^J-@9F`>-'YN'A?KIG_MJ17`JN
M!*.168$N,#,S8KXA1*L>HM%YK[ZZZ,_U&)$5Y=3.B8$QS0`%:`[OHEV+X!F@
M(L(5+'0^*,I140:+_O[`<1I1J/G'^_Y+W)==IH`VXS_:YY?O?MXZ%SG4\L4+
MUKYA.;+Z=GFIH^,;L%385,U6$RPY^)\]9.V5.LS9<6O.2G`D5LC!=]RUYVZV
MNL1J<\7$TR'N?*G#W+UY)7<&']D..O;VL^<(F*=)DNVK,!M3%3*A4DER\AJ$
M#G/W;G!BN"OE#7D%+X&/Z0EU'!4<^1;RG=04=F,RMD//>&HCV,35FPI7.P3M
MN#/D`7=\%7Q-^2-1VJY!&2]^09/]WU;L[[7NC.P9&8XW:[ID9*04[*Q&/+H6
M(GJBC#FCUPLTD?#//20X-)3!(7/2=8`=+^5BM1%2+XB,+X24XLELG,#R-X*O
M3>&8+'6^5C7+-;'T0W6I,J#(`*`2UC)E@+,*`]WQY<TC>"0+O"7%8E46-#%P
MNF>>F-;(-N^L7%CY(E64$Z7F9.WYA4II@[V'@XJ]'01R&)W1O:4(2W*!`?I2
MQ`F<%>QH[V`#H]P:5"_01,5PS^(#:(&%0SY>Q\@N(QO!(B+5Y'-*];-'Q&[Y
M0?N;,.Y^^^<@WZ$,IK.]=TZ/8YIM(\'1PIE9@W,D/*2D.*+7"S3-ANJIP4.S
M#G@'KZ/%#Y]D80P_BG%%.9RR*&9E-*,(H[23;O+<U>E3$T\IP+W(2D=?09\+
M#MX1:=>?C*9*:1,=QQ4ZBJ@C8&1+6V?UPNI7F,I?,$O);%6\GU.NM$R]N=(D
MU,3)NPHGY5SP<#I:"EK&1-)'&.$C\>P#ON0#B=;P+H]"J**Z<#CMQ9LV`U6J
M2FR?*^N)<GA4XG<4%A3>@0N`;H"%.P%F(YI*N^9?$`YC<%.K4:IIOU!=[W)(
MR]`N*'*H'4TE3>`/N-Z`C4(_$J\68K$A#3G/5[9M2H@.7R9H=OI!8ZPQ6@@$
M?1Q*D'8<%QR/0CC"*%J&]_V"IA6Q.L&\UIV5FU//U2.I/13%8(R-6:J,TS*A
MKL.IZ=8HAV?7R9[TY^QV/KN9CD>+R1C-%_#S<7*[F*/9%9I_&-U//LQNQI/[
M.1R$?WZ8+OZ-1K=C://Q#FHFM_/I+Q,TO87_D^Y5\/)L<8SE,[!&UYRN8-GB
M>A2&(K4GUSO@UYQ=C=.3&/8.H=O'O*)=T_2M9DSS3DQ2V^L&E?T@UU'F0EU7
M';]EJ#M.X$B0?7A@\@$W,/VB+)OS@;`("'I0Y@-"&P5O)]O$8S4N4@(;*@UT
M8+%=6LF@6P8-?D?>@;Q271ZID91JBG5?WJBS?6'[:O:N?9YN[^FLR\;56/J:
MB+7$R8:&EZG2L#&0UFV(*`VKGWNT%6[BIYKM+I&_1PX[=RL6O?OPHR;^L2)2
M[F:37*AC3TT3+]7\MH/I\DO[";@GS.S`X>2IGQ<2@X%">][)2*BM_7(B<BAD
ML9`/UK'A[:>7BGQ.0;_)8QF6K90V6']/TKN$0!E&9_3"Z,57KC^G\&X2R9XK
M?N.P2!,=U<A"@8<*P,Y![`_;29$(D[W;8+XFLY5)BD)%'I>KJ6R*I5;/B@X)
M95#V0^@,[/^8B_?]%W>4LH+=FTSF'A.-$[/;YY6[9MY]KC7&R<YUKNR:VHT(
M+5;11..MX"*&4_?1OM9]PG11$I1X1UL5Y5=:6HTH(O1;C(8+GOT#O%>,YM`E
MLYH159N8?X%K9P9Q$@R/7V$2IQ@G:^.)#?@/`8`=,,_.8)B4V9S,`8(2X+7V
M>-.7YJI32U-8:=/KFP`Z'@Z^R`"52X$M.W4-3+]O7V'RZCW'KYP8%K#^7<RO
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M`AX#%`````@`)W2;/,&,FK,MQ```-^L.`!``&````````0```*2!`````&%C
M;"TR,#$P,#,S,2YX;6Q55`4``^HMUTMU>`L``00E#@``!#D!``!02P$"'@,4
M````"``G=)L\++-3RU8-```FN@``%``8```````!````I(%WQ```86-L+3(P
M,3`P,S,Q7V-A;"YX;6Q55`4``^HMUTMU>`L``00E#@``!#D!``!02P$"'@,4
M````"``G=)L\_#66(Z(P``"Y5P(`%``8```````!````I($;T@``86-L+3(P
M,3`P,S,Q7VQA8BYX;6Q55`4``^HMUTMU>`L``00E#@``!#D!``!02P$"'@,4
M````"``G=)L\E([0Y_,9``!JH0$`%``8```````!````I($+`P$`86-L+3(P
M,3`P,S,Q7W!R92YX;6Q55`4``^HMUTMU>`L``00E#@``!#D!``!02P$"'@,4
M````"``G=)L\,:B*]/4'``">/P``$``8```````!````I(%,'0$`86-L+3(P
M,3`P,S,Q+GAS9%54!0`#ZBW72W5X"P`!!"4.```$.0$``%!+!08`````!0`%
+`+H!``"+)0$`````
`
end

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R11.xml
<DESCRIPTION>IDEA: Intangible Assets and Goodwill
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<InstanceReport xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <Version>2.0.0.10</Version>
  <hasSegments>false</hasSegments>
  <ReportName>Intangible Assets and Goodwill</ReportName>
  <ReportLongName>006070 - Disclosure - Intangible Assets and Goodwill</ReportLongName>
  <DisplayLabelColumn>true</DisplayLabelColumn>
  <ShowElementNames>false</ShowElementNames>
  <RoundingOption />
  <HasEmbeddedReports>false</HasEmbeddedReports>
  <Columns>
    <Column>
      <LabelColumn>false</LabelColumn>
      <Id>1</Id>
      <Labels>
        <Label Id="1" Label="3 Months Ended" />
        <Label Id="2" Label="Mar. 31, 2010" />
      </Labels>
      <CurrencyCode>usd</CurrencyCode>
      <CurrencySymbol>$</CurrencySymbol>
      <FootnoteIndexer />
      <hasSegments>false</hasSegments>
      <hasScenarios>false</hasScenarios>
      <Segments />
      <Scenarios />
      <Units>
        <Unit>
          <UnitID>u000</UnitID>
          <UnitType>Standard</UnitType>
          <StandardMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/iso4217</MeasureSchema>
            <MeasureValue>USD</MeasureValue>
            <MeasureNamespace>iso4217</MeasureNamespace>
          </StandardMeasure>
          <Scale>0</Scale>
        </Unit>
        <Unit>
          <UnitID>u001</UnitID>
          <UnitType>Standard</UnitType>
          <StandardMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/instance</MeasureSchema>
            <MeasureValue>shares</MeasureValue>
            <MeasureNamespace>xbrli</MeasureNamespace>
          </StandardMeasure>
          <Scale>0</Scale>
        </Unit>
        <Unit>
          <UnitID>u002</UnitID>
          <UnitType>Divide</UnitType>
          <NumeratorMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/iso4217</MeasureSchema>
            <MeasureValue>USD</MeasureValue>
            <MeasureNamespace>iso4217</MeasureNamespace>
          </NumeratorMeasure>
          <DenominatorMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/instance</MeasureSchema>
            <MeasureValue>shares</MeasureValue>
            <MeasureNamespace>xbrli</MeasureNamespace>
          </DenominatorMeasure>
          <Scale>0</Scale>
        </Unit>
      </Units>
    </Column>
  </Columns>
  <Rows>
    <Row>
      <Id>2</Id>
      <Label>Notes to Financial Statements [Abstract]</Label>
      <Level>0</Level>
      <ElementName>acl_NotesToFinancialStatementsAbstract</ElementName>
      <ElementPrefix>acl</ElementPrefix>
      <IsBaseElement>false</IsBaseElement>
      <BalanceType>na</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>string</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>true</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>false</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>No definition available.</ElementDefenition>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>3</Id>
      <Label>Intangible Assets and Goodwill</Label>
      <Level>1</Level>
      <ElementName>us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>na</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>string</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole>terselabel</PreferredLabelRole>
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>false</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText>&lt;div&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr valign="top"&gt;&lt;td style="WIDTH: 18pt" align="right"&gt;&lt;div&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;(7)&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Intangible Assets and Goodwill&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;(in millions, except per share data)&lt;/font&gt;&lt;/font&gt;&lt;br /&gt;&amp;#160;&lt;/div&gt;&lt;div align="left"&gt;&lt;table style="FONT-SIZE: 10pt; FON
T-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: center" valign="bottom" colspan="6"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;March 31, 2010&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style
="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px; BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="6"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;December 31, 2009&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FO
NT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Gross&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt
;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Gross&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"
&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Carrying&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-S
IZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Accumulated&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Carrying&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&
lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Accumulated&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;
#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Amount&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="
bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Amortization&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Amount&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&
lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Amortization&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;
&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAM
ILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Intangible Assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE:
 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font
&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Subject to amortization:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font st
yle="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times n
ew roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="MARGIN-LEFT: 36pt"&gt;&lt;/font&gt;Licensed technology&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 
10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;444&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(297&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&
lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;332&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bo
ttom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(296&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="MARGIN-LEFT: 36pt"&gt;&lt;/font&gt;Patents&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TE
XT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;278&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt
;(29 &lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;111&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE
: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(24 &lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="MARGIN-LEFT: 36pt"&gt;&lt;/font&gt;Other&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 
0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;120&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDE
R-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(96 &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&
lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;121&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(93 &lt;
/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="52%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: i
nline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font
 style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: 
left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Total subject to amortization&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;842&lt;/font&gt;&lt;/td&gt;&lt;td style
="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(422 &lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&g
t;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;564&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inlin
e; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(413 &lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="52%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" w
idth="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left"
 valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&g
t;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Not subject to amortization:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/
font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: t
imes new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISP
LAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Purchased in process research and &lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;development assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: le
ft" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;104&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0
.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;104&lt;/font&gt;&lt;/td&gt;&lt;td style="PAD
DING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&g
t;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="52%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;
#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 
10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTT
OM: 4px" valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Total intangible assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;946&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLA
Y: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(422&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FON
T-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;668&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: i
nline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(413&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;During the three months ended March 31, 2010, the Company added patents and licensed technology through a business acquisition and an asset purchase.&lt
;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Minor changes in the carrying amount of goodwill for the three months ended March 31, 2010 were as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr&gt;&lt;td valign="bottom" width="64%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;
/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;United States&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;International&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td
 style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" width="64%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: 
inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" width="10%" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Segment&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" width="10%" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEF
T: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Segment&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" width="10%" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; 
TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="64%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Goodwill&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&g
t;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&l
t;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="64%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Balance, December 31, 2009&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;423&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;
&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;265&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: 
times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;688&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="64%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Acquisition of business&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: t
imes new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;16&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;5&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;fon
t style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;21&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom" align="left" width="64%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&
gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Impact of changes in foreign exchange rates&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(5 &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" 
valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(4 &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5p
t solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(9 &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="64%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE
: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowr
ap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="64%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT:
 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Balance, March 31, 2010&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;434&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" val
ign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;266&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px doubl
e; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;700&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</NonNumbericText>
          <NonNumericTextHeader>(7)&amp;#160;&amp;#160;Intangible Assets and Goodwill(in millions, except per share data)&amp;#160;&amp;#160; &amp;#160;March 31, 2010&amp;#160;&amp;#160;December 31, 2009&amp;#160;&amp;#160;</NonNumericTextHeader>
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>Discloses the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subjec
t to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain or loss on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each g
oodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final.  May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss. This element may be used as a single block of text to include the entire intangible asset disclosure including data and tables.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 142
 -Paragraph 42, 43, 44, 45, 46, 47

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
  </Rows>
  <Footnotes />
  <ComparabilityReport>false</ComparabilityReport>
  <NumberOfCols>1</NumberOfCols>
  <NumberOfRows>2</NumberOfRows>
  <HasScenarios>false</HasScenarios>
  <MonetaryRoundingLevel>UnKnown</MonetaryRoundingLevel>
  <SharesRoundingLevel>UnKnown</SharesRoundingLevel>
  <PerShareRoundingLevel>UnKnown</PerShareRoundingLevel>
  <HasPureData>false</HasPureData>
  <SharesShouldBeRounded>true</SharesShouldBeRounded>
</InstanceReport>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R10.xml
<DESCRIPTION>IDEA: Financial Instruments
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<InstanceReport xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <Version>2.0.0.10</Version>
  <hasSegments>false</hasSegments>
  <ReportName>Financial Instruments</ReportName>
  <ReportLongName>006060 - Disclosure - Financial Instruments</ReportLongName>
  <DisplayLabelColumn>true</DisplayLabelColumn>
  <ShowElementNames>false</ShowElementNames>
  <RoundingOption />
  <HasEmbeddedReports>false</HasEmbeddedReports>
  <Columns>
    <Column>
      <LabelColumn>false</LabelColumn>
      <Id>1</Id>
      <Labels>
        <Label Id="1" Label="3 Months Ended" />
        <Label Id="2" Label="Mar. 31, 2010" />
      </Labels>
      <CurrencyCode>usd</CurrencyCode>
      <CurrencySymbol>$</CurrencySymbol>
      <FootnoteIndexer />
      <hasSegments>false</hasSegments>
      <hasScenarios>false</hasScenarios>
      <Segments />
      <Scenarios />
      <Units>
        <Unit>
          <UnitID>u000</UnitID>
          <UnitType>Standard</UnitType>
          <StandardMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/iso4217</MeasureSchema>
            <MeasureValue>USD</MeasureValue>
            <MeasureNamespace>iso4217</MeasureNamespace>
          </StandardMeasure>
          <Scale>0</Scale>
        </Unit>
        <Unit>
          <UnitID>u001</UnitID>
          <UnitType>Standard</UnitType>
          <StandardMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/instance</MeasureSchema>
            <MeasureValue>shares</MeasureValue>
            <MeasureNamespace>xbrli</MeasureNamespace>
          </StandardMeasure>
          <Scale>0</Scale>
        </Unit>
        <Unit>
          <UnitID>u002</UnitID>
          <UnitType>Divide</UnitType>
          <NumeratorMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/iso4217</MeasureSchema>
            <MeasureValue>USD</MeasureValue>
            <MeasureNamespace>iso4217</MeasureNamespace>
          </NumeratorMeasure>
          <DenominatorMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/instance</MeasureSchema>
            <MeasureValue>shares</MeasureValue>
            <MeasureNamespace>xbrli</MeasureNamespace>
          </DenominatorMeasure>
          <Scale>0</Scale>
        </Unit>
      </Units>
    </Column>
  </Columns>
  <Rows>
    <Row>
      <Id>2</Id>
      <Label>Notes to Financial Statements [Abstract]</Label>
      <Level>0</Level>
      <ElementName>acl_NotesToFinancialStatementsAbstract</ElementName>
      <ElementPrefix>acl</ElementPrefix>
      <IsBaseElement>false</IsBaseElement>
      <BalanceType>na</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>string</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>true</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>false</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>No definition available.</ElementDefenition>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>3</Id>
      <Label>Financial Instruments</Label>
      <Level>1</Level>
      <ElementName>us-gaap_FairValueDisclosuresTextBlock</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>na</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>string</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole>verboselabel</PreferredLabelRole>
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>false</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText>&lt;div&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr valign="top"&gt;&lt;td style="WIDTH: 18pt" align="right"&gt;&lt;div&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;(6)&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Financial Instruments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;(in millions, except per share data)&lt;/font&gt;&lt;/font&gt;&lt;br /&gt;&amp;#160;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MA
RGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="DISPLAY: inline; TEXT-DECORATION: underline"&gt;Foreign Currency Risk Management&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;A significant portion of the Company's cash flows is denominated in foreign currencies.&amp;#160;&amp;#160;Alcon relies on ongoing cash flows generated from foreign sources to support its long term commitments to U.S. dollar-based research and development.&amp;#160;&amp;#160;To the extent the dollar value of cash flows is diminished as a result of weakening local currencies relative to the dollar, the Company's ability to fund research and other dollar-based strategic initiatives at a consistent level may 
be impaired.&amp;#160;&amp;#160;The Company has established a foreign currency risk management program to protect against volatility of non-functional currency monetary assets and liabilities and changes in fair value caused by fluctuations in foreign exchange rates.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The Company primarily utilizes forward exchange contracts in countries where they are available and economically beneficial to offset the impact of fluctuations in foreign exchange rates on monetary assets and their related cash flows.&amp;#160;&amp;#160;All outstanding foreign exchange forward contracts are entered into to protect the value of assets or liabilities denominated in currencies other than the entity's functional currency.&amp;#160;&amp;#160;To the ext
ent hedged, the changes in fair value of the forward contracts offset the changes in the value of the assets or liabilities.&amp;#160;&amp;#160;The changes in value of the foreign exchange forward contracts and the assets/liabilities that are being protected are recorded in foreign exchange gains and losses within other income (expense).&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The fair values of forward exchange and option contracts are reported in other current assets and other current liabilities.&amp;#160;&amp;#160;At March 31, 2010, the fair value hedge derivative instruments have settlement dates in the second and third quarters of 2010 and cover a gross notional amount of $606.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /
&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The Company believes that, at the balance sheet date, counterparty credit risk was not significant due to the credit quality of the counterparties to the derivatives, which were all large financial institutions primarily in Switzerland, and the short-term maturities of most derivatives.&amp;#160;&amp;#160;The credit exposure related to these financial instruments is represented by the fair value of contracts with a positive fair value at the reporting date.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&amp;#160;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;For the three months ende
d March 31, 2010, the effects of foreign exchange derivative instruments were:&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" width="19%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Derivatives in Fair Value Hedging Relationships&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="2%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" width="18%"&gt;&lt;div style="DISPLAY: block; MA
RGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Location of Gain (Loss) Recognized in Earnings on Derivatives&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="2%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" width="17%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Amount of Gain (Loss) Recognized in Earnings on Derivatives&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="2%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom"
 width="17%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Amount of Gain (Loss) on the Hedged Items&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="top" width="19%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="2%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="18%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="2%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="17%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAM
ILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="2%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="17%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="top" align="left" width="19%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Foreign exchange forward contracts&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" width="2%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" align="left" width="18%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline;
 FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Gain (loss) from foreign currency, net&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" width="2%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" align="left" width="17%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;17&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" width="2%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" align="left" width="17%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-
INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;(19)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="DISPLAY: inline; TEXT-DECORATION: underline"&gt;Interest Rate Risk Management&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; 
TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The Company may use interest rate swaps on certain investing and borrowing transactions to manage its net exposure to interest rate changes and to reduce its overall cost of borrowing.&amp;#160;&amp;#160;The Company does not use leveraged swaps and does not leverage any of its investment activities that would put capital at risk.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;At March 31, 2010, in connection with a long term bank loan, the Company had an interest rate swap fair value hedge outstanding in the notional principal amount of $54 at the respective quarter-end exchange rate.&amp;#160;&amp;#160;The fair value of the interest rate 
swap agreement is reported in other current assets.&amp;#160;&amp;#160;This interest rate swap did not have a significant effect on results of operations in 2010 and 2009.&amp;#160;&amp;#160;The long term bank loan matures in January 2011.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="DISPLAY: inline; TEXT-DECORATION: underline"&gt;Fair Value of Financial Instruments&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;At March 31, 2010 and 
December 31, 2009, the Company's financial instruments included cash and cash equivalents, investments, trade receivables, accounts payable, short term borrowings, long term debt and the estimated fair value of certain contingent payments.&amp;#160;&amp;#160;The estimated fair value of all of these financial instruments is as noted below.&amp;#160;&amp;#160;Due to the short term maturities of cash and cash equivalents, trade receivables, accounts payable and short term borrowings, the carrying amounts approximate fair values at the respective balance sheet dates.&amp;#160;&amp;#160;The fair values of long term debt were based on interest rates then currently available to the Company for issuance of debt with similar terms and remaining maturities.&amp;#160;&amp;#160;The fair values of investments and acquisition-related contingent payments were determined as discussed below.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table s
tyle="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="14"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; F
ONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="6"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;March 31, 2010&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="6"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" ali
gn="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;December 31, 2009&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Carrying&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style
="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Fair&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom
" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Carrying&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Fair&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WE
IGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Amounts&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&
gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="
2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Amounts&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BO
TTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Assets:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="
DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new ro
man"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Short term trading and available-for-sale investments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new rom
an"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;542&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;542&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; F
ONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;479&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;
font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;479&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Long term available-for-sale investments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&g
t;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;64&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;64&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT
- -ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;73&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&g
t;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;73&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Forward exchange contracts&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&g
t;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;5&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline;
 FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;5&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;6&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" wi
dth="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;6&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Interest rate swaps&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"
&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;1&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td sty
le="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;1&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;1&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times ne
w roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;1&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="52%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; 
FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;fo
nt style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td va
lign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Liabilities:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td val
ign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt
;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt;
 FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
Long term debt, excluding capital lease obligations&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;54&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width=
"1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;54&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;56&lt;/font&gt;&lt;/td&gt;&lt;td style
="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;56&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; 
MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Liability for acquisition-related contingent payments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;88&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt
; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;88&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&g
t;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;71&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;71&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt
;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Forward exchange and option contracts&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;
/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new 
roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="D
ISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="52%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&
lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-A
LIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roma
n"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Financial instruments, such as equity and fixed income securities, other investments, financial liabilities and derivatives, were presented at fair value.&amp;#160;&amp;#160;Fair value is defined as the price at which an asset could be exchanged or a &lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;liability could be transferred in an orderly transaction between knowledgeable and willing market participants within the principal or most advantageous market at the measurement date.&amp;#160;&amp;#160;Where available, fair value is based on or derived from observable market prices or parameters.&amp;#160;&amp;#160;Where observable p
rices or inputs are not available, pricing for similar financial assets or liabilities, dealer quotes or valuation models are applied.&amp;#160;&amp;#160;These valuation techniques involve some level of management estimation and judgment, the degree of which is dependent on the price transparency for the instruments or market and the instruments' complexity.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font&gt;Financial assets and liabilities recorded at fair value in the condensed consolidated balance sheets were categorized based upon the level of judgment associated with the inputs used to measure their fair values.&amp;#160;&amp;#160;The categories, from lowest to highest based on the amount of subjectivity associated with the
 inputs to fair valuation of these assets and liabilities, are as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Level 1 &amp;#8211; Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The types of Company assets carried at Level 1 fair value are equities listed in active markets.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT:
 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Level 2 &amp;#8211; Inputs (other than quoted prices included in Level 1) are either directly or indirectly observable for the assets or liabilities through correlation with market data at the measurement date and for the duration of each instrument's anticipated life.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The Company's assets generally included in this fair value category are various government agency securities, certain investment funds, mortgage backed securities, collateralized mortgage obligations, foreign exchange derivatives and interest rate derivatives.&amp;#160;&amp;#160;Foreign exchange derivatives and interest ra
te derivatives are valued using corroborated, observable market data.&amp;#160;&amp;#160;The Company's liabilities generally included in this fair value category consist of certain foreign exchange derivatives.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Level 3 &amp;#8211; Inputs are unobservable inputs for the assets or liabilities.&amp;#160;&amp;#160;These inputs reflect management's best estimate of what market participants would use in pricing the assets or liabilities at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-I
NDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Generally, the Company's assets carried at fair value included in this category are various hedge fund investments.&amp;#160;&amp;#160;The Company's liabilities carried at fair value in this category are acquisition-related contingent payments.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The Company's Level 3 financial investments are held in funds professionally managed by investment managers.&amp;#160;&amp;#160;The net asset values are furnished in statements received from fund custodians whose statements reflect valuations conducted according to their respective fund pricing policies and asset types.&amp;#160;&amp;#160;The complete details 
of the fund holdings of several of the Company's professionally managed funds may be unavailable at times, limiting the Company's ability to look through to the underlying assets at the date the financial statements are prepared.&amp;#160;&amp;#160;Because of these constraints, the Company classified these fund investments as Level 3.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;As of March 31, 2010, the Company has recorded $88, as the fair value of its obligations to make contingent payments related to acquisitions. The fair value measurements were based on significant inputs not observable in the market and thus represent a level 3 measurement.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: bl
ock; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;In connection with an acquisition in 2009, the Company is obligated to make acquisition-related contingent payments of up to $439 based upon the achievement of future research and development milestones that would be expected to create value for Alcon.&amp;#160;&amp;#160;At March 31, 2010, the fair value of these payments was estimated to be $71.&amp;#160;&amp;#160;Each milestone was assigned a probability based on its current status.&amp;#160;&amp;#160;The resultant probability-weighted cash flows were then discounted using a discount rate of 6%, which the Company believes is appropriate and representative of a market participant assumption.&amp;#160;&amp;#160;The probabilities assigned to payment streams ranged from 5% to 39%.&amp;#160;&amp;#160;An increase &lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&
gt;or decrease of 10 percentage points in the probability assumptions would result in an adjustment to the estimated value of approximately $30.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;In connection with an acquisition in 2010, the Company is obligated to make acquisition-related contingent payments of up to $145 upon achieving certain sales objectives through 2014.&amp;#160;&amp;#160;The fair value of these payments at the acquisition date was estimated to total $17 and was included as a cost of the acquisition.&amp;#160;&amp;#160;&amp;#160;&amp;#160;The fair value estimate was based on the Company&amp;#8217;s estimates of the probability and timing of these sales projection streams.&amp;#160;&amp;#160;Each revenue projection assumption was assigned a probability an
d the resultant probability-weighted cash flows were then discounted using a discount rate of 6%, which the Company believes is appropriate and representative of a market participant assumption.&amp;#160;&amp;#160;Achieving the Company's most optimistic sales assumption would not increase the estimated fair value more than $5.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The fair values of these contingent payments are reviewed each reporting period.&amp;#160;&amp;#160;Any changes in the estimated value not associated with the original purchase price valuation are recorded in the Company&amp;#8217;s results of operations.&amp;#160;&amp;#160;No such changes were recognized in the current period.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&l
t;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"&gt;Fair Value by Category&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font&gt;Financial assets and financial liabilities measured at fair value on a recurring basis were categorized in the tables below based upon the lowest level of input that is significant to the fair value measurement.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table style="FONT-SIZ
E: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="14"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Fair Value as of March 31, 2010&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/
font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: center" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Level 1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font s
tyle="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: center" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Level 2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: center" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TE
XT-INDENT: 0pt; MARGIN-RIGHT: 0pt"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Level 3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: center" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;fon
t style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: tim
es new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td s
tyle="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Financial Assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY
: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt
;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Trading securities - Hedge funds&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&
gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT
- -FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;8&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: i
nline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;8&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Available-for-sale securities:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FON
T-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap
="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-A
LIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="MARGIN-LEFT: 17.25pt"&gt;&lt;/font&gt;U.S. government and agency securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT
- -FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;
font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;185&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td v
align="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;185&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="MARGIN-LEFT: 17.75pt"&gt;&lt;/font&gt;Mortg
age-backed securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLA
Y: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;17&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bo
ttom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;17&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt
" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="MARGIN-LEFT: 17.75pt"&gt;&lt;/font&gt;Senior secured bank loans fund&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT
- -SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;97&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" w
idth="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;97&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt
;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="MARGIN-LEFT: 17.75pt"&gt;&lt;/font&gt;Corporate debt securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10
pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;265&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;fon
t style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;265&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: 
left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="MARGIN-LEFT: 17.75pt"&gt;&lt;/font&gt;Equity securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&
gt;33&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; F
ONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom
" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;33&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="MARGIN-LEFT: 17.75pt"&gt;&lt;/font&gt;Other investments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt
;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;1&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FO
NT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style
="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;1&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Forward exchange contracts&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;f
ont style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;5&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: 
left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#
160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;5&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Interest rate swaps&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: in
line; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&l
t;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;1&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign=
"bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;1&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" va
lign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SI
ZE: 10pt; FONT-FAMILY: times new roman"&gt;33&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;571&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; F
ONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;8&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE
: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;612&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="52%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt
;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ti
mes new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline
; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Financial Liabilities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font styl
e="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right"
 valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#
160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Liability for acquisition-rela
ted contingent payments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inli
ne; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;88&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" wid
th="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;88&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" al
ign="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Foreign exchange and option contracts&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADD
ING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td st
yle="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/fon
t&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: le
ft" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: ri
ght" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;88&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign=
"bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;90&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div st
yle="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&amp;#160;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Cash and cash equivalents of $3,129 were excluded from the table above.&lt;/font&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTT
OM: black 0.5pt solid" valign="bottom" colspan="14"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Fair Value as of December 31, 2009&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: center" valign="bottom"
 colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Level 1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: center" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Level 2&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTT
OM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: center" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Level 3&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="DISPLAY:
 inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: center" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font s
tyle="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Financial Assets&lt;/font&gt;&lt;/div&gt;&lt;
/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: i
nline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-L
EFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Trading securities - Hedge funds&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FON
T-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPL
AY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;22&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;22&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign=
"bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Available-for-sale securities:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" widt
h="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td st
yle="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: tim
es new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="MARGIN-LEFT: 17.25pt"&gt;&lt;/font&gt;U.S. government and agency securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width
="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;179&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="
TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&g
t;179&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="MARGIN-LEFT: 17.75pt"&gt;&lt;/font&gt;Mortgage-backed securities fund&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font st
yle="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;82&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="b
ottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&l
t;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;82&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="MARGIN-LEFT: 17.75pt"&gt;&lt;/font&gt;Mortgage-backed securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline
; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;16&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" now
rap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&
gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;16&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="MARGIN-LEFT: 17.75pt"&gt;&lt;/font&gt;Senior secured bank loans fund&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10
pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"
&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;154&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;154&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="MARGIN-LEFT: 17.75pt"&gt;&lt;/font&
gt;Corporate debt securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style=
"DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;43&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" val
ign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;43&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIG
HT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="MARGIN-LEFT: 17.75pt"&gt;&lt;/font&gt;Equity securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;31&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE:
 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="
9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;31&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&g
t;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="MARGIN-LEFT: 17.75pt"&gt;&lt;/font&gt;Other investments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMIL
Y: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;25&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLA
Y: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;25&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bo
ttom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Forward exchange contracts&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" 
valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;6&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt
;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10
pt; FONT-FAMILY: times new roman"&gt;6&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Interest rate swaps&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style=
"BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;1&lt;/font&gt;&lt;/td
&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;1&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-I
NDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;31&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4
px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;506&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4p
x double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;22&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4p
x double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;559&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="52%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ti
mes new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline
; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" w
idth="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Financial Liabilities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right"
 valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#
160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times ne
w roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Liability for acquisition-related contingent payments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: i
nline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" 
width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;71&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-
ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;71&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Foreign exchange and option contracts&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: t
imes new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-S
IZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style
="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="
1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roma
n"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new 
roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;71&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&
gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;73&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Cash and cash equivalents of $3,007 were excluded from the table
 above.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"&gt;Level 3 Gains and Losses&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;At March 31, 2010, trading securities were the only type of financial assets included in Level 3.&amp;#160;&amp;#160;The trading securities were professionally managed investment funds, which consisted of hedge funds of $8.&amp;#160;&amp;#160;The fair value of the investment funds classified as Level 3 could not be deter
mined by independent market observation or through the use of other observable valuation techniques. The valuation was based on the net asset values as furnished by the funds' custodians.&amp;#160;&amp;#160;If more than an insignificant proportion of a particular fund's assets were Level 3, the entire fund was classified as Level 3, although many of such fund's individual holdings may meet the definition of Level 1 or Level 2.&amp;#160;&amp;#160;The only liabilities included in Level 3 were the acquisition-related contingency payments, discussed earlier in this note.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Total gains or losses (realized and unrealized) for financial assets and liabilities classified as Level 3 that were included in earnings were a component of other
, net, in the condensed consolidated statements of earnings.&amp;#160;&amp;#160;For the three months ended March 31, 2010, net gains (realized and unrealized) from trading securities were not significant, and the Company received proceeds from sales of Level 3 trading securities of $14.&amp;#160;&amp;#160;Realized and unrealized net gains during the period were approximately 1% of the beginning balance for Level 3 trading securities and did not negatively affect or materially impact operations, liquidity or capital resources.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The table presented below summarizes the change in carrying values associated with Level 3 financial instruments during the three months ended March 31, 2010.&lt;/font&gt;&lt;br /&gt;&lt;/div&gt;&lt;div al
ign="left"&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&a
mp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Liabilities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="b
ottom" rowspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2" rowspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Trading Securities - Hedge&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;Funds&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" rowspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-
BOTTOM: 0.5pt" valign="bottom" rowspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2" rowspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Acquisition Related Contingent Payments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" rowspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font style="DIS
PLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roma
n"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Beginning balance&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;22&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&a
mp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;71&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Total gains or losses (realiz
ed/unrealized)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt;
 FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Included in earnings before income taxes&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="
DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" vali
gn="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Included in other comprehensive income&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style=
"TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times
 new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt;
 FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Acquisition-related activities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: in
line; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;17&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom"
 nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&
lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Proceeds on sales and maturities&lt;/font&gt;&lt
;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(14 &lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: tim
es new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&
lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/
font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Ending balance&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT
- -ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;8&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;88&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: lef
t" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#
160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times Ne
w Roman"&gt;Gains and losses (realized and unrealized) on Level 3 financial instruments included in earnings for the three months ended March 31, 2010 were not significant.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;At March 31, 2009, trading securities were the only type of financial assets included in Level 3.&amp;#160;&amp;#160;Total gains or losses (realized and unrealized) for financial assets and liabilities classified as Level 3 that were included in earnings were a component of other, net, in the condensed consolidated statements of earnings.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISP
LAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The table presented below summarizes the change in carrying values associated with Level 3 financial instruments during the three months ended March 31, 2009.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MAR
GIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Trading&lt;/
font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" 
nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="88%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10p
t; FONT-FAMILY: times new roman"&gt;Beginning balance&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;261&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="88%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT
- -FAMILY: times new roman"&gt;Total gains or losses (realized/unrealized)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="88%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline;
 FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Included in earnings&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="88%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inl
ine; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Included in other comprehensive income&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="88%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt
;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="left" width="88%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Proceeds on sales and maturitie
s&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(155 &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="88%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;
/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="88%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Ending ba
lance&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;108&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="88%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/fon
t&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;
Gains and losses (realized and unrealized) on Level 3 financial instruments included in earnings for the three months ended March 31, 2009 were reported in other, net, as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="88%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Total gains or losses included in earnings for the period&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px doubl
e; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="88%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; F
ONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="88%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Change in unrealized gains (losses) related to assets still held at reporting date&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/fo
nt&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;1&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="88%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" widt
h="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&amp;#160;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"&gt;Valuation Techniques&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGI
N-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font&gt;Valuation techniques used for financial assets and liabilities accounted for at fair value are generally categorized into three types:&amp;#160;&amp;#160;market approach, income approach and cost approach.&amp;#160;&amp;#160;The Company valued its Level 3 financial assets and liabilities at March 31, 2010 and 2009 primarily using the market approach and, to a lesser extent, the income approach.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Market Approach&lt;/font&gt;.&amp;#160;&amp;#160;The market approach 
uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities.&amp;#160;&amp;#160;Valuation techniques consistent with the market approach include comparables.&amp;#160;&amp;#160;A majority of the Company's balances measured at fair value on a recurring basis were valued using the market approach.&amp;#160;&amp;#160;Most measurements were market quotes or obtained from other reliable market sources.&amp;#160;&amp;#160;The Company did not use market indices for valuing material balances measured at fair value.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Income Approach&lt;/font&gt;.&amp;#160;&amp;#1
60;Income approach valuation techniques convert future amounts, such as cash flows or earnings, to a single present or discounted amount.&amp;#160;&amp;#160;The measurement is based on the value indicated by current market expectations about those future amounts.&amp;#160;&amp;#160;Examples of income approach valuation techniques include present value techniques, option-pricing models, and binomial or lattice models that incorporate present value techniques and option-pricing models.&amp;#160;&amp;#160;The Company valued certain derivatives, in part or whole, and acquisition-related contingent payments using the income approach.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-STYLE: itali
c"&gt;Cost Approach&lt;/font&gt;.&amp;#160;&amp;#160;The cost approach is based on the amount that currently would be required to replace the service capacity of an asset.&amp;#160;&amp;#160;The Company did not employ the cost approach for determining fair value of financial assets and liabilities.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font&gt;The valuation approaches are consistent with generally accepted valuation methodologies.&amp;#160;&amp;#160;While all three approaches are not applicable to all assets or liabilities accounted for at fair value, where appropriate and possible, one or more valuation techniques may be used.&amp;#160;&amp;#160;Professionally managed investment funds may use a combination of market, incom
e and cost approaches.&amp;#160;&amp;#160;The process of selecting which valuation method(s) to apply considers the definition of an exit price and the nature of the asset or liability being valued and significant expertise and judgment is required.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"&gt;Other-Than-Temporary Impairment of Available-for-Sale Investments&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The Company reviews quarterly its available-for-sale investments to identify impaired equity and debt securities. An
 individual security is impaired if the fair value of the investment is less than its amortized cost basis.&amp;#160;&amp;#160;Impairment may be either temporary or other-than-temporary.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The Company normally reviews securities held in its portfolio that have been in a continuous loss position for twelve months or longer and securities whose fair value is significantly lower than its amortized cost basis.&amp;#160;&amp;#160;Impairment is evaluated using a combination of quantitative and qualitative factors such as considering the length of time and extent to which the fair value has been below cost, the financial condition and near-term prospects of the issuer, as well as the Company's ability and intent to hold the investments 
for an adequate period of time until an anticipated market price recovery or maturity.&amp;#160;&amp;#160;If impairment is determined to be other-than-temporary, the investment is written down to fair value, and a loss is recognized immediately through earnings.&lt;/font&gt;&lt;/div&gt;</NonNumbericText>
          <NonNumericTextHeader>(6)&amp;#160;&amp;#160;Financial Instruments(in millions, except per share data)&amp;#160;Foreign Currency Risk ManagementA significant portion of the Company's cash flows</NonNumericTextHeader>
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>This item represents the complete disclosure regarding the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments, assets, and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the Company is exposed to based on the gross fair value of the related item, (c) 
policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risk is are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 107
 -Paragraph 15B
 -Subparagraph a, b

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 107
 -Paragraph 3, 10, 14, 15

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 133
 -Paragraph 44A, 44B

Reference 4: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 157
 -Paragraph 32, 33, 34

Reference 5: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 107
 -Paragraph 15C, 15D

Reference 6: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 107
 -Paragraph 15A
 -Subparagraph a-d

Reference 7: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 159
 -Paragraph 17-22, 27, 28

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
  </Rows>
  <Footnotes />
  <ComparabilityReport>false</ComparabilityReport>
  <NumberOfCols>1</NumberOfCols>
  <NumberOfRows>2</NumberOfRows>
  <HasScenarios>false</HasScenarios>
  <MonetaryRoundingLevel>UnKnown</MonetaryRoundingLevel>
  <SharesRoundingLevel>UnKnown</SharesRoundingLevel>
  <PerShareRoundingLevel>UnKnown</PerShareRoundingLevel>
  <HasPureData>false</HasPureData>
  <SharesShouldBeRounded>true</SharesShouldBeRounded>
</InstanceReport>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R8.xml
<DESCRIPTION>IDEA: Supplemental Balance Sheet Information
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<InstanceReport xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <Version>2.0.0.10</Version>
  <hasSegments>false</hasSegments>
  <ReportName>Supplemental Balance Sheet Information</ReportName>
  <ReportLongName>006040 - Disclosure - Supplemental Balance Sheet Information</ReportLongName>
  <DisplayLabelColumn>true</DisplayLabelColumn>
  <ShowElementNames>false</ShowElementNames>
  <RoundingOption />
  <HasEmbeddedReports>false</HasEmbeddedReports>
  <Columns>
    <Column>
      <LabelColumn>false</LabelColumn>
      <Id>1</Id>
      <Labels>
        <Label Id="1" Label="3 Months Ended" />
        <Label Id="2" Label="Mar. 31, 2010" />
      </Labels>
      <CurrencyCode>usd</CurrencyCode>
      <CurrencySymbol>$</CurrencySymbol>
      <FootnoteIndexer />
      <hasSegments>false</hasSegments>
      <hasScenarios>false</hasScenarios>
      <Segments />
      <Scenarios />
      <Units>
        <Unit>
          <UnitID>u000</UnitID>
          <UnitType>Standard</UnitType>
          <StandardMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/iso4217</MeasureSchema>
            <MeasureValue>USD</MeasureValue>
            <MeasureNamespace>iso4217</MeasureNamespace>
          </StandardMeasure>
          <Scale>0</Scale>
        </Unit>
        <Unit>
          <UnitID>u001</UnitID>
          <UnitType>Standard</UnitType>
          <StandardMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/instance</MeasureSchema>
            <MeasureValue>shares</MeasureValue>
            <MeasureNamespace>xbrli</MeasureNamespace>
          </StandardMeasure>
          <Scale>0</Scale>
        </Unit>
        <Unit>
          <UnitID>u002</UnitID>
          <UnitType>Divide</UnitType>
          <NumeratorMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/iso4217</MeasureSchema>
            <MeasureValue>USD</MeasureValue>
            <MeasureNamespace>iso4217</MeasureNamespace>
          </NumeratorMeasure>
          <DenominatorMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/instance</MeasureSchema>
            <MeasureValue>shares</MeasureValue>
            <MeasureNamespace>xbrli</MeasureNamespace>
          </DenominatorMeasure>
          <Scale>0</Scale>
        </Unit>
      </Units>
    </Column>
  </Columns>
  <Rows>
    <Row>
      <Id>2</Id>
      <Label>Notes to Financial Statements [Abstract]</Label>
      <Level>0</Level>
      <ElementName>acl_NotesToFinancialStatementsAbstract</ElementName>
      <ElementPrefix>acl</ElementPrefix>
      <IsBaseElement>false</IsBaseElement>
      <BalanceType>na</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>string</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>true</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>false</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>No definition available.</ElementDefenition>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>3</Id>
      <Label>Supplemental Balance Sheet Information</Label>
      <Level>1</Level>
      <ElementName>acl_SupplementalBalanceSheetInformation</ElementName>
      <ElementPrefix>acl</ElementPrefix>
      <IsBaseElement>false</IsBaseElement>
      <BalanceType>na</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>string</ElementDataType>
      <ShortDefinition>This element represents the complete disclosure related to inventory. This may include, but is not limited to, the basis of...</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>false</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText>&lt;div&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr valign="top"&gt;&lt;td style="WIDTH: 18pt" align="right"&gt;&lt;div&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;(4)&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Supplemental Balance Sheet Information&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;(in millions, except per share data)&lt;/font&gt;&lt;/font&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table style="FONT-SIZE: 10pt; FONT-
FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;March 31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;
/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;December 31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT
: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2010&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2009&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowra
p="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Inventories, at Lower of Cost or Market&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: i
nline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Finished products&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FON
T-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;376&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;375&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font st
yle="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Work in process&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;51&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font sty
le="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;50&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;
&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Raw materials&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;185&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" al
ign="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;201&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inl
ine; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom
" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="MARGIN-LEFT: 38.15pt"&gt;&lt;/font&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY:
 inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;612&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLA
Y: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;626&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: lef
t" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&amp;#160;&lt;/div&gt;&lt;div align="left"&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times ne
w roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;March 31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td
&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;December 31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDE
NT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2010&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2009&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&l
t;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Property, Plant and Equipment, Net&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10p
t; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Property, plant and equipment, at cost&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FON
T-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2,647&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2,650&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;fon
t style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Accumulated depreciation&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY:
 times new roman"&gt;(1,356 &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(1,346 &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 1
0pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-
SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="MARGIN-LEFT: 38.15pt"&gt;&lt;/font&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td sty
le="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;1,291&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="
BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;1,304&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="D
ISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" val
ign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&amp;#160;&lt;/div&gt;&lt;div align="left"&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;March 31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td styl
e="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;December 31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt
;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2010&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" col
span="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2009&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Accumulated Other Comprehensive Income (Loss)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font styl
e="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"
&gt;Foreign currency translation adjustment&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;197&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font
 style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;265&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Unrealized gains (losses) on investments, net of income taxes&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" v
align="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;16&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;30&lt;/font&gt;&l
t;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Unrecognized postretirement benefits losses and prior service costs,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY:
 times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign=
"bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 9pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;net of tax benefits&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(90 &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: i
nline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(92 &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT
- -FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FO
NT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="MARGIN-LEFT: 38.15pt"&gt;&lt;/font&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&
lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;123&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;
&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;203&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="D
ISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</NonNumbericText>
          <NonNumericTextHeader>(4)&amp;#160;&amp;#160;Supplemental Balance Sheet Information(in millions, except per share data)&amp;#160; &amp;#160;March 31,&amp;#160;&amp;#160;December 31,&amp;#160;&amp;#160;</NonNumericTextHeader>
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>This element represents the complete disclosure related to inventory. This may include, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the major classes of inventory, and the nature of the cost elements included in inventory. If inventory is stated above cost, accrued net losses on firm purchase commitments for inventory and losses resulting from valuing inventory at the lower-of-cost-or-market may also be included. For LIFO inventory, may disclose the amount and basis for determining the excess of replacement or current cost over stated LIFO value and the effects of a LIFO quantities liquidation that impacts net income. Disclosure of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, building and production equipment. This disclosure may include property plant and equipment accounting policies and methodology, a schedule of prop
erty, plant and equipment gross, additions, deletions, transfers and other changes, depreciation, depletion and amortization expense, net, accumulated depreciation, depletion and amortization expense and useful lives, income statement disclosures, assets held for sale and public utility disclosures. This element may be used as a single block of text to include the entire PPE disclosure, including data and tables. This label may include the following: 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income. Components of comprehensive income include: (1) foreign currency translation adjustments; (2) gains and losses on foreign currency transactions that are designated as, and are effective as, economic hedges of a net investment in a foreign entity; (3
) gains and losses on intercompany foreign currency transactions that are of a long-term-investment nature, when the entities to the transaction are consolidated, combined, or accounted for by the equity method in the reporting enterprise's financial statements; (4) change in the market value of a futures contract that qualifies as a hedge of an asset reported at fair value; (5) unrealized holding gains and losses on available-for-sale securities and that resulting from transfers of debt securities from the held-to-maturity category to the available-for-sale category; (6) a net loss recognized as an additional pension liability not yet recognized as net periodic pension cost; and (7) the net gain or loss and net prior service cost or credit for pension plans and other postretirement benefit plans.</ElementDefenition>
      <ElementReferences>No authoritative reference available.</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
  </Rows>
  <Footnotes />
  <ComparabilityReport>false</ComparabilityReport>
  <NumberOfCols>1</NumberOfCols>
  <NumberOfRows>2</NumberOfRows>
  <HasScenarios>false</HasScenarios>
  <MonetaryRoundingLevel>UnKnown</MonetaryRoundingLevel>
  <SharesRoundingLevel>UnKnown</SharesRoundingLevel>
  <PerShareRoundingLevel>UnKnown</PerShareRoundingLevel>
  <HasPureData>false</HasPureData>
  <SharesShouldBeRounded>true</SharesShouldBeRounded>
</InstanceReport>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R18.xml
<DESCRIPTION>IDEA: Commitments and Contingencies
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<InstanceReport xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <Version>2.0.0.10</Version>
  <hasSegments>false</hasSegments>
  <ReportName>Commitments and Contingencies</ReportName>
  <ReportLongName>006140 - Disclosure - Commitments and Contingencies</ReportLongName>
  <DisplayLabelColumn>true</DisplayLabelColumn>
  <ShowElementNames>false</ShowElementNames>
  <RoundingOption />
  <HasEmbeddedReports>false</HasEmbeddedReports>
  <Columns>
    <Column>
      <LabelColumn>false</LabelColumn>
      <Id>1</Id>
      <Labels>
        <Label Id="1" Label="3 Months Ended" />
        <Label Id="2" Label="Mar. 31, 2010" />
      </Labels>
      <CurrencyCode>usd</CurrencyCode>
      <CurrencySymbol>$</CurrencySymbol>
      <FootnoteIndexer />
      <hasSegments>false</hasSegments>
      <hasScenarios>false</hasScenarios>
      <Segments />
      <Scenarios />
      <Units>
        <Unit>
          <UnitID>u000</UnitID>
          <UnitType>Standard</UnitType>
          <StandardMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/iso4217</MeasureSchema>
            <MeasureValue>USD</MeasureValue>
            <MeasureNamespace>iso4217</MeasureNamespace>
          </StandardMeasure>
          <Scale>0</Scale>
        </Unit>
        <Unit>
          <UnitID>u001</UnitID>
          <UnitType>Standard</UnitType>
          <StandardMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/instance</MeasureSchema>
            <MeasureValue>shares</MeasureValue>
            <MeasureNamespace>xbrli</MeasureNamespace>
          </StandardMeasure>
          <Scale>0</Scale>
        </Unit>
        <Unit>
          <UnitID>u002</UnitID>
          <UnitType>Divide</UnitType>
          <NumeratorMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/iso4217</MeasureSchema>
            <MeasureValue>USD</MeasureValue>
            <MeasureNamespace>iso4217</MeasureNamespace>
          </NumeratorMeasure>
          <DenominatorMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/instance</MeasureSchema>
            <MeasureValue>shares</MeasureValue>
            <MeasureNamespace>xbrli</MeasureNamespace>
          </DenominatorMeasure>
          <Scale>0</Scale>
        </Unit>
      </Units>
    </Column>
  </Columns>
  <Rows>
    <Row>
      <Id>2</Id>
      <Label>Notes to Financial Statements [Abstract]</Label>
      <Level>0</Level>
      <ElementName>acl_NotesToFinancialStatementsAbstract</ElementName>
      <ElementPrefix>acl</ElementPrefix>
      <IsBaseElement>false</IsBaseElement>
      <BalanceType>na</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>string</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>true</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>false</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>No definition available.</ElementDefenition>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>3</Id>
      <Label>Commitments and Contingencies</Label>
      <Level>1</Level>
      <ElementName>us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>na</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>string</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole>terselabel</PreferredLabelRole>
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>false</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText>&lt;div&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr valign="top"&gt;&lt;td style="WIDTH: 18pt" align="right"&gt;&lt;div&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;(14)&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Commitments and Contingencies&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;(in millions, except per share data)&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&amp;#160;&lt;/div&gt;&lt;div&g
t;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"&gt;Minority Shareholder Class Action Lawsuits&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font&gt;On January 4, 2010, Novartis announced that it submitted to the Alcon board of directors a proposal for a merger of Alcon with and into Novartis to be effected under Swiss merger law (note 13).&amp;#160;&amp;#160;Under the terms of the merger proposal, holders of the approximate 23% of Alcon shares that are publicly traded would receive 2.8 Novartis shares for each Alcon share.&lt;/font&gt;&lt;/div&gt;&lt;div style
="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font&gt;The Independent Director Committee was formed in 2008 in connection with Novartis's initial purchase of slightly less than 25% of the Alcon shares from Nestl&amp;#233; to evaluate transactions such as the merger proposed by Novartis.&amp;#160;&amp;#160;The Independent Director Committee engaged independent financial and legal advisors in connection with its evaluation of the proposed merger.&amp;#160;&amp;#160;On January 20, 2010, the Independent Director Committee issued its formal response rejecting the Novartis merger proposal.&amp;#160;&amp;#160;The committee rejected the merger proposal based on its assessment that the price offered and other terms were not acceptable and that Novartis's merger proposal was no
t in the best interests of Alcon and its minority shareholders.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font&gt;Certain Alcon minority shareholders have filed several class action lawsuits related to Novartis's merger proposal concerning the acquisition of the remaining 23% publicly held minority interest.&amp;#160;&amp;#160;The claims vary among the cases, but include allegations of: (i) breach of contract against Alcon; (ii) tortious interference with contract against Novartis and Nestl&amp;#233;; (iii) breach of fiduciary duties against the Alcon board of directors, Nestl&amp;#233; and Novartis; (iv) aiding and abetting breaches of fiduciary duties against the Alcon board of directors, Nestl&amp;#233; and Novartis; (v) bre
ach of Section 13(d) of the Exchange Act against Novartis and Nestl&amp;#233; for an alleged failure to disclose that they were acting as a "group;" and (vi) breach of Section 14(d) of the Exchange Act against Novartis and Nestl&amp;#233; for an alleged failure to file with the U.S. Securities and Exchange Commission the materials required in connection with a "tender offer."&amp;#160;&amp;#160;Seven cases filed in the Southern District of New York have been consolidated into one class action case.&amp;#160;&amp;#160;One case is pending in the U.S. District Court for the Northern District of Texas, Fort Worth Division, but the plaintiffs there have agreed to join the plaintiffs in the Southern District of New York action rather than pursue their claims separately.&amp;#160;&amp;#160;One case, which did not name Alcon, Inc. and its board of directors as parties, had been filed in the Eastern District of New York but was voluntarily dismissed by the plaintiffs on March 18, 2010.&amp;#160;&amp;#160;Two cases fi
led in District Court, Tarrant County and two cases filed in the County Court at Law, Dallas County, Texas have been consolidated for pre-trial purposes by the Texas Multidistrict Litigation Panel in the District Court, Dallas County.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&amp;#160;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;On April 14, 2010, plaintiffs in the Southern District of New York action agreed to dismiss their claims against Nestl&amp;#233; and the five Alcon directors nominated by Nestl&amp;#233; in exchange for Nestl&amp;#233;&amp;#8217;s and its directors&amp;#8217; agreement that, without impairing the directors&amp;#8217; ability to exercise their fiduciary obligations to Alcon
, among other things, during the pendency of the action, they will take no action to (1) amend the Alcon Organizational Regulations, (2) remove or replace the Alcon independent directors or (3) facilitate Novartis&amp;#8217;s proposal to take Alcon private other than &lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;pursuant to a recommendation of the Independent Director Committee.&amp;#160;&amp;#160;On April 21, 2010, plaintiffs in the Southern District of New York action voluntarily dismissed their breach of fiduciary duty and aiding and abetting claims against Novartis, Nestl&amp;#233; and the Alcon board of directors.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&
gt;&lt;/font&gt;We are currently unable to express an opinion on the outcome of these class action cases due to their infancy.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"&gt;Other Contingencies&lt;/font&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;/font&gt;&amp;#160;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160;&amp;#160; Alcon, either alone or jointly with its commercial partners, has
 filed fourteen North American patent infringement actions against six different generic drug companies.&amp;#160;&amp;#160;With the exception of international generic challenges, all of these generic drug companies are seeking U.S. Food and Drug Administration ("FDA") approval to market generic versions of Alcon products, under what are known as Abbreviated New Drug Applications ("ANDAs").&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The first infringement action was filed after Alcon received notice that Teva Pharmaceuticals USA, Inc. had filed an ANDA seeking approval to sell a generic version of Alcon's &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Vigamox&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt
;/font&gt; antibiotic ophthalmic solution.&amp;#160;&amp;#160;Moxifloxacin, the primary ingredient in &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Vigamox&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt;, is licensed to Alcon by Bayer Schering Pharma AG.&amp;#160;&amp;#160;As part of its ANDA, Teva challenged three patents covering Alcon's innovator product &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Vigamox&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt;. Two of the patents are owned by Alcon's licensor, Bayer Schering Pharma AG, and the third, which expires in 2020, is owned by Alcon.&amp;#160;&amp;#160;The two Bayer Schering Pharma AG patents were also the subject of another Teva ANDA seeking approval to sell a generic version of Bayer Schering Pharma AG's systemic moxifloxacin product, Avelox&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIG
N: text-top"&gt;&amp;#174;&lt;/font&gt;.&amp;#160;&amp;#160;Suit was filed by Alcon and Bayer Schering Pharma AG as co-plaintiffs against Teva relative to the ANDA challenging &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Vigamox&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt; on April 5, 2006 in the U.S. District Court in Delaware.&amp;#160;&amp;#160;Bayer Schering Pharma AG subsequently filed suit in the same court relative to the Avelox&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt; ANDA, and the two suits were merged.&amp;#160;&amp;#160;Trial was scheduled to begin February 26, 2008, but the dispute between Bayer Schering Pharma AG and Teva relative to the two Bayer Schering Pharma AG patents was resolved by settlement on the eve of trial.&amp;#160;&amp;#160;Under the terms of the settlement, Teva acknowledged the validity and enforceability of both Bayer Schering Pharma AG pa
tents, and further acknowledged that its proposed generic ophthalmic product would infringe both patents.&amp;#160;&amp;#160;Teva has therefore relinquished any claim that it is entitled to market the generic ophthalmic product prior to September 4, 2014.&amp;#160;&amp;#160;Alcon remains the exclusive ophthalmic licensee under the Bayer Schering Pharma patents.&amp;#160;&amp;#160;The trial relative to the Alcon patent began on February 28, 2008 and concluded on March 6, 2008.&amp;#160;&amp;#160;Since then, Alcon has received a notice of allowance on a related patent application with claims that will cover the &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Vigamox&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic"&gt;&amp;#174;&lt;/font&gt; product and Teva's proposed generic product.&amp;#160;&amp;#160;The issue fee has been paid on that application, and the patent should issue by the first quarter of 2010.&amp;#160;&amp;#160;On October 19, 200
9, the court ruled in Alcon's favor on all counts, finding the Alcon patent to be valid and infringed by the proposed generic product.&amp;#160;&amp;#160;On November 19, 2009, Teva filed a Notice of Appeal, but that appeal was subsequently set aside by the Federal Circuit Court of Appeals as being premature.&amp;#160;&amp;#160;It is expected that the appeal will be reinstated after the lower court amends its form of judgment.&amp;#160;&amp;#160;However, even if Teva were to succeed in having the district court decision reversed on appeal, it would still have to address Alcon's recently allowed second patent before competing with Alcon's &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Vigamox&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt; product in September 2014 when the underlying Bayer patent expires.&amp;#160;&amp;#160;If Teva were to win on appeal and overcome Alcon's second patent, the resulting generic competition would be expe
cted to impact significantly the Company's sales and profits.&amp;#160;&amp;#160;On a related note, Alcon's European counterpart patent to the patent-in-suit was determined to be invalid in a European Patent Office Opposition Proceeding.&amp;#160;&amp;#160;That invalidity decision was upheld by an Enlarged Board of Appeal on October 22, 2009.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&amp;#160;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The second patent infringement action was filed after Alcon received notice that Apotex, a Canadian-based generic drug company, had filed an ANDA challenging one of the patents covering Alcon's &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Patanol&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top
"&gt;&amp;#174;&lt;/font&gt; anti-allergy eye product.&amp;#160;&amp;#160;Alcon's raw material supplier, Kyowa Hakko Kirin Co., Ltd., holds another U.S. patent, which has not been challenged in this case and which expires on December 18, 2010.&amp;#160;&amp;#160;In addition, Alcon has secured a six-month pediatric extension to the patent coverage, which means this generic challenge poses no threat to the &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Patanol&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174; &lt;/font&gt;product market prior to June 2011.&amp;#160;&amp;#160;The patent that Apotex has challenged, which is co-owned by Alcon and Kyowa, will expire in 2015.&amp;#160;&amp;#160;Alcon and Kyowa, as co-plaintiffs, filed suit against Apotex Inc. and Apotex Corp. on &lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;November 15, 2006 in the U.S. District Court in Indianapolis, Indiana.&amp;#160;&amp
;#160;As a result of the lawsuit filing, the FDA was required to delay any approval of the Apotex ANDA for 30 months until April 2009, unless the litigation were earlier resolved or the court were to modify the 30-month stay on FDA approval.&amp;#160;&amp;#160;Because of the protection until June 2011, provided by the unchallenged Kyowa patent, the expiration of the 30-month period was inconsequential. &lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Trial had been scheduled for July 27, 2009, but was postponed and has now been rescheduled for April 26, 2010 (consolidated with the Sandoz case described below).&amp;#160;&amp;#160;Should Apotex succeed in overcoming the challenged patent and secure FDA approval, it would not be entitled to begin selling a generic olopatadine product that would compete with Alcon's &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Patanol&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&g
t;&amp;#174;&lt;/font&gt; product in the United States until June 18, 2011.&amp;#160;&amp;#160;Such competition would be expected to impact significantly the Company's sales and profits.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The third patent infringement action was filed after Alcon received notice on October 1, 2007 that Barr Laboratories, Inc. had filed an ANDA challenging the patents underlying Alcon's &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Patanol&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt; product.&amp;#160;&amp;#160;Unlike the Apotex ANDA described above, which is challenging only the patent jointly owned by Kyowa and Alcon, the Barr ANDA was also cha
llenging Kyowa's composition patent on olopatadine, the active agent in &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Patanol&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt;.&amp;#160;&amp;#160;Alcon and Kyowa filed suit in the Federal District Court in Indianapolis (where the Apotex case is pending) on October 23, 2007.&amp;#160;&amp;#160;As a result of the lawsuit filing, the FDA was required to delay any approval of the Barr ANDA for 30 months unless the litigation were earlier resolved or the court modified the 30-month stay on FDA approval.&amp;#160;&amp;#160;The 30-month period after which the FDA could approve Barr's generic product would expire at the end of March 2010, nine months before the Kyowa composition patent expires.&amp;#160;&amp;#160;Trial was scheduled for late April 2010.&amp;#160;&amp;#160;However, in September 2009, Barr withdrew its ANDA and subsequently has been dismissed from the suit.&lt;/font&gt;&lt;/div&g
t;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The fourth patent infringement action was filed after Alcon received notice in late November 2008 that Barr Laboratories, Inc. had filed an ANDA challenging the patents underlying Alcon's &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Pataday&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#8482;&lt;/font&gt; once daily olopatadine product.&amp;#160;&amp;#160;The Barr ANDA is challenging the patent jointly owned by Kyowa and Alcon (described above), as well as two later issued patents owned by Alcon that cover the &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Pataday&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#8482;&lt;/font&gt; form
ulation.&amp;#160;&amp;#160;Of the two Alcon patents, the latest expiry date is November 2023.&amp;#160;&amp;#160;Barr is not challenging the Kyowa patent on olopatadine that expires in December 2010 (effectively extended until June 2011 by a pediatric extension).&amp;#160;&amp;#160;Alcon and Kyowa filed suit in the Federal District Court in Indianapolis on January 8, 2009.&amp;#160;&amp;#160;As a result of the lawsuit filing, the FDA must delay any approval of the Barr ANDA for 30 months unless the litigation is earlier resolved or the court modifies the 30-month stay on FDA approval.&amp;#160;&amp;#160;The 30-month period after which the FDA could approve Barr's generic product will expire in May 2011.&amp;#160;&amp;#160;This case has been consolidated with the Apotex case (&lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Pataday&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#8482;&lt;/font&gt;) described below.&amp;#160;&amp;#160;Trial has not yet be
en scheduled in this case.&amp;#160;&amp;#160;If Barr succeeds in overcoming all of the challenged patents and secures FDA approval, it would be entitled to begin selling a generic olopatadine product that would compete with Alcon's &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Pataday&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#8482;&lt;/font&gt; product in the United States on June 18, 2011.&amp;#160;&amp;#160;Such competition would be expected to impact significantly the Company's sales and profits.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The fifth and sixth ANDA patent suits were filed February 2, 2009 in the U.S. District Court in Indianapolis against Apotex and Sandoz, respectively.&lt;/font&gt;&lt;/
div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&amp;#160;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Alcon received notice January 12, 2009, that Apotex has followed Barr in filing an ANDA challenging the patents underlying Alcon's &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Pataday&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#8482;&lt;/font&gt; once daily olopatadine product.&amp;#160;&amp;#160;Like Barr's ANDA, the Apotex ANDA is challenging the patent jointly owned by Kyowa and Alcon (described above), as well as two later issued patents owned by Alcon that cover the &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Pataday&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#8482;&
lt;/font&gt; formulation.&amp;#160;&amp;#160;Apotex is not challenging the Kyowa patent on olopatadine that expires in December 2010 (June 2011 with the pediatric extension).&amp;#160;&amp;#160;Because the suit was filed within the statutory 45-day period, the FDA must delay any approval of the Apotex ANDA for 30 months (until June 2011), unless the litigation is earlier resolved or the court modifies the 30-month stay on FDA approval.&amp;#160;&amp;#160;In addition, because Apotex is the second filer, it is also subject to the first filer's 180-day exclusivity period, which could further delay its FDA approval.&amp;#160;&amp;#160;Trial has not yet been scheduled in this case.&amp;#160;&amp;#160;If Apotex succeeds in overcoming both of the challenged patents and secures FDA approval, then after the expiration of Barr's potential 180-day "first filer" exclusivity period, it would be entitled to begin selling a generic olopatadine product that would compete with Alcon's &lt;font style="DISPLAY: inline; FONT-ST
YLE: italic"&gt;Pataday&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#8482;&lt;/font&gt; product in the United States in June 2011.&amp;#160;&amp;#160;Such competition would be expected to impact significantly the Company's sales and profits.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Alcon received notice on January 15, 2009 that Sandoz Inc. (an affiliate of Novartis) has filed an ANDA challenging one of the patents underlying Alcon's &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Patanol&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt; product.&amp;#160;&amp;#160;Similar to the Apotex ANDA on &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Patanol&lt;/font&gt;&lt;font style="DIS
PLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt;, the Sandoz ANDA is challenging only the patent jointly owned by Kyowa and Alcon, but not the Kyowa-owned patent on olopatadine, which expires December 2010 (June 2011 with the pediatric extension).&amp;#160;&amp;#160;Because the suit was filed within the statutory 45-day period, the FDA must delay any approval of the Sandoz ANDA for 30 months (until June 2011) unless the litigation is earlier resolved or the court modifies the 30-month stay on FDA approval.&amp;#160;&amp;#160;However, as a third ANDA filer (behind both Apotex and Barr), Sandoz would not be entitled to receive FDA approval until the expiration or forfeiture of a 180-day exclusivity period that would be granted to Apotex (the first filer) if it were successful in its patent challenge.&amp;#160;&amp;#160;Trial has been scheduled for April 26, 2010, and consolidation with the above-described Apotex suit (&lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Pat
anol&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic"&gt;&amp;#174;&lt;/font&gt;) has been ordered by the court.&amp;#160;&amp;#160;Apotex has advised the court of recent public statements of intent by Novartis to acquire all outstanding shares of Alcon stock, and filed a motion to sever Sandoz from the trial.&amp;#160;&amp;#160;On February 22, 2010, the court granted the motion, ordering the suit against Sandoz to proceed separately and confirming the April 26, 2010 trial date with Apotex.&amp;#160;&amp;#160;A new trial date for the Sandoz case has not yet been set.&amp;#160;&amp;#160;Subject to the possibility of the 180-day exclusivity period that could accrue to Apotex, if Sandoz succeeds in overcoming the challenged patent and secures FDA approval, it would be entitled to begin selling a generic olopatadine product that would compete with Alcon's &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Patanol&lt;/font&gt;&lt;font style="DISPLAY: 
inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt; product in the United States in June 2011.&amp;#160;&amp;#160;Such competition would be expected to impact significantly the Company's sales and profits.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The seventh ANDA patent suit was filed after Alcon received notice by letter dated March 17, 2009, that Barr Laboratories, Inc. had filed a Paragraph IV certification with its ANDA for a generic version of Alcon's &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;TRAVATAN&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt; product containing 0.004% travoprost.&amp;#160;&amp;#160;Barr is challenging the following patents listed in the 
Orange Book for &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;TRAVATAN&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt;: U.S. Patent Nos. 5,510,383; 5,631,287; 5,849,792; 5,889,052; and 6,011,062.&amp;#160;&amp;#160;With the exception of the '383 patent, which expires in 2013, all of the patents will expire in December 2014.&amp;#160;&amp;#160;Alcon filed suit against Barr in the U.S. District Court in Delaware on April 30, 2009 and thereby secured the statutory 30-month stay on FDA approval of the generic product.&amp;#160;&amp;#160;The FDA must delay any approval of the Barr ANDA until September 2011, unless the litigation is earlier resolved or the court modifies the 30-month stay on FDA approval.&amp;#160;&amp;#160;This case has been consolidated with the Par and Apotex cases on &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;TRAVATAN&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt
;&amp;#174; &lt;/font&gt;described below.&amp;#160;&amp;#160;Trial has been scheduled to commence March 7, 2011.&amp;#160;&amp;#160;Should Barr succeed in overcoming all of the challenged patents and secure FDA approval, it would be entitled to begin selling a generic travoprost product that would compete with Alcon's &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;TRAVATAN&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt; product in the United States.&amp;#160;&amp;#160;Such competition would be expected to impact significantly the Company's sales and profits.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The eighth patent suit was filed after Sandoz Canada Inc. (an affiliate of Novartis) notified Alc
on Canada by letter dated April 9, 2009, that Sandoz had filed an Abbreviated New Drug Submission (ANDS) seeking approval from the Canadian Minister of Health to market a generic version of Alcon's &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Patanol&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt; product.&amp;#160;&amp;#160;The Sandoz ANDS is challenging only one of the two patents listed in the Canadian Patent Register for the &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Patanol&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt; product.&amp;#160;&amp;#160;The challenged patent (Canadian Patent No. 2,195,094) is jointly owned by Kyowa and Alcon and expires in May 2016.&amp;#160;&amp;#160;Alcon and Kyowa filed suit on May 25, 2009 in the Federal Court in Toronto, thereby securing a 24-month delay (until May 25, 2011) in the regulatory approval from the Minist
er of Health, which can only be shortened if the litigation is earlier resolved or the court modifies the 24-month stay on such approval.&amp;#160;&amp;#160;Trial has not yet been scheduled in this case.&amp;#160;&amp;#160;Should Sandoz succeed in overcoming the challenged patent and secure Minister of Health approval, it would be entitled to begin selling a generic olopatadine product that would compete with Alcon's &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Patanol&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt; product in Canada well before the patent expiration in 2016, but not before expiration of the unchallenged patent in November 2012.&amp;#160;&amp;#160;Such competition would be expected to impact the Company's sales and profits.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&amp;#160;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0p
t; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The ninth ANDA patent suit was filed after Alcon received notice by letter dated June 1, 2009, that Par Pharmaceutical, Inc. had filed a Paragraph IV certification with its two ANDAs for generic versions of Alcon's &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;TRAVATAN&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic"&gt;&amp;#174;&lt;/font&gt; and &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;TRAVATAN Z&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic"&gt;&amp;#174;&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;&amp;#160;&lt;/font&gt;products.&amp;#160;&amp;#160;Par is challenging the following patents listed in the Orange Book for &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;TRAVATAN&lt;/font&gt;&lt;font 
style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic"&gt;&amp;#174;&lt;/font&gt; and &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;TRAVATAN Z&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic"&gt;&amp;#174;&lt;/font&gt;:&amp;#160;&amp;#160;U.S. Patent Nos. 5,510,383; 5,631,287; 5,849,792; 5,889,052; 6,011,062; 6,503,497; and 6,849,253.&amp;#160;&amp;#160;All of these patents will expire by the end of 2014.&amp;#160;&amp;#160;On July 1, 2009, Alcon filed suit in the U.S. District Court in Delaware, thereby securing a statutory stay under which the FDA must delay any approval of the Par ANDAs until December 2011, unless the litigation is earlier resolved or the court modifies the 30-month &lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;stay on FDA approval.&amp;#160;&amp;#160;All of the cases about &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;TRAVATAN&lt;/
font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174; &lt;/font&gt;and&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#160;&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;TRAVATAN Z&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt; (Barr, Par and Apotex) have now been consolidated.&amp;#160;&amp;#160;Trial has been scheduled for March 7, 2011.&amp;#160;&amp;#160;Subject to the possibility of the 180-day exclusivity period that could accrue to Barr (as first filer) relative to the &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;TRAVATAN&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic"&gt;&amp;#174;&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;&amp;#160;&lt;/font&gt;product, if Par succeeds in overcoming all of the challenged patents and secures FDA approval, it 
would be entitled to begin selling generic travoprost products that would compete with Alcon's&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic"&gt;&amp;#160;&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;TRAVATAN&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic"&gt; &amp;#174;&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;&amp;#160;&lt;/font&gt;and &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;TRAVATAN Z&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic"&gt;&amp;#174; &lt;/font&gt;products in the United States in December 2011.&amp;#160;&amp;#160;Such competition would be expected to impact significantly the Company's sales and profits.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT:
 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The tenth ANDA patent suit was filed after Alcon received notice by letter dated June 24, 2009, that Barr Laboratories, Inc. had filed a Paragraph IV certification with its ANDA for a generic version of Alcon's &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;TRAVATAN Z&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic"&gt;&amp;#174;&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#160;&lt;/font&gt;product.&amp;#160;&amp;#160;Barr is challenging the following patents listed in the Orange Book for &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;TRAVATAN Z&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic"&gt;&amp;#174;&lt;/font&gt;:&amp;#160;&amp;#160;U.S. Patent Nos. 5,510,383; 5,889,052; 6,503,49
7; and 6,849,253.&amp;#160;&amp;#160;All of the patents will expire by the end of 2014.&amp;#160;&amp;#160;On July 13, 2009, Alcon filed suit in the U.S. District Court in Delaware, thereby securing a statutory stay under which the FDA must delay any approval of the Barr ANDA until December 2011, unless the litigation is earlier resolved or the court modifies the 30-month stay on FDA approval.&amp;#160;&amp;#160;Trial has been scheduled for March 7, 2011 in this case, which has been consolidated with the above-described Barr suit (&lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;TRAVATAN&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic"&gt;&amp;#174;&lt;/font&gt;) and Par suit (&lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;TRAVATAN&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic"&gt;&amp;#174;&lt;/font&gt; and &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;TRAVATAN Z&lt
;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic"&gt;&amp;#174;&lt;/font&gt;) and consolidated further to include the Apotex suit (&lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;TRAVATAN&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt;) described below.&amp;#160;&amp;#160;Subject to the possibility of the 180-day exclusivity period that could accrue to Par (as first filer) relative to the &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;TRAVATAN Z&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic"&gt;&amp;#174;&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#160;&lt;/font&gt;product, if Barr succeeds in overcoming all of the challenged patents and secures FDA approval, it would be entitled to begin selling a generic travoprost product that would compete with Alcon's &lt;fo
nt style="DISPLAY: inline; FONT-STYLE: italic"&gt;TRAVATAN Z&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic"&gt;&amp;#174;&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#160;&lt;/font&gt;product in the United States in December 2011.&amp;#160;&amp;#160;Such competition would be expected to impact significantly the Company's sales and profits.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The eleventh ANDA patent suit was filed after Alcon received notice by letter dated September 11, 2009, that Apotex Corp. and Apotex Inc. had filed an ANDA for a generic version of Alcon's &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;TRAVATAN&lt;/font&gt;&lt;font style="DI
SPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic"&gt;&amp;#174;&lt;/font&gt; product.&amp;#160;&amp;#160;Apotex is challenging all five of the Orange Book listed patents for &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;TRAVATAN&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic"&gt;&amp;#174;&lt;/font&gt;: 5,510,383; 5,631,287; 5,849,792; 5,889,052; and 6,011,062.&amp;#160;&amp;#160;Alcon filed suit in the U.S. District Court in Delaware, thereby securing a statutory stay under which the FDA must delay any approval of the Barr ANDA until March 2012, unless the litigation is earlier resolved or the court modifies the 30-month stay on FDA approval.&amp;#160;&amp;#160;This case has been consolidated with the Barr and Par cases (&lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;TRAVATAN&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174; &lt;/font&gt;and &lt;font sty
le="DISPLAY: inline; FONT-STYLE: italic"&gt;TRAVATAN Z&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt;)&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#160;&lt;/font&gt;described above.&amp;#160;&amp;#160;Trial has been scheduled for March 7, 2011.&amp;#160;&amp;#160;Subject to the possibility of the 180-day exclusivity period that could accrue to Barr (as first filer) relative to the &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;TRAVATAN&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic"&gt;&amp;#174;&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;&amp;#160;&lt;/font&gt;product, if Apotex succeeds in overcoming all of the challenged patents and secures FDA approval, it would be entitled to begin selling a generic travoprost product that would compete with Alcon's&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALI
GN: text-top; FONT-STYLE: italic"&gt;&amp;#160;&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;TRAVATAN&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic"&gt; &amp;#174;&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;&amp;#160;&lt;/font&gt;product in the United States in March 2012.&amp;#160;&amp;#160;Such competition would be expected to impact significantly the Company's sales and profits.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Alcon received notice dated October 19, 2009, that Apotex Corp. and Apotex Inc. have filed an ANDA challenging U.S. Patent No. 5,116,863, which covers Alcon's &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Patanase&lt;/font&gt;&lt;font
 style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt; olopatadine hydrochloride nasal spray solution. The patent, which is owned by Alcon's raw material supplier, Kyowa Hakko Kirin Co., Ltd., and licensed to Alcon, has a term extended by regulatory exclusivity that expires October 15, 2011.&amp;#160;&amp;#160;Alcon had until December 3, 2009, to file suit and avail itself of the statutory stay on FDA approval of the ANDA.&amp;#160;&amp;#160;Had suit been filed by that date, the FDA could not have approved the Apotex ANDA for 30 months unless the litigation were earlier resolved or the court modified the 30-month stay on FDA approval.&amp;#160;&amp;#160;In this case, however, the 30-month period would be shortened to coincide with the expiration date of the challenged patent in December 2010 and therefore would be inconsequential.&amp;#160;&amp;#160;Moreover, Alcon has regulatory exclusivity for the &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Patanase&lt;/fo
nt&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic"&gt;&amp;#174; &lt;/font&gt;product&lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;&amp;#160;&lt;/font&gt;extending until October 2011.&amp;#160;&amp;#160;Under these circumstances, Alcon and Kyowa elected not to file suit.&amp;#160;&amp;#160;Alcon also has additional pending patent applications that are potentially relevant to the &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Patanase&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic"&gt;&amp;#174;&lt;/font&gt; product, which are not currently listed in the FDA Orange Book, and which have not been challenged by Apotex.&amp;#160;&amp;#160;These pending applications may or may not issue and may not cover the &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Patanase&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic"&gt;&amp;#17
4;&lt;/font&gt; product.&amp;#160;&amp;#160;Should Apotex succeed in securing FDA approval and overcoming the challenged patent and any other applicable patents that may issue, it would be entitled to immediately begin selling a generic olopatadine product that would compete with Alcon's &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Patanase&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt; product in the United States.&amp;#160;&amp;#160;Such competition would be expected to impact significantly the Company's sales and profits.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&amp;#160;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The twelfth ANDA patent suit was filed after Alcon received notice on December 
15, 2009 that Sandoz Inc. (an affiliate of Novartis), had filed an ANDA with a Paragraph IV certification directed to the Alcon and Kyowa patents &lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;on &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Pataday&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#8482;&lt;/font&gt;.&amp;#160;&amp;#160;The Sandoz ANDA is challenging the patent jointly owned by Kyowa and Alcon (described above), as well as two later issued patents owned by Alcon that cover the &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Pataday&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#8482;&lt;/font&gt; formulation.&amp;#160;&amp;#160;Of the two Alcon patents, the latest expiry date is November 2023.&amp;#160;&amp;#160;Sandoz is not challenging the Kyowa patent on olopatadine that expires in December 2010 (effectively extended until June 2
011 by a pediatric extension).&amp;#160;&amp;#160;On January 27, 2010, Alcon and Kyowa filed suit in the Federal District Court in Indianapolis.&amp;#160;&amp;#160;Because the suit was filed within the statutory 45-day period, the FDA must delay any approval of the Sandoz ANDA for 30 months (until June 2012) unless the litigation is earlier resolved or the court modifies the 30-month stay on FDA approval.&amp;#160;&amp;#160;However, because Sandoz is the third filer (behind both Barr and Apotex) and subject to a potential 180-day exclusivity period of the first filer, the 30-month stay is of no practical consequence.&amp;#160;&amp;#160;Subject to the possibility of the 180-day exclusivity period that potentially could accrue to Barr (as first filer) relative to the &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Pataday&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#8482;&lt;/font&gt; product, if Sandoz were to succeed in overcoming all the challenged 
patents and to secure FDA approval, it would be entitled to begin selling a generic product that would compete with Alcon's &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Pataday&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#8482;&lt;/font&gt; product in the United States.&amp;#160;&amp;#160;Such competition would be expected to impact significantly the Company's sales and profits.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The thirteenth ANDA patent suit was filed after Alcon received notice that Wockhardt Limited (headquartered in India) had filed an ANDA with a Paragraph IV certification for a generic version of Alcon's &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Patanol&lt;
/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt; product.&amp;#160;&amp;#160;Wockhardt is challenging U.S. Patent No. 5,641,805, which is jointly owned by Alcon and its raw material supplier, Kyowa Hakko Kirin Co., Ltd.&amp;#160;&amp;#160;The challenged patent will expire in 2015.&amp;#160;&amp;#160;Wockhardt is not challenging, however, another Kyowa-owned U.S. patent covering &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Patanol&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt;, which expires on December 18, 2010 (effectively extended until June 2011 by a pediatric extension).&amp;#160;&amp;#160;Consequently, Wockhardt's generic challenge poses no threat to the &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Patanol&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt; product market prior to June 2011.&am
p;#160;&amp;#160;Alcon and Kyowa filed suit against Wockhardt in the Federal District Court in Indianapolis on February 12, 2010, to avail themselves of the statutory 30-month stay on FDA approval of the proposed generic product.&amp;#160;&amp;#160;That 30-month period will expire August 2, 2012, unless the litigation is earlier resolved or the court modifies the 30-month stay on FDA approval.&amp;#160;&amp;#160;However, as a third ANDA filer (behind both Apotex and Sandoz), Wockhardt would not be entitled to receive FDA approval until the expiration or forfeiture of a 180-day exclusivity period that would be granted to Apotex (the first filer) if it were successful in its patent challenge.&amp;#160;&amp;#160;Subject to the possibility of such a 180-day exclusivity period that could potentially accrue to Apotex (as first filer) relative to the &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Patanol&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt
;/font&gt; product, if Wockhardt were to succeed in overcoming the challenged patent and to secure FDA approval, it would be entitled to begin selling a generic product that would compete with Alcon's &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Patanol&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt; product in the United States.&amp;#160;&amp;#160;Such competition would be expected to impact significantly the Company's sales and profits.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The fourteenth patent suit was filed after Apotex, Inc. notified Alcon Canada that Apotex had filed an ANDS seeking approval from the Canadian Minister of Health to market a generic version of Alcon's Patanol&amp;#174
; product.&amp;#160;&amp;#160;The Apotex ANDS is challenging only one of the two patents listed in the Canadian Patent Register for the Patanol&amp;#174; product.&amp;#160;&amp;#160;The challenged patent (Canadian Patent No. 2,195,094) is jointly owned by Kyowa and Alcon and expires in May 2016.&amp;#160;&amp;#160;Alcon and Kyowa, by timely initiating this action, are entitled to a 24-month delay (until April 2012) in the regulatory approval from the Minister of Health, which can only be shortened if the litigation is earlier resolved or the court modifies the 24-month stay on such approval.&amp;#160;&amp;#160;Should Apotex succeed in overcoming the challenged patent and secure Minister of Health approval, it would be entitled to begin selling a generic olopatadine product that would compete with Alcon's Patanol&amp;#174; product in Canada well before the patent expiration in 2016, but not before expiration of the unchallenged patent in November 2012.&amp;#160;&amp;#160;Such competition would be expected to 
impact the Company's sales and profits.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Alcon is also enforcing patents against generic challengers in China (Patanol&amp;#174;) and Chile (Vigamox&amp;#174;).&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&amp;#160;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;On April 16, 2008, Synergetics USA, Inc., a microsurgical device company, filed a civil antitrust lawsuit in the U.S. District Court for the Southern District of New York against the Company and its subsidiary, Alcon Laboratories, Inc.&amp;#1
60;&amp;#160;Synergetics asserted that it had suffered losses resulting from alleged unlawful/unfair practices and sought a recovery that it claimed could exceed $100.&amp;#160;&amp;#160;Synergetics also asserted that Alcon engaged in allegedly anti-competitive behavior.&amp;#160;&amp;#160;On June 23, 2008, the Company filed its answer and counterclaim in the district court.&amp;#160;&amp;#160;In 2008 and 2009, subsidiaries of the Company filed suits against Synergetics for patent infringement in the U.S. District Court for the Northern District of Texas in Fort Worth.&amp;#160;&amp;#160;Synergetics answered the complaints.&amp;#160;&amp;#160;A series of &lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;counterclaims and motions followed.&amp;#160;&amp;#160;On April 23, 2010, the parties entered a Confidential Settlement and License Agreement together with a Supply Agreement.&amp;#160;&amp;#160;Under the agreements, Alcon will pay $32 in exchange for worldwide ri
ghts to sell Synergetics patented vitreoretinal products.&amp;#160;&amp;#160;The products will be manufactured by Synergetics and supplied to Alcon.&amp;#160;&amp;#160;The agreements also settle all pending litigation between Alcon and Synergetics, including both the antitrust and the patent litigation, and provide a process for future dispute resolution.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;On December 18, 2008, James M. Nielsen, M.D. filed a patent infringement suit against Alcon, Inc. and Alcon Laboratories, Inc. in the U.S. District Court for the Northern District of Texas in Dallas.&amp;#160;&amp;#160;Dr. Nielsen is asserting that his U.S. Patent No. 5,158,572 entitled "Multifocal Intraocular Lens" is being infringed by the Company's &l
t;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;AcrySof&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic"&gt;&amp;#174;&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt; ReSTOR&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top"&gt;&amp;#174;&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;&amp;#160;&lt;/font&gt;intraocular lens.&amp;#160;&amp;#160;The patent, which expired at the end of October 2009, was previously licensed to Advanced Medical Optics, Inc.&amp;#160;&amp;#160;Alcon filed its Answer January 12, 2009.&amp;#160;&amp;#160;The Answer included a counterclaim for a declaratory judgment that the patent-in-suit is invalid and not infringed.&amp;#160;&amp;#160;The case has been set for trial in August, 2010.&amp;#160;&amp;#160;An adverse ruling by the court, while possible, would not be expected to impact significantly the Company's sales and profits.&lt;/font&gt;&lt
;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;On January 22, 2009, Elan Pharma International Ltd. sued two of the Company's subsidiaries, Alcon Laboratories, Inc. and Alcon Research, Ltd., in the U.S. District Court for the Eastern District of Texas in Sherman, alleging infringement of two Elan patents on nanoparticle technology (U.S. Patent Nos. 5,298,262 and 5,429,842).&amp;#160;&amp;#160;The complaint claims that the Company's &lt;font style="DISPLAY: inline; FONT-STYLE: italic"&gt;Azopt&lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 70%; VERTICAL-ALIGN: text-top; FONT-STYLE: italic"&gt;&amp;#174;&lt;/font&gt; product and, potentially, other products infringe the two patents.&amp;#160;&amp;#160;The Company answered and counterclaimed on May 12, 2009.&amp;#160;&amp;#160;Elan t
hen moved to dismiss certain of the Company's affirmative defenses and counterclaims.&amp;#160;&amp;#160;The Company has filed an amended answer and counterclaims providing greater detail with respect to the Company's inequitable conduct counterclaims.&amp;#160;&amp;#160;The case has been set for trial March 21, 2011.&amp;#160;&amp;#160;The Company believes that it has strong defenses and intends to defend itself vigorously.&amp;#160;&amp;#160;An adverse ruling by the court, however, could impact significantly the Company's sales and profits.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The Company and its subsidiaries are parties to a variety of other legal proceedings arising out of the ordinary course of business, including proceedings relating to product liability and
 patent infringement.&amp;#160;&amp;#160;The Company believes that it has valid defenses and is vigorously defending the litigation pending against it.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;While the results of the aforementioned contingencies cannot be predicted with certainty, management believes that the ultimate liability, if any, will not have a material adverse effect on the Company's consolidated financial position or results of operations.&amp;#160;&amp;#160;Litigation contingencies are subject to change based on settlements and court decisions.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font sty
le="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The Company may be subject to future litigation and infringement claims, which could cause the Company to incur significant expenses or prevent the Company from selling its products.&amp;#160;&amp;#160;The Company operates in an industry susceptible to significant product liability claims.&amp;#160;&amp;#160;Product liability claims may be asserted against the Company in the future arising out of events not known to the Company at the present time.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The Company self-insures through captive insurance subsidiaries almost all of its property and casualty, business interruption and liability risks.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDEN
T: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;In the normal course of business, the Company has entered into research and development arrangements with third parties that require milestone and royalty payments to the third parties contingent upon certain future events linked to the success of the research and development efforts.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&amp;#160;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="LETTER-SPACING: 9pt"&gt;D&lt;/font&gt;uring 2008, Lehman Brothers International (Europe) London filed for administration in England.&amp;#160;&amp;#160;At that time,
 the Company's cash and cash equivalents included $707 of short term securities held in a segregated custodial account of Lehman Brothers International (Europe) London pursuant to a Custody Agreement.&amp;#160;&amp;#160;Nestl&amp;#233; invoiced the Company in December 2008 and, in 2009, the Company reimbursed Nestl&amp;#233;, for a total of $5 in fees paid by Nestl&amp;#233; to the Joint Administrators of Lehman Brothers International (Europe) London (in administration) related to the release of the short-term securities held in the custodial account.&amp;#160;&amp;#160;This amount of fees is subject to adjustment depending on the final costs incurred to settle the administration of Lehman Brothers International (Europe) London. &lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;In order to receive an expedited return of assets held by Lehman Brothers International (Europe) (in administration), Alcon has agreed to return any assets which the Joint Administrators d
etermine should not have been disbursed in settlement.&amp;#160;&amp;#160;The amount of any funds to be returned, if any, would result from the determination by the Joint Administrators that the rights of another claimant in the proceeding have precedence over the Company's claim.&lt;/font&gt;&lt;/div&gt;&lt;/div&gt;</NonNumbericText>
          <NonNumericTextHeader>(14)&amp;#160;&amp;#160;Commitments and Contingencies(in millions, except per share data)&amp;#160;Minority Shareholder Class Action LawsuitsOn January 4, 2010, Novartis</NonNumericTextHeader>
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>Includes disclosure of commitments and contingencies. This element may be used as a single block of text to encapsulate the entire disclosure including data and tables.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name FASB Interpretation (FIN)
 -Number 14
 -Paragraph 3

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 5
 -Paragraph 9, 10, 11, 12

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
  </Rows>
  <Footnotes />
  <ComparabilityReport>false</ComparabilityReport>
  <NumberOfCols>1</NumberOfCols>
  <NumberOfRows>2</NumberOfRows>
  <HasScenarios>false</HasScenarios>
  <MonetaryRoundingLevel>UnKnown</MonetaryRoundingLevel>
  <SharesRoundingLevel>UnKnown</SharesRoundingLevel>
  <PerShareRoundingLevel>UnKnown</PerShareRoundingLevel>
  <HasPureData>false</HasPureData>
  <SharesShouldBeRounded>true</SharesShouldBeRounded>
</InstanceReport>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R12.xml
<DESCRIPTION>IDEA: Short Term Borrowings and Long Term Debt
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<InstanceReport xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <Version>2.0.0.10</Version>
  <hasSegments>false</hasSegments>
  <ReportName>Short Term Borrowings and Long Term Debt</ReportName>
  <ReportLongName>006080 - Disclosure - Short Term Borrowings and Long Term Debt</ReportLongName>
  <DisplayLabelColumn>true</DisplayLabelColumn>
  <ShowElementNames>false</ShowElementNames>
  <RoundingOption />
  <HasEmbeddedReports>false</HasEmbeddedReports>
  <Columns>
    <Column>
      <LabelColumn>false</LabelColumn>
      <Id>1</Id>
      <Labels>
        <Label Id="1" Label="3 Months Ended" />
        <Label Id="2" Label="Mar. 31, 2010" />
      </Labels>
      <CurrencyCode>usd</CurrencyCode>
      <CurrencySymbol>$</CurrencySymbol>
      <FootnoteIndexer />
      <hasSegments>false</hasSegments>
      <hasScenarios>false</hasScenarios>
      <Segments />
      <Scenarios />
      <Units>
        <Unit>
          <UnitID>u000</UnitID>
          <UnitType>Standard</UnitType>
          <StandardMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/iso4217</MeasureSchema>
            <MeasureValue>USD</MeasureValue>
            <MeasureNamespace>iso4217</MeasureNamespace>
          </StandardMeasure>
          <Scale>0</Scale>
        </Unit>
        <Unit>
          <UnitID>u001</UnitID>
          <UnitType>Standard</UnitType>
          <StandardMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/instance</MeasureSchema>
            <MeasureValue>shares</MeasureValue>
            <MeasureNamespace>xbrli</MeasureNamespace>
          </StandardMeasure>
          <Scale>0</Scale>
        </Unit>
        <Unit>
          <UnitID>u002</UnitID>
          <UnitType>Divide</UnitType>
          <NumeratorMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/iso4217</MeasureSchema>
            <MeasureValue>USD</MeasureValue>
            <MeasureNamespace>iso4217</MeasureNamespace>
          </NumeratorMeasure>
          <DenominatorMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/instance</MeasureSchema>
            <MeasureValue>shares</MeasureValue>
            <MeasureNamespace>xbrli</MeasureNamespace>
          </DenominatorMeasure>
          <Scale>0</Scale>
        </Unit>
      </Units>
    </Column>
  </Columns>
  <Rows>
    <Row>
      <Id>2</Id>
      <Label>Notes to Financial Statements [Abstract]</Label>
      <Level>0</Level>
      <ElementName>acl_NotesToFinancialStatementsAbstract</ElementName>
      <ElementPrefix>acl</ElementPrefix>
      <IsBaseElement>false</IsBaseElement>
      <BalanceType>na</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>string</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>true</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>false</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>No definition available.</ElementDefenition>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>3</Id>
      <Label>Short Term Borrowings and Long Term Debt</Label>
      <Level>1</Level>
      <ElementName>acl_ShortTermBorrowingsAndLongTermDebt</ElementName>
      <ElementPrefix>acl</ElementPrefix>
      <IsBaseElement>false</IsBaseElement>
      <BalanceType>na</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>string</ElementDataType>
      <ShortDefinition>This element may be used as a single block of text to encapsulate the entire disclosure for short-term borrowings including...</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>false</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText>&lt;div&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr valign="top"&gt;&lt;td style="WIDTH: 18pt" align="right"&gt;&lt;div&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;(8)&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Short Term Borrowings and Long Term Debt&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;(in millions, except per share data)&lt;/font&gt;&lt;/font&gt;&lt;br /&gt;&amp;#160;&lt;/div&gt;&lt;div align="left"&gt;&lt;table style="FONT-SIZE:
 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;March 31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&a
mp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;December 31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block;
 MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2010&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2009&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="b
ottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; 
FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Short Term Borrowings&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Lines of credit&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEX
T-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;263&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;273&lt;/font&gt;&l
t;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Commercial paper&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;361&lt;/font&gt;&
lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;286&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; 
MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;From affiliates&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;6&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT
- -FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;7&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Bank overdrafts&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"
&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;37&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" v
align="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;41&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMIL
Y: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;
&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Total short term borrowings&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY:
 times new roman"&gt;667&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;607&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-
FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&amp;#160;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;At March 31, 2010, the Company had unsecured credit and commercial paper facilities totaling $2,748, including bank overdraft agreements, with third parties that were denominated in various currencies.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;As of March 31, 2010, total borrowings from Nestl&amp;#233; and its subsidiaries were $6 under unsecured revolving credit facilities of $75.&amp;#160;&amp;#160;In the event of a change of control, these agreements wou
ld no longer be available for additional borrowings, and any outstanding balances would become payable in accordance with the related terms.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;March 31,&
lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="left" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;December 31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: in
line; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2010&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&
gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2009&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td
 style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Long Term Debt&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLA
Y: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARG
IN-LEFT: 9pt; TEXT-INDENT: -9pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Bank loan&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;54&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times ne
w roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;56&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10p
t; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" w
idth="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Less current maturities of long term debt&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPL
AY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;54&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt
;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="botto
m" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Long term debt, net of current maturities&lt;/fon
t&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt
;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;56&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom"
 width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt
;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font&gt;The bank loan, guaranteed by Nestl&amp;#233;, contains provisions that may accelerate the obligation in the event that Nestl&amp;#233;'s ownership of Alcon falls below 51%.&lt;/font&gt;&lt;/div&gt;</NonNumbericText>
          <NonNumericTextHeader>(8)&amp;#160;&amp;#160;Short Term Borrowings and Long Term Debt(in millions, except per share data)&amp;#160;&amp;#160; &amp;#160;March 31,&amp;#160;&amp;#160;December 31,&amp;#160;&amp;#160;</NonNumericTextHeader>
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>This element may be used as a single block of text to encapsulate the entire disclosure for short-term borrowings including data and tables. This element may be used as a single block of text to encapsulate the entire disclosure for long-term borrowings including data and tables.</ElementDefenition>
      <ElementReferences>No authoritative reference available.</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
  </Rows>
  <Footnotes />
  <ComparabilityReport>false</ComparabilityReport>
  <NumberOfCols>1</NumberOfCols>
  <NumberOfRows>2</NumberOfRows>
  <HasScenarios>false</HasScenarios>
  <MonetaryRoundingLevel>UnKnown</MonetaryRoundingLevel>
  <SharesRoundingLevel>UnKnown</SharesRoundingLevel>
  <PerShareRoundingLevel>UnKnown</PerShareRoundingLevel>
  <HasPureData>false</HasPureData>
  <SharesShouldBeRounded>true</SharesShouldBeRounded>
</InstanceReport>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R3.xml
<DESCRIPTION>IDEA: Condensed Consolidated Statements of Earnings (Unaudited)
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<InstanceReport xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <Version>2.0.0.10</Version>
  <hasSegments>false</hasSegments>
  <ReportName>Condensed Consolidated Statements of Earnings (Unaudited) (USD $)</ReportName>
  <ReportLongName>002000 - Statement - Condensed Consolidated Statements of Earnings (Unaudited)</ReportLongName>
  <DisplayLabelColumn>true</DisplayLabelColumn>
  <ShowElementNames>false</ShowElementNames>
  <RoundingOption>In Millions, except Share data</RoundingOption>
  <HasEmbeddedReports>false</HasEmbeddedReports>
  <Columns>
    <Column>
      <LabelColumn>false</LabelColumn>
      <Id>1</Id>
      <Labels>
        <Label Id="1" Label="3 Months Ended" />
        <Label Id="2" Label="Mar. 31, 2010" />
      </Labels>
      <CurrencyCode>usd</CurrencyCode>
      <CurrencySymbol>$</CurrencySymbol>
      <FootnoteIndexer />
      <hasSegments>false</hasSegments>
      <hasScenarios>false</hasScenarios>
      <Segments />
      <Scenarios />
      <Units>
        <Unit>
          <UnitID>u000</UnitID>
          <UnitType>Standard</UnitType>
          <StandardMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/iso4217</MeasureSchema>
            <MeasureValue>USD</MeasureValue>
            <MeasureNamespace>iso4217</MeasureNamespace>
          </StandardMeasure>
          <Scale>0</Scale>
        </Unit>
        <Unit>
          <UnitID>u001</UnitID>
          <UnitType>Standard</UnitType>
          <StandardMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/instance</MeasureSchema>
            <MeasureValue>shares</MeasureValue>
            <MeasureNamespace>xbrli</MeasureNamespace>
          </StandardMeasure>
          <Scale>0</Scale>
        </Unit>
        <Unit>
          <UnitID>u002</UnitID>
          <UnitType>Divide</UnitType>
          <NumeratorMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/iso4217</MeasureSchema>
            <MeasureValue>USD</MeasureValue>
            <MeasureNamespace>iso4217</MeasureNamespace>
          </NumeratorMeasure>
          <DenominatorMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/instance</MeasureSchema>
            <MeasureValue>shares</MeasureValue>
            <MeasureNamespace>xbrli</MeasureNamespace>
          </DenominatorMeasure>
          <Scale>0</Scale>
        </Unit>
      </Units>
    </Column>
    <Column>
      <LabelColumn>false</LabelColumn>
      <Id>2</Id>
      <Labels>
        <Label Id="1" Label="3 Months Ended" />
        <Label Id="2" Label="Mar. 31, 2009" />
      </Labels>
      <CurrencyCode>usd</CurrencyCode>
      <CurrencySymbol>$</CurrencySymbol>
      <FootnoteIndexer />
      <hasSegments>false</hasSegments>
      <hasScenarios>false</hasScenarios>
      <Segments />
      <Scenarios />
      <Units>
        <Unit>
          <UnitID>u000</UnitID>
          <UnitType>Standard</UnitType>
          <StandardMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/iso4217</MeasureSchema>
            <MeasureValue>USD</MeasureValue>
            <MeasureNamespace>iso4217</MeasureNamespace>
          </StandardMeasure>
          <Scale>0</Scale>
        </Unit>
        <Unit>
          <UnitID>u001</UnitID>
          <UnitType>Standard</UnitType>
          <StandardMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/instance</MeasureSchema>
            <MeasureValue>shares</MeasureValue>
            <MeasureNamespace>xbrli</MeasureNamespace>
          </StandardMeasure>
          <Scale>0</Scale>
        </Unit>
        <Unit>
          <UnitID>u002</UnitID>
          <UnitType>Divide</UnitType>
          <NumeratorMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/iso4217</MeasureSchema>
            <MeasureValue>USD</MeasureValue>
            <MeasureNamespace>iso4217</MeasureNamespace>
          </NumeratorMeasure>
          <DenominatorMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/instance</MeasureSchema>
            <MeasureValue>shares</MeasureValue>
            <MeasureNamespace>xbrli</MeasureNamespace>
          </DenominatorMeasure>
          <Scale>0</Scale>
        </Unit>
      </Units>
    </Column>
  </Columns>
  <Rows>
    <Row>
      <Id>2</Id>
      <Label>CONSOLIDATED STATEMENTS OF EARNINGS</Label>
      <Level>0</Level>
      <ElementName>us-gaap_IncomeStatementAbstract</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>na</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>string</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>true</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>false</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>false</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>No definition available.</ElementDefenition>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>3</Id>
      <Label>Sales</Label>
      <Level>1</Level>
      <ElementName>us-gaap_SalesRevenueNet</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>credit</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>true</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>1721000000</NumericAmount>
          <RoundedNumericAmount>1721</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>true</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>1493000000</NumericAmount>
          <RoundedNumericAmount>1493</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>Total revenue from sale of goods and services rendered during the reporting period, in the normal course of business, reduced by sales returns and allowances, and sales discounts.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 03
 -Paragraph 1
 -Article 5

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>4</Id>
      <Label>Cost of goods sold</Label>
      <Level>1</Level>
      <ElementName>us-gaap_CostOfGoodsSold</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>debit</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>392000000</NumericAmount>
          <RoundedNumericAmount>392</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>354000000</NumericAmount>
          <RoundedNumericAmount>354</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>Total costs related to goods produced and sold during the reporting period.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 03
 -Paragraph 2
 -Article 5

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>5</Id>
      <Label>Gross profit</Label>
      <Level>1</Level>
      <ElementName>us-gaap_GrossProfit</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>credit</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole>totallabel</PreferredLabelRole>
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>1329000000</NumericAmount>
          <RoundedNumericAmount>1329</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>1139000000</NumericAmount>
          <RoundedNumericAmount>1139</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</ElementDefenition>
      <ElementReferences>No authoritative reference available.</ElementReferences>
      <IsTotalLabel>true</IsTotalLabel>
    </Row>
    <Row>
      <Id>6</Id>
      <Label>Selling, general and administrative</Label>
      <Level>1</Level>
      <ElementName>acl_SellingGeneralAndAdministrative</ElementName>
      <ElementPrefix>acl</ElementPrefix>
      <IsBaseElement>false</IsBaseElement>
      <BalanceType>na</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative...</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>492000000</NumericAmount>
          <RoundedNumericAmount>492</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>472000000</NumericAmount>
          <RoundedNumericAmount>472</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc., including expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, services, costs of public relations and corporate promotions are typically considered to be marketing costs.</ElementDefenition>
      <ElementReferences>No authoritative reference available.</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>7</Id>
      <Label>Research and development</Label>
      <Level>1</Level>
      <ElementName>us-gaap_ResearchAndDevelopmentExpense</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>debit</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>169000000</NumericAmount>
          <RoundedNumericAmount>169</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>146000000</NumericAmount>
          <RoundedNumericAmount>146</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 141
 -Paragraph 51
 -Subparagraph g

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 2
 -Paragraph 12, 13

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 86
 -Paragraph 11, 12

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>8</Id>
      <Label>Amortization of intangibles</Label>
      <Level>1</Level>
      <ElementName>us-gaap_AmortizationOfIntangibleAssets</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>debit</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>11000000</NumericAmount>
          <RoundedNumericAmount>11</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>7000000</NumericAmount>
          <RoundedNumericAmount>7</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by (used in) operations using the indirect method.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 142
 -Paragraph 45
 -Subparagraph a(2)

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>9</Id>
      <Label>Other operating expenses</Label>
      <Level>1</Level>
      <ElementName>acl_OtherOperatingExpenses</ElementName>
      <ElementPrefix>acl</ElementPrefix>
      <IsBaseElement>false</IsBaseElement>
      <BalanceType>debit</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>The total amount of other operating cost and expense items.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole>terselabel</PreferredLabelRole>
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>4000000</NumericAmount>
          <RoundedNumericAmount>4</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>The total amount of other operating cost and expense items.</ElementDefenition>
      <ElementReferences>No authoritative reference available.</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>10</Id>
      <Label>Operating income</Label>
      <Level>1</Level>
      <ElementName>us-gaap_OperatingIncomeLoss</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>credit</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole>totallabel</PreferredLabelRole>
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>653000000</NumericAmount>
          <RoundedNumericAmount>653</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>514000000</NumericAmount>
          <RoundedNumericAmount>514</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>The net result for the period of deducting operating expenses from operating revenues.</ElementDefenition>
      <ElementReferences>No authoritative reference available.</ElementReferences>
      <IsTotalLabel>true</IsTotalLabel>
    </Row>
    <Row>
      <Id>11</Id>
      <Label>Other income (expense):</Label>
      <Level>1</Level>
      <ElementName>us-gaap_OperatingIncomeLossAbstract</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>na</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>string</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>true</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>false</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>false</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>No definition available.</ElementDefenition>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>12</Id>
      <Label>Loss from foreign currency, net</Label>
      <Level>2</Level>
      <ElementName>us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>credit</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole>label</PreferredLabelRole>
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>-2000000</NumericAmount>
          <RoundedNumericAmount>-2</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>-10000000</NumericAmount>
          <RoundedNumericAmount>-10</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>The aggregate foreign currency transaction gain or loss (both realized and unrealized) included in determining net income for the reporting period. Excludes foreign currency transactions designated as hedges of net investment in a foreign entity and intercompany foreign currency transactions that are of a long-term nature, when the entities to the transaction are consolidated, combined, or accounted for by the equity method in the reporting enterprise's financial statements. For certain enterprises, primarily banks, that are dealers in foreign exchange, foreign currency transaction gains or losses may be disclosed as dealer gains or losses.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 52
 -Paragraph 30

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>13</Id>
      <Label>Interest income</Label>
      <Level>2</Level>
      <ElementName>us-gaap_InvestmentIncomeInterestAndDividend</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>credit</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>8000000</NumericAmount>
          <RoundedNumericAmount>8</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>11000000</NumericAmount>
          <RoundedNumericAmount>11</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>Income derived from investments in debt and equity securities and on cash and cash equivalents. Interest income represents earnings which reflect the time value of money or transactions in which the payments are for the use or forbearance of money. Dividend income represents a distribution of earnings to shareholders by investee companies.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 115
 -Paragraph 14

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 03
 -Paragraph 7
 -Subparagraph a, b
 -Article 5

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>14</Id>
      <Label>Interest expense</Label>
      <Level>2</Level>
      <ElementName>us-gaap_InterestExpense</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>debit</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole>label</PreferredLabelRole>
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>-3000000</NumericAmount>
          <RoundedNumericAmount>-3</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>-5000000</NumericAmount>
          <RoundedNumericAmount>-5</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>The cost of borrowed funds accounted for as interest that was charged against earnings during the period.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 34
 -Paragraph 21

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher OTS
 -Name Federal Regulation (FR)
 -Number Title 12
 -Chapter V
 -Section 563c.102
 -Paragraph 9
 -Subsection II

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 04
 -Paragraph 9
 -Article 9

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>15</Id>
      <Label>Other, net</Label>
      <Level>2</Level>
      <ElementName>us-gaap_OtherNonoperatingIncomeExpense</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>credit</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole>terselabel</PreferredLabelRole>
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>20000000</NumericAmount>
          <RoundedNumericAmount>20</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>4000000</NumericAmount>
          <RoundedNumericAmount>4</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>The net amount of other nonoperating income and expense, which does not qualify for separate disclosure on the income statement under materiality guidelines.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 03
 -Paragraph 9
 -Article 5

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>16</Id>
      <Label>Earnings before income taxes</Label>
      <Level>1</Level>
      <ElementName>us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>credit</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole>totallabel</PreferredLabelRole>
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>676000000</NumericAmount>
          <RoundedNumericAmount>676</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>514000000</NumericAmount>
          <RoundedNumericAmount>514</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>Sum of operating profit and nonoperating income (expense) before income (loss) from equity method investments, income taxes, extraordinary items, cumulative effects of changes in accounting principles, and noncontrolling interest.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 08
 -Paragraph h
 -Subparagraph 1(i)
 -Article 4

</ElementReferences>
      <IsTotalLabel>true</IsTotalLabel>
    </Row>
    <Row>
      <Id>17</Id>
      <Label>Income taxes</Label>
      <Level>1</Level>
      <ElementName>us-gaap_IncomeTaxExpenseBenefit</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>debit</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole>terselabel</PreferredLabelRole>
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>103000000</NumericAmount>
          <RoundedNumericAmount>103</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>62000000</NumericAmount>
          <RoundedNumericAmount>62</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>The sum of the current income tax expense (benefit) and the deferred income tax expense (benefit) pertaining to continuing operations.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 08
 -Paragraph h
 -Article 4

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 109
 -Paragraph 45
 -Subparagraph a, b

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>18</Id>
      <Label>Net earnings</Label>
      <Level>1</Level>
      <ElementName>us-gaap_ProfitLoss</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>credit</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole>totallabel</PreferredLabelRole>
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>true</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>573000000</NumericAmount>
          <RoundedNumericAmount>573</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>true</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>452000000</NumericAmount>
          <RoundedNumericAmount>452</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher AICPA
 -Name Accounting Research Bulletin (ARB)
 -Number 51
 -Paragraph A1, A4, A5

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher AICPA
 -Name Accounting Research Bulletin (ARB)
 -Number 51
 -Paragraph 5
 -Subparagraph b

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher AICPA
 -Name Accounting Research Bulletin (ARB)
 -Number 51
 -Paragraph 29

Reference 4: http://www.xbrl.org/2003/role/presentationRef
 -Publisher AICPA
 -Name Accounting Research Bulletin (ARB)
 -Number 51
 -Paragraph 38
 -Subparagraph a

Reference 5: http://www.xbrl.org/2003/role/presentationRef
 -Publisher AICPA
 -Name Accounting Research Bulletin (ARB)
 -Number 51
 -Paragraph 38
 -Subparagraph c(1)

</ElementReferences>
      <IsTotalLabel>true</IsTotalLabel>
    </Row>
    <Row>
      <Id>19</Id>
      <Label>Basic earnings per common share</Label>
      <Level>1</Level>
      <ElementName>us-gaap_EarningsPerShareBasic</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>na</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>decimal</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>true</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>true</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>1.91</NumericAmount>
          <RoundedNumericAmount>1.91</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>true</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>1.51</NumericAmount>
          <RoundedNumericAmount>1.51</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>The amount of net income or loss for the period per each share of common stock outstanding during the reporting period.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 04
 -Paragraph 21
 -Article 9

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 128
 -Paragraph 36, 37, 38

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 03
 -Paragraph 20
 -Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 04
 -Paragraph 18
 -Article 7

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>20</Id>
      <Label>Diluted earnings per common share</Label>
      <Level>1</Level>
      <ElementName>us-gaap_EarningsPerShareDiluted</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>na</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>decimal</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>true</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>true</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>1.89</NumericAmount>
          <RoundedNumericAmount>1.89</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>true</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>1.51</NumericAmount>
          <RoundedNumericAmount>1.51</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>The amount of net income or loss for the period per each share of common stock and dilutive common stock equivalents outstanding during the reporting period.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 128
 -Paragraph 11, 12, 36

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 03
 -Paragraph 20
 -Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 04
 -Paragraph 18
 -Article 7

Reference 4: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 04
 -Paragraph 21
 -Article 9

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>21</Id>
      <Label>Basic weighted average common shares</Label>
      <Level>1</Level>
      <ElementName>us-gaap_WeightedAverageNumberOfSharesIssuedBasic</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>na</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>shares</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>299980871</NumericAmount>
          <RoundedNumericAmount>299980871.00</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>298581689</NumericAmount>
          <RoundedNumericAmount>298581689.00</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>This element represents the weighted average total number of shares issued throughout the period including the first (beginning balance outstanding) and last (ending balance outstanding) day of the period before considering any reductions (for instance, shares held in treasury) to arrive at the weighted average number of shares outstanding. Weighted average relates to the portion of time within a reporting period that common shares have been issued and outstanding to the total time in that period. Such concept is used in determining the weighted average number of shares outstanding for purposes of calculating earnings per share (basic).</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 128
 -Paragraph 40
 -Subparagraph a

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 128
 -Paragraph 8

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 128
 -Paragraph 10

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>22</Id>
      <Label>Diluted weighted average common shares</Label>
      <Level>1</Level>
      <ElementName>us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>na</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>shares</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>303569998</NumericAmount>
          <RoundedNumericAmount>303569998.00</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>300015135</NumericAmount>
          <RoundedNumericAmount>300015135.00</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>The average number of shares issued and outstanding that are used in calculating diluted EPS, determined based on the timing of issuance of shares in the period.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 128
 -Paragraph 40
 -Subparagraph a

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 128
 -Paragraph 8

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
  </Rows>
  <Footnotes />
  <ComparabilityReport>false</ComparabilityReport>
  <NumberOfCols>2</NumberOfCols>
  <NumberOfRows>21</NumberOfRows>
  <HasScenarios>false</HasScenarios>
  <MonetaryRoundingLevel>Millions</MonetaryRoundingLevel>
  <SharesRoundingLevel>NoRounding</SharesRoundingLevel>
  <PerShareRoundingLevel>NoRounding</PerShareRoundingLevel>
  <HasPureData>false</HasPureData>
  <SharesShouldBeRounded>true</SharesShouldBeRounded>
</InstanceReport>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R14.xml
<DESCRIPTION>IDEA: Business Segments
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<InstanceReport xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <Version>2.0.0.10</Version>
  <hasSegments>false</hasSegments>
  <ReportName>Business Segments</ReportName>
  <ReportLongName>006100 - Disclosure - Business Segments</ReportLongName>
  <DisplayLabelColumn>true</DisplayLabelColumn>
  <ShowElementNames>false</ShowElementNames>
  <RoundingOption />
  <HasEmbeddedReports>false</HasEmbeddedReports>
  <Columns>
    <Column>
      <LabelColumn>false</LabelColumn>
      <Id>1</Id>
      <Labels>
        <Label Id="1" Label="3 Months Ended" />
        <Label Id="2" Label="Mar. 31, 2010" />
      </Labels>
      <CurrencyCode>usd</CurrencyCode>
      <CurrencySymbol>$</CurrencySymbol>
      <FootnoteIndexer />
      <hasSegments>false</hasSegments>
      <hasScenarios>false</hasScenarios>
      <Segments />
      <Scenarios />
      <Units>
        <Unit>
          <UnitID>u000</UnitID>
          <UnitType>Standard</UnitType>
          <StandardMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/iso4217</MeasureSchema>
            <MeasureValue>USD</MeasureValue>
            <MeasureNamespace>iso4217</MeasureNamespace>
          </StandardMeasure>
          <Scale>0</Scale>
        </Unit>
        <Unit>
          <UnitID>u001</UnitID>
          <UnitType>Standard</UnitType>
          <StandardMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/instance</MeasureSchema>
            <MeasureValue>shares</MeasureValue>
            <MeasureNamespace>xbrli</MeasureNamespace>
          </StandardMeasure>
          <Scale>0</Scale>
        </Unit>
        <Unit>
          <UnitID>u002</UnitID>
          <UnitType>Divide</UnitType>
          <NumeratorMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/iso4217</MeasureSchema>
            <MeasureValue>USD</MeasureValue>
            <MeasureNamespace>iso4217</MeasureNamespace>
          </NumeratorMeasure>
          <DenominatorMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/instance</MeasureSchema>
            <MeasureValue>shares</MeasureValue>
            <MeasureNamespace>xbrli</MeasureNamespace>
          </DenominatorMeasure>
          <Scale>0</Scale>
        </Unit>
      </Units>
    </Column>
  </Columns>
  <Rows>
    <Row>
      <Id>2</Id>
      <Label>Notes to Financial Statements [Abstract]</Label>
      <Level>0</Level>
      <ElementName>acl_NotesToFinancialStatementsAbstract</ElementName>
      <ElementPrefix>acl</ElementPrefix>
      <IsBaseElement>false</IsBaseElement>
      <BalanceType>na</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>string</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>true</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>false</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>No definition available.</ElementDefenition>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>3</Id>
      <Label>Business Segments</Label>
      <Level>1</Level>
      <ElementName>us-gaap_SegmentReportingDisclosureTextBlock</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>na</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>string</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole>terselabel</PreferredLabelRole>
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>false</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText>&lt;div&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr valign="top"&gt;&lt;td style="WIDTH: 18pt" align="right"&gt;&lt;div&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;(10)&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Business Segments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;(in millions, except per share data)&lt;/font&gt;&lt;/font&gt;&lt;br /&gt;&amp;#160;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN
- -RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font&gt;The Company conducts its global business through two business segments:&amp;#160;&amp;#160;Alcon United States and Alcon International.&amp;#160;&amp;#160;Alcon United States includes sales to unaffiliated customers located in the United States of America, excluding Puerto Rico.&amp;#160;&amp;#160;Alcon United States operating income is derived from operating profits within the United States.&amp;#160;&amp;#160;Alcon International includes sales to all other unaffiliated customers.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font&gt;Each business segment markets and sel
ls products principally in three product categories of the ophthalmic market: (1) pharmaceutical (prescription drugs), (2) surgical equipment and devices (cataract, vitreoretinal and refractive) and (3) consumer eye care (contact lens disinfectants and cleaning solutions, artificial tears and ocular vitamins).&amp;#160;&amp;#160;Business segment operations generally do not include research and development, certain manufacturing and other corporate functions.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font&gt;Certain manufacturing costs and manufacturing variances are not assigned to business segments because most manufacturing operations produce products for more than one business segment.&amp;#160;&amp;#160;Research and develop
ment costs, excluding regulatory costs which are included in the business segments, are treated as general corporate costs and are not assigned to business segments.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font&gt;Identifiable assets are not assigned by business segment and are not considered in evaluating the performance of the business segments.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/t
d&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inl
ine; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times
 new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="6"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: -0.15pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Depreciation and&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="6"&gt;&lt;d
iv style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Sales&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="6"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Operating Income&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTT
OM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="6"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: -0.15pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Amortization&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bo
ttom" align="left"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Three months ended March 31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2010&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&
lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2009&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt
;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2010&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2009&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5
pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2010&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline
; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2009&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="28%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;United States&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font s
tyle="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;726&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign=
"bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;658&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;431&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;
&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;353&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new rom
an"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;12&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;12&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FON
T-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="left" width="28%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;International&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;995&lt;/font&gt
;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;835&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new r
oman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;463&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: 
times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;379&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT
- -SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;28&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font st
yle="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;20&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="28%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEX
T-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/fo
nt&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-F
AMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLA
Y: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="28%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="MARGIN-LEFT: 15.75pt"&gt;&lt;/font&gt;Segments total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign
="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;1,721&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#
160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;1,493&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;894&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: in
line; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;732&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" wi
dth="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;40&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;32&lt;/font&gt;&lt;/td&gt;&lt;td s
tyle="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="28%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Manufacturing operations&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;
&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: 
times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(17 &lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISP
LAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(17 &lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;14&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="ri
ght" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;12&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="28%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Research and development&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" a
lign="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&
gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(150 &lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE
: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(119 &lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DIS
PLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;4&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;4&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="b
ottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="28%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;General corporate&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="
bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&
gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(56 &lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMIL
Y: times new roman"&gt;(59 &lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;4&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLA
Y: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;3&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="left" width="28%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Share-based compensation&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt"
 valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTO
M: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&
lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(18 &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(23 &lt;/font&gt
;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&
amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="28%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &l
t;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roma
n"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="D
ISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt
;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEX
T-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="28%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="MARGIN-LEFT: 15.75pt"&gt;&lt;/font&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" 
valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;1,721&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;1,493&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valig
n="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;653&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="b
ottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;514&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEX
T-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;62&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEX
T-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;51&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&amp;#160;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font&gt;During the three months ended March 31, 2010, advancements in its sales reporting system permitted the Company to better estimate allowable deductions from sales in the calculation of accrued royalties.&amp;#160;&amp;#160;This change in estimate resulted in a $24 addition to U.S. operating income during the period.&lt;/font&gt;&lt;/div&gt;&lt;d
iv style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font&gt;The Company incurred pretax expenses totaling $4 in the three months ended March 31, 2010 for costs related to the anticipated change of control discussed in note 13 and other costs to support Alcon's board of directors in its evaluation of Novartis's merger proposal.&amp;#160;&amp;#160;These expenses were included above in general corporate expenses.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;On February 11, 2009, the Company announced that it initiated programs to al
ign its operations with the evolving economic conditions and market environment.&amp;#160;&amp;#160;These programs included a staffing reduction of approximately 260 employee positions that resulted in a pretax charge of $18 for the three months ended March 31, 2009, which was included in general corporate expenses.&lt;/font&gt;&lt;/div&gt;</NonNumbericText>
          <NonNumericTextHeader>(10)&amp;#160;&amp;#160;Business Segments(in millions, except per share data)&amp;#160;The Company conducts its global business through two business</NonNumericTextHeader>
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>This element may be used to capture the complete disclosure of reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10% or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 131

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
  </Rows>
  <Footnotes />
  <ComparabilityReport>false</ComparabilityReport>
  <NumberOfCols>1</NumberOfCols>
  <NumberOfRows>2</NumberOfRows>
  <HasScenarios>false</HasScenarios>
  <MonetaryRoundingLevel>UnKnown</MonetaryRoundingLevel>
  <SharesRoundingLevel>UnKnown</SharesRoundingLevel>
  <PerShareRoundingLevel>UnKnown</PerShareRoundingLevel>
  <HasPureData>false</HasPureData>
  <SharesShouldBeRounded>true</SharesShouldBeRounded>
</InstanceReport>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R15.xml
<DESCRIPTION>IDEA: Share-Based Compensation
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<InstanceReport xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <Version>2.0.0.10</Version>
  <hasSegments>false</hasSegments>
  <ReportName>Share-Based Compensation</ReportName>
  <ReportLongName>006110 - Disclosure - Share-Based Compensation</ReportLongName>
  <DisplayLabelColumn>true</DisplayLabelColumn>
  <ShowElementNames>false</ShowElementNames>
  <RoundingOption />
  <HasEmbeddedReports>false</HasEmbeddedReports>
  <Columns>
    <Column>
      <LabelColumn>false</LabelColumn>
      <Id>1</Id>
      <Labels>
        <Label Id="1" Label="3 Months Ended" />
        <Label Id="2" Label="Mar. 31, 2010" />
      </Labels>
      <CurrencyCode>usd</CurrencyCode>
      <CurrencySymbol>$</CurrencySymbol>
      <FootnoteIndexer />
      <hasSegments>false</hasSegments>
      <hasScenarios>false</hasScenarios>
      <Segments />
      <Scenarios />
      <Units>
        <Unit>
          <UnitID>u000</UnitID>
          <UnitType>Standard</UnitType>
          <StandardMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/iso4217</MeasureSchema>
            <MeasureValue>USD</MeasureValue>
            <MeasureNamespace>iso4217</MeasureNamespace>
          </StandardMeasure>
          <Scale>0</Scale>
        </Unit>
        <Unit>
          <UnitID>u001</UnitID>
          <UnitType>Standard</UnitType>
          <StandardMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/instance</MeasureSchema>
            <MeasureValue>shares</MeasureValue>
            <MeasureNamespace>xbrli</MeasureNamespace>
          </StandardMeasure>
          <Scale>0</Scale>
        </Unit>
        <Unit>
          <UnitID>u002</UnitID>
          <UnitType>Divide</UnitType>
          <NumeratorMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/iso4217</MeasureSchema>
            <MeasureValue>USD</MeasureValue>
            <MeasureNamespace>iso4217</MeasureNamespace>
          </NumeratorMeasure>
          <DenominatorMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/instance</MeasureSchema>
            <MeasureValue>shares</MeasureValue>
            <MeasureNamespace>xbrli</MeasureNamespace>
          </DenominatorMeasure>
          <Scale>0</Scale>
        </Unit>
      </Units>
    </Column>
  </Columns>
  <Rows>
    <Row>
      <Id>2</Id>
      <Label>Notes to Financial Statements [Abstract]</Label>
      <Level>0</Level>
      <ElementName>acl_NotesToFinancialStatementsAbstract</ElementName>
      <ElementPrefix>acl</ElementPrefix>
      <IsBaseElement>false</IsBaseElement>
      <BalanceType>na</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>string</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>true</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>false</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>No definition available.</ElementDefenition>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>3</Id>
      <Label>Share-Based Compensation Plans</Label>
      <Level>1</Level>
      <ElementName>us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>na</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>string</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole>terselabel</PreferredLabelRole>
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>false</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText>&lt;div&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr valign="top"&gt;&lt;td style="WIDTH: 18pt" align="right"&gt;&lt;div&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;(11)&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Share-Based Compensation&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;(in millions, except per share data)&lt;/font&gt;&lt;/font&gt;&lt;br /&gt;&amp;#160;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt
; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;On February 10, 2010, pursuant to the Amended 2002 Alcon Incentive Plan, the Company's board of directors approved the grant, effective February 17, 2010, to certain employees of approximately 543,000 share-settled restricted share units ("RSUs").&amp;#160;&amp;#160;The RSUs vest at the end of a three-year period, with forfeitures if the recipient is not fully vested at termination of employment or at retirement before age 62.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Restricted share units are recognized over the required service period at the closing market price for Alcon common shares on the date of grant.&lt;/font&gt;&lt;/div&gt;&lt;div style="DI
SPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font&gt;Forfeitures were estimated based on historical experience.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font&gt;If factors change and the Company employs different assumptions to account for share-based payments in future periods, the compensation expense that the Company records may differ significantly from what the Company has recorded in the current period.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;b
r /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font&gt;The effects of share-based equity awards on operating income and net earnings were as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font
&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="6"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Three months ended March 31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid
" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2010&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2009&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&
lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td v
align="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Total share-based equity award costs applicable for period&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt
;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;18&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;23&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times ne
w roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Costs capitalized in inventory&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td 
style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&
lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman
"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Costs recognized in operating income&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; 
FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;18&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;
&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;23&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Less tax benefit recognized in net earnings&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAM
ILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;6&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; 
FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;7&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="
bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT
: 36pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Reduction to net earnings&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;12&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PA
DDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;16&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;
font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font&gt;Compensation expense for equity awards was calculated on a straight-line basis over the three-year vesting period of the applicable share-based awards, with acceleration of the expense for individuals meeting the requirements for retirement, as described above.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font&gt;The effects of share-based liability awards on operating income for the three months ended March 31, 2010 and 2009 were not significant.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&amp;#160;&lt;/div&gt;&lt;div st
yle="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font&gt;The Company intends to satisfy all equity awards granted prior to December 31, 2003 and after December 31, 2007 with the issuance of new shares from conditional capital authorized for the Amended 2002 Alcon Incentive Plan.&amp;#160;&amp;#160;At March 31, 2010, the Company had reserved approximately 21.7 million Alcon common shares for issuance pursuant to the Amended 2002 Alcon Incentive Plan.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font&gt;The Company's board of directors has authorized the acquisition 
on the open market of Alcon common shares to, among other things, satisfy the share-based awards requirements granted under the Amended 2002 Alcon Incentive Plan.&amp;#160;&amp;#160;At March 31, 2010, outstanding authorizations by the Company's board of directors would have permitted the purchase of approximately 1.7 million Alcon common shares.&amp;#160;&amp;#160;The Company has purchased treasury shares on the open market to satisfy the majority of the outstanding equity awards granted subsequent to December 31, 2003 and prior to January 1, 2008.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Change of Control Provisions&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT
- -INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Upon a change of control in the ownership of Alcon, such as Novartis's intended purchase of Nestl&amp;#233;'s common shares of Alcon (discussed in note 13), the Company's share-based compensation awards granted to employees prior to January 1, 2009 will vest immediately.&amp;#160;&amp;#160;However, the vesting of similar awards granted after January 1, 2009 will accelerate only if the respective participant's employment with the Company or its successor is terminated without cause, or by the participant under certain circumstances, within six months preceding or during the two years following a change of control.&amp;#160;&amp;#160;If Alcon is not the surviving corporation under a change in control, the equivalent value of the successor's securities may be substituted for Alcon shares 
under the awards.&lt;/font&gt;&lt;/div&gt;</NonNumbericText>
          <NonNumericTextHeader>(11)&amp;#160;&amp;#160;Share-Based Compensation(in millions, except per share data)&amp;#160;On February 10, 2010, pursuant to the Amended 2002 Alcon Incentive Plan, the</NonNumericTextHeader>
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>Disclosure of compensation-related costs for share-based compensation which may include disclosure of policies, compensation plan details, allocation of stock compensation, incentive distributions, share-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 123R
 -Paragraph 64, 65, A240

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher AICPA
 -Name Statement of Position (SOP)
 -Number 93-6
 -Paragraph 53

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Staff Accounting Bulletin (SAB)
 -Number Topic 14

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
  </Rows>
  <Footnotes />
  <ComparabilityReport>false</ComparabilityReport>
  <NumberOfCols>1</NumberOfCols>
  <NumberOfRows>2</NumberOfRows>
  <HasScenarios>false</HasScenarios>
  <MonetaryRoundingLevel>UnKnown</MonetaryRoundingLevel>
  <SharesRoundingLevel>UnKnown</SharesRoundingLevel>
  <PerShareRoundingLevel>UnKnown</PerShareRoundingLevel>
  <HasPureData>false</HasPureData>
  <SharesShouldBeRounded>true</SharesShouldBeRounded>
</InstanceReport>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R20.xml
<DESCRIPTION>IDEA: Entity Information
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<InstanceReport xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <Version>2.0.0.10</Version>
  <hasSegments>false</hasSegments>
  <ReportName>Entity Information (USD $)</ReportName>
  <ReportLongName>995400 - Document - Entity Information</ReportLongName>
  <DisplayLabelColumn>true</DisplayLabelColumn>
  <ShowElementNames>false</ShowElementNames>
  <RoundingOption />
  <HasEmbeddedReports>false</HasEmbeddedReports>
  <Columns>
    <Column>
      <LabelColumn>false</LabelColumn>
      <Id>1</Id>
      <Labels>
        <Label Id="1" Label="3 Months Ended" />
        <Label Id="2" Label="Mar. 31, 2010" />
      </Labels>
      <CurrencyCode>usd</CurrencyCode>
      <CurrencySymbol>$</CurrencySymbol>
      <FootnoteIndexer />
      <hasSegments>false</hasSegments>
      <hasScenarios>false</hasScenarios>
      <Segments />
      <Scenarios />
      <Units>
        <Unit>
          <UnitID>u000</UnitID>
          <UnitType>Standard</UnitType>
          <StandardMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/iso4217</MeasureSchema>
            <MeasureValue>USD</MeasureValue>
            <MeasureNamespace>iso4217</MeasureNamespace>
          </StandardMeasure>
          <Scale>0</Scale>
        </Unit>
        <Unit>
          <UnitID>u001</UnitID>
          <UnitType>Standard</UnitType>
          <StandardMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/instance</MeasureSchema>
            <MeasureValue>shares</MeasureValue>
            <MeasureNamespace>xbrli</MeasureNamespace>
          </StandardMeasure>
          <Scale>0</Scale>
        </Unit>
        <Unit>
          <UnitID>u002</UnitID>
          <UnitType>Divide</UnitType>
          <NumeratorMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/iso4217</MeasureSchema>
            <MeasureValue>USD</MeasureValue>
            <MeasureNamespace>iso4217</MeasureNamespace>
          </NumeratorMeasure>
          <DenominatorMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/instance</MeasureSchema>
            <MeasureValue>shares</MeasureValue>
            <MeasureNamespace>xbrli</MeasureNamespace>
          </DenominatorMeasure>
          <Scale>0</Scale>
        </Unit>
      </Units>
    </Column>
  </Columns>
  <Rows>
    <Row>
      <Id>2</Id>
      <Label>Entity [Text Block]</Label>
      <Level>0</Level>
      <ElementName>dei_EntityTextBlock</ElementName>
      <ElementPrefix>dei</ElementPrefix>
      <IsBaseElement>false</IsBaseElement>
      <BalanceType>na</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>string</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>true</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>false</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>Container to serve as parent of six Entity related Table concepts.</ElementDefenition>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>3</Id>
      <Label>Entity Registrant Name</Label>
      <Level>1</Level>
      <ElementName>dei_EntityRegistrantName</ElementName>
      <ElementPrefix>dei</ElementPrefix>
      <IsBaseElement>false</IsBaseElement>
      <BalanceType>na</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>normalizedstring</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>false</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText>ALCON INC</NonNumbericText>
          <NonNumericTextHeader>ALCON INC</NonNumericTextHeader>
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation 12B
 -Number 240
 -Section 12b
 -Subsection 1

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>4</Id>
      <Label>Entity Central Index Key</Label>
      <Level>1</Level>
      <ElementName>dei_EntityCentralIndexKey</ElementName>
      <ElementPrefix>dei</ElementPrefix>
      <IsBaseElement>false</IsBaseElement>
      <BalanceType>na</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>na</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>false</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText>0001167379</NonNumbericText>
          <NonNumericTextHeader>0001167379</NonNumericTextHeader>
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation 12B
 -Number 240
 -Section 12b
 -Subsection 1

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>5</Id>
      <Label>Current Fiscal Year End Date</Label>
      <Level>1</Level>
      <ElementName>dei_CurrentFiscalYearEndDate</ElementName>
      <ElementPrefix>dei</ElementPrefix>
      <IsBaseElement>false</IsBaseElement>
      <BalanceType>na</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>monthday</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>false</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText>--12-31</NonNumbericText>
          <NonNumericTextHeader>--12-31</NonNumericTextHeader>
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>End date of current fiscal year in the format --MM-DD.</ElementDefenition>
      <ElementReferences>No authoritative reference available.</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>6</Id>
      <Label>Entity Current Reporting Status</Label>
      <Level>1</Level>
      <ElementName>dei_EntityCurrentReportingStatus</ElementName>
      <ElementPrefix>dei</ElementPrefix>
      <IsBaseElement>false</IsBaseElement>
      <BalanceType>na</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>na</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>false</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText>Yes</NonNumbericText>
          <NonNumericTextHeader>Yes</NonNumericTextHeader>
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>Indicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</ElementDefenition>
      <ElementReferences>No authoritative reference available.</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>7</Id>
      <Label>Entity Well Known Seasoned Issuer</Label>
      <Level>1</Level>
      <ElementName>dei_EntityWellKnownSeasonedIssuer</ElementName>
      <ElementPrefix>dei</ElementPrefix>
      <IsBaseElement>false</IsBaseElement>
      <BalanceType>na</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>na</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>false</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText>Yes</NonNumbericText>
          <NonNumericTextHeader>Yes</NonNumericTextHeader>
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>Indicate "Yes" or "No" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</ElementDefenition>
      <ElementReferences>No authoritative reference available.</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>8</Id>
      <Label>Entity Voluntary Filers</Label>
      <Level>1</Level>
      <ElementName>dei_EntityVoluntaryFilers</ElementName>
      <ElementPrefix>dei</ElementPrefix>
      <IsBaseElement>false</IsBaseElement>
      <BalanceType>na</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>na</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>false</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText>No</NonNumbericText>
          <NonNumericTextHeader>No</NonNumericTextHeader>
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>Indicate "Yes" or "No" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</ElementDefenition>
      <ElementReferences>No authoritative reference available.</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>9</Id>
      <Label>Entity Filer Category</Label>
      <Level>1</Level>
      <ElementName>dei_EntityFilerCategory</ElementName>
      <ElementPrefix>dei</ElementPrefix>
      <IsBaseElement>false</IsBaseElement>
      <BalanceType>na</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>na</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>false</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText>Large Accelerated Filer</NonNumbericText>
          <NonNumericTextHeader>Large Accelerated Filer</NonNumericTextHeader>
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, or (4) Smaller Reporting Company. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</ElementDefenition>
      <ElementReferences>No authoritative reference available.</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>10</Id>
      <Label>Entity Public Float</Label>
      <Level>1</Level>
      <ElementName>dei_EntityPublicFloat</ElementName>
      <ElementPrefix>dei</ElementPrefix>
      <IsBaseElement>false</IsBaseElement>
      <BalanceType>credit</BalanceType>
      <PeriodType>instant</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>true</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>11324474690</NumericAmount>
          <RoundedNumericAmount>11324474690</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>State aggregate market value of voting and non-voting common equity held by non-affiliates computed by reference to price at which the common equity was last sold, or average bid and asked price of such common equity, as of the last business day of registrant's most recently completed second fiscal quarter. The public float should be reported on the cover page of the registrants form 10K.</ElementDefenition>
      <ElementReferences>No authoritative reference available.</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>11</Id>
      <Label>Entity Common Stock Shares Outstanding</Label>
      <Level>1</Level>
      <ElementName>dei_EntityCommonStockSharesOutstanding</ElementName>
      <ElementPrefix>dei</ElementPrefix>
      <IsBaseElement>false</IsBaseElement>
      <BalanceType>na</BalanceType>
      <PeriodType>instant</PeriodType>
      <ElementDataType>shares</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>300232045</NumericAmount>
          <RoundedNumericAmount>300232045</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>Indicate number of shares outstanding of each of registrant's classes of common stock, as of latest practicable date. Where multiple classes exist define each class by adding class of stock items such as Common Class A [Member], Common Class B [Member] onto the Instrument [Domain] of the Entity Listings, Instrument</ElementDefenition>
      <ElementReferences>No authoritative reference available.</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>12</Id>
      <Label>Document Fiscal Year Focus</Label>
      <Level>1</Level>
      <ElementName>dei_DocumentFiscalYearFocus</ElementName>
      <ElementPrefix>dei</ElementPrefix>
      <IsBaseElement>false</IsBaseElement>
      <BalanceType>na</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>positiveinteger</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>2010</NumericAmount>
          <RoundedNumericAmount>2010</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</ElementDefenition>
      <ElementReferences>No authoritative reference available.</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>13</Id>
      <Label>Document Fiscal Period Focus</Label>
      <Level>1</Level>
      <ElementName>dei_DocumentFiscalPeriodFocus</ElementName>
      <ElementPrefix>dei</ElementPrefix>
      <IsBaseElement>false</IsBaseElement>
      <BalanceType>na</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>na</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>false</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText>Q1</NonNumbericText>
          <NonNumericTextHeader>Q1</NonNumericTextHeader>
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.</ElementDefenition>
      <ElementReferences>No authoritative reference available.</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
  </Rows>
  <Footnotes />
  <ComparabilityReport>false</ComparabilityReport>
  <NumberOfCols>1</NumberOfCols>
  <NumberOfRows>12</NumberOfRows>
  <HasScenarios>false</HasScenarios>
  <MonetaryRoundingLevel>NoRounding</MonetaryRoundingLevel>
  <SharesRoundingLevel>NoRounding</SharesRoundingLevel>
  <PerShareRoundingLevel>UnKnown</PerShareRoundingLevel>
  <HasPureData>false</HasPureData>
  <SharesShouldBeRounded>true</SharesShouldBeRounded>
</InstanceReport>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R4.xml
<DESCRIPTION>IDEA: Condensed Consolidated Statements of Cash Flows (Unaudited)
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<InstanceReport xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <Version>2.0.0.10</Version>
  <hasSegments>false</hasSegments>
  <ReportName>Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)</ReportName>
  <ReportLongName>004000 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</ReportLongName>
  <DisplayLabelColumn>true</DisplayLabelColumn>
  <ShowElementNames>false</ShowElementNames>
  <RoundingOption>In Millions</RoundingOption>
  <HasEmbeddedReports>false</HasEmbeddedReports>
  <Columns>
    <Column>
      <LabelColumn>false</LabelColumn>
      <Id>1</Id>
      <Labels>
        <Label Id="1" Label="3 Months Ended" />
        <Label Id="2" Label="Mar. 31, 2010" />
      </Labels>
      <CurrencyCode>usd</CurrencyCode>
      <CurrencySymbol>$</CurrencySymbol>
      <FootnoteIndexer />
      <hasSegments>false</hasSegments>
      <hasScenarios>false</hasScenarios>
      <Segments />
      <Scenarios />
      <Units>
        <Unit>
          <UnitID>u000</UnitID>
          <UnitType>Standard</UnitType>
          <StandardMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/iso4217</MeasureSchema>
            <MeasureValue>USD</MeasureValue>
            <MeasureNamespace>iso4217</MeasureNamespace>
          </StandardMeasure>
          <Scale>0</Scale>
        </Unit>
        <Unit>
          <UnitID>u001</UnitID>
          <UnitType>Standard</UnitType>
          <StandardMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/instance</MeasureSchema>
            <MeasureValue>shares</MeasureValue>
            <MeasureNamespace>xbrli</MeasureNamespace>
          </StandardMeasure>
          <Scale>0</Scale>
        </Unit>
        <Unit>
          <UnitID>u002</UnitID>
          <UnitType>Divide</UnitType>
          <NumeratorMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/iso4217</MeasureSchema>
            <MeasureValue>USD</MeasureValue>
            <MeasureNamespace>iso4217</MeasureNamespace>
          </NumeratorMeasure>
          <DenominatorMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/instance</MeasureSchema>
            <MeasureValue>shares</MeasureValue>
            <MeasureNamespace>xbrli</MeasureNamespace>
          </DenominatorMeasure>
          <Scale>0</Scale>
        </Unit>
      </Units>
    </Column>
    <Column>
      <LabelColumn>false</LabelColumn>
      <Id>2</Id>
      <Labels>
        <Label Id="1" Label="3 Months Ended" />
        <Label Id="2" Label="Mar. 31, 2009" />
      </Labels>
      <CurrencyCode>usd</CurrencyCode>
      <CurrencySymbol>$</CurrencySymbol>
      <FootnoteIndexer />
      <hasSegments>false</hasSegments>
      <hasScenarios>false</hasScenarios>
      <Segments />
      <Scenarios />
      <Units>
        <Unit>
          <UnitID>u000</UnitID>
          <UnitType>Standard</UnitType>
          <StandardMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/iso4217</MeasureSchema>
            <MeasureValue>USD</MeasureValue>
            <MeasureNamespace>iso4217</MeasureNamespace>
          </StandardMeasure>
          <Scale>0</Scale>
        </Unit>
        <Unit>
          <UnitID>u001</UnitID>
          <UnitType>Standard</UnitType>
          <StandardMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/instance</MeasureSchema>
            <MeasureValue>shares</MeasureValue>
            <MeasureNamespace>xbrli</MeasureNamespace>
          </StandardMeasure>
          <Scale>0</Scale>
        </Unit>
        <Unit>
          <UnitID>u002</UnitID>
          <UnitType>Divide</UnitType>
          <NumeratorMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/iso4217</MeasureSchema>
            <MeasureValue>USD</MeasureValue>
            <MeasureNamespace>iso4217</MeasureNamespace>
          </NumeratorMeasure>
          <DenominatorMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/instance</MeasureSchema>
            <MeasureValue>shares</MeasureValue>
            <MeasureNamespace>xbrli</MeasureNamespace>
          </DenominatorMeasure>
          <Scale>0</Scale>
        </Unit>
      </Units>
    </Column>
  </Columns>
  <Rows>
    <Row>
      <Id>3</Id>
      <Label>Cash provided by (used in) operating activities:</Label>
      <Level>1</Level>
      <ElementName>us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>na</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>string</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>true</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>false</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>false</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>The net cash from (used in) all of the entity's operating activities, including those of discontinued operations, of the reporting entity. Operating activities include all transactions and events that are not defined as investing or financing activities. Operating activities generally involve producing and delivering goods and providing services. Cash flows from operating activities are generally the cash effects of transactions and other events that enter into the determination of net income.</ElementDefenition>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>4</Id>
      <Label>Net earnings</Label>
      <Level>2</Level>
      <ElementName>us-gaap_ProfitLoss</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>credit</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>true</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>573000000</NumericAmount>
          <RoundedNumericAmount>573</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>true</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>452000000</NumericAmount>
          <RoundedNumericAmount>452</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher AICPA
 -Name Accounting Research Bulletin (ARB)
 -Number 51
 -Paragraph A1, A4, A5

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher AICPA
 -Name Accounting Research Bulletin (ARB)
 -Number 51
 -Paragraph 5
 -Subparagraph b

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher AICPA
 -Name Accounting Research Bulletin (ARB)
 -Number 51
 -Paragraph 29

Reference 4: http://www.xbrl.org/2003/role/presentationRef
 -Publisher AICPA
 -Name Accounting Research Bulletin (ARB)
 -Number 51
 -Paragraph 38
 -Subparagraph a

Reference 5: http://www.xbrl.org/2003/role/presentationRef
 -Publisher AICPA
 -Name Accounting Research Bulletin (ARB)
 -Number 51
 -Paragraph 38
 -Subparagraph c(1)

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>5</Id>
      <Label>Adjustments to reconcile net earnings to cash provided from operating activities:</Label>
      <Level>2</Level>
      <ElementName>us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>na</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>string</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>true</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole>label</PreferredLabelRole>
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>false</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>false</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>No definition available.</ElementDefenition>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>6</Id>
      <Label>Depreciation</Label>
      <Level>3</Level>
      <ElementName>us-gaap_Depreciation</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>debit</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>51000000</NumericAmount>
          <RoundedNumericAmount>51</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>44000000</NumericAmount>
          <RoundedNumericAmount>44</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 28

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher AICPA
 -Name Accounting Principles Board Opinion (APB)
 -Number 12
 -Paragraph 5

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>7</Id>
      <Label>Amortization of intangibles</Label>
      <Level>3</Level>
      <ElementName>us-gaap_AmortizationOfIntangibleAssets</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>debit</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>11000000</NumericAmount>
          <RoundedNumericAmount>11</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>7000000</NumericAmount>
          <RoundedNumericAmount>7</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by (used in) operations using the indirect method.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 142
 -Paragraph 45
 -Subparagraph a(2)

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>8</Id>
      <Label>Share-based payments</Label>
      <Level>3</Level>
      <ElementName>us-gaap_ShareBasedCompensation</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>debit</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>18000000</NumericAmount>
          <RoundedNumericAmount>18</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>23000000</NumericAmount>
          <RoundedNumericAmount>23</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock options, amortization of restricted stock, and adjustment for officers compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 28

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>9</Id>
      <Label>Tax benefits (reversals) from share-based compensation</Label>
      <Level>3</Level>
      <ElementName>us-gaap_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>credit</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole>label</PreferredLabelRole>
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>2000000</NumericAmount>
          <RoundedNumericAmount>2</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>-2000000</NumericAmount>
          <RoundedNumericAmount>-2</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>Reductions in the entity's income taxes that arise when compensation cost (from non-qualified share-based compensation) recognized on the entity's tax return exceeds compensation cost from share-based compensation recognized in financial statements. This element reduces net cash provided by operating activities.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 123R
 -Paragraph A96

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>10</Id>
      <Label>Deferred income taxes</Label>
      <Level>3</Level>
      <ElementName>us-gaap_DeferredIncomeTaxExpenseBenefit</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>debit</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>21000000</NumericAmount>
          <RoundedNumericAmount>21</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>76000000</NumericAmount>
          <RoundedNumericAmount>76</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>The component of income tax expense for the period representing the net change in the entity's deferred tax assets and liabilities pertaining to continuing operations.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Staff Accounting Bulletin (SAB)
 -Number Topic 6
 -Section I
 -Subsection 7

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 109
 -Paragraph 45
 -Subparagraph b

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 28

Reference 4: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 109
 -Paragraph 289

Reference 5: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 08
 -Paragraph h
 -Article 4

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>11</Id>
      <Label>Loss (gain) on sale of assets</Label>
      <Level>3</Level>
      <ElementName>us-gaap_GainsLossesOnSalesOfAssets</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>credit</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>-15000000</NumericAmount>
          <RoundedNumericAmount>-15</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>36000000</NumericAmount>
          <RoundedNumericAmount>36</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>The net gain or loss resulting from the sale, transfer, termination, or other disposition of assets during the period, excluding transactions involving capital leases, assets-held- or available-for-lease, and other real estate owned which, to the extent appropriate, are included in gains (losses) on the disposition of assets in nonoperating income (expense).</ElementDefenition>
      <ElementReferences>No authoritative reference available.</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>12</Id>
      <Label>Unrealized appreciation on trading securities</Label>
      <Level>3</Level>
      <ElementName>us-gaap_UnrealizedGainLossOnSecurities</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>credit</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole>label</PreferredLabelRole>
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>-4000000</NumericAmount>
          <RoundedNumericAmount>-4</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>-40000000</NumericAmount>
          <RoundedNumericAmount>-40</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>The increases (decreases) in the market value of unsold securities whose gains (losses) were included in earnings.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 28

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>13</Id>
      <Label>Other, net</Label>
      <Level>3</Level>
      <ElementName>us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesOther</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>debit</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>2000000</NumericAmount>
          <RoundedNumericAmount>2</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>3000000</NumericAmount>
          <RoundedNumericAmount>3</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>Transactions that do not result in cash inflows or outflows in the period in which they occur, but affect net income and thus are removed when calculating net cash flow from operating activities using the indirect cash flow method. This element is used when there is not a more specific and appropriate element.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 28

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>14</Id>
      <Label>Changes in operating assets and liabilities, net of effects from business acquisition:</Label>
      <Level>3</Level>
      <ElementName>us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>na</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>string</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>true</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole>terselabel</PreferredLabelRole>
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>false</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>false</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>No definition available.</ElementDefenition>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>15</Id>
      <Label>Trade receivables</Label>
      <Level>4</Level>
      <ElementName>us-gaap_IncreaseDecreaseInAccountsReceivable</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>credit</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>-139000000</NumericAmount>
          <RoundedNumericAmount>-139</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>-117000000</NumericAmount>
          <RoundedNumericAmount>-117</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>The net change during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 28

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>16</Id>
      <Label>Inventories</Label>
      <Level>4</Level>
      <ElementName>us-gaap_IncreaseDecreaseInInventories</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>credit</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>-9000000</NumericAmount>
          <RoundedNumericAmount>-9</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>-43000000</NumericAmount>
          <RoundedNumericAmount>-43</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>The net change during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 28

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>17</Id>
      <Label>Other assets</Label>
      <Level>4</Level>
      <ElementName>us-gaap_IncreaseDecreaseInOtherOperatingAssets</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>credit</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>-15000000</NumericAmount>
          <RoundedNumericAmount>-15</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>-36000000</NumericAmount>
          <RoundedNumericAmount>-36</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>The net change during the reporting period in other operating assets not otherwise defined in the taxonomy.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 28

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>18</Id>
      <Label>Accounts payable</Label>
      <Level>4</Level>
      <ElementName>us-gaap_IncreaseDecreaseInAccountsPayable</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>debit</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole>terselabel</PreferredLabelRole>
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>-7000000</NumericAmount>
          <RoundedNumericAmount>-7</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>19000000</NumericAmount>
          <RoundedNumericAmount>19</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>The net change during the reporting period in the aggregate amount of obligations due within one year (or one business cycle). This may include trade payables, amounts due to related parties, royalties payable, and other obligations.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 28

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>19</Id>
      <Label>Other current liabilities</Label>
      <Level>4</Level>
      <ElementName>us-gaap_IncreaseDecreaseInOtherAccruedLiabilities</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>debit</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole>terselabel</PreferredLabelRole>
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>-116000000</NumericAmount>
          <RoundedNumericAmount>-116</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>-22000000</NumericAmount>
          <RoundedNumericAmount>-22</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>The net change during the reporting period in other expenses incurred but not yet paid. This element should be used when there is no other more specific or appropriate element.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 28

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>20</Id>
      <Label>Other long term liabilities</Label>
      <Level>4</Level>
      <ElementName>us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>debit</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>15000000</NumericAmount>
          <RoundedNumericAmount>15</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>9000000</NumericAmount>
          <RoundedNumericAmount>9</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>The net change during the reporting period in other operating obligations not otherwise defined in the taxonomy.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 28

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>21</Id>
      <Label>Net cash from operating activities</Label>
      <Level>2</Level>
      <ElementName>us-gaap_NetCashProvidedByUsedInOperatingActivities</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>na</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole>totallabel</PreferredLabelRole>
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>388000000</NumericAmount>
          <RoundedNumericAmount>388</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>409000000</NumericAmount>
          <RoundedNumericAmount>409</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>The net cash from (used in) all of the entity's operating activities, including those of discontinued operations, of the reporting entity. Operating activities generally involve producing and delivering goods and providing services. Operating activity cash flows include transactions, adjustments, and changes in value that are not defined as investing or financing activities.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 28

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 26

</ElementReferences>
      <IsTotalLabel>true</IsTotalLabel>
    </Row>
    <Row>
      <Id>22</Id>
      <Label>Cash provided by (used in) investing activities:</Label>
      <Level>1</Level>
      <ElementName>us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>na</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>string</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>true</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>false</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>false</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>No definition available.</ElementDefenition>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>23</Id>
      <Label>Purchases of property, plant and equipment</Label>
      <Level>2</Level>
      <ElementName>us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>credit</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole>label</PreferredLabelRole>
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>-69000000</NumericAmount>
          <RoundedNumericAmount>-69</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>-52000000</NumericAmount>
          <RoundedNumericAmount>-52</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 15

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 17
 -Subparagraph c

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>24</Id>
      <Label>Acquisition of business, net of cash acquired</Label>
      <Level>2</Level>
      <ElementName>us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>credit</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole>label</PreferredLabelRole>
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>-157000000</NumericAmount>
          <RoundedNumericAmount>-157</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 15, 17

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>25</Id>
      <Label>Purchases of intangible assets</Label>
      <Level>2</Level>
      <ElementName>us-gaap_PaymentsToAcquireIntangibleAssets</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>credit</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole>label</PreferredLabelRole>
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>-113000000</NumericAmount>
          <RoundedNumericAmount>-113</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>-1000000</NumericAmount>
          <RoundedNumericAmount>-1</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 15

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 17
 -Subparagraph c

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>26</Id>
      <Label>Purchases of investments</Label>
      <Level>2</Level>
      <ElementName>us-gaap_PaymentsToAcquireInvestments</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>credit</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole>label</PreferredLabelRole>
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>-569000000</NumericAmount>
          <RoundedNumericAmount>-569</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>-246000000</NumericAmount>
          <RoundedNumericAmount>-246</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>The cash outflow associated with the purchase of all investments (debt, security, other) during the period.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 15, 17

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>27</Id>
      <Label>Proceeds from sales and maturities of investments</Label>
      <Level>2</Level>
      <ElementName>us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>debit</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>520000000</NumericAmount>
          <RoundedNumericAmount>520</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>420000000</NumericAmount>
          <RoundedNumericAmount>420</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>The cash inflow associated with the sale, maturity and collection of all investments such as debt, security and so forth during the period.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 31

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 16

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 115
 -Paragraph 18

Reference 4: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 15

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>28</Id>
      <Label>Other, net</Label>
      <Level>2</Level>
      <ElementName>us-gaap_PaymentsForProceedsFromOtherInvestingActivities</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>credit</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole>terselabel</PreferredLabelRole>
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>1000000</NumericAmount>
          <RoundedNumericAmount>1</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>The net cash outflow (inflow) from other investing activities. This element is used when there is not a more specific and appropriate element in the taxonomy.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 15

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>29</Id>
      <Label>Net cash from investing activities</Label>
      <Level>2</Level>
      <ElementName>us-gaap_NetCashProvidedByUsedInInvestingActivities</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>debit</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole>totallabel</PreferredLabelRole>
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>-387000000</NumericAmount>
          <RoundedNumericAmount>-387</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>121000000</NumericAmount>
          <RoundedNumericAmount>121</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>The net cash inflow (outflow) from investing activity.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 26

</ElementReferences>
      <IsTotalLabel>true</IsTotalLabel>
    </Row>
    <Row>
      <Id>30</Id>
      <Label>Cash provided by (used in) financing activities:</Label>
      <Level>1</Level>
      <ElementName>us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>na</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>string</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>true</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>false</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>false</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>No definition available.</ElementDefenition>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>31</Id>
      <Label>Net proceeds from short term debt</Label>
      <Level>2</Level>
      <ElementName>us-gaap_ProceedsFromRepaymentsOfShortTermDebt</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>debit</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole>label</PreferredLabelRole>
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>78000000</NumericAmount>
          <RoundedNumericAmount>78</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>113000000</NumericAmount>
          <RoundedNumericAmount>113</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>The net cash inflow (outflow) for borrowing having initial term of repayment within one year or the normal operating cycle, if longer.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 18

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>32</Id>
      <Label>Repayment of long term debt</Label>
      <Level>2</Level>
      <ElementName>us-gaap_RepaymentsOfLongTermDebt</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>credit</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole>label</PreferredLabelRole>
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>-1000000</NumericAmount>
          <RoundedNumericAmount>-1</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 18

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 20
 -Subparagraph b

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>33</Id>
      <Label>Acquisition of treasury shares</Label>
      <Level>2</Level>
      <ElementName>us-gaap_PaymentsForRepurchaseOfCommonStock</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>credit</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole>label</PreferredLabelRole>
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>-9000000</NumericAmount>
          <RoundedNumericAmount>-9</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>-4000000</NumericAmount>
          <RoundedNumericAmount>-4</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>The cash outflow to reacquire common stock during the period.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 18

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 20
 -Subparagraph a

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>34</Id>
      <Label>Proceeds from exercise of stock options</Label>
      <Level>2</Level>
      <ElementName>us-gaap_ProceedsFromStockOptionsExercised</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>debit</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>45000000</NumericAmount>
          <RoundedNumericAmount>45</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>5000000</NumericAmount>
          <RoundedNumericAmount>5</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>The cash inflow associated with the amount received from holders exercising their stock options.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 18

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 123R
 -Paragraph A240
 -Subparagraph i

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 19
 -Subparagraph a

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>35</Id>
      <Label>Tax benefits from share-based payment arrangements</Label>
      <Level>2</Level>
      <ElementName>us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>debit</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>13000000</NumericAmount>
          <RoundedNumericAmount>13</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>1000000</NumericAmount>
          <RoundedNumericAmount>1</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>Reductions in the entity's income taxes that arise when compensation cost (from non-qualified share-based compensation) recognized on the entity's tax return exceeds compensation cost from share-based compensation recognized in financial statements. This element represents the cash inflow reported in the enterprise's financing activities.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 123R
 -Paragraph A240
 -Subparagraph i

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Emerging Issues Task Force (EITF)
 -Number 00-15
 -Paragraph 3

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>36</Id>
      <Label>Net cash from financing activities</Label>
      <Level>2</Level>
      <ElementName>us-gaap_NetCashProvidedByUsedInFinancingActivities</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>debit</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole>totallabel</PreferredLabelRole>
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>127000000</NumericAmount>
          <RoundedNumericAmount>127</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>114000000</NumericAmount>
          <RoundedNumericAmount>114</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>The net cash inflow (outflow) from financing activity for the period.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 26

</ElementReferences>
      <IsTotalLabel>true</IsTotalLabel>
    </Row>
    <Row>
      <Id>37</Id>
      <Label>Effect of exchange rates on cash and cash equivalents</Label>
      <Level>1</Level>
      <ElementName>us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>debit</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>-6000000</NumericAmount>
          <RoundedNumericAmount>-6</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>-3000000</NumericAmount>
          <RoundedNumericAmount>-3</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>The effect of exchange rate changes on cash balances held in foreign currencies.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 25

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>38</Id>
      <Label>Net increase in cash and cash equivalents</Label>
      <Level>1</Level>
      <ElementName>us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>na</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole>totallabel</PreferredLabelRole>
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>122000000</NumericAmount>
          <RoundedNumericAmount>122</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>641000000</NumericAmount>
          <RoundedNumericAmount>641</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>The net change between the beginning and ending balance of cash and cash equivalents.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 26

</ElementReferences>
      <IsTotalLabel>true</IsTotalLabel>
    </Row>
    <Row>
      <Id>39</Id>
      <Label>Cash and cash equivalents, beginning of period</Label>
      <Level>1</Level>
      <ElementName>us-gaap_CashAndCashEquivalentsAtCarryingValue</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>debit</BalanceType>
      <PeriodType>instant</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>true</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole>periodstartlabel</PreferredLabelRole>
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>3007000000</NumericAmount>
          <RoundedNumericAmount>3007</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>2449000000</NumericAmount>
          <RoundedNumericAmount>2449</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>Includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the Entity may deposit additional funds at any time and also effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased th
ree years ago does not become a cash equivalent when its remaining maturity is three months. Compensating balance arrangements that do not legally restrict the withdrawal or usage of cash amounts may be reported as Cash and Cash Equivalents, while legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits should not be reported as cash and cash equivalents.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 7, 26

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 8, 9

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 7
 -Footnote 1

Reference 4: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 02
 -Paragraph 1
 -Article 5

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>40</Id>
      <Label>Cash and cash equivalents, end of period</Label>
      <Level>1</Level>
      <ElementName>us-gaap_CashAndCashEquivalentsAtCarryingValue</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>debit</BalanceType>
      <PeriodType>instant</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>true</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole>periodendlabel</PreferredLabelRole>
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>true</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>3129000000</NumericAmount>
          <RoundedNumericAmount>3129</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>true</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>3090000000</NumericAmount>
          <RoundedNumericAmount>3090</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>Includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the Entity may deposit additional funds at any time and also effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased th
ree years ago does not become a cash equivalent when its remaining maturity is three months. Compensating balance arrangements that do not legally restrict the withdrawal or usage of cash amounts may be reported as Cash and Cash Equivalents, while legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits should not be reported as cash and cash equivalents.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 7, 26

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 8, 9

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 7
 -Footnote 1

Reference 4: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 02
 -Paragraph 1
 -Article 5

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
  </Rows>
  <Footnotes />
  <ComparabilityReport>false</ComparabilityReport>
  <NumberOfCols>2</NumberOfCols>
  <NumberOfRows>38</NumberOfRows>
  <HasScenarios>false</HasScenarios>
  <MonetaryRoundingLevel>Millions</MonetaryRoundingLevel>
  <SharesRoundingLevel>UnKnown</SharesRoundingLevel>
  <PerShareRoundingLevel>UnKnown</PerShareRoundingLevel>
  <HasPureData>false</HasPureData>
  <SharesShouldBeRounded>true</SharesShouldBeRounded>
</InstanceReport>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R16.xml
<DESCRIPTION>IDEA: Pension and Postretirement Benefits
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<InstanceReport xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <Version>2.0.0.10</Version>
  <hasSegments>false</hasSegments>
  <ReportName>Pension and Postretirement Benefits</ReportName>
  <ReportLongName>006120 - Disclosure - Pension and Postretirement Benefits</ReportLongName>
  <DisplayLabelColumn>true</DisplayLabelColumn>
  <ShowElementNames>false</ShowElementNames>
  <RoundingOption />
  <HasEmbeddedReports>false</HasEmbeddedReports>
  <Columns>
    <Column>
      <LabelColumn>false</LabelColumn>
      <Id>1</Id>
      <Labels>
        <Label Id="1" Label="3 Months Ended" />
        <Label Id="2" Label="Mar. 31, 2010" />
      </Labels>
      <CurrencyCode>usd</CurrencyCode>
      <CurrencySymbol>$</CurrencySymbol>
      <FootnoteIndexer />
      <hasSegments>false</hasSegments>
      <hasScenarios>false</hasScenarios>
      <Segments />
      <Scenarios />
      <Units>
        <Unit>
          <UnitID>u000</UnitID>
          <UnitType>Standard</UnitType>
          <StandardMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/iso4217</MeasureSchema>
            <MeasureValue>USD</MeasureValue>
            <MeasureNamespace>iso4217</MeasureNamespace>
          </StandardMeasure>
          <Scale>0</Scale>
        </Unit>
        <Unit>
          <UnitID>u001</UnitID>
          <UnitType>Standard</UnitType>
          <StandardMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/instance</MeasureSchema>
            <MeasureValue>shares</MeasureValue>
            <MeasureNamespace>xbrli</MeasureNamespace>
          </StandardMeasure>
          <Scale>0</Scale>
        </Unit>
        <Unit>
          <UnitID>u002</UnitID>
          <UnitType>Divide</UnitType>
          <NumeratorMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/iso4217</MeasureSchema>
            <MeasureValue>USD</MeasureValue>
            <MeasureNamespace>iso4217</MeasureNamespace>
          </NumeratorMeasure>
          <DenominatorMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/instance</MeasureSchema>
            <MeasureValue>shares</MeasureValue>
            <MeasureNamespace>xbrli</MeasureNamespace>
          </DenominatorMeasure>
          <Scale>0</Scale>
        </Unit>
      </Units>
    </Column>
  </Columns>
  <Rows>
    <Row>
      <Id>2</Id>
      <Label>Notes to Financial Statements [Abstract]</Label>
      <Level>0</Level>
      <ElementName>acl_NotesToFinancialStatementsAbstract</ElementName>
      <ElementPrefix>acl</ElementPrefix>
      <IsBaseElement>false</IsBaseElement>
      <BalanceType>na</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>string</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>true</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>false</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>No definition available.</ElementDefenition>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>3</Id>
      <Label>Pension and Postretirement Benefits</Label>
      <Level>1</Level>
      <ElementName>us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>na</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>string</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>false</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText>&lt;div&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr valign="top"&gt;&lt;td style="WIDTH: 18pt" align="right"&gt;&lt;div&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;(12)&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Pension and Postretirement Benefits&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;(in millions, except per share data)&lt;/font&gt;&lt;/font&gt;&lt;br /&gt;&amp;#160;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-
INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Components of net periodic benefit costs:&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="6"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; 
FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Pension Benefits&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="6"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Postretirement Benefits&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; 
FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="left"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Three months ended March 31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2010&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="no
wrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2009&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMIL
Y: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2010&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WE
IGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2009&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Service cost&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" wid
th="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;7&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;5&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;t
d valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;3&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&
gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;3&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Interest cost&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&
lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;7&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;6&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; F
ONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;4&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style
="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;4&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Expected return on assets&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;fo
nt style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(1 &lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(1 &lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" v
align="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(3 &lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td
&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(2 &lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Prior service cost&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&l
t;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times 
new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY
: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Net losses (gains)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valig
n="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: blac
k 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td st
yle="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;1&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;1&lt;/font&gt;&lt;
/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="52%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inlin
e; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font sty
le="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left
" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 9pt; TEXT-INDENT: 27pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Net periodic benefit cost&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="
DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;15&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;12&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font st
yle="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;5&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DIS
PLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;6&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="52%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;
#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 
10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font s
tyle="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Certain U.S. defined benefit plans contain change of control pr
ovisions such that, upon a change in control in the ownership of Alcon, such as Novartis's intended purchase of Nestl&amp;#233;'s common shares of Alcon (discussed in note 13), the Company immediately would recognize special termination benefits and curtailment charges, and payments of related pension benefits would be accelerated.&amp;#160;&amp;#160;Management estimates that such charges would impact significantly the Company's results of operations in the period in which a change of control occurs.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The Company maintains an irrevocable Rabbi trust to be held and invested in an unfunded arrangement for the payment of benefits to participants under certain defined benefit pension plans of the Company.&amp;#160;&amp;#160;At March
 31, 2010, the accompanying condensed consolidated balance sheet included net assets of the trust (cash and cash equivalents of $43 and short term investments of $248) that were restricted to the payment of pension benefits except under certain conditions, such as the Company's insolvency or termination of the trust.&amp;#160;&amp;#160;The Alcon Executive Retirement Plans Trust Agreement provides for the Company to fund the current actuarially determined present value of the aggregate accrued pension benefits of all participants in the event the Company undergoes a change of control, such as &lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Novartis's intended purchase of Nestl&amp;#233;'s common shares of Alcon (discussed in note 13).&amp;#160;&amp;#160;Management estimates that a significant contribution to the trust would be required.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: blo
ck; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;In certain countries, the Company's employees participate in defined benefit plans of Nestl&amp;#233;.&amp;#160;&amp;#160;No separate valuation for the Company's employees has historically been prepared for the plans, as they are not individually material to the Company or to Nestl&amp;#233;.&amp;#160;&amp;#160;Accordingly, these plans are treated as multi-employer plans.&amp;#160;&amp;#160;Annual contributions to these plans are determined by Nestl&amp;#233; and charged to the Company.&amp;#160;&amp;#160;Under a change of control, the participants may or may not be migrated to another plan, and additional contributions by the Company may or may not be required in any new single-employer plans.&lt;/font&gt;&lt;/div&gt;</NonNumbericText>
          <NonNumericTextHeader>(12)&amp;#160;&amp;#160;Pension and Postretirement Benefits(in millions, except per share data)&amp;#160;Components of net periodic benefit costs:&amp;#160; &amp;#160;Pension</NonNumericTextHeader>
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>Description containing the entire pension and other postretirement benefits disclosure as a single block of text.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name FASB Staff Position (FSP)
 -Number FAS106-2
 -Paragraph 20, 21, 22

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 132R
 -Paragraph 5, 6, 7, 8

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 87
 -Paragraph 264

Reference 4: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Implementation Guide (Q and A)
 -Number FAS88
 -Paragraph 63

Reference 5: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 158
 -Paragraph 7, 21, 22

Reference 6: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 132R
 -Paragraph 5
 -Subparagraph b

Reference 7: http://www.xbrl.org/2003/role/presentationRef
 -Publisher AICPA
 -Name Accounting Principles Board Opinion (APB)
 -Number 30
 -Paragraph 26

Reference 8: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 106
 -Paragraph 518

Reference 9: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Emerging Issues Task Force (EITF)
 -Number 03-2
 -Paragraph 8

Reference 10: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 132R
 -Paragraph 8
 -Subparagraph m

Reference 11: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 132R
 -Paragraph 5
 -Subparagraph h

Reference 12: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 132R
 -Paragraph 5
 -Subparagraph a

Reference 13: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 132R
 -Paragraph 5
 -Subparagraph q

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
  </Rows>
  <Footnotes />
  <ComparabilityReport>false</ComparabilityReport>
  <NumberOfCols>1</NumberOfCols>
  <NumberOfRows>2</NumberOfRows>
  <HasScenarios>false</HasScenarios>
  <MonetaryRoundingLevel>UnKnown</MonetaryRoundingLevel>
  <SharesRoundingLevel>UnKnown</SharesRoundingLevel>
  <PerShareRoundingLevel>UnKnown</PerShareRoundingLevel>
  <HasPureData>false</HasPureData>
  <SharesShouldBeRounded>true</SharesShouldBeRounded>
</InstanceReport>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R9.xml
<DESCRIPTION>IDEA: Investments
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<InstanceReport xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <Version>2.0.0.10</Version>
  <hasSegments>false</hasSegments>
  <ReportName>Investments</ReportName>
  <ReportLongName>006050 - Disclosure - Investments</ReportLongName>
  <DisplayLabelColumn>true</DisplayLabelColumn>
  <ShowElementNames>false</ShowElementNames>
  <RoundingOption />
  <HasEmbeddedReports>false</HasEmbeddedReports>
  <Columns>
    <Column>
      <LabelColumn>false</LabelColumn>
      <Id>1</Id>
      <Labels>
        <Label Id="1" Label="3 Months Ended" />
        <Label Id="2" Label="Mar. 31, 2010" />
      </Labels>
      <CurrencyCode>usd</CurrencyCode>
      <CurrencySymbol>$</CurrencySymbol>
      <FootnoteIndexer />
      <hasSegments>false</hasSegments>
      <hasScenarios>false</hasScenarios>
      <Segments />
      <Scenarios />
      <Units>
        <Unit>
          <UnitID>u000</UnitID>
          <UnitType>Standard</UnitType>
          <StandardMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/iso4217</MeasureSchema>
            <MeasureValue>USD</MeasureValue>
            <MeasureNamespace>iso4217</MeasureNamespace>
          </StandardMeasure>
          <Scale>0</Scale>
        </Unit>
        <Unit>
          <UnitID>u001</UnitID>
          <UnitType>Standard</UnitType>
          <StandardMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/instance</MeasureSchema>
            <MeasureValue>shares</MeasureValue>
            <MeasureNamespace>xbrli</MeasureNamespace>
          </StandardMeasure>
          <Scale>0</Scale>
        </Unit>
        <Unit>
          <UnitID>u002</UnitID>
          <UnitType>Divide</UnitType>
          <NumeratorMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/iso4217</MeasureSchema>
            <MeasureValue>USD</MeasureValue>
            <MeasureNamespace>iso4217</MeasureNamespace>
          </NumeratorMeasure>
          <DenominatorMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/instance</MeasureSchema>
            <MeasureValue>shares</MeasureValue>
            <MeasureNamespace>xbrli</MeasureNamespace>
          </DenominatorMeasure>
          <Scale>0</Scale>
        </Unit>
      </Units>
    </Column>
  </Columns>
  <Rows>
    <Row>
      <Id>2</Id>
      <Label>Notes to Financial Statements [Abstract]</Label>
      <Level>0</Level>
      <ElementName>acl_NotesToFinancialStatementsAbstract</ElementName>
      <ElementPrefix>acl</ElementPrefix>
      <IsBaseElement>false</IsBaseElement>
      <BalanceType>na</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>string</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>true</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>false</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>No definition available.</ElementDefenition>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>3</Id>
      <Label>Investments</Label>
      <Level>1</Level>
      <ElementName>us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>na</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>string</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole>terselabel</PreferredLabelRole>
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>false</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText>&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr valign="top"&gt;&lt;td style="WIDTH: 18pt" align="right"&gt;&lt;div&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;(5)&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Investments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;(in millions, except per share data)&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&amp;#160
;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 14.4pt"&gt;&lt;/font&gt;At March 31, 2010 and December 31, 2009, investments were:&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MA
RGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;March 31&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;December 31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bot
tom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 1px; BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: center" valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2010&lt;/font&gt;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE:
 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: center" valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;font style="FONT-WEIGHT: bold"&gt;2009&lt;/font&gt;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Short term investments:&lt;/font&gt;&lt;/div&gt;&lt;/td&g
t;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" 
width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Trading securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;8&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font styl
e="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;22&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Available-for-sale investments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM
: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;534&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BOR
DER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;457&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font 
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: l
eft" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Total short term investments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font s
tyle="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;542&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;479&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt
;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" w
idth="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Long term investments&amp;#8212;available-for-sale inv
estments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;64&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&
gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;73&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left"
 valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&g
t;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 14.4pt"&gt;&lt;/font&gt;At March 31, 2010 and December 31, 2009, trading securities were:&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr&gt;
&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="6"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;March 31, 2010&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WE
IGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="6"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;December 31, 2009&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&g
t;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Net&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Estimated&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FON
T-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Net&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="c
enter"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Estimated&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Unrealized&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom
" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Fair&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DI
SPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Unrealized&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Fair&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FON
T-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Gains (Losses)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td styl
e="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISP
LAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Gains (Losses)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-
ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font st
yle="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times n
ew roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Total trading securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; T
EXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(5&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;8&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" val
ign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(9&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" a
lign="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;22&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="52%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZ
E: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&
gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;At March 31, 2010, available-for-sale investments were:&l
t;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr&gt;&lt;td valign="bottom" width="52%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="
1%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Gross&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIG
HT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Gross&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Estimated&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt
;&lt;td valign="bottom" width="52%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Amortized&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;t
d valign="bottom" width="10%" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Unrealized&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Unrealized&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valig
n="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Fair&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" width="52%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new r
oman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" width="10%" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Cost&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt
;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" width="10%" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Gains&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" width="10%" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bol
d; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Losses&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" width="10%" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bol
d; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Short term investments:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: time
s new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAM
ILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="10%" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;U.S. government and agency securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZ
E: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;128&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;
&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" v
align="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;128&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Mortgage-backed securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left
" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;12&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt
;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; F
ONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;12&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Senior secured bank loans fund&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FON
T-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;80&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" 
width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;17&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&l
t;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;97&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Corporate debt securities&lt;/font&gt;&lt;
/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;266&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMI
LY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(1 &lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;
&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;265&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: 
inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Equity securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;30&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left
" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;1&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;
&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;31&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom" align="left" width="52%"&gt;&lt
;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Other investments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;1&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new r
oman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times n
ew roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt;
 FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;1&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="52%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN
: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&g
t;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: 
times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Total short term investments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt sol
id; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;517&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORD
ER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;18&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(1 &lt;/font&gt;&lt;/td&gt
;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;534&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&
lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="52%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman
"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; F
ONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="b
ottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Long term investments:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;
&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-
ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new rom
an"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;U.S. government and agency securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;58&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT
- -FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="
DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(1 &lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;57&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bott
om" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Mortgage-backed securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;5&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" va
lign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;
/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10p
t; FONT-FAMILY: times new roman"&gt;5&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Equity securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDE
R-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td
 style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/f
ont&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 2px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="52%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&g
t;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;
/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT
- -SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inlin
e; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Total long term investments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;65&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width
="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: le
ft" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(1 &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt soli
d; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;64&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="52%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times ne
w roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT
- -SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="
9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Total available-for-sale investments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-
FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;582&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FON
T-FAMILY: times new roman"&gt;18&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(2&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt
; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;598&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="52%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;
&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: t
imes new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;
font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" al
ign="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The senior secured bank loans fund is a professionally managed fund investing in loans made by banks to large corporate borrowers whose assets are pledged as collateral.&lt;/font&gt;&lt;/div&gt;&lt;div&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;At December 31, 2009, available-for-sale investments were as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;
 &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Gross&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&l
t;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Gross&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-L
EFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Estimated&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Amortized&lt;/font&gt;&lt;/div&gt;&lt
;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Unrealized&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/t
d&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Unrealized&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Fair&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font sty
le="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Cost&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman
"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Gains&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" 
valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Losses&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;
&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Short term investments:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td vali
gn="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 
10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;U.S. government and agency securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; 
FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;129&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font 
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(1&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" wid
th="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;128&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Mortgage-backed securities fund&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bot
tom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;75&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;7&lt;/font&gt;&lt;/td&gt;&l
t;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: ti
mes new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;82&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Mortgage-backed securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT
- -FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;6&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;f
ont style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td val
ign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;6&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Senior secured bank loans fund&lt;/font&gt;&lt;/div&gt;&lt;/td
&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;131&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new r
oman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;23&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="
DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;154&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline;
 FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Corporate debt securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;43&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: lef
t" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&g
t;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;43&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block
; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Equity securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;29&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt
; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&g
t;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;29&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt
;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Other investments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;15&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="botto
m" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" v
align="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM:
 black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;15&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="52%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPL
AY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign=
"bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;t
d style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Total short term investments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZ
E: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;428&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style=
"DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;30&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" wid
th="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(1 &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;457&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowr
ap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="52%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/t
d&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&
lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; F
ONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Long term investments:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; F
ONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="
DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" va
lign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;U.S. government and agency securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;52&lt;/font&gt;&lt;/td&gt;&lt;td style
="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new ro
man"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(1 &lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; 
FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;51&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Mortgage-backed securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLA
Y: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;10&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" alig
n="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;
&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;10&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Equity securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&g
t;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10p
t; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font 
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Other investments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td sty
le="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;8&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&
gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman
"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;10&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-F
AMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="52%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SI
ZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"
&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt
;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Total long term investments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;72&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left"
 valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOT
TOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(1 &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BO
TTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;73&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="52%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="
DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" va
lign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="52%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Total available-for-sale investments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline;
 FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;500&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLA
Y: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;32&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPL
AY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(2&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;530&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY:
 inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="52%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font
 style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: r
ight" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&
amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The senior secured bank loans fund is a professionally managed fund investing in loans made by banks to large corporate borrowers whose assets are pledged as collateral.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The contractual maturities of available-for-sale investments at March 31, 2010 were:&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table style="FONT-SIZE
: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&
gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Estimated&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Amortized&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap
="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Fair&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 
0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Cost&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-L
EFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMI
LY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Securities not due at a single maturity date*&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&
lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;81&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY:
 times new roman"&gt;98&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Other debt securities, maturing:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMIL
Y: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width=
"76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Within one year&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;128&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font st
yle="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;128&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;After 1 year through 10 years&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"
&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;322&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td s
tyle="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;321&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;After 10 years through 15 years&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&l
t;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; 
FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Beyond 15 years&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;19&lt;/font&gt;&lt;/td&gt;
&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;18&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp
;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times ne
w roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Total debt securities recorded at market&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-
SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;550&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" w
idth="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;565&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="T
EXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MA
RGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Equity and other investments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;32&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#
160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;33&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/fo
nt&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt
;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Total available-for-sale investments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: 
left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;582&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN:
 right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;598&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&am
p;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" colspan="8"&gt;&lt;div style="DI
SPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;*Mortgage-backed securities and a senior secured bank loans fund.&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&
gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&amp;#160;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font&gt;Activities related to available-for-sale investments were as shown below.&amp;#160;&amp;#160;The cost of securities was based on the specific identification method.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&l
t;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="6"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="6"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new 
roman"&gt;Three months ended&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;March 31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: blo
ck; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2010&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2009&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign
="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inlin
e; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Proceeds from sales and principal repayments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font st
yle="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;506&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;1&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;
td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td st
yle="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Gross realized gains on sales&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font
&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;19&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FO
NT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt
;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY:
 inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Gross realized losses on sales&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TE
XT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/fo
nt&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SI
ZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The net unrealized holding gains (losses) for available-for-sale investments included in accumulated other comprehensive income (loss) in shareholders' equity at March 31, 2010 and December 31, 2009 were $16 and $30, respectively.&amp;#160;&amp;#160;Net unrealized holding gains on trading securities included in earnings for the three months ended March 31, 2010 and 2009 were $4 and $40, respectively.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SI
ZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The changes in net unrealized gains (losses) on investments, net of taxes, included in accumulated other comprehensive income (loss) were:&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="6"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-
RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Three months ended&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;March 31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/fon
t&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2010&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY:
 times new roman"&gt;2009&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: 
times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Changes in unrealized holding gains arising during the period&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE:
 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;5&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;3&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;f
ont style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Reclassification adjustment for gains included in net income&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="D
ISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(19 &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(1 &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&
lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1
%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Changes in net unrealized gains (losses) on investments, n
et of taxes&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(14&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&a
mp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valig
n="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;
/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FON
T-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 
0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font&gt;As of March 31, 2010, gross unrealized losses and fair value of individual securities with unrealized losses greater than $1 that were not deemed to be other-than-temporarily impaired, summarized by investment category and length of time the individual securities had been in a continuous unrealized loss position, were:&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr&gt;&lt;td valign="bottom" width="25%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom"
 width="17%" colspan="5"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Less than 12 months&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" width="17%" colspan="5"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;12 months or greater&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" width="
18%" colspan="5"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Total&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="25%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="5%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Fair&lt;/font&gt;&lt;/div&
gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="8%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Unrealized&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="5%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0
pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Fair&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="8%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Unrealized&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt;
 FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="6%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Fair&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="8%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Unrealized&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FO
NT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="25%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" width="5%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" width="1%"&gt;&lt;font 
style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" width="8%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Losses&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" width="5%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FON
T-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" width="8%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Losses&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: 
inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" width="6%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Value&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" width="8%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FON
T-FAMILY: times new roman"&gt;Losses&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="25%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="5%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt
;&lt;td valign="bottom" width="8%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="5%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="8%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-
FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="6%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="8%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="
1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="25%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Long term investments:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="5%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&g
t;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="8%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="5%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="8%"&gt;&lt;font style="DIS
PLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="6%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="8%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/
td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="25%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 7.35pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;U.S. government and agencies&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 7.35pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="MARGIN-LEFT: 18.4pt"&gt;&lt;/font&gt;securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/div&
gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="5%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="left" width="1%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="8%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="lef
t" width="1%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="5%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;div style="DISPLAY: block
; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="8%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="6%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-
RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;6&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="8%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(1&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="left" width="1%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DI
SPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font&gt;As of December 31, 2009, there were no gross unrealized losses on available-for-sale investments greater than $1.&lt;/font&gt;&lt;/div&gt;&lt;div&gt;&amp;#160;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-STYLE: italic; FONT-FAMILY: Times New Roman"&gt;Investment Income&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&l
t;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font&gt;In the condensed consolidated statements of earnings, other, net, included gains (losses) on investments as follows:&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/fon
t&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="6"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Three months ended&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;March 31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td 
style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2010&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="D
ISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2009&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT
- -SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Realized gains (losses) on sale of investments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times
 new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;15&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FON
T-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;(36&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;)&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Net unrealized gains on investments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FON
T-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADD
ING-BOTTOM: 0.5pt" valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;classified as trading securities&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;4&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" w
idth="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;40&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt
;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bo
ttom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 18pt; TEXT-INDENT: -18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Net gains on investments&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&
amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;19&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new ro
man"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;4&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</NonNumbericText>
          <NonNumericTextHeader>(5)&amp;#160;&amp;#160;Investments(in millions, except per share data)&amp;#160;At March 31, 2010 and December 31, 2009, investments were:&amp;#160; &amp;#160;March</NonNumericTextHeader>
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>This item represents the entire disclosure related to Investments in Certain Debt and Equity Securities (and certain other trading assets) which include all debt and equity securities (other than those equity securities accounted for under the equity or cost methods of accounting) with readily determinable fair values. Other trading assets include assets that are carried on the balance sheet at fair value and held for trading purposes.  A debt security represents a creditor relationship with an enterprise that is in the form of a security. Debt securities include, among other items, US Treasury securities, US government securities, municipal securities, corporate bonds, convertible debt, commercial paper, and all securitized debt instruments. An equity security represents an ownership interest in an enterprise or the right to acquire or dispose of an ownership interest in an enterprise at fixed or determinable prices. Equity securities include, among other things, common stock, certa
in preferred stock, warrant rights, call options, and put options, but do not include convertible debt. An entity may opt to provide the reader with additional narrative text to better understand the nature of investments in debt and equity securities (and other trading assets).</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 115
 -Paragraph 3, 19, 20, 21, 22, 137

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
  </Rows>
  <Footnotes />
  <ComparabilityReport>false</ComparabilityReport>
  <NumberOfCols>1</NumberOfCols>
  <NumberOfRows>2</NumberOfRows>
  <HasScenarios>false</HasScenarios>
  <MonetaryRoundingLevel>UnKnown</MonetaryRoundingLevel>
  <SharesRoundingLevel>UnKnown</SharesRoundingLevel>
  <PerShareRoundingLevel>UnKnown</PerShareRoundingLevel>
  <HasPureData>false</HasPureData>
  <SharesShouldBeRounded>true</SharesShouldBeRounded>
</InstanceReport>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R6.xml
<DESCRIPTION>IDEA: Earnings Per Share
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<InstanceReport xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <Version>2.0.0.10</Version>
  <hasSegments>false</hasSegments>
  <ReportName>Earnings Per Share</ReportName>
  <ReportLongName>006020 - Disclosure - Earnings Per Share</ReportLongName>
  <DisplayLabelColumn>true</DisplayLabelColumn>
  <ShowElementNames>false</ShowElementNames>
  <RoundingOption />
  <HasEmbeddedReports>false</HasEmbeddedReports>
  <Columns>
    <Column>
      <LabelColumn>false</LabelColumn>
      <Id>1</Id>
      <Labels>
        <Label Id="1" Label="3 Months Ended" />
        <Label Id="2" Label="Mar. 31, 2010" />
      </Labels>
      <CurrencyCode>usd</CurrencyCode>
      <CurrencySymbol>$</CurrencySymbol>
      <FootnoteIndexer />
      <hasSegments>false</hasSegments>
      <hasScenarios>false</hasScenarios>
      <Segments />
      <Scenarios />
      <Units>
        <Unit>
          <UnitID>u000</UnitID>
          <UnitType>Standard</UnitType>
          <StandardMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/iso4217</MeasureSchema>
            <MeasureValue>USD</MeasureValue>
            <MeasureNamespace>iso4217</MeasureNamespace>
          </StandardMeasure>
          <Scale>0</Scale>
        </Unit>
        <Unit>
          <UnitID>u001</UnitID>
          <UnitType>Standard</UnitType>
          <StandardMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/instance</MeasureSchema>
            <MeasureValue>shares</MeasureValue>
            <MeasureNamespace>xbrli</MeasureNamespace>
          </StandardMeasure>
          <Scale>0</Scale>
        </Unit>
        <Unit>
          <UnitID>u002</UnitID>
          <UnitType>Divide</UnitType>
          <NumeratorMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/iso4217</MeasureSchema>
            <MeasureValue>USD</MeasureValue>
            <MeasureNamespace>iso4217</MeasureNamespace>
          </NumeratorMeasure>
          <DenominatorMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/instance</MeasureSchema>
            <MeasureValue>shares</MeasureValue>
            <MeasureNamespace>xbrli</MeasureNamespace>
          </DenominatorMeasure>
          <Scale>0</Scale>
        </Unit>
      </Units>
    </Column>
  </Columns>
  <Rows>
    <Row>
      <Id>2</Id>
      <Label>Notes to Financial Statements [Abstract]</Label>
      <Level>0</Level>
      <ElementName>acl_NotesToFinancialStatementsAbstract</ElementName>
      <ElementPrefix>acl</ElementPrefix>
      <IsBaseElement>false</IsBaseElement>
      <BalanceType>na</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>string</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>true</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>false</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>No definition available.</ElementDefenition>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>3</Id>
      <Label>Earnings Per Share</Label>
      <Level>1</Level>
      <ElementName>us-gaap_EarningsPerSharePolicyTextBlock</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>na</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>string</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole>terselabel</PreferredLabelRole>
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>false</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText>&lt;div&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr valign="top"&gt;&lt;td style="WIDTH: 18pt" align="right"&gt;&lt;div&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;(2)&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Earnings Per Share&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;&lt;/font&gt;&lt;font style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;(in millions, except per share data)&lt;/font&gt;&lt;br /&gt;&amp;#160;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-
INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Basic earnings per common share were computed by dividing net earnings by the weighted average number of common shares outstanding for the relevant period.&amp;#160;&amp;#160;The unvested portion of restricted common shares was excluded in the calculation of basic weighted average common shares outstanding.&amp;#160;&amp;#160;Diluted weighted average common shares reflect the potential dilution, using the treasury stock method, that could occur if employee stock options for the purchase of common shares and share-settled stock appreciation rights were exercised and if share-settled restricted share units, performance share units and contingent restricted common shares granted to employees were vested.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT
: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The following table reconciles the weighted average shares of the basic and diluted share computations:&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" width="20%" colspan="4"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-
FAMILY: times new roman"&gt;Three months ended March 31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-I
NDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2010&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="2%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" width="7%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2009&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;fo
nt style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="10%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="2%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new rom
an"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="7%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Basic weighted average common shares outstanding&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="
1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;299,980,871&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="2%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="7%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;298,581,689&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bott
om" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Effect of dilutive securities:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="10%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times ne
w roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="2%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="7%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" wi
dth="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="MARGIN-LEFT: 17.5pt"&gt;&lt;/font&gt;Employee stock options&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2,087,235&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="2%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&g
t;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="7%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;1,261,409&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new ro
man"&gt;&lt;font style="MARGIN-LEFT: 17.5pt"&gt;&lt;/font&gt;Share-settled stock appreciation rights&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;1,126,119&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="2%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="7%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" al
ign="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="MARGIN-LEFT: 17.5pt"&gt;&lt;/font&gt;Share-settled restricted share units and performance share units&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valig
n="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;334,272&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="2%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" align="right" width="7%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;45,349&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td val
ign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&lt;font style="MARGIN-LEFT: 17.5pt"&gt;&lt;/font&gt;Contingent restricted common shares&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt s
olid" valign="bottom" align="right" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;41,501&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="2%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" align="right" width="7%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;126,688&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new rom
an"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="10%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="2%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width
="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="7%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;D
iluted weighted average common shares outstanding&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double" valign="bottom" align="right" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;303,569,998&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="2%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double" valig
n="bottom" align="right" width="7%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;300,015,135&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" wi
dth="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="10%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="2%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="7%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&
gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Certain executives of the Company had deferred the receipt of 119,188 and 141,954 Alcon common shares at March 31, 2010 and 2009, respectively, into the Alcon Executive Deferred Compensation Plan.&amp;#160;&amp;#160;Alcon common shares held in the plan were reflected as outstanding in the condensed consolidated balance sheets and were included in the applicable basic and diluted earnings per share calculations.&lt;/font&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT
: 0pt" align="left"&gt;&amp;#160;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The computations of diluted weighted average common shares outstanding for the periods ended March 31, 2010 and 2009 did not include the following instruments, as their exercise prices and unrecognized costs were greater than the average market price of the common shares:&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr&gt;&lt;td valign="top" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="1%"&gt;&lt;font style="DISPLAY
: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="top" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2010&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" width="2%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="top" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="top" width="9%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: 
times new roman"&gt;2009&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="top" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="10%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="2%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="9
%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="top" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Stock options&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" align="right" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;--&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top"
 width="2%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" align="right" width="9%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;728,392&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="top" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Share-settled stock appreciation rights&lt;/font&gt;&lt
;/div&gt;&lt;/td&gt;&lt;td valign="top" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" align="right" width="10%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;1,350&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="top" width="2%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" align="right" width="9%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="right"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;5,514,471&lt;/font&gt;&lt;/div&gt;&lt
;/td&gt;&lt;td valign="top" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="top" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="10%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="2%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10
pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="top" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The effect of their inclusion would have been anti-dilutive.&lt;/font&gt;&lt;/div&gt;</NonNumbericText>
          <NonNumericTextHeader>(2)&amp;#160;&amp;#160;Earnings Per Share(in millions, except per share data)&amp;#160;Basic earnings per common share were computed by dividing net earnings by the</NonNumericTextHeader>
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>Discloses the methodology and assumptions used to compute basic and diluted earnings (loss) per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 128
 -Paragraph 40
 -Subparagraph a

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 128
 -Paragraph 6, 8-16, 60

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
  </Rows>
  <Footnotes />
  <ComparabilityReport>false</ComparabilityReport>
  <NumberOfCols>1</NumberOfCols>
  <NumberOfRows>2</NumberOfRows>
  <HasScenarios>false</HasScenarios>
  <MonetaryRoundingLevel>UnKnown</MonetaryRoundingLevel>
  <SharesRoundingLevel>UnKnown</SharesRoundingLevel>
  <PerShareRoundingLevel>UnKnown</PerShareRoundingLevel>
  <HasPureData>false</HasPureData>
  <SharesShouldBeRounded>true</SharesShouldBeRounded>
</InstanceReport>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R5.xml
<DESCRIPTION>IDEA: Condensed Consolidated Financial Statements
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<InstanceReport xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <Version>2.0.0.10</Version>
  <hasSegments>false</hasSegments>
  <ReportName>Condensed Consolidated Financial Statements</ReportName>
  <ReportLongName>006010 - Disclosure - Condensed Consolidated Financial Statements</ReportLongName>
  <DisplayLabelColumn>true</DisplayLabelColumn>
  <ShowElementNames>false</ShowElementNames>
  <RoundingOption />
  <HasEmbeddedReports>false</HasEmbeddedReports>
  <Columns>
    <Column>
      <LabelColumn>false</LabelColumn>
      <Id>1</Id>
      <Labels>
        <Label Id="1" Label="3 Months Ended" />
        <Label Id="2" Label="Mar. 31, 2010" />
      </Labels>
      <CurrencyCode>usd</CurrencyCode>
      <CurrencySymbol>$</CurrencySymbol>
      <FootnoteIndexer />
      <hasSegments>false</hasSegments>
      <hasScenarios>false</hasScenarios>
      <Segments />
      <Scenarios />
      <Units>
        <Unit>
          <UnitID>u000</UnitID>
          <UnitType>Standard</UnitType>
          <StandardMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/iso4217</MeasureSchema>
            <MeasureValue>USD</MeasureValue>
            <MeasureNamespace>iso4217</MeasureNamespace>
          </StandardMeasure>
          <Scale>0</Scale>
        </Unit>
        <Unit>
          <UnitID>u001</UnitID>
          <UnitType>Standard</UnitType>
          <StandardMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/instance</MeasureSchema>
            <MeasureValue>shares</MeasureValue>
            <MeasureNamespace>xbrli</MeasureNamespace>
          </StandardMeasure>
          <Scale>0</Scale>
        </Unit>
        <Unit>
          <UnitID>u002</UnitID>
          <UnitType>Divide</UnitType>
          <NumeratorMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/iso4217</MeasureSchema>
            <MeasureValue>USD</MeasureValue>
            <MeasureNamespace>iso4217</MeasureNamespace>
          </NumeratorMeasure>
          <DenominatorMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/instance</MeasureSchema>
            <MeasureValue>shares</MeasureValue>
            <MeasureNamespace>xbrli</MeasureNamespace>
          </DenominatorMeasure>
          <Scale>0</Scale>
        </Unit>
      </Units>
    </Column>
  </Columns>
  <Rows>
    <Row>
      <Id>2</Id>
      <Label>Notes to Financial Statements [Abstract]</Label>
      <Level>0</Level>
      <ElementName>acl_NotesToFinancialStatementsAbstract</ElementName>
      <ElementPrefix>acl</ElementPrefix>
      <IsBaseElement>false</IsBaseElement>
      <BalanceType>na</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>string</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>true</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>false</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>No definition available.</ElementDefenition>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>3</Id>
      <Label>Condensed Consolidated Financial Statements</Label>
      <Level>1</Level>
      <ElementName>us-gaap_QuarterlyFinancialInformationTextBlock</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>na</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>string</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole>terselabel</PreferredLabelRole>
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>false</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText>&lt;div&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr valign="top"&gt;&lt;td style="WIDTH: 18pt" align="right"&gt;&lt;div&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;(1)&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;Condensed Consolidated Financial Statemen&lt;/font&gt;t&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;s&lt;/font&gt;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;font style="FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;(in millions, except per share data)&lt;/font&gt;&lt;br /&gt;&l
t;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;/font&gt;&amp;#160;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Alcon, Inc. ("Alcon"), a Swiss corporation, is a majority owned subsidiary of Nestl&amp;#233; S.A.&amp;#160;&amp;#160;During July 2008, Nestl&amp;#233; sold approximately 74 million of its Alcon common shares to Novartis AG.&amp;#160;&amp;#160;At December 31, 2009, Nestl&amp;#233; owned 156,076,263 common shares of Alcon.&amp;#160;&amp;#160;In January 2010, Novartis exercised its call option for Nestl&amp;#233;'s remaining Alcon common shares and proposed a merger of Alcon with and into Novartis, as discussed in note 13.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt
;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;The interim condensed consolidated financial statements of Alcon and its subsidiaries (collectively, the "Company") are unaudited.&amp;#160;&amp;#160;Amounts presented at December 31, 2009 are based on the audited consolidated financial statements appearing in Alcon's annual report on Form 20-F filed with the U.S. Securities and Exchange Commission.&amp;#160;&amp;#160;The interim condensed consolidated financial statements and notes thereto do not include all disclosures required by accounting principles generally accepted in the United States of America ("U.S. GAAP") and should be read in conjunction with the audited consolidated financial statements and the notes thereto included in Alcon's annual report on Form 20-F.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&g
t;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Management of the Company has made a number of estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities to prepare these financial statements in conformity with U.S. GAAP.&amp;#160;&amp;#160;Actual results could differ from those estimates.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;In management's opinion, the interim condensed consolidated financial statements reflect all adjustments (consisting only of normal recurring accruals) necessary to present fairly the results for the interim periods pre
sented.&amp;#160;&amp;#160;Results for interim periods are not necessarily indicative of results that ultimately will be achieved for a full year.&lt;/font&gt;&lt;/div&gt;</NonNumbericText>
          <NonNumericTextHeader>(1)&amp;#160;&amp;#160;Condensed Consolidated Financial Statements(in millions, except per share data)&amp;#160;Alcon, Inc. ("Alcon"), a Swiss corporation, is a majority</NonNumericTextHeader>
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>This element can be used to disclose the entire quarterly financial data disclosure in the annual financial statements as a single block of text.  The disclosure includes a tabular presentation of financial information for each fiscal quarter for the current and previous year, including revenues, gross profit, income (loss) before extraordinary items and cumulative effect of a change in accounting principle and earnings per share data. It also includes an indication if the information in the note is unaudited, comments on the aggregate effect of year-end adjustments, and an explanation of matters or transactions that affect comparability or are pertinent to an understanding of the information furnished. Alternatively, the details of this disclosure can be reported using the elements in this group, or by using other taxonomy elements and applying the appropriate quarterly date and period contexts when creating an instance document. For example, the element for "Interest and Dividend I
ncome, Operating" may be used by financial institutions from the Statement of Income, applying the appropriate quarterly date and period context when creating an instance document.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Staff Accounting Bulletin (SAB)
 -Number Topic 6
 -Section G
 -Subsection 1

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher AICPA
 -Name Accounting Principles Board Opinion (APB)
 -Number 28
 -Paragraph 23, 24

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher AICPA
 -Name Accounting Principles Board Opinion (APB)
 -Number 28
 -Paragraph 30
 -Subparagraph a-j

Reference 4: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-K (SK)
 -Number 229
 -Section 302
 -Paragraph a

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
  </Rows>
  <Footnotes />
  <ComparabilityReport>false</ComparabilityReport>
  <NumberOfCols>1</NumberOfCols>
  <NumberOfRows>2</NumberOfRows>
  <HasScenarios>false</HasScenarios>
  <MonetaryRoundingLevel>UnKnown</MonetaryRoundingLevel>
  <SharesRoundingLevel>UnKnown</SharesRoundingLevel>
  <PerShareRoundingLevel>UnKnown</PerShareRoundingLevel>
  <HasPureData>false</HasPureData>
  <SharesShouldBeRounded>true</SharesShouldBeRounded>
</InstanceReport>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>defnref.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XBRL>
<DefinitionAndReference>
  <Element Id="acl_OtherOperatingExpenses">
    <definition>The total amount of other operating cost and expense items.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_Depreciation">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="dei_EntityCommonStockSharesOutstanding">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_RetainedEarningsAccumulatedDeficit">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_DeferredTaxAssetsNetCurrent">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_IncreaseDecreaseInOtherOperatingAssets">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_LongTermInvestments">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_OtherLiabilitiesNoncurrent">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="dei_EntityPublicFloat">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_NetCashProvidedByUsedInFinancingActivities">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_WeightedAverageNumberOfSharesIssuedBasic">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_DeferredTaxLiabilitiesNoncurrent">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_CostOfGoodsSold">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_OtherLiabilitiesCurrent">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_CommonStockSharesOutstanding">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_LiabilitiesCurrent">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_EarningsPerSharePolicyTextBlock">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="acl_SupplementalBalanceSheetInformation">
    <definition>This element represents the complete disclosure related to inventory. This may include, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the major classes of inventory, and the nature of the cost elements included in inventory. If inventory is stated above cost, accrued net losses on firm purchase commitments for inventory and losses resulting from valuing inventory at the lower-of-cost-or-market may also be included. For LIFO inventory, may disclose the amount and basis for determining the excess of replacement or current cost over stated LIFO value and the effects of a LIFO quantities liquidation that impacts net income. Disclosure of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, building and production equipment. This disclosure may include property plant and equipment accounting policies and methodology, a schedule of property, pla
nt and equipment gross, additions, deletions, transfers and other changes, depreciation, depletion and amortization expense, net, accumulated depreciation, depletion and amortization expense and useful lives, income statement disclosures, assets held for sale and public utility disclosures. This element may be used as a single block of text to include the entire PPE disclosure, including data and tables. This label may include the following: 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income. Components of comprehensive income include: (1) foreign currency translation adjustments; (2) gains and losses on foreign currency transactions that are designated as, and are effective as, economic hedges of a net investment in a foreign entity; (3) gains a
nd losses on intercompany foreign currency transactions that are of a long-term-investment nature, when the entities to the transaction are consolidated, combined, or accounted for by the equity method in the reporting enterprise's financial statements; (4) change in the market value of a futures contract that qualifies as a hedge of an asset reported at fair value; (5) unrealized holding gains and losses on available-for-sale securities and that resulting from transfers of debt securities from the held-to-maturity category to the available-for-sale category; (6) a net loss recognized as an additional pension liability not yet recognized as net periodic pension cost; and (7) the net gain or loss and net prior service cost or credit for pension plans and other postretirement benefit plans.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_PaymentsToAcquireIntangibleAssets">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_TreasuryStockShares">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_AccountsPayableCurrent">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="dei_EntityRegistrantName">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_DeferredIncomeTaxExpenseBenefit">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="dei_EntityCentralIndexKey">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_RepaymentsOfLongTermDebt">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="dei_EntityWellKnownSeasonedIssuer">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_SegmentReportingDisclosureTextBlock">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_NetCashProvidedByUsedInInvestingActivities">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_DeferredTaxAssetsNetNoncurrent">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_IncreaseDecreaseInOtherAccruedLiabilities">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="acl_ProposedChangeOfControl">
    <definition>This element describes the impact of a proposed change of control of the reporting entity.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_TreasuryStockValue">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_IncreaseDecreaseInInventories">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="dei_EntityVoluntaryFilers">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_ShortTermInvestments">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_IntangibleAssetsNetExcludingGoodwill">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_CashAndCashEquivalentsAtCarryingValue">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_IncomeTaxDisclosureTextBlock">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_CommonStockSharesIssued">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="dei_DocumentFiscalPeriodFocus">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_SalesRevenueNet">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_EarningsPerShareBasic">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_IncreaseDecreaseInAccountsPayable">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_LongTermDebtNoncurrent">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_GainsLossesOnSalesOfAssets">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_NetCashProvidedByUsedInOperatingActivities">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_ProceedsFromSaleMaturityAndCollectionsOfInvestments">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_AdditionalPaidInCapital">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_PaymentsToAcquireInvestments">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_CommonStockSharesAuthorized">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_UnrealizedGainLossOnSecurities">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_IncomeTaxExpenseBenefit">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="acl_ShortTermBorrowingsAndLongTermDebt">
    <definition>This element may be used as a single block of text to encapsulate the entire disclosure for short-term borrowings including data and tables. This element may be used as a single block of text to encapsulate the entire disclosure for long-term borrowings including data and tables.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_QuarterlyFinancialInformationTextBlock">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_ProceedsFromStockOptionsExercised">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_EarningsPerShareDiluted">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_InvestmentIncomeInterestAndDividend">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_OtherNonoperatingIncomeExpense">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_ShareBasedCompensation">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_AccountsReceivableNetCurrent">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_FairValueDisclosuresTextBlock">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_ProceedsFromRepaymentsOfShortTermDebt">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_CashFlowSupplementalDisclosuresTextBlock">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_LongTermDebtCurrent">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_EffectOfExchangeRateOnCashAndCashEquivalents">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="dei_AmendmentFlag">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="dei_EntityFilerCategory">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="dei_CurrentFiscalYearEndDate">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_OperatingIncomeLoss">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesOther">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_CommonStockValue">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_ExcessTaxBenefitFromShareBasedCompensationOperatingActivities">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_Assets">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_PaymentsForRepurchaseOfCommonStock">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_ResearchAndDevelopmentExpense">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="dei_DocumentType">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_OtherAssetsNoncurrent">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="dei_DocumentFiscalYearFocus">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_GrossProfit">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_ProfitLoss">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="dei_EntityCurrentReportingStatus">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_InventoryNet">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_AmortizationOfIntangibleAssets">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_PropertyPlantAndEquipmentNet">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_Goodwill">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_AssetsCurrent">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_OtherAssetsCurrent">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_LiabilitiesAndStockholdersEquity">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_IncreaseDecreaseInAccountsReceivable">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="acl_SellingGeneralAndAdministrative">
    <definition>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc., including expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, services, costs of public relations and corporate promotions are typically considered to be marketing costs.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_ShortTermBorrowings">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_CommonStockParOrStatedValuePerShare">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="dei_DocumentPeriodEndDate">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
  <Element Id="us-gaap_InterestExpense">
    <definition>No authoritative reference available.</definition>
    <reference>No authoritative reference available.</reference>
  </Element>
</DefinitionAndReference>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R13.xml
<DESCRIPTION>IDEA: Income Taxes
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<InstanceReport xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <Version>2.0.0.10</Version>
  <hasSegments>false</hasSegments>
  <ReportName>Income Taxes</ReportName>
  <ReportLongName>006090 - Disclosure - Income Taxes</ReportLongName>
  <DisplayLabelColumn>true</DisplayLabelColumn>
  <ShowElementNames>false</ShowElementNames>
  <RoundingOption />
  <HasEmbeddedReports>false</HasEmbeddedReports>
  <Columns>
    <Column>
      <LabelColumn>false</LabelColumn>
      <Id>1</Id>
      <Labels>
        <Label Id="1" Label="3 Months Ended" />
        <Label Id="2" Label="Mar. 31, 2010" />
      </Labels>
      <CurrencyCode>usd</CurrencyCode>
      <CurrencySymbol>$</CurrencySymbol>
      <FootnoteIndexer />
      <hasSegments>false</hasSegments>
      <hasScenarios>false</hasScenarios>
      <Segments />
      <Scenarios />
      <Units>
        <Unit>
          <UnitID>u000</UnitID>
          <UnitType>Standard</UnitType>
          <StandardMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/iso4217</MeasureSchema>
            <MeasureValue>USD</MeasureValue>
            <MeasureNamespace>iso4217</MeasureNamespace>
          </StandardMeasure>
          <Scale>0</Scale>
        </Unit>
        <Unit>
          <UnitID>u001</UnitID>
          <UnitType>Standard</UnitType>
          <StandardMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/instance</MeasureSchema>
            <MeasureValue>shares</MeasureValue>
            <MeasureNamespace>xbrli</MeasureNamespace>
          </StandardMeasure>
          <Scale>0</Scale>
        </Unit>
        <Unit>
          <UnitID>u002</UnitID>
          <UnitType>Divide</UnitType>
          <NumeratorMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/iso4217</MeasureSchema>
            <MeasureValue>USD</MeasureValue>
            <MeasureNamespace>iso4217</MeasureNamespace>
          </NumeratorMeasure>
          <DenominatorMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/instance</MeasureSchema>
            <MeasureValue>shares</MeasureValue>
            <MeasureNamespace>xbrli</MeasureNamespace>
          </DenominatorMeasure>
          <Scale>0</Scale>
        </Unit>
      </Units>
    </Column>
  </Columns>
  <Rows>
    <Row>
      <Id>2</Id>
      <Label>Notes to Financial Statements [Abstract]</Label>
      <Level>0</Level>
      <ElementName>acl_NotesToFinancialStatementsAbstract</ElementName>
      <ElementPrefix>acl</ElementPrefix>
      <IsBaseElement>false</IsBaseElement>
      <BalanceType>na</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>string</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>true</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>false</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>No definition available.</ElementDefenition>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>3</Id>
      <Label>Income Taxes</Label>
      <Level>1</Level>
      <ElementName>us-gaap_IncomeTaxDisclosureTextBlock</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>na</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>string</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole>terselabel</PreferredLabelRole>
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>false</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText>&lt;div&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr valign="top"&gt;&lt;td style="WIDTH: 18pt" align="right"&gt;&lt;div&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;(9)&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Income Taxes&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;(in millions, except per share data)&lt;/font&gt;&lt;/font&gt;&lt;br /&gt;&amp;#160;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT
: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font&gt;The Company or one of its subsidiaries files income tax returns in Switzerland, the U.S. federal jurisdiction, and various state and other foreign jurisdictions.&amp;#160;&amp;#160;With few exceptions, the Company is no longer subject to Swiss, U.S. federal, state and local, or non-U.S. income tax examinations by tax authorities for years before 2003.&amp;#160;&amp;#160;In June 2009, the Internal Revenue Service ("IRS") commenced an examination of the Company's U.S. income tax returns for 2006 and 2007 that is anticipated to be completed substantially by the end of 2010.&amp;#160;&amp;#160;In May 2009, the IRS and the Company entered the Compliance Assurance Process (&amp;#8243;CAP&amp;#8243;) program for 2009.&amp;#160;&amp;#160;In January 2010, the IRS and the Company extended the CAP program to 2010.&amp;#160;&amp;#160;The Company also currently is su
bject to income tax examinations by various state, local and other foreign tax authorities.&amp;#160;&amp;#160;In addition, in June 2009, the Company and the IRS signed an advance pricing agreement ("APA") contract memorializing the mutual agreement letter between Switzerland and the United States for years through 2014 that covers all material intercompany transactions involving the Company and its subsidiaries in these two jurisdictions.&amp;#160;&amp;#160;Finally, during the fourth quarter of 2007, the Company submitted a similar request for a bilateral APA between Japanese and Swiss tax authorities that would cover the tax years 2008 through 2012.&amp;#160;&amp;#160;The Company expects that the Japanese-Swiss APA will be concluded in 2010.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Time
s New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font&gt;The Company believes that it takes reasonable positions on its tax returns filed throughout the world; however, tax laws are complex and susceptible to differing interpretations.&amp;#160;&amp;#160;Tax authorities throughout the world, from time to time, routinely challenge positions taken by the Company, particularly in the case of transfer pricing issues.&amp;#160;&amp;#160;The Company has identified its uncertain tax positions and prepared its reserve for contingent tax liabilities to reflect the associated unrecognized tax benefits (the "Tax Reserves") in accordance with Financial Accounting Standards Board ("FASB") guidance which, among other things, requires that the Company assume that it will be subject to examination in every jurisdiction in which it is subject to tax.&amp;#160;&amp;#160;Management believes that the Tax Reserves are fairly stated but believes it is reasonably possible that the total amount of unrecognized tax benefit
s related to transfer pricing, currency translations and other tax positions reflected in the Tax Reserves will significantly increase or decrease within 12 months of the reporting of this financial statement as the result of, among other things, (i) developments with respect to currently active audits or advance pricing agreements and/or (ii) the further development of tax laws through judicial or administrative actions.&amp;#160;&amp;#160;Although tax laws are complex and significant uncertainty exists with respect to the actual date that any of the currently active audits or APA negotiations could &lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;reach final resolution or a new audit could commence, management believes it is reasonably possible that unrecognized tax benefits could increase in the next 12 months by at least 10% or decrease by over 70% as a result of actual payment of amounts included in the Tax Reserves and/or developments in various negotiatio
ns with tax authorities.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font&gt;The total amount of gross unrecognized tax benefits included in the Tax Reserves and the amount that would impact the effective tax rate, if recognized, did not change materially during the first three months of 2010.&amp;#160;&amp;#160;The &lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Company's policy is to classify interest and penalties in income tax expense.&amp;#160;&amp;#160;The gross amount of interest and penalties accrued as part of Tax Reserves did not change materially during the first three months of 2010.&amp;#160;&amp;#160;At March 31, 2010, the condensed consolidated balance sheet included 
$23 in other current liabilities and $58 in other long term liabilities for the Tax Reserves, net of deposits with statutory authorities.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font&gt;During the three months ended March 31, 2010, the Company recognized a $25 tax charge for the write-off of deferred tax assets as a result of provisions of U.S. healthcare reform laws enacted during the period.&lt;/font&gt;&lt;/div&gt;</NonNumbericText>
          <NonNumericTextHeader>(9)&amp;#160;&amp;#160;Income Taxes(in millions, except per share data)&amp;#160;The Company or one of its subsidiaries files income tax returns in Switzerland, the U.S.</NonNumericTextHeader>
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>Description containing the entire income tax disclosure. Examples include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information. This element may be used as a single block of text to encapsulate the entire disclosure including data and tables.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 08
 -Paragraph h
 -Article 4

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 109
 -Paragraph 136, 172

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 109
 -Paragraph 43, 44, 45, 46, 47, 48, 49

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
  </Rows>
  <Footnotes />
  <ComparabilityReport>false</ComparabilityReport>
  <NumberOfCols>1</NumberOfCols>
  <NumberOfRows>2</NumberOfRows>
  <HasScenarios>false</HasScenarios>
  <MonetaryRoundingLevel>UnKnown</MonetaryRoundingLevel>
  <SharesRoundingLevel>UnKnown</SharesRoundingLevel>
  <PerShareRoundingLevel>UnKnown</PerShareRoundingLevel>
  <HasPureData>false</HasPureData>
  <SharesShouldBeRounded>true</SharesShouldBeRounded>
</InstanceReport>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R1.xml
<DESCRIPTION>IDEA: Condensed Consolidated Balance Sheets (Unaudited)
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<InstanceReport xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <Version>2.0.0.10</Version>
  <hasSegments>false</hasSegments>
  <ReportName>Condensed Consolidated Balance Sheets (Unaudited) (USD $)</ReportName>
  <ReportLongName>001000 - Statement - Condensed Consolidated Balance Sheets (Unaudited)</ReportLongName>
  <DisplayLabelColumn>true</DisplayLabelColumn>
  <ShowElementNames>false</ShowElementNames>
  <RoundingOption>In Millions</RoundingOption>
  <HasEmbeddedReports>false</HasEmbeddedReports>
  <Columns>
    <Column>
      <LabelColumn>false</LabelColumn>
      <Id>1</Id>
      <Labels>
        <Label Id="1" Label="Mar. 31, 2010" />
      </Labels>
      <CurrencyCode>usd</CurrencyCode>
      <CurrencySymbol>$</CurrencySymbol>
      <FootnoteIndexer />
      <hasSegments>false</hasSegments>
      <hasScenarios>false</hasScenarios>
      <Segments />
      <Scenarios />
      <Units>
        <Unit>
          <UnitID>u000</UnitID>
          <UnitType>Standard</UnitType>
          <StandardMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/iso4217</MeasureSchema>
            <MeasureValue>USD</MeasureValue>
            <MeasureNamespace>iso4217</MeasureNamespace>
          </StandardMeasure>
          <Scale>0</Scale>
        </Unit>
        <Unit>
          <UnitID>u001</UnitID>
          <UnitType>Standard</UnitType>
          <StandardMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/instance</MeasureSchema>
            <MeasureValue>shares</MeasureValue>
            <MeasureNamespace>xbrli</MeasureNamespace>
          </StandardMeasure>
          <Scale>0</Scale>
        </Unit>
      </Units>
    </Column>
    <Column>
      <LabelColumn>false</LabelColumn>
      <Id>2</Id>
      <Labels>
        <Label Id="1" Label="Dec. 31, 2009" />
      </Labels>
      <CurrencyCode>usd</CurrencyCode>
      <CurrencySymbol>$</CurrencySymbol>
      <FootnoteIndexer />
      <hasSegments>false</hasSegments>
      <hasScenarios>false</hasScenarios>
      <Segments />
      <Scenarios />
      <Units>
        <Unit>
          <UnitID>u000</UnitID>
          <UnitType>Standard</UnitType>
          <StandardMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/iso4217</MeasureSchema>
            <MeasureValue>USD</MeasureValue>
            <MeasureNamespace>iso4217</MeasureNamespace>
          </StandardMeasure>
          <Scale>0</Scale>
        </Unit>
        <Unit>
          <UnitID>u001</UnitID>
          <UnitType>Standard</UnitType>
          <StandardMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/instance</MeasureSchema>
            <MeasureValue>shares</MeasureValue>
            <MeasureNamespace>xbrli</MeasureNamespace>
          </StandardMeasure>
          <Scale>0</Scale>
        </Unit>
      </Units>
    </Column>
  </Columns>
  <Rows>
    <Row>
      <Id>4</Id>
      <Label>Current assets:</Label>
      <Level>2</Level>
      <ElementName>us-gaap_AssetsCurrentAbstract</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>na</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>string</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>true</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>false</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>false</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>No definition available.</ElementDefenition>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>5</Id>
      <Label>Cash and cash equivalents</Label>
      <Level>3</Level>
      <ElementName>us-gaap_CashAndCashEquivalentsAtCarryingValue</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>debit</BalanceType>
      <PeriodType>instant</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>true</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>3129000000</NumericAmount>
          <RoundedNumericAmount>3129</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>true</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>3007000000</NumericAmount>
          <RoundedNumericAmount>3007</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>Includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the Entity may deposit additional funds at any time and also effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased th
ree years ago does not become a cash equivalent when its remaining maturity is three months. Compensating balance arrangements that do not legally restrict the withdrawal or usage of cash amounts may be reported as Cash and Cash Equivalents, while legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits should not be reported as cash and cash equivalents.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 7, 26

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 8, 9

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 7
 -Footnote 1

Reference 4: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 02
 -Paragraph 1
 -Article 5

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>6</Id>
      <Label>Short term investments</Label>
      <Level>3</Level>
      <ElementName>us-gaap_ShortTermInvestments</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>debit</BalanceType>
      <PeriodType>instant</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>542000000</NumericAmount>
          <RoundedNumericAmount>542</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>479000000</NumericAmount>
          <RoundedNumericAmount>479</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>Investments which are intended to be sold in the short term (usually less than one year or the normal operating cycle, whichever is longer) including trading securities, available-for-sale securities, held-to-maturity securities, and other short-term investments not otherwise listed in the existing taxonomy.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 03
 -Paragraph 1
 -Subparagraph g
 -Article 7

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>7</Id>
      <Label>Trade receivables, net</Label>
      <Level>3</Level>
      <ElementName>us-gaap_AccountsReceivableNetCurrent</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>debit</BalanceType>
      <PeriodType>instant</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>1456000000</NumericAmount>
          <RoundedNumericAmount>1456</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>1346000000</NumericAmount>
          <RoundedNumericAmount>1346</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 02
 -Paragraph 3
 -Subparagraph a(1)
 -Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 02
 -Paragraph 4
 -Article 5

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>8</Id>
      <Label>Inventories</Label>
      <Level>3</Level>
      <ElementName>us-gaap_InventoryNet</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>debit</BalanceType>
      <PeriodType>instant</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole>terselabel</PreferredLabelRole>
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>612000000</NumericAmount>
          <RoundedNumericAmount>612</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>626000000</NumericAmount>
          <RoundedNumericAmount>626</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>Carrying amount (lower of cost or market) as of the balance sheet date of inventories less all valuation and other allowances. Excludes noncurrent inventory balances (expected to remain on hand past one year or one operating cycle, if longer).</ElementDefenition>
      <ElementReferences>No authoritative reference available.</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>9</Id>
      <Label>Deferred income tax assets</Label>
      <Level>3</Level>
      <ElementName>us-gaap_DeferredTaxAssetsNetCurrent</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>debit</BalanceType>
      <PeriodType>instant</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>163000000</NumericAmount>
          <RoundedNumericAmount>163</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>162000000</NumericAmount>
          <RoundedNumericAmount>162</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>The current portion of the aggregate tax effects as of the balance sheet date of all future tax deductions arising from temporary differences between tax basis and generally accepted accounting principles basis recognition of assets, liabilities, revenues and expenses, which can only be deducted for tax purposes when permitted under enacted tax laws; after deducting the allocated valuation allowance, if any, to reduce such amount to net realizable value. Deferred tax liabilities and assets shall be classified as current or noncurrent based on the classification of the related asset or liability for financial reporting. A deferred tax liability or asset that is not related to an asset or liability for financial reporting, including deferred tax assets related to carryforwards, shall be classified according to the expected reversal date of the temporary difference. An unrecognized tax benefit that is directly related to a position taken in a tax year that results in a net operating los
s carryforward should be presented as a reduction of the related deferred tax asset.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 109
 -Paragraph 41, 42, 43

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>10</Id>
      <Label>Other current assets</Label>
      <Level>3</Level>
      <ElementName>us-gaap_OtherAssetsCurrent</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>debit</BalanceType>
      <PeriodType>instant</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>226000000</NumericAmount>
          <RoundedNumericAmount>226</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>213000000</NumericAmount>
          <RoundedNumericAmount>213</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>Aggregate carrying amount, as of the balance sheet date, of current assets not separately presented elsewhere in the balance sheet. Current assets are expected to be realized or consumed within one year (or the normal operating cycle, if longer).</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 02
 -Paragraph 8
 -Article 5

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>11</Id>
      <Label>Total current assets</Label>
      <Level>3</Level>
      <ElementName>us-gaap_AssetsCurrent</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>debit</BalanceType>
      <PeriodType>instant</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole>totallabel</PreferredLabelRole>
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>6128000000</NumericAmount>
          <RoundedNumericAmount>6128</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>5833000000</NumericAmount>
          <RoundedNumericAmount>5833</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 02
 -Paragraph 9
 -Article 5

</ElementReferences>
      <IsTotalLabel>true</IsTotalLabel>
    </Row>
    <Row>
      <Id>12</Id>
      <Label>Long term investments</Label>
      <Level>2</Level>
      <ElementName>us-gaap_LongTermInvestments</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>debit</BalanceType>
      <PeriodType>instant</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>64000000</NumericAmount>
          <RoundedNumericAmount>64</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>73000000</NumericAmount>
          <RoundedNumericAmount>73</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).</ElementDefenition>
      <ElementReferences>No authoritative reference available.</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>13</Id>
      <Label>Property, plant and equipment, net</Label>
      <Level>2</Level>
      <ElementName>us-gaap_PropertyPlantAndEquipmentNet</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>debit</BalanceType>
      <PeriodType>instant</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>1291000000</NumericAmount>
          <RoundedNumericAmount>1291</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>1304000000</NumericAmount>
          <RoundedNumericAmount>1304</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>Tangible assets that are held by an entity for use in the production or supply of goods and services, for rental to others, or for administrative purposes and that are expected to provide economic benefit for more than one year; net of accumulated depreciation. Examples include land, buildings, and production equipment.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 02
 -Paragraph 13
 -Subparagraph a
 -Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 12
 -Paragraph 5
 -Subparagraph b, c

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 03
 -Paragraph 8
 -Article 7

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>14</Id>
      <Label>Intangible assets, net</Label>
      <Level>2</Level>
      <ElementName>us-gaap_IntangibleAssetsNetExcludingGoodwill</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>debit</BalanceType>
      <PeriodType>instant</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>524000000</NumericAmount>
          <RoundedNumericAmount>524</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>255000000</NumericAmount>
          <RoundedNumericAmount>255</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 142
 -Paragraph 42, 45

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>15</Id>
      <Label>Goodwill</Label>
      <Level>2</Level>
      <ElementName>us-gaap_Goodwill</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>debit</BalanceType>
      <PeriodType>instant</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>700000000</NumericAmount>
          <RoundedNumericAmount>700</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>688000000</NumericAmount>
          <RoundedNumericAmount>688</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>Carrying amount as of the balance sheet date, which is the cumulative amount paid, adjusted for any amortization recognized prior to adoption of FAS 142 and for any impairment charges, in excess of the fair value of net assets acquired in one or more business combination transactions.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 142
 -Paragraph 43

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>16</Id>
      <Label>Long term deferred income tax assets</Label>
      <Level>2</Level>
      <ElementName>us-gaap_DeferredTaxAssetsNetNoncurrent</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>debit</BalanceType>
      <PeriodType>instant</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>363000000</NumericAmount>
          <RoundedNumericAmount>363</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>391000000</NumericAmount>
          <RoundedNumericAmount>391</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>The noncurrent portion as of the balance sheet date of the aggregate carrying amount of all future tax deductions arising from temporary differences between tax basis and generally accepted accounting principles basis recognition of assets, liabilities, revenues and expenses, which can only be deducted for tax purposes when permitted under enacted tax laws; after the valuation allowance, if any, to reduce such amount to net realizable value. Deferred tax liabilities and assets shall be classified as current or noncurrent based on the classification of the related asset or liability for financial reporting. A deferred tax liability or asset that is not related to an asset or liability for financial reporting, including deferred tax assets related to carryforwards, shall be classified according to the expected reversal date of the temporary difference.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 109
 -Paragraph 41, 42, 43

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>17</Id>
      <Label>Other assets</Label>
      <Level>2</Level>
      <ElementName>us-gaap_OtherAssetsNoncurrent</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>debit</BalanceType>
      <PeriodType>instant</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole>terselabel</PreferredLabelRole>
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>143000000</NumericAmount>
          <RoundedNumericAmount>143</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>142000000</NumericAmount>
          <RoundedNumericAmount>142</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>Aggregate carrying amount, as of the balance sheet date, of noncurrent assets not separately disclosed in the balance sheet due to materiality considerations. Noncurrent assets are expected to be realized or consumed after one year (or the normal operating cycle, if longer).</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 02
 -Paragraph 17
 -Article 5

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>18</Id>
      <Label>Total assets</Label>
      <Level>2</Level>
      <ElementName>us-gaap_Assets</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>debit</BalanceType>
      <PeriodType>instant</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole>totallabel</PreferredLabelRole>
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>9213000000</NumericAmount>
          <RoundedNumericAmount>9213</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>8686000000</NumericAmount>
          <RoundedNumericAmount>8686</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Concepts (CON)
 -Number 6
 -Paragraph 25

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 02
 -Paragraph 18
 -Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 03
 -Paragraph 12
 -Article 7

</ElementReferences>
      <IsTotalLabel>true</IsTotalLabel>
    </Row>
    <Row>
      <Id>20</Id>
      <Label>Current liabilities:</Label>
      <Level>2</Level>
      <ElementName>us-gaap_LiabilitiesCurrentAbstract</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>na</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>string</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>true</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>false</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>false</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>No definition available.</ElementDefenition>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>21</Id>
      <Label>Accounts payable</Label>
      <Level>3</Level>
      <ElementName>us-gaap_AccountsPayableCurrent</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>credit</BalanceType>
      <PeriodType>instant</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>309000000</NumericAmount>
          <RoundedNumericAmount>309</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>321000000</NumericAmount>
          <RoundedNumericAmount>321</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 02
 -Paragraph 19
 -Subparagraph a
 -Article 5

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>22</Id>
      <Label>Short term borrowings</Label>
      <Level>3</Level>
      <ElementName>us-gaap_ShortTermBorrowings</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>credit</BalanceType>
      <PeriodType>instant</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>667000000</NumericAmount>
          <RoundedNumericAmount>667</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>607000000</NumericAmount>
          <RoundedNumericAmount>607</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 02
 -Paragraph 19
 -Subparagraph a
 -Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 03
 -Paragraph 13
 -Subparagraph 2, 3
 -Article 9

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 03
 -Paragraph 16
 -Subparagraph a(1)
 -Article 7

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>23</Id>
      <Label>Current maturities of long term debt</Label>
      <Level>3</Level>
      <ElementName>us-gaap_LongTermDebtCurrent</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>credit</BalanceType>
      <PeriodType>instant</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>54000000</NumericAmount>
          <RoundedNumericAmount>54</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>Total of the portions of the carrying amounts as of the balance sheet date of long-term debt, which may include notes payable, bonds payable, debentures, mortgage loans, and commercial paper, which are scheduled to be repaid within one year or the normal operating cycle, if longer, and after deducting unamortized discount or premiums, if any.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 02
 -Paragraph 20
 -Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 02
 -Paragraph 19
 -Article 5

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>24</Id>
      <Label>Other current liabilities</Label>
      <Level>3</Level>
      <ElementName>us-gaap_OtherLiabilitiesCurrent</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>credit</BalanceType>
      <PeriodType>instant</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>921000000</NumericAmount>
          <RoundedNumericAmount>921</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>1047000000</NumericAmount>
          <RoundedNumericAmount>1047</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>Aggregate carrying amount, as of the balance sheet date, of current obligations not separately disclosed in the balance sheet due to materiality considerations. Current liabilities are expected to be paid within one year (or the normal operating cycle, if longer).</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 02
 -Paragraph 20
 -Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher AICPA
 -Name Accounting Research Bulletin (ARB)
 -Number 43
 -Chapter 3
 -Section A
 -Paragraph 8

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 6
 -Paragraph 15

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>25</Id>
      <Label>Total current liabilities</Label>
      <Level>3</Level>
      <ElementName>us-gaap_LiabilitiesCurrent</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>credit</BalanceType>
      <PeriodType>instant</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole>totallabel</PreferredLabelRole>
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>1951000000</NumericAmount>
          <RoundedNumericAmount>1951</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>1975000000</NumericAmount>
          <RoundedNumericAmount>1975</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 02
 -Paragraph 21
 -Article 5

</ElementReferences>
      <IsTotalLabel>true</IsTotalLabel>
    </Row>
    <Row>
      <Id>26</Id>
      <Label>Long term debt, net of current maturities</Label>
      <Level>2</Level>
      <ElementName>us-gaap_LongTermDebtNoncurrent</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>credit</BalanceType>
      <PeriodType>instant</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>56000000</NumericAmount>
          <RoundedNumericAmount>56</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>Sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year from the balance sheet date or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year (current maturities) or the normal operating cycle, if longer, and after deducting unamortized discount or premiums, if any.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 02
 -Paragraph 22
 -Article 5

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>27</Id>
      <Label>Long term deferred income tax liabilities</Label>
      <Level>2</Level>
      <ElementName>us-gaap_DeferredTaxLiabilitiesNoncurrent</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>credit</BalanceType>
      <PeriodType>instant</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>73000000</NumericAmount>
          <RoundedNumericAmount>73</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>59000000</NumericAmount>
          <RoundedNumericAmount>59</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>Represents the noncurrent portion of deferred tax liabilities, which result from applying the applicable tax rate to net taxable temporary differences pertaining to each jurisdiction to which the entity is obligated to pay income tax. A noncurrent taxable temporary difference is a difference between the tax basis and the carrying amount of a noncurrent asset or liability in the financial statements prepared in accordance with generally accepted accounting principles. In a classified statement of financial position, an enterprise shall separate deferred tax liabilities and assets into a current amount and a noncurrent amount. Deferred tax liabilities and assets shall be classified as current or noncurrent based on the classification of the related asset or liability for financial reporting. A deferred tax liability or asset that is not related to an asset or liability for financial reporting, including deferred tax assets related to carryforwards, shall be classified according to the 
expected reversal date of the temporary difference.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 109
 -Paragraph 41, 42

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>28</Id>
      <Label>Other long term liabilities</Label>
      <Level>2</Level>
      <ElementName>us-gaap_OtherLiabilitiesNoncurrent</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>credit</BalanceType>
      <PeriodType>instant</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole>terselabel</PreferredLabelRole>
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>723000000</NumericAmount>
          <RoundedNumericAmount>723</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>691000000</NumericAmount>
          <RoundedNumericAmount>691</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>Aggregate carrying amount, as of the balance sheet date, of noncurrent obligations not separately disclosed in the balance sheet due to materiality considerations. Noncurrent liabilities are expected to be paid after one year (or the normal operating cycle, if longer).</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 02
 -Paragraph 24
 -Article 5

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>29</Id>
      <Label>Shareholders' equity:</Label>
      <Level>2</Level>
      <ElementName>us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>na</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>string</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>true</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>false</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>false</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>No definition available.</ElementDefenition>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>30</Id>
      <Label>Common shares, par value CHF 0.20 per share; 320,254,200 shares authorized; 304,184,709 shares issued and 300,232,045 shares outstanding at March 31, 2010; 304,016,290 shares issued and 299,550,733 shares outstanding at December 31, 2009</Label>
      <Level>3</Level>
      <ElementName>us-gaap_CommonStockValue</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>credit</BalanceType>
      <PeriodType>instant</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole>label</PreferredLabelRole>
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>42000000</NumericAmount>
          <RoundedNumericAmount>42</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>42000000</NumericAmount>
          <RoundedNumericAmount>42</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>Dollar value of issued common stock whether issued at par value, no par or stated value. This item includes treasury stock repurchased by the entity. Note: elements for number of common shares, par value and other disclosure concepts are in another section within stockholders' equity.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 02
 -Paragraph 30
 -Article 5

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>31</Id>
      <Label>Additional paid-in capital</Label>
      <Level>3</Level>
      <ElementName>us-gaap_AdditionalPaidInCapital</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>credit</BalanceType>
      <PeriodType>instant</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>1563000000</NumericAmount>
          <RoundedNumericAmount>1563</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>1535000000</NumericAmount>
          <RoundedNumericAmount>1535</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of APIC associated with common AND preferred stock. For APIC associated with only common stock, use the element Additional Paid In Capital, Common Stock. For APIC associated with only preferred stock, use the element Additional Paid In Capital, Preferred Stock.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 02
 -Paragraph 31
 -Article 5

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>32</Id>
      <Label>Accumulated other comprehensive income</Label>
      <Level>3</Level>
      <ElementName>us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>credit</BalanceType>
      <PeriodType>instant</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>123000000</NumericAmount>
          <RoundedNumericAmount>123</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>203000000</NumericAmount>
          <RoundedNumericAmount>203</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at fiscal year-end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, and unrealized gains and losses on certain investments in debt and equity securities as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 04
 -Article 3

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher AICPA
 -Name Accounting Principles Board Opinion (APB)
 -Number 12
 -Paragraph 10

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 130
 -Paragraph 14, 17, 26

Reference 4: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 02
 -Paragraph 31
 -Article 5

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>33</Id>
      <Label>Retained earnings</Label>
      <Level>3</Level>
      <ElementName>us-gaap_RetainedEarningsAccumulatedDeficit</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>credit</BalanceType>
      <PeriodType>instant</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>5104000000</NumericAmount>
          <RoundedNumericAmount>5104</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>4533000000</NumericAmount>
          <RoundedNumericAmount>4533</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>The cumulative amount of the reporting entity's undistributed earnings or deficit.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher AICPA
 -Name Accounting Principles Board Opinion (APB)
 -Number 12
 -Paragraph 10

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 02
 -Paragraph 31
 -Article 5

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 04
 -Article 3

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>34</Id>
      <Label>Treasury shares, at cost; 3,952,664 shares at March 31, 2010 and 4,465,557 shares at December 31, 2009</Label>
      <Level>3</Level>
      <ElementName>us-gaap_TreasuryStockValue</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>debit</BalanceType>
      <PeriodType>instant</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole>label</PreferredLabelRole>
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>-366000000</NumericAmount>
          <RoundedNumericAmount>-366</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>-408000000</NumericAmount>
          <RoundedNumericAmount>-408</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>Value of common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury. Treasury stock is issued but is not outstanding. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Note: number of treasury shares concept is in another section within stockholders' equity.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name FASB Technical Bulletin (FTB)
 -Number 85-6
 -Paragraph 3

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>35</Id>
      <Label>Total shareholders' equity</Label>
      <Level>3</Level>
      <ElementName>us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>credit</BalanceType>
      <PeriodType>instant</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole>totallabel</PreferredLabelRole>
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>6466000000</NumericAmount>
          <RoundedNumericAmount>6466</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>5905000000</NumericAmount>
          <RoundedNumericAmount>5905</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>Total of Stockholders' Equity (deficit) items, net of receivables from officers, directors owners, and affiliates of the entity including portions attributable to both the parent and noncontrolling interests (previously referred to as minority interest), if any. The entity including portions attributable to the parent and noncontrolling interests is sometimes referred to as the economic entity. This excludes temporary equity and is sometimes called permanent equity.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher AICPA
 -Name Accounting Research Bulletin (ARB)
 -Number 51
 -Paragraph 25

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher AICPA
 -Name Accounting Research Bulletin (ARB)
 -Number 51
 -Paragraph 26

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher AICPA
 -Name Accounting Research Bulletin (ARB)
 -Number 51
 -Paragraph A3
 -Appendix A

</ElementReferences>
      <IsTotalLabel>true</IsTotalLabel>
    </Row>
    <Row>
      <Id>36</Id>
      <Label>Total liabilities and shareholders' equity</Label>
      <Level>2</Level>
      <ElementName>us-gaap_LiabilitiesAndStockholdersEquity</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>credit</BalanceType>
      <PeriodType>instant</PeriodType>
      <ElementDataType>monetary</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole>totallabel</PreferredLabelRole>
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>true</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>9213000000</NumericAmount>
          <RoundedNumericAmount>9213</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>true</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>8686000000</NumericAmount>
          <RoundedNumericAmount>8686</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>Total of all Liabilities and Stockholders' Equity items.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 02
 -Paragraph 32
 -Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 03
 -Paragraph 25
 -Article 7

</ElementReferences>
      <IsTotalLabel>true</IsTotalLabel>
    </Row>
  </Rows>
  <Footnotes />
  <ComparabilityReport>false</ComparabilityReport>
  <NumberOfCols>2</NumberOfCols>
  <NumberOfRows>32</NumberOfRows>
  <HasScenarios>false</HasScenarios>
  <MonetaryRoundingLevel>Millions</MonetaryRoundingLevel>
  <SharesRoundingLevel>UnKnown</SharesRoundingLevel>
  <PerShareRoundingLevel>UnKnown</PerShareRoundingLevel>
  <HasPureData>false</HasPureData>
  <SharesShouldBeRounded>true</SharesShouldBeRounded>
</InstanceReport>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R2.xml
<DESCRIPTION>IDEA: Parenthetical Data To The Consolidated Balance Sheets
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<InstanceReport xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <Version>2.0.0.10</Version>
  <hasSegments>false</hasSegments>
  <ReportName>Parenthetical Data To The Consolidated Balance Sheets</ReportName>
  <ReportLongName>001010 - Statement - Parenthetical Data To The Consolidated Balance Sheets</ReportLongName>
  <DisplayLabelColumn>true</DisplayLabelColumn>
  <ShowElementNames>false</ShowElementNames>
  <RoundingOption />
  <HasEmbeddedReports>false</HasEmbeddedReports>
  <Columns>
    <Column>
      <LabelColumn>false</LabelColumn>
      <Id>1</Id>
      <Labels>
        <Label Id="1" Label="Mar. 31, 2010" />
      </Labels>
      <CurrencyCode>usd</CurrencyCode>
      <CurrencySymbol>$</CurrencySymbol>
      <FootnoteIndexer />
      <hasSegments>false</hasSegments>
      <hasScenarios>false</hasScenarios>
      <Segments />
      <Scenarios />
      <Units>
        <Unit>
          <UnitID>u000</UnitID>
          <UnitType>Standard</UnitType>
          <StandardMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/iso4217</MeasureSchema>
            <MeasureValue>USD</MeasureValue>
            <MeasureNamespace>iso4217</MeasureNamespace>
          </StandardMeasure>
          <Scale>0</Scale>
        </Unit>
        <Unit>
          <UnitID>u001</UnitID>
          <UnitType>Standard</UnitType>
          <StandardMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/instance</MeasureSchema>
            <MeasureValue>shares</MeasureValue>
            <MeasureNamespace>xbrli</MeasureNamespace>
          </StandardMeasure>
          <Scale>0</Scale>
        </Unit>
      </Units>
    </Column>
    <Column>
      <LabelColumn>false</LabelColumn>
      <Id>2</Id>
      <Labels>
        <Label Id="1" Label="Dec. 31, 2009" />
      </Labels>
      <CurrencyCode>usd</CurrencyCode>
      <CurrencySymbol>$</CurrencySymbol>
      <FootnoteIndexer />
      <hasSegments>false</hasSegments>
      <hasScenarios>false</hasScenarios>
      <Segments />
      <Scenarios />
      <Units>
        <Unit>
          <UnitID>u000</UnitID>
          <UnitType>Standard</UnitType>
          <StandardMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/iso4217</MeasureSchema>
            <MeasureValue>USD</MeasureValue>
            <MeasureNamespace>iso4217</MeasureNamespace>
          </StandardMeasure>
          <Scale>0</Scale>
        </Unit>
        <Unit>
          <UnitID>u001</UnitID>
          <UnitType>Standard</UnitType>
          <StandardMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/instance</MeasureSchema>
            <MeasureValue>shares</MeasureValue>
            <MeasureNamespace>xbrli</MeasureNamespace>
          </StandardMeasure>
          <Scale>0</Scale>
        </Unit>
      </Units>
    </Column>
  </Columns>
  <Rows>
    <Row>
      <Id>4</Id>
      <Label>Shareholders' equity:</Label>
      <Level>2</Level>
      <ElementName>us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAbstract</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>na</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>string</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>true</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>false</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>false</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>No definition available.</ElementDefenition>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>5</Id>
      <Label>Common shares, par value CHF per share</Label>
      <Level>3</Level>
      <ElementName>us-gaap_CommonStockParOrStatedValuePerShare</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>na</BalanceType>
      <PeriodType>instant</PeriodType>
      <ElementDataType>decimal</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0.20</NumericAmount>
          <RoundedNumericAmount>0.20</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0.20</NumericAmount>
          <RoundedNumericAmount>0.20</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>Face amount or stated value of common stock per share; generally not indicative of the fair market value per share.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 129
 -Paragraph 4

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 02
 -Paragraph 30
 -Article 5

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>6</Id>
      <Label>Common shares, shares authorized</Label>
      <Level>3</Level>
      <ElementName>us-gaap_CommonStockSharesAuthorized</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>na</BalanceType>
      <PeriodType>instant</PeriodType>
      <ElementDataType>shares</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>320254200</NumericAmount>
          <RoundedNumericAmount>320254200</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>320254200</NumericAmount>
          <RoundedNumericAmount>320254200</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 02
 -Paragraph 30
 -Article 5

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>7</Id>
      <Label>Common shares, shares issued</Label>
      <Level>3</Level>
      <ElementName>us-gaap_CommonStockSharesIssued</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>na</BalanceType>
      <PeriodType>instant</PeriodType>
      <ElementDataType>shares</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>304184709</NumericAmount>
          <RoundedNumericAmount>304184709</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>304016290</NumericAmount>
          <RoundedNumericAmount>304016290</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 02
 -Paragraph 30
 -Article 5

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>8</Id>
      <Label>Common shares, shares outstanding</Label>
      <Level>3</Level>
      <ElementName>us-gaap_CommonStockSharesOutstanding</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>na</BalanceType>
      <PeriodType>instant</PeriodType>
      <ElementDataType>shares</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>300232045</NumericAmount>
          <RoundedNumericAmount>300232045</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>299550733</NumericAmount>
          <RoundedNumericAmount>299550733</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>Total number of shares of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares represent the ownership interest of the common shareholders. Excludes common shares repurchased by the entity and held as Treasury shares. Shares outstanding equals shares issued minus shares held in treasury. Does not include common shares that have been repurchased.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher AICPA
 -Name Accounting Principles Board Opinion (APB)
 -Number 12
 -Paragraph 10

Reference 2: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 04
 -Article 3

Reference 3: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 02
 -Paragraph 30
 -Article 5

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>9</Id>
      <Label>Treasury shares, at cost; shares</Label>
      <Level>3</Level>
      <ElementName>us-gaap_TreasuryStockShares</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>na</BalanceType>
      <PeriodType>instant</PeriodType>
      <ElementDataType>shares</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>3952664</NumericAmount>
          <RoundedNumericAmount>3952664</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
        <Cell>
          <Id>2</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>true</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>4465557</NumericAmount>
          <RoundedNumericAmount>4465557</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher SEC
 -Name Regulation S-X (SX)
 -Number 210
 -Section 02
 -Paragraph 29, 30
 -Article 5

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
  </Rows>
  <Footnotes />
  <ComparabilityReport>false</ComparabilityReport>
  <NumberOfCols>2</NumberOfCols>
  <NumberOfRows>6</NumberOfRows>
  <HasScenarios>false</HasScenarios>
  <MonetaryRoundingLevel>UnKnown</MonetaryRoundingLevel>
  <SharesRoundingLevel>NoRounding</SharesRoundingLevel>
  <PerShareRoundingLevel>UnKnown</PerShareRoundingLevel>
  <HasPureData>false</HasPureData>
  <SharesShouldBeRounded>true</SharesShouldBeRounded>
</InstanceReport>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<FilingSummary xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <Version>2.0.0.10</Version>
  <MyReports>
    <Report>
      <IsDefault>true</IsDefault>
      <ReportType>Sheet</ReportType>
      <LongName>001000 - Statement - Condensed Consolidated Balance Sheets (Unaudited)</LongName>
      <ShortName>Condensed Consolidated Balance Sheets (Unaudited)</ShortName>
      <Role>http://alcon.com/role/ConsolidatedBalanceSheets</Role>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <XmlFileName>R1.xml</XmlFileName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ReportType>Sheet</ReportType>
      <LongName>001010 - Statement - Parenthetical Data To The Consolidated Balance Sheets</LongName>
      <ShortName>Parenthetical Data To The Consolidated Balance Sheets</ShortName>
      <Role>http://alcon.com/role/ParentheticalDisclosuresToTheConsolidatedBalanceSheets</Role>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <XmlFileName>R2.xml</XmlFileName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ReportType>Sheet</ReportType>
      <LongName>002000 - Statement - Condensed Consolidated Statements of Earnings (Unaudited)</LongName>
      <ShortName>Condensed Consolidated Statements of Earnings (Unaudited)</ShortName>
      <Role>http://alcon.com/role/ConsolidatedStatementsOfEarnings</Role>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <XmlFileName>R3.xml</XmlFileName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ReportType>Sheet</ReportType>
      <LongName>004000 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)</LongName>
      <ShortName>Condensed Consolidated Statements of Cash Flows (Unaudited)</ShortName>
      <Role>http://alcon.com/role/ConsolidatedStatementOfCashFlows</Role>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <XmlFileName>R4.xml</XmlFileName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ReportType>Sheet</ReportType>
      <LongName>006010 - Disclosure - Condensed Consolidated Financial Statements</LongName>
      <ShortName>Condensed Consolidated Financial Statements</ShortName>
      <Role>http://alcon.com/role/CondensedConsolidatedFinancialStatements</Role>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <XmlFileName>R5.xml</XmlFileName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ReportType>Sheet</ReportType>
      <LongName>006020 - Disclosure - Earnings Per Share</LongName>
      <ShortName>Earnings Per Share</ShortName>
      <Role>http://alcon.com/role/EarningsPerShare</Role>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <XmlFileName>R6.xml</XmlFileName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ReportType>Sheet</ReportType>
      <LongName>006030 - Disclosure - Cash Flows-Supplemental Disclosure</LongName>
      <ShortName>Cash Flows-Supplemental Disclosure</ShortName>
      <Role>http://alcon.com/role/CashFlowsSupplementalDisclosure</Role>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <XmlFileName>R7.xml</XmlFileName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ReportType>Sheet</ReportType>
      <LongName>006040 - Disclosure - Supplemental Balance Sheet Information</LongName>
      <ShortName>Supplemental Balance Sheet Information</ShortName>
      <Role>http://alcon.com/role/SupplementalBalanceSheetInformation</Role>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <XmlFileName>R8.xml</XmlFileName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ReportType>Sheet</ReportType>
      <LongName>006050 - Disclosure - Investments</LongName>
      <ShortName>Investments</ShortName>
      <Role>http://alcon.com/role/Investments</Role>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <XmlFileName>R9.xml</XmlFileName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ReportType>Sheet</ReportType>
      <LongName>006060 - Disclosure - Financial Instruments</LongName>
      <ShortName>Financial Instruments</ShortName>
      <Role>http://alcon.com/role/FairValueOfFinancialInstruments</Role>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <XmlFileName>R10.xml</XmlFileName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ReportType>Sheet</ReportType>
      <LongName>006070 - Disclosure - Intangible Assets and Goodwill</LongName>
      <ShortName>Intangible Assets and Goodwill</ShortName>
      <Role>http://alcon.com/role/IntangibleAssetsAndGoodwill</Role>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <XmlFileName>R11.xml</XmlFileName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ReportType>Sheet</ReportType>
      <LongName>006080 - Disclosure - Short Term Borrowings and Long Term Debt</LongName>
      <ShortName>Short Term Borrowings and Long Term Debt</ShortName>
      <Role>http://alcon.com/role/ShortTermBorrowingsAndLongTermDebt</Role>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <XmlFileName>R12.xml</XmlFileName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ReportType>Sheet</ReportType>
      <LongName>006090 - Disclosure - Income Taxes</LongName>
      <ShortName>Income Taxes</ShortName>
      <Role>http://alcon.com/role/IncomeTaxes</Role>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <XmlFileName>R13.xml</XmlFileName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ReportType>Sheet</ReportType>
      <LongName>006100 - Disclosure - Business Segments</LongName>
      <ShortName>Business Segments</ShortName>
      <Role>http://alcon.com/role/BusinessSegments</Role>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <XmlFileName>R14.xml</XmlFileName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ReportType>Sheet</ReportType>
      <LongName>006110 - Disclosure - Share-Based Compensation</LongName>
      <ShortName>Share-Based Compensation</ShortName>
      <Role>http://alcon.com/role/ShareBasedCompensationPlans</Role>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <XmlFileName>R15.xml</XmlFileName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ReportType>Sheet</ReportType>
      <LongName>006120 - Disclosure - Pension and Postretirement Benefits</LongName>
      <ShortName>Pension and Postretirement Benefits</ShortName>
      <Role>http://alcon.com/role/PensionAndPostretirementBenefits</Role>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <XmlFileName>R16.xml</XmlFileName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ReportType>Sheet</ReportType>
      <LongName>006130 - Disclosure - Proposed Change of Control</LongName>
      <ShortName>Proposed Change of Control</ShortName>
      <Role>http://alcon.com/role/ProposedChangeOfControl</Role>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <XmlFileName>R17.xml</XmlFileName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ReportType>Sheet</ReportType>
      <LongName>006140 - Disclosure - Commitments and Contingencies</LongName>
      <ShortName>Commitments and Contingencies</ShortName>
      <Role>http://alcon.com/role/CommitmentsAndContingencies</Role>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <XmlFileName>R18.xml</XmlFileName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ReportType>Sheet</ReportType>
      <LongName>995200 - Document - Document Information</LongName>
      <ShortName>Document Information</ShortName>
      <Role>http://xbrl.us/us-gaap/role/document/DocumentInformation</Role>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <XmlFileName>R19.xml</XmlFileName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ReportType>Sheet</ReportType>
      <LongName>995400 - Document - Entity Information</LongName>
      <ShortName>Entity Information</ShortName>
      <Role>http://xbrl.us/us-gaap/role/document/EntityInformation</Role>
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <XmlFileName>R20.xml</XmlFileName>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <ReportType>Book</ReportType>
      <LongName>All Reports</LongName>
      <ShortName>All Reports</ShortName>
      <Role />
      <ContainEmbeddedReports>false</ContainEmbeddedReports>
      <XmlFileName />
    </Report>
  </MyReports>
  <EntityCount>1</EntityCount>
  <ContextCount>6</ContextCount>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <UnitCount>3</UnitCount>
  <ElementCount>110</ElementCount>
  <FootnotesReported>false</FootnotesReported>
  <TuplesReported>false</TuplesReported>
  <ContextSummary>
    <ContextSummary>
      <ContextName>c00003</ContextName>
      <ElementCount>74</ElementCount>
    </ContextSummary>
    <ContextSummary>
      <ContextName>c00002</ContextName>
      <ElementCount>36</ElementCount>
    </ContextSummary>
    <ContextSummary>
      <ContextName>c00000</ContextName>
      <ElementCount>1</ElementCount>
    </ContextSummary>
    <ContextSummary>
      <ContextName>c00005</ContextName>
      <ElementCount>1</ElementCount>
    </ContextSummary>
    <ContextSummary>
      <ContextName>c00001</ContextName>
      <ElementCount>34</ElementCount>
    </ContextSummary>
    <ContextSummary>
      <ContextName>c00004</ContextName>
      <ElementCount>48</ElementCount>
    </ContextSummary>
  </ContextSummary>
  <BaseTaxonomies />
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>29
<FILENAME>Financial_Report.xls
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xls
MT,\1X*&Q&N$`````````````````````/@`#`/[_"0`&```````````````"
M`````0``````````$```NP````$```#^____```````````"````________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_______________________]_____O____W___\$````!0````8````'````
M"`````D````*````"P````P````-````#@````\````0````$0```!(````3
M````%````!4````6````%P```!@````9````&@```!L````<````'0```!X`
M```?````(````"$````B````(P```"0````E````)@```"<````H````*0``
M`"H````K````+````"T````N````+P```#`````Q````,@```#,````T````
M-0```#8````W````.````#D````Z````.P```#P````]````/@```#\```!`
M````00```$(```!#````1````$4```!&````1P```$@```!)````2@```$L`
M``!,````30```$X```!/````4````%$```!2````4P```%0```!5````5@``
M`%<```!8````60```%H```!;````7````%T```!>````7P```&````!A````
M8@```&,```!D````90```&8```!G````:````&D```!J````:P```&P```!M
M````;@```&\```!P````<0```'(```!S````=````'4```!V````=P```'@`
M``!Y````>@```'L```!\````?0```'X```!_````@````%(`;P!O`'0`(`!%
M`&X`=`!R`'D`````````````````````````````````````````````````
M```````````6``4`__________\"````````````````````````````````
M`````````,!-D'$XYLH!O````$`!````````5P!O`'(`:P!B`&\`;P!K````
M````````````````````````````````````````````````````````````
M`!(``@#_______________\`````````````````````````````````````
M```````````#````YF\!```````%`%,`=0!M`&T`80!R`'D`20!N`&8`;P!R
M`&T`80!T`&D`;P!N````````````````````````````````````*``"`0$`
M```#````_____P``````````````````````````````````````````````
M``````"```````````4`1`!O`&,`=0!M`&4`;@!T`%,`=0!M`&T`80!R`'D`
M20!N`&8`;P!R`&T`80!T`&D`;P!N```````````````X``(`____________
M____`````````````````````````````````````````````````@```*``
M````````@0```((```"#````A````(4```"&````AP```(@```")````B@``
M`(L```",````C0```(X```"/````D````)$```"2````DP```)0```"5````
ME@```)<```"8````F0```)H```";````G````)T```">````GP```*````"A
M````H@```*,```"D````I0```*8```"G````J````*D```"J````JP```*P`
M``"M````K@```*\```"P````L0```+(```"S````M````+4```"V````MP``
M`+@```"Y````N@```/[____^_____O______________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M______________________________\)"!````8%`$88S0?!@```!@(``.$`
M`@"P!,$``@```.(```!<`'``!P``<W-H>&)R;```!@(`````````````````
M````````````````````````````````````````````````````````````
M`````````````````````````````````````````````````````$(``@"P
M!&$!`@```,`!```]`2@``0`"``,`!``%``8`!P`(``D`"@`+``P`#0`.``\`
M$``1`!(`$P`4`)P``@`.`!D``@```!(``@```!,``@```*\!`@```+P!`@``
M`#T`$@#P`%H`3"R+&C@```````$`6`)```(```"-``(````B``(````.``(`
M`0"W`0(```#:``(````Q`!P`R````/]_D`$````````&`50`80!H`&\`;0!A
M`#$`'`#(````_W^0`0````````8!5`!A`&@`;P!M`&$`,0`<`,@```#_?Y`!
M````````!@%4`&$`:`!O`&T`80`Q`!P`R````/]_D`$````````&`50`80!H
M`&\`;0!A`#$`'`#(````_W^\`@````````8!5`!A`&@`;P!M`&$`,0`<`,@`
M``#_?Y`!```A````!@%4`&$`:`!O`&T`80`>!#<`!0`9``$B`"0`(@`C`"P`
M(P`C`#``7P`I`#L`7``H`"``(@`D`"(`(P`L`",`(P`P`%P`(``I`!X$00`&
M`!X``2(`)``B`",`+``C`",`,`!?`"D`.P!;`%(`90!D`%T`7``H`"``(@`D
M`"(`(P`L`",`(P`P`%P`(``I`!X$0P`'`!\``2(`)``B`",`+``C`",`,``N
M`#``,`!?`"D`.P!<`"@`(``B`"0`(@`C`"P`(P`C`#``+@`P`#``7``@`"D`
M'@1-``@`)``!(@`D`"(`(P`L`",`(P`P`"X`,``P`%\`*0`[`%L`4@!E`&0`
M70!<`"@`(``B`"0`(@`C`"P`(P`C`#``+@`P`#``7``@`"D`'@1Q`"H`-@`!
M7P`H`"(`)``B`"H`(``C`"P`(P`C`#``7P`I`#L`7P`H`"(`)``B`"H`(`!<
M`"@`(``C`"P`(P`C`#``7``@`"D`.P!?`"@`(@`D`"(`*@`@`"(`+0`B`%\`
M*0`[`%\`*``@`$``7P`@`"D`'@1?`"D`+0`!7P`H`"H`(``C`"P`(P`C`#``
M7P`I`#L`7P`H`"H`(`!<`"@`(``C`"P`(P`C`#``7``@`"D`.P!?`"@`*@`@
M`"(`+0`B`%\`*0`[`%\`*``@`$``7P`@`"D`'@2!`"P`/@`!7P`H`"(`)``B
M`"H`(``C`"P`(P`C`#``+@`P`#``7P`I`#L`7P`H`"(`)``B`"H`(`!<`"@`
M(``C`"P`(P`C`#``+@`P`#``7``@`"D`.P!?`"@`(@`D`"(`*@`@`"(`+0`B
M`#\`/P!?`"D`.P!?`"@`(`!``%\`(``I`!X$;P`K`#4``5\`*``J`"``(P`L
M`",`(P`P`"X`,``P`%\`*0`[`%\`*``J`"``7``H`"``(P`L`",`(P`P`"X`
M,``P`%P`(``I`#L`7P`H`"H`(``B`"T`(@`_`#\`7P`I`#L`7P`H`"``0`!?
M`"``*0`>!",`I``/``$D`",`+``C`",`,``[`"@`)``C`"P`(P`C`#``*0`>
M!!\`I0`-``$C`"P`(P`C`#``.P`H`",`+``C`",`,``I`!X$*P"F`!,``2,`
M+``C`",`,``N`",`(P`[`"@`(P`L`",`(P`P`"X`(P`C`"D`'@0O`*<`%0`!
M)``C`"P`(P`C`#``+@`C`",`.P`H`"0`(P`L`",`(P`P`"X`(P`C`"D`X``4
M``````#U_R```````````````,`@X``4``$```#U_R```/0``````````$$@
MX``4``$```#U_R```/0``````````$$@X``4``(```#U_R```/0`````````
M`$$@X``4``(```#U_R```/0``````````$$@X``4``````#U_R```/0`````
M`````$$@X``4``````#U_R```/0``````````$$@X``4``````#U_R```/0`
M`````````$$@X``4``````#U_R```/0``````````$$@X``4``````#U_R``
M`/0``````````$$@X``4``````#U_R```/0``````````$$@X``4``````#U
M_R```/0``````````$$@X``4``````#U_R```/0``````````$$@X``4````
M``#U_R```/0``````````$$@X``4``````#U_R```/0``````````$$@X``4
M```````!`"```````````````,`@X``4``$`*P#U_R```/@``````````$$@
MX``4``$`*0#U_R```/@``````````$$@X``4``$`+`#U_R```/@`````````
M`$$@X``4``$`*@#U_R```/@``````````$$@X``4``$`"0#U_R```/@`````
M`````$$@X``4``4````!`"````@``````````,`@X``4``4````!`"@``!@`
M`````````,`@X``4``4````!`"H``!@``````````,`@X``4```````!`"@`
M`!```````````,`@X``4````I``!`"````0``````````,`@X``4````I0`!
M`"````0``````````,`@X``4``8`I0`!`"````P``````````,`@X``4``8`
MI``!`"````P``````````,`@X``4````I@`!`"````0``````````,`@X``4
M````IP`!`"````0``````````,`@X``4```````)`"```````````````,`@
MX``4```````)`"@``!```````````,`@X``4```````)``@``!``````````
M`,`@DP($``"``/^3`@0`$(`#_Y,"!``1@`;_DP($`!*`!/^3`@0`$X`'_Y,"
M!``4@`7_8`$"````A0!&`((R`0```!\!0P!O`&X`9`!E`&X`<P!E`&0`(`!#
M`&\`;@!S`&\`;`!I`&0`80!T`&4`9``@`$(`80!L`&$`;@!C`&4`(`"%`$8`
M.SL!````'P%0`&$`<@!E`&X`=`!H`&4`=`!I`&,`80!L`"``1`!A`'0`80`@
M`%0`;P`@`%0`:`!E`"``0P!O`&X`<P!O`(4`1@`L/@$````?`4,`;P!N`&0`
M90!N`',`90!D`"``0P!O`&X`<P!O`&P`:0!D`&$`=`!E`&0`(`!3`'0`80!T
M`&4`;0!E`&X`A0!&`'%$`0```!\!,0!?`$,`;P!N`&0`90!N`',`90!D`"``
M0P!O`&X`<P!O`&P`:0!D`&$`=`!E`&0`(`!3`'0`80!T`&4`;0"%`$8`6DX!
M````'P%#`&\`;@!D`&4`;@!S`&4`9``@`$,`;P!N`',`;P!L`&D`9`!A`'0`
M90!D`"``1@!I`&X`80!N`&,`:0!A`(4`+`!-4`$````2`44`80!R`&X`:0!N
M`&<`<P`@`%``90!R`"``4P!H`&$`<@!E`(4`1@!`4@$````?`4,`80!S`&@`
M(`!&`&P`;P!W`',`+0!3`'4`<`!P`&P`90!M`&4`;@!T`&$`;``@`$0`:0!S
M`&,`;`!O`',`A0!&`#-4`0```!\!4P!U`'``<`!L`&4`;0!E`&X`=`!A`&P`
M(`!"`&$`;`!A`&X`8P!E`"``4P!H`&4`90!T`"``20!N`&8`;P"%`!X`)E8!
M````"P%)`&X`=@!E`',`=`!M`&4`;@!T`',`A0`R`!E8`0```!4!1@!I`&X`
M80!N`&,`:0!A`&P`(`!)`&X`<P!T`'(`=0!M`&4`;@!T`',`A0!$``Q:`0``
M`!X!20!N`'0`80!N`&<`:0!B`&P`90`@`$$`<P!S`&4`=`!S`"``80!N`&0`
M(`!'`&\`;P!D`'<`:0!L`&P`A0!&`/];`0```!\!4P!H`&\`<@!T`"``5`!E
M`'(`;0`@`$(`;P!R`'(`;P!W`&D`;@!G`',`(`!A`&X`9``@`$P`;P!N`&<`
M(`"%`"``\ET!````#`%)`&X`8P!O`&T`90`@`%0`80!X`&4`<P"%`"H`Y5\!
M````$0%"`'4`<P!I`&X`90!S`',`(`!3`&4`9P!M`&4`;@!T`',`A0`X`-AA
M`0```!@!4P!H`&$`<@!E`"T`0@!A`',`90!D`"``0P!O`&T`<`!E`&X`<P!A
M`'0`:0!O`&X`A0!&`,MC`0```!\!4`!E`&X`<P!I`&\`;@`@`&$`;@!D`"``
M4`!O`',`=`!R`&4`=`!I`'(`90!M`&4`;@!T`"``0@!E`&X`90"%`#P`OF4!
M````&@%0`'(`;P!P`&\`<P!E`&0`(`!#`&@`80!N`&<`90`@`&\`9@`@`$,`
M;P!N`'0`<@!O`&P`A0!"`+%G`0```!T!0P!O`&T`;0!I`'0`;0!E`&X`=`!S
M`"``80!N`&0`(`!#`&\`;@!T`&D`;@!G`&4`;@!C`&D`90!S`(4`,`"D:0$`
M```4`40`;P!C`'4`;0!E`&X`=``@`$D`;@!F`&\`<@!M`&$`=`!I`&\`;@"%
M`"P`^VL!````$@%%`&X`=`!I`'0`>0`@`$D`;@!F`&\`<@!M`&$`=`!I`&\`
M;@",``0``0`!`,$!"`#!`0``5(T!`/P`(""=````G0```#D``4,`;P!N`&0`
M90!N`',`90!D`"``0P!O`&X`<P!O`&P`:0!D`&$`=`!E`&0`(`!"`&$`;`!A
M`&X`8P!E`"``4P!H`&4`90!T`',`(``H`%4`;@!A`'4`9`!I`'0`90!D`"D`
M(``H`%4`4P!$`"``)``I``L``4D`;@`@`$T`:0!L`&P`:0!O`&X`<P`/``%-
M`&$`<@`N`"``,P`Q`"P`(``R`#``,0`P``T`"@`/``%$`&4`8P`N`"``,P`Q
M`"P`(``R`#``,``Y``T`"@`/``%#`'4`<@!R`&4`;@!T`"``80!S`',`90!T
M`',`.@`9``%#`&$`<P!H`"``80!N`&0`(`!C`&$`<P!H`"``90!Q`'4`:0!V
M`&$`;`!E`&X`=`!S`!8``5,`:`!O`'(`=``@`'0`90!R`&T`(`!I`&X`=@!E
M`',`=`!M`&4`;@!T`',`%@`!5`!R`&$`9`!E`"``<@!E`&,`90!I`'8`80!B
M`&P`90!S`"P`(`!N`&4`=``+``%)`&X`=@!E`&X`=`!O`'(`:0!E`',`&@`!
M1`!E`&8`90!R`'(`90!D`"``:0!N`&,`;P!M`&4`(`!T`&$`>``@`&$`<P!S
M`&4`=`!S`!0``4\`=`!H`&4`<@`@`&,`=0!R`'(`90!N`'0`(`!A`',`<P!E
M`'0`<P`4``%4`&\`=`!A`&P`(`!C`'4`<@!R`&4`;@!T`"``80!S`',`90!T
M`',`%0`!3`!O`&X`9P`@`'0`90!R`&T`(`!I`&X`=@!E`',`=`!M`&4`;@!T
M`',`(@`!4`!R`&\`<`!E`'(`=`!Y`"P`(`!P`&P`80!N`'0`(`!A`&X`9``@
M`&4`<0!U`&D`<`!M`&4`;@!T`"P`(`!N`&4`=``6``%)`&X`=`!A`&X`9P!I
M`&(`;`!E`"``80!S`',`90!T`',`+``@`&X`90!T``@``4<`;P!O`&0`=P!I
M`&P`;``D``%,`&\`;@!G`"``=`!E`'(`;0`@`&0`90!F`&4`<@!R`&4`9``@
M`&D`;@!C`&\`;0!E`"``=`!A`'@`(`!A`',`<P!E`'0`<P`,``%/`'0`:`!E
M`'(`(`!A`',`<P!E`'0`<P`,``%4`&\`=`!A`&P`(`!A`',`<P!E`'0`<P`4
M``%#`'4`<@!R`&4`;@!T`"``;`!I`&$`8@!I`&P`:0!T`&D`90!S`#H`$``!
M00!C`&,`;P!U`&X`=`!S`"``<`!A`'D`80!B`&P`90`5``%3`&@`;P!R`'0`
M(`!T`&4`<@!M`"``8@!O`'(`<@!O`'<`:0!N`&<`<P`D``%#`'4`<@!R`&4`
M;@!T`"``;0!A`'0`=0!R`&D`=`!I`&4`<P`@`&\`9@`@`&P`;P!N`&<`(`!T
M`&4`<@!M`"``9`!E`&(`=``9``%/`'0`:`!E`'(`(`!C`'4`<@!R`&4`;@!T
M`"``;`!I`&$`8@!I`&P`:0!T`&D`90!S`!D``50`;P!T`&$`;``@`&,`=0!R
M`'(`90!N`'0`(`!L`&D`80!B`&D`;`!I`'0`:0!E`',`*0`!3`!O`&X`9P`@
M`'0`90!R`&T`(`!D`&4`8@!T`"P`(`!N`&4`=``@`&\`9@`@`&,`=0!R`'(`
M90!N`'0`(`!M`&$`=`!U`'(`:0!T`&D`90!S`"D``4P`;P!N`&<`(`!T`&4`
M<@!M`"``9`!E`&8`90!R`'(`90!D`"``:0!N`&,`;P!M`&4`(`!T`&$`>``@
M`&P`:0!A`&(`:0!L`&D`=`!I`&4`<P`;``%/`'0`:`!E`'(`(`!L`&\`;@!G
M`"``=`!E`'(`;0`@`&P`:0!A`&(`:0!L`&D`=`!I`&4`<P`5``%3`&@`80!R
M`&4`:`!O`&P`9`!E`'(`<P`G`"``90!Q`'4`:0!T`'D`.@#M``%#`&\`;0!M
M`&\`;@`@`',`:`!A`'(`90!S`"P`(`!P`&$`<@`@`'8`80!L`'4`90`@`$,`
M2`!&`"``,``N`#(`,``@`'``90!R`"``<P!H`&$`<@!E`#L`(``S`#(`,``L
M`#(`-0`T`"P`,@`P`#``(`!S`&@`80!R`&4`<P`@`&$`=0!T`&@`;P!R`&D`
M>@!E`&0`.P`@`#,`,``T`"P`,0`X`#0`+``W`#``.0`@`',`:`!A`'(`90!S
M`"``:0!S`',`=0!E`&0`(`!A`&X`9``@`#,`,``P`"P`,@`S`#(`+``P`#0`
M-0`@`',`:`!A`'(`90!S`"``;P!U`'0`<P!T`&$`;@!D`&D`;@!G`"``80!T
M`"``30!A`'(`8P!H`"``,P`Q`"P`(``R`#``,0`P`#L`(``S`#``-``L`#``
M,0`V`"P`,@`Y`#``(`!S`&@`80!R`&4`<P`@`&D`<P!S`'4`90!D`"``80!N
M`&0`(``R`#D`.0`L`#4`-0`P`"P`-P`S`#,`(`!S`&@`80!R`&4`<P`@`&\`
M=0!T`',`=`!A`&X`9`!I`&X`9P`@`&$`=``@`$0`90!C`&4`;0!B`&4`<@`@
M`#,`,0`L`"``,@`P`#``.0`:``%!`&0`9`!I`'0`:0!O`&X`80!L`"``<`!A
M`&D`9``M`&D`;@`@`&,`80!P`&D`=`!A`&P`)@`!00!C`&,`=0!M`'4`;`!A
M`'0`90!D`"``;P!T`&@`90!R`"``8P!O`&T`<`!R`&4`:`!E`&X`<P!I`'8`
M90`@`&D`;@!C`&\`;0!E`!$``5(`90!T`&$`:0!N`&4`9``@`&4`80!R`&X`
M:0!N`&<`<P!F``%4`'(`90!A`',`=0!R`'D`(`!S`&@`80!R`&4`<P`L`"``
M80!T`"``8P!O`',`=``[`"``,P`L`#D`-0`R`"P`-@`V`#0`(`!S`&@`80!R
M`&4`<P`@`&$`=``@`$T`80!R`&,`:``@`#,`,0`L`"``,@`P`#$`,``@`&$`
M;@!D`"``-``L`#0`-@`U`"P`-0`U`#<`(`!S`&@`80!R`&4`<P`@`&$`=``@
M`$0`90!C`&4`;0!B`&4`<@`@`#,`,0`L`"``,@`P`#``.0`:``%4`&\`=`!A
M`&P`(`!S`&@`80!R`&4`:`!O`&P`9`!E`'(`<P`G`"``90!Q`'4`:0!T`'D`
M*@`!5`!O`'0`80!L`"``;`!I`&$`8@!I`&P`:0!T`&D`90!S`"``80!N`&0`
M(`!S`&@`80!R`&4`:`!O`&P`9`!E`'(`<P`G`"``90!Q`'4`:0!T`'D`-0`!
M4`!A`'(`90!N`'0`:`!E`'0`:0!C`&$`;``@`$0`80!T`&$`(`!4`&\`(`!4
M`&@`90`@`$,`;P!N`',`;P!L`&D`9`!A`'0`90!D`"``0@!A`&P`80!N`&,`
M90`@`%,`:`!E`&4`=`!S`"8``4,`;P!M`&T`;P!N`"``<P!H`&$`<@!E`',`
M+``@`'``80!R`"``=@!A`&P`=0!E`"``0P!(`$8`(`!P`&4`<@`@`',`:`!A
M`'(`90`@``%#`&\`;0!M`&\`;@`@`',`:`!A`'(`90!S`"P`(`!S`&@`80!R
M`&4`<P`@`&$`=0!T`&@`;P!R`&D`>@!E`&0`'``!0P!O`&T`;0!O`&X`(`!S
M`&@`80!R`&4`<P`L`"``<P!H`&$`<@!E`',`(`!I`',`<P!U`&4`9``A``%#
M`&\`;0!M`&\`;@`@`',`:`!A`'(`90!S`"P`(`!S`&@`80!R`&4`<P`@`&\`
M=0!T`',`=`!A`&X`9`!I`&X`9P`@``%4`'(`90!A`',`=0!R`'D`(`!S`&@`
M80!R`&4`<P`L`"``80!T`"``8P!O`',`=``[`"``<P!H`&$`<@!E`',`00`!
M0P!O`&X`9`!E`&X`<P!E`&0`(`!#`&\`;@!S`&\`;`!I`&0`80!T`&4`9``@
M`%,`=`!A`'0`90!M`&4`;@!T`',`(`!O`&8`(`!%`&$`<@!N`&D`;@!G`',`
M(``H`%4`;@!A`'4`9`!I`'0`90!D`"D`(``H`%4`4P!$`"``)``I`!X``4D`
M;@`@`$T`:0!L`&P`:0!O`&X`<P`L`"``90!X`&,`90!P`'0`(`!3`&@`80!R
M`&4`(`!D`&$`=`!A`!\``3,`(`!-`&\`;@!T`&@`<P`@`$4`;@!D`&4`9``-
M``H`30!A`'(`+@`@`#,`,0`L`"``,@`P`#$`,``-``H`'P`!,P`@`$T`;P!N
M`'0`:`!S`"``10!N`&0`90!D``T`"@!-`&$`<@`N`"``,P`Q`"P`(``R`#``
M,``Y``T`"@`C``%#`$\`3@!3`$\`3`!)`$0`00!4`$4`1``@`%,`5`!!`%0`
M10!-`$4`3@!4`%,`(`!/`$8`(`!%`$$`4@!.`$D`3@!'`%,`!0`!4P!A`&P`
M90!S`!(``4,`;P!S`'0`(`!O`&8`(`!G`&\`;P!D`',`(`!S`&\`;`!D``P`
M`4<`<@!O`',`<P`@`'``<@!O`&8`:0!T`",``5,`90!L`&P`:0!N`&<`+``@
M`&<`90!N`&4`<@!A`&P`(`!A`&X`9``@`&$`9`!M`&D`;@!I`',`=`!R`&$`
M=`!I`'8`90`8``%2`&4`<P!E`&$`<@!C`&@`(`!A`&X`9``@`&0`90!V`&4`
M;`!O`'``;0!E`&X`=``;``%!`&T`;P!R`'0`:0!Z`&$`=`!I`&\`;@`@`&\`
M9@`@`&D`;@!T`&$`;@!G`&D`8@!L`&4`<P`8``%/`'0`:`!E`'(`(`!O`'``
M90!R`&$`=`!I`&X`9P`@`&4`>`!P`&4`;@!S`&4`<P`0``%/`'``90!R`&$`
M=`!I`&X`9P`@`&D`;@!C`&\`;0!E`!<``4\`=`!H`&4`<@`@`&D`;@!C`&\`
M;0!E`"``*`!E`'@`<`!E`&X`<P!E`"D`.@`?``%,`&\`<P!S`"``9@!R`&\`
M;0`@`&8`;P!R`&4`:0!G`&X`(`!C`'4`<@!R`&4`;@!C`'D`+``@`&X`90!T
M``\``4D`;@!T`&4`<@!E`',`=``@`&D`;@!C`&\`;0!E`!```4D`;@!T`&4`
M<@!E`',`=``@`&4`>`!P`&4`;@!S`&4`"@`!3P!T`&@`90!R`"P`(`!N`&4`
M=``<``%%`&$`<@!N`&D`;@!G`',`(`!B`&4`9@!O`'(`90`@`&D`;@!C`&\`
M;0!E`"``=`!A`'@`90!S``P``4D`;@!C`&\`;0!E`"``=`!A`'@`90!S``P`
M`4X`90!T`"``90!A`'(`;@!I`&X`9P!S`!\``4(`80!S`&D`8P`@`&4`80!R
M`&X`:0!N`&<`<P`@`'``90!R`"``8P!O`&T`;0!O`&X`(`!S`&@`80!R`&4`
M(0`!1`!I`&P`=0!T`&4`9``@`&4`80!R`&X`:0!N`&<`<P`@`'``90!R`"``
M8P!O`&T`;0!O`&X`(`!S`&@`80!R`&4`)``!0@!A`',`:0!C`"``=P!E`&D`
M9P!H`'0`90!D`"``80!V`&4`<@!A`&<`90`@`&,`;P!M`&T`;P!N`"``<P!H
M`&$`<@!E`',`)@`!1`!I`&P`=0!T`&4`9``@`'<`90!I`&<`:`!T`&4`9``@
M`&$`=@!E`'(`80!G`&4`(`!C`&\`;0!M`&\`;@`@`',`:`!A`'(`90!S`$,`
M`4,`;P!N`&0`90!N`',`90!D`"``0P!O`&X`<P!O`&P`:0!D`&$`=`!E`&0`
M(`!3`'0`80!T`&4`;0!E`&X`=`!S`"``;P!F`"``0P!A`',`:``@`$8`;`!O
M`'<`<P`@`"@`50!N`&$`=0!D`&D`=`!E`&0`*0`@`"@`50!3`$0`(``D`"D`
M,``!0P!A`',`:``@`'``<@!O`'8`:0!D`&4`9``@`&(`>0`@`"@`=0!S`&4`
M9``@`&D`;@`I`"``;P!P`&4`<@!A`'0`:0!N`&<`(`!A`&,`=`!I`'8`:0!T
M`&D`90!S`#H`40`!00!D`&H`=0!S`'0`;0!E`&X`=`!S`"``=`!O`"``<@!E
M`&,`;P!N`&,`:0!L`&4`(`!N`&4`=``@`&4`80!R`&X`:0!N`&<`<P`@`'0`
M;P`@`&,`80!S`&@`(`!P`'(`;P!V`&D`9`!E`&0`(`!F`'(`;P!M`"``;P!P
M`&4`<@!A`'0`:0!N`&<`(`!A`&,`=`!I`'8`:0!T`&D`90!S`#H`#``!1`!E
M`'``<@!E`&,`:0!A`'0`:0!O`&X`%``!4P!H`&$`<@!E`"T`8@!A`',`90!D
M`"``<`!A`'D`;0!E`&X`=`!S`#8``50`80!X`"``8@!E`&X`90!F`&D`=`!S
M`"``*`!R`&4`=@!E`'(`<P!A`&P`<P`I`"``9@!R`&\`;0`@`',`:`!A`'(`
M90`M`&(`80!S`&4`9``@`&,`;P!M`'``90!N`',`80!T`&D`;P!N`!4``40`
M90!F`&4`<@!R`&4`9``@`&D`;@!C`&\`;0!E`"``=`!A`'@`90!S`!T``4P`
M;P!S`',`(``H`&<`80!I`&X`*0`@`&\`;@`@`',`80!L`&4`(`!O`&8`(`!A
M`',`<P!E`'0`<P`M``%5`&X`<@!E`&$`;`!I`'H`90!D`"``80!P`'``<@!E
M`&,`:0!A`'0`:0!O`&X`(`!O`&X`(`!T`'(`80!D`&D`;@!G`"``<P!E`&,`
M=0!R`&D`=`!I`&4`<P!6``%#`&@`80!N`&<`90!S`"``:0!N`"``;P!P`&4`
M<@!A`'0`:0!N`&<`(`!A`',`<P!E`'0`<P`@`&$`;@!D`"``;`!I`&$`8@!I
M`&P`:0!T`&D`90!S`"P`(`!N`&4`=``@`&\`9@`@`&4`9@!F`&4`8P!T`',`
M(`!F`'(`;P!M`"``8@!U`',`:0!N`&4`<P!S`"``80!C`'$`=0!I`',`:0!T
M`&D`;P!N`#H`$0`!5`!R`&$`9`!E`"``<@!E`&,`90!I`'8`80!B`&P`90!S
M`"(``4X`90!T`"``8P!A`',`:``@`&8`<@!O`&T`(`!O`'``90!R`&$`=`!I
M`&X`9P`@`&$`8P!T`&D`=@!I`'0`:0!E`',`,``!0P!A`',`:``@`'``<@!O
M`'8`:0!D`&4`9``@`&(`>0`@`"@`=0!S`&4`9``@`&D`;@`I`"``:0!N`'8`
M90!S`'0`:0!N`&<`(`!A`&,`=`!I`'8`:0!T`&D`90!S`#H`*@`!4`!U`'(`
M8P!H`&$`<P!E`',`(`!O`&8`(`!P`'(`;P!P`&4`<@!T`'D`+``@`'``;`!A
M`&X`=``@`&$`;@!D`"``90!Q`'4`:0!P`&T`90!N`'0`+0`!00!C`'$`=0!I
M`',`:0!T`&D`;P!N`"``;P!F`"``8@!U`',`:0!N`&4`<P!S`"P`(`!N`&4`
M=``@`&\`9@`@`&,`80!S`&@`(`!A`&,`<0!U`&D`<@!E`&0`'@`!4`!U`'(`
M8P!H`&$`<P!E`',`(`!O`&8`(`!I`&X`=`!A`&X`9P!I`&(`;`!E`"``80!S
M`',`90!T`',`&``!4`!U`'(`8P!H`&$`<P!E`',`(`!O`&8`(`!I`&X`=@!E
M`',`=`!M`&4`;@!T`',`,0`!4`!R`&\`8P!E`&4`9`!S`"``9@!R`&\`;0`@
M`',`80!L`&4`<P`@`&$`;@!D`"``;0!A`'0`=0!R`&D`=`!I`&4`<P`@`&\`
M9@`@`&D`;@!V`&4`<P!T`&T`90!N`'0`<P`B``%.`&4`=``@`&,`80!S`&@`
M(`!F`'(`;P!M`"``:0!N`'8`90!S`'0`:0!N`&<`(`!A`&,`=`!I`'8`:0!T
M`&D`90!S`#```4,`80!S`&@`(`!P`'(`;P!V`&D`9`!E`&0`(`!B`'D`(``H
M`'4`<P!E`&0`(`!I`&X`*0`@`&8`:0!N`&$`;@!C`&D`;@!G`"``80!C`'0`
M:0!V`&D`=`!I`&4`<P`Z`"$``4X`90!T`"``<`!R`&\`8P!E`&4`9`!S`"``
M9@!R`&\`;0`@`',`:`!O`'(`=``@`'0`90!R`&T`(`!D`&4`8@!T`!L``5(`
M90!P`&$`>0!M`&4`;@!T`"``;P!F`"``;`!O`&X`9P`@`'0`90!R`&T`(`!D
M`&4`8@!T`!X``4$`8P!Q`'4`:0!S`&D`=`!I`&\`;@`@`&\`9@`@`'0`<@!E
M`&$`<P!U`'(`>0`@`',`:`!A`'(`90!S`"<``5``<@!O`&,`90!E`&0`<P`@
M`&8`<@!O`&T`(`!E`'@`90!R`&,`:0!S`&4`(`!O`&8`(`!S`'0`;P!C`&L`
M(`!O`'``=`!I`&\`;@!S`#(``50`80!X`"``8@!E`&X`90!F`&D`=`!S`"``
M9@!R`&\`;0`@`',`:`!A`'(`90`M`&(`80!S`&4`9``@`'``80!Y`&T`90!N
M`'0`(`!A`'(`<@!A`&X`9P!E`&T`90!N`'0`<P`B``%.`&4`=``@`&,`80!S
M`&@`(`!F`'(`;P!M`"``9@!I`&X`80!N`&,`:0!N`&<`(`!A`&,`=`!I`'8`
M:0!T`&D`90!S`#4``44`9@!F`&4`8P!T`"``;P!F`"``90!X`&,`:`!A`&X`
M9P!E`"``<@!A`'0`90!S`"``;P!N`"``8P!A`',`:``@`&$`;@!D`"``8P!A
M`',`:``@`&4`<0!U`&D`=@!A`&P`90!N`'0`<P`I``%.`&4`=``@`&D`;@!C
M`'(`90!A`',`90`@`&D`;@`@`&,`80!S`&@`(`!A`&X`9``@`&,`80!S`&@`
M(`!E`'$`=0!I`'8`80!L`&4`;@!T`',`+@`!0P!A`',`:``@`&$`;@!D`"``
M8P!A`',`:``@`&4`<0!U`&D`=@!A`&P`90!N`'0`<P`L`"``8@!E`&<`:0!N
M`&X`:0!N`&<`(`!O`&8`(`!P`&4`<@!I`&\`9``H``%#`&$`<P!H`"``80!N
M`&0`(`!C`&$`<P!H`"``90!Q`'4`:0!V`&$`;`!E`&X`=`!S`"P`(`!E`&X`
M9``@`&\`9@`@`'``90!R`&D`;P!D`"L``4,`;P!N`&0`90!N`',`90!D`"``
M0P!O`&X`<P!O`&P`:0!D`&$`=`!E`&0`(`!&`&D`;@!A`&X`8P!I`&$`;``@
M`%,`=`!A`'0`90!M`&4`;@!T`',`*``!3@!O`'0`90!S`"``=`!O`"``1@!I
M`&X`80!N`&,`:0!A`&P`(`!3`'0`80!T`&4`;0!E`&X`=`!S`"``6P!!`&(`
M<P!T`'(`80!C`'0`70!"!P$-``T`*``Q`"D`"0`-``T`0P!O`&X`9`!E`&X`
M<P!E`&0`(`!#`&\`;@!S`&\`;`!I`&0`80!T`&4`9``@`$8`:0!N`&$`;@!C
M`&D`80!L`"``4P!T`&$`=`!E`&T`90!N`'0`<P`-``T`*`!I`&X`(`!M`&D`
M;`!L`&D`;P!N`',`+``@`&4`>`!C`&4`<`!T`"``<`!E`'(`(`!S`&@`80!R
M`&4`(`!D`&$`=`!A`"D`#0`-``T`00!L`&,`;P!N`"P`(`!)`&X`8P`N`"``
M*``B`$$`;`!C`&\`;@`B`"D`+``@`&$`(`!3`'<`:0!S`',`(`!C`&\`<@!P
M`&\`<@!A`'0`:0!O`&X`+``@`&D`<P`@`&$`(`!M`&$`:@!O`'(`:0!T`'D`
M(`!O`'<`;@!E`&0`(`!S`'4`8@!S`&D`9`!I`&$`<@!Y`"``;P!F`"``3@!E
M`',`=`!L`"``4P`N`$$`+@!$`'4`<@!I`&X`9P`@`$H`=0!L`'D`(``R`#``
M,``X`"P`(`!.`&4`<P!T`&P`(`!S`&\`;`!D`"``80!P`'``<@!O`'@`:0!M
M`&$`=`!E`&P`>0`@`#<`-``@`&T`:0!L`&P`:0!O`&X`(`!O`&8`(`!I`'0`
M<P`@`$$`;`!C`&\`;@`@`&,`;P!M`&T`;P!N`"``<P!H`&$`<@!E`',`(`!T
M`&\`(`!.`&\`=@!A`'(`=`!I`',`(`!!`$<`+@!!`'0`(`!$`&4`8P!E`&T`
M8@!E`'(`(``S`#$`+``@`#(`,``P`#D`+``@`$X`90!S`'0`;``@`&\`=P!N
M`&4`9``@`#$`-0`V`"P`,``W`#8`+``R`#8`,P`@`&,`;P!M`&T`;P!N`"``
M<P!H`&$`<@!E`',`(`!O`&8`(`!!`&P`8P!O`&X`+@!)`&X`(`!*`&$`;@!U
M`&$`<@!Y`"``,@`P`#$`,``L`"``3@!O`'8`80!R`'0`:0!S`"``90!X`&4`
M<@!C`&D`<P!E`&0`(`!I`'0`<P`@`&,`80!L`&P`(`!O`'``=`!I`&\`;@`@
M`&8`;P!R`"``3@!E`',`=`!L`"<`<P`@`'(`90!M`&$`:0!N`&D`;@!G`"``
M00!L`&,`;P!N`"``8P!O`&T`;0!O`&X`(`!S`&@`80!R`&4`<P`@`&$`;@!D
M`"``<`!R`&\`<`!O`',`90!D`"``80`@`&T`90!R`&<`90!R`"``;P!F`"``
M00!L`&,`;P!N`"``=P!I`'0`:``@`&$`;@!D`"``:0!N`'0`;P`@`$X`;P!V
M`&$`<@!T`&D`<P`L`"``80!S`"``9`!I`',`8P!U`',`<P!E`&0`(`!I`&X`
M(`!N`&\`=`!E`"``,0`S`"X`#0`-``T`5`!H`&4`(`!I`&X`=`!E`'(`:0!M
M`"``8P!O`&X`9`!E`&X`<P!E`&0`(`!C`&\`;@!S`&\`;`!I`&0`80!T`&4`
M9``@`&8`:0!N`&$`;@!C`&D`80!L`"``<P!T`&$`=`!E`&T`90!N`'0`<P`@
M`&\`9@`@`$$`;`!C`&\`;@`@`&$`;@!D`"``:0!T`',`(`!S`'4`8@!S`&D`
M9`!I`&$`<@!I`&4`<P`@`"@`8P!O`&P`;`!E`&,`=`!I`'8`90!L`'D`+``@
M`'0`:`!E`"``(@!#`&\`/``<(`%M`'``80!N`'D`(@`I`"``80!R`&4`(`!U
M`&X`80!U`&0`:0!T`&4`9``N`$$`;0!O`'4`;@!T`',`(`!P`'(`90!S`&4`
M;@!T`&4`9``@`&$`=``@`$0`90!C`&4`;0!B`&4`<@`@`#,`,0`L`"``,@`P
M`#``.0`@`&$`<@!E`"``8@!A`',`90!D`"``;P!N`"``=`!H`&4`(`!A`'4`
M9`!I`'0`90!D`"``8P!O`&X`<P!O`&P`:0!D`&$`=`!E`&0`(`!F`&D`;@!A
M`&X`8P!I`&$`;``@`',`=`!A`'0`90!M`&4`;@!T`',`(`!A`'``<`!E`&$`
M<@!I`&X`9P`@`&D`;@`@`$$`;`!C`&\`;@`G`',`(`!A`&X`;@!U`&$`;``@
M`'(`90!P`&\`<@!T`"``;P!N`"``1@!O`'(`;0`@`#(`,``M`$8`(`!F`&D`
M;`!E`&0`(`!W`&D`=`!H`"``=`!H`&4`(`!5`"X`4P`N`"``4P!E`&,`=0!R
M`&D`=`!I`&4`<P`@`&$`;@!D`"``10!X`&,`:`!A`&X`9P!E`"``0P!O`&T`
M;0!I`',`<P!I`&\`;@`N`%0`:`!E`"``:0!N`'0`90!R`&D`;0`@`&,`;P!N
M`&0`90!N`',`90!D`"``8P!O`&X`<P!O`&P`:0!D`&$`=`!E`&0`(`!F`&D`
M;@!A`&X`8P!I`&$`;``@`',`=`!A`'0`90!M`&4`;@!T`',`(`!A`&X`9``@
M`&X`;P!T`&4`<P`@`'0`:`!E`'(`90!T`&\`(`!D`&\`(`!N`&\`=``@`&D`
M;@!C`&P`=0!D`&4`(`!A`&P`;``@`&0`:0!S`&,`;`!O`',`=0!R`&4`<P`@
M`'(`90!Q`'4`:0!R`&4`9``@`&(`>0`@`&$`8P!C`&\`=0!N`'0`:0!N`&<`
M(`!P`'(`:0!N`&,`:0!P`&P`90!S`"``9P!E`&X`90!R`&$`;`!L`'D`(`!A
M`&,`8P!E`'``=`!E`&0`(`!I`&X`(`!T`&@`90`@`%4`;@!I`'0`90!D`"``
M4P!T`&$`=`!E`',`(`!O`&8`(`!!`&T`90!R`&D`8P!A`"``*``B`%4`+@!3
M`"X`(`!'`$$`00!0`"(`*0`@`&$`;@!D`"``<P!H`&\`=0!L`&0`(`!B`&4`
M(`!R`&4`80!D`"``:0!N`"``8P!O`&X`:@!U`&X`8P!T`&D`;P!N`"``=P!I
M`'0`:``@`'0`:`!E`"``80!U`&0`:0!T`&4`9``@`&,`;P!N`',`;P!L`&D`
M9`!A`'0`90!D`"``9@!I`&X`80!N`&,`:0!A`&P`(`!S`'0`80!T`&4`;0!E
M`&X`=`!S`"``80!N`&0`(`!T`&@`90`@`&X`;P!T`&4`<P`@`'0`:`!E`'(`
M90!T`&\`(`!I`&X`8P!L`'4`9`!E`&0`(`!I`&X`(`!!`&P`8P!O`&X`)P!S
M`"``80!N`&X`=0!A`&P`(`!R`&4`<`!O`'(`=``@`&\`;@`@`$8`;P!R`&T`
M(``R`#``+0!&`"X`#0`-``T`30!A`&X`80!G`&4`;0!E`&X`=``@`&\`9@`@
M`'0`:`!E`"``0P!O`&T`<`!A`&X`>0`@`&@`80!S`"``;0!A`&0`90`@`&$`
M(`!N`'4`;0!B`&4`<@`@`&\`9@`@`&4`<P!T`&D`;0!A`'0`90!S`"``80!N
M`&0`(`!A`',`<P!U`&T`<`!T`&D`;P!N`',`(`!R`&4`;`!A`'0`:0!N`&<`
M(`!T`&\`(`!T`&@`90`@`'(`90!P`&\`<@!T`&D`;@!G`"``;P!F`"``80!S
M`',`90!T`',`(`!A`&X`9``@`&P`:0!A`&(`:0!L`&D`=`!I`&4`<P`@`&$`
M;@!D`"``=`!H`&4`(`!D`&D`<P!C`&P`;P!S`'4`<@!E`"``;P!F`"``8P!O
M`&X`=`!I`&X`9P!E`&X`=``@`&$`<P!S`&4`=`!S`"``80!N`&0`(`!L`&D`
M80!B`&D`;`!I`'0`:0!E`',`(`!T`&\`(`!P`'(`90!P`&$`<@!E`"``=`!H
M`&4`<P!E`"``9@!I`&X`80!N`&,`:0!A`&P`(`!S`'0`80!T`&4`;0!E`&X`
M=`!S`"``:0!N`"``8P!O`&X`9@!O`'(`;0!I`'0`>0`@`'<`:0!T`&@`(`!5
M`"X`4P`N`"``1P!!`$$`4``N`$$`8P!T`'4`80!L`"``<@!E`',`=0!L`'0`
M<P`@`&,`;P!U`&P`9``@`&0`:0!F`&8`90!R`"``9@!R`&\`;0`@`'0`:`!O
M`',`90`@`&4`<P!T`&D`;0!A`'0`90!S`"X`#0`-``T`20!N`"``;0!A`&X`
M80!G`&4`;0!E`&X`=``G`',`(`!O`'``:0!N`&D`;P!N`"P`(`!T`&@`90`@
M`&D`;@!T`&4`<@!I`&T`(`!C`&\`;@!D`&4`;@!S`&4`9``@`&,`;P!N`',`
M;P!L`&D`9`!A`'0`90!D`"``9@!I`&X`80!N`&,`:0!A`&P`(`!S`'0`80!T
M`&4`;0!E`&X`=`!S`"``<@!E`&8`;`!E`&,`=``@`&$`;`!L`"``80!D`&H`
M=0!S`'0`;0!E`&X`=`!S`"``*`!C`&\`;@!S`&D`<P!T`&D`;@!G`"``;P!N
M`&P`>0`@`&\`9@`@`&X`;P!R`&T`80!L`"``<@!E`&,`=0!R`'(`:0!N`&<`
M(`!A`&,`8P!R`'4`80!L`',`*0`@`&X`90!C`&4`<P!S`&$`<@!Y`"``=`!O
M`"``<`!R`&4`<P!E`&X`=``@`&8`80!I`'(`;`!Y`"``=`!H`&4`(`!R`&4`
M<P!U`&P`=`!S`"``9@!O`'(`(`!T`&@`90`@`&D`;@!T`&4`<@!I`&T`(`!P
M`&4`<@!I`&\`9`!S`"``<`!R`&4`<P!E`&X`=`!E`&0`+@!2`&4`<P!U`&P`
M=`!S`"``9@!O`'(`(`!I`&X`=`!E`'(`:0!M`"``<`!E`'(`:0!O`&0`<P`@
M`&$`<@!E`"``;@!O`'0`(`!N`&4`8P!E`',`<P!A`'(`:0!L`'D`(`!I`&X`
M9`!I`&,`80!T`&D`=@!E`"``;P!F`"``<@!E`',`=0!L`'0`<P`@`'0`:`!A
M`'0`(`!U`&P`=`!I`&T`80!T`&4`;`!Y`"``=P!I`&P`;``@`&(`90`@`&$`
M8P!H`&D`90!V`&4`9``@`&8`;P!R`"``80`@`&8`=0!L`&P`(`!Y`&4`80!R
M`"X`$@`!10!A`'(`;@!I`&X`9P!S`"``4`!E`'(`(`!3`&@`80!R`&4`'@D!
M#0`-`"@`,@`I``D`#0`-`$4`80!R`&X`:0!N`&<`<P`@`%``90!R`"``4P!H
M`&$`<@!E``T`#0`H`&D`;@`@`&T`:0!L`&P`:0!O`&X`<P`L`"``90!X`&,`
M90!P`'0`(`!P`&4`<@`@`',`:`!A`'(`90`@`&0`80!T`&$`*0`-``T`0@!A
M`',`:0!C`"``90!A`'(`;@!I`&X`9P!S`"``<`!E`'(`(`!C`&\`;0!M`&\`
M;@`@`',`:`!A`'(`90`@`'<`90!R`&4`(`!C`&\`;0!P`'4`=`!E`&0`(`!B
M`'D`(`!D`&D`=@!I`&0`:0!N`&<`(`!N`&4`=``@`&4`80!R`&X`:0!N`&<`
M<P`@`&(`>0`@`'0`:`!E`"``=P!E`&D`9P!H`'0`90!D`"``80!V`&4`<@!A
M`&<`90`@`&X`=0!M`&(`90!R`"``;P!F`"``8P!O`&T`;0!O`&X`(`!S`&@`
M80!R`&4`<P`@`&\`=0!T`',`=`!A`&X`9`!I`&X`9P`@`&8`;P!R`"``=`!H
M`&4`(`!R`&4`;`!E`'8`80!N`'0`(`!P`&4`<@!I`&\`9``N`%0`:`!E`"``
M=0!N`'8`90!S`'0`90!D`"``<`!O`'(`=`!I`&\`;@`@`&\`9@`@`'(`90!S
M`'0`<@!I`&,`=`!E`&0`(`!C`&\`;0!M`&\`;@`@`',`:`!A`'(`90!S`"``
M=P!A`',`(`!E`'@`8P!L`'4`9`!E`&0`(`!I`&X`(`!T`&@`90`@`&,`80!L
M`&,`=0!L`&$`=`!I`&\`;@`@`&\`9@`@`&(`80!S`&D`8P`@`'<`90!I`&<`
M:`!T`&4`9``@`&$`=@!E`'(`80!G`&4`(`!C`&\`;0!M`&\`;@`@`',`:`!A
M`'(`90!S`"``;P!U`'0`<P!T`&$`;@!D`&D`;@!G`"X`1`!I`&P`=0!T`&4`
M9``@`'<`90!I`&<`:`!T`&4`9``@`&$`=@!E`'(`80!G`&4`(`!C`&\`;0!M
M`&\`;@`@`',`:`!A`'(`90!S`"``<@!E`&8`;`!E`&,`=``@`'0`:`!E`"``
M<`!O`'0`90!N`'0`:0!A`&P`(`!D`&D`;`!U`'0`:0!O`&X`+``@`'4`<P!I
M`&X`9P`@`'0`:`!E`"``=`!R`&4`80!S`'4`<@!Y`"``<P!T`&\`8P!K`"``
M;0!E`'0`:`!O`&0`+``@`'0`:`!A`'0`(`!C`&\`=0!L`&0`(`!O`&,`8P!U
M`'(`(`!I`&8`(`!E`&T`<`!L`&\`>0!E`&4`(`!S`'0`;P!C`&L`(`!O`'``
M=`!I`&\`;@!S`"``9@!O`'(`(`!T`&@`90`@`'``=0!R`&,`:`!A`',`90`@
M`&\`9@`@`&,`;P!M`&T`;P!N`"``<P!H`&$`<@!E`',`(`!A`&X`9``@`',`
M:`!A`'(`90`M`',`90!T`'0`;`!E`&0`(`!S`'0`;P!C`&L`(`!A`'``<`!R
M`&4`8P!I`&$`=`!I`&\`;@`@`'(`:0!G`&@`=`!S`"``=P!E`'(`90`@`&4`
M>`!E`'(`8P!I`',`90!D`"``80!N`&0`(`!I`&8`(`!S`&@`80!R`&4`+0!S
M`&4`=`!T`&P`90!D`"``<@!E`',`=`!R`&D`8P!T`&4`9``@`',`:`!A`'(`
M90`@`'4`;@!I`'0`<P`L`"``<`!E`'(`9@!O`'(`;0!A`&X`8P!E`"``<P!H
M`&$`<@!E`"``=0!N`&D`=`!S`"``80!N`&0`(`!C`&\`;@!T`&D`;@!G`&4`
M;@!T`"``<@!E`',`=`!R`&D`8P!T`&4`9``@`&,`;P!M`&T`;P!N`"``<P!H
M`&$`<@!E`',`(`!G`'(`80!N`'0`90!D`"``=`!O`"``90!M`'``;`!O`'D`
M90!E`',`(`!W`&4`<@!E`"``=@!E`',`=`!E`&0`+@`-``T`#0!4`&@`90`@
M`&8`;P!L`&P`;P!W`&D`;@!G`"``=`!A`&(`;`!E`"``<@!E`&,`;P!N`&,`
M:0!L`&4`<P`@`'0`:`!E`"``=P!E`&D`9P!H`'0`90!D`"``80!V`&4`<@!A
M`&<`90`@`',`:`!A`'(`90!S`"``;P!F`"``=`!H`&4`(`!B`&$`<P!I`&,`
M(`!A`&X`9``@`&0`:0!L`'4`=`!E`&0`(`!S`&@`80!R`&4`(`!C`&\`;0!P
M`'4`=`!A`'0`:0!O`&X`<P`Z``T`#0`)`"``"0`-``T`5`!H`'(`90!E`"``
M;0!O`&X`=`!H`',`(`!E`&X`9`!E`&0`(`!-`&$`<@!C`&@`(``S`#$`+``)
M``D`(``)``T`#0`)`"``"0`-``T`,@`P`#$`,``)``D`(``)``T`#0`R`#``
M,``Y``D`"0`@``D`#0`-``D`(``)``D`(``)``D`(``)``D`(``)``T`#0`-
M`$(`80!S`&D`8P`@`'<`90!I`&<`:`!T`&4`9``@`&$`=@!E`'(`80!G`&4`
M(`!C`&\`;0!M`&\`;@`@`',`:`!A`'(`90!S`"``;P!U`'0`<P!T`&$`;@!D
M`&D`;@!G``D`"0`-``T`,@`Y`#D`+``Y`#@`,``L`#@`-P`Q``D`"0`@``D`
M#0`-`#(`.0`X`"P`-0`X`#$`+``V`#@`.0`)``D`(``)``T`#0`-`$4`9@!F
M`&4`8P!T`"``;P!F`"``9`!I`&P`=0!T`&D`=@!E`"``<P!E`&,`=0!R`&D`
M=`!I`&4`<P`Z``D`"0`@``D`"0`@``D`"0`@``D`"0`-``T`#0!%`&T`<`!L
M`&\`>0!E`&4`(`!S`'0`;P!C`&L`(`!O`'``=`!I`&\`;@!S``D`"0`-``T`
M,@`L`#``.``W`"P`,@`S`#4`"0`)`"``"0`-``T`,0`L`#(`-@`Q`"P`-``P
M`#D`"0`)`"``"0`-``T`#0!3`&@`80!R`&4`+0!S`&4`=`!T`&P`90!D`"``
M<P!T`&\`8P!K`"``80!P`'``<@!E`&,`:0!A`'0`:0!O`&X`(`!R`&D`9P!H
M`'0`<P`)``D`#0`-`#$`+``Q`#(`-@`L`#$`,0`Y``D`"0`@``D`#0`-`"T`
M+0`)``D`(``)``T`#0`-`%,`:`!A`'(`90`M`',`90!T`'0`;`!E`&0`(`!R
M`&4`<P!T`'(`:0!C`'0`90!D`"``<P!H`&$`<@!E`"``=0!N`&D`=`!S`"``
M80!N`&0`(`!P`&4`<@!F`&\`<@!M`&$`;@!C`&4`(`!S`&@`80!R`&4`(`!U
M`&X`:0!T`',`"0`)``T`#0`S`#,`-``L`#(`-P`R``D`"0`@``D`#0`-`#0`
M-0`L`#,`-``Y``D`"0`@``D`#0`-``T`0P!O`&X`=`!I`&X`9P!E`&X`=``@
M`'(`90!S`'0`<@!I`&,`=`!E`&0`(`!C`&\`;0!M`&\`;@`@`',`:`!A`'(`
M90!S``D`"0`-``T`-``Q`"P`-0`P`#$`"0`)`"``"0`-``T`,0`R`#8`+``V
M`#@`.``)``D`(``)``T`#0`)`"``"0`)`"``"0`)`"``"0`)`"``"0`-``T`
M#0!$`&D`;`!U`'0`90!D`"``=P!E`&D`9P!H`'0`90!D`"``80!V`&4`<@!A
M`&<`90`@`&,`;P!M`&T`;P!N`"``<P!H`&$`<@!E`',`(`!O`'4`=`!S`'0`
M80!N`&0`:0!N`&<`"0`)``T`#0`S`#``,P`L`#4`-@`Y`"P`.0`Y`#@`"0`)
M`"``"0`-``T`,P`P`#``+``P`#$`-0`L`#$`,P`U``D`"0`@``D`#0`-``D`
M(``)``D`(``)``D`(``)``D`(``)``T`#0`-`$,`90!R`'0`80!I`&X`(`!E
M`'@`90!C`'4`=`!I`'8`90!S`"``;P!F`"``=`!H`&4`(`!#`&\`;0!P`&$`
M;@!Y`"``:`!A`&0`(`!D`&4`9@!E`'(`<@!E`&0`(`!T`&@`90`@`'(`90!C
M`&4`:0!P`'0`(`!O`&8`(``Q`#$`.0`L`#$`.``X`"``80!N`&0`(``Q`#0`
M,0`L`#D`-0`T`"``00!L`&,`;P!N`"``8P!O`&T`;0!O`&X`(`!S`&@`80!R
M`&4`<P`@`&$`=``@`$T`80!R`&,`:``@`#,`,0`L`"``,@`P`#$`,``@`&$`
M;@!D`"``,@`P`#``.0`L`"``<@!E`',`<`!E`&,`=`!I`'8`90!L`'D`+``@
M`&D`;@!T`&\`(`!T`&@`90`@`$$`;`!C`&\`;@`@`$4`>`!E`&,`=0!T`&D`
M=@!E`"``1`!E`&8`90!R`'(`90!D`"``0P!O`&T`<`!E`&X`<P!A`'0`:0!O
M`&X`(`!0`&P`80!N`"X`00!L`&,`;P!N`"``8P!O`&T`;0!O`&X`(`!S`&@`
M80!R`&4`<P`@`&@`90!L`&0`(`!I`&X`(`!T`&@`90`@`'``;`!A`&X`(`!W
M`&4`<@!E`"``<@!E`&8`;`!E`&,`=`!E`&0`(`!A`',`(`!O`'4`=`!S`'0`
M80!N`&0`:0!N`&<`(`!I`&X`(`!T`&@`90`@`&,`;P!N`&0`90!N`',`90!D
M`"``8P!O`&X`<P!O`&P`:0!D`&$`=`!E`&0`(`!B`&$`;`!A`&X`8P!E`"``
M<P!H`&4`90!T`',`(`!A`&X`9``@`'<`90!R`&4`(`!I`&X`8P!L`'4`9`!E
M`&0`(`!I`&X`(`!T`&@`90`@`&$`<`!P`&P`:0!C`&$`8@!L`&4`(`!B`&$`
M<P!I`&,`(`!A`&X`9``@`&0`:0!L`'4`=`!E`&0`(`!E`&$`<@!N`&D`;@!G
M`',`(`!P`&4`<@`@`',`:`!A`'(`90`@`&,`80!L`&,`=0!L`&$`=`!I`&\`
M;@!S`"X`#0`-``T`5`!H`&4`(`!C`&\`;0!P`'4`=`!A`'0`:0!O`&X`<P`@
M`&\`9@`@`&0`:0!L`'4`=`!E`&0`(`!W`&4`:0!G`&@`=`!E`&0`(`!A`'8`
M90!R`&$`9P!E`"``8P!O`&T`;0!O`&X`(`!S`&@`80!R`&4`<P`@`&\`=0!T
M`',`=`!A`&X`9`!I`&X`9P`@`&8`;P!R`"``=`!H`&4`(`!P`&4`<@!I`&\`
M9`!S`"``90!N`&0`90!D`"``30!A`'(`8P!H`"``,P`Q`"P`(``R`#``,0`P
M`"``80!N`&0`(``R`#``,``Y`"``9`!I`&0`(`!N`&\`=``@`&D`;@!C`&P`
M=0!D`&4`(`!T`&@`90`@`&8`;P!L`&P`;P!W`&D`;@!G`"``:0!N`',`=`!R
M`'4`;0!E`&X`=`!S`"P`(`!A`',`(`!T`&@`90!I`'(`(`!E`'@`90!R`&,`
M:0!S`&4`(`!P`'(`:0!C`&4`<P`@`&$`;@!D`"``=0!N`'(`90!C`&\`9P!N
M`&D`>@!E`&0`(`!C`&\`<P!T`',`(`!W`&4`<@!E`"``9P!R`&4`80!T`&4`
M<@`@`'0`:`!A`&X`(`!T`&@`90`@`&$`=@!E`'(`80!G`&4`(`!M`&$`<@!K
M`&4`=``@`'``<@!I`&,`90`@`&\`9@`@`'0`:`!E`"``8P!O`&T`;0!O`&X`
M(`!S`&@`80!R`&4`<P`Z``T`#0`-``T`"0`@``D`#0`-`#(`,``Q`#``"0`)
M`"``"0`-``T`,@`P`#``.0`)``T`#0`)`"``"0`)`"``"0`)`"``"0`-``T`
M#0!3`'0`;P!C`&L`(`!O`'``=`!I`&\`;@!S``D`"0`-``T`+0`M``D`"0`@
M``D`#0`-`#<`,@`X`"P`,P`Y`#(`"0`-``T`#0!3`&@`80!R`&4`+0!S`&4`
M=`!T`&P`90!D`"``<P!T`&\`8P!K`"``80!P`'``<@!E`&,`:0!A`'0`:0!O
M`&X`(`!R`&D`9P!H`'0`<P`)``D`#0`-`#$`+``S`#4`,``)``D`(``)``T`
M#0`U`"P`-0`Q`#0`+``T`#<`,0`)``T`#0`)`"``"0`)`"``"0`)`"``"0`-
M``T`5`!H`&4`(`!E`&8`9@!E`&,`=``@`&\`9@`@`'0`:`!E`&D`<@`@`&D`
M;@!C`&P`=0!S`&D`;P!N`"``=P!O`'4`;`!D`"``:`!A`'8`90`@`&(`90!E
M`&X`(`!A`&X`=`!I`"T`9`!I`&P`=0!T`&D`=@!E`"X`(@`!0P!A`',`:``@
M`$8`;`!O`'<`<P`M`%,`=0!P`'``;`!E`&T`90!N`'0`80!L`"``1`!I`',`
M8P!L`&\`<P!U`'(`90`C``%#`&$`<P!H`"``1@!L`&\`=P!S`"T`4P!U`'``
M<`!L`&4`;0!E`&X`=`!A`&P`(`!$`&D`<P!C`&P`;P!S`'4`<@!E`',`1P$!
M#0`-`"@`,P`I``D`#0`-`$,`80!S`&@`(`!&`&P`;P!W`',`(``@`%,`=0!P
M`'``;`!E`&T`90!N`'0`80!L`"``1`!I`',`8P!L`&\`<P!U`'(`90`-``T`
M*`!I`&X`(`!M`&D`;`!L`&D`;P!N`',`+``@`&4`>`!C`&4`<`!T`"``<`!E
M`'(`(`!S`&@`80!R`&4`(`!D`&$`=`!A`"D`#0`-`%0`:`!R`&4`90`@`&T`
M;P!N`'0`:`!S`"``90!N`&0`90!D`"``30!A`'(`8P!H`"``,P`Q`"P`"0`-
M``T`#0`R`#``,0`P``D`"0`)``T`#0`R`#``,``Y``D`#0`-``T`4P!U`'``
M<`!L`&4`;0!E`&X`=`!A`&P`(`!$`&D`<P!C`&P`;P!S`'4`<@!E`"``;P!F
M`"``0P!A`',`:``@`$8`;`!O`'<`(`!)`&X`9@!O`'(`;0!A`'0`:0!O`&X`
M"0`)``D`"0`)``T`#0`-`$,`80!S`&@`(`!P`&$`:0!D`"``9`!U`'(`:0!N
M`&<`(`!T`&@`90`@`'``90!R`&D`;P!D`"``9@!O`'(`(`!T`&@`90`@`&8`
M;P!L`&P`;P!W`&D`;@!G`#H`"0`)``D`"0`)``T`#0!)`&X`=`!E`'(`90!S
M`'0`(`!E`'@`<`!E`&X`<P!E`"P`(`!N`&4`=``@`&\`9@`@`&$`;0!O`'4`
M;@!T`"``8P!A`'``:0!T`&$`;`!I`'H`90!D``D`"0`D``D`,P`)``D`"0`D
M``D`-0`)``T`#0!)`&X`8P!O`&T`90`@`'0`80!X`&4`<P`)``D`)``)`#(`
M,P`)``D`"0`D``D`-@`R``D`#0`-``D`)@`!4P!U`'``<`!L`&4`;0!E`&X`
M=`!A`&P`(`!"`&$`;`!A`&X`8P!E`"``4P!H`&4`90!T`"``20!N`&8`;P!R
M`&T`80!T`&D`;P!N`((#`0T`#0`H`#0`*0`)``T`#0!3`'4`<`!P`&P`90!M
M`&4`;@!T`&$`;``@`$(`80!L`&$`;@!C`&4`(`!3`&@`90!E`'0`(`!)`&X`
M9@!O`'(`;0!A`'0`:0!O`&X`#0`-`"@`:0!N`"``;0!I`&P`;`!I`&\`;@!S
M`"P`(`!E`'@`8P!E`'``=``@`'``90!R`"``<P!H`&$`<@!E`"``9`!A`'0`
M80`I`#P`&R`!#0`-`$T`80!R`&,`:``@`#,`,0`L``D`"0`)``T`#0!$`&4`
M8P!E`&T`8@!E`'(`(``S`#$`+``)``T`#0`-`#(`,``Q`#``"0`)``D`#0`-
M`#(`,``P`#D`"0`-``T`#0!)`&X`=@!E`&X`=`!O`'(`:0!E`',`+``@`&$`
M=``@`$P`;P!W`&4`<@`@`&\`9@`@`$,`;P!S`'0`(`!O`'(`(`!-`&$`<@!K
M`&4`=``)``D`"0`)``D`#0`-``T`1@!I`&X`:0!S`&@`90!D`"``<`!R`&\`
M9`!U`&,`=`!S``D`"0`D``D`,P`W`#8`"0`)``D`)``)`#,`-P`U``D`#0`-
M``T`5P!O`'(`:P`@`&D`;@`@`'``<@!O`&,`90!S`',`"0`)``D`-0`Q``D`
M"0`)``D`-0`P``D`#0`-``T`4@!A`'<`(`!M`&$`=`!E`'(`:0!A`&P`<P`)
M``D`"0`Q`#@`-0`)``D`"0`)`#(`,``Q``D`#0`-`%0`;P!T`&$`;``)``D`
M)``)`#8`,0`R``D`"0`)`"0`"0`V`#(`-@`)``T`#0!-`&$`<@!C`&@`(``S
M`#$`+``)``D`"0`-``T`1`!E`&,`90!M`&(`90!R`"``,P`Q`"P`"0`-``T`
M#0`R`#``,0`P``D`"0`)``T`#0`R`#``,``Y``D`#0`-``T`4`!R`&\`<`!E
M`'(`=`!Y`"P`(`!0`&P`80!N`'0`(`!A`&X`9``@`$4`<0!U`&D`<`!M`&4`
M;@!T`"P`(`!.`&4`=``)``D`"0`)``D`#0`-``T`4`!R`&\`<`!E`'(`=`!Y
M`"P`(`!P`&P`80!N`'0`(`!A`&X`9``@`&4`<0!U`&D`<`!M`&4`;@!T`"P`
M(`!A`'0`(`!C`&\`<P!T``D`"0`D``D`,@`L`#8`-``W``D`"0`)`"0`"0`R
M`"P`-@`U`#``"0`-``T`#0!!`&,`8P!U`&T`=0!L`&$`=`!E`&0`(`!D`&4`
M<`!R`&4`8P!I`&$`=`!I`&\`;@`)``D`"0`H`#$`+``S`#4`-@`@``D`*0`)
M``D`"0`H`#$`+``S`#0`-@`@``D`*0`-``T`5`!O`'0`80!L``D`"0`D``D`
M,0`L`#(`.0`Q``D`"0`)`"0`"0`Q`"P`,P`P`#0`"0`-``T`30!A`'(`8P!H
M`"``,P`Q`"P`"0`)``D`#0`-`$0`90!C`&4`;0!B`&4`<@`@`#,`,0`L``D`
M#0`-``T`,@`P`#$`,``)``D`"0`-``T`,@`P`#``.0`)``T`#0`-`$$`8P!C
M`'4`;0!U`&P`80!T`&4`9``@`$\`=`!H`&4`<@`@`$,`;P!M`'``<@!E`&@`
M90!N`',`:0!V`&4`(`!)`&X`8P!O`&T`90`@`"@`3`!O`',`<P`I``D`"0`)
M``D`"0`-``T`#0!&`&\`<@!E`&D`9P!N`"``8P!U`'(`<@!E`&X`8P!Y`"``
M=`!R`&$`;@!S`&P`80!T`&D`;P!N`"``80!D`&H`=0!S`'0`;0!E`&X`=``)
M``D`)``)`#$`.0`W``D`"0`)`"0`"0`R`#8`-0`)``T`#0`-`%4`;@!R`&4`
M80!L`&D`>@!E`&0`(`!G`&$`:0!N`',`(``H`&P`;P!S`',`90!S`"D`(`!O
M`&X`(`!I`&X`=@!E`',`=`!M`&4`;@!T`',`+``@`&X`90!T`"``;P!F`"``
M:0!N`&,`;P!M`&4`(`!T`&$`>`!E`',`"0`)``D`,0`V``D`"0`)``D`,P`P
M``D`#0`-``T`50!N`'(`90!C`&\`9P!N`&D`>@!E`&0`(`!P`&\`<P!T`'(`
M90!T`&D`<@!E`&T`90!N`'0`(`!B`&4`;@!E`&8`:0!T`',`(`!L`&\`<P!S
M`&4`<P`@`&$`;@!D`"``<`!R`&D`;P!R`"``<P!E`'(`=@!I`&,`90`@`&,`
M;P!S`'0`<P`L``D`"0`)``D`"0`-``T`#0!N`&4`=``@`&\`9@`@`'0`80!X
M`"``8@!E`&X`90!F`&D`=`!S``D`"0`)`"@`.0`P`"``"0`I``D`"0`)`"@`
M.0`R`"``"0`I``T`#0!4`&\`=`!A`&P`"0`)`"0`"0`Q`#(`,P`)``D`"0`D
M``D`,@`P`#,`"0`-``T`"0`+``%)`&X`=@!E`',`=`!M`&4`;@!T`',`@`P!
M#0`-`"@`-0`I``D`#0`-`$D`;@!V`&4`<P!T`&T`90!N`'0`<P`-``T`*`!I
M`&X`(`!M`&D`;`!L`&D`;P!N`',`+``@`&4`>`!C`&4`<`!T`"``<`!E`'(`
M(`!S`&@`80!R`&4`(`!D`&$`=`!A`"D`#0`-``T`00!T`"``30!A`'(`8P!H
M`"``,P`Q`"P`(``R`#``,0`P`"``80!N`&0`(`!$`&4`8P!E`&T`8@!E`'(`
M(``S`#$`+``@`#(`,``P`#D`+``@`&D`;@!V`&4`<P!T`&T`90!N`'0`<P`@
M`'<`90!R`&4`.@`-``T`#0`-`$T`80!R`&,`:``@`#,`,0`)``D`"0`-``T`
M1`!E`&,`90!M`&(`90!R`"``,P`Q`"P`"0`-``T`"0`R`#``,0`P``D`"0`)
M`#(`,``P`#D`"0`-``T`#0!3`&@`;P!R`'0`(`!T`&4`<@!M`"``:0!N`'8`
M90!S`'0`;0!E`&X`=`!S`#H`"0`)``D`"0`)``T`#0`-`%0`<@!A`&0`:0!N
M`&<`(`!S`&4`8P!U`'(`:0!T`&D`90!S``D`"0`D``D`.``)``D`"0`D``D`
M,@`R``D`#0`-``T`00!V`&$`:0!L`&$`8@!L`&4`+0!F`&\`<@`M`',`80!L
M`&4`(`!I`&X`=@!E`',`=`!M`&4`;@!T`',`"0`)``D`-0`S`#0`"0`)``D`
M"0`T`#4`-P`)``T`#0!4`&\`=`!A`&P`(`!S`&@`;P!R`'0`(`!T`&4`<@!M
M`"``:0!N`'8`90!S`'0`;0!E`&X`=`!S``D`"0`D``D`-0`T`#(`"0`)``D`
M)``)`#0`-P`Y``D`#0`-`$P`;P!N`&<`(`!T`&4`<@!M`"``:0!N`'8`90!S
M`'0`;0!E`&X`=`!S`&$`=@!A`&D`;`!A`&(`;`!E`"T`9@!O`'(`+0!S`&$`
M;`!E`"``:0!N`'8`90!S`'0`;0!E`&X`=`!S``D`"0`D``D`-@`T``D`"0`)
M`"0`"0`W`#,`"0`-``T`#0`-`$$`=``@`$T`80!R`&,`:``@`#,`,0`L`"``
M,@`P`#$`,``@`&$`;@!D`"``1`!E`&,`90!M`&(`90!R`"``,P`Q`"P`(``R
M`#``,``Y`"P`(`!T`'(`80!D`&D`;@!G`"``<P!E`&,`=0!R`&D`=`!I`&4`
M<P`@`'<`90!R`&4`.@`-``T`30!A`'(`8P!H`"``,P`Q`"P`(``R`#``,0`P
M``D`"0`)``T`#0!$`&4`8P!E`&T`8@!E`'(`(``S`#$`+``@`#(`,``P`#D`
M"0`-``T`#0!.`&4`=``)``D`"0`-``T`10!S`'0`:0!M`&$`=`!E`&0`"0`)
M``D`#0`-`$X`90!T``D`"0`)``T`#0!%`',`=`!I`&T`80!T`&4`9``)``T`
M#0`-`%4`;@!R`&4`80!L`&D`>@!E`&0`"0`)``D`#0`-`$8`80!I`'(`"0`)
M``D`#0`-`%4`;@!R`&4`80!L`&D`>@!E`&0`"0`)``D`#0`-`$8`80!I`'(`
M"0`-``T`#0!'`&$`:0!N`',`(``H`$P`;P!S`',`90!S`"D`"0`)``D`#0`-
M`%8`80!L`'4`90`)``D`"0`-``T`1P!A`&D`;@!S`"``*`!,`&\`<P!S`&4`
M<P`I``D`"0`)``T`#0!6`&$`;`!U`&4`"0`-``T`5`!O`'0`80!L`"``=`!R
M`&$`9`!I`&X`9P`@`',`90!C`'4`<@!I`'0`:0!E`',`"0`)`"0`"0`H`#4`
M"0`I``D`"0`D``D`.``)``D`"0`D``D`*``Y``D`*0`)``D`)``)`#(`,@`)
M``T`#0!!`'0`(`!-`&$`<@!C`&@`(``S`#$`+``@`#(`,``Q`#``+``@`&$`
M=@!A`&D`;`!A`&(`;`!E`"T`9@!O`'(`+0!S`&$`;`!E`"``:0!N`'8`90!S
M`'0`;0!E`&X`=`!S`"``=P!E`'(`90`Z``T`#0!'`'(`;P!S`',`"0`)``D`
M#0`-`$<`<@!O`',`<P`)``D`"0`-``T`10!S`'0`:0!M`&$`=`!E`&0`"0`-
M``T`#0!!`&T`;P!R`'0`:0!Z`&4`9``)``D`"0`-``T`50!N`'(`90!A`&P`
M:0!Z`&4`9``)``D`"0`-``T`50!N`'(`90!A`&P`:0!Z`&4`9``)``D`"0`-
M``T`1@!A`&D`<@`)``T`#0`-`$,`;P!S`'0`"0`)``D`#0`-`$<`80!I`&X`
M<P`)``D`"0`-``T`3`!O`',`<P!E`',`"0`)``D`#0`-`%8`80!L`'4`90`)
M``T`#0`-`%,`:`!O`'(`=``@`'0`90!R`&T`(`!I`&X`=@!E`',`=`!M`&4`
M;@!T`',`.@`)``D`"0`)``D`#0`-``T`50`N`%,`+@`@`&<`;P!V`&4`<@!N
M`&T`90!N`'0`(`!A`&X`9``@`&$`9P!E`&X`8P!Y`"``<P!E`&,`=0!R`&D`
M=`!I`&4`<P`)``D`)``)`#$`,@`X``D`"0`)`"0`"0`M`"T`"0`)``D`)``)
M`"T`+0`)``D`"0`D``D`,0`R`#@`"0`-``T`#0!-`&\`<@!T`&<`80!G`&4`
M+0!B`&$`8P!K`&4`9``@`',`90!C`'4`<@!I`'0`:0!E`',`"0`)``D`,0`R
M``D`"0`)``D`+0`M``D`"0`)``D`+0`M``D`"0`)``D`,0`R``D`#0`-``T`
M4P!E`&X`:0!O`'(`(`!S`&4`8P!U`'(`90!D`"``8@!A`&X`:P`@`&P`;P!A
M`&X`<P`@`&8`=0!N`&0`"0`)``D`.``P``D`"0`)``D`,0`W``D`"0`)``D`
M+0`M``D`"0`)``D`.0`W``D`#0`-``T`0P!O`'(`<`!O`'(`80!T`&4`(`!D
M`&4`8@!T`"``<P!E`&,`=0!R`&D`=`!I`&4`<P`)``D`"0`R`#8`-@`)``D`
M"0`)`"T`+0`)``D`"0`)`"@`,0`@``D`*0`)``D`"0`R`#8`-0`)``T`#0`-
M`$4`<0!U`&D`=`!Y`"``<P!E`&,`=0!R`&D`=`!I`&4`<P`)``D`"0`S`#``
M"0`)``D`"0`Q``D`"0`)``D`+0`M``D`"0`)``D`,P`Q``D`#0`-``T`3P!T
M`&@`90!R`"``:0!N`'8`90!S`'0`;0!E`&X`=`!S``D`"0`)`#$`"0`)``D`
M"0`M`"T`"0`)``D`"0`M`"T`"0`)``D`"0`Q``D`#0`-`%0`;P!T`&$`;``@
M`',`:`!O`'(`=``@`'0`90!R`&T`(`!I`&X`=@!E`',`=`!M`&4`;@!T`',`
M"0`)``D`-0`Q`#<`"0`)``D`"0`Q`#@`"0`)``D`"0`H`#$`(``)`"D`"0`)
M``D`-0`S`#0`"0`-``T`3`!O`&X`9P`@`'0`90!R`&T`(`!I`&X`=@!E`',`
M=`!M`&4`;@!T`',`.@`)``D`"0`)``D`"0`-``T`#0!5`"X`4P`N`"``9P!O
M`'8`90!R`&X`;0!E`&X`=``@`&$`;@!D`"``80!G`&4`;@!C`'D`(`!S`&4`
M8P!U`'(`:0!T`&D`90!S``D`"0`)`#4`.``)``D`"0`)`"T`+0`)``D`"0`)
M`"@`,0`@``D`*0`)``D`"0`U`#<`"0`-``T`#0!-`&\`<@!T`&<`80!G`&4`
M+0!B`&$`8P!K`&4`9``@`',`90!C`'4`<@!I`'0`:0!E`',`"0`)``D`-0`)
M``D`"0`)`"T`+0`)``D`"0`)`"T`+0`)``D`"0`)`#4`"0`-``T`#0!%`'$`
M=0!I`'0`>0`@`',`90!C`'4`<@!I`'0`:0!E`',`"0`)``D`,@`)``D`"0`)
M`"T`+0`)``D`"0`)`"T`+0`)``D`"0`)`#(`"0`-``T`5`!O`'0`80!L`"``
M;`!O`&X`9P`@`'0`90!R`&T`(`!I`&X`=@!E`',`=`!M`&4`;@!T`',`"0`)
M``D`-@`U``D`"0`)``D`+0`M``D`"0`)``D`*``Q`"``"0`I``D`"0`)`#8`
M-``)``T`#0!4`&\`=`!A`&P`(`!A`'8`80!I`&P`80!B`&P`90`M`&8`;P!R
M`"T`<P!A`&P`90`@`&D`;@!V`&4`<P!T`&T`90!N`'0`<P`)``D`)``)`#4`
M.``R``D`"0`)`"0`"0`Q`#@`"0`)``D`)``)`"@`,@`)`"D`"0`)`"0`"0`U
M`#D`.``)``T`#0!4`&@`90`@`',`90!N`&D`;P!R`"``<P!E`&,`=0!R`&4`
M9``@`&(`80!N`&L`(`!L`&\`80!N`',`(`!F`'4`;@!D`"``:0!S`"``80`@
M`'``<@!O`&8`90!S`',`:0!O`&X`80!L`&P`>0`@`&T`80!N`&$`9P!E`&0`
M(`!F`'4`;@!D`"``:0!N`'8`90!S`'0`:0!N`&<`(`!I`&X`(`!L`&\`80!N
M`',`(`!M`&$`9`!E`"``8@!Y`"``8@!A`&X`:P!S`"``=`!O`"``;`!A`'(`
M9P!E`"``8P!O`'(`<`!O`'(`80!T`&4`(`!B`&\`<@!R`&\`=P!E`'(`<P`@
M`'<`:`!O`',`90`@`&$`<P!S`&4`=`!S`"``80!R`&4`(`!P`&P`90!D`&<`
M90!D`"``80!S`"``8P!O`&P`;`!A`'0`90!R`&$`;``N``T`#0`-`$$`=``@
M`$0`90!C`&4`;0!B`&4`<@`@`#,`,0`L`"``,@`P`#``.0`L`"``80!V`&$`
M:0!L`&$`8@!L`&4`+0!F`&\`<@`M`',`80!L`&4`(`!I`&X`=@!E`',`=`!M
M`&4`;@!T`',`(`!W`&4`<@!E`"``80!S`"``9@!O`&P`;`!O`'<`<P`Z``T`
M#0!'`'(`;P!S`',`"0`)``D`#0`-`$<`<@!O`',`<P`)``D`"0`-``T`10!S
M`'0`:0!M`&$`=`!E`&0`"0`-``T`#0!!`&T`;P!R`'0`:0!Z`&4`9``)``D`
M"0`-``T`50!N`'(`90!A`&P`:0!Z`&4`9``)``D`"0`-``T`50!N`'(`90!A
M`&P`:0!Z`&4`9``)``D`"0`-``T`1@!A`&D`<@`)``T`#0`-`$,`;P!S`'0`
M"0`)``D`#0`-`$<`80!I`&X`<P`)``D`"0`-``T`3`!O`',`<P!E`',`"0`)
M``D`#0`-`%8`80!L`'4`90`)``T`#0`-`%,`:`!O`'(`=``@`'0`90!R`&T`
M(`!I`&X`=@!E`',`=`!M`&4`;@!T`',`.@`)``D`"0`)``D`#0`-``T`50`N
M`%,`+@`@`&<`;P!V`&4`<@!N`&T`90!N`'0`(`!A`&X`9``@`&$`9P!E`&X`
M8P!Y`"``<P!E`&,`=0!R`&D`=`!I`&4`<P`)``D`)``)`#$`,@`Y``D`"0`)
M`"0`"0`M`"T`"0`)``D`)``)`"@`,0`)`"D`"0`)`"0`"0`Q`#(`.``)``T`
M#0`-`$T`;P!R`'0`9P!A`&<`90`M`&(`80!C`&L`90!D`"``<P!E`&,`=0!R
M`&D`=`!I`&4`<P`@`&8`=0!N`&0`"0`)``D`-P`U``D`"0`)``D`-P`)``D`
M"0`)`"T`+0`)``D`"0`)`#@`,@`)``T`#0`-`$T`;P!R`'0`9P!A`&<`90`M
M`&(`80!C`&L`90!D`"``<P!E`&,`=0!R`&D`=`!I`&4`<P`)``D`"0`V``D`
M"0`)``D`+0`M``D`"0`)``D`+0`M``D`"0`)``D`-@`)``T`#0`-`%,`90!N
M`&D`;P!R`"``<P!E`&,`=0!R`&4`9``@`&(`80!N`&L`(`!L`&\`80!N`',`
M(`!F`'4`;@!D``D`"0`)`#$`,P`Q``D`"0`)``D`,@`S``D`"0`)``D`+0`M
M``D`"0`)``D`,0`U`#0`"0`-``T`#0!#`&\`<@!P`&\`<@!A`'0`90`@`&0`
M90!B`'0`(`!S`&4`8P!U`'(`:0!T`&D`90!S``D`"0`)`#0`,P`)``D`"0`)
M`"T`+0`)``D`"0`)`"T`+0`)``D`"0`)`#0`,P`)``T`#0`-`$4`<0!U`&D`
M=`!Y`"``<P!E`&,`=0!R`&D`=`!I`&4`<P`)``D`"0`R`#D`"0`)``D`"0`M
M`"T`"0`)``D`"0`M`"T`"0`)``D`"0`R`#D`"0`-``T`#0!/`'0`:`!E`'(`
M(`!I`&X`=@!E`',`=`!M`&4`;@!T`',`"0`)``D`,0`U``D`"0`)``D`+0`M
M``D`"0`)``D`+0`M``D`"0`)``D`,0`U``D`#0`-`%0`;P!T`&$`;``@`',`
M:`!O`'(`=``@`'0`90!R`&T`(`!I`&X`=@!E`',`=`!M`&4`;@!T`',`"0`)
M``D`-``R`#@`"0`)``D`"0`S`#``"0`)``D`"0`H`#$`(``)`"D`"0`)``D`
M-``U`#<`"0`-``T`3`!O`&X`9P`@`'0`90!R`&T`(`!I`&X`=@!E`',`=`!M
M`&4`;@!T`',`.@`)``D`"0`)``D`"0`-``T`#0!5`"X`4P`N`"``9P!O`'8`
M90!R`&X`;0!E`&X`=``@`&$`;@!D`"``80!G`&4`;@!C`'D`(`!S`&4`8P!U
M`'(`:0!T`&D`90!S``D`"0`)`#4`,@`)``D`"0`)`"T`+0`)``D`"0`)`"@`
M,0`@``D`*0`)``D`"0`U`#$`"0`-``T`#0!-`&\`<@!T`&<`80!G`&4`+0!B
M`&$`8P!K`&4`9``@`',`90!C`'4`<@!I`'0`:0!E`',`"0`)``D`,0`P``D`
M"0`)``D`+0`M``D`"0`)``D`+0`M``D`"0`)``D`,0`P``D`#0`-``T`10!Q
M`'4`:0!T`'D`(`!S`&4`8P!U`'(`:0!T`&D`90!S``D`"0`)`#(`"0`)``D`
M"0`M`"T`"0`)``D`"0`M`"T`"0`)``D`"0`R``D`#0`-``T`3P!T`&@`90!R
M`"``:0!N`'8`90!S`'0`;0!E`&X`=`!S``D`"0`)`#@`"0`)``D`"0`R``D`
M"0`)``D`+0`M``D`"0`)``D`,0`P``D`#0`-`%0`;P!T`&$`;``@`&P`;P!N
M`&<`(`!T`&4`<@!M`"``:0!N`'8`90!S`'0`;0!E`&X`=`!S``D`"0`)`#<`
M,@`)``D`"0`)`#(`"0`)``D`"0`H`#$`(``)`"D`"0`)``D`-P`S``D`#0`-
M`%0`;P!T`&$`;``@`&$`=@!A`&D`;`!A`&(`;`!E`"T`9@!O`'(`+0!S`&$`
M;`!E`"``:0!N`'8`90!S`'0`;0!E`&X`=`!S``D`"0`D``D`-0`P`#``"0`)
M``D`)``)`#,`,@`)``D`"0`D``D`*``R``D`*0`)``D`)``)`#4`,P`P``D`
M#0`-`%0`:`!E`"``<P!E`&X`:0!O`'(`(`!S`&4`8P!U`'(`90!D`"``8@!A
M`&X`:P`@`&P`;P!A`&X`<P`@`&8`=0!N`&0`(`!I`',`(`!A`"``<`!R`&\`
M9@!E`',`<P!I`&\`;@!A`&P`;`!Y`"``;0!A`&X`80!G`&4`9``@`&8`=0!N
M`&0`(`!I`&X`=@!E`',`=`!I`&X`9P`@`&D`;@`@`&P`;P!A`&X`<P`@`&T`
M80!D`&4`(`!B`'D`(`!B`&$`;@!K`',`(`!T`&\`(`!L`&$`<@!G`&4`(`!C
M`&\`<@!P`&\`<@!A`'0`90`@`&(`;P!R`'(`;P!W`&4`<@!S`"``=P!H`&\`
M<P!E`"``80!S`',`90!T`',`(`!A`'(`90`@`'``;`!E`&0`9P!E`&0`(`!A
M`',`(`!C`&\`;`!L`&$`=`!E`'(`80!L`"X`#0`-``T`5`!H`&4`(`!C`&\`
M;@!T`'(`80!C`'0`=0!A`&P`(`!M`&$`=`!U`'(`:0!T`&D`90!S`"``;P!F
M`"``80!V`&$`:0!L`&$`8@!L`&4`+0!F`&\`<@`M`',`80!L`&4`(`!I`&X`
M=@!E`',`=`!M`&4`;@!T`',`(`!A`'0`(`!-`&$`<@!C`&@`(``S`#$`+``@
M`#(`,``Q`#``(`!W`&4`<@!E`#H`#0`-``T`#0!%`',`=`!I`&T`80!T`&4`
M9``)``T`#0`-`$$`;0!O`'(`=`!I`'H`90!D``D`"0`)``T`#0!&`&$`:0!R
M``D`#0`-``T`0P!O`',`=``)``D`"0`-``T`5@!A`&P`=0!E``D`#0`-`%,`
M90!C`'4`<@!I`'0`:0!E`',`(`!N`&\`=``@`&0`=0!E`"``80!T`"``80`@
M`',`:0!N`&<`;`!E`"``;0!A`'0`=0!R`&D`=`!Y`"``9`!A`'0`90`J``D`
M"0`D``D`.``Q``D`"0`)`"0`"0`Y`#@`"0`-``T`#0!/`'0`:`!E`'(`(`!D
M`&4`8@!T`"``<P!E`&,`=0!R`&D`=`!I`&4`<P`L`"``;0!A`'0`=0!R`&D`
M;@!G`#H`"0`)`!4``48`:0!N`&$`;@!C`&D`80!L`"``20!N`',`=`!R`'4`
M;0!E`&X`=`!S`(`,`0T`#0`H`#8`*0`)``T`#0!&`&D`;@!A`&X`8P!I`&$`
M;``@`$D`;@!S`'0`<@!U`&T`90!N`'0`<P`-``T`*`!I`&X`(`!M`&D`;`!L
M`&D`;P!N`',`+``@`&4`>`!C`&4`<`!T`"``<`!E`'(`(`!S`#P`&R`!:`!A
M`'(`90`@`&0`80!T`&$`*0`-``T`1@!O`'(`90!I`&<`;@`@`$,`=0!R`'(`
M90!N`&,`>0`@`%(`:0!S`&L`(`!-`&$`;@!A`&<`90!M`&4`;@!T``T`#0`-
M`$$`(`!S`&D`9P!N`&D`9@!I`&,`80!N`'0`(`!P`&\`<@!T`&D`;P!N`"``
M;P!F`"``=`!H`&4`(`!#`&\`;0!P`&$`;@!Y`"<`<P`@`&,`80!S`&@`(`!F
M`&P`;P!W`',`(`!I`',`(`!D`&4`;@!O`&T`:0!N`&$`=`!E`&0`(`!I`&X`
M(`!F`&\`<@!E`&D`9P!N`"``8P!U`'(`<@!E`&X`8P!I`&4`<P`N`$$`;`!C
M`&\`;@`@`'(`90!L`&D`90!S`"``;P!N`"``;P!N`&<`;P!I`&X`9P`@`&,`
M80!S`&@`(`!F`&P`;P!W`',`(`!G`&4`;@!E`'(`80!T`&4`9``@`&8`<@!O
M`&T`(`!F`&\`<@!E`&D`9P!N`"``<P!O`'4`<@!C`&4`<P`@`'0`;P`@`',`
M=0!P`'``;P!R`'0`(`!I`'0`<P`@`&P`;P!N`&<`(`!T`&4`<@!M`"``8P!O
M`&T`;0!I`'0`;0!E`&X`=`!S`"``=`!O`"``50`N`%,`+@`@`&0`;P!L`&P`
M80!R`"T`8@!A`',`90!D`"``<@!E`',`90!A`'(`8P!H`"``80!N`&0`(`!D
M`&4`=@!E`&P`;P!P`&T`90!N`'0`+@!4`&\`(`!T`&@`90`@`&4`>`!T`&4`
M;@!T`"``=`!H`&4`(`!D`&\`;`!L`&$`<@`@`'8`80!L`'4`90`@`&\`9@`@
M`&,`80!S`&@`(`!F`&P`;P!W`',`(`!I`',`(`!D`&D`;0!I`&X`:0!S`&@`
M90!D`"``80!S`"``80`@`'(`90!S`'4`;`!T`"``;P!F`"``=P!E`&$`:P!E
M`&X`:0!N`&<`(`!L`&\`8P!A`&P`(`!C`'4`<@!R`&4`;@!C`&D`90!S`"``
M<@!E`&P`80!T`&D`=@!E`"``=`!O`"``=`!H`&4`(`!D`&\`;`!L`&$`<@`L
M`"``=`!H`&4`(`!#`&\`;0!P`&$`;@!Y`"<`<P`@`&$`8@!I`&P`:0!T`'D`
M(`!T`&\`(`!F`'4`;@!D`"``<@!E`',`90!A`'(`8P!H`"``80!N`&0`(`!O
M`'0`:`!E`'(`(`!D`&\`;`!L`&$`<@`M`&(`80!S`&4`9``@`',`=`!R`&$`
M=`!E`&<`:0!C`"``:0!N`&D`=`!I`&$`=`!I`'8`90!S`"``80!T`"``80`@
M`&,`;P!N`',`:0!S`'0`90!N`'0`(`!L`&4`=@!E`&P`(`!M`&$`>0`@`&(`
M90`@`&D`;0!P`&$`:0!R`&4`9``N`%0`:`!E`"``0P!O`&T`<`!A`&X`>0`@
M`&@`80!S`"``90!S`'0`80!B`&P`:0!S`&@`90!D`"``80`@`&8`;P!R`&4`
M:0!G`&X`(`!C`'4`<@!R`&4`;@!C`'D`(`!R`&D`<P!K`"``;0!A`&X`80!G
M`&4`;0!E`&X`=``@`'``<@!O`&<`<@!A`&T`(`!T`&\`(`!P`'(`;P!T`&4`
M8P!T`"``80!G`&$`:0!N`',`=``@`'8`;P!L`&$`=`!I`&P`:0!T`'D`(`!O
M`&8`(`!N`&\`;@`M`&8`=0!N`&,`=`!I`&\`;@!A`&P`(`!C`'4`<@!R`&4`
M;@!C`'D`(`!M`&\`;@!E`'0`80!R`'D`(`!A`',`<P!E`'0`<P`@`&$`;@!D
M`"``;`!I`&$`8@!I`&P`:0!T`&D`90!S`"``80!N`&0`(`!C`&@`80!N`&<`
M90!S`"``:0!N`"``9@!A`&D`<@`@`'8`80!L`'4`90`@`&,`80!U`',`90!D
M`"``8@!Y`"``9@!L`'4`8P!T`'4`80!T`&D`;P!N`',`(`!I`&X`(`!F`&\`
M<@!E`&D`9P!N`"``90!X`&,`:`!A`&X`9P!E`"``<@!A`'0`90!S`"X`#0`-
M``T`5`!H`&4`(`!#`&\`;0!P`&$`;@!Y`"``<`!R`&D`;0!A`'(`:0!L`'D`
M(`!U`'0`:0!L`&D`>@!E`',`(`!F`&\`<@!W`&$`<@!D`"``90!X`&,`:`!A
M`&X`9P!E`"``8P!O`&X`=`!R`&$`8P!T`',`(`!I`&X`(`!C`&\`=0!N`'0`
M<@!I`&4`<P`@`'<`:`!E`'(`90`@`'0`:`!E`'D`(`!A`'(`90`@`&$`=@!A
M`&D`;`!A`&(`;`!E`"``80!N`&0`(`!E`&,`;P!N`&\`;0!I`&,`80!L`&P`
M>0`@`&(`90!N`&4`9@!I`&,`:0!A`&P`(`!T`&\`(`!O`&8`9@!S`&4`=``@
M`'0`:`!E`"``:0!M`'``80!C`'0`(`!O`&8`(`!F`&P`=0!C`'0`=0!A`'0`
M:0!O`&X`<P`@`&D`;@`@`&8`;P!R`&4`:0!G`&X`(`!E`'@`8P!H`&$`;@!G
M`&4`(`!R`&$`=`!E`',`(`!O`&X`(`!M`&\`;@!E`'0`80!R`'D`(`!A`',`
M<P!E`'0`<P`@`&$`;@!D`"``=`!H`&4`:0!R`"``<@!E`&P`80!T`&4`9``@
M`&,`80!S`&@`(`!F`&P`;P!W`',`+@!!`&P`;``@`&\`=0!T`',`=`!A`&X`
M9`!I`&X`9P`@`&8`;P!R`&4`:0!G`&X`(`!E`'@`8P!H`&$`;@!G`&4`(`!F
M`&\`<@!W`&$`<@!D`"``8P!O`&X`=`!R`&$`8P!T`',`(`!A`'(`90`@`&4`
M;@!T`&4`<@!E`&0`(`!I`&X`=`!O`"``=`!O`"``<`!R`&\`=`!E`&,`=``@
M`'0`:`!E`"``=@!A`&P`=0!E`"``;P!F`"``80!S`',`90!T`',`(`!O`'(`
M(`!L`&D`80!B`&D`;`!I`'0`:0!E`',`(`!D`&4`;@!O`&T`:0!N`&$`=`!E
M`&0`(`!I`&X`(`!C`'4`<@!R`&4`;@!C`&D`90!S`"``;P!T`&@`90!R`"``
M=`!H`&$`;@`@`'0`:`!E`"``90!N`'0`:0!T`'D`)P!S`"``9@!U`&X`8P!T
M`&D`;P!N`&$`;``@`&,`=0!R`'(`90!N`&,`>0`N`%0`;P`@`'0`:`!E`"``
M90!X`'0`90!N`'0`(`!H`&4`9`!G`&4`9``L`"``=`!H`&4`(`!C`&@`80!N
M`&<`90!S`"``:0!N`"``9@!A`&D`<@`@`'8`80!L`'4`90`@`&\`9@`@`'0`
M:`!E`"``9@!O`'(`=P!A`'(`9``@`&,`;P!N`'0`<@!A`&,`=`!S`"``;P!F
M`&8`<P!E`'0`(`!T`&@`90`@`&,`:`!A`&X`9P!E`',`(`!I`&X`(`!T`&@`
M90`@`'8`80!L`'4`90`@`&\`9@`@`'0`:`!E`"``80!S`',`90!T`',`(`!O
M`'(`(`!L`&D`80!B`&D`;`!I`'0`:0!E`',`+@!4`&@`90`@`&,`:`!A`&X`
M9P!E`',`(`!I`&X`(`!V`&$`;`!U`&4`(`!O`&8`(`!T`&@`90`@`&8`;P!R
M`&4`:0!G`&X`(`!E`'@`8P!H`&$`;@!G`&4`(`!F`&\`<@!W`&$`<@!D`"``
M8P!O`&X`=`!R`&$`8P!T`',`(`!A`&X`9``@`'0`:`!E`"``80!S`',`90!T
M`',`+P!L`&D`80!B`&D`;`!I`'0`:0!E`',`(`!T`&@`80!T`"``80!R`&4`
M(`!B`&4`:0!N`&<`(`!P`'(`;P!T`&4`8P!T`&4`9``@`&$`<@!E`"``<@!E
M`&,`;P!R`&0`90!D`"``:0!N`"``9@!O`'(`90!I`&<`;@`@`&4`>`!C`&@`
M80!N`&<`90`@`&<`80!I`&X`<P`@`&$`;@!D`"``;`!O`',`<P!E`',`(`!W
M`&D`=`!H`&D`;@`@`&\`=`!H`&4`<@`@`&D`;@!C`&\`;0!E`"``*`!E`'@`
M<`!E`&X`<P!E`"D`+@`-``T`#0!4`&@`90`@`&8`80!I`'(`(`!V`&$`;`!U
M`&4`<P`@`&\`9@`@`&8`;P!R`'<`80!R`&0`(`!E`'@`8P!H`&$`;@!G`&4`
M(`!A`&X`9``@`&\`<`!T`&D`;P!N`"``8P!O`&X`=`!R`&$`8P!T`',`(`!A
M`'(`90`@`'(`90!P`&\`<@!T`&4`9``@`&D`;@`@`&\`=`!H`&4`<@`@`&,`
M=0!R`'(`90!N`'0`(`!A`',`<P!E`'0`<P`@`&$`;@!D`"``;P!T`&@`90!R
M`"``8P!U`'(`<@!E`&X`=``@`&P`:0!A`&(`:0!L`&D`=`!I`&4`<P`N`$$`
M=``@`$T`80!R`&,`:``@`#,`,0`L`"``,@`P`#$`,``L`"``=`!H`&4`(`!F
M`&$`:0!R`"``=@!A`&P`=0!E`"``:`!E`&0`9P!E`"``9`!E`'(`:0!V`&$`
M=`!I`'8`90`@`&D`;@!S`'0`<@!U`&T`90!N`'0`<P`@`&@`80!V`&4`(`!S
M`&4`=`!T`&P`90!M`&4`;@!T`"``9`!A`'0`90!S`"``:0!N`"``=`!H`&4`
M(`!S`&4`8P!O`&X`9``@`&$`;@!D`"``=`!H`&D`<@!D`"``<0!U`&$`<@!T
M`&4`<@!S`"``;P!F`"``,@`P`#$`,``@`&$`;@!D`"``8P!O`'8`90!R`"``
M80`@`&<`<@!O`',`<P`@`&X`;P!T`&D`;P!N`&$`;``@`&$`;0!O`'4`;@!T
M`"``;P!F`"``)``V`#``-@`N``T`#0`-`%0`:`!E`"``0P!O`&T`<`!A`&X`
M>0`@`&(`90!L`&D`90!V`&4`<P`@`'0`:`!A`'0`+``@`&$`=``@`'0`:`!E
M`"``8@!A`&P`80!N`&,`90`@`',`:`!E`&4`=``@`&0`80!T`&4`+``@`&,`
M;P!U`&X`=`!E`'(`<`!A`'(`=`!Y`"``8P!R`&4`9`!I`'0`(`!R`&D`<P!K
M`"``=P!A`',`(`!N`&\`=``@`',`:0!G`&X`:0!F`&D`8P!A`&X`=``@`&0`
M=0!E`"``=`!O`"``=`!H`&4`(`!C`'(`90!D`&D`=``@`'$`=0!A`&P`:0!T
M`'D`(`!O`&8`(`!T`&@`90`@`&,`;P!U`&X`=`!E`'(`<`!A`'(`=`!I`&4`
M<P`@`'0`;P`@`'0`:`!E`"``9`!E`'(`:0!V`&$`=`!I`'8`90!S`"P`(`!W
M`&@`:0!C`&@`(`!W`&4`<@!E`"``80!L`&P`(`!L`&$`<@!G`&4`(`!F`&D`
M;@!A`&X`8P!I`&$`;``@`&D`;@!S`'0`:0!T`'4`=`!I`&\`;@!S`"``<`!R
M`&D`;0!A`'(`:0!L`'D`(`!I`&X`(`!3`'<`:0!T`'H`90!R`&P`80!N`&0`
M+``@`&$`;@!D`"``=`!H`&4`(`!S`&@`;P!R`'0`+0!T`&4`<@!M`"``;0!A
M`'0`=0!R`&D`=`!I`&4`<P`@`&\`9@`@`&T`;P!S`'0`(`!D`&4`<@!I`'8`
M80!T`&D`=@!E`',`+@!4`&@`90`@`&,`<@!E`&0`:0!T`"``90!X`'``;P!S
M`'4`<@!E`"``<@!E`&P`80!T`&4`9``@`'0`;P`@`'0`:`!E`',`90`@`&8`
M:0!N`&$`;@!C`&D`80!L`"``:0!N`',`=`!R`'4`;0!E`&X`=`!S`"``:0!S
M`"``<@!E`'``<@!E`',`90!N`'0`90!D`"``8@!Y`"``=`!H`&4`(`!F`&$`
M:0!R`"``=@!A`&P`=0!E`"``;P!F`"``8P!O`&X`=`!R`&$`8P!T`',`(`!W
M`&D`=`!H`"``80`@`'``;P!S`&D`=`!I`'8`90`@`&8`80!I`'(`(`!V`&$`
M;`!U`&4`(`!A`'0`(`!T`&@`90`@`'(`90!P`&\`<@!T`&D`;@!G`"``9`!A
M`'0`90`N``T`#0`-`$8`;P!R`"``=`!H`&4`(`!T`&@`<@!E`&4`(`!M`&\`
M;@!T`&@`<P`@`&4`;@!D`&4`9``@`$T`80!R`&,`:``@`#,`,0`L`"``,@`P
M`#$`,``L`"``=`!H`&4`(`!E`&8`9@!E`&,`=`!S`"``;P!F`"``9@!O`'(`
M90!I`&<`;@`@`&4`>`!C`&@`80!N`&<`90`@`&0`90!R`&D`=@!A`'0`:0!V
M`&4`(`!I`&X`<P!T`'(`=0!M`&4`;@!T`',`(`!W`&4`<@!E`#H`#0`-`$0`
M90!R`&D`=@!A`'0`:0!V`&4`<P`@`&D`;@`@`$8`80!I`'(`(`!6`&$`;`!U
M`&4`(`!(`&4`9`!G`&D`;@!G`"``4@!E`&P`80!T`&D`;P!N`',`:`!I`'``
M<P`)``D`#0`-`$P`;P!C`&$`=`!I`&\`;@`@`&\`9@`@`$<`80!I`&X`(``H
M`$P`;P!S`',`*0`@`%(`90!C`&\`9P!N`&D`>@!E`&0`(`!I`&X`(`!%`&$`
M<@!N`&D`;@!G`',`(`!O`&X`(`!$`&4`<@!I`'8`80!T`&D`=@!E`',`"0`)
M``T`#0!!`&T`;P!U`&X`=``@`&\`9@`@`$<`80!I`&X`(``H`$P`;P!S`',`
M*0`@`%(`90!C`&\`9P!N`&D`>@!E`&0`(`!I`&X`(`!%`&$`<@!N`&D`;@!G
M`',`(`!O`&X`(`!$`&4`<@!I`'8`80!T`&D`=@!E`',`"0`)``T`#0!!`&T`
M;P!U`&X`=``@`&\`9@`@`$<`80!I`&X`(``H`$P`;P!S`',`*0`@`&\`;@`@
M`'0`:`!E`"``2`!E`&0`9P!E`&0`(`!)`'0`90!M`',`#0`-``D`(``)``D`
M(``)``D`(``)``T`#0`-`$8`;P!R`&4`:0!G`&X`(`!E`'@`8P!H`&$`;@!G
M`&4`(`!F`&\`<@!W`&$`<@!D`"``8P!O`&X`=`!R`&$`8P!T`',`"0`)``T`
M#0!'`&$`:0!N`"``*`!L`&\`<P!S`"D`(`!F`'(`;P!M`"``9@!O`'(`90!I
M`&<`;@`@`&,`=0!R`'(`90!N`&,`>0`L`"``;@!E`'0`"0`)``T`#0`D`#$`
M-P`)``D`#0`-`"0`*``Q`#D`*0`-``T`20!N`'0`90!R`&4`<P!T`"``4@!A
M`'0`90`@`%(`:0!S`&L`(`!-`&$`;@!A`&<`90!M`&4`;@!T``T`#0`-`%0`
M:`!E`"``0P!O`&T`<`!A`&X`>0`@`&T`80!Y`"``=0!S`&4`(`!I`&X`=`!E
M`'(`90!S`'0`(`!R`&$`=`!E`"``<P!W`&$`<`!S`"``;P!N`"``8P!E`'(`
M=`!A`&D`;@`@`&D`;@!V`&4`<P!T`&D`;@!G`"``80!N`&0`(`!B`&\`<@!R
M`&\`=P!I`&X`9P`@`'0`<@!A`&X`<P!A`&,`=`!I`&\`;@!S`"``=`!O`"``
M;0!A`&X`80!G`&4`(`!I`'0`<P`@`&X`90!T`"``90!X`'``;P!S`'4`<@!E
M`"``=`!O`"``:0!N`'0`90!R`&4`<P!T`"``<@!A`'0`90`@`&,`:`!A`&X`
M9P!E`',`(`!A`&X`9``@`'0`;P`@`'(`90!D`'4`8P!E`"``:0!T`',`(`!O
M`'8`90!R`&$`;`!L`"``8P!O`',`=``@`&\`9@`@`&(`;P!R`'(`;P!W`&D`
M;@!G`"X`5`!H`&4`(`!#`&\`;0!P`&$`;@!Y`"``9`!O`&4`<P`@`&X`;P!T
M`"``=0!S`&4`(`!L`&4`=@!E`'(`80!G`&4`9``@`',`=P!A`'``<P`@`&$`
M;@!D`"``9`!O`&4`<P`@`&X`;P!T`"``;`!E`'8`90!R`&$`9P!E`"``80!N
M`'D`(`!O`&8`(`!I`'0`<P`@`&D`;@!V`&4`<P!T`&T`90!N`'0`(`!A`&,`
M=`!I`'8`:0!T`&D`90!S`"``=`!H`&$`=``@`'<`;P!U`&P`9``@`'``=0!T
M`"``8P!A`'``:0!T`&$`;``@`&$`=``@`'(`:0!S`&L`+@`-``T`#0!!`'0`
M(`!-`&$`<@!C`&@`(``S`#$`+``@`#(`,``Q`#``+``@`&D`;@`@`&,`;P!N
M`&X`90!C`'0`:0!O`&X`(`!W`&D`=`!H`"``80`@`&P`;P!N`&<`(`!T`&4`
M<@!M`"``8@!A`&X`:P`@`&P`;P!A`&X`+``@`'0`:`!E`"``0P!O`&T`<`!A
M`&X`>0`@`&@`80!D`"``80!N`"``:0!N`'0`90!R`&4`<P!T`"``<@!A`'0`
M90`@`',`=P!A`'``(`!F`&$`:0!R`"``=@!A`!X``4D`;@!T`&$`;@!G`&D`
M8@!L`&4`(`!!`',`<P!E`'0`<P`@`&$`;@!D`"``1P!O`&\`9`!W`&D`;`!L
M`.0$`0T`#0`H`#<`*0`)``T`#0!)`&X`=`!A`&X`9P!I`&(`;`!E`"``00!S
M`',`90!T`',`(`!A`&X`9``@`$<`;P!O`&0`=P!I`&P`;``-``T`*`!I`&X`
M(`!M`&D`;`!L`&D`;P!N`',`+``@`&4`>`!C`&4`<`!T`"``<`!E`'(`(`!S
M`&@`80!R`&4`(`!D`&$`=`!A`"D`#0`-`$T`80!R`&,`:``@`#,`,0`L`"``
M,@`P`#$`,``)``D`"0`-``T`1`!E`&,`90!M`&(`90!R`"``,P`Q`"P`(``R
M`#``,``Y``D`#0`-``T`1P!R`&\`<P!S``D`"0`)``D`"0`-``T`1P!R`&\`
M<P!S``D`"0`)``D`#0`-``T`0P!A`'(`<@!Y`&D`;@!G``D`"0`)``T`#0!!
M`&,`8P!U`&T`=0!L`&$`=`!E`&0`"0`)``D`#0`-`$,`80!R`'(`>0!I`&X`
M9P`)``D`"0`-``T`00!C`&,`=0!M`'4`;`!A`'0`90!D``D`#0`-``T`00!M
M`&\`=0!N`'0`"0`)``D`#0`-`$$`;0!O`'(`=`!I`'H`80!T`&D`;P!N``D`
M"0`)``T`#0!!`&T`;P!U`&X`=``)``D`"0`-``T`00!M`&\`<@!T`&D`>@!A
M`'0`:0!O`&X`"0`-``T`20!N`'0`80!N`&<`:0!B`&P`90`@`$$`<P!S`&4`
M=`!S``D`"0`)``D`"0`-``T`#0!3`'4`8@!J`&4`8P!T`"``=`!O`"``80!M
M`&\`<@!T`&D`>@!A`'0`:0!O`&X`.@`)``D`"0`)``D`#0`-``T`3`!I`&,`
M90!N`',`90!D`"``=`!E`&,`:`!N`&\`;`!O`&<`>0`)``D`)``)`#0`-``T
M``D`"0`)`"0`"0`H`#(`.0`W``D`*0`)``D`)``)`#,`,P`R``D`"0`)`"0`
M"0`H`#(`.0`V``D`*0`-``T`#0!0`&$`=`!E`&X`=`!S``D`"0`)`#(`-P`X
M``D`"0`)``D`*``R`#D`(``)`"D`"0`)``D`,0`Q`#$`"0`)``D`"0`H`#(`
M-``@``D`*0`-``T`#0!/`'0`:`!E`'(`"0`)``D`,0`R`#``"0`)``D`"0`H
M`#D`-@`@``D`*0`)``D`"0`Q`#(`,0`)``D`"0`)`"@`.0`S`"``"0`I``T`
M#0!4`&\`=`!A`&P`(`!S`'4`8@!J`&4`8P!T`"``=`!O`"``80!M`&\`<@!T
M`&D`>@!A`'0`:0!O`&X`"0`)``D`.``T`#(`"0`)``D`"0`H`#0`,@`R`"``
M"0`I``D`"0`)`#4`-@`T``D`"0`)``D`*``T`#$`,P`@``D`*0`-``T`3@!O
M`'0`(`!S`'4`8@!J`&4`8P!T`"``=`!O`"``80!M`&\`<@!T`&D`>@!A`'0`
M:0!O`&X`.@`)``D`"0`)``D`"0`-``T`#0!0`'4`<@!C`&@`80!S`&4`9``@
M`&D`;@`@`'``<@!O`&,`90!S`',`(`!R`&4`<P!E`&$`<@!C`&@`(`!A`&X`
M9``@`&0`90!V`&4`;`!O`'``;0!E`&X`=``@`&$`<P!S`&4`=`!S``D`"0`)
M`#$`,``T``D`"0`)``D`+0`M``D`"0`)``D`,0`P`#0`"0`)``D`"0`M`"T`
M"0`-``T`5`!O`'0`80!L`"``:0!N`'0`80!N`&<`:0!B`&P`90`@`&$`<P!S
M`&4`=`!S``D`"0`D``D`.0`T`#8`"0`)``D`)``)`"@`-``R`#(`"0`I``D`
M"0`D``D`-@`V`#@`"0`)``D`)``)`"@`-``Q`#,`"0`I``T`#0!$`'4`<@!I
M`&X`9P`@`'0`:`!E`"``=`!H`'(`90!E`"``;0!O`&X`=`!H`',`(`!E`&X`
M9`!E`&0`(`!-`&$`<@!C`&@`(``S`#$`+``@`#(`,``Q`#``+``@`'0`:`!E
M`"``0P!O`&T`<`!A`&X`>0`@`&$`9`!D`&4`9``@`'``80!T`&4`;@!T`',`
M(`!A`&X`9``@`&P`:0!C`&4`;@!S`&4`9``@`'0`90!C`&@`;@!O`&P`;P!G
M`'D`(`!T`&@`<@!O`'4`9P!H`"``80`@`&(`=0!S`&D`;@!E`',`<P`@`&$`
M8P!Q`'4`:0!S`&D`=`!I`&\`;@`@`&$`;@!D`"``80!N`"``80!S`',`90!T
M`"``<`!U`'(`8P!H`&$`<P!E`"X`#0`-``T`30!I`&X`;P!R`"``8P!H`&$`
M;@!G`&4`<P`@`&D`;@`@`'0`:`!E`"``8P!A`'(`<@!Y`&D`;@!G`"``80!M
M`&\`=0!N`'0`(`!O`&8`(`!G`&\`;P!D`'<`:0!L`&P`(`!F`&\`<@`@`'0`
M:`!E`"``=`!H`'(`90!E`"``;0!O`&X`=`!H`',`(`!E`&X`9`!E`&0`(`!-
M`&$`<@!C`&@`(``S`#$`+``@`#(`,``Q`#P`&R`!,``@`'<`90!R`&4`(`!A
M`',`(`!F`&\`;`!L`&\`=P!S`#H`#0`-`%4`;@!I`'0`90!D`"``4P!T`&$`
M=`!E`',`"0`)``D`#0`-`$D`;@!T`&4`<@!N`&$`=`!I`&\`;@!A`&P`"0`)
M``D`"0`-``T`#0!3`&4`9P!M`&4`;@!T``D`"0`)``T`#0!3`&4`9P!M`&4`
M;@!T``D`"0`)``T`#0!4`&\`=`!A`&P`"0`-``T`#0!'`&\`;P!D`'<`:0!L
M`&P`"0`)``D`"0`)``D`#0`-``T`0@!A`&P`80!N`&,`90`L`"``1`!E`&,`
M90!M`&(`90!R`"``,P`Q`"P`(``R`#``,``Y``D`"0`D``D`-``R`#,`"0`)
M``D`)``)`#(`-@`U``D`"0`)`"0`"0`V`#@`.``)``T`#0`-`$$`8P!Q`'4`
M:0!S`&D`=`!I`&\`;@`@`&\`9@`@`&(`=0!S`&D`;@!E`',`<P`)``D`"0`Q
M`#8`"0`)``D`"0`U``D`"0`)``D`,@`Q``D`#0`-``T`20!M`'``80!C`'0`
M(`!O`&8`(`!C`&@`80!N`&<`90!S`"``:0!N`"``9@!O`'(`90!I`&<`;@`@
M`&4`>`!C`&@`80!N`&<`90`@`'(`80!T`&4`<P`)``D`"0`H`#4`(``)`"D`
M"0`)``D`*``T`"``"0`I``D`"0`)`"@`.0`@``D`*0`-``T`0@!A`&P`80!N
M`&,`90`L`"``30!A`'(`8P!H`"``,P`Q`"P`(``R`#``,0`P``D`"0`D``D`
M-``S`#0`"0`)``D`)``)`#(`-@`V``D`"0`)`"0`"0`W`#``,``H``%3`&@`
M;P!R`'0`(`!4`&4`<@!M`"``0@!O`'(`<@!O`'<`:0!N`&<`<P`@`&$`;@!D
M`"``3`!O`&X`9P`@`%0`90!R`&T`(`!$`&4`8@!T`,<$`0T`#0`H`#@`*0`)
M``T`#0!3`&@`;P!R`'0`(`!4`&4`<@!M`"``0@!O`'(`<@!O`'<`:0!N`&<`
M<P`@`&$`;@!D`"``3`!O`&X`9P`@`%0`90!R`&T`(`!$`&4`8@!T``T`#0`H
M`&D`;@`@`&T`:0!L`&P`:0!O`&X`<P`L`"``90!X`&,`90!P`'0`(`!P`&4`
M<@`@`',`:`!A`'(`90`@`&0`80!T`&$`*0`-``T`30!A`'(`8P!H`"``,P`Q
M`"P`"0`)``D`#0`-`$0`90!C`&4`;0!B`&4`<@`@`#,`,0`L``D`#0`-``T`
M,@`P`#$`,``)``D`"0`-``T`,@`P`#``.0`)``T`#0!3`&@`;P!R`'0`(`!4
M`&4`<@!M`"``0@!O`'(`<@!O`'<`:0!N`&<`<P`)``D`"0`)``D`#0`-``T`
M3`!I`&X`90!S`"``;P!F`"``8P!R`&4`9`!I`'0`"0`)`"0`"0`R`#8`,P`)
M``D`"0`D``D`,@`W`#,`"0`-``T`#0!#`&\`;0!M`&4`<@!C`&D`80!L`"``
M<`!A`'``90!R``D`"0`)`#,`-@`Q``D`"0`)``D`,@`X`#8`"0`-``T`#0!&
M`'(`;P!M`"``80!F`&8`:0!L`&D`80!T`&4`<P`)``D`"0`V``D`"0`)``D`
M-P`)``T`#0`-`$(`80!N`&L`(`!O`'8`90!R`&0`<@!A`&8`=`!S``D`"0`)
M`#,`-P`)``D`"0`)`#0`,0`)``T`#0!4`&\`=`!A`&P`(`!S`&@`;P!R`'0`
M(`!T`&4`<@!M`"``8@!O`'(`<@!O`'<`:0!N`&<`<P`)``D`)``)`#8`-@`W
M``D`"0`)`"0`"0`V`#``-P`)``T`#0`-`$$`=``@`$T`80!R`&,`:``@`#,`
M,0`L`"``,@`P`#$`,``L`"``=`!H`&4`(`!#`&\`;0!P`&$`;@!Y`"``:`!A
M`&0`(`!U`&X`<P!E`&,`=0!R`&4`9``@`&,`<@!E`&0`:0!T`"``80!N`&0`
M(`!C`&\`;0!M`&4`<@!C`&D`80!L`"``<`!A`'``90!R`"``9@!A`&,`:0!L
M`&D`=`!I`&4`<P`@`'0`;P!T`&$`;`!I`&X`9P`@`"0`,@`L`#<`-``X`"P`
M(`!I`&X`8P!L`'4`9`!I`&X`9P`@`&(`80!N`&L`(`!O`'8`90!R`&0`<@!A
M`&8`=``@`&$`9P!R`&4`90!M`&4`;@!T`',`+``@`'<`:0!T`&@`(`!T`&@`
M:0!R`&0`(`!P`&$`<@!T`&D`90!S`"``=`!H`&$`=``@`'<`90!R`&4`(`!D
M`&4`;@!O`&T`:0!N`&$`=`!E`&0`(`!I`&X`(`!V`&$`<@!I`&\`=0!S`"``
M8P!U`'(`<@!E`&X`8P!I`&4`<P`N``T`#0`-`$$`<P`@`&\`9@`@`$T`80!R
M`&,`:``@`#,`,0`L`"``,@`P`#$`,``L`"``=`!O`'0`80!L`"``8@!O`'(`
M<@!O`'<`:0!N`&<`<P`@`&8`<@!O`&T`(`!.`&4`<P!T`&P`(`!A`&X`9``@
M`&D`=`!S`"``<P!U`&(`<P!I`&0`:0!A`'(`:0!E`',`(`!W`&4`<@!E`"``
M)``V`"``=0!N`&0`90!R`"``=0!N`',`90!C`'4`<@!E`&0`(`!R`&4`=@!O
M`&P`=@!I`&X`9P`@`&,`<@!E`&0`:0!T`"``9@!A`&,`:0!L`&D`=`!I`&4`
M<P`@`&\`9@`@`"0`-P`U`"X`20!N`"``=`!H`&4`(`!E`'8`90!N`'0`(`!O
M`&8`(`!A`"``8P!H`&$`;@!G`&4`(`!O`&8`(`!C`&\`;@!T`'(`;P!L`"P`
M(`!T`&@`90!S`&4`(`!A`&<`<@!E`&4`;0!E`&X`=`!S`"``=P!O`'4`;`!D
M`"``;@!O`"``;`!O`&X`9P!E`'(`(`!B`&4`(`!A`'8`80!I`&P`80!B`&P`
M90`@`&8`;P!R`"``80!D`&0`:0!T`&D`;P!N`&$`;``@`&(`;P!R`'(`;P!W
M`&D`;@!G`',`+``@`&$`;@!D`"``80!N`'D`(`!O`'4`=`!S`'0`80!N`&0`
M:0!N`&<`(`!B`&$`;`!A`&X`8P!E`',`(`!W`&\`=0!L`&0`(`!B`&4`8P!O
M`&T`90`@`'``80!Y`&$`8@!L`&4`(`!I`&X`(`!A`&,`8P!O`'(`9`!A`&X`
M8P!E`"``=P!I`'0`:``@`'0`:`!E`"``<@!E`&P`80!T`&4`9``@`'0`90!R
M`&T`<P`N``T`#0!-`&$`<@!C`&@`(``S`#$`+``)``D`"0`-``T`1`!E`&,`
M90!M`&(`90!R`"``,P`Q`"P`"0`-``T`#0`R`#``,0`P``D`"0`)``T`#0`R
M`#``,``Y``D`#0`-`$P`;P!N`&<`(`!4`&4`<@!M`"``1`!E`&(`=``)``D`
M"0`)``D`#0`-``T`0@!A`&X`:P`@`&P`;P!A`&X`"0`)`"0`"0`U`#0`"0`)
M``D`)``)`#4`-@`)``T`#0!,`&4`<P!S`"``8P!U`'(`<@!E`&X`=``@`&T`
M80!T`'4`<@!I`'0`:0!E`',`(`!O`&8`(`!L`&\`;@!G`"``=`!E`'(`;0`@
M`&0`90!B`'0`"0`)``D`-0`T``D`"0`)``D`+0`M``D`#0`-`$P`;P!N`&<`
M(`!T`&4`<@!M`"``9`!E`&(`=``L`"``;@!E`'0`(`!O`&8`(`!C`'4`<@!R
M`&4`;@!T`"``;0!A`'0`=0!R`&D`=`!I`&4`<P`)``D`)``)`"T`+0`)``D`
M"0`D``D`-0`V``D`#0`-`%0`:`!E`"``8@!A`&X`:P`@`&P`;P!A`&X`+``@
M`&<`=0!A`'(`80!N`'0`90!E`&0`(`!B`'D`(`!.`&4`<P!T`&P`+``@`&,`
M;P!N`'0`80!I`&X`<P`@`'``<@!O`'8`:0!S`&D`;P!N`',`(`!T`&@`80!T
M`"``;0!A`'D`(`!A`&,`8P!E`&P`90!R`&$`=`!E`"``=`!H`&4`(`!O`&(`
M;`!I`&<`80!T`&D`;P!N`"``:0!N`"``=`!H`&4`(`!E`'8`90!N`'0`(`!T
M`&@`80!T`"``3@!E`',`=`!L`"<`<P`@`&\`=P!N`&4`<@!S`&@`:0!P`"``
M;P!F`"``00!L`&,`;P!N`"``9@!A`&P`;`!S`"``8@!E`&P`;P!W`"``-0`Q
M`"4`+@`,``%)`&X`8P!O`&T`90`@`%0`80!X`&4`<P"`#`$-``T`*``Y`"D`
M"0`-``T`20!N`&,`;P!M`&4`(`!4`&$`>`!E`',`#0`-`"@`:0!N`"``;0!I
M`&P`;`!I`&\`;@!S`"P`(`!E`'@`8P!E`'``=``@`'``90!R`"``<P!H`&$`
M<@!E`"``9`!A`'0`80`I``T`#0!4`&@`90`@`$,`;P!M`'``80!N`'D`(`!O
M`'(`(`!O`&X`90`@`&\`9@`@`&D`=`!S`"``<P!U`&(`<P!I`&0`:0!A`'(`
M:0!E`',`(`!F`&D`;`!E`',`(`!I`&X`8P!O`&T`90`@`'0`80!X`"``<@!E
M`'0`=0!R`&X`<P`@`&D`;@`@`%,`=P!I`'0`>@!E`'(`;`!A`&X`9``L`"``
M=`!H`&4`(`!5`"X`4P`N`"``9@!E`&0`90!R`&$`;``@`&H`=0!R`&D`<P!D
M`&D`8P!T`&D`;P!N`"P`(`!A`&X`9``@`'8`80!R`&D`;P!U`',`(`!S`'0`
M80!T`&4`(`!A`&X`9``@`&\`=`!H`&4`<@`@`&8`;P!R`&4`:0!G`&X`(`!J
M`'4`<@!I`',`9`!I`&,`=`!I`&\`;@!S`"X`5P!I`'0`:``@`&8`90!W`"``
M90!X`&,`90!P`'0`:0!O`&X`<P`L`"``=`!H`&4`(`!#`&\`;0!P`&$`;@!Y
M`"``:0!S`"``;@!O`"``;`!O`&X`9P!E`'(`(`!S`'4`8@!J`&4`8P!T`"``
M=`!O`"``4P!W`&D`<P!S`"P`(`!5`"X`4P`N`"``9@!E`&0`90!R`&$`;``L
M`"``<P!T`&$`=`!E`"``80!N`&0`(`!L`&\`8P!A`&P`+``@`&\`<@`@`&X`
M;P!N`"T`50`N`%,`+@`@`&D`;@!C`&\`;0!E`"``=`!A`'@`(`!E`'@`80!M
M`&D`;@!A`'0`:0!O`&X`<P`@`&(`>0`@`'0`80!X`"``80!U`'0`:`!O`'(`
M:0!T`&D`90!S`"``9@!O`'(`(`!Y`&4`80!R`',`(`!B`&4`9@!O`'(`90`@
M`#(`,``P`#,`+@!)`&X`(`!*`'4`;@!E`"``,@`P`#``.0`L`"``=`!H`&4`
M(`!)`&X`=`!E`'(`;@!A`&P`(`!2`&4`=@!E`&X`=0!E`"``4P!E`'(`=@!I
M`&,`90`@`"@`(@!)`%(`4P`B`"D`(`!C`&\`;0!M`&4`;@!C`&4`9``@`&$`
M;@`@`&4`>`!A`&T`:0!N`&$`=`!I`&\`;@`@`&\`9@`@`'0`:`!E`"``0P!O
M`&T`<`!A`&X`>0`G`',`(`!5`"X`4P`N`"``:0!N`&,`;P!M`&4`(`!T`&$`
M>``@`'(`90!T`'4`<@!N`',`(`!F`&\`<@`@`#(`,``P`#8`(`!A`&X`9``@
M`#(`,``P`#<`(`!T`&@`80!T`"``:0!S`"``80!N`'0`:0!C`&D`<`!A`'0`
M90!D`"``=`!O`"``8@!E`"``8P!O`&T`<`!L`&4`=`!E`&0`(`!S`'4`8@!S
M`'0`80!N`'0`:0!A`&P`;`!Y`"``8@!Y`"``=`!H`&4`(`!E`&X`9``@`&\`
M9@`@`#(`,``Q`#``+@!)`&X`(`!-`&$`>0`@`#(`,``P`#D`+``@`'0`:`!E
M`"``20!2`%,`(`!A`&X`9``@`'0`:`!E`"``0P!O`&T`<`!A`&X`>0`@`&4`
M;@!T`&4`<@!E`&0`(`!T`&@`90`@`$,`;P!M`'``;`!I`&$`;@!C`&4`(`!!
M`',`<P!U`'(`80!N`&,`90`@`%``<@!O`&,`90!S`',`(``H`$,`00!0`"D`
M(`!P`'(`;P!G`'(`80!M`"``9@!O`'(`(``R`#``,``Y`"X`20!N`"``2@!A
M`&X`=0!A`'(`>0`@`#(`,``Q`#``+``@`'0`:`!E`"``20!2`%,`(`!A`&X`
M9``@`'0`:`!E`"``0P!O`&T`<`!A`&X`>0`@`&4`>`!T`&4`;@!D`&4`9``@
M`'0`:`!E`"``0P!!`%``(`!P`'(`;P!G`'(`80!M`"``=`!O`"``,@`P`#$`
M,``N`%0`:`!E`"``0P!O`&T`<`!A`&X`>0`@`&$`;`!S`&\`(`!C`'4`<@!R
M`&4`;@!T`&P`>0`@`&D`<P`@`',`=0!B`&H`90!C`'0`(`!T`&\`(`!I`&X`
M8P!O`&T`90`@`'0`80!X`"``90!X`&$`;0!I`&X`80!T`&D`;P!N`',`(`!B
M`'D`(`!V`&$`<@!I`&\`=0!S`"``<P!T`&$`=`!E`"P`(`!L`&\`8P!A`&P`
M(`!A`&X`9``@`&\`=`!H`&4`<@`@`&8`;P!R`&4`:0!G`&X`(`!T`&$`>``@
M`&$`=0!T`&@`;P!R`&D`=`!I`&4`<P`N`$D`;@`@`&$`9`!D`&D`=`!I`&\`
M;@`L`"``:0!N`"``2@!U`&X`90`@`#(`,``P`#D`+``@`'0`:`!E`"``0P!O
M`&T`<`!A`&X`>0`@`&$`;@!D`"``=`!H`&4`(`!)`%(`4P`@`',`:0!G`&X`
M90!D`"``80!N`"``80!D`'8`80!N`&,`90`@`'``<@!I`&,`:0!N`&<`(`!A
M`&<`<@!E`&4`;0!E`&X`=``@`"@`(@!!`%``00`B`"D`(`!C`&\`;@!T`'(`
M80!C`'0`(`!M`&4`;0!O`'(`:0!A`&P`:0!Z`&D`;@!G`"``=`!H`&4`(`!M
M`'4`=`!U`&$`;``@`&$`9P!R`&4`90!M`&4`;@!T`"``;`!E`'0`=`!E`'(`
M(`!B`&4`=`!W`&4`90!N`"``4P!W`&D`=`!Z`&4`<@!L`&$`;@!D`"``80!N
M`&0`(`!T`&@`90`@`%4`;@!I`'0`90!D`"``4P!T`&$`=`!E`',`(`!F`&\`
M<@`@`'D`90!A`'(`<P`@`'0`:`!R`&\`=0!G`&@`(``R`#``,0`T`"``=`!H
M`&$`=``@`&,`;P!V`&4`<@!S`"``80!L`&P`(`!M`&$`=`!E`'(`:0!A`&P`
M(`!I`&X`=`!E`'(`8P!O`&T`<`!A`&X`>0`@`'0`<@!A`&X`<P!A`&,`=`!I
M`&\`;@!S`"``:0!N`'8`;P!L`'8`:0!N`&<`(`!T`&@`90`@`$,`;P!M`'``
M80!N`'D`(`!A`&X`9``@`&D`=`!S`"``<P!U`&(`<P!I`&0`:0!A`'(`:0!E
M`',`(`!I`&X`(`!T`&@`90!S`&4`(`!T`'<`;P`@`&H`=0!R`&D`<P!D`&D`
M8P!T`&D`;P!N`',`+@!&`&D`;@!A`&P`;`!Y`"P`(`!D`'4`<@!I`&X`9P`@
M`'0`:`!E`"``9@!O`'4`<@!T`&@`(`!Q`'4`80!R`'0`90!R`"``;P!F`"``
M,@`P`#``-P`L`"``=`!H`&4`(`!#`&\`;0!P`&$`;@!Y`"``<P!U`&(`;0!I
M`'0`=`!E`&0`(`!A`"``<P!I`&T`:0!L`&$`<@`@`'(`90!Q`'4`90!S`'0`
M(`!F`&\`<@`@`&$`(`!B`&D`;`!A`'0`90!R`&$`;``@`$$`4`!!`"``8@!E
M`'0`=P!E`&4`;@`@`$H`80!P`&$`;@!E`',`90`@`&$`;@!D`"``4P!W`&D`
M<P!S`"``=`!A`'@`(`!A`'4`=`!H`&\`<@!I`'0`:0!E`',`(`!T`&@`80!T
M`"``=P!O`'4`;`!D`"``8P!O`'8`90!R`"``=`!H`&4`(`!T`&$`>``@`'D`
M90!A`'(`<P`@`#(`,``P`#@`(`!T`&@`<@!O`'4`9P!H`"``,@`P`#$`,@`N
M`%0`:`!E`"``0P!O`&T`<`!A`&X`>0`@`&4`>`!P`&4`8P!T`',`(`!T`&@`
M80!T`"``=`!H`&4`(`!*`&$`<`!A`&X`90!S`&4`+0!3`'<`:0!S`',`(`!!
M`%``00`@`'<`:0!L`&P`(`!B`&4`(`!C`&\`;@!C`&P`=0!D`&4`9``@`&D`
M;@`@`#(`,``Q`#``+@`-``T`#0!4`&@`90`@`$,`;P!M`'``80!N`'D`(`!B
M`&4`;`!I`&4`=@!E`',`(`!T`&@`80!T`"``:0!T`"``=`!A`&L`90!S`"``
M<@!E`&$`<P!O`&X`80!B`&P`90`@`'``;P!S`&D`=`!I`&\`;@!S`"``;P!N
M`"``:0!T`',`(`!T`&$`>``@`'(`90!T`'4`<@!N`',`(`!F`&D`;`!E`&0`
M(`!T`&@`<@!O`'4`9P!H`&\`=0!T`"``=`!H`&4`(`!W`&\`<@!L`&0`.P`@
M`&@`;P!W`&4`=@!E`'(`+``@`'0`80!X`"``;`!A`'<`<P`@`&$`<@!E`"``
M8P!O`&T`<`!L`&4`>``@`&$`;@!D`"``<P!U`',`8P!E`'``=`!I`&(`;`!E
M`"``=`!O`"``9`!I`&8`9@!E`'(`:0!N`&<`(`!I`&X`=`!E`'(`<`!R`&4`
M=`!A`'0`:0!O`&X`<P`N`%0`80!X`"``80!U`'0`:`!O`'(`:0!T`&D`90!S
M`"``=`!H`'(`;P!U`&<`:`!O`'4`=``@`'0`:`!E`"``=P!O`'(`;`!D`"P`
M(`!F`'(`;P!M`"``=`!I`&T`90`@`'0`;P`@`'0`:0!M`&4`+``@`'(`;P!U
M`'0`:0!N`&4`;`!Y`"``8P!H`&$`;`!L`&4`;@!G`&4`(`!P`&\`<P!I`'0`
M:0!O`&X`<P`@`'0`80!K`&4`;@`@`&(`>0`@`'0`:`!E`"``0P!O`&T`<`!A
M`&X`>0`L`"``<`!A`'(`=`!I`&,`=0!L`&$`<@!L`'D`(`!I`&X`(`!T`&@`
M90`@`&,`80!S`&4`(`!O`&8`(`!T`'(`80!N`',`9@!E`'(`(`!P`'(`:0!C
M`&D`;@!G`"``:0!S`',`=0!E`',`+@!4`&@`90`@`$,`;P!M`'``80!N`'D`
M(`!H`&$`<P`@`&D`9`!E`&X`=`!I`&8`:0!E`&0`(`!I`'0`<P`@`'4`;@!C
M`&4`<@!T`&$`:0!N`"``=`!A`'@`(`!P`&\`<P!I`'0`:0!O`&X`<P`@`&$`
M;@!D`"``<`!R`&4`<`!A`'(`90!D`"``:0!T`',`(`!R`&4`<P!E`'(`=@!E
M`"``9@!O`'(`(`!C`&\`;@!T`&D`;@!G`&4`;@!T`"``=`!A`'@`(`!L`&D`
M80!B`&D`;`!I`'0`:0!E`',`(`!T`&\`(`!R`&4`9@!L`&4`8P!T`"``=`!H
M`&4`(`!A`',`<P!O`&,`:0!A`'0`90!D`"``=0!N`'(`90!C`&\`9P!N`&D`
M>@!E`&0`(`!T`&$`>``@`&(`90!N`&4`9@!I`'0`<P`@`"@`=`!H`&4`(``B
M`%0`80!X`"``4@!E`',`90!R`'8`90!S`"(`*0`@`&D`;@`@`&$`8P!C`&\`
M<@!D`&$`;@!C`&4`(`!W`&D`=`!H`"``1@!I`&X`80!N`&,`:0!A`&P`(`!!
M`&,`8P!O`'4`;@!T`&D`;@!G`"``4P!T`&$`;@!D`&$`<@!D`',`(`!"`&\`
M80!R`&0`(``H`"(`1@!!`%,`0@`B`"D`(`!G`'4`:0!D`&$`;@!C`&4`(`!W
M`&@`:0!C`&@`+``@`&$`;0!O`&X`9P`@`&\`=`!H`&4`<@`@`'0`:`!I`&X`
M9P!S`"P`(`!R`&4`<0!U`&D`<@!E`',`(`!T`&@`80!T`"``=`!H`&4`(`!#
M`&\`;0!P`&$`;@!Y`"``80!S`',`=0!M`&4`(`!T`&@`80!T`"``:0!T`"``
M=P!I`&P`;``@`&(`90`@`',`=0!B`&H`90!C`'0`(`!T`&\`(`!E`'@`80!M
M`&D`;@!A`'0`:0!O`&X`(`!I`&X`(`!E`'8`90!R`'D`(`!J`'4`<@!I`',`
M9`!I`&,`=`!I`&\`;@`@`&D`;@`@`'<`:`!I`&,`:``@`&D`=``@`&D`<P`@
M`',`=0!B`&H`90!C`'0`(`!T`&\`(`!T`&$`>``N`$T`80!N`&$`9P!E`&T`
M90!N`'0`(`!B`&4`;`!I`&4`=@!E`',`(`!T`&@`80!T`"``=`!H`&4`(`!4
M`&$`>``@`%(`90!S`&4`<@!V`&4`<P`@`&$`<@!E`"``9@!A`&D`<@!L`'D`
M(`!S`'0`80!T`&4`9``@`&(`=0!T`"``8@!E`&P`:0!E`'8`90!S`"``:0!T
M`"``:0!S`"``<@!E`&$`<P!O`&X`80!B`&P`>0`@`'``;P!S`',`:0!B`&P`
M90`@`'0`:`!A`'0`(`!T`&@`90`@`'0`;P!T`&$`;``@`&$`;0!O`'4`;@!T
M`"``;P!F`"``=0!N`'(`90!C`&\`9P!N`&D`>@!E`&0`(`!T`&$`>``@`&(`
M90!N`&4`9@!I`'0`<P`@`'(`90!L`&$`=`!E`&0`(`!T`&\`(`!T`'(`80!N
M`',`9@!E`'(`(`!P`'(`:0!C`&D`;@!G`"P`(`!C`'4`<@!R`&4`;@!C`'D`
M(`!T`'(`80!N`',`;`!A`'0`:0!O`&X`<P`@`&$`;@!D`"``;P!T`&@`90!R
M`"``=`!A`'@`(`!P`&\`<P!I`'0`:0!O`&X`<P`@`'(`90!F`&P`90!C`'0`
M90!D`"``:0!N`"``=`!H`&4`(`!4`&$`>``@`%(`90!S`&4`<@!V`&4`<P`@
M`'<`:0!L`&P`(`!S`#P`'"`!:0!G`&X`:0!F`&D`8P!A`&X`=`!L`'D`(`!I
M`&X`8P!R`&4`80!S`&4`(`!O`'(`(`!D`&4`8P!R`&4`80!S`&4`(`!W`&D`
M=`!H`&D`;@`@`#$`,@`@`&T`;P!N`'0`:`!S`"``;P!F`"``=`!H`&4`(`!R
M`&4`<`!O`'(`=`!I`&X`9P`@`&\`9@`@`'0`:`!I`',`(`!F`&D`;@!A`&X`
M8P!I`&$`;``@`',`=`!A`'0`90!M`&4`;@!T`"``80!S`"``=`!H`&4`(`!R
M`&4`<P!U`&P`=``@`&\`9@`L`"``80!M`&\`;@!G`"``;P!T`&@`90!R`"``
M=`!H`&D`;@!G`',`+``@`"@`:0`I`"``9`!E`'8`90!L`&\`<`!M`&4`;@!T
M`',`(`!W`&D`=`!H`"``<@!E`',`<`!E`&,`=``@`'0`;P`@`&,`=0!R`'(`
M90!N`'0`;`!Y`"``80!C`'0`:0!V`&4`(`!A`'4`9`!I`'0`<P`@`&\`<@`@
M`&$`9`!V`&$`;@!C`&4`(`!P`'(`:0!C`&D`;@!G`"``80!G`'(`90!E`&T`
M90!N`'0`<P`@`&$`;@!D`"\`;P!R`"``*`!I`&D`*0`@`'0`:`!E`"``9@!U
M`'(`=`!H`&4`<@`@`&0`90!V`&4`;`!O`'``;0!E`&X`=``@`&\`9@`@`'0`
M80!X`"``;`!A`'<`<P`@`'0`:`!R`&\`=0!G`&@`(`!J`'4`9`!I`&,`:0!A
M`&P`(`!O`'(`(`!A`&0`;0!I`&X`:0!S`'0`<@!A`'0`:0!V`&4`(`!A`&,`
M=`!I`&\`;@!S`"X`00!L`'0`:`!O`'4`9P!H`"``=`!A`'@`(`!L`&$`=P!S
M`"``80!R`&4`(`!C`&\`;0!P`&P`90!X`"``80!N`&0`(`!S`&D`9P!N`&D`
M9@!I`&,`80!N`'0`(`!U`&X`8P!E`'(`=`!A`&D`;@!T`'D`(`!E`'@`:0!S
M`'0`<P`@`'<`:0!T`&@`(`!R`&4`<P!P`&4`8P!T`"``=`!O`"``=`!H`&4`
M(`!A`&,`=`!U`&$`;``@`&0`80!T`&4`(`!T`&@`80!T`"``80!N`'D`(`!O
M`&8`(`!T`&@`90`@`&,`=0!R`'(`90!N`'0`;`!Y`"``80!C`'0`:0!V`&4`
M(`!A`'4`9`!I`'0`<P`@`&\`<@`@`$$`4`!!`"``;@!E`&<`;P!T`&D`80!T
M`&D`;P!N`',`(`!C`&\`=0!L`&0`(`!R`&4`80!C`&@`(`!F`&D`;@!A`&P`
M(`!R`&4`<P!O`&P`=0!T`&D`;P!N`"``;P!R`"``80`@`&X`90!W`"``80!U
M`&0`:0!T`"``8P!O`'4`;`!D`"``8P!O`&T`;0!E`&X`8P!E`"P`(`!M`&$`
M;@!A`&<`90!M`&4`;@!T`"``8@!E`&P`:0!E`'8`90!S`"``:0!T`"``:0!S
M`"``<@!E`&$`<P!O`&X`80!B`&P`>0`@`'``;P!S`',`:0!B`&P`90`@`'0`
M:`!A`'0`(`!U`&X`<@!E`&,`;P!G`&X`:0!Z`&4`9``@`'0`80!X`"``8@!E
M`&X`90!F`&D`=`!S`"``8P!O`'4`;`!D`"``:0!N`&,`<@!E`&$`<P!E`"``
M:0!N`"``=`!H`&4`(`!N`&4`>`!T`"``,0`R`"``;0!O`&X`=`!H`',`(`!B
M`'D`(`!A`'0`(`!L`&4`80!S`'0`(``Q`#``)0`@`&\`<@`@`&0`90!C`'(`
M90!A`',`90`@`&(`>0`@`&\`=@!E`'(`(``W`#``)0`@`&$`<P`@`&$`(`!R
M`&4`<P`1``%"`'4`<P!I`&X`90!S`',`(`!3`&4`9P!M`&4`;@!T`',`.@P!
M#0`-`"@`,0`P`"D`"0`-``T`0@!U`',`:0!N`&4`<P!S`"``4P!E`&<`;0!E
M`&X`=`!S``T`#0`H`&D`;@`@`&T`:0!L`&P`:0!O`&X`<P`L`"``90!X`&,`
M90!P`'0`(`!P`&4`<@`@`',`:`!A`'(`90`@`&0`80!T`&$`*0`-``T`5`!H
M`&4`(`!#`&\`;0!P`&$`;@!Y`"``8P!O`&X`9`!U`&,`=`!S`"``:0!T`',`
M(`!G`&P`;P!B`&$`;``@`&(`=0!S`&D`;@!E`',`<P`@`'0`:`!R`&\`=0!G
M`&@`(`!T`'<`;P`@`&(`=0!S`&D`;@!E`',`<P`@`',`90!G`&T`90!N`'0`
M<P`Z`$$`;`!C`&\`;@`@`%4`;@!I`'0`90!D`"``4P!T`&$`=`!E`',`(`!A
M`&X`9``@`$$`;`!C`&\`;@`@`$D`;@!T`&4`<@!N`&$`=`!I`&\`;@!A`&P`
M+@!!`&P`8P!O`&X`(`!5`&X`:0!T`&4`9``@`%,`=`!A`'0`90!S`"``:0!N
M`&,`;`!U`&0`90!S`"``<P!A`&P`90!S`"``=`!O`"``=0!N`&$`9@!F`&D`
M;`!I`&$`=`!E`&0`(`!C`'4`<P!T`&\`;0!E`'(`<P`@`&P`;P!C`&$`=`!E
M`&0`(`!I`&X`(`!T`&@`90`@`%4`;@!I`'0`90!D`"``4P!T`&$`=`!E`',`
M(`!O`&8`(`!!`&T`90!R`&D`8P!A`"P`(`!E`'@`8P!L`'4`9`!I`&X`9P`@
M`%``=0!E`'(`=`!O`"``4@!I`&,`;P`N`$$`;`!C`&\`;@`@`%4`;@!I`'0`
M90!D`"``4P!T`&$`=`!E`',`(`!O`'``90!R`&$`=`!I`&X`9P`@`&D`;@!C
M`&\`;0!E`"``:0!S`"``9`!E`'(`:0!V`&4`9``@`&8`<@!O`&T`(`!O`'``
M90!R`&$`=`!I`&X`9P`@`'``<@!O`&8`:0!T`',`(`!W`&D`=`!H`&D`;@`@
M`'0`:`!E`"``50!N`&D`=`!E`&0`(`!3`'0`80!T`&4`<P`N`$$`;`!C`&\`
M;@`@`$D`;@!T`&4`<@!N`&$`=`!I`&\`;@!A`&P`(`!I`&X`8P!L`'4`9`!E
M`',`(`!S`&$`;`!E`',`(`!T`&\`(`!A`&P`;``@`&\`=`!H`&4`<@`@`'4`
M;@!A`&8`9@!I`&P`:0!A`'0`90!D`"``8P!U`',`=`!O`&T`90!R`',`+@`-
M``T`#0!%`&$`8P!H`"``8@!U`',`:0!N`&4`<P!S`"``<P!E`&<`;0!E`&X`
M=``@`&T`80!R`&L`90!T`',`(`!A`&X`9``@`',`90!L`&P`<P`@`'``<@!O
M`&0`=0!C`'0`<P`@`'``<@!I`&X`8P!I`'``80!L`&P`>0`@`&D`;@`@`'0`
M:`!R`&4`90`@`'``<@!O`&0`=0!C`'0`(`!C`&$`=`!E`&<`;P!R`&D`90!S
M`"``;P!F`"``=`!H`&4`(`!O`'``:`!T`&@`80!L`&T`:0!C`"``;0!A`'(`
M:P!E`'0`.@`@`"@`,0`I`"``<`!H`&$`<@!M`&$`8P!E`'4`=`!I`&,`80!L
M`"``*`!P`'(`90!S`&,`<@!I`'``=`!I`&\`;@`@`&0`<@!U`&<`<P`I`"P`
M(``H`#(`*0`@`',`=0!R`&<`:0!C`&$`;``@`&4`<0!U`&D`<`!M`&4`;@!T
M`"``80!N`&0`(`!D`&4`=@!I`&,`90!S`"``*`!C`&$`=`!A`'(`80!C`'0`
M+``@`'8`:0!T`'(`90!O`'(`90!T`&D`;@!A`&P`(`!A`&X`9``@`'(`90!F
M`'(`80!C`'0`:0!V`&4`*0`@`&$`;@!D`"``*``S`"D`(`!C`&\`;@!S`'4`
M;0!E`'(`(`!E`'D`90`@`&,`80!R`&4`(``H`&,`;P!N`'0`80!C`'0`(`!L
M`&4`;@!S`"``9`!I`',`:0!N`&8`90!C`'0`80!N`'0`<P`@`&$`;@!D`"``
M8P!L`&4`80!N`&D`;@!G`"``<P!O`&P`=0!T`&D`;P!N`',`+``@`&$`<@!T
M`&D`9@!I`&,`:0!A`&P`(`!T`&4`80!R`',`(`!A`&X`9``@`&\`8P!U`&P`
M80!R`"``=@!I`'0`80!M`&D`;@!S`"D`+@!"`'4`<P!I`&X`90!S`',`(`!S
M`&4`9P!M`&4`;@!T`"``;P!P`&4`<@!A`'0`:0!O`&X`<P`@`&<`90!N`&4`
M<@!A`&P`;`!Y`"``9`!O`"``;@!O`'0`(`!I`&X`8P!L`'4`9`!E`"``<@!E
M`',`90!A`'(`8P!H`"``80!N`&0`(`!D`&4`=@!E`&P`;P!P`&T`90!N`'0`
M+``@`&,`90!R`'0`80!I`&X`(`!M`&$`;@!U`&8`80!C`'0`=0!R`&D`;@!G
M`"``80!N`&0`(`!O`'0`:`!E`'(`(`!C`&\`<@!P`&\`<@!A`'0`90`@`&8`
M=0!N`&,`=`!I`&\`;@!S`"X`#0`-``T`0P!E`'(`=`!A`&D`;@`@`&T`80!N
M`'4`9@!A`&,`=`!U`'(`:0!N`&<`(`!C`&\`<P!T`',`(`!A`&X`9``@`&T`
M80!N`'4`9@!A`&,`=`!U`'(`:0!N`&<`(`!V`&$`<@!I`&$`;@!C`&4`<P`@
M`&$`<@!E`"``;@!O`'0`(`!A`',`<P!I`&<`;@!E`&0`(`!T`&\`(`!B`'4`
M<P!I`&X`90!S`',`(`!S`&4`9P!M`&4`;@!T`',`(`!B`&4`8P!A`'4`<P!E
M`"``;0!O`',`=``@`&T`80!N`'4`9@!A`&,`=`!U`'(`:0!N`&<`(`!O`'``
M90!R`&$`=`!I`&\`;@!S`"``<`!R`&\`9`!U`&,`90`@`'``<@!O`&0`=0!C
M`'0`<P`@`&8`;P!R`"``;0!O`'(`90`@`'0`:`!A`&X`(`!O`&X`90`@`&(`
M=0!S`&D`;@!E`',`<P`@`',`90!G`&T`90!N`'0`+@!2`&4`<P!E`&$`<@!C
M`&@`(`!A`&X`9``@`&0`90!V`&4`;`!O`'``;0!E`&X`=``@`&,`;P!S`'0`
M<P`L`"``90!X`&,`;`!U`&0`:0!N`&<`(`!R`&4`9P!U`&P`80!T`&\`<@!Y
M`"``8P!O`',`=`!S`"``=P!H`&D`8P!H`"``80!R`&4`(`!I`&X`8P!L`'4`
M9`!E`&0`(`!I`&X`(`!T`&@`90`@`&(`=0!S`&D`;@!E`',`<P`@`',`90!G
M`&T`90!N`'0`<P`L`"``80!R`&4`(`!T`'(`90!A`'0`90!D`"``80!S`"``
M9P!E`&X`90!R`&$`;``@`&,`;P!R`'``;P!R`&$`=`!E`"``8P!O`',`=`!S
M`"``80!N`&0`(`!A`'(`90`@`&X`;P!T`"``80!S`',`:0!G`&X`90!D`"``
M=`!O`"``8@!U`',`:0!N`&4`<P!S`"``<P!E`&<`;0!E`&X`=`!S`"X`#0`-
M``T`20!D`&4`;@!T`&D`9@!I`&$`8@!L`&4`(`!A`',`<P!E`'0`<P`@`&$`
M<@!E`"``;@!O`'0`(`!A`',`<P!I`&<`;@!E`&0`(`!B`'D`(`!B`'4`<P!I
M`&X`90!S`',`(`!S`&4`9P!M`&4`;@!T`"``80!N`&0`(`!A`'(`90`@`&X`
M;P!T`"``8P!O`&X`<P!I`&0`90!R`&4`9``@`&D`;@`@`&4`=@!A`&P`=0!A
M`'0`:0!N`&<`(`!T`&@`90`@`'``90!R`&8`;P!R`&T`80!N`&,`90`@`&\`
M9@`@`'0`:`!E`"``8@!U`',`:0!N`&4`<P!S`"``<P!E`&<`;0!E`&X`=`!S
M`"X`#0`-``T`#0!$`&4`<`!R`&4`8P!I`&$`=`!I`&\`;@`@`&$`;@!D``D`
M#0`-``T`4P!A`&P`90!S``D`"0`)``T`#0!/`'``90!R`&$`=`!I`&X`9P`@
M`$D`;@!C`&\`;0!E``D`"0`)``T`#0!!`&T`;P!R`'0`:0!Z`&$`=`!I`&\`
M;@`)``T`#0`-`%0`:`!R`&4`90`@`&T`;P!N`'0`:`!S`"``90!N`&0`90!D
M`"``30!A`'(`8P!H`"``,P`Q`"P`"0`)``T`#0`R`#``,0`P``D`"0`)``T`
M#0`R`#``,``Y``D`"0`)``T`#0`R`#``,0`P``D`"0`)``T`#0`R`#``,``Y
M``D`"0`)``T`#0`R`#``,0`P``D`"0`)``T`#0`R`#``,``Y``D`#0`-``T`
M50!N`&D`=`!E`&0`(`!3`'0`80!T`&4`<P`)``D`)``)`#<`,@`V``D`"0`)
M`"0`"0`V`#4`.``)``D`"0`D``D`-``S`#$`"0`)``D`)``)`#,`-0`S``D`
M"0`)`"0`"0`Q`#(`"0`)``D`)``)`#$`,@`)``T`#0`-`$D`;@!T`&4`<@!N
M`&$`=`!I`&\`;@!A`&P`"0`)``D`.0`Y`#4`"0`)``D`"0`X`#,`-0`)``D`
M"0`)`#0`-@`S``D`"0`)``D`,P`W`#D`"0`)``D`"0`R`#@`"0`)``D`"0`R
M`#``"0`-``T`4P!E`&<`;0!E`&X`=`!S`"``=`!O`'0`80!L``D`"0`)`#$`
M+``W`#(`,0`)``D`"0`)`#$`+``T`#D`,P`)``D`"0`)`#@`.0`T``D`"0`)
M``D`-P`S`#(`"0`)``D`"0`T`#``"0`)``D`"0`S`#(`"0`-``T`#0!-`&$`
M;@!U`&8`80!C`'0`=0!R`&D`;@!G`"``;P!P`&4`<@!A`'0`:0!O`&X`<P`)
M``D`"0`M`"T`"0`)``D`"0`M`"T`"0`)``D`"0`H`#$`-P`@``D`*0`)``D`
M"0`H`#$`-P`@``D`*0`)``D`"0`Q`#0`"0`)``D`"0`Q`#(`"0`-``T`#0!2
M`&4`<P!E`&$`<@!C`&@`(`!A`&X`9``@`&0`90!V`&4`;`!O`'``;0!E`&X`
M=``)``D`"0`M`"T`"0`)``D`"0`M`"T`"0`)``D`"0`H`#$`-0`P`"``"0`I
M``D`"0`)`"@`,0`Q`#D`(``)`"D`"0`)``D`-``)``D`"0`)`#0`"0`-``T`
M#0!'`&4`;@!E`'(`80!L`"``8P!O`'(`<`!O`'(`80!T`&4`"0`)``D`+0`M
M``D`"0`)``D`+0`M``D`"0`)``D`*``U`#8`(``)`"D`"0`)``D`*``U`#D`
M(``)`"D`"0`)``D`-``)``D`"0`)`#,`"0`-``T`#0!3`&@`80!R`&4`+0!B
M`&$`<P!E`&0`(`!C`&\`;0!P`&4`;@!S`&$`=`!I`&\`;@`)``D`"0`M`"T`
M"0`)``D`"0`M`"T`"0`)``D`"0`H`#$`.``@``D`*0`)``D`"0`H`#(`,P`@
M``D`*0`)``D`"0`M`"T`"0`)``D`"0`M`"T`"0`-``T`5`!O`'0`80!L``D`
M"0`D``D`,0`L`#<`,@`Q``D`"0`)`"0`"0`Q`"P`-``Y`#,`"0`)``D`)``)
M`#8`-0`S``D`"0`)`"0`"0`U`#$`-``)``D`"0`D``D`-@`R``D`"0`)`"0`
M"0`U`#$`"0`-``T`#0!$`'4`<@!I`&X`9P`@`'0`:`!E`"``=`!H`'(`90!E
M`"``;0!O`&X`=`!H`',`(`!E`&X`9`!E`&0`(`!-`&$`<@!C`&@`(``S`#$`
M+``@`#(`,``Q`#``+``@`&$`9`!V`&$`;@!C`&4`;0!E`&X`=`!S`"``:0!N
M`"``:0!T`',`(`!S`&$`;`!E`',`(`!R`&4`<`!O`'(`=`!I`&X`9P`@`',`
M>0!S`'0`90!M`"``<`!E`'(`;0!I`'0`=`!E`&0`(`!T`&@`90`@`$,`;P!M
M`'``80!N`'D`(`!T`&\`(`!B`&4`=`!T`&4`<@`@`&4`<P!T`&D`;0!A`'0`
M90`@`&$`;`!L`&\`=P!A`&(`;`!E`"``9`!E`&0`=0!C`'0`:0!O`&X`<P`@
M`&8`<@!O`&T`(`!S`&$`;`!E`',`(`!I`&X`(`!T`&@`90`@`&,`80!L`&,`
M=0!L`&$`=`!I`&\`;@`@`&\`9@`@`&$`8P!C`'(`=0!E`&0`(`!R`&\`>0!A
M`&P`=`!I`&4`<P`N`%0`:`!I`',`(`!C`&@`80!N`&<`90`@`&D`;@`@`&4`
M<P!T`&D`;0!A`'0`90`@`'(`90!S`'4`;`!T`&4`9``@`&D`;@`@`&$`(``D
M`#(`-``@`&$`9`!D`&D`=`!I`&\`;@`@`'0`;P`@`%4`+@!3`"X`(`!O`'``
M90!R`&$`=`!I`&X`9P`@`&D`;@!C`&\`;0!E`"``9`!U`'(`:0!N`&<`(`!T
M`&@`90`@`'``90!R`&D`;P!D`"X`#0`-``T`5`!H`&4`(`!#`&\`;0!P`&$`
M;@!Y`"``:0!N`&,`=0!R`'(`90!D`"``<`!R`&4`=`!A`'@`(`!E`'@`<`!E
M`&X`<P!E`',`(`!T`&\`=`!A`&P`:0!N`&<`(``D`#0`(`!I`&X`(`!T`&@`
M90`@`'0`:`!R`&4`90`@`&T`;P!N`'0`:`!S`"``90!N`&0`90!D`"``30!A
M`'(`8P!H`"``,P`Q`"P`(``R`#``,0`P`"``9@!O`'(`(`!C`&\`<P!T`',`
M(`!R`&4`;`!A`'0`90!D`"``=`!O`"``=`!H`&4`(`!A`&X`=`!I`&,`:0!P
M`&$`=`!E`&0`(`!C`&@`80!N`&<`90`@`&\`9@`@`&,`;P!N`'0`<@!O`&P`
M(`!D`&D`<P!C`'4`<P!S`&4`9``@`&D`;@`@`&X`;P!T`&4`(``Q`#,`(`!A
M`&X`9``@`&\`=`!H`&4`<@`@`&,`;P!S`'0`<P`@`'0`;P`@`',`=0!P`'``
M;P!R`'0`(`!!`&P`8P!O`&X`)P!S`"``8@!O`&$`<@!D`"``;P!F`"``9`!I
M`'(`90!C`'0`;P!R`',`(`!I`&X`(`!I`'0`<P`@`&4`=@!A`&P`=0!A`'0`
M:0!O`&X`(`!O`&8`(`!.`&\`=@!A`'(`=`!I`',`)P!S`"``;0!E`'(`9P!E
M`'(`(`!P`'(`;P!P`&\`<P!A`&P`+@!4`&@`90!S`&4`(`!E`'@`<`!E`&X`
M<P!E`',`(`!W`&4`<@!E`"``:0!N`&,`;`!U`&0`90!D`"``80!B`&\`=@!E
M`"``:0!N`"``9P!E`&X`90!R`&$`;``@`&,`;P!R`'``;P!R`&$`=`!E`"``
M90!X`'``90!N`',`90!S`"X`#0`-``T`3P!N`"``1@!E`&(`<@!U`&$`<@!Y
M`"``,0`Q`"P`(``R`#``,``Y`"P`(`!T`&@`90`@`$,`;P!M`'``80!N`'D`
M(`!A`&X`;@!O`'4`;@!C`&4`9``@`'0`:`!A`'0`(`!I`'0`(`!I`&X`:0!T
M`&D`80!T`&4`9``@`'``<@!O`&<`<@!A`&T`<P`@`'0`;P`@`&$`;`!I`&<`
M;@`@`&D`=`!S`"``;P!P`&4`<@!A`'0`:0!O`&X`<P`@`'<`:0!T`&@`(`!T
M`&@`90`@`&4`=@!O`&P`=@!I`&X`9P`@`&4`8P!O`&X`;P!M`&D`8P`@`&,`
M;P!N`&0`:0!T`&D`;P!N`',`(`!A`&X`9``@`&T`80!R`&L`90!T`"``90!N
M`'8`:0!R`&\`;@!M`&4`;@!T`"X`5`!H`&4`<P!E`"``<`!R`&\`9P!R`&$`
M;0!S`"``:0!N`&,`;`!U`&0`90!D`"``80`@`',`=`!A`&8`9@!I`&X`9P`@
M`'(`90!D`'4`8P!T`&D`;P!N`"``;P!F`"``80!P`'``<@!O`'@`:0!M`&$`
M=`!E`&P`>0`@`#(`-@`P`"``90!M`'``;`!O`'D`90!E`"``<`!O`',`:0!T
M`&D`;P!N`',`(`!T`&@`80!T`"``<@!E`',`=0!L`'0`90!D`"``:0!N`"``
M80`@`'``<@!E`'0`80!X`"``8P!H`&$`<@!G`&4`(`!O`&8`(``D`#$`.``@
M`&8`;P!R`"``=`!H`&4`(`!T`&@`<@!E`&4`(`!M`&\`;@!T`&@`<P`@`&4`
M;@!D`&4`9``@`$T`80!R`&,`:``@`#,`,0`L`"``,@`P`#``.0`L`"``=P!H
M`&D`8P!H`"``=P!A`',`(`!I`&X`8P!L`'4`9`!E`&0`(`!I`&X`(`!G`&4`
M;@!E`'(`80!L`"``8P!O`'(`<`!O`'(`80!T`&4`(`!E`'@`<`!E`&X`<P!E
M`',`+@`8``%3`&@`80!R`&4`+0!"`&$`<P!E`&0`(`!#`&\`;0!P`&4`;@!S
M`&$`=`!I`&\`;@`>``%3`&@`80!R`&4`+0!"`&$`<P!E`&0`(`!#`&\`;0!P
M`&4`;@!S`&$`=`!I`&\`;@`@`%``;`!A`&X`<P"`#`$-``T`*``Q`#$`*0`)
M``T`#0!3`&@`80!R`&4`+0!"`&$`<P!E`&0`(`!#`&\`;0!P`&4`;@!S`&$`
M=`!I`&\`;@`-``T`*`!I`&X`(`!M`&D`;`!L`&D`;P!N`',`+``@`&4`>`!C
M`&4`<`!T`"``<`!E`'(`(`!S`&@`80!R`&4`(`!D`&$`=`!A`"D`#0`-`$\`
M;@`@`$8`90!B`'(`=0!A`'(`>0`@`#$`,``L`"``,@`P`#$`,``L`"``<`!U
M`'(`<P!U`&$`;@!T`"``=`!O`"``=`!H`&4`(`!!`&T`90!N`&0`90!D`"``
M,@`P`#``,@`@`$$`;`!C`&\`;@`@`$D`;@!C`&4`;@!T`&D`=@!E`"``4`!L
M`&$`;@`L`"``=`!H`&4`(`!#`&\`;0!P`&$`;@!Y`"<`<P`@`&(`;P!A`'(`
M9``@`&\`9@`@`&0`:0!R`&4`8P!T`&\`<@!S`"``80!P`'``<@!O`'8`90!D
M`"``=`!H`&4`(`!G`'(`80!N`'0`+``@`&4`9@!F`&4`8P!T`&D`=@!E`"``
M1@`\`!L@`64`8@!R`'4`80!R`'D`(``Q`#<`+``@`#(`,``Q`#``+``@`'0`
M;P`@`&,`90!R`'0`80!I`&X`(`!E`&T`<`!L`&\`>0!E`&4`<P`@`&\`9@`@
M`&$`<`!P`'(`;P!X`&D`;0!A`'0`90!L`'D`(``U`#0`,P`L`#``,``P`"``
M<P!H`&$`<@!E`"T`<P!E`'0`=`!L`&4`9``@`'(`90!S`'0`<@!I`&,`=`!E
M`&0`(`!S`&@`80!R`&4`(`!U`&X`:0!T`',`(``H`"(`4@!3`%4`<P`B`"D`
M+@!4`&@`90`@`%(`4P!5`',`(`!V`&4`<P!T`"``80!T`"``=`!H`&4`(`!E
M`&X`9``@`&\`9@`@`&$`(`!T`&@`<@!E`&4`+0!Y`&4`80!R`"``<`!E`'(`
M:0!O`&0`+``@`'<`:0!T`&@`(`!F`&\`<@!F`&4`:0!T`'4`<@!E`',`(`!I
M`&8`(`!T`&@`90`@`'(`90!C`&D`<`!I`&4`;@!T`"``:0!S`"``;@!O`'0`
M(`!F`'4`;`!L`'D`(`!V`&4`<P!T`&4`9``@`&$`=``@`'0`90!R`&T`:0!N
M`&$`=`!I`&\`;@`@`&\`9@`@`&4`;0!P`&P`;P!Y`&T`90!N`'0`(`!O`'(`
M(`!A`'0`(`!R`&4`=`!I`'(`90!M`&4`;@!T`"``8@!E`&8`;P!R`&4`(`!A
M`&<`90`@`#8`,@`N``T`#0`-`%(`90!S`'0`<@!I`&,`=`!E`&0`(`!S`&@`
M80!R`&4`(`!U`&X`:0!T`',`(`!A`'(`90`@`'(`90!C`&\`9P!N`&D`>@!E
M`&0`(`!O`'8`90!R`"``=`!H`&4`(`!R`&4`<0!U`&D`<@!E`&0`(`!S`&4`
M<@!V`&D`8P!E`"``<`!E`'(`:0!O`&0`(`!A`'0`(`!T`&@`90`@`&,`;`!O
M`',`:0!N`&<`(`!M`&$`<@!K`&4`=``@`'``<@!I`&,`90`@`&8`;P!R`"``
M00!L`&,`;P!N`"``8P!O`&T`;0!O`&X`(`!S`&@`80!R`&4`<P`@`&\`;@`@
M`'0`:`!E`"``9`!A`'0`90`@`&\`9@`@`&<`<@!A`&X`=``N``T`#0`-`$8`
M;P!R`&8`90!I`'0`=0!R`&4`<P`@`'<`90!R`&4`(`!E`',`=`!I`&T`80!T
M`&4`9``@`&(`80!S`&4`9``@`&\`;@`@`&@`:0!S`'0`;P!R`&D`8P!A`&P`
M(`!E`'@`<`!E`'(`:0!E`&X`8P!E`"X`#0`-``T`20!F`"``9@!A`&,`=`!O
M`'(`<P`@`&,`:`!A`&X`9P!E`"``80!N`&0`(`!T`&@`90`@`$,`;P!M`'``
M80!N`'D`(`!E`&T`<`!L`&\`>0!S`"``9`!I`&8`9@!E`'(`90!N`'0`(`!A
M`',`<P!U`&T`<`!T`&D`;P!N`',`(`!T`&\`(`!A`&,`8P!O`'4`;@!T`"``
M9@!O`'(`(`!S`&@`80!R`&4`+0!B`&$`<P!E`&0`(`!P`&$`>0!M`&4`;@!T
M`',`(`!I`&X`(`!F`'4`=`!U`'(`90`@`'``90!R`&D`;P!D`',`+``@`'0`
M:`!E`"``8P!O`&T`<`!E`&X`<P!A`'0`:0!O`&X`(`!E`'@`<`!E`&X`<P!E
M`"``=`!H`&$`=``@`'0`:`!E`"``0P!O`&T`<`!A`&X`>0`@`'(`90!C`&\`
M<@!D`',`(`!M`&$`>0`@`&0`:0!F`&8`90!R`"``<P!I`&<`;@!I`&8`:0!C
M`&$`;@!T`&P`>0`@`&8`<@!O`&T`(`!W`&@`80!T`"``=`!H`&4`(`!#`&\`
M;0!P`&$`;@!Y`"``:`!A`',`(`!R`&4`8P!O`'(`9`!E`&0`(`!I`&X`(`!T
M`&@`90`@`&,`=0!R`'(`90!N`'0`(`!P`&4`<@!I`&\`9``N``T`#0`-`%0`
M:`!E`"``90!F`&8`90!C`'0`<P`@`&\`9@`@`',`:`!A`'(`90`M`&(`80!S
M`&4`9``@`&4`<0!U`&D`=`!Y`"``80!W`&$`<@!D`',`(`!O`&X`(`!O`'``
M90!R`&$`=`!I`&X`9P`@`&D`;@!C`&\`;0!E`"``80!N`&0`(`!N`&4`=``@
M`&4`80!R`&X`:0!N`&<`<P`@`'<`90!R`&4`(`!A`',`(`!F`&\`;`!L`&\`
M=P!S`#H`#0`-`%0`:`!R`&4`90`@`&T`;P!N`'0`:`!S`"``90!N`&0`90!D
M`"``30!A`'(`8P!H`"``,P`Q`"P`"0`-``T`#0`R`#``,0`P``D`"0`)``T`
M#0`R`#``,``Y``D`#0`-`%0`;P!T`&$`;``@`',`:`!A`'(`90`M`&(`80!S
M`&4`9``@`&4`<0!U`&D`=`!Y`"``80!W`&$`<@!D`"``8P!O`',`=`!S`"``
M80!P`'``;`!I`&,`80!B`&P`90`@`&8`;P!R`"``<`!E`'(`:0!O`&0`"0`)
M`"0`"0`Q`#@`"0`)``D`)``)`#(`,P`)``T`#0`-`$,`;P!S`'0`<P`@`&,`
M80!P`&D`=`!A`&P`:0!Z`&4`9``@`&D`;@`@`&D`;@!V`&4`;@!T`&\`<@!Y
M``D`"0`)`"T`+0`)``D`"0`)`"T`+0`)``T`#0!#`&\`<P!T`',`(`!R`&4`
M8P!O`&<`;@!I`'H`90!D`"``:0!N`"``;P!P`&4`<@!A`'0`:0!N`&<`(`!I
M`&X`8P!O`&T`90`)``D`"0`Q`#@`"0`)``D`"0`R`#,`"0`-``T`#0!,`&4`
M<P!S`"``=`!A`'@`(`!B`&4`;@!E`&8`:0!T`"``<@!E`&,`;P!G`&X`:0!Z
M`&4`9``@`&D`;@`@`&X`90!T`"``90!A`'(`;@!I`&X`9P!S``D`"0`)`#8`
M"0`)``D`"0`W``D`#0`-`%(`90!D`'4`8P!T`&D`;P!N`"``=`!O`"``;@!E
M`'0`(`!E`&$`<@!N`&D`;@!G`',`"0`)`"0`"0`Q`#(`"0`)``D`)``)`#$`
M-@`)``T`#0`-`$,`;P!M`'``90!N`',`80!T`&D`;P!N`"``90!X`'``90!N
M`',`90`@`&8`;P!R`"``90!Q`'4`:0!T`'D`(`!A`'<`80!R`&0`<P`@`'<`
M80!S`"``8P!A`&P`8P!U`&P`80!T`&4`9``@`&\`;@`@`&$`(`!S`'0`<@!A
M`&D`9P!H`'0`+0!L`&D`;@!E`"``8@!A`',`:0!S`"``;P!V`&4`<@`@`'0`
M:`!E`"``=`!H`'(`90!E`"T`>0!E`&$`<@`@`'8`90!S`'0`:0!N`&<`(`!P
M`&4`<@!I`&\`9``@`&\`9@`@`'0`:`!E`"``80!P`'``;`!I`&,`80!B`&P`
M90`@`',`:`!A`'(`90`M`&(`80!S`&4`9``@`&$`=P!A`'(`9`!S`"P`(`!W
M`&D`=`!H`"``80!C`&,`90!L`&4`<@!A`'0`:0!O`&X`(`!O`&8`(`!T`&@`
M90`@`&4`>`!P`&4`;@!S`&4`(`!F`&\`<@`@`&D`;@!D`&D`=@!I`&0`=0!A
M`&P`<P`@`&T`90!E`'0`:0!N`&<`(`!T`&@`90`@`'(`90!Q`'4`:0!R`&4`
M;0!E`&X`=`!S`"``9@!O`'(`(`!R`&4`=`!I`'(`90!M`&4`;@!T`"P`(`!A
M`',`(`!D`&4`<P!C`'(`:0!B`&4`9``@`&$`8@!O`'8`90`N``T`#0`-`%0`
M:`!E`"``90!F`&8`90!C`'0`<P`@`&\`9@`@`',`:`!A`'(`90`M`&(`80!S
M`&4`9``@`&P`:0!A`&(`:0!L`&D`=`!Y`"``80!W`&$`<@!D`',`(`!O`&X`
M(`!O`'``90!R`&$`=`!I`&X`9P`@`&D`;@!C`&\`;0!E`"``9@!O`'(`(`!T
M`&@`90`@`'0`:`!R`&4`90`@`&T`;P!N`'0`:`!S`"``90!N`&0`90!D`"``
M30!A`'(`8P!H`"``,P`Q`"P`(``R`#``,0`P`"``80!N`&0`(``R`#``,``Y
M`"``=P!E`'(`90`@`&X`;P!T`"``<P!I`&<`;@!I`&8`:0!C`&$`;@!T`"X`
M#0`-``T`5`!H`&4`(`!#`&\`;0!P`&$`;@!Y`"``:0!N`'0`90!N`&0`<P`@
M`'0`;P`@`',`80!T`&D`<P!F`'D`(`!A`&P`;``@`&4`<0!U`&D`=`!Y`"``
M80!W`&$`<@!D`',`(`!G`'(`80!N`'0`90!D`"``<`!R`&D`;P!R`"``=`!O
M`"``1`!E`&,`90!M`&(`90!R`"``,P`Q`"P`(``R`#``,``S`"``80!N`&0`
M(`!A`&8`=`!E`'(`(`!$`&4`8P!E`&T`8@!E`'(`(``S`#$`+``@`#(`,``P
M`#<`(`!W`&D`=`!H`"``=`!H`&4`(`!I`',`<P!U`&$`;@!C`&4`(`!O`&8`
M(`!N`&4`=P`@`',`:`!A`'(`90!S`"``9@!R`&\`;0`@`&,`;P!N`&0`:0!T
M`&D`;P!N`&$`;``@`&,`80!P`&D`=`!A`&P`(`!A`'4`=`!H`&\`<@!I`'H`
M90!D`"``9@!O`'(`(`!T`&@`90`@`$$`;0!E`&X`9`!E`&0`(``R`#``,``R
M`"``00!L`&,`;P!N`"``20!N`&,`90!N`'0`:0!V`&4`(`!0`&P`80!N`"X`
M00!T`"``30!A`'(`8P!H`"``,P`Q`"P`(``R`#``,0`P`"P`(`!T`&@`90`@
M`$,`;P!M`'``80!N`'D`(`!H`&$`9``@`'(`90!S`&4`<@!V`&4`9``@`&$`
M<`!P`'(`;P!X`&D`;0!A`'0`90!L`'D`(``R`#$`+@`W`"``;0!I`&P`;`!I
M`&\`;@`@`$$`;`!C`&\`;@`@`&,`;P!M`&T`;P!N`"``<P!H`&$`<@!E`',`
M(`!F`&\`<@`@`&D`<P!S`'4`80!N`&,`90`@`'``=0!R`',`=0!A`&X`=``@
M`'0`;P`@`'0`:`!E`"``00!M`&4`;@!D`&4`9``@`#(`,``P`#(`(`!!`&P`
M8P!O`&X`(`!)`&X`8P!E`&X`=`!I`'8`90`@`%``;`!A`&X`+@`-``T`#0!4
M`&@`90`@`$,`;P!M`'``80!N`'D`)P!S`"``8@!O`&$`<@!D`"``;P!F`"``
M9`!I`'(`90!C`'0`;P!R`',`(`!H`&$`<P`@`&$`=0!T`&@`;P!R`&D`>@!E
M`&0`(`!T`&@`90`@`&$`8P!Q`'4`:0!S`&D`=`!I`&\`;@`@`&\`;@`@`'0`
M:`!E`"``;P!P`&4`;@`@`&T`80!R`&L`90!T`"``;P!F`"``00!L`&,`;P!N
M`"``8P!O`&T`;0!O`&X`(`!S`&@`80!R`&4`<P`@`'0`;P`L`"``80!M`&\`
M;@!G`"``;P!T`&@`90!R`"``=`!H`&D`;@!G`',`+``@`',`80!T`&D`<P!F
M`'D`(`!T`&@`90`@`',`:`!A`'(`90`M`&(`80!S`&4`9``@`&$`=P!A`'(`
M9`!S`"``<@!E`'$`=0!I`'(`90!M`&4`;@!T`',`(`!G`'(`80!N`'0`90!D
M`"``=0!N`&0`90!R`"``=`!H`&4`(`!!`&T`90!N`&0`90!D`"``,@`P`#``
M,@`@`$$`;`!C`&\`;@`@`$D`;@!C`&4`;@!T`&D`=@!E`"``4`!L`&$`;@`N
M`$$`=``@`$T`80!R`&,`:``@`#,`,0`L`"``,@`P`#$`,``L`"``;P!U`'0`
M<P!T`&$`;@!D`&D`;@!G`"``80!U`'0`:`!O`'(`:0!Z`&$`=`!I`&\`;@!S
M`"``8@!Y`"``=`!H`&4`(`!#`&\`;0!P`&$`;@!Y`"<`<P`@`&(`;P!A`'(`
M9``@`&\`9@`@`&0`:0!R`&4`8P!T`&\`<@!S`"``=P!O`'4`;`!D`"``:`!A
M`'8`90`@`'``90!R`&T`:0!T`'0`90!D`"``=`!H`&4`(`!P`'4`<@!C`&@`
M80!S`&4`(`!O`&8`(`!A`'``<`!R`&\`>`!I`&T`80!T`&4`;`!Y`"``,0`N
M`#<`(`!M`&D`;`!L`&D`;P!N`"``00!L`&,`;P!N`"``8P!O`&T`;0!O`&X`
M(`!S`&@`80!R`&4`<P`N`%0`:`!E`"``0P!O`&T`<`!A`&X`>0`@`&@`80!S
M`"``<`!U`'(`8P!H`&$`<P!E`&0`(`!T`'(`90!A`',`=0!R`'D`(`!S`&@`
M80!R`&4`<P`@`&\`;@`@`'0`:`!E`"``;P!P`&4`;@`@`&T`80!R`&L`90!T
M`"``=`!O`"``<P!A`'0`:0!S`&8`>0`@`'0`:`!E`"``;0!A`&H`;P!R`&D`
M=`!Y`"``;P!F`"``=`!H`&4`(`!O`'4`=`!S`'0`80!N`&0`:0!N`&<`(`!E
M`'$`=0!I`'0`>0`@`&$`=P!A`'(`9`!S`"``9P!R`&$`;@!T`&4`9``@`',`
M=0!B`',`90!Q`'4`90!N`'0`(`!T`&\`(`!$`&4`8P!E`&T`8@!E`'(`(``S
M`#$`+``@`#(`,``P`#,`(`!A`&X`9``@`'``<@!I`&\`<@`@`'0`;P`@`$H`
M80!N`'4`80!R`'D`(``Q`"P`(``R`#``,``X`"X`#0`-`$,`:`!A`&X`9P!E
M`"``;P!F`"``0P!O`&X`=`!R`&\`;``@`%``<@!O`'8`:0!S`&D`;P!N`',`
M#0`-``T`50!P`&\`;@`@`&$`(`!C`&@`80!N`&<`90`@`&\`9@`@`&,`;P!N
M`'0`<@!O`&P`(`!I`&X`(`!T`&@`90`@`&\`=P!N`&4`<@!S`&@`:0!P`"``
M;P!F`"``00!L`&,`;P!N`"P`(`!S`'4`8P!H`"``80!S`"``3@!O`'8`80!R
M`'0`:0!S`"<`<P`@`&D`;@!T`&4`;@!D`&4`9``@`'``=0!R`&,`:`!A`',`
M90`@`&\`9@`@`$X`90!S`'0`;``G`',`(`!C`&\`;0!M`&\`;@`@`',`:`!A
M`'(`90!S`"``;P!F`"``00!L`&,`;P!N`"``*`!D`&D`<P!C`'4`<P!S`&4`
M9``@`&D`;@`@`&X`;P!T`&4`(``Q`#,`*0`L`"``=`!H`&4`(`!#`&\`;0!P
M`&$`;@!Y`"<`<P`@`',`:`!A`'(`90`M`&(`80!S`&4`9``@`&,`;P!M`'``
M90!N`',`80!T`&D`;P!N`"``80!W`&$`<@!D`',`(`!G`'(`80!N`'0`90!D
M`"``=`!O`"``90!M`'``;`!O`'D`90!E`',`(`!P`'(`:0!O`'(`(`!T`&\`
M(`!*`&$`;@!U`&$`<@!Y`"``,0`L`"``,@`P`#``.0`@`'<`:0!L`&P`(`!V
M`&4`<P!T`"``:0!M`&T`90!D`&D`80!T`&4`;`!Y`"X`2`!O`'<`90!V`&4`
M<@`L`"``=`!H`&4`(`!V`&4`<P!T`&D`;@!G`"``;P!F`"``<P!I`&T`:0!L
M`&$`<@`@`&$`=P!A`'(`9`!S`"``9P!R`&$`;@!T`&4`9``@`&$`9@!T`&4`
M<@`@`$H`80!N`'4`80!R`'D`(``Q`"P`(``R`#``,``Y`"``=P!I`&P`;``@
M`&$`8P!C`&4`;`!E`'(`80!T`&4`(`!O`&X`;`!Y`"``:0!F`"``=`!H`&4`
M(`!R`&4`<P!P`&4`8P!T`&D`=@!E`"``<`!A`'(`=`!I`&,`:0!P`&$`;@!T
M`"<`<P`@`&4`;0!P`&P`;P!Y`&T`90!N`'0`(`!W`&D`=`!H`"``=`!H`&4`
M(`!#`&\`;0!P`&$`;@!Y`"``;P!R`"``:0!T`',`(`!S`'4`8P!C`&4`<P!S
M`&\`<@`@`&D`<P`@`'0`90!R`&T`:0!N`&$`=`!E`&0`(`!W`&D`=`!H`&\`
M=0`C``%0`&4`;@!S`&D`;P!N`"``80!N`&0`(`!0`&\`<P!T`'(`90!T`&D`
M<@!E`&T`90!N`'0`(`!"`&4`;@!E`&8`:0!T`',`-@H!#0`-`"@`,0`R`"D`
M"0`-``T`4`!E`&X`<P!I`&\`;@`@`&$`;@!D`"``4`!O`',`=`!R`&4`=`!I
M`'(`90!M`&4`;@!T`"``0@!E`&X`90!F`&D`=`!S``T`#0`H`&D`;@`@`&T`
M:0!L`&P`:0!O`&X`<P`L`"``90!X`&,`90!P`'0`(`!P`&4`<@`@`',`:`!A
M`'(`90`@`&0`80!T`&$`*0`-``T`0P!O`&T`<`!O`&X`90!N`'0`<P`@`&\`
M9@`@`&X`90!T`"``<`!E`'(`:0!O`&0`:0!C`"``8@!E`&X`90!F`&D`=``@
M`&,`;P!S`'0`<P`Z``T`#0`-``T`4`!E`&X`<P!I`&\`;@`@`$(`90!N`&4`
M9@!I`'0`<P`)``D`"0`-``T`4`!O`',`=`!R`&4`=`!I`'(`90!M`&4`;@!T
M`"``0@!E`&X`90!F`&D`=`!S``D`#0`-``T`5`!H`'(`90!E`"``;0!O`&X`
M=`!H`',`(`!E`&X`9`!E`&0`(`!-`&$`<@!C`&@`(``S`#$`+``)``D`#0`-
M`#(`,``Q`#``"0`)``D`#0`-`#(`,``P`#D`"0`)``D`#0`-`#(`,``Q`#``
M"0`)``D`#0`-`#(`,``P`#D`"0`-``T`#0!3`&4`<@!V`&D`8P!E`"``8P!O
M`',`=``)``D`)``)`#<`"0`)``D`)``)`#4`"0`)``D`)``)`#,`"0`)``D`
M)``)`#,`"0`-``T`#0!)`&X`=`!E`'(`90!S`'0`(`!C`&\`<P!T``D`"0`)
M`#<`"0`)``D`"0`V``D`"0`)``D`-``)``D`"0`)`#0`"0`-``T`#0!%`'@`
M<`!E`&,`=`!E`&0`(`!R`&4`=`!U`'(`;@`@`&\`;@`@`&$`<P!S`&4`=`!S
M``D`"0`)`"@`,0`@``D`*0`)``D`"0`H`#$`(``)`"D`"0`)``D`*``S`"``
M"0`I``D`"0`)`"@`,@`@``D`*0`-``T`#0!0`'(`:0!O`'(`(`!S`&4`<@!V
M`&D`8P!E`"``8P!O`',`=``)``D`"0`M`"T`"0`)``D`"0`M`"T`"0`)``D`
M"0`M`"T`"0`)``D`"0`M`"T`"0`-``T`#0!.`&4`=``@`&P`;P!S`',`90!S
M`"``*`!G`&$`:0!N`',`*0`)``D`"0`R``D`"0`)``D`,@`)``D`"0`)`#$`
M"0`)``D`"0`Q``D`#0`-`$X`90!T`"``<`!E`'(`:0!O`&0`:0!C`"``8@!E
M`&X`90!F`&D`=``@`&,`;P!S`'0`"0`)`"0`"0`Q`#4`"0`)``D`)``)`#$`
M,@`)``D`"0`D``D`-0`)``D`"0`D``D`-@`)``T`#0!#`&4`<@!T`&$`:0!N
M`"``50`N`%,`+@`@`&0`90!F`&D`;@!E`&0`(`!B`&4`;@!E`&8`:0!T`"``
M<`!L`&$`;@!S`"``8P!O`&X`=`!A`&D`;@`@`&,`:`!A`&X`9P!E`"``;P!F
M`"``8P!O`&X`=`!R`&\`;``@`'``<@!O`'8`:0!S`&D`;P!N`',`(`!S`'4`
M8P!H`"``=`!H`&$`=``L`"``=0!P`&\`;@`@`&$`(`!C`&@`80!N`&<`90`@
M`&D`;@`@`&,`;P!N`'0`<@!O`&P`(`!I`&X`(`!T`&@`90`@`&\`=P!N`&4`
M<@!S`&@`:0!P`"``;P!F`"``00!L`&,`;P!N`"P`(`!S`'4`8P!H`"``80!S
M`"``3@!O`'8`80!R`'0`:0!S`"<`<P`@`&D`;@!T`&4`;@!D`&4`9``@`'``
M=0!R`&,`:`!A`',`90`@`&\`9@`@`$X`90!S`'0`;``G`',`(`!C`&\`;0!M
M`&\`;@`@`',`:`!A`'(`90!S`"``;P!F`"``00!L`&,`;P!N`"``*`!D`&D`
M<P!C`'4`<P!S`&4`9``@`&D`;@`@`&X`;P!T`&4`(``Q`#,`*0`L`"``=`!H
M`&4`(`!#`&\`;0!P`&$`;@!Y`"``:0!M`&T`90!D`&D`80!T`&4`;`!Y`"``
M=P!O`'4`;`!D`"``<@!E`&,`;P!G`&X`:0!Z`&4`(`!S`'``90!C`&D`80!L
M`"``=`!E`'(`;0!I`&X`80!T`&D`;P!N`"``8@!E`&X`90!F`&D`=`!S`"``
M80!N`&0`(`!C`'4`<@!T`&$`:0!L`&T`90!N`'0`(`!C`&@`80!R`&<`90!S
M`"P`(`!A`&X`9``@`'``80!Y`&T`90!N`'0`<P`@`&\`9@`@`'(`90!L`&$`
M=`!E`&0`(`!P`&4`;@!S`&D`;P!N`"``8@!E`&X`90!F`&D`=`!S`"``=P!O
M`'4`;`!D`"``8@!E`"``80!C`&,`90!L`&4`<@!A`'0`90!D`"X`30!A`&X`
M80!G`&4`;0!E`&X`=``@`&4`<P!T`&D`;0!A`'0`90!S`"``=`!H`&$`=``@
M`',`=0!C`&@`(`!C`&@`80!R`&<`90!S`"``=P!O`'4`;`!D`"``:0!M`'``
M80!C`'0`(`!S`&D`9P!N`&D`9@!I`&,`80!N`'0`;`!Y`"``=`!H`&4`(`!#
M`&\`;0!P`&$`;@!Y`"<`<P`@`'(`90!S`'4`;`!T`',`(`!O`&8`(`!O`'``
M90!R`&$`=`!I`&\`;@!S`"``:0!N`"``=`!H`&4`(`!P`&4`<@!I`&\`9``@
M`&D`;@`@`'<`:`!I`&,`:``@`&$`(`!C`&@`80!N`&<`90`@`&\`9@`@`&,`
M;P!N`'0`<@!O`&P`(`!O`&,`8P!U`'(`<P`N``T`#0`-`%0`:`!E`"``0P!O
M`&T`<`!A`&X`>0`@`&T`80!I`&X`=`!A`&D`;@!S`"``80`\`!P@`6X`(`!I
M`'(`<@!E`'8`;P!C`&$`8@!L`&4`(`!2`&$`8@!B`&D`(`!T`'(`=0!S`'0`
M(`!T`&\`(`!B`&4`(`!H`&4`;`!D`"``80!N`&0`(`!I`&X`=@!E`',`=`!E
M`&0`(`!I`&X`(`!A`&X`(`!U`&X`9@!U`&X`9`!E`&0`(`!A`'(`<@!A`&X`
M9P!E`&T`90!N`'0`(`!F`&\`<@`@`'0`:`!E`"``<`!A`'D`;0!E`&X`=``@
M`&\`9@`@`&(`90!N`&4`9@!I`'0`<P`@`'0`;P`@`'``80!R`'0`:0!C`&D`
M<`!A`&X`=`!S`"``=0!N`&0`90!R`"``8P!E`'(`=`!A`&D`;@`@`&0`90!F
M`&D`;@!E`&0`(`!B`&4`;@!E`&8`:0!T`"``<`!E`&X`<P!I`&\`;@`@`'``
M;`!A`&X`<P`@`&\`9@`@`'0`:`!E`"``0P!O`&T`<`!A`&X`>0`N`$$`=``@
M`$T`80!R`&,`:``@`#,`,0`L`"``,@`P`#$`,``L`"``=`!H`&4`(`!A`&,`
M8P!O`&T`<`!A`&X`>0!I`&X`9P`@`&,`;P!N`&0`90!N`',`90!D`"``8P!O
M`&X`<P!O`&P`:0!D`&$`=`!E`&0`(`!B`&$`;`!A`&X`8P!E`"``<P!H`&4`
M90!T`"``:0!N`&,`;`!U`&0`90!D`"``;@!E`'0`(`!A`',`<P!E`'0`<P`@
M`&\`9@`@`'0`:`!E`"``=`!R`'4`<P!T`"``*`!C`&$`<P!H`"``80!N`&0`
M(`!C`&$`<P!H`"``90!Q`'4`:0!V`&$`;`!E`&X`=`!S`"``;P!F`"``)``T
M`#,`(`!A`&X`9``@`',`:`!O`'(`=``@`'0`90!R`&T`(`!I`&X`=@!E`',`
M=`!M`&4`;@!T`',`(`!O`&8`(``D`#(`-``X`"D`(`!T`&@`80!T`"``=P!E
M`'(`90`@`'(`90!S`'0`<@!I`&,`=`!E`&0`(`!T`&\`(`!T`&@`90`@`'``
M80!Y`&T`90!N`'0`(`!O`&8`(`!P`&4`;@!S`&D`;P!N`"``8@!E`&X`90!F
M`&D`=`!S`"``90!X`&,`90!P`'0`(`!U`&X`9`!E`'(`(`!C`&4`<@!T`&$`
M:0!N`"``8P!O`&X`9`!I`'0`:0!O`&X`<P`L`"``<P!U`&,`:``@`&$`<P`@
M`'0`:`!E`"``0P!O`&T`<`!A`&X`>0`G`',`(`!I`&X`<P!O`&P`=@!E`&X`
M8P!Y`"``;P!R`"``=`!E`'(`;0!I`&X`80!T`&D`;P!N`"``;P!F`"``=`!H
M`&4`(`!T`'(`=0!S`'0`+@!4`&@`90`@`$$`;`!C`&\`;@`@`$4`>`!E`&,`
M=0!T`&D`=@!E`"``4@!E`'0`:0!R`&4`;0!E`&X`=``@`%``;`!A`&X`<P`@
M`%0`<@!U`',`=``@`$$`9P!R`&4`90!M`&4`;@!T`"``<`!R`&\`=@!I`&0`
M90!S`"``9@!O`'(`(`!T`&@`90`@`$,`;P!M`'``80!N`'D`(`!T`&\`(`!F
M`'4`;@!D`"``=`!H`&4`(`!C`'4`<@!R`&4`;@!T`"``80!C`'0`=0!A`'(`
M:0!A`&P`;`!Y`"``9`!E`'0`90!R`&T`:0!N`&4`9``@`'``<@!E`',`90!N
M`'0`(`!V`&$`;`!U`&4`(`!O`&8`(`!T`&@`90`@`&$`9P!G`'(`90!G`&$`
M=`!E`"``80!C`&,`<@!U`&4`9``@`'``90!N`',`:0!O`&X`(`!B`&4`;@!E
M`&8`:0!T`',`(`!O`&8`(`!A`&P`;``@`'``80!R`'0`:0!C`&D`<`!A`&X`
M=`!S`"``:0!N`"``=`!H`&4`(`!E`'8`90!N`'0`(`!T`&@`90`@`$,`;P!M
M`'``80!N`'D`(`!U`&X`9`!E`'(`9P!O`&4`<P`@`&$`(`!C`&@`80!N`&<`
M90`@`&\`9@`@`&,`;P!N`'0`<@!O`&P`+``@`',`=0!C`&@`(`!A`',`(`!.
M`&\`=@!A`'(`=`!I`',`)P!S`"``:0!N`'0`90!N`&0`90!D`"``<`!U`'(`
M8P!H`&$`<P!E`"``;P!F`"``3@!E`',`=`!L`"<`<P`@`&,`;P!M`&T`;P!N
M`"``<P!H`&$`<@!E`',`(`!O`&8`(`!!`&P`8P!O`&X`(``H`&0`:0!S`&,`
M=0!S`',`90!D`"``:0!N`"``;@!O`'0`90`@`#$`,P`I`"X`30!A`&X`80!G
M`&4`;0!E`&X`=``@`&4`<P!T`&D`;0!A`'0`90!S`"``=`!H`&$`=``@`&$`
M(`!S`&D`9P!N`&D`9@!I`&,`80!N`'0`(`!C`&\`;@!T`'(`:0!B`'4`=`!I
M`&\`;@`@`'0`;P`@`'0`:`!E`"``=`!R`'4`<P!T`"``=P!O`'4`;`!D`"``
M8@!E`"``<@!E`'$`=0!I`'(`90!D`"X`#0`-``T`20!N`"``8P!E`'(`=`!A
M`&D`;@`@`&,`;P!U`&X`=`!R`&D`90!S`"P`(`!T`&@`90`@`$,`;P!M`'``
M80!N`'D`)P!S`"``90!M`'``;`!O`'D`90!E`',`(`!P`&$`<@!T`&D`8P!I
M`'``80!T`&4`(`!I`&X`(`!D`&4`9@!I`&X`90!D`"``8@!E`&X`90!F`&D`
M=``@`'``;`!A`&X`<P`@`&\`9@`@`$X`90!S`'0`;``N`$X`;P`@`',`90!P
M`&$`<@!A`'0`90`@`'8`80!L`'4`80!T`&D`;P!N`"``9@!O`'(`(`!T`&@`
M90`@`$,`;P!M`'``80!N`'D`)P!S`"``90!M`'``;`!O`'D`90!E`',`(`!H
M`&$`<P`@`&@`:0!S`'0`;P!R`&D`8P!A`&P`;`!Y`"``8@!E`&4`;@`@`'``
M<@!E`'``80!R`&4`9``@`&8`;P!R`"``=`!H`&4`(`!P`&P`80!N`',`+``@
M`&$`<P`@`'0`:`!E`'D`(`!A`'(`90`@`&X`;P!T`"``:0!N`&0`:0!V`&D`
M9`!U`&$`;`!L`'D`(`!M`&$`=`!E`'(`:0!A`&P`(`!T`&\`(`!T`&@`90`@
M`$,`;P!M`'``80!N`'D`(`!O`'(`(`!T`&\`(`!.`&4`<P!T`&P`+@!!`&,`
M8P!O`'(`9`!I`&X`9P!L`'D`+``@`'0`:`!E`',`90`@`'``;`!A`&X`<P`@
M`&$`<@!E`"``=`!R`&4`80!T`&4`9``@`&$`<P`@`&T`=0!L`'0`:0`M`&4`
M;0!P`&P`;P!Y`&4`<@`@`'``;`!A`&X`<P`N`$$`;@!N`'4`80!L`"``8P!O
M`&X`=`!R`&D`8@!U`'0`:0!O`&X`<P`@`'0`;P`@`'0`:`!E`',`90`@`'``
M;`!A`&X`<P`@`&$`<@!E`"``9`!E`'0`90!R`&T`:0!N`&4`9``@`&(`>0`@
M`$X`90!S`'0`;``@`&$`;@!D`"``8P!H`&$`<@!G`&4`9``@`'0`;P`@`'0`
M:`!E`"``0P!O`&T`<`!A`&X`>0`N`%4`;@!D`&4`<@`@`&$`(`!C`&@`80!N
M`&<`90`@`&\`9@`@`&,`;P!N`'0`<@!O`&P`+``@`'0`:`!E`"``<`!A`'(`
M=`!I`&,`:0!P`&$`;@!T`',`(`!M`&$`>0`@`&\`<@`@`&T`80!Y`"``;@!O
M`'0`(`!B`&4`(`!M`&D`9P!R`&$`=`!E`&0`(`!T`&\`(`!A`&X`;P!T`&@`
M90!R`"``<`!L`&$`;@`L`"``80!N`&0`(`!A`&0`9`!I`'0`:0!O`&X`80!L
M`"``8P!O`&X`=`!R`&D`8@!U`'0`:0!O`&X`<P`@`&(`>0`@`'0`:`!E`"``
M0P!O`&T`<`!A`&X`>0`@`&T`80!Y`"``;P!R`"``;0!A`'D`(`!N`&\`=``@
M`&(`90`@`'(`90!Q`'4`:0!R`&4`9``@`&D`;@`@`&$`;@!Y`"``;@!E`'<`
M(`!S`&D`;@!G`&P`90`M`&4`;0!P`&P`;P!Y`&4`<@`@`'``;`!A`&X`<P`N
M`!H``5``<@!O`'``;P!S`&4`9``@`$,`:`!A`&X`9P!E`"``;P!F`"``0P!O
M`&X`=`!R`&\`;``:``%0`'(`;P!P`&\`<P!E`&0`(`!C`&@`80!N`&<`90`@
M`&\`9@`@`&,`;P!N`'0`<@!O`&P`@`P!#0`-`"@`,0`S`"D`"0`-``T`4`!R
M`&\`<`!O`',`90!D`"``0P!H`&$`;@!G`&4`(`!O`&8`(`!#`&\`;@!T`'(`
M;P!L``T`#0`H`&D`;@`@`&T`:0!L`&P`:0!O`&X`<P`L`"``90!X`&,`90!P
M`'0`(`!P`&4`<@`@`',`:`!A`'(`90`@`&0`80!T`&$`*0`-``T`3P!N`"``
M00!P`'(`:0!L`"``-@`L`"``,@`P`#``.``L`"``3@!E`',`=`!L`"``80!N
M`&0`(`!.`&\`=@!A`'(`=`!I`',`(`!E`'@`90!C`'4`=`!E`&0`(`!T`&@`
M90`@`%``=0!R`&,`:`!A`',`90`@`&$`;@!D`"``3P!P`'0`:0!O`&X`(`!!
M`&<`<@!E`&4`;0!E`&X`=``@`'``=0!R`',`=0!A`&X`=``@`'0`;P`@`'<`
M:`!I`&,`:``@`$X`90!S`'0`;``@`&$`9P!R`&4`90!D`"``=`!O`"``<P!E
M`&P`;``@`&$`<`!P`'(`;P!X`&D`;0!A`'0`90!L`'D`(``W`#0`(`!M`&D`
M;`!L`&D`;P!N`"``;P!F`"``:0!T`',`(`!S`&@`80!R`&4`<P`@`&\`9@`@
M`$$`;`!C`&\`;@`@`&,`;P!M`&T`;P!N`"``<P!T`&\`8P!K`"``=`!O`"``
M3@!O`'8`80!R`'0`:0!S`"``:0!N`"``80`@`&,`80!S`&@`(`!T`'(`80!N
M`',`80!C`'0`:0!O`&X`(`!A`'0`(`!A`"``<`!R`&D`8P!E`"``;P!F`"``
M)``Q`#0`,P`N`#$`.``@`'``90!R`"``<P!H`&$`<@!E`"X`5`!H`&D`<P`@
M`',`80!L`&4`(`!W`&$`<P`@`&,`;P!N`',`=0!M`&T`80!T`&4`9``@`&\`
M;@`@`$H`=0!L`'D`(``W`"P`(``R`#``,``X`"P`(`!A`&X`9``@`$X`;P!V
M`&$`<@!T`&D`<P`@`&X`;P!W`"``;P!W`&X`<P`@`&$`(`!M`&D`;@!O`'(`
M:0!T`'D`(`!S`'0`80!K`&4`(`!I`&X`(`!!`&P`8P!O`&X`(`!O`&8`(`!S
M`&P`:0!G`&@`=`!L`'D`(`!L`&4`<P!S`"``=`!H`&$`;@`@`#(`-0`E`"``
M;P!F`"``00!L`&,`;P!N`"<`<P`@`&\`=0!T`',`=`!A`&X`9`!I`&X`9P`@
M`',`:`!A`'(`90!S`"P`(`!W`&@`:0!L`&4`(`!.`&4`<P!T`&P`(`!R`&4`
M;0!A`&D`;@!S`"``00!L`&,`;P!N`"<`<P`@`&T`80!J`&\`<@!I`'0`>0`@
M`',`:`!A`'(`90!H`&\`;`!D`&4`<@`@`'<`:0!T`&@`(`!A`'``<`!R`&\`
M>`!I`&T`80!T`&4`;`!Y`"``,0`U`#8`(`!M`&D`;`!L`&D`;P!N`"``00!L
M`&,`;P!N`"``<P!H`&$`<@!E`',`(`!C`&\`;0!P`'(`:0!S`&D`;@!G`"``
M80!P`'``<@!O`'@`:0!M`&$`=`!E`&P`>0`@`#4`,@`E`"``;P!F`"``=`!H
M`&4`(`!#`&\`;0!P`&$`;@!Y`"<`<P`@`&\`=0!T`',`=`!A`&X`9`!I`&X`
M9P`@`',`:`!A`'(`90!S`"X`#0`-``T`5`!H`&4`(`!0`'4`<@!C`&@`80!S
M`&4`(`!A`&X`9``@`$\`<`!T`&D`;P!N`"``00!G`'(`90!E`&T`90!N`'0`
M(`!B`&4`=`!W`&4`90!N`"``3@!E`',`=`!L`"``80!N`&0`(`!.`&\`=@!A
M`'(`=`!I`',`(`!A`&P`<P!O`"``8P!O`&X`=`!A`&D`;@!S`"``<`!U`'0`
M(`!A`&X`9``@`&,`80!L`&P`(`!O`'``=`!I`&\`;@`@`'(`:0!G`&@`=`!S
M`"``;P!N`"``=`!H`&4`(`!B`&$`;`!A`&X`8P!E`"``;P!F`"``80!P`'``
M<@!O`'@`:0!M`&$`=`!E`&P`>0`@`#$`-0`V`"``;0!I`&P`;`!I`&\`;@`@
M`$$`;`!C`&\`;@`@`',`:`!A`'(`90!S`"``;P!W`&X`90!D`"``8@!Y`"``
M3@!E`',`=`!L`"X`5`!H`&4`(`!O`'``=`!I`&\`;@`@`'(`:0!G`&@`=`!S
M`"``8P!O`&T`;0!E`&X`8P!E`&0`(`!O`&X`(`!*`&$`;@!U`&$`<@!Y`"``
M,0`L`"``,@`P`#$`,``@`&$`;@!D`"``90!X`'``:0!R`&4`(`!O`&X`(`!*
M`'4`;`!Y`"``,P`Q`"P`(``R`#``,0`Q`"X`00!S`"``;P!U`'0`;`!I`&X`
M90!D`"``8@!Y`"``=`!H`&4`(`!T`'<`;P`@`'``80!R`'0`:0!E`',`+``@
M`'0`:`!E`',`90`@`'(`:0!G`&@`=`!S`"``9P!R`&$`;@!T`"``*`!I`"D`
M(`!.`&\`=@!A`'(`=`!I`',`(`!A`"``8P!A`&P`;``@`&\`<`!T`&D`;P!N
M`"``=`!O`"``8@!U`'D`(`!A`&P`;``@`&(`=0!T`"``-``N`#$`(`!M`&D`
M;`!L`&D`;P!N`"``*`!O`'(`(``R`"X`-0`E`"D`(`!O`&8`(`!.`&4`<P!T
M`&P`)P!S`"``<@!E`&T`80!I`&X`:0!N`&<`(`!!`&P`8P!O`&X`(`!S`&@`
M80!R`&4`<P`@`&$`=``@`&$`(`!F`&D`>`!E`&0`(`!P`'(`:0!C`&4`(`!O
M`&8`(``D`#$`.``Q`"``<`!E`'(`(`!S`&@`80!R`&4`(`!A`&X`9``@`'0`
M:`!E`"``-``N`#$`(`!M`&D`;`!L`&D`;P!N`"``<P!H`&$`<@!E`',`(`!A
M`'0`(`!T`&@`90`@`&8`:0!R`',`=``@`',`=`!A`&<`90`@`'``<@!I`&,`
M90`@`&\`9@`@`"0`,0`T`#,`+@`Q`#@`(`!P`&4`<@`@`',`:`!A`'(`90`L
M`"``80!N`&0`(``H`&D`:0`I`"``3@!E`',`=`!L`"``80`@`'``=0!T`"``
M;P!P`'0`:0!O`&X`(`!T`&\`(`!S`&4`;`!L`"``=`!O`"``3@!O`'8`80!R
M`'0`:0!S`"``80!L`&P`(`!B`'4`=``@`#0`+@`Q`"``;0!I`&P`;`!I`&\`
M;@`@`&\`9@`@`&D`=`!S`"``<@!E`&T`80!I`&X`:0!N`&<`(`!!`&P`8P!O
M`&X`(`!S`&@`80!R`&4`<P`@`'0`;P`@`$X`;P!V`&$`<@!T`&D`<P`@`&$`
M=``@`'0`:`!E`"``;`!O`'<`90!R`"``;P!F`"``3@!O`'8`80!R`'0`:0!S
M`"<`<P`@`&,`80!L`&P`(`!P`'(`:0!C`&4`(`!O`&8`(``D`#$`.``Q`"``
M<`!E`'(`(`!S`&@`80!R`&4`(`!O`'(`(`!A`"``<`!R`&4`;0!I`'4`;0`@
M`&\`9@`@`&$`<`!P`'(`;P!X`&D`;0!A`'0`90!L`'D`(``R`#``+@`U`"4`
M(`!A`&(`;P!V`&4`(`!T`&@`90`@`'0`:`!E`&X`+0!M`&$`<@!K`&4`=``@
M`'``<@!I`&,`90`@`&\`9@`@`$$`;`!C`&\`;@`@`',`:`!A`'(`90!S`"P`
M(`!W`&@`:0!C`&@`(`!W`&D`;`!L`"``8@!E`"``8P!A`&P`8P!U`&P`80!T
M`&4`9``@`&$`<P`@`'0`:`!E`"``80!V`&4`<@!A`&<`90`@`&T`80!R`&L`
M90!T`"``<`!R`&D`8P!E`"``;P!F`"``00!L`&,`;P!N`"``<P!H`&$`<@!E
M`',`(`!D`'4`<@!I`&X`9P`@`'0`:`!E`"``9@!I`'8`90`@`'0`<@!A`&0`
M:0!N`&<`(`!D`&$`>0!S`"``:0!M`&T`90!D`&D`80!T`&4`;`!Y`"``<`!R
M`&4`8P!E`&0`:0!N`&<`(`!T`&@`90`@`&4`>`!E`'(`8P!I`',`90`@`&0`
M80!T`&4`(`!O`&8`(`!T`&@`90`@`'``=0!T`"``;P!P`'0`:0!O`&X`+``@
M`'<`:0!T`&@`(`!T`&@`90`@`#0`+@`Q`"``;0!I`&P`;`!I`&\`;@`@`',`
M:`!A`'(`90`@`&(`80!L`&$`;@!C`&4`(`!T`&\`(`!B`&4`(`!S`&\`;`!D
M`"``80!T`"``=`!H`&4`(`!F`&D`<@!S`'0`(`!S`'0`80!G`&4`(`!C`&P`
M;P!S`&D`;@!G`"``<`!R`&D`8P!E`"``;P!F`"``)``Q`#0`,P`N`#$`.``@
M`'``90!R`"``<P!H`&$`<@!E`"X`#0`-``T`3P!N`"``2@!A`&X`=0!A`'(`
M>0`@`#0`+``@`#(`,``Q`#``+``@`$X`;P!V`&$`<@!T`&D`<P`@`&$`;@!N
M`&\`=0!N`&,`90!D`"``=`!H`&$`=``@`&D`=``@`&@`80!D`"``90!X`&4`
M<@!C`&D`<P!E`&0`(`!I`'0`<P`@`&\`<`!T`&D`;P!N`"``=`!O`"``<`!U
M`'(`8P!H`&$`<P!E`"``=`!H`&4`(`!R`&4`;0!A`&D`;@!I`&X`9P`@`&$`
M<`!P`'(`;P!X`&D`;0!A`'0`90!L`'D`(``Q`#4`-@`@`&T`:0!L`&P`:0!O
M`&X`(`!!`&P`8P!O`&X`(`!S`&@`80!R`&4`<P`@`&\`=P!N`&4`9``@`&(`
M>0`@`$X`90!S`'0`;``@`&$`=``@`&$`(`!W`&4`:0!G`&@`=`!E`&0`(`!A
M`'8`90!R`&$`9P!E`"``<`!R`&D`8P!E`"``;P!F`"``)``Q`#@`,``@`'``
M90!R`"``<P!H`&$`<@!E`"``:0!N`"``8P!A`',`:``L`"``<`!U`'(`<P!U
M`&$`;@!T`"``=`!O`"``=`!H`&4`(`!0`'4`<@!C`&@`80!S`&4`(`!A`&X`
M9``@`$\`<`!T`&D`;P!N`"``00!G`'(`90!E`&T`90!N`'0`+@!5`'``;P!N
M`"``8P!O`&X`<P!U`&T`;0!A`'0`:0!O`&X`(`!O`&8`(`!T`&@`90`@`'``
M=0!R`&,`:`!A`',`90`L`"``3@!O`'8`80!R`'0`:0!S`"``=P!O`'4`;`!D
M`"``;P!W`&X`(`!A`&X`(`!A`'``<`!R`&\`>`!I`&T`80!T`&4`(``W`#<`
M)0`@`&D`;@!T`&4`<@!E`',`=``@`&D`;@`@`$$`;`!C`&\`;@`N``T`#0`-
M`%0`:`!E`"``8P!O`&X`<P!U`&T`;0!A`'0`:0!O`&X`(`!O`&8`(`!A`"``
M<`!U`'(`8P!H`&$`<P!E`"``80!N`&0`(`!S`&$`;`!E`"``=`!R`&$`;@!S
M`&$`8P!T`&D`;P!N`"``=0!N`&0`90!R`"``=`!H`&4`(`!O`'``=`!I`&\`
M;@`@`'(`:0!G`&@`=``@`&D`<P`@`',`=0!B`&H`90!C`'0`(`!T`&\`(`!R
M`&4`9P!U`&P`80!T`&\`<@!Y`"``80!P`'``<@!O`'8`80!L`',`+@!4`&@`
M90`@`&,`;P!N`',`=0!M`&T`80!T`&D`;P!N`"``=P!O`'4`;`!D`"``=`!R
M`&D`9P!G`&4`<@`@`&,`90!R`'0`80!I`&X`(`!C`&@`80!N`&<`90`@`&\`
M9@`@`&,`;P!N`'0`<@!O`&P`(`!P`'(`;P!V`&D`<P!I`&\`;@!S`"``:0!N
M`"``=`!H`&4`(`!#`&\`;0!P`&$`;@!Y`"<`<P`@`',`:`!A`'(`90`M`&(`
M80!S`&4`9``@`&$`=P!A`'(`9`!S`"``<`!L`&$`;@`@`"@`:0!N`&,`;`!U
M`&0`:0!N`&<`(`!T`&@`90`@`'8`90!S`'0`:0!N`&<`(`!O`&8`(`!C`&4`
M<@!T`&$`:0!N`"``;P!U`'0`<P!T`&$`;@!D`&D`;@!G`"``<P!H`&$`<@!E
M`"T`8@!A`',`90!D`"``80!W`&$`<@!D`',`*0`L`"``8P!E`'(`=`!A`&D`
M;@`@`'(`90!T`&D`<@!E`&T`90!N`'0`(`!P`&P`80!N`',`(`!F`&\`<@`@
M`$,`;P!M`'``80!N`'D`(`!E`&T`<`!L`&\`>0!E`&4`<P`@`&$`;@!D`"``
M;P!T`&@`90!R`"``80!G`'(`90!E`&T`90!N`'0`<P`N``T`#0`-`%4`<`!O
M`&X`(`!C`&\`;@!S`'4`;0!M`&$`=`!I`&\`;@`L`"``=`!H`&4`(`!#`&\`
M;0!P`&$`;@!Y`"``=P!I`&P`;``@`&X`;P`@`&P`;P!N`&<`90!R`"``8@!E
M`&X`90!F`&D`=``@`&8`<@!O`&T`(`!C`&4`<@!T`&$`:0!N`"``<P!Y`&X`
M90!R`&<`:0!E`',`(`!A`',`(`!A`"``<@!E`',`=0!L`'0`(`!O`&8`(`!.
M`&4`<P!T`&P`)P!S`"``;P!W`&X`90!R`',`:`!I`'``+@!!`&P`8P!O`&X`
M(`!H`&$`<P`@`'0`80!K`&4`;@`@`&$`9`!V`&$`;@!T`&$`9P!E`"``;P!F
M`"``=`!H`&4`(`!S`'D`;@!E`'(`9P!I`&4`<P`@`&D`;@`@`',`90!V`&4`
M<@!A`&P`(`!F`'4`;@!C`'0`:0!O`&X`/``<(`%A`&P`(`!A`'(`90!A`',`
M+@!-`&$`;@!A`&<`90!M`&4`;@!T`"``9`!O`&4`<P`@`&X`;P!T`"``80!N
M`'0`:0!C`&D`<`!A`'0`90`@`&$`(`!S`&D`9P!N`&D`9@!I`&,`80!N`'0`
M(`!F`&D`;@!A`&X`8P!I`&$`;``@`&D`;0!P`&$`8P!T`"``=`!O`"``00!L
M`&,`;P!N`"``9`!U`&4`(`!T`&\`(`!T`&@`90`@`&P`;P!S`',`(`!O`&8`
M(`!T`&@`90!S`&4`(`!S`'D`;@!E`'(`9P!I`&4`<P`@`&(`90!C`&$`=0!S
M`&4`(`!T`&@`90`@`$,`;P!M`'``80!N`'D`(`!I`',`(`!C`'4`<@!R`&4`
M;@!T`&P`>0`@`&X`90!G`&\`=`!I`&$`=`!I`&X`9P`@`'<`:0!T`&@`(`!C
M`&4`<@!T`&$`:0!N`"``=@!E`&X`9`!O`'(`<P`O`',`=0!P`'``;`!I`&4`
M<@!S`"``80!N`&0`(`!F`&D`;@!A`&X`8P!I`&$`;``@`',`90!R`'8`:0!C
M`&4`<P`@`'``<@!O`'8`:0!D`&4`<@!S`"``=`!O`"``;0!I`'0`:0!G`&$`
M=`!E`"``80!N`'D`(`!P`&\`=`!E`&X`=`!I`&$`;``@`&D`;0!P`&$`8P!T
M`"``9@!R`&\`;0`@`&$`(`!C`&@`80!N`&<`90`@`&\`9@`@`&,`;P!N`'0`
M<@!O`&P`+@!(`&\`=P!E`'8`90!R`"P`(`!N`&\`(`!A`',`<P!U`'(`80!N
M`&,`90!S`"``8P!A`&X`(`!B`&4`(`!M`&$`9`!E`"``80!T`"``=`!H`&D`
M<P`@`'0`:0!M`&4`+@`-``T`#0!!`',`(`!A`"``<@!E`',`=0!L`'0`(`!O
M`&8`(`!.`&\`=@!A`'(`=`!I`',`)P!S`"``<`!L`&$`;@!N`&4`9``@`&$`
M8P!Q`'4`:0!S`&D`=`!I`&\`;@`@`&\`9@`@`$X`90!S`'0`;``G`',`(`!R
M`&4`;0!A`&D`;@!I`&X`9P`@`$$`;`!C`&\`;@`@`',`:`!A`'(`90!S`"P`
M(`!!`&P`8P!O`&X`)P!S`"``<@!E`&P`80!T`&D`;P!N`',`:`!I`'``<P`@
M`'<`:0!T`&@`(`!T`&@`:0!R`&0`(`!P`&$`<@!T`&D`90!S`"``:0!N`"``
M=`!H`&4`(`!P`&@`80!R`&T`80!C`&4`=0!T`&D`8P!A`&P`(`!A`&X`9``@
M`&\`=`!H`&4`<@`@`&D`;@!D`'4`<P!T`'(`:0!E`',`(`!M`&$`>0`@`&(`
M90`@`&D`;0!P`&$`8P!T`&4`9``L`"``=P!H`&D`8P!H`"``:0!N`"``<P!O
M`&T`90`@`&,`80!S`&4`<P`@`&T`80!Y`"``80!F`&8`90!C`'0`(`!!`&P`
M8P!O`&X`)P!S`"``8@!U`',`:0!N`&4`<P!S`"``9`!E`'8`90!L`&\`<`!M
M`&4`;@!T`"``80!N`&0`(`!L`&D`8P!E`&X`<P!I`&X`9P`@`&\`<`!P`&\`
M<@!T`'4`;@!I`'0`:0!E`',`+@`-``T`#0!.`&\`=@!A`'(`=`!I`',`(`!A
M`&P`<P!O`"``80!N`&X`;P!U`&X`8P!E`&0`(`!T`&@`80!T`"``:0!T`"``
M<P!U`&(`;0!I`'0`=`!E`&0`(`!T`&\`(`!T`&@`90`@`$$`;`!C`&\`;@`@
M`&(`;P!A`'(`9``@`&\`9@`@`&0`:0!R`&4`8P!T`&\`<@!S`"``'0`!0P!O
M`&T`;0!I`'0`;0!E`&X`=`!S`"``80!N`&0`(`!#`&\`;@!T`&D`;@!G`&4`
M;@!C`&D`90!S`(`,`0T`#0`H`#$`-``I``D`#0`-`$,`;P!M`&T`:0!T`&T`
M90!N`'0`<P`@`&$`;@!D`"``0P!O`&X`=`!I`&X`9P!E`&X`8P!I`&4`<P`-
M``T`*`!I`&X`(`!M`&D`;`!L`&D`;P!N`',`+``@`&4`>`!C`&4`<`!T`"``
M<`!E`'(`(`!S`&@`80!R`&4`(`!D`&$`=`!A`"D`#0`-`$T`:0!N`&\`<@!I
M`'0`>0`@`%,`:`!A`'(`90!H`&\`;`!D`&4`<@`@`$,`;`!A`',`<P`@`$$`
M8P!T`&D`;P!N`"``3`!A`'<`<P!U`&D`=`!S``T`#0`-`$\`;@`@`$H`80!N
M`'4`80!R`'D`(``T`"P`(``R`#``,0`P`"P`(`!.`&\`=@!A`'(`=`!I`',`
M(`!A`&X`;@!O`'4`;@!C`&4`9``@`'0`:`!A`'0`(`!I`'0`(`!S`'4`8@!M
M`&D`=`!T`&4`9``@`'0`;P`@`'0`:`!E`"``00!L`&,`;P!N`"``8@!O`&$`
M<@!D`"``;P!F`"``9`!I`'(`90!C`'0`;P!R`',`(`!A`"``<`!R`&\`<`!O
M`',`80!L`"``9@!O`'(`(`!A`"``;0!E`'(`9P!E`'(`(`!O`&8`(`!!`&P`
M8P!O`&X`(`!W`&D`=`!H`"``80!N`&0`(`!I`&X`=`!O`"``3@!O`'8`80!R
M`'0`:0!S`"``=`!O`"``8@!E`"``90!F`&8`90!C`'0`90!D`"``=0!N`&0`
M90!R`"``4P!W`&D`<P!S`"``;0!E`'(`9P!E`'(`(`!L`&$`=P`@`"@`;@!O
M`'0`90`@`#$`,P`I`"X`50!N`&0`90!R`"``=`!H`&4`(`!T`&4`<@!M`',`
M(`!O`&8`(`!T`&@`90`@`&T`90!R`&<`90!R`"``<`!R`&\`<`!O`',`80!L
M`"P`(`!H`&\`;`!D`&4`<@!S`"``;P!F`"``=`!H`&4`(`!A`'``<`!R`&\`
M>`!I`&T`80!T`&4`(``R`#,`)0`@`&\`9@`@`$$`;`!C`&\`;@`@`',`:`!A
M`'(`90!S`"``=`!H`&$`=``@`&$`<@!E`"``<`!U`&(`;`!I`&,`;`!Y`"``
M=`!R`&$`9`!E`&0`(`!W`&\`=0!L`&0`(`!R`&4`8P!E`&D`=@!E`"``,@`N
M`#@`(`!.`&\`=@!A`'(`=`!I`',`(`!S`&@`80!R`&4`<P`@`&8`;P!R`"``
M90!A`&,`:``@`$$`;`!C`&\`;@`@`',`:`!A`'(`90`N``T`#0`-`%0`:`!E
M`"``20!N`&0`90!P`&4`;@!D`&4`;@!T`"``1`!I`'(`90!C`'0`;P!R`"``
M0P!O`&T`;0!I`'0`=`!E`&4`(`!W`&$`<P`@`&8`;P!R`&T`90!D`"``:0!N
M`"``,@`P`#``.``@`&D`;@`@`&,`;P!N`&X`90!C`'0`:0!O`&X`(`!W`&D`
M=`!H`"``3@!O`'8`80!R`'0`:0!S`"<`<P`@`&D`;@!I`'0`:0!A`&P`(`!P
M`'4`<@!C`&@`80!S`&4`(`!O`&8`(`!S`&P`:0!G`&@`=`!L`'D`(`!L`&4`
M<P!S`"``=`!H`&$`;@`@`#(`-0`E`"``;P!F`"``=`!H`&4`(`!!`&P`8P!O
M`&X`(`!S`&@`80!R`&4`<P`@`&8`<@!O`&T`(`!.`&4`<P!T`&P`(`!T`&\`
M(`!E`'8`80!L`'4`80!T`&4`(`!T`'(`80!N`',`80!C`'0`:0!O`&X`<P`@
M`',`=0!C`&@`(`!A`',`(`!T`&@`90`@`&T`90!R`&<`90!R`"``<`!R`&\`
M<`!O`',`90!D`"``8@!Y`"``3@!O`'8`80!R`'0`:0!S`"X`5`!H`&4`(`!)
M`&X`9`!E`'``90!N`&0`90!N`'0`(`!$`&D`<@!E`&,`=`!O`'(`(`!#`&\`
M;0!M`&D`=`!T`&4`90`@`&4`;@!G`&$`9P!E`&0`(`!I`&X`9`!E`'``90!N
M`&0`90!N`'0`(`!F`&D`;@!A`&X`8P!I`&$`;``@`&$`;@!D`"``;`!E`&<`
M80!L`"``80!D`'8`:0!S`&\`<@!S`"``:0!N`"``8P!O`&X`;@!E`&,`=`!I
M`&\`;@`@`'<`:0!T`&@`(`!I`'0`<P`@`&4`=@!A`&P`=0!A`'0`:0!O`&X`
M(`!O`&8`(`!T`&@`90`@`'``<@!O`'``;P!S`&4`9``@`&T`90!R`&<`90!R
M`"X`3P!N`"``2@!A`&X`=0!A`'(`>0`@`#(`,``L`"``,@`P`#$`,``L`"``
M=`!H`&4`(`!)`&X`9`!E`'``90!N`&0`90!N`'0`(`!$`&D`<@!E`&,`=`!O
M`'(`(`!#`&\`;0!M`&D`=`!T`&4`90`@`&D`<P!S`'4`90!D`"``:0!T`',`
M(`!F`&\`<@!M`&$`;``@`'(`90!S`'``;P!N`',`90`@`'(`90!J`&4`8P!T
M`&D`;@!G`"``=`!H`&4`(`!.`&\`=@!A`'(`=`!I`',`(`!M`&4`<@!G`&4`
M<@`@`'``<@!O`'``;P!S`&$`;``N`%0`:`!E`"``8P!O`&T`;0!I`'0`=`!E
M`&4`(`!R`&4`:@!E`&,`=`!E`&0`(`!T`&@`90`@`&T`90!R`&<`90!R`"``
M<`!R`&\`<`!O`',`80!L`"``8@!A`',`90!D`"``;P!N`"``:0!T`',`(`!A
M`',`<P!E`',`<P!M`&4`;@!T`"``=`!H`&$`=``@`'0`:`!E`"``<`!R`&D`
M8P!E`"``;P!F`&8`90!R`&4`9``@`&$`;@!D`"``;P!T`&@`90!R`"``=`!E
M`'(`;0!S`"``=P!E`'(`90`@`&X`;P!T`"``80!C`&,`90!P`'0`80!B`&P`
M90`@`&$`;@!D`"``=`!H`&$`=``@`$X`;P!V`&$`<@!T`&D`<P`G`',`(`!M
M`&4`<@!G`&4`<@`@`'``<@!O`'``;P!S`&$`;``@`'<`80!S`"``;@!O`'0`
M(`!I`&X`(`!T`&@`90`@`&(`90!S`'0`(`!I`&X`=`!E`'(`90!S`'0`<P`@
M`&\`9@`@`$$`;`!C`&\`;@`@`&$`;@!D`"``:0!T`',`(`!M`&D`;@!O`'(`
M:0!T`'D`(`!S`&@`80!R`&4`:`!O`&P`9`!E`'(`<P`N``T`#0`-`$,`90!R
M`'0`80!I`&X`(`!!`&P`8P!O`&X`(`!M`&D`;@!O`'(`:0!T`'D`(`!S`&@`
M80!R`&4`:`!O`&P`9`!E`'(`<P`@`&@`80!V`&4`(`!F`&D`;`!E`&0`(`!S
M`&4`=@!E`'(`80!L`"``8P!L`&$`<P!S`"``80!C`'0`:0!O`&X`(`!L`&$`
M=P!S`'4`:0!T`',`(`!R`&4`;`!A`'0`90!D`"``=`!O`"``3@!O`'8`80!R
M`'0`:0!S`"<`<P`@`&T`90!R`&<`90!R`"``<`!R`&\`<`!O`',`80!L`"``
M8P!O`&X`8P!E`'(`;@!I`&X`9P`@`'0`:`!E`"``80!C`'$`=0!I`',`:0!T
M`&D`;P!N`"``;P!F`"``=`!H`&4`(`!R`&4`;0!A`&D`;@!I`&X`9P`@`#(`
M,P`E`"``<`!U`&(`;`!I`&,`;`!Y`"``:`!E`&P`9``@`&T`:0!N`&\`<@!I
M`'0`>0`@`&D`;@!T`&4`<@!E`',`=``N`%0`:`!E`"``8P!L`&$`:0!M`',`
M(`!V`&$`<@!Y`"``80!M`&\`;@!G`"``=`!H`&4`(`!C`&$`<P!E`',`+``@
M`&(`=0!T`"``:0!N`&,`;`!U`&0`90`@`&$`;`!L`&4`9P!A`'0`:0!O`&X`
M<P`@`&\`9@`Z`"``*`!I`"D`(`!B`'(`90!A`&,`:``@`&\`9@`@`&,`;P!N
M`'0`<@!A`&,`=``@`&$`9P!A`&D`;@!S`'0`(`!!`&P`8P!O`&X`.P`@`"@`
M:0!I`"D`(`!T`&\`<@!T`&D`;P!U`',`(`!I`&X`=`!E`'(`9@!E`'(`90!N
M`&,`90`@`'<`:0!T`&@`(`!C`&\`;@!T`'(`80!C`'0`(`!A`&<`80!I`&X`
M<P!T`"``3@!O`'8`80!R`'0`:0!S`"``80!N`&0`(`!.`&4`<P!T`&P`(``H
M`&D`:0!I`"D`(`!B`'(`90!A`&,`:``@`&\`9@`@`&8`:0!D`'4`8P!I`&$`
M<@!Y`"``9`!U`'0`:0!E`',`(`!A`&<`80!I`&X`<P!T`"``=`!H`&4`(`!!
M`&P`8P!O`&X`(`!B`&\`80!R`&0`(`!O`&8`(`!D`&D`<@!E`&,`=`!O`'(`
M<P`L`"``3@!E`',`=`!L`"``80!N`&0`(`!.`&\`=@!A`'(`=`!I`',`.P`@
M`"@`:0!V`"D`(`!A`&D`9`!I`&X`9P`@`&$`;@!D`"``80!B`&4`=`!T`&D`
M;@!G`"``8@!R`&4`80!C`&@`90!S`"``;P!F`"``9@!I`&0`=0!C`&D`80!R
M`'D`(`!D`'4`=`!I`&4`<P`@`&$`9P!A`&D`;@!S`'0`(`!T`&@`90`@`$$`
M;`!C`&\`;@`@`&(`;P!A`'(`9``@`&\`9@`@`&0`:0!R`&4`8P!T`&\`<@!S
M`"P`(`!.`&4`<P!T`&P`(`!A`&X`9``@`$X`;P!V`&$`<@!T`&D`<P`[`"``
M*`!V`"D`(`!B`'(`90!A`&,`:``@`&\`9@`@`%,`90!C`'0`:0!O`&X`(``Q
M`#,`*`!D`"D`(`!O`&8`(`!T`&@`90`@`$4`>`!C`&@`80!N`&<`90`@`$$`
M8P!T`"``80!G`&$`:0!N`',`=``@`$X`;P!V`&$`<@!T`&D`<P`@`&$`;@!D
M`"``3@!E`',`=`!L`"``9@!O`'(`(`!A`&X`(`!A`&P`;`!E`&<`90!D`"``
M9@!A`&D`;`!U`'(`90`@`'0`;P`@`&0`:0!S`&,`;`!O`',`90`@`'0`:`!A
M`'0`(`!T`&@`90!Y`"``=P!E`'(`90`@`&$`8P!T`&D`;@!G`"``80!S`"``
M80`@`"(`9P!R`&\`=0!P`#L`(@`@`&$`;@!D`"``*`!V`&D`*0`@`&(`<@!E
M`&$`8P!H`"``;P!F`"``4P!E`&,`=`!I`&\`;@`@`#$`-``H`&0`*0`@`&\`
M9@`@`'0`:`!E`"``10!X`&,`:`!A`&X`9P!E`"``00!C`'0`(`!A`&<`80!I
M`&X`<P!T`"``3@!O`'8`80!R`'0`:0!S`"``80!N`&0`(`!.`&4`<P!T`&P`
M(`!F`&\`<@`@`&$`;@`@`&$`;`!L`&4`9P!E`&0`(`!F`&$`:0!L`'4`<@!E
M`"``=`!O`"``9@!I`&P`90`@`'<`:0!T`&@`(`!T`&@`90`@`%4`+@!3`"X`
M(`!3`&4`8P!U`'(`:0!T`&D`90!S`"``80!N`&0`(`!%`'@`8P!H`&$`;@!G
M`&4`(`!#`&\`;0!M`&D`<P!S`&D`;P!N`"``=`!H`&4`(`!M`&$`=`!E`'(`
M:0!A`&P`<P`@`'(`90!Q`'4`:0!R`&4`9``@`&D`;@`@`&,`;P!N`&X`90!C
M`'0`:0!O`&X`(`!W`&D`=`!H`"``80`@`"(`=`!E`&X`9`!E`'(`(`!O`&8`
M9@!E`'(`+@`B`%,`90!V`&4`;@`@`&,`80!S`&4`<P`@`&8`:0!L`&4`9``@
M`&D`;@`@`'0`:`!E`"``4P!O`'4`=`!H`&4`<@!N`"``1`!I`',`=`!R`&D`
M8P!T`"``;P!F`"``3@!E`'<`(`!9`&\`<@!K`"``:`!A`'8`90`@`&(`90!E
M`&X`(`!C`&\`;@!S`&\`;`!I`&0`80!T`&4`9``@`&D`;@!T`&\`(`!O`&X`
M90`@`&,`;`!A`',`<P`@`&$`8P!T`&D`;P!N`"``8P!A`',`90`N`$\`;@!E
M`"``8P!A`',`90`@`&D`<P`@`'``90!N`&0`:0!N`&<`(`!I`&X`(`!T`&@`
M90`@`%4`+@!3`"X`(`!$`&D`<P!T`'(`:0!C`'0`(`!#`&\`=0!R`'0`(`!F
M`&\`<@`@`'0`:`!E`"``3@!O`'(`=`!H`&4`<@!N`"``1`!I`',`=`!R`&D`
M8P!T`"``;P!F`"``5`!E`'@`80!S`"P`(`!&`&\`<@!T`"``5P!O`'(`=`!H
M`"``1`!I`'8`:0!S`&D`;P!N`"P`(`!B`'4`=``@`'0`:`!E`"``<`!L`&$`
M:0!N`'0`:0!F`&8`<P`@`'0`:`!E`'(`90`@`&@`80!V`&4`(`!A`&<`<@!E
M`&4`9``@`'0`;P`@`&H`;P!I`&X`(`!T`&@`90`@`'``;`!A`&D`;@!T`&D`
M9@!F`',`(`!I`&X`(`!T`&@`90`@`%,`;P!U`'0`:`!E`'(`;@`@`$0`:0!S
M`'0`<@!I`&,`=``@`&\`9@`@`$X`90!W`"``60!O`'(`:P`@`&$`8P!T`&D`
M;P!N`"``<@!A`'0`:`!E`'(`(`!T`&@`80!N`"``<`!U`'(`<P!U`&4`(`!T
M`&@`90!I`'(`(`!C`&P`80!I`&T`<P`@`',`90!P`&$`<@!A`'0`90!L`'D`
M+@!/`&X`90`@`&,`80!S`&4`+``@`'<`:`!I`&,`:``@`&0`:0!D`"``;@!O
M`'0`(`!N`&$`;0!E`"``00!L`&,`;P!N`"P`(`!)`&X`8P`N`"``80!N`&0`
M(`!I`'0`<P`@`&(`;P!A`'(`9``@`&\`9@`@`&0`:0!R`&4`8P!T`&\`<@!S
M`"``80!S`"``<`!A`'(`=`!I`&4`<P`L`"``:`!A`&0`(`!B`&4`90!N`"``
M9@!I`&P`90!D`"``:0!N`"``=`!H`&4`(`!%`&$`<P!T`&4`<@!N`"``1`!I
M`',`=`!R`&D`8P!T`"``;P!F`"``3@!E`'<`(`!9`&\`<@!K`"``8@!U`'0`
M(`!W`&$`<P`@`'8`;P!L`'4`;@!T`&$`<@!I`&P`>0`@`&0`:0!S`&T`:0!S
M`',`90!D`"``8@!Y`"``=`!H`&4`(`!P`&P`80!I`&X`=`!I`&8`9@!S`"``
M;P!N`"``30!A`'(`8P!H`"``,0`X`"P`(``R`#``,0`P`"X`5`!W`&\`(`!C
M`&$`<P!E`',`(`!F`&D`;`!E`&0`(`!I`&X`(`!$`&D`<P!T`'(`:0!C`'0`
M(`!#`&\`=0!R`'0`+``@`%0`80!R`'(`80!N`'0`(`!#`&\`=0!N`'0`>0`@
M`&$`;@!D`"``=`!W`&\`(`!C`&$`<P!E`',`(`!F`&D`;`!E`&0`(`!I`&X`
M(`!T`&@`90`@`$,`;P!U`&X`=`!Y`"``0P!O`'4`<@!T`"``80!T`"``3`!A
M`'<`+``@`$0`80!L`&P`80!S`"``0P!O`'4`;@!T`'D`+``@`%0`90!X`&$`
M<P`@`&@`80!V`&4`(`!B`&4`90!N`"``8P!O`&X`<P!O`&P`:0!D`&$`=`!E
M`&0`(`!F`&\`<@`@`'``<@!E`"T`=`!R`&D`80!L`"``<`!U`'(`<`!O`',`
M90!S`"``8@!Y`"``=`!H`&4`(`!4`&4`>`!A`',`(`!-`'4`;`!T`&D`9`!I
M`',`=`!R`&D`8P!T`"``3`!I`'0`:0!G`&$`=`!I`&\`;@`@`%``80!N`&4`
M;``@`&D`;@`@`'0`:`!E`"``1`!I`',`=`!R`&D`8P!T`"``0P!O`'4`<@!T
M`"P`(`!$`&$`;`!L`&$`<P`@`$,`;P!U`&X`=`!Y`"X`#0`-``T`3P!N`"``
M00!P`'(`:0!L`"``,0`T`"P`(``R`#``,0`P`"P`(`!P`&P`80!I`&X`=`!I
M`&8`9@!S`"``:0!N`"``=`!H`&4`(`!3`&\`=0!T`&@`90!R`&X`(`!$`&D`
M<P!T`'(`:0!C`'0`(`!O`&8`(`!.`&4`=P`@`%D`;P!R`&L`(`!A`&,`=`!I
M`&\`;@`@`&$`9P!R`&4`90!D`"``=`!O`"``9`!I`',`;0!I`',`<P`@`'0`
M:`!E`&D`<@`@`&,`;`!A`&D`;0!S`"``80!G`&$`:0!N`',`=``@`$X`90!S
M`'0`;``@`&$`;@!D`"``=`!H`&4`(`!F`&D`=@!E`"``00!L`&,`;P!N`"``
M9`!I`'(`90!C`'0`;P!R`',`(`!N`&\`;0!I`&X`80!T`&4`9``@`&(`>0`@
M`$X`90!S`'0`;``@`&D`;@`@`&4`>`!C`&@`80!N`&<`90`@`&8`;P!R`"``
M3@!E`',`=`!L`',`(`!A`&X`9``@`&D`=`!S`"``9`!I`'(`90!C`'0`;P!R
M`',`(`!A`&<`<@!E`&4`;0!E`&X`=``@`'0`:`!A`'0`+``@`'<`:0!T`&@`
M;P!U`'0`(`!I`&T`<`!A`&D`<@!I`&X`9P`@`'0`:`!E`"``9`!I`'(`90!C
M`'0`;P!R`',`(`!A`&(`:0!L`&D`=``4``%$`&\`8P!U`&T`90!N`'0`(`!)
M`&X`9@!O`'(`;0!A`'0`:0!O`&X`(0`!1`!O`&,`=0!M`&4`;@!T`"``20!N
M`&8`;P!R`&T`80!T`&D`;P!N`"``6P!4`&4`>`!T`"``0@!L`&\`8P!K`%T`
M#0`!1`!O`&,`=0!M`&4`;@!T`"``5`!Y`'``90`#``$V`"T`2P`8``%$`&\`
M8P!U`&T`90!N`'0`(`!0`&4`<@!I`&\`9``@`$4`;@!D`"``1`!A`'0`90`*
M``$R`#``,0`P`"T`,``S`"T`,P`Q``X``4$`;0!E`&X`9`!M`&4`;@!T`"``
M1@!L`&$`9P`%``%F`&$`;`!S`&4`&@`!10!N`'0`:0!T`'D`(`!)`&X`9@!O
M`'(`;0!A`'0`:0!O`&X`(``H`%4`4P!$`"``)``I`!,``44`;@!T`&D`=`!Y
M`"``6P!4`&4`>`!T`"``0@!L`&\`8P!K`%T`%@`!10!N`'0`:0!T`'D`(`!2
M`&4`9P!I`',`=`!R`#P`T@(!80!N`'0`(`!.`&$`;0!E``D``4$`3`!#`$\`
M3@`@`$D`3@!#`!@``44`;@!T`&D`=`!Y`"``0P!E`&X`=`!R`&$`;``@`$D`
M;@!D`&4`>``@`$L`90!Y``H``3``,``P`#$`,0`V`#<`,P`W`#D`'``!0P!U
M`'(`<@!E`&X`=``@`$8`:0!S`&,`80!L`"``60!E`&$`<@`@`$4`;@!D`"``
M1`!A`'0`90`'``$M`"T`,0`R`"T`,P`Q`!\``44`;@!T`&D`=`!Y`"``0P!U
M`'(`<@!E`&X`=``@`%(`90!P`&\`<@!T`&D`;@!G`"``4P!T`&$`=`!U`',`
M`P`!60!E`',`(0`!10!N`'0`:0!T`'D`(`!7`&4`;`!L`"``2P!N`&\`=P!N
M`"``4P!E`&$`<P!O`&X`90!D`"``20!S`',`=0!E`'(`%P`!10!N`'0`:0!T
M`'D`(`!6`&\`;`!U`&X`=`!A`'(`>0`@`$8`:0!L`&4`<@!S``(``4X`;P`5
M``%%`&X`=`!I`'0`>0`@`$8`:0!L`&4`<@`@`$,`80!T`&4`9P!O`'(`>0`7
M``%,`&$`<@!G`&4`(`!!`&,`8P!E`&P`90!R`&$`=`!E`&0`(`!&`&D`;`!E
M`'(`$P`!10!N`'0`:0!T`'D`(`!0`'4`8@!L`&D`8P`@`$8`;`!O`&$`=``F
M``%%`&X`=`!I`'0`>0`@`$,`;P!M`&T`;P!N`"``4P!T`&\`8P!K`"``4P!H
M`&$`<@!E`',`(`!/`'4`=`!S`'0`80!N`&0`:0!N`&<`&@`!1`!O`&,`=0!M
M`&4`;@!T`"``1@!I`',`8P!A`&P`(`!9`&4`80!R`"``1@!O`&,`=0!S`!P`
M`40`;P!C`'4`;0!E`&X`=``@`$8`:0!S`&,`80!L`"``4`!E`'(`:0!O`&0`
M(`!&`&\`8P!U`',``@`!40`Q`/\`H@`(`.X-```,````<@\``)`!``#.$```
M[`(``$H2``!H!```\A4``!`(``"N&```S`H``-(:``#P#```4!P``&X.``">
M'0``O`\``%0@``!R$@``"",``"85``"")0``H!<``!HH```X&@``FTH``)D<
M```7AP``UA@``+W,```^'@``=!0!`)8%``!V+@$`F!\``+$O`0"S````YS`!
M`.D!```*````"0@0```&$`!&&,T'P8````8"```+`A@````````````B````
M`````#@Z`0#P.@$`#0`"``$`#``"`&0`#P`"``$`$0`"````$``(`/RI\=)-
M8E`_7P`"``$`*@`"````*P`"````@@`"``$`@``(````````````)0($````
M_P"!``(`P004````%0```(,``@```(0``@```*$`(@`)`&0``0`!``$`1@!8
M`E@"````````X#\```````#@/P$`50`"``@`?0`,``````"V/`\````$`'T`
M#``!``(`MA@/````!`!]``P``P#_`"0)#P````0```(.```````B```````#
M````"`(0`````````/\````````!#P`(`A```0````(`_P````````$/``@"
M$``"``````#_`````````0\`"`(0``,````"`/\````````!#P`(`A``!```
M``(`_P````````$/``@"$``%`````@#_`````````0\`"`(0``8````"`/\`
M```````!#P`(`A``!P````(`_P````````$/``@"$``(`````@#_````````
M`0\`"`(0``D````"`/\````````!#P`(`A``"@````(`_P````````$/``@"
M$``+`````@#_`````````0\`"`(0``P````"`/\````````!#P`(`A``#0``
M``(`_P````````$/``@"$``.`````@#_`````````0\`"`(0``\````"`/\`
M```````!#P`(`A``$`````(`_P````````$/``@"$``1``````#_````````
M`0\`"`(0`!(````"`/\````````!#P`(`A``$P````(`_P````````$/``@"
M$``4`````@#_`````````0\`"`(0`!4````"`/\````````!#P`(`A``%@``
M``(`_P````````$/``@"$``7`````@#_`````````0\`"`(0`!@````"`/\`
M```````!#P`(`A``&0````(`_P````````$/``@"$``:``````#_````````
M`0\`"`(0`!L````"`/\````````!#P`(`A``'`````(`_P````````$/``@"
M$``=`````@#_`````````0\`"`(0`!X````"`/\````````!#P`(`A``'P``
M``(`_P````````$/`/T`"@``````%P``````_0`*``$````7``$```#]``H`
M`0`!`!<``@```/T`"@`!``(`%P`#````_0`*``(````6``0```#]``H``P``
M`!@`!0```+T`$@`#``$`&0``<JA`&0``?J=``@#]``H`!````!@`!@```+T`
M$@`$``$`&@``\(!`&@``\'U``@#]``H`!0```!@`!P```+T`$@`%``$`&@``
MP)9`&@``")5``@#]``H`!@```!@`"````+T`$@`&``$`&@``((-`&@``D(-`
M`@#]``H`!P```!@`"0```+T`$@`'``$`&@``8&1`&@``0&1``@#]``H`"```
M`!@`"@```+T`$@`(``$`&@``0&Q`&@``H&I``@#]``H`"0```!@`"P```+T`
M$@`)``$`&P``\+=`&P``R;9``@#]``H`"@```!@`#````+T`$@`*``$`&@``
M`%!`&@``0%)``@#]``H`"P```!@`#0```+T`$@`+``$`&@``+)1`&@``8)1`
M`@#]``H`#````!@`#@```+T`$@`,``$`&@``8(!`&@``X&]``@#]``H`#0``
M`!@`#P```+T`$@`-``$`&@``X(5`&@``@(5``@#]``H`#@```!@`$````+T`
M$@`.``$`&@``L'9`&@``<'A``@#]``H`#P```!@`$0```+T`$@`/``$`&@``
MX&%`&@``P&%``@#]``H`$````!@`$@```+T`$@`0``$`&P"`_L%`&P``]\!`
M`@#]``H`$0```!8`$P```/T`"@`2````&``4````O0`2`!(``0`:``!0<T`:
M```0=$`"`/T`"@`3````&``5````O0`2`!,``0`:``#8A$`:``#X@D`"`/T`
M"@`4````&``6````O0`2`!0``0`:````2T`:```````"`/T`"@`5````&``7
M````O0`2`!4``0`:``#(C$`:``!<D$`"`/T`"@`6````&``8````O0`2`!8`
M`0`;``!\GD`;``#<GD`"`/T`"@`7````&``9````O0`2`!<``0`:```````:
M````3$`"`/T`"@`8````&``:````O0`2`!@``0`:``!`4D`:``"`34`"`/T`
M"@`9````&``;````O0`2`!D``0`:``"8AD`:``"8A4`"`/T`"@`:````%@`<
M````_0`*`!L````8`!T```"]`!(`&P`!`!H```!%0!H```!%0`(`_0`*`!P`
M```8`!X```"]`!(`'``!`!H``&R80!H``/R70`(`_0`*`!T````8`!\```"]
M`!(`'0`!`!H``,!>0!H``&!I0`(`_0`*`!X````8`"````"]`!(`'@`!`!H`
M`/"S0!H``+6Q0`(`_0`*`!\````8`"$```"]`!(`'P`!`!H``.!VP!H``(!Y
MP`(`UP!$`*X&``!L`@X`*@`.`"0`)``D`"0`)``D`"0`)``D`"0`)``D`"0`
M)``.`"0`)``D`"0`)``D`"0`)``.`"0`)``D`"0`"`(0`"`````"`/\`````
M```!#P`(`A``(0````(`_P````````$/`/T`"@`@````&``B````O0`2`"``
M`0`;``!"N4`;```1MT`"`/T`"@`A````&``C````O0`2`"$``0`<`(#^P4`<
M``#WP$`"`-<`"`!P````%``D`#X"$@"V!@````!```````````````"@``0`
M9`!D`!T`#P`#`````````0````````#O``8````W````"@````D($```!A``
M1AC-!\&````&`@``"P(4````````````"`````````#5/0$`#0`"``$`#``"
M`&0`#P`"``$`$0`"````$``(`/RI\=)-8E`_7P`"``$`*@`"````*P`"````
M@@`"``$`@``(````````````)0($````_P"!``(`P004````%0```(,``@``
M`(0``@```*$`(@`)`&0``0`!``$`1@!8`E@"````````X#\```````#@/P$`
M50`"``@`?0`,``````"V/`\````$`'T`#``!``(`MA@/````!`!]``P``P#_
M`"0)#P````0```(.```````(```````#````"`(0`````````/\````````!
M#P`(`A```0````(`_P````````$/``@"$``"``````#_`````````0\`"`(0
M``,````"`/\````````!#P`(`A``!`````(`_P````````$/``@"$``%````
M`@#_`````````0\`"`(0``8````"`/\````````!#P`(`A``!P````(`_P``
M``````$/`/T`"@``````%P`D`````0(&``$````7`/T`"@`!``$`%P`"````
M_0`*``$``@`7``,```#]``H``@```!8`'````/T`"@`#````&``E````O0`2
M``,``0`=``$`-$`=``$`-$`"`/T`"@`$````&``F````O0`2``0``0`:`.+#
M6DP:`.+#6DP"`/T`"@`%````&``G````O0`2``4``0`:`!;VA4@:`(JN>T@"
M`/T`"@`&````&``H````O0`2``8``0`:`+:UE$<:`#8@:T<"`/T`"@`'````
M&``I````O0`2``<``0`:``PH3D$:`%:.$`$"`-<`%`"6`0``C``.`"8`#@`D
M`"0`)``D`#X"$@"V``````!```````````````"@``0`9`!D`!T`#P`#````
M`````0````````#O``8````W````"@````D($```!A``1AC-!\&````&`@``
M"P(4````````````%P````````#\0P$`#0`"``$`#``"`&0`#P`"``$`$0`"
M````$``(`/RI\=)-8E`_7P`"``$`*@`"````*P`"````@@`"``$`@``(````
M````````)0($````_P"!``(`P004````%0```(,``@```(0``@```*$`(@`)
M`&0``0`!``$`1@!8`E@"````````X#\```````#@/P$`50`"``@`?0`,````
M``"V/`\````$`'T`#``!``(`MA@/````!`!]``P``P#_`"0)#P````0```(.
M```````7```````#````"`(0`````````/\````````!#P`(`A```0````(`
M_P````````$/``@"$``"``````#_`````````0\`"`(0``,````"`/\`````
M```!#P`(`A``!`````(`_P````````$/``@"$``%`````@#_`````````0\`
M"`(0``8````"`/\````````!#P`(`A``!P````(`_P````````$/``@"$``(
M`````@#_`````````0\`"`(0``D````"`/\````````!#P`(`A``"@````(`
M_P````````$/``@"$``+``````#_`````````0\`"`(0``P````"`/\`````
M```!#P`(`A``#0````(`_P````````$/``@"$``.`````@#_`````````0\`
M"`(0``\````"`/\````````!#P`(`A``$`````(`_P````````$/``@"$``1
M`````@#_`````````0\`"`(0`!(````"`/\````````!#P`(`A``$P````(`
M_P````````$/``@"$``4`````@#_`````````0\`"`(0`!4````"`/\`````
M```!#P`(`A``%@````(`_P````````$/`/T`"@``````%P`J````_0`*``$`
M```7`"L```#]``H``0`!`!<`+````/T`"@`!``(`%P`M````_0`*``(````6
M`"X```#]``H``P```!@`+P```+T`$@`#``$`&0``Y)I`&0``5)=``@#]``H`
M!````!@`,````+T`$@`$``$`&@``@'A`&@``('9``@#]``H`!0```!@`,0``
M`+T`$@`%``$`&P``Q)1`&P``S)%``@#]``H`!@```!@`,@```+T`$@`&``$`
M&@``P'Y`&@``@'U``@#]``H`!P```!@`,P```+T`$@`'``$`&@``(&5`&@``
M0&)``@#]``H`"````!@`-````+T`$@`(``$`&@```"9`&@```!Q``@#]``H`
M"0```!@`-0```+T`$@`)``$`&@```!!`&@```````@#]``H`"@```!@`-@``
M`+T`$@`*``$`&P``:(1`&P``$(!``@#]``H`"P```!8`-P```/T`"@`,````
M&``X````O0`2``P``0`:`````,`:````),`"`/T`"@`-````&``Y````O0`2
M``T``0`:````($`:````)D`"`/T`"@`.````&``Z````O0`2``X``0`:````
M",`:````%,`"`/T`"@`/````&``[````O0`2``\``0`:````-$`:````$$`"
M`/T`"@`0````&``\````O0`2`!```0`;```@A4`;```0@$`"`/T`"@`1````
M&``]````O0`2`!$``0`:``#`64`:````3T`"`/T`"@`2````&``^````O0`2
M`!(``0`<``#H@4`<``!`?$`"`/T`"@`3````&``_````O0`2`!,``0`>``'@
M9T`>``'@8D`"`/T`"@`4````&`!`````O0`2`!0``0`>``&@9T`>``'@8D`"
M`/T`"@`5````&`!!````O0`2`!4``0`:`!YAA4<:`.;Z+T<"`/T`"@`6````
M&`!"````O0`2`!8``0`:`#IQ8$@:`'YXAT<"`-<`,@#,!```N`$.`"H`#@`D
M`"0`)``D`"0`)``D`"0`#@`D`"0`)``D`"0`)``D`"0`)``D`#X"$@"V````
M``!```````````````"@``0`9`!D`!T`#P`#`````````0````````#O``8`
M```W````"@````D($```!A``1AC-!\&````&`@``"P(8````````````*```
M``````#[2P$``TX!``T``@`!``P``@!D``\``@`!`!$``@```!``"`#\J?'2
M36)0/U\``@`!`"H``@```"L``@```((``@`!`(``"````````````"4"!```
M`/\`@0`"`,$$%````!4```"#``(```"$``(```"A`"(`"0!D``$``0`!`$8`
M6`)8`@```````.`_````````X#\!`%4``@`(`'T`#```````MCP/````!`!]
M``P``0`"`+88#P````0`?0`,``,`_P`D"0\````$```"#@``````*```````
M`P````@"$`````````#_`````````0\`"`(0``$````"`/\````````!#P`(
M`A```@``````_P````````$/``@"$``#`````@#_`````````0\`"`(0``0`
M`````/\````````!#P`(`A``!0````(`_P````````$/``@"$``&`````@#_
M`````````0\`"`(0``<````"`/\````````!#P`(`A``"`````(`_P``````
M``$/``@"$``)`````@#_`````````0\`"`(0``H````"`/\````````!#P`(
M`A``"P````(`_P````````$/``@"$``,`````@#_`````````0\`"`(0``T`
M`````/\````````!#P`(`A``#@````(`_P````````$/``@"$``/`````@#_
M`````````0\`"`(0`!`````"`/\````````!#P`(`A``$0````(`_P``````
M``$/``@"$``2`````@#_`````````0\`"`(0`!,````"`/\````````!#P`(
M`A``%`````(`_P````````$/``@"$``5``````#_`````````0\`"`(0`!8`
M```"`/\````````!#P`(`A``%P````(`_P````````$/``@"$``8`````@#_
M`````````0\`"`(0`!D````"`/\````````!#P`(`A``&@````(`_P``````
M``$/``@"$``;`````@#_`````````0\`"`(0`!P````"`/\````````!#P`(
M`A``'0``````_P````````$/``@"$``>`````@#_`````````0\`"`(0`!\`
M```"`/\````````!#P#]``H``````!<`0P```/T`"@`!````%P`!````_0`*
M``$``0`7`"P```#]``H``0`"`!<`+0```/T`"@`"````%@!$````_0`*``,`
M```8`#X```"]`!(``P`!`!D``.B!0!D``$!\0`(`_0`*``0````6`$4```#]
M``H`!0```!@`1@```+T`$@`%``$`&@``@$E`&@```$9``@#]``H`!@```!@`
M-````+T`$@`&``$`&@```"9`&@```!Q``@#]``H`!P```!@`1P```+T`$@`'
M``$`&@```#)`&@```#=``@#]``H`"````!@`2````+T`$@`(``$`&@````!`
M&@````#``@#]``H`"0```!@`20```+T`$@`)``$`&@```#5`&@```%-``@#]
M``H`"@```!@`2@```+T`$@`*``$`&@```"[`&@```$)``@#]``H`"P```!@`
M2P```+T`$@`+``$`&@```!#`&@```$3``@#]``H`#````!@`.P```+T`$@`,
M``$`&@````!`&@````A``@#]``H`#0```!8`3````/T`"@`.````&`!-````
MO0`2``X``0`:``!@8<`:``!`7<`"`/T`"@`/````&``(````O0`2``\``0`:
M````(L`:``"`1<`"`/T`"@`0````&``1````O0`2`!```0`:````+L`:````
M0L`"`/T`"@`1````&``4````O0`2`!$``0`:````',`:````,T`"`/T`"@`2
M````&``7````O0`2`!(``0`:````7<`:````-L`"`/T`"@`3````&``;````
MO0`2`!,``0`:````+D`:````(D`"`/T`"@`4````&`!.````O0`2`!0``0`;
M``!`>$`;``"0>4`"`/T`"@`5````%@!/````_0`*`!8````8`%````"]`!(`
M%@`!`!H``$!1P!H```!*P`(`_0`*`!<````8`%$```"]`!(`%P`!`!H``*!C
MP!H```````(`_0`*`!@````8`%(```"]`!(`&``!`!H``$!<P!H```#POP(`
M_0`*`!D````8`%,```"]`!(`&0`!`!H``,B!P!H``,!NP`(`_0`*`!H````8
M`%0```"]`!(`&@`!`!H``$"`0!H``$!Z0`(`_0`*`!L````8`#L```"]`!(`
M&P`!`!H```#P/QH```````(`_0`*`!P````8`%4```"]`!(`'``!`!L``#!X
MP!L``$!>0`(`_0`*`!T````6`%8```#]``H`'@```!@`5P```+T`$@`>``$`
M&@``@%-`&@``0%Q``@#]``H`'P```!@`6````+T`$@`?``$`&@``````&@``
M`/"_`@#7`$0`@@8``&P"#@`J``X`)``.`"0`)``D`"0`)``D`"0`)``.`"0`
M)``D`"0`)``D`"0`#@`D`"0`)``D`"0`)``D``X`)``(`A``(`````(`_P``
M``````$/``@"$``A`````@#_`````````0\`"`(0`"(````"`/\````````!
M#P`(`A``(P````(`_P````````$/``@"$``D`````@#_`````````0\`"`(0
M`"4````"`/\````````!#P`(`A``)@````(`_P````````$/``@"$``G````
M`@#_`````````0\`_0`*`"`````8`%D```"]`!(`(``!`!H````BP!H````0
MP`(`_0`*`"$````8`%H```"]`!(`(0`!`!H``(!&0!H````40`(`_0`*`"(`
M```8`%L```"]`!(`(@`!`!H````J0!H```#P/P(`_0`*`",````8`%P```"]
M`!(`(P`!`!L``,!?0!L``(!<0`(`_0`*`"0````8`%T```"]`!(`)``!`!H`
M```8P!H````(P`(`_0`*`"4````8`%X```"]`!(`)0`!`!L``(!>0!L```B$
M0`(`_0`*`"8````8`%\```"]`!(`)@`!`!H``'ZG0!H``"*C0`(`_0`*`"<`
M```8`&````"]`!(`)P`!`!D``'*H0!D``"2H0`(`UP`4`,`!``",`"0`)``D
M`"0`)``D`"0`/@(2`+8``````$```````````````*``!`!D`&0`'0`/``,`
M```````!`````````.\`!@```#<````*````"0@0```&$`!&&,T'P8````8"
M```+`A0````````````$`````````/Y/`0`-``(``0`,``(`9``/``(``0`1
M``(````0``@`_*GQTDUB4#]?``(``0`J``(````K``(```""``(``0"```@`
M```````````E`@0```#_`($``@#!!!0````5````@P`"````A``"````H0`B
M``D`9``!``$``0!&`%@"6`(```````#@/P```````.`_`0!5``(`"`!]``P`
M`````+8\#P````0`?0`,``$``0"V&`\````$`'T`#``"`/\`)`D/````!```
M`@X```````0```````(````(`A``````````_P````````$/``@"$``!````
M`0#_`````````0\`"`(0``(``````/\````````!#P`(`A```P````$`_P``
M``````$/`/T`"@``````%P!A`````0(&``$````7`/T`"@`!``$`%P`L````
M_0`*``(````6`&(```#]``H``P```!@`80```/T`"@`#``$`(0!C````UP`,
M`*`````\``X`&``.`#X"$@"V``````!```````````````"@``0`9`!D`!T`
M#P`#`````````0````````#O``8````W````"@````D($```!A``1AC-!\&`
M```&`@``"P(4````````````!`````````#Q40$`#0`"``$`#``"`&0`#P`"
M``$`$0`"````$``(`/RI\=)-8E`_7P`"``$`*@`"````*P`"````@@`"``$`
M@``(````````````)0($````_P"!``(`P004````%0```(,``@```(0``@``
M`*$`(@`)`&0``0`!``$`1@!8`E@"````````X#\```````#@/P$`50`"``@`
M?0`,``````"V/`\````$`'T`#``!``$`MA@/````!`!]``P``@#_`"0)#P``
M``0```(.```````$```````"````"`(0`````````/\````````!#P`(`A``
M`0````$`_P````````$/``@"$``"``````#_`````````0\`"`(0``,````!
M`/\````````!#P#]``H``````!<`9`````$"!@`!````%P#]``H``0`!`!<`
M+````/T`"@`"````%@!B````_0`*``,````8`&0```#]``H``P`!`"$`90``
M`-<`#`"@````/``.`!@`#@`^`A(`M@``````0```````````````H``$`&0`
M9``=``\``P````````$`````````[P`&````-P````H````)"!````80`$88
MS0?!@```!@(```L"%`````````````0`````````Y%,!``T``@`!``P``@!D
M``\``@`!`!$``@```!``"`#\J?'236)0/U\``@`!`"H``@```"L``@```((`
M`@`!`(``"````````````"4"!````/\`@0`"`,$$%````!4```"#``(```"$
M``(```"A`"(`"0!D``$``0`!`$8`6`)8`@```````.`_````````X#\!`%4`
M`@`(`'T`#```````MCP/````!`!]``P``0`!`+88#P````0`?0`,``(`_P`D
M"0\````$```"#@``````!````````@````@"$`````````#_`````````0\`
M"`(0``$````!`/\````````!#P`(`A```@``````_P````````$/``@"$``#
M`````0#_`````````0\`_0`*```````7`&8````!`@8``0```!<`_0`*``$`
M`0`7`"P```#]``H``@```!8`8@```/T`"@`#````&`!G````_0`*``,``0`A
M`&@```#7``P`H````#P`#@`8``X`/@(2`+8``````$```````````````*``
M!`!D`&0`'0`/``,````````!`````````.\`!@```#<````*````"0@0```&
M$`!&&,T'P8````8"```+`A0````````````$`````````-=5`0`-``(``0`,
M``(`9``/``(``0`1``(````0``@`_*GQTDUB4#]?``(``0`J``(````K``(`
M``""``(``0"```@````````````E`@0```#_`($``@#!!!0````5````@P`"
M````A``"````H0`B``D`9``!``$``0!&`%@"6`(```````#@/P```````.`_
M`0!5``(`"`!]``P``````+8\#P````0`?0`,``$``0"V&`\````$`'T`#``"
M`/\`)`D/````!````@X```````0```````(````(`A``````````_P``````
M``$/``@"$``!`````0#_`````````0\`"`(0``(``````/\````````!#P`(
M`A```P````$`_P````````$/`/T`"@``````%P!I`````0(&``$````7`/T`
M"@`!``$`%P`L````_0`*``(````6`&(```#]``H``P```!@`:0```/T`"@`#
M``$`(0!J````UP`,`*`````\``X`&``.`#X"$@"V``````!`````````````
M``"@``0`9`!D`!T`#P`#`````````0````````#O``8````W````"@````D(
M$```!A``1AC-!\&````&`@``"P(4````````````!`````````#*5P$`#0`"
M``$`#``"`&0`#P`"``$`$0`"````$``(`/RI\=)-8E`_7P`"``$`*@`"````
M*P`"````@@`"``$`@``(````````````)0($````_P"!``(`P004````%0``
M`(,``@```(0``@```*$`(@`)`&0``0`!``$`1@!8`E@"````````X#\`````
M``#@/P$`50`"``@`?0`,``````"V/`\````$`'T`#``!``$`MA@/````!`!]
M``P``@#_`"0)#P````0```(.```````$```````"````"`(0`````````/\`
M```````!#P`(`A```0````$`_P````````$/``@"$``"``````#_````````
M`0\`"`(0``,````!`/\````````!#P#]``H``````!<`:P````$"!@`!````
M%P#]``H``0`!`!<`+````/T`"@`"````%@!B````_0`*``,````8`&L```#]
M``H``P`!`"$`;````-<`#`"@````/``.`!@`#@`^`A(`M@``````0```````
M````````H``$`&0`9``=``\``P````````$`````````[P`&````-P````H`
M```)"!````80`$88S0?!@```!@(```L"%`````````````0`````````O5D!
M``T``@`!``P``@!D``\``@`!`!$``@```!``"`#\J?'236)0/U\``@`!`"H`
M`@```"L``@```((``@`!`(``"````````````"4"!````/\`@0`"`,$$%```
M`!4```"#``(```"$``(```"A`"(`"0!D``$``0`!`$8`6`)8`@```````.`_
M````````X#\!`%4``@`(`'T`#```````MCP/````!`!]``P``0`!`+88#P``
M``0`?0`,``(`_P`D"0\````$```"#@``````!````````@````@"$```````
M``#_`````````0\`"`(0``$````!`/\````````!#P`(`A```@``````_P``
M``````$/``@"$``#`````0#_`````````0\`_0`*```````7`&T````!`@8`
M`0```!<`_0`*``$``0`7`"P```#]``H``@```!8`8@```/T`"@`#````&`!M
M````_0`*``,``0`A`&X```#7``P`H````#P`#@`8``X`/@(2`+8``````$``
M`````````````*``!`!D`&0`'0`/``,````````!`````````.\`!@```#<`
M```*````"0@0```&$`!&&,T'P8````8"```+`A0````````````$````````
M`+!;`0`-``(``0`,``(`9``/``(``0`1``(````0``@`_*GQTDUB4#]?``(`
M`0`J``(````K``(```""``(``0"```@````````````E`@0```#_`($``@#!
M!!0````5````@P`"````A``"````H0`B``D`9``!``$``0!&`%@"6`(`````
M``#@/P```````.`_`0!5``(`"`!]``P``````+8\#P````0`?0`,``$``0"V
M&`\````$`'T`#``"`/\`)`D/````!````@X```````0```````(````(`A``
M````````_P````````$/``@"$``!`````0#_`````````0\`"`(0``(`````
M`/\````````!#P`(`A```P````$`_P````````$/`/T`"@``````%P!O````
M`0(&``$````7`/T`"@`!``$`%P`L````_0`*``(````6`&(```#]``H``P``
M`!@`;P```/T`"@`#``$`(0!P````UP`,`*`````\``X`&``.`#X"$@"V````
M``!```````````````"@``0`9`!D`!T`#P`#`````````0````````#O``8`
M```W````"@````D($```!A``1AC-!\&````&`@``"P(4````````````!```
M``````"C70$`#0`"``$`#``"`&0`#P`"``$`$0`"````$``(`/RI\=)-8E`_
M7P`"``$`*@`"````*P`"````@@`"``$`@``(````````````)0($````_P"!
M``(`P004````%0```(,``@```(0``@```*$`(@`)`&0``0`!``$`1@!8`E@"
M````````X#\```````#@/P$`50`"``@`?0`,``````"V/`\````$`'T`#``!
M``$`MA@/````!`!]``P``@#_`"0)#P````0```(.```````$```````"````
M"`(0`````````/\````````!#P`(`A```0````$`_P````````$/``@"$``"
M``````#_`````````0\`"`(0``,````!`/\````````!#P#]``H``````!<`
M<0````$"!@`!````%P#]``H``0`!`!<`+````/T`"@`"````%@!B````_0`*
M``,````8`'$```#]``H``P`!`"$`<@```-<`#`"@````/``.`!@`#@`^`A(`
MM@``````0```````````````H``$`&0`9``=``\``P````````$`````````
M[P`&````-P````H````)"!````80`$88S0?!@```!@(```L"%```````````
M``0`````````EE\!``T``@`!``P``@!D``\``@`!`!$``@```!``"`#\J?'2
M36)0/U\``@`!`"H``@```"L``@```((``@`!`(``"````````````"4"!```
M`/\`@0`"`,$$%````!4```"#``(```"$``(```"A`"(`"0!D``$``0`!`$8`
M6`)8`@```````.`_````````X#\!`%4``@`(`'T`#```````MCP/````!`!]
M``P``0`!`+88#P````0`?0`,``(`_P`D"0\````$```"#@``````!```````
M`@````@"$`````````#_`````````0\`"`(0``$````!`/\````````!#P`(
M`A```@``````_P````````$/``@"$``#`````0#_`````````0\`_0`*````
M```7`',````!`@8``0```!<`_0`*``$``0`7`"P```#]``H``@```!8`8@``
M`/T`"@`#````&`!S````_0`*``,``0`A`'0```#7``P`H````#P`#@`8``X`
M/@(2`+8``````$```````````````*``!`!D`&0`'0`/``,````````!````
M`````.\`!@```#<````*````"0@0```&$`!&&,T'P8````8"```+`A0`````
M```````$`````````(EA`0`-``(``0`,``(`9``/``(``0`1``(````0``@`
M_*GQTDUB4#]?``(``0`J``(````K``(```""``(``0"```@````````````E
M`@0```#_`($``@#!!!0````5````@P`"````A``"````H0`B``D`9``!``$`
M`0!&`%@"6`(```````#@/P```````.`_`0!5``(`"`!]``P``````+8\#P``
M``0`?0`,``$``0"V&`\````$`'T`#``"`/\`)`D/````!````@X```````0`
M``````(````(`A``````````_P````````$/``@"$``!`````0#_````````
M`0\`"`(0``(``````/\````````!#P`(`A```P````$`_P````````$/`/T`
M"@``````%P!U`````0(&``$````7`/T`"@`!``$`%P`L````_0`*``(````6
M`&(```#]``H``P```!@`=0```/T`"@`#``$`(0!V````UP`,`*`````\``X`
M&``.`#X"$@"V``````!```````````````"@``0`9`!D`!T`#P`#````````
M`0````````#O``8````W````"@````D($```!A``1AC-!\&````&`@``"P(4
M````````````!`````````!\8P$`#0`"``$`#``"`&0`#P`"``$`$0`"````
M$``(`/RI\=)-8E`_7P`"``$`*@`"````*P`"````@@`"``$`@``(````````
M````)0($````_P"!``(`P004````%0```(,``@```(0``@```*$`(@`)`&0`
M`0`!``$`1@!8`E@"````````X#\```````#@/P$`50`"``@`?0`,``````"V
M/`\````$`'T`#``!``$`MA@/````!`!]``P``@#_`"0)#P````0```(.````
M```$```````"````"`(0`````````/\````````!#P`(`A```0````$`_P``
M``````$/``@"$``"``````#_`````````0\`"`(0``,````!`/\````````!
M#P#]``H``````!<`=P````$"!@`!````%P#]``H``0`!`!<`+````/T`"@`"
M````%@!B````_0`*``,````8`'@```#]``H``P`!`"$`>0```-<`#`"@````
M/``.`!@`#@`^`A(`M@``````0```````````````H``$`&0`9``=``\``P``
M``````$`````````[P`&````-P````H````)"!````80`$88S0?!@```!@(`
M``L"%`````````````0`````````;V4!``T``@`!``P``@!D``\``@`!`!$`
M`@```!``"`#\J?'236)0/U\``@`!`"H``@```"L``@```((``@`!`(``"```
M`````````"4"!````/\`@0`"`,$$%````!4```"#``(```"$``(```"A`"(`
M"0!D``$``0`!`$8`6`)8`@```````.`_````````X#\!`%4``@`(`'T`#```
M````MCP/````!`!]``P``0`!`+88#P````0`?0`,``(`_P`D"0\````$```"
M#@``````!````````@````@"$`````````#_`````````0\`"`(0``$````!
M`/\````````!#P`(`A```@``````_P````````$/``@"$``#`````0#_````
M`````0\`_0`*```````7`'H````!`@8``0```!<`_0`*``$``0`7`"P```#]
M``H``@```!8`8@```/T`"@`#````&`!Z````_0`*``,``0`A`'L```#7``P`
MH````#P`#@`8``X`/@(2`+8``````$```````````````*``!`!D`&0`'0`/
M``,````````!`````````.\`!@```#<````*````"0@0```&$`!&&,T'P8``
M``8"```+`A0````````````$`````````&)G`0`-``(``0`,``(`9``/``(`
M`0`1``(````0``@`_*GQTDUB4#]?``(``0`J``(````K``(```""``(``0"`
M``@````````````E`@0```#_`($``@#!!!0````5````@P`"````A``"````
MH0`B``D`9``!``$``0!&`%@"6`(```````#@/P```````.`_`0!5``(`"`!]
M``P``````+8\#P````0`?0`,``$``0"V&`\````$`'T`#``"`/\`)`D/````
M!````@X```````0```````(````(`A``````````_P````````$/``@"$``!
M`````0#_`````````0\`"`(0``(``````/\````````!#P`(`A```P````$`
M_P````````$/`/T`"@``````%P!\`````0(&``$````7`/T`"@`!``$`%P`L
M````_0`*``(````6`&(```#]``H``P```!@`?0```/T`"@`#``$`(0!^````
MUP`,`*`````\``X`&``.`#X"$@"V``````!```````````````"@``0`9`!D
M`!T`#P`#`````````0````````#O``8````W````"@````D($```!A``1AC-
M!\&````&`@``"P(4````````````!`````````!5:0$`#0`"``$`#``"`&0`
M#P`"``$`$0`"````$``(`/RI\=)-8E`_7P`"``$`*@`"````*P`"````@@`"
M``$`@``(````````````)0($````_P"!``(`P004````%0```(,``@```(0`
M`@```*$`(@`)`&0``0`!``$`1@!8`E@"````````X#\```````#@/P$`50`"
M``@`?0`,``````"V/`\````$`'T`#``!``$`MA@/````!`!]``P``@#_`"0)
M#P````0```(.```````$```````"````"`(0`````````/\````````!#P`(
M`A```0````$`_P````````$/``@"$``"``````#_`````````0\`"`(0``,`
M```!`/\````````!#P#]``H``````!<`?P````$"!@`!````%P#]``H``0`!
M`!<`+````/T`"@`"````%@!B````_0`*``,````8`'\```#]``H``P`!`"$`
M@````-<`#`"@````/``.`!@`#@`^`A(`M@``````0```````````````H``$
M`&0`9``=``\``P````````$`````````[P`&````-P````H````)"!````80
M`$88S0?!@```!@(```L"%`````````````8`````````J&L!``T``@`!``P`
M`@!D``\``@`!`!$``@```!``"`#\J?'236)0/U\``@`!`"H``@```"L``@``
M`((``@`!`(``"````````````"4"!````/\`@0`"`,$$%````!4```"#``(`
M``"$``(```"A`"(`"0!D``$``0`!`$8`6`)8`@```````.`_````````X#\!
M`%4``@`(`'T`#```````MCP/````!`!]``P``0`!`+88#P````0`?0`,``(`
M_P`D"0\````$```"#@``````!@```````@````@"$`````````#_````````
M`0\`"`(0``$````!`/\````````!#P`(`A```@``````_P````````$/``@"
M$``#`````0#_`````````0\`"`(0``0````!`/\````````!#P`(`A``!0``
M``$`_P````````$/`/T`"@``````%P"!`````0(&``$````7`/T`"@`!``$`
M%P`L````_0`*``(````6`((```#]``H``P```!@`@P```/T`"@`#``$`(0"$
M````_0`*``0````8`(4```#]``H`!``!`"$`A@```/T`"@`%````&`"'````
M_0`*``4``0`A`(@```#7`!````$``&0`#@`8``X`'``<`#X"$@"V``````!`
M``````````````"@``0`9`!D`!T`#P`#`````````0````````#O``8````W
M````"@````D($```!A``1AC-!\&````&`@``"P(4````````````#@``````
M``"#;P$`#0`"``$`#``"`&0`#P`"``$`$0`"````$``(`/RI\=)-8E`_7P`"
M``$`*@`"````*P`"````@@`"``$`@``(````````````)0($````_P"!``(`
MP004````%0```(,``@```(0``@```*$`(@`)`&0``0`!``$`1@!8`E@"````
M````X#\```````#@/P$`50`"``@`?0`,``````"V/`\````$`'T`#``!``$`
MMA@/````!`!]``P``@#_`"0)#P````0```(.```````.```````"````"`(0
M`````````/\````````!#P`(`A```0````$`_P````````$/``@"$``"````
M``#_`````````0\`"`(0``,````!`/\````````!#P`(`A``!`````$`_P``
M``````$/``@"$``%`````0#_`````````0\`"`(0``8````!`/\````````!
M#P`(`A``!P````$`_P````````$/``@"$``(`````0#_`````````0\`"`(0
M``D````!`/\````````!#P`(`A``"@````$`_P````````$/``@"$``+````
M`0#_`````````0\`"`(0``P````!`/\````````!#P`(`A``#0````$`_P``
M``````$/`/T`"@``````%P")`````0(&``$````7`/T`"@`!``$`%P`L````
M_0`*``(````6`(H```#]``H``P```!@`BP```/T`"@`#``$`(0",````_0`*
M``0````8`(T```#]``H`!``!`"$`C@```/T`"@`%````&`"/````_0`*``4`
M`0`A`)````#]``H`!@```!@`D0```/T`"@`&``$`(0"2````_0`*``<````8
M`),```#]``H`!P`!`"$`D@```/T`"@`(````&`"4````_0`*``@``0`A`)4`
M``#]``H`"0```!@`E@```/T`"@`)``$`(0"7````_0`*``H````8`)@````#
M`@X`"@`!`!D````0*NX7!4+]``H`"P```!@`F0```'X""@`+``$`&@"VM91'
M_0`*``P````8`)H```!^`@H`#``!`!H``&B?0/T`"@`-````&`";````_0`*
M``T``0`A`)P```#7`"``A`(```0!#@`8``X`'``<`!P`'``<`!P`'``@`!P`
M'``^`A(`M@``````0```````````````H``$`&0`9``=``\``P````````$`
M````````[P`&````-P````H`````````````````````````````````````
M``$```#^____`P````0```#^____________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M____________________________________________________________
M_________________________O\```4"`@```````````````````````0``
M`."%G_+Y3V@0JY$(`"LGL]DP````4`````,````!````*````````(`P````
M!````#@```````````````(```"P!```$P````D$```?````"````',`<P!H
M`'@`8@!R`&P```#^_P``!0("```````````````````````"`````M7-U9PN
M&Q"3EP@`*RSYKD0````%U<W5G"X;$).7"``K+/FN;````"@````"`````0``
M`!@```````"`(`````(```"P!```$P````D$```T`````P`````````@````
M`0```"0```````"`+``````````"````L`0``!,````)!```````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
C````````````````````````````````````````````````
`
end

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R7.xml
<DESCRIPTION>IDEA: Cash Flows-Supplemental Disclosure
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<InstanceReport xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <Version>2.0.0.10</Version>
  <hasSegments>false</hasSegments>
  <ReportName>Cash Flows-Supplemental Disclosure</ReportName>
  <ReportLongName>006030 - Disclosure - Cash Flows-Supplemental Disclosure</ReportLongName>
  <DisplayLabelColumn>true</DisplayLabelColumn>
  <ShowElementNames>false</ShowElementNames>
  <RoundingOption />
  <HasEmbeddedReports>false</HasEmbeddedReports>
  <Columns>
    <Column>
      <LabelColumn>false</LabelColumn>
      <Id>1</Id>
      <Labels>
        <Label Id="1" Label="3 Months Ended" />
        <Label Id="2" Label="Mar. 31, 2010" />
      </Labels>
      <CurrencyCode>usd</CurrencyCode>
      <CurrencySymbol>$</CurrencySymbol>
      <FootnoteIndexer />
      <hasSegments>false</hasSegments>
      <hasScenarios>false</hasScenarios>
      <Segments />
      <Scenarios />
      <Units>
        <Unit>
          <UnitID>u000</UnitID>
          <UnitType>Standard</UnitType>
          <StandardMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/iso4217</MeasureSchema>
            <MeasureValue>USD</MeasureValue>
            <MeasureNamespace>iso4217</MeasureNamespace>
          </StandardMeasure>
          <Scale>0</Scale>
        </Unit>
        <Unit>
          <UnitID>u001</UnitID>
          <UnitType>Standard</UnitType>
          <StandardMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/instance</MeasureSchema>
            <MeasureValue>shares</MeasureValue>
            <MeasureNamespace>xbrli</MeasureNamespace>
          </StandardMeasure>
          <Scale>0</Scale>
        </Unit>
        <Unit>
          <UnitID>u002</UnitID>
          <UnitType>Divide</UnitType>
          <NumeratorMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/iso4217</MeasureSchema>
            <MeasureValue>USD</MeasureValue>
            <MeasureNamespace>iso4217</MeasureNamespace>
          </NumeratorMeasure>
          <DenominatorMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/instance</MeasureSchema>
            <MeasureValue>shares</MeasureValue>
            <MeasureNamespace>xbrli</MeasureNamespace>
          </DenominatorMeasure>
          <Scale>0</Scale>
        </Unit>
      </Units>
    </Column>
  </Columns>
  <Rows>
    <Row>
      <Id>2</Id>
      <Label>Notes to Financial Statements [Abstract]</Label>
      <Level>0</Level>
      <ElementName>acl_NotesToFinancialStatementsAbstract</ElementName>
      <ElementPrefix>acl</ElementPrefix>
      <IsBaseElement>false</IsBaseElement>
      <BalanceType>na</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>string</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>true</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>false</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>No definition available.</ElementDefenition>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>3</Id>
      <Label>Cash Flows-Supplemental Disclosures</Label>
      <Level>1</Level>
      <ElementName>us-gaap_CashFlowSupplementalDisclosuresTextBlock</ElementName>
      <ElementPrefix>us-gaap</ElementPrefix>
      <IsBaseElement>true</IsBaseElement>
      <BalanceType>na</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>string</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole>terselabel</PreferredLabelRole>
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>false</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText>&lt;div&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr valign="top"&gt;&lt;td style="WIDTH: 18pt" align="right"&gt;&lt;div&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;(3)&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Cash Flows &amp;#8211; Supplemental Disclosure&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;(in millions, except per share data)&lt;/font&gt;&lt;/font&gt;&lt;br /&gt;&lt;/div&gt;&lt;div align="left"&gt;&lt;table style="FONT-SIZE: 10p
t; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="6"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Three months ended March 31,&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&l
t;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2010&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt" valign="bottom"&gt;&lt;font style="DISP
LAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 0.5pt solid" valign="bottom" colspan="2"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="center"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;2009&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 0.5pt; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Supplemental Disclosure of Cash Flow Information&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td v
align="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" align="left"&gt;&lt;div
 style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Cash paid during the period for the following:&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/f
ont&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan="2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" colspan=
"2"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Interest expense, net of amount capitalized&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMI
LY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;3&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMI
LY: times new roman"&gt;5&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" widt
h="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="left" width="76%"&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 27pt; MARGIN-RIGHT: 0pt" a
lign="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;Income taxes&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align="right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;23&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px" valign="bottom" align=
"right" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;$&lt;/font&gt;&lt;/td&gt;&lt;td style="BORDER-BOTTOM: black 4px double; TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;62&lt;/font&gt;&lt;/td&gt;&lt;td style="PADDING-BOTTOM: 4px; TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td valign="bottom" width="76%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160; &lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10
pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: right" valign="bottom" width="9%"&gt;&l
t;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;td style="TEXT-ALIGN: left" valign="bottom" nowrap="nowrap" width="1%"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: times new roman"&gt;&amp;#160;&lt;/font&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</NonNumbericText>
          <NonNumericTextHeader>(3)&amp;#160;&amp;#160;Cash Flows &amp;#8211; Supplemental Disclosure(in millions, except per share data)&amp;#160; &amp;#160;Three months ended March 31,&amp;#160;&amp;#160;</NonNumericTextHeader>
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>Designated to encapsulate the entire footnote disclosure that provides information on the supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</ElementDefenition>
      <ElementReferences>Reference 1: http://www.xbrl.org/2003/role/presentationRef
 -Publisher FASB
 -Name Statement of Financial Accounting Standard (FAS)
 -Number 95
 -Paragraph 32

</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
  </Rows>
  <Footnotes />
  <ComparabilityReport>false</ComparabilityReport>
  <NumberOfCols>1</NumberOfCols>
  <NumberOfRows>2</NumberOfRows>
  <HasScenarios>false</HasScenarios>
  <MonetaryRoundingLevel>UnKnown</MonetaryRoundingLevel>
  <SharesRoundingLevel>UnKnown</SharesRoundingLevel>
  <PerShareRoundingLevel>UnKnown</PerShareRoundingLevel>
  <HasPureData>false</HasPureData>
  <SharesShouldBeRounded>true</SharesShouldBeRounded>
</InstanceReport>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R17.xml
<DESCRIPTION>IDEA: Proposed Change of Control
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<InstanceReport xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <Version>2.0.0.10</Version>
  <hasSegments>false</hasSegments>
  <ReportName>Proposed Change of Control</ReportName>
  <ReportLongName>006130 - Disclosure - Proposed Change of Control</ReportLongName>
  <DisplayLabelColumn>true</DisplayLabelColumn>
  <ShowElementNames>false</ShowElementNames>
  <RoundingOption />
  <HasEmbeddedReports>false</HasEmbeddedReports>
  <Columns>
    <Column>
      <LabelColumn>false</LabelColumn>
      <Id>1</Id>
      <Labels>
        <Label Id="1" Label="3 Months Ended" />
        <Label Id="2" Label="Mar. 31, 2010" />
      </Labels>
      <CurrencyCode>usd</CurrencyCode>
      <CurrencySymbol>$</CurrencySymbol>
      <FootnoteIndexer />
      <hasSegments>false</hasSegments>
      <hasScenarios>false</hasScenarios>
      <Segments />
      <Scenarios />
      <Units>
        <Unit>
          <UnitID>u000</UnitID>
          <UnitType>Standard</UnitType>
          <StandardMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/iso4217</MeasureSchema>
            <MeasureValue>USD</MeasureValue>
            <MeasureNamespace>iso4217</MeasureNamespace>
          </StandardMeasure>
          <Scale>0</Scale>
        </Unit>
        <Unit>
          <UnitID>u001</UnitID>
          <UnitType>Standard</UnitType>
          <StandardMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/instance</MeasureSchema>
            <MeasureValue>shares</MeasureValue>
            <MeasureNamespace>xbrli</MeasureNamespace>
          </StandardMeasure>
          <Scale>0</Scale>
        </Unit>
        <Unit>
          <UnitID>u002</UnitID>
          <UnitType>Divide</UnitType>
          <NumeratorMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/iso4217</MeasureSchema>
            <MeasureValue>USD</MeasureValue>
            <MeasureNamespace>iso4217</MeasureNamespace>
          </NumeratorMeasure>
          <DenominatorMeasure>
            <MeasureSchema>http://www.xbrl.org/2003/instance</MeasureSchema>
            <MeasureValue>shares</MeasureValue>
            <MeasureNamespace>xbrli</MeasureNamespace>
          </DenominatorMeasure>
          <Scale>0</Scale>
        </Unit>
      </Units>
    </Column>
  </Columns>
  <Rows>
    <Row>
      <Id>2</Id>
      <Label>Notes to Financial Statements [Abstract]</Label>
      <Level>0</Level>
      <ElementName>acl_NotesToFinancialStatementsAbstract</ElementName>
      <ElementPrefix>acl</ElementPrefix>
      <IsBaseElement>false</IsBaseElement>
      <BalanceType>na</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>string</ElementDataType>
      <ShortDefinition>No definition available.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>true</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>false</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText />
          <NonNumericTextHeader />
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>No definition available.</ElementDefenition>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
    <Row>
      <Id>3</Id>
      <Label>Proposed change of control</Label>
      <Level>1</Level>
      <ElementName>acl_ProposedChangeOfControl</ElementName>
      <ElementPrefix>acl</ElementPrefix>
      <IsBaseElement>false</IsBaseElement>
      <BalanceType>na</BalanceType>
      <PeriodType>duration</PeriodType>
      <ElementDataType>string</ElementDataType>
      <ShortDefinition>This element describes the impact of a proposed change of control of the reporting entity.</ShortDefinition>
      <IsReportTitle>false</IsReportTitle>
      <IsSegmentTitle>false</IsSegmentTitle>
      <IsSubReportEnd>false</IsSubReportEnd>
      <IsCalendarTitle>false</IsCalendarTitle>
      <IsTuple>false</IsTuple>
      <IsAbstractGroupTitle>false</IsAbstractGroupTitle>
      <IsEquityPrevioslyReportedAsRow>false</IsEquityPrevioslyReportedAsRow>
      <IsEquityAdjustmentRow>false</IsEquityAdjustmentRow>
      <IsBeginningBalance>false</IsBeginningBalance>
      <IsEndingBalance>false</IsEndingBalance>
      <IsReverseSign>false</IsReverseSign>
      <PreferredLabelRole />
      <IsEPS>false</IsEPS>
      <FootnoteIndexer />
      <Cells>
        <Cell>
          <Id>1</Id>
          <ShowCurrencySymbol>false</ShowCurrencySymbol>
          <IsNumeric>false</IsNumeric>
          <IsRatio>false</IsRatio>
          <DisplayZeroAsNone>false</DisplayZeroAsNone>
          <NumericAmount>0</NumericAmount>
          <RoundedNumericAmount>0</RoundedNumericAmount>
          <NonNumbericText>&lt;div&gt;&lt;table style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman" cellspacing="0" cellpadding="0" width="100%"&gt;&lt;tr valign="top"&gt;&lt;td style="WIDTH: 18pt" align="right"&gt;&lt;div&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;(13)&amp;#160;&amp;#160;&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;td&gt;&lt;div style="MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="justify"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Proposed Change of Control&lt;/font&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;font style="DISPLAY: inline; FONT-WEIGHT: bold"&gt;&lt;font style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;(in millions, except per share data)&lt;/font&gt;&lt;/font&gt;&lt;br /&gt;&amp;#160;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18
pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;On April 6, 2008, Nestl&amp;#233; and Novartis executed the Purchase and Option Agreement pursuant to which Nestl&amp;#233; agreed to sell approximately 74 million of its shares of Alcon common stock to Novartis in a cash transaction at a price of $143.18 per share.&amp;#160;&amp;#160;This sale was consummated on July 7, 2008, and Novartis now owns a minority stake in Alcon of slightly less than 25% of Alcon's outstanding shares, while Nestl&amp;#233; remains Alcon's majority shareholder with approximately 156 million Alcon shares comprising approximately 52% of the Company's outstanding shares.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font styl
e="MARGIN-LEFT: 18pt"&gt;&lt;/font&gt;The Purchase and Option Agreement between Nestl&amp;#233; and Novartis also contains put and call option rights on the balance of approximately 156 million Alcon shares owned by Nestl&amp;#233;.&amp;#160;&amp;#160;The option rights commenced on January 1, 2010 and expire on July 31, 2011.&amp;#160;&amp;#160;As outlined by the two parties, these rights grant (i) Novartis a call option to buy all but 4.1 million (or 2.5%) of Nestl&amp;#233;'s remaining Alcon shares at a fixed price of $181 per share and the 4.1 million shares at the first stage price of $143.18 per share, and (ii) Nestl&amp;#233; a put option to sell to Novartis all but 4.1 million of its remaining Alcon shares to Novartis at the lower of Novartis's call price of $181 per share or a premium of approximately 20.5% above the then-market price of Alcon shares, which will be calculated as the average market price of Alcon shares during the five trading days immediately preceding the exercise date of the put op
tion, with the 4.1 million share balance to be sold at the first stage closing price of $143.18 per share.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;On January 4, 2010, Novartis announced that it had exercised its option to purchase the remaining approximately 156 million Alcon shares owned by Nestl&amp;#233; at a weighted average price of $180 per share in cash, pursuant to the Purchase and Option Agreement.&amp;#160;&amp;#160;Upon consummation of the purchase, Novartis would own an approximate 77% interest in Alcon.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FO
NT-FAMILY: Times New Roman"&gt;The consummation of a purchase and sale transaction under the option right is subject to regulatory approvals.&amp;#160;&amp;#160;The consummation would trigger certain change of control provisions in the Company's share-based awards plan (including the vesting of certain outstanding share-based awards), certain retirement plans for Company employees and other agreements.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Upon consummation, the Company will no longer benefit from certain synergies as a result of Nestl&amp;#233;'s ownership.&amp;#160;&amp;#160;Alcon has taken advantage of the synergies in several functional areas.&amp;#160;&amp;#160;Management does not anticipate a significant financial impact to Alcon due to the loss of these syne
rgies because the Company is currently negotiating with certain vendors/suppliers and financial services providers to mitigate any potential impact from a change of control.&amp;#160;&amp;#160;However, no assurances can be made at this time.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;As a result of Novartis's planned acquisition of Nestl&amp;#233;'s remaining Alcon shares, Alcon's relationships with third parties in the pharmaceutical and other industries may be impacted, which in some cases may affect Alcon's business development and licensing opportunities.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 18pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font st
yle="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;Novartis also announced that it submitted to the Alcon board of directors a proposal for a merger of Alcon with and into Novartis to be effected under Swiss merger law.&amp;#160;&amp;#160;Under the terms of the merger proposal, holders of the approximate 23% of Alcon shares that are publicly traded would receive 2.8 Novartis shares for each Alcon share.&amp;#160;&amp;#160;The proposed merger would be contingent upon, among other things, approval by the Alcon board of directors, the &lt;/font&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;closing of the purchase and sale transaction related to the Novartis option exercise as well as receipt of required regulatory approvals.&amp;#160;&amp;#160;Upon Novartis becoming a majority shareholder of Alcon, management believes that the Organizational Regulations provide that the Alcon board of directors may only approve the proposed merger if a majority of the
 Independent Director Committee so recommends; however, management cannot predict the outcome of any judicial proceeding that might be initiated to interpret or challenge this position.&lt;/font&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; TEXT-INDENT: 0pt"&gt;&lt;br /&gt;&lt;/div&gt;&lt;div style="DISPLAY: block; MARGIN-LEFT: 0pt; TEXT-INDENT: 0pt; MARGIN-RIGHT: 0pt" align="left"&gt;&lt;font style="DISPLAY: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman"&gt;&lt;font style="MARGIN-LEFT: 18pt"&gt;&lt;/font&gt;The Independent Director Committee was formed in 2008 in connection with Novartis's initial purchase of slightly less than 25% of the Alcon shares from Nestl&amp;#233; to evaluate transactions such as the merger proposed by Novartis.&amp;#160;&amp;#160;The Independent Director Committee engaged independent financial and legal advisors in connection with its evaluation of the proposed merger.&amp;#160;&amp;#160;On January 20, 2010, the Independent Director Committee issued its formal response reje
cting the Novartis merger proposal.&amp;#160;&amp;#160;The committee rejected the merger proposal based on its assessment that the price offered and other terms were not acceptable and that Novartis's merger proposal was not in the best interests of Alcon and its minority shareholders.&lt;/font&gt;&lt;/div&gt;</NonNumbericText>
          <NonNumericTextHeader>(13)&amp;#160;&amp;#160;Proposed Change of Control(in millions, except per share data)&amp;#160;On April 6, 2008, Nestl&amp;#233; and Novartis executed the Purchase and Option</NonNumericTextHeader>
          <FootnoteIndexer />
          <hasSegments>false</hasSegments>
          <hasScenarios>false</hasScenarios>
          <DisplayDateInUSFormat>false</DisplayDateInUSFormat>
        </Cell>
      </Cells>
      <OriginalInstanceReportColumns />
      <ElementDefenition>This element describes the impact of a proposed change of control of the reporting entity.</ElementDefenition>
      <ElementReferences>No authoritative reference available.</ElementReferences>
      <IsTotalLabel>false</IsTotalLabel>
    </Row>
  </Rows>
  <Footnotes />
  <ComparabilityReport>false</ComparabilityReport>
  <NumberOfCols>1</NumberOfCols>
  <NumberOfRows>2</NumberOfRows>
  <HasScenarios>false</HasScenarios>
  <MonetaryRoundingLevel>UnKnown</MonetaryRoundingLevel>
  <SharesRoundingLevel>UnKnown</SharesRoundingLevel>
  <PerShareRoundingLevel>UnKnown</PerShareRoundingLevel>
  <HasPureData>false</HasPureData>
  <SharesShouldBeRounded>true</SharesShouldBeRounded>
</InstanceReport>
</XBRL>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
